PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	De Filette, M; Martens, W; Roose, K; Deroo, T; Vervalle, F; Bentahir, M; Vandekerckhove, J; Fiers, W; Saelens, X				De Filette, Marina; Martens, Wouter; Roose, Kenny; Deroo, Tom; Vervalle, Frederik; Bentahir, Mostafa; Vandekerckhove, Joel; Fiers, Walter; Saelens, Xavier			An influenza A vaccine based on tetrameric ectodomain of matrix protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEIN; M2 PROTEIN; VIRUS-REPLICATION; ANTIBODY-RESPONSE; DISULFIDE BONDS; NEURAMINIDASE; ELECTROPHORESIS; HEMAGGLUTININ; RECOMBINANT; EXPRESSION	Matrix protein 2 (M2) of influenza A is a tetrameric type III membrane protein that functions as a proton-selective channel. The extracellular domain (M2e) has remained nearly invariable since the first human influenza strain was isolated in 1933. By linking a modified form of the leucine zipper of the yeast transcription factor GCN4 to M2e, we obtained a recombinant tetrameric protein, M2e-tGCN4. This protein mimics the quaternary structure of the ectodomain of the natural M2 protein. M2e-tGCN4 was purified, biochemically characterized, and used to immunize BALB/c mice. High M2e-specific serum IgG antibody titers were obtained following either intraperitoneal or intranasal administration. Immunized mice were protected fully against a potentially lethal influenza A virus challenge. Antibodies raised by M2e-tGCN4 immunization specifically bound to the surface of influenza-infected cells and to an M2-expressing cell line. Using a M2e peptide competition enzymelinked immunosorbent assay with M2-expressing cells as target, we obtained evidence that M2e-tGCN4 induces antibodies that are specific for the native tetrameric M2 ectodomain. Therefore, fusion of an oligomerization domain to the extracellular part of a transmembrane protein allows it to mimic the natural quaternary structure and can promote the induction of oligomer- specific antibodies.	[De Filette, Marina; Martens, Wouter; Roose, Kenny; Deroo, Tom; Vervalle, Frederik; Bentahir, Mostafa; Fiers, Walter; Saelens, Xavier] Univ Ghent, Dept Mol Biol, Ghent, Belgium; [Vandekerckhove, Joel] Univ Ghent, Dept Biochem, Ghent, Belgium; [De Filette, Marina; Martens, Wouter; Roose, Kenny; Deroo, Tom; Vervalle, Frederik; Fiers, Walter; Saelens, Xavier] Vlaams Inst Biotechnol VIB, Dept Mol Biomed Res, Ghent, Belgium; [Vandekerckhove, Joel] Vlaams Inst Biotechnol VIB, Dept Med Prot Res, Ghent, Belgium	Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB)	Saelens, X (corresponding author), Univ Ghent VIB, Dept Mol Biol Med Res, Technol Pk 927,B9052, Ghent, Belgium.	xavier.saelens@dmbr.ugent.be	Saelens, Xavier/N-5728-2015	, Xavier/0000-0002-3861-6965	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055632] Funding Source: NIH RePORTER; NIAID NIH HHS [5R01AI055632] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLACK RA, 1993, J GEN VIROL, V74, P143, DOI 10.1099/0022-1317-74-1-143; BRYAN JK, 1977, ANAL BIOCHEM, V78, P513, DOI 10.1016/0003-2697(77)90111-7; BUCHER DJ, 1972, J VIROL, V10, P60, DOI 10.1128/JVI.10.1.60-66.1972; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; De Filette M, 2006, VACCINE, V24, P544, DOI 10.1016/j.vaccine.2005.08.061; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; Deroo T, 1996, VACCINE, V14, P561, DOI 10.1016/0264-410X(95)00157-V; Feng JQ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-102; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; LAVER WG, 1969, VIROLOGY, V38, P105, DOI 10.1016/0042-6822(69)90132-9; Liu WL, 2003, FEMS IMMUNOL MED MIC, V35, P141, DOI 10.1016/S0928-8244(03)00009-9; MERTENS N, 1995, GENE, V164, P9, DOI 10.1016/0378-1119(95)00505-Z; Mould JA, 2003, DEV CELL, V5, P175, DOI 10.1016/S1534-5807(03)00190-4; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; WARD CW, 1983, FEBS LETT, V153, P29, DOI 10.1016/0014-5793(83)80113-6; WATERMAN MJ, 1996, NUCLEIC ACIDS RES, V22, P3113; WILEY DC, 1977, VIROLOGY, V79, P446, DOI 10.1016/0042-6822(77)90371-3; ZEBEDEE SL, 1985, J VIROL, V56, P502, DOI 10.1128/JVI.56.2.502-511.1985	27	108	135	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11382	11387		10.1074/jbc.M800650200	http://dx.doi.org/10.1074/jbc.M800650200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18252707	Green Published, hybrid			2022-12-27	WOS:000255067400035
J	Guo, W; Flanagan, J; Jasuja, R; Kirkland, J; Jiang, L; Bhasin, S				Guo, Wen; Flanagan, John; Jasuja, Ravi; Kirkland, James; Jiang, Lan; Bhasin, Shalender			The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; GROSS MUSCLE HYPERTROPHY; SKELETAL-MUSCLE; TGF-BETA; ADIPOCYTE DIFFERENTIATION; WNT; MICE; GENE; PROLIFERATION; INHIBITION	The effects of myostatin on adipogenic differentiation are poorly understood, and the underlying mechanisms are unknown. We determined the effects of human recombinant myostatin protein on adipogenesis of bone marrow-derived human mesenchymal stem cells (hMSCs) and adipose tissue-derived preadipocytes. For both progenitor cell types, differentiation in the presence of myostatin caused a dose-dependent reduction of lipid accumulation and diminished incorporation of exogenous fatty acid into cellular lipids. Myostatin significantly down-regulated the expression of adipocyte markers PPAR gamma, C/EBP alpha, leptin, and aP2, but not C/EBP beta. Overexpression of PPAR gamma, but not C/EBP beta,blocked the inhibitory effects of myostatin on adipogenesis. Myostatin induced phosphorylation of Smad3 in hMSCs; knockdown of Smad3 by RNAi or inhibition of its upstream kinase by an Alk5 inhibitor blocked the inhibitory effect of myostatin on adipogenesis in hMSCs, implying an important role of Smad3 activation in this event. Furthermore, myostatin enhanced nuclear translocation of beta-catenin and formation of the Smad3-beta-catenin-TCF4 complex, together with the altered expression of a number of Wnt/beta-catenin pathway genes in hMSCs. The inhibitory effects of myostatin on adipogenesis were blocked by RNAi silencing of beta-catenin and diminished by overexpression of dominant-negative TCF4. The conclusion is that myostatin inhibited adipogenesis in human bone marrow-derived mesenchymal stem cells and preadipocytes. These effects were mediated, in part, by activation of Smad3 and cross-communication of the TGF beta/Smad signal to Wnt/beta-catenin/TCF4 pathway, leading to down-regulation of PPAR gamma.	[Guo, Wen; Flanagan, John; Jasuja, Ravi; Kirkland, James; Jiang, Lan; Bhasin, Shalender] Boston Univ, Sch Med, Boston Med Ctr, Endocrinol Sect, Boston, MA 02118 USA; [Guo, Wen; Flanagan, John; Jasuja, Ravi; Kirkland, James; Jiang, Lan; Bhasin, Shalender] Boston Univ, Sch Med, Boston Med Ctr, Sect Diabet, Boston, MA 02118 USA; [Guo, Wen; Flanagan, John; Jasuja, Ravi; Kirkland, James; Jiang, Lan; Bhasin, Shalender] Boston Univ, Sch Med, Boston Med Ctr, Sect Nutr & Geriatr, Boston, MA 02118 USA; [Flanagan, John] Karolinska Inst, SE-17177 Stockholm, Sweden	Boston Medical Center; Boston University; Boston Medical Center; Boston University; Boston Medical Center; Boston University; Karolinska Institutet	Guo, W (corresponding author), 670 Albany St, Boston, MA 02118 USA.	wguo@bu.edu	Flanagan, John/AAG-4857-2019	Flanagan, John/0000-0001-6957-756X; Guo, Wen/0000-0002-4474-2837	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059261, R01DK049296, R01DK078512] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK059261, R01 DK078512, R01 DK 49296, R01 DK 70431, DK 42600, R01 DK 59261] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Briata P, 2003, MOL CELL, V12, P1201, DOI 10.1016/S1097-2765(03)00407-6; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; COWTHORN WP, 2007, IN PRESS CELL DEATH; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Fischer L, 2002, J BIOL CHEM, V277, P30870, DOI 10.1074/jbc.M109330200; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Guo W, 2007, AM J PHYSIOL-ENDOC M, V292, pE1041, DOI 10.1152/ajpendo.00557.2006; Hammarstedt A, 2007, BIOCHEM BIOPH RES CO, V357, P700, DOI 10.1016/j.bbrc.2007.03.202; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hirai S, 2007, DOMEST ANIM ENDOCRIN, V32, P1, DOI 10.1016/j.domaniend.2005.12.001; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Liang YC, 2007, J EXP BIOL, V210, P477, DOI 10.1242/jeb.02665; Mackay DL, 2006, J CELL PHYSIOL, V207, P722, DOI 10.1002/jcp.20617; Marcell TJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1159, DOI 10.1152/ajpendo.2001.281.6.E1159; Martyn JK, 2004, ANAT REC PART A, V281A, P1363, DOI 10.1002/ar.a.20140; McMahon CD, 2003, AM J PHYSIOL-ENDOC M, V285, pE82, DOI 10.1152/ajpendo.00275.2002; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nakamura T, 2003, BIOCHEM BIOPH RES CO, V303, P306, DOI 10.1016/S0006-291X(03)00325-5; Nishi M, 2002, BIOCHEM BIOPH RES CO, V293, P247, DOI 10.1016/S0006-291X(02)00209-7; Pal R, 2006, STEM CELLS DEV, V15, P29, DOI 10.1089/scd.2006.15.29; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Rodgers BD, 2001, ENDOCRINOLOGY, V142, P1412, DOI 10.1210/en.142.4.1412; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sato M, 2006, ACTA DERM-VENEREOL, V86, P300, DOI 10.2340/00015555-0101; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shelton GD, 2007, NEUROMUSCULAR DISORD, V17, P721, DOI 10.1016/j.nmd.2007.06.008; Steelman CA, 2006, FASEB J, V20, P580, DOI 10.1096/fj.05-5125fje; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Warner DR, 2005, FEBS LETT, V579, P3539, DOI 10.1016/j.febslet.2005.05.024; Wehling M, 2000, FASEB J, V14, P103, DOI 10.1096/fasebj.14.1.103; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339; Xie W, 2006, LIPIDS, V41, P267, DOI 10.1007/s11745-006-5096-4; Yang XL, 2004, BIOCHEM BIOPH RES CO, V317, P1045, DOI 10.1016/j.bbrc.2004.03.152; Zhou SH, 2005, J BIOL CHEM, V280, P22688, DOI 10.1074/jbc.M412953200; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	57	85	96	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9136	9145		10.1074/jbc.M708968200	http://dx.doi.org/10.1074/jbc.M708968200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18203713	Green Published, hybrid			2022-12-27	WOS:000254465800043
J	Liu, PF; Theruvathu, JA; Darwanto, A; Lao, VV; Pascal, T; Goddard, WA; Sowers, LC				Liu, Pingfang; Theruvathu, Jacob A.; Darwanto, Agus; Lao, Victoria Valinluck; Pascal, Tod; Goddard, William A., III; Sowers, Lawrence C.			Mechanisms of base selection by the Escherichia coli mispaired uracil glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE-DNA GLYCOSYLASE; EXCISION-REPAIR; CATALYTIC MECHANISM; HYPOCHLOROUS ACID; RECOGNITION; MISMATCH; CELLS; SMUG1; STABILITY; DUPLEXES	The repair of the multitude of single-base lesions formed daily in cells of all living organisms is accomplished primarily by the base excision repair pathway that initiates repair through a series of lesion-selective glycosylases. In this article, singleturnover kinetics have been measured on a series of oligonucleotide substrates containing both uracil and purine analogs for the Escherichia coli mispaired uracil glycosylase ( MUG). The relative rates of glycosylase cleavage have been correlated with the free energy of helix formation and with the size and electronic inductive properties of a series of uracil 5-substituents. Data are presented that MUG can exploit the reduced thermodynamic stability of mispairs to distinguish U: A from U: G pairs. Discrimination against the removal of thymine results primarily from the electron-donating property of the thymine 5-methyl substituent, whereas the size of the methyl group relative to a hydrogen atom is a secondary factor. A series of parameters have been obtained that allow prediction of relative MUG cleavage rates that correlate well with observed relative rates that vary over 5 orders of magnitude for the series of base analogs examined. We propose that these parameters may be common among DNA glycosylases; however, specific glycosylases may focus more or less on each of the parameters identified. The presence of a series of glycosylases that focus on different lesion properties, all coexisting within the same cell, would provide a robust and partially redundant repair system necessary for the maintenance of the genome.	[Liu, Pingfang; Theruvathu, Jacob A.; Darwanto, Agus; Lao, Victoria Valinluck; Sowers, Lawrence C.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92354 USA; [Pascal, Tod; Goddard, William A., III; Sowers, Lawrence C.] CALTECH, Dept Chem, Pasadena, CA 91125 USA	Loma Linda University; California Institute of Technology	Sowers, LC (corresponding author), Alumni Hall Basic Sci, Rm 101,11021 Campus St, Loma Linda, CA 92354 USA.	lsowers@llu.edu			NATIONAL CANCER INSTITUTE [R01CA112293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050351] Funding Source: NIH RePORTER; NCI NIH HHS [CA 112293] Funding Source: Medline; NIGMS NIH HHS [GM 50351] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allawi HT, 1997, BIOCHEMISTRY-US, V36, P10581, DOI 10.1021/bi962590c; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Bianchet MA, 2003, BIOCHEMISTRY-US, V42, P12455, DOI 10.1021/bi035372+; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; CARADONNA SJ, 1980, J BIOL CHEM, V255, P2293; CHEONG C, 1988, NUCLEIC ACIDS RES, V16, P5115, DOI 10.1093/nar/16.11.5115; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; ERITJA R, 1986, NUCLEIC ACIDS RES, V14, P8135, DOI 10.1093/nar/14.20.8135; Fujimoto J, 1996, NUCLEIC ACIDS RES, V24, P754, DOI 10.1093/nar/24.4.754; GAIT MJ, 1983, OLIGONUCLEOTIDES SYN; Hang B, 2002, BIOCHEMISTRY-US, V41, P2158, DOI 10.1021/bi011542b; HANSCH C, 1973, J MED CHEM, V16, P1207, DOI 10.1021/jm00269a003; Henderson JP, 2003, J BIOL CHEM, V278, P23522, DOI 10.1074/jbc.M303928200; Henderson JP, 2001, J BIOL CHEM, V276, P7867, DOI 10.1074/jbc.M005379200; Jang YH, 2001, J PHYS CHEM A, V105, P274, DOI 10.1021/jp994432b; Jiang Q, 2003, J BIOL CHEM, V278, P32834, DOI 10.1074/jbc.M304021200; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Krosky DJ, 2004, BIOCHEMISTRY-US, V43, P4188, DOI 10.1021/bi036303y; Lari SU, 2006, DNA REPAIR, V5, P1407, DOI 10.1016/j.dnarep.2006.06.009; Law SM, 1996, BIOCHEMISTRY-US, V35, P12329, DOI 10.1021/bi9614545; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; Lindahl T, 1980, Methods Enzymol, V65, P284; Liu PF, 2003, DNA REPAIR, V2, P199, DOI 10.1016/S1568-7864(02)00198-2; Liu PF, 2002, CHEM RES TOXICOL, V15, P1001, DOI 10.1021/tx020030a; Matsubara M, 2004, NUCLEIC ACIDS RES, V32, P5291, DOI 10.1093/nar/gkh859; Minetti CASA, 2003, J MOL BIOL, V328, P1047, DOI 10.1016/S0022-2836(03)00365-6; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; MULLAART E, 1990, MUTAT RES, V237, P189, DOI 10.1016/0921-8734(90)90001-8; NEDDERMANN P, 1993, J BIOL CHEM, V268, P21218; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Nilsen H, 2001, EMBO J, V20, P4278, DOI 10.1093/emboj/20.15.4278; O'Neill RJ, 2003, J BIOL CHEM, V278, P20526, DOI 10.1074/jbc.M210860200; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; PARKER WB, 1990, PHARMACOL THERAPEUT, V48, P381, DOI 10.1016/0163-7258(90)90056-8; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; PETRUSKA J, 1986, P NATL ACAD SCI USA, V83, P1559, DOI 10.1073/pnas.83.6.1559; RICHARD EG, 1975, CRC HDB BIOCH MOL BI, V1, P589; SAAVA R, 1995, NATURE, V373, P487; Sagi J, 1999, CHEM RES TOXICOL, V12, P917, DOI 10.1021/tx990088y; Saul R L, 1986, Basic Life Sci, V38, P529; Seiple L, 2006, NUCLEIC ACIDS RES, V34, P140, DOI 10.1093/nar/gkj430; SHAPIRO R, 1969, BIOCHEMISTRY-US, V8, P1806, DOI 10.1021/bi00833a004; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; SOBER HA, 1970, HDB BIOCH, pJ3; Sousa MML, 2007, MOL ASPECTS MED, V28, P276, DOI 10.1016/j.mam.2007.04.006; SUN B, 1995, J BIOL CHEM, V270, P19501, DOI 10.1074/jbc.270.33.19501; Sung JS, 2000, BIOCHEMISTRY-US, V39, P10224, DOI 10.1021/bi0007066; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Valinluck V, 2006, CHEM RES TOXICOL, V19, P556, DOI 10.1021/tx050341w; Valinluck V, 2002, CHEM RES TOXICOL, V15, P1595, DOI 10.1021/tx020062y; Watkins NE, 2005, NUCLEIC ACIDS RES, V33, P6258, DOI 10.1093/nar/gki918; Whiteman M, 1997, CHEM RES TOXICOL, V10, P1240, DOI 10.1021/tx970086i; Wibley JEA, 2003, MOL CELL, V11, P1647, DOI 10.1016/S1097-2765(03)00235-1; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Wong I, 2002, J BIOL CHEM, V277, P19424, DOI 10.1074/jbc.M201198200	56	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8829	8836		10.1074/jbc.M707174200	http://dx.doi.org/10.1074/jbc.M707174200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18208817	hybrid, Green Published			2022-12-27	WOS:000254465800009
J	Chiribau, CB; Cheng, LH; Cucoranu, IC; Yu, YS; Clempus, RE; Sorescu, D				Chiribau, Calin B.; Cheng, Lihong; Cucoranu, Ioan C.; Yu, Yong-Shen; Clempus, Roza E.; Sorescu, Dan			FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; NECROSIS-FACTOR-ALPHA; MAMMALIAN PEROXIREDOXIN; REDUCE PEROXIDES; OXIDATIVE STRESS; PROTEINS; ISOFORMS; PHOSPHORYLATION; MITOCHONDRIA; THIOREDOXIN	Human cardiac fibroblasts are protected from oxidative stress triggered by inflammation after myocardial injury (Li, P. F., Dietz, R., and von Harsdorf, R. (1999) FEBS Lett. 448, 206 - 210) by expressing potent antioxidant defenses such as superoxide dismutases, catalases, glutathione-peroxidases, and peroxiredoxins. Recently the transcription factor FOXO3A has been shown to increase resistance to oxidative stress by up-regulation of mitochondrial superoxide dismutase and peroxisomal catalase (Kops, G. J., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W., Coffer, P. J., Huang, T. T., Bos, J. L., Medema, R. H., and Burgering, B. M. (2002) Nature 419, 316 - 321; Nemoto, S., and Finkel, T. (2002) Science 295, 2450 - 2452). We hypothesized that FOXO3A also regulates the expression of Prx III, the mitochondrial peroxiredoxin, in human cardiac fibroblasts. We found that depletion of FOXO3A leads to a dramatic reduction of Prx III mRNA and protein in serum-deprived human cardiac fibroblasts. These data suggest that endogenous FOXO3A is necessary for base-line expression of Prx III. Next, we identified two putative FOXO3A DNA binding sites in Prx III promoter at -267 and -244 nucleotides relative to the start codon. We demonstrated that both sequences are required for binding of endogenous FOXO3A to the Prx III promoter by performing electromobility shift assays and chromatin immunoprecipitation assays. Inhibition of endogenous FOXO3A by insulin growth factor 1 prevented binding of FOXO3A to Prx III promoter. In contrast, overexpression of FOXO3A increased Prx III promoter activity. Furthermore, depletion of Prx III was associated with enhanced apoptosis and oxidative stress after serum deprivation. We conclude that FOXO3A mediates Prx III expression, and this may play a critical role in the resistance to oxidative stress in cardiac fibroblasts.	[Chiribau, Calin B.; Cheng, Lihong; Cucoranu, Ioan C.; Yu, Yong-Shen; Clempus, Roza E.; Sorescu, Dan] Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA	Emory University	Sorescu, D (corresponding author), Emory Univ, Sch Med, Div Cardiol, Dept Med, 1639 Pierce Dr,Woodruff Mem Bldg,Rm 319, Atlanta, GA 30322 USA.	dsoresc@emory.edu						Araki M, 1999, J BIOL CHEM, V274, P2271, DOI 10.1074/jbc.274.4.2271; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Chae HZ, 1999, METHOD ENZYMOL, V300, P219; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hansen JM, 2006, TOXICOL SCI, V91, P643, DOI 10.1093/toxsci/kfj175; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li PF, 1999, FEBS LETT, V448, P206, DOI 10.1016/S0014-5793(99)00370-1; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Neufeld KL, 1997, P NATL ACAD SCI USA, V94, P3034, DOI 10.1073/pnas.94.7.3034; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; Wonsey DR, 2002, P NATL ACAD SCI USA, V99, P6649, DOI 10.1073/pnas.102523299; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhang H, 2007, ARCH BIOCHEM BIOPHYS, V465, P119, DOI 10.1016/j.abb.2007.05.001; Zheng WH, 2000, J BIOL CHEM, V275, P39152, DOI 10.1074/jbc.M002417200	26	104	107	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8211	8217		10.1074/jbc.M710610200	http://dx.doi.org/10.1074/jbc.M710610200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18195003	hybrid, Green Published			2022-12-27	WOS:000254288000018
J	Bennett, RP; Presnyak, V; Wedekind, JE; Smith, HC				Bennett, Ryan P.; Presnyak, Vladimir; Wedekind, Joseph E.; Smith, Harold C.			Nuclear exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B MESSENGER-RNA; INDUCED CYTIDINE DEAMINASE; CLASS SWITCH RECOMBINATION; VIRUS-LIKE PARTICLES; EDITING ENZYME; SOMATIC HYPERMUTATION; LINE-1 RETROTRANSPOSITION; REVERSE TRANSCRIPTION; CATALYTIC SUBUNIT; STRESS GRANULES	Human APOBEC3G ( hA3G) is a host factor that defends against HIV-1 as well as other exogenous retroviruses and endogenous retroelements. To this end, hA3G is restricted to the cytoplasm of T lymphocytes where it interacts with viral RNA and proteins to assemble with viral particles causing a post-entry block during reverse transcription. hA3G also exhibits a mechanism to inhibit the reverse transcription of retroelements by RNA binding and sequestration into mRNA processing centers in the cytoplasm. We have determined that the molecular basis for this specialized property of hA3G is a novel cytoplasmic retention signal ( CRS) that is necessary and sufficient to restrict wild-type hA3G and chimeric constructs to the cytoplasm. The CRS resides within amino acids 113-128 and is embedded within a basic flanking sequence and does not require RNA binding to retain hA3G in the cytoplasm. Paralogs of hA3G that have nuclear or cytoplasmic distributions differ from hA3G within the region encompassing the CRS motif with respect to charge and amino acid composition. We propose that the CRS enables hA3G to interact with cytoplasmic factors, and thereby enables hA3G to serve in host cell defense by restricting an antiviral sentinel to the cytoplasm. The CRS lies in a region involved in both Gag and Vif interactions; therefore, identification of this motif has important implications for the design of therapeutics that target HIV-1 while maintaining antiviral and cellular functions.	[Bennett, Ryan P.; Presnyak, Vladimir; Wedekind, Joseph E.; Smith, Harold C.] Univ Rochester, Sch Med & Dent, Dept Biochem, Rochester, NY 14642 USA	University of Rochester	Smith, HC (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem, Rochester, NY 14642 USA.	harold.smith@rochester.edu		Presnyak, Vladimir/0000-0001-6695-7102; Smith, Harold/0000-0001-6257-6791	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058789, T32AI049815] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI49815, T32 AI049815, AI058789] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Bennett RP, 2006, BIOCHEM BIOPH RES CO, V350, P214, DOI 10.1016/j.bbrc.2006.09.032; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Duquette ML, 2005, ONCOGENE, V24, P5791, DOI 10.1038/sj.onc.1208746; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; HIGUCHI K, 1992, J LIPID RES, V33, P1753; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; HUANG J, 2007, J BIOL CHEM; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; LAU PP, 1991, J BIOL CHEM, V266, P20550; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; MACELREVEY C, 2008, IN PRESS RNA DNA EDI; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Oppezzo P, 2003, BLOOD, V101, P4029, DOI 10.1182/blood-2002-10-3175; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rucci F, 2006, GENE, V377, P150, DOI 10.1016/j.gene.2006.03.024; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Skuse GR, 1996, NUCLEIC ACIDS RES, V24, P478, DOI 10.1093/nar/24.3.478; Smith HC, 1998, METHODS, V15, P27, DOI 10.1006/meth.1998.0603; Sowden M, 1996, J BIOL CHEM, V271, P3011, DOI 10.1074/jbc.271.6.3011; Sowden MP, 2002, J CELL SCI, V115, P1027; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; von Wronski MA, 1998, METABOLISM, V47, P869, DOI 10.1016/S0026-0495(98)90128-7; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wichroski MJ, 2005, J BIOL CHEM, V280, P8387, DOI 10.1074/jbc.M408048200; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Yamanaka S, 1996, J BIOL CHEM, V271, P11506, DOI 10.1074/jbc.271.19.11506; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321; Yang Y, 1997, J BIOL CHEM, V272, P27700, DOI 10.1074/jbc.272.44.27700; Yang Y, 1997, P NATL ACAD SCI USA, V94, P13075, DOI 10.1073/pnas.94.24.13075; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	79	41	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7320	7327		10.1074/jbc.M708567200	http://dx.doi.org/10.1074/jbc.M708567200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18165230	hybrid			2022-12-27	WOS:000253997900005
J	Huang, WQ; Zhu, CL; Wang, H; Horvath, E; Eklund, EA				Huang, Weiqi; Zhu, Chunliu; Wang, Hao; Horvath, Elizabeth; Eklund, Elizabeth A.			The interferon consensus sequence-binding protein (ICSBP/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE; GP91(PHOX) EXPRESSION; FAS LIGATION; LEUKEMIA; PU.1; FAP-1; APOPTOSIS; MACROPHAGES; DEATH; DNA	The interferon consensus sequence-binding protein (ICSBP/IRF8) is an interferon regulatory factor that is expressed in myeloid and B-cells. ICSBP-deficient mice develop a myeloproliferative disorder characterized by cytokine hypersensitivity and apoptosis resistance. To identify ICSBP target genes involved in these effects, we screened a CpG island microarray with chromatin that co-immunoprecipitated with ICSBP from myeloid cells. Using this technique, we identified PTPN13 as an ICSBP target gene. PTPN13 encodes Fas-associated phosphatase 1 (Fap-1), a ubiquitously expressed protein-tyrosine phosphatase. This was of interest because interaction of Fap-1 with Fas results in Fas dephosphorylation and inhibition of Fas-induced apoptosis. In this study, we found that ICSBP influenced Fas-induced apoptosis in a Fap-1-dependent manner. We also found that ICSBP interacted with a cis element in the proximal PTPN13 promoter and repressed transcription. This interaction increased during myeloid differentiation and was regulated by phosphorylation of conserved tyrosine residues in the interferon regulatory factor domain of ICSBP. ICSBP deficiency was present in human myeloid malignancies, including chronic myeloid leukemia. Therefore, these studies identified a mechanism for increased survival of mature myeloid cells in the ICSBP-deficient murine model and in human myeloid malignancies with decreased ICSBP expression.	[Huang, Weiqi; Zhu, Chunliu; Wang, Hao; Horvath, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Huang, Weiqi; Zhu, Chunliu; Wang, Hao; Horvath, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprahens Canc Ctr, Chicago, IL 60611 USA; [Horvath, Elizabeth; Eklund, Elizabeth A.] Jesse Brown Vet Hlth Adm Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, 710 N Fairbanks Ct,Olson 8524, Chicago, IL 60611 USA.	e-eklund@northwestern.edu	Huang, Weiqi/E-4341-2010	Wang, Hao/0000-0003-2131-0377	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088747] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL088747] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eklund EA, 1999, J IMMUNOL, V163, P6095; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Gabriele L, 1999, J EXP MED, V190, P411, DOI 10.1084/jem.190.3.411; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Huang WQ, 2007, J BIOL CHEM, V282, P6629, DOI 10.1074/jbc.M607760200; Huang WQ, 2006, MOL CELL BIOL, V26, P6311, DOI 10.1128/MCB.00036-06; Inazawa J, 1996, GENOMICS, V31, P240, DOI 10.1006/geno.1996.0039; Ivanov VN, 2003, MOL CELL BIOL, V23, P3623, DOI 10.1128/MCB.23.10.3623-3635.2003; Josefsen D, 1999, EXP HEMATOL, V27, P1451, DOI 10.1016/S0301-472X(99)00073-9; Kautz B, 2001, J BIOL CHEM, V276, P37868; Kim YM, 1999, J IMMUNOL, V163, P2000; Komada Y, 1997, BRIT J HAEMATOL, V99, P325, DOI 10.1046/j.1365-2141.1997.3903204.x; KONIECZNA I, 2008, INPRESS J CLIN INVES; Kuwata T, 2002, MOL CELL BIOL, V22, P7439, DOI 10.1128/MCB.22.21.7439-7448.2002; LARRICK JW, 1980, J IMMUNOL, V125, P6; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; NELSON N, 1993, MOL CELL BIOL, V13, P588, DOI 10.1128/MCB.13.1.588; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Otten HG, 2004, LEUKEMIA, V18, P1401, DOI 10.1038/sj.leu.2403414; Qian ZJ, 2002, P NATL ACAD SCI USA, V99, P14925, DOI 10.1073/pnas.222491799; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Sharf R, 1997, J BIOL CHEM, V272, P9785; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Yoshida S, 2002, J HUM GENET, V47, P614, DOI 10.1007/s100380200094; Zhang Y, 1998, P NATL ACAD SCI USA, V95, P2586, DOI 10.1073/pnas.95.5.2586; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	38	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7921	7935		10.1074/jbc.M706710200	http://dx.doi.org/10.1074/jbc.M706710200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18195016	hybrid			2022-12-27	WOS:000253997900068
J	Sparling, DP; Griesel, BA; Weems, J; Olson, AL				Sparling, David P.; Griesel, Beth A.; Weems, Juston; Olson, Ann Louise			GLUT4 enhancer factor (GEF) interacts with MEF2A and HDAC5 to regulate the GLUT4 promoter in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE GLUCOSE TRANSPORTER; II HISTONE DEACETYLASES; TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; TRANSGENIC MICE; GENE PROMOTER; ADIPOSE-TISSUE; DB/DB MICE; EXPRESSION; ACTIVATION	The insulin-responsive glucose transporter, GLUT4, is regulated in various physiologic states at the transcriptional level. When expressed in transgenic mice, the human GLUT4 promoter is governed by two cis-acting sequences: an MEF2 binding domain and Domain I, that function both as positive and negative regulators depending on the physiologic state. MEF2 proteins and GLUT4 enhancer factor ( GEF) are known ligands for these cis-acting elements, but their mechanism of action is unclear. To begin to understand this important process, we have characterized GEF structural domains and its interactions with the MEF2A isoform. We find that the C terminus of GEF comprises its DNA-binding domain, but does not contribute to GEF homo-oligomerization. We also have found that GEF dimerizes with increased affinity to a hypophosphorylated form of MEF2A. Furthermore, we demonstrated that MEF2A binding to its cognate binding site can increase the DNA binding activity of GEF to Domain I, suggesting a novel mechanism for MEF2A transcriptional activation. Finally, we have demonstrated that the transcriptional co-repressor HDAC5 can interact with GEF in the absence of MEF2 proteins and specifically inhibit GLUT4 promoter activity. These findings lead to the hypothesis that GEF and the MEF2 proteins form a complex on the GLUT4 promoter that allows for recruitment of transcriptional co-regulators ( repressors and/ or activators) to control GLUT4 promoter activity.	[Sparling, David P.; Griesel, Beth A.; Weems, Juston; Olson, Ann Louise] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Olson, AL (corresponding author), POB 26901,Rm 853, Oklahoma City, OK 73190 USA.	ann-olson@ouhsc.edu		Sparling, David/0000-0001-5940-1544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062341] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK062341, R01 DK062341] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERGER J, 1989, NATURE, V340, P70, DOI 10.1038/340070a0; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; Brozinick JT, 2001, DIABETES, V50, P593, DOI 10.2337/diabetes.50.3.593; Charron MJ, 1999, J BIOL CHEM, V274, P3253, DOI 10.1074/jbc.274.6.3253; Christ-Roberts CY, 2004, METABOLISM, V53, P1233, DOI 10.1016/j.metabol.2004.03.022; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Eyster CA, 2005, J BIOL CHEM, V280, P17978, DOI 10.1074/jbc.M409806200; GARVEY WT, 1989, SCIENCE, V245, P60, DOI 10.1126/science.2662408; GIBBS EM, 1995, J CLIN INVEST, V95, P1512, DOI 10.1172/JCI117823; Han AD, 2005, J MOL BIOL, V345, P91, DOI 10.1016/j.jmb.2004.10.033; Holmes BF, 2004, AM J PHYSIOL-ENDOC M, V287, pE739, DOI 10.1152/ajpendo.00080.2004; KAHN BB, 1988, J CLIN INVEST, V82, P691, DOI 10.1172/JCI113649; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; MacLean PS, 2002, BIOCHEM BIOPH RES CO, V292, P409, DOI 10.1006/bbrc.2002.6654; McGee SL, 2004, DIABETES, V53, P1208, DOI 10.2337/diabetes.53.5.1208; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Mora S, 2001, ENDOCRINOLOGY, V142, P1999, DOI 10.1210/en.142.5.1999; Morin S, 2005, J BIOL CHEM, V280, P32272, DOI 10.1074/jbc.M507640200; OLSON AL, 1995, J BIOL CHEM, V270, P23491, DOI 10.1074/jbc.270.40.23491; Oshel KM, 2000, J BIOL CHEM, V275, P23666, DOI 10.1074/jbc.M001452200; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; SINHA MK, 1991, DIABETES, V40, P472, DOI 10.2337/diabetes.40.4.472; SIVITZ WI, 1989, NATURE, V340, P72, DOI 10.1038/340072a0; Sparling DP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1149, DOI 10.1152/ajpendo.00521.2006; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; ZIEL FH, 1988, DIABETES, V37, P885, DOI 10.2337/diabetes.37.7.885	30	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7429	7437		10.1074/jbc.M800481200	http://dx.doi.org/10.1074/jbc.M800481200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18216015	Green Published, hybrid			2022-12-27	WOS:000253997900017
J	Olson, GE; Winfrey, VP; Hill, KE; Burk, RF				Olson, Gary E.; Winfrey, Virginia P.; Hill, Kristina E.; Burk, Raymond F.			Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA GLUTATHIONE-PEROXIDASE; LIPOPROTEIN RECEPTOR FAMILY; ALPHA-2-MACROGLOBULIN RECEPTOR; BRAIN SELENIUM; MICE LACKING; 2 MEMBERS; ENDOCYTOSIS; BINDING; PROTEIN; GP330	Selenoprotein P (Sepp1) contains most of the selenium in blood plasma, and it is utilized by the kidney, brain, and testis as a selenium source for selenoprotein synthesis. We recently demonstrated that apolipoprotein E receptor-2 (ApoER2) is required for Sepp1 uptake by the testis and that deletion of ApoER2 reduces testis and brain, but not kidney, selenium levels. This study examined the kidney Sepp1 uptake pathway. Immunolocalization experiments demonstrated that Sepp1 passed into the glomerular filtrate and was specifically taken up by proximal tubule epithelial cells. Neither the C terminus selenocysteine-rich domain of Sepp1 nor ApoER2 was required for Sepp1 uptake by proximal tubules. Tissue ligand binding assays using cryosections of Sepp1(-/-) kidneys revealed that the proximal tubule epithelium contained Sepp1-binding sites that were blocked by the receptor-associated protein, RAP, an inhibitor of lipoprotein receptor-ligand interactions. Ligand blotting assays of kidney membrane preparations fractionated by SDS-PAGE revealed that Sepp1 binds megalin, a lipoprotein receptor localized to the proximal tubule epithelium. Immunolocalization analyses confirmed the in vivo co-localization of Sepp1 and megalin in wild type kidneys and demonstrated the absence of proximal tubule Sepp1 uptake in megalin null mice. These results demonstrate that kidney selenium homeostasis is mediated by a megalin-dependent Sepp1 uptake pathway in the proximal tubule.	[Olson, Gary E.; Winfrey, Virginia P.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Hill, Kristina E.; Burk, Raymond F.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Olson, GE (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	gary.olson@vanderbilt.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002497, R01ES002497] Funding Source: NIH RePORTER; NICHD NIH HHS [HD044863] Funding Source: Medline; NIEHS NIH HHS [ES02497] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AVISSAR N, 1994, AM J PHYSIOL, V266, pC367, DOI 10.1152/ajpcell.1994.266.2.C367; Bajari TM, 2005, METHODS, V36, P109, DOI 10.1016/j.ymeth.2004.11.007; Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Chapon C, 2005, ANAT EMBRYOL, V209, P263, DOI 10.1007/s00429-004-0451-9; Christensen EI, 2001, AM J PHYSIOL-RENAL, V280, pF562, DOI 10.1152/ajprenal.2001.280.4.F562; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; CHRISTENSEN EI, 1995, EUR J CELL BIOL, V66, P349; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2007, J BIOL CHEM, V282, P10972, DOI 10.1074/jbc.M700436200; KASIK JW, 1995, PLACENTA, V16, P67, DOI 10.1016/0143-4004(95)90082-9; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; Kim DH, 1997, J BIOL CHEM, V272, P8498, DOI 10.1074/jbc.272.13.8498; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Ma SG, 2002, J BIOL CHEM, V277, P12749, DOI 10.1074/jbc.M111462200; MASER RL, 1994, J BIOL CHEM, V269, P27066; May P, 2005, CELL MOL LIFE SCI, V62, P2325, DOI 10.1007/s00018-005-5231-z; May Petra, 2003, Sci STKE, V2003, pPE12, DOI 10.1126/stke.2003.176.pe12; MOESTRUP SK, 1993, J BIOL CHEM, V268, P16564; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Nielsen R, 2007, P NATL ACAD SCI USA, V104, P5407, DOI 10.1073/pnas.0700330104; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Orlando RA, 1997, P NATL ACAD SCI USA, V94, P2368, DOI 10.1073/pnas.94.6.2368; Renko K, 2008, BIOCHEM J, V409, P741, DOI 10.1042/BJ20071172; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Schneider WJ, 2003, CELL MOL LIFE SCI, V60, P892, DOI 10.1007/s00018-003-2183-z; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Whitin JC, 1998, MOL GENET METAB, V65, P238, DOI 10.1006/mgme.1998.2760; Whitin JC, 2002, AM J PHYSIOL-RENAL, V283, pF20, DOI 10.1152/ajprenal.00014.2001; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; WILSON DS, 1993, J INORG BIOCHEM, V51, P707, DOI 10.1016/0162-0134(93)85003-Q; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531, DOI 10.1177/42.4.7510321; Zou ZY, 2004, J BIOL CHEM, V279, P34302, DOI 10.1074/jbc.M405608200	44	126	133	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6854	6860		10.1074/jbc.M709945200	http://dx.doi.org/10.1074/jbc.M709945200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18174160	hybrid			2022-12-27	WOS:000253779600028
J	Sohl, CD; Isin, EM; Eoff, RL; Marsch, GA; Stec, DF; Guengerich, FP				Sohl, Christal D.; Isin, Emre M.; Eoff, Robert L.; Marsch, Glenn A.; Stec, Donald F.; Guengerich, F. Peter			Cooperativity in oxidation reactions catalyzed by cytochrome P450 1A2 - Highly cooperative pyrene hydroxylation and multiphasic kinetics of ligand binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PURIFIED CYTOCHROME-P-450; ESCHERICHIA-COLI; DRUG-METABOLISM; DIFFERENT FORMS; MULTIPLE FORMS; ACTIVE-SITE; RABBIT; ACTIVATION; 3A4	Rabbit liver cytochrome P450 ( P450) 1A2 was found to catalyze the 5,6-epoxidation of alpha-naphthoflavone (alpha NF), 1-hydroxylation of pyrene, and the subsequent 6-, 8-, and other hydroxylations of 1-hydroxy ( OH) pyrene. Plots of steady-state rates of product formation versus substrate concentration were hyperbolic for alpha NF epoxidation but highly cooperative ( Hill n coefficients of 2 - 4) for pyrene and 1-OH pyrene hydroxylation. When any of the three substrates (alpha NF, pyrene, 1-OH pyrene) were mixed with ferric P450 1A2 using stopped-flow methods, the changes in the heme Soret spectra were relatively slow and multiphasic. Changes in the fluorescence of all of the substrates were much faster, consistent with rapid initial binding to P450 1A2 in a manner that does not change the heme spectrum. For binding of pyrene to ferrous P450 1A2, the course of the spectra revealed sequential changes in opposite directions, consistent with P450 1A2 being involved in a series of transitions to explain the kinetic multiphasicity as opposed to multiple, slowly inter-converting populations of enzyme undergoing the same event at different rates. Models of rabbit P450 1A2 based on a published crystal structure of a human P450 1A2-alpha NF complex show active site space for only one alpha NF or for two pyrenes. The spectral changes observed for binding and hydroxylation of pyrene and 1-OH pyrene could be fit to a kinetic model in which hydroxylation occurs only when two substrates are bound. Elements of this mechanism may be relevant to other cases of P450 cooperativity.	[Sohl, Christal D.; Isin, Emre M.; Eoff, Robert L.; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Sohl, Christal D.; Isin, Emre M.; Eoff, Robert L.; Guengerich, F. Peter] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA; [Marsch, Glenn A.] Grove City Coll, Dept Phys, Grove City, PA 16127 USA; [Stec, Donald F.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Isin, Emre/0000-0003-3402-7685	NATIONAL CANCER INSTITUTE [F32CA119776, R37CA090426] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA119776, R37 CA090426] Funding Source: Medline; NCRR NIH HHS [S10 RR019022] Funding Source: Medline; NIEHS NIH HHS [P30 ES000267] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALTERMAN MA, 1990, BIOMED CHROMATOGR, V4, P221, DOI 10.1002/bmc.1130040510; Atkins WM, 2006, EXPERT OPIN DRUG MET, V2, P573, DOI 10.1517/17425255.2.4.573; Atkins WM, 2005, ANNU REV PHARMACOL, V45, P291, DOI 10.1146/annurev.pharmtox.45.120403.100004; BAUER E, 1995, CHEM RES TOXICOL, V8, P136, DOI 10.1021/tx00043a018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUENING MK, 1978, BIOCHEM BIOPH RES CO, V82, P348, DOI 10.1016/0006-291X(78)90616-2; BURLEIGH BD, 1969, ANAL BIOCHEM, V27, P536, DOI 10.1016/0003-2697(69)90067-0; CAMBILLAU C, 1997, TURBO FRODO; Chetiyanukornkul T, 2002, J CHROMATOGR A, V961, P107, DOI 10.1016/S0021-9673(02)00363-1; Chun YJ, 2007, J BIOL CHEM, V282, P17486, DOI 10.1074/jbc.M700863200; CONNEY AH, 1982, CANCER RES, V42, P4875; Dabrowski MJ, 2002, J AM CHEM SOC, V124, P11866, DOI 10.1021/ja027552x; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Fernando H, 2007, ARCH BIOCHEM BIOPHYS, V460, P129, DOI 10.1016/j.abb.2006.12.025; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; FOUST GP, 1969, ANAL BIOCHEM, V27, P530, DOI 10.1016/0003-2697(69)90066-9; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; GOTOH O, 1992, J BIOL CHEM, V267, P83; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GRIFFIN BW, 1972, BIOCHEMISTRY-US, V11, P4740, DOI 10.1021/bi00775a017; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; GUENGERICH FP, 1983, BIOCHEMISTRY-US, V22, P2811, DOI 10.1021/bi00281a007; GUENGERICH FP, 1977, J BIOL CHEM, V252, P3970; GUENGERICH FP, 1994, P 8 INT C CYT P450 B, P97; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; HAUGEN DA, 1976, J BIOL CHEM, V251, P7929; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; HUANG MT, 1981, J BIOL CHEM, V256, P6829; Hutzler JM, 2002, DRUG METAB DISPOS, V30, P355, DOI 10.1124/dmd.30.4.355; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; JOHNSON EF, 1983, J BIOL CHEM, V258, P2785; JOHNSON EF, 1977, J BIOL CHEM, V252, P2839; JOHNSON EF, 1979, MOL PHARMACOL, V15, P708; Johnson Kenneth A., 2003, P1; Jushchyshyn MI, 2005, ARCH BIOCHEM BIOPHYS, V438, P21, DOI 10.1016/j.abb.2005.02.027; KAPITULNIK J, 1977, CLIN PHARMACOL THER, V22, P475; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim D, 2005, ANNU REV PHARMACOL, V45, P27, DOI 10.1146/annurev.pharmtox.45.120403.100010; Kim YD, 2004, ENVIRON RES, V94, P262, DOI 10.1016/S0013-9351(03)00134-8; Koley AP, 1997, J BIOL CHEM, V272, P3149, DOI 10.1074/jbc.272.6.3149; KUBY SA, 1991, STUDY ENZYMES, V1, P283; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P9; LAMBERT M, 1994, APPL ENVIRON MICROB, V60, P3597, DOI 10.1128/AEM.60.10.3597-3601.1994; LASKER JM, 1982, SCIENCE, V216, P1419, DOI 10.1126/science.7089530; LAUNEN L, 1995, CAN J MICROBIOL, V41, P477, DOI 10.1139/m95-064; Lehrer SS, 1997, METHOD ENZYMOL, V278, P286; MCMANUS ME, 1984, CARCINOGENESIS, V5, P1717, DOI 10.1093/carcin/5.12.1717; Miller GP, 2001, BIOCHEMISTRY-US, V40, P7262, DOI 10.1021/bi010402z; NEBERT DW, 1968, J BIOL CHEM, V243, P6242; Ngui JS, 2000, DRUG METAB DISPOS, V28, P1043; OHAVER TC, 1976, ANAL CHEM, V48, P312, DOI 10.1021/ac60366a016; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; PALMER G, 1992, J BIOL CHEM, V267, P665; Parikh A, 1997, NAT BIOTECHNOL, V15, P784, DOI 10.1038/nbt0897-784; Parikh A, 1999, BIOCHEMISTRY-US, V38, P5283, DOI 10.1021/bi990142+; QUATTROCHI LC, 1986, P NATL ACAD SCI USA, V83, P6731, DOI 10.1073/pnas.83.18.6731; RAHA CR, 1983, J CHROMATOGR, V264, P453, DOI 10.1016/S0021-9673(01)95052-6; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; Roberts AG, 2005, BIOCHEMISTRY-US, V44, P1353, DOI 10.1021/bi0481390; SANDHU P, 1994, ARCH BIOCHEM BIOPHYS, V309, P168, DOI 10.1006/abbi.1994.1099; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Schrag ML, 2000, DRUG METAB DISPOS, V28, P1198; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SCHWAB GE, 1988, MOL PHARMACOL, V33, P493; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Segel I.H., 1975, ENZYME KINETICS; Shimada T, 1998, CHEM RES TOXICOL, V11, P1048, DOI 10.1021/tx980090+; Shiu WY, 2000, J PHYS CHEM REF DATA, V29, P41, DOI 10.1063/1.556055; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; Tracy Timothy S, 2006, Drugs R D, V7, P349, DOI 10.2165/00126839-200607060-00004; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; WIEBEL FJ, 1971, ARCH BIOCHEM BIOPHYS, V144, P78, DOI 10.1016/0003-9861(71)90456-5; WIEBEL FJ, 1975, P NATL ACAD SCI USA, V72, P3917, DOI 10.1073/pnas.72.10.3917; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Witherow LE, 1999, J PHARMACOL EXP THER, V290, P58; YANG CS, 1985, CANCER RES, V45, P1140; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200	87	51	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7293	7308		10.1074/jbc.M709783200	http://dx.doi.org/10.1074/jbc.M709783200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18187423	hybrid			2022-12-27	WOS:000253779600074
J	Tran, S; Norstrom, E; Dahlback, B				Tran, Sinh; Norstrom, Eva; Dahlback, Bjorn			Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-BOND CLEAVAGES; BLOOD-COAGULATION; FACTOR-XA; ANTICOAGULANT ACTIVITY; BINDING-SITE; HEAVY-CHAIN; GLA DOMAIN; FACTOR VA(R506Q); HONG-KONG; COMPLEX	The factor Va(FVa) inactivation by activated protein C( APC), mediated by cleavages at Arg(306) and Arg(506) in FVa, is inhibited by both factor Xa (FXa) and prothrombin. Although FXa is known to specifically inhibit the Arg506 cleavage, the effect of prothrombin has not been confined to one cleavage site. We used recombinant FV variants, FV: R506Q/R679Q and FV: R306Q/R679Q, to investigate the effect of prothrombin on the individual cleavage sites. The APC-mediated FVa inhibition was monitored by a prothrombinase-based FVa assay, and apparent first order rate constants were calculated for each of the cleavage sites both in the presence and absence of prothrombin. Prothrombin impaired cleavages at both Arg306 and Arg506 and the inhibition correlated with a delayed appearance of proteolytic products on Western blots. Almost complete inhibition was obtained at around 3 mu M prothrombin, whereas half-maximal inhibition was obtained at 0.7 mu M prothrombin. After cleavage of prothrombin by thrombin, the inhibitory activity was lost. The inhibitory effect of prothrombin on APC-mediated inhibition of FVa was seen both in the presence and absence of protein S, but in particular for the Arg306 sites, it was more pronounced in the presence of protein S. Thus, prothrombin inhibition of APC inactivation of FVa appears to be due to both impaired APC function and decreased APC cofactor function of protein S. In conclusion, FVa, being part of the prothrombinase complex, is protected from APC by both FXa and prothrombin. Release of products of prothrombin activation from the prothrombinase complex would alleviate the protection, allowing APC-mediated inactivation of FVa.	[Tran, Sinh; Norstrom, Eva; Dahlback, Bjorn] Lund Univ, Univ Hosp, Dept Lab Med, Wallenberg Lab, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Dahlback, B (corresponding author), Lund Univ, Univ Hosp, Dept Lab Med, Wallenberg Lab, SE-20502 Malmo, Sweden.	bjorn.dahlback@med.lu.se		Dahlback, Bjorn/0000-0003-1546-0328				Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; Autin L, 2006, PROTEINS, V63, P440, DOI 10.1002/prot.20848; BAKKER HM, 1994, J BIOL CHEM, V269, P20662; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Blostein MD, 2000, J BIOL CHEM, V275, P38120, DOI 10.1074/jbc.M007174200; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; Bukys MA, 2006, J BIOL CHEM, V281, P39194, DOI 10.1074/jbc.M604482200; Butenas S, 2002, BIOCHEMISTRY-MOSCOW+, V67, P3; Chan WP, 1998, BLOOD, V91, P1135, DOI 10.1182/blood.V91.4.1135; Chen L, 2003, J BIOL CHEM, V278, P27564, DOI 10.1074/jbc.M302707200; DAHLBACK B, 1983, BIOCHEM J, V209, P837, DOI 10.1042/bj2090837; DAHLBACK B, 1992, BIOCHEMISTRY-US, V31, P12769, DOI 10.1021/bi00166a009; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; Dahlback B, 2005, J INTERN MED, V257, P209, DOI 10.1111/j.1365-2796.2004.01444.x; Deguchi H, 1997, BIOCHEM J, V321, P729, DOI 10.1042/bj3210729; Esmon CT, 2000, BBA-PROTEIN STRUCT M, V1477, P349, DOI 10.1016/S0167-4838(99)00266-6; Fiske CH, 1925, J BIOL CHEM, V66, P375; Gale AJ, 2002, PROTEIN SCI, V11, P2091, DOI 10.1110/ps.0210002; Gale AJ, 2007, J BIOL CHEM, V282, P21848, DOI 10.1074/jbc.M702192200; KALAFATIS M, 1994, BBA-MOL BASIS DIS, V1227, P113, DOI 10.1016/0925-4439(94)90086-8; KALAFATIS M, 1994, J BIOL CHEM, V269, P31869; KOTKOW KJ, 1995, J BIOL CHEM, V270, P4551, DOI 10.1074/jbc.270.9.4551; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; LUCKOW EA, 1989, BIOCHEMISTRY-US, V28, P2348, DOI 10.1021/bi00431a055; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Mann KG, 1997, J BIOL CHEM, V272, P20678, DOI 10.1074/jbc.272.33.20678; MITCHELL CA, 1988, J CLIN INVEST, V82, P2142, DOI 10.1172/JCI113836; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Norstrom E, 2002, BLOOD, V100, P524, DOI 10.1182/blood-2002-02-0343; Norstrom EA, 2003, J BIOL CHEM, V278, P24904, DOI 10.1074/jbc.M303829200; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; ROSING J, 1980, J BIOL CHEM, V255, P274; Schenone M, 2004, CURR OPIN HEMATOL, V11, P272, DOI 10.1097/01.moh.0000130308.37353.d4; Segers K, 2007, THROMB HAEMOSTASIS, V98, P530, DOI 10.1160/TH07-02-0150; Shen L, 1997, BIOCHEMISTRY-US, V36, P16025, DOI 10.1021/bi971730v; Shen MC, 2001, THROMB HAEMOSTASIS, V85, P270; Smirnov MD, 1999, BLOOD, V94, P3839, DOI 10.1182/blood.V94.11.3839.423k07_3839_3846; Smirnov MD, 1998, J BIOL CHEM, V273, P9031, DOI 10.1074/jbc.273.15.9031; SOLYMOSS S, 1988, J BIOL CHEM, V263, P14884; Sun YH, 2004, J BIOL CHEM, V279, P47528, DOI 10.1074/jbc.M407366200; Tosetto A, 1998, BRIT J HAEMATOL, V103, P871, DOI 10.1046/j.1365-2141.1998.01028.x; VANRIJN JLML, 1984, BIOCHEMISTRY-US, V23, P4557, DOI 10.1021/bi00315a008; Williamson D, 1998, BLOOD, V91, P1140, DOI 10.1182/blood.V91.4.1140; Yegneswaran S, 2004, J BIOL CHEM, V279, P49019, DOI 10.1074/jbc.M406645200	47	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6648	6655		10.1074/jbc.M708036200	http://dx.doi.org/10.1074/jbc.M708036200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18198180	hybrid			2022-12-27	WOS:000253779600006
J	Ashe, M; de Bruin, RAM; Kalashnikova, T; McDonald, WH; Yates, JR; Wittenberg, C				Ashe, Mabelle; de Bruin, Robertus A. M.; Kalashnikova, Tatyana; McDonald, W. Hayes; Yates, John R., III; Wittenberg, Curt			The SBF- and MBF-associated protein Msa1 is required for proper timing of G(1)-specific transcription in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST-CELL-CYCLE; G1-SPECIFIC TRANSCRIPTION; BUDDING YEAST; SIZE CONTROL; G1 CYCLINS; CLN3; MECHANISMS; DIVISION; KINASE; PHOSPHORYLATION	In the budding yeast Saccharomyces cerevisiae, cell cycle initiation is prompted during G(1) phase by Cln3/cyclin-dependent protein kinase-mediated transcriptional activation of G(1)-specific genes. A recent screening performed to reveal novel inter-actors of SCB-binding factor (SBF) and MCB-binding factor (MBF) identified, in addition to the SBF-specific repressor Whi5 and the MBF-specific corepressor Nrm1, a pair of homologous proteins, Msa1 and Msa2 (encoded by YOR066w and YKR077w), as interactors of SBF and MBF, respectively. MSA1 is expressed periodically during the cell cycle with peak mRNA levels occurring at the late M/early G(1) phase and peak protein levels occurring in early G(1). Msa1 associates with SBF- and MBF-regulated target promoters consistent with a role in G(1)-specific transcriptional regulation. Msa1 affects cell cycle initiation by advancing the timing of transcription of G(1)-specific genes. Msa1 binds to SBF- and MBF-regulated promoters and binding is maximal during the G(1) phase. Binding depends upon the cognate transcription factor. Msa1 overexpression advances the timing of SBF- dependent transcription and budding, whereas depletion delays both indicators of cell cycle initiation. Similar effects on MBF-regulated transcription are observed. Based upon these results, we conclude that Msa1 acts to advance the timing of G(1)-specific transcription and cell cycle initiation.	[Ashe, Mabelle; de Bruin, Robertus A. M.; Kalashnikova, Tatyana; Wittenberg, Curt] Scripps Res Inst, Dept Mol Biol, MB 3, La Jolla, CA 92037 USA; [McDonald, W. Hayes; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wittenberg, C (corresponding author), Scripps Res Inst, Dept Mol Biol, MB 3, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	curtw@scripps.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059441, R01GM043487] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR 11823] Funding Source: Medline; NIGMS NIH HHS [GM 043487, GM 059441] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Costanzo M, 2003, MOL CELL BIOL, V23, P5064, DOI 10.1128/MCB.23.14.5064-5077.2003; CROSS F, 1992, CIBA F SYMP, V170, P20; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; HADWIGER JA, 1988, MOL CELL BIOL, V8, P2976, DOI 10.1128/MCB.8.7.2976; Hatakeyama M, 1995, Prog Cell Cycle Res, V1, P9; Ho W, 1999, MOL CELL BIOL, V19, P5267; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Johnson David G., 1998, Frontiers in Bioscience, V3, pD447; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LEW DJ, 1993, CELL, V72, P488, DOI 10.1016/0092-8674(93)90068-2; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McDonald WH, 2002, DIS MARKERS, V18, P99, DOI 10.1155/2002/505397; Miller ME, 2001, MOL CELL BIOL, V21, P6292, DOI 10.1128/MCB.21.18.6292-6311.2001; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Pan HC, 1998, MOL CELL, V2, P283, DOI 10.1016/S1097-2765(00)80273-7; Reed SI, 1997, CANCER SURV, V29, P7; Siegmund RF, 1996, MOL CELL BIOL, V16, P2647; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Titz B, 2006, NUCLEIC ACIDS RES, V34, P955, DOI 10.1093/nar/gkj493; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Wijnen H, 1999, GENETICS, V153, P1131; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Wu WS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-421; Yu YX, 2000, MOL CELL BIOL, V20, P2350, DOI 10.1128/MCB.20.7.2350-2357.2000	40	28	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6040	6049		10.1074/jbc.M708248200	http://dx.doi.org/10.1074/jbc.M708248200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18160399	hybrid			2022-12-27	WOS:000253779500009
J	Welscher, YMT; Ten Napel, HH; Balague, MM; Souza, CM; Riezman, H; De Kruijff, B; BreukinkO, E				Welscher, Yvonne M. Te; Ten Napel, Hendrik H.; Balague, Miriam Masia; Souza, Cleiton M.; Riezman, Howard; De Kruijff, Ben; BreukinkO, Eefjan			Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBIOTIC-STEROL INTERACTIONS; POLYENE MACROLIDE ANTIBIOTICS; ACHOLEPLASMA-LAIDLAWII CELLS; AMPHOTERICIN-B; INTRACELLULAR PH; SACCHAROMYCES-CEREVISIAE; LECITHIN LIPOSOMES; CANDIDA-ALBICANS; OXIDATIVE DAMAGE; YEAST	Natamycin is a polyene antibiotic that is commonly used as an antifungal agent because of its broad spectrum of activity and the lack of development of resistance. Other polyene antibiotics, like nystatin and filipin are known to interact with sterols, with some specificity for ergosterol thereby causing leakage of essential components and cell death. The mode of action of natamycin is unknown and is investigated in this study using different in vitro and in vivo approaches. Isothermal titration calorimetry and direct binding studies revealed that natamycin binds specifically to ergosterol present in model membranes. Yeast sterol biosynthetic mutants revealed the importance of the double bonds in the B-ring of ergosterol for the natamycin-ergosterol interaction and the consecutive block of fungal growth. Surprisingly, in strong contrast to nystatin and filipin, natamycin did not change the permeability of the yeast plasma membrane under conditions that growth was blocked. Also, in ergosterol containing model membranes, natamycin did not cause a change in bilayer permeability. This demonstrates that natamycin acts via a novel mode of action and blocks fungal growth by binding specifically to ergosterol.	[Welscher, Yvonne M. Te; Ten Napel, Hendrik H.; Balague, Miriam Masia; De Kruijff, Ben; BreukinkO, Eefjan] Univ Utrecht, Biomembrane Inst, Bijvoet Ctr, Dept Membrane Biochem, NL-3584 CH Utrecht, Netherlands; [Souza, Cleiton M.; Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland	Utrecht University; University of Geneva	Welscher, YMT (corresponding author), Padualaan 8, NL-3584 CH Utrecht, Netherlands.	m.tewelscher@uu.nl	Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660; Riezman, Howard/0000-0003-4680-9422				Aparicio JF, 1999, J BIOL CHEM, V274, P10133, DOI 10.1074/jbc.274.15.10133; BAGINSKI M, 1989, EUR BIOPHYS J BIOPHY, V17, P159, DOI 10.1007/BF00254770; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X; BOYER MJ, 1994, METHOD CELL BIOL, V41, P135; Bracey D, 1998, J APPL MICROBIOL, V85, P1056, DOI 10.1111/j.1365-2672.1998.tb05271.x; Bracey D, 1998, J MICROBIOL METH, V31, P113, DOI 10.1016/S0167-7012(97)00095-X; BRAJTBURG J, 1985, ANTIMICROB AGENTS CH, V27, P172, DOI 10.1128/AAC.27.2.172; Breukink E, 1997, BIOCHEMISTRY-US, V36, P6968, DOI 10.1021/bi970008u; CLEJAN S, 1985, J BIOL CHEM, V260, P2884; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P30, DOI 10.1016/0005-2736(74)90330-7; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P57, DOI 10.1016/0005-2736(74)90332-0; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; Lascombe MB, 2002, ACTA CRYSTALLOGR D, V58, P1442, DOI 10.1107/S0907444902011745; Lopes SCDN, 2004, J AM CHEM SOC, V126, P5396, DOI 10.1021/ja031782+; MILHAUD J, 1992, BIOCHIM BIOPHYS ACTA, V1105, P307, DOI 10.1016/0005-2736(92)90209-5; MILHAUD J, 1989, EUR BIOPHYS J BIOPHY, V17, P151; MISHRA P, 1992, BIOCHIM BIOPHYS ACTA, V1127, P1, DOI 10.1016/0005-2760(92)90194-Z; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Munn AL, 2001, BBA-MOL BASIS DIS, V1535, P236, DOI 10.1016/S0925-4439(01)00028-X; Rodrigues ML, 2006, BBA-PROTEINS PROTEOM, V1764, P110, DOI 10.1016/j.bbapap.2005.09.008; ROUSER G, 1970, LIPIDS, V5, P496; SOKOLANDERSON ML, 1986, J INFECT DIS, V154, P76, DOI 10.1093/infdis/154.1.76; Takeda T, 2005, CURR BIOL, V15, P1331, DOI 10.1016/j.cub.2005.07.009; van Kan EJM, 2002, BIOCHEMISTRY-US, V41, P7529, DOI 10.1021/bi012162t; Volpon L, 2002, EUR J BIOCHEM, V269, P4533, DOI 10.1046/j.1432-1033.2002.03147.x; Wachtler V, 2006, TRENDS CELL BIOL, V16, P1, DOI 10.1016/j.tcb.2005.11.008	30	171	178	3	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6393	6401		10.1074/jbc.M707821200	http://dx.doi.org/10.1074/jbc.M707821200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165687	hybrid			2022-12-27	WOS:000253779500047
J	Hsu, YH; Burke, JE; Stephens, DL; Deems, RA; Li, S; Asmus, KM; Woods, VL; Dennis, EA				Hsu, Yuan-Hao; Burke, John E.; Stephens, Daren L.; Deems, Raymond A.; Li, Sheng; Asmus, Kyle M.; Woods, Virgil L., Jr.; Dennis, Edward A.			Calcium binding rigidifies the C2 domain and the intradomain interaction of GIVA phospholipase A(2) as revealed by hydrogen/deuterium exchange mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-SPECIFIC ASSAYS; CYTOSOLIC PHOSPHOLIPASE; HYDROGEN-EXCHANGE; CRYSTAL-STRUCTURE; ARACHIDONIC-ACID; CATALYTIC DOMAIN; PROTEIN; MEMBRANE; MECHANISM; PHOSPHORYLATION	The GIVA phospholipase A(2) (PLA(2)) contains two domains: a calcium-binding domain (C2) and a catalytic domain. These domains are linked via a flexible tether. GIVA PLA(2) activity is Ca2+-dependent in that calcium binding promotes protein docking to the phospholipid membrane. In addition, the catalytic domain has a lid that covers the active site, presumably regulating GIVA PLA(2) activity. We now present studies that explore the dynamics and conformational changes of this enzyme in solution utilizing peptide amide hydrogen/deuterium (H/D) exchange coupled with liquid chromatography-mass spectrometry (DXMS) to probe the solvent accessibility and backbone flexibility of the C2 domain, the catalytic domain, and the intact GIVA PLA(2). We also analyzed the changes in H/D exchange of the intact GIVA PLA(2) upon Ca2+ binding. The DXMS results showed a fast H/D-exchanging lid and a slow exchanging central core. The C2 domain showed two distinct regions: a fast exchanging region facing away from the catalytic domain and a slow exchanging region present in the "cleft" region between the C2 and catalytic domains. The slow exchanging region of the C2 domain is in tight proximity to the catalytic domain. The effects of Ca2+ binding on GIVA PLA(2) are localized in the C2 domain and suggest that binding of two distinct Ca2+ ions causes tightening up of the regions that surround the anion hole at the tip of the C2 domain. This conformational change may be the initial step in GIVA PLA(2) activation.	[Li, Sheng; Asmus, Kyle M.; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Hsu, Yuan-Hao; Burke, John E.; Stephens, Daren L.; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Hsu, Yuan-Hao; Burke, John E.; Stephens, Daren L.; Deems, Raymond A.; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Woods, VL (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; edennis@ucsd.edu	Burke, John/H-3922-2019; Burke, John/A-5659-2013; hsu, yuan-hao/B-5744-2009; Dennis, Edward A./M-5554-2019	Burke, John/0000-0001-7904-9859; Burke, John/0000-0003-1668-2109; Dennis, Edward A./0000-0003-3738-3140	NATIONAL CANCER INSTITUTE [R33CA099835, R21CA099835, R21CA118595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684] Funding Source: NIH RePORTER; NCI NIH HHS [CA 118595, CA 099835] Funding Source: Medline; NIAID NIH HHS [AI 0220221, AI 022160] Funding Source: Medline; NIGMS NIH HHS [GM 20501, R01 GM020501, GM 037684] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALONSO F, 1986, BIOCHIM BIOPHYS ACTA, V878, P273, DOI 10.1016/0005-2760(86)90156-6; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; Das S, 2002, J BIOL CHEM, V277, P23838, DOI 10.1074/jbc.M202322200; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Engen JR, 2001, ANAL CHEM, V73, p256A, DOI 10.1021/ac012452f; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; GOETZL EJ, 1995, FASEB J, V9, P1051, DOI 10.1096/fasebj.9.11.7649404; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hochrein JM, 2006, PROTEIN SCI, V15, P65, DOI 10.1110/ps.051782206; Hoofnagle AN, 2001, P NATL ACAD SCI USA, V98, P956, DOI 10.1073/pnas.98.3.956; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; KRAMER RM, 1995, AGENT ACTION SUPPL, V46, P65; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lucas KK, 2005, BRIT J PHARMACOL, V144, P940, DOI 10.1038/sj.bjp.0706116; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Malkova S, 2005, BIOPHYS J, V89, P1861, DOI 10.1529/biophysj.105.061515; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Nalefski EA, 1997, BIOCHEMISTRY-US, V36, P12011, DOI 10.1021/bi9717340; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Sapirstein A, 2000, BBA-MOL CELL BIOL L, V1488, P139, DOI 10.1016/S1388-1981(00)00116-5; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Xu GY, 1998, J MOL BIOL, V280, P485, DOI 10.1006/jmbi.1998.1874; Yang HC, 1999, ANAL BIOCHEM, V269, P278, DOI 10.1006/abio.1999.4053	40	36	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9820	9827		10.1074/jbc.M708143200	http://dx.doi.org/10.1074/jbc.M708143200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18211893	Green Published, hybrid			2022-12-27	WOS:000254671600037
J	Romeo, GR; Kazlauskas, A				Romeo, Giulio R.; Kazlauskas, Andrius			Oxysterol and diabetes activate STAT3 and control endothelial expression of profilin-1 via OSBP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; INSULIN-RESISTANCE; RECEPTOR; ATHEROSCLEROSIS; TRANSCRIPTION; INFLAMMATION; DYSFUNCTION; LDL; GENERATION; INHIBITION	Endothelial dysfunction plays a central role in diabetic vascular disease, but its molecular bases are not completely defined. We showed previously that the actin-binding protein proflin-1 was increased in the diabetic endothelium and that attenuated expression of profilin-1 protected against atherosclerosis. Also 7-ketocholesterol up-regulated profilin-1 in endothelial cells via transcriptional mechanisms. The present study addressed the pathways responsible for profilin-1 gene expression in 7-ketocholesterol-stimulated endothelial cells and in the diabetic aorta. In luciferase reporter assays, the response to 7-ketocholesterol within the 5'-flanking region of profilin-1 was dependent on a single STAT response element. In aortic endothelial cells, 7-ketocholesterol enhanced STAT3 activation, which required JAK2 and tyrosine 394 phosphorylation of oxysterol-binding protein-1. These changes were recapitulated in the aorta of diabetic rats. Also 7-ketocholesterol in cultured endothelial cells and diabetes in the aorta elicited the recruitment of STAT3 and relevant coregulatory factors to the oxysterol-responsive region of the profilin-1 promoter. These events were required for profilin-1 up-regulation. These studies identify a previously unrecognized oxysterol-binding protein-mediated mode of activation of STAT3 that controls the expression of the proatherogenic protein profilin-1 in response to 7-ketocholesterol and the diabetic milieu.	[Romeo, Giulio R.; Kazlauskas, Andrius] Harvard Univ, Sch Med, Eye Res Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Romeo, GR (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02115 USA.	giulio.romeo@joslin.harvard.edu						Agrawal S, 2002, MOL CELL BIOL, V22, P1981, DOI 10.1128/MCB.22.7.1981-1992.2002; Banes-Berceli AKL, 2007, AM J PHYSIOL-HEART C, V293, pH1291, DOI 10.1152/ajpheart.00181.2007; Brown AJ, 1997, J LIPID RES, V38, P1730; Chikani G, 2004, AM J PHYSIOL-ENDOC M, V287, pE386, DOI 10.1152/ajpendo.00106.2004; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; deKoning JP, 1996, BLOOD, V87, P1335, DOI 10.1182/blood.V87.4.1335.bloodjournal8741335; Didry D, 1998, J BIOL CHEM, V273, P25602, DOI 10.1074/jbc.273.40.25602; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Fledderus JO, 2007, BLOOD, V109, P4249, DOI 10.1182/blood-2006-07-036020; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; JOHNSTONE MT, 1993, CIRCULATION, V88, P2510, DOI 10.1161/01.CIR.88.6.2510; Kang F, 1999, J BIOL CHEM, V274, P36963, DOI 10.1074/jbc.274.52.36963; Lamharzi N, 2004, DIABETES, V53, P3217, DOI 10.2337/diabetes.53.12.3217; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Massey JB, 2006, CURR OPIN LIPIDOL, V17, P296, DOI 10.1097/01.mol.0000226123.17629.ab; Olkkonen VM, 2004, BIOCHEM CELL BIOL, V82, P87, DOI 10.1139/o03-088; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Pennathur S, 2001, J CLIN INVEST, V107, P853, DOI 10.1172/JCI11194; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Romeo G, 2004, FASEB J, V18, P725, DOI 10.1096/fj.03-0841fje; Romeo GR, 2007, CIRC RES, V101, P357, DOI 10.1161/CIRCRESAHA.107.151399; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Shao H, 2004, J BIOL CHEM, V279, P18967, DOI 10.1074/jbc.M314037200; Sheppard HM, 2001, MOL CELL BIOL, V21, P39, DOI 10.1128/MCB.21.1.39-50.2001; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Steinberg HO, 1997, CIRCULATION, V96, P3287; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; TESFAMARIAM B, 1990, J CLIN INVEST, V85, P929, DOI 10.1172/JCI114521; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	43	47	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9595	9605		10.1074/jbc.M710092200	http://dx.doi.org/10.1074/jbc.M710092200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18230613	hybrid			2022-12-27	WOS:000254671600013
J	Takaya, T; Kawamura, T; Morimoto, T; Ono, K; Kita, T; Shimatsu, A; Hasegawa, K				Takaya, Tomohide; Kawamura, Teruhisa; Morimoto, Tatsuya; Ono, Koh; Kita, Toru; Shimatsu, Akira; Hasegawa, Koji			Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; CREB-BINDING PROTEIN; HEAVY-CHAIN GENE; EMBRYONIC STEM-CELLS; MOLECULAR-CLONING; COACTIVATOR P300; HEART-FAILURE; IN-VIVO; EXPRESSION; DIFFERENTIATION	A zinc finger protein, GATA4, is one of the hypertrophy-responsive transcription factors and increases its DNA binding and transcriptional activities in response to hypertrophic stimuli in cardiac myocytes. Activation of GATA4 during this process is mediated, in part, through acetylation by intrinsic histone acetyltransferases such as a transcriptional coactivator p300. However, p300-targeted acetylated sites of GATA4 during myocardial cell hypertrophy have not been identified. By mutational analysis, we showed that 4 lysine residues located between amino acids 311 and 322 are required for synergistic activation of atrial natriuretic factor and endothelin-1 promoters by GATA4 and p300. A tetra-mutant GATA4, in which these 4 lysine residues were simultaneously mutated, retained the ability to localize in nuclei and to interact with cofactors including FOG-2, GATA6, and p300 but lacked p300-induced acetylation, DNA binding, and transcriptional activities. Furthermore, coexpression of the tetra-mutant GATA4 with wild-type GATA4 impaired the p300-induced acetylation, DNA binding, and transcriptional activities of the wild type. When we expressed the tetra-mutant GATA4 in neonatal rat cardiac myocytes using a lentivirus vector, this mutant suppressed phenylephrine-induced increases in cell size, protein synthesis, and expression of hypertrophy-responsive genes. However, its expression did not affect the basal state. Thus, we have identified the most critical lysine residues acting as p300-mediated acetylation targets in GATA4 during hypertrophic responses in cardiac myocytes. The results also demonstrate that GATA4 with simultaneous mutation of these sites specifically suppresses hypertrophic responses as a dominant-negative form, providing further evidence for the acetylation of GATA4 as one of critical nuclear events in myocardial cell hypertrophy.	[Takaya, Tomohide; Kawamura, Teruhisa; Morimoto, Tatsuya; Hasegawa, Koji] Natl Hosp Org, Div Translat Res, Kyoto Med Ctr, Fushimi Ku, Kyoto 6128555, Japan; [Shimatsu, Akira] Natl Hosp Org, Clin Res Inst, Kyoto Med Ctr, Fushimi Ku, Kyoto 6128555, Japan; [Takaya, Tomohide; Ono, Koh; Kita, Toru] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Hasegawa, K (corresponding author), Natl Hosp Org, Div Translat Res, Kyoto Med Ctr, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.	koj@kuhp.kyoto-u.ac.jp	Shimatsu, Akira/I-3856-2019; Takaya, Tomohide/D-6372-2012	Takaya, Tomohide/0000-0002-3610-0906				ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Chan HM, 2001, J CELL SCI, V114, P2363; Charron F, 1999, MOL CELL BIOL, V19, P4355; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Dai YS, 2001, J BIOL CHEM, V276, P37178, DOI 10.1074/jbc.M103731200; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Gheorghiu I, 2001, J BIOL CHEM, V276, P44331, DOI 10.1074/jbc.M107591200; Hasegawa K, 1997, J BIOL CHEM, V272, P20049, DOI 10.1074/jbc.272.32.20049; Hasegawa K, 1997, CIRCULATION, V96, P3943; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Hidaka K, 2003, FASEB J, V17, P740, DOI 10.1096/fj.02-0104fje; Hirai M, 2004, J BIOL CHEM, V279, P37640, DOI 10.1074/jbc.M401737200; Hosseinkhani M, 2007, BIOCHEM BIOPH RES CO, V356, P386, DOI 10.1016/j.bbrc.2007.02.151; Hung HL, 1999, MOL CELL BIOL, V19, P3496; IP HS, 1994, MOL CELL BIOL, V14, P7517, DOI 10.1128/MCB.14.11.7517; Iwanaga Y, 1998, CIRCULATION, V98, P2065, DOI 10.1161/01.CIR.98.19.2065; Kaburagi S, 1999, CIRCULATION, V99, P292, DOI 10.1161/01.CIR.99.2.292; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Miyamoto S, 2006, CIRCULATION, V113, P679, DOI 10.1161/CIRCULATIONAHA.105.585182; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Morimoto T, 1999, J BIOL CHEM, V274, P12811, DOI 10.1074/jbc.274.18.12811; Morimoto T, 2000, J BIOL CHEM, V275, P13721, DOI 10.1074/jbc.275.18.13721; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1997, J BIOL CHEM, V272, P8515, DOI 10.1074/jbc.272.13.8515; Morrisey EE, 1997, DEV BIOL, V183, P21, DOI 10.1006/dbio.1996.8485; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Suzuki E, 1996, GENOMICS, V38, P283, DOI 10.1006/geno.1996.0630; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Tanaka Y, 2000, MECH DEVELOP, V95, P133, DOI 10.1016/S0925-4773(00)00360-9; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057; Wada H, 2000, J BIOL CHEM, V275, P25330, DOI 10.1074/jbc.M000828200; Yamagata T, 2000, EMBO J, V19, P4676, DOI 10.1093/emboj/19.17.4676; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003; Yanazume T, 2002, J BIOL CHEM, V277, P8618, DOI 10.1074/jbc.M107924200; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	45	73	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9828	9835		10.1074/jbc.M707391200	http://dx.doi.org/10.1074/jbc.M707391200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18252717	hybrid, Green Submitted			2022-12-27	WOS:000254671600038
J	Gavira, JA; Camara-Artigas, A; De Jesus-Bonilla, W; Lopez-Garriga, J; Lewis, A; Pietri, R; Yeh, SR; Cadilla, CL; Garcia-Ruiz, JM				Gavira, Jose A.; Camara-Artigas, Ana; De Jesus-Bonilla, Walleska; Lopez-Garriga, Juan; Lewis, Ariel; Pietri, Ruth; Yeh, Syun-Ru; Cadilla, Carmen L.; Garcia-Ruiz, Juan Manuel			Structure and ligand selection of hemoglobin II from Lucina pectinata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAPHARCA DIMERIC HEMOGLOBIN; SULFIDE-REACTIVE HEMOGLOBIN; AMINO-ACID-SEQUENCE; TYROSINE B10; MYCOBACTERIUM-TUBERCULOSIS; BACTERIA SYMBIOSIS; CRYSTAL-STRUCTURE; HEME REACTIVITY; BINDING; MODEL	Lucina pectinata ctenidia harbor three heme proteins: sulfide-reactive hemoglobin I (HbI(Lp)) and the oxygen transporting hemoglobins II and III (HbII(Lp) and HbIII(Lp)) that remain unaffected by the presence of H2S. The mechanisms used by these three proteins for their function, including ligand control, remain unknown. The crystal structure of oxygen-bound HbII(Lp) shows a dimeric oxyHbII(Lp) where oxygen is tightly anchored to the heme through hydrogen bonds with Tyr(30)(B10) and Gln(65)(E7). The heme group is buried farther within HbII(Lp) than in HbI(Lp). The proximal His(97)(F8) is hydrogen bonded to a water molecule, which interacts electrostatically with a propionate group, resulting in a Fe-His vibration at 211 cm(-1). The combined effects of the HbIILp small heme pocket, the hydrogen bonding network, the His97 trans-effect, and the orientation of the oxygen molecule confer stability to the oxy-HbII(Lp) complex. Oxidation of HbI(Lp) Phe(B10) -> Tyr and HbII(Lp) only occurs when the pH is decreased from pH 7.5 to 5.0. Structural and resonance Raman spectroscopy studies suggest that HbII(Lp) oxygen binding and transport to the host bacteria may be regulated by the dynamic displacements of the Gln65(E7) and Tyr30(B10) pair toward the heme to protect it from changes in the heme oxidation state from Fe-II to Fe-III.	[De Jesus-Bonilla, Walleska; Lopez-Garriga, Juan; Lewis, Ariel; Pietri, Ruth] Univ Puerto Rico, Dept Chem, Mayaguez, PR 00681 USA; [Gavira, Jose A.; Garcia-Ruiz, Juan Manuel] PT Ciencias Salud, CSIC, Lab Estudios Cristalog, Granada 18100, Spain; [Camara-Artigas, Ana] Univ Almeria, Dept Quim Fis, Almeria 04120, Spain; [Yeh, Syun-Ru] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Cadilla, Carmen L.] Univ Puerto Rico, Dept Biochem, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Mayaguez; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Almeria; Yeshiva University; Albert Einstein College of Medicine; University of Puerto Rico	Lopez-Garriga, J (corresponding author), Univ Puerto Rico, Dept Chem, POB 9019,Mayaguez Campus, Mayaguez, PR 00681 USA.	lopezj@uprm.edu	Gavira, Jose A./C-2491-2009; Garcia-Ruiz, Juan Manuel/C-4389-2015; García-Ruiz, Juan Manuel/U-1085-2019; Camara-Artigas, Ana/M-2252-2019	Gavira, Jose A./0000-0002-7386-6484; Garcia-Ruiz, Juan Manuel/0000-0002-4743-8718; García-Ruiz, Juan Manuel/0000-0002-4743-8718; Camara-Artigas, Ana/0000-0003-2197-726X; Yeh, Syun-Ru/0000-0002-9858-386X	NCRR NIH HHS [G12 RR003051, P20 RR 016470, G12 RR 03051] Funding Source: Medline; NHLBI NIH HHS [HL 65465] Funding Source: Medline; NIGMS NIH HHS [S06 GM 08103-34] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051, P20RR016470] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008103] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; BLAXTER ML, 1994, J BIOL CHEM, V269, P30181; Bolognesi M, 1999, BIOPHYS J, V77, P1093, DOI 10.1016/S0006-3495(99)76959-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Califano S., 1976, VIBRATIONAL STATES, P95; CARVER TE, 1992, J BIOL CHEM, V267, P14443; Cerda J, 1999, BIOSPECTROSCOPY, V5, P289; CONDON PJ, 1994, J BIOL CHEM, V269, P25259; COULSON CA, 1947, NATURE, V159, P794; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Das TK, 1999, J BIOL CHEM, V274, P2916, DOI 10.1074/jbc.274.5.2916; De Jesus-Bonilla W, 2006, J BIOL INORG CHEM, V11, P334, DOI 10.1007/s00775-006-0082-0; De Jesus-Bonilla W, 2007, BIOCHEMISTRY-US, V46, P10451, DOI 10.1021/bi7003262; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Alberti S, 2006, BIOPHYS J, V91, P1698, DOI 10.1529/biophysj.106.081646; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Garcia-Ruiz JM, 2003, METHOD ENZYMOL, V368, P130, DOI 10.1016/S0076-6879(03)68008-0; Gavira JA, 2006, ACTA CRYSTALLOGR F, V62, P196, DOI 10.1107/S1744309106002648; Hirota S, 1996, J AM CHEM SOC, V118, P7845, DOI 10.1021/ja9608297; HOCKENHULLJOHNSON JD, 1991, J PROTEIN CHEM, V10, P609, DOI 10.1007/BF01025713; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KRAUS DW, 1990, J BIOL CHEM, V265, P16043; KRAUS DW, 1990, J BIOL CHEM, V265, P16054; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leon RG, 2004, PROTEIN EXPRES PURIF, V38, P184, DOI 10.1016/j.pep.2004.08.014; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Mukai M, 2001, J BIOL CHEM, V276, P7272, DOI 10.1074/jbc.M009280200; Navarro AM, 1996, INORG CHIM ACTA, V243, P161, DOI 10.1016/0020-1693(95)04903-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pardanani A, 1998, J MOL BIOL, V284, P729, DOI 10.1006/jmbi.1998.2195; Peterson ES, 1997, BIOCHEMISTRY-US, V36, P13110, DOI 10.1021/bi971156n; Pietri R, 2005, BBA-PROTEINS PROTEOM, V1747, P195, DOI 10.1016/j.bbapap.2004.11.005; Pietri R, 2006, BBA-PROTEINS PROTEOM, V1764, P758, DOI 10.1016/j.bbapap.2005.11.006; READ KRH, 1965, COMP BIOCHEM PHYSIOL, V15, P137; Rizzi M, 1996, J MOL BIOL, V258, P1, DOI 10.1006/jmbi.1996.0228; RIZZI M, 1994, J MOL BIOL, V244, P86, DOI 10.1006/jmbi.1994.1706; Royer WE, 1996, P NATL ACAD SCI USA, V93, P14526, DOI 10.1073/pnas.93.25.14526; ROYER WE, 1995, J MOL BIOL, V253, P168, DOI 10.1006/jmbi.1995.0543; Royer WE, 2001, TRENDS BIOCHEM SCI, V26, P297, DOI 10.1016/S0968-0004(01)01811-4; Saroff HA, 2004, J THEOR BIOL, V229, P113, DOI 10.1016/j.jtbi.2004.03.007; SMERDON SJ, 1993, BIOCHEMISTRY-US, V32, P5132, DOI 10.1021/bi00070a023; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres-Mercado E, 2003, J PROTEIN CHEM, V22, P683, DOI 10.1023/B:JOPC.0000008734.44356.b7; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YANG J, 1995, P NATL ACAD SCI USA, V92, P4224, DOI 10.1073/pnas.92.10.4224; Zhou YQ, 2003, J MOL BIOL, V326, P593, DOI 10.1016/S0022-2836(02)01329-3	53	22	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9414	9423		10.1074/jbc.M705026200	http://dx.doi.org/10.1074/jbc.M705026200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18203714	Green Published, hybrid			2022-12-27	WOS:000254465800071
J	Zhao, Y; Chen, YQ; Bonacci, TM; Bredt, DS; Li, SY; Bensch, WR; Moller, DE; Kowala, M; Konrad, RJ; Cao, GQ				Zhao, Yang; Chen, Yan-Qun; Bonacci, Tabetha M.; Bredt, David S.; Li, Shuyu; Bensch, William R.; Moller, David E.; Kowala, Mark; Konrad, Robert J.; Cao, Guoqing			Identification and characterization of a major liver lysophosphatidylcholine acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; ACYL-COA; SACCHAROMYCES-CEREVISIAE; TRIACYLGLYCEROL SYNTHESIS; ACID ACYLTRANSFERASE; O-ACYLTRANSFERASES; II CELLS; METABOLISM; CLONING; GLYCEROLIPIDS	Phosphatidylcholine (PC) is synthesized through the Kennedy pathway, but more than 50% of PC is remodeled through the Lands cycle, i.e. the deacylation and reacylation of PC to attain the final and proper fatty acids within PC. The reacylation step is catalyzed by lysophosphatidylcholine acyltransferase (LPCAT), and we report here the identification of a novel LPCAT, which we named LPCAT3. LPCAT3 belongs to the membrane-bound O-acyltransferase (MBOAT) family and encodes a protein of 487 amino acids with a calculated molecular mass of 56 kDa. Membranes from HEK293 cells overexpressing LPCAT3 showed significantly increased LPCAT activity as assessed by thin layer chromatography analysis with substrate preference toward unsaturated fatty acids. LPCAT3 is localized within the endoplasmic reticulum and is primarily expressed in metabolic tissues including liver, adipose, and pancreas. In a human hepatoma Huh7 cells, RNA interference-mediated knockdown of LPCAT3 resulted in virtually complete loss of membrane LPCAT activity, suggesting that LPCAT3 is primarily responsible for hepatic LPCAT activity. Furthermore, peroxisome proliferator-activated receptor alpha agonists dose-dependently regulated LPCAT3 in liver in a peroxisome proliferatoractivated receptor alpha-dependent fashion, implicating a role of LPCAT3 in lipid homeostasis. Our studies identify a long-sought enzyme that plays a critical role in PC remodeling in metabolic tissues and provide an invaluable tool for future investigations on how PC remodeling may potentially impact glucose and lipid homeostasis.	[Zhao, Yang; Chen, Yan-Qun; Bonacci, Tabetha M.; Bredt, David S.; Li, Shuyu; Bensch, William R.; Moller, David E.; Kowala, Mark; Konrad, Robert J.; Cao, Guoqing] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly	Cao, GQ (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	guoqing_cao@lilly.com		Chen, Yan Q/0000-0001-9311-6077				Agarwal AK, 2007, J ENDOCRINOL, V193, P445, DOI 10.1677/JOe-07-0027; Aguado B, 1998, J BIOL CHEM, V273, P4096, DOI 10.1074/jbc.273.7.4096; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Choy PC, 1997, BBA-LIPID LIPID MET, V1348, P124, DOI 10.1016/S0005-2760(97)00114-8; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; KENNEDY EP, 1989, PHOSPHATIDYLCHOLINE, P1; Lands W., 1976, ENZYMES BIOL MEMBRAN, V2, P3; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1982, J BIOL CHEM, V257, P4968; LANDS WEM, 1963, J BIOL CHEM, V238, P898; MACDONALD JIS, 1991, BIOCHIM BIOPHYS ACTA, V1084, P105, DOI 10.1016/0005-2760(91)90209-Z; MERKL I, 1963, J BIOL CHEM, V238, P905; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Tran K, 2006, BBA-MOL CELL BIOL L, V1761, P463, DOI 10.1016/j.bbalip.2006.03.018; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200	30	120	126	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8258	8265		10.1074/jbc.M710422200	http://dx.doi.org/10.1074/jbc.M710422200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18195019	hybrid			2022-12-27	WOS:000254288000023
J	Chen, LC; Nievera, CJ; Lee, AYL; Wu, XH				Chen, Longchuan; Nievera, Christian J.; Lee, Alan Yueh-Luen; Wu, Xiaohua			Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELOMERASE CATALYTIC SUBUNIT; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; TUMOR-SUPPRESSOR; MAMMALIAN-CELLS; IONIZING-RADIATION; VERTEBRATE CELLS; SYNDROME PROTEIN; MEIOTIC CELLS; END RESECTION	BRCA1 plays an important role in the homologous recombination (HR)-mediated DNA double-strand break (DSB) repair, but the mechanism is not clear. Here we describe that BRCA1 forms a complex with CtIP and MRN (Mre11/Rad50/Nbs1) in a cell cycle-dependent manner. Significantly, the complex formation, especially the ionizing radiation-enhanced association of BRCA1 with MRN, requires cyclin-dependent kinase activity. CtIP directly interacts with Nbs1. The in vivo association of BRCA1 with MRN is largely dependent on the association of CtIP with the BRCT domains at the C terminus of BRCA1, whereas the N terminus of BRCA1 also contributes to its association with MRN. CtIP, as well as the interaction of BRCA1 with CtIP and MRN, is critical for IR-induced single-stranded DNA formation and cellular resistance to radiation. Consistently, CtIP itself is required for efficient HR-mediated DSB repair, like BRCA1 and MRN. These studies suggest that the complex formation of BRCA1.CtIP.MRN is important for facilitating DSB resection to generate single-stranded DNA that is needed for HR-mediated DSB repair. Because cyclin-dependent kinase is important for establishing IR-enhanced interaction of MRN with BRCA1, we propose that the cell cycle-dependent complex formation of BRCA1, CtIP, and MRN contributes to the activation of HR-mediated DSB repair in the S and G(2) phases of the cell cycle.	[Nievera, Christian J.; Lee, Alan Yueh-Luen; Wu, Xiaohua] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Chen, Longchuan] Vet Affairs Med Ctr, Dept Pathol, Long Beach, CA 90822 USA	Scripps Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu	Lee, Alan Yueh-Luen/A-9141-2010; Lee, Alan Yueh-Luen/B-1097-2010	Lee, Alan Yueh-Luen/0000-0003-0252-0571	NATIONAL CANCER INSTITUTE [R01CA102361] Funding Source: NIH RePORTER; NCI NIH HHS [CA102361] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; Caspari T, 2002, GENE DEV, V16, P1195, DOI 10.1101/gad.221402; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; CHEONG N, 1994, MUTAT RES, V314, P77, DOI 10.1016/0921-8777(94)90063-9; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Fusco C, 1998, GENOMICS, V51, P351, DOI 10.1006/geno.1998.5368; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Moynahan ME, 2001, CANCER RES, V61, P4842; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Penkner A, 2007, EMBO J, V26, P5071, DOI 10.1038/sj.emboj.7601916; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Ranganathan V, 2001, CURR BIOL, V11, P962, DOI 10.1016/S0960-9822(01)00267-6; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Snouwaert JN, 1999, ONCOGENE, V18, P7900, DOI 10.1038/sj.onc.1203334; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Starita LM, 2003, CURR OPIN CELL BIOL, V15, P345, DOI 10.1016/S0955-0674(03)00042-5; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tauchi H, 2002, NATURE, V420, P93, DOI 10.1038/nature01125; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang Y, 2000, GENE DEV, V14, P927; Williams RS, 2003, J BIOL CHEM, V278, P53007, DOI 10.1074/jbc.M310182200; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Wu X, 2000, COLD SPRING HARB SYM, V65, P535, DOI 10.1101/sqb.2000.65.535; Wu X, 2000, Science, V289, P11; Wu XH, 2004, GENE DEV, V18, P1305, DOI 10.1101/gad.1182804; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu X, 2000, J BIOL CHEM, V275, P18541, DOI 10.1074/jbc.M909494199; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	61	303	314	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7713	7720		10.1074/jbc.M710245200	http://dx.doi.org/10.1074/jbc.M710245200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18171670	hybrid			2022-12-27	WOS:000253997900048
J	Harris, M; Garcia-Caballero, A; Stutts, MJ; Firsov, D; Rossier, BC				Harris, Michael; Garcia-Caballero, Agustin; Stutts, M. Jackson; Firsov, Dmitri; Rossier, Bernard C.			Preferential assembly of epithelial sodium channel (ENaC) subunits in Xenopus Oocytes - Role of furin-mediated endogenous proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNIT; ALPHA-SUBUNIT; NA+ CHANNEL; RAT-KIDNEY; EXPRESSION; MATURATION	The epithelial sodium channel ( ENaC) is preferentially assembled into heteromeric alpha beta gamma complexes. The alpha and gamma ( not beta) subunits undergo proteolytic cleavage by endogenous furin-like activity correlating with increased ENaC function. We identified full-length subunits and their fragments at the cell surface, as well as in the intracellular pool, for all homo- and heteromeric combinations (alpha, beta, gamma, alpha beta, alpha gamma, beta gamma, and alpha beta gamma). We assayed corresponding channel function as amiloride-sensitive sodium transport (I-Na). We varied furin-mediated proteolysis by mutating the P1 site in alpha and/ or gamma subunit furin consensus cleavage sites (alpha(mu)t and gamma(mut)). Our findings were as follows. (i) The beta subunit alone is not transported to the cell surface nor cleaved upon assembly with the alpha and/ or gamma subunits. ( ii) The alpha subunit alone ( or in combination with beta and/ or gamma) is efficiently transported to the cell surface; a surface-expressed 65-kDa alpha ENaC fragment is undetected in alpha(mut)beta gamma, and I-Na is decreased by 60%. ( iii) The gamma subunit alone does not appear at the cell surface; gamma co-expressed with alpha reaches the surface but is not detectably cleaved; and gamma in alpha beta gamma complexes appears mainly as a 76-kDa species in the surface pool. Although basal INa of alpha beta gamma(mut) was similar to alpha beta gamma, gamma(mut) was not detectably cleaved at the cell surface. Thus, furin-mediated cleavage is not essential for participation of alpha and gamma in alpha beta gamma heteromers. Basal I-Na is reduced by preventing furin-mediated cleavage of the alpha, but not gamma, subunits. Residual current in the absence of furin-mediated proteolysis may be due to non-furin endogenous proteases.	[Harris, Michael; Firsov, Dmitri; Rossier, Bernard C.] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Garcia-Caballero, Agustin; Stutts, M. Jackson] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of Lausanne; University of North Carolina; University of North Carolina Chapel Hill	Rossier, BC (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, 27 Rue Bugnon, CH-1005 Lausanne, Switzerland.	Bernard.Rossier@unil.ch			NHLBI NIH HHS [HL034322] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Bonny O, 1999, J CLIN INVEST, V104, P967, DOI 10.1172/JCI6821; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Eskandari S, 1999, J BIOL CHEM, V274, P27281, DOI 10.1074/jbc.274.38.27281; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; FIRSOV D, 1997, NOVA ACTA LEOPOLDINA, V302, P13; Frindt G, 2002, AM J PHYSIOL-RENAL, V283, pF717, DOI 10.1152/ajprenal.00379.2001; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Rubera I, 2003, J CLIN INVEST, V112, P554, DOI 10.1172/JCI200316956; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681	19	50	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7455	7463		10.1074/jbc.M707399200	http://dx.doi.org/10.1074/jbc.M707399200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18195015	Green Published, hybrid			2022-12-27	WOS:000253997900020
J	Mahrour, N; Redwine, WB; Florens, L; Swanson, SK; Martin-Brown, S; Bradford, WD; Staehling-Hampton, K; Washburn, MP; Conaway, RC; Conaway, JW				Mahrour, Nawel; Redwine, William B.; Florens, Laurence; Swanson, Selene K.; Martin-Brown, Skylar; Bradford, William D.; Staehling-Hampton, Karen; Washburn, Michael P.; Conaway, Ronald C.; Conaway, Joan W.			Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to elongin BC-based ubiquitin ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; TUMOR-SUPPRESSOR COMPLEX; SOCS-BOX; SHOTGUN PROTEOMICS; ADAPTER PROTEIN; BINDING; GENE; FAMILY; DEFINES; CLONING	The Elongin BC-box protein family includes the von Hippel-Lindau tumor suppressor and suppressor of cytokine signaling proteins, which are substrate recognition subunits of structurally related classes of E3 ubiquitin ligases composed of Elongin C-Elongin B-Cullin 2-Rbx1 (Cul2 ubiquitin ligases) or of Elongin C-Elongin B-Cullin 5-Rbx2 (Cul5 ubiquitin ligases). The Elongin BC complex acts as an adaptor that links a substrate recognition subunit to heterodimers of either Cullin 2 (Cul2) and RING finger protein Rbx1 or Cullin 5 (Cul5) and Rbx2. It has been shown (Kamura, T., Maenaka, K., Kotoshiba, S., Matsumoto, M., Kohda, D., Conaway, R. C., Conaway, J. W., and Nakayama, K. I. (2004) Genes Dev. 18, 3055 - 3065) that interaction of BC-box proteins with their cognate Cul-Rbx module is determined by specific regions, called Cul2- or Cul5-boxes, located immediately downstream of their BC-boxes. Here, we investigate further the mechanisms governing assembly of BC-box proteins with their specific Cul-Rbx modules. Through purification and characterization of a larger collection of BC-box proteins that serve as substrate recognition subunits of Cul2 and Cul5 ubiquitin ligases and through structure-function studies, we define Cul2- and Cul5-boxes in greater detail. Although it previously appeared that there was little sequence similarity between Cul5- and Cul2-box motifs, analyses of newly identified BC-box proteins reveal that residues conserved in the Cul2-box represent a subset of those conserved in the Cul5-box. The sequence motif LP phi P, which is conserved in most Cul5-boxes and has been suggested to specify assembly of Cul5 ligases, is compatible with Cul2 interaction. Finally, the spacing between BC- and Cullin- boxes is much more flexible than has been appreciated and can vary from as few as 3 and as many as similar to 80 amino acids. Taken together, our findings shed new light on the mechanisms by which BC- box proteins direct recruitment of Cullin-Rbx modules during reconstitution of ubiquitin ligases.	[Mahrour, Nawel; Redwine, William B.; Florens, Laurence; Swanson, Selene K.; Martin-Brown, Skylar; Bradford, William D.; Staehling-Hampton, Karen; Washburn, Michael P.; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers-institute.org		Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585; Conaway, Joan/0000-0002-2786-0663	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41628] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Elkins MB, 2006, DEV DYNAM, V235, P1845, DOI 10.1002/dvdy.20824; ENDO T, 2007, NATURE, V387, P921; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens Laurence, 2006, V328, P159; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hooper JD, 2000, GENOMICS, V66, P113, DOI 10.1006/geno.2000.6167; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Lim R, 2002, J BIOL CHEM, V277, P40997, DOI 10.1074/jbc.M206041200; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Luo K, 2007, FASEB J, V21, P1742, DOI 10.1096/fj.06-7241com; Makarova KS, 2002, TRENDS BIOCHEM SCI, V27, P384, DOI 10.1016/S0968-0004(02)02140-0; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Vasudevan S, 2007, EMBO REP, V8, P279, DOI 10.1038/sj.embor.7400895; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zheng PZ, 1998, P NATL ACAD SCI USA, V95, P14745, DOI 10.1073/pnas.95.25.14745; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	32	120	126	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					8005	8013		10.1074/jbc.M706987200	http://dx.doi.org/10.1074/jbc.M706987200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18187417	hybrid			2022-12-27	WOS:000253997900075
J	Tchesnokova, V; Aprikian, P; Yakovenko, O; Larock, C; Kidd, B; Vogel, V; Thomas, W; Sokurenko, E				Tchesnokova, Veronika; Aprikian, Pavel; Yakovenko, Olga; Larock, Christopher; Kidd, Brian; Vogel, Viola; Thomas, Wendy; Sokurenko, Evgeni			Integrin-like allosteric properties of the catch bond-forming FimH adhesin of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL ADHESION; P-SELECTIN; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; LIGAND-BINDING; ACTIVATION; DOMAIN; AFFINITY; SHEAR; FORCE	FimH is the adhesive subunit of type 1 fimbriae of the Escherichia coli that is composed of a mannose-binding lectin domain and a fimbria-incorporating pilin domain. FimH is able to interact with mannosylated surface via a shear-enhanced catch bond mechanism. We show that the FimH lectin domain possesses a ligand-induced binding site (LIBS), a type of allosterically regulated epitopes characterized in integrins. Analogous to integrins, in FimH the LIBS epitope becomes exposed in the presence of the ligand (or "activating" mutations) and is located far from the ligand-binding site, close to the interdomain interface. Also, the antibody binding to the LIBS shifts adhesin from the low to high affinity state. Binding of streptavidin to the biotinylated residue within the LIBS also locks FimH in the high affinity state, suggesting that the allosteric perturbations in FimH are sustained by the interdomain wedging. In the presence of antibodies, the strength of bacterial adhesion to mannose is increased similar to the increase observed under shear force, suggesting the same allosteric mechanism, a shift in the interdomain configuration. Thus, an integrin-like allosteric link between the binding pocket and the interdomain conformation can serve as the basis for the catch bond property of FimH and, possibly, other adhesive proteins.	[Yakovenko, Olga; Kidd, Brian; Thomas, Wendy] Univ Washington, Dept Bioengn, Seattle, WA 98105 USA; [Tchesnokova, Veronika; Aprikian, Pavel; Yakovenko, Olga; Larock, Christopher; Sokurenko, Evgeni] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA; [Thomas, Wendy; Sokurenko, Evgeni] Univ Washington, Nanotechnol Ctr, Seattle, WA 98105 USA; [Vogel, Viola] ETH, Dept Mat, CH-8093 Zurich, Switzerland	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich	Thomas, W (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98105 USA.	wendyt@u.washington.edu; evs@u.washington.edu	LaRock, Christopher/E-1554-2013; Vogel, Viola/O-8025-2015	LaRock, Christopher/0000-0003-3035-5331; Vogel, Viola/0000-0003-2898-7671; Thomas, Wendy/0000-0001-8602-0819; Kidd, Brian/0000-0003-2110-1145				Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Doggett TA, 2002, BIOPHYS J, V83, P194, DOI 10.1016/S0006-3495(02)75161-8; DU XP, 1993, J BIOL CHEM, V268, P23087; Dustin ML, 2006, P NATL ACAD SCI USA, V103, P4335, DOI 10.1073/pnas.0600899103; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Hall DA, 2000, MOL PHARMACOL, V58, P1412, DOI 10.1124/mol.58.6.1412; Hammer DA, 2005, CURR BIOL, V15, pR96, DOI 10.1016/j.cub.2005.01.028; Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; Khaspekova S G, 1996, Biokhimiia, V61, P412; KIMURA T, 1995, J BIOL CHEM, V270, P16056, DOI 10.1074/jbc.270.27.16056; Konstantopoulos K, 2003, CURR BIOL, V13, pR611, DOI 10.1016/S0960-9822(03)00529-3; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mould AP, 2005, J BIOL CHEM, V280, P4238, DOI 10.1074/jbc.M412240200; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Qi SY, 2006, P NATL ACAD SCI USA, V103, P4416, DOI 10.1073/pnas.0510991103; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; SATO M, 1992, J BIOCHEM-TOKYO, V111, P331, DOI 10.1093/oxfordjournals.jbchem.a123758; Schoolmeester A, 2004, BLOOD, V104, P390, DOI 10.1182/blood-2003-12-4224; Sokurenko EV, 2001, MOL MICROBIOL, V41, P675, DOI 10.1046/j.1365-2958.2001.02545.x; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Thomas W, 2006, J CELL BIOL, V174, P911, DOI 10.1083/jcb.200609029; TUCEK S, 1995, TRENDS PHARMACOL SCI, V16, P205, DOI 10.1016/S0165-6147(00)89023-9; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200	48	55	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7823	7833		10.1074/jbc.M707804200	http://dx.doi.org/10.1074/jbc.M707804200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18174167	hybrid			2022-12-27	WOS:000253997900058
J	Zhang, J; Goodson, ML; Hong, Y; Sarge, KD				Zhang, Jie; Goodson, Michael L.; Hong, Yiling; Sarge, Kevin D.			MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; POLYCOMB; CONJUGATION; UBIQUITIN	In a previous study we found that sumoylation of the DNA-binding protein heat shock factor 2 ( HSF2) is up-regulated during mitosis, but the mechanism that mediates this regulation was unknown. Here we show that HSF2 interacts with the polycomb protein MEL-18, that this interaction decreases during mitosis, and that overexpression and RNA interference-mediated reduction of MEL-18 result in decreased and increased HSF2 sumoylation, respectively. Other results suggest that MEL-18 may also function to inhibit the sumoylation of other cellular proteins. The results also show that MEL-18 is able to interact with the small ubiquitin-like modifier ( SUMO) ubiquitin carrier protein ( E2) enzyme UBC9 and that MEL-18 inhibits the ability of UBC9 to transfer the SUMO protein to target proteins. Together, the results in this work suggest a mechanism in which MEL-18 bound to HSF2 inhibits its sumoylation by binding to and inhibiting the activity of UBC9 enzymes in the vicinity of HSF2. These results provide an explanation for how mitotic HSF2 sumoylation is regulated and suggest that MEL-18, in contrast to the sumoylation-stimulating activities of the polycomb protein PC2, actually functions like an anti-SUMO ubiquitin-protein isopeptide ligase ( E3), interacting both with HSF2 and the SUMO E2 UBC9 but acting to inhibit UBC9 activity to decrease sumoylation of a target protein, in this case that of HSF2.	[Zhang, Jie; Goodson, Michael L.; Hong, Yiling; Sarge, Kevin D.] Univ Kentucky, Albert B Chandler Med Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Sarge, KD (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	kdsarge@uky.edu	Goodson, Michael L/G-4175-2010	Goodson, Michael/0000-0002-3464-490X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061053, R01GM064606] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM064606, R01 GM061053-01A1, R01 GM064606-04, R01 GM061053-04, R01 GM064606-01A2, R01 GM061053-03, GM64606, R01 GM061053, GM61053, R01 GM061053-02, R01 GM064606-02, R01 GM064606-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Breiling A, 2007, INT REV CYTOL, V258, P83, DOI 10.1016/S0074-7696(07)58002-2; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hilgarth Roland S., 2005, V301, P329; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Li B, 2007, BIOCHEM J, V405, P369, DOI 10.1042/BJ20061873; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478	28	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7464	7469		10.1074/jbc.M707122200	http://dx.doi.org/10.1074/jbc.M707122200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18211895	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000253997900021
J	D'hoedt, D; Owsianik, G; Prenen, J; Cuajungco, MP; Grimm, C; Heller, S; Voets, T; Nilius, B				D'hoedt, Dieter; Owsianik, Grzegorz; Prenen, Jean; Cuajungco, Math Pham; Grimm, Christian; Heller, Stefan; Voets, Thomas; Nilius, Bernd			Stimulus-specific modulation of the cation channel TRPV4 by PACSIN 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-EVOKED ACTIVATION; ANKYRIN REPEAT DOMAIN; MICE LACKING TRPV4; ENDOTHELIAL-CELLS; ION-CHANNEL; PROTEIN; CA2+; EXPRESSION; LOCALIZATION; SENSITIVITY	TRPV4, a member of the vanilloid subfamily of the transient receptor potential (TRP) channels, is activated by a variety of stimuli, including cell swelling, moderate heat, and chemical compounds such as synthetic 4 alpha-phorbol esters. TRPV4 displays a widespread expression in various cells and tissues and has been implicated in diverse physiological processes, including osmotic homeostasis, thermo- and mechanosensation, vasorelaxation, tuning of neuronal excitability, and bladder voiding. The mechanisms that regulate TRPV4 in these different physiological settings are currently poorly understood. We have recently shown that the relative amount of TRPV4 in the plasma membrane is enhanced by interaction with the SH3 domain of PACSIN 3, a member of the PACSIN family of proteins involved in synaptic vesicular membrane trafficking and endocytosis. Here we demonstrate that PACSIN 3 strongly inhibits the basal activity of TRPV4 and its activation by cell swelling and heat, while leaving channel gating induced by the synthetic ligand 4 alpha-phorbol 12,13-didecanoate unaffected. A single proline mutation in the SH3 domain of PACSIN 3 abolishes its inhibitory effect on TRPV4, indicating that PACSIN 3 must bind to the channel to modulate its function. In line herewith, mutations at specific proline residues in the N terminus of TRPV4 abolish binding of PACSIN 3 and render the channel insensitive to PACSIN 3-induced inhibition. Taken together, these data suggest that PACSIN 3 acts as an auxiliary protein of TRPV4 channel that not only affects the channel's subcellular localization but also modulates its function in a stimulus-specific manner.	[D'hoedt, Dieter; Owsianik, Grzegorz; Prenen, Jean; Voets, Thomas; Nilius, Bernd] Katholieke Univ Leuven, Dept Physiol, B-3000 Louvain, Belgium; [Cuajungco, Math Pham; Grimm, Christian; Heller, Stefan] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg & Mol & Cellula, Stanford, CA 94305 USA; [Cuajungco, Math Pham] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92831 USA	KU Leuven; Stanford University; California State University System; California State University Fullerton	D'hoedt, D (corresponding author), Katholieke Univ Leuven, Dept Physiol, Campus Gasthuisberg,O&N 1,Herestr 49 Bus 802, B-3000 Louvain, Belgium.	dieter.dhoedt@med.kuleuven.be	Grimm, Christian/ABF-9121-2020; Voets, Thomas/AAD-4389-2019; Voets, Thomas/E-2466-2012; Cuajungco, Math/B-2647-2008	Grimm, Christian/0000-0002-0177-5559; Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Cuajungco, Math/0000-0003-0749-9564	NIDCD NIH HHS [DC 004563] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004563] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; Delany NS, 2001, PHYSIOL GENOMICS, V4, P165, DOI 10.1152/physiolgenomics.2001.4.3.165; Fernandez-Fernandez JM, 2002, AM J PHYSIOL-CELL PH, V283, pC1705, DOI 10.1152/ajpcell.00245.2002; Fu Y, 2006, AM J PHYSIOL-RENAL, V290, pF1305, DOI 10.1152/ajprenal.00391.2005; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Guler AD, 2002, J NEUROSCI, V22, P6408; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim DE, 2005, PROTEINS, V61, P193, DOI 10.1002/prot.20737; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Liedtke W., 2007, V179, P473; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2007, EXP PHYSIOL, V92, P507, DOI 10.1113/expphysiol.2006.035642; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Mangos S, 2007, GENE EXPR PATTERNS, V7, P480, DOI 10.1016/j.modgep.2006.10.011; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Modregger J, 2000, J CELL SCI, V113, P4511; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Owsianik G, 2006, REV PHYSIOL BIOCH P, V156, P61, DOI 10.1007/s10254-005-0006-3; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; PaltaufDoburzynska J, 1997, CELL CALCIUM, V21, P43, DOI 10.1016/S0143-4160(97)90095-6; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Ritter B, 1999, FEBS LETT, V454, P356, DOI 10.1016/S0014-5793(99)00830-3; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Sidhaye VK, 2006, P NATL ACAD SCI USA, V103, P4747, DOI 10.1073/pnas.0511211103; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Sumoy L, 2001, GENE, V262, P199, DOI 10.1016/S0378-1119(00)00531-X; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	54	91	96	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6272	6280		10.1074/jbc.M706386200	http://dx.doi.org/10.1074/jbc.M706386200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18174177	Green Published, hybrid			2022-12-27	WOS:000253779500034
J	Walsh, H; Govind, AP; Mastro, R; Hoda, JC; Bertrand, D; Vallejo, Y; Green, WN				Walsh, Heather; Govind, Anitha P.; Mastro, Ryan; Hoda, J. C.; Bertrand, Daniel; Vallejo, Yolanda; Green, William N.			Up-regulation of nicotinic receptors by nicotine varies with receptor subtype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-BUNGAROTOXIN RECEPTORS; RAT STRIATAL SYNAPTOSOMES; SUBUNIT MESSENGER-RNA; ACETYLCHOLINE-RECEPTORS; BINDING-SITES; CONOTOXIN-MII; MOUSE-BRAIN; EXPRESSION; PROTEIN; AUTORADIOGRAPHY	Recent evidence suggests that in addition to alpha 4 beta 2 and alpha 3-containing nicotinic receptors, alpha 6-containing receptors are present in midbrain dopaminergic neurons and involved in the nicotine reward pathway. Using heterologous expression, we found that alpha 6 beta 2, like alpha 3 beta 2 and alpha 4 beta 2 receptors, formed high affinity epibatidine binding complexes that are pentameric, trafficked to the cell surface, and produced acetylcholine-evoked currents. Chronic nicotine exposure up-regulated alpha 6 beta 2 receptors with differences in up-regulation time course and concentration dependence compared with alpha 4 beta 2 receptors, the predominant high affinity nicotine binding site in brain. The alpha 6 beta 2 receptor up-regulation required higher nicotine concentrations than for alpha 4 beta 2 but lower than for alpha 3 beta 2 receptors. The alpha 6 beta 2 up-regulation occurred 10-fold faster than for alpha 4 beta 2 and slightly faster than for alpha 3 beta 2. Our data suggest that nicotinic receptor up-regulation is subtype-specific such that alpha 6-containing receptors up-regulate in response to transient, high nicotine exposures, whereas sustained, low nicotine exposures up-regulate alpha 4 beta 2 receptors.	[Walsh, Heather; Govind, Anitha P.; Mastro, Ryan; Vallejo, Yolanda; Green, William N.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Hoda, J. C.; Bertrand, Daniel] Univ Geneva, Fac Med, Dept Neurosci, CH-1211 Geneva 4, Switzerland	University of Chicago; University of Geneva	Green, WN (corresponding author), 947 E 58th St, Chicago, IL 60637 USA.	wgreen@midway.uchicago.edu						Benowitz NL, 2006, CLIN PHARMACOL THER, V80, P703, DOI 10.1016/j.clpt.2006.09.007; BENOWITZ NL, 1988, CLIN PHARMACOL THER, V44, P23, DOI 10.1038/clpt.1988.107; BENOWITZ NL, 1983, NEW ENGL J MED, V309, P139, DOI 10.1056/NEJM198307213090303; BENOWITZ NL, 1990, CIBA F SYMP, V152, P186; Brody AL, 2006, ARCH GEN PSYCHIAT, V63, P907, DOI 10.1001/archpsyc.63.8.907; Buisson B, 1998, MOL PHARMACOL, V53, P555, DOI 10.1124/mol.53.3.555; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Chen DN, 1997, J BIOL CHEM, V272, P24024, DOI 10.1074/jbc.272.38.24024; Chubet RG, 1996, BIOTECHNIQUES, V20, P136; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; Dani JA, 2003, MOL PSYCHIATR, V8, P255, DOI 10.1038/sj.mp.4001284; DEVREOTES PN, 1975, J CELL BIOL, V65, P335, DOI 10.1083/jcb.65.2.335; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Eertmoed AL, 1998, METHOD ENZYMOL, V293, P564; Evans NM, 2003, EUR J PHARMACOL, V466, P31, DOI 10.1016/S0014-2999(03)01540-1; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Ghosheh OA, 2001, DRUG METAB DISPOS, V29, P645; Gopalakrishnan M, 1996, J PHARMACOL EXP THER, V276, P289; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Grinevich VP, 2005, J PHARMACOL EXP THER, V312, P619, DOI 10.1124/jpet.104.075069; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kaiser SA, 1998, J NEUROCHEM, V70, P1069; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kishi M, 2006, MOL PHARMACOL, V70, P2037, DOI 10.1124/mol.106.029298; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kulak JM, 1997, J NEUROSCI, V17, P5263; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Lai A, 2005, MOL PHARMACOL, V67, P1639, DOI 10.1124/mol.104.006429; LeNovere N, 1996, EUR J NEUROSCI, V8, P2428; Lindstrom J, 1996, Ion Channels, V4, P377; MARGIOTTA JF, 1987, J NEUROSCI, V7, P3612; Marks MJ, 1998, J PHARMACOL EXP THER, V285, P377; MARKS MJ, 1992, J NEUROSCI, V12, P2765; McCallum SE, 2006, J NEUROCHEM, V96, P1028, DOI 10.1111/j.1471-4159.2005.03646.x; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Mugnaini M, 2002, EUR J NEUROSCI, V16, P1633, DOI 10.1046/j.1460-9568.2002.02220.x; Nashmi R, 2007, BIOCHEM PHARMACOL, V74, P1145, DOI 10.1016/j.bcp.2007.06.040; Nelson ME, 2001, J GEN PHYSIOL, V118, P563, DOI 10.1085/jgp.118.5.563; Nguyen HN, 2003, J PHARMACOL EXP THER, V307, P1090, DOI 10.1124/jpet.103.056408; Nicke A, 2004, FEBS LETT, V575, P52, DOI 10.1016/j.febslet.2004.08.035; Parker SL, 2004, MOL PHARMACOL, V65, P611, DOI 10.1124/mol.65.3.611; PENG X, 1994, MOL PHARMACOL, V46, P523; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; PERRY DC, 1995, J PHARMACOL EXP THER, V275, P1030; Quik M, 2006, J PHARMACOL EXP THER, V316, P481, DOI 10.1124/jpet.105.094375; Rakhilin S, 1999, J CELL BIOL, V146, P203; Rangwala F, 1997, J NEUROSCI, V17, P8201; Ruskin DN, 2007, EUR J PHARMACOL, V559, P161, DOI 10.1016/j.ejphar.2007.01.006; Sallette J, 2004, J BIOL CHEM, V279, P18767, DOI 10.1074/jbc.M308260200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHWARTZ RD, 1985, J NEUROCHEM, V45, P427, DOI 10.1111/j.1471-4159.1985.tb04005.x; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Webster JC, 1999, BRIT J PHARMACOL, V127, P1337, DOI 10.1038/sj.bjp.0702686; Whiteaker P, 2000, MOL PHARMACOL, V57, P913; Whiteaker P, 2002, J NEUROSCI, V22, P2522, DOI 10.1523/JNEUROSCI.22-07-02522.2002; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Wonnacott S, 2005, CURR OPIN PHARMACOL, V5, P53, DOI 10.1016/j.coph.2004.12.002; Zoli M, 2002, J NEUROSCI, V22, P8785	65	73	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6022	6032		10.1074/jbc.M703432200	http://dx.doi.org/10.1074/jbc.M703432200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18174175	hybrid			2022-12-27	WOS:000253779500007
J	Cheng, XL; Shen, Z; Yang, JY; Lu, SH; Cui, YP				Cheng, Xiaolong; Shen, Zheng; Yang, Jianyi; Lu, Shih-Hsin; Cui, Yongping			ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; ASSEMBLY CHECKPOINT; DUPLICATION; CANCER; MPS1; P53; OVEREXPRESSION; ANEUPLOIDY; CENTRIOLE; UBIQUITINATION	Cancer cells contain an abnormal number of chromosomes (aneuploidy), which is a prevalent form of genetic instability in human cancers. Abnormal amplification of centrosomes and defects of spindle assembly checkpoint are the major causes of chromosome instability in cancer cells. Here we present biochemical evidence to suggest a role of ECRG2, a novel tumor suppressor gene, in maintaining chromosome stability. ECRG2 localized to centrosomes during interphase and kinetochores during mitosis. Further analysis revealed that ECRG2 participates in centrosome amplification in a p53-dependent manner. Depletion of ECRG2 not only destabilized p53, down-regulated p21, and increased the cyclin E/CDK2 activity, thus initiating centrosome amplification, but also abolished the ability of p53 localize to centrosomes. Overexpression of ECRG2 restored the p53-dependent suppression of centrosome duplication. Furthermore, ECRG2-depleted cells show severely disrupted spindle phenotype but fail to maintain the mitotic arrest due to minimal BUBR1 protein levels. Taken together, our results indicate that ECRG2 is important for ensuring centrosome duplication, spindle assembly checkpoint, and accurate chromosome segregation, and its depletion may contribute to chromosome instability and aneuploidy in human cancers.	[Cheng, Xiaolong; Yang, Jianyi; Cui, Yongping] Shanxi Med Univ, Dept Cell Biol & Genet, Taiyuan 030001, Peoples R China; [Cheng, Xiaolong; Cui, Yongping] Key Lab Cellular Physiol, Minist Educ, Taiyuan 030001, Peoples R China; [Shen, Zheng] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 10008, Peoples R China; [Lu, Shih-Hsin] Chinese Acad Med Sci, Peking Union Med Coll, Inst Canc, Dept Etiol, Beijing 100021, Peoples R China	Shanxi Medical University; Chinese Academy of Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Cui, YP (corresponding author), Shanxi Med Univ, Dept Cell Biol & Genet, Taiyuan 030001, Peoples R China.	cuiy0922@yahoo.com	yang, jian/HIK-0188-2022					Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; Chi YH, 2007, J CELL BIOCHEM, V102, P531, DOI 10.1002/jcb.21484; Cui YP, 2003, BIOCHEM BIOPH RES CO, V302, P904, DOI 10.1016/S0006-291X(03)00122-0; Duensing A, 2006, CELL CYCLE, V5, P2899, DOI 10.4161/cc.5.24.3567; Fisk HA, 2004, CURR BIOL, V14, pR1058, DOI 10.1016/j.cub.2004.11.047; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Fisk HA, 2002, CURR OPIN CELL BIOL, V14, P700, DOI 10.1016/S0955-0674(02)00385-X; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; HA CH, 2007, CANCER RES, V67, P7155; Hoffmann Ingrid, 2006, V42, P93, DOI 10.1007/b138827; Hontz AE, 2007, CANCER RES, V67, P2957, DOI 10.1158/0008-5472.CAN-06-3296; Huang G, 2005, HYBRIDOMA, V24, P86, DOI 10.1089/hyb.2005.24.86; Huang G, 2007, CARCINOGENESIS, V28, P2274, DOI 10.1093/carcin/bgm140; Jefford CE, 2006, CRIT REV ONCOL HEMAT, V59, P1, DOI 10.1016/j.critrevonc.2006.02.005; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Koutsami MK, 2006, J PATHOL, V209, P512, DOI 10.1002/path.2005; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Mattison Christopher P., 2006, V42, P111, DOI 10.1007/b136685; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Mussman JG, 2000, ONCOGENE, V19, P1635, DOI 10.1038/sj.onc.1203460; Oikawa T, 2005, MOL CELL BIOL, V25, P4046, DOI 10.1128/MCB.25.10.4046-4061.2005; Orr B, 2007, MOL BIOL CELL, V18, P850, DOI 10.1091/mbc.E06-07-0587; Pelletier L, 2007, CURR BIOL, V17, pR770, DOI 10.1016/j.cub.2007.07.025; Peters JM, 2007, NATURE, V446, P868, DOI 10.1038/446868a; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Sankaran S, 2006, J CELL BIOCHEM, V99, P1240, DOI 10.1002/jcb.21003; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Srsen V, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-26; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Winey M, 1999, CURR BIOL, V9, pR449, DOI 10.1016/S0960-9822(99)80279-6; Yamamoto Y, 2007, CANCER GENET CYTOGEN, V174, P42, DOI 10.1016/j.cancergencyto.2006.11.012; Yamamoto Y, 2006, ONCOLOGY-BASEL, V70, P231, DOI 10.1159/000094416	44	17	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5888	5898		10.1074/jbc.M708145200	http://dx.doi.org/10.1074/jbc.M708145200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18162463	hybrid			2022-12-27	WOS:000253426700067
J	Ghosh, AK; Ramakrishnan, G; Rajasekharan, R				Ghosh, Ananda K.; Ramakrishnan, Geetha; Rajasekharan, Ram			YLR099C (ICT1) encodes a soluble Acyl-CoA-dependent lysophosphatidic acid acyltransferase responsible for enhanced phospholipid synthesis on organic solvent stress in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA/BETA-HYDROLASE FOLD; ESCHERICHIA-COLI; CHOLESTEROL ACYLTRANSFERASE; TOLERANCE; YEAST; BIOSYNTHESIS; MEMBRANE; PROTEIN; TOLUENE; ADAPTATION	One of the major determinants of organic solvent tolerance is the increase in membrane phospholipids. Here we report for the first time that an increase in the synthesis of phosphatidic acid is responsible for enhanced phospholipid synthesis that confers tolerance to the organic solvent in Saccharomyces cerevisiae. This increase in phosphatidic acid formation is because of the induction of Ict1p, a soluble oleoyl-CoA: lysophosphatidic acid acyltransferase. YLR099C (ICT1) was reported to be maximally expressed during solvent tolerance (Miura, S., Zou, W., Ueda, M., and Tanaka, A. (2000) Appl. Environ. Microbiol. 66, 4883 4889); however, its physiological significance was not understood. In silico analysis revealed the absence of any transmembrane domain in Ict1p. Domain analysis showed that it has a hydrolase/acyltransferase domain with a distinct lipid-binding motif and a lysophospholipase domain. Analysis of ict1 Delta strain showed a drastic reduction in phosphatidic acid suggesting the role of Ict1p in phosphatidic acid biosynthesis. Overexpression of Ict1p in S. cerevisiae showed an increase in phosphatidic acid and other phospholipids on organic solvent exposure. To understand the biochemical function of Ict1p, the gene was cloned and expressed in Escherichia coli. The purified recombinant enzyme was found to specifically acylate lysophosphatidic acid. Specific activity of Ict1p was found to be higher for oleoyl-CoA as compared with palmitoyl- and stearoyl-CoAs. This study provides a mechanism for organic solvent tolerance from the point of membrane dynamics in S. cerevisiae.	[Ghosh, Ananda K.; Ramakrishnan, Geetha; Rajasekharan, Ram] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Rajasekharan, Ram] Monash Univ, Sch Arts & Sci, Petaling Jaya 46150, Malaysia	Indian Institute of Science (IISC) - Bangalore; Monash University; Monash University Sunway	Rajasekharan, R (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	lipid@biochem.iisc.ernet.in	Rajasekharan, Ram/R-2257-2019; R, Rajasekharan/D-3420-2009	Ram, Rajasekharan/0000-0002-4114-0654; Rajasekharan, Ram/0000-0002-2124-6013				Akiyama M, 2003, J INVEST DERMATOL, V121, P1029, DOI 10.1046/j.1523-1747.2003.12520.x; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUCKLEY JT, 1983, BIOCHEMISTRY-US, V22, P5490, DOI 10.1021/bi00293a006; COLEMAN J, 1990, J BIOL CHEM, V265, P17215; Engvall E, 1980, Methods Enzymol, V70, P419; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Gangar A, 2001, J BIOL CHEM, V276, P10290, DOI 10.1074/jbc.M009550200; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; HEIPIEPER HJ, 1994, APPL ENVIRON MICROB, V60, P4440, DOI 10.1128/AEM.60.12.4440-4444.1994; HILTON S, 1991, J BIOL CHEM, V266, P997; INGRAM LO, 1986, TRENDS BIOTECHNOL, V4, P40, DOI 10.1016/0167-7799(86)90152-6; INOUE A, 1989, NATURE, V338, P264, DOI 10.1038/338264a0; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; Matsui K, 2006, APPL MICROBIOL BIOT, V71, P75, DOI 10.1007/s00253-006-0328-3; MELCHIOR DL, 1982, CURR TOP MEMBR TRANS, V17, P263; Miura S, 2000, APPL ENVIRON MICROB, V66, P4883, DOI 10.1128/AEM.66.11.4883-4889.2000; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Okazaki K, 2006, PLANT PHYSIOL, V141, P546, DOI 10.1104/pp.105.075796; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pinkart HC, 1997, J BACTERIOL, V179, P4219, DOI 10.1128/jb.179.13.4219-4226.1997; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; Ramos JL, 1997, J BIOL CHEM, V272, P3887, DOI 10.1074/jbc.272.7.3887; RIKHOT WR, 2006, BIOL CHEM, V281, P36588; RUSSELL NJ, 1985, J GEN MICROBIOL, V131, P781; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saulnier-Blache JS, 2000, J LIPID RES, V41, P1947; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Singh SR, 2004, NUCLEIC ACIDS RES, V32, P201, DOI 10.1093/nar/gkh163; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; WOLDRINGH CL, 1973, J BACTERIOL, V114, P1359, DOI 10.1128/JB.114.3.1359-1361.1973	38	53	56	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9768	9775		10.1074/jbc.M708418200	http://dx.doi.org/10.1074/jbc.M708418200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18252723	Green Published, hybrid			2022-12-27	WOS:000254671600031
J	Bogunovic, B; Stojakovic, M; Chen, L; Maric, M				Bogunovic, Branka; Stojakovic, Milica; Chen, Leonard; Maric, Maja			An unexpected functional link between lysosomal thiol reductase and mitochondrial manganese superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MNSOD GENE-EXPRESSION; NF-KAPPA-B; OXIDATIVE STRESS; DILATED CARDIOMYOPATHY; ANTIOXIDANT ENZYMES; HYDROGEN-PEROXIDE; REDOX REGULATION; DISULFIDE BONDS; DEFICIENT MICE; CELL-GROWTH	Gamma interferon-inducible thiol reductase ( GILT) is an enzyme involved in the initial steps of antigen processing and presentation. Recently we have shown that GILT is also expressed in mouse T cells, where it exerts an inhibitory role on T cell activation. In this study, we identified mitochondrial manganese superoxide dismutase (SOD2) as one of the key intermediaries affected by GILT expression in fibroblasts. Expression and activity of SOD2 is reduced in the absence of GILT because of reduced SOD2 protein stability. The forced increase in SOD2 expression in the absence of GILT restores fibroblast proliferation to wild-type levels. Thus, GILT appears to have a fundamental role in cellular proliferation mediated through its influence on SOD2 protein activity and expression.	[Bogunovic, Branka; Chen, Leonard; Maric, Maja] Georgetown Univ, Dept Microbiol & Immunol, Med Ctr, Washington, DC 20057 USA; [Stojakovic, Milica] Childrens Natl Med Ctr, Childrens Res Inst, Ctr Canc & Immunol Res, Washington, DC 20010 USA	Georgetown University; Children's National Health System	Maric, M (corresponding author), Georgetown Univ, Dept Microbiol & Immunol, Med Ctr, 3900 Reservoir Rd NW,Med Dent C301, Washington, DC 20057 USA.	mam254@georgetown.edu						ALLEN RG, 1991, P SOC EXP BIOL MED, V196, P117; Aquilano K, 2006, FASEB J, V20, P1683, DOI 10.1096/fj.05-5225fje; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Arunachalam B, 1998, J IMMUNOL, V160, P5797; Barjaktarevic I, 2006, J IMMUNOL, V177, P4369, DOI 10.4049/jimmunol.177.7.4369; BASS DA, 1983, J IMMUNOL, V130, P1910; Bickerstaff AA, 2000, J IMMUNOL, V164, P5132, DOI 10.4049/jimmunol.164.10.5132; BIZE IB, 1980, CANCER RES, V40, P3686; Bravard A, 1999, FREE RADICAL BIO MED, V26, P1027, DOI 10.1016/S0891-5849(98)00299-8; Bravard A, 2002, CARCINOGENESIS, V23, P705, DOI 10.1093/carcin/23.5.705; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; CHURCH SL, 1993, P NATL ACAD SCI USA, V90, P3113, DOI 10.1073/pnas.90.7.3113; DAS KC, 1995, MOL CELL BIOCHEM, V148, P45, DOI 10.1007/BF00929502; DAS KC, 1995, AM J PHYSIOL-LUNG C, V269, pL588, DOI 10.1152/ajplung.1995.269.5.L588; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; Duttaroy A, 2003, GENETICS, V165, P2295; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925; Gilbert DL, 1999, REACTIVE OXYGEN SPEC, P138; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Halliwell B., 2007, FREE RADICALS BIOL M; Hernandez-Saavedra D, 2003, CANCER RES, V63, P159; Huang TT, 2001, FREE RADICAL BIO MED, V31, P1101, DOI 10.1016/S0891-5849(01)00694-3; Huang TT, 1997, ARCH BIOCHEM BIOPHYS, V344, P424, DOI 10.1006/abbi.1997.0237; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Keller T, 2003, NITRIC OXIDE-BIOL CH, V9, P183, DOI 10.1016/j.niox.2004.01.003; Laurent A, 2005, CANCER RES, V65, P948; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Li SJ, 2000, CANCER RES, V60, P3927; Li W, 2004, AM J PHYSIOL-HEART C, V286, pH47, DOI 10.1152/ajpheart.00730.2003; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; LUNDSTROMLJUNG J, 1998, PROLYL HYDROXYLASE P, P297; LUSTER AD, 1988, J BIOL CHEM, V263, P12036; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; MEISLER AI, 1973, J CELL SCI, V12, P847; Mukhopadhyay S, 2004, J BIOMED BIOTECHNOL, P195, DOI 10.1155/S1110724304401016; OBERLEY LW, 1988, MOL CELL BIOCHEM, V84, P147, DOI 10.1007/BF00421049; Patenaude A, 2004, J BIOL CHEM, V279, P27302, DOI 10.1074/jbc.M402496200; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Rahimi F, 2005, FEBS J, V272, P2811, DOI 10.1111/j.1742-4658.2005.04703.x; Raina S, 1997, ANNU REV MICROBIOL, V51, P179, DOI 10.1146/annurev.micro.51.1.179; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Roos G, 2007, J MOL BIOL, V368, P800, DOI 10.1016/j.jmb.2007.02.045; Samper E, 2003, AGING CELL, V2, P277, DOI 10.1046/j.1474-9728.2003.00062.x; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scorziello A, 2007, J NEUROCHEM, V103, P1472, DOI 10.1111/j.1471-4159.2007.04845.x; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Van Remmen H, 2001, AM J PHYSIOL-HEART C, V281, pH1422, DOI 10.1152/ajpheart.2001.281.3.H1422; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	55	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8855	8862		10.1074/jbc.M708998200	http://dx.doi.org/10.1074/jbc.M708998200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18218638	hybrid			2022-12-27	WOS:000254465800012
J	Ecroyd, H; Koudelka, T; Thorn, DC; Williams, DM; Devlin, G; Hoffmann, P; Carver, JA				Ecroyd, Heath; Koudelka, Tomas; Thorn, David C.; Williams, Danielle M.; Devlin, Glyn; Hoffmann, Peter; Carver, John A.			Dissociation from the oligomeric state is the rate-limiting step in fibril formation by kappa-casein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE MAMMARY-GLAND; CORPORA-AMYLACEA; PROTEIN AGGREGATION; AMYLOID FIBRILS; IN-VITRO; SEQUENCE; PREDICTION; BEHAVIOR; REVEALS	Amyloid fibrils are aggregated and precipitated forms of protein in which the protein exists in highly ordered, long, unbranching threadlike formations that are stable and resistant to degradation by proteases. Fibril formation is an ordered process that typically involves the unfolding of a protein to partially folded states that subsequently interact and aggregate through a nucleation-dependent mechanism. Here we report on studies investigating the molecular basis of the inherent propensity of the milk protein, kappa-casein, to form amyloid fibrils. Using reduced and carboxymethylated kappa-casein ( RCM kappa-CN), we show that fibril formation is accompanied by a characteristic increase in thioflavin T fluorescence intensity, solution turbidity, and beta-sheet content of the protein. However, the lag phase of RCM kappa-CN fibril formation is independent of protein concentration, and the rate of fibril formation does not increase upon the addition of seeds ( preformed fibrils). Therefore, its mechanism of fibril formation differs from the archetypal nucleation-dependent aggregation mechanism. By digestion with trypsin or proteinase K and identification by mass spectrometry, we have determined that the region from Tyr(25) to Lys(86) is incorporated into the core of the fibrils. We suggest that this region, which is predicted to be aggregation-prone, accounts for the amyloidogenic nature of kappa-casein. Based on these data, we propose that fibril formation by RCM kappa-CN occurs through a novel mechanism whereby the rate-limiting step is the dissociation of an amyloidogenic precursor from an oligomeric state rather than the formation of stable nuclei, as has been described for most other fibril-forming systems.	[Ecroyd, Heath; Koudelka, Tomas; Thorn, David C.; Williams, Danielle M.; Carver, John A.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Koudelka, Tomas; Hoffmann, Peter] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Devlin, Glyn] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Adelaide; University of Adelaide; University of Cambridge	Ecroyd, H (corresponding author), Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia.	heath.ecroyd@adelaide.edu.au	Thorn, David/GSD-6867-2022; Carver, John Adrian/J-3825-2014; Ecroyd, Heath/E-7140-2015; Hoffmann, Peter/U-5996-2017	Thorn, David/0000-0002-7332-2292; Carver, John Adrian/0000-0002-2441-8108; Hoffmann, Peter/0000-0001-8493-2208; Ecroyd, Heath/0000-0001-7574-0044				BEEMS RB, 1978, VET PATHOL, V15, P347, DOI 10.1177/030098587801500309; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Claudon C, 1998, TISSUE CELL, V30, P589, DOI 10.1016/S0040-8166(98)80040-2; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; DEKRUIF CG, 1991, EUR J BIOCHEM, V200, P431, DOI 10.1111/j.1432-1033.1991.tb16201.x; Dobson CM, 2004, METHODS, V34, P4, DOI 10.1016/j.ymeth.2004.03.002; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Farrell HM, 2003, J PROTEIN CHEM, V22, P259, DOI 10.1023/A:1025020503769; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FOX PF, 1998, ADV DAIRY CHEM, P165; Fox PF, 2003, ADV DAIRY CHEM 1 PRO, P9; Groves ML, 1998, J PROTEIN CHEM, V17, P73, DOI 10.1023/A:1022518613574; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; KUMOSINSKI TF, 1993, J DAIRY SCI, V76, P2507, DOI 10.3168/jds.S0022-0302(93)77586-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Morgan PE, 2005, J AGR FOOD CHEM, V53, P2670, DOI 10.1021/jf048329h; Myers SL, 2006, RAPID COMMUN MASS SP, V20, P1628, DOI 10.1002/rcm.2482; NICKERSON SC, 1987, CYTOBIOS, V51, P81; NICKERSON SC, 1985, J DAIRY SCI, V68, P709, DOI 10.3168/jds.S0022-0302(85)80877-8; Niewold TA, 1999, AMYLOID, V6, P244, DOI 10.3109/13506129909007335; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; RASMUSSEN LK, 1992, EUR J BIOCHEM, V207, P215, DOI 10.1111/j.1432-1033.1992.tb17040.x; REID IM, 1972, J COMP PATHOL, V82, P409, DOI 10.1016/0021-9975(72)90040-0; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Syme CD, 2002, EUR J BIOCHEM, V269, P148, DOI 10.1046/j.0014-2956.2001.02633.x; Taniyama H, 2000, VET PATHOL, V37, P104, DOI 10.1354/vp.37-1-104; Thorn DC, 2005, BIOCHEMISTRY-US, V44, P17027, DOI 10.1021/bi051352r; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; VREEMAN HJ, 1981, BIOPHYS CHEM, V14, P185, DOI 10.1016/0301-4622(81)85018-1; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904	49	66	67	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9012	9022		10.1074/jbc.M709928200	http://dx.doi.org/10.1074/jbc.M709928200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18245081	Green Published, hybrid			2022-12-27	WOS:000254465800031
J	Hocking, HG; Herbert, AP; Kavanagh, D; Soares, DC; Ferreira, VP; Pangburn, MK; Uhrin, D; Barlow, PN				Hocking, Henry G.; Herbert, Andrew P.; Kavanagh, David; Soares, Dinesh C.; Ferreira, Viviana P.; Pangburn, Michael K.; Uhrin, Dusan; Barlow, Paul N.			Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE COFACTOR PROTEIN; ALTERNATIVE PATHWAY; REGULATORY DOMAINS; BINDING-SITES; NEUTRON-SCATTERING; CRYSTAL-STRUCTURE; COMPONENT C3; NMR; DECAY; ACTIVATION	Factor H is a regulatory glycoprotein of the complement system. We expressed the three N-terminal complement control protein modules of human factor H (FH1-3) and confirmed FH1-3 to be the minimal unit with cofactor activity for C3b proteolysis by factor I. We reconstructed FH1-3 from NMR-derived structures of FH1-2 and FH2-3 revealing an similar to 105-angstrom-long rod-like arrangement of the modules. In structural comparisons with other C3b-engaging proteins, factor H module 3 most closely resembles factor B module 3, consistent with factor H competing with factor B for binding C3b. Factor H modules 1, 2, and 3 each has a similar backbone structure to first, second, and third modules, respectively, of functional sites in decay accelerating factor and complement receptor type 1; the equivalent intermodular tilt and twist angles are also broadly similar. Resemblance between molecular surfaces is closest for first modules but absent in the case of second modules. Substitution of buried Val-62 with Ile (a factor H single nucleotide polymorphism potentially protective for age-related macular degeneration and dense deposit disease) causes rearrangements within the module 1 core and increases thermal stability but does not disturb the interface with module 2. Replacement of partially exposed (in module 1) Arg-53 by His (an atypical hemolytic uremic syndrome-linked mutation) did not impair structural integrity at 37 C, but this FH1-2 mutant was less stable at higher temperatures; furthermore, chemical shift differences indicated potential for small structural changes at the module 1-2 interface.	[Hocking, Henry G.; Herbert, Andrew P.; Kavanagh, David; Soares, Dinesh C.; Uhrin, Dusan; Barlow, Paul N.] Univ Edinburgh, Sch Chem, Edinburgh Biomol NMR Unit, Edinburgh EH9 3JJ, Midlothian, Scotland; [Hocking, Henry G.; Herbert, Andrew P.; Kavanagh, David; Soares, Dinesh C.; Uhrin, Dusan; Barlow, Paul N.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JJ, Midlothian, Scotland; [Soares, Dinesh C.] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Ferreira, Viviana P.; Pangburn, Michael K.] Univ Texas Hlth Sci Ctr Tyler, Dept Biochem, Tyler, TX 75708 USA	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Barlow, PN (corresponding author), Univ Edinburgh, Sch Chem, Edinburgh Biomol NMR Unit, Joseph Black Chem Bldg,W Mains Rd, Edinburgh EH9 3JJ, Midlothian, Scotland.	Paul.Barlow@ed.ac.uk	Soares, Dinesh C/A-4425-2012; Kavanagh, David/E-8498-2011; Herbert, Andy P/F-6693-2010; Barlow, Paul N/G-2853-2011; Herbert, Andrew P/C-4755-2008; Mohammed, Imran/J-8271-2012	Soares, Dinesh C/0000-0001-7557-0495; Kavanagh, David/0000-0003-4718-0072; Herbert, Andy P/0000-0002-4549-6965; Herbert, Andrew P/0000-0002-4549-6965; Mohammed, Imran/0000-0002-8412-0768; Ferreira, Viviana/0000-0001-8923-5671; Hocking, Henry/0000-0003-0933-9265	Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Abrera-Abeleda MA, 2006, J MED GENET, V43, P582, DOI 10.1136/jmg.2005.038315; Alam MN, 2004, J IMMUNOL METHODS, V293, P107, DOI 10.1016/j.jim.2004.07.005; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ball G, 2006, J MAGN RESON, V180, P127, DOI 10.1016/j.jmr.2006.01.017; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biro A, 2006, MOL DIAGN THER, V10, P303, DOI 10.1007/BF03256205; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Brodbeck WG, 1996, J IMMUNOL, V156, P2528; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Casasnovas JM, 1999, EMBO J, V18, P2911, DOI 10.1093/emboj/18.11.2911; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; de Cordoba SR, 1999, MOL IMMUNOL, V36, P803, DOI 10.1016/S0161-5890(99)00100-5; DeLano W.L, PYMOL MOL GRAPHICS S; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; GORDON DL, 1995, J IMMUNOL, V155, P348; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Harris CL, 2007, J IMMUNOL, V178, P352, DOI 10.4049/jimmunol.178.1.352; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11259, DOI 10.1021/bi00093a001; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jenkins HT, 2006, J BIOL CHEM, V281, P3690, DOI 10.1074/jbc.M511563200; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jokiranta TS, 1996, FEBS LETT, V393, P297; Kavanagh D, 2006, BRIT MED BULL, V77-78, P5, DOI 10.1093/bmb/ldl004; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; KRISTENSEN T, 1986, P NATL ACAD SCI USA, V83, P3963, DOI 10.1073/pnas.83.11.3963; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Kuhn S, 1996, EUR J IMMUNOL, V26, P2383, DOI 10.1002/eji.1830261017; KUHN S, 1995, J IMMUNOL, V155, P5663; Kuttner-Kondo LA, 2001, J IMMUNOL, V167, P2164, DOI 10.4049/jimmunol.167.4.2164; Kuttner-Kondo L, 2007, J BIOL CHEM, V282, P18552, DOI 10.1074/jbc.M611650200; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; Lukacik P, 2004, P NATL ACAD SCI USA, V101, P1279, DOI 10.1073/pnas.0307200101; McRae JL, 2002, GENETICA, V114, P157, DOI 10.1023/A:1015114512924; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mullick J, 2005, J VIROL, V79, P12382, DOI 10.1128/JVI.79.19.12382-12393.2005; Murthy KHM, 2001, CELL, V104, P301, DOI 10.1016/S0092-8674(01)00214-8; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pangburn MK, 2000, J IMMUNOL, V164, P4742, DOI 10.4049/jimmunol.164.9.4742; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; Perkins SJ, 2002, BIOCHEM SOC T, V30, P996, DOI 10.1042/bst0300996; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Permi P, 1999, J MAGN RESON, V141, P44, DOI 10.1006/jmre.1999.1886; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281; Saunders RE, 2007, HUM MUTAT, V28, P222, DOI 10.1002/humu.20435; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; Sitkoff D, 1996, J PHYS CHEM-US, V100, P2744, DOI 10.1021/jp952986i; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Smith BO, 2002, CELL, V108, P769, DOI 10.1016/S0092-8674(02)00672-4; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; Soares DC, 2005, PROTEIN ENG DES SEL, V18, P379, DOI 10.1093/protein/gzi039; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	81	52	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9475	9487		10.1074/jbc.M709587200	http://dx.doi.org/10.1074/jbc.M709587200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18252712	Green Published, hybrid			2022-12-27	WOS:000254465800077
J	Itoh, S; Kim, HW; Nakagawa, O; Ozumi, K; Lessner, SM; Aoki, H; Akram, K; McKinney, RD; Ushio-Fukai, M; Fukai, T				Itoh, Shinichi; Kim, Ha Won; Nakagawa, Osamu; Ozumi, Kiyoshi; Lessner, Susan M.; Aoki, Hiroki; Akram, Kamran; McKinney, Ronald D.; Ushio-Fukai, Masuko; Fukai, Tohru			Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; ANGIOTENSIN-II; LYSYL OXIDASE; DNA-BINDING; PROTEIN; GENE; TETRATHIOMOLYBDATE; METALLOCHAPERONE; METALLOTHIONEIN; CERULOPLASMIN	Copper plays a fundamental role in regulating cell growth. Many types of human cancer tissues have higher copper levels than normal tissues. Copper can also induce gene expression. However, transcription factors that mediate copper-induced cell proliferation have not been identified in mammals. Here we show that antioxidant-1 (Atox1), previously appreciated as a copper chaperone, represents a novel copper-dependent transcription factor that mediates copper-induced cell proliferation. Stimulation of mouse embryonic fibroblasts (MEFs) with copper markedly increased cell proliferation, cyclin D1 expression, and entry into S phase, which were completely abolished in Atox1(-/-) MEFs. Promoter analysis and EMSA revealed that copper stimulates the Atox1 binding to a previously undescribed cis element in the cyclin D1 promoter. The ChIP assay confirms that copper stimulates Atox1 binding to the DNA in vivo. Transfection of Atox1 fused to the DNA-binding domain of Gal4 demonstrated a copper-dependent transactivation in various cell types, including endothelial and cancer cells. Furthermore, Atox1 translocated to the nucleus in response to copper through its highly conserved C-terminal KKTGK motif and N-terminal copper-binding sites. Finally, the functional role of nuclear Atox1 is demonstrated by the observation that re-expression of nuclear-targeted Atox1 in Atox1(-/-) MEFs rescued the defective copper- induced cell proliferation. Thus, Atox1 functions as a novel transcription factor that, when activated by copper, undergoes nuclear translocation, DNA binding, and transactivation, thereby contributing to cell proliferation.	[Itoh, Shinichi; Kim, Ha Won; Ozumi, Kiyoshi; Akram, Kamran; Ushio-Fukai, Masuko; Fukai, Tohru] Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA; [Kim, Ha Won; Ozumi, Kiyoshi; McKinney, Ronald D.; Fukai, Tohru] Univ Illinois, Cardiovasc Res Ctr, Dept Med, Cardiol Sect, Chicago, IL 60612 USA; [Kim, Ha Won; Ozumi, Kiyoshi; McKinney, Ronald D.; Fukai, Tohru] Univ Illinois, Cardiovasc Res Ctr, Dept Pharmacol, Chicago, IL 60612 USA; [Nakagawa, Osamu] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Nakagawa, Osamu] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Div Cardiol, Dallas, TX 75390 USA; [Lessner, Susan M.] Univ S Carolina, Sch Med, Dept Cell & Dev Biol & Anat, Columbia, SC 29208 USA; [Akram, Kamran] Yamaguchi Univ, Sch Med, Dept Mol Cardiovasc Biol, Yamaguchi 7558505, Japan; [McKinney, Ronald D.; Ushio-Fukai, Masuko] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	Emory University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Yamaguchi University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Fukai, T (corresponding author), 835 S Wolcott,M-C868,E403 MSB, Chicago, IL 60612 USA.	tfukai@uic.edu		Lessner, Susan/0000-0002-8409-5216; Kim, Ha Won/0000-0001-6272-4248	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077524, P01HL058000, R01HL070187] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 077524, R01 HL077524, R01 HL 70187, P01 HL 58000] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARNOLD M, 1961, CANCER RES, V21, P761; Birkaya B, 2005, J NEUROBIOL, V63, P49, DOI 10.1002/neu.20114; Brewer GJ, 2005, CURR CANCER DRUG TAR, V5, P195, DOI 10.2174/1568009053765807; Brewer GJ, 2000, CLIN CANCER RES, V6, P1; Chan CK, 1998, GENE THER, V5, P1204, DOI 10.1038/sj.gt.3300708; CHU FF, 1985, BIOCHEM BIOPH RES CO, V126, P15, DOI 10.1016/0006-291X(85)90565-0; Culotta V.C., 2001, METABOLIC MOL BASES, P3105; Daniel KG, 2004, FRONT BIOSCI-LANDMRK, V9, P2652, DOI 10.2741/1424; FISCHERFANTUZZI L, 1988, MOL CELL BIOL, V8, P5495, DOI 10.1128/MCB.8.12.5495; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; FUCHS AG, 1989, ONCOLOGY, V46, P183; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; Goodman VL, 2004, ENDOCR-RELAT CANCER, V11, P255, DOI 10.1677/erc.0.0110255; Hamza I, 2003, P NATL ACAD SCI USA, V100, P1215, DOI 10.1073/pnas.0336230100; Hamza I, 2001, P NATL ACAD SCI USA, V98, P6848, DOI 10.1073/pnas.111058498; Harris ED, 2004, NUTR REV, V62, P60, DOI 10.1301/nr.2004.feb.60-64; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hu GF, 1998, J CELL BIOCHEM, V69, P326, DOI 10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A; Hung IH, 1998, J BIOL CHEM, V273, P1749, DOI 10.1074/jbc.273.3.1749; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Jeney V, 2005, CIRC RES, V96, P723, DOI 10.1161/01.RES.0000162001.57896.66; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791; Lin SJ, 1997, J BIOL CHEM, V272, P9215; LINDER MC, 1991, BIOCH COPPER, P1; Mandinov L, 2003, P NATL ACAD SCI USA, V100, P6700, DOI 10.1073/pnas.1231994100; MCAUSLAN BR, 1980, T OPHTHAL SOC UK, V100, P354; Moore SDP, 2002, MAMM GENOME, V13, P563, DOI 10.1007/s00335-002-2172-9; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Percival SS, 1998, AM J CLIN NUTR, V67, p1064S, DOI 10.1093/ajcn/67.5.1064S; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Redman BG, 2003, CLIN CANCER RES, V9, P1666; Rosenzweig AC, 2001, ACCOUNTS CHEM RES, V34, P119, DOI 10.1021/ar000012p; Rucker RB, 1998, AM J CLIN NUTR, V67, p996S, DOI 10.1093/ajcn/67.5.996S; Sen CK, 2002, AM J PHYSIOL-HEART C, V282, pH1821, DOI 10.1152/ajpheart.01015.2001; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Ushio-Fukai M, 2001, ARTERIOSCL THROM VAS, V21, P489, DOI 10.1161/01.ATV.21.4.489; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Volker W, 1997, ATHEROSCLEROSIS, V130, P29, DOI 10.1016/S0021-9150(96)06039-X; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; WINGE DR, 1985, J BIOL CHEM, V260, P4464; Winge DR, 1997, J BIOL INORG CHEM, V2, P2, DOI 10.1007/s007750050100	45	177	184	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9157	9167		10.1074/jbc.M709463200	http://dx.doi.org/10.1074/jbc.M709463200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18245776	Green Published, hybrid			2022-12-27	WOS:000254465800045
J	Kaiserova, K; Tang, XL; Srivastava, S; Bhatnagar, A				Kaiserova, Karin; Tang, Xian-Liang; Srivastava, Sanjay; Bhatnagar, Aruni			Role of nitric oxide in regulating aldose reductase activation in the ischemic heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SULFENIC ACIDS; SMOOTH-MUSCLE-CELLS; REPERFUSION INJURY; MYOCARDIAL-CONTRACTILITY; S-NITROSYLATION; MOUSE HEART; LATE-PHASE; RAT-HEART; PEROXYNITRITE; AKT	Aldose reductase (AR) catalyzes the reduction of several aldehydes ranging from lipid peroxidation products to glucose. The activity of AR is increased in the ischemic heart due to oxidation of its cysteine residues, but the underlying mechanisms remain unclear. To examine signaling mechanisms regulating AR activation, we studied the role of nitric oxide ( NO). Treatment with the NO synthase ( NOS) inhibitor, N-nitro-L-arginine methyl ester prevented ischemia-induced AR activation and myocardial sorbitol accumulation in rat hearts subjected to global ischemia ex vivo or coronary ligation in situ, whereas inhibition of inducible NOS and neuronal NOS had no effect. Activation of AR in the ischemic heart was abolished by pretreatment with peroxynitrite scavengers hesperetin or 5, 10, 15, 20-tetrakis-[4-sulfonatophenyl]- porphyrinato-iron [III]. Site-directed mutagenesis and electrospray ionization mass spectrometry analyses showed that Cys-298 of AR was readily oxidized to sulfenic acid by peroxynitrite. Treatment with bradykinin and insulin led to a phosphatidylinositol 3-kinase ( PI3K)- dependent increase in the phosphorylation of endothelial NOS at Ser-1177 and, even in the absence of ischemia, was sufficient in activating AR. Activation of AR by bradykinin and insulin was reversed upon reduction with dithiothreitol or by inhibiting NOS or PI3K. Treatment with AR inhibitors sorbinil or tolrestat reduced post-ischemic recovery in the rat hearts subjected to global ischemia and increased the infarct size when given before ischemia or upon reperfusion. These results suggest that AR is a cardioprotective protein and that its activation in the ischemic heart is due to peroxynitrite-mediated oxidation of Cys-298 to sulfenic acid via the PI3K/Akt/endothelial NOS pathway.	[Kaiserova, Karin; Tang, Xian-Liang; Srivastava, Sanjay; Bhatnagar, Aruni] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40202 USA	University of Louisville	Bhatnagar, A (corresponding author), Univ Louisville, Inst Mol Cardiol, Louisville, KY 40202 USA.	aruni@louisville.edu	Srivastava, Sanjay/D-3921-2012; Tang, Xian-Liang/L-5703-2015		NHLBI NIH HHS [HL 59378, HL 65618, HL 78825, HL 55477] Funding Source: Medline; NIEHS NIH HHS [ES 11860, ES 11594] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078825, R01HL065618, R01HL055477, R01HL059378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011594, P01ES011860] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bell RM, 2003, J MOL CELL CARDIOL, V35, P185, DOI 10.1016/S0022-2828(02)00310-3; Berges A, 2007, PHARMACOL RES, V55, P72, DOI 10.1016/j.phrs.2006.10.008; BHATNAGAR A, 1992, BIOCHEM MED METAB B, V48, P91, DOI 10.1016/0885-4505(92)90055-4; BHATNAGAR A, 1990, BIOCHEM PHARMACOL, V39, P1115, DOI 10.1016/0006-2952(90)90292-S; BHATNAGAR A, 1995, J CARDIOVASC PHARM, V26, P343, DOI 10.1097/00005344-199509000-00001; Bolli R, 2000, CIRC RES, V87, P972, DOI 10.1161/01.RES.87.11.972; Chandra A, 1997, BBA-PROTEIN STRUCT M, V1341, P217, DOI 10.1016/S0167-4838(97)00084-8; Chandra A, 1997, BIOCHEMISTRY-US, V36, P15801, DOI 10.1021/bi9714722; Chandra D, 2002, DIABETES, V51, P3095, DOI 10.2337/diabetes.51.10.3095; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; DEMASTER EG, 1995, BIOCHEMISTRY-US, V34, P11494, DOI 10.1021/bi00036a023; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dixit BL, 2000, J BIOL CHEM, V275, P21587, DOI 10.1074/jbc.M909235199; DOWNEY JM, 1990, ANNU REV PHYSIOL, V52, P487, DOI 10.1146/annurev.ph.52.030190.002415; Ferdinandy P, 2000, CIRC RES, V87, P241, DOI 10.1161/01.RES.87.3.241; Flesch M, 1999, J AM COLL CARDIOL, V33, P1062, DOI 10.1016/S0735-1097(98)00660-3; Folmes CDL, 2006, CIRC RES, V99, P61, DOI 10.1161/01.RES.0000229656.05244.11; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hwang YC, 2001, FASEB J, V15, P243, DOI 10.1096/fj.01-0368fje; Hwang YYC, 2003, FASEB J, V17, P2331, DOI 10.1096/fj.03-0128fje; Ishii T, 1999, BIOCHEM PHARMACOL, V58, P133, DOI 10.1016/S0006-2952(99)00060-X; Iwata K, 2006, J PHARMACOL SCI, V102, P37, DOI 10.1254/jphs.FP0060218; JOHNSTON DL, 1991, CIRC RES, V68, P714, DOI 10.1161/01.RES.68.3.714; Kaiserova K, 2005, CIRCULATION, V112, pU337; Kaiserova K, 2006, J BIOL CHEM, V281, P15110, DOI 10.1074/jbc.M600837200; KLONER RA, 1989, CIRCULATION, V80, P1115, DOI 10.1161/01.CIR.80.5.1115; Kloner RA, 2001, CIRCULATION, V104, P3158, DOI 10.1161/hc5001.100039; Lancel S, 2004, J AM COLL CARDIOL, V43, P2348, DOI 10.1016/j.jacc.2004.01.047; Liu Q, 2002, J AM COLL CARDIOL, V39, P718, DOI 10.1016/S0735-1097(01)01803-4; Martinez-Ruiz A, 2004, CARDIOVASC RES, V62, P43, DOI 10.1016/j.cardiores.2004.01.013; Matsui T, 2001, CIRCULATION, V104, P330; Mungrue IN, 2002, J CLIN INVEST, V109, P735, DOI 10.1172/JCI200213265; Ng DTF, 1998, DIABETES, V47, P961, DOI 10.2337/diabetes.47.6.961; Node K, 1996, CIRCULATION, V93, P356, DOI 10.1161/01.CIR.93.2.356; Nossuli TO, 1997, CIRCULATION, V96, P2317; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Percival MD, 1999, BIOCHEMISTRY-US, V38, P13574, DOI 10.1021/bi991028u; PETRASH JM, 1992, J BIOL CHEM, V267, P24833; Ping PP, 1999, AM J PHYSIOL-HEART C, V277, pH1771, DOI 10.1152/ajpheart.1999.277.5.H1771; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; RADI R, 1991, J BIOL CHEM, V266, P4244; Ramana KV, 2000, BIOCHEMISTRY-US, V39, P12172, DOI 10.1021/bi000796e; Ramana KV, 2003, FASEB J, V17, P417, DOI 10.1096/fj.02-0722com; Ramasamy R, 1997, DIABETES, V46, P292, DOI 10.2337/diabetes.46.2.292; Ramasamy R, 1998, AM J PHYSIOL-HEART C, V275, pH195, DOI 10.1152/ajpheart.1998.275.1.H195; Rittner HL, 1999, J CLIN INVEST, V103, P1007, DOI 10.1172/JCI4711; ROCHETTE L, 1980, J CARDIOVASC PHARM, V2, P267, DOI 10.1097/00005344-198005000-00005; Sergeev P, 2004, ANESTHESIOLOGY, V100, P474, DOI 10.1097/00000542-200403000-00005; Shinmura K, 2002, CIRC RES, V91, P240, DOI 10.1161/01.RES.0000029970.97247.57; Spycher SE, 1997, FASEB J, V11, P181, DOI 10.1096/fasebj.11.2.9039961; Srivastava S, 1999, BIOCHEMISTRY-US, V38, P42, DOI 10.1021/bi981794l; Srivastava S, 2004, J BIOL CHEM, V279, P53395, DOI 10.1074/jbc.M403416200; Srivastava S, 2001, BIOCHEM J, V358, P111, DOI 10.1042/0264-6021:3580111; Srivastava S, 1998, J BIOL CHEM, V273, P10893, DOI 10.1074/jbc.273.18.10893; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Tracey WR, 2000, AM J PHYSIOL-HEART C, V279, pH1447, DOI 10.1152/ajpheart.2000.279.4.H1447; Ungvari Zoltan, 2005, Current Vascular Pharmacology, V3, P221, DOI 10.2174/1570161054368607; Vikramadithyan RK, 2005, J CLIN INVEST, V115, P2434, DOI 10.1172/JCI24819; Xie P, 2000, J BIOL CHEM, V275, P24907, DOI 10.1074/jbc.M001051200; Yang JC, 2000, CIRCULATION, V102, P3046	67	39	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9101	9112		10.1074/jbc.M709671200	http://dx.doi.org/10.1074/jbc.M709671200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18223294	Green Published, hybrid			2022-12-27	WOS:000254465800040
J	Chen, YD; Erickson, HP				Chen, Yaodong; Erickson, Harold P.			In vitro assembly studies of FtsZ/Tubulin-like proteins (TubZ) from Bacillus plasmids - Evidence for a capping mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THURINGIENSIS SUBSP ISRAELENSIS; DNA SEGREGATION; CELL-DIVISION; FTSZ; POLYMERIZATION; TUBULIN; PBTOXIS; CYTOSKELETON; REPLICATION; HYDROLYSIS	Proteins with a weak sequence similarity to tubulin and FtsZ are expressed from large plasmids of Bacillus anthracis and Bacillus thuringiensis and are probably involved in plasmid segregation. Previously designated RepX and TubZ, we designate them here as TubZ-Ba and TubZ-Bt. We have expressed and purified the proteins for in vitro studies. TubZ-Ba and TubZ-Bt share only 21% amino acid identity, but they have remarkably similar biochemical properties. They both assemble into two-stranded filaments and larger bundles above a critical concentration, and they hydrolyze GTP at a very high rate, similar to 20 GTP min(-1) TubZ(-1). Assembly is also supported by GTP gamma S. A tiny amount of GTP gamma S stabilizes polymers assembled in GTP and inhibits the GTPase by a mechanism involving cooperativity. The nucleotide in the polymers is almost 100% GDP, which is similar to microtubules but very different from the 20-30% GDP in FtsZ polymers. This suggests that the TubZ polymers have a capping mechanism that may be related to the GTP cap that produces dynamic instability of microtubules.	[Chen, Yaodong; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Erickson, HP (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	h.Erickson@cellbio.duke.edu	Chen, Yaodong/X-8923-2019; Chen, Yaodong/C-6138-2011	Chen, Yaodong/0000-0002-3751-0923	NIGMS NIH HHS [R01 GM066014, R01 GM066014-06, GM 66014] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066014] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; ERICKSON HP, 1992, ANNU REV BIOPH BIOM, V21, P145, DOI 10.1146/annurev.bb.21.060192.001045; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Margolin W, 2007, CURR BIOL, V17, pR633, DOI 10.1016/j.cub.2007.06.020; Minton AP, 2005, J PHARM SCI-US, V94, P1668, DOI 10.1002/jps.20417; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; Scheffers DJ, 2000, MOL MICROBIOL, V35, P1211, DOI 10.1046/j.1365-2958.2000.01791.x; Tang M, 2007, J BACTERIOL, V189, P8053, DOI 10.1128/JB.00908-07; Tang MJ, 2006, APPL ENVIRON MICROB, V72, P6948, DOI 10.1128/AEM.00976-06; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5	24	44	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8102	8109		10.1074/jbc.M709163200	http://dx.doi.org/10.1074/jbc.M709163200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18198178	Green Published, hybrid			2022-12-27	WOS:000254288000006
J	El-Mashtoly, SF; Gu, Y; Yoshimura, H; Yoshioka, S; Aono, S; Kitagawa, T				El-Mashtoly, Samir F.; Gu, Yuzong; Yoshimura, Hideaki; Yoshioka, Shiro; Aono, Shigetoshi; Kitagawa, Teizo			Protein conformation changes of HemAT-Bs upon ligand binding probed by ultraviolet resonance Raman spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; OXYGEN SENSOR; ESCHERICHIA-COLI; SENSING MECHANISM; HYDROGEN-BOND; SIDE-CHAINS; EC DOS; SIGNAL; TRYPTOPHAN; PHOSPHODIESTERASE	HemAT from Bacillus subtilis (HemAT-Bs) is a heme-based O-2 sensor protein that acts as a signal transducer responsible for aerotaxis. HemAT-Bs discriminates its physiological effector (O-2) from other gas molecules (CO and NO), although all of them bind to a heme. To monitor the conformational changes in the protein moiety upon binding of different ligands, we have investigated ultraviolet resonance Raman (UVRR) spectra of the ligand-free and O-2-, CO-, and NO-bound forms of full-length HemAT-Bs and several mutants (Y70F, H86A, T95A, and Y133F) and found that Tyr(70) in the heme distal side and Tyr(133) and Trp(132) from the G-helix in the heme proximal side undergo environmental changes upon ligand binding. In addition, the UVRR results confirmed our previous model, which suggested that Thr(95) forms a hydrogen bond with heme-bound O-2, but Tyr(70) does not. It is deduced from this study that hydrogen bonds between Thr(95) and heme-bound O-2 and between His(86) and heme 6-propionate communicate the heme structural changes to the protein moiety upon O-2 binding but not upon CO and NO binding. Accordingly, the present UVRR results suggest that O-2 binding to heme causes displacement of the G-helix, which would be important for transduction of the conformational changes from the sensor domain to the signaling domain.	[El-Mashtoly, Samir F.; Gu, Yuzong; Yoshimura, Hideaki; Yoshioka, Shiro; Aono, Shigetoshi; Kitagawa, Teizo] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Kitagawa, T (corresponding author), Toyota Phys & Chem Res Inst, Nagakute, Aichi 4801192, Japan.	teizo@ims.ac.jp	El-Mashtoly, Samir/C-8761-2014; Asano, Yasuhisa/K-5898-2016; Yoshimura, Hideaki/T-4488-2017; Aono, Shigetoshi/ABD-7618-2020; Yoshimura, Hideaki/AAV-3735-2020	El-Mashtoly, Samir/0000-0001-6087-8817; Asano, Yasuhisa/0000-0003-3645-3952; Yoshimura, Hideaki/0000-0002-7287-7712; Aono, Shigetoshi/0000-0002-2870-3694; Yoshimura, Hideaki/0000-0002-7287-7712				Aki M, 2000, J PHYS CHEM B, V104, P10765, DOI 10.1021/jp000357p; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; Aono S, 1999, COORDIN CHEM REV, V190, P267, DOI 10.1016/S0010-8545(99)00070-3; Austin J. C., 1993, BIOMOLECULAR SPECT A, P55; BISCHOFF DS, 1992, MOL MICROBIOL, V6, P23, DOI 10.1111/j.1365-2958.1992.tb00833.x; Chan MK, 2001, CURR OPIN CHEM BIOL, V5, P216, DOI 10.1016/S1367-5931(00)00193-9; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Chi ZH, 1998, J PHYS CHEM B, V102, P9595, DOI 10.1021/jp9828336; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; El-Mashtoly SF, 2007, J AM CHEM SOC, V129, P3556, DOI 10.1021/ja0669777; El-Mashtoly SF, 2005, J PHYS CHEM B, V109, P23666, DOI 10.1021/jp054772z; Gao Y, 2006, J BIOL CHEM, V281, P24637, DOI 10.1074/jbc.M603198200; GARRITY LF, 1995, PHARMACOL THERAPEUT, V68, P87, DOI 10.1016/0163-7258(95)00027-5; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Harada I, 1986, SPECTROSCOPY BIOL SY, P113; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Kachalova GS, 1999, SCIENCE, V284, P473, DOI 10.1126/science.284.5413.473; Kubo M, 2006, J BIOL CHEM, V281, P11271, DOI 10.1074/jbc.M513261200; Matsuno M, 1998, B CHEM SOC JPN, V71, P851, DOI 10.1246/bcsj.71.851; MIURA T, 1989, J RAMAN SPECTROSC, V20, P667, DOI 10.1002/jrs.1250201007; MIURA T, 1988, BIOCHEMISTRY-US, V27, P88, DOI 10.1021/bi00401a015; Nakamura H, 2004, P NATL ACAD SCI USA, V101, P2742, DOI 10.1073/pnas.0305795101; Ohta T, 2005, INORG CHEM, V44, P758, DOI 10.1021/ic0486318; Ohta T, 2004, J AM CHEM SOC, V126, P15000, DOI 10.1021/ja046896f; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Pinakoulaki E, 2006, P NATL ACAD SCI USA, V103, P14796, DOI 10.1073/pnas.0604248103; Pinakoulaki E, 2006, BIOCHEMISTRY-US, V45, P7763, DOI 10.1021/bi0604072; RODGERS KR, 1992, J AM CHEM SOC, V114, P3697, DOI 10.1021/ja00036a019; Rodgers KR, 1999, CURR OPIN CHEM BIOL, V3, P158, DOI 10.1016/S1367-5931(99)80028-3; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Szurmant H, 2004, J MOL BIOL, V344, P919, DOI 10.1016/j.jmb.2004.09.093; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Takeuchi H, 2003, BIOPOLYMERS, V72, P305, DOI 10.1002/bip.10440; TAKEUCHI H, 1989, J RAMAN SPECTROSC, V20, P233, DOI 10.1002/jrs.1250200407; Tanaka A, 2007, J BIOL CHEM, V282, P21301, DOI 10.1074/jbc.M701920200; TERAOKA J, 1981, J BIOL CHEM, V256, P3969; Uchida T, 2005, ACCOUNTS CHEM RES, V38, P662, DOI 10.1021/ar030267d; Yoshimura H, 2007, BIOCHEM BIOPH RES CO, V357, P1053, DOI 10.1016/j.bbrc.2007.04.041; Yoshimura H, 2006, BIOCHEMISTRY-US, V45, P8301, DOI 10.1021/bi060315c; Zhang W, 2005, BIOPHYS J, V88, P2801, DOI 10.1529/biophysj.104.047936; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	44	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6942	6949		10.1074/jbc.M709209200	http://dx.doi.org/10.1074/jbc.M709209200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18162468	hybrid			2022-12-27	WOS:000253779600038
J	Etheridge, KT; Compton, SA; Barrientos, KS; Ozgur, S; Griffith, JD; Counter, CM				Etheridge, Katherine T.; Compton, Sarah A.; Barrientos, Katharine S.; Ozgur, Sezgin; Griffith, Jack D.; Counter, Christopher M.			Tethering telomeric double- and single-stranded DNA-binding proteins inhibits telomere elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; COMPLEX; POT1; LENGTH; TRF1; END; INSTABILITY; MAINTAIN; YEAST	Mammalian telomeres are composed of G-rich repetitive double-stranded (ds) DNA with a 3 ' single-stranded (ss) overhang and associated proteins that together maintain chromosome end stability. Complete replication of telomeric DNA requires de novo elongation of the ssDNA by the enzyme telomerase, with telomeric proteins playing a key role in regulating telomerase-mediated telomere replication. In regards to the protein component of mammalian telomeres, TRF1 and TRF2 bind to the dsDNA of telomeres, whereas POT1 binds to the ssDNA portion. These three proteins are linked through either direct interactions or by the proteins TIN2 and TPP1. To determine the biological consequence of connecting telomeric dsDNA to ssDNA through a multiprotein assembly, we compared the effect of expressing TRF1 and POT1 in trans versus in cis in the form of a fusion of these two proteins, on telomere length in telomerase-positive cells. When expressed in trans these two proteins induced extensive telomere elongation. Fusing TRF1 to POT1 abrogated this effect, inducing mild telomere shortening, and generated looped DNA structures, as assessed by electron microscopy, consistent with the protein forming a complex with dsDNA and ssDNA. We speculate that such a protein bridge between dsDNA and ssDNA may inhibit telomerase access, promoting telomere shortening.	[Etheridge, Katherine T.; Barrientos, Katharine S.; Ozgur, Sezgin; Counter, Christopher M.] DUMC 3813, Dept Radiat Oncol, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Compton, Sarah A.; Ozgur, Sezgin; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Counter, CM (corresponding author), DUMC 3813, Dept Radiat Oncol, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	count004@mc.duke.edu		Counter, Christopher M/0000-0003-0748-3079	NATIONAL CANCER INSTITUTE [R01CA082481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER; NCI NIH HHS [CA82481] Funding Source: Medline; NIEHS NIH HHS [ES13773] Funding Source: Medline; NIGMS NIH HHS [GM31819] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armbruster BN, 2004, MOL CELL BIOL, V24, P3552, DOI 10.1128/MCB.24.8.3552-3561.2004; Armbruster BN, 2003, MOL CELL BIOL, V23, P3237, DOI 10.1128/MCB.23.9.3237-3246.2003; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Chai WH, 2005, MOL CELL BIOL, V25, P2158, DOI 10.1128/MCB.25.6.2158-2168.2005; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stansel RM, 2001, EMBO J, V20, P5532; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Vega LR, 2003, NAT REV MOL CELL BIO, V4, P948, DOI 10.1038/nrm1256; Veldman T, 2004, CURR BIOL, V14, P2264, DOI 10.1016/j.cub.2004.12.031; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404	33	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6935	6941		10.1074/jbc.M708711200	http://dx.doi.org/10.1074/jbc.M708711200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18178559	hybrid, Green Published			2022-12-27	WOS:000253779600037
J	Hodges, AR; Krementsova, EB; Trybus, KM				Hodges, Alex R.; Krementsova, Elena B.; Trybus, Kathleen M.			She3p binds to the rod of yeast myosin V and prevents it from dimerizing, forming a single-headed motor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASH1 MESSENGER-RNA; MONOMERIC MYOSIN; SACCHAROMYCES-CEREVISIAE; STRUCTURAL ELEMENTS; LOCALIZATION; PROCESSIVITY; PROTEIN; MYO4P; ACTIN; COORDINATION	Vertebrate myosin Va is a dimeric processive motor that walks on actin filaments to deliver cargo. In contrast, the two class V myosins in budding yeast, Myo2p and Myo4p, are non-processive (Reck-Peterson, S. L., Tyska, M. J., Novick, P. J., and Mooseker, M. S. ( 2001) J. Cell Biol. 153, 1121-1126). We previously showed that a chimera with the motor domain of Myo4p on the backbone of vertebrate myosin Va was processive, demonstrating that the Myo4p motor domain has a high duty ratio. Here we examine the properties of a chimera containing the rod and globular tail of Myo4p joined to the motor domain and neck of mouse myosin Va. Surprisingly, the adaptor protein She3p binds to the rod region of Myo4p and forms a homogeneous single-headed myosin-She3p complex, based on sedimentation equilibrium and velocity data. We propose that She3p forms a heterocoiled-coil with Myo4p and is a subunit of the motor. She3p does not affect the maximal actin-activated ATPase in solution or the velocity of movement in an ensemble in vitro motility assay. At the single molecule level, the monomeric myosin-She3p complex showed no processivity. When this construct was dimerized with a leucine zipper, short processive runs were obtained. Robust continuous movement was observed when multiple monomeric myosin-She3p motors were bound to a quantum dot "cargo." We propose that continuous transport of mRNA by Myo4p-She3p in yeast is accomplished either by multiple high duty cycle monomers or by molecules that may be dimerized by She2p, the homodimeric downstream binding partner of She3p.	[Hodges, Alex R.; Krementsova, Elena B.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Vermont	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, 149 Beaumont Ave, Burlington, VT 05405 USA.	kathleen.trybus@uvm.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078097] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM078097] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Bohl F, 2000, EMBO J, V19, P5514, DOI 10.1093/emboj/19.20.5514; Chartrand P, 1999, CURR BIOL, V9, P333, DOI 10.1016/S0960-9822(99)80144-4; Darzacq X, 2003, CURR OPIN MICROBIOL, V6, P614, DOI 10.1016/j.mib.2003.10.005; Diefenbach RJ, 1998, BIOCHEMISTRY-US, V37, P16663, DOI 10.1021/bi981163r; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; Dunn BD, 2007, J CELL BIOL, V178, P1193, DOI 10.1083/jcb.200707080; Estrada P, 2003, J CELL BIOL, V163, P1255, DOI 10.1083/jcb.200304030; Gonsalvez GB, 2005, BIOL CELL, V97, P75; Gonzalez I, 1999, CURR BIOL, V9, P337, DOI 10.1016/S0960-9822(99)80145-6; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Heuck A, 2007, P NATL ACAD SCI USA, V104, P19778, DOI 10.1073/pnas.0706780104; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Jambhekar A, 2005, P NATL ACAD SCI USA, V102, P18005, DOI 10.1073/pnas.0509229102; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Krementsova EB, 2006, J BIOL CHEM, V281, P6079, DOI 10.1074/jbc.M510041200; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Long RM, 2000, EMBO J, V19, P6592, DOI 10.1093/emboj/19.23.6592; Lu HL, 2006, J BIOL CHEM, V281, P31987, DOI 10.1074/jbc.M605181200; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; Niessing D, 2004, CELL, V119, P491, DOI 10.1016/j.cell.2004.10.018; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; VATANABE S, 2007, J BIOL CHEM      DEC; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Vilfan A, 2005, BIOPHYS J, V88, P3792, DOI 10.1529/biophysj.104.046763; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892	42	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6906	6914		10.1074/jbc.M708865200	http://dx.doi.org/10.1074/jbc.M708865200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18175803	hybrid			2022-12-27	WOS:000253779600034
J	Marden, JJ; Zhang, YL; Oakley, FD; Zhou, WH; Luo, MH; Jia, HP; McCray, PB; Yaniv, M; Weitzman, JB; Engelhard, JF				Marden, Jennifer J.; Zhang, Yulong; Oakley, Fredrick D.; Zhou, Weihong; Luo, Meihui; Jia, Hong Peng; McCray, Paul B., Jr.; Yaniv, Moshe; Weitzman, Jonathan B.; Engelhard, John F.			JunD protects the liver from ischemia/reperfusion injury by dampening AP-1 transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1 EXPRESSION; DNA-BINDING ACTIVITY; C-JUN; ISCHEMIA-REPERFUSION; HEPATIC-INJURY; MOUSE-LIVER; PROLIFERATION; SUPEROXIDE; KINASE; CELLS	The AP-1 transcription factor modulates a wide range of cellular processes, including cellular proliferation, programmed cell death, and survival. JunD is a major component of the AP-1 complex following liver ischemia/reperfusion (I/R) injury; however, its precise function in this setting remains unclear. We investigated the functional significance of JunD in regulating AP-1 transcription following partial lobar I/R injury to the liver, as well as the downstream consequences for hepatocellular remodeling. Our findings demonstrate that JunD plays a protective role, reducing I/R injury to the liver by suppressing acute transcriptional activation of AP-1. In the absence of JunD, c-Jun phosphorylation and AP-1 activation in response to I/R injury were elevated, and this correlated with increased caspase activation, injury, and alterations in hepatocyte proliferation. The expression of dominant negative JNK1 inhibited c-Jun phosphorylation, AP-1 activation, and hepatic injury following I/R in JunD-/- mice but, paradoxically, led to an enhancement of AP-1 activation and liver injury in JunD(+/-) littermates. Enhanced JunD/JNK1-dependent liver injury correlated with the acute induction of diphenylene iodonium-sensitive NADPH-dependent superoxide production by the liver following I/R. In this context, dominant negative JNK1 expression elevated both Nox2 and Nox4 mRNA levels in the liver in a JunD-dependent manner. These findings suggest that JunD counterbalances JNK1 activation and the downstream redox-dependent hepatic injury that results from I/R, and may do so by regulating NADPH oxidases.	[Zhang, Yulong; Oakley, Fredrick D.; Zhou, Weihong; Luo, Meihui; Engelhard, John F.] Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Jia, Hong Peng; McCray, Paul B., Jr.] Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA; [McCray, Paul B., Jr.; Engelhard, John F.] Univ Iowa, Coll Med, Ctr Gene Therapy, Iowa City, IA 52242 USA; [Marden, Jennifer J.] Univ Iowa, Coll Med, Mol & Cell Biol Interdisciplinary Grad Program, Iowa City, IA 52242 USA; [Weitzman, Jonathan B.] Inst Pasteur, F-75724 Paris, France; [Weitzman, Jonathan B.] Univ Paris 07, INSERM Epigenet Pathol & Dev, U741, F-75724 Paris 15, France	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Engelhard, JF (corresponding author), Univ Iowa, Coll Med, Dept Anat & Cell Biol, 51 Newton Rd, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu	jia, jhp@mm8899/AAH-6611-2020	Weitzman, Jonathan/0000-0001-8445-0102; McCray, Paul/0000-0002-4067-577X; Engelhardt, John/0000-0003-2389-9277	NIDDK NIH HHS [R01 DK067928, DK51315, P30 DK054759, R01 DK051315, DK067928, DK54759] Funding Source: Medline; NIGMS NIH HHS [T32 GM007337] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759, R01DK067928, R01DK051315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Ameyar-Zazoua M, 2005, ONCOGENE, V24, P2298, DOI 10.1038/sj.onc.1208424; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; ARTHUR MJP, 1985, GASTROENTEROLOGY, V89, P1114, DOI 10.1016/0016-5085(85)90218-5; ATALLA SL, 1985, TRANSPLANTATION, V40, P584, DOI 10.1097/00007890-198512000-00002; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Colletti LM, 1996, HEPATOLOGY, V23, P506; Davis RJ, 1999, BIOCHEM SOC SYMP, P1; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Harada H, 2004, ARCH BIOCHEM BIOPHYS, V423, P103, DOI 10.1016/j.abb.2003.08.035; Ishii M, 2004, J IMMUNOL, V172, P2569, DOI 10.4049/jimmunol.172.4.2569; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Kim Yang-Il, 2003, J Hepatobiliary Pancreat Surg, V10, P195; KOO A, 1992, HEPATOLOGY, V15, P507, DOI 10.1002/hep.1840150325; Kretzschmar M, 2003, EXP TOXICOL PATHOL, V54, P423, DOI 10.1078/0940-2993-00291; Kupiec-Weglinski JW, 2005, TRANSPL P, V37, P1653, DOI 10.1016/j.transproceed.2005.03.134; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; MATHEWS WR, 1994, FREE RADICAL BIO MED, V16, P763, DOI 10.1016/0891-5849(94)90191-0; Okaya T, 2003, J INVEST SURG, V16, P141, DOI 10.1080/08941930390205782; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; Qiao L, 2003, MOL CELL BIOL, V23, P3052, DOI 10.1128/MCB.23.9.3052-3066.2003; Ronai Z, 2004, MOL CELL, V15, P843, DOI 10.1016/j.molcel.2004.09.011; Sabapathy K, 2004, CELL CYCLE, V3, P1520, DOI 10.4161/cc.3.12.1315; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Schlossberg H, 1996, HEPATOLOGY, V23, P1546, DOI 10.1053/jhep.1996.v23.pm0008675176; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Sheerin A, 2001, MECH AGEING DEV, V122, P1813, DOI 10.1016/S0047-6374(01)00319-0; Smyrniotis V, 2003, J AM COLL SURGEONS, V197, P949, DOI 10.1016/j.jamcollsurg.2003.07.009; Thepot D, 2000, DEVELOPMENT, V127, P143; Troen G, 2004, J MOL DIAGN, V6, P297, DOI 10.1016/S1525-1578(10)60525-9; Uehara T, 2005, J HEPATOL, V42, P850, DOI 10.1016/j.jhep.2005.01.030; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Xiao L, 2007, BIOCHEM J, V403, P573, DOI 10.1042/BJ20061436; Yazgan O, 2002, J BIOL CHEM, V277, P29710, DOI 10.1074/jbc.M204552200; Zhou WH, 2001, HEPATOLOGY, V33, P902, DOI 10.1053/jhep.2001.23073; Zwacka RM, 1998, NAT MED, V4, P698, DOI 10.1038/nm0698-698	38	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6687	6695		10.1074/jbc.M705606200	http://dx.doi.org/10.1074/jbc.M705606200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18182393	Green Accepted, hybrid			2022-12-27	WOS:000253779600010
J	Zhou, DH; Palam, LR; Jiang, L; Narasimhan, J; Staschke, KA; Wek, RC				Zhou, Donghui; Palam, L. Reddy; Jiang, Li; Narasimhan, Jana; Staschke, Kirk A.; Wek, Ronald C.			Phosphorylation of eIF2 directs ATF5 translational control in response to diverse stress conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA TRANSLATION; UNFOLDED PROTEIN RESPONSE; NEURAL PROGENITOR CELLS; AMINO-ACID CONTROL; GENE-EXPRESSION; EUKARYOTIC INITIATION-FACTOR-2; BINDING; CHOP; GCN4	Phosphorylation of eukaryotic initiation factor 2 ( eIF2) is an important mechanism regulating global and gene-specific translation in response to different environmental stresses. Central to the eIF2 kinase response is the preferential translation of ATF4 mRNA, encoding a transcriptional activator of genes involved in stress remediation. In this report, we addressed whether there are additional transcription factors whose translational expression is regulated by eIF2 kinases. We show that the expression of the basic zipper transcriptional regulator ATF5 is induced in response to many different stresses, including endoplasmic reticulum stress, arsenite exposure, and proteasome inhibition, by a mechanism requiring eIF2 phosphorylation. ATF5 is subject to translational control as illustrated by the preferential association of ATF5 mRNA with large polyribosomes in response to stress. ATF5 translational control involves two upstream open reading frames ( uORFs) located in the 5'-leader of the ATF5 mRNA, a feature shared with ATF4. Mutational analyses of the 5'-leader of ATF5 mRNA fused to a luciferase reporter suggest that the 5'-proximal uORF1 is positive-acting, allowing scanning ribosomes to reinitiate translation of a downstream ORF. During non-stressed conditions, when eIF2 phosphorylation is low, ribosomes reinitiate translation at the next ORF, the inhibitory uORF2. Phosphorylation of eIF2 during stress delays translation reinitiation, allowing scanning ribosomes to bypass uORF2, and instead translate the ATF5 coding region. In addition to translational control, ATF5 mRNA levels are significantly reduced in ATF4(-/-) mouse embryo fibroblasts, suggesting that ATF4 contributes to basal ATF5 transcription. These results demonstrate that eIF2 kinases direct the translational expression of multiple transcription regulators by a mechanism involving delayed translation reinitiation.	[Zhou, Donghui; Palam, L. Reddy; Jiang, Li; Narasimhan, Jana; Staschke, Kirk A.; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iupui.edu	Staschke, Kirk/HGC-5664-2022; palam, lakshmi reddy/H-4902-2015	Staschke, Kirk/0000-0001-8722-9585; 	NIGMS NIH HHS [R01GM49164, R01GM64350] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064350, R01GM049164] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angelastro JM, 2003, J NEUROSCI, V23, P4590; Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Angelastro JM, 2005, J NEUROSCI, V25, P3889, DOI 10.1523/JNEUROSCI.3447-04.2005; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dong SM, 2005, J NEUROPATH EXP NEUR, V64, P948, DOI 10.1097/01.jnen.0000186940.14779.90; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Hansen MB, 2002, GENOMICS, V80, P344, DOI 10.1006/geno.2002.6838; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Hoffmann B, 2001, MOL BIOL CELL, V12, P2846, DOI 10.1091/mbc.12.9.2846; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; JOHANNES G, 1998, RNA N Y, V12, P1500; Kevil CG, 1997, BIOCHEM BIOPH RES CO, V238, P277, DOI 10.1006/bbrc.1997.7284; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mason JL, 2005, MOL CELL NEUROSCI, V29, P372, DOI 10.1016/j.mcn.2005.03.004; Mathews M. B., 1996, TRANSLATIONAL CONTRO, P1; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; PALUH JL, 1988, P NATL ACAD SCI USA, V85, P3728, DOI 10.1073/pnas.85.11.3728; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Tripathi G, 2002, EMBO J, V21, P5448, DOI 10.1093/emboj/cdf507; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2004, TOP CURR GENET, V7, P171; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	41	191	194	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7064	7073		10.1074/jbc.M708530200	http://dx.doi.org/10.1074/jbc.M708530200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18195013	hybrid			2022-12-27	WOS:000253779600051
J	Hu, JCC; Hu, YY; Smith, CE; Mckee, MD; Wright, JT; Yamakoshi, Y; Papagerakis, P; Hunter, GK; Feng, JQ; Yamakoshi, F; Simmer, JP				Hu, Jan C. -C.; Hu, Yuanyuan; Smith, Charles E.; Mckee, Marc D.; Wright, J. Timothy; Yamakoshi, Yasuo; Papagerakis, Petros; Hunter, Graeme K.; Feng, Jerry Q.; Yamakoshi, Fumiko; Simmer, James P.			Enamel defects and ameloblast-specific expression in Enam knock-out/lacZ knock-in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOMATURATION AMELOGENESIS-IMPERFECTA; DEVELOPING MOUSE MOLARS; PORCINE TOOTH GERMS; DENTAL ENAMEL; MANDIBULAR INCISORS; BETA-GALACTOSIDASE; MOLECULAR-CLONING; GENE-EXPRESSION; CALCIUM-BINDING; MUTATION	Enamelin is critical for proper dental enamel formation, and defects in the human enamelin gene cause autosomal dominant amelogenesis imperfecta. We used gene targeting to generate a knock-in mouse carrying a null allele of enamelin (Enam) that has a lacZ reporter gene replacing the Enam translation initiation site and gene sequences through exon 7. Correct targeting of the transgene was confirmed by Southern blotting and PCR analyses. No enamelin protein could be detected by Western blotting in the Enam-null mice. Histochemical 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-gal) staining demonstrated ameloblast-specific expression of enamelin. The enamel of the Enam(+/-) mice was nearly normal in the maxillary incisors, but the mandibular incisors were discolored and tended to wear rapidly where they contacted the maxillary incisors. The Enam(+/-) mice showed no true enamel. Radiography, microcomputed tomography, and light and scanning electron microscopy were used to document changes in the enamel of Enam(+/-) mice but did not discern any perturbations of bone, dentin, or any other tissue besides the enamel layer. Although a thick layer of enamel proteins covered normal-appearing dentin of unerupted teeth, von Kossa staining revealed almost a complete absence of mineral formation in this protein layer. However, a thin, highly irregular, mineralized crust covered the dentin on erupted teeth, apparently arising from the formation and fusion of small mineralization foci (calcospherites) in the deeper part of the accumulated enamel protein layer. These results demonstrate ameloblast-specific expression of enamelin and reveal that enamelin is essential for proper enamel matrix organization and mineralization.	[Hu, Jan C. -C.; Hu, Yuanyuan; Papagerakis, Petros; Yamakoshi, Fumiko] Univ Michigan, Dent Res Lab, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48108 USA; [Yamakoshi, Yasuo; Simmer, James P.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48108 USA; [Smith, Charles E.] Univ Montreal, Fac Med Dent, Lab Study Calcified Tissues & Biomat, Montreal, PQ H3C 3J7, Canada; [Mckee, Marc D.] McGill Univ, Fac Med Dent, Dept Anat & Cell Biol,McGill Ctr Bone & Peridodon, Jamson TN Wong Labs Calcified Tissue Res, Montreal, PQ H3A 2B2, Canada; [Mckee, Marc D.] McGill Univ, Fac Med Dent, Fonds Rech Sante Quebec Network Oral & Bone Hlth, Montreal, PQ H3A 2B2, Canada; [Wright, J. Timothy] Univ N Carolina, Dept Pediat Dent, Chapel Hill, NC 27599 USA; [Hunter, Graeme K.] Univ Western Ontario, Schulich Sch Med & Dent, Canadian Inst Hlth Res Grp Skeletal Dev & Remodel, London, ON N6A 5C1, Canada; [Feng, Jerry Q.] Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universite de Montreal; McGill University; McGill University; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Hu, JCC (corresponding author), Univ Michigan, Dent Res Lab, Sch Dent, Dept Orthodont & Pediat Dent, 1210 Eisenhower Pl, Ann Arbor, MI 48108 USA.	janhu@umich.edu	McKee, Marc D/E-2187-2011; Hu, Jan C-C./F-5679-2015; Testes, Olga/E-8912-2013; Wright, John Timothy/AAX-5755-2020	McKee, Marc D/0000-0001-8349-965X; Hu, Jan C-C./0000-0002-9294-0248; Simmer, James/0000-0002-7192-6105	NIDCR NIH HHS [DE 11301] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE011301, R01DE011301, R56DE011301] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bartlett JD, 1996, GENE, V183, P123, DOI 10.1016/S0378-1119(96)00525-2; Bartlett JD, 2004, J DENT RES, V83, P909, DOI 10.1177/154405910408301204; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; Chai Y, 2000, DEVELOPMENT, V127, P1671; DACULSI G, 1978, J ULTRA MOL STRUCT R, V65, P163, DOI 10.1016/S0022-5320(78)90053-9; DEUTSCH D, 2006, EUR J ORAL SCI, V114, P381; Deutsch D, 2006, EUR J ORAL SCI, V114, P183, DOI 10.1111/j.1600-0722.2006.00301.x; Dohi N, 1998, CELL TISSUE RES, V293, P313, DOI 10.1007/s004410051123; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Fukae M, 1996, Adv Dent Res, V10, P111; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; GRYNPAS MD, 1988, J BONE MINER RES, V3, P159; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Hart TC, 2003, J MED GENET, V40, P900, DOI 10.1136/jmg.40.12.900; Hu CC, 1998, CONNECT TISSUE RES, V39, P47, DOI 10.3109/03008209809023911; Hu CC, 1997, J DENT RES, V76, P1720, DOI 10.1177/00220345970760110201; Hu CC, 1997, J DENT RES, V76, P648, DOI 10.1177/00220345970760020501; Hu CC, 2000, J DENT RES, V79, P912, DOI 10.1177/00220345000790040501; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Hu JCC, 2002, EUR J ORAL SCI, V110, P307, DOI 10.1034/j.1600-0722.2002.21301.x; Hu JCC, 2005, CELLS TISSUES ORGANS, V181, P219, DOI 10.1159/000091383; Hu JCC, 2000, GENE, V251, P1, DOI 10.1016/S0378-1119(00)00203-1; Hu JCC, 2003, CRIT REV ORAL BIOL M, V14, P387, DOI 10.1177/154411130301400602; Hu JCC, 2001, EUR J ORAL SCI, V109, P125, DOI 10.1034/j.1600-0722.2001.00998.x; HU Y, IN PRESS EUR J ORAL; HWANG WSS, 1965, J DENT RES, V44, P42, DOI 10.1177/00220345650440012901; Iwata T, 2007, J DENT RES, V86, P153, DOI 10.1177/154405910708600209; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Kim JW, 2006, EUR J ORAL SCI, V114, P3, DOI 10.1111/j.1600-0722.2006.00278.x; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Kim JW, 2005, J DENT RES, V84, P278, DOI 10.1177/154405910508400314; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Li Y., 2006, EUR J ORAL SCI, V114, P381; Li Y, 2006, EUR J ORAL SCI, V114, P190, DOI 10.1111/j.1600-0722.2006.00286.x; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Masuya H, 2005, HUM MOL GENET, V14, P575, DOI 10.1093/hmg/ddi054; Moinichen CB, 1996, J ANAT, V189, P325; Nanci A, 2008, 10 CATES ORAL HISTOL, P141; NANCI A, 2003, 10 CATES ORAL HISTOL, P218; Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114; NESS A. R., 1965, ARCH ORAL BIOL, V10, P439, DOI 10.1016/0003-9969(65)90109-3; Obiezu CV, 2005, CLIN CHEM, V51, P1432, DOI 10.1373/clinchem.2005.049692; Ozdemir D, 2005, J DENT RES, V84, P1031, DOI 10.1177/154405910508401112; Ozdemir D, 2005, J DENT RES, V84, P1036, DOI 10.1177/154405910508401113; Pampena DA, 2004, BIOCHEM J, V378, P1083, DOI 10.1042/BJ20031150; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; Risnes S, 1995, CONNECT TISSUE RES, V32, P183, DOI 10.3109/03008209509013722; ROBINSON C, 1988, CELL TISSUE RES, V254, P655; RONNHOLM E, 1962, J ULTRA MOL STRUCT R, V6, P249, DOI 10.1016/S0022-5320(62)80036-7; ROSEN D, 1981, NEUROPATH APPL NEURO, V7, P331, DOI 10.1111/j.1365-2990.1981.tb00236.x; Ryu OH, 1999, J DENT RES, V78, P743, DOI 10.1177/00220345990780030601; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Seedorf H, 2007, J DENT RES, V86, P764, DOI 10.1177/154405910708600815; Simmer J. P., 2004, P 8 INT S BIOM NIIG, P348; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; Simmer JP, 1998, J DENT RES, V77, P377, DOI 10.1177/00220345980770020601; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; SNEAD ML, 1985, BIOCHEM BIOPH RES CO, V129, P812, DOI 10.1016/0006-291X(85)91964-3; SNEAD ML, 1983, P NATL ACAD SCI-BIOL, V80, P7254, DOI 10.1073/pnas.80.23.7254; TANABE T, 1990, CALCIFIED TISSUE INT, V46, P205, DOI 10.1007/BF02555046; UCHIDA T, 1991, HISTOCHEMISTRY, V96, P129, DOI 10.1007/BF00315983; UCHIDA T, 1991, ARCH HISTOL CYTOL, V54, P527, DOI 10.1679/aohc.54.527; Weiss DJ, 1999, HISTOCHEM J, V31, P231, DOI 10.1023/A:1003642025421; Wright JT, 2006, AM J MED GENET A, V140A, P2547, DOI 10.1002/ajmg.a.31358; YAMAKOSHI Y, 1995, CALCIFIED TISSUE INT, V56, P323, DOI 10.1007/BF00318054; Yamakoshi Y, 1998, CONNECT TISSUE RES, V39, P39, DOI 10.3109/03008209809023910; Yamakoshi Y, 2001, ARCH ORAL BIOL, V46, P1005, DOI 10.1016/S0003-9969(01)00070-X; YAMAKOSHI Y, 2001, P 8 INT S BIOM NIIG, P338; YAMAKOSHI Y, 2004, BIOMINERALIZATION FO, P326; Yamakoshi Y, 2006, EUR J ORAL SCI, V114, P266, DOI 10.1111/j.1600-0722.2006.00279.x; YOUNG DC, 1993, ANAL BIOCHEM, V215, P24, DOI 10.1006/abio.1993.1549; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	75	123	127	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10858	10871		10.1074/jbc.M710565200	http://dx.doi.org/10.1074/jbc.M710565200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18252720	hybrid, Green Published			2022-12-27	WOS:000254894700068
J	Newstead, SL; Potter, JA; Wilson, JC; Xu, GG; Chien, CH; Watts, AG; Withers, SG; Taylor, GL				Newstead, Simon L.; Potter, Jane A.; Wilson, Jennifer C.; Xu, Guogang; Chien, Chin-Hsiang; Watts, Andrew G.; Withers, Stephen G.; Taylor, Garry L.			The structure of Clostridium perfringens NanI sialidase and its catalytic intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; VIRUS NEURAMINIDASE; BACTERIAL SIALIDASE; BINDING; WATER; RECOGNITION; MECHANISM; HYDRATION; DOMAINS; COMPLEX	Clostridium perfringens is a Gram-positive bacterium responsible for bacteremia, gas gangrene, and occasionally food poisoning. Its genome encodes three sialidases, nanH, nanI, and nanJ, that are involved in the removal of sialic acids from a variety of glycoconjugates and that play a role in bacterial nutrition and pathogenesis. Recent studies on trypanosomal ( trans-) sialidases have suggested that catalysis in all sialidases may proceed via a covalent intermediate similar to that of other retaining glycosidases. Here we provide further evidence to support this suggestion by reporting the 0.97 angstrom resolution atomic structure of the catalytic domain of the C. perfringens NanI sialidase, and complexes with its substrate sialic acid ( N-acetylneuramic acid) also to 0.97 A resolution, with a transition-state analogue (2-deoxy2,3-dehydro-N-acetylneuraminic acid) to 1.5 A resolution, and with a covalent intermediate formed using a fluorinated sialic acid analogue to 1.2 angstrom resolution. Together, these structures provide high resolution snapshots along the catalytic pathway. The crystal structures suggested that NanI is able to hydrate 2-deoxy-2,3-dehydro-N-acetylneuraminic acid to N-acetylneuramic acid. This was confirmed by NMR, and a mechanism for this activity is suggested.	[Newstead, Simon L.; Potter, Jane A.; Xu, Guogang; Taylor, Garry L.] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; [Chien, Chin-Hsiang] Natl Yang Ming Univ, Sch Life Sci, Inst Biochem, Taipei 112, Taiwan; [Watts, Andrew G.; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of St Andrews; National Yang Ming Chiao Tung University; University of British Columbia	Taylor, GL (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland.	glt2@st-andrews.ac.uk	Taylor, Garry/G-3017-2014; Wilson, Jennifer/H-5297-2013; Xu, Guogang/AAN-9289-2020	Newstead, Simon/0000-0001-7432-2270; Taylor, Garry/0000-0001-9486-566X; /0000-0002-3056-9578; Xu, Guogang/0000-0002-6380-3500; Watts, Andrew/0000-0003-4299-2717	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURMEISTER WP, 1993, STRUCTURE, V1, P19, DOI 10.1016/0969-2126(93)90005-2; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; CHONG AKJ, 1992, EUR J BIOCHEM, V207, P335, DOI 10.1111/j.1432-1033.1992.tb17055.x; Clarke C, 2001, J AM CHEM SOC, V123, P12238, DOI 10.1021/ja004315q; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; CRENNELL SJ, 1993, P NATL ACAD SCI USA, V90, P9852, DOI 10.1073/pnas.90.21.9852; FLASHNER M, 1983, ARCH BIOCHEM BIOPHYS, V221, P188, DOI 10.1016/0003-9861(83)90135-2; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; GLOSTER TM, 2004, J CHEM SOC CHEM COMM, V16, P1794; HEHRE EJ, 1977, BIOCHEMISTRY-US, V16, P1780, DOI 10.1021/bi00628a003; Holdgate GA, 1997, BIOCHEMISTRY-US, V36, P9663, DOI 10.1021/bi970294+; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kruse S, 1996, PROTEIN EXPRES PURIF, V7, P415, DOI 10.1006/prep.1996.0062; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; LAI ECK, 1994, BIOCHEMISTRY-US, V33, P14743, DOI 10.1021/bi00253a012; LEGLER G, 1990, ADV CARBOHYD CHEM BI, V48, P319, DOI 10.1016/S0065-2318(08)60034-7; LOU Y, 1998, J MOL BIOL, V285, P323; LOU Y, 1998, STRUCTURE CAMB, V6, P521; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; Newstead S, 2004, ACTA CRYSTALLOGR D, V60, P2063, DOI 10.1107/S090744490402181X; Newstead SL, 2005, ACTA CRYSTALLOGR D, V61, P1483, DOI 10.1107/S0907444905026132; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; ROGGENTIN P, 1995, BIOL CHEM H-S, V376, P569; ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Taylor G, 1996, CURR OPIN STRUC BIOL, V6, P830, DOI 10.1016/S0959-440X(96)80014-5; TAYLOR G, 1999, SIALOBIOLOGY OTHER N, P187; Thobhani S, 2003, J AM CHEM SOC, V125, P7154, DOI 10.1021/ja029759w; TRAVING C, 1994, GLYCOCONJUGATE J, V11, P141, DOI 10.1007/BF00731154; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Watson JN, 2003, BIOCHEMISTRY-US, V42, P12682, DOI 10.1021/bi035396g; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; WENTWORTH DF, 1974, BIOCHEMISTRY-US, V13, P4715, DOI 10.1021/bi00720a006	47	92	100	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9080	9088		10.1074/jbc.M710247200	http://dx.doi.org/10.1074/jbc.M710247200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18218621	Green Published, hybrid			2022-12-27	WOS:000254465800038
J	Lu, TC; He, JC; Wang, ZH; Feng, X; Fukumi-Tominaga, T; Chen, N; Xu, J; Iyengar, R; Klotman, PE				Lu, Ting-chi; He, John Cijiang; Wang, Zhao-hui; Feng, Xiaobei; Fukumi-Tominaga, Tomoko; Chen, Nan; Xu, Jin; Iyengar, Ravi; Klotman, Paul E.			HIV-1 nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; RHO ACTIVITY; NEPHROPATHY; ACTIVATION; TYPE-1; INFECTION; RAC; ORGANIZATION; DISEASE; AIDS	The ability of the human immunodeficiency virus, type 1 (HIV-1) protein Nef to induce cytoskeleton changes in infected host cells is a key event in viral replication. In renal podocytes, we found that Nef induced loss of stress fibers and increased lamellipodia, pathological changes leading to proteinuria in HIV-associated nephropathy. These morphological changes were mediated by Nef-induced Rac1 activation and RhoA inhibition. We identified a new interaction between Nef and diaphanous interacting protein (DIP), a recently described regulator of Rho and Rac signaling. We found that the Src homology 3 binding domain of DIP and the Nef PXXP motif were required for this interaction. Nef also interacts with Vav2 in podocytes. DIP and Vav2 both interact directly with Nef in a competitive manner. DIP interacts with p190RhoGAP, and intact DIP was required for Nef-induced phosphorylation of p190RhoGAP. DIP also interacts with Vav2, and although DIP enhanced baseline phosphorylation of Vav2, it was not required for Nef- induced Vav2 activation. In Nef- infected podocytes, Src kinase induces phosphorylation of DIP, p190RhoGAP, and Vav2, leading to RhoA inhibition and Rac1 activation. Inhibition of the Nef- induced signaling pathway by using a dominant negative of either Src or DIP or siRNA for DIP or p190RhoAGAP restored RhoA activity and stress fiber formation in Nef- infected podocytes, whereas siRNA for Vav2 reduced Rac1 activity and formation of lamellipodia. We conclude that in HIV-infected podocytes, Nef, through the recruitment of DIP and p190RhoAGAP to Nef- Src complex, activates p190RhoAGAP and down-regulates RhoA activity.	[Lu, Ting-chi; He, John Cijiang; Wang, Zhao-hui; Feng, Xiaobei; Klotman, Paul E.] Mt Sinai Sch Med, Div Nephrol, Dept Med, New York, NY 10029 USA; [Iyengar, Ravi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [He, John Cijiang] James J Peters Vet Affair Med Ctr, Bronx, NY 10468 USA; [Wang, Zhao-hui; Feng, Xiaobei; Chen, Nan] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nephrol, Shanghai 200025, Peoples R China; [Fukumi-Tominaga, Tomoko] Natl Inst Nat Sci, Natl Inst Physiol Sci, Sect Cell Signalling, Okazaki, Aichi 4448585, Japan	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Shanghai Jiao Tong University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	He, JC (corresponding author), Mt Sinai Sch Med, Div Nephrol, Dept Med, Box 1243,1 Gustave L Levy Pl, New York, NY 10029 USA.	Cijiang.he@mssm.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK065495, P01DK056492, R01DK078897, K08DK079781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508] Funding Source: NIH RePORTER; NIDDK NIH HHS [K08 DK 079781, P01 DK 056492, K08 DK 065495, R01 DK 078897] Funding Source: Medline; NIGMS NIH HHS [R01 GM054508, R01 GM 54508] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Barisoni L, 1999, J AM SOC NEPHROL, V10, P51; Barisoni L, 2000, KIDNEY INT, V58, P173, DOI 10.1046/j.1523-1755.2000.00152.x; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; CHANDER P, 1987, AM J PATHOL, V126, P513; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Chuang PY, 2007, KIDNEY INT, V72, P965, DOI 10.1038/sj.ki.5002456; DAGATI V, 1989, KIDNEY INT, V35, P1358, DOI 10.1038/ki.1989.135; DAgati V, 1997, J AM SOC NEPHROL, V8, P138; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dennis CA, 2005, PROTEINS, V60, P658, DOI 10.1002/prot.20544; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Fackler OT, 1997, EUR J BIOCHEM, V247, P843, DOI 10.1111/j.1432-1033.1997.00843.x; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589, DOI 10.1177/002215540305101203; KAMINCHIK J, 1994, AIDS RES HUM RETROV, V10, P1003, DOI 10.1089/aid.1994.10.1003; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Meng WX, 2004, EMBO J, V23, P760, DOI 10.1038/sj.emboj.7600095; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; RAO TKS, 1987, NEW ENGL J MED, V316, P1062, DOI 10.1056/NEJM198704233161705; Renkema GH, 1999, CURR BIOL, V9, P1407, DOI 10.1016/S0960-9822(00)80086-X; RIDLEY AJ, 1992, COLD SPRING HARB SYM, V57, P661, DOI 10.1101/SQB.1992.057.01.072; Ridley AJ, 1999, NAT CELL BIOL, V1, pE64, DOI 10.1038/11034; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Satoh S, 2001, J BIOL CHEM, V276, P39290, DOI 10.1074/jbc.M107026200; Schwartz EJ, 2001, J AM SOC NEPHROL, V12, P1677, DOI 10.1681/ASN.V1281677; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Sunamoto M, 2003, KIDNEY INT, V64, P1695, DOI 10.1046/j.1523-1755.2003.00283.x; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Winston JA, 2001, NEW ENGL J MED, V344, P1979, DOI 10.1056/NEJM200106283442604; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f; Zhong JY, 2005, KIDNEY INT, V68, P1048, DOI 10.1111/j.1523-1755.2005.00497.x; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775; Zuo YQ, 2006, J AM SOC NEPHROL, V17, P2832, DOI 10.1681/ASN.2005080878	47	71	73	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8173	8182		10.1074/jbc.M708920200	http://dx.doi.org/10.1074/jbc.M708920200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18234668	Green Published, hybrid			2022-12-27	WOS:000254288000014
J	Pan, YP; Weng, J; Cao, Y; Bhosle, RC; Zhou, M				Pan, Yaping; Weng, Jun; Cao, Yu; Bhosle, Rahul C.; Zhou, Ming			Functional coupling between the Kv1.1 channel and aldoketoreductase Kv beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED K+ CHANNELS; POTASSIUM CHANNEL; BETA-SUBUNIT; METHIONINE OXIDATION; MOLECULAR-BASIS; FAST INACTIVATION; ION CHANNELS; RAT-BRAIN; VOLTAGE; ALPHA	The Shaker family voltage-dependent potassium channels (Kv1) assemble with cytosolic beta-subunits (Kv beta) to form a stable complex. All Kv beta subunits have a conserved core domain, which in one of them (Kv beta 2) is an aldoketoreductase that utilizes NADPH as a cofactor. In addition to this core, Kv beta 1 has an N terminus that closes the channel by the N-type inactivation mechanism. Point mutations in the putative catalytic site of Kv beta 1 alter the on-rate of inactivation. Whether the core of Kv beta 1 functions as an enzyme and whether its enzymatic activity affects N-type inactivation had not been explored. Here, we show that Kv beta 1 is a functional aldoketoreductase and that oxidation of the Kv beta 1-bound cofactor, either enzymatically by a substrate or non-enzymatically by hydrogen peroxide or NADP(+), induces a large increase in open channel current. The modulation is not affected by deletion of the distal C terminus of the channel, which has been suggested in structural studies to interact with Kv beta. The rate of increase in current, which reflects NADPH oxidation, is similar to 2-fold faster at 0-mV membrane potential than at similar to 100 mV. Thus, cofactor oxidation by Kv beta 1 is regulated by membrane potential, presumably via voltage-dependent structural changes in Kv1.1 channels.	[Pan, Yaping; Weng, Jun; Cao, Yu; Bhosle, Rahul C.; Zhou, Ming] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University	Zhou, M (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 West 168th St, New York, NY 10032 USA.	mz2140@columbia.edu	Cao, Yu/GNP-6653-2022	Cao, Yu/0000-0003-1409-2068	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086392] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 086392, R01 HL086392] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adelman JP, 1995, NEURON, V15, P1449, DOI 10.1016/0896-6273(95)90022-5; ALDRICH RW, 1979, J PHYSIOL-LONDON, V291, P531, DOI 10.1113/jphysiol.1979.sp012829; Bahring R, 2001, J BIOL CHEM, V276, P22923, DOI 10.1074/jbc.M100483200; Cahalan MD, 2001, J CLIN IMMUNOL, V21, P235, DOI 10.1023/A:1010958907271; Ciorba MA, 1999, FEBS LETT, V442, P48, DOI 10.1016/S0014-5793(98)01616-0; Ciorba MA, 1997, P NATL ACAD SCI USA, V94, P9932, DOI 10.1073/pnas.94.18.9932; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Heilstedt HA, 2001, EPILEPSIA, V42, P1103, DOI 10.1046/j.1528-1157.2001.08801.x; Heinemann SH, 1995, FEBS LETT, V377, P383, DOI 10.1016/0014-5793(95)01377-6; Hoshi T, 2001, J PHYSIOL-LONDON, V531, P1, DOI 10.1111/j.1469-7793.2001.0001j.x; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; Lee SY, 2003, AM J PHYSIOL-CELL PH, V284, pC1614, DOI 10.1152/ajpcell.00429.2002; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCORMACK T, 1994, CELL, V79, P1133, DOI 10.1016/0092-8674(94)90004-3; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Parcej DN, 2003, J MOL BIOL, V333, P103, DOI 10.1016/j.jmb.2003.07.009; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RHODES KJ, 1995, J NEUROSCI, V15, P5360; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P3538, DOI 10.1021/bi9723055; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; Sokolova O, 2003, P NATL ACAD SCI USA, V100, P12607, DOI 10.1073/pnas.2235650100; Tipparaju SM, 2005, AM J PHYSIOL-CELL PH, V288, pC366, DOI 10.1152/ajpcell.00354.2004; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Weng J, 2006, J BIOL CHEM, V281, P15194, DOI 10.1074/jbc.M513809200; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	38	46	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8634	8642		10.1074/jbc.M709304200	http://dx.doi.org/10.1074/jbc.M709304200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18222921	Green Published, hybrid			2022-12-27	WOS:000254288000062
J	Scheurwater, EM; Clarke, AJ				Scheurwater, Edie M.; Clarke, Anthony J.			The C-terminal domain of Escherichia coli YfhD functions as a lytic transglycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; MUREIN HYDROLASES; OUTER-MEMBRANE; PEPTIDOGLYCAN; IDENTIFICATION; MECHANISM; FAMILY; LYSIS; PURIFICATION	The hypothetical Escherichia coli protein YfhD has been identified as the archetype for the family 1B lytic transglycosylases despite a complete lack of experimental characterization. The yfhD gene was amplified from the genomic DNA of E. coli W3110 and cloned to encode a fusion protein with a C-terminal His(6) sequence. The enzyme was found to be localized to the outer membrane of E. coli, as would be expected for a lytic transglycosylase. Its gene was engineered for the production of a truncated soluble enzyme derivative lacking an N-terminal signal sequence and membrane anchor. The soluble YfhD derivative was purified to apparent homogeneity, and three separate in vitro assays involving high pressure liquid chromatography and matrix-assisted laser desorption ionization time-of-flight mass spectrometry were used to demonstrate the YfhD-catalyzed release of 1,6-anhydromuro-peptides from insoluble peptidoglycan. In addition, an in vivo bioassay developed using the bacteriophage lambda lysis system confirmed that the enzyme functions as an autolysin. Based on these data, the enzyme was renamed membrane-bound lytic transglycosylase F. The modular structure of MltF was investigated through genetic engineering for the separate production of identified N-terminal and C-terminal domains. The ability to bind peptidoglycan and lytic activity were only associated with the isolated C-terminal domain. The enzymatic properties of this lytic transglycosylase domain were found to be very similar to those of the wild-type enzyme. The one notable exception was that the N-terminal domain appears to modulate the lytic behavior of the C-terminal domain to permit continued lysis of insoluble peptidoglycan, a unique feature of MltF compared with other characterized lytic transglycosylases.	[Scheurwater, Edie M.; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Clarke, AJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 1W1, Canada.	aclarke@uoguelph.ca						BERNADSKY G, 1994, J BACTERIOL, V176, P5225, DOI 10.1128/JB.176.17.5225-5232.1994; BIENKOWSKASZEWCZYK K, 1981, MOL GEN GENET, V184, P111, DOI 10.1007/BF00271205; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Blackburn NT, 2000, ANAL BIOCHEM, V284, P388, DOI 10.1006/abio.2000.4707; Chaput C, 2007, J BACTERIOL, V189, P422, DOI 10.1128/JB.01270-06; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; Clarke AJ, 2000, GLYCOMICROBIOLOGY, P187; Dijkstra AJ, 1996, MICROB DRUG RESIST, V2, P141, DOI 10.1089/mdr.1996.2.141; EHLERT K, 1995, MOL MICROBIOL, V16, P761, DOI 10.1111/j.1365-2958.1995.tb02437.x; HASH JH, 1967, J BACTERIOL, V93, P1201, DOI 10.1128/JB.93.3.1201-1202.1967; Heidrich C, 2002, J BACTERIOL, V184, P6093, DOI 10.1128/JB.184.22.6093-6099.2002; HILL CW, 1981, P NATL ACAD SCI-BIOL, V78, P7069, DOI 10.1073/pnas.78.11.7069; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; KOONIN EV, 1994, TRENDS BIOCHEM SCI, V19, P106; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; Korsak D, 2005, ANTIMICROB AGENTS CH, V49, P1404, DOI 10.1128/AAC.49.4.1404-1409.2005; Kraft AR, 1998, J BACTERIOL, V180, P3441, DOI 10.1128/JB.180.13.3441-3447.1998; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lommatzsch J, 1997, J BACTERIOL, V179, P5465, DOI 10.1128/jb.179.17.5465-5470.1997; MASSAD G, 1994, GENE, V150, P101, DOI 10.1016/0378-1119(94)90866-4; OH BH, 1993, J BIOL CHEM, V268, P11348; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Popham DL, 2003, CURR OPIN MICROBIOL, V6, P594, DOI 10.1016/j.mib.2003.10.002; Rahn A, 2003, MOL MICROBIOL, V47, P1045, DOI 10.1046/j.1365-2958.2003.03354.x; Reid CW, 2007, FEBS LETT, V581, P4988, DOI 10.1016/j.febslet.2007.09.037; Reid CW, 2006, BIOCHEMISTRY-US, V45, P2129, DOI 10.1021/bi052342t; Reid CW, 2004, BIOCHEMISTRY-US, V43, P11275, DOI 10.1021/bi049496d; SCHEURWATER E, 2008, IN PRESS INT J BIOCH; Smith LK, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r87; SUSSMAN R, 1962, CR HEBD ACAD SCI, V254, P1517; Ursinus A, 2004, J BACTERIOL, V186, P6728, DOI 10.1128/JB.186.20.6728-6737.2004; URSINUS A, 1994, J BACTERIOL, V176, P338, DOI 10.1128/JB.176.2.338-343.1994; WALDERICH B, 1991, J BACTERIOL, V173, P5668, DOI 10.1128/jb.173.18.5668-5676.1991; WATT SR, 1994, FEMS MICROBIOL LETT, V124, P113, DOI 10.1111/j.1574-6968.1994.tb07270.x; Watt SR, 1997, CAN J MICROBIOL, V43, P1054, DOI 10.1139/m97-150; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s; YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4; YOUNG RY, 1992, MICROBIOL REV, V56, P430, DOI 10.1128/MMBR.56.3.430-481.1992	41	42	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8363	8373		10.1074/jbc.M710135200	http://dx.doi.org/10.1074/jbc.M710135200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18234673	Green Published, hybrid			2022-12-27	WOS:000254288000034
J	Seabold, GK; Wang, PY; Chang, K; Wang, CY; Wang, YX; Petralia, RS; Wenthold, RJ				Seabold, Gail K.; Wang, Philip Y.; Chang, Kai; Wang, Chang-Yu; Wang, Ya-Xian; Petralia, Ronald S.; Wenthold, Robert J.			The SALM family of adhesion-like molecules forms heteromeric and homomeric complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEAT; OLFACTORY-BULB AXONS; CELL-ADHESION; TRANSMEMBRANE PROTEINS; HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH; SYNAPSE FORMATION; NERVOUS-SYSTEM; SLIT PROTEINS; NMDA RECEPTOR	Synaptic adhesion-like molecules (SALMs) are a newly discovered family of adhesion molecules that play roles in synapse formation and neurite outgrowth. The SALM family is comprised of five homologous molecules that are expressed largely in the central nervous system. SALMs 1 - 3 contain PDZ-binding domains, whereas SALMs 4 and 5 do not. We are interested in characterizing the interactions of the SALMs both among the individual members and with other binding partners. In the present study, we focused on the interactions formed by the five SALM members in rat brain and heterologous cells. In brain, we found that SALMs 1 -3 strongly co-immunoprecipitated with each other, whereas SALMs 4 and 5 did not, suggesting that SALMs 4 and 5 mainly form homomeric complexes. In heterologous cells transfected with SALMs, co-immunoprecipitation studies showed that all five SALMs form heteromeric and homomeric complexes. We also determined if SALMs could form trans-cellular associations between transfected heterologous cells. Both SALMs 4 and 5 formed homophilic, but not heterophilic associations, whereas no trans associations were formed by the other SALMs. The ability of SALM4 to form trans interactions is due to its extracellular N terminus because chimeras of SALM4 N terminus and SALM2 C terminus can form trans interactions, whereas chimeras of SALM2 N terminus and SALM4 C terminus cannot. Co-culture experiments using HeLa cells and rat hippocampal neurons expressing the SALMs showed that SALM4 is recruited to points of contact between the cells. In neurons, these points of contact were seen in both axons and dendrites.	[Seabold, Gail K.; Wang, Philip Y.; Chang, Kai; Wang, Chang-Yu; Wang, Ya-Xian; Petralia, Ronald S.; Wenthold, Robert J.] NIDCD, NIH, Neurochem Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Wenthold, RJ (corresponding author), 50 S Dr,Bldg 50 Rm 4140, Bethesda, MD 20892 USA.	wenthold@nidcd.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, Z01DC000003] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Bando T, 2005, MOL CELL BIOL, V25, P4166, DOI 10.1128/MCB.25.10.4166-4175.2005; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Battye R, 2001, J NEUROSCI, V21, P4290, DOI 10.1523/JNEUROSCI.21-12-04290.2001; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Buchstaller A, 1996, J CELL BIOL, V135, P1593, DOI 10.1083/jcb.135.6.1593; Carim-Todd L, 2003, EUR J NEUROSCI, V18, P3167, DOI 10.1111/j.1460-9568.2003.03003.x; Chen JH, 2001, J NEUROSCI, V21, P1548, DOI 10.1523/JNEUROSCI.21-05-01548.2001; Chen YN, 2006, BRAIN RES REV, V51, P265, DOI 10.1016/j.brainresrev.2005.11.005; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; ESHHAR N, 1993, NEUROSCIENCE, V57, P943, DOI 10.1016/0306-4522(93)90040-M; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fournier AE, 2002, J NEUROSCI, V22, P8876; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gomi F, 2000, J NEUROSCI, V20, P3206, DOI 10.1523/JNEUROSCI.20-09-03206.2000; Haines BP, 2005, DEV BIOL, V281, P145, DOI 10.1016/j.ydbio.2005.01.030; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Karaulanov EE, 2006, EMBO REP, V7, P283, DOI 10.1038/sj.embor.7400614; KINGSTON RE, 1997, CURRENT PROTOCOLS MO; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Kuja-Panula J, 2003, J CELL BIOL, V160, P963, DOI 10.1083/jcb.200209074; Kunz S, 1998, J CELL BIOL, V143, P1673, DOI 10.1083/jcb.143.6.1673; Lacy SE, 1999, GENOMICS, V62, P417, DOI 10.1006/geno.1999.6033; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li WW, 2004, J BIOL CHEM, V279, P43780, DOI 10.1074/jbc.M401803200; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Liu Z, 2004, MOL CELL NEUROSCI, V26, P232, DOI 10.1016/j.mcn.2004.01.002; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Milligan ED, 2001, J NEUROSCI, V21, P2808, DOI 10.1523/JNEUROSCI.21-08-02808.2001; Morimura N, 2006, GENE, V380, P72, DOI 10.1016/j.gene.2006.05.014; Ono T, 2003, J NEUROSCI, V23, P5887; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Petralia RS, 1999, METH MOL B, V128, P73; Philibert RA, 2000, GENE, V246, P303, DOI 10.1016/S0378-1119(00)00049-4; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Sonderegger P, 1998, PROG BRAIN RES, V117, P93; Stoeckli ET, 1996, DEV BIOL, V177, P15, DOI 10.1006/dbio.1996.0141; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Taguchi A, 1996, MOL BRAIN RES, V35, P31, DOI 10.1016/0169-328X(95)00178-U; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Wang CY, 2006, J NEUROSCI, V26, P2174, DOI 10.1523/JNEUROSCI.3799-05.2006; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8	64	44	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8395	8405		10.1074/jbc.M709456200	http://dx.doi.org/10.1074/jbc.M709456200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18227064	hybrid, Green Published			2022-12-27	WOS:000254288000037
J	Holmstrom, TH; Mialon, A; Kallio, M; Nymalm, Y; Mannermaa, L; Holm, T; Johansson, H; Black, E; Gillespie, D; Salminen, TA; Langel, U; Valdez, BC; Westermarck, J				Holmstrom, Tim H.; Mialon, Antoine; Kallio, Marko; Nymalm, Yvonne; Mannermaa, Leni; Holm, Tina; Johansson, Henrik; Black, Elizabeth; Gillespie, David; Salminen, Tiina A.; Langel, Ulo; Valdez, Benigno C.; Westermarck, Jukka			c-Jun supports ribosomal RNA processing and nucleolar localization of RNA helicase DDX21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE COMPLEMENTATION; CELL-PROLIFERATION; PROTEIN; II/GU; DIFFERENTIATION; TRANSFORMATION; TRANSCRIPTION; BIOGENESIS; APOPTOSIS; COFACTOR	The molecular mechanisms by which the AP-1 transcription factor c-Jun exerts its biological functions are not clearly understood. In addition to its well established role in transcriptional regulation of gene expression, several reports have suggested that c-Jun may also regulate cell behavior by non-transcriptional mechanisms. Here, we report that small interfering RNA-mediated depletion of c-Jun from mammalian cells results in inhibition of 28 S and 18 S rRNA accumulation. Moreover, we show that c-Jun depletion results in partial translocation of RNA helicase DDX21, implicated in rRNA processing, from the nucleolus to the nucleoplasm. We demonstrate that DDX21 translocation is rescued by exogenous c-Jun expression and that c-Jun depletion inhibits rRNA binding of DDX21. Furthermore, the direct interaction between c-Jun and DDX21 regulates nucleolar localization of DDX21. These results demonstrate that in addition to its transcriptional effects, c-Jun regulates rRNA processing and nucleolar compartmentalization of the rRNA processing protein DDX21. Thus, our results demonstrate a nucleolar mechanism through which c-Jun can regulate cell behavior. Moreover, these results suggest that the phenotypes observed previously in c-Jun-depleted mouse models and cell lines could be partly due to the effects of c-Jun on rRNA processing.	[Westermarck, Jukka] Univ Tampere, Inst Med Technol, Tampere 33520, Finland; [Westermarck, Jukka] Tampere Univ Hosp, Inst Med Technol, Tampere 33520, Finland; [Holmstrom, Tim H.; Mialon, Antoine; Kallio, Marko; Mannermaa, Leni; Westermarck, Jukka] Univ Turku, Ctr Biotechnol, FIN-20520 Turku, Finland; [Holmstrom, Tim H.; Mialon, Antoine; Kallio, Marko; Mannermaa, Leni; Westermarck, Jukka] Abo Akad Univ, Ctr Biotechnol, FIN-20520 Turku, Finland; [Valdez, Benigno C.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA; [Gillespie, David] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Black, Elizabeth; Gillespie, David] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Holm, Tina; Johansson, Henrik; Langel, Ulo] Univ Stockholm, Dept Neurochem, S-10691 Stockholm, Sweden; [Nymalm, Yvonne; Salminen, Tiina A.] Abo Akad Univ, Dept Biochem & Pharm, FIN-20520 Turku, Finland; [Holmstrom, Tim H.; Kallio, Marko] State Tech Res Ctr Finland, Turku 20521, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Turku; Abo Akademi University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Glasgow; Beatson Institute; Stockholm University; Abo Akademi University	Westermarck, J (corresponding author), Univ Tampere, Inst Med Technol, Teiskontie 35, Tampere 33520, Finland.	ltjuwe@uta.fi	Johansson, Henrik J/O-3363-2014; Salminen, Tiina A./AAM-5443-2021; Salminen, Tiina A/G-7492-2019; Westermarck, Jukka/AAL-6464-2020	Johansson, Henrik J/0000-0003-4729-4205; Salminen, Tiina A./0000-0002-4135-8020; Salminen, Tiina A/0000-0002-4135-8020; Westermarck, Jukka/0000-0001-7478-3018; Langel, Ulo/0000-0001-6107-0844; Kallio, Marko/0000-0002-6345-1680; Gillespie, David/0000-0002-6338-0544				Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Black EJ, 2004, ONCOGENE, V23, P2357, DOI 10.1038/sj.onc.1207377; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Mariani O, 2007, CANCER CELL, V11, P361, DOI 10.1016/j.ccr.2007.02.007; Mialon A, 2005, MOL CELL BIOL, V25, P5040, DOI 10.1128/MCB.25.12.5040-5051.2005; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Valdez BC, 2000, EUR J BIOCHEM, V267, P6395, DOI 10.1046/j.1432-1327.2000.01727.x; Valdez BC, 1998, BIOTECHNIQUES, V24, P1032, DOI 10.2144/98246cr03; Valdez BC, 1996, NUCLEIC ACIDS RES, V24, P1220, DOI 10.1093/nar/24.7.1220; Valdez BC, 1997, EUR J BIOCHEM, V250, P800, DOI 10.1111/j.1432-1033.1997.00800.x; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Westermarck J, 2002, EMBO J, V21, P451, DOI 10.1093/emboj/21.3.451; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Yang CS, 2005, MOL CELL BIOL, V25, P1298, DOI 10.1128/MCB.25.4.1298-1308.2005; Yang HS, 2003, J BIOL CHEM, V278, P38847, DOI 10.1074/jbc.M302258200	27	41	43	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7046	7053		10.1074/jbc.M709613200	http://dx.doi.org/10.1074/jbc.M709613200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18180292	hybrid			2022-12-27	WOS:000253779600049
J	Kang, JA; Zhou, Y; Weis, TL; Liu, H; Ulaszek, J; Satgurunathan, N; Zhou, L; van Besien, K; Crispino, J; Verma, A; Low, PS; Wickrema, A				Kang, Jeong-Ah; Zhou, Ying; Weis, Tahlia L.; Liu, Hui; Ulaszek, Jodie; Satgurunathan, Nilesh; Zhou, Li; van Besien, Koen; Crispino, John; Verma, Amit; Low, Philip S.; Wickrema, Amittha			Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROID PROGENITOR CELLS; PROTEIN-KINASE; SIGNALING PATHWAY; GENE-EXPRESSION; DEFICIENT MICE; ERYTHROPOIETIN; PHOSPHORYLATION; ACTIVATION; SURVIVAL; DIFFERENTIATION	Erythropoietin and stem cell factor are the key cytokines that regulate early stages of erythroid differentiation. However, it remains undetermined whether additional cytokines also play a role in the differentiation program. Here, we report that osteopontin (OPN) is highly expressed and secreted by erythroblasts during differentiation. We also demonstrate that OPN-deficient human and mouse erythroblasts exhibit defects in F-actin filaments, and addition of exogenous OPN to OPN-deficient erythroblasts restored the F-actin filaments in these cells. Furthermore, our studies demonstrate that OPN contributes to erythroblast proliferation. OPN knock-out male mice exhibit lower hematocrit and hemoglobin levels compared with their wild-type counterparts. We also show that OPN mediates phosphorylation or activation of multiple proteins including Rac-1 GTPase and the actin-binding protein, adducin, in human erythroblasts. In addition, we show that the OPN effects include regulation of intracellular calcium in human erythroblasts. Finally, we demonstrate that human erythroblasts express CD44 and integrins beta(1) and alpha(4), three known receptors for OPN, and that the integrin beta(1) receptor is involved in transmitting the proliferative signal. Together these results provide evidence for signal transduction by OPN and contribution to multiple functions during the erythroid differentiation program in human and mouse.	[Kang, Jeong-Ah; Zhou, Ying; Liu, Hui; Ulaszek, Jodie; Satgurunathan, Nilesh; van Besien, Koen; Crispino, John; Wickrema, Amittha] Univ Chicago, Hematol Oncol Sect, MC2115, Dept Med, Chicago, IL 60637 USA; [Weis, Tahlia L.; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Zhou, Li; Verma, Amit] Albert Einstein Univ, Dept Med, New York, NY 10461 USA	University of Chicago; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Yeshiva University	Wickrema, A (corresponding author), Univ Chicago, Hematol Oncol Sect, MC2115, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	Awickrem@medicine.bsd.uchicago.edu	van Besien, Koen W./G-4221-2012	van Besien, Koen W./0000-0002-8164-6211; Low, Philip/0000-0001-9042-5528; Crispino, John/0000-0002-8182-8306	NCI NIH HHS [R01 CA098550] Funding Source: Medline; NHLBI NIH HHS [R01 HL082946-02, HL082946, R01 HL082946-01, R01 HL082946] Funding Source: Medline; NIGMS NIH HHS [T32-GM008296-17, R01 GM024417, T32 GM008296] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098550] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024417, T32GM008296] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arai A, 2002, ONCOGENE, V21, P2641, DOI 10.1038/sj.onc.1205346; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; DENHARDT DT, 1995, ANN NY ACAD SCI, V760, P127, DOI 10.1111/j.1749-6632.1995.tb44625.x; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Duvall CL, 2007, J BONE MINER RES, V22, P286, DOI 10.1359/JBMR.061103; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Iwata M, 2004, BLOOD, V103, P4496, DOI 10.1182/blood-2004-01-0256; JacobsHelber SM, 1997, J BIOL CHEM, V272, P6850, DOI 10.1074/jbc.272.11.6850; KALTA TA, 2006, BLOOD, V108, P3637; Katagiri YU, 1999, CANCER RES, V59, P219; KELLEY LL, 1993, BLOOD, V82, P2340; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; KOURY ST, 1989, J CELL BIOL, V109, P3005, DOI 10.1083/jcb.109.6.3005; Lin YH, 2000, MOL CELL BIOL, V20, P2734, DOI 10.1128/MCB.20.8.2734-2742.2000; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Manno S, 2005, J BIOL CHEM, V280, P7581, DOI 10.1074/jbc.M410650200; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; MUTA K, 1994, J CLIN INVEST, V94, P34, DOI 10.1172/JCI117327; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; Razzouk S, 2002, BONE, V30, P40, DOI 10.1016/S8756-3282(01)00637-8; Rittling SR, 1999, EXP NEPHROL, V7, P103; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; WASEEM A, 1988, EUR J BIOCHEM, V178, P563, DOI 10.1111/j.1432-1033.1988.tb14483.x; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; WICKREMA A, 1992, BLOOD, V80, P1940, DOI 10.1182/blood.V80.8.1940.1940; Wickrema A, 1999, J BIOL CHEM, V274, P24469, DOI 10.1074/jbc.274.35.24469; WICKREMA A, 1994, J CELL PHYSIOL, V160, P417, DOI 10.1002/jcp.1041600304	33	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6997	7006		10.1074/jbc.M706712200	http://dx.doi.org/10.1074/jbc.M706712200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18174176	hybrid, Green Accepted			2022-12-27	WOS:000253779600044
J	Murtaza, I; Wang, HX; Feng, X; Alenina, N; Bader, M; Prabhakar, BS; Li, PF				Murtaza, Iram; Wang, Hong-Xia; Feng, Xue; Alenina, Natalia; Bader, Michael; Prabhakar, Bellur S.; Li, Pei-Feng			Down-regulation of catalase and oxidative modification of protein kinase CK2 lead to the failure of apoptosis repressor with caspase recruitment domain to inhibit cardiomyocyte hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; RAT CARDIAC MYOCYTE; TRANSGENIC MICE; ANGIOTENSIN-II; CYTOCHROME-C; VENTRICULAR MYOCYTES; CELL-DEATH; HEART; ARC; RECEPTOR	Cardiac hypertrophy is regulated by a complex interplay of pro- and anti-hypertrophic factors. Here, we report a novel anti-hypertrophic pathway composed of catalase, protein kinase CK2 ( CK2), and apoptosis repressor with caspase recruitment domain ( ARC). Our results showed that ARC phosphorylation levels, CK2 activity, and catalase expression levels were decreased in the hearts of the angiotensinogen transgenic mice and in cardiomyocytes treated with the hypertrophic stimuli, including phenylephrine, tumor necrosis factor-alpha, and angiotensin II. To understand the role of ARC in hypertrophy, we observed that enforced expression of ARC could inhibit hypertrophy. Knockdown of endogenous ARC or inhibition of its phosphorylation could sensitize cardiomyocytes to undergoing hypertrophy. The phosphorylatable, but not the nonphosphorylatable, ARC could inhibit hypertrophy. Thus, ARC is able to inhibit hypertrophy in a phosphorylation-dependent manner. In exploring the molecular mechanism by which CK2 activity is reduced, we found that CK2 was carbonylated in angiotensinogen transgenic mice and in cardiomyocytes treated with the hypertrophic stimuli. The decrease in catalase expression led to an elevated level of reactive oxygen species. The latter oxidatively modified CK2, resulting in its carbonylation. CK2 lost its catalytic activity upon carbonylation. ARC is phosphorylated by CK2, and ARC phosphorylation levels were reduced as a consequence of the decrease of CK2 activity. To understand the molecular mechanism by which ARC inhibits hypertrophy, we observed that ARC could inhibit the activation of mitochondrial permeability transition. These results suggest that catalase, CK2, and ARC constitute an anti-hypertrophic pathway in the heart.	[Murtaza, Iram; Wang, Hong-Xia; Feng, Xue; Li, Pei-Feng] Chinese Acad Sci, Inst Zool, Natl Key Lab Biomembrane & Membrane Biotechnol, Div Cardiovasc Res, Beijing 100101, Peoples R China; [Prabhakar, Bellur S.] Univ Illinois, Coll Med, Chicago, IL 60612 USA; [Alenina, Natalia; Bader, Michael] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Li, PF (corresponding author), Chinese Acad Sci, Inst Zool, Natl Key Lab Biomembrane & Membrane Biotechnol, Div Cardiovasc Res, Beijing 100101, Peoples R China.	peifli@ioz.ac.cn	Murtaza, Iram/I-6804-2013; Bader, Michael/K-2124-2013; Li, Peifeng/AHE-6906-2022; Li, Peifeng/ABD-5663-2021	Murtaza, Iram/0000-0001-8092-5211; Li, Peifeng/0000-0002-0969-9407; Bader, Michael/0000-0003-4780-4164				Barlucchi L, 2001, CIRC RES, V88, P298, DOI 10.1161/01.RES.88.3.298; Capetanaki Y, 1998, Subcell Biochem, V31, P463; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Conrad Craig C, 2000, Biol Proced Online, V2, P39, DOI 10.1251/bpo17; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Ekhterae D, 1999, CIRC RES, V85, pE70; Geertman R, 1996, BBA-GENE STRUCT EXPR, V1306, P147, DOI 10.1016/0167-4781(96)00036-X; Grune T, 2005, FREE RADICAL BIO MED, V39, P1208, DOI 10.1016/j.freeradbiomed.2005.06.009; Guo JF, 2006, CIRC RES, V99, P1367, DOI 10.1161/01.RES.0000252830.01581.fd; Gustafsson AB, 2002, CIRCULATION, V106, P735, DOI 10.1161/01.CIR.0000023943.50821.F7; Gustafsson AB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5; Javadov S, 2005, J MOL CELL CARDIOL, V38, P135, DOI 10.1016/j.yjmcc.2004.10.007; Kang NL, 2002, J MOL MED, V80, P359, DOI 10.1007/s00109-002-0326-6; KIMURA S, 1992, EMBO J, V11, P821, DOI 10.1002/j.1460-2075.1992.tb05119.x; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; Kuster GM, 2005, CIRCULATION, V111, P1192, DOI 10.1161/01.CIR.0000157148.59308.F5; Li J, 2002, APOPTOSIS, V7, P511, DOI 10.1023/A:1020639025669; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Li PF, 1997, CIRCULATION, V96, P3602; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Nebigil CG, 2003, CIRCULATION, V107, P3223, DOI 10.1161/01.CIR.0000074224.57016.01; Neuss M, 2001, J BIOL CHEM, V276, P33915, DOI 10.1074/jbc.M104080200; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; Weisleder N, 2004, P NATL ACAD SCI USA, V101, P769, DOI 10.1073/pnas.0303202101; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Xia Y, 2004, J MOL CELL CARDIOL, V37, P1063, DOI 10.1016/j.yjmcc.2004.07.002; Zhang YQ, 2006, J CELL BIOCHEM, V99, P575, DOI 10.1002/jcb.20946; Zhou CM, 2006, CIRC RES, V98, P1040, DOI 10.1161/01.RES.0000218989.52072.e7	43	76	83	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					5996	6004		10.1074/jbc.M706466200	http://dx.doi.org/10.1074/jbc.M706466200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18171680	hybrid			2022-12-27	WOS:000253779500004
J	Hato, T; Yamanouchi, J; Tamura, T; Yakushijin, Y; Sakai, I; Yasukawa, M				Hato, Takaaki; Yamanouchi, Jun; Tamura, Tatsushiro; Yakushijin, Yoshihiro; Sakai, Ikuya; Yasukawa, Masaki			Cooperative role of the membrane-proximal and -distal residues of the integrin beta 3 cytoplasmic domain in regulation of talin-mediated alpha IIb beta 3 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING AFFINITY; INSIDE-OUT; STRUCTURAL BASIS; GLANZMANN THROMBASTHENIA; FILAMIN BINDING; OUTSIDE-IN; ACTIVATION; ALPHA(IIB)BETA(3); SUBUNIT; TAIL	Integrin cytoplasmic tails regulate integrin activation that is required for high affinity binding with ligands. The interaction of the integrin beta subunit tail with a cytoplasmic protein, talin, largely contributes to integrin activation. Here we report the cooperative interaction of the beta 3 membrane-proximal and -distal residues in regulation of talin-mediated alpha IIb beta 3 activation. Because a chimeric integrin, alpha IIb beta 3/beta 1, in which the beta 3 tail was replaced with the beta 1 tail was constitutively active, we searched for the residues responsible for integrin activation among the residues that differed between the beta 3 and beta 1 tails. Single amino acid substitutions of Ile-719 and Glu-749 in the beta 3 membraneproximal and -distal regions, respectively, with the corresponding beta 1 residues or alanine rendered alpha IIb beta 3 constitutively active. The I719M/E749S double mutant had the same ligand binding activity as alpha IIb beta 3/beta 1. These beta 3 mutations also induced alpha V beta 3 activation. Conversely, substitution of Met-719 or Ser-749 in the beta 1 tail with the corresponding beta 3 tail residue (M7191 or S749E) inhibited alpha IIb beta 3/beta 1 activation, and the M719I/S749E double mutant inhibited ligand binding to a level comparable with that of the wild-type alpha IIb beta 3. Knock down of talin by short hairpin RNA inhibited the I719M- and E749S-induced alpha IIb beta 3 activation. These results suggest that the beta 3 membraneproximal and -distal residues cooperatively regulate talin-mediated alpha IIb beta 3 activation.	[Hato, Takaaki] Ehime Univ, Grad Sch Med, Div Blood Transfus, Shigenobu, Ehime 7910295, Japan; [Yamanouchi, Jun; Tamura, Tatsushiro; Yakushijin, Yoshihiro; Sakai, Ikuya; Yasukawa, Masaki] Ehime Univ, Grad Sch Med, Dept Bioregulat Med, Shigenobu, Ehime 7910295, Japan	Ehime University; Ehime University	Hato, T (corresponding author), 454 Shitsukawa, Shigenobu, Ehime 7910295, Japan.	takahato@m.ehime-u.ac.jp	Hato, Takaaki/AAH-8356-2021					Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ginsberg MH, 2001, J BIOL CHEM, V276, P22514, DOI 10.1074/jbc.M101915200; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Huang CL, 2004, J BIOL CHEM, V279, P42279, DOI 10.1074/jbc.M402540200; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Leisner TM, 1999, J BIOL CHEM, V274, P12945, DOI 10.1074/jbc.274.18.12945; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wang RG, 1997, J CLIN INVEST, V100, P2393, DOI 10.1172/JCI119780; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yamanouchi J, 2004, BIOCHEM J, V379, P317, DOI 10.1042/BJ20031753; Yamanouchi J, 2002, THROMB HAEMOSTASIS, V87, P756, DOI 10.1055/s-0037-1613076	33	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5662	5668		10.1074/jbc.M707246200	http://dx.doi.org/10.1074/jbc.M707246200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18174155	hybrid			2022-12-27	WOS:000253426700046
J	Folgueras, AR; Fueyo, A; Garcia-Suarez, O; Cox, J; Astudillo, A; Tortorella, P; Campestre, C; Gutierrez-Fernandez, A; Fanjul-Fernandez, M; Pennington, CJ; Edwards, DR; Overall, CM; Lopez-Otin, C				Folgueras, Alicia R.; Fueyo, Antonio; Garcia-Suarez, Olivia; Cox, Jennifer; Astudillo, Aurora; Tortorella, Paolo; Campestre, Cristina; Gutierrez-Fernandez, Ana; Fanjul-Fernandez, Miriam; Pennington, Caroline J.; Edwards, Dylan R.; Overall, Christopher M.; Lopez-Otin, Carlos			Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES MMPS; MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; GELATINASE-B; UP-REGULATION; EXPRESSION; INFLAMMATION; EXTRAVASATION; MINOCYCLINE; RESISTANCE	Matrix metalloproteinases (MMPs) have been implicated in a variety of human diseases, including neuroimmunological disorders such as multiple sclerosis. However, the recent finding that some MMPs play paradoxical protective roles in these diseases has made necessary the detailed study of the specific function of each family member in their pathogenesis. To determine the relevance of collagenase-2 (MMP-8) in experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis, we have performed two different analyses involving genetic and biochemical approaches. First, we have analyzed the development of EAE in mutant mouse deficient in MMP-8, with the finding that the absence of this proteolytic enzyme is associated with a marked reduction in the clinical symptoms of EAE. We have also found that MMP-8(-/-) mice exhibit a marked reduction in central nervous system-infiltrating cells and demyelinating lesions. As a second approach, we have carried out a pharmacological inhibition of MMP-8 with a selective inhibitor against this protease (IC50 = 0.4 nM). These studies have revealed that the administration of the MMP-8 selective inhibitor to mice with EAE also reduces the severity of the disease. Based on these findings, we conclude that MMP-8 plays an important role in EAE development and propose that this enzyme may be a novel therapeutic target in human neuro-inflammatory diseases such as multiple sclerosis.	[Folgueras, Alicia R.; Gutierrez-Fernandez, Ana; Fanjul-Fernandez, Miriam; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Fueyo, Antonio] Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Biol Func, E-33006 Oviedo, Spain; [Garcia-Suarez, Olivia; Astudillo, Aurora] Univ Oviedo, Hosp Cent Asturias, Serv Anat Patol, E-33006 Oviedo, Spain; [Cox, Jennifer; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Cox, Jennifer; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Tortorella, Paolo] Univ Bari, Dipartimento Farm Chim, I-70125 Bari, Italy; [Campestre, Cristina] Univ G dAnnunzio, Dipartimento Sci Farm, I-66013 Chieti, Italy; [Pennington, Caroline J.; Edwards, Dylan R.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; University of Oviedo; University of British Columbia; University of British Columbia; Universita degli Studi di Bari Aldo Moro; G d'Annunzio University of Chieti-Pescara; University of East Anglia	Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	clo@uniovi.es	Folgueras, Alicia/B-3281-2017; Gutierrez-Fernandez, Ana/ABG-6678-2020; López-Otín, Carlos/AAB-2106-2020; Gutierrez-Fernandez, Ana/AAS-9954-2021; Fueyo, Antonio/ABH-3243-2020; Edwards, Dylan R/B-4734-2009	Folgueras, Alicia/0000-0003-3426-9502; López-Otín, Carlos/0000-0001-6964-1904; Gutierrez-Fernandez, Ana/0000-0002-9287-8843; Fueyo, Antonio/0000-0002-7121-9398; Edwards, Dylan R/0000-0002-3292-2064; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809; Miriam, Fanjul Fernandez/0000-0002-0074-2325; CAMPESTRE, Cristina/0000-0001-5870-7509	Medical Research Council [G0100250] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Balbin M, 1998, J BIOL CHEM, V273, P23959, DOI 10.1074/jbc.273.37.23959; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Bernard CCA, 1997, J MOL MED-JMM, V75, P77, DOI 10.1007/s001090050092; Bettelli E, 1998, J IMMUNOL, V161, P3299; Biasone A, 2007, BIOORGAN MED CHEM, V15, P791, DOI 10.1016/j.bmc.2006.10.047; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; D'Souza CA, 2002, J BIOL CHEM, V277, P13589, DOI 10.1074/jbc.M108817200; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; GIJBELS K, 1993, J NEUROSCI RES, V36, P432, DOI 10.1002/jnr.490360409; Giuliani F, 2005, J NEUROIMMUNOL, V165, P83, DOI 10.1016/j.jneuroim.2005.04.020; Graesser D, 2000, J NEUROIMMUNOL, V109, P121, DOI 10.1016/S0165-5728(00)00275-7; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Liedtke W, 1998, ANN NEUROL, V44, P35, DOI 10.1002/ana.410440110; Lindberg RLP, 2001, BRAIN, V124, P1743, DOI 10.1093/brain/124.9.1743; McColl SR, 1998, J IMMUNOL, V161, P6421; Muller DM, 2005, J NEUROIMMUNOL, V160, P162, DOI 10.1016/j.jneuroim.2004.11.011; Nygardas PT, 2002, CLIN EXP IMMUNOL, V128, P245, DOI 10.1046/j.1365-2249.2002.01855.x; Opdenakker G, 2003, LANCET NEUROL, V2, P747, DOI 10.1016/S1474-4422(03)00587-8; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pirila E, 2003, DIGEST DIS SCI, V48, P93, DOI 10.1023/A:1021790532723; PROOST P, 1993, BIOCHEM BIOPH RES CO, V192, P1175, DOI 10.1006/bbrc.1993.1540; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Sorsa T, 2004, ORAL DIS, V10, P311, DOI 10.1111/j.1601-0825.2004.01038.x; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Toft-Hansen H, 2004, J IMMUNOL, V173, P5209, DOI 10.4049/jimmunol.173.8.5209; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Yong VW, 2007, J NEUROL SCI, V259, P79, DOI 10.1016/j.jns.2006.11.021; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127	43	57	58	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9465	9474		10.1074/jbc.M709522200	http://dx.doi.org/10.1074/jbc.M709522200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18245084	hybrid, Green Published			2022-12-27	WOS:000254465800076
J	Wang, YH; Srinivasan, K; Siddiqui, MR; George, SP; Tomar, A; Khurana, S				Wang, Yaohong; Srinivasan, Kamalakkannan; Siddiqui, Mohammad Rizwan; George, Sudeep P.; Tomar, Alok; Khurana, Seema			A novel role for villin in intestinal epithelial cell survival and homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULCERATIVE-COLITIS; CYTOCHROME-C; PHOSPHOLIPASE C-GAMMA(1); MITOCHONDRIAL FISSION; ISCHEMIA-REPERFUSION; ACTIN CYTOSKELETON; AXONAL-TRANSPORT; BRUSH-BORDERS; F-ACTIN; APOPTOSIS	Apoptosis is a key regulator for the normal turnover of the intestinal mucosa, and abnormalities associated with this function have been linked to inflammatory bowel disease and colorectal cancer. Despite this, little is known about the mechanism (s) mediating intestinal epithelial cell apoptosis. Villin is an actin regulatory protein that is expressed in every cell of the intestinal epithelium as well as in exocrine glands associated with the gastrointestinal tract. In this study we demonstrate for the first time that villin is an epithelial cell-specific anti-apoptotic protein. Absence of villin predisposes mice to dextran sodium sulfate-induced colitis by promoting apoptosis. To better understand the cellular and molecular mechanisms of the anti-apoptotic function of villin, we overexpressed villin in the Madin-Darby canine kidney Tet-Off epithelial cell line to demonstrate that expression of villin protects cells from apoptosis by maintaining mitochondrial integrity thus inhibiting the activation of caspase-9 and caspase-3. Furthermore, we report that the anti-apoptotic response of villin depends on activation of the pro-survival proteins, phosphatidylinositol 3-kinase and phosphorylated Akt. The results of our studies shed new light on the previously unrecognized function of villin in the regulation of apoptosis in the gastrointestinal epithelium.	[Wang, Yaohong; Srinivasan, Kamalakkannan; Siddiqui, Mohammad Rizwan; George, Sudeep P.; Tomar, Alok; Khurana, Seema] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Khurana, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Nash 402,894 Union Ave, Memphis, TN 38163 USA.	skhurana@utmem.edu		Khurana, Seema/0000-0002-6884-810X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054755, R01DK065006] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 65006, DK 54755] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; BEDI A, 1995, CANCER RES, V55, P1811; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Bullen TF, 2006, LAB INVEST, V86, P1052, DOI 10.1038/labinvest.3700464; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; DEBEAUREGARD MAC, 1995, EMBO J, V14, P409, DOI 10.1002/j.1460-2075.1995.tb07017.x; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; ELSASSER HP, 1991, HISTOCHEMISTRY, V95, P383, DOI 10.1007/BF00266966; Erichsen K, 2005, INFLAMM BOWEL DIS, V11, P744, DOI 10.1097/01.MIB.0000174374.83601.86; Ferrary E, 1999, J CELL BIOL, V146, P819, DOI 10.1083/jcb.146.4.819; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gauthier R, 2001, AM J PHYSIOL-CELL PH, V280, pC1540, DOI 10.1152/ajpcell.2001.280.6.C1540; George SP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703617200; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Hagiwara C, 2002, J GASTROEN HEPATOL, V17, P758, DOI 10.1046/j.1440-1746.2002.02791.x; HALL PA, 1994, J CELL SCI, V107, P3569; Hill MM, 2002, PHARMACOL THERAPEUT, V93, P243, DOI 10.1016/S0163-7258(02)00193-6; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Imoto M, 1998, J CELL SCI, V111, P1341; Iwamoto M, 1996, J PATHOL, V180, P152; Kersting S, 2004, AM J PATHOL, V165, P425, DOI 10.1016/S0002-9440(10)63308-1; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Koon HW, 2007, P NATL ACAD SCI USA, V104, P2013, DOI 10.1073/pnas.0610664104; Koya RC, 2000, J BIOL CHEM, V275, P15343, DOI 10.1074/jbc.275.20.15343; Kruidenier L, 2003, J PATHOL, V201, P28, DOI 10.1002/path.1409; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; Kusano H, 2000, ONCOGENE, V19, P4807, DOI 10.1038/sj.onc.1203868; Louvard RAD, 2003, MOL BIOL CELL, V14, P4641, DOI 10.1091/mbc.E03-02-0091; Mahajan NP, 1998, NAT BIOTECHNOL, V16, P547, DOI 10.1038/nbt0698-547; Martinez JA, 2006, GASTROENTEROLOGY, V131, P579, DOI 10.1053/j.gastro.2006.06.009; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; MERRITT AJ, 1995, J CELL SCI, V108, P2261; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Noda T, 1998, AM J PHYSIOL-GASTR L, V274, pG270, DOI 10.1152/ajpgi.1998.274.2.G270; Ohkawara T, 2006, IMMUNOL LETT, V107, P148, DOI 10.1016/j.imlet.2006.09.002; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Panebra A, 2001, AM J PHYSIOL-CELL PH, V281, pC1046, DOI 10.1152/ajpcell.2001.281.3.C1046; PASRICHA PJ, 1995, GASTROENTEROLOGY, V109, P994, DOI 10.1016/0016-5085(95)90411-5; Paul G, 2005, CLIN EXP IMMUNOL, V140, P547, DOI 10.1111/j.1365-2249.2005.02775.x; Phillips MJ, 2003, LANCET, V362, P1112, DOI 10.1016/S0140-6736(03)14467-4; Pinson KI, 1998, DEV DYNAM, V211, P109, DOI 10.1002/(SICI)1097-0177(199801)211:1<109::AID-AJA10>3.0.CO;2-7; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; RIMM DL, 1995, DIGEST DIS SCI, V40, P389, DOI 10.1007/BF02065426; Seidelin JB, 2006, APMIS, V114, P508, DOI 10.1111/j.1600-0463.2006.apm_116.x; Tomar A, 2004, MOL BIOL CELL, V15, P4807, DOI 10.1091/mbc.E04-05-0431; Tomar A, 2006, J BIOL CHEM, V281, P31972, DOI 10.1074/jbc.M604323200; Vachon PH, 2002, GASTROENTEROLOGY, V123, P1980, DOI 10.1053/gast.2002.37072; Vetuschi A, 2002, DIGEST DIS SCI, V47, P1447, DOI 10.1023/A:1015931128583; Wang YH, 2007, AM J PHYSIOL-CELL PH, V292, pC1775, DOI 10.1152/ajpcell.00420.2006; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wu B, 2003, FASEB J, V17, P1156, DOI 10.1096/fj.02-0499fje; Yu YM, 2004, IMMUNOL RES, V29, P55, DOI 10.1385/IR:29:1-3:055; Yukawa M, 2002, INT J COLORECTAL DIS, V17, P70, DOI 10.1007/s003840100340	60	61	65	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9454	9464		10.1074/jbc.M707962200	http://dx.doi.org/10.1074/jbc.M707962200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18198174	hybrid			2022-12-27	WOS:000254465800075
J	Chessa, D; Dorsey, CW; Winter, M; Baumler, AJ				Chessa, Daniela; Dorsey, Caleb W.; Winter, Maria; Baumler, Andreas J.			Binding specificity of Salmonella plasmid-encoded fimbriae assessed by glycomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 FIMBRIAE; KLEBSIELLA-PNEUMONIAE; TISSUE DISTRIBUTION; ESCHERICHIA-COLI; TYPHIMURIUM; EXPRESSION; GENES; CONSTRUCTION; INFECTION; PATHOLOGY	The Salmonella enterica serotype Typhimurium (S. Typhimurium) genome encodes 12 intestinal colonization factors of the chaperone/usher fimbrial assembly class; however, the binding specificity is known for only one of these adhesins, known as type 1 fimbriae. Here we explored the utility of glycomics to determine the carbohydrate binding specificity of plasmid-encoded fimbriae from S. Typhimurium. A cosmid carrying the pef operon was introduced into Escherichia coli and expression of fimbrial filaments composed of PefA confirmed by flow cytometry and immune-electron microscopy. Plasmid-encoded fimbriae were purified from the surface of E. coli, and the resulting preparation was shown to contain PefA as the sole major protein component. The binding of purified plasmid-encoded fimbriae to a glycanarray suggested that this adhesin specifically binds the trisaccharide Gal beta 1-4(Fuc alpha 1-3)GlcNAc, also known as the Lewis X (Le(x)) blood group antigen. Results from the glycanarray were validated by enzyme-linked immunosorbent assay (ELISA) in which plasmid-encoded fimbriae bound Lex-coated wells in a concentration-dependent manner. The binding of plasmid-encoded fimbriae to Le(x)-coated wells could be inhibited by co-incubation with soluble Le(x) antigen. Our results establish glycomic analysis as a promising new approach for determining the carbohydrate binding specificity of bacterial adhesins.	[Chessa, Daniela; Winter, Maria; Baumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Dorsey, Caleb W.; Baumler, Andreas J.] Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Microbiol & Immunol, College Stn, TX 77843 USA	University of California System; University of California Davis; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, 1 Shields Ave, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Baumler, Andreas J/H-2301-2011	Baumler, Andreas J/0000-0001-9152-7809; Chessa, Daniela/0000-0002-1260-2805	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065534, R29AI040124, R01AI044170, R01AI040124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI040124, AI 065534, AI 044170, AI 040124] Funding Source: Medline; NIGMS NIH HHS [GM 62116] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumler AJ, 1996, INFECT IMMUN, V64, P61; BOYD JF, 1985, GUT, V26, P935, DOI 10.1136/gut.26.9.935; CLEGG S, 1987, INFECT IMMUN, V55, P281, DOI 10.1128/IAI.55.2.281-287.1987; CLEGG S, 1985, INFECT IMMUN, V48, P275, DOI 10.1128/IAI.48.2.275-279.1985; DUGUID JP, 1966, J PATHOL BACTERIOL, V92, P107, DOI 10.1002/path.1700920113; Duncan MJ, 2005, J BIOL CHEM, V280, P37707, DOI 10.1074/jbc.M501249200; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FRIEDRICH MJ, 1993, MOL MICROBIOL, V8, P543, DOI 10.1111/j.1365-2958.1993.tb01599.x; GRUBER A, 1995, BIOTECHNIQUES, V19, P28; Hancox LS, 1997, FEMS IMMUNOL MED MIC, V19, P289, DOI 10.1016/S0928-8244(97)00095-3; Humphries A, 2005, INFECT IMMUN, V73, P5329, DOI 10.1128/IAI.73.9.5329-5338.2005; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Kisiela D, 2005, INFECT IMMUN, V73, P6187, DOI 10.1128/IAI.73.9.6187-6190.2005; Kisiela D, 2006, MICROBIOL-SGM, V152, P1337, DOI 10.1099/mic.0.28588-0; KOSCIELAK J, 1986, GLYCOCONJUGATE J, V3, P95, DOI 10.1007/BF01108615; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; MCGOVERN VJ, 1979, AM J SURG PATHOL, V3, P483, DOI 10.1097/00000478-197912000-00001; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Nicholson B, 2000, MOL MICROBIOL, V35, P728, DOI 10.1046/j.1365-2958.2000.01743.x; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; PURCELL BK, 1987, J BACTERIOL, V169, P5831, DOI 10.1128/jb.169.12.5831-5834.1987; Ravn V, 2000, APMIS, V108, P1, DOI 10.1034/j.1600-0463.2000.d01-1.x; Reis BP, 2003, VET MICROBIOL, V97, P269, DOI 10.1016/j.vetmic.2003.09.019; Santos RL, 2002, VET PATHOL, V39, P200, DOI 10.1354/vp.39-2-200; Santos RL, 2001, INFECT IMMUN, V69, P4610, DOI 10.1128/IAI.69.7.4610-4617.2001; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Thankavel K, 1999, J BIOL CHEM, V274, P5797, DOI 10.1074/jbc.274.9.5797; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; WOODALL LD, 1993, J BACTERIOL, V175, P2770, DOI 10.1128/JB.175.9.2770-2778.1993	29	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8118	8124		10.1074/jbc.M710095200	http://dx.doi.org/10.1074/jbc.M710095200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18211897	hybrid			2022-12-27	WOS:000254288000008
J	Yang, PH; Cheung, WKC; Peng, Y; He, ML; Wu, GQ; Xie, D; Jiang, BH; Huang, QH; Chen, Z; Lin, MCM; Kung, HF				Yang, Pai-Hao; Cheung, William K. C.; Peng, Ying; He, Ming-Liang; Wu, Guo-Qing; Xie, Dan; Jiang, Bing-Hua; Huang, Qiu-Hua; Chen, Zhu; Lin, Marie C. M.; Kung, Hsiang-Fu			Makorin-2 is a neurogenesis inhibitor downstream of phosphatidylinositol 3-kinase/Akt (PI3K/Akt) signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY XENOPUS EMBRYO; PROTEIN-KINASE-B; NEURAL INDUCTION; FINGER PROTEINS; MESSENGER-RNA; GROWTH-FACTOR; PI 3-KINASE; EXPRESSION; CELLS; GENE	Makorin-2 belongs to the makorin RING zinc finger gene family, which encodes putative ribonucleoproteins. Here we cloned the Xenopus makorin-2 (mkrn2) and characterized its function in Xenopus neurogenesis. Forced overexpression of mkrn2 produced tadpoles with dorso-posterior deficiencies and small-head/short-tail phenotype, whereas knockdown of mkrn2 by morpholino antisense oligonucleotides induced double axis in tadpoles. In Xenopus animal cap explant assay, mkrn2 inhibited activin, and retinoic acid induced animal cap neuralization, as evident from the suppression of a pan neural marker, neural cell adhesion molecule. Surprisingly, the anti-neurogenic activity of mkrn2 is independent of the two major neurogenesis signaling cascades, BMP-4 and Wnt8 pathways. Instead, mkrn2 works specifically through the phosphatidylinositol 3-kinase( PI3K) and Akt-mediated neurogenes is pathway. Overexpression of mkrn2 completely abrogated constitutively active PI3K-and Akt-induced, but not dominant negative glycogen synthase kinase-3 beta(GSK-3 beta)-induced, neural cell adhesion molecule expression, indicating that mkrn2 acts downstream of PI3K and Akt and upstream of GSK-3 beta. Moreover, mkrn2 up-regulated them RNA and protein levels of GSK-3 beta. These results revealed for the first time the important role of mkrn2 as a new player in PI3K/Akt-mediated neurogenesis during Xenopus embryonic development.	[Yang, Pai-Hao; Cheung, William K. C.; Wu, Guo-Qing; Lin, Marie C. M.] Univ Hong Kong, Dept Chem, Inst Mol Technol, Open Lab Chem Biol, Pokfulam, Hong Kong, Peoples R China; [Yang, Pai-Hao; He, Ming-Liang; Wu, Guo-Qing; Xie, Dan; Kung, Hsiang-Fu] Sun Yat Sen Univ, Joiny State Key Lab Oncol S China, Guangzhou 510120, Peoples R China; [Yang, Pai-Hao; He, Ming-Liang; Wu, Guo-Qing; Xie, Dan; Kung, Hsiang-Fu] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Peng, Ying] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou 510120, Peoples R China; [Jiang, Bing-Hua] Nanjing Med Univ, Dept Pathol, Ctr Canc, Nanjing 210029, Jiangsu, Peoples R China; [Huang, Qiu-Hua; Chen, Zhu] Shanghai Med Univ 2, Rui Jin Hosp, Shanghai Inst Hematol, Shanghai 200025, Peoples R China	University of Hong Kong; Sun Yat Sen University; Chinese University of Hong Kong; Sun Yat Sen University; Nanjing Medical University; Shanghai Jiao Tong University	Lin, MCM (corresponding author), Univ Hong Kong, Dept Chem, Inst Mol Technol, Open Lab Chem Biol, Pokfulam, Hong Kong, Peoples R China.	mcllin@hkusua.hku.hk; hkung@cuhk.edu.hk	HE, Ming-Liang/AFK-4738-2022; HE, Ming-Liang/AAG-3397-2022	HE, Mingliang/0000-0002-9942-9151; Jiang, Bing-Hua/0000-0003-4526-2031; He, Ming-Liang/0000-0002-4317-2836				Baker JC, 1999, GENE DEV, V13, P3149, DOI 10.1101/gad.13.23.3149; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De J, 1999, GENE, V228, P133, DOI 10.1016/S0378-1119(98)00617-9; Duronio V, 1998, CELL SIGNAL, V10, P233, DOI 10.1016/S0898-6568(97)00129-0; Gray TA, 2000, GENOMICS, V66, P76, DOI 10.1006/geno.2000.6199; Gray TA, 2001, GENOMICS, V77, P119, DOI 10.1006/geno.2001.6627; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Jiang BH, 1998, P NATL ACAD SCI USA, V95, P14179, DOI 10.1073/pnas.95.24.14179; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; KINTNER CR, 1987, DEVELOPMENT, V99, P311; Lai WS, 1999, MOL CELL BIOL, V19, P4311; MAENO M, 1994, P NATL ACAD SCI USA, V91, P10260, DOI 10.1073/pnas.91.22.10260; Nieuwkoop P. D., 1994, NORMAL TABLE XENOPUS, P162; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Omwancha J, 2006, ENDOCRINE, V29, P363, DOI 10.1385/ENDO:29:2:363; Peng Y, 2004, J BIOL CHEM, V279, P28509, DOI 10.1074/jbc.M402294200; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; Umbhauer M, 2000, J CELL SCI, V113, P2865; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogt PK, 2001, TRENDS MOL MED, V7, P482, DOI 10.1016/S1471-4914(01)02161-X; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; XU RH, 1995, BIOCHEM BIOPH RES CO, V212, P212, DOI 10.1006/bbrc.1995.1958; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200	31	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8486	8495		10.1074/jbc.M704768200	http://dx.doi.org/10.1074/jbc.M704768200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18198183	Green Published, hybrid			2022-12-27	WOS:000254288000047
J	Hagemann, IS; Miller, DL; Klco, JM; Nikiforovich, GV; Baranski, TJ				Hagemann, Ian S.; Miller, Daniel L.; Klco, Jeffery M.; Nikiforovich, Gregory V.; Baranski, Thomas J.			Structure of the complement factor 5a receptor-ligand complex studied by disulfide trapping and molecular modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; HUMAN C5A RECEPTOR; SITE-DIRECTED MUTAGENESIS; CRITICAL RESIDUES; DRUG DISCOVERY; BINDING SITE; ACTIVATION; IDENTIFICATION; ANAPHYLATOXIN; REGION	Complement factor 5a (C5a) is an anaphylatoxin that acts by binding to a G protein-coupled receptor, the C5aR. The relative orientation of this ligand-receptor pair is investigated here using the novel technique of disulfide trapping by random mutagenesis (DTRM) and molecular modeling. In the DTRM technique, an unpaired cysteine is introduced in the ligand, and a library of randomly mutagenized receptors is screened to identify mutants that introduce a cysteine at a position in the receptor that allows functional interactions with the ligand. By repeating this analysis at six positions of C5a, we identify six unique sets of intermolecular interactions for the C5a-C5aR complex, which are then compared with an independently developed computational three-dimensional model of the complex. This analysis reveals that the interface of the receptor N terminus with the cysteine-containing ligand molecules is selected from a variety of possible receptor conformations that exist in dynamic equilibrium. In contrast, DTRM identifies a single position in the second extracellular loop of the receptor that interacts specifically with a cysteine probe placed in the C-terminal tail of the C5a ligand.	[Hagemann, Ian S.; Miller, Daniel L.; Klco, Jeffery M.; Baranski, Thomas J.] Washington Univ, Dept Med, St Louis, MO 63110 USA; [Hagemann, Ian S.; Miller, Daniel L.; Klco, Jeffery M.; Baranski, Thomas J.] Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; [Nikiforovich, Gregory V.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Baranski, TJ (corresponding author), 660 S Euclid Ave,Campus Box 8127, St Louis, MO 63110 USA.	baranski@wustl.edu	Hagemann, Ian/ABB-2854-2021; Klco, Jeffery/M-9717-2018	Hagemann, Ian/0000-0002-3855-9745; Klco, Jeffery/0000-0003-2961-6960	NIGMS NIH HHS [GM22086, GM63720, GM71634] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071634, R01GM022086, R56GM022086, R01GM063720] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allegretti M, 2005, CURR MED CHEM, V12, P217, DOI 10.2174/0929867053363379; Baranski TJ, 1999, J BIOL CHEM, V274, P15757, DOI 10.1074/jbc.274.22.15757; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; BUBECK P, 1994, EUR J BIOCHEM, V219, P897, DOI 10.1111/j.1432-1033.1994.tb18571.x; Cain SA, 2003, BIOCHEM PHARMACOL, V66, P1833, DOI 10.1016/S0006-2952(03)00473-8; Cain SA, 2001, BIOCHEMISTRY-US, V40, P14047, DOI 10.1021/bi011055w; Chen ZG, 1998, J BIOL CHEM, V273, P10411, DOI 10.1074/jbc.273.17.10411; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DEMARTINO JA, 1995, J BIOL CHEM, V270, P15966, DOI 10.1074/jbc.270.27.15966; DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Finch AM, 1997, J MED CHEM, V40, P877, DOI 10.1021/jm960727r; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Gerber BO, 2001, J BIOL CHEM, V276, P3394, DOI 10.1074/jbc.M007748200; Geva A, 2000, J BIOL CHEM, V275, P35393, DOI 10.1074/jbc.M005602200; Hagemann IS, 2006, J BIOL CHEM, V281, P36783, DOI 10.1074/jbc.M607686200; Higginbottom A, 2005, J BIOL CHEM, V280, P17831, DOI 10.1074/jbc.M410797200; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; KAWAI M, 1992, J MED CHEM, V35, P220, DOI 10.1021/jm00080a004; Klco JM, 2006, J BIOL CHEM, V281, P12010, DOI 10.1074/jbc.M600548200; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; KOLAKOWSKI LF, 1995, J BIOL CHEM, V270, P18077, DOI 10.1074/jbc.270.30.18077; Matsumoto ML, 2007, J BIOL CHEM, V282, P3105, DOI 10.1074/jbc.M607679200; MERY L, 1994, J BIOL CHEM, V269, P3457; MERY L, 1993, EUR J HAEMATOL, V51, P282; MOLLISON KW, 1989, P NATL ACAD SCI USA, V86, P292, DOI 10.1073/pnas.86.1.292; Nikiforovich GV, 2005, BIOPHYS J, V89, P3780, DOI 10.1529/biophysj.105.070722; Nikiforovich GV, 2003, BIOCHEMISTRY-US, V42, P9110, DOI 10.1021/bi034586o; Raffetseder U, 1996, EUR J BIOCHEM, V235, P82, DOI 10.1111/j.1432-1033.1996.00082.x; SICILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214, DOI 10.1073/pnas.91.4.1214; TOTH MJ, 1994, PROTEIN SCI, V3, P1159, DOI 10.1002/pro.5560030802; Vogen SM, 1999, J PEPT RES, V53, P8, DOI 10.1111/j.1399-3011.1999.tb01612.x; Zhang XL, 1997, PROTEIN SCI, V6, P65; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P172, DOI 10.1021/bi00427a025	38	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7763	7775		10.1074/jbc.M709467200	http://dx.doi.org/10.1074/jbc.M709467200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18195008	hybrid			2022-12-27	WOS:000253997900053
J	Shen, G; Schluchter, WM; Bryant, DA				Shen, Gaozhong; Schluchter, Wendy M.; Bryant, Donald A.			Biogenesis of phycobiliproteins - I. cpcS-I and cpcU mutants of the cyanobacterium Synechococcus sp PCC 7002 define a heterodimeric phyococyanobilin lyase specific for beta-phycocyanin and allophycocyanin subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE ANALYSIS; LIGHT-HARVESTING PROTEINS; GAMMA-N-METHYLASPARAGINE; SP STRAIN PCC-7002; C-PHYCOCYANIN; ENERGY-TRANSFER; LINKER-POLYPEPTIDE; AGMENELLUM-QUADRUPLICATUM; MASTIGOCLADUS-LAMINOSUS; FREMYELLA-DIPLOSIPHON	Phycobilin lyases covalently attach phycobilin chromophores to apo-phycobiliproteins ( PBPs). Genome analyses of the unicellular, marine cyanobacterium Synechococcus sp. PCC 7002 identified three genes, denoted cpcS-I, cpcU, and cpcV, that were possible candidates to encode phycocyanobilin ( PCB) lyases. Single and double mutant strains for cpcS-I and cpcU exhibited slower growth rates, reduced PBP levels, and impaired assembly of phycobilisomes, but a cpcV mutant had no discernable phenotype. A cpcS-I cpcU cpcT triple mutant was nearly devoid of PBP. SDS-PAGE and mass spectrometry demonstrated that the cpcS-I and cpcU mutants produced an altered form of the phycocyanin ( PC) beta subunit, which had a mass similar to 588 Da smaller than the wild-type protein. Some free PCB ( mass = 588 Da) was tentatively detected in the phycobilisome fraction purified from the mutants. The modified PC from the cpcS-I, cpcU, and cpcS-I cpcU mutant strains was purified, and biochemical analyses showed that Cys-153 of CpcB carried a PCB chromophore but Cys-82 did not. These results show that both CpcS-I and CpcU are required for covalent attachment of PCB to Cys-82 of the PC beta subunit in this cyanobacterium. Suggesting that CpcS-I and CpcU are also required for attachment of PCB to allophycocyanin subunits in vivo, allophycocyanin levels were significantly reduced in all but the CpcV-less strain. These conclusions have been validated by in vitro experiments described in the accompanying report ( Saunee, N. A., Williams, S. R., Bryant, D. A., and Schluchter, W. M. ( 2008) J. Biol. Chem. 283, 7513- 7522). We conclude that the maturation of PBP in vivo depends on three PCB lyases: CpcE-CpcF, CpcS-I-CpcU, and CpcT.	[Shen, Gaozhong; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Schluchter, Wendy M.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Louisiana System; University of New Orleans	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, S-235 Frear Bldg,Univ Pk, University Pk, PA 16802 USA.	dab14@psu.edu	Schluchter, Wendy/G-9662-2013		NIGMS NIH HHS [GM-31625] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031625] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; Bryant D.A., 1991, CELL CULTURE SOMATIC, V1st ed., P255; BRYANT DA, 1990, ARCH MICROBIOL, V153, P550, DOI 10.1007/BF00245264; COBLEY J, 2000, 10 INT S PHOT PROK B, P81; Cobley JG, 2002, MOL MICROBIOL, V44, P1517, DOI 10.1046/j.1365-2958.2002.02966.x; DEBRECZENY MP, 1993, J PHYS CHEM-US, V97, P9852, DOI 10.1021/j100140a050; DEBRECZENY MP, 1995, J PHYS CHEM-US, V99, P8412, DOI 10.1021/j100020a080; DELORIMIER R, 1990, BIOCHIM BIOPHYS ACTA, V1019, P29, DOI 10.1016/0005-2728(90)90121-J; DELORIMIER R, 1990, ARCH MICROBIOL, V153, P541, DOI 10.1007/BF00245263; DELORIMIER R, 1984, P NATL ACAD SCI-BIOL, V81, P7946; DUERRING M, 1991, J MOL BIOL, V217, P577, DOI 10.1016/0022-2836(91)90759-Y; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; Frigaard NU, 2004, METH MOL B, V274, P325; GINDT YM, 1992, J PHOTOCH PHOTOBIO B, V15, P75, DOI 10.1016/1011-1344(92)87007-V; GINDT YM, 1994, BBA-BIOENERGETICS, V1186, P153, DOI 10.1016/0005-2728(94)90174-0; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Glockner G, 2000, J MOL EVOL, V51, P382; Gomez-Lojero C, 2003, BIOCHEMISTRY-US, V42, P13800, DOI 10.1021/bi0346998; Hirschberg J., 1994, MOL BIOL CYANOBACTER, DOI [10.1007/978-94-011-0227-8_18, DOI 10.1007/978-94-011-0227-8_18]; KLOTZ AV, 1987, J BIOL CHEM, V262, P17350; KLOTZ AV, 1986, J BIOL CHEM, V261, P5891; Lecomte JTJ, 1996, PROTEINS, V25, P267, DOI 10.1002/(SICI)1097-0134(199607)25:3<267::AID-PROT1>3.3.CO;2-8; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; MacKinney G, 1941, J BIOL CHEM, V140, P315; MAXSON P, 1989, BIOCHIM BIOPHYS ACTA, V977, P40, DOI 10.1016/S0005-2728(89)80007-6; Miller CA, 2007, THESIS U NEW ORLEANS; ONG LJ, 1988, LIGHT ENERGY TRANSDU, P102; PLANK T, 1995, J BACTERIOL, V177, P6798, DOI 10.1128/jb.177.23.6798-6803.1995; PLANK T, 1995, J BACTERIOL, V177, P6804, DOI 10.1128/jb.177.23.6804-6809.1995; RAPS S, 1990, PLANT PHYSIOL, V92, P358, DOI 10.1104/pp.92.2.358; Reuter W, 1999, P NATL ACAD SCI USA, V96, P1363, DOI 10.1073/pnas.96.4.1363; Sakamoto T, 1998, ARCH MICROBIOL, V169, P10; SAUNEE NA, 2006, THESIS U NEW ORLEANS; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; SCHIRMER T, 1985, J MOL BIOL, V184, P257, DOI 10.1016/0022-2836(85)90379-1; SCHIRMER T, 1986, J MOL BIOL, V188, P651, DOI 10.1016/S0022-2836(86)80013-4; SCHIRMER T, 1987, J MOL BIOL, V196, P677, DOI 10.1016/0022-2836(87)90040-4; Shen G., 2004, PS 2004 LIGHT HARV S, P14; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; SHEN GZ, 1995, PHOTOSYNTH RES, V44, P41, DOI 10.1007/BF00018295; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; STEVENS SE, 1980, P NATL ACAD SCI-BIOL, V77, P6052, DOI 10.1073/pnas.77.10.6052; SWANSON RV, 1992, J BIOL CHEM, V267, P16146; SWANSON RV, 1990, J MOL BIOL, V214, P787, DOI 10.1016/0022-2836(90)90293-U; Toole CM, 1998, MOL MICROBIOL, V30, P475, DOI 10.1046/j.1365-2958.1998.01082.x; ZHAO JD, 1989, ARCH MICROBIOL, V152, P447, DOI 10.1007/BF00446927; Zhao JD, 2001, BBA-BIOENERGETICS, V1505, P248, DOI 10.1016/S0005-2728(01)00175-X; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; ZHOU J, 1992, THESIS PENNSYLVANIA; ZHOU JH, 1992, J BIOL CHEM, V267, P16138	53	72	83	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7503	7512		10.1074/jbc.M708164200	http://dx.doi.org/10.1074/jbc.M708164200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18199754	hybrid			2022-12-27	WOS:000253997900025
J	Vogl, C; Klein, CM; Batke, AF; Schweingruber, ME; Stolz, J				Vogl, Christian; Klein, Cornelia M.; Batke, Angelika F.; Schweingruber, M. Ernst; Stolz, Juergen			Characterization of Thi9, a novel thiamine (vitamin B-1) transporter from Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPRESSIBLE EXPRESSION VECTORS; YEAST SACCHAROMYCES-CEREVISIAE; FISSION YEAST; GENETIC-REGULATION; BIOSYNTHETIC GENE; THIAZOLE BIOSYNTHESIS; HETEROLOGOUS MODULES; SHUTTLE VECTORS; NMT1 PROMOTER; FAMILY	Thiamine is an essential component of the human diet and thiamine diphosphate-dependent enzymes play an important role in carbohydrate metabolism in all living cells. Although the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe can derive thiamine from biosynthesis, both are also able to take up thiamine from external sources, leading to the down-regulation of the enzymes involved in its formation. We have isolated the S. pombe thiamine transporter Thi9 by genetic complementation of mutants defective in thiamine biosynthesis and transport. Thi9 localizes to the S. pombe cell surface and works as a high-affinity proton/ thiamine symporter. The uptake of thiamine was reduced in the presence of pyrithiamine, oxythiamine, amprolium, and the thiazole part of thiamine, indicating that these compounds are substrates of Thi9. In pyrithiamine-resistant mutants, a conserved glutamate residue close to the first of the 12 transmembrane domains is exchanged by a lysine and this causes aberrant localization of the protein. Thiamine uptake is significantly increased in thiamine-deficient medium and this is associated with an increase in thi9(+) mRNA and protein levels. Upon addition of thiamine, the thi9(+) mRNA becomes undetectable within minutes, whereas the Thi9 protein appears to be stable. The protein is distantly related to transporters for amino acids, gamma-aminobutyric acid and polyamines, and not to any of the known thiamine transporters. We also found that the pyridoxine transporter Bsu1 has a marked contribution to the thiamine uptake activity of S. pombe cells.	[Vogl, Christian; Klein, Cornelia M.; Batke, Angelika F.; Stolz, Juergen] Univ Regensburg, Lehrstuhl Zellbiol & Plfazenphysiol, D-93040 Regensburg, Germany; [Schweingruber, M. Ernst] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland	University of Regensburg; University of Bern	Stolz, J (corresponding author), Tech Univ Munich, Lehrstuhl Ernahrungsphysiol, Am Forum 5, D-85350 Freising Weihenstephan, Germany.	stolz@wzw.tum.de						Andoh T, 2004, BIOCHEM BIOPH RES CO, V317, P1138, DOI 10.1016/j.bbrc.2004.03.171; Ashokkumar B, 2006, AM J PHYSIOL-RENAL, V291, pF796, DOI 10.1152/ajprenal.00078.2006; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BARBET N, 1992, GENE, V114, P59, DOI 10.1016/0378-1119(92)90707-V; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bassler K., 2002, VITAMIN LEXIKON; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; Brachmann CB, 1998, YEAST, V14, P115; Chatterjee A, 2007, J AM CHEM SOC, V129, P2914, DOI 10.1021/ja067606t; Chatterjee A, 2006, J AM CHEM SOC, V128, P7158, DOI 10.1021/ja061413o; CROTT MT, 2006, EUKARYOT CELL, V5, P1175; Diaz GA, 1999, NAT GENET, V22, P309, DOI 10.1038/10385; Dutta B, 1999, J BIOL CHEM, V274, P31925, DOI 10.1074/jbc.274.45.31925; Enjo F, 1997, J BIOL CHEM, V272, P19165, DOI 10.1074/jbc.272.31.19165; Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112; FANKHAUSER H, 1994, GENE, V147, P141, DOI 10.1016/0378-1119(94)90054-X; Fleming JC, 1999, NAT GENET, V22, P305, DOI 10.1038/10379; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Ganapathy V, 2004, PFLUG ARCH EUR J PHY, V447, P641, DOI 10.1007/s00424-003-1068-1; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goffeau A, 1997, YEAST, V13, P43, DOI 10.1002/(SICI)1097-0061(199701)13:1<43::AID-YEA56>3.0.CO;2-J; Grossmann G, 2006, EUKARYOT CELL, V5, P945, DOI 10.1128/EC.00206-05; Hohmann S, 1998, BBA-PROTEIN STRUCT M, V1385, P201, DOI 10.1016/S0167-4838(98)00069-7; IWASHIMA A, 1990, BIOCHIM BIOPHYS ACTA, V1022, P211, DOI 10.1016/0005-2736(90)90116-6; IWASHIMA A, 1973, BIOCHIM BIOPHYS ACTA, V330, P222, DOI 10.1016/0005-2736(73)90227-7; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Koser S.A., 1968, VITAMIN REQUIREMENTS; Labay V, 1999, NAT GENET, V22, P300, DOI 10.1038/10372; Liang DT, 1999, J CELL SCI, V112, P559; MANETTI AGO, 1994, YEAST, V10, P1075, DOI 10.1002/yea.320100809; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; McQuire TA, 2006, CURR GENET, V50, P269, DOI 10.1007/s00294-006-0086-x; Miranda-Rios J, 2001, P NATL ACAD SCI USA, V98, P9736, DOI 10.1073/pnas.161168098; Mitchison JM, 1970, METHOD CELL PHYSIOL, V4, P131; Mojzita D, 2006, MOL GENET GENOMICS, V276, P147, DOI 10.1007/s00438-006-0130-z; Moreno MB, 2000, YEAST, V16, P861; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Niederberger C, 1996, GENE, V171, P119, DOI 10.1016/0378-1119(96)00101-1; Nosaka K, 2005, MOL MICROBIOL, V58, P467, DOI 10.1111/j.1365-2958.2005.04835.x; Nosaka K, 2006, APPL MICROBIOL BIOT, V72, P30, DOI 10.1007/s00253-006-0464-9; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; PRAEKELT UM, 1994, YEAST, V10, P481, DOI 10.1002/yea.320100407; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; ROSE AB, 1990, METHOD ENZYMOL, V185, P234; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHWEINGRUBER AM, 1991, CURR GENET, V19, P249, DOI 10.1007/BF00355050; SCHWEINGRUBER ME, 1990, CURR GENET, V17, P191, DOI 10.1007/BF00312609; SCHWEINGRUBER ME, 1986, J BIOL CHEM, V261, P5877; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; Settembre E, 2003, CURR OPIN STRUC BIOL, V13, P739, DOI 10.1016/j.sbi.2003.10.006; Siam R, 2004, METHODS, V33, P189, DOI 10.1016/j.ymeth.2003.11.013; Singleton CK, 1997, GENE, V199, P111, DOI 10.1016/S0378-1119(97)00354-5; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Stolz J, 2005, EUKARYOT CELL, V4, P319, DOI 10.1128/EC.4.2.319-326.2005; Stolz J, 2003, J BIOL CHEM, V278, P18990, DOI 10.1074/jbc.M300949200; Subramanian VS, 2007, J PHYSIOL-LONDON, V582, P73, DOI 10.1113/jphysiol.2007.128843; TANG CSL, 1994, J BIOL CHEM, V269, P11921; TOMMASINO M, 1991, CURR GENET, V20, P63, DOI 10.1007/BF00312766; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Webb E, 1997, J BACTERIOL, V179, P4399, DOI 10.1128/jb.179.13.4399-4402.1997; Wightman R, 2003, MICROBIOL-SGM, V149, P1447, DOI 10.1099/mic.0.26194-0; Williams RJ, 1930, J BIOL CHEM, V87, P581; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Zhao RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1512, DOI 10.1152/ajpcell.00547.2001; ZURLINDEN A, 1994, J BACTERIOL, V176, P6631, DOI 10.1128/JB.176.21.6631-6635.1994; ZURLINDEN A, 1992, GENE, V117, P141, DOI 10.1016/0378-1119(92)90503-H; Zurlinden A, 1997, J BACTERIOL, V179, P5956, DOI 10.1128/jb.179.18.5956-5958.1997	73	18	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7379	7389		10.1074/jbc.M708275200	http://dx.doi.org/10.1074/jbc.M708275200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18201975	hybrid			2022-12-27	WOS:000253997900012
J	Kiryu-Seo, S; Kato, R; Ogawa, T; Nakagomi, S; Nagata, K; Kiyama, H				Kiryu-Seo, Sumiko; Kato, Ryuichi; Ogawa, Tokiko; Nakagomi, Saya; Nagata, Kenichi; Kiyama, Hiroshi			Neuronal injury-inducible gene is synergistically regulated by ATF3, c-Jun, and STAT3 through the interaction with Sp1 in damaged neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; NERVE GROWTH-FACTOR; AXOTOMIZED FACIAL MOTONEURONS; AXONAL REGENERATION; ENDOPEPTIDASE DINE; PERIPHERIN GENE; TRANSGENIC MICE; IN-VIVO; EXPRESSION; PROMOTER	Nerve injury requires the expression of large ensembles of genes. The key molecular mechanism for this gene transcription regulation in injured neurons is poorly understood. Among many nerve injury-inducible genes, the gene encoding damage-induced neuronal endopeptidase (DINE) showed most marked expression response to various kinds of nerve injuries in central and peripheral nervous system neurons. This unique feature led us to examine the promoter region of the DINE gene and clarify both the injury-responsive element within the promoter and its related transcriptional machinery. This study showed that DINE promoter was activated by leukemia inhibitory factor and nerve growth factor withdrawal, which were pivotal for the up-regulation of DINE mRNA after nerve injury. The injury-inducible transcription factors such as activating transcription factor 3 (ATF3), c-Jun, and STAT3, which were located at the downstream of leukemia inhibitory factor and nerve growth factor withdrawal, seemed to be involved in the activation of the DINE promoter. Surprisingly, these transcription factors did not bind to the DINE promoter directly. Instead, the general transcription factor, Sp1, bound to a GC box within the promoter. ATF3, c-Jun, and STAT3 interacted with Sp1 and are associated with the GC box region of the DINE gene in injured neurons. These findings suggested that Sp1 recruit ATF3, c-Jun, and STAT3 to obtain the requisite synergistic effect. Of these transcription factors, ATF3 may be the most critical, because ATF3 is specifically expressed after nerve injury.	[Kiryu-Seo, Sumiko; Kato, Ryuichi; Ogawa, Tokiko; Nakagomi, Saya; Nagata, Kenichi; Kiyama, Hiroshi] Osaka City Univ, Grad Sch Med, Dept Anat & Neurobiol, Abeno Ku, Osaka 5458585, Japan	Osaka Metropolitan University	Kiyama, H (corresponding author), Osaka City Univ, Grad Sch Med, Dept Anat & Neurobiol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	kiyama@med.osaka-cu.ac.jp	Kiyama, Hiroshi/M-8867-2014; Nakagomi, Saya/ABE-4676-2020; Kiryu-Seo, Sumiko/M-8865-2014	Kiyama, Hiroshi/0000-0001-5963-046X; Nakagomi, Saya/0000-0002-8272-6192; Kiryu-Seo, Sumiko/0000-0001-6213-1258				Bacon A, 2007, J NEUROSCI, V27, P6573, DOI 10.1523/JNEUROSCI.1596-07.2007; BELECKYADAMS T, 1993, J NEUROSCI, V13, P5056, DOI 10.1523/JNEUROSCI.13-12-05056.1993; Boeshore KL, 2004, J NEUROBIOL, V59, P216, DOI 10.1002/neu.10308; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen BK, 2000, P NATL ACAD SCI USA, V97, P10406, DOI 10.1073/pnas.180321497; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; GLOSTER A, 1994, J NEUROSCI, V14, P7319; Haas CA, 1999, J NEUROBIOL, V41, P559, DOI 10.1002/(SICI)1097-4695(199912)41:4<559::AID-NEU11>3.0.CO;2-A; Hai T, 1999, GENE EXPRESSION, V7, P321; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Kato R, 2002, J NEUROSCI, V22, P9410; Kirsch M, 2003, MOL CELL NEUROSCI, V24, P130, DOI 10.1016/S1044-7431(03)00130-1; Kiryu S, 1995, J NEUROSCI, V15, P7872; Kiryu-Seo S, 2000, P NATL ACAD SCI USA, V97, P4345, DOI 10.1073/pnas.070509897; KISSELEVA T, 2002, GENE, V281, P1; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin SB, 2006, MOL ENDOCRINOL, V20, P3376, DOI 10.1210/me.2006-0177; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; Maehara K, 2002, BIOCHEM BIOPH RES CO, V295, P187, DOI 10.1016/S0006-291X(02)00646-0; Makwana M, 2005, FEBS J, V272, P2628, DOI 10.1111/j.1742-4658.2005.04699.x; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Namikawa K, 2000, J NEUROSCI, V20, P2875; Ohba N, 2004, J NEUROCHEM, V91, P956, DOI 10.1111/j.1471-4159.2004.02784.x; Okuyama N, 2007, BRAIN RES, V1132, P36, DOI 10.1016/j.brainres.2006.11.019; Pearson AG, 2003, MOL BRAIN RES, V120, P38, DOI 10.1016/j.molbrainres.2003.09.014; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Ryu H, 2003, J NEUROSCI, V23, P3597; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Shadiack AM, 2001, J NEUROSCI, V21, P363, DOI 10.1523/JNEUROSCI.21-02-00363.2001; Shadiack AM, 1998, P NATL ACAD SCI USA, V95, P7727, DOI 10.1073/pnas.95.13.7727; Takeda M, 2000, INVEST OPHTH VIS SCI, V41, P2412; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Uveges TE, 2002, J NEUROSCI, V22, P7959; Valdenaire O, 1999, MOL BRAIN RES, V64, P211, DOI 10.1016/S0169-328X(98)00321-0; VANSELOW J, 1994, J NEUROSCI, V14, P499; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Yang J, 2005, CANCER RES, V65, P939; Yao GL, 1997, EUR J NEUROSCI, V9, P1047, DOI 10.1111/j.1460-9568.1997.tb01455.x	48	61	61	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6988	6996		10.1074/jbc.M707514200	http://dx.doi.org/10.1074/jbc.M707514200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18192274	hybrid			2022-12-27	WOS:000253779600043
J	Kabra, R; Knight, KK; Zhou, R; Snyder, PM				Kabra, Rajesh; Knight, Kristin K.; Zhou, Ruifeng; Snyder, Peter M.			Nedd4-2 induces endocytosis and degradation of proteolytically cleaved epithelial Na+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; PY MOTIF; SURFACE EXPRESSION; LIDDLE-SYNDROME; GAMMA-SUBUNIT; WW DOMAIN; A6 CELLS; ENAC; MUTATIONS; ACTIVATION	As a pathway for Na+ reabsorption, the epithelial Na+ channel ENaC is critical for Na+ homeostasis and blood pressure control. Na+ transport is regulated by Nedd4-2, an E3 ubiquitin ligase that decreases ENaC expression at the cell surface. To investigate the underlying mechanisms, we proteolytically cleaved/activated ENaC at the cell surface and then quantitated the rate of disappearance of cleaved channels using electro-physiological and biochemical assays. We found that cleaved ENaC channels were rapidly removed from the cell surface. Deletion or mutation of the Nedd4-2 binding motifs in alpha,beta, and gamma ENaC dramatically reduced endocytosis, whereas a mutation that disrupts a YXXempty set endocytosis motif had no effect. ENaC endocytosis was also decreased by silencing of Nedd4-2 and by expression of a dominant negative Nedd4-2 construct. Conversely, Nedd4-2 overexpression increased ENaC endocytosis in human embryonic kidney 293 cells but had no effect in Fischer rat thyroid epithelia. In addition to its effect on endocytosis, Nedd4-2 also increased the rate of degradation of the cell surface pool of cleaved alpha ENaC. Together the data indicate that Nedd4-2 reduces ENaC surface expression by altering its trafficking at two distinct sites in the endocytic pathway, inducing endocytosis of cleaved channels and targeting them for degradation.	[Snyder, Peter M.] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu						BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Itani OA, 2005, AM J PHYSIOL-RENAL, V289, pF334, DOI 10.1152/ajprenal.00394.2004; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kleyman TR, 2006, KIDNEY INT, V70, P1391, DOI 10.1038/sj.ki.5001860; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Mohan S, 2004, J BIOL CHEM, V279, P32071, DOI 10.1074/jbc.M405091200; Russo CJ, 2005, HYPERTENSION, V46, P488, DOI 10.1161/01.HYP.0000178594.63193.c0; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 2000, J CLIN INVEST, V105, P45, DOI 10.1172/JCI7869; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staruschenko A, 2005, J BIOL CHEM, V280, P39161, DOI 10.1074/jbc.M509608200; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Volk KA, 2005, J BIOL CHEM, V280, P18348, DOI 10.1074/jbc.M413689200; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wiemuth D, 2007, BIOCHEM J, V405, P147, DOI 10.1042/BJ20060747; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	44	74	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6033	6039		10.1074/jbc.M708555200	http://dx.doi.org/10.1074/jbc.M708555200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18174164	hybrid			2022-12-27	WOS:000253779500008
J	Pabla, N; Huang, S; Mi, QS; Daniel, R; Dong, Z				Pabla, Navjotsingh; Huang, Shuang; Mi, Qing-Sheng; Daniel, Rene; Dong, Zheng			ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULAR CELL APOPTOSIS; TUMOR-SUPPRESSOR; ATM; CHK2; DEATH; PATHWAY; REPAIR; ALPHA; INVOLVEMENT; MECHANISMS	Cisplatin is one of the most effective anti-cancer drugs; however, the use of cisplatin is limited by its toxicity in normal tissues, particularly injury of the kidneys. The mechanisms underlying the therapeutic effects of cisplatin in cancers and side effects in normal tissues are largely unclear. Recent work has suggested a role for p53 in cisplatin-induced renal cell apoptosis and kidney injury; however, the signaling pathway leading to p53 activation and renal apoptosis is unknown. Here we demonstrate an early DNA damage response during cisplatin treatment of renal cells and tissues. Importantly, in the DNA damage response, we demonstrate a critical role for ATR, but not ATM (ataxia telangiectasia mutated) or DNA-PK (DNA-dependent protein kinase), in cisplatin-induced p53 activation and apoptosis. We show that ATR is specifically activated during cisplatin treatment and co-localizes with H2AX, forming nuclear foci at the site of DNA damage. Blockade of ATR with a dominant-negative mutant inhibits cisplatin-induced p53 activation and renal cell apoptosis. Consistently, cisplatin-induced p53 activation and apoptosis are suppressed in ATR-deficient fibroblasts. Downstream of ATR, both Chk1 and Chk2 are phosphorylated during cisplatin treatment in an ATR-dependent manner. Interestingly, following phosphorylation, Chk1 is degraded via the proteosomal pathway, whereas Chk2 is activated. Inhibition of Chk2 by a dominant-negative mutant or gene deficiency attenuates cisplatin-induced p53 activation and apoptosis. In vivo in C57BL/6 mice, ATR and Chk2 are activated in renal tissues following cisplatin treatment. Together, the results suggest an important role for the DNA damage response mediated by ATR-Chk2 in p53 activation and renal cell apoptosis during cisplatin nephrotoxicity.	[Pabla, Navjotsingh; Dong, Zheng] Med Coll Georgia, Dept Cell Biol & Anat, Augusta, GA 30912 USA; [Huang, Shuang] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Mi, Qing-Sheng] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Mi, Qing-Sheng] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA 30912 USA; [Daniel, Rene] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jefferson University	Dong, Z (corresponding author), Med Coll Georgia, Dept Cell Biol & Anat, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	zdong@mail.mcg.edu	Pabla, Navjotsingh/H-3568-2011	Pabla, Navjot/0000-0001-9408-0539; Daniel, Rene/0000-0002-3876-6242	NATIONAL CANCER INSTITUTE [R01CA125272] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA125272] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; AGARWAL A, 1995, KIDNEY INT, V48, P1298, DOI 10.1038/ki.1995.414; Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Baliga R, 1999, DRUG METAB REV, V31, P971, DOI 10.1081/DMR-100101947; Berns JS, 1997, SEMIN NEPHROL, V17, P54; Busby EC, 2000, CANCER RES, V60, P2108; Colton SL, 2006, J BIOL CHEM, V281, P27117, DOI 10.1074/jbc.M602826200; Cummings BS, 2002, J PHARMACOL EXP THER, V302, P8, DOI 10.1124/jpet.302.1.8; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jiang M, 2004, AM J PHYSIOL-RENAL, V287, pF1140, DOI 10.1152/ajprenal.00262.2004; Jiang M, 2007, BIOCHEM PHARMACOL, V73, P1499, DOI 10.1016/j.bcp.2007.01.010; Jiang M, 2007, J BIOL CHEM, V282, P2636, DOI 10.1074/jbc.M606928200; Joe YS, 2006, J BIOL CHEM, V281, P28764, DOI 10.1074/jbc.M604392200; Jung YW, 2003, J BIOL CHEM, V278, P52084, DOI 10.1074/jbc.M310120200; Li SY, 2004, AM J PHYSIOL-RENAL, V287, pF990, DOI 10.1152/ajprenal.00206.2004; MIYASHITA T, 1995, CELL, V80, P293; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Price PM, 2003, SEMIN NEPHROL, V23, P449, DOI 10.1016/S0270-9295(03)00087-1; Ramesh G, 2004, KIDNEY INT, V66, pS56, DOI 10.1111/j.1523-1755.2004.09109.x; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; TAKAHARA PM, 1995, NATURE, V377, P649, DOI 10.1038/377649a0; Turchi JJ, 2000, NUCLEIC ACIDS RES, V28, P4634, DOI 10.1093/nar/28.23.4634; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang J, 2004, J BIOL CHEM, V279, P39584, DOI 10.1074/jbc.M400015200; Wang JZ, 2006, AM J PHYSIOL-RENAL, V291, pF1300, DOI 10.1152/ajprenal.00509.2005; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Wei Q, 2007, KIDNEY INT, V72, P53, DOI 10.1038/sj.ki.5002256; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; Wei QQ, 2005, AM J NEPHROL, V25, P491, DOI 10.1159/000088171; Wilsker D, 2007, MOL CANCER THER, V6, P1406, DOI 10.1158/1535-7163.MCT-06-0679; Woost PG, 1996, KIDNEY INT, V50, P125, DOI 10.1038/ki.1996.295; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	50	217	222	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6572	6583		10.1074/jbc.M707568200	http://dx.doi.org/10.1074/jbc.M707568200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18162465	hybrid			2022-12-27	WOS:000253779500063
J	Sun, X; Belouzard, S; Whittaker, GR				Sun, Xiangjie; Belouzard, Sandrine; Whittaker, Gary R.			Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MEMBRANE-FUSION; TRYPTOPHAN RESIDUES; SEMLIKI-FOREST; INFLUENZA HEMAGGLUTININ; ENVELOPE GLYCOPROTEIN; CONFORMATIONAL CHANGE; CHOLESTEROL-BINDING; MUTATIONAL EVIDENCE; CRYSTAL-STRUCTURE	The glycoprotein of vesicular stomatitis virus (VSV G) mediates fusion of the viral envelope with the host cell, with the conformational changes that mediate VSV G fusion activation occurring in a reversible, low pH-dependent manner. Based on its novel structure, VSV G has been classified as class III viral fusion protein, having a predicted bipartite fusion domain comprising residues Trp-72, Tyr-73, Tyr-116, and Ala-117 that interacts with the host cell membrane to initiate the fusion reaction. Here, we carried out a systematic mutagenesis study of the predicted VSV G fusion loops, to investigate the functional role of the fusion domain. Using assays of low pH-induced cell-cell fusion and infection studies of mutant VSV G incorporated into viral particles, we show a fundamental role for the bipartite fusion domain. We show that Trp-72 is a critical residue for VSV G-mediated membrane fusion. Trp-72 could only tolerate mutation to a phenylalanine residue, which allowed only limited fusion. Tyr-73 and Tyr-116 could be mutated to other aromatic residues without major effect but could not tolerate any other substitution. Ala-117 was a less critical residue, with only charged residues unable to allow fusion activation. These data represent a functional analysis of predicted bipartite fusion loops of VSV G, a founder member of the class III family of viral fusion proteins.	[Sun, Xiangjie; Belouzard, Sandrine; Whittaker, Gary R.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Sun, Xiangjie] Cornell Univ, Grad Program Microbiol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Whittaker, GR (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, C4127 VMC, Ithaca, NY 14853 USA.	grw7@cornell.edu	Belouzard, Sandrine/AAX-1584-2021; Sun, Xiangjie/AAP-5409-2020; Belouzard, Sandrine/O-8527-2016	Belouzard, Sandrine/0000-0002-9972-4054; Belouzard, Sandrine/0000-0002-9972-4054				Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001; BACKOVIC M, 2007, VIROLOGY; Backovic M, 2007, J VIROL, V81, P9596, DOI 10.1128/JVI.00758-07; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Carneiro FA, 2006, EUR BIOPHYS J BIOPHY, V35, P145, DOI 10.1007/s00249-005-0012-z; Carneiro FA, 2003, J BIOL CHEM, V278, P13789, DOI 10.1074/jbc.M210615200; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; Da Poian AT, 2005, BRAZ J MED BIOL RES, V38, P813, DOI 10.1590/S0100-879X2005000600002; Duntsch CD, 2004, J NEUROSURG, V100, P1049, DOI 10.3171/jns.2004.100.6.1049; Durell SR, 1997, MOL MEMBR BIOL, V14, P97, DOI 10.3109/09687689709048170; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; FREDERICKSEN BL, 1995, J VIROL, V69, P1435, DOI 10.1128/JVI.69.3.1435-1443.1995; Gaudin Y, 2000, Subcell Biochem, V34, P379; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Hannah BP, 2007, J VIROL, V81, P4858, DOI 10.1128/JVI.02755-06; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Jayakar HR, 2004, VIRUS RES, V106, P117, DOI 10.1016/j.virusres.2004.08.009; Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036; KLENK HD, 1994, COLD SPRING HARBOR M, P241; Lai AL, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P279; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; LEFRANCOIS L, 1983, J IMMUNOL, V130, P394; LEVYMINTZ P, 1991, J VIROL, V65, P4292, DOI 10.1128/JVI.65.8.4292-4300.1991; LI Y, 1993, J VIROL, V67, P4070, DOI 10.1128/JVI.67.7.4070-4077.1993; Lyles D, 2007, FIELDS VIROLOGY, P1364; MARSH M, 1989, ADV VIRUS RES, V36, P107, DOI 10.1016/S0065-3527(08)60583-7; Nakamura M, 1998, J BIOCHEM, V123, P1145; Norman KE, 2006, BIOPHYS J, V91, P2046, DOI 10.1529/biophysj.105.080275; Pak CC, 1997, BIOCHEMISTRY-US, V36, P8890, DOI 10.1021/bi9702851; Plassmeyer ML, 2007, VIROLOGY, V358, P273, DOI 10.1016/j.virol.2006.08.050; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; REGAN AD, 2008, VIRAL ENTRY HOST CEL; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Russell D., 2001, ENDOCYTOSIS PATHOG E, P247; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; SekinoSuzuki N, 1996, EUR J BIOCHEM, V241, P941, DOI 10.1111/j.1432-1033.1996.00941.x; Shokralla S, 1998, VIROLOGY, V242, P39, DOI 10.1006/viro.1997.8986; Steven AC, 2006, SCIENCE, V313, P177, DOI 10.1126/science.1129761; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z; Walker PJ, 1999, J GEN VIROL, V80, P1211, DOI 10.1099/0022-1317-80-5-1211; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WIMLEY WC, 1992, BIOCHEMISTRY-US, V31, P12813, DOI 10.1021/bi00166a015; YAMADA S, 1986, BIOCHEMISTRY-US, V25, P3703, DOI 10.1021/bi00360a034; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; ZHANG L, 1994, J VIROL, V68, P2186, DOI 10.1128/JVI.68.4.2186-2193.1994	58	48	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6418	6427		10.1074/jbc.M708955200	http://dx.doi.org/10.1074/jbc.M708955200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165228	hybrid			2022-12-27	WOS:000253779500049
J	Oliva, JL; Caino, MC; Senderowicz, AM; Kazanietz, MG				Oliva, Jose L.; Caino, M. Cecilia; Senderowicz, Adrian M.; Kazanietz, Marcelo G.			S-Phase-specific activation of PKC alpha induces senescence in non-small cell lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; VASCULAR ENDOTHELIAL-CELLS; CYCLIN-DEPENDENT KINASES; H-RAS ONCOGENE; PHORBOL ESTER; P21(WAF1/CIP1) EXPRESSION; TUMOR SUPPRESSION; MELANOMA-CELLS; MESSENGER-RNA; DNA-SYNTHESIS	Protein kinase C (PKC) has been widely implicated in positive and negative control of cell proliferation. We have recently shown that treatment of non-small cell lung cancer (NSCLC) cells with phorbol 12-myristate 13-acetate (PMA) during G(1) phase inhibits the progression into S phase, an effect mediated by PKC delta-induced up-regulation of the cell cycle inhibitor p21(Cip1). However, PMA treatment in asynchronously growing NSCLC cells leads to accumulation of cells in G(2)/M. Studies in post-G(1) phases revealed that PMA induced an irreversible G(2)/M cell cycle arrest in NSCLC cells and conferred morphological and biochemical features of senescence, including elevated SA-beta-Gal activity and reduced telomerase activity. Remarkably, this effect was phase-specific, as it occurred only when PKC was activated in S, but not in G(1) phase. Mechanistic analysis revealed a crucial role for the classical PKC alpha isozyme as mediator of the G(2)/M arrest and senescence, as well as for inducing p21(Cip1) an obligatory event for conferring the senescence phenotype. In addition to the unappreciated role of PKC isozymes, and specifically PKC alpha, in senescence, our data introduce the paradigm that discrete PKCs trigger distinctive responses when activated in different phases of the cell cycle via a common mechanism that involves p21(Cip1) up-regulation.	[Kazanietz, Marcelo G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Oliva, Jose L.; Caino, M. Cecilia; Kazanietz, Marcelo G.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Dept Pharmacol, Philadelphia, PA 19104 USA; [Oliva, Jose L.; Senderowicz, Adrian M.] CDER, Food & Drug Adm, Silver Spring, MD 20993 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Food & Drug Administration (FDA)	Oliva, JL (corresponding author), Ctr Nacl Microbiol Virol & Inmunol Sanitarias Maja, Inst Salud Carlos III, Unidad Biol Celular, Carretera Majadahonda Pozuelo,Km 2 Majahonda, Madrid 28220, Spain.	jloliva@isciii.es; marcelo@spirit.gcrc.upenn.edu			NATIONAL CANCER INSTITUTE [R01CA089202, P01CA092537] Funding Source: NIH RePORTER; NCI NIH HHS [CA-92537, CA-89202] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akashi M, 1999, BIOCHEM J, V337, P607, DOI 10.1042/0264-6021:3370607; Arita Y, 1998, EXP CELL RES, V242, P381, DOI 10.1006/excr.1997.3911; Barboule N, 1999, FEBS LETT, V444, P32, DOI 10.1016/S0014-5793(99)00022-8; Barry OP, 2001, CURR PHARM DESIGN, V7, P1725, DOI 10.2174/1381612013397041; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cozzi SJ, 2006, CANCER RES, V66, P10083, DOI 10.1158/0008-5472.CAN-06-0348; Dangi S, 2006, CELL PROLIFERAT, V39, P261, DOI 10.1111/j.1365-2184.2006.00388.x; Deng WG, 2007, CANCER RES, V67, P709, DOI 10.1158/0008-5472.CAN-06-3463; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Esposito F, 1997, EUR J BIOCHEM, V245, P730, DOI 10.1111/j.1432-1033.1997.00730.x; Facchinetti MM, 2004, CANCER RES, V64, P3629, DOI 10.1158/0008-5472.CAN-03-3741; Fishman DD, 1998, INT J ONCOL, V12, P181; Fong KM, 2003, THORAX, V58, P892, DOI 10.1136/thorax.58.10.892; Frey MR, 1997, J BIOL CHEM, V272, P9424; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Gavrielides MV, 2004, CURR DRUG TARGETS, V5, P431, DOI 10.2174/1389450043345380; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guadagno TM, 1996, CELL, V84, P73, DOI 10.1016/S0092-8674(00)80994-0; Han ZT, 1998, P NATL ACAD SCI USA, V95, P5362, DOI 10.1073/pnas.95.9.5362; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HSIAO WLW, 1989, MOL CELL BIOL, V9, P2641, DOI 10.1128/MCB.9.6.2641; Kashiwagi M, 2000, ONCOGENE, V19, P6334, DOI 10.1038/sj.onc.1204028; Khan QA, 2001, TOXICOL APPL PHARM, V173, P105, DOI 10.1006/taap.2001.9172; Kosaka C, 1996, AM J PHYSIOL-CELL PH, V270, pC170, DOI 10.1152/ajpcell.1996.270.1.C170; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; LACAL JC, 1987, MOL CELL BIOL, V7, P4146, DOI 10.1128/MCB.7.11.4146; Liu Y, 1996, CANCER RES, V56, P31; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Marquez VE, 2003, ACCOUNTS CHEM RES, V36, P434, DOI 10.1021/ar020124b; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Nakagawa M, 2005, J BIOL CHEM, V280, P33926, DOI 10.1074/jbc.M505748200; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Ostrovsky O, 2003, J BIOL CHEM, V278, P21221, DOI 10.1074/jbc.M211357200; Paz-Ares L, 2006, J CLIN ONCOL, V24, P1428, DOI 10.1200/JCO.2005.04.3299; Roninson IB, 2003, CANCER RES, V63, P2705; Russo M, 2003, ONCOGENE, V22, P3330, DOI 10.1038/sj.onc.1206493; Schiller JH, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055385; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Strair RK, 2002, CLIN CANCER RES, V8, P2512; te Poele RH, 2002, CANCER RES, V62, P1876; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Zeng YX, 1996, ONCOGENE, V12, P1557; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; ZHOU W, 1993, J BIOL CHEM, V268, P23041; Zou YY, 1998, J NATL CANCER I, V90, P1130, DOI 10.1093/jnci/90.15.1130	55	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5466	5476		10.1074/jbc.M707576200	http://dx.doi.org/10.1074/jbc.M707576200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18162471	hybrid			2022-12-27	WOS:000253426700027
J	Wiener, R; Haitin, Y; Shamgar, L; Fernandez-Alonso, MC; Martos, A; Chomsky-Hecht, O; Rivas, G; Attali, B; Hirsch, JA				Wiener, Reuven; Haitin, Yoni; Shamgar, Liora; Fernandez-Alonso, M. Carmen; Martos, Ariadna; Chomsky-Hecht, Orna; Rivas, German; Attali, Bernard; Hirsch, Joel A.			The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit assembly and protein interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL COILED-COILS; POTASSIUM CHANNELS; K+ CHANNEL; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; CALMODULIN; DOMAIN; ULTRACENTRIFUGATION; MODULATION; TETRAMERIZATION	The Kv7 subfamily of voltage-dependent potassium channels, distinct from other subfamilies by dint of its large intracellular COOH terminus, acts to regulate excitability in cardiac and neuronal tissues. KCNQ1 (Kv7.1), the founding subfamily member, encodes a channel subunit directly implicated in genetic disorders, such as the long QT syndrome, a cardiac pathology responsible for arrhythmias. We have used a recombinant protein preparation of the COOH terminus to probe the structure and function of this domain and its individual modules. The COOH-terminal proximal half associates with one calmodulin constitutively bound to each subunit where calmodulin is critical for proper folding of the whole intracellular domain. The distal half directs tetramerization, employing tandem coiled-coils. The first coiled-coil complex is dimeric and undergoes concentration dependent self-association to form a dimer of dimers. The outer coiled-coil is parallel tetrameric, the details of which have been elucidated based on 2.0 angstrom crystallographic data. Both coiled-coils act in a coordinate fashion to mediate the formation and stabilization of the tetrameric distal half. Functional studies, including characterization of structure-based and long QT mutants, prove the requirement for both modules and point to complex roles for these modules, including folding, assembly, trafficking, and regulation.	[Wiener, Reuven; Martos, Ariadna; Chomsky-Hecht, Orna; Hirsch, Joel A.] Fac Life Sci, Daniella Rich Inst Struct Biol, Dept Biochem, Tel Aviv, Israel; [Haitin, Yoni; Shamgar, Liora; Attali, Bernard] Tel Aviv Univ, Fac Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel; [Fernandez-Alonso, M. Carmen; Rivas, German] CSIC, CIB, E-28040 Madrid, Spain	Tel Aviv University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Hirsch, JA (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Biochem, IL-69978 Ramat Aviv, Israel.	jhirsch@post.tau.ac.il	Rivas, German/AFL-7528-2022; Haitin, Yoni/AAQ-4571-2021; Hirsch, Joel/AAC-8000-2021; Rivas, German/AAG-7458-2022	Rivas, German/0000-0003-3450-7478; Haitin, Yoni/0000-0002-1648-6792; Hirsch, Joel/0000-0001-7544-8668; Rivas, German/0000-0003-3450-7478				Abbott G W, 2001, Mol Interv, V1, P95; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cole JL, 2004, METHOD ENZYMOL, V384, P212; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Ducros V, 1998, NAT STRUCT BIOL, V5, P310, DOI 10.1038/nsb0498-310; Fleming PJ, 2000, J MOL BIOL, V299, P487, DOI 10.1006/jmbi.2000.3750; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J NEUROSCI, V23, P84; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Kanki H, 2004, J BIOL CHEM, V279, P33976, DOI 10.1074/jbc.M404539200; Kass RS, 2003, TRENDS CARDIOVAS MED, V13, P52, DOI 10.1016/S1050-1738(02)00211-6; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee DL, 2001, J MOL BIOL, V306, P539, DOI 10.1006/jmbi.2000.4351; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Minton A.P., 1994, MODERN ANAL ULTRACEN, P81; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rivas G, 1999, METHODS, V19, P194, DOI 10.1006/meth.1999.0851; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; van Holde K. E., 1986, PHYSICAL BIOCH, P110; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; WAXMAN E, 1993, BIOCHEMISTRY-US, V32, P3005, DOI 10.1021/bi00063a011; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797	47	102	105	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5815	5830		10.1074/jbc.M707541200	http://dx.doi.org/10.1074/jbc.M707541200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165683	Green Published, hybrid			2022-12-27	WOS:000253426700062
J	Hastie, C; Masters, JR; Moss, SE; Naaby-Hansen, S				Hastie, Claire; Masters, John R.; Moss, Stephen E.; Naaby-Hansen, Soren			Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER A1; PROTEIN-KINASE-C; IFN-GAMMA; DOWN-REGULATION; PLASMINOGEN-ACTIVATOR; MALIGNANT PROGRESSION; RECYCLING ENDOSOMES; CHOLESTEROL EFFLUX; ANTIGEN EXPRESSION; ABCA1 TRANSPORTER	The effect of interferon-gamma (IFN gamma) treatment on cell surface protein expression was studied in the human prostate cancer cell line 1542CP3TX. IFN gamma increased both the number and abundance of proteins in membrane fractions. In contrast, the expression of annexin 2 and its binding partner p11 decreased by 4-fold after 24 h of exposure, with the remaining anx2(t) complexes localized to lipid rafts. Within the same time scale, IFN gamma reduced the abundance of the peripherally attached, anx2(t)-associated proteases procathepsin B and plasminogen. The invasive capacity of the cancer cells was reduced by treatment with IFN gamma or antibody to annexin 2 in 1542CP3TX cells, but not in LNCaP, an annexin 2-negative prostate cancer cell line. Expression of annexin 2 in LNCaP cells increased their invasiveness. IFN gamma induced calpain expression and activation and increased the phosphorylation and degradation of the calpain substrate ABCA1 in 1542CP3TX cancer cells. Surface expression of annexin 2 was reduced in cells treated with glyburide, an ABCA1 inhibitor, whereas inhibition of calpain abrogated IFN gamma-induced annexin 2 down-regulation and suppression of Matrigel invasion. The findings suggest annexin 2 externalization is coupled to lipid efflux in prostate epithelium and that IFN gamma induces down-regulation of the protease-binding anx2t scaffold at the cell surface and consequently acts to suppress invasiveness through calpain-mediated degradation of the lipid transporter ABCA1.	[Naaby-Hansen, Soren] Arhus Univ Hosp, Dept Clin Immunol, Aalborg Sygehus, DK-9100 Aalborg, Denmark; [Hastie, Claire] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2UP, Hants, England; [Masters, John R.] Royal Free & UCL Med Sch, Prostate Canc Res Ctr, London W1W 7EJ, England; [Moss, Stephen E.] UCL, Div Cell Biol, Inst Ophthalmol, London WC1E 6BT, England	Aalborg University; Aarhus University; University of Portsmouth; University of London; University College London; University of London; University College London	Naaby-Hansen, S (corresponding author), Aalborg Sygehus Nord, Klin Immunol Afdeling, DK-9100 Aalborg, Denmark.	sonh@rn.dk	aukim-hastie, claire/A-7485-2011; Masters, John R/C-5694-2011		NATIONAL INSTITUTE ON AGING [R01AG014960] Funding Source: NIH RePORTER; Medical Research Council [G0100116] Funding Source: Medline; NIA NIH HHS [R01 AG14960] Funding Source: Medline; MRC [G0100116] Funding Source: UKRI	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aas V, 1999, CELL SIGNAL, V11, P101, DOI 10.1016/S0898-6568(98)00040-0; Amrani Y, 2001, AM J RESP CRIT CARE, V164, P2098, DOI 10.1164/ajrccm.164.11.2108005; Anderson F, 2002, CLIN IMMUNOL, V102, P200, DOI 10.1006/clim.2001.5161; Brichory FM, 2001, P NATL ACAD SCI USA, V98, P9824, DOI 10.1073/pnas.171320598; Bright RK, 1997, CANCER RES, V57, P995; Brownstein C, 2001, ANN NY ACAD SCI, V947, P143; Chapman LP, 2003, ENDOCRINOLOGY, V144, P1062, DOI 10.1210/en.2002-220650; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chetcuti A, 2001, CANCER RES, V61, P6331; Choi S, 2000, CLIN EXP METASTAS, V18, P45, DOI 10.1023/A:1026507713080; CHUNG CY, 1994, J CELL BIOL, V126, P539, DOI 10.1083/jcb.126.2.539; Diaz VM, 2004, GUT, V53, P993, DOI 10.1136/gut.2003.026831; Dieu-Nosjean MC, 2001, J IMMUNOL, V167, P5594, DOI 10.4049/jimmunol.167.10.5594; DiPaolo RS, 1999, J CLIN ONCOL, V17, P2213, DOI 10.1200/JCO.1999.17.7.2213; Emoto K, 2001, CANCER, V92, P1419, DOI 10.1002/1097-0142(20010915)92:6<1419::AID-CNCR1465>3.0.CO;2-J; Falcone DJ, 2001, BLOOD, V97, P777, DOI 10.1182/blood.V97.3.777; Fitzpatrick SL, 2000, BIOCHEMISTRY-US, V39, P1021, DOI 10.1021/bi991411z; Flieger D, 2001, CLIN EXP IMMUNOL, V123, P9, DOI 10.1046/j.1365-2249.2001.01435.x; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GLENNEY JR, 1989, J CELL BIOL, V108, P569, DOI 10.1083/jcb.108.2.569; GROVES A, 1992, THESIS U COLL LONDON; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hastie C, 2005, ONCOGENE, V24, P5905, DOI 10.1038/sj.onc.1208747; Heinzel S, 2001, CANCER IMMUNOL IMMUN, V49, P671, DOI 10.1007/s002620000163; Hobeika AC, 1998, INT J CANCER, V77, P138, DOI 10.1002/(SICI)1097-0215(19980703)77:1<138::AID-IJC21>3.0.CO;2-9; Hobeika AC, 1997, ONCOGENE, V14, P1165, DOI 10.1038/sj.onc.1200939; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Ibrahim EC, 2001, CANCER RES, V61, P6838; Jacovina AT, 2001, J BIOL CHEM, V276, P49350, DOI 10.1074/jbc.M106289200; Kaul M, 2001, FEBS LETT, V500, P91, DOI 10.1016/S0014-5793(01)02592-3; Kominsky SL, 2000, CANCER RES, V60, P3904; Kramer G, 2001, J INTERF CYTOK RES, V21, P475, DOI 10.1089/10799900152434349; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Loftus IM, 2002, BRIT J SURG, V89, P680, DOI 10.1046/j.1365-2168.2002.02099.x; Ma JX, 2000, J BIOL CHEM, V275, P12806, DOI 10.1074/jbc.275.17.12806; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; Mai JX, 2000, BBA-PROTEIN STRUCT M, V1477, P215, DOI 10.1016/S0167-4838(99)00274-5; Menell JS, 1999, NEW ENGL J MED, V340, P994, DOI 10.1056/NEJM199904013401303; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Miller A, 2000, THYROID, V10, P945, DOI 10.1089/thy.2000.10.945; Mita Y, 2001, IMMUNOL LETT, V78, P97, DOI 10.1016/S0165-2478(01)00241-3; Naaby-Hansen Soren, 2003, Methods Mol Med, V81, P277; Nagano K, 2004, ONCOGENE, V23, P1693, DOI 10.1038/sj.onc.1207297; Neufeld EB, 2004, J BIOL CHEM, V279, P15571, DOI 10.1074/jbc.M314160200; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Rand JH, 2000, BBA-MOL CELL RES, V1498, P169, DOI 10.1016/S0167-4889(00)00093-8; Raynor CM, 1999, BIOCHEMISTRY-US, V38, P5089, DOI 10.1021/bi982095b; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Ryu SY, 2000, ANTICANCER RES, V20, P3331; Satish L, 2005, MOL CELL BIOL, V25, P1922, DOI 10.1128/MCB.25.5.1922-1941.2005; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Shinohara N, 1998, PROSTATE, V35, P56, DOI 10.1002/(SICI)1097-0045(19980401)35:1<56::AID-PROS8>3.0.CO;2-F; SINGH RK, 1995, P NATL ACAD SCI USA, V92, P4562, DOI 10.1073/pnas.92.10.4562; Slovin SF, 1998, CLIN CANCER RES, V4, P643; So EY, 2000, J IMMUNOL, V165, P5472, DOI 10.4049/jimmunol.165.10.5472; Solito E, 2003, ENDOCRINOLOGY, V144, P1164, DOI 10.1210/en.2002-220592; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang XQ, 2002, BIOCHEM BIOPH RES CO, V290, P891, DOI 10.1006/bbrc.2001.6293; Wang XQ, 2002, ARTERIOSCL THROM VAS, V22, pE5, DOI 10.1161/01.ATV.0000018287.03856.DD; WRIGHT JF, 1994, BIOCHEM BIOPH RES CO, V198, P983, DOI 10.1006/bbrc.1994.1140; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200; Yan DH, 1999, ONCOGENE, V18, P807, DOI 10.1038/sj.onc.1202369; Zeuschner D, 2001, EUR J CELL BIOL, V80, P499, DOI 10.1078/0171-9335-00184; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387	66	20	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12595	12603		10.1074/jbc.M800189200	http://dx.doi.org/10.1074/jbc.M800189200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18211896	Green Published, hybrid			2022-12-27	WOS:000255340000076
J	Carreno, R; Li, D; Sen, M; Nira, I; Yamakawa, T; Ma, Q; Legge, GB				Carreno, Roberto; Li, Dan; Sen, Mehmet; Nira, Iris; Yamakawa, Tatsuo; Ma, Qing; Legge, Glen B.			A mechanism for antibody-mediated outside-in activation of LFA-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; INTERCELLULAR-ADHESION MOLECULE-3; LEUKOCYTE BETA(2) INTEGRINS; BINDING-SITES; HIGH-AFFINITY; CR3-DEPENDENT ADHESION; IMMUNOLOGICAL SYNAPSE; MONOCLONAL-ANTIBODY; STRUCTURAL BASIS; CELL-ACTIVATION	MEM83 is an inserted domain (I-domain)-specific antibody that up-regulates the interaction of LFA-1 with ICAM-1 through an outside-in activation mechanism. We demonstrate here that there is no change in the affinity of the MEM83 antibody for the I-domain in either its low (wild-type) or high affinity form and that MEM83 does not enhance the binding of the wild-type I-domain to ICAM-1. Furthermore, we show that the antibody acts as an activating agent to induce LFA-1/ICAM-1-dependent homotypic cell aggregation only as an IgG, but not as a Fab fragment. On the basis of these data, we propose an avidity-based mechanism that requires no direct activation of the LFA-1 I-domain by the binding of the antibody; rather, activation is enhanced when there is an interaction with both arms of the IgG. A molecular model of the antibody interaction with LFA-1 illustrates the symmetry and accessibility of the two MEM83 epitopes across the LFA-1/ICAM-1 heterotetramer. We hypothesize that MEM83 stabilizes adjacent LFA-1 molecules in their active form by the free energy that is gained from the binding of the I-domains to each arm of the IgG. This leads to stabilization of the open state of the integrin and outside-in signaling. Our model supports a mechanism in which both affinity and avidity regulation are required in the activation of LFA-1.	[Carreno, Roberto; Sen, Mehmet; Nira, Iris; Yamakawa, Tatsuo; Legge, Glen B.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Li, Dan; Ma, Qing] Univ Texas Houston, MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA	University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Legge, GB (corresponding author), Univ Houston, Dept Biol & Biochem, 4800 Calhoun Rd, Houston, TX 77204 USA.	glegge@uh.edu	Smith, Iris/AAK-2032-2020	Smith, Iris/0000-0001-5560-8871				Adler AJ, 2007, CURR CANCER DRUG TAR, V7, P3, DOI 10.2174/156800907780006931; Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; BAILLY P, 1994, P NATL ACAD SCI USA, V91, P5306, DOI 10.1073/pnas.91.12.5306; BAZIL V, 1990, FOLIA BIOL-PRAGUE, V36, P41; Binnerts ME, 1996, J BIOL CHEM, V271, P9962, DOI 10.1074/jbc.271.17.9962; BINNERTS ME, 1994, EUR J IMMUNOL, V24, P2155, DOI 10.1002/eji.1830240933; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; Dorfleutner A, 2004, MOL BIOL CELL, V15, P4416, DOI 10.1091/mbc.E03-09-0640; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; DUSTIN ML, 1989, COLD SPRING HARB SYM, V54, P753; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Eniola AO, 2005, BIOPHYS J, V89, P3577, DOI 10.1529/biophysj.104.057729; Gamberg JC, 1999, AIDS, V13, P2043, DOI 10.1097/00002030-199910220-00006; Giblin PA, 2006, CURR PHARM DESIGN, V12, P2771, DOI 10.2174/138161206777947731; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hermand P, 2000, J BIOL CHEM, V275, P26002, DOI 10.1074/jbc.M002823200; HOGG N, 1993, AM REV RESPIR DIS, V148, pS55, DOI 10.1164/ajrccm/148.6_Pt_2.S55; Huang LL, 2006, J LEUKOCYTE BIOL, V80, P905, DOI 10.1189/jlb.1105649; Ihanus E, 2003, EUR J BIOCHEM, V270, P1710, DOI 10.1046/j.1432-1033.2003.03528.x; Ihanus E, 2007, BLOOD, V109, P802, DOI 10.1182/blood-2006-04-014878; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; JOHNSTON SC, 1990, J IMMUNOL, V145, P1181; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kaplan MJ, 2000, IMMUNOL INVEST, V29, P427; KEIZER GD, 1988, J IMMUNOL, V140, P1393; KELLEHER D, 1995, J LEUKOCYTE BIOL, V58, P539, DOI 10.1002/jlb.58.5.539; Kelly TA, 1999, J IMMUNOL, V163, P5173; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Knorr R, 1997, J EXP MED, V186, P719, DOI 10.1084/jem.186.5.719; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LANDIS RC, 1994, J CELL BIOL, V126, P529, DOI 10.1083/jcb.126.2.529; LANDIS RC, 1993, J CELL BIOL, V120, P1519, DOI 10.1083/jcb.120.6.1519; Last-Barney K, 2001, J AM CHEM SOC, V123, P5643, DOI 10.1021/ja0104249; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Lebedeva T, 2005, CURR OPIN IMMUNOL, V17, P251, DOI 10.1016/j.coi.2005.04.008; Legge GB, 2000, J MOL BIOL, V295, P1251, DOI 10.1006/jmbi.1999.3409; Legge GB, 2002, PROTEINS, V48, P151, DOI 10.1002/prot.10134; Lu CF, 2004, J IMMUNOL, V173, P3972, DOI 10.4049/jimmunol.173.6.3972; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; LUB M, 1995, IMMUNOL TODAY, V16, P479, DOI 10.1016/0167-5699(95)80031-X; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Ma Q, 2002, J BIOL CHEM, V277, P10638, DOI 10.1074/jbc.M112417200; Malissen B, 1999, SCIENCE, V285, P207, DOI 10.1126/science.285.5425.207; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Perez OD, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-2; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; Shi C, 2006, TRENDS CARDIOVAS MED, V16, P146, DOI 10.1016/j.tcm.2006.03.002; Shi CW, 1996, P NATL ACAD SCI USA, V93, P4051, DOI 10.1073/pnas.93.9.4051; Shimaoka M, 2004, CURR TOP MED CHEM, V4, P1485, DOI 10.2174/1568026043387575; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sumen C, 2004, J CELL BIOL, V166, P579, DOI 10.1083/jcb.200404059; Tanaka Y, 2000, HISTOL HISTOPATHOL, V15, P1169, DOI 10.14670/HH-15.1169; Tian L, 2000, EUR J IMMUNOL, V30, P810, DOI 10.1002/1521-4141(200003)30:3<810::AID-IMMU810>3.3.CO;2-O; Watanabe T, 1998, INT J CARDIOL, V66, pS45, DOI 10.1016/S0167-5273(98)00147-8; Weitz-Schmidt G, 2003, ENDOTHELIUM-J ENDOTH, V10, P43, DOI 10.1080/10623320303360; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7; Yung Raymond L., 2003, Biol Proced Online, V5, P211, DOI 10.1251/bpo64	69	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10642	10648		10.1074/jbc.M704699200	http://dx.doi.org/10.1074/jbc.M704699200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18199751	hybrid			2022-12-27	WOS:000254894700046
J	Dierssen, U; Beraza, N; Lutz, HH; Liedtke, C; Ernst, M; Wasmuth, HE; Trautwein, C				Dierssen, Uta; Beraza, Naiara; Lutz, Holger H.; Liedtke, Christian; Ernst, Matthias; Wasmuth, Hermann E.; Trautwein, Christian			Molecular dissection of gp 130-dependent pathways in hepatocytes during liver regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE RECEPTOR GP130; GROWTH-FACTOR RECEPTOR; SIGNAL TRANSDUCER; KERATINOCYTE MIGRATION; STAT ACTIVATION; IN-VIVO; PROLIFERATION; INTERLEUKIN-6; SOCS3; TRANSCRIPTION	Interleukin-6 (IL-6) via its signal transducer gp130 is an important mediator of liver regeneration involved in protecting from lipopolysaccharide (LPS)-induced liver injury after partial hepatectomy (PH). Here we generated mice either defective (Delta) in hepatocyte- specific gp130-dependent Ras or STAT activation to define their role during liver regeneration. Deletion of gp130-dependent signaling had major impact on acute phase gene (APG) regulation after PH. APG expression was blocked in gp130-Delta STAT animals, whereas gp130-Delta Ras mice showed an enhanced APG response and stronger SOCS3 regulation correlating with delayed hepatocyte proliferation. To define the role of SOCS3 during hepatocyte proliferation, primary hepatocytes were co-stimulated with IL-6 and hepatocyte growth factor. Higher SOCS3 expression in gp130-Delta Ras hepatocytes correlated with delayed hepatocyte proliferation. Next, we tested the impact of LPS, mimicking bacterial infection, on liver regeneration. LPS and PH induced SOCS3 and APG in all animal strains and delayed cell cycle progression. Additionally, IL-6/gp130 dependent STAT3 activation in hepatocytes was essential in mediating protection and thus required for maximal proliferation. Unexpectedly, oncostatin M was most strongly induced in gp130-Delta STAT animals after PH/LPS-induced stress and was associated with hepatocyte proliferation in this strain. In summary, gp130-dependent STAT3 activation and concomitant SOCS3 during liver regeneration is involved in timing of DNA synthesis and protects hepatocyte proliferation during stress conditions.	[Dierssen, Uta; Beraza, Naiara; Lutz, Holger H.; Liedtke, Christian; Wasmuth, Hermann E.; Trautwein, Christian] Rhein Westfal TH Aachen, Univ Hosp, Med Klin 3, D-52074 Aachen, Germany; [Ernst, Matthias] Ludwig Inst Canc Res, Colon Mol & Cell Biol Lab, Melbourne, Vic 3050, Australia	RWTH Aachen University; RWTH Aachen University Hospital; Ludwig Institute for Cancer Research	Trautwein, C (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Med Klin 3, Pauwelsstr 30, D-52074 Aachen, Germany.	ctrautwein@ukaachen.de	Ernst, Matthias/D-5111-2012; Liedtke, Christian/DTV-1874-2022	Ernst, Matthias/0000-0002-6399-1177; Liedtke, Christian/0000-0003-4681-7887; Beraza, Naiara/0000-0003-0718-0940				Beraza N, 2005, HEPATOLOGY, V41, P460, DOI 10.1002/hep.20590; Blindenbacher A, 2003, HEPATOLOGY, V38, P674, DOI 10.1053/jhep.2003.50378; Cacalano NA, 2001, NAT CELL BIOL, V3, P460, DOI 10.1038/35074525; Coutant A, 2002, HEPATOLOGY, V36, P1079, DOI 10.1053/jhep.2002.36160; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Deshpande RR, 2002, ANN SURG, V236, P248, DOI 10.1097/00000658-200208000-00014; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Ernst M, 2001, J EXP MED, V194, P189, DOI 10.1084/jem.194.2.189; Evans MK, 2007, ONCOGENE, V26, P1941, DOI 10.1038/sj.onc.1209993; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Gerhartz C, 1996, J BIOL CHEM, V271, P12991, DOI 10.1074/jbc.271.22.12991; Goren I, 2006, J INVEST DERMATOL, V126, P477, DOI 10.1038/sj.jid.5700063; Hirano T, 1998, Int Rev Immunol, V16, P249; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Kadry Z, 2004, LIVER TRANSPLANT, V10, P1078, DOI 10.1002/lt.20200; Kim JS, 2005, TRANSPLANTATION, V79, P1206, DOI 10.1097/01.TP.0000160758.13505.D2; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Ledda-Columbano GM, 1998, ONCOGENE, V17, P1039, DOI 10.1038/sj.onc.1202018; Leu JI, 2001, MOL CELL BIOL, V21, P414, DOI 10.1128/MCB.21.2.414-424.2001; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Luedde T, 2001, HEPATOLOGY, V34, p384A, DOI 10.1053/jhep.2001.0341254; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; PINES J, 1995, ADV CANCER RES, V66, P181, DOI 10.1016/S0065-230X(08)60254-7; Sommer U, 2005, J BIOL CHEM, V280, P31478, DOI 10.1074/jbc.M506008200; Streetz KL, 2000, GUT, V47, P309, DOI 10.1136/gut.47.2.309; Stross C, 2006, J BIOL CHEM, V281, P8458, DOI 10.1074/jbc.M511212200; Suda T, 2002, CYTOKINE, V17, P335, DOI 10.1006/cyto.2002.1023; Sun R, 2005, BIOCHEM BIOPH RES CO, V338, P1943, DOI 10.1016/j.bbrc.2005.10.171; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; Thoresen GH, 2003, CELL PHYSIOL BIOCHEM, V13, P229; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; Tokumaru S, 2005, BIOCHEM BIOPH RES CO, V327, P100, DOI 10.1016/j.bbrc.2004.11.145; Trautwein C, 1996, GASTROENTEROLOGY, V110, P1854, DOI 10.1053/gast.1996.v110.pm8964411; Wuestefeld T, 2003, J BIOL CHEM, V278, P11281, DOI 10.1074/jbc.M208470200; Xia L, 2002, J BIOL CHEM, V277, P30716, DOI 10.1074/jbc.M202823200	41	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9886	9895		10.1074/jbc.M705483200	http://dx.doi.org/10.1074/jbc.M705483200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18216023	hybrid			2022-12-27	WOS:000254671600045
J	Genge, BR; Wu, LNY; Wuthier, RE				Genge, Brian R.; Wu, Licia N. Y.; Wuthier, Roy E.			Mineralization of annexin-5-containing lipid-calcium-phosphate complexes - Modulation by varying lipid composition and incubation with cartilage collagens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-PLATE CARTILAGE; RELEASED MATRIX VESICLES; CII ANNEXIN-V; X-COLLAGEN; BINDING-PROTEINS; ANCHORIN-CII; FREEZE-SUBSTITUTION; NUCLEATIONAL CORE; PHOSPHATIDYLSERINE; CHONDROCYTES	Matrix vesicles (MVs) in the growth plate bind to cartilage collagens and initiate mineralization of the extracellular matrix. Native MVs have been shown to contain a nucleational core responsible for mineral formation that is comprised of Mg2+-containing amorphous calcium phosphate and lipid-calcium-phosphate complexes (CPLXs) and the lipid-dependent Ca2+-binding proteins, especially annexin-5 (Anx-5), which greatly enhances mineral formation. Incorporation of non-Ca2+-binding-MV lipids impedes mineral formation by phosphatidylserine (PS)-CPLX. In this study, nucleators based on amorphous calcium phosphate (with or without Anx-5) were prepared with PS alone, PS + phosphatidylethanolamine (PE), or PS + PE and other MV lipids. These were incubated in synthetic cartilage lymph containing no collagen or containing type II or type X collagen. Dilution of PS with PE and other MV lipids progressively retarded nucleation. Incorporation of Anx-5 restored nucleational activity to the PS: PE CPLX; thus PS and Anx-5 proved to be critical for nucleation of mineral. Without Anx-5, induction of mineral formation was slow unless high levels of Ca2+ were used. The presence of type II collagen in synthetic cartilage lymph improved both the rate and amount of mineral formation but did not enhance nucleation. This stimulatory effect required the presence of the nonhelical telopeptides. Although type X collagen slowed induction, it also increased the rate and amount of mineral formation. Both type II and X collagens markedly increased mineral formation by the MV-like CPLX, requiring Anx-5 to do so. Thus, Anx-5 enhances nucleation by the CPLXs and couples this to propagation of mineral formation by the cartilage collagens.	[Genge, Brian R.; Wu, Licia N. Y.; Wuthier, Roy E.] Univ S Carolina, Dept Chem & Biochem, Grad Sci Res Ctr, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Wuthier, RE (corresponding author), Univ S Carolina, Dept Chem & Biochem, Grad Sci Res Ctr, 631 Sumter St, Columbia, SC 29208 USA.	wuthier@mail.chem.sc.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR018983, R01AR042359] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 18983, AR 42359] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABRAMSON MB, 1964, J BIOL CHEM, V239, P70; ALI SY, 1970, P NATL ACAD SCI USA, V67, P1513, DOI 10.1073/pnas.67.3.1513; ANDERSON HC, 1988, RHEUM DIS CLIN N AM, V14, P303; ANDERSON HC, 1967, J CELL BIOL, V35, P81, DOI 10.1083/jcb.35.1.81; ARSENAULT AL, 1988, CALCIFIED TISSUE INT, V42, P119, DOI 10.1007/BF02556344; ARSENAULT AL, 1994, MICROSC RES TECHNIQ, V28, P409, DOI 10.1002/jemt.1070280507; Balcerzak M, 2007, ANAL BIOCHEM, V361, P176, DOI 10.1016/j.ab.2006.10.001; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; BONUCCI E, 1967, J ULTRA MOL STRUCT R, V20, P33, DOI 10.1016/S0022-5320(67)80034-0; BORG TK, 1981, ANAT REC, V199, P449, DOI 10.1002/ar.1091990402; BOSKEY AL, 1982, CALCIFIED TISSUE INT, V34, pS1; BOSKEY AL, 1977, CALC TISS RES, V22, P197; BOYANSALYERS BD, 1980, CALCIFIED TISSUE INT, V30, P167, DOI 10.1007/BF02408622; BRECEVIC L, 1972, CALC TISS RES, V10, P82, DOI 10.1007/BF02012538; COTMORE JM, 1971, SCIENCE, V172, P1339, DOI 10.1126/science.172.3990.1339; EANES ED, 1992, GLYCOBIOLOGY, V2, P571, DOI 10.1093/glycob/2.6.571; Ernst JD, 1998, ANAL BIOCHEM, V260, P18, DOI 10.1006/abio.1998.2677; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; GENGE BR, 1992, J BONE MINER RES, V7, P807, DOI 10.1002/jbmr.5650070710; Genge BR, 2003, ANAL BIOCHEM, V322, P104, DOI 10.1016/S0003-2697(03)00462-7; GENGE BR, 1990, J BIOL CHEM, V265, P4703; GENGE BR, 1989, J BIOL CHEM, V264, P10917; GENGE BR, 1991, J BIOL CHEM, V266, P10678; GENGE BR, 1988, J BIOL CHEM, V263, P18513; Genge BR, 2007, J BIOL CHEM, V282, P26035, DOI 10.1074/jbc.M701057200; Genge BR, 2007, ANAL BIOCHEM, V367, P159, DOI 10.1016/j.ab.2007.04.029; Glimcher M J, 1987, Instr Course Lect, V36, P49; Howell David S, 2002, Curr Rheumatol Rep, V4, P265, DOI 10.1007/s11926-002-0075-0; HUBER R, 1990, EMBO J, V9, P3867, DOI 10.1002/j.1460-2075.1990.tb07605.x; HUNZIKER EB, 1984, J CELL BIOL, V98, P267, DOI 10.1083/jcb.98.1.267; HUNZIKER EB, 1984, J CELL BIOL, V98, P277, DOI 10.1083/jcb.98.1.277; IANNOTTI JP, 1994, CLIN ORTHOP RELAT R, P222; ISHIKAWA Y, 1992, BONE MINER, V17, P152, DOI 10.1016/0169-6009(92)90727-U; KIRSCH T, 1990, BIOCHEM J, V265, P453, DOI 10.1042/bj2650453; KIRSCH T, 1994, J BIOL CHEM, V269, P11462; Kirsch T, 1997, BIOCHEMISTRY-US, V36, P3359, DOI 10.1021/bi9626867; KIRSCH T, 1992, FEBS LETT, V310, P143, DOI 10.1016/0014-5793(92)81316-E; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; Kirsch T, 2003, J BONE MINER RES, V18, P1872, DOI 10.1359/jbmr.2003.18.10.1872; LANDIS WJ, 1991, CONNECT TISSUE RES, V25, P181, DOI 10.3109/03008209109029155; LANDIS WJ, 1991, J STRUCT BIOL, V107, P116, DOI 10.1016/1047-8477(91)90015-O; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJESKA RJ, 1979, CALCIFIED TISSUE INT, V27, P41, DOI 10.1007/BF02441159; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; MOLLENHAUER J, 1984, J CELL BIOL, V98, P1572, DOI 10.1083/jcb.98.4.1572; NASH HA, 1964, P NATL ACAD SCI USA, V51, P476, DOI 10.1073/pnas.51.3.476; PERESS NS, 1974, CALC TISS RES, V14, P275, DOI 10.1007/BF02060301; PITA JC, 1970, J CLIN INVEST, V49, P2188, DOI 10.1172/JCI106437; POOLE AR, 1989, ANAT REC, V224, P167; SAUER GR, 1988, J BIOL CHEM, V263, P13718; SCHMID T M, 1991, In Vivo (Attiki), V5, P533; SCHMID TM, 1990, ANN NY ACAD SCI, V580, P64, DOI 10.1111/j.1749-6632.1990.tb17918.x; SCHMID TM, 1983, J BIOL CHEM, V258, P9504; Stuart MCA, 1998, EUR J CELL BIOL, V76, P77, DOI 10.1016/S0171-9335(98)80019-8; TANIMURA A, 1986, Journal of Experimental Pathology (New York), V2, P261; TANIMURA A, 1983, P SOC EXP BIOL MED, V172, P173; Taylor MG, 1998, CELL MOL LIFE SCI, V54, P196, DOI 10.1007/s000180050143; TERMINE JD, 1967, P SOC EXP BIOL MED, V125, P4; Wu LNY, 2008, J BIOL CHEM, V283, P3827, DOI 10.1074/jbc.M707653200; Wu LNY, 2002, J BIOL CHEM, V277, P5126, DOI 10.1074/jbc.M107899200; WU LNY, 1989, J BIOL CHEM, V264, P21346; Wu LNY, 2003, J INORG BIOCHEM, V94, P221, DOI 10.1016/S0162-0134(03)00003-5; WU LNY, 1993, J BIOL CHEM, V268, P25084; WU LNY, 1991, J BIOL CHEM, V266, P1195; WU LNY, 1991, J BIOL CHEM, V266, P1187; Wu LNY, 1996, CONNECT TISSUE RES, V35, P309, DOI 10.3109/03008209609029205; Wu LNY, 1997, J BIOL CHEM, V272, P4404, DOI 10.1074/jbc.272.7.4404; WUTHIER RE, 1975, BIOCHIM BIOPHYS ACTA, V409, P128, DOI 10.1016/0005-2760(75)90087-9; WUTHIER RE, 1977, CALC TISS RES, V23, P125, DOI 10.1007/BF02012777; WUTHIER RE, 1975, CALC TISS RES, V19, P197, DOI 10.1007/BF02564004; WUTHIER RE, 1978, BIOCHEMISTRY-US, V17, P1431, DOI 10.1021/bi00601a011; WUTHIER RE, 1985, CALCIFIED TISSUE INT, V37, P401, DOI 10.1007/BF02553710; WUTHIER RE, 1969, CALC TISS RES, V4, P20, DOI 10.1007/BF02279103; WUTHIER RE, 1977, CALC TISS RES, V24, P163, DOI 10.1007/BF02223311	76	31	31	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9737	9748		10.1074/jbc.M706523200	http://dx.doi.org/10.1074/jbc.M706523200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18250169	Green Published, hybrid			2022-12-27	WOS:000254671600028
J	Reiter, W; Watt, S; Dawson, K; Lawrence, CL; Bahler, J; Jones, N; Wilkinson, CRM				Reiter, Wolfgang; Watt, Stephen; Dawson, Keren; Lawrence, Clare L.; Bahler, Juerg; Jones, Nic; Wilkinson, Caroline R. M.			Fission yeast MAP kinase Sty1 is recruited to stress-induced genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MEIOTIC RECOMBINATION HOTSPOT; TRANSCRIPTION FACTOR ATF1; SCHIZOSACCHAROMYCES-POMBE; OSMOTIC-STRESS; ENVIRONMENTAL-STRESS; SEXUAL DEVELOPMENT; TARGET GENES; HOG1 KINASE; HOT-SPOT	The stress-induced expression of many fission yeast genes is dependent upon the Sty1 mitogen-activated protein kinase (MAPK) and Atf1 transcription factor. Atf1 is phosphorylated by Sty1 yet this phosphorylation is not required for stress-induced gene expression, suggesting another mechanism exists whereby Sty1 activates transcription. Here we show that Sty1 associates with Atf1-dependent genes and is recruited to both their promoters and coding regions. This occurs in response to various stress conditions coincident with the kinetics of the activation of Sty1. Association with promoters is not a consequence of increased nuclear accumulation of Sty1 nor does it require the phosphorylation of Atf1. However, recruitment is completely abolished in a mutant lacking Sty1 kinase activity. Both Atf1 and its binding partner Pcr1 are required for association of Sty1 with Atf1-dependent promoters, suggesting that this heterodimer must be intact for optimal recruitment of the MAPK. However, many Atf1-dependent genes are still expressed in a pcr1 Delta mutant but with significantly delayed kinetics, thus providing an explanation for the relatively mild stress sensitivity displayed by pcr1 Delta. Consistent with this delay, Sty1 and Atf1 cannot be detected at these promoters in this condition, suggesting that their association with chromatin is weak or transient in the absence of Pcr1.	[Reiter, Wolfgang; Dawson, Keren; Lawrence, Clare L.; Jones, Nic; Wilkinson, Caroline R. M.] Univ Manchester, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; [Watt, Stephen; Bahler, Juerg] Welcome Trust Sanger Inst, Canc Res UK Fiss Yeast Genom Grp, Cambridge CB10 1HH, England	Paterson Institute for Cancer Research; University of Manchester; Wellcome Trust Sanger Institute	Jones, N (corresponding author), Univ Manchester, Paterson Inst Canc Res, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	njones@picr.man.ac.uk; cwilkinson@picr.man.ac.uk	Bahler, Jurg/B-4572-2009	Bahler, Jurg/0000-0003-4036-1532; Reiter, Wolfgang/0000-0003-1266-8975; Lawrence, Clare/0000-0003-0170-0079	Cancer Research UK [A6517] Funding Source: Medline; Wellcome Trust [098051, 077118] Funding Source: Medline; Cancer Research UK [12485] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)		Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Castillo EA, 2003, J BIOL CHEM, V278, P40565, DOI 10.1074/jbc.M305859200; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; Degols G, 1996, MOL CELL BIOL, V16, P2870; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; Fox ME, 2000, GENETICS, V156, P59; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; Gasch AP, 2007, YEAST, V24, P961, DOI 10.1002/yea.1512; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Kon N, 1998, MOL CELL BIOL, V18, P7575, DOI 10.1128/MCB.18.12.7575; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nguyen AN, 2002, MOL BIOL CELL, V13, P2651, DOI 10.1091/mbc.02-03-0043; Ohmiya R, 1999, MOL GEN GENET, V261, P297, DOI 10.1007/s004380050970; Pascual-Ahuir A, 2007, EMBO J, V26, P3098, DOI 10.1038/sj.emboj.7601756; Petersen J, 2001, J CELL SCI, V114, P4371; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138	46	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9945	9956		10.1074/jbc.M710428200	http://dx.doi.org/10.1074/jbc.M710428200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18252721	hybrid, Green Accepted			2022-12-27	WOS:000254671600051
J	Zhou, W; Milder, JB; Freed, CR				Zhou, Wenbo; Milder, Julie B.; Freed, Curt R.			Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein - A progressive neurodegenerative model of diffuse Lewy body disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE NEURON DEATH; A-BETA COMPONENT; PARKINSONS-DISEASE; OXIDATIVE STRESS; AGGREGATE FORMATION; PRECURSOR PROTEIN; CROSS-LINKING; IN-VITRO; BODIES; DEMENTIA	Abnormal aggregation of human alpha-synuclein in Lewy bodies and Lewy neurites is a pathological hallmark of Parkinson disease and dementia with Lewy bodies. Studies have shown that oxidation and nitration of alpha-synuclein lead to the formation of stable dimers and oligomers through dityrosine cross-linking. Previously we have reported that tyrosine-to-cysteine mutations, particularly at the tyrosine 39 residue (Y39C), significantly enhanced alpha-synuclein fibril formation and neurotoxicity. In the current study, we have generated transgenic mice expressing the Y39C mutant human alpha-synuclein gene controlled by the mouse Thy1 promoter. Mutant human alpha-synuclein was widely expressed in transgenic mouse brain, resulting in 150% overexpression relative to endogenous mouse alpha-synuclein. At age 9 - 12 months, transgenic mice began to display motor dysfunction in rotarod testing. Older animals aged 15 - 18 months showed progressive accumulation of human alpha-synuclein oligomers, associated with worse motor function and cognitive impairment in the Morris water maze. By age 21 - 24 months, alpha-synuclein aggregates were further increased, accompanied by severe behavioral deficits. At this age, transgenic mice developed neuropathology, such as Lewy body-like alpha-synuclein and ubiquitin-positive inclusions, phosphorylation at Ser(129) of human alpha-synuclein, and increased apoptotic cell death. In summary, Y39C human alpha-synuclein transgenic mice show age-dependent, progressive neuronal degeneration with motor and cognitive deficits similar to diffuse Lewy body disease. The time course of alpha-synuclein oligomer accumulation coincided with behavioral and pathological changes, indicating that these oligomers may initiate protein aggregation, disrupt cellular function, and eventually lead to neuronal death.	[Zhou, Wenbo; Freed, Curt R.] Univ Colorado, Sch Med, Div Clin Pharmacol & Toxicol, Dept Med, Denver, CO 80262 USA; [Milder, Julie B.; Freed, Curt R.] Univ Colorado, Sch Med, Grad Program Neurosci, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Zhou, W (corresponding author), Univ Colorado, Sch Med, Div Clin Pharmacol & Toxicol, Dept Med, E 9th Ave, Denver, CO 80262 USA.	wenbo.zhou@uchsc.edu						Baba M, 1998, AM J PATHOL, V152, P879; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dalfo E, 2004, J NEUROPATH EXP NEUR, V63, P302, DOI 10.1093/jnen/63.4.302; Di Rosa G, 2003, HISTOL HISTOPATHOL, V18, P1257, DOI 10.14670/HH-18.1257; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Hsu LJ, 1998, J NEUROCHEM, V71, P338; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Ischiropoulos H, 2003, ANN NY ACAD SCI, V991, P93; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Maskri L, 2004, NEURODEGENER DIS, V1, P255, DOI 10.1159/000085064; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Munch G, 2000, J CHEM NEUROANAT, V20, P253, DOI 10.1016/S0891-0618(00)00096-X; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Paik SR, 2000, ARCH BIOCHEM BIOPHYS, V378, P269, DOI 10.1006/abbi.2000.1822; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200; Zhou WB, 2004, J BIOL CHEM, V279, P10128, DOI 10.1074/jbc.M307563200; Zhou WB, 1998, BRAIN RES, V792, P97, DOI 10.1016/S0006-8993(98)00125-5; Zhou WB, 2002, BRAIN RES, V926, P42, DOI 10.1016/S0006-8993(01)03292-9	47	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9863	9870		10.1074/jbc.M710232200	http://dx.doi.org/10.1074/jbc.M710232200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18238775	hybrid			2022-12-27	WOS:000254671600042
J	Charalambous, C; Gsandtner, I; Keuerleber, S; Milan-Lobo, L; Kudlacek, O; Freissmuth, M; Zezula, J				Charalambous, Christoforos; Gsandtner, Ingrid; Keuerleber, Simon; Milan-Lobo, Laura; Kudlacek, Oliver; Freissmuth, Michael; Zezula, Juergen			Restricted collision coupling of the A(2A) receptor revisited - Evidence for physical separation of two signaling cascades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISRUPT MICROFILAMENT ORGANIZATION; HUMAN SEROTONIN TRANSPORTER; ACTIVATED PROTEIN-KINASE; A2 ADENOSINE RECEPTORS; A(2A)-ADENOSINE RECEPTOR; ADENYLATE-CYCLASE; LIPID RAFTS; MEMBRANE MICRODOMAINS; ALPHA-SUBUNITS; CELL-MEMBRANES	The A(2A)-adenosine receptor is a prototypical G(s) protein-coupled receptor but stimulates MAPK/ERK in a G(s)-independent way. The A(2A) receptor has long been known to undergo restricted collision coupling with Gs; the mechanistic basis for this mode of coupling has remained elusive. Here we visualized agonist-induced changes in mobility of the yellow fluorescent protein-tagged receptor by fluorescence recovery after photo-bleaching microscopy. Stimulation with a specific A(2A) receptor agonist did not affect receptor mobility. In contrast, stimulation with dopamine decreased the mobility of the D-2 receptor. When coexpressed in the same cell, the A(2A) receptor precluded the agonist-induced change in D-2 receptor mobility. Thus, the A(2A) receptor did not only undergo restricted collision coupling, but it also restricted the mobility of the D-2 receptor. Restricted mobility was not due to tethering to the actin cytoskeleton but was, in part, related to the cholesterol content of the membrane. Depletion of cholesterol increased receptor mobility but blunted activation of adenylyl cyclase, which was accounted for by impaired formation of the ternary complex of agonist, receptor, and G protein. These observations support the conclusion that the A(2A) receptor engages G(s) and thus signals to adenylyl cyclase in cholesterol-rich domains of the membrane. In contrast, stimulation of MAPK by the A(2A) receptor was not impaired. These findings are consistent with a model where the recruitment of these two pathways occurs in physically segregated membrane microdomains. Thus, the A(2A) receptor is the first example of a G protein-coupled receptor documented to select signaling pathways in a manner dependent on the lipid microenvironment of the membrane.	[Charalambous, Christoforos; Gsandtner, Ingrid; Keuerleber, Simon; Milan-Lobo, Laura; Kudlacek, Oliver; Freissmuth, Michael; Zezula, Juergen] Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria	Medical University of Vienna	Freissmuth, M (corresponding author), Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, Wahringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at		Kudlacek, Oliver/0000-0002-3086-8551; Freissmuth, Michael/0000-0001-9398-1765				Babiychuk EB, 2006, BIOCHEM J, V397, P407, DOI 10.1042/BJ20060056; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; BRAUN S, 1979, BIOCHEMISTRY-US, V18, P2134, DOI 10.1021/bi00577a045; BRAUN S, 1979, MOL PHARMACOL, V16, P737; Burgueno J, 2003, J BIOL CHEM, V278, P37545, DOI 10.1074/jbc.M302809200; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; FERRE S, 1991, P NATL ACAD SCI USA, V88, P7238, DOI 10.1073/pnas.88.16.7238; Fuxe K, 2005, J MOL NEUROSCI, V26, P209, DOI 10.1385/JMN:26:2-3:209; Gimpl G, 2000, EUR J BIOCHEM, V267, P2483, DOI 10.1046/j.1432-1327.2000.01280.x; GROSS W, 1991, MOL PHARMACOL, V39, P524; Gsandtner I, 2005, J BIOL CHEM, V280, P31898, DOI 10.1074/jbc.M506515200; Gsandtner I, 2006, MOL PHARMACOL, V70, P447, DOI 10.1124/mol.106.026757; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hering H, 2003, J NEUROSCI, V23, P3262; Hernandez-Deviez DJ, 2002, NAT NEUROSCI, V5, P623, DOI 10.1038/nn865; INOKUCHI JI, 1987, J LIPID RES, V28, P565; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kleuss C, 2003, EMBO J, V22, P826, DOI 10.1093/emboj/cdg095; Klinger M, 2002, J BIOL CHEM, V277, P32490, DOI 10.1074/jbc.M200556200; Klinger M, 2002, N-S ARCH PHARMACOL, V366, P287, DOI 10.1007/s00210-002-0617-z; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Kudlacek O, 2003, NEUROPSYCHOPHARMACOL, V28, P1317, DOI 10.1038/sj.npp.1300181; Kudlacek O, 2001, J BIOL CHEM, V276, P3010, DOI 10.1074/jbc.M007910200; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Lissandron V, 2005, J MOL BIOL, V354, P546, DOI 10.1016/j.jmb.2005.09.089; LOHSE MJ, 1991, MOL PHARMACOL, V39, P517; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; NANOFF C, 1993, J RECEPTOR RES, V13, P961, DOI 10.3109/10799899309073703; NANOFF C, 1991, MOL PHARMACOL, V39, P130; Navratil AM, 2003, J BIOL CHEM, V278, P31593, DOI 10.1074/jbc.M304273200; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; ROSENWALD AG, 1992, BIOCHEMISTRY-US, V31, P3581, DOI 10.1021/bi00129a005; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Seidel MG, 1999, J BIOL CHEM, V274, P25833, DOI 10.1074/jbc.274.36.25833; Sexl V, 1997, J BIOL CHEM, V272, P5792, DOI 10.1074/jbc.272.9.5792; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3811, DOI 10.1021/bi00611a021; Waldhoer M, 1999, J BIOL CHEM, V274, P30571, DOI 10.1074/jbc.274.43.30571; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	47	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9276	9288		10.1074/jbc.M706275200	http://dx.doi.org/10.1074/jbc.M706275200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18218631	hybrid			2022-12-27	WOS:000254465800058
J	Okuda, H; Sakuhana, C; Yamamoto, R; Mizukami, Y; Kawai, R; Sumita, Y; Koga, M; Shirai, M; Matsuda, K				Okuda, Hiroshi; Sakuhana, Chihaya; Yamamoto, Risa; Mizukami, Yuko; Kawai, Rika; Sumita, Yusuke; Koga, Motoki; Shirai, Mutsunori; Matsuda, Kazuhiko			The intermediate domain defines broad nucleotide selectivity for protein folding in Chlamydophila GroEL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONIN GROEL; ALLOSTERIC TRANSITIONS; CHLAMYDIA-PNEUMONIAE; ESCHERICHIA-COLI; IN-VITRO; ATP; RELEASE; ADP; ATHEROSCLEROSIS; RECONSTITUTION	The chaperonin GroEL assists protein folding in the presence of ATP and magnesium through substrate protein capsulation in combination with the cofactor GroES. Recent studies have revealed the details of folding cycles of GroEL from Escherichia coli, yet little is known about the GroEL-assisted protein folding mechanisms in other bacterial species. Using three model enzyme assays, we have found that GroEL1 from Chlamydophila pneumoniae, an obligate human pathogen, has a broader selectivity for nucleotides in the refolding reaction. To elucidate structural factors involved in such nucleotide selectivity, GroEL chimeras were constructed by exchanging apical, intermediate, and equatorial domains between E. coli GroEL and C. pneumoniae GroEL1. In vitro folding assays using chimeras revealed that the intermediate domain is the major contributor to the nucleotide selectivity of C. pneumoniae GroEL1. Additional site-directed mutation experiments led to the identification of Gln(400) and Ile(404) in the intermediate domain of C. pneumoniae GroEL1 as residues that play a key role in defining the nucleotide selectivity of the protein refolding reaction.	[Okuda, Hiroshi; Sakuhana, Chihaya; Yamamoto, Risa; Mizukami, Yuko; Kawai, Rika; Sumita, Yusuke; Koga, Motoki; Matsuda, Kazuhiko] Kinki Univ, Sch Agr, Dept Appl Biol Chem, Nara 6318505, Japan; [Shirai, Mutsunori] Yamaguchi Univ, Sch Med, Dept Microbiol, Ube, Yamaguchi 7558505, Japan	Kindai University (Kinki University); Yamaguchi University	Matsuda, K (corresponding author), Kinki Univ, Sch Agr, Dept Appl Biol Chem, 3327-204 Nakamachi, Nara 6318505, Japan.	kmatsuda@nara.kindai.ac.jp	Matsuda, Kazuhiko/AAX-4926-2020	Okuda, Hiroshi/0000-0002-5747-8086				BADCOE IG, 1991, BIOCHEMISTRY-US, V30, P9195, DOI 10.1021/bi00102a010; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; Chapman E, 2006, P NATL ACAD SCI USA, V103, P15800, DOI 10.1073/pnas.0607534103; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Goyal K, 2006, J MOL EVOL, V63, P781, DOI 10.1007/s00239-006-0037-7; GRAYSTON JT, 1989, INT J SYST BACTERIOL, V39, P88, DOI 10.1099/00207713-39-1-88; HAYERHARTL MK, 1995, SCIENCE, V269, P836, DOI 10.1126/science.7638601; HOLLNEUGEBAUER B, 1991, BIOCHEMISTRY-US, V30, P11609; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Huang YS, 1999, J BIOL CHEM, V274, P10405, DOI 10.1074/jbc.274.15.10405; Hyeon C, 2006, P NATL ACAD SCI USA, V103, P18939, DOI 10.1073/pnas.0608759103; Karunakaran KP, 2003, J BACTERIOL, V185, P1958, DOI 10.1128/JB.185.6.1958-1966.2003; KAWATA Y, 1994, FEBS LETT, V345, P229, DOI 10.1016/0014-5793(94)00456-0; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kipnis Y, 2007, P NATL ACAD SCI USA, V104, P3119, DOI 10.1073/pnas.0700070104; KUBO T, 1993, J BIOL CHEM, V268, P19346; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MIZOBATA T, 1992, J BIOL CHEM, V267, P17773; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Okuda H, 2007, BIOMETALS, V20, P903, DOI 10.1007/s10534-006-9078-z; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Stan G, 2007, P NATL ACAD SCI USA, V104, P8803, DOI 10.1073/pnas.0700607104; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zheng WJ, 2006, P NATL ACAD SCI USA, V103, P7664, DOI 10.1073/pnas.0510426103	33	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9300	9307		10.1074/jbc.M710057200	http://dx.doi.org/10.1074/jbc.M710057200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18230606	hybrid			2022-12-27	WOS:000254465800060
J	LaRochelle, O; Labbe, S; Harrisson, JF; Simard, C; Tremblay, V; St-Gelais, G; Govindan, MV; Seguin, C				LaRochelle, Olivier; Labbe, Simon; Harrisson, Jean-Francois; Simard, Carl; Tremblay, Veronique; St-Gelais, Genevieve; Govindan, Manjapra V.; Seguin, Carl			Nuclear factor-1 and metal transcription factor-1 synergistically activate the mouse metallothionein-1 gene in response to metal ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT-HOMOLOGOUS SEQUENCES; REGULATORY ELEMENTS; FACTOR MTF-1; ENCODING METALLOTHIONEIN; BINDING PROTEINS; PROMOTER; EXPRESSION; ZINC; FAMILY; VIVO	Metal activation of metallothionein (MT) gene transcription is dependent on the presence of metal regulatory elements (MREs), which are present in five non-identical copies (MREa through MREe) in the promoter of the mouse MT-1 gene and on the capacity of metal transcription factor-1 (MTF-1) to bind to the MREs in the presence of zinc. We detected a protein, distinct from MTF-1, specifically binding to the MREc region. DNA binding competition experiments using synthetic oligonucleotides and specific anti-NF1 antibodies showed that this protein binds to an NF1 site overlapping the MREc element as well as to a second site upstream of the Sp1a site and corresponds to NF1 or a related protein. Transfection experiments showed that loss of the two NF1 sites decreased metal-induced MT promoter activity by 55-70% in transiently transfected cells and almost completely abrogated metal and tert-butylhydroquinone (tBHQ) induction in stably transfected cells. Similarly, expression of an inactive NF1 protein strongly inhibited MT-1 promoter activity. Using synthetic promoters containing NF1 and MRE sites fused to a minimal MT promoter, we showed that these NF1 sites did not confer metal induction but enhanced metal-induced promoter activity. Chromatin immunoprecipitation assays confirmed that NF1 binds to the mouse MT-1 promoter in vivo and showed that NF1 binding is zinc- inducible. In addition, zinc- induced NF1 DNA binding was MTF-1-dependent. Taken together, these studies show that NF1 acts synergistically with MTF-1 to activate the mouse MT-1 promoter in response to metal ions and tert-butylhydroquinone and contributes to maximal activation of the gene.	[Seguin, Carl] Univ Laval, CHUQ, Hotel Dieu Quebec, Ctr Rech Cancerol, Quebec City, PQ G1R 2J6, Canada; Univ Laval, Fac Med, Dept Anat & Physiol, Ste Foy, PQ G1K 7P4, Canada	Laval University; Laval University	Seguin, C (corresponding author), Univ Laval, CHUQ, Hotel Dieu Quebec, Ctr Rech Cancerol, 11 Cote Palais, Quebec City, PQ G1R 2J6, Canada.	carl.seguin@crhdq.ulaval.ca		Labbe, Simon/0000-0002-4947-523X				Adilakshmi T, 2002, J BIOL CHEM, V277, P4147, DOI 10.1074/jbc.M109785200; Andrews GK, 2001, EMBO J, V20, P1114, DOI 10.1093/emboj/20.5.1114; Aniskovitch LP, 1997, ARCH BIOCHEM BIOPHYS, V341, P337, DOI 10.1006/abbi.1997.9976; Aniskovitch LP, 1998, ONCOGENE, V16, P1475, DOI 10.1038/sj.onc.1201659; APARICIO O, 2005, CURRENT PROTOCOLS MO; Bi YY, 2004, BIOCHEM J, V380, P695, DOI 10.1042/BJ20031677; Blomquist P, 1996, J BIOL CHEM, V271, P153, DOI 10.1074/jbc.271.1.153; Candeliere GA, 1996, MOL CELL BIOL, V16, P584; CARTER AD, 1984, P NATL ACAD SCI-BIOL, V81, P7392, DOI 10.1073/pnas.81.23.7392; CARTHEW RW, 1987, GENE DEV, V1, P973, DOI 10.1101/gad.1.9.973; Chen XH, 1999, BIOCHEMISTRY-US, V38, P12915, DOI 10.1021/bi9913000; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; CULOTTA VC, 1989, MOL CELL BIOL, V9, P1376, DOI 10.1128/MCB.9.3.1376; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; Daniels PJ, 2003, NUCLEIC ACIDS RES, V31, P6710, DOI 10.1093/nar/gkg913; Datta PK, 1997, BIOCHEM BIOPH RES CO, V230, P159, DOI 10.1006/bbrc.1996.5655; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; Faraonio R, 2000, EUR J BIOCHEM, V267, P1743, DOI 10.1046/j.1432-1327.2000.01167.x; Ghoshal K, 2002, MOL CELL BIOL, V22, P8302, DOI 10.1128/MCB.22.23.8302-8319.2002; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Hung CF, 1999, MOL ENDOCRINOL, V13, P1704, DOI 10.1210/me.13.10.1704; Jacob ST, 2002, ENVIRON HEALTH PERSP, V110, P827, DOI 10.1289/ehp.02110s5827; LABBE S, 1993, NUCLEIC ACIDS RES, V21, P1549, DOI 10.1093/nar/21.7.1549; LABBE S, 1991, NUCLEIC ACIDS RES, V19, P4225, DOI 10.1093/nar/19.15.4225; Laity JH, 2007, ARCH BIOCHEM BIOPHYS, V463, P201, DOI 10.1016/j.abb.2007.03.019; LaRochelle O, 2001, J BIOL CHEM, V276, P41879, DOI 10.1074/jbc.M108313200; LaRochelle O, 2001, BIOCHEM J, V353, P591, DOI 10.1042/0264-6021:3530591; Li QW, 1998, NUCLEIC ACIDS RES, V26, P5182, DOI 10.1093/nar/26.22.5182; MACARTHUR CA, 1987, J BIOL CHEM, V262, P2161; Majumder S, 2001, GENE EXPRESSION, V9, P203, DOI 10.3727/000000001783992588; Marr MT, 2006, GENE DEV, V20, P1458, DOI 10.1101/gad.1418806; MARTINEZ E, 1991, MOL CELL BIOL, V11, P2937, DOI 10.1128/MCB.11.6.2937; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; Moffatt P, 1998, DNA CELL BIOL, V17, P501, DOI 10.1089/dna.1998.17.501; MUELLER PR, 1988, GENE DEV, V2, P412, DOI 10.1101/gad.2.4.412; Murphy BJ, 1999, CANCER RES, V59, P1315; OIKARINEN J, 1987, J BIOL CHEM, V262, P11064; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; PALMITER RD, 1992, P NATL ACAD SCI USA, V89, P6333, DOI 10.1073/pnas.89.14.6333; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; POUYSSEGUR J, 1999, METHODS MOL MED VASC, P315; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; RADTKE F, 1995, NUCLEIC ACIDS RES, V23, P2277, DOI 10.1093/nar/23.12.2277; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SEARLE PF, 1985, MOL CELL BIOL, V5, P1480, DOI 10.1128/MCB.5.6.1480; SEGUIN C, 1988, NUCLEIC ACIDS RES, V16, P10547, DOI 10.1093/nar/16.22.10547; SENEAR AW, 1982, COLD SPRING HARB SYM, V47, P539; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; STUART GW, 1984, P NATL ACAD SCI-BIOL, V81, P7318, DOI 10.1073/pnas.81.23.7318; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Sutter NB, 2003, P NATL ACAD SCI USA, V100, P1105, DOI 10.1073/pnas.242732999; THOMASSIN H, 1992, NUCLEIC ACIDS RES, V20, P3091, DOI 10.1093/nar/20.12.3091; Wang Y, 2004, BIOL CHEM, V385, P623, DOI 10.1515/BC.2004.077; WESTIN G, 1988, EMBO J, V7, P3763, DOI 10.1002/j.1460-2075.1988.tb03260.x; WU L, 1992, P NATL ACAD SCI USA, V89, P4811, DOI 10.1073/pnas.89.11.4811; Yin H, 2005, PROSTATE, V62, P209, DOI 10.1002/pros.20136	61	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8190	8201		10.1074/jbc.M800640200	http://dx.doi.org/10.1074/jbc.M800640200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18230604	hybrid			2022-12-27	WOS:000254288000016
J	Badarau, A; Shi, Q; Chow, JW; Zajicek, J; Mobashery, S; Vakulenko, S				Badarau, Adriana; Shi, Qicun; Chow, Joseph W.; Zajicek, Jaroslav; Mobashery, Shahriar; Vakulenko, Sergei			Aminoglycoside 2 ''-phosphotransferase type IIIa from Enterococcus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBIOTIC KINASE APH(3')-IIIA; THEORELL-CHANCE MECHANISM; KINETIC MECHANISM; STAPHYLOCOCCUS-AUREUS; CATALYTIC MECHANISM; ESCHERICHIA-COLI; RESISTANCE; PHOSPHOTRANSFERASE; ACETYLTRANSFERASE; ENZYME	Aminoglycoside 2 ''-phosphotransferases mediate high level resistance to aminoglycoside antibiotics in Gram-positive microorganisms, thus posing a serious threat to the treatment of serious enterococcal infections. This work reports on cloning, purification, and detailed mechanistic characterization of aminoglycoside 2 ''-phosphotransferase, known as type Ic enzyme. In an unexpected finding, the enzyme exhibits strong preference for guanosine triphosphate over adenosine triphosphate as the phosphate donor, a unique observation among all characterized aminoglycoside phosphotransferases. The enzyme phosphorylates only certain 4,6-disubstituted aminoglycosides exclusively at the 2 ''-hydroxyl with k(cat) values of 0.5-1.0 s(-1) and K-m values in the nanomolar range for all substrates but kanamycin A. Based on this unique substrate profile, the enzyme is renamed aminoglycoside 2 ''-phosphotransferase type IIIa. Product and deadend inhibition patterns indicated a random sequential Bi Bi mechanism. Both the solvent viscosity effect and determination of the rate constant for dissociation of guanosine triphosphate indicated that at pH 7.5 the release of guanosine triphosphate is rate-limiting. A computational model for the enzyme is presented that sheds light on the structural aspects of interest in this family of enzymes.	[Badarau, Adriana; Shi, Qicun; Zajicek, Jaroslav; Mobashery, Shahriar; Vakulenko, Sergei] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Chow, Joseph W.] Merck Res Labs, Dept Infect Dis Clin Res, N Wales, PA 19454 USA	University of Notre Dame; Merck & Company	Vakulenko, S (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 417 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	svakulen@nd.edu	Chow, Joseph W/W-4164-2017	Chow, Joseph W/0000-0002-5934-5877	NIAID NIH HHS [R01 AI057393, R01 AI057393-03, AI 057393] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057393] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Azucena E, 1997, J AM CHEM SOC, V119, P2317, DOI 10.1021/ja964278w; BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013; Boehr DD, 2001, J BIOL CHEM, V276, P23929, DOI 10.1074/jbc.M100540200; CASE DA, 2004, AMBER, V8; Chen-Goodspeed M, 1999, BIOORG CHEM, V27, P395, DOI 10.1006/bioo.1999.1144; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; COLE PA, 1994, J BIOL CHEM, V269, P30880; Draker KA, 2003, BIOCHEMISTRY-US, V42, P6565, DOI 10.1021/bi034148h; Fromm H J, 1979, Methods Enzymol, V63, P467; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Jana S, 2005, BIOTECHNOL LETT, V27, P519, DOI 10.1007/s10529-005-2544-9; Kim C, 2005, BIOORG CHEM, V33, P149, DOI 10.1016/j.bioorg.2004.11.001; Kim C, 2004, BIOCHEMISTRY-US, V43, P2373, DOI 10.1021/bi036095+; Lee HK, 2002, ANTIMICROB AGENTS CH, V46, P3253, DOI 10.1128/AAC.46.10.3253-3256.2002; Leskovac V., 2003, COMPREHENSIVE ENZYME, P111; LIDE DR, 2004, HDB CHEM PHYS, P58; Magnet S, 2003, ANTIMICROB AGENTS CH, V47, P1577, DOI 10.1128/AAC.47.5.1577-1583.2003; Magnet S, 2001, BIOCHEMISTRY-US, V40, P3700, DOI 10.1021/bi002736e; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; MARTEL A, 1983, EUR J BIOCHEM, V133, P515, DOI 10.1111/j.1432-1033.1983.tb07494.x; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; MCKAY GA, 1995, J BIOL CHEM, V270, P24686, DOI 10.1074/jbc.270.42.24686; McKay GA, 1996, BIOCHEMISTRY-US, V35, P8680, DOI 10.1021/bi9603884; MENARD R, 1993, ANTIMICROB AGENTS CH, V37, P78, DOI 10.1128/AAC.37.1.78; Morrison J. F., 2001, ENCY LIFE SCI, P1; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SIREGAR JJ, 1995, BIOCHEMISTRY-US, V34, P12681, DOI 10.1021/bi00039a026; SIREGAR JJ, 1994, ANTIMICROB AGENTS CH, V38, P641, DOI 10.1128/AAC.38.4.641; Thompson PR, 2002, BIOCHEMISTRY-US, V41, P7001, DOI 10.1021/bi0256680; Toth M, 2007, BIOCHEMISTRY-US, V46, P5570, DOI 10.1021/bi6024512; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003	35	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7638	7647		10.1074/jbc.M709645200	http://dx.doi.org/10.1074/jbc.M709645200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18199745	hybrid			2022-12-27	WOS:000253997900039
J	Heller, WP; Hayes, ML; Hanson, MR				Heller, Wade P.; Hayes, Michael L.; Hanson, Maureen R.			Cross-competition in editing of chloroplast RNA transcripts in vitro implicates sharing of trans-factors between different C targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; PSBL MESSENGER-RNA; ARABIDOPSIS-THALIANA; MITOCHONDRIAL GENOME; PEA-CHLOROPLASTS; INITIATION CODON; TOBACCO; SEQUENCE; SITES; ELEMENTS	C -> U plant organellar RNA editing is required for the translation of evolutionarily conserved and functional proteins. 28 different C targets of RNA editing have been identified in maize chloroplasts, and hundreds of Cs are edited in mitochondria. Mutant analysis in Arabidopsis has indicated that absence of a single site-specific recognition protein can result in loss of editing of a single C target, raising the possibility that each C target requires a recognition protein. Here we show that transcripts encompassing two editing sites, ZMrpoB C467 and ZMrps14 C80, can compete editing activity from each other in vitro despite limited sequence similarity. The signal causing competition overlaps a 5'-cis element required for editing efficiency. A single five-nucleotide mutation spanning the region from -20 to -16 relative to the edited C of rpoB C467 is sufficient to eliminate its substrate editing as well as its ability to compete editing activity from rps14 C80 substrates. A corresponding mutation in an rps14 C80 competitor likewise eliminated its ability to compete editing activity from rpoB C467 substrates. Taken together, our results indicate that the RNA sequences mediating both editing efficiency and cross-competition are highly similar and that a common protein is involved in their editing. Sharing of trans-factors can facilitate editing of the large number of different C targets in plant organelles so that a different protein factor would not be required for every editing site.	[Heller, Wade P.; Hayes, Michael L.; Hanson, Maureen R.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Hanson, MR (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Biotech Bldg, Ithaca, NY 14853 USA.	mrh5@cornell.edu	Hanson, Maureen R/D-3879-2009	Hanson, Maureen R/0000-0001-8141-3058; Heller, Wade/0000-0002-5964-9715				BARKAN A, 1994, EMBO J, V13, P3170, DOI 10.1002/j.1460-2075.1994.tb06616.x; BOCK R, 1994, EMBO J, V13, P4623, DOI 10.1002/j.1460-2075.1994.tb06784.x; Chateigner-Boutin AL, 2002, MOL CELL BIOL, V22, P8448, DOI 10.1128/MCB.22.24.8448-8456.2002; CHAUDHURI S, 1995, EMBO J, V14, P2951, DOI 10.1002/j.1460-2075.1995.tb07295.x; Corneille S, 2000, MOL GEN GENET, V264, P419, DOI 10.1007/s004380000295; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Hayes ML, 2007, RNA, V13, P281, DOI 10.1261/rna.295607; Hayes ML, 2006, NUCLEIC ACIDS RES, V34, P3742, DOI 10.1093/nar/gkl490; Hegeman CE, 2005, PLANT J, V42, P124, DOI 10.1111/j.1365-313X.2005.02360.x; Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144; HOCH B, 1991, NATURE, V353, P178, DOI 10.1038/353178a0; Inada M, 2004, PLANT CELL PHYSIOL, V45, P1615, DOI 10.1093/pcp/pch191; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; KUDLA J, 1992, EMBO J, V11, P1099, DOI 10.1002/j.1460-2075.1992.tb05149.x; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Miyamoto T, 2004, P NATL ACAD SCI USA, V101, P48, DOI 10.1073/pnas.0307163101; Miyamoto T, 2002, MOL CELL BIOL, V22, P6726, DOI 10.1128/MCB.22.19.6726-6734.2002; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Reed ML, 2001, GENE, V272, P165, DOI 10.1016/S0378-1119(01)00545-5; Reed ML, 2001, NUCLEIC ACIDS RES, V29, P1507, DOI 10.1093/nar/29.7.1507; Sasaki Y, 2001, J BIOL CHEM, V276, P3937, DOI 10.1074/jbc.M008166200; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; Tillich M, 2005, PLANT J, V43, P708, DOI 10.1111/j.1365-313X.2005.02484.x; Tillich M, 2001, MAIZE GENET COOP NEW, V75, P42; Tsudzuki T, 2001, J MOL EVOL, V53, P327, DOI 10.1007/s002390010222; Zito F, 1997, PLANT MOL BIOL, V33, P79, DOI 10.1023/A:1005734809834	30	21	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7314	7319		10.1074/jbc.M709595200	http://dx.doi.org/10.1074/jbc.M709595200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18192271	hybrid, Green Published			2022-12-27	WOS:000253997900004
J	Spohr, TCDSE; Choi, JW; Gardell, SE; Herr, DR; Rehen, SK; Gomes, FCA; Chun, J				Spohr, Tania Cristina de Sampaio E.; Choi, Ji Woong; Gardell, Shannon E.; Herr, Deron R.; Rehen, Stevens Kastrup; Gomes, Flavia Carvalho Alcantara; Chun, Jerold			Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE; RADIAL GLIA; LYSOPHOSPHOLIPID RECEPTORS; SIGNALING DEFICITS; CORTICAL-NEURONS; CEREBRAL-CORTEX; SOLUBLE FACTORS; RAT ASTROCYTES; PROTEIN KINASE; GENE PROMOTER	Lysophosphatidic acid ( LPA) is a simple phospholipid derived from cell membranes that has extracellular signaling properties mediated by at least five G protein-coupled receptors referred to as LPA(1)-LPA(5). In the nervous system, receptor-mediated LPA signaling has been demonstrated to influence a range of cellular processes; however, an unaddressed aspect of LPA signaling is its potential to produce specific secondary effects, whereby LPA receptor-expressing cells exposed to, or "primed," by LPA may then act on other cells via distinct, yet LPA-initiated, mechanisms. In the present study, we examined cerebral cortical astrocytes as possible indirect mediators of the effects of LPA on developing cortical neurons. Cultured astrocytes express at least four LPA receptor subtypes, known as LPA1-LPA4. Cerebral cortical astrocytes primed by LPA exposure were found to increase neuronal differentiation of cortical progenitor cells. Treatment of unprimed astrocyte-progenitor cocultures with conditioned medium derived from LPA-primed astrocytes yielded similar results, suggesting the involvement of an astrocyte-derived soluble factor induced by LPA. At least two LPA receptor subtypes are involved in LPA priming, since the priming effect was lost in astrocytes derived from LPA receptor double-null mice( LPA(1)((-/-))/ LPA(2)((-/-))). Moreover, the loss of LPA-dependent differentiation in receptor double-null astrocytes could be rescued by retrovirally transduced expression of a single deleted receptor. These data demonstrate that receptor-mediated LPA signaling in astrocytes can induce LPA-dependent, indirect effects on neuronal differentiation.	[Choi, Ji Woong; Gardell, Shannon E.; Herr, Deron R.; Chun, Jerold] Scripps Res Inst, Dept Mol Biol, Helen L Dorris Child Adolescent Neuropsuchiat Dis, La Jolla, CA 92037 USA; [Spohr, Tania Cristina de Sampaio E.; Rehen, Stevens Kastrup; Gomes, Flavia Carvalho Alcantara] Univ Fed Rio de Janeiro, Dept Anat, Inst Ciencias Biomed, BR-21949590 Rio De Janeiro, RJ, Brazil	Scripps Research Institute; Universidade Federal do Rio de Janeiro	Chun, J (corresponding author), Scripps Res Inst, Dept Mol Biol, Helen L Dorris Child Adolescent Neuropsuchiat Dis, ICND 118,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	fgomes@anato.ufrj.br; jchun@scripps.edu	Rehen, Stevens/J-5874-2012; Spohr, Tania/I-4299-2015; Herr, Deron/AAB-7380-2020; Neurociencia, Inct/I-1011-2013; Chun, Jerold/Y-4670-2019; Gomes, Flavia/AAX-6354-2021; Gomes, Flavia/C-5383-2013	Rehen, Stevens/0000-0003-4216-9501; Spohr, Tania/0000-0001-8691-5962; Herr, Deron/0000-0001-5755-0896; Gomes, Flavia/0000-0003-2966-0638	NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051699, R01MH051699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048478] Funding Source: NIH RePORTER; NIMH NIH HHS [MH051699] Funding Source: Medline; NINDS NIH HHS [NS048478] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chun J, 2006, CURR PHARM DESIGN, V12, P161, DOI 10.2174/138161206775193109; Chun J, 1996, MOL CELL NEUROSCI, V7, P304, DOI 10.1006/mcne.1996.0023; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; De Sampaio E., 2002, EUR J NEUROSCI, V16, P2059, DOI [10.1046/j.1460-9568.2002.02283.x, DOI 10.1046/J.1460-9568.2002.02283.X]; ESTIVILLTORRUS G, 2008, IN PRESS CEREBRAL CO; Freire E, 2004, J CELL SCI, V117, P4067, DOI 10.1242/jcs.01276; Fukushima N, 2000, DEV BIOL, V228, P6, DOI 10.1006/dbio.2000.9930; Fukushima N, 2002, MOL CELL NEUROSCI, V20, P271, DOI 10.1006/mcne.2002.1123; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Fukushima N, 2007, NEUROCHEM INT, V50, P302, DOI 10.1016/j.neuint.2006.09.008; Garcia-Segura LM, 1999, J NEUROBIOL, V40, P574, DOI 10.1002/(SICI)1097-4695(19990915)40:4<574::AID-NEU12>3.0.CO;2-8; GARCIAABREU J, 1995, J NEUROSCI RES, V40, P471, DOI 10.1002/jnr.490400406; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Gomes FCA, 1999, GLIA, V26, P97; Gomes FCA, 2001, BRAZ J MED BIOL RES, V34, P611, DOI 10.1590/S0100-879X2001000500008; Gomes FCA, 1999, GLIA, V25, P247, DOI 10.1002/(SICI)1098-1136(19990201)25:3<247::AID-GLIA5>3.0.CO;2-2; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P1170, DOI 10.1016/j.mcn.2003.09.001; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Keller JN, 1997, J NEUROCHEM, V69, P1073; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Kornyei Z, 2007, FASEB J, V21, P2496, DOI 10.1096/fj.06-7756com; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Martinez R, 2005, J NEUROSCI RES, V80, P341, DOI 10.1002/jnr.20463; Martinez R, 2002, J BIOL CHEM, V277, P49311, DOI 10.1074/jbc.M209284200; Moller T, 2001, J BIOL CHEM, V276, P25946, DOI 10.1074/jbc.M102691200; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Patten BA, 2006, J NEUROSCI, V26, P3102, DOI 10.1523/JNEUROSCI.4829-05.2006; Rao TS, 2003, BRAIN RES, V990, P182, DOI 10.1016/S0006-8993(03)03527-3; Rouach N, 2006, EUR J NEUROSCI, V23, P1453, DOI 10.1111/j.1460-9568.2006.04671.x; Sato K, 2005, J NEUROCHEM, V92, P904, DOI 10.1111/j.1471-4159.2004.02933.x; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Sousa VD, 2004, EUR J NEUROSCI, V19, P1721, DOI 10.1111/j.1460.9568.2004.03249.x; Steiner MR, 2002, BBA-MOL CELL BIOL L, V1582, P154, DOI 10.1016/S1388-1981(02)00150-6; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Svetlov SI, 2004, STEM CELLS DEV, V13, P685, DOI 10.1089/scd.2004.13.685; Tabuchi S, 2000, NEUROCHEM RES, V25, P573, DOI 10.1023/A:1007542532395; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tomas M, 2003, J NEUROCHEM, V87, P220, DOI 10.1046/j.1471-4159.2003.01993.x; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Weiner JA, 1998, J COMP NEUROL, V398, P587; Weiner JA, 1999, P NATL ACAD SCI USA, V96, P5233, DOI 10.1073/pnas.96.9.5233; Ye XQ, 2002, NEUROREPORT, V13, P2169, DOI 10.1097/00001756-200212030-00002; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	61	65	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7470	7479		10.1074/jbc.M707758200	http://dx.doi.org/10.1074/jbc.M707758200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18198181	Green Published, hybrid			2022-12-27	WOS:000253997900022
J	Stork, R; Zettlitz, KA; Muller, D; Rether, M; Hanisch, FG; Kontermann, RE				Stork, Roland; Zettlitz, Kirstin A.; Mueller, Dafne; Rether, Miriam; Hanisch, Franz-Georg; Kontermann, Roland E.			N-glycosylation as novel strategy to improve pharmacokinetic properties of bispecific single-chain diabodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; ALBUMIN-BINDING FAB; HUMAN SERUM-ALBUMIN; THERAPEUTIC PROTEINS; STRUCTURAL-CHARACTERIZATION; ANTIBODY MOLECULES; HUMAN RECOMBINANT; FUSION PROTEIN; HEPATITIS-C; CELL-LINE	The therapeutic efficacy of recombinant antibodies such as single-chain Fv fragments and small bispecific or bifunctional molecules is often limited by rapid elimination from the circulation because of their small size. Here, we have investigated the effects of N-glycosylation on the activity and pharmacokinetics of a small bispecific single-chain diabody (scDb CEACD3) developed for the retargeting of cytotoxic T cells to CEA-expressing tumor cells. We could show that the introduction of N-glycosylation sequons into the flanking linker and a C-terminal extension results in the production of N-glycosylated molecules after expression in transfected HEK293 cells. N-Glycosylated scDb variants possessing 3, 6, or 9 N-glycosylation sites, respectively, retained antigen binding activity and bispecificity for target and effector cells as shown in a target cell-dependent IL-2 release assay, although activity was reduced similar to 3-5-fold compared with the unmodified scDb. All N-glycosylated scDb variants exhibited a prolonged circulation time compared with scDb, leading to a 2-3-fold increase of the area under curve (AUC). In comparison, conjugation of a branched 40-kDa PEG chain increased AUC by a factor of 10.6, while a chimeric anti-CEA IgG1 molecule had the longest circulation time with a 17-fold increase in AUC. Thus, N-glycosylation complements the repertoire of strategies to modulate pharmacokinetics of small recombinant antibody molecules by an approach that moderately prolongs circulation time.	[Stork, Roland; Zettlitz, Kirstin A.; Mueller, Dafne; Rether, Miriam; Kontermann, Roland E.] Univ Stuttgart, Inst Zellbiol & Immunol, D-70569 Stuttgart, Germany; [Hanisch, Franz-Georg] Univ Cologne, Zentrum Mol Med Koln, Fak Med, Inst Biochem 2, D-50931 Cologne, Germany	University of Stuttgart; University of Cologne	Stork, R (corresponding author), Univ Stuttgart, Inst Zellbiol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.	roland.kontermann@izi.uni-stuttgart.de	Kontermann, Roland E./F-9263-2014; Zettlitz, Kirstin/AAC-1015-2022	Zettlitz, Kirstin/0000-0003-4870-6603; Mueller, Dafne/0000-0002-1544-3475				Bailon P, 2001, BIOCONJUGATE CHEM, V12, P195, DOI 10.1021/bc000082g; Bain VG, 2006, J HEPATOL, V44, P671, DOI 10.1016/j.jhep.2005.12.011; Baker KN, 2001, BIOTECHNOL BIOENG, V73, P188, DOI 10.1002/bit.1051; Bragonzi A, 2000, BBA-GEN SUBJECTS, V1474, P273, DOI 10.1016/S0304-4165(00)00023-4; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; CHESTER KA, 1994, LANCET, V343, P455, DOI 10.1016/S0140-6736(94)92695-6; Chuang VTG, 2002, PHARMACEUT RES, V19, P569; Cohen O, 2004, BIOCHEM J, V378, P117, DOI 10.1042/BJ20031305; Dennis MS, 2007, CANCER RES, V67, P254, DOI 10.1158/0008-5472.CAN-06-2531; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Engelmann K, 2005, GLYCOBIOLOGY, V15, P1111, DOI 10.1093/glycob/cwi099; Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499; Groulet A, 2002, INT J CANCER, V100, P367, DOI 10.1002/ijc.10477; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; HOVGAARD D, 1993, EUR J HAEMATOL, V50, P32; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jefferis R, 2005, ADV EXP MED BIOL, V564, P143; Kaufmann B, 2004, GLYCOBIOLOGY, V14, P609, DOI 10.1093/glycob/cwh063; KAWATSU M, 1990, J PHARMACOBIO-DYNAM, V13, P549, DOI 10.1248/bpb1978.13.549; Kubetzko S, 2005, MOL PHARMACOL, V68, P1439, DOI 10.1124/mol.105.014910; Kubetzko S, 2006, J BIOL CHEM, V281, P35186, DOI 10.1074/jbc.M604127200; Lencer WI, 2005, TRENDS CELL BIOL, V15, P5, DOI 10.1016/j.tcb.2004.11.004; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Mahmood I, 2005, CLIN PHARMACOKINET, V44, P331, DOI 10.2165/00003088-200544040-00001; Muller D, 2007, J BIOL CHEM, V282, P12650, DOI 10.1074/jbc.M700820200; Natarajan A, 2005, BIOCONJUGATE CHEM, V16, P113, DOI 10.1021/bc0498121; Nguyen A, 2006, PROTEIN ENG DES SEL, V19, P291, DOI 10.1093/protein/gzl011; Ni HY, 2000, THROMB RES, V99, P407, DOI 10.1016/S0049-3848(00)00263-2; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Perlman S, 2003, J CLIN ENDOCR METAB, V88, P3227, DOI 10.1210/jc.2002-021201; SARENEVA T, 1993, J INTERFERON RES, V13, P267, DOI 10.1089/jir.1993.13.267; Schlereth B, 2005, CANCER RES, V65, P2882, DOI 10.1158/0008-5472.CAN-04-2637; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Stork R, 2007, PROTEIN ENG DES SEL, V20, P569, DOI 10.1093/protein/gzm061; TERNANT D, 2005, EXP OPIN BIOL THE S1, V5, P537; Wang ML, 1998, PROTEIN ENG, V11, P1277, DOI 10.1093/protein/11.12.1277; Weenen C, 2004, J CLIN ENDOCR METAB, V89, P5204, DOI 10.1210/jc.2004-0425; Werner RG, 2007, ACTA PAEDIATR, V96, P17, DOI 10.1111/j.1651-2227.2007.00199.x; Wuttke M, 2001, J BIOL CHEM, V276, P36839, DOI 10.1074/jbc.M105689200	43	69	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7804	7812		10.1074/jbc.M709179200	http://dx.doi.org/10.1074/jbc.M709179200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18211902	hybrid			2022-12-27	WOS:000253997900056
J	Truscott, SM; Wang, X; Lybarger, L; Biddison, WE; McBerry, C; Martinko, JM; Connolly, JM; Linette, GP; Fremont, DH; Hansen, TH; Carreno, BM				Truscott, Steven M.; Wang, Xiaoli; Lybarger, Lonnie; Biddison, William E.; McBerry, Cortez; Martinko, John M.; Connolly, Janet M.; Linette, Gerald P.; Fremont, Daved H.; Hansen, Ted H.; Carreno, Beatriz M.			Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOTOXIC T-LYMPHOCYTES; SINGLE-CHAIN TRIMERS; CELL-RECEPTOR; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; DNA VACCINES; EPITOPE; HLA-A2; RECOGNITION; HLA-B27	The ongoing discovery of disease-associated epitopes detected by CD8 T cells greatly facilitates peptide-based vaccine approaches and the construction of multimeric soluble recombinant proteins ( e. g. tetramers) for isolation and enumeration of antigen-specific CD8 T cells. Related to these outcomes of epitope discovery is the recent demonstration that MHC class I/peptide complexes can be expressed as single chain trimers ( SCTs) with peptide, beta(2)m and heavy chain connected by linkers to form a single polypeptide chain. Studies using clinically relevant mouse models of human disease have shown that SCTs expressed by DNA vaccination are potent stimulators of cytotoxic T lymphocytes. Their vaccine efficacy has been attributed to the fact that SCTs contain a preprocessed and preloaded peptide that is stably displayed on the cell surface. Although SCTs of HLA class I/ peptide complexes have been previously reported, they have not been characterized for biochemical stability or susceptibility to exogenous peptide binding. Here we demonstrate that human SCTs remain almost exclusively intact when expressed in cells and can incorporate a disulfide trap that dramatically excludes the binding of exogenous peptides. The mechanistic and practical applications of these findings for vaccine development and T cell isolation/ enumeration are discussed.	[Truscott, Steven M.; Wang, Xiaoli; Connolly, Janet M.; Fremont, Daved H.; Hansen, Ted H.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Truscott, Steven M.; Wang, Xiaoli; Connolly, Janet M.; Fremont, Daved H.; Hansen, Ted H.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA; [Linette, Gerald P.; Carreno, Beatriz M.] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Biddison, William E.] Natl Inst Hlth, NINDS, Mol Immunol Sect, Neuroimmunol Branch, Bethesda, MD 20892 USA; [Lybarger, Lonnie] Univ Arizona, Arizona Hlth Sci Ctr, Dept Cell Biol & Anat, Tucson, AZ 85724 USA; [McBerry, Cortez; Martinko, John M.] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Arizona; University of Arizona Health Sciences; Southern Illinois University System; Southern Illinois University	Hansen, TH (corresponding author), Washington Univ, Sch Med, Dept Pathol, Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	hansen@pathology.wustl.edu		Fremont, Daved/0000-0002-8544-2689	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055849, R56AI055849, U54AI057160, R01AI027568] Funding Source: NIH RePORTER; NIAID NIH HHS [AI055849, AI027568, U54-AI057160] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 2004, METHOD CELL BIOL, V75, P433; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Biddison WE, 2003, J IMMUNOL, V171, P3064, DOI 10.4049/jimmunol.171.6.3064; BRODSKY FM, 1979, IMMUNOL REV, V47, P3, DOI 10.1111/j.1600-065X.1979.tb00288.x; CARRENO BM, 1992, J IMMUNOL, V148, P894; CARRENO BM, 1990, P NATL ACAD SCI USA, V87, P3420, DOI 10.1073/pnas.87.9.3420; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Crew MD, 2005, MOL IMMUNOL, V42, P1205, DOI 10.1016/j.molimm.2004.11.013; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Ge Q, 2002, P NATL ACAD SCI USA, V99, P13729, DOI 10.1073/pnas.212515299; Granfors Kaisa, 2002, Arthritis Rheum, V46, P606, DOI 10.1002/art.10041; Greten TF, 2002, J IMMUNOL METHODS, V271, P125, DOI 10.1016/S0022-1759(02)00346-0; Hansen TH, 2006, CANCER IMMUNOL IMMUN, V55, P235, DOI 10.1007/s00262-005-0091-9; Harris MR, 2001, INT IMMUNOL, V13, P1275, DOI 10.1093/intimm/13.10.1275; Huang CH, 2005, GENE THER, V12, P1180, DOI 10.1038/sj.gt.3302519; HUET S, 1990, INT IMMUNOL, V2, P311, DOI 10.1093/intimm/2.4.311; Hung CF, 2007, VACCINE, V25, P127, DOI 10.1016/j.vaccine.2006.06.087; Jaramillo A, 2004, BREAST CANCER RES TR, V88, P29, DOI 10.1007/s10549-004-8918-1; KANNAGI M, 1992, J VIROL, V66, P2928, DOI 10.1128/JVI.66.5.2928-2933.1992; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; KAWAKAMI Y, 1995, J IMMUNOL, V154, P3961; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lauterbach H, 2006, J IMMUNOL, V176, P4600, DOI 10.4049/jimmunol.176.8.4600; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; LIE WR, 1991, J EXP MED, V173, P449, DOI 10.1084/jem.173.2.449; Linette GP, 2005, CLIN CANCER RES, V11, P7692, DOI 10.1158/1078-0432.CCR-05-1198; LURQUIN C, 1989, CELL, V58, P293, DOI 10.1016/0092-8674(89)90844-1; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; Mitaksov V, 2007, CHEM BIOL, V14, P909, DOI 10.1016/j.chembiol.2007.07.010; MORRISON J, 1992, EUR J IMMUNOL, V22, P903, DOI 10.1002/eji.1830220404; Myers NB, 2000, J IMMUNOL, V165, P5656, DOI 10.4049/jimmunol.165.10.5656; Oved K, 2005, CANCER IMMUNOL IMMUN, V54, P867, DOI 10.1007/s00262-005-0666-5; PARKER KC, 1994, J IMMUNOL, V152, P163; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Primeau T, 2005, IMMUNOL RES, V32, P109, DOI 10.1385/IR:32:1-3:109; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; REDDEHASE MJ, 1989, NATURE, V337, P651, DOI 10.1038/337651a0; Schott E, 2002, P NATL ACAD SCI USA, V99, P13735, DOI 10.1073/pnas.212515399; SMITH JD, 1993, J EXP MED, V178, P2035, DOI 10.1084/jem.178.6.2035; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; Stevenson FK, 2004, P NATL ACAD SCI USA, V101, P14646, DOI 10.1073/pnas.0404896101; TRUSCOTT SM, 2007, THESIS WASHINGTON U; Truscott SM, 2007, J IMMUNOL, V178, P6280, DOI 10.4049/jimmunol.178.10.6280; Utz U, 1996, J VIROL, V70, P843, DOI 10.1128/JVI.70.2.843-851.1996; Wang ZC, 2002, J IMMUNOL, V169, P3146, DOI 10.4049/jimmunol.169.6.3146; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Yu YYL, 1999, INT IMMUNOL, V11, P1897, DOI 10.1093/intimm/11.12.1897; Yu YYL, 2002, J IMMUNOL, V168, P3145, DOI 10.4049/jimmunol.168.7.3145; Zhang YX, 2007, IMMUNOLOGY, V121, P105, DOI 10.1111/j.1365-2567.2007.02543.x	56	16	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7480	7490		10.1074/jbc.M709935200	http://dx.doi.org/10.1074/jbc.M709935200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18195006	Green Published, hybrid			2022-12-27	WOS:000253997900023
J	Wang, PY; Weng, J; Lee, S; Anderson, RGW				Wang, Ping-Yuan; Weng, Jian; Lee, Sungsoo; Anderson, Richard G. W.			The N terminus controls sterol binding while the C terminus regulates the scaffolding function of OSBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; PLECKSTRIN HOMOLOGY DOMAIN; HAMSTER OVARY CELLS; GOLGI LOCALIZATION; LIGAND-BINDING; CHOLESTEROL; MEMBRANE; 25-HYDROXYCHOLESTEROL; PHOSPHORYLATION; SPECIFICITY	Previously we reported that when cell cholesterol is acutely lowered with beta-methyl-cyclodextrin the amount of activated ERK1/2 in caveolae dramatically increases. We traced the origin of this novel method of pERK1/2 accumulation to a macromolecular complex with dual specific phosphatase activity that contains the serine/threonine phosphatase PP2A, the tyrosine phosphatase HePTP, the oxysterol-binding protein OSBP and cholesterol. When cell cholesterol is lowered, or oxysterols is introduced, the complex disassembles and pERK1/2 increases. In an effort to better understand how OSBP functions as a cholesterol-regulated scaffolding protein, we have mapped the functional parts of the molecule. The command center of the molecule is a centrally located, 51 amino acids (408-459) long sterol-binding domain that can bind both cholesterol and 25-hydroxycholesterol. This domain is functional whether attached to the N- or the C-terminal half of OSBP. Introduction of a Y458S mutation impairs binding. Even though 25-hydroxycholesterol will compete for cholesterol binding to OSBP408-809, it will not compete for cholesterol binding in full-length OSBP. Upon further analysis we found that a glycine-alanine-rich region at the N- terminal end of OSBP works with the PH domain to control cholesterol binding without affecting 25-hydroxycholesterol binding. Finally, we found that HePTP and PP2A bind the C-terminal half of OSBP, HePTP binds a coiled-coil domain ( amino acids 732-761), and PP2A binds neither the coiled-coil nor HePTP. On the basis of this information we propose a new model for how OSBP is able to sense both membrane cholesterol and oxidized sterols and link this information to the ERK1/2 signaling pathway.	[Wang, Ping-Yuan; Weng, Jian; Lee, Sungsoo; Anderson, Richard G. W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Anderson, RGW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	richard.anderson@utsouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052016] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL20948] Funding Source: Medline; NIGMS NIH HHS [R01 GM052016-14, GM52016, R01 GM052016] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Augustine KA, 2000, ANAT REC, V258, P221, DOI 10.1002/(SICI)1097-0185(20000301)258:3<221::AID-AR1>3.0.CO;2-W; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Clark R, 2005, J BIOL CHEM, V280, P30935, DOI 10.1074/jbc.M504698200; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DAWSON PA, 1989, J BIOL CHEM, V264, P9046; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; Lagace TA, 1997, BIOCHEM J, V326, P205, DOI 10.1042/bj3260205; Levine T, 2005, MOL CELL, V19, P722, DOI 10.1016/j.molcel.2005.08.006; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Mohammadi A, 2001, J LIPID RES, V42, P1062; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Storey MK, 1998, BIOCHEM J, V336, P247, DOI 10.1042/bj3360247; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Sullivan DP, 2006, BIOCHEM SOC T, V34, P356, DOI 10.1042/BST0340356; TAYLOR FR, 1985, CHEM PHYS LIPIDS, V38, P187, DOI 10.1016/0009-3084(85)90066-0; Wang PH, 2005, EMBO J, V24, P2989, DOI 10.1038/sj.emboj.7600764; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Xiao H, 2005, J AM SOC MASS SPECTR, V16, P869, DOI 10.1016/j.jasms.2005.02.020; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	30	40	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					8034	8045		10.1074/jbc.M707631200	http://dx.doi.org/10.1074/jbc.M707631200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18165705	hybrid			2022-12-27	WOS:000253997900078
J	Wang, QY; Li, LY; Ye, YH				Wang, Qiuyan; Li, Lianyun; Ye, Yihong			Inhibition of p97-dependent protein degradation by Eeyarestatin I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; TRANSMEMBRANE CONDUCTANCE REGULATOR; RETICULUM-ASSOCIATED DEGRADATION; UBIQUITIN-PROTEASOME SYSTEM; CELL ANTIGEN RECEPTOR; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MEMBRANE-PROTEIN; MISFOLDED GLYCOPROTEINS; AAA-ATPASE	Elimination of misfolded proteins from the endoplasmic reticulum ( ER) by ER-associated degradation involves substrate retro-translocation from the ER lumen into the cytosol for degradation by the proteasome. For many substrates, retrotranslocation requires the action of ubiquitinating enzymes, which polyubiquitinate substrates emerging from the ER lumen, and of the p97-Ufd1-Npl4 ATPase complex, which hydrolyzes ATP to dislocate polyubiquitinated substrates into the cytosol. Polypeptides extracted by p97 are eventually transferred to the proteasome for destruction. In mammalian cells, ERAD can be blocked by a chemical inhibitor termed Eeyarestatin I, but the mechanism of EerI action is unclear. Here we report that EerI can associate with a p97 complex to inhibit ERAD. The interaction of EerI with the p97 complex appears to negatively influence a deubiquitinating process that is mediated by p97-associated deubiquitinating enzymes. We further show that ataxin-3, a p97-associated deubiquitinating enzyme previously implicated in ER-associated degradation, is among those affected. Interestingly, p97-associated deubiquitination is also involved in degradation of a soluble substrate. Our analyses establish a role for a novel deubiquitinating process in proteasome-dependent protein turnover.	[Wang, Qiuyan; Li, Lianyun; Ye, Yihong] NIDDK, Mol Biol Lab, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ye, YH (corresponding author), NIDDK, Mol Biol Lab, Natl Inst Hlth, 5 Ctr Dr, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov		Li, Lianyun/0000-0003-4194-3059	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036136, Z01DK036136] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Kikkert M, 2001, BIOCHEM J, V358, P369, DOI 10.1042/0264-6021:3580369; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, ESSAYS BIOCHEM, V41, P99, DOI 10.1042/EB0410099; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	60	149	157	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7445	7454		10.1074/jbc.M708347200	http://dx.doi.org/10.1074/jbc.M708347200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18199748	hybrid, Green Published			2022-12-27	WOS:000253997900019
J	Zubieta, C; Arkus, KAJ; Cahoon, RE; Jez, JM				Zubieta, Chloe; Arkus, Kiani A. J.; Cahoon, Rebecca E.; Jez, Joseph M.			A single amino acid change is responsible for evolution of acyltransferase specificity in bacterial methionine biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-CATALYZED ACYLATION; HOMOSERINE TRANSACETYLASE; ESCHERICHIA-COLI; BACILLUS-CEREUS; MECHANISTIC CHARACTERIZATION; S-ADENOSYLMETHIONINE; CRYSTAL-STRUCTURE; TRANSSUCCINYLASE; CYSTATHIONINE; SUBSTRATE	Bacteria and yeast rely on either homoserine transsuccinylase (HTS, metA) or homoserine transacetylase (HTA; met2) for the biosynthesis of methionine. Although HTS and HTA catalyze similar chemical reactions, these proteins are typically unrelated in both sequence and three-dimensional structure. Here we present the 2.0 angstrom resolution x-ray crystal structure of the Bacillus cereus metA protein in complex with homoserine, which provides the first view of a ligand bound to either HTA or HTS. Surprisingly, functional analysis of the B. cereus metA protein shows that it does not use succinyl-CoA as a substrate. Instead, the protein catalyzes the transacetylation of homoserine using acetyl-CoA. Therefore, the B. cereus metA protein functions as an HTA despite greater than 50% sequence identity with bona fide HTS proteins. This result emphasizes the need for functional confirmation of annotations of enzyme function based on either sequence or structural comparisons. Kinetic analysis of site-directed mutants reveals that the B. cereus metA protein and the E. coli HTS share a common catalytic mechanism. Structural and functional examination of the B. cereus metA protein reveals that a single amino acid in the active site determines acetyl-CoA (Glu-111) versus succinyl-CoA (Gly-111) specificity in the metA-like of acyltransferases. Switching of this residue provides a mechanism for evolving substrate specificity in bacterial methionine biosynthesis. Within this enzyme family, HTS and HTA activity likely arises from divergent evolution in a common structural scaffold with conserved catalytic machinery and homoserine binding sites.	[Zubieta, Chloe; Arkus, Kiani A. J.; Cahoon, Rebecca E.; Jez, Joseph M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Jez, JM (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	jjez@danforthcenter.org		Zubieta, Chloe/0000-0003-4558-9333				AGUILAR A, 1982, ANTIMICROB AGENTS CH, V21, P381, DOI 10.1128/AAC.21.3.381; Auger S, 2002, MICROBIOL-SGM, V148, P507, DOI 10.1099/00221287-148-2-507; Bareich DC, 2003, CHEM BIOL, V10, P967, DOI 10.1016/j.chembiol.2003.09.016; Born TL, 1999, BIOCHEMISTRY-US, V38, P14416, DOI 10.1021/bi991710o; Born TL, 2000, BIOCHEMISTRY-US, V39, P8556, DOI 10.1021/bi000462p; Bourhy P, 1997, J BACTERIOL, V179, P4396, DOI 10.1128/jb.179.13.4396-4398.1997; BRUSH A, 1971, BIOCHEM BIOPH RES CO, V45, P735, DOI 10.1016/0006-291X(71)90478-5; Coe DM, 2007, ARCH BIOCHEM BIOPHYS, V461, P211, DOI 10.1016/j.abb.2007.03.004; DATKO AH, 1974, J BIOL CHEM, V249, P1139; Ejim L, 2004, BIOORGAN MED CHEM, V12, P3825, DOI 10.1016/j.bmc.2004.05.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goudarzi M, 2006, EXTREMOPHILES, V10, P469, DOI 10.1007/s00792-006-0522-3; Hanzelka BL, 1996, J BACTERIOL, V178, P5291, DOI 10.1128/jb.178.17.5291-5294.1996; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jacques SL, 2003, CHEM BIOL, V10, P989, DOI 10.1016/j.chembiol.2003.09.015; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAPLAN MM, 1966, J BIOL CHEM, V241, P4463; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mirza IA, 2005, BIOCHEMISTRY-US, V44, P15768, DOI 10.1021/bi051951y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nazi I, 2005, BIOCHEMISTRY-US, V44, P13560, DOI 10.1021/bi0514764; Park SD, 1998, MOL CELLS, V8, P286; Penning TM, 2001, CHEM REV, V101, P3027, DOI 10.1021/cr000049n; ROHL F, 1987, ARCH MICROBIOL, V147, P315, DOI 10.1007/BF00406126; Rosen R, 2004, FEBS LETT, V577, P386, DOI 10.1016/j.febslet.2004.10.037; ROWBURY RJ, 1964, J GEN MICROBIOL, V36, P341, DOI 10.1099/00221287-36-3-341; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; Val DL, 1998, J BACTERIOL, V180, P2644, DOI 10.1128/JB.180.10.2644-2651.1998; Viola RE, 2001, ACCOUNTS CHEM RES, V34, P339, DOI 10.1021/ar000057q; WYMAN A, 1975, J BIOL CHEM, V250, P3897; Ziegler K, 2007, BIOCHEM BIOPH RES CO, V361, P510, DOI 10.1016/j.bbrc.2007.07.044; Ziegler K, 2007, BIOCHEMISTRY-US, V46, P2674, DOI 10.1021/bi0620252; Zubieta C, 2007, PROTEINS, V68, P999, DOI 10.1002/prot.21208	34	15	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7561	7567		10.1074/jbc.M709283200	http://dx.doi.org/10.1074/jbc.M709283200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18216013	hybrid			2022-12-27	WOS:000253997900031
J	Diao, A; Frost, L; Morohashi, Y; Lowe, M				Diao, Aipo; Frost, Laura; Morohashi, Yuichi; Lowe, Martin			Coordination of golgin tethering and SNARE assembly - GM130 binds syntaxin 5 in a p115-regulated manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX PROTEIN GM130; GIANTIN INTERACTS; MEMBRANE-FUSION; IN-VIVO; P115; VESICLE; COMPLEX; TRANSPORT; DOCKING; GRASP65	During membrane traffic, transport carriers are first tethered to the target membrane prior to undergoing fusion. Mechanisms exist to connect tethering with fusion, but in most cases, the details remain poorly understood. GM130 is a member of the golgin family of coiled-coil proteins that is involved in membrane tethering at the endoplasmic reticulum ( ER) to Golgi intermediate compartment and cis-Golgi. Here, we demonstrate that GM130 interacts with syntaxin 5, a t-SNARE also localized to the early secretory pathway. Binding to syntaxin 5 is specific, direct, and mediated by the membrane-proximal region of GM130. Interestingly, interaction with syntaxin 5 is inhibited by the binding of the vesicle docking protein p115 to a distal binding site in GM130. The interaction between GM130 and the small GTPase Rab1 is also inhibited by p115 binding. Our findings suggest a mechanism for coupling membrane tethering and fusion at the ER to Golgi intermediate compartment and cis-Golgi, with GM130 playing a central role in linking these processes. Consistent with this hypothesis, we find that depletion of GM130 by RNA interference slows the rate of ER to Golgi trafficking in vivo. The interactions of GM130 with syntaxin 5 and Rab1 are also regulated by mitotic phosphorylation, which is likely to contribute to the inhibition of ER to Golgi trafficking that occurs when mammalian cells enter mitosis.	[Diao, Aipo; Frost, Laura; Morohashi, Yuichi; Lowe, Martin] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Lowe, M (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	martin.lowe@manchester.ac.uk			MRC [G117/494] Funding Source: UKRI; Medical Research Council [G117/494, g117/494] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Alvarez C, 2001, J BIOL CHEM, V276, P2693, DOI 10.1074/jbc.M007957200; BAILLY E, 1991, NATURE, V350, P715, DOI 10.1038/350715a0; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; Bentley M, 2006, J BIOL CHEM, V281, P38825, DOI 10.1074/jbc.M606044200; Brandon E, 2006, MOL BIOL CELL, V17, P2996, DOI 10.1091/mbc.e05-09-0862; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Hui N, 1997, MOL BIOL CELL, V8, P1777, DOI 10.1091/mbc.8.9.1777; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lesa GM, 2000, J BIOL CHEM, V275, P2831, DOI 10.1074/jbc.275.4.2831; Levine TP, 1996, J BIOL CHEM, V271, P17304, DOI 10.1074/jbc.271.29.17304; Linstedt AD, 2000, J BIOL CHEM, V275, P10196, DOI 10.1074/jbc.275.14.10196; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Lupashin V, 2005, BBA-MOL CELL RES, V1744, P325, DOI 10.1016/j.bbamcr.2005.03.013; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Muller JMM, 2002, J CELL BIOL, V157, P1161, DOI 10.1083/jcb.200202082; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Puthenveedu MA, 2001, J CELL BIOL, V155, P227, DOI 10.1083/jcb.200105005; Rosing M, 2007, EXP CELL RES, V313, P2318, DOI 10.1016/j.yexcr.2007.03.031; Seemann J, 2002, SCIENCE, V295, P848, DOI 10.1126/science.1068064; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Suga K, 2005, FEBS LETT, V579, P4226, DOI 10.1016/j.febslet.2005.06.053; Vasile E, 2003, TRAFFIC, V4, P254, DOI 10.1034/j.1600-0854.2003.00080.x; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; Yoshimura S, 2004, J BIOCHEM, V135, P201, DOI 10.1093/jb/mvh024	45	61	72	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6957	6967		10.1074/jbc.M708401200	http://dx.doi.org/10.1074/jbc.M708401200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18167358	hybrid			2022-12-27	WOS:000253779600040
J	Konitsiotis, AD; Raynal, N; Bihan, D; Hohenester, E; Farndale, RW; Leitinger, B				Konitsiotis, Antonios D.; Raynal, Nicolas; Bihan, Dominique; Hohenester, Erhard; Farndale, Richard W.; Leitinger, Birgit			Characterization of high affinity binding motifs for the discoidin domain receptor DDR2 in collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; STRUCTURAL BASIS; INTEGRINS ALPHA(1)BETA(1); EXTRACELLULAR-MATRIX; CELL INVASION; ACTIVATION; SITE; PROLIFERATION; PEPTIDES; IDENTIFICATION	The discoidin domain receptors, DDR1 and DDR2, are receptor tyrosine kinases that are activated by native triple-helical collagen. Here we have located three specific DDR2 binding sites by screening the entire triple-helical domain of collagen II, using the Collagen II Toolkit, a set of overlapping triple-helical peptides. The peptide sequence that bound DDR2 with highest affinity interestingly contained the sequence for the high affinity binding site for von Willebrand factor in collagen III. Focusing on this sequence, we used a set of truncated and alanine-substituted peptides to characterize the sequence GVMGFO (O is hydroxyproline) as the minimal collagen sequence required for DDR2 binding. Based on a recent NMR analysis of the DDR2 collagen binding domain, we generated a model of the DDR2-collagen interaction that explains why a triple-helical conformation is required for binding. Triple-helical peptides comprising the DDR2 binding motif not only inhibited DDR2 binding to collagen II but also activated DDR2 transmembrane signaling. Thus, DDR2 activation may be effected by single triple-helices rather than fibrillar collagen.	[Raynal, Nicolas; Bihan, Dominique; Farndale, Richard W.] Univ Cambridge, Cambridge CB2 1QW, England; [Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Konitsiotis, Antonios D.; Leitinger, Birgit] Univ London Imperial Coll Sci Technol & Med, Div Natl Heart & Lung Inst NHLI, Mol Med Sect, London SW7 2AZ, England	University of Cambridge; Imperial College London; Imperial College London	Farndale, RW (corresponding author), Univ Cambridge, Cambridge CB2 1QW, England.	rwf10@mole.bio.cam.ac.uk; b.leitinger@imperial.ac.uk			Medical Research Council [G0400701] Funding Source: Medline; Wellcome Trust [054334] Funding Source: Medline; MRC [G0400701] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Ferri N, 2004, AM J PATHOL, V164, P1575, DOI 10.1016/S0002-9440(10)63716-9; Flamant M, 2006, J AM SOC NEPHROL, V17, P3374, DOI 10.1681/ASN.2006060677; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Lebbink RJ, 2007, INT IMMUNOL, V19, P1011, DOI 10.1093/intimm/dxm071; Leitinger B, 2004, J MOL BIOL, V344, P993, DOI 10.1016/j.jmb.2004.09.089; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Matsuyama W, 2005, J IMMUNOL, V174, P6490, DOI 10.4049/jimmunol.174.10.6490; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; ONLEY DJ, 2001, THESIS U CAMBRIDGE; Ram R, 2006, J NEURO-ONCOL, V76, P239, DOI 10.1007/s11060-005-6874-1; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shah NK, 1996, BIOCHEMISTRY-US, V35, P10262, DOI 10.1021/bi960046y; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yoshida D, 2007, J NEURO-ONCOL, V82, P29, DOI 10.1007/s11060-006-9246-6; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200	35	152	156	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6861	6868		10.1074/jbc.M709290200	http://dx.doi.org/10.1074/jbc.M709290200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18201965	Green Submitted, hybrid			2022-12-27	WOS:000253779600029
J	Gao, F; Koenitzer, JR; Tobolewski, JM; Jiang, DH; Liang, JR; Noble, PW; Oury, TD				Gao, Fei; Koenitzer, Jeffrey R.; Tobolewski, Jacob M.; Jiang, Dianhua; Liang, Jiurong; Noble, Paul W.; Oury, Tim D.			Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; METAL-CATALYZED OXIDATION; HEPARIN-BINDING DOMAIN; PULMONARY EC-SOD; LUNG INJURY; RECEPTOR RHAMM; NITRIC-OXIDE; I COLLAGEN; CD44; ACCUMULATION	Extracellular superoxide dismutase (EC-SOD) is expressed at high levels in lungs. EC-SOD has a polycationic matrix-binding domain that binds to polyanionic constituents in the matrix. Previous studies indicate that EC-SOD protects the lung in both bleomycin- and asbestos-induced models of pulmonary fibrosis. Although the mechanism of EC-SOD protection is not fully understood, these studies indicate that EC-SOD plays an important role in regulating inflammatory responses to pulmonary injury. Hyaluronan is a polyanionic high molecular mass polysaccharide found in the extracellular matrix that is sensitive to oxidant-mediated fragmentation. Recent studies found that elevated levels of low molecular mass hyaluronan are associated with inflammatory conditions. We hypothesize that EC-SOD may inhibit pulmonary inflammation in part by preventing superoxide-mediated fragmentation of hyaluronan to low molecular mass fragments. We found that EC-SOD directly binds to hyaluronan and significantly inhibits oxidant-induced degradation of this glycosaminoglycan. In vitro human polymorphic neutrophil chemotaxis studies indicate that oxidative fragmentation of hyaluronan results in polymorphic neutrophil chemotaxis and that EC-SOD can completely prevent this response. Intratracheal injection of crocidolite asbestos in mice leads to pulmonary inflammation and injury that is enhanced in EC-SOD knock-out mice. Notably, hyaluronan levels are increased in the bronchoalveolar lavage fluid after asbestos-induced pulmonary injury, and this response is markedly enhanced in EC-SOD knock-out mice. These data indicate that inhibition of oxidative hyaluronan fragmentation probably represents one mechanism by which EC-SOD inhibits inflammation in response to lung injury.	[Gao, Fei; Koenitzer, Jeffrey R.; Tobolewski, Jacob M.; Oury, Tim D.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Jiang, Dianhua; Liang, Jiurong; Noble, Paul W.] Duke Univ, Dept Med, Durham, NC 27708 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University	Gao, F (corresponding author), Univ Pittsburgh, Dept Pathol, W905 BST,200 Lothrop St, Pittsburgh, PA 15261 USA.	Feg2@pitt.edu	Jiang, Dianhua/B-1421-2009; Liang, Carol Jiurong/AAI-4963-2021	Jiang, Dianhua/0000-0002-4508-3829; Liang, Jiurong/0000-0001-5179-5016	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES015383] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL063700, R01 HL063700-07, R01 HL 63700] Funding Source: Medline; NIEHS NIH HHS [F32 ES 015383-01, F32 ES015383] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADACHI T, 1992, ARCH BIOCHEM BIOPHYS, V297, P155, DOI 10.1016/0003-9861(92)90654-F; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; BARRY FP, 1995, J BIOL CHEM, V270, P20516, DOI 10.1074/jbc.270.35.20516; BJERMER L, 1989, THORAX, V44, P126, DOI 10.1136/thx.44.2.126; Bowler RP, 2002, AM J PHYSIOL-LUNG C, V282, pL719, DOI 10.1152/ajplung.00058.2001; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Clark RA, 1996, J CELL BIOL, V134, P1075, DOI 10.1083/jcb.134.4.1075; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Deguine V, 1998, INT J BIOL MACROMOL, V22, P17, DOI 10.1016/S0141-8130(97)00084-6; Dorger M, 2002, TOXICOL APPL PHARM, V181, P93, DOI 10.1006/taap.2002.9388; Fattman CL, 2000, BIOCHEM BIOPH RES CO, V275, P542, DOI 10.1006/bbrc.2000.3327; Fattman CL, 2006, FREE RADICAL BIO MED, V40, P601, DOI 10.1016/j.freeradbiomed.2005.09.030; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P763, DOI 10.1016/S0891-5849(03)00402-7; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Fattman CL, 2001, FREE RADICAL BIO MED, V31, P1198, DOI 10.1016/S0891-5849(01)00699-2; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; Ghio AJ, 1998, FREE RADICAL BIO MED, V24, P11, DOI 10.1016/S0891-5849(97)00063-4; GUNTENHONER MW, 1992, MATRIX, V12, P388, DOI 10.1016/S0934-8832(11)80035-1; HALLGREN R, 1989, AM REV RESPIR DIS, V139, P682; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; HERNNAS J, 1992, EUR RESPIR J, V5, P404; Ikegami-Kawai M, 2004, GLYCOBIOLOGY, V14, P65, DOI 10.1093/glycob/cwh011; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; KARLSSON K, 1988, BIOCHEM J, V256, P29, DOI 10.1042/bj2560029; Kato Y, 2001, FREE RADICAL BIO MED, V31, P624, DOI 10.1016/S0891-5849(01)00623-2; Kinnula VL, 2005, AM J RESP CRIT CARE, V172, P417, DOI 10.1164/rccm.200501-017PP; Kinnula VL, 1999, EUR RESPIR J, V14, P706, DOI 10.1034/j.1399-3003.1999.14c35.x; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; Lookene A, 2000, BIOCHEMISTRY-US, V39, P230, DOI 10.1021/bi991512x; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MARKLUND SL, 1982, CLIN CHIM ACTA, V126, P41, DOI 10.1016/0009-8981(82)90360-6; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; MIURA RO, 1995, ANAL BIOCHEM, V225, P333, DOI 10.1006/abio.1995.1163; MIYAKE K, 1990, J EXP MED, V172, P69, DOI 10.1084/jem.172.1.69; MONBOISSE JC, 1990, BIOCHEM J, V270, P459, DOI 10.1042/bj2700459; MOSSMAN BT, 1989, NEW ENGL J MED, V320, P1721, DOI 10.1056/NEJM198906293202604; Mossman BT, 1997, AM J PUBLIC HEALTH, V87, P689, DOI 10.2105/AJPH.87.4.689; Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; NETTELBLADT O, 1989, AM REV RESPIR DIS, V140, P1028, DOI 10.1164/ajrccm/140.4.1028; NETTELBLADT O, 1989, AM REV RESPIR DIS, V139, P759, DOI 10.1164/ajrccm/139.3.759; Noble Paul W, 2006, Proc Am Thorac Soc, V3, P401, DOI 10.1513/pats.200604-097AW; Noble PW, 2004, CLIN CHEST MED, V25, P749, DOI 10.1016/j.ccm.2004.04.003; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; OURY TD, 1994, LAB INVEST, V70, P889; Oury TD, 1996, BIOCHEM J, V317, P51, DOI 10.1042/bj3170051; Oury TD, 2002, AM J PHYSIOL-LUNG C, V283, pL777, DOI 10.1152/ajplung.00011.2002; Oury TD, 1996, FREE RADICAL BIO MED, V20, P957, DOI 10.1016/0891-5849(95)02222-8; Pascal M, 2000, T ROY SOC TROP MED H, V94, P66, DOI 10.1016/S0035-9203(00)90443-7; Petersen SV, 2004, J BIOL CHEM, V279, P13705, DOI 10.1074/jbc.M310217200; Porter DW, 2006, TOXICOL SCI, V90, P188, DOI 10.1093/toxsci/kfj075; RAUCH U, 1992, J BIOL CHEM, V267, P19536; SAARI H, 1991, ANN RHEUM DIS, V50, P389, DOI 10.1136/ard.50.6.389; SANDSTROM J, 1992, J BIOL CHEM, V267, P18205; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; Shukla A, 2003, FREE RADICAL BIO MED, V34, P1117, DOI 10.1016/S0891-5849(03)00060-1; SODERBERG M, 1989, INT ARCH ALLER A IMM, V88, P373, DOI 10.1159/000234719; Tan RJ, 2006, AM J RESP CELL MOL, V34, P226, DOI 10.1165/rcmb.2005-0212OC; Tan RJ, 2004, J APPL PHYSIOL, V97, P2006, DOI 10.1152/japplphysiol.00480.2004; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; TENGBLAD A, 1979, BIOCHIM BIOPHYS ACTA, V578, P281, DOI 10.1016/0005-2795(79)90158-2; Tibell LAE, 1997, BBA-PROTEIN STRUCT M, V1340, P21, DOI 10.1016/S0167-4838(97)00024-1; UCHIYAMA H, 1990, J BIOL CHEM, V265, P7753; Watanabe H, 1997, J BIOL CHEM, V272, P28057, DOI 10.1074/jbc.272.44.28057; Zaman A, 2005, AM J RESP CELL MOL, V33, P447, DOI 10.1165/rcmb.2004-0333OC; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zen K, 2006, J IMMUNOL METHODS, V309, P86, DOI 10.1016/j.jim.2005.11.014; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; Zhao F, 1997, J BIOL CHEM, V272, P9019	73	142	148	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6058	6066		10.1074/jbc.M709273200	http://dx.doi.org/10.1074/jbc.M709273200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165226	Green Accepted, hybrid			2022-12-27	WOS:000253779500011
J	Sato, Y; Shibata, H; Nakano, H; Matsuzono, Y; Kashiwayama, Y; Kobayashi, Y; Fujiki, Y; Imanaka, T; Kato, H				Sato, Yasuhiko; Shibata, Hiroyuki; Nakano, Hiroaki; Matsuzono, Yuji; Kashiwayama, Yoshinori; Kobayashi, Yuji; Fujiki, Yukio; Imanaka, Tsuneo; Kato, Hiroaki			Characterization of the interaction between recombinant human peroxin Pex3p and Pex19p - Identification of Trp-104 in Pex3p as a critical residue for the interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEINS; TARGETING SIGNAL RECEPTOR; ZELLWEGER-SYNDROME; FUNCTIONAL COMPLEMENTATION; BIOGENESIS DISORDERS; IMPORT; BINDS; MUTATIONS; CHAPERONE; MULTIPLE	Proteins required for peroxisome biogenesis are termed peroxins. The peroxin Pex3p is a peroxisomal membrane protein (PMP), involved in peroxisomal membrane biogenesis. It acts as a docking receptor for another peroxin Pex19p, which is a specific carrier protein for newly synthesized PMPs. Here we have determined the physicochemical properties and binding manners of Pex3p-Pex19p interaction, in terms of the affinity, the stoichiometry, and the binding site in Pex3p. The cytosolic domain of human Pex3p was overproduced, using an Escherichia coli expression system and was highly purified by two chromatography steps. Gel filtration chromatography analyses and intrinsic tryptophan fluorescence titrations revealed that a one-to-one complex is formed between monomeric Pex3p and monomeric Pex19p. The tryptophan fluorescence spectrum of Pex3p showed a large 18-nm blue shift of the maximum emission wavelength by the binding of Pex19p. This result indicates that either one or two tryptophan residues of Pex3p (Trp-104 and Trp-224) are directly involved in binding to Pex19p. We investigated the binding activities of the wild-type and tryptophan mutants of Pex3p by pull-down assays and surface plasmon resonance analyses. As a result, the wild-type and the W104A and W104F mutants showed K-D values of 3.4 nM, 1080 nM, and 66.2 nM, respectively. The affinity differences with mutation affected their peroxisome restoring activities in pex3 ZPG208 cells. These findings suggest that the indole ring of Trp-104 directly interacts with Pex19p to facilitate the specific peroxisomal translocation of the Pex19p-PMP complexes.	[Sato, Yasuhiko; Nakano, Hiroaki; Kato, Hiroaki] Kyoto Univ, Sch Pharmaceut Sci, Dept Biol Struct, Sakyo Ku, Kyoto 6068501, Japan; [Shibata, Hiroyuki] Natl Cardiovasc Ctr, Res Inst, Dept Cardiac Physiol, Osaka 5658565, Japan; [Matsuzono, Yuji; Fujiki, Yukio] Kyushu Univ, Grad Sch, Fac Sci, JST,CREST,Dept Biol,Higashi Ku, Fukuoka 8128581, Japan; [Kashiwayama, Yoshinori; Imanaka, Tsuneo] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biol Chem, Toyama 9300194, Japan; [Kobayashi, Yuji] Osaka Univ Pharmaceut Sci, Takatsuki, Osaka 5691094, Japan	Kyoto University; National Cerebral & Cardiovascular Center - Japan; Japan Science & Technology Agency (JST); Kyushu University; University of Toyama; Osaka University of Pharmaceutical Sciences	Kato, H (corresponding author), Kyoto Univ, Sch Pharmaceut Sci, Dept Biol Struct, Sakyo Ku, 46-29 Yoshida Shimoadachi Cho, Kyoto 6068501, Japan.	katohiro@pharm.kyoto-u.ac.jp		Kato, Hiroaki/0000-0002-5993-4532; Imanaka, Tsuneo/0000-0003-4677-1356				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fransen M, 2005, J MOL BIOL, V346, P1275, DOI 10.1016/j.jmb.2005.01.013; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; Ghaedi K, 2000, MOL BIOL CELL, V11, P2085, DOI 10.1091/mbc.11.6.2085; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gloeckner CJ, 2000, BIOCHEM BIOPH RES CO, V271, P144, DOI 10.1006/bbrc.2000.2572; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Honsho M, 2002, J BIOL CHEM, V277, P44513, DOI 10.1074/jbc.M206139200; ITO W, 1991, GENE, V102, P67, DOI 10.1016/0378-1119(91)90539-N; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kammerer S, 1998, FEBS LETT, V429, P53, DOI 10.1016/S0014-5793(98)00557-2; Kashiwayama Y, 2005, BBA-MOL CELL RES, V1746, P116, DOI 10.1016/j.bbamcr.2005.10.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsuzono Y, 2006, J BIOL CHEM, V281, P36, DOI 10.1074/jbc.M509819200; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Matsuzono Y, 2006, J CELL SCI, V119, P3539, DOI 10.1242/jcs.03100; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; Muntau AC, 2000, AM J HUM GENET, V67, P967, DOI 10.1086/303071; Muntau AC, 2003, EUR J CELL BIOL, V82, P333, DOI 10.1078/0171-9335-00325; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; Shimozawa N, 2000, HUM MOL GENET, V9, P1995, DOI 10.1093/hmg/9.13.1995; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; Urquhart AJ, 2000, J BIOL CHEM, V275, P4127, DOI 10.1074/jbc.275.6.4127; Wanders RJA, 1998, MOL ASPECTS MED, V19, P71, DOI 10.1016/S0098-2997(98)00003-X	34	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6136	6144		10.1074/jbc.M706139200	http://dx.doi.org/10.1074/jbc.M706139200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18174172	hybrid			2022-12-27	WOS:000253779500020
J	Badarau, A; Firbank, SJ; Waldron, KJ; Yanagisawa, S; Robinson, NJ; Banfield, MJ; Dennison, C				Badarau, Adriana; Firbank, Susan J.; Waldron, Kevin J.; Yanagisawa, Sachiko; Robinson, Nigel J.; Banfield, Mark J.; Dennison, Christopher			FutA2 is a ferric binding protein from Synechocystis PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT IRON COORDINATION; PATHOGENIC NEISSERIA; TRANSPORT PROTEIN; CRYSTAL-STRUCTURE; MANGANESE; IDENTIFICATION; MEMBRANE; ANION; IDIA; CYANOBACTERIA	Synechocystis PCC 6803 has a high demand for iron (10 times greater than Escherichia coli) to sustain photosynthesis and is unusual in possessing at least two putative iron-binding proteins of a type normally associated with ATP-binding cassette-type importers. It has been suggested that one of these, FutA2, binds ferrous iron, but herein we clearly demonstrate that this protein avidly binds Fe(III), the oxidation state preference of periplasmic iron-binding proteins. Structures of apo-FutA2 and Fe-FutA2 have been determined at 1.7 and 2.7 A, respectively. The metal ion is bound in a distorted trigonal bipyramidal arrangement with no exogenous anions as ligands. The metal-binding environment, including the second coordination sphere and charge properties, is consistent with a preference for Fe( III). Atypically, FutA2 has a Tat signal peptide, and its inability to coordinate divalent cations may be crucial to prevent metals from binding to the folded protein prior to export from the cytosol. A loop containing the His43 ligand undergoes considerable movement in apo-versus Fe-FutA2 and may control metal release to the importer. Although these data are consistent with FutA2 being the periplasmic component involved in iron uptake, deletion of another putative ferric binding protein, FutA1, has a greater effect on the accumulation of iron and is more analogous to a Delta futA1 Delta futA2 double mutant than Delta futA2. Here, we also discover that there is a reduced level of ferric FutA2 in the periplasm of the Delta futA1 mutant providing an explanation for its severe iron-uptake phenotype.	[Badarau, Adriana; Firbank, Susan J.; Waldron, Kevin J.; Yanagisawa, Sachiko; Robinson, Nigel J.; Banfield, Mark J.; Dennison, Christopher] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Dennison, C (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	christopher.dennison@ncl.ac.uk	Robinson, Nigel J/J-6363-2012; Waldron, Kevin/J-2368-2016; Waldron, Kevin John/HHM-8983-2022; Banfield, Mark/C-7453-2013	Robinson, Nigel J/0000-0001-5586-1092; Waldron, Kevin/0000-0002-5577-7357; Waldron, Kevin John/0000-0002-5577-7357; Banfield, Mark/0000-0001-8921-3835; Dennison, Christopher/0000-0001-8665-052X	BBSRC [BB/E001688/1, BB/E016529/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E016529, BB/E016529/1, BB/E001688/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ADHIKARI P, 1995, J BIOL CHEM, V270, P25142, DOI 10.1074/jbc.270.42.25142; AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; ANDERSON BF, 1987, P NATL ACAD SCI USA, V84, P1769, DOI 10.1073/pnas.84.7.1769; ANGERER A, 1990, J BACTERIOL, V172, P572, DOI 10.1128/jb.172.2.572-578.1990; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker E., 1994, ADV INORG CHEM, P389, DOI [10.1016/S0898-8838(08)60176-2, DOI 10.1016/S0898-8838(08)60176-2]; Baker EN, 1997, NAT STRUCT BIOL, V4, P869, DOI 10.1038/nsb1197-869; Baker HM, 2003, P NATL ACAD SCI USA, V100, P3579, DOI 10.1073/pnas.0637295100; Banci L, 2006, P NATL ACAD SCI USA, V103, P8320, DOI 10.1073/pnas.0600142103; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; BARTSEVICH VV, 1995, EMBO J, V14, P1845, DOI 10.1002/j.1460-2075.1995.tb07176.x; Bartsevich VV, 1996, J BIOL CHEM, V271, P26057, DOI 10.1074/jbc.271.42.26057; Braun V, 1999, TRENDS BIOCHEM SCI, V24, P104, DOI 10.1016/S0968-0004(99)01359-6; Bruns CM, 1997, NAT STRUCT BIOL, V4, P919, DOI 10.1038/nsb1197-919; Bruns CM, 2001, BIOCHEMISTRY-US, V40, P15631, DOI 10.1021/bi0156759; CHEN CY, 1993, MOL MICROBIOL, V10, P311, DOI 10.1111/j.1365-2958.1993.tb01957.x; Clarke Teresa E., 2001, Current Topics in Medicinal Chemistry, V1, P7, DOI 10.2174/1568026013395623; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; Guo ML, 2003, J BIOL CHEM, V278, P2490, DOI 10.1074/jbc.M208776200; HARRIS DC, 1973, BIOCHIM BIOPHYS ACTA, V329, P156, DOI 10.1016/0304-4165(73)90019-6; HARRIS WR, 1986, J INORG BIOCHEM, V27, P41, DOI 10.1016/0162-0134(86)80107-6; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Huang F, 2004, MOL CELL PROTEOMICS, V3, P586, DOI 10.1074/mcp.M300137-MCP200; Huang F, 2002, MOL CELL PROTEOMICS, V1, P956, DOI 10.1074/mcp.M200043-MCP200; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P823, DOI 10.1093/pcp/pce106; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Koropatkin N, 2007, J BIOL CHEM, V282, P27468, DOI 10.1074/jbc.M704136200; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lombardi A, 2000, P NATL ACAD SCI USA, V97, P11922, DOI 10.1073/pnas.97.22.11922; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; Michel KP, 1998, PLANTA, V205, P73, DOI 10.1007/s004250050298; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; NOWALK AJ, 1994, BIOCHEMISTRY-US, V33, P12769, DOI 10.1021/bi00209a007; Petrat F, 2003, J BIOL CHEM, V278, P46403, DOI 10.1074/jbc.M305291200; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Rukhman V, 2005, J MOL BIOL, V348, P961, DOI 10.1016/j.jmb.2005.03.006; Shouldice SR, 2005, J BIOL CHEM, V280, P5820, DOI 10.1074/jbc.M411238200; Shouldice SR, 2004, J BACTERIOL, V186, P3903, DOI 10.1128/JB.186.12.3903-3910.2004; Shouldice SR, 2003, J BIOL CHEM, V278, P41093, DOI 10.1074/jbc.M306821200; Srivastava R, 2005, PROTEOMICS, V5, P4905, DOI 10.1002/pmic.200500111; Taboy CH, 2001, J BIOL CHEM, V276, P2719, DOI 10.1074/jbc.M004763200; Tolle J, 2002, MICROBIOL-SGM, V148, P3293, DOI 10.1099/00221287-148-10-3293; Tom-Yew SAL, 2005, J BIOL CHEM, V280, P9283, DOI 10.1074/jbc.M412479200; Vogel AI, 1978, TXB QUANTITATIVE INO, P742; Waldron KJ, 2007, J BIOL CHEM, V282, P3837, DOI 10.1074/jbc.M609916200; Welch KD, 2002, ARCH BIOCHEM BIOPHYS, V397, P360, DOI 10.1006/abbi.2001.2694; [No title captured]	59	48	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12520	12527		10.1074/jbc.M709907200	http://dx.doi.org/10.1074/jbc.M709907200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18252722	hybrid			2022-12-27	WOS:000255340000068
J	Klopocki, AG; Yago, T; Mehta, P; Yang, J; Wu, T; Leppanen, A; Bovin, NV; Cummings, RD; Zhu, C; McEever, RP				Klopocki, Arkadiusz G.; Yago, Tadayuki; Mehta, Padmaja; Yang, Jun; Wu, Tao; Leppanen, Anne; Bovin, Nicolai V.; Cummings, Richard D.; Zhu, Cheng; McEever, Rodger P.			Replacing a lectin domain residue in L-selectin enhances binding to P-selectin glycoprotein ligand-1 but not to 6-sulfo-sialyl Lewis x	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; CATCH BONDS; KINETIC-ANALYSIS; THRESHOLD SHEAR; FLOW; GLYCOSULFOPEPTIDES; REQUIRES; AFFINITY; FORCE	Selectin-ligand interactions (bonds) mediate leukocyte rolling on vascular surfaces. The molecular basis for differential ligand recognition by selectins is poorly understood. Here, we show that substituting one residue (A108H) in the lectin domain of L-selectin increased its force-free affinity for a glycosulfopeptide binding site (2-GSP-6) on P-selectin glycoprotein ligand-1 (PSGL-1) but not for a sulfated-glycan binding site (6-sulfo-sialyl Lewis x) on peripheral node addressin. The increased affinity of L-selectinA108H for 2-GSP-6 was due to a faster on-rate and to a slower off-rate that increased bond lifetimes in the absence of force. Rather than first prolonging (catching) and then shortening (slipping) bond lifetimes, increasing force monotonically shortened lifetimes of L-selectinA108H bonds with 2-GSP-6. When compared with microspheres bearing L-selectin, L-selectinA108H microspheres rolled more slowly and regularly on 2-GSP-6 at low flow rates. A reciprocal substitution in P-selectin (H108A) caused faster microsphere rolling on 2-GSP-6. These results distinguish molecular mechanisms for L-selectin to bind to PSGL-1 and peripheral node addressin and explain in part the shorter lifetimes of PSGL-1 bonds with L-selectin than P-selectin.	[Klopocki, Arkadiusz G.; Yago, Tadayuki; Mehta, Padmaja; McEever, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Leppanen, Anne; Cummings, Richard D.; McEever, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Yang, Jun; Wu, Tao; Zhu, Cheng] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Bovin, Nicolai V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	McEever, RP (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.org	Zhu, Cheng/A-5724-2011; Bovin, Nicolai/P-2948-2017	Bovin, Nicolai/0000-0001-8669-4477				Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Korchagina EY., 1992, SOVIET J BIOORG CHEM, V18, P153; Leppanen A, 2003, J BIOL CHEM, V278, P26391, DOI 10.1074/jbc.M303551200; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2005, NAT IMMUNOL, V6, P1067, DOI 10.1038/ni1105-1067; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Mehta P, 1997, BLOOD, V90, P2381, DOI 10.1182/blood.V90.6.2381.2381_2381_2389; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Turk D., 1992, THESIS TU MUENCHEN; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041; Yago T, 2007, BIOPHYS J, V92, P330, DOI 10.1529/biophysj.106.090969	24	44	44	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11493	11500		10.1074/jbc.M709785200	http://dx.doi.org/10.1074/jbc.M709785200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18250165	Green Published, hybrid			2022-12-27	WOS:000255067400048
J	Rytinki, MM; Palvimo, JJ				Rytinki, Miia M.; Palvimo, Jorma J.			SUMOylation modulates the transcription repressor function of RIP140	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INTERACTING PROTEIN-140; SUBNUCLEAR LOCALIZATION; COREPRESSOR RIP140; ESTROGEN-RECEPTOR; ANDROGEN RECEPTOR; SUMO MODIFICATION; PIAS PROTEINS; ACTIVATION; UBIQUITIN; DOMAINS	RIP140/NRIP1 (receptor-interacting protein 140) functions as a corepressor of nuclear receptors. It plays an important role in the transcriptional control of energy metabolism and female fertility. RIP140 contains four distinct repression domains (RD1-RD4), and the repressive activity of RIP140 involves complex mechanisms. The function of both RD1 and RD2 is linked to recruitment of histone deacetylases and C-terminal binding protein, respectively, but the mechanism of repression for RD3 and RD4 has remained elusive. Because covalent modification by small ubiquitin-like modifiers (SUMO-1, -2, and -3; SUMOylation) is often associated with transcriptional repression, we studied whether SUMOylation is involved in the repressive activity of RIP140. We show that two conserved lysines, Lys(756) and Lys(1154), located in RD3 and RD4, respectively, are subject to reversible SUMOylation, with SUMO-1 being more efficiently conjugated than SUMO-2. Interestingly, mutations of the RIP140 SUMOylation sites compromised the transcription repressor function of RIP140 and blunted its capacity to repress estrogen receptor alpha-dependent transcription. Conjugation of SUMO-1 also influenced the subnuclear distribution pattern of RIP140. In sum, our demonstration that the function of RIP140 repression domains 3 and 4 can be modulated by reversible SUMO modification thus adds a novel level to the regulation of RIP140 activity, which may have ramifications in the control of gene networks exerted by RIP140.	[Rytinki, Miia M.; Palvimo, Jorma J.] Univ Kuopio, Inst Biomed Med Biochem, FI-70211 Kuopio, Finland	University of Eastern Finland	Palvimo, JJ (corresponding author), Univ Kuopio, Inst Biomed Med Biochem, POB 1627, FI-70211 Kuopio, Finland.	jorma.palvimo@uku.fi		Palvimo, Jorma/0000-0003-2373-0578				Augereau P, 2006, J STEROID BIOCHEM, V102, P51, DOI 10.1016/j.jsbmb.2006.09.005; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Castet A, 2004, NUCLEIC ACIDS RES, V32, P1957, DOI 10.1093/nar/gkh524; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Christian M, 2004, J BIOL CHEM, V279, P15645, DOI 10.1074/jbc.M313906200; Christian M, 2006, TRENDS ENDOCRIN MET, V17, P243, DOI 10.1016/j.tem.2006.06.008; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Heldring N, 2004, MOL CELL BIOL, V24, P3445, DOI 10.1128/MCB.24.8.3445-3459.2004; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Huq MDM, 2005, MOL CELL PROTEOMICS, V4, P975, DOI 10.1074/mcp.M500015-MCP200; Huq MDM, 2005, PROTEOMICS, V5, P2157, DOI 10.1002/pmic.200401090; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kotaja N, 2000, MOL ENDOCRINOL, V14, P1986, DOI 10.1210/me.14.12.1986; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Mellgren G, 2003, MOL CELL ENDOCRINOL, V203, P91, DOI 10.1016/S0303-7207(03)00097-2; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Peters GA, 1999, MOL ENDOCRINOL, V13, P286, DOI 10.1210/me.13.2.286; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Spengler ML, 2005, CELL SIGNAL, V17, P153, DOI 10.1016/j.cellsig.2004.06.007; Steel JH, 2005, J ENDOCRINOL, V185, P1, DOI 10.1677/joe.1.05896; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tazawa H, 2003, MOL CELL BIOL, V23, P4187, DOI 10.1128/MCB.23.12.4187-4198.2003; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Wei LN, 2004, MOL CELL ENDOCRINOL, V218, P39, DOI 10.1016/j.mce.2003.12.010; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; White R, 2000, NAT MED, V6, P1368, DOI 10.1038/82183; Windahl SH, 1999, J STEROID BIOCHEM, V71, P93, DOI 10.1016/S0960-0760(99)00128-4; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7	43	40	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11586	11595		10.1074/jbc.M709359200	http://dx.doi.org/10.1074/jbc.M709359200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18211901	hybrid			2022-12-27	WOS:000255067400059
J	Bartholomaeus, I; Milan-Lobo, L; Nicke, A; Dutertre, S; Hastrup, H; Jha, A; Gether, U; Sitte, HH; Betz, H; Eulenburg, V				Bartholomaeus, Ingo; Milan-Lobo, Laura; Nicke, Annette; Dutertre, Sebastien; Hastrup, Hanne; Jha, Alok; Gether, Ulrik; Sitte, Harald H.; Betz, Heinrich; Eulenburg, Volker			Glycine transporter dimers - Evidence for occurrence in the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; HUMAN DOPAMINE TRANSPORTER; AMINOBUTYRIC-ACID TRANSPORTER-1; HUMAN SEROTONIN TRANSPORTER; RAT GABA TRANSPORTER-1; LIVING CELLS; NEUROTRANSMITTER TRANSPORTERS; HYDRODYNAMIC PROPERTIES; TRANSMEMBRANE SEGMENT; ENDOPLASMIC-RETICULUM	Different Na+/Cl--dependent neurotransmitter transporters of the SLC6a family have been shown to form dimers or oligomers in both intracellular compartments and at the cell surface. In contrast, the glycine transporters (GlyTs) GlyT1 and -2 have been reported to exist as monomers in the plasma membrane based on hydrodynamic and native gel electrophoretic studies. Here, we used cysteine substitution and oxidative cross-linking to show that of GlyT1 and GlyT2 also form dimeric complexes within the plasma membrane. GlyT oligomerization at the cell surface was confirmed for both GlyT1 and GlyT2 by fluorescence resonance energy transfer microscopy. Endoglycosidase treatment and surface biotinylation further revealed that complex-glycosylated GlyTs form dimers located at the cell surface. Furthermore, substitution of tryptophan 469 of GlyT2 by an arginine generated a transporter deficient in dimerization that was retained intracellulary. Based on these results and GlyT structures modeled by using the crystal structure of the bacterial homolog LeuT(Aa), as a template, residues located within the extracellular loop 3 and at the beginning of transmembrane domain 6 are proposed to contribute to the dimerization interface of GlyTs.	[Bartholomaeus, Ingo; Nicke, Annette; Dutertre, Sebastien; Betz, Heinrich; Eulenburg, Volker] Max Planck Inst Brain Res, Dept Neurochem, D-60529 Frankfurt, Germany; [Milan-Lobo, Laura; Jha, Alok; Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Biomol Med & Pharmacol, A-1090 Vienna, Austria; [Hastrup, Hanne; Gether, Ulrik] Univ Copenhagen, Dept Pharmacol, Mol Neuropharmacol Grp, DK-2200 Copenhagen, Denmark; [Hastrup, Hanne; Gether, Ulrik] Univ Copenhagen, Mol Neuropharmacol Grp, DK-2200 Copenhagen, Denmark; [Hastrup, Hanne; Gether, Ulrik] Univ Copenhagen, Dept Pharmacol, Panum Inst, DK-2200 Copenhagen, Denmark	Max Planck Society; Medical University of Vienna; University of Copenhagen; University of Copenhagen; University of Copenhagen	Sitte, HH (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, Deutschordenstr 46, D-60529 Frankfurt, Germany.	harald.sitte@meduniwien.ac.at; eulenburg@mpih-frankfurt.mpg.de	Sitte, Harald/N-2681-2013; Sitte, Harald/O-7025-2019; Eulenburg, Volker/B-7263-2013; Eulenburg, Volker/B-7263-2013	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Eulenburg, Volker/0000-0002-4878-5746; Nicke, Annette/0000-0001-6798-505X; Dutertre, Sebastien/0000-0002-2945-1484; Eulenburg, Volker/0000-0001-6314-566X; Jha, Alok/0000-0001-7600-7127; Gether, Ulrik/0000-0002-0020-3807	Austrian Science Fund FWF [P 18706] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Aragon C, 1998, METHOD ENZYMOL, V296, P3; Armsen W, 2007, MOL CELL NEUROSCI, V36, P369, DOI 10.1016/j.mcn.2007.07.011; Cai GQ, 2005, FEBS J, V272, P1625, DOI 10.1111/j.1742-4658.2005.04595.x; Dingledine R, 1990, Adv Exp Med Biol, V268, P17; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Ebihara S, 2004, BIOCHEM BIOPH RES CO, V317, P857, DOI 10.1016/j.bbrc.2004.03.125; Eulenburg V, 2005, TRENDS BIOCHEM SCI, V30, P325, DOI 10.1016/j.tibs.2005.04.004; Eulenburg V, 2006, BIOCHEM BIOPH RES CO, V348, P400, DOI 10.1016/j.bbrc.2006.07.080; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; FERNANDEZ S, 2007, BIOCHEM J, V409, P669; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fornes A, 2004, J BIOL CHEM, V279, P22934, DOI 10.1074/jbc.M401337200; Gabernet L, 2005, NEUROSCI LETT, V373, P79, DOI 10.1016/j.neulet.2004.09.064; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; GIROS B, 1992, MOL PHARMACOL, V42, P383; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Hahn MK, 2003, J NEUROSCI, V23, P4470; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Horiuchi M, 2001, P NATL ACAD SCI USA, V98, P1448, DOI 10.1073/pnas.041329498; Jess U, 1996, FEBS LETT, V394, P44, DOI 10.1016/0014-5793(96)00916-7; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Korkhov VM, 2004, J BIOL CHEM, V279, P55728, DOI 10.1074/jbc.M409449200; LOPEZCORCUERA B, 1993, J BIOL CHEM, V268, P2239; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; NUNEZ E, 1994, J BIOL CHEM, V269, P16920; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Schmid JA, 2003, CURR OPIN ONCOL, V15, P55, DOI 10.1097/00001622-200301000-00008; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Tsai G, 2004, P NATL ACAD SCI USA, V101, P8485, DOI 10.1073/pnas.0402662101; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	45	47	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10978	10991		10.1074/jbc.M800622200	http://dx.doi.org/10.1074/jbc.M800622200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18252709	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000254894700079
J	Piantadosi, CA; Suliman, HB				Piantadosi, Claude A.; Suliman, Hagir B.			Transcriptional regulation of SDHa flavoprotein by nuclear respiratory factor-1 prevents pseudo-hypoxia in aerobic cardiac cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR-I; CONTROLLING MITOCHONDRIAL BIOGENESIS; SUCCINATE-DEHYDROGENASE; GENE-EXPRESSION; COMPLEX-II; SIGNAL-TRANSDUCTION; PROLYL HYDROXYLASE; ACTIVATION; OXYGEN; CHAIN	Nuclear respiratory factor-1 (NRF-1) is integral to the transcriptional regulation of mitochondrial biogenesis, but its control over various respiratory genes overlaps other regulatory elements including those involved in O-2 sensing. Aerobic metabolism generally suppresses hypoxia-sensitive genes, e. g. via hypoxia-inducible factor-1 (HIF-1), but mutations in Complex II-succinate dehydrogenase (SDH), a tumor suppressor, stabilize HIF-1, producing pseudo-hypoxia. In aerobic cardiomyocytes, which rely on oxidative phosphorylation, we tested the hypothesis that NRF-1 regulates Complex II expression and opposes hypoxia-inducible factor-1. NRF-1 gene silencing blocked aerobic succinate oxidation, increasing nuclear HIF-1 alpha protein prior to the loss of Complex I function. We postulated that NRF-1 suppression either specifically decreases the expression of one or more SDH subunits and increases succinate availability to regulate HIF-1 prolyl hydroxylases, or stimulates mitochondrial reactive oxygen production, which interferes with HIF-1 alpha degradation. Using promoter analysis, gene silencing, and chromatin immunoprecipitation, NRF-1 was found to bind to the gene promoters of two of four nuclear-encoded Complex II subunits: SDHa and SDHd, but the enzyme activity was dynamically regulated through the catalytic SDHa flavoprotein. Complex II was inactivated by SDHa silencing, which led to aerobic HIF-1 alpha stabilization, nuclear translocation, and enhanced expression of glucose transporters and heme oxygenase-1. This was unrelated to mitochondrial ROS production, reversible by high alpha-ketoglutarate concentrations, and coherent with regulation of HIF-1 by succinate reported in tumor cells. These findings disclose a novel role for NRF-1 in the transcriptional control of Complex II and prevention of pseudo-hypoxic gene expression in aerobic cardiac cells.	[Piantadosi, Claude A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Suliman, Hagir B.] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27710 USA; [Suliman, Hagir B.] Durham Veterans Adm Med Ctr, Durham, NC 27710 USA	Duke University; Duke University	Piantadosi, CA (corresponding author), Duke Univ, Med Ctr, Dept Med, CR 2 Bldg,Box 3315, Durham, NC 27710 USA.	piant001@mc.duke.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090679] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL090679] Funding Source: Medline; PHS HHS [P01 42-444] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANGELINI C, 1993, JPN HEART J, V34, P63; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Briere JJ, 2005, HUM MOL GENET, V14, P3263, DOI 10.1093/hmg/ddi359; BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Frederiksen CM, 2003, J CANCER RES CLIN, V129, P263, DOI 10.1007/s00432-003-0434-x; Gao L, 2004, FEBS LETT, V569, P256, DOI 10.1016/j.febslet.2004.06.004; Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Habano W, 2003, ONCOL REP, V10, P1375; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hammerman PS, 2004, TRENDS BIOCHEM SCI, V29, P586, DOI 10.1016/j.tibs.2004.09.008; HOHL C, 1987, ARCH BIOCHEM BIOPHYS, V259, P527, DOI 10.1016/0003-9861(87)90519-4; Janssen RJRJ, 2004, EXPERT REV MOL DIAGN, V4, P143, DOI 10.1586/14737159.4.2.143; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Li HY, 2001, CELL MOTIL CYTOSKEL, V48, P11, DOI 10.1002/1097-0169(200101)48:1<11::AID-CM2>3.0.CO;2-I; Malhotra R, 1999, J BIOL CHEM, V274, P12567, DOI 10.1074/jbc.274.18.12567; Mathupala SP, 1997, J BIOL CHEM, V272, P22776, DOI 10.1074/jbc.272.36.22776; Menard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063; Mizuarai S, 2005, J BIOL CHEM, V280, P32434, DOI 10.1074/jbc.M503152200; Mole DR, 2003, BIOORG MED CHEM LETT, V13, P2677, DOI 10.1016/S0960-894X(03)00539-0; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Robey RB, 2005, CELL CYCLE, V4, P654, DOI 10.4161/cc.4.5.1678; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Selak MA, 2006, BBA-BIOENERGETICS, V1757, P567, DOI 10.1016/j.bbabio.2006.05.015; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200; Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wang CG, 2006, P NATL ACAD SCI USA, V103, P11567, DOI 10.1073/pnas.0603363103; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	53	37	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10967	10977		10.1074/jbc.M709741200	http://dx.doi.org/10.1074/jbc.M709741200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18252725	hybrid, Green Published			2022-12-27	WOS:000254894700078
J	Vinge, LE; Von Lueder, TG; Aasum, E; Qvigstad, E; Gravning, JA; How, OJ; Edvardsen, T; Bjornerheim, R; Ahmed, MS; Mikkelsen, BW; Oie, E; Attramadal, T; Skomedal, T; Smiseth, OA; Koch, WJ; Larsen, TS				Vinge, Leif Erik; Von Lueder, Thomas G.; Aasum, Ellen; Qvigstad, Eirik; Gravning, Jorgen A.; How, Ole-Jakob; Edvardsen, Thor; Bjornerheim, Reidar; Ahmed, M. Shakil; Mikkelsen, Birthe W.; Oie, Erik; Attramadal, Toril; Skomedal, Tor; Smiseth, Otto A.; Koch, Walter J.; Larsen, Terje S.		Havard Attramadal	Cardiac-restricted expression of the carboxyl-terminal fragment of GRK3 uncovers distinct functions of GRK3 in regulation of cardiac contractility and growth - GRK3 controls cardiac alpha(1)-adrenergic receptor responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; ALPHA(1B)-ADRENERGIC RECEPTOR; TRANSGENIC MICE; BLOOD-PRESSURE; HEART-FAILURE; G-PROTEINS; HYPERTROPHY; KINASE; OVEREXPRESSION; PHOSPHORYLATION	G protein-coupled receptor kinase-2 and -3 (GRK2 and GRK3) in cardiac myocytes catalyze phosphorylation and desensitization of different G protein-coupled receptors through specificity controlled by their carboxyl-terminal pleckstrin homology domain. Although GRK2 has been extensively investigated, the function of cardiac GRK3 remains unknown. Thus, in this study cardiac function of GRK3 was investigated in transgenic (Tg) mice with cardiac-restricted expression of a competitive inhibitor of GRK3, i.e. the carboxyl-terminal plasma membrane targeting domain of GRK3 (GRK3ct). Cardiac myocytes from Tg-GRK3ct mice displayed significantly enhanced agonist-stimulated alpha(1)-adrenergic receptor-mediated activation of ERK1/2 versus cardiac myocytes from nontransgenic littermate control (NLC) mice consistent with inhibition of GRK3. Tg-GRK3ct mice did not display alterations of cardiac mass or left ventricular dimensions compared with NLC mice. Tail-cuff plethysmography of 3- and 9-month-old mice revealed elevated systolic blood pressure in Tg-GRK3ct mice versus control mice (3- month-old mice, 136.8 +/- 3.6 versus 118.3 +/- 4.7 mm Hg, p < 0.001), an observation confirmed by radiotelemetric recording of blood pressure of conscious, unrestrained mice. Simultaneous recording of left ventricular pressure and volume in vivo by miniaturized conductance micromanometry revealed increased systolic performance with significantly higher stroke volume and stroke work in Tg-GRK3ct mice than in NLC mice. This phenotype was corroborated in electrically paced ex vivo perfused working hearts. However, analysis of left ventricular function ex vivo as a function of increasing filling pressure disclosed significantly reduced (dP/dt)(min) and prolonged time constant of relaxation (tau) in Tg-GRK3ct hearts at elevated supraphysiological filling pressure compared with control hearts. Thus, inhibition of GRK3 apparently reduces tolerance to elevation of preload. In conclusion, inhibition of cardiac GRK3 causes hypertension because of hyperkinetic myocardium and increased cardiac output relying at least partially on cardiac myocyte alpha(1)-adrenergic receptor hyper-responsiveness. The reduced tolerance to elevation of preload may cause impaired ability to withstand pathophysiological mechanisms of heart failure.	Rikshosp Radiumhosp Med Ctr, Inst Surg Res, N-0027 Oslo, Norway; Univ Oslo, N-0027 Oslo, Norway; [Von Lueder, Thomas G.; Edvardsen, Thor; Oie, Erik; Smiseth, Otto A.] Rikshosp Radiumhosp Med Ctr, Dept Cardiol, N-0027 Oslo, Norway; [Aasum, Ellen] Univ Tromso, Dept Med Physiol, N-9037 Tromso, Norway; [Qvigstad, Eirik; Skomedal, Tor] Univ Oslo, Dept Pharmacol, N-0316 Oslo, Norway; [Bjornerheim, Reidar] Ullevaal Univ Hosp, Dept Cardiol, N-0407 Oslo, Norway; [Koch, Walter J.] Jefferson Med Coll, Ctr Translat Med, Philadelphia, PA 19107 USA	University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University of Oslo; University of Oslo; Jefferson University	Vinge, LE (corresponding author), Rikshosp Radiumhosp Med Ctr, Inst Surg Res, N-0027 Oslo, Norway.		Edvardsen, Thor/A-1876-2008; Edvardsen, Thor/F-4079-2012	Edvardsen, Thor/0000-0002-3800-765X; Attramadal, Havard/0000-0001-9506-0687				Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Andersen GO, 2002, AM J PHYSIOL-HEART C, V283, pH1471, DOI 10.1152/ajpheart.00232.2002; Arnett DK, 2001, HYPERTENSION, V38, P767, DOI 10.1161/hy1001.092650; Eckhart AD, 2000, CIRC RES, V86, P43, DOI 10.1161/01.RES.86.1.43; Gan XQ, 2000, J BIOL CHEM, V275, P8469, DOI 10.1074/jbc.275.12.8469; Georgakopoulos D, 1998, AM J PHYSIOL-HEART C, V274, pH1416, DOI 10.1152/ajpheart.1998.274.4.H1416; Grupp IL, 1998, AM J PHYSIOL-HEART C, V275, pH1338, DOI 10.1152/ajpheart.1998.275.4.H1338; How OJ, 2005, AM J PHYSIOL-HEART C, V288, pH2979, DOI 10.1152/ajpheart.00084.2005; Iaccarino G, 1998, AM J PHYSIOL-HEART C, V275, pH1298, DOI 10.1152/ajpheart.1998.275.4.H1298; IKEDA U, 1991, AM J PHYSIOL, V260, pH953, DOI 10.1152/ajpheart.1991.260.3.H953; JULIUS S, 1988, AM HEART J, V116, P600, DOI 10.1016/0002-8703(88)90557-1; Keys JR, 2002, HYPERTENSION, V40, P660, DOI 10.1161/01.HYP.0000035397.73223.CE; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lemire I, 2001, AM J PHYSIOL-HEART C, V281, pH931, DOI 10.1152/ajpheart.2001.281.2.H931; Lin G, 2001, CIRC RES, V89, P343, DOI 10.1161/hh1601.095912; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; Mills PA, 2000, J APPL PHYSIOL, V88, P1537, DOI 10.1152/jappl.2000.88.5.1537; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; Vinge LE, 2001, AM J PHYSIOL-HEART C, V281, pH2490, DOI 10.1152/ajpheart.2001.281.6.H2490; Vinge LE, 2007, MOL PHARMACOL, V72, P582, DOI 10.1124/mol.107.035766; Walker JKL, 1999, AM J PHYSIOL-REG I, V276, pR1214, DOI 10.1152/ajpregu.1999.276.4.R1214	26	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10601	10610		10.1074/jbc.M708912200	http://dx.doi.org/10.1074/jbc.M708912200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18165681	hybrid			2022-12-27	WOS:000254894700042
J	Sprague, CR; Fraley, TS; Jang, HS; Lal, S; Greenwood, JA				Sprague, Chelsea R.; Fraley, Tamara S.; Jang, Hyo Sang; Lal, Sangeet; Greenwood, Jeffrey A.			Phosphoinositide binding to the substrate regulates susceptibility to proteolysis by calpain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ACTININ; CELL-MIGRATION; MU-CALPAIN; PROTEIN; KINASE; MEMBRANE; IDENTIFICATION; ACTIVATION; 3-KINASE; LOCALIZATION	Calpain-mediated proteolysis regulates cytoskeletal dynamics and is altered during aging and the progression of numerous diseases or pathological conditions. Although several cytoskeletal proteins have been identified as substrates, how localized calpain activity is regulated and the mechanisms controlling substrate recognition are not clear. In this study, we report that phosphoinositide binding regulates the susceptibility of the cytoskeletal adhesion protein alpha-actinin to proteolysis by calpains 1 and 2. At first, alpha-actinin did not appear to be a substrate for calpain 2; however, phosphatidylinositol 3,4,5-trisphosphate ( PtdIns( 3,4,5) P-3) binding to alpha-actinin resulted in nearly complete proteolysis of the full-length protein, producing stable breakdown products. Calpain 1 was able to cleave alpha-actinin in the absence of phosphoinositide binding; however, PtdIns( 3,4,5) P-3 binding increased the rate of proteolysis, and phosphatidylinositol 4,5-diphosphate ( PtdIns( 4,5)P-2) binding significantly inhibited cleavage. Phosphoinositide binding appeared to regulate calpain proteolysis of alpha-actinin by modulating the exposure of a highly sensitive cleavage site within the calponin homology 2 domain. In U87MG glioblastoma cells, which contain elevated levels of PtdIns( 3,4,5) P-3, alpha-actinin colocalized with calpain within dynamic actin cytoskeletal structures. Furthermore, proteolysis of alpha-actinin producing stable breakdown products was observed in U87MG cells treated with calcium ionophore to activate the calcium-dependent calpains. Additional evidence of PtdIns( 3,4,5) P-3-mediated calpain proteolysis of alpha-actinin was observed in rat embryonic fibroblasts. These results suggest that PtdIns( 3,4,5) P-3 binding is a critical determinant for alpha-actinin proteolysis by calpain. In conclusion, phosphoinositide binding to the substrate is a potential mechanism for regulating susceptibility to proteolysis by calpain.	[Sprague, Chelsea R.; Fraley, Tamara S.; Jang, Hyo Sang; Lal, Sangeet; Greenwood, Jeffrey A.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Greenwood, JA (corresponding author), Oregon State Univ, Dept Biochem & Biophys, ALS 2011, Corvallis, OR 97331 USA.	jeffrey.greenwood@orst.edu		Jang, Hyo Sang/0000-0003-0460-9924; Greenwood, Juliet/0000-0001-6438-964X	Howard Hughes Medical Institute [52003741] Funding Source: Medline; NIEHS NIH HHS [P30 ES 00210] Funding Source: Medline; NIGMS NIH HHS [GM 63711] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063711] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aki T, 2002, J BIOCHEM, V132, P921, DOI 10.1093/oxfordjournals.jbchem.a003305; BECKERLE MC, 1987, CELL, V51, P569, DOI 10.1016/0092-8674(87)90126-7; Borrego-Diaz E, 2006, J STRUCT BIOL, V155, P230, DOI 10.1016/j.jsb.2006.01.013; Corgan AM, 2004, BIOCHEM J, V378, P1067, DOI 10.1042/BJ20031124; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; EDMUNDS T, 1991, BIOCHIM BIOPHYS ACTA, V1077, P197, DOI 10.1016/0167-4838(91)90059-9; FERAMISCO JR, 1980, J BIOL CHEM, V255, P1194; Flanagan LA, 1997, BIOPHYS J, V73, P1440, DOI 10.1016/S0006-3495(97)78176-1; FOX JEB, 1985, J BIOL CHEM, V260, P1060; Fraley TS, 2005, J BIOL CHEM, V280, P15479, DOI 10.1074/jbc.M500631200; Fraley TS, 2003, J BIOL CHEM, V278, P24039, DOI 10.1074/jbc.M213288200; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Greenwood JA, 2000, J CELL BIOL, V150, P627, DOI 10.1083/jcb.150.3.627; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; MCGREGOR A, 1994, BIOCHEM J, V301, P225, DOI 10.1042/bj3010225; Nuzzi PA, 2007, MOL BIOL CELL, V18, P795, DOI 10.1091/mbc.E06-09-0876; OHALLORAN T, 1985, NATURE, V317, P449, DOI 10.1038/317449a0; ONJI T, 1987, BIOCHIM BIOPHYS ACTA, V912, P283, DOI 10.1016/0167-4838(87)90099-9; Palecek SP, 1998, J CELL SCI, V111, P929; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; Ronnstrand L, 2001, INT J CANCER, V91, P757, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1136>3.0.CO;2-J; SAIDO TC, 1991, BIOMED BIOCHIM ACTA, V50, P485; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; Selliah N, 1996, J IMMUNOL, V156, P3215; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Shiraha H, 1999, J CELL BIOL, V146, P243; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Tang JH, 2001, J MOL BIOL, V310, P845, DOI 10.1006/jmbi.2001.4789; Tompa P, 2001, BIOCHEM BIOPH RES CO, V280, P1333, DOI 10.1006/bbrc.2001.4279; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; vonWillebrand M, 1996, EUR J BIOCHEM, V235, P828; Wu MQ, 2006, FEBS LETT, V580, P3246, DOI 10.1016/j.febslet.2006.05.003; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Young P, 2000, EMBO J, V19, P6331, DOI 10.1093/emboj/19.23.6331; Zamir E, 2001, J CELL SCI, V114, P3583	49	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9217	9223		10.1074/jbc.M707436200	http://dx.doi.org/10.1074/jbc.M707436200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18258589	Green Published, hybrid			2022-12-27	WOS:000254465800051
J	Moss, BL; Gross, S; Gammon, ST; Vinjamoori, A; Piwnica-Worms, D				Moss, Britney L.; Gross, Shimon; Gammon, Seth T.; Vinjamoori, Anant; Piwnica-Worms, David			Identification of a ligand-induced transient refractory period in nuclear factor-kappa B signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; CANCER DEVELOPMENT; TEMPORAL CONTROL; GENE-EXPRESSION; KINASE-ACTIVITY; IKK-BETA; ALPHA; CELLS; ACTIVATION; DYNAMICS	In response to a variety of extracellular ligands, nuclear factor-kappa B (NF-kappa B) signaling regulates inflammation, cell proliferation, and apoptosis. It is likely that cells are not continuously exposed to stimulating ligands in vivo but rather experience transient pulses. To study the temporal regulation of NF-kappa B and its major regulator, inhibitor of NF-kappa B alpha(I kappa B alpha), in real time, we utilized a novel transcriptionally coupled I kappa B alpha-firefly luciferase fusion reporter and characterized the dynamics and responsiveness of I kappa B alpha processing upon a short 30-s pulse of tumor necrosis factor alpha( TNF alpha) or a continuous challenge of TNF alpha following a 30-s preconditioning pulse. Strikingly, a 30-s pulse of TNF alpha robustly activated inhibitor of NF-kappa B kinase (IKK), leading to I kappa B alpha degradation, NF-kappa B nuclear translocation, and strong transcriptional up-regulation of I kappa B alpha. Furthermore, we identified a transient refractory period (lasting up to 120 min) following preconditioning, during which the cells were not able to fully degrade I kappa B alpha upon a second TNF alpha challenge. Kinase assays of IKK activity revealed that regulation of IKK activity correlated in part with this transient refractory period. In contrast, experiments involving sequential exposure to TNF alpha and interleukin-1 alpha indicated that receptor dynamics could not explain this phenomenon. Utilizing a well accepted computational model of NF-kappa B dynamics, we further identified an additional layer of regulation, downstream of IKK, that may govern the temporal capacity of cells to respond to a second proinflammatory insult. Overall, the data suggested that nuclear export of NF-kappa B.I kappa B alpha complexes represented another rate-limiting step that may impact this refractory period, thereby providing an additional regulatory mechanism.	[Moss, Britney L.; Gross, Shimon; Gammon, Seth T.; Vinjamoori, Anant; Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Mol Imaging Ctr, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Piwnica-Worms, D (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Mol Imaging Ctr, 510 S Kingshighway Blvd,Box 8225, St Louis, MO 63110 USA.	piwnica-wormsd@mir.wustl.edu	Gammon, Seth/C-8778-2014	Gammon, Seth/0000-0001-8647-0975; Moss, Britney/0000-0002-1037-5717	NCI NIH HHS [P50 CA 94056] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERTS B, 1994, MOL BIOL CELL, P771; Barken D, 2005, SCIENCE, V308, DOI 10.1126/science.1107904; Blanque R, 1998, GEN PHARMACOL, V31, P301, DOI 10.1016/S0306-3623(97)00434-5; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dri P, 2000, J IMMUNOL, V165, P2165, DOI 10.4049/jimmunol.165.4.2165; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HIGUCHI M, 1994, J IMMUNOL, V152, P3550; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; HOLTMANN H, 1987, J IMMUNOL, V139, P1161; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karmann K, 1996, J EXP MED, V184, P173, DOI 10.1084/jem.184.1.173; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Naamane N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-55; Nejjari M, 1999, INT J CANCER, V83, P518, DOI 10.1002/(SICI)1097-0215(19991112)83:4<518::AID-IJC14>3.3.CO;2-H; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Pando MP, 2000, J BIOL CHEM, V275, P21278, DOI 10.1074/jbc.M002532200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Place RF, 2003, J CELL PHYSIOL, V195, P470, DOI 10.1002/jcp.10262; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Winsauer G, 2007, THROMB HAEMOSTASIS, V97, P364, DOI 10.1160/TH06-08-0473; Wullaert A, 2007, ENDOCR REV, V28, P365, DOI 10.1210/er.2006-0031; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang LP, 2006, J AM CHEM SOC, V128, P4766, DOI 10.1021/ja0580439	40	16	17	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8687	8698		10.1074/jbc.M706831200	http://dx.doi.org/10.1074/jbc.M706831200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18203717	hybrid, Green Published			2022-12-27	WOS:000254288000067
J	Lin, DH; Kamsteeg, EJ; Zhang, Y; Jin, Y; Sterling, H; Yue, P; Roos, M; Duffield, A; Spencer, J; Caplan, M; Wang, WH				Lin, Daohong; Kamsteeg, Erik-Jan; Zhang, Yan; Jin, Yan; Sterling, Hyacinth; Yue, Peng; Roos, Marcel; Duffield, Amy; Spencer, Joanna; Caplan, Michael; Wang, Wen-Hui			Expression of tetraspan protein CD63 activates protein-tyrosine kinase (PTK) and enhances the PTK-induced inhibition of ROMK channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIETARY K-INTAKE; POTASSIUM-TRANSPORT; DISTAL NEPHRON; RPTP-ALPHA; PHOSPHORYLATION; INTERNALIZATION; ENDOCYTOSIS; SECRETION; MEMBRANE; PKC	In the present study, we tested the role of CD63 in regulating ROMK1 channels by protein-tyrosine kinase (PTK). Immunocytochemical staining shows that CD63 and receptor-linked tyrosine phosphatase alpha(RPTP alpha) are expressed in the cortical collecting duct and outer medulla collecting duct. Immunoprecipitation of tissue lysates from renal cortex and outer medulla or 293T cells transfected with CD63 reveals that CD63 was associated with RPTP alpha both in situ and in transfected cells. Expression of CD63 in 293T cells stimulated the phosphorylation of tyrosine residue 416 of c-Src but decreased the phosphorylation of tyrosine residue 527, indicating that expression of CD63 stimulates the activity of c-Src. Furthermore, c-Src was coimmunoprecipitated with RPTP alpha and CD63 both in 293T cells transfected with CD63 and in lysates prepared from native rat kidney. Potassium restriction had no effect on the expression of RPTP alpha, but it increased the association between c-Src and RPTP alpha in the renal cortex and outer medulla. We also used two-electrode voltage clamp to study the effect of CD63 on ROMK channels in Xenopus oocytes. Expression of CD63 had no significant effect on potassium currents in oocytes injected with ROMK1; however, it significantly enhanced the c-Src-induced inhibition of ROMK channels in oocytes injected with ROMK1 + c-Src. The effect of CD63 on the c-Src-induced inhibition was not due to a decreased expression of ROMK1 channels, because blocking PTK with herbimycin A abolished the inhibitory effect of c-Src on ROMK channels in oocytes injected with ROMK1 + cSrc + CD63. Furthermore, coexpression of CD63 enhanced tyrosine phosphorylation of ROMK1. We conclude that CD63 plays a role in the regulation of ROMK channels through its association with RPTP alpha, which in turn interacts with and activates Src family PTK, thus reducing ROMK activity.	[Lin, Daohong; Zhang, Yan; Jin, Yan; Sterling, Hyacinth; Yue, Peng; Wang, Wen-Hui] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Kamsteeg, Erik-Jan; Roos, Marcel; Duffield, Amy; Spencer, Joanna; Caplan, Michael] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	New York Medical College; Yale University	Wang, WH (corresponding author), New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA.	wenhui_wang@nymc.edu		Duffield, Amy/0000-0003-2018-1964	NHLBI NIH HHS [P01 HL034300] Funding Source: Medline; NIDDK NIH HHS [R01 DK054983, DK54983, DK17433] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054983, P01DK017433] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babilonia E, 2005, J BIOL CHEM, V280, P10790, DOI 10.1074/jbc.M414610200; Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Brandt DT, 2003, J BIOL CHEM, V278, P34073, DOI 10.1074/jbc.M211650200; CARMO AM, 1995, EUR J IMMUNOL, V25, P2090, DOI 10.1002/eji.1830250743; Chu PY, 2003, AM J PHYSIOL-RENAL, V285, pF1179, DOI 10.1152/ajprenal.00150.2003; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; DAUM G, 1994, J BIOL CHEM, V269, P10524; Duffield A, 2003, P NATL ACAD SCI USA, V100, P15560, DOI 10.1073/pnas.2536699100; Flagg TP, 1999, J GEN PHYSIOL, V114, P685, DOI 10.1085/jgp.114.5.685; Giebisch G, 1998, AM J PHYSIOL-RENAL, V274, pF817, DOI 10.1152/ajprenal.1998.274.5.F817; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; HEIJNEN HF, 2003, J THROMB HAEMOST, V6, P1173; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Israels SJ, 2005, THROMB HAEMOSTASIS, V93, P311, DOI 10.1160/TH04-08-0503; KANEKO T, 1995, AM J PHYSIOL-RENAL, V268, pF1102, DOI 10.1152/ajprenal.1995.268.6.F1102; Kohda Y, 1998, KIDNEY INT, V54, P1214, DOI 10.1046/j.1523-1755.1998.00120.x; Lin DH, 2004, AM J PHYSIOL-RENAL, V286, pF881, DOI 10.1152/ajprenal.00301.2003; Lin DH, 2002, AM J PHYSIOL-RENAL, V283, pF671, DOI 10.1152/ajprenal.00160.2002; Macica CM, 1996, AM J PHYSIOL-RENAL, V271, pF588, DOI 10.1152/ajprenal.1996.271.3.F588; Moral Z, 2001, J BIOL CHEM, V276, P7156, DOI 10.1074/jbc.M008671200; Odintsova E, 2003, J CELL SCI, V116, P4557, DOI 10.1242/jcs.00793; Okochi H, 1999, J CLIN GASTROENTEROL, V29, P63, DOI 10.1097/00004836-199907000-00016; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Palmer LG, 1997, AM J PHYSIOL-RENAL, V273, pF404, DOI 10.1152/ajprenal.1997.273.3.F404; Palmer LG, 1999, AM J PHYSIOL-RENAL, V277, pF821, DOI 10.1152/ajprenal.1999.277.6.F821; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Sackin H, 2004, BIOPHYS J, V86, P2145, DOI 10.1016/S0006-3495(04)74274-5; Satlin LM, 1999, SEMIN NEPHROL, V19, P155; Skubitz KM, 1996, J IMMUNOL, V157, P3617; Sterling H, 2004, AM J PHYSIOL-RENAL, V286, pF1072, DOI 10.1152/ajprenal.00425.2003; Sterling H, 2002, J BIOL CHEM, V277, P4317, DOI 10.1074/jbc.M109739200; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang WH, 2000, AM J PHYSIOL-RENAL, V278, pF165, DOI 10.1152/ajprenal.2000.278.1.F165; Wei Y, 2001, AM J PHYSIOL-RENAL, V281, pF206, DOI 10.1152/ajprenal.2001.281.2.F206; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	37	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7674	7681		10.1074/jbc.M705574200	http://dx.doi.org/10.1074/jbc.M705574200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18211905	Green Published, hybrid			2022-12-27	WOS:000253997900043
J	Mishra, A; Dikshit, P; Purkayastha, S; Sharma, J; Nukina, N; Jana, NR				Mishra, Amit; Dikshit, Priyanka; Purkayastha, Sudarshana; Sharma, Jaiprakash; Nukina, Nobuyuki; Jana, Nihar Ranjan			E6-AP promotes misfolded polyglutamine proteins for proteasomal degradation and suppresses polyglutamine protein aggregation and toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BULBAR MUSCULAR-ATROPHY; ANDROGEN RECEPTOR PROTEIN; TRANSGENIC MOUSE MODEL; N-TERMINAL HUNTINGTIN; WILD-TYPE HUNTINGTIN; CO-CHAPERONE CHIP; UBIQUITIN LIGASE; EXPANDED POLYGLUTAMINE; E6-ASSOCIATED PROTEIN; AMELIORATES PHENOTYPES	The accumulation of intracellular protein deposits as inclusion bodies is the common pathological hallmark of most age-related neurodegenerative disorders including polyglutamine diseases. Appearance of aggregates of the misfolded mutant disease proteins suggest that cells are unable to efficiently degrade them, and failure of clearance leads to the severe disturbances of the cellular quality control system. Recently, the quality control ubiquitin ligase CHIP has been shown to suppress the polyglutamine protein aggregation and toxicity. Here we have identified another ubiquitin ligase, called E6-AP, which is able to promote the proteasomal degradation of misfolded polyglutamine proteins and suppress the polyglutamine protein aggregation and polyglutamine protein-induced cell death. E6-AP interacts with the soluble misfolded polyglutamine protein and associates with their aggregates in both cellular and transgenic mouse models. Partial knockdown of E6-AP enhances the rate of aggregate formation and cell death mediated by the polyglutamine protein. Finally, we have demonstrated the up-regulation of E6-AP in the expanded polyglutamine protein-expressing cells as well as cells exposed to proteasomal stress. These findings suggest that E6-AP is a critical mediator of the neuronal response to misfolded polyglutamine proteins and represents a potential therapeutic target in the polyglutamine diseases.	[Mishra, Amit; Dikshit, Priyanka; Purkayastha, Sudarshana; Sharma, Jaiprakash; Jana, Nihar Ranjan] Natl Brain Res Ctr, Mol & Cellular Neurosci Lab, Manesar 122050, Gurgaon, India; [Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); RIKEN	Jana, NR (corresponding author), Natl Brain Res Ctr, Mol & Cellular Neurosci Lab, Manesar 122050, Gurgaon, India.	nihar@nbrc.ac.in	Nukina, Nobuyuki/GPP-6265-2022	Mishra, Amit/0000-0001-9401-4400; Jana, Nihar/0000-0002-6549-4211				Adachi H, 2003, J NEUROSCI, V23, P2203; Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Bates GP, 2005, NAT REV GENET, V6, P766, DOI 10.1038/nrg1686; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Cattaneo E, 2003, NEWS PHYSIOL SCI, V18, P34, DOI 10.1152/nips.01410.2002; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dikshit P, 2007, BIOCHEM BIOPH RES CO, V357, P761, DOI 10.1016/j.bbrc.2007.04.018; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jana NR, 2003, J CHEM NEUROANAT, V26, P95, DOI 10.1016/S0891-0618(03)00029-2; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Khan OY, 2006, MOL ENDOCRINOL, V20, P544, DOI 10.1210/me.2005-0110; Kuhne C, 1998, J BIOL CHEM, V273, P34302, DOI 10.1074/jbc.273.51.34302; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Martin-Aparicio E, 2001, J NEUROSCI, V21, P8772, DOI 10.1523/JNEUROSCI.21-22-08772.2001; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Reiner A, 2003, MOL NEUROBIOL, V28, P259, DOI 10.1385/MN:28:3:259; Reiter LT, 2006, HUM MOL GENET, V15, P2825, DOI 10.1093/hmg/ddl225; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Wang GH, 1999, NEUROREPORT, V10, P2435, DOI 10.1097/00001756-199908200-00001; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	49	64	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7648	7656		10.1074/jbc.M706620200	http://dx.doi.org/10.1074/jbc.M706620200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18201976	hybrid			2022-12-27	WOS:000253997900040
J	Enesa, K; Zakkar, M; Chaudhury, H; Luong, LA; Rawlinson, L; Mason, JC; Haskard, DO; Dean, JLE; Evans, PC				Enesa, Karine; Zakkar, Mustafa; Chaudhury, Hera; Luong, Le A.; Rawlinson, Lesley; Mason, Justin C.; Haskard, Dorian O.; Dean, Jonathan L. E.; Evans, Paul C.			NF-kappa B suppression by the deubiquitinating enzyme Cezanne - A novel negative feedback loop in pro-inflammatory signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER PROTEIN A20; UBIQUITIN-DEPENDENT KINASE; SHEAR-STRESS; GENE-EXPRESSION; ACTIVATION; CYLD; IDENTIFICATION; OSCILLATIONS; INTERACTS; RESPONSES	Transcription factors belonging to the NF-kappa B family regulate inflammation by inducing pro-inflammatory molecules (e. g. interleukin (IL)-8) in response to cytokines (e. g. tumor necrosis factor (TNF) alpha, IL-1) or other stimuli. Several negative regulators of NF-kappa B, including the ubiquitin-editing enzyme A20, participate in the resolution of inflammatory responses. We report that Cezanne, a member of the A20 family of the deubiquitinating cysteine proteases, can be induced by TNF alpha in cultured cells. Silencing of endogenous Cezanne using small interfering RNA led to elevated NF-kappa B luciferase reporter gene activity and enhanced expression of IL-8 transcripts in TNF alpha-treated cells. Thus we conclude that endogenous Cezanne can attenuate NF-kappa B activation and the induction of pro-inflammatory transcripts in response to TNF receptor (TNFR) signaling. Overexpression studies revealed that Cezanne suppressed NF-kappa B nuclear translocation and transcriptional activity by targeting the TNFR signaling pathway at the level of the I kappa B kinase complex or upstream from it. These effects were not observed in a form of Cezanne that was mutated at the catalytic cysteine residue (Cys(209)), indicating that the deubiquitinating activity of Cezanne is essential for NF-kappa B regulation. Finally, we demonstrate that Cezanne can be recruited to activated TNFRs where it suppresses the build-up of polyubiquitinated RIP1 signal adapter proteins. Thus we conclude that Cezanne forms a novel negative feedback loop in pro-inflammatory signaling and that it suppresses NF-kappa B activation by targeting RIP1 signaling intermediaries for deubiquitination.	[Enesa, Karine; Zakkar, Mustafa; Chaudhury, Hera; Luong, Le A.; Mason, Justin C.; Haskard, Dorian O.; Evans, Paul C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, BHF Cardiocvasc Sci Unit, London W12 0NN, England; [Rawlinson, Lesley; Dean, Jonathan L. E.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, London W12 0NN, England	Imperial College London; Imperial College London; University of Oxford	Evans, PC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, BHF Cardiocvasc Sci Unit, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.	paul.evans@imperial.ac.uk		Mason, Justin/0000-0001-7783-1660	British Heart Foundation Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Alford KA, 2007, J BIOL CHEM, V282, P6232, DOI 10.1074/jbc.M610987200; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Evans Paul C., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009415; Evans PC, 2001, BIOCHEM J, V357, P617, DOI 10.1042/0264-6021:3570617; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Ganguli A, 2005, CIRC RES, V96, P626, DOI 10.1161/01.RES.0000160435.83210.95; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Partridge J, 2007, FASEB J, V21, P3553, DOI 10.1096/fj.06-8059com; Passerini AG, 2004, P NATL ACAD SCI USA, V101, P2482, DOI 10.1073/pnas.0305938101; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamawaki H, 2003, CIRCULATION, V108, P1619, DOI 10.1161/01.CIR.0000089373.49941.C4; Zetoune FS, 2001, CYTOKINE, V15, P282, DOI 10.1006/cyto.2001.0921; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	37	162	169	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7036	7045		10.1074/jbc.M708690200	http://dx.doi.org/10.1074/jbc.M708690200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18178551	hybrid			2022-12-27	WOS:000253779600048
J	Garapaty, S; Mahajan, MA; Samuels, HH				Garapaty, Shivani; Mahajan, Muktar A.; Samuels, Herbert H.			Components of the CCR4-NOT complex function as nuclear hormone receptor coactivators via association with the NRC-interacting factor NIF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TERMINAL A/B DOMAIN; THYROID-HORMONE; IN-VIVO; TRANSCRIPTIONAL COACTIVATOR; GENE-EXPRESSION; BINDING PROTEIN; MEDIATED TRANSCRIPTION; YEAST; ACTIVATION	CCR4-NOT is an evolutionarily conserved, multicomponent complex known to be involved in transcription as well as mRNA degradation. Various subunits (e.g. CNOT1 and CNOT7/CAF1) have been reported to be involved in influencing nuclear hormone receptor activities. Here, we show that CCR4/CNOT6 and RCD1/CNOT9, members of the CCR4-NOT complex, potentiate nuclear receptor activity. RCD1 interacts in vivo and in vitro with NIF-1 (NRC-interacting factor), a previously characterized nuclear receptor cotransducer that activates nuclear receptors via its interaction with NRC. As with NIF-1, RCD1 and CCR4 do not directly associate with nuclear receptors; however, they enhance ligand-dependent transcriptional activation by nuclear hormone receptors. CCR4 mediates its effect through the ligand binding domain of nuclear receptors and small interference RNA-mediated silencing of endogenous CCR4 results in a marked decrease in nuclear receptor activation. Furthermore, knockdown of CCR4 results in an attenuated stimulation of RAR alpha target genes ( e. g. Sox9 and HoxA1) as shown by quantitative PCR assays. The silencing of endogenous NIF-1 also resulted in a comparable decrease in the RAR-mediated induction of both Sox9 and HoxA1. Furthermore, CCR4 associates in vivo with NIF-1. In addition, the CCR4-enhanced transcriptional activation by nuclear receptors is dependent on NIF-1. The small interference RNA-mediated knockdown of NIF-1 blocks the ligand-dependent potentiating effect of CCR4. Our results suggest that CCR4 plays a role in the regulation of certain endogenous RAR alpha target genes and that RCD1 and CCR4 might mediate their function through their interaction with NIF-1.	[Garapaty, Shivani; Mahajan, Muktar A.; Samuels, Herbert H.] NYU, Sch Med, Dept Med & Pharmacol, New York, NY 10016 USA	New York University	Samuels, HH (corresponding author), NYU, Sch Med, Dept Pharmacol, 550 First Ave,MSB 424, New York, NY 10016 USA.	samuels@med.nyu.edu		Mahajan, Muktar/0000-0003-1024-6808	NIDDK NIH HHS [DK 16636] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK016636, R37DK016636, R01DK016636] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Acconcia F, 2006, CANCER LETT, V238, P1, DOI 10.1016/j.canlet.2005.06.018; Afonja O, 2002, ONCOGENE, V21, P7850, DOI 10.1038/sj.onc.1205985; Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Aoyagi S, 2005, VITAM HORM, V70, P281, DOI 10.1016/S0083-6729(05)70009-1; Badarinarayana V, 2000, GENETICS, V155, P1045; Belakavadi M, 2006, REV PHYSIOL BIOCH P, V156, P23, DOI 10.1007/s10254-005-0002-7; Berthet C, 2004, MOL CELL BIOL, V24, P5808, DOI 10.1128/MCB.24.13.5808-5820.2004; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Blazek E, 2005, CHROMOSOMA, V113, P399, DOI 10.1007/s00412-005-0329-5; Caira F, 2000, J BIOL CHEM, V275, P5308, DOI 10.1074/jbc.275.8.5308; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chang TC, 2004, GENE DEV, V18, P2010, DOI 10.1101/gad.1219104; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chen JJ, 2001, J MOL BIOL, V314, P683, DOI 10.1006/jmbi.2001.5162; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Chen YH, 2006, CANCER RES, V66, P8749, DOI 10.1158/0008-5472.CAN-06-0581; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; DENIS CL, 1984, GENETICS, V108, P833; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Flamant F, 2007, MOL ENDOCRINOL, V21, P321, DOI 10.1210/me.2006-0035; Fu MF, 2004, BIOCHEM PHARMACOL, V68, P1199, DOI 10.1016/j.bcp.2004.05.037; Garces RG, 2007, PROTEIN SCI, V16, P176, DOI 10.1110/ps.062600507; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Goodson Michael, 2005, Nucl Recept Signal, V3, pe003; Hadzic E, 1998, J BIOL CHEM, V273, P10270, DOI 10.1074/jbc.273.17.10270; Hager GL, 2004, BBA-GENE STRUCT EXPR, V1677, P46, DOI 10.1016/j.bbaexp.2003.09.016; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Herdick M, 2000, J MOL BIOL, V304, P793, DOI 10.1006/jmbi.2000.4267; Hiroi N, 2002, EMBO J, V21, P5235, DOI 10.1093/emboj/cdf521; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Inoue A, 2002, J MOL ENDOCRINOL, V29, P175, DOI 10.1677/jme.0.0290175; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Jayne S, 2006, BIOCHEM J, V398, P461, DOI 10.1042/BJ20060406; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; Kim H, 2005, ONCOGENE, V24, P5629, DOI 10.1038/sj.onc.1208718; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Kuang SQ, 2002, J BIOL CHEM, V277, P45356, DOI 10.1074/jbc.C200509200; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Li DS, 2004, MOL CELL BIOL, V24, P3838, DOI 10.1128/MCB.24.9.3838-3848.2004; Li DS, 1999, MOL CELL BIOL, V19, P7191; Liu HY, 2001, J BIOL CHEM, V276, P7541, DOI 10.1074/jbc.M009112200; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Lonard DM, 2005, TRENDS BIOCHEM SCI, V30, P126, DOI 10.1016/j.tibs.2005.01.001; Mahajan MA, 2005, ENDOCR REV, V26, P583, DOI 10.1210/er.2004-0012; Mahajan MA, 2002, MOL CELL BIOL, V22, P6883, DOI 10.1128/MCB.22.19.6883-6894.2002; Mahajan MA, 2000, MOL CELL BIOL, V20, P5048, DOI 10.1128/MCB.20.14.5048-5063.2000; Mahajan MA, 2007, MOL ENDOCRINOL, V21, P1822, DOI 10.1210/me.2005-0529; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Morel AP, 2003, J CELL SCI, V116, P2929, DOI 10.1242/jcs.00480; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Nakamura T, 2004, NAT GENET, V36, P528, DOI 10.1038/ng1344; Okazaki N, 1998, MOL CELL BIOL, V18, P887, DOI 10.1128/MCB.18.2.887; ONATE SA, 1995, SCIENCE, V270, P1354; Prevot D, 2001, J BIOL CHEM, V276, P9640, DOI 10.1074/jbc.M008201200; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Stallcup MR, 2003, J STEROID BIOCHEM, V85, P139, DOI 10.1016/S0960-0760(03)00222-X; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Takeshita A, 1996, ENDOCRINOLOGY, V137, P3594, DOI 10.1210/en.137.8.3594; Tian HH, 2006, MOL ENDOCRINOL, V20, P2036, DOI 10.1210/me.2005-0437; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Ugai H, 1999, J MOL MED, V77, P481, DOI 10.1007/s001099900021; Urahama N, 2005, GENES CELLS, V10, P1127, DOI 10.1111/j.1365-2443.2005.00906.x; Warnmark A, 2003, MOL ENDOCRINOL, V17, P1901, DOI 10.1210/me.2002-0384; Winkler GS, 2006, EMBO J, V25, P3089, DOI 10.1038/sj.emboj.7601194; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Xu W, 2005, BIOCHEM CELL BIOL, V83, P418, DOI 10.1139/O05-057; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zhu YJ, 2000, J BIOL CHEM, V275, P13510, DOI 10.1074/jbc.275.18.13510; Zwartjes CGM, 2004, J BIOL CHEM, V279, P10848, DOI 10.1074/jbc.M311747200	83	33	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6806	6816		10.1074/jbc.M706986200	http://dx.doi.org/10.1074/jbc.M706986200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18180299	hybrid			2022-12-27	WOS:000253779600023
J	Hwang, SK; Nagai, Y; Kim, D; Okita, TW				Hwang, Seon-Kap; Nagai, Yasuko; Kim, Dongwook; Okita, Thomas W.			Direct appraisal of the potato tuber ADP-glucose pyrophosphorylase large subunit in enzyme function by study of a novel mutant form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL REDOX-MODIFICATION; ADPGLUCOSE PYROPHOSPHORYLASE; ESCHERICHIA-COLI; STARCH SYNTHESIS; CRYSTAL-STRUCTURE; MUTAGENESIS; ACTIVATION; SITE; MECHANISM; ACID	The higher plant ADP-glucose pyrophosphorylase is a heterotetramer consisting of two subunit types, which have evolved at different rates from a common ancestral gene. The potato tuber small subunit ( SS) displays both catalytic and regulatory properties, whereas the exact role of the large subunit (LS), which contains substrate and effector binding sites, remains unresolved. We identified a mutation, S302N, which increased the solubility of the recombinant potato tuber LS and, in turn, enabling it to form a homotetrameric structure. The LS302N homotetramer possesses very little enzyme activity at a level 100-fold less than that seen for the unactivated SS homotetramer. Unlike the SS enzyme, however, the LS302N homotetramer enzyme is neither activated by the effector 3-phosphoglycerate nor inhibited by Pi. When combined with the catalytically silenced SS, S-D143N, however, the LS302N-containing enzyme shows significantly enhanced catalytic activity and restored 3-PGA activation. This unmasking of catalytic and regulatory potential of the LS is conspicuously evident when the activities of the resurrected L-K41R.T51K.S302N homotetramer are compared with its heterotetrameric form assembled with S-D143N. Overall, these results indicate that the LS possesses catalytic and regulatory properties only when assembled with SS and that the net properties of the heterotetrameric enzyme is a product of subunit synergy.	[Hwang, Seon-Kap; Nagai, Yasuko; Kim, Dongwook; Okita, Thomas W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Okita, TW (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	okita@wsu.edu		Okita, Tom/0000-0002-2246-0599; Hwang, Paul/0000-0001-9552-5341				BALL K, 1994, J BIOL CHEM, V269, P24706; Ballicora MA, 2005, J BIOL CHEM, V280, P10189, DOI 10.1074/jbc.M413540200; Ballicora MA, 1998, PLANT PHYSIOL, V118, P265, DOI 10.1104/pp.118.1.265; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2000, J BIOL CHEM, V275, P1315, DOI 10.1074/jbc.275.2.1315; Blankenfeldt W, 2000, EMBO J, V19, P6652, DOI 10.1093/emboj/19.24.6652; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; Burger BT, 2003, PLANTA, V217, P449, DOI 10.1007/s00425-003-1000-0; Cross JM, 2004, PLANT PHYSIOL, V135, P137, DOI 10.1104/pp.103.036699; Doan DNP, 1999, PLANT PHYSIOL, V121, P965, DOI 10.1104/pp.121.3.965; Frueauf JB, 2003, PLANT J, V33, P503, DOI 10.1046/j.1365-313X.2003.01643.x; Frueauf JB, 2001, J BIOL CHEM, V276, P46319, DOI 10.1074/jbc.M107408200; Fu YB, 1998, PLANT PHYSIOL, V117, P989, DOI 10.1104/pp.117.3.989; Fu YB, 1998, J BIOL CHEM, V273, P25045, DOI 10.1074/jbc.273.39.25045; Geigenberger P, 2005, J EXP BOT, V56, P1469, DOI 10.1093/jxb/eri178; Georgelis N, 2007, PLANT CELL, V19, P1458, DOI 10.1105/tpc.106.049676; Gomez-Casati DF, 2000, ARCH BIOCHEM BIOPHYS, V384, P319, DOI 10.1006/abbi.2000.2101; Greene TW, 1998, P NATL ACAD SCI USA, V95, P10322, DOI 10.1073/pnas.95.17.10322; Greene TW, 1996, P NATL ACAD SCI USA, V93, P1509, DOI 10.1073/pnas.93.4.1509; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Hwang SK, 2007, PHYTOCHEMISTRY, V68, P464, DOI 10.1016/j.phytochem.2006.11.027; Hwang SK, 2006, FEBS LETT, V580, P6741, DOI 10.1016/j.febslet.2006.11.029; Hwang SK, 2005, FEBS LETT, V579, P983, DOI 10.1016/j.febslet.2004.12.067; Hwang SK, 2004, PROTEIN EXPRES PURIF, V38, P99, DOI 10.1016/j.pep.2004.07.018; IGLESIAS AA, 1993, J BIOL CHEM, V268, P1081; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; LACOGNATA U, 1995, MOL GEN GENET, V246, P538, DOI 10.1007/BF00298960; OKITA TW, 1990, PLANT PHYSIOL, V93, P785, DOI 10.1104/pp.93.2.785; Salamone PR, 2000, FEBS LETT, V482, P113, DOI 10.1016/S0014-5793(00)01985-2; Salamone PR, 2002, P NATL ACAD SCI USA, V99, P1070, DOI 10.1073/pnas.012603799; Slattery CJ, 2000, TRENDS PLANT SCI, V5, P291, DOI 10.1016/S1360-1385(00)01657-5; Tiessen A, 2002, PLANT CELL, V14, P2191, DOI 10.1105/tpc.003640	33	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6640	6647		10.1074/jbc.M707447200	http://dx.doi.org/10.1074/jbc.M707447200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18199755	hybrid			2022-12-27	WOS:000253779600005
J	Lyons, PJ; Callaway, MB; Fricker, LD				Lyons, Peter J.; Callaway, Myrasol B.; Fricker, Lloyd D.			Characterization of carboxypeptidase A6, an extracellular matrix peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL CARBOXYPEPTIDASE; DUANE-SYNDROME; RAT-BRAIN; NEUROTENSIN; GENE; ENKEPHALIN; INHIBITOR; REGION; IDENTIFICATION; DEGENERATION	Carboxypeptidase A6 (CPA6) is a member of the M14 metallocarboxypeptidase family that is highly expressed in the adult mouse olfactory bulb and broadly expressed in embryonic brain and other tissues. A disruption in the human CPA6 gene is linked to Duane syndrome, a defect in the abducens nerve/lateral rectus muscle connection. In this study the cellular distribution, processing, and substrate specificity of human CPA6 were investigated. The 50-kDa pro-CPA6 is routed through the constitutive secretory pathway, processed by furin or a furin-like enzyme into the 37-kDa active form, and secreted into the extracellular matrix. CPA6 cleaves the C-terminal residue from a range of substrates, including small synthetic substrates, larger peptides, and proteins. CPA6 has a preference for large hydrophobic C-terminal amino acids as well as histidine. Peptides with a penultimate glycine or proline are very poorly cleaved. Several neuropeptides were found to be processed by CPA6, including Met- and Leu-enkephalin, angiotensin I, and neurotensin. Whereas CPA6 converts enkephalin and neurotensin into forms known to be inactive toward their receptors, CPA6 converts inactive angiotensin I into the biologically active angiotensin II. Taken together, these data suggest a role for CPA6 in the regulation of neuropeptides in the extracellular environment within the olfactory bulb and other parts of the brain.	[Lyons, Peter J.; Callaway, Myrasol B.; Fricker, Lloyd D.] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	fricker@aecom.yu.edu		Lyons, Peter/0000-0001-5214-5445	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-04494] Funding Source: Medline; NIDDK NIH HHS [DK-51271] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; AVILES FX, 1993, EUR J BIOCHEM, V211, P381, DOI 10.1111/j.1432-1033.1993.tb17561.x; Bennett GW, 1998, DEV BRAIN RES, V111, P189, DOI 10.1016/S0165-3806(98)00137-0; BOGAN N, 1982, NEUROSCIENCE, V7, P895, DOI 10.1016/0306-4522(82)90050-1; Bouma BN, 2006, ANN MED, V38, P378, DOI 10.1080/07853890600852898; Calabrese G, 2000, EUR J HUM GENET, V8, P319, DOI 10.1038/sj.ejhg.5200461; Calabrese G, 1998, EUR J HUM GENET, V6, P187, DOI 10.1038/sj.ejhg.5200173; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; COLE KR, 1991, BIOCHEMISTRY-US, V30, P648, DOI 10.1021/bi00217a009; Davila-Garcia M I, 1990, Adv Exp Med Biol, V265, P75; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Doobay MF, 2007, AM J PHYSIOL-REG I, V292, pR373, DOI 10.1152/ajpregu.00292.2006; Escobar ML, 1997, BRAIN RES, V751, P330, DOI 10.1016/S0006-8993(96)01373-X; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Fontenele-Neto JD, 2005, MOL BRAIN RES, V137, P132, DOI 10.1016/j.molbrainres.2005.02.026; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; FRICKER LD, 2004, HDB PROTEOLYTIC ENZY, V1, P848; FRICKER LD, 2004, HDB PROTEOLYTIC ENZY, V1, P840; Fricker LD, 2007, ENDOCRINOLOGY, V148, P4185, DOI 10.1210/en.2007-0123; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Geisler S, 2006, PEPTIDES, V27, P2364, DOI 10.1016/j.peptides.2006.03.037; GENAIN CP, 1985, J CLIN INVEST, V76, P1939, DOI 10.1172/JCI112191; Goodman R.R., 1983, P827; Gutowski NJ, 2000, EUR J NEUROL, V7, P145, DOI 10.1046/j.1468-1331.2000.00029.x; HAMBROOK JM, 1976, NATURE, V262, P782, DOI 10.1038/262782a0; Huang HJ, 1999, CANCER RES, V59, P2981; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Karamyan VT, 2007, REGUL PEPTIDES, V143, P15, DOI 10.1016/j.regpep.2007.03.006; Kitabgi P, 2006, PEPTIDES, V27, P2515, DOI 10.1016/j.peptides.2005.12.017; Lee M, 1999, BIOORGAN MED CHEM, V7, P1755, DOI 10.1016/S0968-0896(99)00110-8; Lundequist A, 2004, J BIOL CHEM, V279, P32339, DOI 10.1074/jbc.M405576200; MAZELLA J, 1988, J BIOL CHEM, V263, P144; MEEK JL, 1977, NEUROPHARMACOLOGY, V16, P151, DOI 10.1016/0028-3908(77)90064-8; MOLINA MA, 1994, J BIOL CHEM, V269, P21467; MOYSE E, 1987, NEUROSCIENCE, V22, P525, DOI 10.1016/0306-4522(87)90350-2; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; OLIANAS MC, 1992, MOL PHARMACOL, V42, P109; Pizzuti A, 2002, INVEST OPHTH VIS SCI, V43, P3609; Saavedra JM, 2005, CELL MOL NEUROBIOL, V25, P485, DOI 10.1007/s10571-005-4011-5; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Thomas AG, 2006, ADV EXP MED BIOL, V576, P327; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Varlamov O, 1996, J BIOL CHEM, V271, P6077, DOI 10.1074/jbc.271.11.6077; VINCENT C, 1994, HUM MOL GENET, V3, P1859, DOI 10.1093/hmg/3.10.1859; VOGEL Z, 1977, FEBS LETT, V80, P332, DOI 10.1016/0014-5793(77)80469-9; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200	47	41	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7054	7063		10.1074/jbc.M707680200	http://dx.doi.org/10.1074/jbc.M707680200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18178555	hybrid			2022-12-27	WOS:000253779600050
J	Machida, K; Kono-Okada, A; Hongo, K; Mizobata, T; Kawata, Y				Machida, Kodai; Kono-Okada, Akane; Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi			Hydrophilic residues (526)KNDAAD(531) in the flexible C-terminal region of the chaperonin GroEL are critical for substrate protein folding within the central cavity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI GROEL; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; CRYOELECTRON MICROSCOPY; MALATE-DEHYDROGENASE; COMPLEX; INTERMEDIATE; ATP; POLYPEPTIDE; CIS	The final 23 residues in the C-terminal region of Escherichia coli GroEL are invisible in crystallographic analyses due to high flexibility. To probe the functional role of these residues in the chaperonin mechanism, we generated and characterized C-terminal truncated, double ring, and single ring mutants of GroEL. The ability to assist the refolding of substrate proteins rhodanese and malate dehydrogenase decreased suddenly when 23 amino acids were truncated, indicating that a sudden change in the environment within the central cavity had occurred. From further experiments and analyses of the hydropathy of the C-terminal region, we focused on the hydrophilicity of the sequence region (526)KNDAAD(531) and generated two GroEL mutants where these residues were changed to a neutral hydropathy sequence ((526)GGGAAG(531)) and a hydrophobic sequence ((526)IGIAAI(531)), respectively. Very interestingly, the two mutants were found to be defective in function both in vitro and in vivo. Deterioration of function was not observed in mutants where this region was replaced by a scrambled ((526)NKADDA(531)) or homologous ((526)RQEGGE(531)) sequence, indicating that the hydrophilicity of this sequence was important. These results highlight the importance of the hydrophilic nature of (526)KNDAAD(531) residues in the flexible C-terminal region for proper protein folding within the central cavity of GroEL.	Tottori Univ, Grad Sch Med Sci, Fac Engn, Dept Biotechnol, Tottori 6808552, Japan; Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Tottori 6808552, Japan	Tottori University; Tottori University	Kawata, Y (corresponding author), Tottori Univ, Grad Sch Med Sci, Fac Engn, Dept Biotechnol, Tottori 6808552, Japan.	kawata@bio.tottori-u.ac.jp	Kawata, Yasushi/ABA-9608-2021; Mizobata, Tomohiro/V-6672-2019	Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506				BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BURNETT BP, 1994, J BACTERIOL, V176, P6980, DOI 10.1128/JB.176.22.6980-6985.1994; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; ELLIS RJ, 1994, CURR BIOL, V4, P633; Fairclough R H, 1978, Methods Enzymol, V48, P347; Falke S, 2005, J MOL BIOL, V348, P219, DOI 10.1016/j.jmb.2005.02.027; Fang YC, 2002, J BIOMED SCI, V9, P223; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; Farr GW, 2003, EMBO J, V22, P3220, DOI 10.1093/emboj/cdg313; Fenton WA, 1997, PROTEIN SCI, V6, P743; GETHING MJ, 1992, NATURE, V355, P3; Getz EB, 1999, ANAL BIOCHEM, V273, P73, DOI 10.1006/abio.1999.4203; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayer-Hartl M, 2000, METH MOL B, V140, P127; HOLLNEUGEBAUER B, 1991, BIOCHEMISTRY-US, V30, P11609; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Inobe T, 2001, BBA-PROTEIN STRUCT M, V1545, P160, DOI 10.1016/S0167-4838(00)00274-0; Kawata Y, 1999, BIOCHEMISTRY-US, V38, P15731, DOI 10.1021/bi9909750; Koradi R, 1996, J MOL GRAPHICS, V14, P29; KUBO T, 1993, J BIOL CHEM, V268, P19346; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MCLENNAN NF, 1994, MOL MICROBIOL, V14, P309, DOI 10.1111/j.1365-2958.1994.tb01292.x; MCLENNAN NF, 1993, MOL MICROBIOL, V7, P49, DOI 10.1111/j.1365-2958.1993.tb01096.x; MILLER AD, 1993, BIOCHEM J, V291, P139, DOI 10.1042/bj2910139; Miyazaki T, 2002, J BIOL CHEM, V277, P50621, DOI 10.1074/jbc.M209183200; Motojima F, 2004, P NATL ACAD SCI USA, V101, P15005, DOI 10.1073/pnas.0406132101; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sakikawa C, 1999, J BIOL CHEM, V274, P21251, DOI 10.1074/jbc.274.30.21251; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; Wang JD, 1998, P NATL ACAD SCI USA, V95, P12163, DOI 10.1073/pnas.95.21.12163; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4; Weber F, 1998, NAT STRUCT BIOL, V5, P977, DOI 10.1038/2952; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yoshimi T, 2006, J BIOCHEM, V139, P407, DOI 10.1093/jb/mvj043	49	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6886	6896		10.1074/jbc.M708002200	http://dx.doi.org/10.1074/jbc.M708002200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18184659	hybrid, Green Submitted			2022-12-27	WOS:000253779600032
J	Taylor, K; Clarke, DJ; McCullough, B; Chin, W; Seo, E; Yang, D; Oppenheim, J; Uhrin, D; Govan, JRW; Campopiano, DJ; MacMillan, D; Barran, P; Dorin, JR				Taylor, Karen; Clarke, David J.; McCullough, Bryan; Chin, Wutharath; Seo, Emily; Yang, De; Oppenheim, Joost; Uhrin, Dusan; Govan, John R. W.; Campopiano, Dominic J.; MacMillan, Derek; Barran, Perdita; Dorin, Julia R.			Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-DEFENSINS; IMMATURE DENDRITIC CELLS; INDUCIBLE PEPTIDE; HOST-DEFENSE; CHEMOKINE; CCR6; IDENTIFICATION; RECEPTOR; INNATE; IMMUNITY	beta-Defensins are important in mammalian immunity displaying both antimicrobial and chemoattractant activities. Three canonical disulfide intramolecular bonds are believed to be dispensable for antimicrobial activity but essential for chemoattractant ability. However, here we show that HBD3 ( human beta-defensin 3) alkylated with iodoactemide and devoid of any disulfide bonds is still a potent chemoattractant. Furthermore, when the canonical six cysteine residues are replaced with alanine, the peptide is no longer active as a chemoattractant. These findings are replicated by the murine ortholog Defb14. We restore the chemoattractant activity of Defb14 and HBD3 by introduction of a single cysteine in the fifth position (Cys(V)) of the beta-defensin six cysteine motif. In contrast, a peptide with a single cysteine at the first position (Cys(I)) is inactive. Moreover, a range of overlapping linear fragments of Defb14 do not act as chemoattractants, suggesting that the chemotactic activity of this peptide is not dependent solely on an epitope surrounding Cys(V). Full-length peptides either with alkylated cysteine residues or with cysteine residues replaced with alanine are still strongly antimicrobial. Defb14 peptide fragments were also tested for antimicrobial activity, and peptides derived from the N-terminal region display potent antimicrobial activity. Thus, the chemoattractant and antimicrobial activities of beta-defensins can be separated, and both of these functions are independent of intramolecular disulfide bonds. These findings are important for further understanding of the mechanism of action of defensins and for therapeutic design.	[Taylor, Karen; Dorin, Julia R.] Western Gen Hosp, MRC, Human Res Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Clarke, David J.; McCullough, Bryan; Chin, Wutharath; Seo, Emily; Uhrin, Dusan; Campopiano, Dominic J.; Barran, Perdita] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland; [Yang, De; Oppenheim, Joost] NCI Frederick, NIH, Sci Applicat & Int Cooperat Inc, Ctr Canc Res,Lab Mol Immunoregulat, Frederick, MD 21702 USA; [Govan, John R. W.] Univ Edinburgh, Cyst Fibrosis Lab, Edinburgh EH16 4SB, Midlothian, Scotland; [MacMillan, Derek] UCL, Christopher Ingold Labs, Dept Chem, London WC1H 0AJ, England	University of Edinburgh; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of Edinburgh; University of London; University College London	Dorin, JR (corresponding author), Western Gen Hosp, MRC, Human Res Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	julia.dorin@hgu.mrc.ac.uk	Barran, Perdita/AAY-6303-2021	Clarke, David/0000-0002-3741-2952; Campopiano, Dominic/0000-0001-8573-6735; Barran, Perdita/0000-0002-7720-586X	MRC [MC_U127527201] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/S77639/01, EP/C541561/1] Funding Source: researchfish; Medical Research Council [MC_U127527201] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ali MF, 2001, BBA-PROTEIN STRUCT M, V1550, P81, DOI 10.1016/S0167-4838(01)00272-2; Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Bauer F, 2001, PROTEIN SCI, V10, P2470, DOI 10.1110/ps.ps.24401; Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Bohling A, 2006, BIOCHEMISTRY-US, V45, P5663, DOI 10.1021/bi052026e; Boniotto M, 2003, BIOCHEM J, V374, P707, DOI 10.1042/BJ20030528; Campopiano DJ, 2004, J BIOL CHEM, V279, P48671, DOI 10.1074/jbc.M404690200; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; HOOVER DM, 2002, J BIOL CHEM; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Jia HP, 2001, GENE, V263, P211; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Malik ZA, 2006, ACTA CRYSTALLOGR F, V62, P631, DOI 10.1107/S1744309106006890; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Morrison GM, 2002, MAMM GENOME, V13, P445, DOI 10.1007/s00335-002-3014-5; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; PAZGIER M, 2006, J BIOL CHEM; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Sawai MV, 2001, BIOCHEMISTRY-US, V40, P3810, DOI 10.1021/bi002519d; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Semple CAM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-32; Semple CA, 2006, MOL DIVERS, V10, P575, DOI 10.1007/s11030-006-9031-7; Sorensen OE, 2005, J IMMUNOL, V174, P4870, DOI 10.4049/jimmunol.174.8.4870; Soruri A, 2007, EUR J IMMUNOL, V37, P2474, DOI 10.1002/eji.200737292; Taylor K, 2007, ANTIMICROB AGENTS CH, V51, P1719, DOI 10.1128/AAC.01531-06; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 1999, J IMMUNOL, V163, P1737; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	41	78	81	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6631	6639		10.1074/jbc.M709238200	http://dx.doi.org/10.1074/jbc.M709238200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18180295	hybrid			2022-12-27	WOS:000253779600004
J	Bouaouina, M; Lad, Y; Calderwood, DA				Bouaouina, Mohamed; Lad, Yatish; Calderwood, David A.			The N-terminal domains of talin cooperate with the phosphotyrosine binding-like domain to activate beta 1 and beta 3 integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA CYTOPLASMIC DOMAIN; INTEGRIN ACTIVATION; FERM DOMAIN; INSIDE-OUT; TRANSDOMINANT INHIBITION; CYTOSKELETAL PROTEINS; MAP KINASE; TAILS; ALPHA(IIB)BETA(3); ALPHA-IIB-BETA-3	The activation of integrin adhesion receptors from low to high affinity in response to intracellular cues controls cell adhesion and signaling. Binding of the cytoskeletal protein talin to the beta 3 integrin cytoplasmic tail is required for beta 3 activation, and the integrin-binding PTB-like F3 domain of talin is sufficient to activate beta 3 integrins. Here we report that, whereas the conserved talin-integrin interaction is also required for beta 1 activation, and talin F3 binds beta 1 and beta 3 integrins with comparable affinity, expression of the talin F3 domain is not sufficient to activate beta 1 integrins. beta 1 integrin activation could, however, be detected following expression of larger talin fragments that included the N-terminal and F1 domains, and mutagenesis indicates that these domains cooperate with talin F3 to mediate beta 1 activation. This effect is not due to increased affinity for the integrin beta tail and we hypothesize that the N-terminal domains function by targeting or orienting talin in such a way as to optimize the interaction with the integrin tail. Analysis of beta 3 integrin activation indicates that inclusion of the N-terminal and F1 domains also enhances F3-mediated beta 3 activation. Our results therefore reveal a role for the N-terminal and F1 domains of talin during integrin activation and highlight differences in talin-mediated activation of beta 1 and beta 3 integrins.	Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Interdept Program Vasc Biol & Transplantat, New Haven, CT 06520 USA	Yale University; Yale University	Calderwood, DA (corresponding author), 333 Ceder St,POB 208066, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Calderwood, David A/AAC-6954-2019	Calderwood, David A/0000-0002-0791-4142	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 089433] Funding Source: Medline; NIGMS NIH HHS [GM 068600] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; BROWN PJ, 1985, SCIENCE, V228, P1448, DOI 10.1126/science.4012302; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chen H, 2006, GENE DEV, V20, P927, DOI 10.1101/gad.1408306; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; DiazGonzalez F, 1996, MOL BIOL CELL, V7, P1939, DOI 10.1091/mbc.7.12.1939; Evans RD, 2003, J CELL BIOL, V160, P589, DOI 10.1083/jcb.200209016; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Heckmann D, 2007, ANGEW CHEM INT EDIT, V46, P3571, DOI 10.1002/anie.200700008; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Keller RS, 2001, AM J PATHOL, V158, P1079, DOI 10.1016/S0002-9440(10)64055-2; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Kuo JC, 2006, J CELL BIOL, V172, P619, DOI 10.1083/jcb.200505138; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Martin-Bermudo MD, 1998, J CELL BIOL, V141, P1073, DOI 10.1083/jcb.141.4.1073; McDowall A, 2003, J CLIN INVEST, V111, P51, DOI 10.1172/JCI200314076; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Tremuth L, 2004, J BIOL CHEM, V279, P22258, DOI 10.1074/jbc.M400947200; Ulmer TS, 2003, BIOCHEMISTRY-US, V42, P8307, DOI 10.1021/bi034384s; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131; Zou ZY, 2007, BLOOD, V109, P3284, DOI 10.1182/blood-2006-10-051664	52	110	114	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6118	6125		10.1074/jbc.M709527200	http://dx.doi.org/10.1074/jbc.M709527200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165225	hybrid			2022-12-27	WOS:000253779500018
J	Davis, B; Koster, G; Douet, LJ; Scigelova, M; Woffendin, G; Ward, JM; Smith, A; Humphries, J; Burnand, KG; Macphee, CH; Postle, AD				Davis, Bill; Koster, Grielof; Douet, Lisa J.; Scigelova, Michaela; Woffendin, Gary; Ward, Joanna M.; Smith, Alberto; Humphries, Julia; Burnand, Kevin G.; Macphee, Colin H.; Postle, Anthony D.			Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A(2) in oxidized human low density lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; SCAVENGER RECEPTOR CD36; CORONARY-HEART-DISEASE; FACTOR ACETYLHYDROLASE; OXIDATION-PRODUCTS; ENDOTHELIAL-CELLS; STRUCTURAL IDENTIFICATION; ATHEROSCLEROTIC LESIONS; THERAPEUTIC TARGET; PROTEIN	There is increasing evidence that modified phospholipid products of low density lipoprotein (LDL) oxidation mediate inflammatory processes within vulnerable atherosclerotic lesions. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is present in vulnerable plaque regions where it acts on phospholipid oxidation products to generate the pro-inflammatory lysophsopholipids and oxidized non-esterified fatty acids. This association together with identification of circulating Lp-PLA(2) levels as an independent predictor of cardiovascular disease provides a rationale for development of Lp-PLA(2) inhibitors as therapy for atherosclerosis. Here we report a systematic analysis of the effects of in vitro oxidation in the absence and presence of an Lp-PLA(2) inhibitor on the phosphatidylcholine (PC) composition of human LDL. Mass spectrometry identifies three classes of PC whose concentration is significantly enhanced during LDL oxidation. Of these, a series of molecules, represented by peaks in the m/z range 594-666 and identified as truncated PC oxidation products by accurate mass measurements using an LTQ Orbitrap mass spectrometer, are the predominant substrates for Lp-PLA(2). A second series of oxidation products, represented by peaks in the m/z range 746-830 and identified by LTQ Orbitrap analysis as non-truncated oxidized PCs, are quantitatively more abundant but are less efficient Lp-PLA(2) substrates. The major PC products of Lp-PLA(2), saturated and mono-unsaturated lyso-PC, constitute the third class. Mass spectrometric analysis confirms the presence of many of these PCs within human atherosclerotic lesions, suggesting that they could potentially be used as in vivo markers of atherosclerotic disease progression and response to Lp-PLA(2) inhibitor therapy.	[Davis, Bill; Ward, Joanna M.] GlaxoSmithKline Inc, Clin Unit, Cambridge, England; [Davis, Bill; Ward, Joanna M.] Addenbrookes Ctr Clin Invest, Cambridge CB2 2GG, England; [Koster, Grielof; Douet, Lisa J.; Postle, Anthony D.] Univ Southampton, Sch Med, Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England; [Scigelova, Michaela; Woffendin, Gary] Thermo Elect Corp, Hempstead HP2 7GE, England; [Smith, Alberto; Humphries, Julia; Burnand, Kevin G.] St Thomas Hosp, Univ London Kings Coll, Div Cardiovasc, Acad Dept Surg, London SE1 7EH, England; [Macphee, Colin H.] GlaxoSmithKline Inc, Cardiovasc Ctr Excellence Drug Discovery, King Of Prussia, PA 19406 USA	GlaxoSmithKline; University of Southampton; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; GlaxoSmithKline	Davis, B (corresponding author), GlaxoSmithKline Inc, Clin Unit, Cambridge, England.	Bill.G.Davis@GSK.com	koster, grielof/F-3129-2012	, Julia/0000-0003-2672-6654; Postle, Anthony/0000-0001-7361-0756				Berliner J, 2002, VASC PHARMACOL, V38, P187, DOI 10.1016/S1537-1891(02)00168-4; Berliner JA, 2001, TRENDS CARDIOVAS MED, V11, P142, DOI 10.1016/S1050-1738(01)00098-6; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Carpenter KLH, 2001, FEBS LETT, V505, P357, DOI 10.1016/S0014-5793(01)02840-X; Caslake MJ, 2000, ATHEROSCLEROSIS, V150, P413, DOI 10.1016/S0021-9150(99)00406-2; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Furnkranz A, 2004, CURR PHARM DESIGN, V10, P915, DOI 10.2174/1381612043452929; Harrison KA, 2000, J MASS SPECTROM, V35, P224, DOI 10.1002/(SICI)1096-9888(200002)35:2<224::AID-JMS933>3.0.CO;2-G; Hoff HF, 2003, ARTERIOSCL THROM VAS, V23, P275, DOI 10.1161/01.ATV.0000051407.42536.73; Hunt AN, 2001, J BIOL CHEM, V276, P8492, DOI 10.1074/jbc.M009878200; Ishida M, 2004, RAPID COMMUN MASS SP, V18, P2486, DOI 10.1002/rcm.1650; Koenig W, 2004, CIRCULATION, V110, P1903, DOI 10.1161/01.CIR.0000143377.53389.C8; Kohno M, 1998, CIRCULATION, V98, P353, DOI 10.1161/01.CIR.98.4.353; Koivusalo M, 2001, J LIPID RES, V42, P663; Kolodgie FD, 2006, ARTERIOSCL THROM VAS, V26, P2523, DOI 10.1161/01.ATV.0000244681.72738.bc; Leach CA, 2001, FARMACO, V56, P45, DOI 10.1016/S0014-827X(01)01011-4; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Macphee CH, 2006, CURR OPIN PHARMACOL, V6, P154, DOI 10.1016/j.coph.2005.11.008; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; Min JH, 1999, BIOCHEMISTRY-US, V38, P12935, DOI 10.1021/bi991149u; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Oei HHS, 2005, CIRCULATION, V111, P570, DOI 10.1161/01.CIR.0000154553.12214.CD; Ohkura N, 2004, ANTIOXID REDOX SIGN, V6, P705, DOI 10.1089/1523086041361686; Ozaki H, 1999, ATHEROSCLEROSIS, V143, P261, DOI 10.1016/S0021-9150(98)00297-4; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Rikitake Y, 2000, ATHEROSCLEROSIS, V152, P79, DOI 10.1016/S0021-9150(99)00453-0; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; Stafforini DM, 1999, J BIOL CHEM, V274, P7018, DOI 10.1074/jbc.274.11.7018; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4215; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Subbanagounder G, 2002, VASC PHARMACOL, V38, P201, DOI 10.1016/S1537-1891(02)00170-2; Subbanagounder G, 2002, J BIOL CHEM, V277, P7271, DOI 10.1074/jbc.M107602200; Suckling Keith E, 2002, Expert Opin Ther Targets, V6, P309; Trostchansky A, 2001, ARCH BIOCHEM BIOPHYS, V395, P225, DOI 10.1006/abbi.2001.2583; Ueno Y, 1999, FEBS LETT, V457, P241, DOI 10.1016/S0014-5793(99)01049-2; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Watson AD, 1999, J BIOL CHEM, V274, P24787, DOI 10.1074/jbc.274.35.24787; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Witztum JL, 1998, CURR OPIN LIPIDOL, V9, P441, DOI 10.1097/00041433-199810000-00008; Zalewski A, 2005, ARTERIOSCL THROM VAS, V25, P923, DOI 10.1161/01.ATV.0000160551.21962.a7	47	96	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6428	6437		10.1074/jbc.M709970200	http://dx.doi.org/10.1074/jbc.M709970200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165686	hybrid			2022-12-27	WOS:000253779500050
J	Stoecklin, G; Tenenbaum, SA; Mayo, T; Chittur, SV; George, AD; Baroni, TE; Blackshear, PJ; Anderson, P				Stoecklin, Georg; Tenenbaum, Scott A.; Mayo, Thomas; Chittur, Sridar V.; George, Ajish D.; Baroni, Timothy E.; Blackshear, Perry J.; Anderson, Paul			Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; AU-RICH ELEMENT; ZINC-FINGER PROTEINS; PROBE LEVEL DATA; FACTOR-ALPHA; RIBONUCLEOPROTEIN COMPLEXES; DEGRADATION PATHWAY; BINDING PROTEINS; EXPRESSION; TURNOVER	Tristetraprolin (TTP) is an RNA-binding protein required for the rapid degradation of mRNAs containing AU-rich elements. Targets regulated by TTP include the mRNAs encoding tumor necrosis factor-alpha, granulocyte-macrophage colony-stimulating factor, interleukin-2 (IL-2), and immediate early response 3. To identify novel target mRNAs of TTP in macrophages, we used a genome-wide approach that combines RNA immunoprecipitation and microarray analysis. A list was compiled of 137 mRNAs that are associated with TTP with an estimated accuracy on the order of 90%. Sequence analysis revealed a highly significant enrichment of AU-rich element motifs, with AUUUA pentamers present in 96% and UUAUUUAUU nonamers present in 44% of TTP-associated mRNAs. We further show that IL-10 is a novel target regulated by TTP. IL-10 mRNA levels were found to be elevated because of a reduced decay rate in primary macrophages from TTP-/- mice. Our study demonstrates the importance of experimental approaches for identifying targets of RNA-binding proteins.	[Stoecklin, Georg] DKFZ ZMBH Alliance, German Canc Res Ctr, D-69120 Heidelberg, Germany; [Stoecklin, Georg; Mayo, Thomas; Anderson, Paul] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Tenenbaum, Scott A.; Chittur, Sridar V.; George, Ajish D.; Baroni, Timothy E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Gen NY Sis Ctr Excellence Canc Genom, Rensselaer, NY 12144 USA; [Tenenbaum, Scott A.; Chittur, Sridar V.; George, Ajish D.; Baroni, Timothy E.] SUNY Albany, Sch Publ Hlth, Ctr Funct Genom, Rensselaer, NY 12144 USA; [Blackshear, Perry J.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Brigham & Women's Hospital; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Stoecklin, G (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	g.stoecklin@dkfz.de	Blackshear, Perry J./C-6206-2019; /W-2676-2019; Tenenbaum, Scott A/H-4744-2019	Blackshear, Perry J./0000-0002-9561-8529; Stoecklin, Georg/0000-0001-9284-9834	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004571, R21HG003679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033600, R01AI050167, R56AI033600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080, Z01ES090080] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01HG004571, R21HG003679] Funding Source: Medline; NIAID NIH HHS [AI-33600, AI-50167] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bolstad B, 2005, BIOINFORMATICS COMPU; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Briata P, 2003, MOL CELL, V12, P1201, DOI 10.1016/S1097-2765(03)00407-6; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Brooks SA, 2002, ARTHRITIS RHEUM, V46, P1362, DOI 10.1002/art.10235; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Fechir M, 2005, MOL PHARMACOL, V67, P2148, DOI 10.1124/mol.104.008763; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; George Ajish D, 2006, RNA Biol, V3, P57; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gringhuis SI, 2005, MOL CELL BIOL, V25, P6454, DOI 10.1128/MCB.25.15.6454-6463.2005; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JALONEN U, 2006, MEDIAT INFLAMM, P1; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; PLATZER C, 1995, INT IMMUNOL, V7, P517, DOI 10.1093/intimm/7.4.517; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; STOECKLIN G, 1994, J BIOL CHEM, V269, P28591; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2001, RNA, V7, P1578; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yu H, 2003, J BIOL CHEM, V278, P13912, DOI 10.1074/jbc.M213027200; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	52	195	196	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11689	11699		10.1074/jbc.M709657200	http://dx.doi.org/10.1074/jbc.M709657200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18256032	Green Published, hybrid			2022-12-27	WOS:000255067400069
J	Cotner-Gohara, E; Kim, IK; Tomkinson, AE; Ellenberger, T				Cotner-Gohara, Elizabeth; Kim, In-Kwon; Tomkinson, Alan E.; Ellenberger, Tom			Two DNA-binding and nick recognition modules in human DNA ligase III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; ZINC-FINGER DOMAIN; CRYSTAL-STRUCTURE; BRCT DOMAIN; POLY(ADP-RIBOSE) POLYMERASE-1; GENE ENCODES; REPAIR; ALPHA; REPLICATION; EXPRESSION	Human DNA ligase III contains an N-terminal zinc finger domain that binds to nicks and gaps in DNA. This small domain has been described as a DNA nick sensor, but it is not required for DNA nick joining activity in vitro. In light of new structural information for mammalian ligases, we measured the DNA binding affinity and specificity of each domain of DNA ligase III. These studies identified two separate, independent DNA-binding modules in DNA ligase III that each bind specifically to nicked DNA over intact duplex DNA. One of these modules comprises the zinc finger domain and DNA-binding domain, which function together as a single DNA binding unit. The catalytic core of ligase III is the second DNA nick-binding module. Both binding modules are required for ligation of blunt ended DNA substrates. Although the zinc finger increases the catalytic efficiency of nick ligation, it appears to occupy the same binding site as the DNA ligase III catalytic core. We present a jackknife model for ligase III that posits conformational changes during nick sensing and ligation to extend the versatility of the enzyme.	[Cotner-Gohara, Elizabeth] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA 02115 USA; [Cotner-Gohara, Elizabeth; Kim, In-Kwon; Ellenberger, Tom] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Tomkinson, Alan E.] Univ Maryland, Sch Med, Dept Radiat Oncol, Radiat Oncol Res Lab, Baltimore, MD 21201 USA	Harvard University; Harvard Medical School; Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore	Ellenberger, T (corresponding author), 660 S Euclid Ave,Campus Box 8231, St Louis, MO 63110 USA.	tome@biochem.wustl.edu	Classen, Scott/AAY-8176-2020		NCI NIH HHS [P01 CA092584] Funding Source: Medline; NIEHS NIH HHS [ES12512] Funding Source: Medline; NIGMS NIH HHS [GM52504] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012512] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bogenhagen DF, 2001, PROG NUCLEIC ACID RE, V68, P257; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Dulic A, 2001, BIOCHEMISTRY-US, V40, P5906, DOI 10.1021/bi002701e; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Krishnan VV, 2001, BIOCHEMISTRY-US, V40, P13158, DOI 10.1021/bi010979g; Kulczyk AW, 2004, J MOL BIOL, V341, P723, DOI 10.1016/j.jmb.2004.06.035; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668; LECAM E, 1994, J MOL BIOL, V235, P1062, DOI 10.1006/jmbi.1994.1057; Lee JY, 2000, EMBO J, V19, P1119, DOI 10.1093/emboj/19.5.1119; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Mackenney VJ, 1997, J BIOL CHEM, V272, P11550; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Mackey ZB, 1997, MOL CELL BIOL, V17, P989, DOI 10.1128/MCB.17.2.989; Martin IV, 2002, GENOME BIOL, V3; MENISSIERDEMURCIA J, 1989, J MOL BIOL, V210, P229, DOI 10.1016/0022-2836(89)90302-1; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Odell M, 1999, J BIOL CHEM, V274, P14032, DOI 10.1074/jbc.274.20.14032; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Petrucco S, 2003, NUCLEIC ACIDS RES, V31, P6689, DOI 10.1093/nar/gkg890; Petrucco S, 2002, J BIOL CHEM, V277, P23675, DOI 10.1074/jbc.M201411200; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Sekiguchi J, 1997, J VIROL, V71, P9679, DOI 10.1128/JVI.71.12.9679-9684.1997; Sekiguchi J, 1997, NUCLEIC ACIDS RES, V25, P727, DOI 10.1093/nar/25.4.727; Sleeth KM, 2004, BIOCHEMISTRY-US, V43, P12924, DOI 10.1021/bi0492612; Subramanya HS, 1996, CELL, V85, P607, DOI 10.1016/S0092-8674(00)81260-X; Taylor RM, 1998, NUCLEIC ACIDS RES, V26, P4804, DOI 10.1093/nar/26.21.4804; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; Thornton KH, 2001, PROTEIN EXPRES PURIF, V21, P401, DOI 10.1006/prep.2001.1391; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Tomkinson AE, 1998, MUTAT RES-DNA REPAIR, V407, P1, DOI 10.1016/S0921-8777(97)00050-5; Tomkinson AE, 1997, BIOESSAYS, V19, P893, DOI 10.1002/bies.950191009; WAGA S, 1994, J BIOL CHEM, V269, P10923; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Windhofer F, 2007, J CELL PHYSIOL, V213, P475, DOI 10.1002/jcp.21120	49	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10764	10772		10.1074/jbc.M708175200	http://dx.doi.org/10.1074/jbc.M708175200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18238776	Green Published, hybrid			2022-12-27	WOS:000254894700059
J	Ekici, M; Hohl, M; Schuit, F; Martinez-Serrano, A; Thiel, G				Ekici, Myriam; Hohl, Mathias; Schuit, Frans; Martinez-Serrano, Alberto; Thiel, Gerald			Transcription of genes encoding synaptic vesicle proteins in human neural stem cells - Chromatin accessibility, histone methylation pattern, and the essential role of rest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROBLASTOMA-CELLS; EPIDERMAL-GROWTH-FACTOR; BCL-X-L; NEURONAL DIFFERENTIATION; NEUROTROPHIC FACTOR; BIOLOGICAL-ACTIVITY; PROGENITOR CELLS; REPRESSOR REST; TARGET GENES; HUMAN CNS	Human HNSC. 100 neural stem cells up-regulate expression of GFAP following withdrawal of mitogens. Activation of the ERK signaling pathway prevented the up-regulation of GFAP expression. Incubation of cells with retinoic acid in the absence of mitogens enhanced basal neuronal differentiation that was accompanied by an up-regulation of neuronal gene expression and a down-regulation of GFAP and nestin expression. Retinoic acid treatment changed the histone code of neuronal genes encoding synapsin I, synaptophysin, and synaptotagmins II, IV, and VII from a transcriptionally inactive ( methylation of lysine residue 9 of histone 3) to a transcriptionally active state ( methylation of lysine residue 4 of histone 3). In contrast, the chromatin structure of the GFAP gene is transformed from a transcriptionally active state in unstimulated neural stem cells to a transcriptionally inactive state in retinoic acid-stimulated cells. Additionally, retinoic acid treatment reduced the binding of histone deacetylase-1 and REST to neuronal genes. The inhibition of histone deacetylase activity induced expression of genes encoding synaptic vesicle proteins in unstimulated neural stem cells. Similarly, neuronal gene transcription was enhanced following expression of a mutant of REST that contained a transcriptional activation domain. These data indicate that in undifferentiated human neural stem cells, neuronal genes encoding synaptic vesicle proteins are accessible for the REST mutant and are sensitive to enhanced histone acetylation.	[Ekici, Myriam; Hohl, Mathias; Thiel, Gerald] Univ Saarland, Med Ctr, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany; [Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Martinez-Serrano, Alberto] UAM, CSIC, Ctr Mol Biol Severo Ochoa, Madrid 28049, Spain	Saarland University; KU Leuven; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Thiel, G (corresponding author), Univ Saarland, Med Ctr, Dept Med Biochem & Mol Biol, Bldg 44, D-66421 Homburg, Germany.	gerald.thiel@uniklinik-saarland.de	Martínez-Serrano, Alberto/J-8146-2014	Martinez Serrano, Alberto/0000-0003-3927-6699				Al-Sarraj A, 2005, J CELL BIOCHEM, V94, P153, DOI 10.1002/jcb.20305; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; BALLAS N, 2006, CURR OPIN NEUROBIOL, V15, P1; Bauer I, 2007, J CELL BIOCHEM, V100, P242, DOI 10.1002/jcb.21075; Bruce AW, 2006, J NEUROCHEM, V98, P1828, DOI 10.1111/j.1471-4159.2006.04010.x; Cibelli G, 2002, J NEUROSCI RES, V67, P450, DOI 10.1002/jnr.10141; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Greenway DJ, 2007, STEM CELLS, V25, P354, DOI 10.1634/stemcells.2006-0207; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hohl M, 2005, EUR J NEUROSCI, V22, P2216, DOI 10.1111/j.1460-9568.2005.04404.x; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Kaufmann K, 2002, J CELL BIOCHEM, V85, P381, DOI 10.1002/jcb.10145; KITCHENS DL, 1994, J NEUROBIOL, V25, P797, DOI 10.1002/neu.480250705; Lietz M, 2003, EUR J BIOCHEM, V270, P2, DOI 10.1046/j.1432-1033.2003.03360.x; Lietz M, 2001, EUR J NEUROSCI, V14, P1303, DOI 10.1046/j.0953-816x.2001.01762.x; Liste I, 2007, CELL DEATH DIFFER, V14, P1880, DOI 10.1038/sj.cdd.4402205; Liste I, 2004, J NEUROSCI, V24, P10786, DOI 10.1523/JNEUROSCI.3208-04.2004; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McMahon M, 2001, METHOD ENZYMOL, V332, P401; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Rossler OG, 2008, ARCH BIOCHEM BIOPHYS, V470, P93, DOI 10.1016/j.abb.2007.11.008; Rossler OG, 2004, AM J PHYSIOL-CELL PH, V286, pC1118, DOI 10.1152/ajpcell.00301.2003; Rossler OG, 2004, J NEUROCHEM, V88, P1240, DOI 10.1046/j.1471-4159.2003.02255.x; Rubio FJ, 2000, MOL CELL NEUROSCI, V16, P1, DOI 10.1006/mcne.2000.0854; Sah DWY, 1997, NAT BIOTECHNOL, V15, P574, DOI 10.1038/nbt0697-574; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Su XH, 2004, MOL CELL BIOL, V24, P8018, DOI 10.1128/MCB.24.18.8018-8025.2004; Thiel G, 1998, J BIOL CHEM, V273, P26891, DOI 10.1074/jbc.273.41.26891; Thiel G, 2004, EUR J BIOCHEM, V271, P2855, DOI 10.1111/j.1432-1033.2004.04174.x; Thiel G, 2006, TRANSCRIPTION FACTOR, P113; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237	40	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9257	9268		10.1074/jbc.M709388200	http://dx.doi.org/10.1074/jbc.M709388200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18234667	hybrid, Green Published			2022-12-27	WOS:000254465800056
J	Gao, L; Hanson, MN; Balakrishnan, M; Boyer, PL; Roques, BP; Hughes, SH; Kim, B; Bambara, RA				Gao, Lu; Hanson, Mark Nils; Balakrishnan, Mini; Boyer, Paul L.; Roques, Bernard P.; Hughes, Stephen H.; Kim, Baek; Bambara, Robert A.			Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; HIGH-LEVEL RESISTANCE; IN-VITRO; RNASE-H; GENETIC-RECOMBINATION; STERIC HINDRANCE; DRUG-RESISTANCE; 3TC RESISTANCE; WILD-TYPE	The 2', 3'-dideoxy-3'-thiacytidine drug-resistant M184I HIV-1 reverse transcriptase (RT) has been shown to synthesize DNA with decreased processivity compared with the wild-type RT. M184A displays an even more severe processivity defect. However, the basis of this decreased processivity has been unclear, and both primer-template binding and dNTP interaction defects have been proposed to account for it. In this study, we show that the altered properties of the M184I and M184A RT mutants that we have measured, including decreased processivity, a slower rate of primer extension, and increased strand transfer activity, can all be explained by a defect in dNTP utilization. These alterations are observed only at low dNTP concentration and vanish as the dNTP concentration is raised. The mutant RTs exhibit a normal dissociation rate from a DNA primer-RNA template while paused during synthesis. Slower than normal synthesis at physiological dNTP concentration, coupled with normal dissociation from the primer-template, results in the lowered processivity. The mutant RTs exhibit normal DNA 3'-end-directed and RNA 5'-end-directed ribonuclease H activity. The reduced rate of DNA synthesis causes an increase in the ratio of ribonuclease H to polymerase activity thereby promoting increased strand transfer. These latter results are consistent with an observed higher rate of recombination by HIV-1 strains with Met-184 mutations.	[Gao, Lu; Hanson, Mark Nils; Balakrishnan, Mini; Bambara, Robert A.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Boyer, Paul L.; Hughes, Stephen H.] NCI, NIH, HIV Drug Resistance Program, Frederick, MD 21702 USA; Univ Paris 05, CNRS, UFR Sci Pharmaceut & Biol,UMR 8600, Unite Pharmacochim Mol & Struct,INSERM U266, F-75270 Paris 06, France	University of Rochester; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bambara, RA (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Box 712,601 Elmwood Ave, Rochester, NY 14642 USA.	Robert_Bambara@urmc.rochester.edu			NATIONAL CANCER INSTITUTE [ZIABC010481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM 49573] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Back NKT, 1997, ANTIMICROB AGENTS CH, V41, P2484, DOI 10.1128/AAC.41.11.2484; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; Balakrishnan M, 2001, J BIOL CHEM, V276, P36482, DOI 10.1074/jbc.M102860200; BAMBARA RA, 1978, J BIOL CHEM, V253, P413; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; Boyer PL, 2001, J VIROL, V75, P6321, DOI 10.1128/JVI.75.14.6321-6328.2001; BOYER PL, 1995, ANTIMICROB AGENTS CH, V39, P1624, DOI 10.1128/AAC.39.7.1624; CLAVEL F, 1989, J VIROL, V63, P1455, DOI 10.1128/JVI.63.3.1455-1459.1989; DEROCQUIGNY H, 1991, BIOCHEM BIOPH RES CO, V180, P1010, DOI 10.1016/S0006-291X(05)81166-0; DESTEFANO JJ, 1993, BIOCHEMISTRY-US, V32, P6908, DOI 10.1021/bi00078a014; DESTEFANO JJ, 1992, J VIROL, V66, P6370, DOI 10.1128/JVI.66.11.6370-6378.1992; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Feng JY, 1999, BIOCHEMISTRY-US, V38, P9440, DOI 10.1021/bi990709m; Fuentes GM, 1996, J BIOL CHEM, V271, P1966, DOI 10.1074/jbc.271.4.2063; Gao HQ, 1998, J MOL BIOL, V277, P559, DOI 10.1006/jmbi.1998.1624; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; GAO Q, 1993, ANTIMICROB AGENTS CH, V37, P1390, DOI 10.1128/AAC.37.6.1390; Halvas EK, 2000, J VIROL, V74, P6669, DOI 10.1128/JVI.74.14.6669-6674.2000; HU WS, 1990, P NATL ACAD SCI USA, V87, P1556, DOI 10.1073/pnas.87.4.1556; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jamburuthugoda VK, 2008, J BIOL CHEM, V283, P9206, DOI 10.1074/jbc.M710149200; Julias JG, 2004, VIROLOGY, V322, P13, DOI 10.1016/j.virol.2004.01.004; Kew Y, 1998, J BIOL CHEM, V273, P7529, DOI 10.1074/jbc.273.13.7529; LARDER BA, 1987, NATURE, V327, P716, DOI 10.1038/327716a0; Nikolenko GN, 2004, J VIROL, V78, P8761, DOI 10.1128/JVI.78.16.8761-8770.2004; Operario DJ, 2006, J BIOL CHEM, V281, P32113, DOI 10.1074/jbc.M604665200; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Ray AS, 2002, ANTIVIR RES, V56, P189, DOI 10.1016/S0166-3542(02)00102-X; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sharma PL, 1999, J VIROL, V73, P8448, DOI 10.1128/JVI.73.10.8448-8456.1999; Skasko M, 2005, J BIOL CHEM, V280, P12190, DOI 10.1074/jbc.M412859200; Song M, 2006, J BIOL CHEM, V281, P24227, DOI 10.1074/jbc.M603097200; Svarovskaia ES, 2000, J VIROL, V74, P7171, DOI 10.1128/JVI.74.15.7171-7178.2000; TANESE N, 1991, J VIROL, V65, P4387, DOI 10.1128/JVI.65.8.4387-4397.1991; Telesnitsky A., 1997, P121; TELESNITSKY A, 1990, P NATL ACAD SCI USA, V87, P2052; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Wilson JE, 1996, J BIOL CHEM, V271, P13656, DOI 10.1074/jbc.271.23.13656; Wisniewski M, 2000, P NATL ACAD SCI USA, V97, P11978, DOI 10.1073/pnas.210392297	40	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9196	9205		10.1074/jbc.M710148200	http://dx.doi.org/10.1074/jbc.M710148200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18218634	Green Published, hybrid			2022-12-27	WOS:000254465800049
J	McAndrew, RP; Wang, YD; Mohsen, AW; He, M; Vockley, J; Kim, JJP				McAndrew, Ryan P.; Wang, Yudong; Mohsen, Al-Walid; He, Miao; Vockley, Jerry; Kim, Jung-Ja P.			Structural basis for substrate fatty acyl chain specificity - Crystal structure of human very-long-chain acyl-CoA dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; COENZYME-A DEHYDROGENASE; BETA-OXIDATION; 3-DIMENSIONAL STRUCTURE; CATALYTIC BASE; WILD-TYPE; ACID; PURIFICATION; DEFICIENCY; COMPLEX	Very-long-chain acyl-CoA dehydrogenase (VLCAD) is a member of the family of acyl-CoA dehydrogenases (ACADs). Unlike the other ACADs, which are soluble homotetramers, VLCAD is a homodimer associated with the mitochondrial membrane. VLCAD also possesses an additional 180 residues in the C terminus that are not present in the other ACADs. We have determined the crystal structure of VLCAD complexed with myristoyl-CoA, obtained by co-crystallization, to 1.91-A resolution. The overall fold of the N-terminal similar to 400 residues of VLCAD is similar to that of the soluble ACADs including medium-chain acyl-CoA dehydrogenase (MCAD). The novel C-terminal domain forms an alpha-helical bundle that is positioned perpendicular to the two N-terminal helical domains. The fatty acyl moiety of the bound substrate/product is deeply imbedded inside the protein; however, the adenosine pyrophosphate portion of the C14-CoA ligand is disordered because of partial hydrolysis of the thioester bond and high mobility of the CoA moiety. The location of Glu-422 with respect to the C2-C3 of the bound ligand and FAD confirms Glu-422 to be the catalytic base. In MCAD, Gln-95 and Glu-99 form the base of the substrate binding cavity. In VLCAD, these residues are glycines (Gly-175 and Gly-178), allowing the binding channel to extend for an additional 12 angstrom and permitting substrate acyl chain lengths as long as 24 carbons to bind. VLCAD deficiency is among the more common defects of mitochondrial beta-oxidation and, if left undiagnosed, can be fatal. This structure allows us to gain insight into how a variant VLCAD genotype results in a clinical phenotype.	[McAndrew, Ryan P.; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Wang, Yudong; Mohsen, Al-Walid; He, Miao; Vockley, Jerry] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA	Medical College of Wisconsin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim, JJP (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jjkim@mcw.edu	Vockley, Jerry/B-5210-2016; Mohsen, Al-Walid/D-6577-2018; Wang, Yudong/ABG-1086-2021; Vockley, Jerry/AAF-8523-2020	Vockley, Jerry/0000-0002-8180-6457; Mohsen, Al-Walid/0000-0002-0096-5959; Wang, Yudong/0000-0003-3224-4555; Vockley, Jerry/0000-0002-8180-6457	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029076] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 29076] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368; Battaile KP, 2004, J BIOL CHEM, V279, P16526, DOI 10.1074/jbc.M400034200; Battaile KP, 2002, J BIOL CHEM, V277, P12200, DOI 10.1074/jbc.M111296200; Beinert H., 1963, ENZYMES, P447; BROSS P, 1990, J BIOL CHEM, V265, P7116; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; CRANE FL, 1956, J BIOL CHEM, V218, P717; DeLano WL, 2002, PYMOL USERS MANUAL; DJORDJEVIC S, 1994, BIOCHEMISTRY-US, V33, P4258, DOI 10.1021/bi00180a021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; FRERMAN FE, 1985, BIOCHEM MED METAB B, V33, P38, DOI 10.1016/0006-2944(85)90124-3; Fu ZJ, 2004, BIOCHEMISTRY-US, V43, P9674, DOI 10.1021/bi049290c; GARLAND PB, 1965, BIOCHEM J, V97, P587, DOI 10.1042/bj0970587; GHISLA S, 1984, BIOCHEMISTRY-US, V23, P3154, DOI 10.1021/bi00309a008; Goetzman ES, 2007, MOL GENET METAB, V91, P138, DOI 10.1016/j.ymgme.2007.01.013; Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174.abs; Greville G D, 1968, Essays Biochem, V4, P155; Hanley PJ, 2003, J PHYSIOL-LONDON, V547, P387, DOI 10.1113/jphysiol.2002.037044; HOWARD AJ, 2000, CRYSTALLOGRAPHIC COM, V7; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; IZAI K, 1992, J BIOL CHEM, V267, P1027; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; KUMAR NR, 1996, FLAVIN FLAVOPROTEINS, P633; Le WP, 2000, BBA-MOL CELL BIOL L, V1485, P121, DOI 10.1016/S1388-1981(00)00034-2; Lee HJ, 1996, BIOCHEMISTRY-US, V35, P12412, DOI 10.1021/bi9607867; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; MCANDREW RP, 2007, FASEB J, V649, P649; McPherson A., 1999, CRYSTALLIZATION BIOL; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima Y, 2002, J BIOCHEM, V131, P365, DOI 10.1093/oxfordjournals.jbchem.a003111; Nina M, 2000, EUR BIOPHYS J BIOPHY, V29, P439, DOI 10.1007/PL00006649; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; RUZICKA FJ, 1977, J BIOL CHEM, V252, P8440; Satoh A, 2003, J BIOCHEM, V134, P297, DOI 10.1093/jb/mvg143; Souri M, 1998, EUR J BIOCHEM, V257, P592, DOI 10.1046/j.1432-1327.1998.2570592.x; Souri M, 1998, J BIOL CHEM, V273, P4227, DOI 10.1074/jbc.273.7.4227; Souri M, 1998, FEBS LETT, V426, P187, DOI 10.1016/S0014-5793(98)00343-3; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tiffany KA, 1997, BIOCHEMISTRY-US, V36, P8455, DOI 10.1021/bi970422u; Tokuoka K, 2006, J BIOCHEM, V139, P789, DOI 10.1093/jb/mvj088; TRIEVEL RC, 1995, BIOCHEMISTRY-US, V34, P8597, DOI 10.1021/bi00027a009; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Zhang J, 2002, BIOCHEM BIOPH RES CO, V297, P1033, DOI 10.1016/S0006-291X(02)02336-7	51	75	92	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9435	9443		10.1074/jbc.M709135200	http://dx.doi.org/10.1074/jbc.M709135200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18227065	hybrid, Green Published			2022-12-27	WOS:000254465800073
J	Suzuki, N; Bajad, S; Shuman, J; Shulaev, V; Mittler, R				Suzuki, Nobuhiro; Bajad, Sunil; Shuman, Joel; Shulaev, Vladimir; Mittler, Ron			The transcriptional co-activator MBF1c is a key regulator of thermotolerance in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC ASCORBATE PEROXIDASE-1; FINGER PROTEIN ZAT12; SALICYLIC-ACID; TEMPERATURE-STRESS; REACTIVE OXYGEN; ABSCISIC-ACID; CELL-DEATH; HEAT; EXPRESSION; DEFENSE	The ability of an organism to acclimate to its environment is a key determinant in its global distribution and capacity to compete with other organisms. The heat stress response, a highly conserved environmental and developmental program in eukaryotic and prokaryotic organisms, is an important component of the acclimation response of plants. Previous studies have shown that heat shock transcription factors play an important role in thermotolerance in plants and other organisms, controlling the expression of different heat shock proteins and detoxifying enzymes. In contrast, although several other pathways, involving ethylene, salicylic acid ( SA), and trehalose, were recently shown to play a central role in thermotolerance in plants, a key regulator of these responses was not identified. Here we report that the highly conserved transcriptional coactivator, MBF1c ( multiprotein bridging factor 1c), is a key regulator of thermotolerance in Arabidopsis thaliana. MBF1c protein accumulates rapidly and is localized to nuclei during heat stress. MBF1c is required for thermotolerance and functions upstream to SA, trehalose, ethylene, and pathogenesis-related protein 1 during heat stress. In contrast, MBF1c is not required for the expression of transcripts encoding HSFA2 and different heat shock proteins. Interestingly, MBF1c interacts with TPS5 ( trehalose phosphate synthase 5), which is also heat-inducible, and mutants deficient in TPS5 are thermosensitive. Our results provide evidence for the existence of a tightly coordinated heat stress-response network, involving trehalose- ,SA-, and ethylene-signaling pathways, that is under the control of MBF1c.	[Suzuki, Nobuhiro; Mittler, Ron] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Bajad, Sunil; Shuman, Joel; Shulaev, Vladimir] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Mittler, Ron] Hebrew Univ Jerusalem, Dept Plant Sci, IL-91904 Jerusalem, Israel	Nevada System of Higher Education (NSHE); University of Nevada Reno; Virginia Polytechnic Institute & State University; Hebrew University of Jerusalem	Mittler, R (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, MS200, Reno, NV 89557 USA.	ronm@unr.edu	Suzuki, Nobuhiro/Y-2851-2019; Mittler, Ron/ABE-6496-2020	Suzuki, Nobuhiro/0000-0002-0225-1597	NCRR NIH HHS [P20 RR 016464] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; Brendel C, 2002, MOL ENDOCRINOL, V16, P1367, DOI 10.1210/me.16.6.1367; Busk PK, 2003, EXP CELL RES, V286, P102, DOI 10.1016/S0014-4827(03)00091-0; Cancel JD, 2002, PLANT PHYSIOL, V129, P1557, DOI 10.1104/pp.003780; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Clarke SM, 2004, PLANT J, V38, P432, DOI 10.1111/j.1365-313X.2004.02054.x; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Eastmond PJ, 2003, CURR OPIN PLANT BIOL, V6, P231, DOI 10.1016/S1369-5266(03)00037-2; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; Grennan AK, 2007, PLANT PHYSIOL, V144, P3, DOI 10.1104/pp.104.900223; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kotak S, 2007, PLANT CELL, V19, P182, DOI 10.1105/tpc.106.048165; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Larkindale J, 2002, PLANT PHYSIOL, V128, P682, DOI 10.1104/pp.010320; Leyman B, 2001, TRENDS PLANT SCI, V6, P510, DOI 10.1016/S1360-1385(01)02125-2; Lindquist S, 1992, CURR OPIN GENET DEV, V2, P748, DOI 10.1016/S0959-437X(05)80135-2; Liu QX, 2003, DEVELOPMENT, V130, P719, DOI 10.1242/dev.00297; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Mishra SK, 2002, GENE DEV, V16, P1555, DOI 10.1101/gad.228802; MITTLER R, 1995, PLANT CELL, V7, P29, DOI 10.1105/tpc.7.1.29; Myouga F, 2006, PLANT J, V48, P249, DOI 10.1111/j.1365-313X.2006.02873.x; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Panchuk II, 2002, PLANT PHYSIOL, V129, P838, DOI 10.1104/pp.001362; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rizhsky L, 2003, J BIOL CHEM, V278, P38921, DOI 10.1074/jbc.M304987200; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; SHULAEV V, 1995, PLANT CELL, V7, P1691, DOI 10.1105/tpc.7.10.1691; Sijwali PS, 2001, PROTEIN EXPRES PURIF, V22, P128, DOI 10.1006/prep.2001.1416; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Takemaru K, 1997, P NATL ACAD SCI USA, V94, P7251, DOI 10.1073/pnas.94.14.7251; Takemaru K, 1998, MOL CELL BIOL, V18, P4971, DOI 10.1128/MCB.18.9.4971; Tsuda K, 2004, BBA-GENE STRUCT EXPR, V1680, P1, DOI 10.1016/j.bbaexp.2004.08.004; Tsuda K, 2004, PLANT CELL PHYSIOL, V45, P225, DOI 10.1093/pcp/pch017; VAN DER STRAETEN D, 1993, PLANT PHYSIOL, V102, P401, DOI 10.1104/pp.102.2.401; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Wingler A, 2000, PLANT PHYSIOL, V124, P105, DOI 10.1104/pp.124.1.105; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	46	189	209	6	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9269	9275		10.1074/jbc.M709187200	http://dx.doi.org/10.1074/jbc.M709187200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18201973	hybrid, Green Published			2022-12-27	WOS:000254465800057
J	Adam, SA; Sengupta, K; Goldman, RD				Adam, Stephen A.; Sengupta, Kaushik; Goldman, Robert D.			Regulation of nuclear lamin polymerization by importin alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION SITES; ENVELOPE; PROTEIN; RAN; RECOGNITION; EXPRESSION; PATHWAY; BINDING; DOMAIN; CELLS	Nuclear lamins are integral components of the nuclear envelope and are important for the regulation of many aspects of nuclear function, including gene transcription and DNA replication. During interphase, the lamins form an intranuclear intermediate filament network that must be disassembled and reassembled when cells divide. Little is known about factors regulating this assembly/disassembly cycle. Using in vitro nuclear assembly and lamin assembly assays, we have identified a role for the nuclear transport factor importin alpha in the regulation of lamin assembly. Exogenous importin alpha inhibited nuclear lamin assembly in Xenopus interphase egg nuclear assembly assays. Fractionation of the egg extract used for nuclear assembly identified a high molecular weight complex containing the major egg lamin, XLB3, importin alpha, and importin beta. This complex could be dissociated by RanGTP or a competing nuclear localization sequence, indicating that lamin assembly is Ran-and importin alpha-dependent in the egg extract. We show that the addition of importin alpha to purified lamin B3 prevents the assembly of lamins in solution. Lamin assembly assays show that importin alpha prevents the self-association of lamins required to assemble lamin filaments into the typical paracrystals formed in vitro. These results suggest a role for importin alpha in regulating lamin assembly and possibly modulating the interactions of lamins with lamin-binding proteins.	[Adam, Stephen A.; Sengupta, Kaushik; Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Adam, SA (corresponding author), W129 303 E Chicago Ave, Chicago, IL 60611 USA.	s-adam@northwestern.edu		Adam, Stephen/0000-0003-3444-7655	NATIONAL CANCER INSTITUTE [R01CA031760] Funding Source: NIH RePORTER; NCI NIH HHS [5 R01 CA 031760-25] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; Burke B, 1990, CURR OPIN CELL BIOL, V2, P514, DOI 10.1016/0955-0674(90)90136-3; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; CLARKE PR, 2004, S SOC EXP BIOL, V56, P193; DESSEV G, 1991, J CELL BIOL, V112, P523, DOI 10.1083/jcb.112.4.523; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200; Dickmanns A, 1996, J CELL SCI, V109, P1449; Dorner D, 2007, FEBS J, V274, P1362, DOI 10.1111/j.1742-4658.2007.05695.x; EGGERT M, 1993, EUR J BIOCHEM, V213, P659, DOI 10.1111/j.1432-1033.1993.tb17806.x; Ellenberg J, 1999, METHODS, V19, P362, DOI 10.1006/meth.1999.0872; Foisner Roland, 2003, ScientificWorldJournal, V3, P1; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Geles KG, 2002, MOL BIOL CELL, V13, P3138, DOI 10.1091/mbc.E02-02-0069; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; HAAS M, 1993, EUR J CELL BIOL, V62, P237; Hachet V, 2004, EMBO J, V23, P1526, DOI 10.1038/sj.emboj.7600154; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; JENKINS H, 1993, J CELL SCI, V106, P275; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3; LEUKEL M, 1995, EUR J CELL BIOL, V68, P133; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; LOEWINGER L, 1988, EMBO J, V7, P2301, DOI 10.1002/j.1460-2075.1988.tb03073.x; Lopez-Soler RI, 2001, J CELL BIOL, V154, P61, DOI 10.1083/jcb.200101025; Lourim D, 1998, J CELL SCI, V111, P3675; Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007; MOIR RD, 1991, J CELL SCI, V99, P363; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; NAKAJIMA N, 1995, FEBS LETT, V365, P108, DOI 10.1016/0014-5793(95)00453-G; NEWPORT JW, 1990, J CELL BIOL, V111, P2247, DOI 10.1083/jcb.111.6.2247; Nigg E A, 1992, Semin Cell Biol, V3, P245, DOI 10.1016/1043-4682(92)90026-R; Pemberton LF, 1999, J CELL BIOL, V145, P1407, DOI 10.1083/jcb.145.7.1407; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; ROBER RA, 1989, DEVELOPMENT, V105, P365; Shumaker DK, 2005, P NATL ACAD SCI USA, V102, P15494, DOI 10.1073/pnas.0507612102; Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4; SINENSKY M, 1994, J CELL SCI, V107, P61; STICK R, 1988, EMBO J, V7, P3189, DOI 10.1002/j.1460-2075.1988.tb03186.x; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102	43	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8462	8468		10.1074/jbc.M709572200	http://dx.doi.org/10.1074/jbc.M709572200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18227062	Green Published, hybrid			2022-12-27	WOS:000254288000044
J	Liu, QYP; Yuan, HP; Bennett, EP; Levery, SB; Nudelman, E; Spence, J; Pietz, G; Saunders, K; White, T; Olsson, ML; Henrissat, B; Sulzenbacher, G; Clausen, H				Liu, Qiyong P.; Yuan, Huaiping; Bennett, Eric P.; Levery, Steven B.; Nudelman, Edward; Spence, Jean; Pietz, Greg; Saunders, Kristen; White, Thayer; Olsson, Martin L.; Henrissat, Bernard; Sulzenbacher, Gerlind; Clausen, Henrik			Identification of a GH110 subfamily of alpha 1,3-galactosidases - Novel enzymes for removal of the alpha 3Gal xenotransplantation antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GALACTOSIDASE-C; MOLECULAR-CLONING; EXPRESSION; SEQUENCE; PURIFICATION; GLYCOSIDASES; CDNA; EVOLUTIONARY; XENOANTIGEN; GENE	In search of alpha-galactosidases with improved kinetic properties for removal of the immunodominant alpha 1,3-linked galactose residues of blood group B antigens, we recently identified a novel prokaryotic family of alpha-galactosidases (CAZy GH110) with highly restricted substrate specificity and neutral pH optimum (Liu, Q. P., Sulzenbacher, G., Yuan, H., Bennett, E. P., Pietz, G., Saunders, K., Spence, J., Nudelman, E., Levery, S. B., White, T., Neveu, J. M., Lane, W. S., Bourne, Y., Olsson, M. L., Henrissat, B., and Clausen, H. (2007) Nat. Biotechnol. 25, 454-464). One member of this family from Bacteroides fragilis had exquisite substrate specificity for the branched blood group B structure Gal alpha 1-3(Fuc alpha 1-2) Gal, whereas linear oligosaccharides terminated by alpha 1,3-linked galactose such as the immunodominant xenotransplantation epitope Gal alpha 1-3Gal beta 1-4GlcNAc did not serve as substrates. Here we demonstrate the existence of two distinct subfamilies of GH110 in B. fragilis and thetaiotaomicron strains. Members of one subfamily have exclusive specificity for the branched blood group B structures, whereas members of a newly identified subfamily represent linkage specific alpha 1,3-galactosidases that act equally well on both branched blood group B and linear alpha 1,3Gal structures. We determined by one-dimensional H-1 NMR spectroscopy that GH110 enzymes function with an inverting mechanism, which is in striking contrast to all other known alpha-galactosidases that use a retaining mechanism. The novel GH110 subfamily offers enzymes with highly improved performance in enzymatic removal of the immunodominant alpha 3Gal xenotransplantation epitope.	[Liu, Qiyong P.; Yuan, Huaiping; Nudelman, Edward; Spence, Jean; Pietz, Greg; Saunders, Kristen; White, Thayer; Clausen, Henrik] ZymeQuest Inc, Beverly, MA 01915 USA; [Bennett, Eric P.; Pietz, Greg; Clausen, Henrik] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Bennett, Eric P.; Pietz, Greg; Clausen, Henrik] Univ Copenhagen, Dept Odontol, DK-2200 Copenhagen, Denmark; [Levery, Steven B.] Univ New Hampshire, Dept Chem, Durham, NH 03824 USA; [Olsson, Martin L.] Lund Univ, Div Hematol & Transfus Med, SE-22185 Lund, Sweden; [Olsson, Martin L.] Lund Univ, Dept Lab Med, SE-22185 Lund, Sweden; [Olsson, Martin L.] Univ Lund Hosp, Ctr Blood, SE-22185 Lund, Sweden; [Olsson, Martin L.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Olsson, Martin L.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Henrissat, Bernard; Sulzenbacher, Gerlind] Univ Aix Marseille 1, Architecture & Fonct Macromol Biol, CNRS, UMR6098, F-13288 Marseille 9, France; [Henrissat, Bernard; Sulzenbacher, Gerlind] Univ Aix Marseille 2, Architecture & Fonct Macromol Biol, CNRS, UMR6098, F-13288 Marseille 9, France	University of Copenhagen; University of Copenhagen; University System Of New Hampshire; University of New Hampshire; Lund University; Lund University; Lund University; Skane University Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Liu, QYP (corresponding author), ZymeQuest Inc, 100 Cummings Ctr,Suite 436H, Beverly, MA 01915 USA.	pliu@zymequest.com	clausen, henrik/AAD-8016-2021; Sulzenbacher, Gerlind/A-6801-2018; Henrissat, Bernard/J-2475-2012; Bennett, Eric/AAG-6120-2020	Sulzenbacher, Gerlind/0000-0003-4844-2820; Henrissat, Bernard/0000-0002-3434-8588; Bennett, Eric/0000-0002-4976-0647; Olsson, Martin L/0000-0003-1647-9610; Clausen, Henrik/0000-0002-0915-5055				Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BOCK K, 1982, ANNU REP NMR SPECTRO, V13, P1; BRECHER ME, 2005, TECHNICAL MANUAL, P732; Brouns SJJ, 2006, J BACTERIOL, V188, P2392, DOI 10.1128/JB.188.7.2392-2399.2006; Calcutt MJ, 2002, FEMS MICROBIOL LETT, V214, P77, DOI 10.1111/j.1574-6968.2002.tb11327.x; CLAUSEN H, 1985, BIOCHEMISTRY-US, V24, P3578, DOI 10.1021/bi00335a028; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; Coutinho PM, 1999, ROY SOC CH, P3; DABROWSKI J, 1988, BIOCHEMISTRY-US, V27, P5149, DOI 10.1021/bi00414a030; Davis MO, 1997, BIOCHEM MOL BIOL INT, V42, P453; Davis MO, 1996, BIOCHEM MOL BIOL INT, V39, P471; Desnick RJ, 2004, J INHERIT METAB DIS, V27, P385, DOI 10.1023/B:BOLI.0000031101.12838.c6; DISTLER JJ, 1973, J BIOL CHEM, V248, P6772; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ezzelarab M, 2005, XENOTRANSPLANTATION, V12, P278, DOI 10.1111/j.1399-3089.2005.00236.x; Galili U, 2006, TRANSFUS APHER SCI, V35, P45, DOI 10.1016/j.transci.2006.05.007; GLASGOW LR, 1977, J BIOL CHEM, V252, P8615; GOLDSTEIN J, 1982, SCIENCE, V215, P168, DOI 10.1126/science.6274021; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Henrissat B, 1998, BIOCHEM SOC T, V26, P153, DOI 10.1042/bst0260153; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Keusch JJ, 2000, J BIOL CHEM, V275, P25308, DOI 10.1074/jbc.M002629200; KOBATA A, 1979, ANAL BIOCHEM, V100, P1, DOI 10.1016/0003-2697(79)90102-7; Liu DG, 2002, XENOTRANSPLANTATION, V9, P228, DOI 10.1034/j.1399-3089.2002.01068.x; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Luo Y, 1999, XENOTRANSPLANTATION, V6, P238, DOI 10.1034/j.1399-3089.1999.00035.x; Milland J, 2006, J IMMUNOL, V176, P2448, DOI 10.4049/jimmunol.176.4.2448; Ogawa H, 2002, XENOTRANSPLANTATION, V9, P290, DOI 10.1034/j.1399-3089.2002.01098.x; Ogawa H, 2000, J BIOL CHEM, V275, P19368, DOI 10.1074/jbc.M001888200; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Rajan SS, 2004, STRUCTURE, V12, P1619, DOI 10.1016/j.str.2004.06.020; Rigden DJ, 2002, FEBS LETT, V523, P17, DOI 10.1016/S0014-5793(02)02879-X; Royle Louise, 2006, V347, P125; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Sharma A, 2003, TRANSPLANTATION, V75, P430, DOI 10.1097/01.TP.0000053615.98201.77; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Stam MR, 2005, CARBOHYD RES, V340, P2728, DOI 10.1016/j.carres.2005.09.018; Stone KR, 2007, ARTHROSCOPY, V23, P411, DOI 10.1016/j.arthro.2006.12.024; WANG AM, 1990, J BIOL CHEM, V265, P21859; Watanabe S, 2008, GLYCOBIOLOGY, V18, P9, DOI 10.1093/glycob/cwm114; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zeleny R, 1997, ANAL BIOCHEM, V246, P96, DOI 10.1006/abio.1996.9973; ZHU A, 1993, GENE, V137, P309, DOI 10.1016/0378-1119(93)90026-Y; Zhu A, 1995, ARCH BIOCHEM BIOPHYS, V324, P65, DOI 10.1006/abbi.1995.9928; ZHU A, 1994, GENE, V140, P227, DOI 10.1016/0378-1119(94)90548-7	45	40	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8545	8554		10.1074/jbc.M709020200	http://dx.doi.org/10.1074/jbc.M709020200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18227066	Green Published, hybrid			2022-12-27	WOS:000254288000053
J	Hu, P; Kinyamu, HK; Wang, LL; Martin, J; Archer, TK; Teng, C				Hu, Peng; Kinyamu, H. Karimi; Wang, Liangli; Martin, Jessica; Archer, Trevor K.; Teng, Christina			Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; PROTEIN-COUPLED RECEPTOR; INDEPENDENT TRANSCRIPTIONAL ACTIVATION; HORMONE RESPONSE ELEMENT; HUMAN LACTOFERRIN GENE; GROWTH-FACTOR RECEPTOR; LIGAND-BINDING DOMAIN; NUCLEAR RECEPTORS; ORPHAN RECEPTOR; COACTIVATOR-1-ALPHA PGC-1-ALPHA	Estrogen-related receptor alpha(ERR alpha), a member of the nuclear receptor superfamily, is closely related to the estrogen receptors (ER alpha and ER beta). The ERR alpha gene is estrogen-responsive in several mouse tissues and cell lines, and a multiple hormone-response element (MHRE) in the promoter is an important regulatory region for estrogen- induced ERR alpha gene expression. ERR alpha was recently shown to be a negative prognostic factor for breast cancer survival, with its expression being highest in cancer cells lacking functional ER alpha. The contribution of ERR alpha in breast cancer progression remains unknown but may have important clinical implications. In this study, we investigated ERR alpha gene expression and chromatin structural changes under the influence of 17 beta- estradiol in both ER-positive MCF-7 and ER-negative SKBR3 breast cancer cells. We mapped the nucleosome positions of the ERR alpha promoter around the MHRE region and found that the MHRE resides within a single nucleosome. Local chromatin structure of the MHRE exhibited increased restriction enzyme hypersensitivity and enhanced histone H3 and H4 acetylation upon estrogen treatment. Interestingly, estrogen- induced chromatin structural changes could be repressed by estrogen antagonist ICI 182 780 in MCF-7 cells yet were enhanced in SKBR3 cells. We demonstrated, using chromatin immunoprecipitation assays, that 17 beta- estradiol induces ERR alpha gene expression in MCF-7 cells through active recruitment of co-activators and release of co-repressors when ERR alpha and AP1 bind and ER alpha is tethered to the MHRE. We also found that this estrogen effect requires the MAPK signaling pathway in both cell lines.	[Hu, Peng; Wang, Liangli; Martin, Jessica; Teng, Christina] NIEHS, NIH, Reprod & Dev Toxicol Lab, Gene Regulat Sect, Res Triangle Pk, NC 27709 USA; [Hu, Peng; Wang, Liangli; Martin, Jessica; Teng, Christina] NIEHS, NIH, Chromatin & Gene Express Sect, Res Triangle Pk, NC 27709 USA; [Kinyamu, H. Karimi; Archer, Trevor K.] NIEHS, NIH, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Teng, C (corresponding author), NIEHS, NIH, Reprod & Dev Toxicol Lab, Gene Regulat Sect, 111 Alexander Dr,POB 12233,MD E2-01, Res Triangle Pk, NC 27709 USA.	teng1@niehs.nih.gov	kinyamu, Harriet/AAG-9069-2019; Archer, Trevor K/E-5191-2019	kinyamu, Harriet/0000-0002-2377-7408; Archer, Trevor K/0000-0001-7651-3644	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071006, ZIAES071006, Z01ES070067] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Ariazi EA, 2002, CANCER RES, V62, P6510; Ariazi EA, 2007, MOL CANCER RES, V5, P71, DOI 10.1158/1541-7786.MCR-06-0227; Auwerx J, 1999, CELL, V97, P161; Barry JB, 2006, MOL ENDOCRINOL, V20, P302, DOI 10.1210/me.2005-0313; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; Bonnelye E, 1997, MECH DEVELOP, V65, P71, DOI 10.1016/S0925-4773(97)00059-2; Cavallini A, 2005, EUR J CANCER, V41, P1487, DOI 10.1016/j.ejca.2005.04.008; Chen JG, 2006, MOL ENDOCRINOL, V20, P1, DOI 10.1210/me.2005-0192; Chen S, 1999, ENDOCR-RELAT CANCER, V6, P149, DOI 10.1677/erc.0.0060149; CLARK GM, 1983, BREAST CANCER RES TR, V3, pS69, DOI 10.1007/BF01855130; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Fujimura T, 2007, INT J CANCER, V120, P2325, DOI 10.1002/ijc.22363; Gao M, 2006, INT J GYNECOL CANCER, V16, P827, DOI 10.1111/j.1525-1438.2006.00527.x; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Gustafsson JA, 2000, SEMIN PERINATOL, V24, P66, DOI 10.1016/S0146-0005(00)80059-2; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Johnston SD, 1997, MOL ENDOCRINOL, V11, P342, DOI 10.1210/me.11.3.342; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Katzenellenbogen BS, 2000, BREAST CANCER RES, V2, P335, DOI 10.1186/bcr78; Klinge CM, 2004, J MOL ENDOCRINOL, V33, P387, DOI 10.1677/jme.1.01541; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraus RJ, 2002, J BIOL CHEM, V277, P24826, DOI 10.1074/jbc.M202952200; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu D, 2005, J MOL ENDOCRINOL, V34, P473, DOI 10.1677/jme.1.01586; Liu DX, 2003, ENDOCRINOLOGY, V144, P4894, DOI 10.1210/en.2003-0432; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Moggs JG, 2001, EMBO REP, V2, P775, DOI 10.1093/embo-reports/kve185; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Prossnitz ER, 2007, MOL CELL ENDOCRINOL, V265, P138, DOI 10.1016/j.mce.2006.12.010; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Seely J, 2005, ENDOCRINOLOGY, V146, P3605, DOI 10.1210/en.2004-1619; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi HP, 1997, GENOMICS, V44, P52, DOI 10.1006/geno.1997.4850; Shigeta H, 1997, J MOL ENDOCRINOL, V19, P299, DOI 10.1677/jme.0.0190299; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Stein RA, 2006, ENDOCR-RELAT CANCER, V13, pS25, DOI 10.1677/erc.1.01292; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; TENG CT, 1986, BIOCHEM J, V240, P413, DOI 10.1042/bj2400413; Teng CT, 2002, MOL HUM REPROD, V8, P58, DOI 10.1093/molehr/8.1.58; Tremblay GB, 2002, CRIT REV EUKAR GENE, V12, P1, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i1.10; UMAYAHARA Y, 1994, J BIOL CHEM, V269, P16433; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; Vasudevan N, 2007, ENDOCR REV, V28, P1, DOI 10.1210/er.2005-0021; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Wehling M, 2006, J STEROID BIOCHEM, V102, P180, DOI 10.1016/j.jsbmb.2006.09.016; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yang C, 1998, CANCER RES, V58, P5695; Yang NY, 1996, J BIOL CHEM, V271, P5795, DOI 10.1074/jbc.271.10.5795; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhang ZP, 2007, MOL CELL ENDOCRINOL, V264, P128, DOI 10.1016/j.mce.2006.11.002; Zhang ZP, 2006, MOL ENDOCRINOL, V20, P1547, DOI 10.1210/me.2005-0252; Zhang ZP, 2000, J BIOL CHEM, V275, P20837, DOI 10.1074/jbc.M001880200	83	19	21	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6752	6763		10.1074/jbc.M705937200	http://dx.doi.org/10.1074/jbc.M705937200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18174157	hybrid			2022-12-27	WOS:000253779600017
J	Meran, S; Thomas, DW; Stephens, P; Enoch, S; Martin, J; Steadman, R; Phillips, AO				Meran, Soma; Thomas, David W.; Stephens, Phillip; Enoch, Stuart; Martin, John; Steadman, Robert; Phillips, Aled O.			Hyaluronan facilitates transforming growth factor-beta(1)-mediated fibroblast proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX REORGANIZATION; RICH PERICELLULAR MATRIX; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; SIGNAL-TRANSDUCTION; ORAL FIBROBLASTS; CD44 INTERACTION; RECEPTOR; VERSICAN	This study aims to understand the role of the matrix polysaccharide hyaluronan (HA) in influencing fibroblast proliferation and thereby affecting wound healing outcomes. To determine mechanisms that underlie scarred versus scar-free healing, patient-matched dermal and oral mucosal fibroblasts were used as models of scarring and non-scarring fibroblast phenotypes. Specifically, differences in HA generation between these distinct fibroblast populations have been examined and related to differences in transforming growth factor-beta(1) (TGF-beta(1))-dependent proliferative responses and Smad signaling. There was a differential growth response to TGF-beta(1), with it inducing proliferation in dermal fibroblasts but an anti-proliferative response in oral fibroblasts. Both responses were Smad3-dependent. Furthermore, the two fibroblast populations also demonstrated differences in their HA regulation, with dermal fibroblasts generating increased levels of HA, compared with oral fibroblasts. Inhibition of HA synthesis in dermal fibroblasts was shown to abrogate the TGF-beta(1)-mediated induction of proliferation. Inhibition of HA synthesis also led to an attenuation of Smad3 signaling in dermal fibroblasts. Microarray analysis demonstrated no difference in the genes involved in TGF-beta(1) signaling between dermal and oral fibroblasts, whereas there was a distinct difference in the pattern of genes involved in HA regulation. In conclusion, these two distinct fibroblast populations demonstrate a differential proliferative response to TGF-beta(1), which is associated with differences in HA generation. TGF-beta(1) regulates proliferation through Smad3 signaling in both fibroblast populations; however, it is the levels of HA generated by the cells that influence the outcome of this response.	[Meran, Soma; Martin, John; Steadman, Robert; Phillips, Aled O.] Cardiff Univ Heath Pk, Inst Nephrol, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Thomas, David W.; Stephens, Phillip; Enoch, Stuart] Cardiff Univ Heath Pk, Dept Oral Surg, Sch Dent, Cardiff Inst Tissue Engn & Repair, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University	Phillips, AO (corresponding author), Cardiff Univ Heath Pk, Inst Nephrol, Sch Med, Cardiff CF14 4XN, S Glam, Wales.	phillipsao@cf.ac.uk	Steadman, Robert/O-1614-2016	Steadman, Robert/0000-0002-1303-2496; Thomas, David/0000-0001-7319-5820				Anttila MA, 2000, CANCER RES, V60, P150; ANVERSA P, 1993, CARDIOVASC RES, V27, P145, DOI 10.1093/cvr/27.2.145; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Auvinen PK, 1997, INT J CANCER, V74, P477, DOI 10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.3.CO;2-X; Bedossa P, 2003, J PATHOL, V200, P504, DOI 10.1002/path.1397; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; BORDER WA, 1995, J CLIN INVEST, V96, P655, DOI 10.1172/JCI118107; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bourguignon Lilly Y. W., 1998, Frontiers in Bioscience, V3, pD637; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; BOURGUIGNON LYW, 1992, MOL CELL BIOL, V12, P4464, DOI 10.1128/MCB.12.10.4464; Brown J A, 2004, J Wound Care, V13, P48; Cantor Jerome O., 2006, Inflammation & Allergy Drug Targets, V5, P257, DOI 10.2174/187152806779010936; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; FRANCIS GS, 1995, AM J CARDIOL, V75, pA11, DOI 10.1016/S0002-9149(99)80378-6; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Geary RL, 1998, J VASC SURG, V27, P96, DOI 10.1016/S0741-5214(98)70296-4; Green FHY, 2002, CHEST, V122, p334S, DOI 10.1378/chest.122.6_suppl.334S; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; HALLGREN R, 1985, BRIT MED J, V290, P1778, DOI 10.1136/bmj.290.6484.1778; HELDIN P, 1993, EXP CELL RES, V208, P422, DOI 10.1006/excr.1993.1264; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; Johnsson C, 1996, KIDNEY INT, V50, P1224, DOI 10.1038/ki.1996.431; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Knudson CB, 1999, BIOCHEM SOC T, V27, P142, DOI 10.1042/bst0270142; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; KNUDSON CB, 1995, DEV DYNAM, V204, P186, DOI 10.1002/aja.1002040209; KNUDSON CB, 1990, CANCER LETT, V52, P113, DOI 10.1016/0304-3835(90)90253-T; KNUDSON CB, 1985, DEV BIOL, V112, P308, DOI 10.1016/0012-1606(85)90401-4; Knudson Warren, 1998, Frontiers in Bioscience, V3, pD604; Krieg T, 1989, Recenti Prog Med, V80, P594; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Kurtis MS, 2001, J ORTHOP RES, V19, P1122, DOI 10.1016/S0736-0266(01)00051-1; Labropoulou VT, 2006, HISTOPATHOLOGY, V49, P582, DOI 10.1111/j.1365-2559.2006.02558.x; Laurent TC, 1996, ANN MED, V28, P241, DOI 10.3109/07853899609033126; Lemire JM, 2007, J CELL BIOCHEM, V101, P753, DOI 10.1002/jcb.21235; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lewington AJP, 2000, AM J PHYSIOL-REG I, V278, pR247, DOI 10.1152/ajpregu.2000.278.1.R247; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MERAN S, 2006, J AM SOC NEPHROL, V17, P126; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nakamura T, 1997, BIOCHEM MOL BIOL INT, V43, P263; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; Nara Y, 1997, HISTOCHEM J, V29, P21, DOI 10.1023/A:1026460700592; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Nicolas FJ, 2003, J BIOL CHEM, V278, P3251, DOI 10.1074/jbc.M209019200; Okamoto I, 1999, J BIOL CHEM, V274, P25525, DOI 10.1074/jbc.274.36.25525; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Roberts AB, 2001, CHEST, V120, p43S, DOI 10.1378/chest.120.1_suppl.S43-a; Sakaguchi M, 2004, J CELL BIOL, V164, P979, DOI 10.1083/jcb.200312041; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; SHIHAB FS, 1995, J AM SOC NEPHROL, V6, P286; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Stephens P, 1996, J DENT RES, V75, P1358, DOI 10.1177/00220345960750060601; Stephens P, 2001, BRIT J DERMATOL, V144, P229, DOI 10.1046/j.1365-2133.2001.04006.x; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Wang LW, 1998, J BIOL CHEM, V273, P8522, DOI 10.1074/jbc.273.14.8522; WELLS A, 1993, TRANSPLANTATION, V55, P1346, DOI 10.1097/00007890-199306000-00025; Wenner CE, 2003, J CELL PHYSIOL, V196, P42, DOI 10.1002/jcp.10243; WOLF YG, 1994, J CLIN INVEST, V93, P1172, DOI 10.1172/JCI117070; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	80	97	103	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6530	6545		10.1074/jbc.M704819200	http://dx.doi.org/10.1074/jbc.M704819200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18174158	hybrid			2022-12-27	WOS:000253779500060
J	Ding, B; Lengyel, P				Ding, Bo; Lengyel, Peter			p204 protein is a novel modulator of Ras activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; NF-KAPPA-B; H-RAS; TUMOR-SUPPRESSOR; K-RAS; MYOBLAST DIFFERENTIATION; CELL-PROLIFERATION; TRANSFORMING GENE; MULTIPLE PATHWAYS; GROWTH-FACTOR	The murine p200 family protein, p204, modulates cell proliferation and tissue differentiation. Many of its activities are exerted in the nucleus. However, in cardiac myocytes, p204 accumulated in the cytoplasm. A yeast two-hybrid assay revealed a p204-cytoplasmic Ras protein interaction. This was confirmed (i) by coimmunoprecipitation of p204 with Ras in mouse heart extract and with endogenous or ectopic H-Ras and K-Ras in cell lysates as well as (ii) by binding of purified H-RasGTP to purified p204 in vitro. p204 inhibited (i) the cleavage of RasGTP to RasGDP by RasGAP; (ii) the binding to RasGTP of Raf-1, phosphatidylinositol 3-kinase, and Ral-GDS, effectors of Ras signaling; and (iii) activation by the Ras pathway of the phosphorylation and thus activation of downstream targets (e. g. MEK, Akt, and p38(MAPK)). Oncogenic Ras expression triggered the phosphorylation and translocation of p204 from the nucleus to the cytoplasm. This is expected to increase the interaction between the two proteins. Translocation triggered by Ras oncoprotein was blocked by the LY294002 inhibitor of phosphatidylinositol 3-kinase. Ras did not promote phosphorylation or translocation to the cytoplasm of mutated p204 in which serine 179 was replaced by alanine. p204 overexpression inhibited the anchorage-independent proliferation of cells expressing Ras(Q61L) oncoprotein. Ras oncoprotein triggered in MEF3T3 cells the rearrangement of the actin cytoskeleton and the enhancement of cell migration through a membrane. Overexpression of p204 inhibited both. Ras oncoprotein or activated, wild-type Ras was described to increase Egr-1 transcription factor expression. We report that a sequence in the gene encoding p204 bound Egr-1, and Egr-1 activated p204 expression. Ras oncoprotein or activated wild-type Ras increased the expression in 3T3 cells of p204 together with that of Egr-1. Furthermore, the activation of expression of a single copy of K-ras oncogene in cultured murine embryonic cells induced the expression of a high level of p204 as well as its distribution between the nuclei and the cytoplasm. Thus, p204 may serve as a negative feedback inhibitor of Ras activity.	[Ding, Bo; Lengyel, Peter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Lengyel, P (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	peter.lengyel@yale.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012320, R21AI012320, R01AI012320] Funding Source: NIH RePORTER; NIAID NIH HHS [AI12320] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Asefa B, 2006, FEBS LETT, V580, P1205, DOI 10.1016/j.febslet.2006.01.032; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bouck N, 1979, Methods Enzymol, V58, P296; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; CHOUBEY D, 1992, J CELL BIOL, V116, P1333, DOI 10.1083/jcb.116.6.1333; CHOUBEY D, 1989, J BIOL CHEM, V264, P17182; Classon M, 2000, P NATL ACAD SCI USA, V97, P10826, DOI 10.1073/pnas.190343597; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cuenda A, 2000, METH MOL B, V99, P161; Dalal K, 2006, FEBS LETT, V580, P3083, DOI 10.1016/j.febslet.2006.04.056; Dauffy J, 2006, J LEUKOCYTE BIOL, V79, P173, DOI 10.1189/jlb.0205083; Deschamps S, 2003, GENOMICS, V82, P34, DOI 10.1016/S0888-7543(03)00092-2; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Ding B, 2006, J BIOL CHEM, V281, P14882, DOI 10.1074/jbc.M511747200; Ding Y, 2006, MOL CELL BIOL, V26, P1979, DOI 10.1128/MCB.26.5.1979-1996.2006; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; Goldberg L, 2006, CANCER RES, V66, P11709, DOI 10.1158/0008-5472.CAN-06-1878; GOLDFARB M, 1982, NATURE, V296, P404, DOI 10.1038/296404a0; GOODY RS, 1992, PHILOS T ROY SOC B, V336, P3, DOI 10.1098/rstb.1992.0037; GUPTA MP, 1991, J BIOL CHEM, V266, P12813; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Hertel L, 2000, ONCOGENE, V19, P3598, DOI 10.1038/sj.onc.1203697; Hjoberg J, 2004, AM J PHYSIOL-LUNG C, V286, pL817, DOI 10.1152/ajplung.00190.2003; HOFER F, 1994, P NATL ACAD SCI USA, V91, P11089, DOI 10.1073/pnas.91.23.11089; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Liu CJ, 2000, MOL CELL BIOL, V20, P7024, DOI 10.1128/MCB.20.18.7024-7036.2000; Liu CJ, 1999, EMBO J, V18, P2845, DOI 10.1093/emboj/18.10.2845; Liu CJ, 2005, J BIOL CHEM, V280, P2788, DOI 10.1074/jbc.M412604200; Liu CJ, 2002, MOL CELL BIOL, V22, P2893, DOI 10.1128/MCB.22.9.2893-2905.2002; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Ma XY, 2003, J BIOL CHEM, V278, P23008, DOI 10.1074/jbc.M302105200; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MARUTA H, 1994, BIOESSAYS, V16, P489, DOI 10.1002/bies.950160708; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; MCMAHON SB, 1995, J EXP MED, V181, P417, DOI 10.1084/jem.181.1.417; Min W, 1996, MOL CELL BIOL, V16, P359; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; Oxford G, 2003, CANCER LETT, V189, P117, DOI 10.1016/S0304-3835(02)00510-4; Pan F, 2007, NATURE, V445, P433, DOI 10.1038/nature05476; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; PULCIANI S, 1982, P NATL ACAD SCI-BIOL, V79, P2845, DOI 10.1073/pnas.79.9.2845; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rolle S, 2001, VIROLOGY, V286, P249, DOI 10.1006/viro.2001.1021; Samuel CE, 2007, J BIOL CHEM, V282, P20045, DOI 10.1074/jbc.R700025200; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shao HP, 2000, J BIOL CHEM, V275, P26914; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; SHIROUZU M, 1994, ONCOGENE, V9, P2153; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; SWEET RW, 1984, NATURE, V311, P273, DOI 10.1038/311273a0; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WEBER H, 1987, EMBO J, V6, P591, DOI 10.1002/j.1460-2075.1987.tb04795.x; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Xin H, 2003, J CELL BIOCHEM, V88, P191, DOI 10.1002/jcb.10372; YAMADA H, 1990, MOL CELL BIOL, V10, P1822, DOI 10.1128/MCB.10.4.1822; Yang JJ, 1998, MOL CELL BIOL, V18, P2586, DOI 10.1128/MCB.18.5.2586; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200	85	17	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5831	5848		10.1074/jbc.M709680200	http://dx.doi.org/10.1074/jbc.M709680200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165224	hybrid			2022-12-27	WOS:000253426700063
J	Kotzsch, A; Nickel, J; Seher, A; Heinecke, K; van Geersdaele, L; Herrmann, T; Sebald, W; Mueller, TD				Kotzsch, Alexander; Nickel, Joachim; Seher, Axel; Heinecke, Kai; van Geersdaele, Laura; Herrmann, Thomas; Sebald, Walter; Mueller, Thomas D.			Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA SUPERFAMILY; GROWTH-FACTOR-BETA; CELL-LINE; MUTATIONS; BINDING; DIFFERENTIATION; BMP-2; OSTEOBLAST; LIGAND; GENE	Bone morphogenetic proteins regulate many developmental processes during embryogenesis as well as tissue homeostasis in the adult. Signaling of bone morphogenetic proteins (BMPs) is accomplished by binding to two types of serine/threonine kinase transmembrane receptors termed type I and type II. Because a large number of ligands signal through a limited number of receptors, ligand-receptor interaction in the BMP superfamily is highly promiscuous, with a ligand binding to various receptors and a receptor binding many different BMP ligands. In this study we investigate the interaction of BMP-2 with its two high affinity type I receptors, BMP receptors IA (BMPR-IA) and BMPR-IB. Interestingly, 50% of the residues in the BMP-2 binding epitope of the BMPR-IA receptor are exchanged in BMPR-IB without a decrease in binding affinity or specificity for BMP-2. Our structural and functional analyses show that promiscuous binding of BMP-2 to both type I receptors is achieved by inherent backbone and side-chain flexibility as well as by variable hydration of the ligand-receptor interface enabling the BMP-2 surface to adapt to different receptor geometries. Despite the high degree of amino acid variability found in BMPR-IA and BMPR-IB binding equally to BMP-2, three single point missense mutations in the ectodomain of BMPR-IA cannot be tolerated. In juvenile polyposis syndrome these mutations have been shown to inactivate BMPR-IA. On the basis of our biochemical and biophysical analyses, we can show that the mutations, which are located outside the ligand binding epitope, alter the local or global fold of the receptor, thereby inactivating BMPR-IA and causing a loss of the BMP-2 tumor suppressor function in colon epithelial cells.	[Kotzsch, Alexander; Mueller, Thomas D.] Univ Wurzburg, Lehrstuhl Bot 1, Julius Von Sachs Inst, D-97082 Wurzburg, Germany; [Nickel, Joachim; Seher, Axel; Heinecke, Kai; van Geersdaele, Laura; Sebald, Walter] Univ Wurzburg, Lehrstuhl Physiol Chem 2, Theodor Boveri Inst, Biowissenschaften Biozentrum, D-97074 Wurzburg, Germany; [Herrmann, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, D-97070 Wurzburg, Germany; [Sebald, Walter; Mueller, Thomas D.] Univ Wurzburg, Rudolf Virchow Zentrum, Deutsch Forschungsgemeinschaft Forschungzentrum, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Mueller, TD (corresponding author), Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius Von Sachs Platz 2, D-97082 Wurzburg, Germany.	mueller@biozentrum.uni-wuerzburg.de	Herrmann, Thomas/J-4943-2012	Herrmann, Thomas/0000-0002-1093-0194; Mueller, Thomas/0000-0003-1862-7357				Akiyama S, 1997, EXP CELL RES, V235, P362, DOI 10.1006/excr.1997.3680; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Ebisawa T, 1999, J CELL SCI, V112, P3519; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Ely KR, 2002, J MOL RECOGNIT, V15, P286, DOI 10.1002/jmr.589; Everman DB, 2002, AM J MED GENET, V112, P291, DOI 10.1002/ajmg.10777; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; HEMMATIBRIVANLOU A, 1995, DEV GENET, V17, P78, DOI 10.1002/dvg.1020170109; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Howe JR, 2004, J MED GENET, V41, P484, DOI 10.1136/jmg.2004.018598; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Kaplan FS, 2007, EXPERT OPIN BIOL TH, V7, P705, DOI 10.1517/14712598.7.5.705; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kwan KM, 2004, GENESIS, V39, P10, DOI 10.1002/gene.20021; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Li CL, 2003, J BIOL CHEM, V278, P50523, DOI 10.1074/jbc.M309381200; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Mace PD, 2006, BIOCHEM BIOPH RES CO, V351, P831, DOI 10.1016/j.bbrc.2006.10.109; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; Phillips DJ, 1999, J ENDOCRINOL, V162, P111, DOI 10.1677/joe.0.1620111; Ro TB, 2004, ONCOGENE, V23, P3024, DOI 10.1038/sj.onc.1207386; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; URIST MR, 1983, P SOC EXP BIOL MED, V173, P194; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002	47	47	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5876	5887		10.1074/jbc.M706029200	http://dx.doi.org/10.1074/jbc.M706029200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18160401	hybrid			2022-12-27	WOS:000253426700066
J	Yu, SB; Jiang, Y; Galson, DL; Luo, M; Lai, YM; Lu, Y; Ouyang, HJ; Zhang, J; Xiao, GZ				Yu, Shibing; Jiang, Yu; Galson, Deborah L.; Luo, Min; Lai, Yumei; Lu, Yi; Ouyang, Hong-Jiao; Zhang, Jian; Xiao, Guozhi			General transcription factor IIA-gamma increases osteoblast-specific Osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; IN-VITRO; BONE-FORMATION; FACTOR TFIIA; COOPERATIVE INTERACTIONS; CLEIDOCRANIAL DYSPLASIA; SELECTIVE INHIBITORS; SIGNALING PATHWAYS; BINDING PROTEINS; RESPONSE ELEMENT	ATF4 (activating transcription factor 4) is an osteoblast-enriched transcription factor that regulates terminal osteoblast differentiation and bone formation. ATF4 knock-out mice have reduced bone mass ( severe osteoporosis) throughout life. Runx2 (runt-related transcription factor 2) is a runt domain-containing transcription factor that is essential for bone formation during embryogenesis and postnatal life. In this study, we identified general transcription factor IIA gamma(TFIIA gamma) as a Runx2- interacting factor in a yeast two-hybrid screen. Immunoprecipitation assays confirmed that TFIIA gamma interacts with Runx2 in osteoblasts and when coexpressed in COS-7 cells or using purified glutathione S-transferase fusion proteins. Chromatin immuno-precipitation assay of MC3T3-E1 ( clone MC-4) preosteoblast cells showed that in intact cells TFIIA gamma is recruited to the region of the osteocalcin promoter previously shown to bind Runx2 and ATF4. A small region of Runx2 ( amino acids 258 - 286) was found to be required for TFIIA gamma binding. Although TFIIA gamma interacts with Runx2, it does not activate Runx2. Instead, TFIIA gamma binds to and activates ATF4. Furthermore, TFIIA gamma together with ATF4 and Runx2 stimulates osteocalcin promoter activity and endogenous mRNA expression. Small interfering RNA silencing of TFIIA gamma markedly reduces levels of endogenous ATF4 protein and Ocn mRNA in osteoblastic cells. Overexpression of TFIIA gamma increases levels of ATF4 protein. Finally, TFIIA gamma significantly prevents ATF4 degradation. This study shows that a general transcription factor, TFIIA gamma, facilitates osteoblast-specific gene expression through interactions with two important bone transcription factors ATF4 and Runx2.	[Yu, Shibing; Galson, Deborah L.; Luo, Min; Lai, Yumei; Lu, Yi; Ouyang, Hong-Jiao; Zhang, Jian; Xiao, Guozhi] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15240 USA; [Jiang, Yu] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xiao, GZ (corresponding author), Univ Pittsburgh, Vet Affairs Pittsburg Healthcare Syst Res & Dev, Dept Med, Div Hematol & Oncol, 151-U Rm 2W-111,Univ Dr, Pittsburgh, PA 15240 USA.	xiaog@upmc.edu	YU, SHIBING/B-7648-2012; Galson, Deborah L./E-9370-2010; ZHANG, JIAN/Q-6334-2018; Lu, Yi/J-6746-2018	Galson, Deborah L./0000-0002-2045-8807; Lu, Yi/0000-0002-1060-6925	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072230] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR059647] Funding Source: Medline; NIDDK NIH HHS [R01 DK072230-01A2, R01 DK072230-03, R01 DK072230, DK072230, R01 DK072230-02S1, R01 DK072230-02] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Clemens KE, 1996, MOL CELL BIOL, V16, P4656; CONAWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356, DOI 10.1073/pnas.86.19.7356; De Cesare D, 2003, MOL ENDOCRINOL, V17, P2554, DOI 10.1210/me.2003-0280; DEJONG J, 1995, P NATL ACAD SCI USA, V92, P3313, DOI 10.1073/pnas.92.8.3313; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; DUVALL JF, 1995, J VIROL, V69, P5077, DOI 10.1128/JVI.69.8.5077-5086.1995; Frendo JL, 1998, J BIOL CHEM, V273, P30509, DOI 10.1074/jbc.273.46.30509; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Guo B, 1997, P NATL ACAD SCI USA, V94, P121, DOI 10.1073/pnas.94.1.121; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hatta M, 2006, INT J MOL MED, V17, P425; Hoiby T, 2004, EMBO J, V23, P3083, DOI 10.1038/sj.emboj.7600304; HOIBY T, 2007, BIOCHIM BIOPHYS ACTA, V1769, P529; Hurley MM, 1999, J BONE MINER RES, V14, P776, DOI 10.1359/jbmr.1999.14.5.776; Jiang D, 2004, J BIOL CHEM, V279, P5329, DOI 10.1074/jbc.M311547200; Jurutka PW, 1997, J BIOL CHEM, V272, P14592, DOI 10.1074/jbc.272.23.14592; KARPINSKI BA, 1992, P NATL ACAD SCI USA, V89, P4820, DOI 10.1073/pnas.89.11.4820; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krishnan V, 2003, MOL ENDOCRINOL, V17, P423, DOI 10.1210/me.2002-0225; Kurihara N, 2004, J BONE MINER RES, V19, P1154, DOI 10.1359/JBMR.040312; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lassot I, 2005, J BIOL CHEM, V280, P41537, DOI 10.1074/jbc.M505294200; Lavery DN, 2006, BIOCHEM SOC T, V34, P1054, DOI 10.1042/BST0341054; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lian J. B., 2003, Current Pharmaceutical Design, V9, P2677, DOI 10.2174/1381612033453659; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; MERRIMAN HL, 1995, BIOCHEMISTRY-US, V34, P13125, DOI 10.1021/bi00040a025; Meyer T, 1997, J BIOL CHEM, V272, P30709, DOI 10.1074/jbc.272.49.30709; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; Newberry EP, 1997, BIOCHEMISTRY-US, V36, P10451, DOI 10.1021/bi971008x; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SASSONECORSI P, 1994, EMBO J, V13, P4717, DOI 10.1002/j.1460-2075.1994.tb06797.x; Stein GS, 1997, MOL BIOL REP, V24, P185, DOI 10.1023/A:1006803615430; TSUJIMOTO A, 1991, J VIROL, V65, P1420, DOI 10.1128/JVI.65.3.1420-1426.1991; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang J, 2004, CANCER RES, V64, P1861, DOI 10.1158/0008-5472.CAN-03-2968; Willis DM, 2002, J BIOL CHEM, V277, P37280, DOI 10.1074/jbc.M206482200; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Zhang X, 2002, BIOCHEM BIOPH RES CO, V290, P526, DOI 10.1006/bbrc.2001.6217; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006; ZIFF EB, 1990, TRENDS GENET, V6, P69, DOI 10.1016/0168-9525(90)90081-G	66	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5542	5553		10.1074/jbc.M705653200	http://dx.doi.org/10.1074/jbc.M705653200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18171674	Green Accepted, hybrid			2022-12-27	WOS:000253426700035
J	Zhao, Y; Fang, QH; Straub, SG; Sharp, GWG				Zhao, Ying; Fang, Qinghua; Straub, Susanne G.; Sharp, Geoffrey W. G.			Both G(i) and G(o) Heterotrimeric G proteins are required to exert the full effect of norepinephrine on the beta-cell K-ATP channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE POTASSIUM CHANNELS; GTP-BINDING PROTEINS; ADENYLYL-CYCLASE; INDUCED HYPERPOLARIZATION; INSULIN-SECRETION; GAMMA-SUBUNIT; ACTIVATION; INHIBITION; SOMATOSTATIN; GLUCOSE	The effects of norepinephrine (NE), an inhibitor of insulin secretion, were examined on membrane potential and the ATP-sensitive K+ channel (K-ATP) in INS 832/13 cells. Membrane potential was monitored under the whole cell current clamp mode. NE hyperpolarized the cell membrane, an effect that was abolished by tolbutamide. The effect of NE on K-ATP channels was investigated in parallel using outside-out single channel recording. This revealed that NE enhanced the open activities of the K-ATP channels similar to 2-fold without changing the single channel conductance, demonstrating that NE-induced hyperpolarization was mediated by activation of the K-ATP channels. The NE effect was abolished in cells preincubated with pertussis toxin, indicating coupling to heterotrimeric G(i)/G(o) proteins. To identify the G proteins involved, antisera raised against alpha and beta subunits (anti-G alpha(common), anti-G beta, anti-G alpha(i1/2/3), and anti-G alpha(o)) were used. Anti-G alpha(common) totally blocked the effects of NE on membrane potential and KATP channels. Individually, anti-G alpha(i1/2/3) and anti-G alpha(o) only partially inhibited the action of NE on K-ATP channels. However, the combination of both completely eliminated the action. Antibodies against G(beta) had no effects. To confirm these results and to further identify the G protein subunits involved, the blocking effects of peptides containing the sequence of 11 amino acids at the C termini of the alpha subunits were used. The data obtained were similar to those derived from the antibody work with the additional information that G alpha(i3) and G alpha(o1) were not involved. In conclusion, both G(i) and G(o) proteins are required for the full effect of norepinephrine to activate the K-ATP channel.	[Zhao, Ying; Straub, Susanne G.; Sharp, Geoffrey W. G.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Fang, Qinghua] Cornell Univ, Dept Appl Engn & Phys, Ithaca, NY 14853 USA	Cornell University; Cornell University	Sharp, GWG (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	gws2@cornell.edu			NIDDK NIH HHS [DK54243, DK56737] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054243, R01DK056737] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel KB, 1996, PFLUG ARCH EUR J PHY, V432, P89, DOI 10.1007/s004240050109; Bloc A, 2000, J PHYSIOL-LONDON, V529, P723, DOI 10.1111/j.1469-7793.2000.00723.x; Bryan J, 2005, CURR PHARM DESIGN, V11, P2699, DOI 10.2174/1381612054546879; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; DEWEILLE JR, 1989, P NATL ACAD SCI USA, V86, P2971; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; DUNNE MJ, 1989, EMBO J, V8, P413, DOI 10.1002/j.1460-2075.1989.tb03392.x; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; FINDLAY I, 1987, J PHYSIOL-LONDON, V391, P611, DOI 10.1113/jphysiol.1987.sp016759; Gilchrist A, 1998, J BIOL CHEM, V273, P14912, DOI 10.1074/jbc.273.24.14912; Gilchrist A, 2001, J BIOL CHEM, V276, P25672, DOI 10.1074/jbc.M100914200; Gribble FM, 1997, J PHYSIOL-LONDON, V504, P35, DOI 10.1111/j.1469-7793.1997.00035.x; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; INAGAKI N, 1995, J BIOL CHEM, V270, P5691, DOI 10.1074/jbc.270.11.5691; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; Kanzaki M, 1997, J BIOL CHEM, V272, P14733, DOI 10.1074/jbc.272.23.14733; Kuzhikandathil EV, 2002, MOL PHARMACOL, V62, P119, DOI 10.1124/mol.62.1.119; Leech CA, 1999, BIOCHEM BIOPH RES CO, V254, P703, DOI 10.1006/bbrc.1998.9906; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MCDERMOTT AM, 1995, DIABETES, V44, P453, DOI 10.2337/diabetes.44.4.453; MOGAMI H, 1995, ENDOCRINOLOGY, V136, P2960, DOI 10.1210/en.136.7.2960; PETERSEN OH, 1987, PHYSIOL REV, V67, P1054, DOI 10.1152/physrev.1987.67.3.1054; PHILIPSON LH, 1995, J BIOL CHEM, V270, P14604, DOI 10.1074/jbc.270.24.14604; Reimann F, 1999, J PHYSIOL-LONDON, V520, P661, DOI 10.1111/j.1469-7793.1999.00661.x; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; RIBALET B, 1995, J PHYSIOL-LONDON, V485, P73, DOI 10.1113/jphysiol.1995.sp020713; RORSMAN P, 1991, NATURE, V349, P77, DOI 10.1038/349077a0; SACKMANN B, 1995, SINGLE CHANNEL RECOR, P45; Schermerhorn T, 2000, CELL CALCIUM, V27, P163, DOI 10.1054/ceca.2000.0107; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Sharp GWG, 1996, AM J PHYSIOL-CELL PH, V271, pC1781, DOI 10.1152/ajpcell.1996.271.6.C1781; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Sieg A, 2004, AM J PHYSIOL-ENDOC M, V286, pE463, DOI 10.1152/ajpendo.00365.2003; Smith PA, 2001, J PHYSIOL-LONDON, V532, P127, DOI 10.1111/j.1469-7793.2001.0127g.x; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; ULLRICH S, 1984, J BIOL CHEM, V259, P4111; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Yamada M, 1998, PHARMACOL REV, V50, P723; Yan LM, 2003, J BIOL CHEM, V278, P18177, DOI 10.1074/jbc.M301116200; Yang SM, 2004, MOL ENDOCRINOL, V18, P2312, DOI 10.1210/me.2004-0148	49	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5306	5316		10.1074/jbc.M707695200	http://dx.doi.org/10.1074/jbc.M707695200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18162464	hybrid			2022-12-27	WOS:000253426700010
J	Nakayama, T; Ishii, T; Hotta, T; Mizuno, K				Nakayama, Takateru; Ishii, Takeharu; Hotta, Takashi; Mizuno, Koichi			Radial microtubule organization by histone H1 on nuclei of cultured tobacco BY-2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHER-PLANT CELLS; 49 KDA PROTEIN; GAMMA-TUBULIN; ORGANIZING CENTERS; NUCLEATION; SITES; SPINDLE; LOCALIZATION; CYTOSKELETON; CENTROSOMES	In acentriolar higher plant cells, the surface of the nucleus acts as a microtubule-organizing center, substituting for the centrosome. However, the protein factors responsible for this microtubule organization are unknown. The nuclear surfaces of cultured tobacco BY-2 cells possess particles that generate microtubules. We attempted to isolate the proteins in these particles to determine their role in microtubule organization. When incubated with plant or mammalian tubulin, some, but not all, of the isolated nuclei generated abundant microtubules radially from their surfaces. The substance to induce the formation of radial microtubules was confirmed by SDS-PAGE to be a protein with apparent molecular mass of 38 kDa. Partial analysis of the amino acid sequences of the peptide fragments suggested it was a histone H1-related protein. Cloning and cDNA sequence analysis confirmed this and revealed that when the recombinant protein was incubated with tubulin, it could organize microtubules as well as the 38-kDa protein. Histone H1 and tubulin formed complexes immediately, even on ice, and then clusters of these structures were formed. These clusters generated radial microtubules. This microtubule-organizing property was confined to histone H1; all other core histones failed to act as organizers. On immunoblot analysis, rabbit antibodies raised against the 38-kDa protein cross-reacted with histone H1 proteins from tobacco BY-2 cells. These antibodies virtually abolished the ability of the nucleus to organize radial microtubules. Indirect immunofluorescence showed that the antigen was distributed at the nuclear plasm and particularly at nuclear periphery independently from DNA.	[Nakayama, Takateru; Ishii, Takeharu; Hotta, Takashi; Mizuno, Koichi] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan	Osaka University	Mizuno, K (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Machikaneyama Cho, Osaka 5600043, Japan.	kmizuno@bio.sci.osaka-u.ac.jp						Baluska F, 1997, INT REV CYTOL, V175, P91, DOI 10.1016/S0074-7696(08)62126-9; BASKIN TI, 1990, ANNU REV PLANT PHYS, V41, P277, DOI 10.1146/annurev.pp.41.060190.001425; CLAYTON L, 1985, J CELL BIOL, V101, P319, DOI 10.1083/jcb.101.1.319; Erhardt M, 2002, J CELL SCI, V115, P2423; FALCONER MM, 1988, PROTOPLASMA, V144, P46, DOI 10.1007/BF01320279; FLANDERS DJ, 1990, DEVELOPMENT, V110, P897; GIDDINGS TH, 1991, CYTOSKELETAL BASIS P, P229; GUNNING BES, 1985, J CELL SCI, P157, DOI 10.1242/jcs.1985.Supplement_2.9; HASEZAWA S, 1993, PROTOPLASMA, V176, P64, DOI 10.1007/BF01378940; HASEZAWA S, 1991, BOT ACTA, V104, P206, DOI 10.1111/j.1438-8677.1991.tb00218.x; HORIO T, 1991, J CELL SCI, V99, P693; Hotta T, 2007, CELL STRUCT FUNCT, V32, P79, DOI 10.1247/csf.07031; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Iwamatsu A, 1991, Seikagaku, V63, P139; Kaczanowski S, 2001, J MOL EVOL, V53, P19, DOI 10.1007/s002390000000; Kumagai F, 1999, EUR J CELL BIOL, V78, P109, DOI 10.1016/S0171-9335(99)80012-0; Kumagai F, 2001, PLANT CELL PHYSIOL, V42, P723, DOI 10.1093/pcp/pce091; KUMAGAI F, 1995, BOT ACTA, V108, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERT AM, 1980, CHROMOSOMA, V76, P295, DOI 10.1007/BF00327268; Lambert AM, 1993, CURR OPIN CELL BIOL, V5, P116, DOI 10.1016/S0955-0674(05)80016-X; LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239; LIU B, 1993, J CELL SCI, V104, P1217; LIU B, 1994, PLANT CELL, V6, P303, DOI 10.1105/tpc.6.2.303; MITHIEUX G, 1984, J BIOL CHEM, V259, P5523; MIZUNO K, 1993, PROTOPLASMA, V173, P77, DOI 10.1007/BF01378864; MIZUNO K, 1981, J BIOCHEM-TOKYO, V89, P329, DOI 10.1093/oxfordjournals.jbchem.a133199; MULTIGNER L, 1992, NATURE, V360, P33, DOI 10.1038/360033a0; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; PICKETTHEAPS JD, 1966, J CELL SCI, V1, P109; Schmit AC, 2002, INT REV CYTOL, V220, P257; Schmit AC, 1996, CHROMOSOMA, V104, P405, DOI 10.1007/BF00352264; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SHIBAOKA H, 1994, CURR OPIN CELL BIOL, V6, P10, DOI 10.1016/0955-0674(94)90110-4; Shimamura M, 2004, PLANT CELL, V16, P45, DOI 10.1105/tpc.016501; Staiger CJ, 1991, CURR OPIN CELL BIOL, V3, P33, DOI 10.1016/0955-0674(91)90163-S; STEARNS T, 1991, CELL, V32, P577; Stoppin V, 1996, EUR J CELL BIOL, V69, P11; STOPPIN V, 1994, PLANT CELL, V6, P1099, DOI 10.1105/tpc.6.8.1099; SZEKERES M, 1995, PLANT MOL BIOL, V27, P597, DOI 10.1007/BF00019325; Wasteneys GO, 2004, PLANT PHYSIOL, V136, P3884, DOI 10.1104/pp.104.900133; ZHENG YX, 1991, CELL, V65, P817, DOI 10.1016/0092-8674(91)90389-G	43	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2008	283	24					16632	16640		10.1074/jbc.M705764200	http://dx.doi.org/10.1074/jbc.M705764200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	309YW	18184653	hybrid			2022-12-27	WOS:000256497100040
J	Hayes, VH; Devlin, G; Quinlan, RA				Hayes, Victoria H.; Devlin, Glyn; Quinlan, Roy A.			Truncation of alpha B-crystallin by the myopathy-causing Q151X mutation significantly destabilizes the protein leading to aggregate formation in transfected cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; CHAPERONE-LIKE ACTIVITY; DESMIN-RELATED MYOPATHY; A-CRYSTALLIN; METHANOCOCCUS-JANNASCHII; FILAMENT INTERACTIONS; IMMUNOREACTIVE ALPHA; QUATERNARY STRUCTURE; LENS; ASSEMBLIES	Here we investigate the effects of a myopathy-causing mutation in alpha B-crystallin, Q151X, upon its structure and function. This mutation removes the C-terminal domain of alpha B-crystallin, which is expected to compromise both its oligomerization and chaperone activity. We compared this to two other alpha B-crystallin mutants (450delA, 464delCT) and also to a series of C-terminal truncations (E164X, E165X, K174X, and A171X). We find that the effects of the Q151X mutation were not always as predicted. Specifically, we have found that although the Q151X mutation decreased oligomerization of alpha B-crystallin and even increased some chaperone activities, it also significantly destabilized alpha B-crystallin causing it to self-aggregate. This conclusion was supported by our analyses of both the other disease-causing mutants and the series of C-terminal truncation constructs of alpha B-crystallin. The 450delA and 464delCT mutants could only be refolded and assayed as a complex with wild type alpha B-crystallin, which was not the case for Q151X alpha B-crystallin. From these studies, we conclude that all three disease-causing mutations (450delA, 464delCT, and Q151X) in the C-terminal extension destabilize alpha B-crystallin and increase its tendency to self-aggregate. We propose that it is this, rather than a catastrophic loss of chaperone activity, which is a major factor in the development of the reported diseases for the three disease-causing mutations studied here. In support of this hypothesis, we show that Q151X alpha B-crystallin is found mainly in the insoluble fraction of cell extracts from transient transfected cells, due to the formation of cytoplasmic aggregates.	[Hayes, Victoria H.; Quinlan, Roy A.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Devlin, Glyn] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Durham University; University of Cambridge	Quinlan, RA (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	r.a.quinlan@durham.ac.uk	Quinlan, Roy/A-1348-2012	Quinlan, Roy/0000-0003-0644-4123	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS042803] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council Funding Source: Medline; NINDS NIH HHS [P01NS42803, P01 NS042803, P01 NS042803-010004] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; BLOEMENDAL H, 1991, PROG NUCLEIC ACID RE, V41, P259; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Colvis CM, 2000, ELECTROPHORESIS, V21, P2219, DOI 10.1002/1522-2683(20000601)21:11<2219::AID-ELPS2219>3.0.CO;2-R; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Doss-Pepe EW, 1998, EXP EYE RES, V67, P657, DOI 10.1006/exer.1998.0561; Feil IK, 2001, J BIOL CHEM, V276, P12024, DOI 10.1074/jbc.M010856200; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Ghosh JG, 2008, INT J BIOCHEM CELL B, V40, P954, DOI 10.1016/j.biocel.2007.10.035; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P9878, DOI 10.1021/bi060970k; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Haley DA, 2000, J MOL BIOL, V298, P261, DOI 10.1006/jmbi.2000.3657; HE SM, 1995, J MASS SPECTROM, V30, P424, DOI 10.1002/jms.1190300305; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2004, EXP EYE RES, V79, P817, DOI 10.1016/j.exer.2004.05.007; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; IWAKI T, 1991, KIDNEY INT, V40, P52, DOI 10.1038/ki.1991.178; Jimenez-Asensio J, 1999, J BIOL CHEM, V274, P32287, DOI 10.1074/jbc.274.45.32287; Kappe G, 2001, BBA-GENE STRUCT EXPR, V1520, P1, DOI 10.1016/S0167-4781(01)00237-8; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P201, DOI 10.1016/0304-4165(91)90062-L; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1080, P173, DOI 10.1016/0167-4838(91)90146-Q; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kim R, 1998, P NATL ACAD SCI USA, V95, P9129, DOI 10.1073/pnas.95.16.9129; Kim R, 2003, P NATL ACAD SCI USA, V100, P8151, DOI 10.1073/pnas.1032940100; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Meehan S, 2007, J MOL BIOL, V372, P470, DOI 10.1016/j.jmb.2007.06.060; Morner C., 1894, HOPPE SEYL, V18, P61; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Pasta SY, 2004, MOL VIS, V10, P655; Pasta SY, 2003, J BIOL CHEM, V278, P51159, DOI 10.1074/jbc.M307523200; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; Perng MD, 1999, J CELL SCI, V112, P2099; Plater ML, 1996, J BIOL CHEM, V271, P28558, DOI 10.1074/jbc.271.45.28558; QUINLAN RA, 1989, J CELL SCI, V93, P71; Rajan S, 2006, BIOCHEMISTRY-US, V45, P15684, DOI 10.1021/bi060705z; Schroder R, 2007, J CELL MOL MED, V11, P416, DOI 10.1111/j.1582-4934.2007.00057.x; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Simon S, 2007, J BIOL CHEM, V282, P34276, DOI 10.1074/jbc.M703267200; SMITH JB, 1995, J PROTEIN CHEM, V14, P179, DOI 10.1007/BF01980330; Sreelakshmi Y, 2006, MOL VIS, V12, P581; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Thampi P, 2003, BIOCHEMISTRY-US, V42, P11857, DOI 10.1021/bi030129w; Thampi P, 2002, INVEST OPHTH VIS SCI, V43, P3265; Treweek TM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001046; Ueda Y, 2002, MOL CELL PROTEOMICS, V1, P357, DOI 10.1074/mcp.M200007-MCP200; Ueda Y, 2002, INVEST OPHTH VIS SCI, V43, P205; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; VANKLEEF FSM, 1976, EUR J BIOCHEM, V66, P477; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; White HE, 2006, STRUCTURE, V14, P1197, DOI 10.1016/j.str.2006.05.021; ZANTEMA A, 1992, J BIOL CHEM, V267, P12936	62	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10500	10512		10.1074/jbc.M706453200	http://dx.doi.org/10.1074/jbc.M706453200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18230612	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000254894700032
J	Minicozzi, V; Stellato, F; Comai, M; Dalla Serra, M; Potrich, C; Meyer-Klaucke, W; Morante, S				Minicozzi, Velia; Stellato, Francesco; Comai, Massimiliano; Dalla Serra, Mauro; Potrich, Cristina; Meyer-Klaucke, Wolfram; Morante, Silvia			Identifying the minimal copper- and zinc-binding site sequence in amyloid-beta peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-ABSORPTION; MULTIPLE-SCATTERING THEORY; CURVED-WAVE THEORY; ALZHEIMERS-DISEASE; FINE-STRUCTURE; NEURODEGENERATIVE DISEASES; INFRARED-SPECTROSCOPY; METAL-BINDING; PRION PROTEIN; A-BETA	With a combination of complementary experimental techniques, namely sedimentation assay, Fourier transform infrared spectroscopy, and x-ray absorption spectroscopy, we are able to determine the atomic structure around the metal-binding site in samples where amyloid-beta (A beta) peptides are complexed with either Cu(II) or Zn(II). Exploiting information obtained on a selected set of fragments of the A beta peptide, we identify along the sequence the histidine residues coordinated to the metal in the various peptides we have studied (A beta(1-40), A beta(1-16), A beta(1-28), A beta(5-23), and A beta(17-40)). Our data can be consistently interpreted assuming that all of the peptides encompassing the minimal 1-16 amino acidic sequence display a copper coordination mode that involves three histidines (His(6), His(13), and His(14)). In zinc-A beta complexes, despite the fact that the metal coordination appears to be more sensitive to solution condition and shows a less rigid geometry around the binding site, a four-histidine coordination mode is seen to be preferred. Lacking a fourth histidine along the A beta peptide sequence, this geometrical arrangement hints at a Zn(II)-promoted interpeptide aggregation mode.	[Minicozzi, Velia; Stellato, Francesco; Morante, Silvia] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Minicozzi, Velia; Stellato, Francesco; Morante, Silvia] Ist Nazl Fis Nucl, I-00133 Rome, Italy; [Comai, Massimiliano; Dalla Serra, Mauro; Potrich, Cristina] CNR, Fdn Bruno Kessler, Ist Biofis, Unita Trento, I-38100 Povo, TN, Italy; [Meyer-Klaucke, Wolfram] DESY, European Mol Biol Lab, D-22603 Hamburg, Germany; [Morante, Silvia] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy	University of Rome Tor Vergata; Istituto Nazionale di Fisica Nucleare (INFN); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Fondazione Bruno Kessler; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Sapienza University Rome	Morante, S (corresponding author), Univ Roma Tor Vergata, Dipartimento Fis, Via Ric Sci 1, I-00133 Rome, Italy.	silvia.morante@roma2.infn.it	Meyer-Klaucke, Wolfram/G-1148-2010; Stellato, Francesco/AAZ-4379-2020; Potrich, Cristina/AAR-7812-2020; Serra, Mauro Dalla/AAK-9299-2021; Serra, Mauro Dalla/A-6218-2010	Potrich, Cristina/0000-0002-0793-7547; Serra, Mauro Dalla/0000-0003-1048-2739; Serra, Mauro Dalla/0000-0003-1048-2739; Minicozzi, Velia/0000-0001-9851-9932; Morante, Silvia/0000-0002-3913-5733				Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; BENFATTO M, 1986, PHYS REV B, V34, P5774, DOI 10.1103/PhysRevB.34.5774; Benfatto M, 2004, BIOPHYS CHEM, V110, P191, DOI 10.1016/j.bpc.2004.02.003; BIANCONI A, 1986, P NATL ACAD SCI USA, V83, P7736, DOI 10.1073/pnas.83.20.7736; BINSTED N, 1992, BIOCHEMISTRY-US, V31, P12117, DOI 10.1021/bi00163a021; Binsted N., 1998, HIGH PERFORMANCE COM; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Chauhan VPS, 2001, NEUROREPORT, V12, P587, DOI 10.1097/00001756-200103050-00031; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Danielsson J, 2007, FEBS J, V274, P46, DOI 10.1111/j.1742-4658.2006.05563.x; del Pino P, 2007, EUR BIOPHYS J BIOPHY, V36, P239, DOI 10.1007/s00249-006-0124-0; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Dong JJ, 2006, J AM CHEM SOC, V128, P3540, DOI 10.1021/ja055973j; FONDA L, 1992, J PHYS-CONDENS MAT, V4, P8269, DOI 10.1088/0953-8984/4/43/004; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Goormaghtigh E, 1994, Subcell Biochem, V23, P363; GURMAN SJ, 1986, J PHYS C SOLID STATE, V19, P1845, DOI 10.1088/0022-3719/19/11/021; Jacquamet L, 1998, BIOCHEMISTRY-US, V37, P2564, DOI 10.1021/bi9721344; Koningsberger D.C., 1988, XRAY ABSORPTION PRIN; Korbas M, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2209954; Kowalik-Jankowska T, 2003, J INORG BIOCHEM, V95, P270, DOI 10.1016/S0162-0134(03)00128-4; LEE PA, 1975, PHYS REV B, V11, P2795, DOI 10.1103/PhysRevB.11.2795; LEE PA, 1981, REV MOD PHYS, V53, P769, DOI 10.1103/RevModPhys.53.769; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Ma QF, 2006, BIOPOLYMERS, V83, P20, DOI 10.1002/bip.20523; Meneghini C, 1998, BIOPHYS J, V75, P1953, DOI 10.1016/S0006-3495(98)77636-2; Menestrina G, 1999, BIOCHEM BIOPH RES CO, V254, P174, DOI 10.1006/bbrc.1998.9898; MINICOZZI V, 2007, P NIC WORKSH, V36, P223; Miura T, 2000, BIOCHEMISTRY-US, V39, P7024, DOI 10.1021/bi0002479; Morante S, 2004, J BIOL CHEM, V279, P11753, DOI 10.1074/jbc.M312860200; NATOLI CR, 1986, J PHYS COLLQUES, V47, pC811; Opazo C, 2003, BIOMETALS, V16, P91, DOI 10.1023/A:1020795422185; Paradis E, 1996, J NEUROSCI, V16, P7533; Pepys MB, 2001, PHILOS T R SOC B, V356, P203, DOI 10.1098/rstb.2000.0766; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; REHR JJ, 1990, PHYS REV B, V41, P8139, DOI 10.1103/PhysRevB.41.8139; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Stellato F, 2006, EUR BIOPHYS J BIOPHY, V35, P340, DOI 10.1007/s00249-005-0041-7; Suzuki K, 2001, BIOCHEM BIOPH RES CO, V285, P991, DOI 10.1006/bbrc.2001.5263; Syme CD, 2006, BBA-PROTEINS PROTEOM, V1764, P246, DOI 10.1016/j.bbapap.2005.09.012; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; TEO BK, 1979, J AM CHEM SOC, V101, P2815, DOI 10.1021/ja00505a003; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; TYSON TA, 1992, PHYS REV B, V46, P5997, DOI 10.1103/PhysRevB.46.5997; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Wong BS, 2000, BIOCHEM BIOPH RES CO, V275, P249, DOI 10.1006/bbrc.2000.3158; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Zirah S, 2006, J BIOL CHEM, V281, P2151, DOI 10.1074/jbc.M504454200	50	165	168	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10784	10792		10.1074/jbc.M707109200	http://dx.doi.org/10.1074/jbc.M707109200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18234670	hybrid			2022-12-27	WOS:000254894700061
J	Dror, V; Kalynyak, TB; Bychkivska, Y; Frey, MHZ; Tee, M; Jeffrey, KD; Nguyen, V; Luciani, DS; Johnson, JD				Dror, Vardit; Kalynyak, Tatyana B.; Bychkivska, Yaryna; Frey, Matthew H. Z.; Tee, May; Jeffrey, Kristin D.; Nguyen, Vy; Luciani, Dan S.; Johnson, James D.			Glucose and endoplasmic reticulum calcium channels regulate HIF-1 beta via presenilin in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; GENE-EXPRESSION; RYANODINE RECEPTORS; IN-VIVO; MEDIATED APOPTOSIS; INTRACELLULAR CA2+; HYPOXIA; ISLETS; RELEASE; LOCALIZATION	Pancreatic beta-cell death is a critical event in type 1 diabetes, type 2 diabetes, and clinical islet transplantation. We have previously shown that prolonged block of ryanodine receptor (RyR)-gated release from intracellular Ca2+ stores activates calpain-10-dependent apoptosis in beta-cells. In the present study, we further characterized intracellular Ca2+ channel expression and function in human islets and the MIN6 beta-cell line. All three RyR isoforms were identified in human islets and MIN6 cells, and these endoplasmic reticulum channels were observed in close proximity to mitochondria. Blocking RyR channels, but not sarco/endoplasmic reticulum ATPase (SERCA) pumps, reduced the ATP/ADP ratio. Blocking Ca2+ flux through RyR or inositol trisphosphate receptor channels, but not SERCA pumps, increased the expression of hypoxia-inducible factor (HIF-1 beta). Moreover, inhibition of RyR or inositol trisphosphate receptor channels, but not SERCA pumps, increased the expression of presenilin-1. Both HIF-1 beta and presenilin-1 expression were also induced by low glucose. Overexpression of presenilin-1 increased HIF-1 beta, suggesting that HIF is downstream of presenilin. Our results provide the first evidence of a presenilin-HIF signaling network in beta-cells. We demonstrate that this pathway is controlled by Ca2+ flux through intracellular channels, likely via changes in mitochondrial metabolism and ATP. These findings provide a mechanistic understanding of the signaling pathways activated when intracellular Ca2+ homeostasis and metabolic activity are suppressed in diabetes and islet transplantation.	[Dror, Vardit; Kalynyak, Tatyana B.; Bychkivska, Yaryna; Frey, Matthew H. Z.; Tee, May; Jeffrey, Kristin D.; Nguyen, Vy; Luciani, Dan S.; Johnson, James D.] Univ British Columbia, Diabet Res Grp, Dept Cellular & Physiol Sci, Lab Mol Signaling Diabet, Vancouver, BC V6T 1Z3, Canada; [Dror, Vardit; Kalynyak, Tatyana B.; Bychkivska, Yaryna; Frey, Matthew H. Z.; Tee, May; Jeffrey, Kristin D.; Nguyen, Vy; Luciani, Dan S.; Johnson, James D.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Johnson, JD (corresponding author), Univ British Columbia, Diabet Res Grp, Dept Cellular & Physiol Sci, Lab Mol Signaling Diabet, 5358 Life Sci Bldg 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	jimjohn@interchange.ubc.ca		Luciani, Dan/0000-0002-4318-4159; Johnson, James/0000-0002-7523-9433				Anantharaman M, 2006, AM J PATHOL, V168, P1608, DOI 10.2353/ajpath.2006.051223; Ankarcrona M, 2002, BIOCHEM BIOPH RES CO, V295, P766, DOI 10.1016/S0006-291X(02)00735-0; Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; Bazan NG, 2002, J BIOL CHEM, V277, P30359, DOI 10.1074/jbc.M203201200; Beauvois MC, 2004, J PHYSIOL-LONDON, V559, P141, DOI 10.1113/jphysiol.2004.067454; Bergsten P, 2000, DIABETES-METAB RES, V16, P179, DOI 10.1002/1520-7560(200005/06)16:3<179::AID-DMRR115>3.3.CO;2-3; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cai CX, 2006, J BIOL CHEM, V281, P16649, DOI 10.1074/jbc.M512026200; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Cui JG, 2004, NEUROREPORT, V15, P2025, DOI 10.1097/00001756-200409150-00006; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Doglio LE, 2006, NEURON, V50, P359, DOI 10.1016/j.neuron.2006.03.038; Dotsch J, 2006, EUR J ENDOCRINOL, V154, P781, DOI 10.1530/eje.1.02150; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Ferraro-Peyret C, 2002, J IMMUNOL, V169, P4805, DOI 10.4049/jimmunol.169.9.4805; Figueroa DJ, 2001, J ALZHEIMERS DIS, V3, P393, DOI 10.3233/JAD-2001-3405; Gasparini L, 1999, ANN NY ACAD SCI, V893, P294, DOI 10.1111/j.1749-6632.1999.tb07840.x; George CH, 2007, CIRC RES, V100, P874, DOI 10.1161/01.RES.0000260804.77807.cf; Ghidoni R, 2003, J NEURAL TRANSM, V110, P1029, DOI 10.1007/s00702-003-0015-9; Giacomello M, 2005, NEUROBIOL DIS, V18, P638, DOI 10.1016/j.nbd.2004.10.016; Giuliani M, 2005, CELL TRANSPLANT, V14, P67, DOI 10.3727/000000005783983287; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hajnoczky G, 2000, CELL CALCIUM, V28, P349, DOI 10.1054/ceca.2000.0169; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Higashide S, 2004, J NEUROCHEM, V91, P1191, DOI 10.1111/j.1471-4159.2004.02798.x; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Hung MS, 2006, HUM MOL GENET, V15, P2732, DOI 10.1093/hmg/ddl209; Jaikaran ETAS, 1999, J CELL SCI, V112, P2137; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Lah JJ, 1997, J NEUROSCI, V17, P1971; Lee SM, 2005, J NEUROSCI RES, V82, P542, DOI 10.1002/jnr.20655; Lee SY, 2006, FASEB J, V20, pA173; Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900; Li JH, 1997, CELL, V90, P917, DOI 10.1016/S0092-8674(00)80356-6; Liauw J, 2002, MOL BRAIN RES, V109, P56, DOI 10.1016/S0169-328X(02)00491-6; Lukiw WJ, 2001, NEUROREPORT, V12, P53, DOI 10.1097/00001756-200101220-00019; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Martins IJ, 2006, MOL PSYCHIATR, V11, P721, DOI 10.1038/sj.mp.4001854; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Mattson MP, 2000, J NEUROSCI, V20, P1358; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Mohuczy D, 2002, REGUL PEPTIDES, V110, P1, DOI 10.1016/S0167-0115(02)00225-2; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Park KT, 2005, MOL PHARMACOL, V67, P612, DOI 10.1124/mol.104.005223; Popescu BO, 2002, J CELL MOL MED, V6, P555, DOI 10.1111/j.1582-4934.2002.tb00454.x; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Takeda T, 2005, FASEB J, V19, P2069, DOI 10.1096/fj.05-3744fje; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1046/j.1365-2613.2000.00169.x; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4	65	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9909	9916		10.1074/jbc.M710601200	http://dx.doi.org/10.1074/jbc.M710601200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18174159	hybrid			2022-12-27	WOS:000254671600047
J	Stowell, SR; Arthur, CM; Mehta, P; Slanina, KA; Blixt, O; Leffler, H; Smith, DF; Cummings, RD				Stowell, Sean R.; Arthur, Connie M.; Mehta, Padmaja; Slanina, Kristen A.; Blixt, Ola; Leffler, Hakon; Smith, David F.; Cummings, Richard D.			Galectin-1,-2, and-3 exhibit differential recognition of sialylated glycans and blood group antigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; CARBOHYDRATE-BINDING PROTEIN-35; N-ACETYLLACTOSAMINE UNITS; HAMSTER OVARY CELLS; HIGH-AFFINITY; STRUCTURAL DETERMINANTS; INFLAMMATORY RESPONSES; ACETYL LACTOSAMINE; GANGLIOSIDE GM(1); ENDOGENOUS LECTIN	Human galectins have functionally divergent roles, although most of the members of the galectin family bind weakly to the simple disaccharide lactose (Gal beta 1-4Glc). To assess the specificity of galectin-glycan interactions in more detail, we explored the binding of several important galectins (Gal-1, Gal-2, and Gal-3) using a dose-response approach toward a glycan microarray containing hundreds of structurally diverse glycans, and we compared these results to binding determinants on cells. All three galectins exhibited differences in glycan binding characteristics. On both the microarray and on cells, Gal-2 and Gal-3 exhibited higher binding than Gal-1 to fucose-containing A and B blood group antigens. Gal-2 exhibited significantly reduced binding to all sialylated glycans, whereas Gal-1 bound alpha 2-3-but not alpha 2-6-sialylated glycans, and Gal-3 bound to some glycans terminating in either alpha 2-3- or alpha 2-6-sialic acid. The effects of sialylation on Gal-1, Gal-2, and Gal-3 binding to cells also reflected differences in cellular sensitivity to Gal-1-, Gal-2-, and Gal-3-induced phosphatidylserine exposure. Each galectin exhibited higher binding for glycans with poly-N-acetyllactosamine (poly(LacNAc)) sequences (Gal beta 1-4GlcNAc)(n) when compared with N-acetyllactosamine (LacNAc) glycans (Gal beta 1-4GlcNAc). However, only Gal-3 bound internal LacNAc within poly(LacNAc). These results demonstrate that each of these galectins mechanistically differ in their binding to glycans on the microarrays and that these differences are reflected in the determinants required for cell binding and signaling. The specific glycan recognition by each galectin underscores the basis for differences in their biological activities.	[Stowell, Sean R.; Arthur, Connie M.; Slanina, Kristen A.; Smith, David F.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Mehta, Padmaja] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Blixt, Ola] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Leffler, Hakon] Lund Univ, Sect Microbiol Immunol & Glycobiol, S-22362 Lund, Sweden	Emory University; Oklahoma Medical Research Foundation; Scripps Research Institute; Lund University	Cummings, RD (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	rdcummi@emory.edu	Leffler, Hakon/A-2416-2019	Blixt, Ola/0000-0003-4143-6276; Leffler, Hakon/0000-0003-4482-8945	NHLBI NIH HHS [HL 085607, P01 HL085607] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169, GM 62116] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169, U54GM062116] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Ahmad N, 2004, GLYCOBIOLOGY, V14, P817, DOI 10.1093/glycob/cwh095; Allen HJ, 1998, GLYCOCONJUGATE J, V15, P691, DOI 10.1023/A:1006988515346; Almkvist J, 2002, J IMMUNOL, V168, P4034, DOI 10.4049/jimmunol.168.8.4034; Almkvist J, 2001, INFECT IMMUN, V69, P832, DOI 10.1128/IAI.69.2.832-837.2001; Appukuttan PS, 2002, J MOL RECOGNIT, V15, P180, DOI 10.1002/jmr.573; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Breuilh L, 2007, INFECT IMMUN, V75, P5148, DOI 10.1128/IAI.02006-06; Brewer CF, 2002, GLYCOCONJUGATE J, V19, P459, DOI 10.1023/B:GLYC.0000014075.62724.d0; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; COOPER DNW, 1991, J CELL BIOL, V115, P1437, DOI 10.1083/jcb.115.5.1437; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Dias-Baruffi M, 2003, J BIOL CHEM, V278, P41282, DOI 10.1074/jbc.M306624200; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; FEIZI T, 1994, BIOCHEMISTRY-US, V33, P6342, DOI 10.1021/bi00186a038; FRIGERI LG, 1993, BIOCHEMISTRY-US, V32, P7644, DOI 10.1021/bi00081a007; Fukumori T, 2003, CANCER RES, V63, P8302; Glinsky VV, 2001, CANCER RES, V61, P4851; Glinsky VV, 2003, CANCER RES, V63, P3805; Hahn HP, 2004, CELL DEATH DIFFER, V11, P1277, DOI 10.1038/sj.cdd.4401485; Hatch NE, 2006, J BIOL CHEM, V281, P27292, DOI 10.1074/jbc.M600448200; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HOKKE CH, 1995, EUR J BIOCHEM, V228, P981, DOI 10.1111/j.1432-1033.1995.tb20350.x; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Ilarregui JM, 2005, ANN RHEUM DIS, V64, P96, DOI 10.1136/ard.2005.044347; JENG KCG, 1994, IMMUNOL LETT, V42, P113, DOI 10.1016/0165-2478(94)90072-8; Jiang JX, 2006, NEUROSIGNALS, V15, P266, DOI 10.1159/000105517; Karmakar S, 2005, J BIOL CHEM, V280, P28623, DOI 10.1074/jbc.M414140200; KNIBBS RN, 1993, J BIOL CHEM, V268, P14940; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Kopitz J, 1998, J BIOL CHEM, V273, P11205, DOI 10.1074/jbc.273.18.11205; Kopitz J, 2001, J BIOL CHEM, V276, P35917, DOI 10.1074/jbc.M105135200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; La M, 2003, AM J PATHOL, V163, P1505, DOI 10.1016/S0002-9440(10)63507-9; LEFFLER H, 1986, J BIOL CHEM, V261, P119; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; LOTAN R, 1975, J BIOL CHEM, V250, P8518; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; Moiseeva EP, 2003, BBA-GEN SUBJECTS, V1619, P125, DOI 10.1016/S0304-4165(02)00447-6; Nam HJ, 2006, J BIOL CHEM, V281, P25670, DOI 10.1074/jbc.M604421200; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; NOVOGRODSKY A, 1975, J IMMUNOL, V115, P1243; Oliveira FL, 2007, J LEUKOCYTE BIOL, V82, P300, DOI 10.1189/jlb.1206747; ORIOL R, 1986, VOX SANG, V51, P161, DOI 10.1111/j.1423-0410.1986.tb01946.x; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Pelletier I, 2003, J BIOL CHEM, V278, P22223, DOI 10.1074/jbc.M302693200; Pelletier I, 2002, J BIOL CHEM, V277, P17663, DOI 10.1074/jbc.M201562200; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Rabinovich GA, 2000, EUR J IMMUNOL, V30, P1331, DOI 10.1002/(SICI)1521-4141(200005)30:5<1331::AID-IMMU1331>3.3.CO;2-8; REED RA, 1987, BIOCHEMISTRY-US, V26, P824, DOI 10.1021/bi00377a025; Rubinstein N, 2004, TISSUE ANTIGENS, V64, P1, DOI 10.1111/j.0001-2815.2004.00278.x; Sangeetha SR, 2005, INT J BIOL MACROMOL, V35, P269, DOI 10.1016/j.ijbiomac.2005.03.004; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sato S, 2002, GLYCOCONJUGATE J, V19, P583, DOI 10.1023/B:GLYC.0000014089.17121.cc; SATO S, 1992, J BIOL CHEM, V267, P6983; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Siebert HC, 2003, BIOCHEMISTRY-US, V42, P14762, DOI 10.1021/bi035477c; SOLOMON JC, 1991, CARBOHYD RES, V213, P293, DOI 10.1016/S0008-6215(00)90616-5; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; SPRINGER GF, 1969, J CLIN INVEST, V48, P1280, DOI 10.1172/JCI106094; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Stowell SR, 2004, GLYCOBIOLOGY, V14, P157, DOI 10.1093/glycob/cwh018; Sturm A, 2004, J IMMUNOL, V173, P3825, DOI 10.4049/jimmunol.173.6.3825; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; VIITALA J, 1984, EUR J BIOCHEM, V138, P393, DOI 10.1111/j.1432-1033.1984.tb07928.x; WOO HJ, 1990, J BIOL CHEM, V265, P7097; YAMAOKA A, 1995, J IMMUNOL, V154, P3479; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y; Zhang PJ, 2005, MOL PHARMACOL, V67, P1334, DOI 10.1124/mol.104.004481; ZHOU Q, 1990, ARCH BIOCHEM BIOPHYS, V281, P27, DOI 10.1016/0003-9861(90)90408-Q	79	312	316	3	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10109	10123		10.1074/jbc.M709545200	http://dx.doi.org/10.1074/jbc.M709545200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18216021	Green Published, hybrid			2022-12-27	WOS:000254671600065
J	Andreasson, C; Fiaux, J; Rampelt, H; Mayer, MP; Bukau, B				Andreasson, Claes; Fiaux, Jocelyne; Rampelt, Heike; Mayer, Matthias P.; Bukau, Bernd			Hsp110 is a nucleotide-activated exchange factor for Hsp70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMIDE HYDROGEN-EXCHANGE; MOLECULAR CHAPERONE SSE1; CONFORMATIONAL-CHANGES; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PROTEIN DYNAMICS; ATPASE ACTIVITY; BINDING; FAMILY	Hsp110 proteins constitute a subfamily of the Hsp70 chaperones and are potent nucleotide exchange factors ( NEFs) for canonical Hsp70s of the eukaryotic cytosol. Here, we show that the NEF activity of the yeast Hsp110 homologue Sse1 itself is controlled by nucleotide. Nucleotide binding results in formation of a stabilized conformation of Sse1 that is required for association with the yeast Hsp70 Ssa1. The interaction triggers release of bound ADP from Ssa1, but nucleotide persists bound to Sse1 in the complex. Surprisingly, removal of this nucleotide does not affect the integrity of the complex. Instead, rebinding of ATP to the Hsp70 prompts the dissociation of the complex. Our data demonstrate that in contrast to previously characterized NEFs for Hsp70 chaperones, the NEF activity of Sse1 requires nucleotide binding and let us propose a new model for Hsp110 function.	[Andreasson, Claes; Fiaux, Jocelyne; Rampelt, Heike; Mayer, Matthias P.; Bukau, Bernd] Univ Heidelberg, DKFZ ZBH Alliance, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bukau, B (corresponding author), Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	bukau@zmbh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112; Rampelt, Heike/0000-0002-5458-5652; Bukau, Bernd/0000-0003-0521-7199; Andreasson, Claes/0000-0001-8948-0685				BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; CRAI EA, 2005, PROTEIN FOLDING HDB, V2, P490; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; HA JH, 1999, MOL CHAPERONES FOLDI, V1, P573; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rist W, 2005, PROTEIN SCI, V14, P626, DOI 10.1110/ps.041098305; Rist W, 2003, J BIOL CHEM, V278, P51415, DOI 10.1074/jbc.M307160200; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Trott A, 2005, GENETICS, V170, P1009, DOI 10.1534/genetics.105.043109; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; Yamagishi N, 2004, J BIOL CHEM, V279, P41727, DOI 10.1074/jbc.M407947200; ZYLICZ M, 1987, J BIOL CHEM, V262, P17437	27	112	113	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8877	8884		10.1074/jbc.M710063200	http://dx.doi.org/10.1074/jbc.M710063200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18218635	hybrid			2022-12-27	WOS:000254465800015
J	Ohta, T; Imagawa, T; Ito, S				Ohta, Toshio; Imagawa, Toshiaki; Ito, Shigeo			Novel gating and sensitizing mechanism of capsaicin receptor (TRPV1) - Tonic inhibitory regulation of extracellular sodium through the external protonation sites on TRPV1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENTIAL V1 PTRPV1; VANILLOID RECEPTOR-1; SENSORY NEURONS; ANTAGONIST CAPSAZEPINE; NEUROPATHIC PAIN; IN-VIVO; ACTIVATION; CHANNELS; SENSITIVITY; DETERMINANTS	Transient receptor potential V1 (TRPV1) is a nonselective cation channel expressed in nociceptors and activated by capsaicin. TRPV1 detects diverse stimuli, including acid, heat, and endogenous vanilloids, and functions as a molecular integrator of pain perception. Herein we demonstrate a novel regulatory role of extracellular Na+ ([Na+](o)) on TRPV1 function. In human embryonic kidney 293 cells expressing porcine TRPV1, low [ Na+](o) evoked increases of [Ca2+](i) that were suppressed by TRPV1 antagonists and facilitated responses to capsaicin, protons, heat, and an endovanilloid. [Na+](o) removal simultaneously elicited a [Ca2+](i) increase and outward-rectified current with a reversal potential similar to those of capsaicin. Neutralization of the two acidic residues which confer the proton sensitivity to TRPV1 resulted in a reduction of low [Na+](o)-induced responses. In primary culture of porcine sensory neurons, the removal of [Na+](o) produced a [Ca2+](i) increase and current responses only in the cells responding to capsaicin. Low [Na+](o) evoked a [Ca2+](i) increase in sensory neurons of wild type mice, but not TRPV1-null mice, and in human embryonic kidney 293 cells expressing human TRPV1. The present results suggest that [Na+](o) negatively regulates the gating and polymodal sensitization of the TRPV1 channel. [Na+](o) surrounding several proton-sensitive sites on the extracellular side of the pore-forming loop of the TRPV1 channel may play an important role as a brake to suppress the excessive activity of this channel under physiological conditions.	[Ohta, Toshio; Ito, Shigeo] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Pharmacol Lab, Sapporo, Hokkaido 0600818, Japan; [Imagawa, Toshiaki] Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Hokkaido University	Ohta, T (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Pharmacol Lab, N18W9, Sapporo, Hokkaido 0600818, Japan.	tohta@vetmed.hokudai.ac.jp	Imagawa, Toshiaki/A-4255-2012					Ahern GP, 2006, J BIOL CHEM, V281, P8991, DOI 10.1074/jbc.M513429200; Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Correll CC, 2004, NEUROSCI LETT, V370, P55, DOI 10.1016/j.neulet.2004.07.058; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Goswami C, 2006, J NEUROCHEM, V96, P254, DOI 10.1111/j.1471-4159.2005.03551.x; HOLZER P, 1991, PHARMACOL REV, V43, P143; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jerman JC, 2000, BRIT J PHARMACOL, V130, P916, DOI 10.1038/sj.bjp.0703390; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kim SR, 2005, J NEUROSCI, V25, P662, DOI 10.1523/JNEUROSCI.4166-04.2005; Liu LJ, 2007, J NEUROPHYSIOL, V97, P2001, DOI 10.1152/jn.00887.2006; Lukacz ES, 2001, OBSTET GYNECOL, V98, P974, DOI 10.1016/S0029-7844(01)01490-9; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; McIntyre P, 2001, BRIT J PHARMACOL, V132, P1084, DOI 10.1038/sj.bjp.0703918; Meier SD, 2006, J NEUROSCI METH, V155, P251, DOI 10.1016/j.jneumeth.2006.01.009; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Offenstadt G, 2006, MINERVA ANESTESIOL, V72, P353; Ohta T, 2005, BIOCHEM PHARMACOL, V71, P173, DOI 10.1016/j.bcp.2005.09.028; Ohta T, 2007, BIOCHEM PHARMACOL, V73, P1646, DOI 10.1016/j.bcp.2007.01.029; Ohta T, 2006, J PHYSIOL-LONDON, V576, P809, DOI 10.1113/jphysiol.2006.112250; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Pomonis JD, 2003, J PHARMACOL EXP THER, V306, P387, DOI 10.1124/jpet.102.046268; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Schroder UH, 1999, NEUROPHARMACOLOGY, V38, P319, DOI 10.1016/S0028-3908(98)00198-1; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tousova K, 2005, MOL CELL NEUROSCI, V30, P207, DOI 10.1016/j.mcn.2005.07.004; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Walker KM, 2003, J PHARMACOL EXP THER, V304, P56, DOI 10.1124/jpet.102.042010	38	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9377	9387		10.1074/jbc.M709377200	http://dx.doi.org/10.1074/jbc.M709377200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18230619	hybrid			2022-12-27	WOS:000254465800068
J	Patrakitkomjorn, S; Kobayashi, D; Morikawa, T; Wilson, MM; Tsubota, N; Irie, A; Ozawa, T; Aoki, M; Arimura, N; Kaibuchi, K; Saya, H; Araki, N				Patrakitkomjorn, Siriporn; Kobayashi, Daiki; Morikawa, Takashi; Wilson, Masayo Morifuji; Tsubota, Nobuyuki; Irie, Atsushi; Ozawa, Tatsuya; Aoki, Masashi; Arimura, Nariko; Kaibuchi, Kozo; Saya, Hideyuki; Araki, Norie			Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; GENE-PRODUCT; ALZHEIMERS-DISEASE; SENSORY NEURONS; NERVOUS-SYSTEM; PHOSPHORYLATION; KINASE; PATHWAY; FAMILY; RHO	Neurofibromatosis type 1 (NF1) tumor suppressor gene product, neurofibromin, functions in part as a Ras-GAP, a negative regulator of Ras. Neurofibromin is implicated in the neuronal abnormality of NF1 patients; however, the precise cellular function of neurofibromin has yet to be clarified. Using proteomic strategies, we identified a set of neurofibromin-associating cellular proteins, including axon regulator CRMP-2 (Collapsin response mediator protein-2). CRMP-2 directly bound to the C-terminal domain of neurofibromin, and this association was regulated by the manner of CRMP-2 phosphorylation. In nerve growth factor-stimulated PC12 cells, neurofibromin and CRMP-2 co-localized particularly on the distal tips and branches of extended neurites. Suppression of neurofibromin using NF1 small interfering RNA significantly inhibited this neurite outgrowth and up-regulated a series of CRMP-2 phosphorylations by kinases identified as CDK5, GSK-3b, and Rho kinase. Overexpression of the NF1-RAS-GAP-related domain rescued these NF1 small interfering RNA-induced events. Our results suggest that neurofibromin regulates neuronal differentiation by performing one or more complementary roles. First, neurofibromin directly regulates CRMP-2 phosphorylation accessibility through the complex formation. Also, neurofibromin appears to indirectly regulate CRMP-2 activity by suppressing CRMP-2-phosphorylating kinase cascades via its Ras-GAP function. Our study demonstrates that the functional association of neurofibromin and CRMP-2 is essential for neuronal cell differentiation and that lack of expression or abnormal regulation of neurofibromin can result in impaired function of neuronal cells, which is likely a factor in NF1-related pathogenesis.	[Patrakitkomjorn, Siriporn; Kobayashi, Daiki; Morikawa, Takashi; Wilson, Masayo Morifuji; Tsubota, Nobuyuki; Ozawa, Tatsuya; Aoki, Masashi; Saya, Hideyuki; Araki, Norie] Kumamoto Univ, Sch Med, Grad Sch Med Sci, Dept Tumor Genet & Biol, Kumamoto 8608556, Japan; [Irie, Atsushi] Kumamoto Univ, Sch Med, Grad Sch Med Sci, Dept Immunogenet, Kumamoto 8608556, Japan; [Arimura, Nariko; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4668550, Japan	Kumamoto University; Kumamoto University; Nagoya University	Araki, N (corresponding author), Kumamoto Univ, Sch Med, Grad Sch Med Sci, Dept Tumor Genet & Biol, Kumamoto 8608556, Japan.	nori@gpo.kumamoto-u.ac.jp	Saya, Hideyuki/J-4325-2013	Kobayashi, Daiki/0000-0003-4131-5220				Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; BOLLAG G, 1993, EMBO J, V12, P1923, DOI 10.1002/j.1460-2075.1993.tb05841.x; Byk T, 1998, EUR J BIOCHEM, V254, P14, DOI 10.1046/j.1432-1327.1998.2540014.x; Byk T, 1996, J NEUROSCI, V16, P688; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Dasgupta B, 2003, CURR OPIN GENET DEV, V13, P20, DOI 10.1016/S0959-437X(02)00015-1; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; Feng LP, 2004, FEBS LETT, V557, P275, DOI 10.1016/S0014-5793(03)01507-2; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GREGORY PE, 1993, SOMAT CELL MOLEC GEN, V19, P265, DOI 10.1007/BF01233074; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Lee S, 2002, J BIOL CHEM, V277, P6542, DOI 10.1074/jbc.M108047200; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li CJ, 2001, DEV BRAIN RES, V130, P231, DOI 10.1016/S0165-3806(01)00190-0; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MINTURN JE, 1995, J COMP NEUROL, V355, P369, DOI 10.1002/cne.903550304; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Owen R, 2003, MOL CELL NEUROSCI, V23, P626, DOI 10.1016/S1044-7431(03)00095-2; Ozawa T, 2005, J BIOL CHEM, V280, P39524, DOI 10.1074/jbc.M503707200; Ozon S, 1998, J NEUROCHEM, V70, P2386; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; STEPHENS K, 1987, Genomics, V1, P353, DOI 10.1016/0888-7543(87)90037-1; Tokuo H, 2001, FEBS LETT, V494, P48, DOI 10.1016/S0014-5793(01)02309-2; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Wang LH, 1996, J NEUROSCI, V16, P6197; Xu HM, 1997, BRAIN RES, V759, P149, DOI 10.1016/S0006-8993(97)00328-4; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yunoue S, 2003, J BIOL CHEM, V278, P26958, DOI 10.1074/jbc.M209413200	42	67	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9399	9413		10.1074/jbc.M708206200	http://dx.doi.org/10.1074/jbc.M708206200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18218617	hybrid			2022-12-27	WOS:000254465800070
J	Granata, A; Watson, R; Collinson, LM; Schiavo, G; Warner, TT				Granata, Alessandra; Watson, Rose; Collinson, Lucy M.; Schiavo, Giampietro; Warner, Thomas T.			The dystonia-associated protein torsinA modulates synaptic vesicle recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT TORSINA; MOUSE MODEL; NUCLEAR-ENVELOPE; SNAPIN; BINDING; EXOCYTOSIS; INTERACTS; MEMBRANE; PHOSPHORYLATION; IDENTIFICATION	The loss of a glutamic acid residue in the AAA-ATPase (ATPases associated with diverse cellular activities) torsinA is responsible for most cases of early onset autosomal dominant primary dystonia. In this study, we found that snapin, which binds SNAP-25 (synaptosome-associated protein of 25,000 Da) and enhances the association of the SNARE complex with synaptotagmin, is an interacting partner for both wild type and mutant torsinA. Snapin co-localized with endogenous torsinA on dense core granules in PC12 cells and was recruited to perinuclear inclusions containing mutant Delta E-torsinA in neuroblastoma SH-SY5Y cells. In view of these observations, synaptic vesicle recycling was analyzed using the lipophilic dye FM1 - 43 and an antibody directed against an intravesicular epitope of synaptotagmin I. We found that overexpression of wild type torsinA negatively affects synaptic vesicle endocytosis. Conversely, overexpression of Delta E-torsinA in neuroblastoma cells increases FM1 - 43 uptake. Knockdown of snapin and/or torsinA using small interfering RNAs had a similar inhibitory effect on the exo-endocytic process. In addition, down-regulation of torsinA causes the persistence of synaptotagmin I on the plasma membrane, which closely resembles the effect observed by the overexpression of the Delta E-torsinA mutant. Altogether, these findings suggest that torsinA plays a role together with snapin in regulated exocytosis and that Delta E-torsinA exerts its pathological effects through a loss of function mechanism. This may affect neuronal uptake of neurotransmitters, such as dopamine, playing a role in the development of dystonic movements.	[Granata, Alessandra; Watson, Rose; Collinson, Lucy M.; Schiavo, Giampietro] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, London WC2A 3PX, England; [Granata, Alessandra; Warner, Thomas T.] Royal Free & Univ Coll Med Sch, UCL Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England	Cancer Research UK; University of London; University College London	Schiavo, G (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, 44 Licolns Inn Fields, London WC2A 3PX, England.	giampietro.schiavo@cancer.org.uk; t.warner@medsch.ucl.ac.uk		Collinson, Lucy/0000-0003-0260-613X; Schiavo, Giampietro/0000-0002-4319-8745; Warner, Thomas/0000-0001-6195-6995	Cancer Research UK Funding Source: Medline; Wellcome Trust Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Augood SJ, 1999, ANN NEUROL, V46, P761, DOI 10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.3.CO;2-Q; Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Bandmann O, 1998, ANN NEUROL, V44, P649, DOI 10.1002/ana.410440411; BRESSMAN SB, 1994, ANN NEUROL, V36, P771, DOI 10.1002/ana.410360514; Brumback AC, 2004, METHODS, V33, P287, DOI 10.1016/j.ymeth.2004.01.002; Buxton P, 2003, BIOCHEM J, V375, P433, DOI 10.1042/BJ20030427; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Callan AC, 2007, BIOCHEM J, V401, P607, DOI 10.1042/BJ20061313; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Cookson MR, 2005, NEURON, V48, P875, DOI 10.1016/j.neuron.2005.12.006; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Fahn S, 1998, Adv Neurol, V78, P1; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Herreros J, 2001, MOL BIOL CELL, V12, P2947, DOI 10.1091/mbc.12.10.2947; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; ISHIKAWA A, 1995, MOV DISCORD, V40, P482; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Lalli G, 1999, J CELL SCI, V112, P2715; Liu ZH, 2003, BIOCHEM J, V374, P117, DOI 10.1042/BJ20030258; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Matteoli M, 2004, TRENDS CELL BIOL, V14, P133, DOI 10.1016/j.tcb.2004.01.007; McNaught KS, 2004, ANN NEUROL, V56, P540, DOI 10.1002/ana.20225; Misbahuddin A, 2005, MOVEMENT DISORD, V20, P432, DOI 10.1002/mds.20351; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Muraro NI, 2006, J NEUROBIOL, V66, P1338, DOI 10.1002/neu.20313; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Neuwald AF, 1999, GENOME RES, V9, P27; Oorschot V, 2002, J HISTOCHEM CYTOCHEM, V50, P1067, DOI 10.1177/002215540205000809; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Pisani A, 2006, NEUROBIOL DIS, V24, P318, DOI 10.1016/j.nbd.2006.07.006; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; ROPOSO G, 1997, IMMUNOGLOD LABELING, P78; Rostasy K, 2003, NEUROBIOL DIS, V12, P11, DOI 10.1016/S0969-9961(02)00010-4; Ruder C, 2005, MOL BIOL CELL, V16, P1245, DOI 10.1091/mbc.E04-09-0817; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Shashidharan P, 2000, BRAIN RES, V853, P197, DOI 10.1016/S0006-8993(99)02232-5; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Thakur P, 2004, J NEUROSCI, V24, P6476, DOI 10.1523/JNEUROSCI.0590-04.2004; Tian JH, 2005, J NEUROSCI, V25, P10546, DOI 10.1523/JNEUROSCI.3275-05.2005; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Vites O, 2004, J BIOL CHEM, V279, P26251, DOI 10.1074/jbc.M404079200	50	84	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7568	7579		10.1074/jbc.M704097200	http://dx.doi.org/10.1074/jbc.M704097200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18167355	hybrid			2022-12-27	WOS:000253997900032
J	Kienlen-Campard, P; Tasiaux, B; Van Hees, J; Li, M; Huysseune, S; Sato, T; Fei, JZ; Aimoto, S; Courtoy, PJ; Smith, SO; Constantinescu, SN; Octave, JN				Kienlen-Campard, Pascal; Tasiaux, Bernadette; Van Hees, Joanne; Li, Mingli; Huysseune, Sandra; Sato, Takeshi; Fei, Jeffrey Z.; Aimoto, Saburo; Courtoy, Pierre J.; Smith, Steven O.; Constantinescu, Stefan N.; Octave, Jean-Noel			Amyloidogenic processing but not amyloid precursor protein (APP) intracellular C-terminal domain production requires a precisely oriented APP dimer assembled by transmembrane GXXXG motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; CELL-SURFACE-RECEPTOR; ALZHEIMERS-DISEASE; BETA-SECRETASE; A-BETA; SIGNAL-TRANSDUCTION; HELIX ASSOCIATION; MEMBRANE-PROTEINS; GLYCOPHORIN-A; ALPHA-HELICES	The beta-amyloid peptide (A beta) is the major constituent of the amyloid core of senile plaques found in the brain of patients with Alzheimer disease. A beta is produced by the sequential cleavage of the amyloid precursor protein (APP) by beta-and gamma-secretases. Cleavage of APP by gamma-secretase also generates the APP intracellular C-terminal domain (AICD) peptide, which might be involved in regulation of gene transcription. APP contains three Gly-XXX-Gly (GXXXG) motifs in its jux-tamembrane and transmembrane (TM) regions. Such motifs are known to promote dimerization via close apposition of TM sequences. We demonstrate that pairwise replacement of glycines by leucines or isoleucines, but not alanines, in a GXXXG motif led to a drastic reduction of A beta 40 and A beta 42 secretion. beta-Cleavage of mutant APP was not inhibited, and reduction of A beta secretion resulted from inhibition of gamma-cleavage. It was anticipated that decreased gamma-cleavage of mutant APP would result from inhibition of its dimerization. Surprisingly, mutations of the GXXXG motif actually enhanced dimerization of the APP C-terminal fragments, possibly via a different TM alpha-helical interface. Increased dimerization of the TM APP C-terminal domain did not affect AICD production.	[Van Hees, Joanne; Li, Mingli; Constantinescu, Stefan N.] Univ Catholique Louvain, Christian de Duve Inst, B-1200 Brussels, Belgium; [Van Hees, Joanne; Li, Mingli; Constantinescu, Stefan N.] Univ Catholique Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Courtoy, Pierre J.] Univ Catholique Louvain, Christian de Duve Inst Cellular Pathol, Cell Unit, B-1200 Brussels, Belgium; [Kienlen-Campard, Pascal; Tasiaux, Bernadette; Huysseune, Sandra; Octave, Jean-Noel] Univ Catholique Louvain, Ctr Neurosci, Expt Pharmacol Unit, B-1200 Brussels, Belgium; [Fei, Jeffrey Z.; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Struct Biol Ctr, Stony Brook, NY 11794 USA; [Sato, Takeshi; Aimoto, Saburo] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Osaka University	Constantinescu, SN (corresponding author), Univ Catholique Louvain, Christian de Duve Inst, Av Hippocrate 74, B-1200 Brussels, Belgium.	stefan.constantinescu@bru.licr.org; octave@nchm.ucl.ac.be	Constantinescu, Stefan N/E-5277-2012; Smith, Steven/HDM-9496-2022	Kienlen-Campard, Pascal/0000-0003-1086-2942; Constantinescu, Stefan N./0000-0002-8599-2699	NATIONAL INSTITUTE ON AGING [RF1AG027317, R01AG027317] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG027317, R01 AG027317-01, R01 AG027317-02, AG027317, RF1 AG027317, R01 AG027317-03] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; ALVES DC, 2006, J NEUROSCI, V26, P6377; Annaert W, 1999, TRENDS NEUROSCI, V22, P439, DOI 10.1016/S0166-2236(99)01455-1; BORMANN BJ, 1989, J BIOL CHEM, V264, P4033; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Eilers M, 2002, BIOPHYS J, V82, P2720, DOI 10.1016/S0006-3495(02)75613-0; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Huysseune S, 2007, BIOCHEM BIOPH RES CO, V361, P317, DOI 10.1016/j.bbrc.2007.06.186; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; LEIGHTON F, 1968, J CELL BIOL, V37, P482, DOI 10.1083/jcb.37.2.482; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu W, 2005, BIOCHEMISTRY-US, V44, P3591, DOI 10.1021/bi047827g; Macq AF, 1998, J BIOL CHEM, V273, P28931, DOI 10.1074/jbc.273.44.28931; Marchesi VT, 2005, P NATL ACAD SCI USA, V102, P9093, DOI 10.1073/pnas.0503181102; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Muresan Z, 2004, HUM MOL GENET, V13, P475, DOI 10.1093/hmg/ddh054; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Octave JN, 2000, J BIOL CHEM, V275, P1525, DOI 10.1074/jbc.275.3.1525; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; Pitsi D, 2004, J BIOL CHEM, V279, P25333, DOI 10.1074/jbc.M312710200; Pitsi D, 2002, J NEUROCHEM, V83, P390, DOI 10.1046/j.1471-4159.2002.01138.x; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Sergeant N, 2002, J NEUROCHEM, V81, P663, DOI 10.1046/j.1471-4159.2002.00901.x; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Smith SO, 2001, BIOCHEMISTRY-US, V40, P6553, DOI 10.1021/bi010357v; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	59	115	117	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7733	7744		10.1074/jbc.M707142200	http://dx.doi.org/10.1074/jbc.M707142200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18201969	Green Accepted, hybrid			2022-12-27	WOS:000253997900050
J	Pearson, JL; Robinson, TJ; Munoz, MJ; Kornblihtt, AR; Garcia-Blanco, MA				Pearson, James L.; Robinson, Timothy J.; Munoz, Manuel J.; Kornblihtt, Alberto R.; Garcia-Blanco, Mariano A.			Identification of the cellular targets of the transcription factor TCERG1 reveals a prevalent role in mRNA processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICING IN-VIVO; POLYMERASE-II; HUNTINGTONS-DISEASE; TERMINAL DOMAIN; BINDING-PROTEIN; CA150 INTERACTS; EXPRESSION DATA; FF DOMAINS; ELONGATION; GENE	The transcription factor TCERG1 (also known as CA150) associates with RNA polymerase II holoenzyme and alters the elongation efficiency of reporter transcripts. TCERG1 is also found as a component of highly purified spliceosomes and has been implicated in splicing. To elucidate the function of TCERG1, we used short interfering RNA-mediated knockdown followed by en masse gene expression analysis to identify its cellular targets. Analysis of data from HEK293 and HeLa cells identified high confidence targets of TCERG1. We found that targets of TCERG1 were enriched in microRNA-binding sites, suggesting the possibility of post-transcriptional regulation. Consistently, reverse transcription-PCR analysis revealed that many of the changes observed upon TCERG1 knockdown were because of differences in alternative mRNA processing of the 3'-untranslated regions. Furthermore, a novel computational approach, which can identify alternatively processed events from conventional microarray data, showed that TCERG1 led to widespread alterations in mRNA processing. These findings provide the strongest support to date for a role of TCERG1 in mRNA processing and are consistent with proposals that TCERG1 couples transcription and processing.	[Pearson, James L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Dept Mol Genet & Mirobiol, Durham, NC 27710 USA; [Robinson, Timothy J.] Duke Univ, Med Ctr, Dept Mol Canc Biol, Durham, NC 27710 USA; [Robinson, Timothy J.] Duke Univ, Med Ctr, Med Sci Training Program, Durham, NC 27710 USA; [Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Pearson, James L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Ctr RNA Biol, Durham, NC 27710 USA; [Munoz, Manuel J.; Kornblihtt, Alberto R.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IFIBYNE CONICET, Dept Fisiol Biol Mol & Celular,Lab Fisiol & Biol, Buenos Aires, DF, Argentina	Duke University; Duke University; Duke University; Duke University; Duke University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Garcia-Blanco, MA (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Mirobiol, Durham, NC 27710 USA.	garci001@mc.duke.edu		Munoz, Manuel J./0000-0002-1152-5449; Kornblihtt, Alberto/0000-0003-4322-0831	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071037] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01 GM071037] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andresen JM, 2007, J MED GENET, V44, P44, DOI 10.1136/jmg.2006.045153; Arango M, 2006, J NEUROSCI, V26, P4649, DOI 10.1523/JNEUROSCI.5409-05.2006; Bird G, 2004, MOL CELL BIOL, V24, P8963, DOI 10.1128/MCB.24.20.8963-8969.2004; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Chattopadhyay B, 2003, NEUROSCI LETT, V345, P93, DOI 10.1016/S0304-3940(03)00436-1; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Dresios J, 2005, P NATL ACAD SCI USA, V102, P1865, DOI 10.1073/pnas.0409764102; Fan WH, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-19; Florez PM, 2005, J VIROL, V79, P6172, DOI 10.1128/JVI.79.10.6172-6179.2005; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; GOLDSTROHM AC, 2001, THESIS DUKE U DURHAM; Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798; Hu GK, 2001, GENOME RES, V11, P1237, DOI 10.1101/gr.165501; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; Kita H, 2002, HUM MOL GENET, V11, P2279, DOI 10.1093/hmg/11.19.2279; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Sanchez-Alvarez M, 2006, MOL CELL BIOL, V26, P4998, DOI 10.1128/MCB.01991-05; Smart F, 2007, J NEUROCHEM, V101, P1367, DOI 10.1111/j.1471-4159.2007.04521.x; Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004; Stalteri MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-13; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun X, 2004, CHROMOSOMA, V113, P244, DOI 10.1007/s00412-004-0314-4; SUNE C, 1995, J VIROL, V69, P3098; Sune C, 1999, MOL CELL BIOL, V19, P4719; Sune C, 1997, MOL CELL BIOL, V17, P6029, DOI 10.1128/MCB.17.10.6029; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7	43	37	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7949	7961		10.1074/jbc.M709402200	http://dx.doi.org/10.1074/jbc.M709402200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18187414	hybrid, Green Published			2022-12-27	WOS:000253997900070
J	Graille, M; Chaillet, M; van Tilbeurgh, H				Graille, Marc; Chaillet, Maxime; van Tilbeurgh, Herman			Structure of yeast Dom34 - A protein related to translation termination factor eRF1 and involved in No-Go decay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; RELEASE FACTOR ERF1; STOP CODON RECOGNITION; SM-LIKE PROTEINS; MOLECULAR-BIOLOGY; CRYSTAL-STRUCTURE; NONSENSE; DEGRADATION; RIBOSOME; COMPLEX	The yeast protein Dom34 has been described to play a critical role in a newly identified mRNA decay pathway called No-Go decay. This pathway clears cells from mRNAs inducing translational stalls through endonucleolytic cleavage. Dom34 is related to the translation termination factor eRF1 and physically interacts with Hbs1, which is itself related to eRF3. We have solved the 2.5-angstrom resolution crystal structure of Saccharomyces cerevisiae Dom34. This protein is organized in three domains with the central and C-terminal domains structurally homologous to those from eRF1. The N-terminal domain of Dom34 is different from eRF1. It adopts a Sm-fold that is often involved in the recognition of mRNA stem loops or in the recruitment of mRNA degradation machinery. The comparison of eRF1 and Dom34 domains proposed to interact directly with eRF3 and Hbs1, respectively, highlights striking structural similarities with eRF1 motifs identified to be crucial for the binding to eRF3. In addition, as observed for eRF1 that enhances eRF3 binding to GTP, the interaction of Dom34 with Hbs1 results in an increase in the affinity constant of Hbs1 for GTP but not GDP. Taken together, these results emphasize that eukaryotic cells have evolved two structurally related complexes able to interact with ribosomes either paused at a stop codon or stalled in translation by the presence of a stable stem loop and to trigger ribosome release by catalyzing chemical bond hydrolysis.	[Graille, Marc; Chaillet, Maxime; van Tilbeurgh, Herman] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619,IFR 115, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Graille, M (corresponding author), Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619,IFR 115, F-91405 Orsay, France.	marc.graille@u-psud.fr	GRAILLE, Marc/D-3242-2014	GRAILLE, Marc/0000-0002-7853-5852; Chaillet, Maxime/0000-0001-6812-4147				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adham IM, 2003, MOL CELL BIOL, V23, P1470, DOI 10.1128/MCB.23.4.1470-1476.2003; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; Bertram G, 2000, RNA, V6, P1236, DOI 10.1017/S1355838200000777; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chavatte L, 2002, EMBO J, V21, P5302, DOI 10.1093/emboj/cdf484; Clement SL, 2006, NAT STRUCT MOL BIOL, V13, P299, DOI 10.1038/nsmb0406-299; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; Davis L, 1998, GENETICS, V149, P45; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; EBERHART CG, 1995, DEVELOPMENT, V121, P3477; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Eurwilaichitr L, 1999, MOL MICROBIOL, V32, P485, DOI 10.1046/j.1365-2958.1999.01346.x; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Frolova L, 1996, RNA, V2, P334; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Heurgue-Hamard V, 2006, J BIOL CHEM, V281, P36140, DOI 10.1074/jbc.M608571200; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Inagaki Y, 2003, NUCLEIC ACIDS RES, V31, P4227, DOI 10.1093/nar/gkg440; Ito K, 1998, RNA, V4, P958, DOI 10.1017/S1355838298971874; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Kobayashi T, 2004, J BIOL CHEM, V279, P45693, DOI 10.1074/jbc.M405163200; KOONIN EV, 1994, NUCLEIC ACIDS RES, V22, P2166, DOI 10.1093/nar/22.11.2166; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Le Hir H, 2000, GENE DEV, V14, P1098; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; LIBBY RT, 1991, MOL MICROBIOL, V5, P999, DOI 10.1111/j.1365-2958.1991.tb01872.x; Maquat LE, 2002, SCIENCE, V295, P2221, DOI 10.1126/science.1071285; MARQUAT LE, 2004, NAT REV MOL CELL BIO, V5, P89; Merkulova TI, 1999, FEBS LETT, V443, P41, DOI 10.1016/S0014-5793(98)01669-X; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Pillai RS, 2001, EMBO J, V20, P5470, DOI 10.1093/emboj/20.19.5470; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005; Roth M, 2002, ACTA CRYSTALLOGR D, V58, P805, DOI 10.1107/S0907444902003943; Salas-Marco J, 2004, MOL CELL BIOL, V24, P7769, DOI 10.1128/MCB.24.17.7769-7778.2004; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tollervey D, 2006, NATURE, V440, P425, DOI 10.1038/440425a; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Wallrapp C, 1998, FEBS LETT, V440, P387, DOI 10.1016/S0014-5793(98)01492-6; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; Xi RW, 2005, DEVELOPMENT, V132, P5365, DOI 10.1242/dev.02151; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	72	67	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7145	7154		10.1074/jbc.M708224200	http://dx.doi.org/10.1074/jbc.M708224200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18180287	hybrid, Green Published			2022-12-27	WOS:000253779600060
J	Berthold, CL; Toyota, CG; Richards, NGJ; Lindqvist, Y				Berthold, Catrine L.; Toyota, Cory G.; Richards, Nigel G. J.; Lindqvist, Ylva			Reinvestigation of the catalytic mechanism of formyl-CoA transferase, a class IIICoA-transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A TRANSFERASE; CRYSTAL-STRUCTURE; ENZYME; FAMILY; IDENTIFICATION; DECARBOXYLASE; INTERMEDIATE; PURIFICATION; OXALATE; LYASE	Formyl-coenzyme A transferase from Oxalobacter formigenes belongs to the Class III coenzyme A transferase family and catalyzes the reversible transfer of a CoA carrier between formyl-CoA and oxalate, forming oxalyl-CoA and formate. Formyl-CoA transferase has a unique three-dimensional fold composed of two interlaced subunits locked together like rings of a chain. We here present an intermediate in the reaction, formyl-CoA transferase containing the covalent beta-aspartyl-CoA thioester, adopting different conformations in the two active sites of the dimer, which was identified through crystallographic freeze-trapping experiments with formyl-CoA and oxalyl-CoA in the absence of acceptor carboxylic acid. The formation of the enzyme-CoA thioester was also confirmed by mass spectrometric data. Further structural data include a trapped aspartyl-formyl anhydride protected by a glycine loop closing down over the active site. In a crystal structure of the beta-aspartyl-CoA thioester of an inactive mutant variant, oxalate was found bound to the open conformation of the glycine loop. Together with hydroxylamine trapping experiments and kinetic as well as mutagenesis data, the structures of these formyl-CoA transferase complexes provide new information on the Class III CoA-transferase family and prompt redefinition of the catalytic steps and the modified reaction mechanism of formyl-CoA transferase proposed here.	[Berthold, Catrine L.; Lindqvist, Ylva] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Toyota, Cory G.; Richards, Nigel G. J.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA	Karolinska Institutet; State University System of Florida; University of Florida	Lindqvist, Y (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	Ylva.Lindqvist@ki.se	Lindqvist, Ylva/F-9009-2010	Lindqvist, Ylva/0000-0003-3162-8661	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061666] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK 61666] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLISON MJ, 1985, ARCH MICROBIOL, V141, P1, DOI 10.1007/BF00446731; BAETZ AL, 1990, J BACTERIOL, V172, P3537, DOI 10.1128/jb.172.7.3537-3540.1990; BAETZ AL, 1989, J BACTERIOL, V171, P2605, DOI 10.1128/jb.171.5.2605-2608.1989; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berthold CL, 2005, J BIOL CHEM, V280, P41645, DOI 10.1074/jbc.M509921200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUCKEL W, 1976, EUR J BIOCHEM, V64, P255, DOI 10.1111/j.1432-1033.1976.tb10295.x; Cornick NA, 1996, APPL ENVIRON MICROB, V62, P3011, DOI 10.1128/AEM.62.8.3011-3013.1996; DeLano W, 2002, PYMOL 0 99; Dickert S, 2000, EUR J BIOCHEM, V267, P3874, DOI 10.1046/j.1432-1327.2000.01427.x; DIMROTH P, 1975, P NATL ACAD SCI USA, V72, P3458, DOI 10.1073/pnas.72.9.3458; Gruez A, 2003, J BIOL CHEM, V278, P34582, DOI 10.1074/jbc.C300282200; Heider J, 2001, FEBS LETT, V509, P345, DOI 10.1016/S0014-5793(01)03178-7; Jonsson S, 2004, J BIOL CHEM, V279, P36003, DOI 10.1074/jbc.M404873200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Leutwein C, 2001, J BACTERIOL, V183, P4288, DOI 10.1128/JB.183.14.4288-4295.2001; Lloyd AJ, 2001, BIOCHEMISTRY-US, V40, P2455, DOI 10.1021/bi002169v; Lohkamp B., 2005, CCP4 NEWSLETTER, V42; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; QUAYLE JR, 1963, BIOCHEM J, V87, P368, DOI 10.1042/bj0870368; Rangarajan ES, 2005, J BIOL CHEM, V280, P42919, DOI 10.1074/jbc.M510522200; Rangarajan ES, 2005, BIOCHEMISTRY-US, V44, P5728, DOI 10.1021/bi047656f; Ricagno S, 2003, EMBO J, V22, P3210, DOI 10.1093/emboj/cdg333; Selmer T, 1999, J BIOL CHEM, V274, P20772, DOI 10.1074/jbc.274.30.20772; Sidhu H, 1997, J CLIN MICROBIOL, V35, P350, DOI 10.1128/JCM.35.2.350-353.1997; SOLOMON F, 1969, J BIOL CHEM, V244, P1079; Stenmark P, 2004, BIOCHEMISTRY-US, V43, P13996, DOI 10.1021/bi048481c; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	30	29	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6519	6529		10.1074/jbc.M709353200	http://dx.doi.org/10.1074/jbc.M709353200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18162462	hybrid			2022-12-27	WOS:000253779500059
J	Gillen, CM; Courtney, HS; Schulze, K; Rohde, M; Wilson, MR; Timmer, AM; Guzman, CA; Nizet, V; Chhatwal, GS; Walker, MJ				Gillen, Christine M.; Courtney, Harry S.; Schulze, Kai; Rohde, Manfred; Wilson, Mark R.; Timmer, Anjuli M.; Guzman, Carlos A.; Nizet, Victor; Chhatwal, G. S.; Walker, Mark J.			Opacity factor activity and epithelial cell binding by the serum opacity factor protein of Streptococcus pyogenes are functionally discrete	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; HIGH-DENSITY-LIPOPROTEIN; FIBRONECTIN-BINDING; SURFACE PROTEIN; M1 PROTEIN; INTRANASAL IMMUNIZATION; INTRACELLULAR INVASION; CONFORMATIONAL EPITOPE; NORTHERN-TERRITORY; LIPOTEICHOIC ACID	Serum opacity factor (SOF) is a unique multifunctional virulence determinant expressed at the surface of Streptococcus pyogenes and has been shown to elicit protective immunity against GAS infection in a murine challenge model. SOF consists of two distinct domains with different binding capacities: an N-terminal domain that binds apolipoprotein AI and a C-terminal repeat domain that binds fibronectin and fibrinogen. The capacity of SOF to opacify serum by disrupting the structure of high density lipoproteins may preclude its use as a vaccine antigen in humans. This study generated mutant forms of recombinant SOF with reduced (100-fold) or abrogated opacity factor (OF) activity, for use as vaccine antigens. However, alterations introduced into the N-terminal SOF peptide (SOF Delta Fn) by mutagenesis to abrogate OF activity, abolish the capacity of SOF to protect against lethal systemic S. pyogenes challenge in a murine model. Mutant forms of purified SOF Delta Fn peptide were also used to assess the contribution of OF activity to the pathogenic processes of cell adhesion and cell invasion. Using latex beads coated with full-length SOF, SOF Delta Fn peptide, or a peptide encompassing the C-terminal repeats (FnBD), we demonstrate that adhesion to HEp-2 cells is mediated by both SOF Delta Fn and FnBD. The HEp-2 cell binding displayed by the N-terminal SOF Delta Fn peptide is independent of OF activity. We demonstrate that while the N terminus of SOF does not directly mediate intracellular uptake by epithelial cells, this domain enhances epithelial cell uptake mediated by full-length SOF, in comparison to the FnBD alone.	[Gillen, Christine M.; Wilson, Mark R.; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Courtney, Harry S.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38104 USA; [Courtney, Harry S.] Univ Tennessee, Ctr Hlth Sci, Vet Affairs Med Ctr, Memphis, TN 38104 USA; [Schulze, Kai; Guzman, Carlos A.] Helmholtz Ctr Infect Res, Dept Vaccinol, Braunschweig, Germany; [Rohde, Manfred; Chhatwal, G. S.] Helmholtz Ctr Infect Res, Dept Microbiol Pathogen, D-38124 Braunschweig, Germany; [Timmer, Anjuli M.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, Div Pharmacol & Drug Discovery, La Jolla, CA 92093 USA	University of Wollongong; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; University of California System; University of California San Diego	Walker, MJ (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia.	mwalker@uow.edu.au	Wilson, Mark R/B-3254-2018; Nizet, Victor/AAF-3190-2019; Walker, Mark J./F-6940-2011; Gillen, Christine M/A-2717-2014	Wilson, Mark R/0000-0002-9551-7445; Duplancic, Christine/0000-0002-1775-3055; Walker, Mark/0000-0001-7423-2769; Nizet, Victor/0000-0003-3847-0422				[Anonymous], 1982, PHYS BIOCH APPL BIOC; [Anonymous], 1996, CIRCULAR DICHROISM C; Beall B, 2000, MICROBIOL-SGM, V146, P1195, DOI 10.1099/00221287-146-5-1195; BESSEN D, 1988, INFECT IMMUN, V56, P2666, DOI 10.1128/IAI.56.10.2666-2672.1988; BISNO AL, 1995, PRINCIPLES PRACTICE, V2, P1786; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Courtney HS, 2006, J BIOL CHEM, V281, P5515, DOI 10.1074/jbc.M512538200; Courtney HS, 2006, MOL MICROBIOL, V59, P936, DOI 10.1111/j.1365-2958.2005.04977.x; Courtney HS, 1999, MOL MICROBIOL, V32, P89, DOI 10.1046/j.1365-2958.1999.01328.x; Courtney HS, 2003, INFECT IMMUN, V71, P5097, DOI 10.1128/IAI.71.9.5097-5103.2003; Courtney HS, 2002, CURR MICROBIOL, V44, P236, DOI 10.1007/s00284-001-0037-1; Cue D, 2001, MICROB PATHOGENESIS, V31, P231, DOI 10.1006/mpat.2001.0467; Cue D, 1998, INFECT IMMUN, V66, P4593, DOI 10.1128/IAI.66.10.4593-4601.1998; Cue D, 2000, P NATL ACAD SCI USA, V97, P2858, DOI 10.1073/pnas.050587897; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Currie B J, 2000, Australas J Dermatol, V41, P139, DOI 10.1046/j.1440-0960.2000.00417.x; Dombek PE, 1999, MOL MICROBIOL, V31, P859, DOI 10.1046/j.1365-2958.1999.01223.x; EMANCIPATOR K, 1992, INFECT IMMUN, V60, P596, DOI 10.1128/IAI.60.2.596-601.1992; Finger Florian, 2004, N Z Med J, V117, pU847; Gillard BK, 2007, BIOCHEMISTRY-US, V46, P12968, DOI 10.1021/bi701525w; Gillen CM, 2002, MICROBIOL-SGM, V148, P169, DOI 10.1099/00221287-148-1-169; Goodfellow AM, 2000, J CLIN MICROBIOL, V38, P389; Gravekamp C, 1996, INFECT IMMUN, V64, P3576, DOI 10.1128/IAI.64.9.3576-3583.1996; Grunfeld C, 1999, J LIPID RES, V40, P245; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Ionescu RM, 1999, NAT STRUCT BIOL, V6, P304; Jadoun J, 1998, J INFECT DIS, V178, P147, DOI 10.1086/515589; Jeng A, 2003, J BACTERIOL, V185, P1208, DOI 10.1128/JB.185.4.1208-1217.2003; Katerov V, 2000, CURR MICROBIOL, V40, P149, DOI 10.1007/s002849910031; Kawabata S, 2001, INFECT IMMUN, V69, P924, DOI 10.1128/IAI.69.2.924-930.2001; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; KREIKEMEYER B, 1995, MOL MICROBIOL, V17, P137, DOI 10.1111/j.1365-2958.1995.mmi_17010137.x; Kreikemeyer B, 1999, FEMS MICROBIOL LETT, V178, P305, DOI 10.1016/S0378-1097(99)00373-0; Levels JHM, 2003, INFECT IMMUN, V71, P3280, DOI 10.1128/IAI.71.6.3280-3284.2003; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; McArthur J, 2004, INFECT IMMUN, V72, P7342, DOI 10.1128/IAI.72.12.7342-7345.2004; McArthur JD, 2006, MOL MICROBIOL, V59, P1, DOI 10.1111/j.1365-2958.2005.04967.x; Medina E, 1999, J IMMUNOL, V163, P3396; Molinari G, 2000, CELL MICROBIOL, V2, P145, DOI 10.1046/j.1462-5822.2000.00040.x; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Oehmcke S, 2004, INFECT IMMUN, V72, P4302, DOI 10.1128/IAI.72.7.4302-4308.2004; Okada N, 1998, MICROBIOL-SGM, V144, P3079, DOI 10.1099/00221287-144-11-3079; OWENS RJ, 1990, J CLIN INVEST, V86, P1142, DOI 10.1172/JCI114819; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Podbielski A, 1999, MOL MICROBIOL, V31, P1051, DOI 10.1046/j.1365-2958.1999.01241.x; Purushothaman SS, 2003, INFECT IMMUN, V71, P5823, DOI 10.1128/IAI.71.10.5823-5830.2003; RAKONJAC JV, 1995, INFECT IMMUN, V63, P622, DOI 10.1128/IAI.63.2.622-631.1995; Relf WA, 1996, PEPTIDE RES, V9, P12; Reymond MT, 1997, PROTEIN SCI, V6, P706; Rezcallah MS, 2005, CELL MICROBIOL, V7, P645, DOI 10.1111/j.1462-5822.2004.00497.x; Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; SARAVANI GA, 1990, FEMS MICROBIOL LETT, V68, P35; Schmid FX., 1989, SPECTRAL METHODS CHA, P251; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Schulze K, 2006, VACCINE, V24, P1446, DOI 10.1016/j.vaccine.2005.06.039; SRINIVAS RV, 1991, J CELL BIOCHEM, V45, P224, DOI 10.1002/jcb.240450214; Svartman M, 1980, STREPTOCOCCAL DIS IM, P669; TADA N, 1993, MOL CELL BIOCHEM, V119, P171, DOI 10.1007/BF00926868; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; Timmer AM, 2006, MOL MICROBIOL, V62, P15, DOI 10.1111/j.1365-2958.2006.05337.x; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; WESSELS MR, 1994, INFECT IMMUN, V62, P433, DOI 10.1128/IAI.62.2.433-441.1994; Winram SB, 1996, MICROBIOL-SGM, V142, P2311, DOI 10.1099/13500872-142-8-2311; Zou W, 1999, J IMMUNOL, V163, P820	68	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6359	6366		10.1074/jbc.M706739200	http://dx.doi.org/10.1074/jbc.M706739200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18180300	Green Submitted, hybrid			2022-12-27	WOS:000253779500043
J	Heikkinen, LS; Kazlauskas, A; Melen, K; Wagner, R; Ziegler, T; Julkunen, I; Saksela, K				Heikkinen, Leena S.; Kazlauskas, Arunas; Melen, Krister; Wagner, Ralf; Ziegler, Thedi; Julkunen, Ilkka; Saksela, Kalle			Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL src homology 3 domains to activate host cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNAS; ADAPTER PROTEIN; SH3 DOMAINS; 3-KINASE/AKT PATHWAY; ANTIVIRAL RESPONSES; PANDEMIC INFLUENZA; PHAGE-DISPLAY; SPECIFICITY; INTERFERON; SEQUENCE	NS1 (nonstructural protein 1) is an important virulence factor of the influenza A virus. We observed that NS1 proteins of the 1918 pandemic virus (A/ Brevig Mission/ 1/ 18) and many avian influenza A viruses contain a consensus Src homology 3 (SH3) domain-binding motif. Screening of a comprehensive human SH3 phage library revealed the N-terminal SH3 of Crk and CrkL as the preferred binding partners. Studies with recombinant proteins confirmed avid binding of NS1 proteins of the 1918 virus and a representative avian H7N3 strain to Crk/ CrkL SH3 but not to other SH3 domains tested, including p85 alpha and p85 beta. Endogenous CrkL readily co-precipitated NS1 from cells infected with the H7N3 virus. In transfected cells association with CrkL was observed for NS1 of the 1918 and H7N3 viruses but not A/ Udorn/ 72 or A/WSN/ 33 NS1 lacking this sequence motif. SH3 binding was dispensable for suppression of interferoninduced gene expression by NS1 but was associated with enhanced phosphatidylinositol 3-kinase signaling, as evidenced by increased Akt phosphorylation. Thus, the Spanish Flu virus resembles avian influenza A viruses in its ability to recruit Crk/CrkL to modulate host cell signaling.	[Heikkinen, Leena S.; Kazlauskas, Arunas; Saksela, Kalle] Univ Helsinki, Cent Hosp, Hoartman Inst, Dept Virol, FIN-00014 Helsinki, Finland; [Melen, Krister; Ziegler, Thedi; Julkunen, Ilkka] Natl Inst Publ Hlth, Dept Viral Dis & Immunol, FIN-00300 Helsinki, Finland; [Wagner, Ralf] Univ Regensburg, Inst Med Microbiol & Hyg, D-93053 Regensburg, Germany	University of Helsinki; Helsinki University Central Hospital; University of Regensburg	Saksela, K (corresponding author), Univ Helsinki, Cent Hosp, Hoartman Inst, Dept Virol, Haartmaninkatu 3 POB 21, FIN-00014 Helsinki, Finland.	kalle.saksela@helsinki.fi		Saksela, Kalle/0000-0003-0827-122X				Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Bliska J, 1996, CHEM BIOL, V3, P7, DOI 10.1016/S1074-5521(96)90076-9; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Dupraz P, 1997, J VIROL, V71, P2615, DOI 10.1128/JVI.71.4.2615-2620.1997; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Garcia-Sastre A, 2004, CURR TOP MICROBIOL, V283, P249; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Gelkop S, 2001, J BIOL CHEM, V276, P36174, DOI 10.1074/jbc.M100731200; Hale BG, 2007, BIOCHEM SOC T, V35, P186, DOI 10.1042/BST0350186; Hale BG, 2008, J BIOL CHEM, V283, P1372, DOI 10.1074/jbc.M708862200; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hayman A, 2007, J VIROL, V81, P2318, DOI 10.1128/JVI.01856-06; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kay-Jackson PC, 2004, J GEN VIROL, V85, P119, DOI 10.1099/vir.0.19435-0; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; KNUDSEN BS, 1995, EMBO J, V14, P2191, DOI 10.1002/j.1460-2075.1995.tb07213.x; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Korkaya H, 2001, J BIOL CHEM, V276, P42389, DOI 10.1074/jbc.M101546200; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Lamb RA, 2001, FIELDS VIROL, V1, P1487; Li EG, 2000, J BIOL CHEM, V275, P14729, DOI 10.1074/jbc.275.19.14729; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Longnecker R, 2000, EXP CELL RES, V257, P332, DOI 10.1006/excr.2000.4900; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Mayer B.J., 2004, STRUCTURE FUNCTION M, P37; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; McMullen JR, 2007, CELL CYCLE, V6, P910, DOI 10.4161/cc.6.8.4124; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; RONNI T, 1995, J IMMUNOL, V154, P2764; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Subbarao K, 2006, INFLUENZA VIROLOGY: CURRENT TOPICS, P229; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; ZHAO JJ, 2006, SCI STKE; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	59	79	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5719	5727		10.1074/jbc.M707195200	http://dx.doi.org/10.1074/jbc.M707195200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165234	hybrid			2022-12-27	WOS:000253426700053
J	Laviad, EL; Albee, L; Pankova-Kholmyansky, I; Epstein, S; Park, H; Merrill, AH; Futerman, AH				Laviad, Elad L.; Albee, Lee; Pankova-Kholmyansky, Irene; Epstein, Sharon; Park, Hyejung; Merrill, Alfred H., Jr.; Futerman, Anthony H.			Characterization of ceramide synthase 2 - Tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONGEVITY ASSURANCE GENE-1; HOUSEKEEPING GENES; FAMILY-MEMBERS; SPHINGOLIPIDS; SPHINGOSINE-1-PHOSPHATE; IDENTIFICATION; TRAFFICKING; APOPTOSIS; GROWTH; LAG1	Ceramide is an important lipid signaling molecule and a key intermediate in sphingolipid biosynthesis. Recent studies have implied a previously unappreciated role for the ceramide N-acyl chain length, inasmuch as ceramides containing specific fatty acids appear to play defined roles in cell physiology. The discovery of a family of mammalian ceramide synthases (CerS), each of which utilizes a restricted subset of acyl-CoAs for ceramide synthesis, strengthens this notion. We now report the characterization of mammalian CerS2. qPCR analysis reveals that CerS2 mRNA is found at the highest level of all CerS and has the broadest tissue distribution. CerS2 has a remarkable acyl-CoA specificity, showing no activity using C16:0-CoA and very low activity using C18:0, rather utilizing longer acyl-chain CoAs (C20 - C26) for ceramide synthesis. There is a good correlation between CerS2 mRNA levels and levels of ceramide and sphingomyelin containing long acyl chains, at least in tissues where CerS2 mRNA is expressed at high levels. Interestingly, the activity of CerS2 can be regulated by another bioactive sphingolipid, sphingosine 1-phosphate (S1P), via interaction of S1P with two residues that are part of an S1P receptor-like motif found only in CerS2. These findings provide insight into the biochemical basis for the ceramide N-acyl chain composition of cells, and also reveal a novel and potentially important interplay between two bioactive sphingolipids that could be relevant to the regulation of sphingolipid metabolism and the opposing functions that these lipids play in signaling pathways.	[Laviad, Elad L.; Albee, Lee; Pankova-Kholmyansky, Irene; Epstein, Sharon; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Petit Ins Bioengn & Biosci, Atlanta, GA 30332 USA	Weizmann Institute of Science; University System of Georgia; Georgia Institute of Technology	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il		Futerman, Anthony/0000-0003-0013-0115; Merrill, Alfred/0000-0002-6673-968X	NIGMS NIH HHS [GM076217] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKER I, 2007, IN PRESS HISTOCHEM C; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eller CD, 2007, GENE, V390, P153, DOI 10.1016/j.gene.2006.09.018; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; Ganapathi M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-126; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Johnson KR, 2003, J BIOL CHEM, V278, P34541, DOI 10.1074/jbc.M301741200; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Merrill AH, 2007, TRENDS BIOCHEM SCI, V32, P457, DOI 10.1016/j.tibs.2007.09.004; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Schenck M, 2007, ARCH BIOCHEM BIOPHYS, V462, P171, DOI 10.1016/j.abb.2007.03.031; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; SULLARDS MC, 2001, SCI STKE, V67, P1; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zondag GCM, 1998, BIOCHEM J, V330, P605, DOI 10.1042/bj3300605	36	343	351	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5677	5684		10.1074/jbc.M707386200	http://dx.doi.org/10.1074/jbc.M707386200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165233	hybrid			2022-12-27	WOS:000253426700048
J	Li, F; Sonbuchner, L; Kyes, SA; Epp, C; Deitsch, KW				Li, Felomena; Sonbuchner, Lakshmi; Kyes, Sue A.; Epp, Christian; Deitsch, Kirk W.			Nuclear non-coding RNAs are transcribed from the centromeres of plasmodium falciparum and are associated with centromeric chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITES; GENE-EXPRESSION; ERYTHROCYTIC STAGES; FISSION YEAST; ANTISENSE TRANSCRIPTS; HETEROCHROMATIN; DNA; TRANSFORMATION; LOCALIZATION; PROTEINS	Non-coding RNAs (ncRNAs) play an important role in a variety of nuclear processes, including genetic imprinting, RNA interference-mediated transcriptional repression, and dosage compensation. These transcripts are thought to influence chromosome organization and, in some cases, gene expression by directing the assembly of specific chromatin modifications to targeted regions of the genome. In the malaria parasite Plasmodium falciparum, little is known about the regulation of nuclear organization or gene expression, although a notable scarcity of identifiable transcription factors encoded in its genome has led to speculation that this organism may be unusually reliant on chromatin modifications as a mechanism for regulating gene expression. To study the mechanisms that regulate chromatin structure in malaria parasites, we examined the role of ncRNAs in the assembly of chromatin at the centromeres of P. falciparum. We show that centromeric regions within the Plasmodium genome contain bidirectional promoter activity driving the expression of short ncRNAs that are localized within the nucleus and appear to associate with the centromeres themselves, strongly suggesting that they are central characters in the maintenance and function of centromeric chromatin. These observations support the hypothesis that ncRNAs play an important role in the proper organizational assembly of chromatin in P. falciparum, perhaps compensating for a lack of both regulatory transcription factors and RNA interference machinery.	[Li, Felomena; Sonbuchner, Lakshmi; Epp, Christian; Deitsch, Kirk W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Kyes, Sue A.] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9D5, England	Cornell University; University of Oxford	Deitsch, KW (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, 1300 York Ave,Box 62, New York, NY 10021 USA.	kwd2001@med.cornell.edu			NIAID NIH HHS [R01 AI052390, AI52390] Funding Source: Medline; NIGMS NIH HHS [T32 GM007739, GM07739] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Chang SC, 2006, FRONT BIOSCI-LANDMRK, V11, P852, DOI 10.2741/1842; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; Cooke HJ, 2004, TRENDS BIOTECHNOL, V22, P319, DOI 10.1016/j.tibtech.2004.04.015; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; de la Espina SMD, 2005, EUR J CELL BIOL, V84, P137, DOI 10.1016/j.ejcb.2005.01.002; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Ekwall K, 2004, CHROMOSOME RES, V12, P535, DOI 10.1023/B:CHRO.0000036584.40567.e5; FIDOCK DA, 1994, MOL BIOCHEM PARASIT, V64, P219, DOI 10.1016/0166-6851(94)00012-3; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gerbi SA, 2002, MOL BIOL CELL, V13, P3123, DOI 10.1091/mbc.01-12-0596; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Gunasekera AM, 2004, MOL BIOCHEM PARASIT, V136, P35, DOI 10.1016/j.molbiopara.2004.02.007; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Kelly JM, 2006, P NATL ACAD SCI USA, V103, P6706, DOI 10.1073/pnas.0510363103; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes SA, 2003, MOL MICROBIOL, V48, P1339, DOI 10.1046/j.1365-2958.2003.03505.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lewis A, 2006, CYTOGENET GENOME RES, V113, P81, DOI 10.1159/000090818; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Malhotra P, 2002, MOL MICROBIOL, V45, P1245, DOI 10.1046/j.1365-2958.2002.03105.x; Marty AJ, 2006, MOL MICROBIOL, V62, P72, DOI 10.1111/j.1365-2958.2006.05364.x; Mizuta R, 2005, J ELECTRON MICROSC, V54, P403, DOI 10.1093/jmicro/dfi058; Morey C, 2004, FEBS LETT, V567, P27, DOI 10.1016/j.febslet.2004.03.117; Nakano M, 2003, J CELL SCI, V116, P4021, DOI 10.1242/jcs.00697; Patankar S, 2001, MOL BIOL CELL, V12, P3114, DOI 10.1091/mbc.12.10.3114; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Rea S, 2006, CURR TOP MICROBIOL, V310, P117; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Thompson Joanne, 2002, Methods Mol Med, V72, P225, DOI 10.1385/1-59259-271-6:225; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRAGER W, 1977, B WORLD HEALTH ORGAN, V55, P363; Valgardsdottir R, 2005, MOL BIOL CELL, V16, P2597, DOI 10.1091/mbc.E04-12-1078; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wickstead B, 2003, MICROBIOL MOL BIOL R, V67, P360, DOI 10.1128/MMBR.67.3.360-375.2003; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; ZOTALL M, 2006, MOL CELL, V22, P681	45	56	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5692	5698		10.1074/jbc.M707344200	http://dx.doi.org/10.1074/jbc.M707344200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165241	hybrid			2022-12-27	WOS:000253426700050
J	Gey, U; Czupalla, C; Hoflack, B; Rodel, G; Krause-Buchholz, U				Gey, Uta; Czupalla, Cornelia; Hoflack, Bernard; Roedel, Gerhard; Krause-Buchholz, Udo			Yeast pyruvate dehydrogenase complex is regulated by a concerted activity of two kinases and two phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN PHOSPHATASE; MAMMALIAN PYRUVATE; PHOSPHORYLATION-DEPHOSPHORYLATION; PHOSPHOPROTEOME ANALYSIS; MITOCHONDRIAL PROTEOME; MASS-SPECTROMETRY; LACTIC-ACIDOSIS; ELECTROPHORESIS; DISSOCIATION	The activity of yeast pyruvate dehydrogenase complex is regulated by reversible phosphorylation. Recently we identified two enzymes that are involved in the phosphorylation (Pkp1p) and dephosphorylation (Ppp1p) of Pda1p, the alpha-subunit of the pyruvate dehydrogenase complex. Here we provide evidence that two additional mitochondrial proteins, Pkp2p (Yg1059wp) and Ppp2p (Ycr079wp), are engaged in the regulation of this complex by affecting the phosphorylation state of Pda1p. Our data indicate complementary activities of the kinases and a redundant function for the phosphatases. Both proteins are associated with the complex. We propose a model for the role of the regulatory enzymes and the phosphorylation state of Pda1p in the assembly process of the pyruvate dehydrogenase complex.	[Gey, Uta; Roedel, Gerhard; Krause-Buchholz, Udo] Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany; [Czupalla, Cornelia; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Krause-Buchholz, U (corresponding author), Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany.	Udo.Krause-Buchholz@tu-dresden.de	HOFLACK, Bernard/AAZ-6668-2020; Roedel, Gerhard/AAH-3762-2022; Roedel, Gerhard/AFQ-8997-2022; Krause, Udo/N-8167-2014	Krause, Udo/0000-0001-9493-4522				Agrawal GK, 2005, PROTEOMICS, V5, P4684, DOI 10.1002/pmic.200500021; Bao HY, 2004, BIOCHEMISTRY-US, V43, P13442, DOI 10.1021/bi0494875; Bao HY, 2004, BIOCHEMISTRY-US, V43, P13432, DOI 10.1021/bi049488x; Boubekeur S, 1999, J BIOL CHEM, V274, P21044, DOI 10.1074/jbc.274.30.21044; Boubekeur S, 2001, EUR J BIOCHEM, V268, P5057, DOI 10.1046/j.1432-1327.2001.02418.x; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Czupalla C, 2005, PROTEOMICS, V5, P3868, DOI 10.1002/pmic.200402059; DAUM G, 1982, J BIOL CHEM, V257, P3028; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gonzalez A, 2006, J BIOL CHEM, V281, P35057, DOI 10.1074/jbc.M607919200; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Henderson NS, 2000, ELECTROPHORESIS, V21, P2925, DOI 10.1002/1522-2683(20000801)21:14<2925::AID-ELPS2925>3.0.CO;2-2; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JAMES AG, 1995, FEBS LETT, V373, P111, DOI 10.1016/0014-5793(95)01020-F; Kaiser C. S., 1994, METHODS YEAST GENETI, P207; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Korotchkina LG, 2001, J BIOL CHEM, V276, P37223, DOI 10.1074/jbc.M103069200; Krause-Buchholz U, 2006, FEBS LETT, V580, P2553, DOI 10.1016/j.febslet.2006.04.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; Maj MC, 2005, J CLIN ENDOCR METAB, V90, P4101, DOI 10.1210/jc.2005-0123; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Murray J, 2004, ELECTROPHORESIS, V25, P2520, DOI 10.1002/elps.200406006; Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Patel MS, 2003, BIOCHEM MOL BIOL EDU, V31, P5, DOI 10.1002/bmb.2003.494031010156; POPOV KM, 1992, J BIOL CHEM, V267, P13127; Ray R, 2003, METHOD ENZYMOL, V366, P95; Reed L J, 1981, Curr Top Cell Regul, V18, P95; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; ROBINSON BH, 1975, PEDIATR RES, V9, P935, DOI 10.1203/00006450-197512000-00015; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Ruan HH, 2007, FEMS YEAST RES, V7, P209, DOI 10.1111/j.1567-1364.2006.00160.x; RUBENSTEIN EM, 2007, CELL, V6, P571; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Sakumoto N, 2002, YEAST, V19, P587, DOI 10.1002/yea.860; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Seyda A, 2001, J INHERIT METAB DIS, V24, P551, DOI 10.1023/A:1012463726810; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Stoops JK, 1997, J BIOL CHEM, V272, P5757, DOI 10.1074/jbc.272.9.5757; Strumilo S, 2005, ACTA BIOCHIM POL, V52, P759; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; SUGDEN PH, 1978, BIOCHEM J, V169, P433, DOI 10.1042/bj1690433; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; UHLINGER DJ, 1986, BIOCHEMISTRY-US, V25, P5673, DOI 10.1021/bi00367a049; WENZEL TJ, 1992, EUR J BIOCHEM, V209, P697, DOI 10.1111/j.1432-1033.1992.tb17338.x; WENZEL TJ, 1993, EUR J BIOCHEM, V218, P405, DOI 10.1111/j.1432-1033.1993.tb18390.x; WIELAND O, 1969, FEBS LETT, V3, P271, DOI 10.1016/0014-5793(69)80156-0; WIELAND OH, 1982, REV PHYSIOL BIOCH P, V96, P123, DOI 10.1007/BFb0031008; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	61	66	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9759	9767		10.1074/jbc.M708779200	http://dx.doi.org/10.1074/jbc.M708779200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18180296	hybrid			2022-12-27	WOS:000254671600030
J	Devi, L; Raghavendran, V; Prabhu, BM; Avadhani, NG; Anandatheerthavarada, HK				Devi, Latha; Raghavendran, Vijayendran; Prabhu, Badanavalu M.; Avadhani, Narayan G.; Anandatheerthavarada, Hindupur K.			Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; EARLY-ONSET PARKINSONISM; OXIDATIVE STRESS; CELL-DEATH; NEURODEGENERATIVE DISEASES; ENDOPLASMIC-RETICULUM; MUTATIONS; PHOSPHORYLATION; DJ-1; LOCALIZATION	alpha-Synuclein, a protein implicated in the pathogenesis of Parkinson disease ( PD), is thought to affect mitochondrial functions, although the mechanisms of its action remain unclear. In this study we show that the N-terminal 32 amino acids of human alpha-synuclein contain cryptic mitochondrial targeting signal, which is important for mitochondrial targeting of alpha-synuclein. Mitochondrial imported alpha-synuclein is predominantly associated with the inner membrane. Accumulation of wild-type alpha-synuclein in the mitochondria of human dopaminergic neurons caused reduced mitochondrial complex I activity and increased production of reactive oxygen species. However, these defects occurred at an early time point in dopaminergic neurons expressing familial alpha-synuclein with A53T mutation as compared with wild-type alpha-synuclein. Importantly, alpha-synuclein that lacks mitochondrial targeting signal failed to target to the mitochondria and showed no detectable effect on complex I function. The PD relevance of these results was investigated using mitochondria of substantia nigra, striatum, and cerebellum of postmortem late-onset PD and normal human brains. Results showed the constitutive presence of similar to 14- kDa alpha-synuclein in the mitochondria of all three brain regions of normal subjects. Mitochondria of PD-vulnerable substantia nigra and striatum but not cerebellum from PD subjects showed significant accumulation of alpha-synuclein and decreased complex I activity. Analysis of mitochondria from PD brain and alpha-synuclein expressing dopaminergic neuronal cultures using blue native gel electrophoresis and immunocapture technique showed the association of alpha-synuclein with complex I. These results provide evidence that mitochondrial accumulated alpha-synuclein may interact with complex I and interfere with its functions.	[Devi, Latha; Raghavendran, Vijayendran; Prabhu, Badanavalu M.; Avadhani, Narayan G.; Anandatheerthavarada, Hindupur K.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Anandatheerthavarada, HK (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St, Philadelphia, PA 19104 USA.	ann1234@vet.upenn.edu	Raghavendran, Vijay/G-6425-2015	Raghavendran, Vijay/0000-0002-2021-2786	NATIONAL INSTITUTE ON AGING [R01AG021920] Funding Source: NIH RePORTER; NIA NIH HHS [AG 021920] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abou-Sleiman PM, 2006, ANN NEUROL, V60, P414, DOI 10.1002/ana.20960; Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Ahn M, 2006, BIOCHEM BIOPH RES CO, V346, P1142, DOI 10.1016/j.bbrc.2006.05.213; ALI SF, 1994, SYNAPSE, V18, P27, DOI 10.1002/syn.890180105; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Fiskum G, 2003, ANN NY ACAD SCI, V991, P111; Gasser T, 2001, J NEUROL, V248, P833, DOI 10.1007/s004150170066; Greenamyre JT, 2003, PARKINSONISM RELAT D, V9, pS59, DOI 10.1016/S1353-8020(03)00023-3; Gu M, 1997, MOVEMENT DISORD, V12, P418, DOI 10.1002/mds.870120323; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Ramakrishnan M, 2003, BIOCHEMISTRY-US, V42, P12919, DOI 10.1021/bi035048e; Recchia A, 2004, FASEB J, V18, P617, DOI 10.1096/fj.03-0338rev; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Wang Y, 2006, BIOCHEM PHARMACOL, V72, P881, DOI 10.1016/j.bcp.2006.06.032; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600	50	720	731	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9089	9100		10.1074/jbc.M710012200	http://dx.doi.org/10.1074/jbc.M710012200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18245082	Green Published, hybrid			2022-12-27	WOS:000254465800039
J	Voong, LN; Slater, AR; Kratovac, S; Cressman, DE				Voong, Lilien N.; Slater, Allison R.; Kratovac, Sebila; Cressman, Drew E.			Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; BARE-LYMPHOCYTE-SYNDROME; CIITA GENE-EXPRESSION; HISTOCOMPATIBILITY COMPLEX EXPRESSION; CREB BINDING-PROTEIN; LEUCINE-RICH REPEATS; X-BOX REGION; IFN-GAMMA; GTP-BINDING; ANTIGEN PRESENTATION	The expression of major histocompatibility class II genes is necessary for proper antigen presentation and induction of an immune response. This expression is initiated by the class II transactivator, CIITA. The establishment of the active form of CIITA is controlled by a series of post-translational events, including GTP binding, ubiquitination, and dimerization. However, the role of phosphorylation is less clearly defined as are the consequences of phosphorylation on CIITA activity and the identity of the kinases involved. In this study we show that the extracellular signal-regulated kinases 1 and 2 ( ERK1/2) interact directly with CIITA, targeting serine residues in the amino terminus of the protein, including serine 288. Inhibition of this phosphorylation by dominant-negative forms of ERK or by treatment of cells with the ERK inhibitor PD98059 resulted in the increase in CIITA-mediated gene expression from a class II promoter, enhanced the nuclear concentration of CIITA, and impaired its ability to bind to the nuclear export factor, CRM1. In contrast, inhibition of ERK1/2 activity had little effect on serine-to-alanine mutant forms of CIITA. These data suggest a model whereby ERK1/2-mediated phosphorylation of CIITA down-regulates CIITA activity by priming it for nuclear export, thus providing a means for cells to tightly regulate the extent of antigen presentation.	[Voong, Lilien N.; Slater, Allison R.; Kratovac, Sebila; Cressman, Drew E.] Sarah Lawrence Coll, Dept Biol, Bronxville, NY 10708 USA	Sarah Lawrence College	Cressman, DE (corresponding author), 1 Mead Way, Bronxville, NY 10708 USA.	dcressma@slc.edu						Al-Kandari W, 2007, J MOL BIOL, V369, P1175, DOI 10.1016/j.jmb.2007.04.033; Bewry NN, 2007, J BIOL CHEM, V282, P26178, DOI 10.1074/jbc.M611747200; Boss JM, 2003, CURR OPIN IMMUNOL, V15, P105, DOI 10.1016/S0952-7915(02)00015-8; Boss JM, 1999, MICROBES INFECT, V1, P847, DOI 10.1016/S1286-4579(99)00234-8; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brown JA, 1998, NUCLEIC ACIDS RES, V26, P4128, DOI 10.1093/nar/26.18.4128; Camacho-Carvajal MM, 2004, INT IMMUNOL, V16, P65, DOI 10.1093/intimm/dxh010; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; Chin KC, 1997, J IMMUNOL, V159, P2789; Chin KC, 1997, P NATL ACAD SCI USA, V94, P2501, DOI 10.1073/pnas.94.6.2501; Cobb MH, 1991, CURR OPIN CELL BIOL, V3, P1025, DOI 10.1016/0955-0674(91)90124-H; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; Cressman DE, 2001, J IMMUNOL, V167, P3626, DOI 10.4049/jimmunol.167.7.3626; DeSandro AM, 2000, MOL CELL BIOL, V20, P6587, DOI 10.1128/MCB.20.17.6587-6599.2000; Drozina G, 2006, J BIOL CHEM, V281, P39963, DOI 10.1074/jbc.M608538200; Fontes JD, 1999, MOL CELL BIOL, V19, P941; Giroux M, 2003, J IMMUNOL, V171, P4187, DOI 10.4049/jimmunol.171.8.4187; Greer SF, 2004, J IMMUNOL, V173, P376, DOI 10.4049/jimmunol.173.1.376; GRILLI M, 1993, INT REV CYTOL, V143, P1; Hake SB, 2000, MOL CELL BIOL, V20, P7716, DOI 10.1128/MCB.20.20.7716-7725.2000; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; Jabrane-Ferrat N, 2003, INT IMMUNOL, V15, P467, DOI 10.1093/intimm/dxg048; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Kretsovali A, 2001, J BIOL CHEM, V276, P32191, DOI 10.1074/jbc.M103164200; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Kwon MJ, 2007, MOL IMMUNOL, V44, P2841, DOI 10.1016/j.molimm.2007.01.035; Kwon MJ, 2006, J IMMUNOL, V177, P950, DOI 10.4049/jimmunol.177.2.950; Li GX, 2001, MOL CELL BIOL, V21, P4626, DOI 10.1128/MCB.21.14.4626-4635.2001; Linhoff MW, 2001, MOL CELL BIOL, V21, P3001, DOI 10.1128/MCB.21.9.3001-3011.2001; Lochamy J, 2007, MOL IMMUNOL, V44, P837, DOI 10.1016/j.molimm.2006.04.004; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; MORENO CS, 1995, J IMMUNOL, V155, P4313; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; Mudhasani R, 2002, MOL CELL BIOL, V22, P5019, DOI 10.1128/MCB.22.14.5019-5026.2002; Nagarajan UM, 2002, J IMMUNOL, V169, P5078, DOI 10.4049/jimmunol.169.9.5078; Nekrep N, 2001, MOL CELL BIOL, V21, P5566, DOI 10.1128/MCB.21.16.5566-5576.2001; Nikodemova M, 2007, J BIOL CHEM, V282, P15208, DOI 10.1074/jbc.M611907200; Raval A, 2003, J IMMUNOL, V170, P922, DOI 10.4049/jimmunol.170.2.922; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; Sisk TJ, 2001, MOL CELL BIOL, V21, P4919, DOI 10.1128/MCB.21.15.4919-4928.2001; Sisk TJ, 2003, INT IMMUNOL, V15, P1195, DOI 10.1093/intimm/dxg116; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Taxman DJ, 2000, J IMMUNOL, V165, P1410, DOI 10.4049/jimmunol.165.3.1410; Tosi G, 2002, EMBO J, V21, P5467, DOI 10.1093/emboj/cdf557; Towey M, 2002, MOL IMMUNOL, V38, P627, DOI 10.1016/S0161-5890(01)00093-1; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yao YX, 2006, J IMMUNOL, V177, P70, DOI 10.4049/jimmunol.177.1.70; Zhao M, 2007, MOL IMMUNOL, V44, P2923, DOI 10.1016/j.molimm.2007.01.009; Zhao WL, 2007, J IMMUNOL, V179, P463, DOI 10.4049/jimmunol.179.1.463; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9; Zhu XS, 2000, MOL CELL BIOL, V20, P6051, DOI 10.1128/MCB.20.16.6051-6061.2000; Zika E, 2005, P NATL ACAD SCI USA, V102, P16321, DOI 10.1073/pnas.0505045102; Zika E, 2005, CURR OPIN IMMUNOL, V17, P58, DOI 10.1016/j.coi.2004.11.008; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003	67	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9031	9039		10.1074/jbc.M706487200	http://dx.doi.org/10.1074/jbc.M706487200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18245089	hybrid, Green Published			2022-12-27	WOS:000254465800033
J	Bae, GU; Gaio, U; Yang, YJ; Lee, HJ; Kang, JS; Krauss, RS				Bae, Gyu-Un; Gaio, Ursula; Yang, Youn-Joo; Lee, Hye-Jin; Kang, Jong-Sun; Krauss, Robert S.			Regulation of myoblast motility and fusion by the CXCR4-associated sialomucin, CD164	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE-PROTEINS; CHEMOKINE RECEPTOR CXCR4; MUSCLE PROGENITOR CELLS; SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; NEGATIVE REGULATOR; SATELLITE CELLS; ENDOLYN CD164; BONE-MARROW; MIGRATION	Myoblast fusion is fundamental to the development and regeneration of skeletal muscle. To fuse, myoblasts undergo cell-cell recognition and adhesion and merger of membranes between apposing cells. Cell migration must occur in advance of these events to bring myoblasts into proximity, but the factors that regulate myoblast motility are not fully understood. CD164 is a cell surface sialomucin that is targeted to endosomes and lysosomes via its intracellular region. In hematopoietic progenitor cells, CD164 forms complexes with the motility-stimulating chemokine receptor, CXCR4, in response to the CXCR4 ligand, CXCL12/SDF-1 (Forde, S., Tye, B. J., Newey, S. E., Roubelakis, M., Smythe, J., McGuckin, C. P., Pettengell, R., and Watt, S. M. (2007) Blood 109, 1825-1833). We have previously shown that CD164 stimulates myotube formation in vitro. We report here that CD164 is associated with CXCR4 in C2C12 myoblasts. Cells in which CD164 levels are increased or decreased via overexpression or RNA interference-mediated knockdown, respectively, show enhanced or reduced myotube formation and cell migration, the latter both basally and in response to CXCL12/SDF-1. Furthermore, expression of CD164 cytoplasmic tail mutants that alter the endosome/lysosome targeting sequence and, consequently, the subcellular localization in myoblasts, reveals a similar correlation between cell motility and myotube formation. Finally, Cd164 mRNA is expressed in the dorsal somite (the early myogenic compartment of the mouse embryo) and in premuscle masses. Taken together, these results suggest that CD164 is a regulator of myoblast motility and that this property contributes to its ability to promote myoblast fusion into myotubes.	[Bae, Gyu-Un; Gaio, Ursula; Yang, Youn-Joo; Krauss, Robert S.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Lee, Hye-Jin; Kang, Jong-Sun] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea	Icahn School of Medicine at Mount Sinai; Sungkyunkwan University (SKKU)	Krauss, RS (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, Box 1020, New York, NY 10029 USA.	Robert.Krauss@mssm.edu			NIAMS NIH HHS [AR 050403] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050403] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAE GU, UNPUB; Becciolini L, 2006, BBA-MOL CELL BIOL L, V1761, P43, DOI 10.1016/j.bbalip.2006.01.006; Bischoff R, 1997, DEV DYNAM, V208, P505, DOI 10.1002/(SICI)1097-0177(199704)208:4<505::AID-AJA6>3.0.CO;2-M; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Bondesen BA, 2007, FASEB J, V21, P3338, DOI 10.1096/fj.06-7070com; Chan JYH, 2001, J BIOL CHEM, V276, P2139, DOI 10.1074/jbc.M007965200; Donati C, 2004, FASEB J, V18, P449, DOI 10.1096/fj.04-1780fje; Fernando RN, 2007, J NEUROCHEM, V102, P967, DOI 10.1111/j.1471-4159.2007.04659.x; Forde S, 2007, BLOOD, V109, P1825, DOI 10.1182/blood-2006-05-023028; Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085; Gogos JA, 1996, J CELL BIOL, V134, P837, DOI 10.1083/jcb.134.4.837; Han JW, 2001, J BIOL CHEM, V276, P42084, DOI 10.1074/jbc.M106688200; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; Ihrke G, 2004, TRAFFIC, V5, P946, DOI 10.1111/j.1600-0854.2004.00236.x; Ihrke G, 2000, BIOCHEM J, V345, P287, DOI 10.1042/0264-6021:3450287; Ihrke G, 2001, EMBO J, V20, P6256, DOI 10.1093/emboj/20.22.6256; Jansen KM, 2006, J CELL BIOL, V174, P403, DOI 10.1083/jcb.200601102; Jorgensen-Tye B, 2005, TISSUE ANTIGENS, V65, P220, DOI 10.1111/j.1399-0039.2005.00358.x; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; Lee YN, 2001, MOL CELL BIOL, V21, P7696, DOI 10.1128/MCB.21.22.7696-7706.2001; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mulieri PJ, 2000, DEV DYNAM, V219, P40, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1032>3.0.CO;2-M; Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724; Odemis V, 2005, MOL CELL NEUROSCI, V30, P494, DOI 10.1016/j.mcn.2005.07.019; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; Potter BA, 2006, TRAFFIC, V7, P146, DOI 10.1111/j.1600-0854.2005.00371.x; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Suzuki J, 2000, MOL CELL BIOL, V20, P4658, DOI 10.1128/MCB.20.13.4658-4665.2000; Tajbakhsh S, 2000, CURR TOP DEV BIOL, V48, P225; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Vasyutina E, 2006, ANAT EMBRYOL, V211, pS37, DOI 10.1007/s00429-006-0118-9; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Watt SM, 2000, LEUKEMIA LYMPHOMA, V37, P1, DOI 10.3109/10428190009057625; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zannettino ACW, 1998, BLOOD, V92, P2613, DOI 10.1182/blood.V92.8.2613.420k15_2613_2628; Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	44	55	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8301	8309		10.1074/jbc.M706730200	http://dx.doi.org/10.1074/jbc.M706730200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18227060	Green Published, hybrid			2022-12-27	WOS:000254288000028
J	Miao, Q; Sun, Y; Wei, TT; Zhao, XY; Zhao, K; Yan, L; Zhang, XJ; Shu, HJ; Yang, FY				Miao, Qi; Sun, Yang; Wei, Taotao; Zhao, Xingyu; Zhao, Kai; Yan, Ling; Zhang, Xujia; Shu, Hongjun; Yang, Fuyu			Chymotrypsin B cached in rat liver lysosomes and involved in apoptotic regulation through a mitochondrial pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; SERINE PROTEASES; CASPASES; CLEAVAGE; ACTIVATION; PERMEABILIZATION; MEMBRANE; STEP	Lysosomes can trigger the mitochondrial apoptotic pathway by releasing proteases. Here we report that a 25-kDa protein purified from rat liver lysosomes possesses a long standing potent Bid cleavage activity at neutral pH, and the truncated Bid can in turn induce rapid mitochondrial release of cytochrome c. This protease was revealed as chymotrypsin B by biochemical and mass spectrometric analysis. Although it was long recognized as a digestive protease exclusively secreted by the exocrine pancreas, our data support that it also expresses and intracellularly resides in rat liver lysosomes. Translocation of lysosomal chymotrypsin B into cytosol was triggered by apoptotic stimuli such as tumor necrosis factor-alpha, and intracellular delivery of chymotrypsin B protein induced apoptotic cell death with a potency comparable with cathepsin B, suggestive of a lysosomal-mitochondrial pathway to apoptosis regulated by chymotrypsin B following its release. Noteworthily, either knockdown of chymotrypsin B expression by RNA interference or pretreatment with chymotrypsin B inhibitor N-p-tosyl- L-phenylalanine chloromethyl ketone significantly reduced tumor necrosis factor-alpha-induce apoptosis. These results demonstrate for the first time that chymotrypsin B is not only restricted to the pancreas but can function intracellularly as a pro-apoptotic protease.	[Miao, Qi; Sun, Yang; Wei, Taotao; Zhao, Xingyu; Zhao, Kai; Yan, Ling; Zhang, Xujia; Yang, Fuyu] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Shu, Hongjun] Univ N Texas, Hlth Sci Ctr, Adv Mass Spectrometry Lab, Ft Worth, TX 76107 USA; [Sun, Yang; Zhao, Xingyu; Zhao, Kai] Grad Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of North Texas System; University of North Texas Health Science Center; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, FY (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	yangfy@sun5.ibp.ac.cn						Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; BELL GI, 1984, J BIOL CHEM, V259, P4265; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Egger L, 2003, CELL DEATH DIFFER, V10, P1188, DOI 10.1038/sj.cdd.4401288; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Grabarek J, 2002, INT J ONCOL, V20, P225; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Hirsch T, 1998, J IMMUNOL, V161, P35; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mathiasen IS, 2002, TRENDS MOL MED, V8, P212, DOI 10.1016/S1471-4914(02)02328-6; Murn J, 2004, GENES CELLS, V9, P1103, DOI 10.1111/j.1365-2443.2004.00794.x; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Salvesen GS, 2001, J CLIN INVEST, V107, P21, DOI 10.1172/JCI11829; Stenson-Cox C, 2003, BIOCHEM PHARMACOL, V66, P1469, DOI 10.1016/S0006-2952(03)00499-4; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Turk B, 2002, BIOL CHEM, V383, P1035, DOI 10.1515/BC.2002.112; Venekei I, 1996, FEBS LETT, V379, P143, DOI 10.1016/0014-5793(95)01484-5; Werneburg NW, 2002, AM J PHYSIOL-GASTR L, V283, pG947, DOI 10.1152/ajpgi.00151.2002; Yan L, 2003, FEBS LETT, V555, P545, DOI 10.1016/s0014-5793(03)01346-2; Yuan XM, 2002, P NATL ACAD SCI USA, V99, P6286, DOI 10.1073/pnas.092135599; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200; Zhai DY, 2001, EUR J BIOCHEM, V268, P48, DOI 10.1046/j.1432-1327.2001.01841.x	27	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8218	8228		10.1074/jbc.M709789200	http://dx.doi.org/10.1074/jbc.M709789200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18211899	hybrid			2022-12-27	WOS:000254288000019
J	Seravalli, J; Ragsdale, SW				Seravalli, Javier; Ragsdale, Stephen W.			Pulse-chase studies of the synthesis of acetyl-CoA by carbon monoxide dehydrogenase/acetyl-CoA synthase - Evidence for a random mechanism of methyl and carbonyl addition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A SYNTHASE; IRON-SULFUR PROTEIN; WOOD-LJUNGDAHL PATHWAY; CLOSTRIDIUM-THERMOACETICUM; KINETIC CHARACTERIZATION; ALPHA-SUBUNIT; ACTIVE-SITE; DECARBONYLASE/SYNTHASE COMPLEX; MOORELLA-THERMOACETICA; REDUCTIVE ACTIVATION	Carbon monoxide dehydrogenase/acetyl-CoA synthase catalyzes acetyl-CoA synthesis from CO, CoA, and a methylated corrinoid iron-sulfur protein, which acts as a methyl donor. This reaction is the last step in the Wood-Ljungdahl pathway of anaerobic carbon fixation. The binding sequence for the three substrates has been debated for over a decade. Different binding orders imply different mechanisms (i.e. paramagnetic versus diamagnetic mechanisms). Ambiguity arises because CO and CoA can each undergo isotopic exchange with acetyl-CoA, suggesting that either of these two substrates could be the last to bind to the acetyl-CoA synthase active site. Furthermore, carbonylation, CoA binding, and methyl transfer can all occur in the absence of the other two substrates. Here, we report pulse-chase studies, which unambiguously establish the order in which the three substrates bind. Although a CoA pulse is substantially diluted by excess CoA in the chase, isotope recovery of a pulse of labeled CO or methyl group is unaffected by the presence of excess unlabeled CO or methyl group in the chase. These results demonstrate that CoA is the last substrate to bind and that CO and the methyl group bind randomly as the first substrate in acetyl-CoA synthesis. Up to 100% of the methyl groups and CoA and up to 60 - 70% of the CO employed in the pulse phase can be trapped in the product acetyl-CoA.	[Seravalli, Javier; Ragsdale, Stephen W.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Ragsdale, SW (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu			NIGMS NIH HHS [R01 GM039451] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039451] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andi B, 2004, BIOCHEMISTRY-US, V43, P11790, DOI 10.1021/bi048766p; ANDREESE.JR, 1973, J BACTERIOL, V114, P743, DOI 10.1128/JB.114.2.743-751.1973; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Barondeau DP, 1997, J AM CHEM SOC, V119, P3959, DOI 10.1021/ja963597k; Bhaskar B, 1998, BIOCHEMISTRY-US, V37, P14491, DOI 10.1021/bi9812423; Bramlett MR, 2006, BIOCHEMISTRY-US, V45, P8674, DOI 10.1021/bi060003+; Darnault C, 2003, NAT STRUCT BIOL, V10, P271, DOI 10.1038/nsb912; Dobbek H, 2001, SCIENCE, V293, P1281, DOI 10.1126/science.1061500; Doukov T, 2000, STRUCTURE, V8, P817, DOI 10.1016/S0969-2126(00)00172-6; Doukov TI, 2007, J BIOL CHEM, V282, P6609, DOI 10.1074/jbc.M609828200; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; Errey JC, 2006, BIOCHEMISTRY-US, V45, P3033, DOI 10.1021/bi052297p; George SJ, 2005, J AM CHEM SOC, V127, P13500, DOI 10.1021/ja0528329; GORST CM, 1991, J BIOL CHEM, V266, P20687; Grahame DA, 1996, BIOCHEMISTRY-US, V35, P593, DOI 10.1021/bi9511494; Gu WW, 2003, J AM CHEM SOC, V125, P15343, DOI 10.1021/ja036602a; KUMAR M, 1993, J AM CHEM SOC, V115, P11646, DOI 10.1021/ja00077a093; KUMAR M, 1992, J AM CHEM SOC, V114, P8713, DOI 10.1021/ja00048a062; LEBERTZ H, 1987, J AM CHEM SOC, V109, P3173, DOI 10.1021/ja00244a066; Lindahl PA, 2004, J BIOL INORG CHEM, V9, P516, DOI 10.1007/s00775-004-0564-x; Lindahl PA, 2002, BIOCHEMISTRY-US, V41, P2097, DOI 10.1021/bi015932+; Loke HK, 2002, J AM CHEM SOC, V124, P8667, DOI 10.1021/ja025924w; LU WP, 1991, J BIOL CHEM, V266, P3554; LU WP, 1990, J BIOL CHEM, V265, P3124; LU Z, 1995, J AM CHEM SOC, V117, P3994, DOI 10.1021/ja00119a014; LUNDIE LL, 1984, J BACTERIOL, V159, P700, DOI 10.1128/JB.159.2.700-703.1984; Maynard EL, 1999, J AM CHEM SOC, V121, P9221, DOI 10.1021/ja992120g; Maynard EL, 2001, BIOCHEMISTRY-US, V40, P13262, DOI 10.1021/bi015604+; Maynard EL, 2001, J AM CHEM SOC, V123, P4697, DOI 10.1021/ja004017t; Menon S, 1996, BIOCHEMISTRY-US, V35, P12119, DOI 10.1021/bi961014d; Menon S, 1998, BIOCHEMISTRY-US, V37, P5689, DOI 10.1021/bi9727996; PEZACKA E, 1984, P NATL ACAD SCI-BIOL, V81, P6261, DOI 10.1073/pnas.81.20.6261; PEZACKA E, 1988, J BIOL CHEM, V263, P16000; Ragsdale SW, 2006, CHEM REV, V106, P3317, DOI 10.1021/cr0503153; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; Ragsdale SW, 2004, CRIT REV BIOCHEM MOL, V39, P165, DOI 10.1080/10409230490496577; RAGSDALE SW, 1985, J BIOL CHEM, V260, P3970; RAGSDALE SW, 1985, P NATL ACAD SCI USA, V82, P6811, DOI 10.1073/pnas.82.20.6811; RAGSDALE SW, 1983, J BIOL CHEM, V258, P2364; RAM MS, 1995, J AM CHEM SOC, V117, P2365, DOI 10.1021/ja00113a032; Ram MS, 1997, J AM CHEM SOC, V119, P1648, DOI 10.1021/ja963061z; RAMER SE, 1989, BIOCHEMISTRY-US, V28, P4675, DOI 10.1021/bi00437a025; RAYBUCK SA, 1988, BIOCHEMISTRY-US, V27, P7698, DOI 10.1021/bi00420a019; ROBERTS DL, 1989, P NATL ACAD SCI USA, V86, P32, DOI 10.1073/pnas.86.1.32; Rose I A, 1980, Methods Enzymol, V64, P47; Russell WK, 1998, BIOCHEMISTRY-US, V37, P10016, DOI 10.1021/bi980149b; Schenker RP, 2003, J AM CHEM SOC, V125, P13962, DOI 10.1021/ja037893q; Seravalli J, 2004, BIOCHEMISTRY-US, V43, P3944, DOI 10.1021/bi036194n; Seravalli J, 2000, BIOCHEMISTRY-US, V39, P1274, DOI 10.1021/bi991812e; Seravalli J, 2002, BIOCHEMISTRY-US, V41, P1807, DOI 10.1021/bi011687i; Seravalli J, 2001, J AM CHEM SOC, V123, P1786, DOI 10.1021/ja005709k; Seravalli J, 1999, BIOCHEMISTRY-US, V38, P5728, DOI 10.1021/bi982473c; SHIN W, 1992, BIOCHEMISTRY-US, V31, P6003, DOI 10.1021/bi00141a007; SHIN WS, 1992, BIOCHEMISTRY-US, V31, P12870, DOI 10.1021/bi00166a023; SIEGEL IH, 1975, ENZYME KINETICS BEHA; Svetlitchnyi V, 2004, P NATL ACAD SCI USA, V101, P446, DOI 10.1073/pnas.0304262101; Tan XS, 2006, J AM CHEM SOC, V128, P12331, DOI 10.1021/ja0627702; Tan XS, 2003, J AM CHEM SOC, V125, P318, DOI 10.1021/ja028442t; Tan XS, 2002, J AM CHEM SOC, V124, P6277, DOI 10.1021/ja016676r; Volbeda A, 2004, J BIOL INORG CHEM, V9, P525, DOI 10.1007/s00775-004-0565-9; Webster CE, 2004, J AM CHEM SOC, V126, P3410, DOI 10.1021/ja038083h; WILKINSON KD, 1979, J BIOL CHEM, V254, P2567; Xia JQ, 1997, J AM CHEM SOC, V119, P8301, DOI 10.1021/ja971025+; XIA JQ, 1995, J AM CHEM SOC, V117, P7065, DOI 10.1021/ja00132a004; Xia JQ, 1996, J AM CHEM SOC, V118, P483, DOI 10.1021/ja952845u; Yu M, 2006, BIOCHEMISTRY-US, V45, P14788, DOI 10.1021/bi061621t; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008	67	43	46	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8384	8394		10.1074/jbc.M709470200	http://dx.doi.org/10.1074/jbc.M709470200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18203715	hybrid, Green Published			2022-12-27	WOS:000254288000036
J	Ikushiro, H; Fujii, S; Shiraiwa, Y; Hayashi, H				Ikushiro, Hiroko; Fujii, Shigeru; Shiraiwa, Yuka; Hayashi, Hideyuki			Acceleration of the substrate C alpha deprotonation by an analogue of the second substrate palmitoyl-CoA in serine palmitoyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOLIPID SYNTHESIS; 8-AMINO-7-OXONONANOATE SYNTHASE; 5-AMINOLEVULINATE SYNTHASE; SACCHAROMYCES-CEREVISIAE; REACTION-MECHANISM; KEY ENZYME; BIOSYNTHESIS; CLONING; LCB1; COMPONENT	Serine palmitoyltransferase (SPT) is a key enzyme of sphingolipid biosynthesis and catalyzes the pyridoxal 5'-phosphate (PLP)-dependent decarboxylative condensation reaction of L-serine with palmitoyl-CoA to generate 3-ketodihydrosphingosine. The binding of L-serine alone to SPT leads to the formation of the external aldimine but does not produce a detectable amount of the quinonoid intermediate. However, the further addition of S-(2-oxoheptadecyl)-CoA, a nonreactive analogue of palmitoyl-CoA, caused the apparent accumulation of the quinonoid. NMR studies showed that the hydrogen-deuterium exchange at C alpha of L-serine is very slow in the SPT-L-serine external aldimine complex, but the rate is 100-fold increased by the addition of S-(2-oxoheptadecyl)CoA, showing a remarkable substrate synergism in SPT. In addition, the observation that the nonreactive palmitoyl-CoA facilitated alpha-deprotonation indicates that the alpha-deprotonation takes place before the Claisen-type C -C bond formation, which is consistent with the accepted mechanism of the alpha-oxamine synthase subfamily enzymes. Structural modeling of both the SPT-L-serine external aldimine complex and SPT-L-serine -palmitoyl-CoA ternary complex suggests a mechanism in which the binding of palmitoyl-CoA to SPT induced a conformation change in the PLP-L-serine external aldimine so that the C alpha-H bond of L-serine becomes perpendicular to the plane of the PLP-pyridine ring and is favorable for the alpha-deprotonation. The model also proposed that the two alternative hydrogen bonding interactions of His(159) with L-serine and palmitoyl-CoA play an important role in the conformational change of the external aldimine. This is the unique mechanism of SPT that prevents the formation of the reactive intermediate before the binding of the second substrate.	[Ikushiro, Hiroko; Shiraiwa, Yuka; Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Osaka 5698686, Japan; [Fujii, Shigeru] Kansai Med Univ, Chem Lab, Osaka 5731136, Japan	Osaka Medical College; Kansai Medical University	Ikushiro, H (corresponding author), Osaka Med Coll, Dept Biochem, 2-7 Daigakumachi, Osaka 5698686, Japan.	ikushiro@art.osaka-med.ac.jp; hayashi@art.osaka-med.ac.jp						Alexeev D, 2006, ORG BIOMOL CHEM, V4, P1209, DOI 10.1039/b517922j; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Bashir Q, 2006, CHEM COMMUN, P5065, DOI 10.1039/b609925d; BRAUN PE, 1968, J BIOL CHEM, V243, P3775; BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; Ikushiro H, 2003, BBA-PROTEINS PROTEOM, V1647, P116, DOI 10.1016/S1570-9639(03)00074-8; Ikushiro H, 2000, BIOCHEMISTRY AND MOLECULAR BIOLOGY OF VITAMIN B6 AND PQQ-DEPENDENT PROTEINS, P251; Ikushiro H, 2001, J BIOL CHEM, V276, P18249, DOI 10.1074/jbc.M101550200; Ikushiro H, 2007, J BACTERIOL, V189, P5749, DOI 10.1128/JB.00194-07; KARLSSON KA, 1970, CHEM PHYS LIPIDS, V5, P6, DOI 10.1016/0009-3084(70)90008-3; KRISNANGKURA K, 1976, J BIOL CHEM, V251, P1597; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nagiec MM, 1996, GENE, V177, P237, DOI 10.1016/0378-1119(96)00309-5; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; ONUFFER JJ, 1994, PROTEIN ENG, V7, P413, DOI 10.1093/protein/7.3.413; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Ploux O, 1996, EUR J BIOCHEM, V236, P301, DOI 10.1111/j.1432-1033.1996.00301.x; RUDNICK DA, 1991, J BIOL CHEM, V266, P9732; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; Zhang JS, 2002, J BIOL CHEM, V277, P44660, DOI 10.1074/jbc.M203584200	34	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7542	7553		10.1074/jbc.M706874200	http://dx.doi.org/10.1074/jbc.M706874200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18167344	hybrid			2022-12-27	WOS:000253997900029
J	Li, K; Li, YC; Wu, WJ; Gordon, WR; Chang, DW; Lu, M; Scoggin, S; Fu, TH; Vien, L; Histen, G; Zheng, J; Martin-Hollister, R; Duensing, T; Singh, S; Blacklow, SC; Yao, ZB; Aster, JC; Zhou, BBS				Li, Kang; Li, Yucheng; Wu, Wenjuan; Gordon, Wendy R.; Chang, David W.; Lu, Mason; Scoggin, Shane; Fu, Tihui; Vien, Long; Histen, Gavin; Zheng, Ji; Martin-Hollister, Rachel; Duensing, Thomas; Singh, Sanjaya; Blacklow, Stephen C.; Yao, Zhengbin; Aster, Jon C.; Zhou, Bin-Bing S.			Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALAGILLE-SYNDROME; GAMMA-SECRETASE; PROTEOLYTIC ACTIVATION; INTRACELLULAR DOMAIN; HUMAN JAGGED1; STEM-CELLS; MUTATIONS; LIGAND; MICE; CLEAVAGE	The Notch pathway regulates the development of many tissues and cell types and is involved in a variety of human diseases, making it an attractive potential therapeutic target. This promise has been limited by the absence of potent inhibitors or agonists that are specific for individual human Notch receptors (NOTCH1-4). Using an unbiased functional screening, we identified monoclonal antibodies that specifically inhibit or induce activating proteolytic cleavages in NOTCH3. Remarkably, the most potent inhibitory and activating antibodies bind to overlapping epitopes within a juxtamembrane negative regulatory region that protects NOTCH3 from proteolysis and activation in its resting autoinhibited state. The inhibitory antibodies revert phenotypes conveyed on 293T cells by NOTCH3 signaling, such as increased cellular proliferation, survival, and motility, whereas the activating antibody mimics some of the effects of ligand-induced Notch activation. These findings provide insights into the mechanisms of Notch autoinhibition and activation and pave the way for the further development of specific antibody-based modulators of the Notch receptors, which are likely to be of utility in a wide range of experimental and therapeutic settings.	[Li, Kang; Li, Yucheng; Wu, Wenjuan; Chang, David W.; Lu, Mason; Scoggin, Shane; Fu, Tihui; Vien, Long; Zheng, Ji; Martin-Hollister, Rachel; Duensing, Thomas; Singh, Sanjaya; Yao, Zhengbin; Zhou, Bin-Bing S.] Tanox Inc, Houston, TX 77025 USA; [Gordon, Wendy R.; Histen, Gavin; Blacklow, Stephen C.; Aster, Jon C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Li, K (corresponding author), Pfizer La Jolla, 10628 Sci Ctr Dr, San Diego, CA 92121 USA.	kyfli@yahoo.com; binbing_s_zhou@yahoo.com	Wu, wenjuan/GPX-6968-2022	Scoggin, Shane/0000-0003-2510-2823; Gordon, Wendy/0000-0001-7696-5560	NCI NIH HHS [P01 CA119070, P01 CA119070-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA119070] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Dallman MJ, 2005, CURR OPIN IMMUNOL, V17, P259, DOI 10.1016/j.coi.2005.04.002; de Pooter Renee F., 2006, V330, P113; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fung M, 2003, CLIN EXP IMMUNOL, V133, P160, DOI 10.1046/j.1365-2249.2003.02213.x; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Krebs LT, 2000, GENE DEV, V14, P1343; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; McCright B, 2001, DEVELOPMENT, V128, P491; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shimizu K, 2002, EMBO J, V21, P294, DOI 10.1093/emboj/21.3.294; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Sun X, 1997, DEVELOPMENT, V124, P3439; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Vas V, 2004, J LEUKOCYTE BIOL, V75, P714, DOI 10.1189/jlb.1003462; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644	46	158	198	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					8046	8054		10.1074/jbc.M800170200	http://dx.doi.org/10.1074/jbc.M800170200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18182388	hybrid			2022-12-27	WOS:000253997900079
J	Roepstorff, K; Rasmussen, I; Sawada, M; Cudre-Maroux, C; Salmon, P; Bokoch, G; van Deurs, B; Vilhardt, F				Roepstorff, Kirstine; Rasmussen, Izabela; Sawada, Makoto; Cudre-Maroux, Cristophe; Salmon, Patrick; Bokoch, Gary; van Deurs, Bo; Vilhardt, Frederik			Stimulus-dependent regulation of the phagocyte NADPH oxidase by a VAV1, Rac1, and PAK1 signaling axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RESPIRATORY BURST OXIDASE; PHOSPHORYLATION-INDUCED ACTIVATION; RECEPTOR-MEDIATED PHAGOCYTOSIS; NUCLEOTIDE EXCHANGE FACTOR; HUMAN NEUTROPHILS; P21-ACTIVATED-KINASE-1 PAK1; ARACHIDONIC-ACID; EPITHELIAL-CELLS; PLASMA-MEMBRANE	The p21-activated kinase-1 (PAK1) is best known for its role in the regulation of cytoskeletal and transcriptional signaling pathways. We show here in the microglia cell line Ra2 that PAK1 regulates NADPH oxidase (NOX-2) activity in a stimulus-specific manner. Thus, conditional expression of PAK1 dominant-positive mutants enhanced, whereas dominant-negative mutants inhibited, NADPH oxidase-mediated superoxide generation following formyl-methionyl-leucylphenylalanine or phorbol 12-myristate 13-acetate stimulation. Both Rac1 and the GTP exchange factor VAV1 were required as upstream signaling proteins in the formyl-methionylleucyl- phenylalanine-induced activation of endogenous PAK1. In contrast, PAK1 mutants had no effect on superoxide generation downstream of Fc gamma R signaling during phagocytosis of IgG-immune complexes. We further present evidence that the effect of PAK1 on the respiratory burst is mediated through phosphorylation of p47(Phox), and we show that expression of a p47(Phox) (S303D/ S304D/ S320D) mutant, which mimics phosphorylation by PAK1, induced basal superoxide generation in vivo. In contrast PAK1 substrates LIMK-1 or RhoGDI are not likely to contribute to the PAK1 effect on NADPH oxidase activation. Collectively, our findings define a VAV1-Rac1-PAK1 signaling axis in mononuclear phagocytes regulating superoxide production in a stimulusdependent manner.	[Roepstorff, Kirstine; Rasmussen, Izabela; van Deurs, Bo; Vilhardt, Frederik] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Cudre-Maroux, Cristophe; Salmon, Patrick] Univ Geneva, Dept Microbiol, CH-1211 Geneva, Switzerland; [Bokoch, Gary] Scripps Res Inst, Dept Immunol & Cell Biol, La Jolla, CA 92037 USA; [Sawada, Makoto] Nagoya Univ, Environm Med Res Inst, Dept Brain Funct, Nagoya, Aichi 4648601, Japan	University of Copenhagen; University of Geneva; Scripps Research Institute; Nagoya University	Vilhardt, F (corresponding author), Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Fac Hlth Sci, Bldg 18-4,Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	f.vilhardt@mai.ku.dk	Vilhardt, Frederik/AAX-4766-2021	Vilhardt, Frederik/0000-0001-8604-7165	NHLBI NIH HHS [HL48008] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048008] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Bey EA, 2004, J IMMUNOL, V173, P5730, DOI 10.4049/jimmunol.173.9.5730; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; DORSEUIL O, 1995, J LEUKOCYTE BIOL, V58, P108, DOI 10.1002/jlb.58.1.108; ElBenna J, 1996, J BIOL CHEM, V271, P6374; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; GABIG TG, 1995, BLOOD, V85, P804, DOI 10.1182/blood.V85.3.804.bloodjournal853804; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Heyworth PG, 1997, HISTOCHEM CELL BIOL, V108, P221, DOI 10.1007/s004180050162; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Inoue H, 1999, GLIA, V28, P265, DOI 10.1002/(SICI)1098-1136(199912)28:3<265::AID-GLIA10>3.0.CO;2-F; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kim C, 2006, J LEUKOCYTE BIOL, V79, P223, DOI 10.1189/jlb.0705371; Kim C, 2003, J IMMUNOL, V171, P4425, DOI 10.4049/jimmunol.171.8.4425; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Korchak HM, 1998, J BIOL CHEM, V273, P27292, DOI 10.1074/jbc.273.42.27292; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; MALY FE, 1994, J BIOL CHEM, V269, P18743; Martyn KD, 2005, BLOOD, V106, P3962, DOI 10.1182/blood-2005-03-0859; Matsui S, 2002, J BIOL CHEM, V277, P544, DOI 10.1074/jbc.M110153200; Morgan D, 2007, J PHYSIOL-LONDON, V579, P327, DOI 10.1113/jphysiol.2006.124248; MUKHERJEE G, 1994, J LEUKOCYTE BIOL, V55, P685, DOI 10.1002/jlb.55.6.685; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; QUINN MT, 1993, J BIOL CHEM, V268, P20983; Sawada M., 2007, U.S. Patent, Patent No. [6.673,6,5, 667365]; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Vilhardt F, 1999, MOL BIOL CELL, V10, P179, DOI 10.1091/mbc.10.1.179; Vutskits GV, 2006, BREAST CANCER RES TR, V99, P143, DOI 10.1007/s10549-006-9195-y; Waki K, 2006, FREE RADICAL RES, V40, P359, DOI 10.1080/10715760500539121; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wu RF, 2004, J VIROL, V78, P779, DOI 10.1128/JVI.78.2.779-789.2004; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhang JM, 2005, MOL BIOL CELL, V16, P824, DOI 10.1091/mbc.e04-06-0463	56	48	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7983	7993		10.1074/jbc.M708281200	http://dx.doi.org/10.1074/jbc.M708281200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18160398	hybrid			2022-12-27	WOS:000253997900073
J	Bai, Y; Ahmad, U; Wang, Y; Li, JH; Choy, JC; Kim, RW; Kirkiles-Smith, N; Maher, SE; Karras, JG; Bennett, CF; Bothwell, ALM; Pober, JS; Tellides, G				Bai, Yalai; Ahmad, Usman; Wang, Yinong; Li, Jie H.; Choy, Jonathan C.; Kim, Richard W.; Kirkiles-Smith, Nancy; Maher, Stephen E.; Karras, James G.; Bennett, C. Frank; Bothwell, Alfred L. M.; Pober, Jordan S.; Tellides, George			Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and noxa expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE RESPONSE FACTOR; IFN-GAMMA; GENE-EXPRESSION; TRANSCRIPTION FACTOR; SIGNAL TRANSDUCERS; HUMAN NEUTROPHILS; STIMULATED GENE; ONCOSTATIN-M; INDUCTION; ALPHA	Interferon (IFN)-gamma actions on the vessel wall play an important role in the pathogenesis of arteriosclerosis, yet the contribution of different IFN-gamma signaling pathways to the phenotypic modulation of vascular smooth muscle cells (VSMCs) are poorly understood. We investigated the effects of IFN-gamma on VSMCs and arteries through interactions involving signal transducer and activator of transcription (STAT) proteins. In addition to STAT1 activation, IFN-gamma consistently phosphorylated STAT3 in human VSMCs but weakly or not at all in human endothelial cells or mouse VSMCs. STAT3 activation resulted in nuclear translocation of this transcription factor. By selectively inhibiting STAT3 and not STAT1 signaling, we identified a number of candidate IFN-gamma-inducible, STAT3-dependent gene products by microarray analysis. Results for selected genes, including the pro-apoptotic molecules X-linked inhibitor of apoptosis associated factor-1 (XAF1) and Noxa, were verified by real time quantitative reverse transcription-PCR and immunoblot analyses. IFN-gamma-induced STAT3 and STAT1 signaling in VSMCs demonstrated reciprocal inhibition. STAT3 activation by IFN-gamma sensitized VSMCs to apoptosis triggered by both death receptor- and mitochondrial-mediated pathways. Knock down of XAF1 and Noxa expression inhibited the priming of VSMCs to apoptotic stimuli by IFN-gamma. Finally, we confirmed the in vivo relevance of our observations using a chimeric animal model of immunodeficient mice bearing human coronary artery grafts in which the expression of XAF1 and Noxa as well as the pro-apoptotic effects induced by IFN-gamma were dependent on STAT3. The data suggest STAT1-independent signaling by IFN-gamma via STAT3 that promotes the death of human VSMCs.	[Bai, Yalai; Ahmad, Usman; Wang, Yinong; Kim, Richard W.; Kirkiles-Smith, Nancy; Tellides, George] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Li, Jie H.; Choy, Jonathan C.; Pober, Jordan S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Maher, Stephen E.; Bothwell, Alfred L. M.; Pober, Jordan S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Interdept Program Vasc Biol & Transplantat, New Haven, CT 06510 USA; [Karras, James G.; Bennett, C. Frank] ISIS Pharmaceut, Carlsbad, CA 92008 USA	Yale University; Yale University; Yale University; Yale University; Isis Pharmaceuticals Inc	Tellides, G (corresponding author), Yale Univ, Sch Med, Dept Surg, 295 Congress Ave 454, New Haven, CT 06510 USA.	george.tellides@yale.edu		Choy, Jonathan/0000-0003-1837-8514	NHLBI NIH HHS [P01 HL70295] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070295] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abell K, 2005, NAT CELL BIOL, V7, P392, DOI 10.1038/ncb1242; Alsayed Y, 2000, J IMMUNOL, V164, P1800, DOI 10.4049/jimmunol.164.4.1800; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Burns WR, 2005, AM J TRANSPLANT, V5, P1226, DOI 10.1111/j.1600-6143.2005.00892.x; Butler M, 1997, LAB INVEST, V77, P379; Caldenhoven E, 1999, J LEUKOCYTE BIOL, V65, P391, DOI 10.1002/jlb.65.3.391; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; CAMPBELL GS, 1995, J BIOL CHEM, V270, P3974, DOI 10.1074/jbc.270.8.3974; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Cowburn AS, 2006, J BIOL CHEM, V281, P12458, DOI 10.1074/jbc.M511277200; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; El-Hashemite N, 2004, CANCER RES, V64, P3436, DOI 10.1158/0008-5472.CAN-03-3609; Fang P, 2006, EXP CELL RES, V312, P1229, DOI 10.1016/j.yexcr.2005.12.011; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Gamero AM, 2006, J BIOL CHEM, V281, P16238, DOI 10.1074/jbc.M509516200; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Kaur N, 2003, J NEUROCHEM, V87, P437, DOI 10.1046/j.1471-4159.2003.02012.x; KORDULA T, 1995, BIOCHEM BIOPH RES CO, V216, P999, DOI 10.1006/bbrc.1995.2719; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Leaman DW, 2002, J BIOL CHEM, V277, P28504, DOI 10.1074/jbc.M204851200; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Lu Y, 2006, J BIOL CHEM, V281, P36683, DOI 10.1074/jbc.M607374200; Mahboubi K, 2002, J BIOL CHEM, V277, P8012, DOI 10.1074/jbc.M107542200; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Peilot H, 2000, J BIOL CHEM, V275, P22895, DOI 10.1074/jbc.M002783200; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Radaeva S, 2004, BIOCHEM J, V379, P199, DOI 10.1042/BJ20031495; Ramana CV, 2005, BIOCHEM BIOPH RES CO, V327, P727, DOI 10.1016/j.bbrc.2004.12.074; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Ramana CV, 2001, P NATL ACAD SCI USA, V98, P6674, DOI 10.1073/pnas.111164198; RAZ R, 1994, J BIOL CHEM, V269, P24391; Rosner D, 2006, AM J PATHOL, V168, P2054, DOI 10.2353/ajpath.2006.050473; Sakamoto E, 2005, J LEUKOCYTE BIOL, V78, P301, DOI 10.1189/jlb.1104690; Sato T, 1997, BLOOD, V90, P4749, DOI 10.1182/blood.V90.12.4749.4749_4749_4758; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stephanou A, 2005, GROWTH FACTORS, V23, P177, DOI 10.1080/08977190500178745; Stephens JM, 1998, J BIOL CHEM, V273, P31408, DOI 10.1074/jbc.273.47.31408; Sun YP, 2005, J BIOL CHEM, V280, P15561, DOI 10.1074/jbc.m412630200; Tamai M, 2006, J LAB CLIN MED, V147, P182, DOI 10.1016/j.lab.2005.12.001; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; Tellides G, 2007, CIRC RES, V100, P622, DOI 10.1161/01.RES.0000258861.72279.29; Wang YN, 2004, FASEB J, V18, P606, DOI 10.1096/fj.03-0840fje; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	52	31	35	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6832	6842		10.1074/jbc.M706021200	http://dx.doi.org/10.1074/jbc.M706021200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18192275	hybrid			2022-12-27	WOS:000253779600026
J	Kaden, D; Munter, LM; Joshi, M; Treiber, C; Weise, C; Bethge, T; Voigt, P; Schaefer, M; Beyermann, M; Reif, B; Multhaup, G				Kaden, Daniela; Munter, Lisa-Marie; Joshi, Mangesh; Treiber, Carina; Weise, Christoph; Bethge, Tobias; Voigt, Philipp; Schaefer, Michael; Beyermann, Michael; Reif, Bernd; Multhaup, Gerd			Homophilic interactions of the amyloid precursor protein (APP) ectodomain are regulated by the loop region and affect beta-secretase cleavage of APP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; EXTRACELLULAR DOMAIN; BINDING DOMAIN; RECEPTOR; PATHWAY; HETERODIMERIZATION; HOMODIMERIZATION; DIMERIZATION; MECHANISMS	We found previously by fluorescence resonance energy transfer experiments that amyloid precursor protein( APP) homodimerizes in living cells. APP homodimerization is likely to be mediated by two sites of the ectodomain and a third site within the transmembrane sequence of APP. We have now investigated the role of the N-terminal growth factor-like domain in APP dimerization by NMR, biochemical, and cell biological approaches. Under nonreducing conditions, the N-terminal domain of APP formed SDS-labile and SDS-stable complexes. The presence of SDS was sufficient to convert native APP dimers entirely into monomers. Addition of an excess of a synthetic peptide ( APP residues 91 - 116) containing the disulfide bridge-stabilized loop inhibited cross linking of preexisting SDS-labile APP ectodomain dimers. Surface plasmon resonance analysis revealed that this peptide specifically bound to the N-terminal domain of APP and that binding was entirely dependent on the oxidation of the thiol groups. By solution-state NMR we detected small chemical shift changes indicating that the loop peptide interacted with a large protein surface rather than binding to a defined pocket. Finally, we studied the effect of the loop peptide added to the medium of living cells. Whereas the levels of alpha-secretory APP increased, soluble beta-cleaved APP levels decreased. Because A beta 40 and A beta 42 decreased to similar levels as soluble beta-cleaved APP, we conclude either that beta-secretase binding to APP was impaired or that the peptide allosterically affected APP processing. We suggest that APP acquires a loop-mediated homodimeric state that is further stabilized by interactions of hydrophobic residues of neighboring domains.	[Kaden, Daniela; Munter, Lisa-Marie; Treiber, Carina; Bethge, Tobias; Voigt, Philipp; Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Joshi, Mangesh; Beyermann, Michael; Reif, Bernd] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Voigt, Philipp; Schaefer, Michael] Charite, Neurowissensch Forsch Zentrum, D-14195 Berlin, Germany	Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Multhaup, G (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Thielallee 63, D-14195 Berlin, Germany.	multhaup@chemie.fu-berlin.de	Horstmann, Britta/C-2154-2008	Reif, Bernd/0000-0001-7368-7198; Munter, Lisa/0000-0001-5736-1462; Voigt, Philipp/0000-0003-4366-0490				Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; CHANAT E, 1993, EMBO J, V12, P2159, DOI 10.1002/j.1460-2075.1993.tb05864.x; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045; Dulubova I, 2004, BIOCHEMISTRY-US, V43, P9583, DOI 10.1021/bi049041o; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; GREENBERG SM, 1995, NEUROSCI LETT, V198, P52, DOI 10.1016/0304-3940(95)11944-R; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; HILBICH C, 1993, J BIOL CHEM, V268, P26571; HYNES TR, 1990, BIOCHEMISTRY-US, V29, P10018, DOI 10.1021/bi00495a002; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; KITAGUCHI N, 1990, BIOCHIM BIOPHYS ACTA, V1038, P105, DOI 10.1016/0167-4838(90)90017-A; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Morimoto T, 1998, J NEUROSCI RES, V51, P185, DOI 10.1002/(SICI)1097-4547(19980115)51:2<185::AID-JNR7>3.0.CO;2-9; MULTHAUP G, 1994, BIOCHIMIE, V76, P304, DOI 10.1016/0300-9084(94)90163-5; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; OKAMOTO T, 1995, J BIOL CHEM, V270, P4205, DOI 10.1074/jbc.270.9.4205; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schmechel A, 2004, J BIOL CHEM, V279, P39710, DOI 10.1074/jbc.M402785200; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMALL DH, 1994, J NEUROSCI, V14, P2117; SMALL DH, 1992, J NEUROSCI, V12, P4143; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Stiegler AL, 2006, J MOL BIOL, V364, P424, DOI 10.1016/j.jmb.2006.09.019; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Wilson IA, 1999, CURR OPIN STRUC BIOL, V9, P696, DOI 10.1016/S0959-440X(99)00032-9; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200	37	81	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7271	7279		10.1074/jbc.M708046200	http://dx.doi.org/10.1074/jbc.M708046200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18182389	hybrid, Green Published			2022-12-27	WOS:000253779600072
J	Arany, I; Faisal, A; Nagamine, Y; Safirstein, RL				Arany, Istvan; Faisal, Amir; Nagamine, Yoshikuni; Safirstein, Robert L.			p66(shc) inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF-RECEPTOR; ACTIVATION; EXPRESSION; PROTEIN; KINASE; SHC; INJURY; ERK; PATHWAY; PHOSPHORYLATION	The fully executed epidermal growth factor receptor (EGFR)/Ras/MEK/ERK pathway serves a pro-survival role in renal epithelia under moderate oxidative stress. We and others have demonstrated that during severe oxidative stress, however, the activated EGFR is disconnected from ERK activation in cultured renal proximal tubule cells and also in renal proximal tubules after ischemia/reperfusion injury, resulting in necrotic death. Studies have shown that the tyrosine-phosphorylated p46/52 isoforms of the ShcA family of adaptor proteins connect the activated EGFR to activation of Ras and ERK, whereas the p66(shc) isoform can inhibit this p46/52(shc) function. Here, we determined that severe oxidative stress ( after a brief period of activation) terminates activation of the Ras/MEK/ERK pathway, which coincides with ERK/JNK-dependent Ser(36) phosphorylation of p66(shc). Isoform-specific knockdown of p66(shc) or mutation of Ser(36) to Ala, but not to Asp, attenuated severe oxidative stress-mediated ERK inhibition and cell death in vitro. Also, severe oxidative stress ( unlike ligand stimulation and moderate oxidative stress, both of which support survival) increased binding of p66(shc) to the activated EGFR and Grb2. This binding dissociated the SOS1 adaptor protein from the EGFR-recruited signaling complex, leading to termination of Ras/MEK/ERK activation. Notably, Ser(36) phosphorylation of p66(shc) and its increased binding to the EGFR also occurred in the kidney after ischemia/reperfusion injury in vivo. At the same time, SOS1 binding to the EGFR declined, similar to the in vitro findings. Thus, the mechanism we propose in vitro offers a means to ameliorate oxidative stress-induced cell injury by either inhibiting Ser(36) phosphorylation of p66(shc) or knocking down p66(sh)c expression in vivo.	[Arany, Istvan] Univ Mississippi, Med Ctr, Dept Pediat, Div Pediat Nephrol, Jackson, MS 39126 USA; [Arany, Istvan; Safirstein, Robert L.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA; [Arany, Istvan; Safirstein, Robert L.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Faisal, Amir] Lincolns Inn Fields Labs, Canc Res UK London Res Inst, Prot Phosphorylat Lab, London WC2A 3PX, England; [Nagamine, Yoshikuni] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	University of Mississippi; University of Mississippi Medical Center; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; Cancer Research UK; Friedrich Miescher Institute for Biomedical Research	Arany, I (corresponding author), Univ Mississippi, Med Ctr, Dept Pediat, Div Pediat Nephrol, 2500 N State St, Jackson, MS 39126 USA.	iarany@ped.umsmed.edu	Faisal, Amir/AAE-8992-2020	Faisal, Amir/0000-0002-7376-8286	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058324] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01 DK 58324-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andreucci M, 2003, KIDNEY INT, V64, P1189, DOI 10.1046/j.1523-1755.2003.00204.x; Arany I, 2008, KIDNEY INT, V73, P5, DOI 10.1038/sj.ki.5002583; Arany I, 2005, KIDNEY INT, V68, P1573, DOI 10.1111/j.1523-1755.2005.00569.x; Arany I, 2004, KIDNEY INT, V65, P1231, DOI 10.1111/j.1523-1755.2004.00500.x; Arany I, 2002, ANTIVIR RES, V55, P331, DOI 10.1016/S0166-3542(02)00070-0; BREYER MD, 1990, AM J PHYSIOL, V259, pF553, DOI 10.1152/ajprenal.1990.259.4.F553; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Di Mari JF, 1999, AM J PHYSIOL-RENAL, V277, pF195, DOI 10.1152/ajprenal.1999.277.2.F195; Dong J, 2004, AM J PHYSIOL-RENAL, V287, pF1049, DOI 10.1152/ajprenal.00132.2004; Faisal A, 2004, J BIOL CHEM, V279, P3202, DOI 10.1074/jbc.M310010200; GAMOU S, 1995, FEBS LETT, V357, P161, DOI 10.1016/0014-5793(94)01335-X; Goldkorn T, 1998, AM J RESP CELL MOL, V19, P786, DOI 10.1165/ajrcmb.19.5.3249; HARRIS RC, 1991, AM J KIDNEY DIS, V17, P627, DOI 10.1016/S0272-6386(12)80336-2; Hu YY, 2005, MOL BIOL CELL, V16, P3705, DOI 10.1091/mbc.E05-04-0301; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Ichiki T, 2003, HYPERTENSION, V42, P177, DOI 10.1161/01.HYP.0000079791.26014.04; Iordanov MS, 2002, MOL CELL BIOL, V22, P5380, DOI 10.1128/MCB.22.15.5380-5394.2002; Khanday FA, 2006, J CELL BIOL, V172, P817, DOI 10.1083/jcb.200506001; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Kleiner S, 2007, FEBS J, V274, P227, DOI 10.1111/j.1742-4658.2006.05578.x; Le S, 2001, J BIOL CHEM, V276, P48332, DOI 10.1074/jbc.M106612200; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; Meves A, 2001, TOXICOL LETT, V122, P205, DOI 10.1016/S0378-4274(01)00359-9; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Migliaccio E, 2006, ANTIOXID REDOX SIGN, V8, P600, DOI 10.1089/ars.2006.8.600; NORMAN J, 1990, CLIN SCI, V78, P445, DOI 10.1042/cs0780445; Okada S, 1997, J BIOL CHEM, V272, P28042, DOI 10.1074/jbc.272.44.28042; Pellegrini M, 2005, APOPTOSIS, V10, P13, DOI 10.1007/s10495-005-6057-8; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Purdom S, 2003, BIOGERONTOLOGY, V4, P181, DOI 10.1023/A:1025123413403; Purdom S, 2003, TRENDS MOL MED, V9, P206, DOI 10.1016/S1471-4914(03)00048-0; Rao GN, 1996, ONCOGENE, V13, P713; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Safirstein RL, 1999, RENAL FAILURE, V21, P359, DOI 10.3109/08860229909085099; Skulachev VP, 2000, IUBMB LIFE, V49, P177; Sorenson CM, 2002, AM J PHYSIOL-RENAL, V283, pF1085, DOI 10.1152/ajprenal.00380.2001; Taira T, 1996, VIRCHOWS ARCH, V427, P583; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; TOUBEAU GN, 1994, EXP NEPHROL, V2, P229; Wang ZF, 2003, J AM SOC NEPHROL, V14, P3147, DOI 10.1097/01.ASN.0000098681.56240.1A; Yamakawa T, 2000, HYPERTENSION, V35, P313, DOI 10.1161/01.HYP.35.1.313; Yano T, 1999, NEPHRON, V81, P230, DOI 10.1159/000045281; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F; Zhougang SG, 2004, AM J PHYSIOL-RENAL, V286, pF858, DOI 10.1152/ajprenal.00282.2003	45	73	79	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6110	6117		10.1074/jbc.M708799200	http://dx.doi.org/10.1074/jbc.M708799200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18174162	hybrid			2022-12-27	WOS:000253779500017
J	Hirano, S; Asamizu, S; Onaka, H; Shiro, Y; Nagano, S				Hirano, Satoshi; Asamizu, Shumpei; Onaka, Hiroyasu; Shiro, Yoshitsugu; Nagano, Shingo			Crystal structure of VioE, a key player in the construction of the molecular skeleton of violacein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC-PATHWAY; CHROMOPYRROLIC ACID; STAUROSPORINE; TRYPTOPHAN; SOFTWARE; MODEL; MAD	Violacein and the indolocarbazoles are naturally occurring bisindole products with various biological activities, including antitumor activity. Although these compounds have markedly different molecular skeletons, their biosynthetic pathways share the same intermediate "compound X," which is produced from L-tryptophan via indole-3-pyruvic acid imine. Compound X is a short-lived intermediate that is spontaneously converted to chromopyrrolic acid for indolocarbazole biosynthesis, whereas VioE transforms compound X into protodeoxyviolaceinic acid, which is further modified by other enzymes to produce violacein. Thus, VioE plays a key role in the construction of the molecular skeleton of violacein. Here, we present the crystal structure of VioE, which consists of two subunits, each of which forms a structure resembling a baseball glove. Each subunit has a positively charged pocket at the center of the concave surface of the structure. Mutagenesis analysis of the surface pocket and other surface residues showed that the surface pocket serves as an active site. We have also solved the crystal structure of a complex of VioE and phenylpyruvic acid as an analogue of a VioE-substrate complex. A docking simulation with VioE and the IPA imine dimer, which is proposed to be compound X, agreed with the results from the mutational analysis and the VioE-phenylpyruvic acid complex structure. Based on these results, we propose that VioE traps the highly reactive substrate within the surface pocket to suppress CPA formation and promote protodeoxyviolaceinic acid formation caused by proximity and orientation effects.	[Asamizu, Shumpei; Onaka, Hiroyasu] Toyama Prefectural Univ, Dept Biotechnol, Fac Engn, Toyama 9390398, Japan; [Hirano, Satoshi; Shiro, Yoshitsugu; Nagano, Shingo] RIKEN, SPring Ctr 8, Biomet Sci Lab, Mikazuki, Hyogo 6795148, Japan; [Onaka, Hiroyasu] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan	Toyama Prefectural University; RIKEN; Toyama Prefectural University	Onaka, H (corresponding author), Toyama Prefectural Univ, Dept Biotechnol, Fac Engn, Toyama 9390398, Japan.	onaka@putoyama.ac.jp	Shiro, Yoshitsugu Y/J-3757-2014; Asamizu, Shumpei/GOJ-8839-2022	Shiro, Yoshitsugu Y/0000-0003-0695-8327; Asamizu, Shumpei/0000-0002-7178-5410; Onaka, Hiroyasu/0000-0003-4536-1881				Asamizu S, 2006, TETRAHEDRON LETT, V47, P473, DOI 10.1016/j.tetlet.2005.11.061; Asamizu S, 2007, TETRAHEDRON LETT, V48, P2923, DOI 10.1016/j.tetlet.2007.02.062; August PR, 2000, J MOL MICROB BIOTECH, V2, P513; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; DeLano W.L, PYMOL MOL GRAPHICS S; Duran N, 2001, CRIT REV MICROBIOL, V27, P201, DOI 10.1080/20014091096747; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HOSHINO T, 1993, BIOSCI BIOTECH BIOCH, V57, P775, DOI 10.1271/bbb.57.775; Kim DY, 2007, P NATL ACAD SCI USA, V104, P8779, DOI 10.1073/pnas.0703117104; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Makino M, 2007, P NATL ACAD SCI USA, V104, P11591, DOI 10.1073/pnas.0702946104; Matz C, 2004, APPL ENVIRON MICROB, V70, P1593, DOI 10.1128/AEM.70.3.1593-1599.2004; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; OMURA S, 1995, J ANTIBIOT, V48, P535, DOI 10.7164/antibiotics.48.535; Onaka H, 2002, J ANTIBIOT, V55, P1063, DOI 10.7164/antibiotics.55.1063; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sanchez C, 2006, CHEMBIOCHEM, V7, P1231, DOI 10.1002/cbic.200600029; Shinoda K, 2007, CHEM COMMUN, P4140, DOI 10.1039/b705358d; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965	27	32	32	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6459	6466		10.1074/jbc.M708109200	http://dx.doi.org/10.1074/jbc.M708109200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18171677	hybrid			2022-12-27	WOS:000253779500053
J	Jeppesen, B; Smith, C; Gibson, DF; Tait, JF				Jeppesen, Brian; Smith, Christina; Gibson, Donald F.; Tait, Jonathan F.			Entropic and enthalpic contributions to annexin V-membrane binding - A comprehensive quantitative model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL ANTICOAGULANT PROTEIN; CALCIUM-DEPENDENT BINDING; X-RAY CRYSTALLOGRAPHY; PHOSPHOLIPID-BINDING; KINASE-C; PHOSPHATIDYLSERINE EXPOSURE; CELL-DEATH; IN-VIVO; VESICLES; DYNAMICS	Annexin V binds to membranes with very high affinity, but the factors responsible remain to be quantitatively elucidated. Analysis by isothermal microcalorimetry and calcium titration under conditions of low membrane occupancy showed that there was a strongly positive entropy change upon binding. For vesicles containing 25% phosphatidylserine at 0.15 M ionic strength, the free energy of binding was -53 kcal/mol protein, whereas the enthalpy of binding was -38 kcal/mol. Addition of 4 M urea decreased the free energy of binding by about 30% without denaturing the protein, suggesting that hydrophobic forces make a significant contribution to binding affinity. This was confirmed by mutagenesis studies that showed that binding affinity was modulated by the hydrophobicity of surface residues that are likely to enter the interfacial region upon protein-membrane binding. The change in free energy was quantitatively consistent with predictions from the Wimley-White scale of interfacial hydrophobicity. In contrast, binding affinity was not increased by making the protein surface more positively charged, nor decreased by making it more negatively charged, ruling out general ionic interactions as major contributors to binding affinity. The affinity of annexin V was the same regardless of the head group present on the anionic phospholipids tested (phosphatidylserine, phosphatidylglycerol, phosphatidylmethanol, and cardiolipin), ruling out specific interactions between the protein and non-phosphate moieties of the head group as a significant contributor to binding affinity. Analysis by fluorescence resonance energy transfer showed that multimers did not form on phosphatidylserine membranes at low occupancy, indicating that annexin-annexin interactions did not contribute to binding affinity. In summary, binding of annexin V to membranes is driven by both enthalpic and entropic forces. Dehydration of hydrophobic regions of the protein surface as they enter the interfacial region makes an important contribution to overall binding affinity, supplementing the role of protein-calcium-phosphate chelates.	[Jeppesen, Brian; Smith, Christina; Gibson, Donald F.; Tait, Jonathan F.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Tait, Jonathan F.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Tait, Jonathan F.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tait, JF (corresponding author), Univ Washington, Dept Lab Med, Box 357110, Seattle, WA 98195 USA.	tait@u.washington.edu	Smith, Christina/GXG-6941-2022		NCI NIH HHS [CA 102348] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102348] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P7970, DOI 10.1021/bi00246a014; BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P7961, DOI 10.1021/bi00246a013; BAZZI MD, 1993, CELL SIGNAL, V5, P357, DOI 10.1016/0898-6568(93)90075-W; BLACKWOOD RA, 1990, BIOCHEM J, V266, P195, DOI 10.1042/bj2660195; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; Budisa N, 1998, EUR J BIOCHEM, V253, P1, DOI 10.1046/j.1432-1327.1998.2530001.x; Campos B, 1998, BIOCHEMISTRY-US, V37, P8004, DOI 10.1021/bi973142n; Cesarman-Maus G, 2006, BLOOD, V107, P4375, DOI 10.1182/blood-2005-07-2636; Cezanne L, 1999, BIOCHEMISTRY-US, V38, P2779, DOI 10.1021/bi9818568; CONCHA NO, 1992, FEBS LETT, V314, P159, DOI 10.1016/0014-5793(92)80964-I; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; EVANS TC, 1994, BIOCHEMISTRY-US, V33, P13231, DOI 10.1021/bi00249a009; FUNAKOSHI T, 1987, BIOCHEMISTRY-US, V26, P5572, DOI 10.1021/bi00391a053; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GILMANSHIN R, 1994, BIOCHEMISTRY-US, V33, P8225, DOI 10.1021/bi00193a008; HAVERSTICK DM, 1987, P NATL ACAD SCI USA, V84, P4475, DOI 10.1073/pnas.84.13.4475; HUBER R, 1992, J MOL BIOL, V223, P683, DOI 10.1016/0022-2836(92)90984-R; Isas JM, 2005, BIOCHEMISTRY-US, V44, P16435, DOI 10.1021/bi051751m; Isas JM, 2004, J BIOL CHEM, V279, P32492, DOI 10.1074/jbc.M402568200; Jin M, 2004, J BIOL CHEM, V279, P40351, DOI 10.1074/jbc.M405846200; JUNKER M, 1993, BIOCHEMISTRY-US, V32, P9968, DOI 10.1021/bi00089a012; Kastl K, 2006, CHEMBIOCHEM, V7, P106, DOI 10.1002/cbic.200500265; Kohler G, 1997, BIOCHEMISTRY-US, V36, P8189, DOI 10.1021/bi9703960; Ladokhin AS, 2005, BIOCHEMISTRY-US, V44, P3402, DOI 10.1021/bi047805u; Lahorte CMM, 2004, EUR J NUCL MED MOL I, V31, P887, DOI 10.1007/s00259-004-1555-4; Langen R, 1998, J BIOL CHEM, V273, P22453, DOI 10.1074/jbc.273.35.22453; Lee ME, 2006, J AM CHEM SOC, V128, P4948, DOI 10.1021/ja058600r; MEERS P, 1994, BIOCHEMISTRY-US, V33, P5829, DOI 10.1021/bi00185a022; MEERS P, 1993, BIOCHEMISTRY-US, V32, P5411, DOI 10.1021/bi00071a016; Megli FM, 1998, BIOCHEMISTRY-US, V37, P10540, DOI 10.1021/bi9801255; Menke M, 2005, BIOCHEMISTRY-US, V44, P15296, DOI 10.1021/bi051585i; Mo Y, 2003, J BIOL CHEM, V278, P2437, DOI 10.1074/jbc.M210286200; MOORE PB, 1982, J BIOL CHEM, V257, P9663; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Oling F, 2000, J MOL BIOL, V304, P561, DOI 10.1006/jmbi.2000.4183; Patel DR, 2005, BIOCHEMISTRY-US, V44, P2833, DOI 10.1021/bi047642+; Patel DR, 2001, BIOCHEMISTRY-US, V40, P7054, DOI 10.1021/bi010345+; PLAGER DA, 1994, BIOCHEMISTRY-US, V33, P13239, DOI 10.1021/bi00249a010; Rand JH, 2004, THROMB RES, V114, P383, DOI 10.1016/j.thromres.2004.07.021; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rezus YLA, 2006, P NATL ACAD SCI USA, V103, P18417, DOI 10.1073/pnas.0606538103; REZUS YL, 2007, PHYS REV LETT, V99; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; TAIT JF, 1989, J BIOL CHEM, V264, P7944; TAIT JF, 1992, ARCH BIOCHEM BIOPHYS, V298, P187, DOI 10.1016/0003-9861(92)90111-9; Tait JF, 1999, J BIOL CHEM, V274, P3048, DOI 10.1074/jbc.274.5.3048; Tait JF, 2004, ANAL BIOCHEM, V329, P112, DOI 10.1016/j.ab.2004.02.043; Tait JF, 2006, J NUCL MED, V47, P1546; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; VOGES D, 1994, J MOL BIOL, V238, P199, DOI 10.1006/jmbi.1994.1281; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wood BL, 1996, BLOOD, V88, P1873	56	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6126	6135		10.1074/jbc.M707637200	http://dx.doi.org/10.1074/jbc.M707637200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18174168	hybrid			2022-12-27	WOS:000253779500019
J	Ramachandran, B; Yu, GS; Gulick, T				Ramachandran, Bindu; Yu, Gengsheng; Gulick, Tod			Nuclear respiratory factor 1 controls myocyte enhancer factor 2A transcription to provide a mechanism for coordinate expression of respiratory chain subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; CONTROLLING MITOCHONDRIAL BIOGENESIS; ACTIVATED PROTEIN-KINASE; GLUT4 GENE-EXPRESSION; SKELETAL-MUSCLE; DNA-BINDING; GLUCOSE-TRANSPORTER; HEART/MUSCLE ISOFORM; MOUSE EMBRYOGENESIS; COACTIVATOR PGC-1	Nuclear respiratory factors NRF1 and NRF2 regulate the expression of nuclear genes encoding heme biosynthetic enzymes, proteins required for mitochondrial genome transcription and protein import, and numerous respiratory chain subunits. NRFs thereby coordinate the expression of nuclear and mitochondrial genes relevant to mitochondrial biogenesis and respiration. Only two of the nuclear-encoded respiratory chain subunits have evolutionarily conserved tissue-specific forms: the cytochrome c oxidase (COX) subunits VIa and VIIa heart/muscle (H) and ubiquitous (L) isoforms. We used genome comparisons to conclude that the promoter regions of COX6A(H) and COX7A(H) lack NRF sites but have conserved myocyte enhancer factor 2 (MEF2) elements. We show that MEF2A mRNA is induced with forced expression of NRF1 and that the MEF2A 5'-regulatory region contains an evolutionarily conserved canonical element that binds endogenous NRF1 in chromatin immunoprecipitation (ChIP) assays. NRF1 regulates MEF2A promoter-reporters according to overexpression, RNA interference underexpression, and promoter element mutation studies. As there are four mammalian MEF2 isotypes, we used an isoform-specific antibody in ChIP to confirm MEF2A binding to the COX6A(H) promoter. These findings support a role for MEF2A as an intermediary in coordinating respiratory chain subunit expression in heart and muscle through a NRF1 -> MEF2A -> COXH transcriptional cascade. MEF2A also bound the MEF2A and PPARGC1A promoters in ChIP, placing it within a feedback loop with PGC1 alpha in controlling NRF1 activity. Interruption of this cascade and loop may account for striated muscle mitochondrial defects in mef2a null mice. Our findings also account for the previously described indirect regulation by NRF1 of other MEF2 targets in muscle such as GLUT4.	[Ramachandran, Bindu; Yu, Gengsheng; Gulick, Tod] Massachusetts Gen Hosp, Diabet Res Lab, Dept Med, Charlestown, MA 02129 USA; [Yu, Gengsheng; Gulick, Tod] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gulick, T (corresponding author), Massachusetts Gen Hosp, Diabet Res Lab, Dept Med, CNY 149 8219, Charlestown, MA 02129 USA.	gulick@helix.mgh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, K02DK002461, R01DK055875] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL72713] Funding Source: Medline; NIDDK NIH HHS [DK02461, P30-DK40561, DK55875] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANTHONY G, 1993, P NATL ACAD SCI USA, V90, P1652, DOI 10.1073/pnas.90.5.1652; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Baar K, 2003, FASEB J, V17, P1666, DOI 10.1096/fj.03-0049com; Bachman NJ, 1997, GENOMICS, V42, P146, DOI 10.1006/geno.1997.4687; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; BREITBART RE, 1993, DEVELOPMENT, V118, P1095; CALZONE FJ, 1991, DEVELOPMENT, V112, P335; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; CHAU CMA, 1992, J BIOL CHEM, V267, P6999; Cripps RM, 2004, DEV BIOL, V267, P536, DOI 10.1016/j.ydbio.2003.12.004; Cuthbertson DJ, 2007, DIABETES, V56, P2078, DOI 10.2337/db06-1716; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; DeSimone S, 1996, DEVELOPMENT, V122, P31; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Fazio IK, 2001, J BIOL CHEM, V276, P18710, DOI 10.1074/jbc.M100080200; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; GOPALAKRISHNAN L, 1995, J BIOL CHEM, V270, P18019, DOI 10.1074/jbc.270.30.18019; GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102; Gugneja S, 1997, J BIOL CHEM, V272, P18732, DOI 10.1074/jbc.272.30.18732; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Holmes BF, 2005, AM J PHYSIOL-ENDOC M, V289, pE1071, DOI 10.1152/ajpendo.00606.2004; Huo L, 1999, GENE, V233, P213, DOI 10.1016/S0378-1119(99)00135-3; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lenka N, 1998, PROG NUCLEIC ACID RE, V61, P309, DOI 10.1016/S0079-6603(08)60830-2; Li B, 1999, J BIOL CHEM, V274, P17534, DOI 10.1074/jbc.274.25.17534; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; LIU ML, 1994, J BIOL CHEM, V269, P28514; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Nguyen HT, 1998, DEV BIOL, V204, P550, DOI 10.1006/dbio.1998.9081; Parsons WJ, 1996, AM J PHYSIOL-HEART C, V270, pH567, DOI 10.1152/ajpheart.1996.270.2.H567; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Ramachandran B, 2008, J BIOL CHEM, V283, P10318, DOI 10.1074/jbc.M707623200; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Schaff er I. E., 1999, MITOCHONDRIA, P141; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Subramanian SV, 1996, MECH DEVELOP, V57, P103, DOI 10.1016/0925-4773(96)00542-4; TAANMAN JW, 1993, BIOCHIM BIOPHYS ACTA, V1225, P95, DOI 10.1016/0925-4439(93)90128-N; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tripoli G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r11; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; WAN B, 1995, J BIOL CHEM, V270, P26433, DOI 10.1074/jbc.270.44.26433; Wang CG, 2006, P NATL ACAD SCI USA, V103, P11567, DOI 10.1073/pnas.0603363103; Watanabe T, 1998, MOL CELL BIOL, V18, P442, DOI 10.1128/MCB.18.1.442; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yu M, 2002, BBA-GENE STRUCT EXPR, V1574, P345, DOI 10.1016/S0167-4781(02)00228-2; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zhu BM, 2005, J BIOL CHEM, V280, P28749, DOI 10.1074/jbc.M502491200; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	66	72	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11935	11946		10.1074/jbc.M707389200	http://dx.doi.org/10.1074/jbc.M707389200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18222924	hybrid, Green Published			2022-12-27	WOS:000255340000009
J	Inforzato, A; Rivieccio, V; Morreale, AP; Bastone, A; Salustri, A; Scarchilli, L; Verdoliva, A; Vincenti, S; Gallo, G; Chiapparino, C; Pacello, L; Nucera, E; Serlupi-Crescenzi, O; Day, AJ; Bottazzi, B; Mantovani, A; De Santis, R; Salvatori, G				Inforzato, Antonio; Rivieccio, Vincenzo; Morreale, Antonio P.; Bastone, Antonio; Salustri, Antonietta; Scarchilli, Laura; Verdoliva, Antonio; Vincenti, Silvia; Gallo, Grazia; Chiapparino, Caterina; Pacello, Lucrezia; Nucera, Eleonora; Serlupi-Crescenzi, Ottaviano; Day, Anthony J.; Bottazzi, Barbara; Mantovani, Alberto; De Santis, Rita; Salvatori, Giovanni			Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; LONG PENTRAXIN PTX3; SERUM AMYLOID-P; RECOGNITION RECEPTOR PTX3; ACUTE PHASE PROTEINS; DENDRITIC CELLS; CHROMOSOMAL LOCALIZATION; COMPLEMENT ACTIVATION; GEL ELECTROPHORESIS; GENOMIC STRUCTURE	PTX3 is an acute phase glycoprotein that plays keyroles in resistance to certain pathogens and in female fertility. PTX3 exerts its functions by interacting with a number of structurally unrelated molecules, a capacity that is likely to rely on its complex multimeric structure stabilized by interchain disulfide bonds. In this study, PAGE analyses performed under both native and denaturing conditions indicated that human recombinant PTX3 is mainly composed of covalently linked octamers. The network of disulfide bonds supporting this octameric assembly was resolved by mass spectrometry and Cys to Ser site-directed mutagenesis. Here we report that cysteine residues at positions 47, 49, and 103 in the N-terminal domain form three symmetric interchain disulfide bonds stabilizing four protein subunits in a tetrameric arrangement. Additional interchain disulfide bonds formed by the C-terminal domain cysteines Cys(317) and Cys(318) are responsible for linking the PTX3 tetramers into octamers. We also identified three intrachain disulfide bonds within the C-terminal domain that we used as structural constraints to build a new three-dimensional model for this domain. Previously it has been shown that PTX3 is a key component of the cumulus oophorus extracellular matrix, which forms around the oocyte prior to ovulation, because cumuli from PTX3(-/-) mice show defective matrix organization. Recombinant PTX3 is able to restore the normal phenotype ex vivo in cumuli from PTX3(-/-) mice. Here we demonstrate that PTX3 Cys to Ser mutants, mainly assembled into tetramers, exhibited wild type rescue activity, whereas a mutant, predominantly composed of dimers, had impaired functionality. These findings indicate that protein oligomerization is essential forPTX3activity within the cumulus matrix and implicate PTX3 tetramers as the functional molecular units required for cumulus matrix organization and stabilization.	[Inforzato, Antonio; Morreale, Antonio P.; Vincenti, Silvia; Gallo, Grazia; Chiapparino, Caterina; Pacello, Lucrezia; Nucera, Eleonora; Serlupi-Crescenzi, Ottaviano; De Santis, Rita; Salvatori, Giovanni] Sigma Tau Res & Dev, I-00040 Pomezia, Italy; [Inforzato, Antonio; Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Rivieccio, Vincenzo; Verdoliva, Antonio] Tecnogen SpA, I-81015 Piana Di Monte Verna, Italy; [Bastone, Antonio] Ist Ric Farmacol Mario Negri, I-20157 Milan, Italy; [Salustri, Antonietta; Scarchilli, Laura] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, I-00133 Rome, Italy; [Bottazzi, Barbara; Mantovani, Alberto] Ist Clin Humanitas ICH, I-20089 Rozzano, Italy	University of Manchester; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Rome Tor Vergata; IRCCS Humanitas Research Hospital	Salvatori, G (corresponding author), Sigma Tau Ind Farmaceut Riunite SpA, Immunol Area, R&D Dept, Via Pontina Km 30-400, I-00040 Rome, Italy.	giovanni.salvatori@sigma-tau.it	bottazzi, barbara/ABH-9274-2020; Mantovani, Alberto/HCI-7449-2022; Day, Anthony/O-1658-2015; Inforzato, Antonio/ABG-4513-2020; Inforzato, Antonio/K-6954-2012	bottazzi, barbara/0000-0002-1930-9257; Mantovani, Alberto/0000-0001-5578-236X; Day, Anthony/0000-0002-1415-3134; Inforzato, Antonio/0000-0001-8110-0027; SALUSTRI, ANTONIETTA/0000-0002-8731-1041; DE SANTIS, Rita/0000-0002-5037-0611	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Wellcome Trust Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Wellcome Trust(Wellcome TrustEuropean Commission)		Agrawal A, 2001, J IMMUNOL, V166, P3998, DOI 10.4049/jimmunol.166.6.3998; ALLES VV, 1994, BLOOD, V84, P3483; ANDREWS P, 1970, METHOD BIOCHEM ANAL, P113; Baruah P, 2006, BLOOD, V107, P151, DOI 10.1182/blood-2005-03-1112; Baruah P, 2006, J LEUKOCYTE BIOL, V80, P87, DOI 10.1189/jlb.0805445; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; BRISTOW CL, 1986, MOL IMMUNOL, V23, P1045, DOI 10.1016/0161-5890(86)90003-9; BUTTERMAN M, 1988, ELECTROPHORESIS, V9, P293, DOI 10.1002/elps.1150090702; Camozzi M, 2005, ARTERIOSCL THROM VAS, V25, P1837, DOI 10.1161/01.ATV.0000177807.54959.7d; Camozzi M, 2006, J BIOL CHEM, V281, P22605, DOI 10.1074/jbc.M601023200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Doni A, 2006, J LEUKOCYTE BIOL, V79, P797, DOI 10.1189/jlb.0905493; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Goodman Adam R., 1996, Cytokine and Growth Factor Reviews, V7, P191, DOI 10.1016/1359-6101(96)00019-6; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HSU YC, 1995, GENOMICS, V28, P220, DOI 10.1006/geno.1995.1134; Inforzato A, 2006, BIOCHEMISTRY-US, V45, P11540, DOI 10.1021/bi0607453; Introna M, 1996, BLOOD, V87, P1862; KAPLAN MH, 1974, J IMMUNOL, V112, P2135; Khreiss T, 2004, CIRCULATION, V110, P2713, DOI 10.1161/01.CIR.0000146846.00816.DD; Kishore U, 2001, Results Probl Cell Differ, V33, P225; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE GW, 1993, J IMMUNOL, V150, P1804; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Omeis IA, 1996, GENOMICS, V36, P543, DOI 10.1006/geno.1996.0503; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Presta M, 2007, J CELL MOL MED, V11, P723, DOI 10.1111/j.1582-4934.2007.00061.x; RASSOULI M, 1992, J BIOL CHEM, V267, P2947; Rivieccio V, 2007, PROTEIN EXPRES PURIF, V51, P49, DOI 10.1016/j.pep.2006.07.009; RO A, 2007, IMMUNOLOGY, V121, P40; ROBYT JF, 1971, ARCH BIOCHEM BIOPHYS, V147, P262, DOI 10.1016/0003-9861(71)90334-1; RODBARD D, 1970, P NATL ACAD SCI USA, V65, P970, DOI 10.1073/pnas.65.4.970; Roumenina LT, 2006, BIOCHEMISTRY-US, V45, P4093, DOI 10.1021/bi052646f; Rovere P, 2000, BLOOD, V96, P4300; Rusnati M, 2004, BLOOD, V104, P92, DOI 10.1182/blood-2003-10-3433; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Shrive AK, 1999, J MOL BIOL, V290, P997, DOI 10.1006/jmbi.1999.2956; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; van Rossum AP, 2004, ARTHRITIS RHEUM-US, V50, P2667, DOI 10.1002/art.20370; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; VouretCraviari V, 1997, INFECT IMMUN, V65, P1345, DOI 10.1128/IAI.65.4.1345-1350.1997; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X; YING SC, 1993, J IMMUNOL, V150, P169; Zouki C, 2001, J IMMUNOL, V167, P5355, DOI 10.4049/jimmunol.167.9.5355	53	104	109	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10147	10161		10.1074/jbc.M708535200	http://dx.doi.org/10.1074/jbc.M708535200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18223257	hybrid			2022-12-27	WOS:000254671600068
J	Huising, MO; Vaughan, JM; Shah, SH; Grillot, KL; Donaldson, CJ; Rivier, J; Flik, G; Vale, WW				Huising, Mark O.; Vaughan, Joan M.; Shah, Shaili H.; Grillot, Katherine L.; Donaldson, Cynthia J.; Rivier, Jean; Flik, Gert; Vale, Wylie W.			Residues of corticotropin releasing factor-binding protein (CRF-BP) that selectively abrogate binding to CRF but not to urocortin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL HEART-FAILURE; ALZHEIMERS-DISEASE; HORMONE CRH; COUPLED RECEPTOR; HIGH-AFFINITY; HUMAN-PLASMA; UROTENSIN-I; PEPTIDE; ANTAGONISTS; LIGAND	Corticotropin releasing factor-binding protein ( CRF-BP) binds CRF and urocortin 1 ( Ucn 1) with high affinity, thus preventing CRF receptor ( CRFR) activation. Despite recent progress on the molecular details that govern interactions between CRF family neuropeptides and their cognate receptors, little is known concerning the mechanisms that allow CRF-BP to bind CRF and Ucn 1 with picomolar affinity. We conducted a comprehensive alanine scan of 76 evolutionarily conserved residues of CRF-BP and identified several residues that differentially affected the affinity for CRF over Ucn 1. We determined that both neuropeptides derive their similarly high affinity from distinct binding surfaces on CRF-BP. Alanine substitutions of arginine 56 ( R56A) and aspartic acid 62 ( D62A) reduce the affinity for CRF by similar to 100-fold, while only marginally affecting the affinity for Ucn 1. The selective reduction in affinity for CRF depends on glutamic acid 25 in the CRF peptide, as substitution of Glu(25) reduces the affinity for CRF-BP by approximately 2 orders of magnitude, but only in the presence of both Arg(56) and Asp(62) in human CRF-BP. We show that CRF-BPR56A and CRF-BPD62A have lost the ability to inhibit CRFR1-mediated responses to CRF that activate luciferase induction in HEK293T cells and ACTH release from cultured rat anterior pituitary cells. In contrast, both CRF- BP mutants retain the ability to inhibit Ucn 1-induced CRFR1 activation. Collectively our findings demonstrate that CRF- BP has distinct and separable binding surfaces for CRF and Ucn 1, opening new avenues for the design of ligand-specific antagonists based on CRF- BP.	[Huising, Mark O.; Vaughan, Joan M.; Shah, Shaili H.; Grillot, Katherine L.; Donaldson, Cynthia J.; Rivier, Jean; Vale, Wylie W.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Huising, Mark O.; Flik, Gert] Radboud Univ Nijmegen, Dept Anim Physiol, NL-6525 ED Nijmegen, Netherlands	Salk Institute; Radboud University Nijmegen	Huising, MO (corresponding author), 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	huising@salk.edu	Flik, Gert/C-8229-2011; Huising, Mark O./H-3885-2019	Flik, Gert/0000-0001-9285-7957; Huising, Mark O./0000-0002-6594-2205	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01 DK 26741] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALDERMAN SL, 2007, COMP NEUROL, V502, P783; BEHAN DP, 1995, NATURE, V378, P284, DOI 10.1038/378284a0; Bilezikjian LM, 2001, ENDOCRINOLOGY, V142, P1065, DOI 10.1210/en.142.3.1065; Boorse GC, 2005, ENDOCRINOLOGY, V146, P4851, DOI 10.1210/en.2005-0497; Chen A, 2006, P NATL ACAD SCI USA, V103, P16580, DOI 10.1073/pnas.0607337103; DESOUZA EB, 1986, NATURE, V319, P593, DOI 10.1038/319593a0; DeSouza EB, 1995, PSYCHONEUROENDOCRINO, V20, P789, DOI 10.1016/0306-4530(95)00011-9; Doyon C, 2005, J ENDOCRINOL, V186, P123, DOI 10.1677/joe.1.06142; Eckart K, 2001, P NATL ACAD SCI USA, V98, P11142, DOI 10.1073/pnas.211424998; Fekete EM, 2007, FRONT NEUROENDOCRIN, V28, P1, DOI 10.1016/j.yfrne.2006.09.002; FISCHER WH, 1994, J BIOL CHEM, V269, P4313; Grace CRR, 2007, BIOPOLYMERS, V87, P196, DOI 10.1002/bip.20818; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Huising M, 2004, J MOL ENDOCRINOL, V32, P627, DOI 10.1677/jme.0.0320627; Huising MO, 2005, ENDOCRINOLOGY, V146, P2165, DOI 10.1210/en.2004-1514; Jahn O, 2002, P NATL ACAD SCI USA, V99, P12055, DOI 10.1073/pnas.192449299; Jahn O, 2001, PEPTIDES, V22, P47, DOI 10.1016/S0196-9781(00)00356-9; Kemp CF, 1998, PEPTIDES, V19, P1119, DOI 10.1016/S0196-9781(98)00057-6; Kobayashi T, 2005, WORLD J MICROB BIOT, V21, P961, DOI 10.1007/s11274-004-7162-5; LEAKE A, 1990, BIOL PSYCHIAT, V28, P603, DOI 10.1016/0006-3223(90)90398-L; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; LINTON EA, 1988, CLIN ENDOCRINOL, V28, P315, DOI 10.1111/j.1365-2265.1988.tb01218.x; MAY C, 1987, NEUROLOGY, V37, P535, DOI 10.1212/WNL.37.3.535; ORTH DN, 1987, BIOCHEM BIOPH RES CO, V143, P411, DOI 10.1016/0006-291X(87)91369-6; PALLAI PV, 1983, P NATL ACAD SCI-BIOL, V80, P6770, DOI 10.1073/pnas.80.22.6770; PERUTZ MF, 1990, ANNU REV PHYSIOL, V52, P1; POTTER E, 1991, NATURE, V349, P423, DOI 10.1038/349423a0; POTTER E, 1992, P NATL ACAD SCI USA, V89, P4192, DOI 10.1073/pnas.89.9.4192; Rademaker MT, 2005, EUR HEART J, V26, P2055, DOI 10.1093/eurheartj/ehi351; Rademaker MT, 2002, J AM COLL CARDIOL, V40, P1495, DOI 10.1016/S0735-1097(02)02170-8; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Rijkers DTS, 2004, CHEMBIOCHEM, V5, P340, DOI 10.1002/cbic.200300769; Rivier J, 2002, J MED CHEM, V45, P4737, DOI 10.1021/jm0202122; Ruhmann A, 1998, P NATL ACAD SCI USA, V95, P15264, DOI 10.1073/pnas.95.26.15264; SAPHIER PW, 1992, J ENDOCRINOL, V133, P487, DOI 10.1677/joe.0.1330487; Sauer RT, 1996, FASEB J, V10, P42, DOI 10.1096/fasebj.10.1.8566546; Schurmeyer T H, 1987, Horm Metab Res Suppl, V16, P24; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; SUDA T, 1988, J CLIN ENDOCR METAB, V67, P1278, DOI 10.1210/jcem-67-6-1278; SUDA T, 1989, BIOCHEM BIOPH RES CO, V165, P703, DOI 10.1016/S0006-291X(89)80023-3; SUTTON SW, 1995, ENDOCRINOLOGY, V136, P1097, DOI 10.1210/en.136.3.1097; VALE W, 1983, METHOD ENZYMOL, V103, P565; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; VAUGHAN JM, 1989, ENDOCRINOLOGY, V125, P1660, DOI 10.1210/endo-125-3-1660; Webster EL, 1996, ENDOCRINOLOGY, V137, P5747, DOI 10.1210/en.137.12.5747; Woods RJ, 1999, J CLIN ENDOCR METAB, V84, P2788, DOI 10.1210/jc.84.8.2788; Yamada Y, 2004, J MED CHEM, V47, P1075, DOI 10.1021/jm034180+; Zorrilla EP, 2003, TRENDS PHARMACOL SCI, V24, P421, DOI 10.1016/S0165-6147(03)00177-9	52	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8902	8912		10.1074/jbc.M709904200	http://dx.doi.org/10.1074/jbc.M709904200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18234674	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000254465800018
J	Jamburuthugoda, VK; Santos-Velazquez, JM; Skasko, M; Operario, DJ; Purohit, V; Chugh, P; Szymanski, EA; Wedekind, JE; Bambara, RA; Kim, B				Jamburuthugoda, Varuni K.; Santos-Velazquez, Jose M.; Skasko, Mark; Operario, Darwin J.; Purohit, Vandana; Chugh, Pauline; Szymanski, Erika A.; Wedekind, Joseph E.; Bambara, Robert A.; Kim, Baek			Reduced dNTP binding affinity of 3TC-resistant M184I HIV-1 reverse transcriptase variants responsible for viral infection failure in macrophage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIGH-LEVEL RESISTANCE; DNA-SYNTHESIS; 3TC RESISTANCE; IN-VITRO; POLYMERASE FIDELITY; PROCESSIVITY DEFECT; NUCLEOSIDE ANALOG; ESCHERICHIA-COLI; STERIC HINDRANCE	We characterized HIV-1 reverse transcriptase (RT) variants either with or without the (-)-2',3'-deoxy-3'-thiacytidine-resistant M184I mutation isolated from a single HIV-1 infected patient. First, unlike variants with wild-type M184, M184I RT variants displayed significantly reduced DNA polymerase activity at low dNTP concentrations, which is indicative of reduced dNTP binding affinity. Second, the M184I variant displayed a similar to 10- to 13-fold reduction in dNTP binding affinity, compared with the Met-184 variant. However, the k(pol) values of these two RTs were similar. Third, unlike HIV-1 vectors with wild-type RT, the HIV-1 vector harboring M184I RT failed to transduce cell types containing low dNTP concentrations, such as human macrophage, likely due to the reduced DNA polymerization activity of the M184IRT under low cellular dNTP concentration conditions. Finally, we compared the binary complex structures of wild-type and M184I RTs. The Ile mutation at position 184 with a longer and more rigid beta-branched side chain, which was previously known to alter the RT-template interaction, also appears to deform the shape of the dNTP binding pocket. This can restrict ground state dNTP binding and lead to inefficient DNA synthesis particularly at low dNTP concentrations, ultimately contributing to viral replication failure in macrophage and instability in vivo of the M184I mutation.	[Jamburuthugoda, Varuni K.; Skasko, Mark; Operario, Darwin J.; Chugh, Pauline; Szymanski, Erika A.; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Santos-Velazquez, Jose M.; Purohit, Vandana; Wedekind, Joseph E.; Bambara, Robert A.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu			NIAID NIH HHS [AI 49781, T32 AI049815] Funding Source: Medline; NIGMS NIH HHS [R25 GM 64133] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815, R01AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM064133] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aquaro S, 2005, J ANTIMICROB CHEMOTH, V55, P872, DOI 10.1093/jac/dki104; Avidan O, 2002, EUR J BIOCHEM, V269, P859, DOI 10.1046/j.0014-2956.2001.02719.x; Back NKT, 1997, ANTIMICROB AGENTS CH, V41, P2484, DOI 10.1128/AAC.41.11.2484; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; BAKHANASHVILI M, 1993, BIOCHEMISTRY-US, V32, P7559, DOI 10.1021/bi00080a030; BAMBARA RA, 1978, J BIOL CHEM, V253, P413; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; Cherry E, 1997, ANTIMICROB AGENTS CH, V41, P2763, DOI 10.1128/AAC.41.12.2763; DESTEFANO JJ, 1992, J VIROL, V66, P6370, DOI 10.1128/JVI.66.11.6370-6378.1992; Deval J, 2004, J BIOL CHEM, V279, P509, DOI 10.1074/jbc.M308806200; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Diamond TL, 2003, J BIOL CHEM, V278, P29913, DOI 10.1074/jbc.M211754200; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; Essink BBO, 1997, NUCLEIC ACIDS RES, V25, P3212, DOI 10.1093/nar/25.16.3212; Feng JY, 1999, BIOCHEMISTRY-US, V38, P9440, DOI 10.1021/bi990709m; Feng JY, 1999, BIOCHEMISTRY-US, V38, P55, DOI 10.1021/bi982340r; Frost SDW, 2000, J VIROL, V74, P6262, DOI 10.1128/JVI.74.14.6262-6268.2000; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; Gao L, 2008, J BIOL CHEM, V283, P9196, DOI 10.1074/jbc.M710148200; GAO Q, 1993, ANTIMICROB AGENTS CH, V37, P1390, DOI 10.1128/AAC.37.6.1390; Gulick R, 1998, AIDS, V12, pS17; Hsu ML, 1997, NUCLEIC ACIDS RES, V25, P4532, DOI 10.1093/nar/25.22.4532; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; JAMBURUTHUGODA VK, UNPUB; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Julias JG, 2004, VIROLOGY, V322, P13, DOI 10.1016/j.virol.2004.01.004; Kim B, 1997, METHODS, V12, P318, DOI 10.1006/meth.1997.0485; LARDER BA, 1987, NATURE, V327, P716, DOI 10.1038/327716a0; Mathe C, 2006, ANTIVIR RES, V71, P276, DOI 10.1016/j.antiviral.2006.04.017; Operario DJ, 2005, VIROLOGY, V335, P106, DOI 10.1016/j.virol.2005.02.010; Perez-Bercoff D, 2007, J VIROL, V81, P4540, DOI 10.1128/JVI.01620-06; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Rezende LF, 1998, NUCLEIC ACIDS RES, V26, P3066, DOI 10.1093/nar/26.12.3066; ROBERTS JD, 1989, MOL CELL BIOL, V9, P469, DOI 10.1128/MCB.9.2.469; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; Selmi B, 2001, J BIOL CHEM, V276, P48466, DOI 10.1074/jbc.M107003200; Skasko M, 2005, J BIOL CHEM, V280, P12190, DOI 10.1074/jbc.M412859200; SUO Z, 1998, J BIOL CHEM, V273, P27257; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vaccaro JA, 2000, ANTIMICROB AGENTS CH, V44, P217, DOI 10.1128/AAC.44.1.217-221.2000; Van Rompay KKA, 2002, J VIROL, V76, P6083, DOI 10.1128/JVI.76.12.6083-6092.2002; Weiss KK, 2000, BIOCHEMISTRY-US, V39, P10684, DOI 10.1021/bi000788y; Weiss KK, 2004, BIOCHEMISTRY-US, V43, P4490, DOI 10.1021/bi035258r; Weiss KK, 2002, J BIOL CHEM, V277, P22662, DOI 10.1074/jbc.M200202200	49	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9206	9216		10.1074/jbc.M710149200	http://dx.doi.org/10.1074/jbc.M710149200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18218633	Green Published, hybrid			2022-12-27	WOS:000254465800050
J	Belova, GI; Postnikov, YV; Furusawa, T; Birger, Y; Bustin, M				Belova, Galina I.; Postnikov, Yuri V.; Furusawa, Takashi; Birger, Yehudit; Bustin, Michael			Chromosomal protein HMGN1 enhances the heat shock-induced remodeling of Hsp70 chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILITY-GROUP PROTEINS; LINKER HISTONE H1; RNA-POLYMERASE-II; IN-VIVO; TRANSCRIPTION FACTOR; GENE-REGULATION; PHOSPHORYLATION; BINDING; EXPRESSION; ELONGATION	The nucleosome-binding protein HMGN1 affects the structure and function of chromatin; however, its role in regulating specific gene expression in living cells is not fully understood. Here we use embryonic fibroblasts from Hmgn1(+/+) and Hmgn1(-/-) mice to examine the effect of HMGN1 on the heat shock-induced transcriptional activation of Hsp70, a well characterized gene known to undergo a rapid chromatin re-structuring during transcriptional activation. We find that loss of HMGN1 decreases the levels of Hsp70 transcripts at the early stages of heat shock. HMGN1 enhances the rate of heat shock-induced changes in the Hsp70 chromatin but does not affect the chromatin structure before induction, an indication that it does not predispose the gene to rapid activation. Heat shock elevates the levels of H3K14 acetylation in the Hsp70 chromatin of wild type cells more efficiently than in the chromatin of Hmgn1(+/+) cells, whereas treatment with histone deacetylase inhibitors abrogates the effects of HMGN1 on the heat shock response. We suggest that HMGN1 enhances the rate of heat shock-induced H3K14 acetylation in the Hsp70 promoter, thereby enhancing the rate of chromatin remodeling and the subsequent transcription during the early rounds of Hsp70 activation when the gene is still associated with histones in a nucleosomal conformation.	[Belova, Galina I.; Postnikov, Yuri V.; Furusawa, Takashi; Birger, Yehudit; Bustin, Michael] NCI, Prot Sect, Lab Metab, NIH, Bethesda, MD 20892 USA; [Birger, Yehudit] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chaim Sheba Medical Center	Bustin, M (corresponding author), NCI, Prot Sect, Lab Metab, NIH, 37 Convent Dr,Rm 3122, Bethesda, MD 20892 USA.	bustinm@mail.nih.gov	Bustin, Michael/G-6155-2015	Bustin, Michael/0000-0002-5147-7242	NATIONAL CANCER INSTITUTE [ZIABC011154, ZIABC004496] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC004496-30] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ausio J, 2000, BIOESSAYS, V22, P873, DOI 10.1002/1521-1878(200010)22:10<873::AID-BIES1>3.3.CO;2-I; BARRATT A, 1994, AM J PUBLIC HEALTH, V84, P779, DOI 10.2105/AJPH.84.5.779; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Birger Y, 2005, CANCER RES, V65, P6711, DOI 10.1158/0008-5472.CAN-05-0310; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; BUSTIN M, 1989, METHOD ENZYMOL, V170, P214; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P431, DOI 10.1016/S0968-0004(01)01855-2; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Catez F, 2003, BIOCHEM CELL BIOL, V81, P113, DOI 10.1139/o03-040; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; DING HF, 1994, SCIENCE, V265, P796, DOI 10.1126/science.8047885; Dyson MH, 2005, CELL CYCLE, V4, P13, DOI 10.4161/cc.4.1.1362; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Hill DA, 2000, BIOCHEMISTRY-US, V39, P11649, DOI 10.1021/bi001330z; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Horn PJ, 2002, NAT STRUCT BIOL, V9, P263, DOI 10.1038/nsb776; HUNT CR, 1993, GENOMICS, V16, P193, DOI 10.1006/geno.1993.1158; KARPOV VL, 1984, CELL, V36, P423, DOI 10.1016/0092-8674(84)90235-6; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lee JS, 2002, EXP MOL MED, V34, P131, DOI 10.1038/emm.2002.19; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lim JH, 2005, EMBO J, V24, P3038, DOI 10.1038/sj.emboj.7600768; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; PARANJAPE SM, 1995, GENE DEV, V9, P1978, DOI 10.1101/gad.9.16.1978; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Postnikov YV, 2006, BIOCHEMISTRY-US, V45, P15092, DOI 10.1021/bi0613271; POSTNIKOV YV, 1991, NUCLEIC ACIDS RES, V19, P717, DOI 10.1093/nar/19.4.717; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Rubinstein YR, 2005, FEBS J, V272, P5853, DOI 10.1111/j.1742-4658.2005.04980.x; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; TRIESCHMANN L, 1995, EMBO J, V14, P1478, DOI 10.1002/j.1460-2075.1995.tb07134.x; Ueda T, 2006, J BIOL CHEM, V281, P10182, DOI 10.1074/jbc.M600821200; VAN H, 1989, CHROMATIN, P16; WEINTRAUB H, 1984, CELL, V38, P17, DOI 10.1016/0092-8674(84)90522-1; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zlatanova J, 2000, FASEB J, V14, P1697, DOI 10.1096/fj.99-0869rev	54	23	23	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8080	8088		10.1074/jbc.M709782200	http://dx.doi.org/10.1074/jbc.M709782200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18218636	Green Accepted, hybrid			2022-12-27	WOS:000254288000004
J	Chatterjee, N; Stegmuller, J; Schatzle, P; Karram, K; Koroll, M; Werner, HB; Nave, KA; Trotter, J				Chatterjee, Nivedita; Stegmueller, Judith; Schaetzle, Philipp; Karram, Khalad; Koroll, Michael; Werner, Hauke B.; Nave, Klaus-Armin; Trotter, Jacqueline			Interaction of syntenin-1 and the NG2 proteoglycan in migratory oligodendrocyte precursor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; PDZ DOMAINS; PROTEIN; MEMBRANE; EXPRESSION; RECEPTORS; COMPLEXES; MOLECULE; SURFACE; MYELIN	Migration of oligodendrocyte precursors along axons is a necessary prerequisite for myelination, but little is known about underlying mechanisms. NG2 is a large membrane proteoglycan implicated in oligodendrocyte migration. Here we show that a PDZ domain protein termed syntenin-1 interacts with NG2 and that syntenin-1 is necessary for normal rates of migration. The association of syntenin-1 with NG2, identified in a yeast two-hybrid screen, was confirmed by colocalization of both proteins within processes of oligodendroglial precursor cells and by coimmunoprecipitation from cell extracts. Syntenin-1 also colocalizes with NG2 in "co-capping" assays, demonstrating a lateral association of both proteins in live oligodendrocytes. RNA interference-mediated down-regulation of syntenin-1 in glial cells results in a significant reduction of migration in vitro, as does the presence of polyclonal antibody against NG2. Thus syntenin plays a role in the migration of oligodendroglial precursors, and we suggest that NG2-syntenin-1 interactions contribute to this.	[Chatterjee, Nivedita; Stegmueller, Judith; Schaetzle, Philipp; Karram, Khalad; Trotter, Jacqueline] Johannes Gutenberg Univ Mainz, Dept Biol, D-55128 Mainz, Germany; [Koroll, Michael] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Werner, Hauke B.; Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany	Johannes Gutenberg University of Mainz; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society	Trotter, J (corresponding author), Johannes Gutenberg Univ Mainz, Dept Biol, Bentzelweg 3, D-55128 Mainz, Germany.	trotter@uni-mainz.de	Nave, Klaus-Armin/C-8883-2011; Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Werner, Hauke/0000-0002-7710-5738				Barritt DS, 2000, J CELL BIOCHEM, V79, P213, DOI 10.1002/1097-4644(20001101)79:2<213::AID-JCB50>3.0.CO;2-G; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Butt AM, 2002, J NEUROCYTOL, V31, P551, DOI 10.1023/A:1025751900356; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Fialka I, 1999, J BIOL CHEM, V274, P26233, DOI 10.1074/jbc.274.37.26233; Gimferrer I, 2005, J IMMUNOL, V175, P1406, DOI 10.4049/jimmunol.175.3.1406; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hirbec H, 2005, MOL CELL NEUROSCI, V28, P737, DOI 10.1016/j.mcn.2004.12.005; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Jannatipour M, 2001, J BIOL CHEM, V276, P33093, DOI 10.1074/jbc.M105792200; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Karram K, 2005, J ANAT, V207, P735, DOI 10.1111/j.1469-7580.2005.00461.x; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Kramer EM, 1997, J BIOL CHEM, V272, P8937; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Majumdar M, 2003, CELL SIGNAL, V15, P79, DOI 10.1016/S0898-6568(02)00045-1; Makagiansar IT, 2004, J BIOL CHEM, V279, P55262, DOI 10.1074/jbc.M411045200; MAYER B, 1990, J NEUROIMMUNOL, V29, P193, DOI 10.1016/0165-5728(90)90162-G; Niehaus A, 1999, J NEUROSCI, V19, P4948; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Ohno K, 2004, MOL CELL NEUROSCI, V26, P518, DOI 10.1016/j.mcn.2004.04.007; Pluschke G, 1996, P NATL ACAD SCI USA, V93, P9710, DOI 10.1073/pnas.93.18.9710; Sarkar D, 2004, PHARMACOL THERAPEUT, V104, P101, DOI 10.1016/j.pharmthera.2004.08.004; Schneider S, 2001, J NEUROSCI, V21, P920, DOI 10.1523/JNEUROSCI.21-03-00920.2001; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Stegmuller J, 2003, J BIOL CHEM, V278, P3590, DOI 10.1074/jbc.M210010200; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; TROTTER J, 1989, J NEUROSCI RES, V22, P369, DOI 10.1002/jnr.490220402; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	37	47	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8310	8317		10.1074/jbc.M706074200	http://dx.doi.org/10.1074/jbc.M706074200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18218632	hybrid			2022-12-27	WOS:000254288000029
J	Ren, H; Salous, AK; Paul, JM; Lamb, KA; Dwyer, DS; Peoples, RW				Ren, Hong; Salous, Abdelghaffar K.; Paul, Jaclyn M.; Lamb, Kaitlin A.; Dwyer, Donard S.; Peoples, Robert W.			Functional interactions of alcohol-sensitive sites in the N-methyl-D-aspartate receptor M3 and M4 domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC-ACID; MEMBRANE-ASSOCIATED DOMAIN; ACTIVATED ION CURRENT; ETHANOL INHIBITION; HIPPOCAMPAL-NEURONS; GLYCINE RECEPTORS; NMDA RECEPTORS; SINGLE-CHANNEL; SUBUNIT; GABA(A)	The N-methyl-D-aspartate receptor is an important mediator of the behavioral effects of ethanol in the central nervous system. Previous studies have demonstrated sites in the third and fourth membrane- associated (M) domains of the N-methyl-D-aspartate receptor NR2A subunit that influence alcohol sensitivity and ion channel gating. We investigated whether two of these sites, Phe-637 in M3 and Met-823 in M4, interactively regulate the ethanol sensitivity of the receptor by testing dual substitution mutants at these positions. A majority of the mutations decreased steady-state glutamate EC50 values and maximal steady-state to peak current ratios (I-ss/I-p), whereas only two mutations altered peak glutamate EC50 values. Steady-state glutamate IC50 values were correlated with maximal glutamate Iss/Ip values, suggesting that changes in glutamate potency were attributable to changes in desensitization. In addition, there was a significant interaction between the substituents at positions 637 and 823 with respect to glutamate potency and desensitization. IC50 values for ethanol among the mutants varied over the approximate range 100-325mM. The sites in M3 and M4 significantly interacted in regulating ethanol sensitivity, although this was apparently dependent upon the presence of methionine in position 823. Molecular dynamics simulations of the NR2A subunit revealed possible binding sites for ethanol near both positions in the M domains. Consistent with this finding, the sum of the molecular volumes of the substituents at the two positions was not correlated with ethanol IC50 values. Thus, there is a functional interaction between Phe-637 and Met-823 with respect to glutamate potency, desensitization, and ethanol sensitivity, but the two positions do not appear to form a unitary site of alcohol action.	[Ren, Hong; Salous, Abdelghaffar K.; Paul, Jaclyn M.; Lamb, Kaitlin A.; Peoples, Robert W.] Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53201 USA; [Dwyer, Donard S.] Louisiana State Univ, Hlth Sci Ctr, Dept Psychiat, Shreveport, LA 71130 USA	Marquette University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Peoples, RW (corresponding author), Marquette Univ, Dept Biomed Sci, SC 446,POB 1881, Milwaukee, WI 53201 USA.	robert.peoples@marquette.edu			NIAAA NIH HHS [AA 015203-01A1] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015203] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Alvestad RM, 2003, J BIOL CHEM, V278, P11020, DOI 10.1074/jbc.M210167200; Beck C, 1999, NEURON, V22, P559, DOI 10.1016/S0896-6273(00)80710-2; CHU B, 1995, J NEUROCHEM, V65, P140; Clark M, 2006, J CHEM INF MODEL, V46, P231, DOI 10.1021/ci050268f; DILDY JE, 1989, BRAIN RES, V499, P383, DOI 10.1016/0006-8993(89)90789-0; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; GONZALES RA, 1990, J PHARMACOL EXP THER, V253, P1138; GOTHERT M, 1989, N-S ARCH PHARMACOL, V340, P516; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jung SW, 2005, J BIOL CHEM, V280, P308, DOI 10.1074/jbc.M409871200; Koltchine VV, 1999, MOL PHARMACOL, V56, P1087, DOI 10.1124/mol.56.5.1087; Krasowski MD, 2000, BRIT J PHARMACOL, V129, P731, DOI 10.1038/sj.bjp.0703087; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; LIMALANDMAN MTR, 1989, FEBS LETT, V247, P61, DOI 10.1016/0014-5793(89)81241-4; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; LOVINGER DM, 1990, J NEUROSCI, V10, P1372; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; MIRSHAHI T, 1995, NEUROPHARMACOLOGY, V34, P347, DOI 10.1016/0028-3908(94)00155-L; Mohrmann R, 2002, J NEUROSCI RES, V68, P265, DOI 10.1002/jnr.10219; Moykkynen T, 2003, J PHARMACOL EXP THER, V306, P546, DOI 10.1124/jpet.103.050666; Peoples RW, 2000, NEUROPHARMACOLOGY, V39, P1681, DOI 10.1016/S0028-3908(00)00067-8; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; PEOPLES RW, 1992, BRAIN RES, V571, P342, DOI 10.1016/0006-8993(92)90674-X; Peoples RW, 1997, BRIT J PHARMACOL, V122, P1035, DOI 10.1038/sj.bjp.0701483; Ren H, 2007, BRIT J PHARMACOL, V151, P749, DOI 10.1038/sj.bjp.0707254; Ren H, 2003, J BIOL CHEM, V278, P48815, DOI 10.1074/jbc.M302097200; Ren H, 2003, J BIOL CHEM, V278, P276, DOI 10.1074/jbc.M209486200; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; Rutter AR, 2002, J NEUROCHEM, V81, P1298, DOI 10.1046/j.1471-4159.2002.00923.x; Sobolevsky AI, 2007, J GEN PHYSIOL, V129, P509, DOI 10.1085/jgp.200609718; Topf N, 2003, ANESTHESIOLOGY, V98, P306, DOI 10.1097/00000542-200302000-00007; Ueno S, 1999, BRIT J PHARMACOL, V127, P377, DOI 10.1038/sj.bjp.0702563; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Wright JM, 1996, BRAIN RES, V738, P249, DOI 10.1016/S0006-8993(96)00780-9; Yamakura T, 1999, J BIOL CHEM, V274, P23006, DOI 10.1074/jbc.274.33.23006	41	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8250	8257		10.1074/jbc.M705933200	http://dx.doi.org/10.1074/jbc.M705933200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18208816	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000254288000022
J	Lopez, JJ; Lorch, M				Lopez, Jakob J.; Lorch, Mark			Location and orientation of serotonin receptor 1a agonists in model and complex lipid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRON-DIFFRACTION; SPINNING NMR; MAS NMR; CHOLESTEROL; BILAYERS; SPHINGOLIPIDS; LOCALIZATION; SPECTROSCOPY; TRYPTOPHAN; DOMAINS	Magic angle spinning (MAS) NMR has been used to investigate the location and orientation of five serotonin receptor 1a agonists (serotonin, buspirone, quipazine, 8-OH-DPAT, and LY-163,165) in single component model lipid and brain lipid membranes. The agonist locations are probed by monitoring changes in the lipid proton chemical shifts and by MAS-assisted nuclear Overhauser enhancement spectroscopy, which indicates the orientation of the agonists with respect to the 1,2-dioleoyl-sn-glycero-3-phosphocholine lipids. In the single component bilayer, the membrane agonists are found predominantly in the top of the hydrophobic chain or in the glycerol region of the membrane. Most of the agonists orient approximately parallel to the membrane plane, with the exception of quipazine, whose piperazine ring is found in the glycerol region, whereas its benzene ring is located within the lipid hydrophobic chain. The location of the agonist in brain lipid membranes is similar to the 1,2-dioleoyl-sn-glycero-3-phosphocholine lipid bilayers; however, many of the agonists appear to locate close to the cholesterol in the membrane in preference to the phospholipids.	[Lorch, Mark] Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England; [Lopez, Jakob J.] JW Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany	University of Hull; Goethe University Frankfurt	Lorch, M (corresponding author), Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England.	M.Lorch@hull.ac.uk			Engineering and Physical Sciences Research Council [EP/C508912/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Castanho MARB, 2006, EUR BIOPHYS J BIOPHY, V35, P92, DOI 10.1007/s00249-005-0007-9; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; FORBES J, 1988, J AM CHEM SOC, V110, P1059, DOI 10.1021/ja00212a010; Gaede HC, 2005, J PHYS CHEM B, V109, P13014, DOI 10.1021/jp0511000; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Gross JD, 1997, J AM CHEM SOC, V119, P796, DOI 10.1021/ja962951b; Holland GP, 2006, J MAGN RESON, V181, P316, DOI 10.1016/j.jmr.2006.05.017; Huster D, 1999, J PHYS CHEM B, V103, P243, DOI 10.1021/jp983428h; Keller R., 2004, COMPUTER AIDED RESON, V1; Leonard A, 2001, LANGMUIR, V17, P2019, DOI 10.1021/la001382p; Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020; McIntosh TJ, 2003, BIOPHYS J, V85, P1656, DOI 10.1016/S0006-3495(03)74595-0; MILLAN MJ, 1995, J PHARMACOL EXP THER, V273, P1418; OBRIEN JS, 1965, J LIPID RES, V6, P537; Ollila F, 2002, ARCH BIOCHEM BIOPHYS, V399, P103, DOI 10.1006/abbi.2001.2759; PEROUTKA SJ, 1986, J NEUROCHEM, V47, P529; Pinkus A. G., 1970, Journal of Physical Chemistry, V74, P1042, DOI 10.1021/j100700a013; Polozov IV, 2004, BIOPHYS J, V87, P1741, DOI 10.1529/biophysj.104.040725; Pucadyil TJ, 2005, CELL MOL NEUROBIOL, V25, P553, DOI 10.1007/s10571-005-3969-3; Ramstedt B, 2006, BBA-BIOMEMBRANES, V1758, P1945, DOI 10.1016/j.bbamem.2006.05.020; Scheidt HA, 2004, BBA-BIOMEMBRANES, V1663, P97, DOI 10.1016/j.bbamem.2004.02.004; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; STAMM H, 1989, J AM CHEM SOC, V111, P6544, DOI 10.1021/ja00199a010; SUBCZYNSKI WK, 1994, BIOCHEMISTRY-US, V33, P7670, DOI 10.1021/bi00190a022; Villalain J, 1996, EUR J BIOCHEM, V241, P586, DOI 10.1111/j.1432-1033.1996.00586.x; Warschawski DE, 2005, EUR BIOPHYS J BIOPHY, V34, P987, DOI 10.1007/s00249-005-0482-z; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; WIMLEY WC, 1993, BIOCHEMISTRY-US, V32, P6307, DOI 10.1021/bi00076a001; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	31	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7813	7822		10.1074/jbc.M707480200	http://dx.doi.org/10.1074/jbc.M707480200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18187421	Green Published, hybrid			2022-12-27	WOS:000253997900057
J	Perroy, J; Raynaud, F; Homburger, V; Rousset, MC; Telley, L; Bockaert, J; Fagni, L				Perroy, Julie; Raynaud, Fabrice; Homburger, Vincent; Rousset, Marie-Claude; Telley, Ludovic; Bockaert, Joel; Fagni, Laurent			Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTORS; LONG-TERM DEPRESSION; RESONANCE ENERGY-TRANSFER; NMDA RESPONSES; IP3 RECEPTORS; HOMER BINDS; NEURONS; POTENTIATION; HIPPOCAMPUS; ACTIVATION	Functional interplay between ionotropic and metabotropic receptors frequently involves complex intracellular signaling cascades. The group I metabotropic glutamate receptor mGlu5a co-clusters with the ionotropic N-methyl-D-aspartate (NMDA) receptor in hippocampal neurons. In this study, we report that a more direct cross-talk can exist between these types of receptors. Using bioluminescence resonance energy transfer in living HEK293 cells, we demonstrate that mGlu5a and NMDA receptor clustering reflects the existence of direct physical interactions. Consequently, the mGlu5a receptor decreased NMDA receptor current, and reciprocally, the NMDA receptor strongly reduced the ability of the mGlu5a receptor to release intracellular calcium. We show that deletion of the C terminus of the mGlu5a receptor abolished both its interaction with the NMDA receptor and reciprocal inhibition of the receptors. This direct functional interaction implies a higher degree of target-effector specificity, timing, and subcellular localization of signaling than could ever be predicted with complex signaling pathways.	[Perroy, Julie; Raynaud, Fabrice; Homburger, Vincent; Rousset, Marie-Claude; Telley, Ludovic; Bockaert, Joel; Fagni, Laurent] Univ Montpellier 1 & 2, CNRS UMR 5203, INSERM,U661, Inst Genom Font, F-34094 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Perroy, J (corresponding author), Univ Montpellier 1 & 2, CNRS UMR 5203, INSERM,U661, Inst Genom Font, 141 Rue Cardonille, F-34094 Montpellier, France.	julie.perroy@igf.cnrs.fr		Raynaud, Fabrice/0000-0003-3055-0524; perroy, julie/0000-0001-6199-0448; Telley, Ludovic/0000-0002-5041-1997				Ango F, 1999, NEUROPHARMACOLOGY, V38, P793, DOI 10.1016/S0028-3908(99)00005-2; ANIKSZTEJN L, 1992, EUR J NEUROSCI, V4, P500, DOI 10.1111/j.1460-9568.1992.tb00900.x; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Attucci S, 2001, BRIT J PHARMACOL, V132, P799, DOI 10.1038/sj.bjp.0703904; Awad H, 2000, J NEUROSCI, V20, P7871; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; BASHIR ZI, 1993, EUR J PHARMACOL, V239, P265, DOI 10.1016/0014-2999(93)91009-C; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Bortolotto ZA, 1999, CURR OPIN NEUROBIOL, V9, P299, DOI 10.1016/S0959-4388(99)80044-0; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; Doherty AJ, 1997, NEUROPHARMACOLOGY, V36, P265, DOI 10.1016/S0028-3908(97)00001-4; Ehrengruber MU, 2004, MOL NEUROBIOL, V29, P213, DOI 10.1385/MN:29:3:213; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Fagni L, 2004, SEMIN CELL DEV BIOL, V15, P289, DOI 10.1016/j.semcdb.2003.12.018; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; HARVEY J, 1993, BRIT J PHARMACOL, V109, P1085, DOI 10.1111/j.1476-5381.1993.tb13733.x; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kotecha SA, 2003, J BIOL CHEM, V278, P27742, DOI 10.1074/jbc.M301946200; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; MELLON P, 1981, CELL, V27, P279, DOI 10.1016/0092-8674(81)90411-6; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Pisani A, 2001, NEUROSCIENCE, V106, P579, DOI 10.1016/S0306-4522(01)00297-4; Pisani A, 1997, BRIT J PHARMACOL, V120, P1007, DOI 10.1038/sj.bjp.0700999; Tsien Roger Y., 1993, Trends in Cell Biology, V3, P242, DOI 10.1016/0962-8924(93)90124-J; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Ugolini A, 1997, NEUROPHARMACOLOGY, V36, P1047, DOI 10.1016/S0028-3908(97)00103-2; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	37	92	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6799	6805		10.1074/jbc.M705661200	http://dx.doi.org/10.1074/jbc.M705661200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18182392	hybrid			2022-12-27	WOS:000253779600022
J	Mariappan, M; Radhakrishnan, K; Dierks, T; Schmidt, B; von Figura, K				Mariappan, Malaiyalam; Radhakrishnan, Karthikeyan; Dierks, Thomas; Schmidt, Bernhard; von Figura, Kurt			ERp44 mediates a thiol-independent retention of formylglycine-generating enzyme in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SULFATASE DEFICIENCY; PROTEIN MODIFICATION; CRYSTAL-STRUCTURE; HUMAN ARYLSULFATASE; MECHANISM; CYSTEINE; CONVERSION; MUTATIONS; CATALYSIS; PARALOG	Inside the endoplasmic reticulum (ER) formylglycine-generating enzyme (FGE) catalyzes in newly synthesized sulfatases the post-translational oxidation of a specific cysteine. Thereby formylglycine is generated, which is essential for sulfatase activity. Here we show that ERp44 interacts with FGE forming heterodimeric and, to a lesser extent, also heterotetrameric and octameric complexes, which are stabilized through disulfide bonding between cysteine 29 of ERp44 and cysteines 50 and 52 in the N-terminal region of FGE. ERp44 mediates FGE retrieval to the ER via its C-terminal RDEL signal. Increasing ERp44 levels by overexpression enhances and decreasing ERp44 levels by silencing reduces ER retention of FGE. Suppressing disulfide bonding by mutating the critical cysteines neither abrogates ERp44.FGE complex formation nor interferes with ERp44-mediated retention of FGE, indicating that noncovalent interactions between ERp44 and FGE are sufficient to mediate ER retention. The N-terminal region of FGE harboring Cys(50) and Cys(52) is dispensible for catalytic activity in vitro but required for FGE-mediated activation of sulfatases in vivo. This in vivo activity is affected neither by overexpression nor by silencing of ERp44, indicating that a further ER component interacting with the N-terminal extension of FGE is critical for sulfatase activation.	[Radhakrishnan, Karthikeyan; Dierks, Thomas] Univ Bielefeld, Fak Chem Biochem 1, D-33615 Bielefeld, Germany; [Mariappan, Malaiyalam; Schmidt, Bernhard; von Figura, Kurt] Univ Gottingen, Zentrum Biochem & Mol Zellbiol, Biochem Abt 2, D-37073 Gottingen, Germany	University of Bielefeld; University of Gottingen	Dierks, T (corresponding author), Univ Bielefeld, Fak Chem Biochem 1, Univ Str 25, D-33615 Bielefeld, Germany.	thomas.dierks@uni-bielefeld.de	Dierks, Thomas/A-3596-2012; mariappan, malaiyalam/K-9024-2012	Dierks, Thomas/0000-0001-6426-1339; Radhakrishnan, Karthikeyan/0000-0003-1731-7410				Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Annunziata Ida, 2007, Hum Mutat, V28, P928, DOI 10.1002/humu.9504; Boltes I, 2001, STRUCTURE, V9, P483, DOI 10.1016/S0969-2126(01)00609-8; CONARY J, 1986, EUR J BIOCHEM, V158, P71, DOI 10.1111/j.1432-1033.1986.tb09722.x; Cosma MP, 2004, HUM MUTAT, V23, P576, DOI 10.1002/humu.20040; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dickmanns A, 2005, J BIOL CHEM, V280, P15180, DOI 10.1074/jbc.M414317200; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; DIERKS T, 2001, ENCY MOL MED, P3042; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hopwood JJ, 2001, METABOLIC MOL BASES, P3725; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Mariappan M, 2005, J BIOL CHEM, V280, P15173, DOI 10.1074/jbc.M413698200; Miech C, 1998, J BIOL CHEM, V273, P4835, DOI 10.1074/jbc.273.9.4835; Otsu M, 2006, ANTIOXID REDOX SIGN, V8, P274, DOI 10.1089/ars.2006.8.274; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; Sardiello M, 2005, HUM MOL GENET, V14, P3203, DOI 10.1093/hmg/ddi351; Schlotawa Lars, 2008, Hum Mutat, V29, P205, DOI 10.1002/humu.9515; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Selmer T, 1996, EUR J BIOCHEM, V238, P341, DOI 10.1111/j.1432-1033.1996.0341z.x; von Bulow R, 2001, J MOL BIOL, V305, P269, DOI 10.1006/jmbi.2000.4297; von Figura K, 1998, BIOESSAYS, V20, P505, DOI 10.1002/(SICI)1521-1878(199806)20:6<505::AID-BIES9>3.0.CO;2-K; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06	31	41	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6375	6383		10.1074/jbc.M709171200	http://dx.doi.org/10.1074/jbc.M709171200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18178549	hybrid			2022-12-27	WOS:000253779500045
J	Ginger, RS; Askew, SE; Ogborne, RM; Wilson, S; Ferdinando, D; Dadd, T; Smith, AM; Kazi, S; Szerencsei, RT; Winkfein, RJ; Schnetkamp, PPM; Green, MR				Ginger, Rebecca S.; Askew, Sarah E.; Ogborne, Richard M.; Wilson, Stephen; Ferdinando, Dudley; Dadd, Tony; Smith, Adrian M.; Kazi, Shubana; Szerencsei, Robert T.; Winkfein, Robert J.; Schnetkamp, Paul P. M.; Green, Martin R.			SLC24A5 encodes a trans-golgi network protein with potassium-dependent sodium-calcium exchange activity that regulates human epidermal melanogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ BINDING POCKET; SKIN PIGMENTATION; RETINAL CONE; FUNCTIONAL-PROPERTIES; MOLECULAR-CLONING; TYROSINASE; CA2+; EXPRESSION; NCKX2; RESIDUES	A non-synonymous single nucleotide polymorphism in the human SLC24A5 gene is associated with natural human skin color variation. Multiple sequence alignments predict that this gene encodes a member of the potassium-dependent sodium-calcium exchanger family denoted NCKX5. In cultured human epidermal melanocytes we show using affinity-purified antisera that native human NCKX5 runs as a triplet of similar to 43 kDa on SDS-PAGE and is partially localized to the trans-Golgi network. Removal of the NCKX5 protein through small interfering RNA-mediated knockdown disrupts melanogenesis in human and murine melanocytes, causing a significant reduction in melanin pigment production. Using a heterologous expression system, we confirm for the first time that NCKX5 possesses the predicted exchanger activity. Site-directed mutagenesis of NCKX5 and NCKX2 in this system reveals that the non-synonymous single nucleotide polymorphism in SLC24A5 alters a residue that is important for NCKX5 and NCKX2 activity. We suggest that NCKX5 directly regulates human epidermal melanogenesis and natural skin color through its intracellular potassium-dependent exchanger activity.	[Ginger, Rebecca S.; Askew, Sarah E.; Ogborne, Richard M.; Wilson, Stephen; Ferdinando, Dudley; Dadd, Tony; Smith, Adrian M.; Kazi, Shubana; Green, Martin R.] Unilever Res Labs Colworth, Colworth Sci Parks, Sharnbrook MK44 1LQ, Beds, England; [Szerencsei, Robert T.; Winkfein, Robert J.; Schnetkamp, Paul P. M.] Univ Calgary, Hotchkiss Brain Inst, Dept Phys & Biophys, Calgary, AB T2N 4N1, Canada	Unilever; University of Calgary	Ginger, RS (corresponding author), Unilever Res Labs Colworth, Colworth Sci Parks, Sharnbrook MK44 1LQ, Beds, England.	rebecca.ginger@unilever.com		Smith, Adrian/0000-0001-8833-2330				Altimimi HF, 2007, CHANNELS, V1, P62, DOI 10.4161/chan.4366; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Annunziato L, 2007, ANN NY ACAD SCI, V1099, P413, DOI 10.1196/annals.1387.050; Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Chen K, 2004, PIGM CELL RES, V17, P36, DOI 10.1046/j.1600-0749.2003.00106.x; Chen K, 2002, MOL BIOL CELL, V13, P1953, DOI 10.1091/mbc.02-02-0022; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; Dolman NJ, 2006, CELL CALCIUM, V40, P505, DOI 10.1016/j.ceca.2006.08.012; Fuller BB, 2001, EXP CELL RES, V262, P197, DOI 10.1006/excr.2000.5092; Halaban R, 2002, J BIOL CHEM, V277, P14821, DOI 10.1074/jbc.M111497200; Hall AM, 2005, PIGM CELL RES, V18, P122, DOI 10.1111/j.1600-0749.2005.00213.x; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; HUNT MW, 1995, ADV MATER PROCESS, V147, P4; IOZUMI K, 1993, J INVEST DERMATOL, V100, P806, DOI 10.1111/1523-1747.ep12476630; Izagirre N, 2006, MOL BIOL EVOL, V23, P1697, DOI 10.1093/molbev/msl030; Jackson IJ, 2006, EUR J HUM GENET, V14, P978, DOI 10.1038/sj.ejhg.5201659; Kang HY, 1998, PFLUG ARCH EUR J PHY, V435, P350, DOI 10.1007/s004240050522; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; Kinjo TG, 2005, BIOCHEMISTRY-US, V44, P7787, DOI 10.1021/bi0502442; Kinjo TG, 2003, BIOCHEMISTRY-US, V42, P2485, DOI 10.1021/bi0270788; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; LASKIN JD, 1982, J CELL PHYSIOL, V113, P481, DOI 10.1002/jcp.1041130318; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; Myles S, 2007, HUM GENET, V120, P613, DOI 10.1007/s00439-006-0256-4; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; NIKOMATSU L, 2007, IN PRESS J INVESTIG; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Prinsen CFM, 2000, J NEUROSCI, V20, P1424; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Schallreuter KU, 1999, BIOCHEM BIOPH RES CO, V262, P423, DOI 10.1006/bbrc.1999.1241; Schallreuter KU, 2001, J PHOTOCH PHOTOBIO B, V64, P179, DOI 10.1016/S1011-1344(01)00235-4; Sheng JZ, 2000, BIOPHYS J, V79, P1945, DOI 10.1016/S0006-3495(00)76443-5; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Smith DR, 2004, EXP CELL RES, V298, P521, DOI 10.1016/j.yexcr.2004.04.033; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Szerencsei RT, 2000, J BIOL CHEM, V275, P669, DOI 10.1074/jbc.275.1.669; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; Visser F, 2007, J BIOL CHEM, V282, P4453, DOI 10.1074/jbc.M610582200; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x	51	97	105	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5486	5495		10.1074/jbc.M707521200	http://dx.doi.org/10.1074/jbc.M707521200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18166528				2022-12-27	WOS:000253426700029
J	Chen, S; Li, B; Grundke-Iqbal, I; Iqbal, K				Chen, She; Li, Bin; Grundke-Iqbal, Inge; Iqbal, Khalid			I-1(PP2A) affects Tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; ALZHEIMER NEUROFIBRILLARY DEGENERATION; PAIRED HELICAL FILAMENTS; ACIDIC NUCLEAR-PROTEIN; LEUCINE-RICH REPEATS; HYPERPHOSPHORYLATED-TAU; RAT-BRAIN; ABNORMAL PHOSPHORYLATION; DISEASE BRAIN; 2A	In Alzheimer disease (AD) brain, the level of I-1(PP2A), a 249-amino acid long endogenous inhibitor of protein phosphatase 2A(PP2A), is increased, the activity of the phosphatase is decreased, and the microtubule-associated protein Tau is abnormally hyperphosphorylated. However, little is known about the detailed regulatory mechanism by which PP2A activity is inhibited by I-1(PP2A) and the consequent events in mammalian cells. In this study, we found that both I-1(PP2A) and its N-terminal half I-1(PP2A(1-120)), but neither I-1(PP2A(1-163)) nor I-1(PP2A(164-249)), inhibited PP2A activity in vitro, suggesting an autoinhibition by amino acid residues 121-163 and its neutralization by the C-terminal region. Furthermore, transfection of NIH3T3 cells produced a dose-dependent inhibition of PP2A activity by I-1(PP2A). I-1(PP2A) and PP2A were found to colocalize in PC12 cells. I-1(PP2A) could only interact with the catalytic subunit of PP2A (PP2Ac) and had no interaction with the regulatory subunits of PP2A (PP2A-A or PP2A-B) using a glutathione S-transferase-pulldown assay. The interaction was further confirmed by coimmunoprecipitation of I-1(PP2A) and PP2Ac from lysates of transiently transfected NIH3T3 cells. The N-terminal isotype specific region of I-1(PP2A) was required for its association with PP2Ac as well as PP2A inhibition. In addition, the phosphorylation of Tau was significantly increased in PC12/Tau441 cells transiently transfected with full-length I-1(PP2A) and with PP2Ac-interacting I-1(PP2A) deletion mutant 1-120 (I-1(PP2A)Delta C2). Double immunofluorescence staining showed that I-1(PP2A) and I-1(PP2A)Delta C2 increased Tau phosphorylation and impaired the microtubule network and neurite outgrowth in PC12 cells treated with nerve growth factor.	[Chen, She; Li, Bin; Grundke-Iqbal, Inge; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA	Institute for Basic Research in Developmental Disabilities	Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	iqbalk@wordlnet.att.net			NATIONAL INSTITUTE ON AGING [R01AG019158] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG019158-08, AG-019158, R01 AG019158] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Alonso AD, 2006, P NATL ACAD SCI USA, V103, P8864, DOI 10.1073/pnas.0603214103; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Bennecib M, 2000, ALZHEIMERS REP, V3, P295; Bennecib M, 2000, FEBS LETT, V485, P87, DOI 10.1016/S0014-5793(00)02203-1; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; Gong CX, 2000, BRAIN RES, V853, P299, DOI 10.1016/S0006-8993(99)02294-5; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HASEGAWA M, 1993, J NEUROCHEM, V60, P2068, DOI 10.1111/j.1471-4159.1993.tb03491.x; Hong R, 2004, BIOCHEMISTRY-US, V43, P10157, DOI 10.1021/bi0493968; IQBAL K, 1986, LANCET, V2, P421; Iqbal K, 1998, J NEURAL TRANSM-SUPP, P169; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; IQBAL K, 1997, BRAIN MICROTUBULE AS, P95; Kins S, 2003, AM J PATHOL, V163, P833, DOI 10.1016/S0002-9440(10)63444-X; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Li B, 2007, ACTA NEUROPATHOL, V113, P501, DOI 10.1007/s00401-007-0207-8; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Liang L, 2004, FEBS LETT, V566, P261, DOI 10.1016/j.febslet.2004.04.047; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; MATSUOKA K, 1994, P NATL ACAD SCI USA, V91, P9670, DOI 10.1073/pnas.91.21.9670; Mencinger M, 1998, BBA-GENE STRUCT EXPR, V1395, P176, DOI 10.1016/S0167-4781(97)00165-6; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Pei JJ, 2003, AM J PATHOL, V163, P845, DOI 10.1016/S0002-9440(10)63445-1; Pei JJ, 2003, ACTA NEUROPATHOL, V105, P381, DOI 10.1007/s00401-002-0657-y; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sengupta A, 2006, FEBS LETT, V580, P5925, DOI 10.1016/j.febslet.2006.09.060; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; Tanimukai H, 2004, MOL BRAIN RES, V126, P146, DOI 10.1016/j.molbrainres.2004.04.003; Tolnay M, 1999, NEUROPATH APPL NEURO, V25, P171; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; Tsujio I, 2005, FEBS LETT, V579, P363, DOI 10.1016/j.febslet.2004.11.097; Ulitzur N, 1997, J BIOL CHEM, V272, P30577, DOI 10.1074/jbc.272.48.30577; Ulitzur N, 1997, P NATL ACAD SCI USA, V94, P5084, DOI 10.1073/pnas.94.10.5084; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; WALENSKY LD, 1993, CANCER RES, V53, P4720; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wang JZ, 1996, MOL BRAIN RES, V38, P200, DOI 10.1016/0169-328X(95)00316-K; Yu LG, 2004, J BIOL CHEM, V279, P41377, DOI 10.1074/jbc.M400017200	64	59	64	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10513	10521		10.1074/jbc.M709852200	http://dx.doi.org/10.1074/jbc.M709852200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18245083	Green Published, hybrid			2022-12-27	WOS:000254894700033
J	Gackiere, F; Bidaux, G; Delcourt, P; Van Coppenolle, F; Katsogiannou, M; Dewailly, E; Bavencoffe, A; Van Chuoi-Mariot, MT; Mauroy, B; Prevarskaya, N; Mariot, P				Gackiere, Florian; Bidaux, Gabriel; Delcourt, Philippe; Van Coppenolle, Fabien; Katsogiannou, Maria; Dewailly, Etienne; Bavencoffe, Alexis; Van Chuoi-Mariot, Myriam Tran; Mauroy, Brigitte; Prevarskaya, Natalia; Mariot, Pascal			CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-THRESHOLD EXOCYTOSIS; PROTEIN-KINASE-C; ACID-PHOSPHATASE; CA2+ CHANNELS; EPITHELIAL-CELLS; TUMOR-CELLS; DIFFERENTIATION; EXPRESSION; PROLIFERATION; FLUORESCENCE	Because prostate cancer is, in its early stages, an androgen-dependent pathology, treatments aiming at decreasing testosterone plasma concentration have been developed for many years now. However, a significant proportion of patients suffer a relapse after a few years of hormone therapy. The androgen-independent stage of prostate cancer has been shown to be associated with the development of neuroendocrine differentiation. We previously demonstrated that neuroendocrine prostate cancer cells derived from LNCaP cells overexpress CaV3.2 T-type voltage-dependent calcium channels. We demonstrate here using prostatic acid phosphatase as a marker of prostate secretion and FM1-43 fluorescence imaging of membrane trafficking that neuroendocrine differentiation is associated with an increase in calcium-dependent secretion which critically relies on CaV3.2 T-type calcium channel activity. In addition, we show that these channels are expressed by neuroendocrine cells in prostate cancer tissues obtained from patients after surgery. We propose that CaV3.2 T-type calcium channel up-regulation may account for the alteration of secretion during prostate cancer development and that these channels, by promoting the secretion of potential mitogenic factors, could participate in the progression of the disease toward an androgen-independent stage.	[Gackiere, Florian; Bidaux, Gabriel; Delcourt, Philippe; Van Coppenolle, Fabien; Katsogiannou, Maria; Dewailly, Etienne; Bavencoffe, Alexis; Van Chuoi-Mariot, Myriam Tran; Mauroy, Brigitte; Prevarskaya, Natalia; Mariot, Pascal] INSERM, Lab Physiol Cellulaire, Equipe Labellisee Ligue Contre Canc, U800, F-59650 Villeneuve Dascq, France; [Gackiere, Florian; Bidaux, Gabriel; Delcourt, Philippe; Van Coppenolle, Fabien; Katsogiannou, Maria; Dewailly, Etienne; Bavencoffe, Alexis; Van Chuoi-Mariot, Myriam Tran; Mauroy, Brigitte; Prevarskaya, Natalia; Mariot, Pascal] Univ Sci & Tech Lille, F-59650 Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Mariot, P (corresponding author), Univ Sci & Tech Lille, INSERM, U800, Lab Physiol Cellulaire, Batiment SN3, F-59655 Villeneuve Dascq, France.	Pascal.Mariot@univ-lille1.fr	; Bidaux, Gabriel/F-1294-2016	Mariot, Pascal/0000-0001-7226-9162; Prevarskaya, natacha/0000-0003-0316-197X; Bidaux, Gabriel/0000-0002-6162-3223; Bavencoffe, Alexis Guillaume/0000-0001-5659-5988				Asaga S, 2006, ANTICANCER RES, V26, P35; Aumuller G, 1999, UROLOGY, V53, P1041, DOI 10.1016/S0090-4295(98)00631-1; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bonkhoff H, 1998, PROSTATE, P18; BONKHOFF H, 1991, PROSTATE, V19, P91, DOI 10.1002/pros.2990190202; Brumback AC, 2004, METHODS, V33, P287, DOI 10.1016/j.ymeth.2004.01.002; Carbone E, 2006, PFLUG ARCH EUR J PHY, V453, P373, DOI 10.1007/s00424-006-0100-7; Carbone E, 2006, CELL CALCIUM, V40, P147, DOI 10.1016/j.ceca.2006.04.019; Chemin J, 2004, NEUROREPORT, V15, P671, DOI 10.1097/00001756-200403220-00019; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; COHEN RJ, 1991, BRIT J UROL, V68, P258, DOI 10.1111/j.1464-410X.1991.tb15318.x; COHEN RJ, 1990, BRIT J UROL, V66, P405, DOI 10.1111/j.1464-410X.1990.tb14963.x; COHEN RJ, 1992, ARCH PATHOL LAB MED, V116, P65; Cox ME, 1999, CANCER RES, V59, P3821; Cox ME, 2000, J BIOL CHEM, V275, P13812, DOI 10.1074/jbc.275.18.13812; Darszon A, 2006, CELL CALCIUM, V40, P241, DOI 10.1016/j.ceca.2006.04.028; Dizeyi N, 2004, PROSTATE, V59, P328, DOI 10.1002/pros.10374; Exintaris B, 2006, AUTON NEUROSCI-BASIC, V126, P371, DOI 10.1016/j.autneu.2006.02.019; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gackiere F, 2006, CELL CALCIUM, V39, P357, DOI 10.1016/j.ceca.2005.12.003; Gee KR, 1999, ANAL BIOCHEM, V273, P41, DOI 10.1006/abio.1999.4202; Giancippoli A, 2006, BIOPHYS J, V90, P1830, DOI 10.1529/biophysj.105.071647; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Huang JT, 2006, PROSTATE, V66, P1399, DOI 10.1002/pros.20434; ISHIBE M, 1991, J CLIN ENDOCR METAB, V73, P785, DOI 10.1210/jcem-73-4-785; Johnson JL, 2005, BIOCHEM J, V391, P699, DOI 10.1042/BJ20050380; Kim JH, 2003, PFLUG ARCH EUR J PHY, V446, P88, DOI 10.1007/s00424-002-0995-6; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Lin MF, 2001, CELL BIOL INT, V25, P1139, DOI 10.1006/cbir.2001.0794; Lu FM, 2008, CELL CALCIUM, V43, P49, DOI 10.1016/j.ceca.2007.03.006; Mansvelder HD, 2000, J PHYSIOL-LONDON, V526, P327, DOI 10.1111/j.1469-7793.2000.t01-1-00327.x; Mariot P, 2002, J BIOL CHEM, V277, P10824, DOI 10.1074/jbc.M108754200; MASUMOTO N, 1995, CELL CALCIUM, V18, P223, DOI 10.1016/0143-4160(95)90067-5; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; Nunez L, 2000, ENDOCRINOLOGY, V141, P2012, DOI 10.1210/en.141.6.2012; Pan ZH, 2001, NEURON, V32, P89, DOI 10.1016/S0896-6273(01)00454-8; Panner A, 2005, CELL CALCIUM, V37, P105, DOI 10.1016/j.ceca.2004.07.002; Park JY, 2003, FEBS LETT, V547, P37, DOI 10.1016/S0014-5793(03)00665-3; SHORTE SL, 1993, J PHYSIOL-LONDON, V470, P191, DOI 10.1113/jphysiol.1993.sp019854; Taira AL, 2007, ONCOLOGY-NY, V21, P1003; Thebault S, 2003, J CLIN INVEST, V111, P1691, DOI 10.1172/JCI200316293; Theodoropoulos VE, 2005, UROLOGY, V66, P897, DOI 10.1016/j.urology.2005.04.064; Toyota M, 1999, CANCER RES, V59, P4535; Veeramani S, 2005, ENDOCR-RELAT CANCER, V12, P805, DOI 10.1677/erc.1.00950; Weinstein MH, 1996, HUM PATHOL, V27, P683, DOI 10.1016/S0046-8177(96)90398-6; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043; Zelivianski S, 2001, BBA-MOL CELL RES, V1539, P28, DOI 10.1016/S0167-4889(01)00087-8	50	66	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10162	10173		10.1074/jbc.M707159200	http://dx.doi.org/10.1074/jbc.M707159200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18230611	hybrid, Green Published			2022-12-27	WOS:000254671600069
J	Golczak, M; Maeda, A; Bereta, G; Maeda, T; Kiser, PD; Hunzelmann, S; von Lintig, J; Blaner, WS; Palczewski, K				Golczak, Marcin; Maeda, Akiko; Bereta, Grzegorz; Maeda, Tadao; Kiser, Philip D.; Hunzelmann, Silke; von Lintig, Johannes; Blaner, William S.; Palczewski, Krzysztof			Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARGARDTS MACULAR DEGENERATION; LEBER CONGENITAL AMAUROSIS; PIGMENT EPITHELIAL-CELLS; MEDIATED GENE-TRANSFER; BINDING-PROTEIN; VITAMIN-A; MOUSE MODEL; CHILDHOOD BLINDNESS; SUBSTRATE SPECIFICITIES; LIPOFUSCIN FLUOROPHORE	In vertebrate retinal photoreceptors, the absorption of light by rhodopsin leads to photoisomerization of 11-cis-retinal to its all-trans isomer. To sustain vision, a metabolic system evolved that recycles all-trans-retinal back to 11-cis-retinal. The importance of this visual (retinoid) cycle is underscored by the fact that mutations in genes encoding visual cycle components induce a wide spectrum of diseases characterized by abnormal levels of specific retinoid cycle intermediates. In addition, intense illumination can produce retinoid cycle by-products that are toxic to the retina. Thus, inhibition of the retinoid cycle has therapeutic potential in physiological and pathological states. Four classes of inhibitors that include retinoid and nonretinoid compounds have been identified. We investigated the modes of action of these inhibitors by using purified visual cycle components and in vivo systems. We report that retinylamine was the most potent and specific inhibitor of the retinoid cycle among the tested compounds and that it targets the retinoid isomerase, RPE65. Hydrophobic primary amines like farnesylamine also showed inhibitory potency but a short duration of action, probably due to rapid metabolism. These compounds also are reactive nucleophiles with potentially high cellular toxicity. We also evaluated the role of a specific protein-mediated mechanism on retinoid cycle inhibitor uptake by the eye. Our results show that retinylamine is transported to and taken up by the eye by retinol-binding protein-independent and retinoic acid-responsive gene product 6-independent mechanisms. Finally, we provide evidence for a crucial role of lecithin: retinol acyltransferase activity in mediating tissue specific absorption and long lasting therapeutic effects of retinoid-based visual cycle inhibitors.	[Golczak, Marcin; Maeda, Akiko; Bereta, Grzegorz; Maeda, Tadao; Kiser, Philip D.; Hunzelmann, Silke; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Hunzelmann, Silke; von Lintig, Johannes] Univ Freiburg, Inst Biol 1, D-79104 Freiburg, Germany; [Blaner, William S.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Case Western Reserve University; University of Freiburg; Columbia University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Wood Bldg 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu		von Lintig, Johannes/0000-0002-2079-2143	NATIONAL EYE INSTITUTE [R01EY009339, T32EY007157, P30EY011373] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY009339-19S1, P30 EY 11373, EY 09339, 2T32 EY 007157, P30 EY011373-129005, R01 EY009339, P30 EY011373, T32 EY007157, R01 EY009339-19] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aleman TS, 2004, INVEST OPHTH VIS SCI, V45, P1259, DOI 10.1167/iovs.03-1230; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; BERNI R, 1992, FEBS LETT, V308, P43, DOI 10.1016/0014-5793(92)81046-O; BLANER WS, 1985, J LIPID RES, V26, P1241; Caffery B E, 1988, J Am Optom Assoc, V59, P221; CANADA FJ, 1990, BIOCHEMISTRY-US, V29, P9690, DOI 10.1021/bi00493a026; Caruso RC, 1998, ARCH OPHTHALMOL-CHIC, V116, P759, DOI 10.1001/archopht.116.6.759; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; Conley B, 2000, J CLIN ONCOL, V18, P275, DOI 10.1200/JCO.2000.18.2.275; Coxon FP, 2001, J BIOL CHEM, V276, P48213, DOI 10.1074/jbc.M106473200; De S, 2002, J GEN PHYSIOL, V120, P147, DOI 10.1085/jgp.20028566; DELAEY JJ, 1995, RETINA-J RET VIT DIS, V15, P399, DOI 10.1097/00006982-199515050-00005; DOLENCE JM, 1995, P NATL ACAD SCI USA, V92, P5008, DOI 10.1073/pnas.92.11.5008; Edmondson DE, 2007, ARCH BIOCHEM BIOPHYS, V464, P269, DOI 10.1016/j.abb.2007.05.006; ELDRED GE, 1993, NATURE, V364, P396; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Gamble MV, 2000, BBA-PROTEIN STRUCT M, V1476, P3, DOI 10.1016/S0167-4838(99)00232-0; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Gollapalli DR, 2004, P NATL ACAD SCI USA, V101, P10030, DOI 10.1073/pnas.0401936101; Huang CC, 2000, BIOCHEMISTRY-US, V39, P2593, DOI 10.1021/bi992356x; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Isken A, 2007, J BIOL CHEM, V282, P1144, DOI 10.1074/jbc.M609109200; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jones TH, 2003, J NAT PROD, V66, P325, DOI 10.1021/np020558f; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Khalil AA, 2000, CHEM RES TOXICOL, V13, P31, DOI 10.1021/tx990146f; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KOTHAPALLI R, 1993, LIPIDS, V28, P969, DOI 10.1007/BF02537116; Kuksa V, 2003, VISION RES, V43, P2959, DOI 10.1016/S0042-6989(03)00482-6; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; LAW WC, 1989, BIOCHEM BIOPH RES CO, V161, P825, DOI 10.1016/0006-291X(89)92674-0; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Maiti P, 2005, BIOCHEMISTRY-US, V44, P14463, DOI 10.1021/bi0510779; Maiti P, 2007, BIOCHEMISTRY-US, V46, P8700, DOI 10.1021/bi701061k; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; McBee JK, 2001, J BIOL CHEM, V276, P48483, DOI 10.1074/jbc.M105840200; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Molnar G, 2001, BIOCHEMISTRY-US, V40, P10542, DOI 10.1021/bi011158e; MUINDI JR, 1994, LEUKEMIA, V8, P16; NOY N, 1990, BIOCHEMISTRY-US, V29, P3888, DOI 10.1021/bi00468a014; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Radu Roxana A, 2004, Novartis Found Symp, V255, P51; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rohrer B, 2003, INVEST OPHTH VIS SCI, V44, P310, DOI 10.1167/iovs.02-0567; SAARI JC, 1990, METHOD ENZYMOL, V190, P156; SAGAMI H, 1992, ARCH BIOCHEM BIOPHYS, V297, P314, DOI 10.1016/0003-9861(92)90678-P; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Stecher H, 2000, METHOD ENZYMOL, V316, P330; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Ura H, 1998, MOL CARCINOGEN, V21, P93, DOI 10.1002/(SICI)1098-2744(199802)21:2<93::AID-MC3>3.0.CO;2-P; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; Vogel S, 2002, BIOCHEMISTRY-US, V41, P15360, DOI 10.1021/bi0268551; Wabbels B, 2006, GRAEF ARCH CLIN EXP, V244, P36, DOI 10.1007/s00417-005-0043-2; Xie YS, 1998, PROTEIN EXPRES PURIF, V14, P31, DOI 10.1006/prep.1998.0944	79	80	82	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9543	9554		10.1074/jbc.M708982200	http://dx.doi.org/10.1074/jbc.M708982200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18195010	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000254671600007
J	Moreno, I; Norambuena, L; Maturana, D; Toro, M; Vergara, C; Orellana, A; Zurita-Silva, A; Ordenes, VR				Moreno, Ignacio; Norambuena, Lorena; Maturana, Daniel; Toro, Mauricio; Vergara, Cecilia; Orellana, Ariel; Zurita-Silva, Andres; Ordenes, Viviana R.			AtHMA1 is a thapsigargin-sensitive Ca2+/heavy metal pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; SITE-DIRECTED MUTAGENESIS; CA2+ TRANSPORT ATPASE; ENDOPLASMIC-RETICULUM; SARCOPLASMIC-RETICULUM; BINDING DOMAIN; CALCIUM-PUMP; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; P-1B-TYPE ATPASE	The Arabidopsis thaliana AtHMA1 protein is a member of the P-IB-ATPase family, which is implicated in heavy metal transport. However, sequence analysis reveals that AtHMA1 possesses a predicted stalk segment present in SERCA (sarcoplasmic/endoplasmic reticulum Ca2+ ATPase)-type pumps that is involved in inhibition by thapsigargin. To analyze the ion specificity of AtHMA1, we performed functional complementation assays using mutant yeast strains defective in Ca2+ homeostasis or heavy metal transport. The heterologous expression of AtHMA1 complemented the phenotype of both types of mutants and, interestingly, increased heavy metal tolerance of wildtype yeast. Biochemical analyses were performed to describe the activity of AtHMA1 in microsomal fractions isolated from complemented yeast. Zinc, copper, cadmium, and cobalt activate the ATPase activity of AtHMA1, which corroborates the results of metal tolerance assays. The outcome establishes the role of AtHMA1 in Cd2+ detoxification in yeast and suggests that this pump is able to transport other heavy metals ions. Further analyses were performed to typify the active Ca2+ transport mediated by AtHMA1. Ca2+ transport displayed high affinity with an apparent K-m of 370 nM and a V-max of 1.53 nmol mg(-1) min(-1). This activity was strongly inhibited by thapsigargin (IC50 = 16.74 nM), demonstrating the functionality of its SERCA-like stalk segment. In summary, these results demonstrate that AtHMA1 functions as a Ca2+/heavy metal pump. This protein is the first described plant P-type pump specifically inhibited by thapsigargin.	[Toro, Mauricio; Zurita-Silva, Andres; Ordenes, Viviana R.] Univ La Serena, Lab Biol Mol Vegetal, Ctr Estudios Avanzados Zonas Aridas CEAZA, La Serena 1720170, Chile; [Norambuena, Lorena] Univ Chile, Fac Ciencias, Lab Biol Mol Vegetal, Santiago 1720170, Chile; [Moreno, Ignacio; Maturana, Daniel; Vergara, Cecilia; Ordenes, Viviana R.] Univ Chile, Fac Ciencias, Lab Fisiol Celular, Santiago 7800024, Chile; [Orellana, Ariel] Univ Andres Bello, Ctr Biotecnol Vegetal, Millenium Nucleus Plant Cell Biotechnol, Santiago 8370146, Chile	Universidad de La Serena; Universidad de Chile; Universidad de Chile; Universidad Andres Bello	Ordenes, VR (corresponding author), Univ La Serena, Lab Biol Mol Vegetal, Ctr Estudios Avanzados Zonas Aridas CEAZA, Campus Andres Bello,Casilla 599, La Serena 1720170, Chile.	viviana.ordenes@ceaza.cl	Zurita-Silva, Andres/A-6879-2015; Vergara, Cecilia/H-6964-2014; Norambuena, Lorena/I-1248-2013; Zurita-Silva, Andres/O-4991-2019; Orellana, Ariel/AAE-4866-2021; Orellana, Ariel/E-2166-2014	Zurita-Silva, Andres/0000-0001-7274-2765; Vergara, Cecilia/0000-0002-4015-7438; Norambuena, Lorena/0000-0002-6031-2394; Zurita-Silva, Andres/0000-0001-7274-2765; Orellana, Ariel/0000-0002-9243-808X; Orellana, Ariel/0000-0002-9243-808X; Toro-Nahuelpan, Mauricio/0000-0001-5333-3640				ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bassham DC, 2000, PLANT PHYSIOL, V122, P999, DOI 10.1104/pp.122.4.999; BITTER GA, 1984, GENE, V32, P263, DOI 10.1016/0378-1119(84)90002-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cobbett CS, 2003, NEW PHYTOL, V159, P315, DOI 10.1046/j.1469-8137.2003.00785.x; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Del Aguila EM, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-9; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Efremov RG, 2004, BIOCHEM J, V382, P293, DOI 10.1042/BJ20040326; Eren E, 2004, PLANT PHYSIOL, V136, P3712, DOI 10.1104/pp.104.046292; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Geisler M, 2000, BBA-BIOMEMBRANES, V1465, P52, DOI 10.1016/S0005-2736(00)00131-0; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gravot A, 2004, FEBS LETT, V561, P22, DOI 10.1016/S0014-5793(04)00072-9; Harper JF, 1998, J BIOL CHEM, V273, P1099, DOI 10.1074/jbc.273.2.1099; HIGUCHI M, 2005, PHOTOSYNTHESIS FUNDA, P716; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Liang F, 1997, P NATL ACAD SCI USA, V94, P8579, DOI 10.1073/pnas.94.16.8579; Liang F, 1998, PLANT PHYSIOL, V118, P817, DOI 10.1104/pp.118.3.817; LODDENKOTTER B, 1993, P NATL ACAD SCI USA, V90, P2155, DOI 10.1073/pnas.90.6.2155; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Rutherford JC, 1999, J BIOL CHEM, V274, P25827, DOI 10.1074/jbc.274.36.25827; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAVINSKY MH, 2006, J BIOL CHEM, V281, P11161; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Stokes DL, 2003, ANNU REV BIOPH BIOM, V32, P445, DOI 10.1146/annurev.biophys.32.110601.142433; Tong L, 2002, J BACTERIOL, V184, P5027, DOI 10.1128/JB.184.18.5027-5035.2002; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; WILLIAMS L, 2005, TRENDS PLANT SCI, V10, P1360; Wootton LL, 2006, J BIOL CHEM, V281, P6970, DOI 10.1074/jbc.M510978200; Wu ZY, 2002, PLANT PHYSIOL, V130, P128, DOI 10.1104/pp.004440; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200; ZHANG ZY, 1993, FEBS LETT, V335, P261, DOI 10.1016/0014-5793(93)80742-D; Zhong L, 1998, J BIOL CHEM, V273, P12994, DOI 10.1074/jbc.273.21.12994	52	100	104	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9633	9641		10.1074/jbc.M800736200	http://dx.doi.org/10.1074/jbc.M800736200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18252706	hybrid			2022-12-27	WOS:000254671600017
J	Agarwal, R; Burley, SK; Swaminathan, S				Agarwal, Rakhi; Burley, Stephen K.; Swaminathan, Subramanyam			Structure of human dual specificity protein phosphatase 23, VHZ, enzyme-substrate/product complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; TRANSITION-STATE STRUCTURES; CRYSTAL-STRUCTURE; SPECIFICITY; PEPTIDE; RECOGNITION; MECHANISM; FAMILY; GENE	Protein phosphorylation plays a crucial role in mitogenic signal transduction and regulation of cell growth and differentiation. Dual specificity protein phosphatase 23 ( DUSP23) or VHZ mediates dephosphorylation of phospho-tyrosyl ( pTyr) and phospho-seryl/threonyl ( pSer/pThr) residues in specific proteins. In vitro, it can dephosphorylate p44ERK1 but not p54SAPK-beta and enhance activation of c-Jun N-terminal kinase ( JNK) and p38. Human VHZ, the smallest of the catalytically active protein-tyrosine phosphatases ( PTP) reported to date ( 150 residues), is a class I Cys-based PTP and bears the distinctive active site signature motif HCXXGXXRS( T). We present the crystal structure of VHZ determined at 1.93 angstrom resolution. The polypeptide chain adopts the typical alpha beta alpha PTP fold, giving rise to a shallow active site cleft that supports dual phosphorylated substrate specificity. Within our crystals, the Thr-135-Tyr-136 from a symmetry-related molecule bind in the active site with a malate ion, where they mimic the phosphorylated TY motif of the MAPK activation loop in an enzyme-substrate/product complex. Analyses of intermolecular interactions between the enzyme and this pseudo substrate/product along with functional analysis of Phe-66, Leu-97, and Phe-99 residues provide insights into the mechanism of substrate binding and catalysis in VHZ.	[Agarwal, Rakhi; Swaminathan, Subramanyam] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Burley, Stephen K.] SGX Pharmaceut Inc, San Diego, CA 92121 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Swaminathan, S (corresponding author), Brookhaven Natl Lab, Dept Biol, Bldg 463, Upton, NY 11973 USA.	swami@bnl.gov		Burley, Stephen K./0000-0002-2487-9713	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074945] Funding Source: NIH RePORTER; NIGMS NIH HHS [U54 GM 074945] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Chen L, 1996, BIOCHEMISTRY-US, V35, P9349, DOI 10.1021/bi960700+; *COLL COMP PROJ NU, 1994, ACTA CRYSTALLOGR D, V70, P760; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DELANO WL, 2002, PY MOL USERS MANUAL; den Hertog J, 2003, EMBO REP, V4, P1027, DOI 10.1038/sj.embor.7400009; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; Hengge AC, 1996, BIOCHEMISTRY-US, V35, P7084, DOI 10.1021/bi960255i; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedersen AK, 2004, BIOCHEM J, V378, P421, DOI 10.1042/BJ20030565; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rossi R, 1998, J BIOL CHEM, V273, P19198, DOI 10.1074/jbc.273.30.19198; Sarmiento M, 2000, BIOCHEMISTRY-US, V39, P8171, DOI 10.1021/bi000319w; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher MA, 2002, BIOCHEMISTRY-US, V41, P3009, DOI 10.1021/bi015799l; Sun JP, 2003, J BIOL CHEM, V278, P12406, DOI 10.1074/jbc.M212491200; Takagaki K, 2004, BIOCHEM J, V383, P447, DOI 10.1042/BJ20040498; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wu L, 1996, BIOCHEMISTRY-US, V35, P5426, DOI 10.1021/bi952885a; Wu QH, 2004, INT J BIOCHEM CELL B, V36, P1542, DOI 10.1016/j.biocel.2003.12.014; Yang J, 2001, J CELL BIOCHEM, V83, P14, DOI 10.1002/jcb.1195; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; ZHANG ZY, 1994, J BIOL CHEM, V269, P8140; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; ZHANG ZY, 1995, J BIOL CHEM, V270, P11199, DOI 10.1074/jbc.270.19.11199; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624; Zhang ZY, 1998, CRIT REV BIOCHEM MOL, V33, P1, DOI 10.1080/10409239891204161; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P15266, DOI 10.1021/bi00255a007; ZHOU GC, 1994, J BIOL CHEM, V269, P28084	34	20	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8946	8953		10.1074/jbc.M708945200	http://dx.doi.org/10.1074/jbc.M708945200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18245086	hybrid			2022-12-27	WOS:000254465800023
J	Bose, M; Whittal, RM; Miller, WL; Bose, HS				Bose, Mahuya; Whittal, Randy M.; Miller, Walter L.; Bose, Himangshu S.			Steroidogenic activity of StAR requires contact with mitochondrial VDAC1 and phosphate carrier protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE REGULATORY PROTEIN; DEPENDENT ANION CHANNEL; BENZODIAZEPINE-RECEPTOR; CHOLESTEROL-BINDING; IMPORT; MEMBRANE; IDENTIFICATION; INHIBITION; TRANSPORT; SEQUENCE	The steroidogenic acute regulatory protein ( StAR) is required for adrenal and gonadal steroidogenesis and for male sexual differentiation. StAR acts on the outer mitochondrial membrane (OMM) to facilitate movement of cholesterol from the OMM to the inner mitochondrial membrane to be converted to pregnenolone, the precursor of all steroid hormones. The mechanisms of the action of StAR remain unclear; the peripheral benzodiazepine receptor, an OMM protein, appears to be involved, but the identity of OMM proteins that interact with StAR remain unknown. Here we demonstrate that phosphorylated StAR interacts with voltage-dependent anion channel 1 (VDAC1) on the OMM, which then facilitates processing of the 37-kDa phospho-StAR to the 32-kDa intermediate. In the absence of VDAC1, phospho-StAR is degraded by cysteine proteases prior to mitochondrial import. Phosphorylation of StAR by protein kinase A requires phosphate carrier protein on the OMM, which appears to interact with StAR before it interacts with VDAC1. VDAC1 and phosphate carrier protein are the first OMM proteins shown to contact StAR.	[Bose, Mahuya; Bose, Himangshu S.] Univ Florida, Dept Physiol & Func Genom, Gainesville, FL 32610 USA; [Whittal, Randy M.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2E1, Canada; [Miller, Walter L.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	State University System of Florida; University of Florida; University of Alberta; University of California System; University of California San Francisco	Bose, HS (corresponding author), Mercer Univ, Sch Med, Dept Biomed Sci, 4700 Water Ave, Savannah, GA 31404 USA.	bosehi1@memorialhealth.com	Miller, Walter L/J-3696-2012	Whittal, Randy/0000-0003-1174-8172	Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [DK 37922] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037922] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alconada A, 1995, METHOD ENZYMOL, V260, P263, DOI 10.1016/0076-6879(95)60144-9; Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; Baker BY, 2005, J BIOL CHEM, V280, P41753, DOI 10.1074/jbc.M510241200; BLAHOS J, 1995, J BIOL CHEM, V270, P20285, DOI 10.1074/jbc.270.35.20285; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; DOBLE A, 1987, MOL PHARMACOL, V31, P42; Galiegue S, 1999, J BIOL CHEM, V274, P2938, DOI 10.1074/jbc.274.5.2938; GENCHI G, 1988, BIOCHIM BIOPHYS ACTA, V936, P413, DOI 10.1016/0005-2728(88)90018-7; HARIKRISHNA JA, 1993, DNA CELL BIOL, V12, P371, DOI 10.1089/dna.1993.12.371; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Jo Y, 2005, BIOL REPROD, V73, P244, DOI 10.1095/biolreprod.104.037721; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; KOLBE HVJ, 1985, J BIOL CHEM, V260, P5899; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Lingappa VR, 2005, MT SINAI J MED, V72, P141; MANGAN PS, 1987, P NATL ACAD SCI USA, V84, P4896, DOI 10.1073/pnas.84.14.4896; Manna PR, 2006, MOL ENDOCRINOL, V20, P362, DOI 10.1210/me.2004-0526; MASACARDO RN, 1988, J PHARMACOL EXP THER, V244, P361; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Miller WL, 2007, MOL ENDOCRINOL, V21, P589, DOI 10.1210/me.2006-0303; MURAKAMI H, 1990, NATURE, V347, P488, DOI 10.1038/347488a0; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; STONER CD, 1973, J CELL BIOL, V56, P65, DOI 10.1083/jcb.56.1.65; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Yaworsky DC, 2005, J BIOL CHEM, V280, P2045, DOI 10.1074/jbc.M410937200; Zara V, 1996, MOL CELL BIOL, V16, P6524	41	95	100	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8837	8845		10.1074/jbc.M709221200	http://dx.doi.org/10.1074/jbc.M709221200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18250166	Green Published, hybrid			2022-12-27	WOS:000254465800010
J	Brandt, W; Khandekar, M; Suzuki, N; Yamamoto, M; Lim, KC; Engel, JD				Brandt, William; Khandekar, Melin; Suzuki, Norio; Yamamoto, Masayuki; Lim, Kim-Chew; Engel, James Douglas			Defining the functional boundaries of the Gata2 locus by rescue with a linked bacterial artificial chromosome transgene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-2; IN-VIVO; HEMATOPOIETIC DEFECT; RECOMBINATION; EXPRESSION; DIFFERENTIATION; SYSTEM; CELLS; SELECTION; MULTIPLE	Transcription factor GATA-2 is vital for both hematopoietic progenitor cell function and urogenital patterning. Transgenic mapping studies have shown that the hematopoietic and urogenital enhancers are located hundreds of kbp 5' and 3' to the Gata2 structural gene, and both are vital for embryonic development. Because the size of mammalian genes, including all of their associated regulatory elements, can exceed a megabase, transgenic complementation in mice has, in specific instances, proven to be a formidable hurdle. After incorporating the Gata2 structural gene as well as the distant hematopoietic and urogenital enhancers into a single, contiguous piece of DNA by fusing two bacterial artificial chromosomes ( BACs) into one, we formally tested the hypothesis that the functional boundaries of this locus are contained within this contiguous genomic span. We show that two independent lines of transgenic mice bearing a multicopy 413-kbp-linked Gata2 BAC transgene ( bearing sequences from -187 to +226 kbp of the locus) are able to fully rescue Gata2 null mutant embryonic lethality and that the rescued animals behave and reproduce normally. Surprisingly, the linked BAC confers expression in the ureteric epithelium, whereas sequences within any of the overlapping parental BACs and a yeast artificial chromosome that were originally tested do not, and thus these experiments also define a novel synthetic enhancer activity that has not been previously described. These genetic complementation studies define the required outer limits of the Gata2 locus and formally demonstrate that enhancers lying beyond those boundaries are not necessary for Gata2-regulated viability or fecundity.	[Brandt, William; Khandekar, Melin; Lim, Kim-Chew; Engel, James Douglas] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Suzuki, Norio; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 9808575, Japan	University of Michigan System; University of Michigan; Tohoku University	Engel, JD (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, 3071 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	engel@umich.edu	Suzuki, Norio/F-3456-2010; Suzuki, Norio/AAZ-9458-2021; Yamamoto, Masayuki/A-4873-2010	Suzuki, Norio/0000-0001-6100-3350; Yamamoto, Masayuki/0000-0002-9073-9436	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028896, T32GM008152, T32GM007315] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007315, GM 28896, GM 07315, GM 08152] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blanton J, 2003, GENE DEV, V17, P664, DOI 10.1101/gad.1052003; BRIEGEL K, 1993, GENE DEV, V7, P1097, DOI 10.1101/gad.7.6.1097; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; Frengen E, 1999, GENOMICS, V58, P250, DOI 10.1006/geno.1998.5693; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; Khandekar M, 2004, MOL CELL BIOL, V24, P10263, DOI 10.1128/MCB.24.23.10263-10276.2004; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; Kitajima K, 2002, EMBO J, V21, P3060, DOI 10.1093/emboj/cdf301; Kotzamanis G, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-1; Kouprina N, 1999, GENOMICS, V56, P262, DOI 10.1006/geno.1998.5727; LARIONOV V, 1994, NUCLEIC ACIDS RES, V22, P4154, DOI 10.1093/nar/22.20.4154; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Ma GT, 1997, DEVELOPMENT, V124, P907; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Osoegawa K, 2000, GENOME RES, V10, P116; Podolsky T, 1996, PLASMID, V36, P112, DOI 10.1006/plas.1996.0038; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Siegel RW, 2001, FEBS LETT, V499, P147, DOI 10.1016/S0014-5793(01)02541-8; Sopher BL, 2006, GENE, V371, P136, DOI 10.1016/j.gene.2005.11.034; Suzuki N, 2006, P NATL ACAD SCI USA, V103, P2202, DOI 10.1073/pnas.0508928103; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Zhang XM, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng081; Zhou YH, 2000, DEVELOPMENT, V127, P3829; Zhou YH, 1998, EMBO J, V17, P6689, DOI 10.1093/emboj/17.22.6689	31	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8976	8983		10.1074/jbc.M709364200	http://dx.doi.org/10.1074/jbc.M709364200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18211891	Green Published, hybrid			2022-12-27	WOS:000254465800027
J	Gao, YJ; Chotoo, CK; Balut, CM; Sun, F; Bailey, MA; Devor, DC				Gao, Yajuan; Chotoo, Cavita K.; Balut, Corina M.; Sun, Fei; Bailey, Mark A.; Devor, Daniel C.			Role of s3 and s4 transmembrane domain charged amino acids in channel biogenesis and Gating of KCa2.3 and KCa3.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNEL; ACTIVATED POTASSIUM CHANNELS; VOLTAGE SENSOR; INTERMEDIATE CONDUCTANCE; ELECTROSTATIC INTERACTIONS; DEPENDENT ACTIVATION; CYSTIC-FIBROSIS; AAA ATPASE; RESIDUES; SEGMENTS	The role of positively charged arginines in the fourth transmembrane domain ( S4) and a single negatively charged amino acid in the third transmembrane domain ( S3) on channel biogenesis and gating of voltage-gated K+ channels (Kv) has been well established. Both intermediate ( KCa3.1) and small ( KCa2.x) conductance, Ca2+-activated K+ channels have two conserved arginines in S4 and a single conserved glutamic acid in S3, although these channels are voltage- independent. We demonstrate that mutation of any of these charged amino acids in KCa3.1 or KCa2.3 to alanine, glutamine, or charge reversal mutations results in a rapid degradation (< 30 min) of total protein, confirming the critical role of these amino acids in channel biogenesis. Mutation of the S4 arginine closest to the cytosolic side of KCa3.1 to histidine resulted in expression at the cell surface. Excised patch clamp experiments revealed that this Arg/ His mutation had a dramatically reduced open probability (P-o), relative to wild type channels. Additionally, we demonstrate, using a combination of short hairpin RNA, dominant negative, and co-immunoprecipitation studies, that both KCa3.1 and KCa2.3 are translocated out of the endoplasmic reticulum associated with Derlin-1. These misfolded channels are poly-ubiquitylated, recognized by p97, and targeted for proteasomal degradation. Our results suggest that S3 and S4 charged amino acids play an evolutionarily conserved role in the biogenesis and gating of KCa channels. Furthermore, these improperly folded K+ channels are translocated out of the endoplasmic reticulum in a Derlin-1- and p97-dependent fashion, poly-ubiquitylated, and targeted for proteasomal degradation.	[Gao, Yajuan; Chotoo, Cavita K.; Balut, Corina M.; Sun, Fei; Bailey, Mark A.; Devor, Daniel C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Devor, DC (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, S331 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	dd2@pitt.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083060] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 083060] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Anderson PAV, 2001, COMP BIOCHEM PHYS B, V129, P17, DOI 10.1016/S1096-4959(01)00376-1; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jones HM, 2007, CHANNELS, V1, P80, DOI 10.4161/chan.3999; Jones HM, 2005, J BIOL CHEM, V280, P37257, DOI 10.1074/jbc.M508601200; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; Myers MP, 2004, FEBS LETT, V568, P110, DOI 10.1016/j.febslet.2004.05.023; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Sato Y, 2003, J BIOL CHEM, V278, P13227, DOI 10.1074/jbc.M300431200; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1977, NATURE, V270, P265, DOI 10.1038/270265a0; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Silverman WR, 2003, P NATL ACAD SCI USA, V100, P2935, DOI 10.1073/pnas.0636603100; Singh S, 2001, J PHARMACOL EXP THER, V296, P600; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Traynelis SF, 1998, TRENDS NEUROSCI, V21, P137, DOI 10.1016/S0166-2236(98)01238-7; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zhang M, 2005, J MEMBRANE BIOL, V207, P169, DOI 10.1007/s00232-005-0812-1	34	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9049	9059		10.1074/jbc.M708022200	http://dx.doi.org/10.1074/jbc.M708022200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18227067	hybrid, Green Published			2022-12-27	WOS:000254465800035
J	Lin, YW; Bushman, JD; Yan, FF; Haidar, S; MacMullen, C; Ganguly, A; Stanley, CA; Shyng, SL				Lin, Yu-Wen; Bushman, Jeremy D.; Yan, Fei-Fei; Haidar, Sara; MacMullen, Courtney; Ganguly, Arupa; Stanley, Charles A.; Shyng, Show-Ling			Destabilization of ATP-sensitive potassium channel activity by novel KCNJ11 mutations identified in congenital hyperinsulinism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING MUTATIONS; FUNCTIONAL-ANALYSIS; SUBUNIT KIR6.2; K+ CHANNELS; STOICHIOMETRY; RECTIFICATION; DETERMINANTS; HYPOGLYCEMIA; TRAFFICKING; INFANCY	The inwardly rectifying potassium channel Kir6.2 is the pore-forming subunit of the ATP-sensitive potassium (K-ATP) channel, which controls insulin secretion by coupling glucose metabolism to membrane potential in beta-cells. Loss of channel function because of mutations in Kir6.2 or its associated regulatory subunit, sulfonylurea receptor 1, causes congenital hyperinsulinism (CHI), a neonatal disease characterized by persistent insulin secretion despite severe hypoglycemia. Here, we report a novel KATP channel gating defect caused by CHI-associated Kir6.2 mutations at arginine 301 ( to cysteine, glycine, histidine, or proline). These mutations in addition to reducing channel expression at the cell surface also cause rapid, spontaneous current decay, a gating defect we refer to as inactivation. Based on the crystal structures of Kir3.1 and KirBac1.1, Arg-301 interacts with several residues in the neighboring Kir6.2 subunit. Mutation of a subset of these residues also induces channel inactivation, suggesting that the disease mutations may cause inactivation by disrupting subunit-subunit interactions. To evaluate the effect of channel inactivation on beta-cell function, we expressed an alternative inactivation mutant R301A, which has equivalent surface expression efficiency as wild type channels, in the insulin-secreting cell line INS-1. Mutant expression resulted in more depolarized membrane potential and elevated insulin secretion at basal glucose concentration ( 3 mM) compared with cells expressing wild type channels, demonstrating that the inactivation gating defect itself is sufficient to cause loss of channel function and hyperinsulinism. Our studies suggest the importance of Kir6.2 subunit-subunit interactions in KATP channel gating and function and reveal a novel gating defect underlying CHI.	[Lin, Yu-Wen; Bushman, Jeremy D.; Yan, Fei-Fei; Haidar, Sara; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; [MacMullen, Courtney; Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol Diabet, Philadelphia, PA 19104 USA; [Ganguly, Arupa] Univ Penn, Sch Med, Dept Geriatr, Philadelphia, PA 19104 USA	Oregon Health & Science University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu		STANLEY, CHARLES/0000-0003-4881-9392	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053012, R01DK056268, R01DK066485] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR 024134] Funding Source: Medline; NIDDK NIH HHS [2R01 DK 53012-09, R01 DK 66485, 2R01 DK 56268-07] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; Casamassima M, 2003, J BIOL CHEM, V278, P43533, DOI 10.1074/jbc.M306596200; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Cukras CA, 2002, J GEN PHYSIOL, V120, P437, DOI 10.1085/jgp.20028621; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Girard CAJ, 2006, PFLUG ARCH EUR J PHY, V453, P323, DOI 10.1007/s00424-006-0112-3; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Haider S, 2007, EMBO J, V26, P3749, DOI 10.1038/sj.emboj.7601809; Henwood MJ, 2005, J CLIN ENDOCR METAB, V90, P789, DOI 10.1210/jc.2004-1604; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huopio H, 2002, AM J PHYSIOL-ENDOC M, V283, pE207, DOI 10.1152/ajpendo.00047.2002; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Leng Q, 2006, P NATL ACAD SCI USA, V103, P1982, DOI 10.1073/pnas.0510610103; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; Magge SN, 2004, J CLIN ENDOCR METAB, V89, P4450, DOI 10.1210/jc.2004-0441; Mankouri J, 2006, EMBO J, V25, P4142, DOI 10.1038/sj.emboj.7601275; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Rapedius M, 2006, EMBO REP, V7, P611, DOI 10.1038/sj.embor.7400678; Riedel MJ, 2005, DIABETES, V54, P2070, DOI 10.2337/diabetes.54.7.2070; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1998, DIABETES, V47, P1145, DOI 10.2337/diabetes.47.7.1145; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; Taschenberger G, 2002, J BIOL CHEM, V277, P17139, DOI 10.1074/jbc.M200363200; Tureckova J, 2001, J BIOL CHEM, V276, P39264, DOI 10.1074/jbc.M104991200; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150	38	44	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9146	9156		10.1074/jbc.M708798200	http://dx.doi.org/10.1074/jbc.M708798200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18250167	Green Published, hybrid			2022-12-27	WOS:000254465800044
J	Magdesian, MH; Carvalho, MMVF; Mendes, FA; Saraiva, LM; Juliano, MA; Juliano, L; Garcia-Abreu, J; Ferreira, ST				Magdesian, Margaret H.; Carvalho, Milena M. V. F.; Mendes, Fabio A.; Saraiva, Leonardo M.; Juliano, Maria A.; Juliano, Luiz; Garcia-Abreu, Jose; Ferreira, Sergio T.			Amyloid-beta binds to the extracellular cysteine-rich domain of frizzled and inhibits wnt/beta-catenin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE-PROTEIN OLIGOMERS; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; WNT PATHWAY; PEPTIDE NEUROTOXICITY; PHAGE DISPLAY; RECEPTOR; IDENTIFICATION; TRANSCRIPTION; TRANSDUCTION	The amyloid-beta peptide (A beta) plays a major role in neuronal dysfunction and neurotoxicity in Alzheimer disease. However, the signal transduction mechanisms involved in A beta-induced neuronal dysfunction remain to be fully elucidated. A major current unknown is the identity of the protein receptor(s) involved in neuronal A beta binding. Using phage display of peptide libraries, we have identified a number of peptides that bind A beta and are homologous to neuronal receptors putatively involved in A beta interactions. We report here on a cysteine-linked cyclic heptapeptide (denominated cSP5) that binds A beta with high affinity and is homologous to the extracellular cysteine-rich domain of several members of the Frizzled (Fz) family of Wnt receptors. Based on this homology, we investigated the interaction between A beta and Fz. The results show that A beta binds to the Fz cysteine-rich domain at or in close proximity to the Wnt-binding site and inhibits the canonical Wnt signaling pathway. Interestingly, the cSP5 peptide completely blocks A beta binding to Fz and prevents inhibition of Wnt signaling. These results indicate that the A beta- binding site in Fz is homologous to cSP5 and that this is a relevant target for A beta-instigated neurotoxicity. Furthermore, they suggest that blocking the interaction of A beta with Fz might lead to novel therapeutic approaches to prevent neuronal dysfunction in Alzheimer disease.	[Magdesian, Margaret H.; Carvalho, Milena M. V. F.; Saraiva, Leonardo M.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim Biofis Celular, BR-21944 Rio De Janeiro, RJ, Brazil; [Mendes, Fabio A.; Garcia-Abreu, Jose] Univ Fed Rio de Janeiro, Dept Anat, BR-21944 Rio De Janeiro, RJ, Brazil; [Juliano, Maria A.; Juliano, Luiz] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biofis, BR-04044 Sao Paulo, SP, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP)	Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim Biofis Celular, Bloco H,Sala 19,CCS, BR-21944 Rio De Janeiro, RJ, Brazil.	ferreira@bioqmed.ufrj.br	Mendes, Fabio/J-6911-2015; Ferreira, Sergio/AAZ-1576-2020; Abreu, Jose G/G-6159-2010; Complexos, INCT Fluidos/H-9172-2013; Juliano, Luiz/D-7204-2012; Abreu, Jose G/ABB-1199-2021; Neurociencia, Inct/I-1011-2013	Ferreira, Sergio/0000-0001-7160-9866; Abreu, Jose G/0000-0002-9875-7786; Juliano, Luiz/0000-0002-5589-2822; Abreu, Jose G/0000-0002-1363-1755; 	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Baum L, 1996, MOL CHEM NEUROPATHOL, V29, P253, DOI 10.1007/BF02815006; Bhat RV, 2002, NEUROSIGNALS, V11, P251, DOI 10.1159/000067423; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Caricasole A, 2003, TRENDS PHARMACOL SCI, V24, P233, DOI 10.1016/S0165-6147(03)00100-7; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; DEFELICE FG, 2007, IN PRESS NEUROBIOL A; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Fradkin LG, 2005, J NEUROSCI, V25, P10376, DOI 10.1523/JNEUROSCI.3429-05.2005; Fuentealba RA, 2004, BRAIN RES REV, V47, P275, DOI 10.1016/j.brainresrev.2004.07.018; Garrido JL, 2002, FASEB J, V16, P1982, DOI 10.1096/fj.02-0327fje; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Inestrosa NC, 2007, IUBMB LIFE, V59, P316, DOI 10.1080/15216540701242490; Kang CK, 2003, NEUROBIOL DIS, V14, P146, DOI 10.1016/S0969-9961(03)00105-0; KLEIN WL, 2006, ALZHEIMERS DEMENT, P260; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Levesque G, 1999, J NEUROCHEM, V72, P999, DOI 10.1046/j.1471-4159.1999.0720999.x; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lima AR, 2004, PROTEIN J, V23, P287, DOI 10.1023/B:JOPC.0000027853.93513.34; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200; Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200; Mudher A, 2002, TRENDS NEUROSCI, V25, P22, DOI 10.1016/S0166-2236(00)02031-2; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nishimura M, 1999, NAT MED, V5, P164, DOI 10.1038/5526; Orner BP, 2006, J AM CHEM SOC, V128, P11882, DOI 10.1021/ja0619861; Palacino JJ, 2001, J BIOL CHEM, V276, P38563, DOI 10.1074/jbc.M105376200; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Salins P, 2007, NEUROSCI LETT, V412, P211, DOI 10.1016/j.neulet.2006.07.045; Salomon D, 1997, J CELL BIOL, V139, P1325, DOI 10.1083/jcb.139.5.1325; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4	44	187	193	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9359	9368		10.1074/jbc.M707108200	http://dx.doi.org/10.1074/jbc.M707108200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18234671	Green Published, hybrid			2022-12-27	WOS:000254465800066
J	Javed, A; Bae, JS; Afzal, F; Gutierrez, S; Pratap, J; Zaidi, SK; Lou, Y; van Wijnen, AJ; Stein, JL; Stein, GS; Lian, JB				Javed, Amjad; Bae, Jong-Sup; Afzal, Faiza; Gutierrez, Soraya; Pratap, Jitesh; Zaidi, Sayyed K.; Lou, Yang; van Wijnen, Andre J.; Stein, Janet L.; Stein, Gary S.; Lian, Jane B.			Structural coupling of smad and Runx2 for execution of the BMP2 osteogenic signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CLEIDOCRANIAL DYSPLASIA; RUNX/CBFA/AML FACTORS; NUCLEAR-MATRIX; STEM-CELLS; ACTIVATION; DOMAIN	Two regulatory pathways, bone morphogenetic protein (BMP)/transforming growth factor-beta(TGF beta) and the transcription factor RUNX2, are required for bone formation in vivo. Here we show the interdependent requirement of these pathways to induce an osteogenic program. A panel of Runx2 deletion and point mutants was used to examine RUNX2-SMAD protein-protein interaction and the biological consequences on BMP2-induced osteogenic signaling determined in Runx2 null cells. These cells do not respond to BMP2 signal in the absence of Runx2. We established that a triple mutation in the C-terminal domain of RUNX2, HTY (426 - 428), disrupts the RUNX2-SMAD interaction, is deficient in its ability to integrate the BMP2/TGF beta signal on promoter reporter assays, and is only marginally functional in promoting early stages of osteoblast differentiation. Furthermore, the HTY mutation overlaps the unique nuclear matrix targeting signal of Runx factors and exhibits reduced subnuclear targeting. Thus, formation of a RUNX2-SMAD osteogenic complex and subnuclear targeting are structurally and functionally inseparable. Our results establish the critical residues of RUNX2 for execution and completion of BMP2 signaling for osteoblastogenesis through a mechanism that requires RUNX2-SMAD transcriptional activity.	[Pratap, Jitesh; Zaidi, Sayyed K.; Lou, Yang; van Wijnen, Andre J.; Stein, Janet L.; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Pratap, Jitesh; Zaidi, Sayyed K.; Lou, Yang; van Wijnen, Andre J.; Stein, Janet L.; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lian, JB (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 55 Lake Ave N, Worcester, MA 01655 USA.	jane.lian@umassmed.edu	Zaidi, Sayyed Kaleem/I-5596-2019; Bae, Jong-Sup/AAU-9724-2020; van Wijnen, Andre J./AAG-3578-2019	Zaidi, Sayyed Kaleem/0000-0001-6664-5168; van Wijnen, Andre J./0000-0002-4458-0946; Javed, Amjad/0000-0002-0847-8266	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048818, R01AR049069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012528] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR049069, P01 AR 48818] Funding Source: Medline; NIDCR NIH HHS [DE 012528] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Afzal F, 2005, J CELL PHYSIOL, V204, P63, DOI 10.1002/jcp.20258; Bae JS, 2007, J CELL BIOCHEM, V100, P434, DOI 10.1002/jcb.21039; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Haag J, 2006, ARTHRITIS RHEUM, V54, P3878, DOI 10.1002/art.22261; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hendy GN, 2005, HORM METAB RES, V37, P375, DOI 10.1055/s-2005-870152; Holleville N, 2007, DEV BIOL, V304, P860, DOI 10.1016/j.ydbio.2007.01.003; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Javed A, 2000, J CELL SCI, V113, P2221; Kanzler B, 2000, DEVELOPMENT, V127, P1095; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Li XL, 2006, EXP CELL RES, V312, P854, DOI 10.1016/j.yexcr.2005.12.002; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague Joan, 2003, Clin Adv Hematol Oncol, V1, P576; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tang L, 1999, J BIOL CHEM, V274, P33580, DOI 10.1074/jbc.274.47.33580; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yang XL, 2002, TRENDS MOL MED, V8, P340, DOI 10.1016/S1471-4914(02)02340-7; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332; Zaidi SK, 2006, J CELL PHYSIOL, V209, P935, DOI 10.1002/jcp.20791; Zaidi SK, 2002, P NATL ACAD SCI USA, V99, P8048, DOI 10.1073/pnas.112664499; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zhu W, 2004, J BONE MINER RES, V19, P2021, DOI 10.1359/JBMR.040821	45	178	188	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8412	8422		10.1074/jbc.M705578200	http://dx.doi.org/10.1074/jbc.M705578200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18204048	Green Published, hybrid			2022-12-27	WOS:000254288000039
J	Lanza, A; Cirillo, N; Rossiello, R; Rienzo, M; Cutillo, L; Casamassimi, A; de Nigris, F; Schiano, C; Rossiello, L; Femiano, F; Gombos, F; Napoli, C				Lanza, Alessandro; Cirillo, Nicola; Rossiello, Raffaele; Rienzo, Monica; Cutillo, Luisa; Casamassimi, Amelia; de Nigris, Filomena; Schiano, Concetta; Rossiello, Luigi; Femiano, Felice; Gombos, Fernando; Napoli, Claudio			Evidence of key role of Cdk2 overexpression in pemphigus vulgaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATERNAL-HYPERCHOLESTEROLEMIA; INTERMEDIATE-FILAMENTS; KERATINOCYTE ADHESION; SIGNALING PATHWAYS; CELL-SURFACE; CYCLIN-E; C-MYC; DISEASE; SKIN; DESMOGLEIN-3	The pathogenesis of pemphigus vulgaris (PV) is still poorly understood. Autoantibodies present in PV patients can promote detrimental effects by triggering altered transduction of signals, which results in a final acantholysis. To investigate mechanisms involved in PV, cultured keratinocytes were treated with PV serum. PV sera were able to promote the cell cycle progression, inducing the accumulation of cyclin-dependent kinase 2 (Cdk2). Microarray analysis on keratinocytes detected that PV serum induced important changes in genes coding for one and the same proteins with known biological functions involved in PV disease (560 differentially expressed genes were identified). Then, we used two different approaches to investigate the role of Cdk2. First, small interfering RNA depletion of Cdk2 prevented cell-cell detachment induced by PV sera. Second, pharmacological inhibition of Cdk2 activity through roscovitine prevented blister formation and acantholysis in the mouse model of the disease. In vivo PV serum was found to alter multiple different pathways by microarray analysis (1463 differentially expressed genes were identified). Major changes in gene expression induced by roscovitine were studied through comparison of effects of PV serum alone and in association with roscovitine. The most significantly enriched pathways were cell communication, gap junction, focal adhesion, adherens junction, and tight junction. Our data indicate that major Cdk2-dependent multiple gene regulatory events are present in PV. This alteration may influence the evolution of PV and its therapy.	[Rienzo, Monica; Casamassimi, Amelia; de Nigris, Filomena; Schiano, Concetta; Napoli, Claudio] Univ Naples 2, Dept Gen Pathol, Sch Med & Surg 1, I-80138 Naples, Italy; [Lanza, Alessandro; Cirillo, Nicola; Femiano, Felice; Gombos, Fernando; Napoli, Claudio] Univ Naples 2, Sch Med & Surg 1, Reg Ctr Craniofacial Malformat, I-80134 Naples, Italy; [Rossiello, Luigi] Univ Naples 2, Div Dermatol, Sch Med & Surg 1, I-80138 Naples, Italy; [Cutillo, Luisa] Theleton Inst Genet & Med Naples, I-80131 Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Napoli, C (corresponding author), Univ Naples 2, Dept Gen Pathol, Sch Med & Surg 1, Complesso S Andrea Dame,Via L Crecchio 7, I-80138 Naples, Italy.	claudio.napoli@unina2.it	Casamassimi, Amelia/AAD-2816-2020; Schiano, Concetta/GOE-4310-2022; Femiano, Felice/AAQ-3711-2021; Schiano, Concetta/K-6431-2016	Casamassimi, Amelia/0000-0002-6010-4261; Cutillo, Luisa/0000-0002-2205-0338; Rienzo, Monica/0000-0002-4496-4894; Schiano, Concetta/0000-0002-2570-6910; Cirillo, NIcola/0000-0003-1429-1323; Lanza, Alessandro/0000-0002-5762-5613; FEMIANO, Felice/0000-0001-9341-2490; Napoli, Claudio/0000-0002-5455-555X; de nigris, filomena/0000-0002-2322-1557				AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amagai M, 2006, EXP DERMATOL, V15, P815, DOI 10.1111/j.1600-0625.2006.00499.x; Amagai M, 2000, J CLIN INVEST, V105, P625, DOI 10.1172/JCI8748; ANHALT GJ, 1982, NEW ENGL J MED, V306, P1189, DOI 10.1056/NEJM198205203062001; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Bhol KC, 2000, CYTOKINE, V12, P1076, DOI 10.1006/cyto.1999.0642; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bystryn JC, 2005, LANCET, V366, P61, DOI 10.1016/S0140-6736(05)66829-8; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Cirillo N, 2007, IMMUNOLOGY, V121, P377, DOI 10.1111/j.1365-2567.2007.02585.x; Cirillo N, 2007, J CELL PHYSIOL, V210, P411, DOI 10.1002/jcp.20856; Cirlllo N, 2006, FEBS LETT, V580, P3276, DOI 10.1016/j.febslet.2006.04.089; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; de Nigris F, 2006, CELL CYCLE, V5, P1621, DOI 10.4161/cc.5.15.3138; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FARB RM, 1978, P NATL ACAD SCI USA, V75, P459, DOI 10.1073/pnas.75.1.459; Feliciani C, 2000, J INVEST DERMATOL, V114, P71, DOI 10.1046/j.1523-1747.2000.00835.x; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Garcia JF, 2003, BLOOD, V101, P681, DOI 10.1182/blood-2002-04-1128; Gombos F, 1974, Arch Stomatol (Napoli), V15, P69; Gombos F, 1978, Arch Stomatol (Napoli), V19, P239; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Harwell RM, 2004, J BIOL CHEM, V279, P12695, DOI 10.1074/jbc.M313407200; Huber O, 2003, CELL MOL LIFE SCI, V60, P1872, DOI 10.1007/s00018-003-3050-7; Kaldis P, 2005, CELL CYCLE, V4, P1491, DOI 10.4161/cc.4.11.2124; Lanza A, 2006, INT J IMMUNOPATH PH, V19, P399, DOI 10.1177/039463200601900216; LAVKER RM, 1991, AM J PATHOL, V138, P687; Li N, 2005, J CLIN INVEST, V115, P3440, DOI 10.1172/JCI24394; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Napoli C, 2000, FASEB J, V14, P1996, DOI 10.1096/fj.99-0986com; Napoli C, 2005, METH MOLEC MED, V108, P215; Napoli C, 2002, CIRCULATION, V105, P1360, DOI 10.1161/01.CIR.0000013090.96919.FA; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nguyen VT, 2000, J CLIN INVEST, V106, P1467, DOI 10.1172/JCI10305; Nguyen VT, 2004, EXP CELL RES, V294, P534, DOI 10.1016/j.yexcr.2003.12.010; Nguyen VT, 2004, J BIOL CHEM, V279, P2135, DOI 10.1074/jbc.M309000200; Olvera M, 2001, MODERN PATHOL, V14, P1036, DOI 10.1038/modpathol.3880432; Osada K, 1997, J INVEST DERMATOL, V108, P482, DOI 10.1111/1523-1747.ep12289726; Pascale RM, 2002, HEPATOLOGY, V35, P1341, DOI 10.1053/jhep.2002.33682; Puviani M, 2003, J INVEST DERMATOL, V120, P164, DOI 10.1046/j.1523-1747.2003.12014.x; Schang LM, 2004, BBA-PROTEINS PROTEOM, V1697, P197, DOI 10.1016/j.bbapap.2003.11.024; Schmidt E, 2007, BRIT J DERMATOL, V156, P352, DOI 10.1111/j.1365-2133.2006.07646.x; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; SWANSON DL, 1983, J INVEST DERMATOL, V81, P258, DOI 10.1111/1523-1747.ep12518278; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224	51	41	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8736	8745		10.1074/jbc.M702186200	http://dx.doi.org/10.1074/jbc.M702186200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18199752	hybrid			2022-12-27	WOS:000254288000071
J	Wan, KF; Chan, SL; Sukumaran, SK; Lee, MC; Yu, VC				Wan, Kah Fei; Chan, Shing-Leng; Sukumaran, Sunil Kumar; Lee, Mei-Chin; Yu, Victor C.			Chelerythrine induces apoptosis through a Bax/Bak-independent mitochondrial mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY PROTEINS; CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION PORE; PROGRAMMED CELL-DEATH; BH3-ONLY PROTEINS; TRANSMEMBRANE DEPOLARIZATION; CANCER-CELLS; BH3 DOMAINS; BAX; INHIBITOR	Although murine embryonic fibroblasts (MEFs) with Bax or Bak deleted displayed no defect in apoptosis signaling, MEFs with Bax and Bak double knock-out (DKO) showed dramatic resistance to diverse apoptotic stimuli, suggesting that Bax and Bak are redundant but essential regulators for apoptosis signaling. Chelerythrine has recently been identified as a Bcl-xL inhibitor that is capable of triggering apoptosis via direct action on mitochondria. Here we report that in contrast to classic apoptotic stimuli, chelerythrine is fully competent in inducing apoptosis in the DKO MEFs. Wild-type and DKO MEFs are equally sensitive to chelerythrine-induced morphological and biochemical changes associated with apoptosis phenotype. Interestingly, chelerythrine-mediated release of cytochrome c is rapid and precedes Bax translocation and integration. Although the BH3 peptide of Bim is totally inactive in releasing cytochrome c from isolated mitochondria of DKO MEFs, chelerythrine maintains its potency and efficacy in inducing direct release of cytochrome c from these mitochondria. Furthermore, chelerythrine-mediated mitochondrial swelling and loss in mitochondrial membrane potential (Delta Psi(m)) are inhibited by cyclosporine A, suggesting that mitochondrial permeability transition pore is involved in chelerythrine-induced apoptosis. Although certain apoptotic stimuli have been shown to elicit cytotoxic effect in the DKO MEFs through alternate death mechanisms, chelerythrine does not appear to engage necrotic or autophagic death mechanism to trigger cell death in the DKO MEFs. These results, thus, argue for the existence of an alternative Bax/Bak-independent apoptotic mechanism that involves cyclosporine A-sensitive mitochondrial membrane permeability.	ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Chan, Shing-Leng] Natl Univ Singapore, Oncol Res Inst, Ctr Life Sci, Canc Program, Singapore 117456, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Lee, MC (corresponding author), ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr Proteos, Singapore 138673, Singapore.	mcbyuck@imcb.a-star.edu.sg	Chan, S.L./X-4154-2018; Yu, Victor/A-7899-2015	Chan, S.L./0000-0002-3270-0525; Yu, Victor/0000-0003-3270-4734; Lee, Mei Chin/0000-0001-7689-6446				Armstrong JS, 2001, EXP CELL RES, V262, P170, DOI 10.1006/excr.2000.5091; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bouillet P, 2002, J CELL SCI, V115, P1567; Chan SL, 2004, CLIN EXP PHARMACOL P, V31, P119, DOI 10.1111/j.1440-1681.2004.03975.x; Chan SL, 2003, J BIOL CHEM, V278, P20453, DOI 10.1074/jbc.C300138200; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chmura SJ, 2000, CLIN CANCER RES, V6, P737; Crompton M, 1999, BIOCHEM SOC SYMP, V66, P167, DOI 10.1042/bss0660167; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Degenhardt K, 2002, CANCER CELL, V2, P193, DOI 10.1016/S1535-6108(02)00126-5; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Galindo MF, 2003, BRIT J PHARMACOL, V139, P797, DOI 10.1038/sj.bjp.0705309; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Kroll SL, 1998, AM J PHYSIOL-CELL PH, V274, pC167, DOI 10.1152/ajpcell.1998.274.1.C167; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lickliter JD, 2003, LEUKEMIA, V17, P2074, DOI 10.1038/sj.leu.2403102; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Malikova J, 2006, CELL BIOL TOXICOL, V22, P439, DOI 10.1007/s10565-006-0109-x; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Milanesi E, 2006, J BIOL CHEM, V281, P10066, DOI 10.1074/jbc.M513708200; Mizuta T, 2007, J BIOL CHEM, V282, P16623, DOI 10.1074/jbc.M611060200; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Oliver CL, 2005, MOL CANCER THER, V4, P23; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Real PJ, 2004, CANCER RES, V64, P7947, DOI 10.1158/0008-5472.CAN-04-0945; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; Tan KO, 2005, P NATL ACAD SCI USA, V102, P14623, DOI 10.1073/pnas.0503524102; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wilson-Annan J, 2003, J CELL BIOL, V162, P877, DOI 10.1083/jcb.200302144; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zhang YH, 2006, J MOL BIOL, V364, P536, DOI 10.1016/j.jmb.2006.09.023; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	51	50	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8423	8433		10.1074/jbc.M707687200	http://dx.doi.org/10.1074/jbc.M707687200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18230621	Green Published, hybrid			2022-12-27	WOS:000254288000040
J	Chu, WK; Dai, PM; Li, HL; Chen, JK				Chu, Wing-Keung; Dai, Pei-Min; Li, Hsin-Lun; Chen, Jan-Kan			Transcriptional activity of the Delta Np63 promoter is regulated by STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 HOMOLOG; EXPRESSION; P63; APOPTOSIS; CELLS; ACTIVATION; PATHWAY; CLONING; TUMORS	The N terminus-truncated splicing variant of TAp63 is known as Delta Np63.Delta Np63 lacks transactivation function and is thought to antagonize the transcriptional regulation of the p53 and TAp63 target genes. Overexpression of Delta Np63 has been observed in a number of human cancers, suggesting a role in carcinogenesis. In the present study we present data showing that the Delta Np63 gene promoter activity is positively regulated by Delta Np63 alpha, and such positive autoregulation is mediated via activation of STAT3 activity. We show that expression of Delta Np63 alpha in Hep3B cells induces Stat3 phosphorylation on Tyr-705 and Ser-727. A putative STAT3-responsive element ( STAT3-RE) is identified in the Delta Np63 promoter region. Electrophoretic mobility shift and avidin biotin-Conjugated DNA assays show direct binding of STAT3 to STAT3-RE of the Delta Np63 promoter, and such binding is stimulated by Delta Np63 alpha. Binding of the endogenous STAT3 to the Delta Np63 promoter in Hep3B cells was demonstrated by a chromatin immunoprecipitation assay. The stimulation of the Delta Np63 transcriptional activity by Delta Np63 alpha is abolished by Janus kinase 2 ( JAK2)/ STAT3 inhibitor AG490, dominant-negative STAT3, STAT3 small interfering RNA, and deletion of the STAT3-RE sequence from Delta Np63 promoter. Taken together these observations clearly indicated that autoregulation of Delta Np63 gene transcription is mediated through activation of STAT3 and its subsequent binding to the STAT3-RE. Because the activation of STAT3 by interleukin-6 also leads to Delta Np63 up-regulation and the blockade of Delta Np63 or STAT3 expression by siRNA leads to repression of the cell growth, the identified regulatory pathway is presumably of cell physiological significance.	[Chu, Wing-Keung; Dai, Pei-Min; Li, Hsin-Lun; Chen, Jan-Kan] Chang Gung Univ, Dept Physiol, Coll Med, Tao Yuan 333, Taiwan	Chang Gung University	Chen, JK (corresponding author), Chang Gung Univ, Dept Physiol, Coll Med, Tao Yuan 333, Taiwan.	jkc508@mail.cgu.edu.tw						Barbieri CE, 2003, J BIOL CHEM, V278, P51408, DOI 10.1074/jbc.M309943200; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chu WK, 2006, BIOCHEM BIOPH RES CO, V342, P1356, DOI 10.1016/j.bbrc.2006.02.111; COFFER P, 1995, ONCOGENE, V10, P985; Crook T, 2000, ONCOGENE, V19, P3439, DOI 10.1038/sj.onc.1203656; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Harmes DC, 2003, ONCOGENE, V22, P7607, DOI 10.1038/sj.onc.1207129; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Ishida S, 2000, JPN J CANCER RES, V91, P174, DOI 10.1111/j.1349-7006.2000.tb00929.x; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Lee H, 2006, BIOCHEM BIOPH RES CO, V344, P166, DOI 10.1016/j.bbrc.2006.03.128; Massion PP, 2003, CANCER RES, V63, P7113; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mora LB, 2002, CANCER RES, V62, P6659; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Nylander K, 2000, INT J CANCER, V87, P368, DOI 10.1002/1097-0215(20000801)87:3<368::AID-IJC9>3.3.CO;2-A; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Park BJ, 2000, CANCER RES, V60, P3370; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; Trompeter HI, 2005, J IMMUNOL, V174, P4135, DOI 10.4049/jimmunol.174.7.4135; Wang DY, 2003, INVEST OPHTH VIS SCI, V44, P4698, DOI 10.1167/iovs.03-0272; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Westfall MD, 2004, CARCINOGENESIS, V25, P857, DOI 10.1093/carcin/bgh148; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zamo A, 2002, ONCOGENE, V21, P1038, DOI 10.1038/sj.onc.1205152; Zhang F, 2003, ONCOGENE, V22, P894, DOI 10.1038/sj.onc.1206158	32	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7328	7337		10.1074/jbc.M800183200	http://dx.doi.org/10.1074/jbc.M800183200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18198175	hybrid			2022-12-27	WOS:000253997900006
J	Koshkin, V; Dai, FF; Robson-Doucette, CA; Chan, CB; Wheeler, MB				Koshkin, Vasilij; Dai, Feihan F.; Robson-Doucette, Christine A.; Chan, Catherine B.; Wheeler, Michael B.			Limited mitochondrial permeabilization is an early manifestation of palmitate-induced lipotoxicity in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RAT-LIVER MITOCHONDRIA; MONOUNSATURATED FATTY-ACIDS; GLUCOSE-STIMULATED EFFLUX; TRANSITION PORE; OXIDATIVE STRESS; CYCLOSPORINE-A; INSULIN-SECRETION; PROTEIN-KINASE; INDUCED APOPTOSIS; NITRIC-OXIDE	Involvement o(f) the mitochondrial permeability transition (MPT) pore in early stages of lipotoxic stress in the pancreatic beta-cell lines MIN6 and INS-1 was the focus of this study. Both long term (indirect) and acute (direct) effects of fatty acid (FA) application on beta-cell susceptibility to Ca2+- induced MPT induction were examined using both permeabilized and intact beta-cells. Long term exposure to moderate (i.e. below cytotoxic) levels of the saturated FA palmitate sensitized beta-cell mitochondria to MPT induced by Ca2+. Long term exposure to palmitate was significantly a more efficient inducer of MPT than the unsaturated FA oleate, although upon acute application both caused similar MPT activation. Application of antioxidants, inhibitors of the ceramide pathway, or modifiers of membrane fluidity did not protect beta-cell mitochondria from FA exposure. However, significant protection was provided by co-application of the unsaturated FA oleate in a phosphatidylinositol 3-kinase-dependent manner. Characterization of MPT pore opening in response to moderate palmitate treatment revealed the opening of a unique form of MPT in beta-cells as it encompassed features of both low and high conductance MPT states. Specifically, this MPT showed solute selectivity, characteristic of a low conductance MPT; however, it affected mitochondrial respiration and membrane potential in a way typical of a high conductance MPT. Activation of the full-size/high conductance form of MPT required application of high levels of FA that reduced growth and initiated apoptosis. These findings suggest that in the beta-cell, MPTs can act as both initiators of cell death and as versatile modulators of cell metabolism, depending on the mode of the MPT pore induced.	[Koshkin, Vasilij; Dai, Feihan F.; Robson-Doucette, Christine A.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Koshkin, Vasilij; Dai, Feihan F.; Robson-Doucette, Christine A.; Wheeler, Michael B.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Chan, Catherine B.] Univ Alberta, Dept Physiol & Agr, Edmonton, AB T6G 2H7, Canada	University of Toronto; University of Toronto; University of Alberta	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	michael.wheeler@utoronto.ca	Chan, Catherine/C-1162-2011	Chan, Catherine/0000-0003-3882-0592; Wheeler, Michael B./0000-0002-7480-7267; Doucette, Christine/0000-0002-5070-2639				Aikawa R, 2000, CIRCULATION, V102, P2873; Aikin R, 2006, DIABETOLOGIA, V49, P2900, DOI 10.1007/s00125-006-0476-0; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; ALNASSER I, 1986, BIOCHEM J, V239, P19, DOI 10.1042/bj2390019; ARKHAMMAR P, 1989, BIOCHEM BIOPH RES CO, V159, P223, DOI 10.1016/0006-291X(89)92426-1; ARKHAMMAR P, 1990, FEBS LETT, V273, P182, DOI 10.1016/0014-5793(90)81079-4; Asghar Z, 2006, DIABETOLOGIA, V49, P90, DOI 10.1007/s00125-005-0045-y; Barbu A, 2002, MOL CELL ENDOCRINOL, V190, P75, DOI 10.1016/S0303-7207(02)00009-6; Barrand MA, 1997, GEN PHARMACOL, V28, P639, DOI 10.1016/S0306-3623(96)00284-4; Beeharry N, 2004, APOPTOSIS, V9, P599, DOI 10.1023/B:APPT.0000038039.82506.0c; Belosludtsev KN, 2005, BIOCHEMISTRY-MOSCOW+, V70, P815, DOI 10.1007/s10541-005-0189-x; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 2002, VITAM HORM, V65, P97, DOI 10.1016/S0083-6729(02)65061-7; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Biden TJ, 2004, DIABETES, V53, pS159, DOI 10.2337/diabetes.53.2007.S159; Bodrova ME, 2003, BIOCHEMISTRY-MOSCOW+, V68, P391, DOI 10.1023/A:1023691628110; Bodrova ME, 2000, IUBMB LIFE, V50, P189; Broekemeier KM, 1998, BIOCHEMISTRY-US, V37, P13059, DOI 10.1021/bi980820c; Brustovetsky N, 2000, J NEUROSCI, V20, P103, DOI 10.1523/JNEUROSCI.20-01-00103.2000; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Busch AK, 2002, DIABETES, V51, P977, DOI 10.2337/diabetes.51.4.977; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Civelek VN, 1996, BIOCHEM J, V318, P615, DOI 10.1042/bj3180615; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dai FHF, 2006, J BIOL CHEM, V281, P21942, DOI 10.1074/jbc.M512924200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Dufer M, 2001, MOL PHARMACOL, V60, P873; Dymkowska D, 2006, BBA-MOL CELL RES, V1763, P152, DOI 10.1016/j.bbamcr.2005.12.009; El-Kholy W, 2003, FASEB J, V17, P720, DOI 10.1096/fj.02-0802fje; ELLIOTT JI, 1980, J INORG BIOCHEM, V12, P323; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; FRY JR, 1976, ANAL BIOCHEM, V71, P341, DOI 10.1016/S0003-2697(76)80003-6; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Hardy S, 2000, CANCER RES, V60, P6353; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; HOEK JB, 1995, BBA-MOL BASIS DIS, V1271, P93, DOI 10.1016/0925-4439(95)00015-V; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Jimenez-Chillaron JC, 2005, DIABETES, V54, P702, DOI 10.2337/diabetes.54.3.702; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Joshi MS, 2006, AM J RESP CRIT CARE, V173, P999, DOI 10.1164/rccm.200411-1507OC; Kong JY, 2000, BBA-MOL CELL BIOL L, V1485, P45, DOI 10.1016/S1388-1981(00)00028-7; Korge P, 1999, EUR J BIOCHEM, V265, P273, DOI 10.1046/j.1432-1327.1999.00724.x; Koshkin V, 2004, J BIOL CHEM, V279, P41368, DOI 10.1074/jbc.M406914200; Koshkin V, 2003, J BIOL CHEM, V278, P19709, DOI 10.1074/jbc.M209709200; Kowaltowski AJ, 2000, AM J PHYSIOL-CELL PH, V279, pC852, DOI 10.1152/ajpcell.2000.279.3.C852; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Krasnikov BF, 2005, BBA-BIOENERGETICS, V1708, P375, DOI 10.1016/j.bbabio.2005.05.009; Kristal BS, 1996, J BIOL CHEM, V271, P6033, DOI 10.1074/jbc.271.11.6033; Kushnareva YE, 2000, ARCH BIOCHEM BIOPHYS, V376, P377, DOI 10.1006/abbi.2000.1730; Lecoeur H, 2001, CYTOMETRY, V44, P65, DOI 10.1002/1097-0320(20010501)44:1<65::AID-CYTO1083>3.0.CO;2-Q; LeRoith D, 2002, AM J MED, V113, p3S; LOTSCHER HR, 1979, P NATL ACAD SCI USA, V76, P4340, DOI 10.1073/pnas.76.9.4340; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; MERRITT JE, 1990, BIOCHEM J, V269, P513, DOI 10.1042/bj2690513; Migita K, 2003, IMMUNOL LETT, V90, P87, DOI 10.1016/j.imlet.2003.07.003; Moore PC, 2004, DIABETES, V53, P2610, DOI 10.2337/diabetes.53.10.2610; Novgorodov SA, 1996, J BIOENERG BIOMEMBR, V28, P139, DOI 10.1007/BF02110644; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Panaretakis T, 2001, TOXICOL APPL PHARM, V173, P56, DOI 10.1006/taap.2001.9159; Park SY, 2005, APOPTOSIS, V10, P537, DOI 10.1007/s10495-005-1884-1; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Penzo D, 2002, BBA-BIOENERGETICS, V1555, P160, DOI 10.1016/S0005-2728(02)00272-4; QUINLAN PT, 1983, BIOCHEM J, V214, P395, DOI 10.1042/bj2140395; Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945; Rello S, 2005, APOPTOSIS, V10, P201, DOI 10.1007/s10495-005-6075-6; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; RILEY WW, 1985, J BIOL CHEM, V260, P2416; Rosenstock TR, 2004, J NEUROCHEM, V88, P1220, DOI 10.1046/j.1471-4159.2003.02250.x; Sabin MA, 2007, J CELL PHYSIOL, V211, P244, DOI 10.1002/jcp.20922; SCHONFELD P, 1990, FEBS LETT, V264, P246, DOI 10.1016/0014-5793(90)80259-L; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Smaili SS, 1999, CELL CALCIUM, V26, P121, DOI 10.1054/ceca.1999.0061; Smaili SS, 2001, J BIOL CHEM, V276, P23329, DOI 10.1074/jbc.M100989200; Smart N, 2006, CARDIOVASC RES, V69, P164, DOI 10.1016/j.cardiores.2005.08.017; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124, DOI 10.1152/ajpheart.2000.279.5.H2124; Stavrovskaya IG, 2005, FREE RADICAL BIO MED, V38, P687, DOI 10.1016/j.freeradbiomed.2004.11.032; Takuma K, 2001, J BIOL CHEM, V276, P48093, DOI 10.1074/jbc.M108622200; Thomas A.P., 1991, CELLULAR CALCIUM PRA, P1; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; Vieira HLA, 2001, ONCOGENE, V20, P4305, DOI 10.1038/sj.onc.1204575; Wang XL, 2004, DIABETES, V53, P129, DOI 10.2337/diabetes.53.1.129; Ward MW, 2000, J NEUROSCI, V20, P7208; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Wieckowski MR, 1998, FEBS LETT, V423, P339, DOI 10.1016/S0014-5793(98)00118-5; WOITCZAK L, 1993, BIOCHIM BIOPHYS ACTA, V1183, P41, DOI 10.1016/0005-2728(93)90004-Y; Xia SH, 2007, J BIOL CHEM, V282, P13199, DOI 10.1074/jbc.M610225200; Zago EB, 2000, FEBS LETT, V478, P29, DOI 10.1016/S0014-5793(00)01815-9; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	104	62	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7936	7948		10.1074/jbc.M705652200	http://dx.doi.org/10.1074/jbc.M705652200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18162472	hybrid			2022-12-27	WOS:000253997900069
J	Malik, S; Bagla, S; Chaurasia, P; Duan, Z; Bhaumik, SR				Malik, Shivani; Bagla, Shruti; Chaurasia, Priyasri; Duan, Zhen; Bhaumik, Sukesh R.			Elongating RNA polymerase II is disassembled through specific degradation of its largest but not other Subunits in response to DNA damage in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-COUPLED REPAIR; INDUCED UBIQUITINATION; MOLECULAR-MECHANISMS; GENOME MAINTENANCE; PYRIMIDINE DIMERS; EXCISION-REPAIR; CELL-CYCLE; DHFR GENE; STRAND; YEAST	Although previous biochemical studies have demonstrated global degradation of the largest subunit, Rpb1p, of RNA polymerase II in response to DNA damage, it is still not clear whether the initiating or elongating form of Rpb1p is targeted for degradation in vivo. Further, whether other components of RNA polymerase II are degraded in response to DNA damage remains unknown. Here, we show that the Rpb1p subunit of the elongating, but not initiating, form of RNA polymerase II is degraded at the active genes in response to 4-nitroquinoline-1-oxide-induced DNA damage in Saccharomyces cerevisiae. However, other subunits of RNA polymerase II are not degraded in response to DNA damage. Further, we show that Rpb1p is essential for RNA polymerase II assembly at the active gene, and thus, the degradation of Rpb1p following DNA damage disassembles elongating RNA polymerase II. Taken together, our data demonstrate that Rpb1p but not other subunits of elongating RNA polymerase II is specifically degraded in response to DNA damage, and such a degradation of Rpb1p is critical for the disassembly of elongating RNA polymerase II at the DNA lesion in vivo.	[Malik, Shivani; Bagla, Shruti; Chaurasia, Priyasri; Duan, Zhen; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Bhaumik, SR (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	sbhaumik@siumed.edu						Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; BOOTSMA D, 2002, GENETIC BASIS HUMAN, P221; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chen XF, 2007, MOL CELL BIOL, V27, P4617, DOI 10.1128/MCB.00404-07; CHRISTIANS FC, 1992, MUTAT RES, V274, P93, DOI 10.1016/0921-8777(92)90056-9; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Cooper PK, 1997, SCIENCE, V275, P990, DOI 10.1126/science.275.5302.990; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Hanawalt PC, 2001, MUTAT RES-DNA REPAIR, V485, P3, DOI 10.1016/S0921-8777(00)00071-9; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1992, CANCER-AM CANCER SOC, V69, P2615, DOI 10.1002/1097-0142(19920515)69:10<2615::AID-CNCR2820691036>3.0.CO;2-1; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kalogeraki VS, 2003, J BIOL CHEM, V278, P19558, DOI 10.1074/jbc.M301060200; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Leadon SA, 2000, COLD SPRING HARB SYM, V65, P561, DOI 10.1101/sqb.2000.65.561; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Ljungman M, 1996, ONCOGENE, V13, P823; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luo ZH, 2001, MUTAT RES-DNA REPAIR, V486, P259, DOI 10.1016/S0921-8777(01)00097-0; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; SMERDON MJ, 1990, CELL, V61, P675, DOI 10.1016/0092-8674(90)90479-X; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; SWEDER KS, 1993, SCIENCE, V262, P439, DOI 10.1126/science.8211165; SWEDER KS, 1992, P NATL ACAD SCI USA, V89, P10696, DOI 10.1073/pnas.89.22.10696; Tornaletti S, 1999, J BIOL CHEM, V274, P24124, DOI 10.1074/jbc.274.34.24124; van den Boom V, 2002, BIOESSAYS, V24, P780, DOI 10.1002/bies.10150; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; YAMAIZUMI M, 1994, ONCOGENE, V9, P2775; Yu SL, 2003, MOL CELL BIOL, V23, P382, DOI 10.1128/MCB.23.1.382-388.2003	42	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6897	6905		10.1074/jbc.M707649200	http://dx.doi.org/10.1074/jbc.M707649200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18195014	hybrid			2022-12-27	WOS:000253779600033
J	Doi, H; Okamura, K; Bauer, PO; Furukawa, Y; Shimizu, H; Kurosawa, M; Machida, Y; Miyazaki, H; Mitsui, K; Kuroiwa, Y; Nukina, N				Doi, Hiroshi; Okamura, Kazumasa; Bauer, Peter O.; Furukawa, Yoshiaki; Shimizu, Hideaki; Kurosawa, Masaru; Machida, Yoko; Miyazaki, Haruko; Mitsui, Kenichi; Kuroiwa, Yoshiyuki; Nukina, Nobuyuki			RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE TRANSGENIC MICE; STRIATAL SPINY NEURONS; N-TERMINAL HUNTINGTIN; CELLULAR TOXICITY; IN-VITRO; INTRANUCLEAR INCLUSIONS; CASPASE ACTIVATION; DENDRITIC SPINES; POLYMERASE-II; MOUSE MODEL	Formation of intracellular aggregates is the hallmark of polyglutamine (polyQ) diseases. We analyzed the components of purified nuclear polyQ aggregates by mass spectrometry. As a result, we found that the RNA-binding protein translocated in liposarcoma (TLS) was one of the major components of nuclear polyQ aggregate-interacting proteins in a Huntington disease cell model and was also associated with neuronal intranuclear inclusions of R6/2 mice. In vitro study revealed that TLS could directly bind to truncated N-terminal huntingtin (tNhtt) aggregates but could not bind to monomer GST-tNhtt with 18, 42, or 62Q, indicating that the tNhtt protein acquired the ability to sequester TLS after forming aggregates. Thioflavin T assay and electron microscopic study further supported the idea that TLS bound to tNhtt-42Q aggregates at the early stage of tNhtt-42Q amyloid formation. Immunohistochemistry showed that TLS was associated with neuronal intranuclear inclusions of Huntington disease human brain. Because TLS has a variety of functional roles, the sequestration of TLS to polyQ aggregates may play a role in diverse pathological changes in the brains of patients with polyQ diseases.	[Doi, Hiroshi; Okamura, Kazumasa; Bauer, Peter O.; Furukawa, Yoshiaki; Shimizu, Hideaki; Kurosawa, Masaru; Machida, Yoko; Miyazaki, Haruko; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan; [Mitsui, Kenichi] RIKEN, Brain Sci Inst, Res Resource Ctr, Wako, Saitama 3510198, Japan; [Doi, Hiroshi; Kuroiwa, Yoshiyuki] Yokohama City Univ, Grad Sch Med, Dept Neurol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	RIKEN; RIKEN; Yokohama City University	Nukina, N (corresponding author), 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nukina@brain.riken.jp	Furukawa, Yoshiaki/F-2871-2014; Nukina, Nobuyuki/GPP-6265-2022; Shimizu, Hideaki/C-4142-2017; Longo, Kenneth A/A-5631-2010; Bauer, Peter O./AAD-6502-2022	Furukawa, Yoshiaki/0000-0002-1918-372X; Shimizu, Hideaki/0000-0003-0174-5947; Bauer, Peter O./0000-0003-2811-1354				Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Delva L, 2004, ONCOGENE, V23, P4389, DOI 10.1038/sj.onc.1207578; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Mitsui K, 2002, J NEUROSCI, V22, P9267; Mitsui K, 2006, METHOD ENZYMOL, V412, P63, DOI 10.1016/S0076-6879(06)12005-4; Nagai Y, 2003, HUM MOL GENET, V12, P1253, DOI 10.1093/hmg/ddg144; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Oyama F, 2006, J NEUROCHEM, V98, P518, DOI 10.1111/j.1471-4159.2006.03893.x; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tanaka M, 2003, J BIOL CHEM, V278, P34717, DOI 10.1074/jbc.M209852200; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wang GH, 1999, NEUROREPORT, V10, P2435, DOI 10.1097/00001756-199908200-00001; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; Zemskov EA, 2003, J NEUROCHEM, V87, P395, DOI 10.1046/j.1471-4159.2003.02002.x; Zinszner H, 1997, J CELL SCI, V110, P1741	48	91	95	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6489	6500		10.1074/jbc.M705306200	http://dx.doi.org/10.1074/jbc.M705306200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167354	hybrid			2022-12-27	WOS:000253779500056
J	Gao, T; Brognard, J; Newton, AC				Gao, Tianyan; Brognard, John; Newton, Alexandra C.			The phosphatase PHLPP controls the cellular levels of protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE-DEPENDENT KINASE; DOWN-REGULATION; IN-VIVO; BETA-II; COLON CARCINOGENESIS; PHOSPHORYLATION; DEPHOSPHORYLATION; ALPHA; AUTOPHOSPHORYLATION; CONTRIBUTES	The life cycle of protein kinase C (PKC) is controlled by multiple phosphorylation and dephosphorylation steps. The maturation of PKC requires three ordered phosphorylations, one at the activation loop and two at COOH-terminal sites, the turn motif and the hydrophobic motif, to yield a stable and signaling-competent enzyme. Dephosphorylation of the enzyme leads to protein degradation. We have recently discovered a novel family of protein phosphatases named PH domain leucine-rich repeat protein phosphatase (PHLPP) whose members terminate Akt signaling by dephosphorylating the hydrophobic motif on Akt. Here we show that the two PHLPP isoforms, PHLPP1 and PHLPP2, also dephosphorylate the hydrophobic motif on PKC beta II, an event that shunts PKC to the detergent-insoluble fraction, effectively terminating its life cycle. Deletion mutagenesis reveals that the PH domain is necessary for the effective dephosphorylation of PKC beta II by PHLPP in cells, whereas the PDZ-binding motif, required for Akt regulation, is dispensable. The phorbol ester-mediated dephosphorylation of the hydrophobic site, but not the turn motif or activation loop, is insensitive to okadaic acid, consistent with PHLPP, a PP2C family member, controlling the hydrophobic site. In addition, knockdown of PHLPP expression reduces the rate of phorbol ester-triggered dephosphorylation of the hydrophobic motif, but not turn motif, of PKC alpha. Last, we show that depletion of PHLPP in colon cancer and normal breast epithelial cells results in an increase in conventional and novel PKC levels. These data reveal that PHLPP controls the cellular levels of PKC by specifically dephosphorylating the hydrophobic motif, thus destabilizing the enzyme and promoting its degradation.	[Gao, Tianyan; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Brognard, John] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu	Brognard, John/T-5099-2019	Brognard, John/0000-0002-9243-6615	NATIONAL CANCER INSTITUTE [K01CA102098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, R01GM067946] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA 10209-03] Funding Source: Medline; NIGMS NIH HHS [GM 067946, R01 GM043154, R01 GM067946, R01 GM 43154] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Balendran A, 2000, FEBS LETT, V484, P217, DOI 10.1016/S0014-5793(00)02162-1; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; BORNER C, 1988, P NATL ACAD SCI USA, V85, P2110, DOI 10.1073/pnas.85.7.2110; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; COHEN P, 1989, J BIOL CHEM, V264, P21435; Cohen PTW, 2002, J CELL SCI, V115, P241; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; Gokmen-Polar Y, 2001, CANCER RES, V61, P1375; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gysin S, 1997, EUR J BIOCHEM, V249, P156, DOI 10.1111/j.1432-1033.1997.t01-2-00156.x; Gysin S, 1996, EUR J BIOCHEM, V240, P747, DOI 10.1111/j.1432-1033.1996.0747h.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Hill MM, 2001, J BIOL CHEM, V276, P25643, DOI 10.1074/jbc.C100174200; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; KILEY SC, 1991, J BIOL CHEM, V266, P23761; Lee HW, 1996, AM J PHYSIOL-CELL PH, V271, pC304, DOI 10.1152/ajpcell.1996.271.1.C304; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; MURRAY NR, 1993, J BIOL CHEM, V268, P15847; Murray NR, 1999, J CELL BIOL, V145, P699, DOI 10.1083/jcb.145.4.699; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NEWTON AC, 1987, J BIOL CHEM, V262, P10185; Parker PJ, 2001, BIOCHEM SOC T, V29, P860, DOI 10.1042/0300-5127:0290860; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710	33	150	155	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6300	6311		10.1074/jbc.M707319200	http://dx.doi.org/10.1074/jbc.M707319200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18162466	hybrid			2022-12-27	WOS:000253779500037
J	Forouhar, F; Abashidze, M; Xu, HM; Grochowski, LL; Seetharaman, J; Hussain, M; Kuzin, A; Chen, YH; Zhou, W; Xiao, R; Acton, TB; Montelione, GT; Galinier, A; White, RH; Tong, L				Forouhar, Farhad; Abashidze, Mariam; Xu, Huimin; Grochowski, Laura L.; Seetharaman, Jayaraman; Hussain, Munif; Kuzin, Alexandre; Chen, Yang; Zhou, Weihong; Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.; Galinier, Anne; White, Robert H.; Tong, Liang			Molecular insights into the biosynthesis of the F-420 coenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOCALDOCOCCUS-JANNASCHII; METHANOCOCCUS-JANNASCHII; PHOTOREACTIVATING ENZYME; BACILLUS-SUBTILIS; GENE-CLUSTER; PROTEIN; IDENTIFICATION; TUBERCULOSIS; PROGRAM; DEHYDROGENASE	Coenzyme F-420, a hydride carrier, is found in Archaea and some bacteria and has crucial roles in methanogenesis, antibiotic biosynthesis, DNA repair, and activation of antitubercular compounds. CofD, 2-phospho-L-lactate transferase, catalyzes the last step in the biosynthesis of F-420-0(F-420 without polyglutamate), by transferring the lactyl phosphate moiety of lactyl(2) diphospho-(5') guanosine to 7,8-didemethyl-8-hydroxy-5-deazariboflavin ribitol (Fo). CofD is highly conserved among F-420-producing organisms, and weak sequence homologs are also found in non-F-420-producing organisms. This superfamily does not share any recognizable sequence conservation with other proteins. Here we report the first crystal structures of CofD, the free enzyme and two ternary complexes, with Fo and Pi or with Fo and GDP, from Methanosarcina mazei. The active site is located at the C-terminal end of a Rossmann fold core, and three large insertions make significant contributions to the active site and dimer formation. The observed binding modes of Fo and GDP can explain known biochemical properties of CofD and are also supported by our binding assays. The structures provide significant molecular insights into the biosynthesis of the F-420 coenzyme. Large structural differences in the active site region of the non-F-420-producing CofD homologs suggest that they catalyze a different biochemical reaction.	[Forouhar, Farhad; Abashidze, Mariam; Seetharaman, Jayaraman; Hussain, Munif; Kuzin, Alexandre; Chen, Yang; Zhou, Weihong; Tong, Liang] Columbia Univ, Dept Biol Sci, NE Struct Genom Consortium, New York, NY 10027 USA; [Xu, Huimin; Grochowski, Laura L.; White, Robert H.] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, NE Struct Genom Consortium, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Galinier, Anne] CNRS, Inst Biol Struct & Microbiol, UPR 9043, Chim Bacterienne Lab, F-13009 Marseille, France	Columbia University; Virginia Polytechnic Institute & State University; Rutgers State University New Brunswick; Centre National de la Recherche Scientifique (CNRS)	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, NE Struct Genom Consortium, New York, NY 10027 USA.	ltong@columbia.edu		Montelione, Gaetano/0000-0002-9440-3059; Tong, Liang/0000-0002-0563-6468	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958, P50GM062413] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM062413, U54 GM074958] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Aufhammer SW, 2004, STRUCTURE, V12, P361, DOI 10.1016/j.str.2004.02.010; AUTHAMMER SW, 2006, PROTEIN SCI, V14, P1840; Bair TB, 2001, ARCH MICROBIOL, V176, P37, DOI 10.1007/s002030100290; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COATS JH, 1989, J ANTIBIOT, V42, P472, DOI 10.7164/antibiotics.42.472; DeLano W.L., 2002, PYMOL MANUAL; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; DIVITA G, 1993, J BIOL CHEM, V268, P13178; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; EKER AP, 1988, BIOCHEMISTRY-US, V27, P1758, DOI 10.1021/bi00405a056; EKER APM, 1990, J BIOL CHEM, V265, P8009; Gorke B, 2005, MICROBIOL-SGM, V151, P3777, DOI 10.1099/mic.0.28172-0; Graham DE, 2003, ARCH MICROBIOL, V180, P455, DOI 10.1007/s00203-003-0614-8; Graham DE, 2002, NAT PROD REP, V19, P133, DOI 10.1039/b103714p; Graupner M, 2002, BIOCHEMISTRY-US, V41, P3754, DOI 10.1021/bi011937v; Graupner M, 2001, BIOCHEMISTRY-US, V40, P10859, DOI 10.1021/bi0107703; Grochowski LL, 2006, J BACTERIOL, V188, P2836, DOI 10.1128/JB.188.8.2836-2844.2006; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ikeno S, 2006, J ANTIBIOT, V59, P18, DOI 10.1038/ja.2006.4; Jansson M, 1996, J BIOMOL NMR, V7, P131; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; Johnson EF, 2005, J BIOL CHEM, V280, P38776, DOI 10.1074/jbc.M503492200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lessner DJ, 2006, P NATL ACAD SCI USA, V103, P17921, DOI 10.1073/pnas.0608833103; Li H, 2003, P NATL ACAD SCI USA, V100, P9785, DOI 10.1073/pnas.1733391100; Li H, 2003, BIOCHEMISTRY-US, V42, P9771, DOI 10.1021/bi034779b; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; MCCORMICK JRD, 1982, J AM CHEM SOC, V104, P4014, DOI 10.1021/ja00378a044; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PESCHKE U, 1995, MOL MICROBIOL, V16, P1137, DOI 10.1111/j.1365-2958.1995.tb02338.x; Pompeo F, 2007, J BACTERIOL, V189, P1154, DOI 10.1128/JB.01575-06; RHODES PM, 1981, J GEN MICROBIOL, V124, P329; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Warkentin E, 2001, EMBO J, V20, P6561, DOI 10.1093/emboj/20.23.6561; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504	40	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11832	11840		10.1074/jbc.M710352200	http://dx.doi.org/10.1074/jbc.M710352200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18252724	hybrid, Green Published			2022-12-27	WOS:000255067400082
J	Mueckler, M; Makepeace, C				Mueckler, Mike; Makepeace, Carol			Transmembrane segment 6 of the Glut1 glucose transporter is an outer helix and contains amino acid side chains essential for transport activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; SUGAR PERMEATION PATHWAY; XENOPUS-OOCYTES; ESCHERICHIA-COLI; ACCESSIBILITY; MECHANISM; BINDING; PROTEINS; DOMAINS; FAMILY	Experimental data and homology modeling suggest a structure for the exofacial configuration of the Glut1 glucose transporter in which 8 transmembrane helices form an aqueous cavity in the bilayer that is stabilized by four outer helices. The role of transmembrane segment 6, predicted to be an outer helix in this model, was examined by cysteine-scanning mutagenesis and the substituted cysteine accessibility method using the membrane-impermeant, sulfhydryl-specific reagent, p-chloromercuribenzene-sulfonate (pCMBS). A fully functional Glut1 molecule lacking all 6 native cysteine residues was used as a template to produce a series of 21 Glut1 point mutants in which each residue along helix 6 was individually changed to cysteine. These mutants were expressed in Xenopus oocytes, and their expression levels, functional activities, and sensitivities to inhibition by pCMBS were determined. Cysteine substitutions at Leu(204) and Pro(205) abolished transport activity, whereas substitutions at Ile(192), Pro(196), Gln(200), and Gly(201) resulted in inhibition of activity that ranged from similar to 35 to similar to 80%. Cysteine substitutions at Leu(188), Ser(191), and Leu(199) moderately augmented specific transport activity relative to the control. These results were dramatically different from those previously reported for helix 12, the structural cognate of helix 6 in the pseudo-symmetrical structural model, for which none of the 21 single-cysteine mutants exhibited reduced activity. Only the substitution at Leu(188) conferred inhibition by pCMBS, suggesting that most of helix 6 is not exposed to the external solvent, consistent with its proposed role as an outer helix. These data suggest that helix 6 contains amino acid side chains that are critical for transport activity and that structurally analogous outer helices may play distinct roles in the function of membrane transporters.	[Mueckler, Mike; Makepeace, Carol] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mueckler, M (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	mike@cellbio.wustl.edu	Mueckler, Mike M/F-6115-2012		NIDDK NIH HHS [P30 DK056341, P30 DK056341-07, P30 DK056341-08] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; BALDWIN SA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P17, DOI 10.1016/0304-4157(93)90015-G; BALDWIN SA, 1989, METHOD ENZYMOL, V174, P39; BARNETT JEG, 1973, BIOCHEM J, V131, P211, DOI 10.1042/bj1310211; CARRUTHERS A, 1990, PHYSIOL REV, V70, P1135, DOI 10.1152/physrev.1990.70.4.1135; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; Heinze M, 2004, BIOCHEMISTRY-US, V43, P931, DOI 10.1021/bi030175w; HRESKO RC, 1994, J BIOL CHEM, V269, P32110; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; Hruz PW, 2000, BIOCHEMISTRY-US, V39, P9367, DOI 10.1021/bi000821g; Hruz PW, 1999, J BIOL CHEM, V274, P36176, DOI 10.1074/jbc.274.51.36176; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; KELLER K, 1989, J BIOL CHEM, V264, P18884; MARSHALL BA, 1993, J BIOL CHEM, V268, P26193; Mueckler M, 1999, J BIOL CHEM, V274, P10923, DOI 10.1074/jbc.274.16.10923; Mueckler M, 1997, BIOCHEM SOC T, V25, P951, DOI 10.1042/bst0250951; Mueckler M, 2004, J BIOL CHEM, V279, P46876, DOI 10.1074/jbc.M408632200; Mueckler M, 2004, J BIOL CHEM, V279, P10494, DOI 10.1074/jbc.M310786200; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Mueckler M, 2002, J BIOL CHEM, V277, P3498, DOI 10.1074/jbc.M109157200; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; Mueckler M, 1997, J BIOL CHEM, V272, P30141, DOI 10.1074/jbc.272.48.30141; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Mueckler M, 2006, J BIOL CHEM, V281, P36993, DOI 10.1074/jbc.M608158200; Olsowski A, 2000, BIOCHEMISTRY-US, V39, P2469, DOI 10.1021/bi992160x; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PESSIN JE, 1992, ANNU REV PHYSIOL, V54, P911, DOI 10.1146/annurev.ph.54.030192.004403; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; WELLNER M, 1995, FEBS LETT, V370, P19, DOI 10.1016/0014-5793(95)00783-6	32	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11550	11555		10.1074/jbc.M708896200	http://dx.doi.org/10.1074/jbc.M708896200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18245775	Green Published, hybrid			2022-12-27	WOS:000255067400055
J	Harrison, B; Kraus, M; Burch, L; Stevens, C; Craig, A; Gordon-Weeks, P; Hupp, TR				Harrison, Ben; Kraus, Michaela; Burch, Lindsay; Stevens, Craig; Craig, Ashley; Gordon-Weeks, Phillip; Hupp, Ted R.			DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; CELL-DEATH; INTERACTION NETWORKS; INDUCED APOPTOSIS; P53 CONTAINS; DOCKING SITE; KINASE; DOMAIN; MDM2; CHECKPOINT	DAPK-1 (death-activated protein kinase) has wide ranging functions in cell growth control; however, DAPK-1 interacting proteins that mediate these effects are not well defined. Protein-protein interactions are driven in part by linear interaction motifs, and combinatorial peptide libraries were used to identify peptide interfaces for the kinase domain of DAPK-1. Peptides bound to DAPK-1 core kinase domain fragments had homology to the N-terminal domain of the microtubule-associated protein MAP1B. Immunobinding assays demonstrated that DAPK-1 can bind to the full-length human MAP1B, a smaller N-terminal miniprotein containing amino acids 1-126 and the 12-amino acid polypeptides acquired by peptide selection. Amino acid starvation of cells induced a stable immune complex between MAP1B and DAPK-1, identifying a signal that forms the endogenous complex in cells. DAPK-1 and MAP1B co-expression form a synthetic lethal interaction as they cooperate to induce growth inhibition in a clonogenic assay. In cells, two co-localizing populations of DAPK-1 and MAP1B were observed using confocal microscopy; one pool co-localized with MAP1B plus tubulin, and a second pool co-localized with MAP1B plus cortical F-actin. Reduction of MAP1B protein using short interfering RNA attenuated DAPK-1-stimulated autophagy. Transfected MAP1B can synergize with DAPK-1 to stimulate membrane blebbing, whereas reduction of MAP1B using short interfering RNA attenuates DAPK-1 membrane blebbing activity. The autophagy inhibitor 3-methyladenine inhibits the DAPK-1 plus MAP1B-mediated membrane blebbing. These data highlight the utility of peptide aptamers to identify novel binding interfaces and highlight a role for MAP1B in DAPK-1-dependent signaling in autophagy and membrane blebbing.	[Harrison, Ben; Burch, Lindsay; Stevens, Craig; Craig, Ashley; Hupp, Ted R.] Univ Edinburgh, Ctr Canc, Cell Signaling Unit, Edinburgh EH4 2XR, Midlothian, Scotland; [Kraus, Michaela; Gordon-Weeks, Phillip] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England	University of Edinburgh; University of London; King's College London	Hupp, TR (corresponding author), Univ Edinburgh, Ctr Canc, Cell Signaling Unit, S Crewe Rd, Edinburgh EH4 2XR, Midlothian, Scotland.	ted.hupp@ed.ac.uk	Gordon-Weeks, Phillip R./C-5328-2009	Gordon-Weeks, Phillip R./0000-0002-4738-4246; Harrison, Benjamin/0000-0002-6078-5060	MRC [G9900989, G0400034] Funding Source: UKRI; Cancer Research UK Funding Source: Medline; Medical Research Council [G9900989, G0400034] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; Burch L, 2004, J MOL BIOL, V337, P129, DOI 10.1016/j.jmb.2004.01.017; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Chen CH, 2005, EMBO J, V24, P294, DOI 10.1038/sj.emboj.7600510; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Craig AL, 2004, ONCOGENE, V23, P8411, DOI 10.1038/sj.onc.1208035; Craig AL, 1999, BIOCHEM J, V342, P133, DOI 10.1042/0264-6021:3420133; Craig AL, 2007, MOL CELL BIOL, V27, P3542, DOI 10.1128/MCB.01595-06; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Del Rio JA, 2004, CURR BIOL, V14, P840, DOI 10.1016/j.cub.2004.04.046; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; Finlan L, 2004, J BIOL CHEM, V279, P49395, DOI 10.1074/jbc.M405974200; Gonzalez-Billault C, 2001, MOL BIOL CELL, V12, P2087, DOI 10.1091/mbc.12.7.2087; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hunter T, 2005, CELL, V123, P765, DOI 10.1016/j.cell.2005.11.017; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Jimenez-Mateos EM, 2006, BIOCHEM J, V397, P53, DOI 10.1042/BJ20060205; Jin YJ, 2003, J BIOL CHEM, V278, P51587, DOI 10.1074/jbc.M309165200; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Jin YJ, 2001, J BIOL CHEM, V276, P39667, DOI 10.1074/jbc.M101886200; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kastan MB, 2001, ACTA ONCOL, V40, P686; Kawai T, 2003, MOL CELL BIOL, V23, P6174, DOI 10.1128/MCB.23.17.6174-6186.2003; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Lin Y, 2007, J BIOL CHEM, V282, P16792, DOI 10.1074/jbc.M611559200; Luciani MG, 2000, J MOL BIOL, V300, P503, DOI 10.1006/jmbi.2000.3830; McEntyre JR, 2004, TRENDS BIOCHEM SCI, V29, P627, DOI 10.1016/j.tibs.2004.10.006; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Raveh T, 2000, P NATL ACAD SCI USA, V97, P1572, DOI 10.1073/pnas.020519497; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; RIEDERER B, 1986, J NEUROCYTOL, V15, P763, DOI 10.1007/BF01625193; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Stevens C, 2007, J BIOL CHEM, V282, P13791, DOI 10.1074/jbc.M605649200; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Trivedi N, 2005, J CELL SCI, V118, P993, DOI 10.1242/jcs.01697; Uchida Y, 2003, J BIOL CHEM, V278, P366, DOI 10.1074/jbc.M210091200; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050; Xu ZX, 2007, CELL DEATH DIFFER, V14, P1948, DOI 10.1038/sj.cdd.4402207; York JD, 2004, SCIENCE, V306, P2053, DOI 10.1126/science.1107225	56	111	119	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9999	10014		10.1074/jbc.M706040200	http://dx.doi.org/10.1074/jbc.M706040200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18195017	hybrid			2022-12-27	WOS:000254671600056
J	Holtje, M; Hofmann, F; Lux, R; Veh, RW; Just, I; Ahnert-Hilger, G				Hoeltje, Markus; Hofmann, Fred; Lux, Romy; Veh, Ruediger W.; Just, Ingo; Ahnert-Hilger, Gudrun			Glutamate uptake and release by Astrocytes are enhanced by Clostridium botulinum C3 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPSES; RHO	Inhibition of Rho activity by Clostridium botulinum C3 transferase ( C3bot) versatily changes functional properties of neural cells. Using cultivated mouse astrocytes, we show here that C3bot increases both uptake and secretion of glutamate. The enhanced glutamate uptake is initiated by an NF kappa B-dependent up-regulation of the glial glutamate transporter 1 that is efficaciously sorted to the plasma membrane. The increase in cytosolic glutamate concentration promotes vesicular glutamate storage in astrocytes treated with C3bot. Parallel to the increased storage, C3-induced impairment of Rho-dependent pathways strongly enhances Ca2+-dependent secretion of glutamate. This is accompanied by higher levels of the SNARE protein synaptobrevin. Synaptobrevin inactivation by botulinum neurotoxin D almost completely inhibits Ca2+-dependent glutamate secretion triggered by C3bot, indicating that the enhanced release of glutamate mainly originates from exocytosis. In addition, C3bot increases the exocytosis/endocytosis turnover, as analyzed by the stimulated accumulation of the fluorescent dye AM1-43. The release of glutamine, the main metabolite of glutamate, is only moderately affected by C3bot. In conclusion, inhibition of Rho-dependent pathways shifts astrocytes to a secretory active stage in which they may modulate neuronal excitability.	[Hoeltje, Markus; Lux, Romy; Veh, Ruediger W.; Ahnert-Hilger, Gudrun] Univ Berlin, Charite Med, Inst Integrat Neuroanat, Ctr Anat, D-10115 Berlin, Germany; [Hofmann, Fred; Just, Ingo] Med Hochschule Hannover, Inst Toxikol, D-30625 Hannover, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School	Holtje, M (corresponding author), Univ Berlin, Charite Med, Inst Integrat Neuroanat, Ctr Anat, Philippstr 12, D-10115 Berlin, Germany.	markus.hoeltje@charite.de		Holtje, Markus/0000-0003-3193-4140; Veh, Rudiger/0000-0002-6253-9808				Abe K, 2003, DEV BRAIN RES, V143, P99, DOI 10.1016/S0165-3806(03)00096-8; Aktories K, 2005, CURR TOP MICROBIOL, V291, P113; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; Bertrand J, 2007, NEUROBIOL DIS, V25, P65, DOI 10.1016/j.nbd.2006.08.008; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Boquet P, 1998, CURR OPIN MICROBIOL, V1, P66, DOI 10.1016/S1369-5274(98)80144-6; Broer A, 2004, GLIA, V48, P298, DOI 10.1002/glia.20081; Chen XK, 2005, J NEUROSCI, V25, P9236, DOI 10.1523/JNEUROSCI.1640-05.2005; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; FIELDS R, 1971, BIOCHEM J, V124, P581, DOI 10.1042/bj1240581; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fritz G, 2001, J BIOL CHEM, V276, P3115, DOI 10.1074/jbc.M005058200; Gegelashvili G, 1997, MOL PHARMACOL, V52, P6, DOI 10.1124/mol.52.1.6; Gegelashvili G, 2001, Prog Brain Res, V132, P267; Harada A, 2000, J BIOL CHEM, V275, P36885, DOI 10.1074/jbc.M004069200; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; IINO M, 2001, SCIENCE, V5518, P926; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Li LB, 2006, J NEUROCHEM, V97, P759, DOI 10.1111/j.1471-4159.2006.03743.x; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; NAGLER K, 2001, J PHYSL, P665; Parpura V, 1995, FEBS LETT, V377, P489, DOI 10.1016/0014-5793(95)01401-2; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; POITRY Y, 2002, J NEUROCHEM, V4, P987; Ramakers GJA, 1998, EXP CELL RES, V245, P252, DOI 10.1006/excr.1998.4224; Rattan R, 2003, FREE RADICAL BIO MED, V35, P1037, DOI 10.1016/S0891-5849(03)00459-3; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rodriguez-Kern A, 2003, NEUROCHEM INT, V43, P363, DOI 10.1016/S0197-0186(03)00023-8; Rothman DL, 2003, ANNU REV PHYSIOL, V65, P401, DOI 10.1146/annurev.physiol.65.092101.142131; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sasaki S, 2000, ACTA NEUROPATHOL, V100, P138, DOI 10.1007/s004019900159; Sattler R, 2006, HANDB EXP PHARM, V175, P277; Shiga H, 2006, J NEUROSCI RES, V84, P338, DOI 10.1002/jnr.20885; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Swanson RA, 1997, J NEUROSCI, V17, P932; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Ullian EM, 2004, MOL CELL NEUROSCI, V26, P544, DOI 10.1016/j.mcn.2004.05.002; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Winter S, 2005, J NEUROSCI, V25, P4672, DOI 10.1523/JNEUROSCI.0549-05.2005; Zschocke J, 2005, J BIOL CHEM, V280, P34924, DOI 10.1074/jbc.M502581200	48	29	30	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9289	9299		10.1074/jbc.M706499200	http://dx.doi.org/10.1074/jbc.M706499200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18234672	hybrid			2022-12-27	WOS:000254465800059
J	Ito, H; Yokono, M; Tanaka, R; Tanaka, A				Ito, Hisashi; Yokono, Makio; Tanaka, Ryouichi; Tanaka, Ayumi			Identification of a novel vinyl reductase gene essential for the biosynthesis of monovinyl chlorophyll in Synechocystis sp PCC6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOBACTERIUM-THERMOAUTOTROPHICUM; PCC 6803; ARABIDOPSIS-THALIANA; DIVINYL-CHLOROPHYLLS; EUGLENA-GRACILIS; PHOTOSYSTEM-II; CYANOBACTERIUM; OXYGENASE; LIGHT; MUTANTS	The vast majority of oxygenic photosynthetic organisms use monovinyl chlorophyll for their photosynthetic reactions. For the biosynthesis of this type of chlorophyll, the reduction of the 8-vinyl group that is located on the B-ring of the macrocycle is essential. Previously, we identified the gene encoding 8-vinyl reductase responsible for this reaction in higher plants and termed it DVR. Among the sequenced genomes of cyanobacteria, only several Synechococcus species contain DVR homologues. Therefore, it has been hypothesized that many other cyanobacteria producing monovinyl chlorophyll should contain a vinyl reductase that is unrelated to the higher plant DVR. To identify the cyanobacterial gene that is responsible for monovinyl chlorophyll synthesis, we developed a bioinformatics tool, correlation coefficient calculation tool, which calculates the correlation coefficient between the distributions of a certain phenotype and genes among a group of organisms. The program indicated that the distribution of a gene encoding a putative dehydrogenase protein is best correlated with the distribution of the DVR-less cyanobacteria. We subsequently knocked out the corresponding gene ( Slr1923) in Synechocystis sp. PCC6803 and characterized the mutant. The knock-out mutant lost its ability to synthesize monovinyl chlorophyll and accumulated 3,8-divinyl chlorophyll instead. We concluded that Slr1923 encodes the vinyl reductase or a subunit essential for monovinyl chlorophyll synthesis. The function and evolution of 8-vinyl reductase genes are discussed.	[Ito, Hisashi; Yokono, Makio; Tanaka, Ryouichi; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan	Hokkaido University	Ito, H (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan.	ito98@lowtem.hokudai.ac.jp	Ito, Hisashi/A-4211-2012; Yokono, Makio/N-8425-2015; Tanaka, Ryouichi/A-4030-2012; Tanaka, Ayumi/D-9003-2012	Ito, Hisashi/0000-0002-2482-5870; Tanaka, Ryouichi/0000-0002-5858-5326; Yokono, Makio/0000-0002-4813-2120				Ahmadinejad N, 2007, GENE, V402, P35, DOI 10.1016/j.gene.2007.07.023; Akimoto S, 2005, CHEM PHYS LETT, V409, P167, DOI 10.1016/j.cplett.2005.05.006; ALEX LA, 1990, BIOCHEMISTRY-US, V29, P7237, DOI 10.1021/bi00483a011; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BRAKS IJ, 1994, J BACTERIOL, V176, P7677, DOI 10.1128/JB.176.24.7677-7687.1994; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; Fromme P, 2003, FEBS LETT, V555, P40, DOI 10.1016/S0014-5793(03)01124-4; Giorgi LB, 1996, J BIOL CHEM, V271, P2093, DOI 10.1074/jbc.271.4.2093; Hihara Y, 1998, PLANT PHYSIOL, V117, P1205, DOI 10.1104/pp.117.4.1205; Jen CH, 2006, PLANT J, V46, P336, DOI 10.1111/j.1365-313X.2006.02681.x; Lee S, 2000, CURR MICROBIOL, V40, P283, DOI 10.1007/s002849910056; LIVINGSTON DJ, 1987, BIOCHEMISTRY-US, V26, P4228, DOI 10.1021/bi00388a008; Manning WM, 1943, J BIOL CHEM, V151, P1; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Maresca JA, 2004, J BACTERIOL, V186, P2558, DOI 10.1128/JB.186.9.2558-2566.2004; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Nakanishi H, 2005, PLANT CELL PHYSIOL, V46, P467, DOI 10.1093/pcp/pci053; Obornik M, 2005, MOL BIOL EVOL, V22, P2343, DOI 10.1093/molbev/msi230; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satoh S, 2001, J BIOL CHEM, V276, P4293, DOI 10.1074/jbc.M008238200; Satoh S, 2006, PLANT CELL PHYSIOL, V47, P1622, DOI 10.1093/pcp/pcl026; Schafer L, 2006, PLANT CELL ENVIRON, V29, P1349, DOI 10.1111/j.1365-3040.2006.01515.x; Schafer L, 2005, J PHOTOCH PHOTOBIO B, V78, P195, DOI 10.1016/j.jphotobiol.2004.11.007; Stanier G., 1988, METHOD ENZYMOL, V167, P157, DOI DOI 10.1016/0076-6879(88)67017-0; SUZUKI JY, 1995, J BIOL CHEM, V270, P3732, DOI 10.1074/jbc.270.8.3732; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tanaka R, 2003, PLANT CELL PHYSIOL, V44, P1266, DOI 10.1093/pcp/pcg172; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomo T, 2007, P NATL ACAD SCI USA, V104, P7283, DOI 10.1073/pnas.0701847104; WEINSTEIN JD, 1983, J BIOL CHEM, V258, P6799	34	73	75	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9002	9011		10.1074/jbc.M708369200	http://dx.doi.org/10.1074/jbc.M708369200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18230620	hybrid, Green Published			2022-12-27	WOS:000254465800030
J	Dorwart, MR; Shcheynikov, N; Baker, JMR; Forman-Kay, JD; Muallem, S; Thomas, PJ				Dorwart, Michael R.; Shcheynikov, Nikolay; Baker, Jennifer M. R.; Forman-Kay, Julie D.; Muallem, Shmuel; Thomas, Philip J.			Congenital chloride-losing diarrhea causing mutations in the STAS domain result in misfolding and mistrafficking of SLC26A3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSPLASIA SULFATE TRANSPORTER; ANTI-SIGMA FACTOR; TRANSCRIPTION FACTOR SIGMA(F); HIGH ENDOTHELIAL VENULES; ADENOMA DRA GENE; BACILLUS-SUBTILIS; PENDRED-SYNDROME; ANION-EXCHANGER; FUNCTIONAL-ANALYSIS; FACTOR SPOIIAB	Congenital chloride-losing diarrhea (CLD) is a genetic disorder causing watery stool and dehydration. Mutations in SLC26A3 ( solute carrier 26 family member 3), which functions as a coupled Cl-/HCO3- exchanger, cause CLD. SLC26A3 is a membrane protein predicted to contain 12 transmembrane-spanning alpha-helices and a C-terminal STAS (sulfate transporters and anti-sigma-factor) domain homologous to the bacterial anti-sigma-factor antagonists. The STAS domain is required for SLC26A3 Cl-/HCO3- exchange function and for the activation of cystic fibrosis transmembrane conductance regulator by SLC26A3. Here we investigate the molecular mechanism(s) by which four CLD-causing mutations (Delta Y526/ 7, I544N, I675/6ins, and G702Tins) in the STAS domain lead to disease. In a heterologous mammalian expression system biochemical, immunohistochemical, and ion transport experiments suggest that the four CLD mutations cause SLC26A3 transporter misfolding and/or mistrafficking. Expression studies with the isolated STAS domain suggest that the I675/6ins and G702Tins mutations disrupt the STAS domain directly, whereas limited proteolysis experiments suggest that the Delta Y526/ 7 and I544N mutations affect a later step in the folding and/ or trafficking pathway. The data suggest that these CLD-causing mutations cause disease by at least two distinct molecular mechanisms, both ultimately leading to loss of functional protein at the plasma membrane.	[Dorwart, Michael R.; Shcheynikov, Nikolay; Muallem, Shmuel; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Dorwart, Michael R.] Univ Texas SW Med Ctr Dallas, Mol Biophys Program, Dallas, TX 75390 USA; [Baker, Jennifer M. R.; Forman-Kay, Julie D.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Baker, Jennifer M. R.; Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Thomas, PJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Philip.Thomas@utsouthwestern.edu	Thomas, Philip J/F-7115-2012	Forman-Kay, Julie/0000-0001-8265-972X	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049835, R01DK038938, R01DK049835] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE 12309] Funding Source: Medline; NIDDK NIH HHS [DK 38938, DK 49835] Funding Source: Medline; NIGMS NIH HHS [GM 08203] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarez BV, 2005, EMBO J, V24, P2499, DOI 10.1038/sj.emboj.7600736; Aravind L, 2000, CURR BIOL, V10, pR53, DOI 10.1016/S0960-9822(00)00335-3; Byeon MK, 1998, PROTEIN EXPRES PURIF, V12, P67, DOI 10.1006/prep.1997.0809; Byeon MK, 1996, ONCOGENE, V12, P387; Campbell C, 2001, HUM MUTAT, V17, P403, DOI 10.1002/humu.1116; Canani RB, 2004, GASTROENTEROLOGY, V127, P630, DOI 10.1053/j.gastro.2004.03.071; Chapman JM, 2002, CANCER RES, V62, P5083; Chernova MN, 2003, J PHYSIOL-LONDON, V549, P3, DOI 10.1113/jphysiol.2003.039818; Clarkson J, 2003, BIOCHEM J, V372, P113, DOI 10.1042/BJ20021748; Dawson PA, 2005, CURR MED CHEM, V12, P385, DOI 10.2174/0929867053363144; Deak L, 2005, J PHYSIOL-LONDON, V563, P483, DOI 10.1113/jphysiol.2004.078857; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DUNCAN L, 1993, P NATL ACAD SCI USA, V90, P2325, DOI 10.1073/pnas.90.6.2325; Duncan L, 1996, J MOL BIOL, V260, P147, DOI 10.1006/jmbi.1996.0389; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Garsin DA, 1998, J MOL BIOL, V284, P557, DOI 10.1006/jmbi.1998.2201; Girard JP, 1999, P NATL ACAD SCI USA, V96, P12772, DOI 10.1073/pnas.96.22.12772; Hemminki A, 1998, ONCOGENE, V16, P681, DOI 10.1038/sj.onc.1201538; Hihnala S, 2006, J PEDIATR GASTR NUTR, V42, P369, DOI 10.1097/01.mpg.0000214161.37574.9a; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Hoglund P, 1998, AM J HUM GENET, V63, P760, DOI 10.1086/301998; HOLMBERG C, 1986, CLIN GASTROENTEROL, V15, P583; Jacob P, 2002, GASTROENTEROLOGY, V122, P709, DOI 10.1053/gast.2002.31875; Jiang Z, 2002, J BIOL CHEM, V277, P33963, DOI 10.1074/jbc.M202660200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Karniski LP, 2004, HUM MOL GENET, V13, P2165, DOI 10.1093/hmg/ddh242; Karniski LP, 1998, AM J PHYSIOL-RENAL, V275, pF79, DOI 10.1152/ajprenal.1998.275.1.F79; Karniski LP, 2001, HUM MOL GENET, V10, P1485, DOI 10.1093/hmg/10.14.1485; Kere J, 1999, AM J PHYSIOL-GASTR L, V276, pG7, DOI 10.1152/ajpgi.1999.276.1.G7; Kim KH, 2005, J BIOL CHEM, V280, P6463, DOI 10.1074/jbc.M409162200; Knauf F, 2001, P NATL ACAD SCI USA, V98, P9425, DOI 10.1073/pnas.141241098; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Kovacs H, 1998, P NATL ACAD SCI USA, V95, P5067, DOI 10.1073/pnas.95.9.5067; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Lohi H, 2003, AM J PHYSIOL-CELL PH, V284, pC769, DOI 10.1152/ajpcell.00270.2002; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Lohi H, 2002, AM J PHYSIOL-GASTR L, V283, pG567, DOI 10.1152/ajpgi.00356.2001; Lohi H, 2000, GENOMICS, V70, P102, DOI 10.1006/geno.2000.6355; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Magnin T, 1996, MOL MICROBIOL, V19, P901, DOI 10.1046/j.1365-2958.1996.434964.x; Makela S, 2002, HUM MUTAT, V20, P425, DOI 10.1002/humu.10139; Masuda S, 2004, J MOL BIOL, V340, P941, DOI 10.1016/j.jmb.2004.05.040; Moseley RH, 1999, AM J PHYSIOL-GASTR L, V276, pG185, DOI 10.1152/ajpgi.1999.276.1.G185; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; NAJAFI SMA, 1995, J BACTERIOL, V177, P2912, DOI 10.1128/jb.177.10.2912-2913.1995; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Park M, 2002, J BIOL CHEM, V277, P50503, DOI 10.1074/jbc.M201862200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; Rotman-Pikielny P, 2002, HUM MOL GENET, V11, P2625, DOI 10.1093/hmg/11.21.2625; Rouached H, 2005, J BIOL CHEM, V280, P15976, DOI 10.1074/jbc.M501635200; Royaux IE, 2000, ENDOCRINOLOGY, V141, P839, DOI 10.1210/en.141.2.839; Satoh H, 1998, J BIOL CHEM, V273, P12307, DOI 10.1074/jbc.273.20.12307; Scott DA, 2000, AM J PHYSIOL-CELL PH, V278, pC207, DOI 10.1152/ajpcell.2000.278.1.C207; Seavers PR, 2001, STRUCTURE, V9, P605, DOI 10.1016/S0969-2126(01)00623-2; Shcheynikov N, 2006, J GEN PHYSIOL, V127, P511, DOI 10.1085/jgp.200509392; Shibagaki N, 2004, J BIOL CHEM, V279, P30791, DOI 10.1074/jbc.M403248200; Shibagaki N, 2006, J BIOL CHEM, V281, P22964, DOI 10.1074/jbc.M603462200; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Taylor JP, 2002, J CLIN ENDOCR METAB, V87, P1778, DOI 10.1210/jc.87.4.1778; Toure A, 2001, J BIOL CHEM, V276, P20309, DOI 10.1074/jbc.M011740200; Vincourt JB, 2003, FASEB J, V17, P890, DOI 10.1096/fj.02-0787fje; Vincourt JB, 2002, GENOMICS, V79, P249, DOI 10.1006/geno.2002.6689; Waldegger S, 2001, GENOMICS, V72, P43, DOI 10.1006/geno.2000.6445; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002; Zheng J, 2001, NEUROREPORT, V12, P1929, DOI 10.1097/00001756-200107030-00032	70	48	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8711	8722		10.1074/jbc.M704328200	http://dx.doi.org/10.1074/jbc.M704328200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18216024	Green Published, hybrid			2022-12-27	WOS:000254288000069
J	Slugoski, MD; Ng, AML; Yao, SYM; Smith, KM; Lin, CC; Zhang, J; Karpinski, E; Cass, CE; Baldwin, SA; Young, JD				Slugoski, Melissa D.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Smith, Kyla M.; Lin, Colin C.; Zhang, Jing; Karpinski, Edward; Cass, Carol E.; Baldwin, Stephen A.; Young, James D.			A proton-mediated conformational shift identifies a mobile pore-lining cysteine residue (Cys-561) in human concentrative nucleoside transporter 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; ELECTROPHYSIOLOGICAL CHARACTERIZATION; MOLECULAR-CLONING; COTRANSPORTER; CHANNEL; PURINE; FAMILY; HCNT1; ACCESSIBILITY; MUTAGENESIS	The concentrative nucleoside transporter (CNT) protein family in humans is represented by three members, hCNT1, hCNT2, and hCNT3. Belonging to a CNT subfamily phylogenetically distinct from hCNT1/2, hCNT3 mediates transport of a broad range of purine and pyrimidine nucleosides and nucleoside drugs, whereas hCNT1 and hCNT2 are pyrimidine and purine nucleoside-selective, respectively. All three hCNTs are Na+-coupled. Unlike hCNT1/2, however, hCNT3 is also capable of H+-mediated nucleoside cotransport. Using site-directed mutagenesis in combination with heterologous expression in Xenopus oocytes, we have identified a C-terminal intramembranous cysteine residue of hCNT3 (Cys-561) that reversibly binds the hydrophilic thiol-reactive reagent p-chloromercuribenzene sulfonate (PCMBS). Access of this membrane-impermeant probe to Cys-561, as determined by inhibition of hCNT3 transport activity, required H+, but not Na+, and was blocked by extracellular uridine. Although this cysteine residue is also present in hCNT1 and hCNT2, neither transporter was affected by PCMBS. We conclude that Cys-561 is located in the translocation pore in a mobile region within or closely adjacent to the nucleoside binding pocket and that access of PCMBS to this residue reports a specific H+-induced conformational state of the protein.	[Slugoski, Melissa D.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Smith, Kyla M.; Lin, Colin C.; Karpinski, Edward; Young, James D.] Univ Alberta, Dept Physiol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Zhang, Jing; Cass, Carol E.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada; [Zhang, Jing; Cass, Carol E.] Cross Canc Inst, Edmonton, AB T6G 2H7, Canada; [Baldwin, Stephen A.] Univ Leeds, Inst Membrane & Syst Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Alberta; University of Alberta; University of Alberta; University of Leeds	Young, JD (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Res Grp, 7-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	james.young@ualberta.ca	Cass, Carol E/F-5861-2010					AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; CASS CE, 1995, DRUG TRANSPORT ANTIM, P403; Damaraju VL, 2003, ONCOGENE, V22, P7524, DOI 10.1038/sj.onc.1206952; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Hu HK, 2006, MOL PHARMACOL, V69, P1542, DOI 10.1124/mol.105.018945; HUANG QQ, 1994, J BIOL CHEM, V269, P17757; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; KRUPKA RM, 1994, BBA-BIOMEMBRANES, V1193, P165, DOI 10.1016/0005-2736(94)90346-8; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loewen SK, 1999, J BIOL CHEM, V274, P24475, DOI 10.1074/jbc.274.35.24475; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Loewen SK, 2003, YEAST, V20, P661, DOI 10.1002/yea.1000; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; ROTHSTEIN A, 1970, CURRENT TOPICS MEMBR, V1, P135; Slugoski MD, 2007, BIOCHEMISTRY-US, V46, P1684, DOI 10.1021/bi061692s; Smith FM, 2007, MOL MEMBR BIOL, V24, P53, DOI 10.1080/09687860600942534; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Xiao GQ, 2001, MOL PHARMACOL, V59, P339, DOI 10.1124/mol.59.2.339; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YAN RT, 1993, CELL, V75, P37, DOI 10.1016/S0092-8674(05)80082-0; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Yao SY, 2002, AM J PHYSIOL-CELL PH, V283, pC155, DOI 10.1152/ajpcell.00587.2001; Yao SYM, 2007, J BIOL CHEM, V282, P30607, DOI 10.1074/jbc.M703285200; Yao SYM, 2000, PRACT APPROACH SER, P47; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Young JD, 2001, CURR TOP MEMBR, V50, P329; Zhang J, 2006, BIOCHEM J, V394, P389, DOI 10.1042/BJ20051476	39	16	16	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8496	8507		10.1074/jbc.M710433200	http://dx.doi.org/10.1074/jbc.M710433200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18199742	Green Published, hybrid			2022-12-27	WOS:000254288000048
J	Vicente, R; Villalonga, N; Calvo, M; Escalada, A; Solsona, C; Soler, C; Tamkun, MM; Felipe, A				Vicente, Ruben; Villalonga, Nuria; Calvo, Maria; Escalada, Artur; Solsona, Carles; Soler, Concepcio; Tamkun, Michael M.; Felipe, Antonio			Kv1.5 association modifies Kv1.3 traffic and membrane localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CHANNEL SURFACE EXPRESSION; LYMPHOCYTE K+ CHANNEL; JURKAT T-LYMPHOCYTES; POTASSIUM CHANNEL; CELL-SURFACE; LIPID RAFTS; SUBUNIT COMPOSITION; ION CHANNELS; MACROPHAGES	Kv1.3 activity is determined by raft association. In addition to Kv1.3, leukocytes also express Kv1.5, and both channels control physiological responses. Because the oligomeric composition may modify the channel targeting to the membrane, we investigated heterotetrameric Kv1.3/Kv1.5 channel traffic and targeting in HEK cells. Kv1.3 and Kv1.5 generate multiple heterotetramers with differential surface expression according to the subunit composition. FRET analysis and pharmacology confirm the presence of functional hybrid channels. Raft association was evaluated by cholesterol depletion, caveolae colocalization, and lateral diffusion at the cell surface. Immunoprecipitation showed that both Kv1.3 and heteromeric channels associate with caveolar raft domains. However, homomeric Kv1.3 channels showed higher association with caveolin traffic. Moreover, FRAP analysis revealed higher mobility for hybrid Kv1.3/Kv1.5 than Kv1.3 homotetramers, suggesting that heteromers target to distinct surface microdomains. Studies with lipopolysaccharide-activated macrophages further supported that different physiological mechanisms govern Kv1.3 and Kv1.5 targeting to rafts. Our results implicate the traffic and localization of Kv1.3/Kv1.5 heteromers in the complex regulation of immune system cells.	[Vicente, Ruben; Villalonga, Nuria; Felipe, Antonio] Univ Barcelona, Mol Physiol Lab, Dept Bioquim & Biol Mol, Inst Biomed, E-08028 Barcelona, Spain; [Calvo, Maria] Univ Barcelona, Dept Biol Cellular, Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; [Escalada, Artur; Solsona, Carles; Soler, Concepcio] Univ Barcelona, Dept Patol & Terapeut Expt, Hosp Llobregat, E-08907 Barcelona, Spain; [Tamkun, Michael M.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Colorado State University	Felipe, A (corresponding author), Univ Barcelona, Mol Physiol Lab, Dept Bioquim & Biol Mol, Inst Biomed, Avda Diagonal 645, E-08028 Barcelona, Spain.	afelipe@ub.edu	Felipe, Antonio/M-8297-2015; García, Rubén Vicente/L-1097-2014; Calvo, Maria/I-1872-2015; Soler, Concepció/L-1185-2014	Felipe, Antonio/0000-0002-7294-6431; García, Rubén Vicente/0000-0003-0401-4808; Calvo, Maria/0000-0002-7473-0474; Soler, Concepció/0000-0001-6502-5012	NHLBI NIH HHS [HL 49330] Funding Source: Medline; NINDS NIH HHS [NS 41542] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041542] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beeton C, 2005, NEUROSCIENTIST, V11, P550, DOI 10.1177/1073858405278016; Bock J, 2003, BIOCHEM BIOPH RES CO, V305, P890, DOI 10.1016/S0006-291X(03)00763-0; Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1; Coleman SK, 1999, J NEUROCHEM, V73, P849, DOI 10.1046/j.1471-4159.1999.0730849.x; Colley BS, 2007, NEUROSCIENCE, V144, P531, DOI 10.1016/j.neuroscience.2006.09.055; El-Yazbi AF, 2006, AM J PHYSIOL-GASTR L, V291, pG1020, DOI 10.1152/ajpgi.00159.2006; Eldstrom J, 2002, FEBS LETT, V531, P529, DOI 10.1016/S0014-5793(02)03572-X; Eldstrom J, 2006, FEBS LETT, V580, P6039, DOI 10.1016/j.febslet.2006.09.069; Folco EJ, 2004, AM J PHYSIOL-HEART C, V287, pH681, DOI 10.1152/ajpheart.00152.2004; Hajdu P, 2003, PFLUG ARCH EUR J PHY, V445, P674, DOI 10.1007/s00424-002-0974-y; Holmes TC, 1996, J NEUROSCI, V16, P1581; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Isshiki M, 1999, CELL CALCIUM, V26, P201, DOI 10.1054/ceca.1999.0073; Koch RO, 1997, J BIOL CHEM, V272, P27577, DOI 10.1074/jbc.272.44.27577; Kwak YG, 1999, J BIOL CHEM, V274, P13928, DOI 10.1074/jbc.274.20.13928; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; Li HL, 2005, J MOL CELL CARDIOL, V39, P121, DOI 10.1016/j.yjmcc.2005.03.013; Liu YT, 2007, J CELL PHYSIOL, V211, P205, DOI 10.1002/jcp.20924; Manganas LN, 2004, BIOCHEM BIOPH RES CO, V322, P577, DOI 10.1016/j.bbrc.2004.06.182; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Martel J, 1998, J MEMBRANE BIOL, V161, P183, DOI 10.1007/s002329900325; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; McCormack T, 1999, J BIOL CHEM, V274, P20123, DOI 10.1074/jbc.274.29.20123; MCEWEN DP, 2007, MOL PHARM; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Mullen KM, 2006, ANN NEUROL, V60, P118, DOI 10.1002/ana.20884; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; Pannasch U, 2006, MOL CELL NEUROSCI, V33, P401, DOI 10.1016/j.mcn.2006.08.009; Panyi G, 2004, P NATL ACAD SCI USA, V101, P1285, DOI 10.1073/pnas.0307421100; Park SA, 2006, BIOCHEM BIOPH RES CO, V346, P567, DOI 10.1016/j.bbrc.2006.05.149; PAYET MD, 1992, J BIOL CHEM, V267, P18270; PHILIPSON LH, 1993, BIOCHIM BIOPHYS ACTA, V1153, P111, DOI 10.1016/0005-2736(93)90282-5; Pottosin II, 2007, PFLUG ARCH EUR J PHY, V454, P235, DOI 10.1007/s00424-007-0208-4; Prevostel C, 2000, J CELL SCI, V113, P2575; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rybin VO, 1999, CIRC RES, V84, P980, DOI 10.1161/01.RES.84.9.980; Schilling T, 2003, PFLUG ARCH EUR J PHY, V447, P312, DOI 10.1007/s00424-003-1155-3; Schlegel A, 1998, CELL SIGNAL, V10, P457, DOI 10.1016/S0898-6568(98)00007-2; Szabo I, 2004, PFLUG ARCH EUR J PHY, V448, P304, DOI 10.1007/s00424-004-1259-4; Vicente R, 2005, J IMMUNOL, V174, P4736, DOI 10.4049/jimmunol.174.8.4736; Vicente R, 2003, J BIOL CHEM, V278, P46307, DOI 10.1074/jbc.M304388200; Vicente R, 2006, J BIOL CHEM, V281, P37675, DOI 10.1074/jbc.M605617200; Villalonga N, 2007, BIOCHEM BIOPH RES CO, V352, P913, DOI 10.1016/j.bbrc.2006.11.120; Wong W, 2004, J BIOL CHEM, V279, P444, DOI 10.1074/jbc.M304675200; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Zhu J, 2003, J BIOL CHEM, V278, P25558, DOI 10.1074/jbc.M207984200	50	59	60	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8756	8764		10.1074/jbc.M708223200	http://dx.doi.org/10.1074/jbc.M708223200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18218624	Green Published, hybrid			2022-12-27	WOS:000254288000073
J	Bradley, EW; Ruan, MM; Oursler, MJ				Bradley, Elizabeth W.; Ruan, Ming M.; Oursler, Merry J.			Novel pro-survival functions of the Kruppel-like transcription factor Egr2 in promotion of macrophage colony-stimulating factor-mediated osteoclast survival downstream of the MEK/ERK pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B PATHWAYS; BCL-2 FAMILY; CELL-DIFFERENTIATION; DEPENDENT DEGRADATION; ACTIVATES APOPTOSIS; SIGNALING PATHWAY; BH3 DOMAIN; IN-VITRO; C-CBL	Determining the underlying mechanisms of macrophage colony-stimulating factor (M-CSF)-mediated osteoclast survival may be important in identifying novel approaches for treating excessive bone loss. This study investigates M-CSF-mediated MEK/ERK activation and identifies a downstream effector of this pathway. M-CSF activates MEK/ERK and induces MEK-dependent expression of the immediate early gene Egr2. Inhibition of either MEK1/2 or inhibition of Egr2 increases osteoclast apoptosis. In contrast, wild-type Egr2 or an Egr2 point mutant unable to bind the endogenous repressors Nab1/2 (caEgr2) suppresses basal osteoclast apoptosis and rescues osteoclasts from apoptosis induced by MEK1/2 or Egr2 inhibition. Mechanistically, Egr2 induces pro-survival Blc2 family member Mcl1 while stimulating proteasome-mediated degradation of pro-apoptotic Bim. In addition, Egr2 increased the expression of c-Cbl, the E3 ubiquitin ligase that catalyzes Bim ubiquitination. M-CSF, therefore, promotes osteoclast survival through MEK/ ERK-dependent induction of Egr2 to control the Mcl1/Bim ratio, documenting a novel function of Egr2 in promoting survival.	[Ruan, Ming M.; Oursler, Merry J.] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA; [Bradley, Elizabeth W.; Oursler, Merry J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Oursler, MJ (corresponding author), Mayo Clin, Endocrine Res Unit, 200,1st St SW, Rochester, MN 55905 USA.	oursler.merryjo@mayo.edu		Bradley, Elizabeth/0000-0002-8814-5524	NIDCR NIH HHS [R01 DE14680] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014680] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Akiyama T, 2005, BIOL PROCED ONLINE, V7, P48, DOI 10.1251/bpo105; Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; Bouyer P, 2007, ENDOCRINOLOGY, V148, P831, DOI 10.1210/en.2006-0547; BOYD JM, 1995, ONCOGENE, V11, P1921; Carter JH, 2007, J IMMUNOL, V178, P6796, DOI 10.4049/jimmunol.178.11.6796; Carter JH, 2007, J IMMUNOL, V178, P3038, DOI 10.4049/jimmunol.178.5.3038; Chen JR, 2005, J BIOL CHEM, V280, P4632, DOI 10.1074/jbc.M411530200; Clohessy JG, 2006, J BIOL CHEM, V281, P5750, DOI 10.1074/jbc.M505688200; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; Ehrengruber MU, 2000, GENE, V258, P63, DOI 10.1016/S0378-1119(00)00445-5; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; FULLER K, 1993, J EXP MED, V178, P1733, DOI 10.1084/jem.178.5.1733; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; Hegde R, 1998, J BIOL CHEM, V273, P7783, DOI 10.1074/jbc.273.14.7783; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Inohara N, 1998, J BIOL CHEM, V273, P8705, DOI 10.1074/jbc.273.15.8705; Jaworowski A, 1996, BIOCHEM J, V320, P1011, DOI 10.1042/bj3201011; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Karst M, 2004, J CELL PHYSIOL, V200, P99, DOI 10.1002/jcp.20036; Ke JY, 2006, J BIOL CHEM, V281, P39806, DOI 10.1074/jbc.M604671200; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Levi G, 1996, DEVELOPMENT, V122, P113; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Lim JH, 2007, APOPTOSIS, V12, P411, DOI 10.1007/s10495-006-0576-9; Lucerna M, 2006, CANCER RES, V66, P6708, DOI 10.1158/0008-5472.CAN-05-2732; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Nakamura H, 2003, J BONE MINER RES, V18, P1198, DOI 10.1359/jbmr.2003.18.7.1198; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; OPTERMAN JT, 2006, CELL DEATH DIFFER, V13, P1260; Oursler MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC156, DOI 10.1152/ajpcell.00092.2004; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Sato S, 2004, J BIOL CHEM, V279, P33759, DOI 10.1074/jbc.M402055200; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; Unoki M, 2003, ONCOGENE, V22, P2172, DOI 10.1038/sj.onc.1206222; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Xiao DM, 2005, CANCER RES, V65, P9934, DOI 10.1158/0008-5472.CAN-05-1830; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zhan QM, 1997, ONCOGENE, V14, P1031, DOI 10.1038/sj.onc.1200927; Zhuang J, 2006, CELL DEATH DIFFER, V13, P1263, DOI 10.1038/sj.cdd.4401952	65	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					8055	8064		10.1074/jbc.M709500200	http://dx.doi.org/10.1074/jbc.M709500200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18198176	hybrid			2022-12-27	WOS:000253997900080
J	Kavurma, MM; Schoppet, M; Bobryshev, YV; Khachigian, LM; Bennett, MR				Kavurma, Mary M.; Schoppet, Michael; Bobryshev, Yuri V.; Khachigian, Levon M.; Bennett, Martin R.			TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-kappa B and induction of insulin-like growth factor-1 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING LIGAND; ATHEROSCLEROTIC PLAQUE; DEATH DOMAIN; LIPID RAFTS; EXPRESSION; SURVIVAL; OSTEOPROTEGERIN; GENE; SP1; IDENTIFICATION	TRAIL/Apo2L (tumor necrosis factor-related apoptosis-inducing ligand) is a multifunctional protein regulating homeostasis of the immune system, infection, autoimmune diseases, and apoptosis. However, its function in normal, nontransformed tissues is not clear. Here we show that TRAIL increases vascular smooth muscle cell (VSMC) proliferation in vitro, effects that can be blocked with neutralizing antibodies to TRAIL receptors DR4 and DcR1. In aortocoronary saphenous vein bypass grafts in vivo, TRAIL co-localizes with VSMC, proliferating cell nuclear antigen, and insulin-like growth factor type 1 receptor (IGF1R) expression but not active caspase-3. TRAIL is required for serum-inducible IGF1R expression, and antisense IGF1R inhibits TRAIL-induced VSMC proliferation. At 1 ng/ml, TRAIL stimulates IGF1R mRNA expression greater than insulin-like growth factor-1 and also activates the IGF1R promoter 7-fold. TRAIL-inducible IGF1R expression requires NF-kappa B activation. Consistent with this, ammonium pyrrolidine dithiocarbamate, a pharmacological inhibitor of NF-kappa B, blocks TRAIL-induced IGF1R expression, and p65 overexpression increases IGF1R protein levels. In addition, NF-kappa B binds a novel TRAIL-responsive element on the IGF1R promoter. Our findings suggest that the biological functions of TRAIL in VSMC extend beyond its role in promoting apoptosis. Thus, TRAIL may play an important role in atherosclerosis by regulating IGF1R expression in VSMC in an NF-kappa B-dependent manner.	[Kavurma, Mary M.; Khachigian, Levon M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; [Kavurma, Mary M.; Schoppet, Michael; Bennett, Martin R.] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge CB2 2QQ, England; [Bobryshev, Yuri V.] Univ New S Wales, Fac Med, Kensington, NSW 2052, Australia	University of New South Wales Sydney; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of New South Wales Sydney	Kavurma, MM (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia.	m.kavurma@unsw.edu.au	Bobryshev, Yuri/J-2838-2013; Khachigian, Levon/AAZ-7458-2020	Khachigian, Levon/0000-0003-3446-0323; Kavurma, Mary/0000-0001-7353-0932; Bennett, Martin/0000-0002-2565-1825	British Heart Foundation [RG/04/001, PG/04/005/16497] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; BEITNERJOHNSON D, 1995, MOL ENDOCRINOL, V9, P1147, DOI 10.1210/me.9.9.1147; BENNETT MR, 1995, J CLIN INVEST, V95, P2266, DOI 10.1172/JCI117917; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Corallini F, 2007, J CELL PHYSIOL, V212, P89, DOI 10.1002/jcp.21006; DU J, 1995, CIRC RES, V76, P963, DOI 10.1161/01.RES.76.6.963; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Gochuico BR, 2000, AM J PHYSIOL-LUNG C, V278, pL1045, DOI 10.1152/ajplung.2000.278.5.L1045; Griffith TS, 1998, J IMMUNOL, V161, P2833; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Idelman G, 2003, J BIOL CHEM, V278, P3474, DOI 10.1074/jbc.M211606200; Kavurma MM, 2007, BIOCHEM J, V407, P79, DOI 10.1042/BJ20070380; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; LI SW, 1994, J BIOL CHEM, V269, P32558; Lim HJ, 2004, BIOCHEM BIOPH RES CO, V325, P1106, DOI 10.1016/j.bbrc.2004.10.175; Ma YW, 2006, ENDOCRINOLOGY, V147, P1256, DOI 10.1210/en.2005-0888; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Marsters SA, 1996, CURR BIOL, V6, P750, DOI 10.1016/S0960-9822(09)00456-4; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Morel J, 2005, J BIOL CHEM, V280, P15709, DOI 10.1074/jbc.M414469200; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; Niessner A, 2006, CIRCULATION, V114, P2482, DOI 10.1161/CIRCULATIONAHA.106.642801; Okura Y, 2001, J MOL CELL CARDIOL, V33, P1777, DOI 10.1006/jmcc.2001.1441; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Patel VA, 2001, CIRC RES, V88, P895, DOI 10.1161/hh0901.090305; Petersohn D, 1996, EUR J BIOCHEM, V239, P827, DOI 10.1111/j.1432-1033.1996.0827u.x; Robertson NM, 2002, J IMMUNOL, V169, P5986, DOI 10.4049/jimmunol.169.10.5986; Sato K, 2006, J EXP MED, V203, P239, DOI 10.1084/jem.20051062; Schoppet M, 2006, ATHEROSCLEROSIS, V184, P446, DOI 10.1016/j.atherosclerosis.2005.10.028; Schoppet M, 2004, J CLIN ENDOCR METAB, V89, P4104, DOI 10.1210/jc.2003-031432; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Secchiero P, 2004, NEOPLASIA, V6, P364, DOI 10.1593/neo.03421; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zhang J, 2001, J BIOL CHEM, V276, P29815, DOI 10.1074/jbc.M103838200; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	42	75	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7754	7762		10.1074/jbc.M706927200	http://dx.doi.org/10.1074/jbc.M706927200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18178561	hybrid			2022-12-27	WOS:000253997900052
J	Noguchi, T; Ishii, K; Fukutomi, H; Naguro, I; Matsuzawa, A; Takeda, K; Ichijo, H				Noguchi, Takuya; Ishii, Ken; Fukutomi, Hisashi; Naguro, Isao; Matsuzawa, Atsushi; Takeda, Kohsuke; Ichijo, Hidenori			Requirement of reactive oxygen species-dependent activation of ASK1-p38 MAPK pathway for extracellular ATP-induced apoptosis in macrophage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATING KINASE-1; TUMOR-NECROSIS-FACTOR; INDUCED CELL-DEATH; P2X(7) RECEPTOR; NADPH OXIDASE; NUCLEOTIDE RECEPTOR; DENDRITIC CELLS; STRESS; INDUCTION; MYCOBACTERIA	Extracellular ATP, an autocrine or paracrine intercellular transmitter, is known to induce apoptosis in macrophages. However, the precise signaling mechanisms of ATP-induced apoptosis remain to be elucidated. Here we showed that activation of p38 mitogen-activated protein kinase (MAPK) plays a critical role in ATP-induced apoptosis. p38 activation and apoptosis in macrophages were induced by ATP. ATP-induced apoptosis was mediated in part by production of reactive oxygen species (ROS) derived from NOX2/gp91(phox), a component of the NADPH oxidase complex expressed in macrophages and neutrophils. Furthermore, ATP-induced ROS generation, p38 activation, and apoptosis were almost completely inhibited by selective P2X(7) receptor antagonists. We also found that ATP-induced apoptosis were diminished in ASK1-deficient macrophages accompanied by the lack of p38 activation. These results demonstrate that ROS-mediated activation of the ASK1-p38 MAPK pathway downstream of P2X(7) receptor is required for ATP-induced apoptosis in macrophages.	[Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Ctr Excellence Program,Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Japan Sci & Technol Corp, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Ichijo, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Ctr Excellence Program,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ichijo@mol.f.u-tokyo.ac.jp	Noguchi, Takuya/T-6767-2019; Naguro, Isao/P-1337-2019; Matsuzawa, Atsushi/GLU-1387-2022	Noguchi, Takuya/0000-0001-6187-6645; Naguro, Isao/0000-0002-0338-8026; Ichijo, Hidenori/0000-0002-5005-6438; Matsuzawa, Atsushi/0000-0001-8303-3905; Takeda, Kohsuke/0000-0002-8359-8399				Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BOKOCH GM, 1994, CURR OPIN CELL BIOL, V6, P212, DOI 10.1016/0955-0674(94)90138-4; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Coutinho-Silva R, 1999, AM J PHYSIOL-CELL PH, V276, pC1139, DOI 10.1152/ajpcell.1999.276.5.C1139; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Donnelly-Roberts DL, 2004, J PHARMACOL EXP THER, V308, P1053, DOI 10.1124/jpet.103.059600; Fernando SL, 2005, J INFECT DIS, V192, P149, DOI 10.1086/430622; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hibell AD, 2001, J PHARMACOL EXP THER, V296, P947; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kornfeld H, 1999, CELL DEATH DIFFER, V6, P71, DOI 10.1038/sj.cdd.4400454; Kusner DJ, 2000, J IMMUNOL, V164, P379, DOI 10.4049/jimmunol.164.1.379; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nihei OK, 2000, BLOOD, V96, P996, DOI 10.1182/blood.V96.3.996.015k02_996_1005; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; North RA, 1997, CURR OPIN NEUROBIOL, V7, P346, DOI 10.1016/S0959-4388(97)80062-1; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pfeiffer ZA, 2004, J LEUKOCYTE BIOL, V75, P1173, DOI 10.1189/jlb.1203648; Pfeiffer ZA, 2007, FREE RADICAL BIO MED, V42, P1506, DOI 10.1016/j.freeradbiomed.2007.02.010; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; ZANOVELLO P, 1990, J IMMUNOL, V145, P1545; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	44	150	154	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7657	7665		10.1074/jbc.M708402200	http://dx.doi.org/10.1074/jbc.M708402200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18211888	hybrid			2022-12-27	WOS:000253997900041
J	Saunee, NA; Williams, SR; Bryan, DA; Schluchter, WM				Saunee, Nicolle A.; Williams, Shervonda R.; Bryan, Donald A.; Schluchter, Wendy M.			Biogenesis of phycobiliproteins - II. CpcS-I and CpcU comprise the heterodimeric bilin lyase that attaches phycocyanobilin to Cys-82 of beta-phycocyanin and Cys-81 of allophycocyanin subunits in synechococcus sp PCC 7002	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE ANALYSIS; C-PHYCOCYANIN; ENERGY-TRANSFER; MASTIGOCLADUS-LAMINOSUS; LINKER-POLYPEPTIDE; ALPHA-SUBUNITS; CYANOBACTERIAL PHYCOBILISOMES; MOLECULAR CHARACTERIZATION; AGMENELLUM-QUADRUPLICATUM; CHROMOPHORE ATTACHMENT	The Synechococcus sp. PCC 7002 genome encodes three genes, denoted cpcS-I, cpcU, cpcV, with sequence similarity to cpeS. CpcS-I copurified with His(6)-tagged (HT) CpcU as a heterodimer, CpcSU. When CpcSU was assayed for bilin lyase activity in vitro with phycocyanobilin (PCB) and apophycocyanin, the reaction product had an absorbance maximum of 622 nm and was highly fluorescent (lambda(max) = 643 nm). In control reactions with PCB and apophycocyanin, the products had absorption maxima at 635 nm and very low fluorescence yields, indicating they contained the more oxidized mesobiliverdin (Arciero, D. M., Bryant, D. A., and Glazer, A. N. (1988) J. Biol. Chem. 263, 18343-18349). Tryptic peptide mapping showed that the CpcSU-dependent reaction product had one major PCB-containing peptide that contained the PCB binding site Cys-82. The CpcSU lyase was also tested with recombinant apoHT-allophycocyanin (aporHT-AP) and PCB in vitro. AporHT-AP formed an ApcA/ ApcB heterodimer with an apparent mass of similar to 27 kDa. When aporHT-AP was incubated with PCB and CpcSU, the product had an absorbance maximum of 614 nm and a fluorescence emission maximum at 636 nm, the expected maxima for monomeric holo-AP. When no enzyme or CpcS-I or CpcU was added alone, the products had absorbance maxima between 645 and 647 nm and were not fluorescent. When these reaction products were analyzed by gel electrophoresis and zinc-enhanced fluorescence emission, only the reaction products from CpcSU had PCB attached to both AP subunits. Therefore, CpcSU is the bilin lyase-responsible for attachment of PCB to Cys-82 of CpcB and Cys-81 of ApcA and ApcB.	[Saunee, Nicolle A.; Williams, Shervonda R.; Schluchter, Wendy M.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Bryan, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Louisiana System; University of New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schluchter, WM (corresponding author), Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA.	wschluch@uno.edu	Schluchter, Wendy/G-9662-2013		NIGMS NIH HHS [GM-31625] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031625] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; BECK WF, 1992, J PHYS CHEM-US, V96, P4658, DOI 10.1021/j100190a094; BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; Bryant D.A., 1988, LIGHT ENERGY TRANSDU, P62; BRYANT DA, 1990, ARCH MICROBIOL, V153, P550, DOI 10.1007/BF00245264; BRYANT DA, 1991, PHOTOSYNTHETIC APPAR, P255; CAPUANO V, 1991, J BIOL CHEM, V266, P7239; Cobley JG, 2002, MOL MICROBIOL, V44, P1517, DOI 10.1046/j.1365-2958.2002.02966.x; DEBRECZENY MP, 1993, J PHYS CHEM-US, V97, P9852, DOI 10.1021/j100140a050; DELORIMIER R, 1990, BIOCHIM BIOPHYS ACTA, V1019, P29, DOI 10.1016/0005-2728(90)90121-J; DELORIMIER R, 1990, ARCH MICROBIOL, V153, P541, DOI 10.1007/BF00245263; DELORIMIER R, 1984, P NATL ACAD SCI-BIOL, V81, P7946; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; GINDT YM, 1992, J PHOTOCH PHOTOBIO B, V15, P75, DOI 10.1016/1011-1344(92)87007-V; GINDT YM, 1994, BBA-BIOENERGETICS, V1186, P153, DOI 10.1016/0005-2728(94)90174-0; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1973, J BIOL CHEM, V248, P659; Gomez-Lojero C, 2003, BIOCHEMISTRY-US, V42, P13800, DOI 10.1021/bi0346998; GYSI JR, 1979, BIOCHEM J, V181, P577, DOI 10.1042/bj1810577; Hu IC, 2006, BIOCHEMISTRY-US, V45, P7092, DOI 10.1021/bi052067a; JUNG LJ, 1995, J BIOL CHEM, V270, P12877, DOI 10.1074/jbc.270.21.12877; Kahn K, 1997, J BACTERIOL, V179, P998, DOI 10.1128/jb.179.4.998-1006.1997; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Li H, 2002, ARCH MICROBIOL, V178, P256, DOI 10.1007/s00203-002-0446-y; MAXSON P, 1989, BIOCHIM BIOPHYS ACTA, V977, P40, DOI 10.1016/S0005-2728(89)80007-6; Miller CA, 2007, THESIS U NEW ORLEANS; MIMURO M, 1986, BIOCHIM BIOPHYS ACTA, V848, P155, DOI 10.1016/0005-2728(86)90037-X; Reuter W, 1999, P NATL ACAD SCI USA, V96, P1363, DOI 10.1073/pnas.96.4.1363; SAUER K, 1987, PHOTOCHEM PHOTOBIOL, V46, P427, DOI 10.1111/j.1751-1097.1987.tb04790.x; SCHIRMER T, 1986, J MOL BIOL, V188, P651, DOI 10.1016/S0022-2836(86)80013-4; SCHIRMER T, 1987, J MOL BIOL, V196, P677, DOI 10.1016/0022-2836(87)90040-4; SCHIRMER T, 1987, BIOCHIM BIOPHYS ACTA, V893, P379, DOI 10.1016/0005-2728(87)90090-9; SCHLUCHTER WM, 1992, BIOCHEMISTRY-US, V31, P3092, DOI 10.1021/bi00127a009; SCHLUCHTER WM, 1994, THESIS PENNSYLVANIA; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; SWANSON RV, 1992, J BIOL CHEM, V267, P16146; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008; Zhao KH, 2004, BBA-BIOENERGETICS, V1657, P131, DOI 10.1016/j.bbabio.2004.04.010; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X; ZHOU J, 1992, THESIS PENNSYLVANIA; ZHOU JH, 1992, J BIOL CHEM, V267, P16138	50	54	57	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7513	7522		10.1074/jbc.M708165200	http://dx.doi.org/10.1074/jbc.M708165200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18199753	Green Published, hybrid			2022-12-27	WOS:000253997900026
J	Blount, AL; Vaughan, JM; Vale, WW; Bilezikjian, LM				Blount, Amy L.; Vaughan, Joan M.; Vale, Wylie W.; Bilezikjian, Louise M.			A smad-binding element in intron 1 participates in activin-dependent regulation of the follistatin gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; GONADOTROPIN-RELEASING-HORMONE; RIBONUCLEIC-ACID LEVELS; GNRH RECEPTOR GENE; RAT ESTROUS-CYCLE; BETA-SUBUNIT GENE; TGF-BETA; PITUITARY FOLLISTATIN; TRANSCRIPTION ACTIVATION; SIGNAL-TRANSDUCTION	Follistatins exert critical autocrine or paracrine control in many tissues by binding and bio-neutralizing activin and several other transforming growth factor-beta ligands. In the pituitary, activin acts locally to induce follistatin expression and thus modulate its own actions. This local feedback loop safeguards against excessive activin signaling and maintains the necessary balance of activin and follistatin tone. To better understand the mechanisms underlying the activation of follistatin by activin A, follistatin transcription was evaluated in gonadotrope-derived alpha T3-1 cells. Transient transfection experiments established that follistatin-luciferase plasmids that incorporate up to 2.86 kb of the upstream region of the rat follistatin gene are not induced by activin A in alpha T3-1 cells. On the other hand, plasmids that incorporate intron 1 are responsive to activin A and induced by a constitutively active form of ALK4. These experiments ultimately identified a conserved Smad-binding element (SBE1) in intron 1, between +1791 and +1795. In alpha T3-1 cells treated with activin A, SBE1 preferentially recruits Smad3, but not Smad2, and mediates Smad3-dependent activation of follistatin transcription. shRNA knockdown of endogenous Smad3 in these cells compromises SBE1-mediated transcription in response to activin A and interferes with its ability to positively regulate follistatin mRNA levels. The findings of the current work illustrate the critical role of intron 1 of the follistatin gene in mediating Smad-dependent effects of activin and regulating the expression level of this gene in some cell types, such as pituitary cells of gonadotrope lineage.	[Blount, Amy L.; Vaughan, Joan M.; Vale, Wylie W.; Bilezikjian, Louise M.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute	Bilezikjian, LM (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bilezikjian@salk.edu			NICHD NIH HHS [HD46941, HD13527, R01 HD046941] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046941] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD013527] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; Attisano L, 1996, MOL CELL BIOL, V16, P1066; Bailey JS, 2004, MOL ENDOCRINOL, V18, P1158, DOI 10.1210/me.2003-0442; Bartholin L, 2002, ONCOGENE, V21, P2227, DOI 10.1038/sj.onc.1205294; Bartholin L, 2001, ONCOGENE, V20, P5409, DOI 10.1038/sj.onc.1204720; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Besecke LM, 1997, ENDOCRINOLOGY, V138, P2841, DOI 10.1210/en.138.7.2841; Bilezikjian LM, 1996, ENDOCRINOLOGY, V137, P4277, DOI 10.1210/en.137.10.4277; Bilezikjian LM, 2003, ENDOCRINOLOGY, V144, P732, DOI 10.1210/en.2002-220703; BILEZIKJIAN LM, 1993, ENDOCRINOLOGY, V133, P2554, DOI 10.1210/en.133.6.2554; Bilezikjian LM, 2006, REPRODUCTION, V132, P207, DOI 10.1530/rep.1.01073; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Danila DC, 2000, J CLIN ENDOCR METAB, V85, P1009, DOI 10.1210/jc.85.3.1009; de Groot E, 2000, MOL BIOL REP, V27, P129, DOI 10.1023/A:1007159031000; DePaolo LV, 1997, P SOC EXP BIOL MED, V214, P328; DEPAOLO LV, 1993, ENDOCRINOLOGY, V132, P2221, DOI 10.1210/en.132.5.2221; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; ESCH FS, 1987, MOL ENDOCRINOL, V1, P849, DOI 10.1210/mend-1-11-849; Ethier JF, 2001, REPRODUCTION, V121, P667, DOI 10.1530/rep.0.1210667; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Guo QX, 1998, MOL ENDOCRINOL, V12, P96, DOI 10.1210/mend.12.1.0053; HALVORSON LM, 1994, ENDOCRINOLOGY, V134, P1247, DOI 10.1210/en.134.3.1247; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; HORN F, 1991, MOL ENDOCRINOL, V5, P347, DOI 10.1210/mend-5-3-347; Jeong KH, 2004, MOL CELL BIOL, V24, P6127, DOI 10.1128/MCB.24.14.6127-6139.2004; KAISER UB, 1992, ENDOCRINOLOGY, V130, P3048, DOI 10.1210/en.130.5.3048; KAISER UB, 1993, CLIN INVESTIG, V91, P25223; LEBRUN JJ, 1997, INHIBIN ACTIVIN FOLL, P1; Liu B, 1999, MOL CELL BIOL, V19, P424; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; McGillivray SM, 2005, ENDOCRINOLOGY, V146, P2180, DOI 10.1210/en.2004-1566; MICHEL U, 1993, MOL CELL ENDOCRINOL, V91, P1, DOI 10.1016/0303-7207(93)90248-I; MICHEL U, 1990, BIOCHEM BIOPH RES CO, V173, P401, DOI 10.1016/S0006-291X(05)81072-1; MIYANAGA K, 1993, MOL CELL ENDOCRINOL, V92, P99, DOI 10.1016/0303-7207(93)90080-4; Muttukrishna S, 2004, MOL CELL ENDOCRINOL, V225, P45, DOI 10.1016/j.mce.2004.02.012; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Norris DP, 2002, DEVELOPMENT, V129, P3455; Norwitz ER, 2002, J BIOL CHEM, V277, P37469, DOI 10.1074/jbc.M206571200; Osada SI, 2000, DEVELOPMENT, V127, P2503; Penabad JL, 1996, J CLIN ENDOCR METAB, V81, P3397, DOI 10.1210/jc.81.9.3397; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schneyer A, 2004, MOL CELL ENDOCRINOL, V225, P25, DOI 10.1016/j.mce.2004.02.009; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHIMASAKI S, 1989, MOL ENDOCRINOL, V3, P651, DOI 10.1210/mend-3-4-651; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; SHIMONAKA M, 1991, ENDOCRINOLOGY, V128, P3313, DOI 10.1210/endo-128-6-3313; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Suszko MI, 2005, MOL ENDOCRINOL, V19, P1849, DOI 10.1210/me.2004-0475; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; VALE WW, 1990, PEPTIDE GROWTH FACTO, V95, P211; Watanabe M, 2002, DEV DYNAM, V225, P448, DOI 10.1002/dvdy.10176; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; West BE, 2004, ENDOCRINOLOGY, V145, P4866, DOI 10.1210/en.2004-0598; Winters SJ, 1997, ENDOCRINOLOGY, V138, P4324, DOI 10.1210/en.138.10.4324; Winters SJ, 2007, MOL CELL ENDOCRINOL, V271, P45, DOI 10.1016/j.mce.2007.03.006; Zakaria MM, 2002, MOL ENDOCRINOL, V16, P1840, DOI 10.1210/me.2002-0088; Zhang H, 2006, MOL ENDOCRINOL, V20, P2909, DOI 10.1210/me.2006-0109; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3	70	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7016	7026		10.1074/jbc.M709502200	http://dx.doi.org/10.1074/jbc.M709502200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18184649	hybrid			2022-12-27	WOS:000253779600046
J	Wooten, MW; Geetha, T; Babu, JR; Seibenhener, ML; Peng, JM; Cox, N; Diaz-Meco, MT; Moscat, J				Wooten, Marie W.; Geetha, Thangiah; Babu, J. Ramesh; Seibenhener, M. Lamar; Peng, Junmin; Cox, Nancy; Diaz-Meco, Maria-T.; Moscat, Jorge			Essential role of sequestosome 1/p62 in regulating accumulation of Lys(63)-ubiquitinated proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P62; UBIQUITIN; PROTEASOME; DISEASE; POLYUBIQUITINATION; NEURODEGENERATION; DEGRADATION; AGGREGATION; INCLUSIONS; HYDROLASE	Sequestosome 1 (SQSTM1)/p62 is an interacting partner of the atypical protein kinase C zeta/i and serves as a scaffold for cell signaling and ubiquitin binding, which is critical for several cell functions in vivo such as osteoclastogenesis, adipogenesis, and T cell activation. Here we report that in neurons of p62(-/-) mouse brain there is a detectable increase in ubiquitin staining paralleled by accumulation of insoluble ubiquitinated proteins. The absolute amount of each ubiquitin chain linkage measured by quantitative mass spectrometry demonstrated hyperaccumulation of Lys(63) chains in the insoluble fraction recovered from the brain of p62(-/-) mice, which correlated with increased levels of Lys(63)-ubiquitinated TrkA receptor. The increase in Lys(63) chains was attributed in part to diminished activity of the TRAF6-interacting the Lys(63)-deubiquitinating enzyme (DUB), cylindromatosis tumor suppressor (CYLD). The interaction of CYLD with TRAF6 was dependent upon p62, thus defining a mechanism that accounts for decreased activity of CYLD in the absence of p62. These findings reveal that p62 serves as an adapter for the formation of this complex, thereby regulating the DUB activity of CYLD by TRAF6 interaction. Thus, p62 has a bifunctional role in regulation of an E3 ubiquitin-protein ligase, TRAF6, and a DUB, CYLD, to balance the turnover of Lys(63)-polyubiquitinated proteins such as TrkA.	[Wooten, Marie W.; Geetha, Thangiah; Babu, J. Ramesh; Seibenhener, M. Lamar] Auburn Univ, Dept Biol Sci, Program Cell & Mol Biosci, Auburn, AL 36849 USA; [Peng, Junmin] Emory Univ, Alzheimer Dis Res Ctr, Atlanta, GA 30322 USA; [Cox, Nancy] Auburn Univ, Coll Vet Med, Scott Ritchey Res Ctr, Auburn, AL 36849 USA; [Diaz-Meco, Maria-T.; Moscat, Jorge] Univ Cincinnati, Genome Res Inst, Dept Genome Sci, Cincinnati, OH 45237 USA	Auburn University System; Auburn University; Emory University; Auburn University System; Auburn University; University System of Ohio; University of Cincinnati	Wooten, MW (corresponding author), Auburn Univ, Dept Biol Sci, Program Cell & Mol Biosci, 331 Funchess Hall, Auburn, AL 36849 USA.	wootemw@auburn.edu	Thangiah, Geetha/W-6796-2019; Peng, Junmin/N-2614-2018; Moscat, Jorge/A-7011-2009	Peng, Junmin/0000-0003-0472-7648; Diaz-Meco, Maria/0000-0003-0147-0998; Ramesh Babu, Jeganathan/0000-0002-3719-932X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033661] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-33661] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arai T, 2003, NEUROSCI LETT, V342, P41, DOI 10.1016/S0304-3940(03)00216-7; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Capsoni S, 2000, P NATL ACAD SCI USA, V97, P6826, DOI 10.1073/pnas.97.12.6826; Dawbarn D, 2003, NEUROPATH APPL NEURO, V29, P211, DOI 10.1046/j.1365-2990.2003.00487.x; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Geetha T, 2003, J BIOL CHEM, V278, P4730, DOI 10.1074/jbc.M208468200; HUANG F, 2006, MOL CELL, V21, P1; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Tanemura K, 2002, J NEUROSCI, V22, P133, DOI 10.1523/JNEUROSCI.22-01-00133.2002; Vigouroux S, 2003, J NEUROCHEM, V84, P392, DOI 10.1046/j.1471-4159.2003.01534.x; Wang ZY, 2005, MOL CELL NEUROSCI, V29, P222, DOI 10.1016/j.mcn.2005.02.011; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	28	140	147	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6783	6789		10.1074/jbc.M709496200	http://dx.doi.org/10.1074/jbc.M709496200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18174161	hybrid			2022-12-27	WOS:000253779600020
J	Saito, S; Matsui, H; Kawano, M; Kumagai, K; Tomishige, N; Hanada, K; Echigo, S; Tamura, S; Kobayashi, T				Saito, Satoko; Matsui, Hiroyuki; Kawano, Miyuki; Kumagai, Keigo; Tomishige, Nario; Hanada, Kentaro; Echigo, Seishi; Tamura, Shinri; Kobayashi, Takayasu			Protein phosphatase 2C epsilon is an endoplasmic reticulum integral membrane protein that dephosphorylates the ceramide transport protein CERT to enhance its association with organelle membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYSTEROL-BINDING PROTEIN; FFAT MOTIF; INTRACELLULAR TRAFFICKING; MOLECULAR MACHINERY; GENE-PRODUCT; VAP; PHOSPHORYLATION; APOPTOSIS; SURVIVAL; COMPLEX	Protein phosphatase 2C epsilon(PP2C epsilon), a mammalian PP2C family member, is expressed in various tissues and is implicated in the negative regulation of stress-activated protein kinase pathways. We show that PP2C epsilon is an endoplasmic reticulum (ER) transmembrane protein with a transmembrane domain at the amino terminus and the catalytic domain facing the cytoplasm. Yeast two-hybrid screening of a human brain library using PP2C epsilon as bait resulted in the isolation of a cDNA that encoded vesicle-associated membrane protein-associated protein A (VAPA). VAPA is an ER resident integral membrane protein involved in recruiting lipid-binding proteins such as the ceramide transport protein CERT to the ER membrane. Expression of PP2C epsilon resulted in dephosphorylation of CERT in a VAPA expression-dependent manner, which was accompanied by redistribution of CERT from the cytoplasm to the Golgi apparatus. The expression of PP2C epsilon also enhanced the association between CERT and VAPA. In addition, knockdown of PP2C epsilon expression by short interference RNA attenuated the interaction between CERT and VAPA and the sphingomyelin synthesis. These results suggest that CERT is a physiological substrate of PP2C epsilon and that dephosphorylation of CERT by PP2C epsilon may play an important role in the regulation of ceramide trafficking from the ER to the Golgi apparatus.	[Saito, Satoko; Matsui, Hiroyuki; Tamura, Shinri; Kobayashi, Takayasu] Tohoku Univ, Dept Biochem, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Saito, Satoko; Echigo, Seishi] Tohoku Univ, Div Oral Surg, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kawano, Miyuki; Kumagai, Keigo; Tomishige, Nario; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	Tohoku University; Tohoku University; National Institute of Infectious Diseases (NIID)	Tamura, S (corresponding author), Tohoku Univ, Dept Biochem, Inst Dev Aging & Canc, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	tamura@idac.tohoku.ac.jp; takayasu@idac.tohoku.ac.jp	Kumagai, Keigo/AAG-1385-2021	KAWANO-KAWADA, Miyuki/0000-0002-1168-9291; Kumagai, Keigo/0000-0002-1663-2905; Hanada, Kentaro/0000-0003-1383-2781				Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; Hanada K, 2006, MOL CELL BIOCHEM, V286, P23, DOI 10.1007/s11010-005-9044-z; Joshi M, 2007, BIOCHEM BIOPH RES CO, V356, P38, DOI 10.1016/j.bbrc.2007.02.108; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Li MG, 2003, J BIOL CHEM, V278, P12013, DOI 10.1074/jbc.M211474200; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Neddermann P, 2004, J VIROL, V78, P13306, DOI 10.1128/JVI.78.23.13306-13314.2004; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Saito J, 2007, BIOCHEM J, V405, P591, DOI 10.1042/BJ20070231; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Tamura S, 2004, TOP CURR GENET, V5, P91; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Walter DM, 1998, J BIOL CHEM, V273, P29565, DOI 10.1074/jbc.273.45.29565; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052	33	69	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6584	6593		10.1074/jbc.M707691200	http://dx.doi.org/10.1074/jbc.M707691200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165232	hybrid			2022-12-27	WOS:000253779500064
J	Terao, Y; Mori, Y; Yamaguchi, M; Shimizu, Y; Ooe, K; Hamada, S; Kawabata, S				Terao, Yutaka; Mori, Yuka; Yamaguchi, Masaya; Shimizu, Yoshikata; Ooe, Kenji; Hamada, Shigeyuki; Kawabata, Shigetada			Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; ALTERNATIVE COMPLEMENT PATHWAY; SHOCK-LIKE SYNDROME; H-LIKE PROTEIN-1; EPITHELIAL-CELLS; PYOGENES; GENE; SPEB; INACTIVATION; ACTIVATION	A relative lack of neutrophils around Streptococcus pyogenes is observed in streptococcal toxic shock syndrome (STSS). Because the bacteria spread rapidly into various organs in STSS, we speculated that S. pyogenes is equipped with molecules to evade the host innate immune system. Complement C3b opsonizes the pathogen to facilitate phagocytosis, and a complex of C3b converts C5 into anaphylatoxin. Because we found that C3 (C3b) is degraded in sera from patients with STSS, we investigated the mechanism of C3 (C3b) degradation by S. pyogenes. We incubated human C3b or serum with recombinant SpeB (rSpeB), a wild-type S. pyogenes strain isolated from an STSS patient or its isogenic Delta speB mutant and examined the supernatant by Western blotting with anti-human C3b. Western blot and Biacore analyses revealed that rSpeB and wild-type S. pyogenes rapidly degrade C3b. Additionally, C3 (C3b) was not detected in sera collected from infected areas of STSS patients. Furthermore, the survival rate in human blood and in mice was lower for the Delta speB mutant than the wild-type strain. Histopathological observations demonstrated that neutrophils were recruited toandphagocytosedthe Delta speB mutant, whereas with the wild-type strain, few neutrophils migrated to the site of infection, and the bacteria spread along the fascia. We observed the degradation of C3 (C3b) in sera from STSS patients and the degradation of C3 (C3b) by rSpeB. This suggests that SpeB contributes to the escape of S. pyogenes from phagocytosis at the site of initial infection, allowing it to invade host tissues during severe infections.	[Terao, Yutaka; Mori, Yuka; Yamaguchi, Masaya; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka 5650871, Japan; [Shimizu, Yoshikata] Asahi Gen Hosp, Dept Anaesthesia, Chiba 2892511, Japan; [Ooe, Kenji] Asahi Gen Hosp, Dept Pathol & Lab Med, Chiba 2892511, Japan; [Hamada, Shigeyuki] Nihon Univ Adv Res Inst Sci & Human, Dept Life Sci, Tokyo 1020073, Japan	Osaka University; Nihon University	Kawabata, S (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp	Yamaguchi, Masaya/I-8156-2019	Yamaguchi, Masaya/0000-0001-6218-7112; Terao, Yutaka/0000-0002-4450-5583				Andre I, 2006, BIOCHEMISTRY-US, V45, P4559, DOI 10.1021/bi052455c; BOHACH GA, 1988, INFECT IMMUN, V56, P1665, DOI 10.1128/IAI.56.6.1665-1667.1988; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; CHEN CC, 1990, J BIOL CHEM, V265, P3161; Cockerill FR, 1998, CLIN INFECT DIS, V26, P1448, DOI 10.1086/516376; Cue D, 2000, P NATL ACAD SCI USA, V97, P2858, DOI 10.1073/pnas.050587897; DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Felto MJ, 2007, MOL IMMUNOL, V44, P3571, DOI 10.1016/j.molimm.2007.03.012; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; HANSKI E, 1992, P NATL ACAD SCI USA, V89, P6172, DOI 10.1073/pnas.89.13.6172; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Kuo CF, 2004, MICROB PATHOGENESIS, V36, P273, DOI 10.1016/j.micpath.2004.01.003; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; Loughman JA, 2006, J BACTERIOL, V188, P399, DOI 10.1128/JB.188.2.399-408.2006; Lukomski S, 1998, INFECT IMMUN, V66, P771, DOI 10.1128/IAI.66.2.771-776.1998; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; Lukomski S, 1999, INFECT IMMUN, V67, P1779; Muller-Eberhard H J, 1980, Adv Immunol, V29, P1, DOI 10.1016/S0065-2776(08)60042-5; Nilsson M, 2005, EUR J IMMUNOL, V35, P1472, DOI 10.1002/eji.200424850; Nyberg P, 2004, MICROBIOL-SGM, V150, P1559, DOI 10.1099/mic.0.27076-0; Okamoto S, 2004, INFECT IMMUN, V72, P6068, DOI 10.1128/IAI.72.10.6068-6075.2004; Pandiripally V, 2003, INFECT IMMUN, V71, P7119, DOI 10.1128/IAI.71.12.7119-7128.2003; Pandiripally V, 2002, INFECT IMMUN, V70, P6206, DOI 10.1128/IAI.70.11.6206-6214.2002; PANGBURN MK, 1980, J IMMUNOL, V124, P977; Raeder R, 1998, RES MICROBIOL, V149, P539, DOI 10.1016/S0923-2508(99)80001-1; Steinrucke P, 2000, ANAL BIOCHEM, V286, P26, DOI 10.1006/abio.2000.4780; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Terao Y, 2005, J INFECT DIS, V192, P2081, DOI 10.1086/498162; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Wei L, 2005, INFECT IMMUN, V73, P2040, DOI 10.1128/IAI.73.4.2040-2050.2005; Yuste J, 2006, J IMMUNOL, V176, P6112, DOI 10.4049/jimmunol.176.10.6112	39	80	83	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6253	6260		10.1074/jbc.M704821200	http://dx.doi.org/10.1074/jbc.M704821200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18160402	hybrid			2022-12-27	WOS:000253779500032
J	Alfaro, JA; Zheng, RB; Persson, M; Letts, JA; Polakowski, R; Bai, Y; Borisova, SN; Seto, NOL; Lowary, TL; Palcic, MM; Evans, SV				Alfaro, Javier A.; Zheng, Ruixiang Blake; Persson, Mattias; Letts, James A.; Polakowski, Robert; Bai, Yu; Borisova, Svetlana N.; Seto, Nina O. L.; Lowary, Todd L.; Palcic, Monica M.; Evans, Stephen V.			ABO(H) blood group A and B glycosyltransferases recognize substrate via specific conformational changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HUMAN GLUCURONOSYLTRANSFERASE; DIFFERENTIAL RECOGNITION; ENZYMATIC-SYNTHESIS; DONOR SPECIFICITY; ACCEPTOR; GALACTOSYLTRANSFERASE; BIOSYNTHESIS; ANALOGS	The final step in the enzymatic synthesis of the ABO(H) blood group A and B antigens is catalyzed by two closely related glycosyltransferases, an alpha-(1 -> 3)-N-acetylgalactosaminyltransferase (GTA) and an alpha-(1 -> 3)-galactosyltransferase (GTB). Of their 354 amino acid residues, GTA and GTB differ by only four "critical" residues. High resolution structures for GTB and the GTA/GTB chimeric enzymes GTB/G176R and GTB/G176R/G235S bound to a panel of donor and acceptor analog substrates reveal "open," " semi-closed," and "closed" conformations as the enzymes go from the unliganded to the liganded states. In the open form the internal polypeptide loop (amino acid residues 177-195) adjacent to the active site in the unliganded or H-antigen-bound enzymes is composed of two alpha-helices spanning Arg(180) - Met(186) and Arg(188) - Asp(194), respectively. The semi-closed and closed forms of the enzymes are generated by binding of UDP or of UDP and Hantigen analogs, respectively, and show that these helices merge to form a single distorted helical structure with alternating alpha-3(10)-alpha character that partially occludes the active site. The closed form is distinguished from the semi-closed form by the ordering of the final nine C-terminal residues through the formation of hydrogen bonds to both UDP and H antigen analogs. The semi-closed forms for various mutants generally show significantly more disorder than the open forms, whereas the closed forms display little or no disorder depending strongly on the identity of residue 176. Finally, the use of synthetic analogs reveals how H antigen acceptor binding can be critical in stabilizing the closed conformation. These structures demonstrate a delicately balanced substrate recognition mechanism and give insight on critical aspects of donor and acceptor specificity, on the order of substrate binding, and on the requirements for catalysis.	[Alfaro, Javier A.; Letts, James A.; Borisova, Svetlana N.; Seto, Nina O. L.; Evans, Stephen V.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Zheng, Ruixiang Blake; Polakowski, Robert; Bai, Yu; Palcic, Monica M.] Univ Alberta, Alberta Ingenuity Ctr Carbohydrate Sci, Edmonton, AB T6G 2G2, Canada; [Zheng, Ruixiang Blake; Polakowski, Robert; Bai, Yu; Palcic, Monica M.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Persson, Mattias; Palcic, Monica M.] Carlsberg Lab, DK-2500 Copenhagen, Denmark; [Seto, Nina O. L.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Victoria; University of Alberta; University of Alberta; National Research Council Canada	Evans, SV (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055, Victoria, BC V8W 3P6, Canada.	svevans@uvic.ca	Lowary, Todd L/F-9608-2019; Letts, James Anthony/AAN-6632-2020; Alfaro, Javier/ABA-5639-2020	Lowary, Todd L/0000-0002-8331-8211; Letts, James Anthony/0000-0002-9864-3586; Alfaro, Javier/0000-0002-5553-6991; Evans, Stephen/0000-0002-0366-4027				Angulo J, 2006, J AM CHEM SOC, V128, P13529, DOI 10.1021/ja063550r; Bai Y, 2006, CARBOHYD RES, V341, P1702, DOI 10.1016/j.carres.2006.03.018; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLANKEN WM, 1985, J BIOL CHEM, V260, P2927; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; EVANS SV, 2003, J MOL GRAPHICS, V11, P134; Greenwell P, 1997, GLYCOCONJUGATE J, V14, P159, DOI 10.1023/A:1018581503164; HEARN VM, 1968, BIOCHEM J, V109, P315, DOI 10.1042/bj1090315; Heissigerova H, 2003, GLYCOBIOLOGY, V13, P377, DOI 10.1093/glycob/cwg042; Hu Y, 2004, CHEM BIOL, V11, P703, DOI 10.1016/j.chembiol.2004.02.024; Hu YN, 2002, CHEM BIOL, V9, P1287, DOI 10.1016/S1074-5521(02)00295-8; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; KABAT EA, 1956, BLOOD GROUP SUBSTANC, P135; Kakuda S, 2004, J BIOL CHEM, V279, P22693, DOI 10.1074/jbc.M400622200; Kamath VP, 1999, GLYCOCONJUGATE J, V16, P599; KOBATA A, 1968, BIOCHEM BIOPH RES CO, V32, P272, DOI 10.1016/0006-291X(68)90380-X; Laferte S, 2000, EUR J BIOCHEM, V267, P4840, DOI 10.1046/j.1432-1327.2000.01544.x; Lee HJ, 2005, J BIOL CHEM, V280, P525, DOI 10.1074/jbc.M410245200; Letts JA, 2006, J BIOL CHEM, V281, P3625, DOI 10.1074/jbc.M507620200; Letts JA, 2007, ACTA CRYSTALLOGR D, V63, P860, DOI 10.1107/S0907444907026479; LOWARY TL, 1993, CARBOHYD RES, V249, P163, DOI 10.1016/0008-6215(93)84068-H; LOWARY TL, 1994, CARBOHYD RES, V251, P33, DOI 10.1016/0008-6215(94)84275-2; Marcus SL, 2003, J BIOL CHEM, V278, P12403, DOI 10.1074/jbc.M212002200; Nakahara T, 2006, PROTEIN ENG DES SEL, V19, P571, DOI 10.1093/protein/gzl046; Nguyen HP, 2003, J BIOL CHEM, V278, P49191, DOI 10.1074/jbc.M308770200; PALCIC MM, 1988, GLYCOCONJUGATE J, V5, P49, DOI 10.1007/BF01048331; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Persson M, 2007, J BIOL CHEM, V282, P9564, DOI 10.1074/jbc.M610998200; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; SCHWYZER M, 1977, J BIOL CHEM, V252, P2346; Seto NOL, 1999, EUR J BIOCHEM, V259, P770, DOI 10.1046/j.1432-1327.1999.00086.x; Seto NOL, 2000, CARBOHYD RES, V324, P161, DOI 10.1016/S0008-6215(99)00297-9; Seto NOL, 1997, J BIOL CHEM, V272, P14133, DOI 10.1074/jbc.272.22.14133; Somsak L, 2003, CURR PHARM DESIGN, V9, P1177, DOI 10.2174/1381612033454919; Sujino K, 2000, J AM CHEM SOC, V122, P1261, DOI 10.1021/ja990964u; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; WATKINS W M, 1959, Vox Sang, V4, P97; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0	51	71	78	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10097	10108		10.1074/jbc.M708669200	http://dx.doi.org/10.1074/jbc.M708669200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18192272	hybrid			2022-12-27	WOS:000254671600064
J	Courville, P; Urbankova, E; Rensing, C; Chaloupka, R; Quick, M; Cellier, MFM				Courville, Pascal; Urbankova, Eva; Rensing, Christopher; Chaloupka, Roman; Quick, Matthias; Cellier, Mathieu F. M.			Solute carrier 11 cation symport requires distinct residues in transmembrane helices 1 and 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-ION TRANSPORTERS; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; FUNCTIONAL DIVERGENCE; ACTIVE-TRANSPORT; ANION CHANNEL; NRAMP FAMILY; IDENTIFICATION; SELECTIVITY; TOPOLOGY	Ubiquitous solute carriers 11 (SLC11) contribute to metal-ion homeostasis by importing Me2+ and H+ into the cytoplasm. To identify residues mediating cation symport, Escherichia coli proton-dependent manganese transporter (MntH) was mutated at five SLC11-specific transmembrane (TM) sites; each mutant activity was compared with wild-type MntH, and the biochemical results were tested by homology threading. Cd2+ and H+ uptake kinetics were analyzed in whole cells as a function of pH and temperature, and right-side out membrane vesicles were used to detail energy requirements and to probe site accessibility by Cys replacement and thiol modification. This approach revealed that TM segment 1 (TMS1) residue Asp(34) couples H+ and Me2+ symport and contributes to MntH forward transport electrogenicity, whereas the TMS6 His(211) residue mediates pH-dependent Me2+ uptake; MntH Asn(37), Asn(250), and Asn(401) in TMS1, TMS7, and TMS11 participate in transporter cycling and/or helix packing interactions. These biochemical results fit the LeuT/SLC6 structural fold, which suggests that conserved peptide motifs Asp(34)-Pro-Gly (TMS1) and Met-Pro-His(211) (TMS6) form antiparallel "TM helix/extended peptide" boundaries, lining a "pore" cavity and enabling H+-dependent Me2+ import.	[Courville, Pascal; Cellier, Mathieu F. M.] INRS Inst Armand Frappier, Laval, PQ H7V 1B7, Canada; [Quick, Matthias] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Rensing, Christopher] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA; [Urbankova, Eva; Chaloupka, Roman] Charles Univ Prague, Inst Phys, Fac Math & Phys, CR-12116 Prague 2, Czech Republic	University of Quebec; Institut national de la recherche scientifique (INRS); Columbia University; University of Arizona; Charles University Prague	Cellier, MFM (corresponding author), INRS Inst Armand Frappier, 531 Bd Prairies, Laval, PQ H7V 1B7, Canada.	mathieu.cellier@iaf.inrs.ca	courville, pascal/A-5170-2009; Rensing, Christopher/D-3947-2011	Rensing, Christopher/0000-0002-5012-7953				Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; BHATTACHARYYA P, 1970, J BACTERIOL, V104, P1307, DOI 10.1128/JB.104.3.1307-1311.1970; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; CELLIER M, 1995, P NATL ACAD SCI USA, V92, P10089, DOI 10.1073/pnas.92.22.10089; Cellier MF, 2007, MICROBES INFECT, V9, P1662, DOI 10.1016/j.micinf.2007.09.006; Chaloupka R, 2005, BIOCHEMISTRY-US, V44, P726, DOI 10.1021/bi048014v; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Chen XZ, 1999, J BIOL CHEM, V274, P35089, DOI 10.1074/jbc.274.49.35089; Cheng HC, 2001, J PHARMACOL TOX MET, V46, P61, DOI 10.1016/S1056-8719(02)00166-1; Cohen A, 2003, P NATL ACAD SCI USA, V100, P10694, DOI 10.1073/pnas.1934572100; Courville P, 2006, BIOCHEM CELL BIOL, V84, P960, DOI 10.1139/O06-193; Courville P, 2004, J BIOL CHEM, V279, P3318, DOI 10.1074/jbc.M309913200; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Dutta SJ, 2007, BIOCHEMISTRY-US, V46, P3692, DOI 10.1021/bi0616394; Fortier A, 2005, J LEUKOCYTE BIOL, V77, P868, DOI 10.1189/jlb.1004616; Gaucher EA, 2002, TRENDS BIOCHEM SCI, V27, P315, DOI 10.1016/S0968-0004(02)02094-7; Granseth E, 2007, MOL MEMBR BIOL, V24, P329, DOI 10.1080/09687680701413882; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haemig HAH, 2004, J MEMBRANE BIOL, V201, P97, DOI 10.1007/s00232-004-0711-x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Jones DT, 2005, PROTEINS, V61, P143, DOI 10.1002/prot.20731; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam-Yuk-Tseung S, 2003, BLOOD, V101, P3699, DOI 10.1182/blood-2002-07-2108; Larsen RA, 2007, J BACTERIOL, V189, P2825, DOI 10.1128/JB.01925-06; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; Likitvivatanavong S, 2006, ARCH BIOCHEM BIOPHYS, V445, P46, DOI 10.1016/j.abb.2005.11.007; Liu GY, 1996, J BIOL CHEM, V271, P19717, DOI 10.1074/jbc.271.33.19717; Liu K, 2005, P NATL ACAD SCI USA, V102, P2192, DOI 10.1073/pnas.0409232102; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P571, DOI 10.1007/s00424-003-1141-9; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; Matsushita K, 2005, J BACTERIOL, V187, P4346, DOI 10.1128/JB.187.13.4346-4352.2005; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Pornillos O, 2006, FEBS LETT, V580, P358, DOI 10.1016/j.febslet.2005.12.054; Quick M, 2003, BIOCHEMISTRY-US, V42, P9147, DOI 10.1021/bi034842x; Rahman M, 2007, MOL MEMBR BIOL, V24, P407, DOI 10.1080/09687860701243998; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Richer E, 2003, J MOL EVOL, V57, P363, DOI 10.1007/s00239-003-2472-z; ROBERTSON DE, 1980, BIOCHEMISTRY-US, V19, P5692, DOI 10.1021/bi00566a005; Sacher A, 2001, J EXP BIOL, V204, P1053; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Su CC, 2006, J BACTERIOL, V188, P7290, DOI 10.1128/JB.00684-06; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Zhang W, 2000, BIOCHEMISTRY-US, V39, P14538, DOI 10.1021/bi001947g; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	60	37	37	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9651	9658		10.1074/jbc.M709906200	http://dx.doi.org/10.1074/jbc.M709906200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18227061	hybrid			2022-12-27	WOS:000254671600019
J	Kourimate, S; Le May, C; Langhi, C; Jarnoux, AL; Ouguerram, K; Zaier, Y; Nguyen, P; Krempf, M; Cariou, B; Costet, P				Kourimate, Sanae; Le May, Cedric; Langhi, Cedric; Jarnoux, Anne Laure; Ouguerram, Khadija; Zaier, Yassine; Nguyen, Patrick; Krempf, Michel; Cariou, Bertrand; Costet, Philippe			Dual mechanisms for the fibrate-mediated repression of proprotein convertase subtilisin/kexin type 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; CORONARY-HEART-DISEASE; PROLIFERATOR-ACTIVATED RECEPTORS; COMBINED HYPERLIPIDEMIA; SECRETED PCSK9; FAMILIAL HYPERCHOLESTEROLEMIA; MICRONIZED FENOFIBRATE; DIABETES-MELLITUS; PLUS FENOFIBRATE; CONTROLLED-TRIAL	Proprotein convertase subtilisin/kexin type 9 (PCSK9) is associated with familial autosomal dominant hypercholesterolemia and is a natural inhibitor of the LDL receptor (LDLr). PCSK9 is degraded by other proprotein convertases: PC5/6A and furin. Both PCSK9 and the LDLr are up-regulated by the hypocholesterolemic statins. Thus, inhibitors or repressors of PCSK9 should amplify their beneficial effects. In the present study, we showed that PPAR alpha activation counteracts PCSK9 induction by statins by repressing PCSK9 promoter activity and by increasing PC5/6A and furin expression. Quantification of mRNA and protein levels showed that various fibrates decreased PCSK9 and increased PC5/6A and furin expression. Fenofibric acid (FA) reduced PCSK9 protein content in immortalized human hepatocytes (IHH) as well as its cellular secretion. FA suppressed PCSK9 induction by statins or by the liver X receptor agonist TO901317. PCSK9 repression is occurring at the promoter level. We showed that PC5/6A and furin fibrate-mediated up-regulation is PPAR alpha-dependent. As a functional test, we observed that FA increased by 30% the effect of pravastatin on the LDLr activity in vitro. In conclusion, fibrates simultaneously decreased PCSK9 expression while increasing PC5/6A and furin expression, indicating a broad action of PPAR alpha activation in proprotein convertase-mediated lipid homeostasis. Moreover, this study validates the functional relevance of a combined therapy associating PCSK9 repressors and statins.	[Kourimate, Sanae; Le May, Cedric; Langhi, Cedric; Ouguerram, Khadija; Zaier, Yassine; Krempf, Michel; Cariou, Bertrand; Costet, Philippe] INSERM, CHU Hotel Dieu, U915, F-44000 Nantes, France; [Jarnoux, Anne Laure] INSERM, U539, F-44000 Nantes, France; [Kourimate, Sanae; Costet, Philippe] CRNH Nantes, F-44000 Nantes, France; [Zaier, Yassine; Krempf, Michel; Cariou, Bertrand] CHU Nantes, Inst Thorax, Clin Endocrinol & Nutr, F-44000 Nantes, France; [Nguyen, Patrick] Ecole Natl Vet Nantes, F-44000 Nantes, France; [Ouguerram, Khadija; Krempf, Michel] Univ Nantes, Inst Thorax, Fac Med, F-44000 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes	Costet, P (corresponding author), INSERM, CHU Hotel Dieu, U915, 3ENORD,9 Quai Moncousu, F-44000 Nantes, France.	philippe.costet@univ-nantes.fr	Le May, cedric/D-2691-2009; costet, philippe/A-5314-2010	Le May, cedric/0000-0002-7554-792X; Langhi, Cedric/0000-0002-7732-3882; Cariou, Bertrand/0000-0002-1580-8040; Krempf, Michel/0000-0002-4353-9511				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Ballantyne CM, 2005, AM J CARDIOL, V96, p14K, DOI 10.1016/j.amjcard.2005.08.003; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costet P, 2006, J BIOL CHEM, V281, P6211, DOI 10.1074/jbc.M508582200; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Derosa G, 2004, CLIN THER, V26, P1599, DOI 10.1016/j.clinthera.2004.10.008; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Farnier M, 2000, AM J CARDIOL, V85, P53, DOI 10.1016/S0002-9149(99)00606-2; Fasano T, 2007, ARTERIOSCL THROM VAS, V27, P677, DOI 10.1161/01.ATV.0000255311.26383.2f; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Geyeregger R, 2006, CELL MOL LIFE SCI, V63, P524, DOI 10.1007/s00018-005-5398-3; Goto D, 1997, ARTERIOSCL THROM VAS, V17, P2707, DOI 10.1161/01.ATV.17.11.2707; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Grundy SM, 2005, AM J CARDIOL, V95, P462, DOI 10.1016/j.amjcard.2004.10.012; Guerin M, 1996, ARTERIOSCL THROM VAS, V16, P763, DOI 10.1161/01.ATV.16.6.763; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ishimoto K, 2006, FEBS LETT, V580, P4929, DOI 10.1016/j.febslet.2006.08.010; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Konig B, 2007, BIOCHEM PHARMACOL, V73, P574, DOI 10.1016/j.bcp.2006.10.027; Krempf M, 2000, DIABETES METAB, V26, P184; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lalanne F, 2005, J LIPID RES, V46, P1312, DOI 10.1194/jlr.M400396-JLR200; Lambert G, 2006, TRENDS ENDOCRIN MET, V17, P79, DOI 10.1016/j.tem.2006.02.001; Lambert G, 2006, ENDOCRINOLOGY, V147, P4985, DOI 10.1210/en.2006-0098; Mascaro C, 1998, J BIOL CHEM, V273, P8560, DOI 10.1074/jbc.273.15.8560; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Paumelle R, 2007, CIRC RES, V100, P1394, DOI 10.1161/01.RES.0000269334.42814.d2; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Steinmetz A, 1996, J CARDIOVASC PHARM, V27, P563, DOI 10.1097/00005344-199604000-00016; Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	52	81	107	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9666	9673		10.1074/jbc.M705831200	http://dx.doi.org/10.1074/jbc.M705831200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18245819	hybrid			2022-12-27	WOS:000254671600021
J	Hoogeboom, D; Essers, MAG; Polderman, PE; Voets, E; Smits, LMM; Burgering, BMT				Hoogeboom, Diana; Essers, Marieke A. G.; Polderman, Paulien E.; Voets, Erik; Smits, Lydia M. M.; Burgering, Boudewijn M. Th.			Interaction of FOXO with beta-catenin inhibits beta-Catenin/T cell factor activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTORS; WNT SIGNALING PATHWAY; PROTEIN-KINASE-B; F-BOX PROTEIN; OXIDATIVE STRESS; FUNCTIONAL INTERACTION; LIFE-SPAN; DROSOPHILA; WINGLESS; LEF-1	Wingless ( Wnt) signaling regulates many aspects of development and tissue homeostasis, and aberrant Wnt signaling can lead to cancer. Upon a Wnt signal beta-catenin degradation is halted and consequently the level of beta-catenin in the cytoplasm increases. This allows entry of beta-catenin into the nucleus where it can regulate gene transcription by direct binding to members of the lymphoid enhancer factor/T cell factor ( TCF) family of transcription factors. Recently, we identified Forkhead box-O ( FOXO) transcription factors as novel interaction partners of beta-catenin ( Essers, M. A., de Vries-Smits, L. M., Barker, N., Polderman, P. E., Burgering, B. M., and Korswagen, H. C. ( 2005) Science 308, 1181-1184). Here we show that the beta-catenin binding to FOXO serves a dual effect. beta-catenin, through binding, enhances FOXO transcriptional activity. In addition, FOXO competes with TCF for interaction with beta-catenin, thereby inhibiting TCF transcriptional activity. Reduced binding between TCF and beta-catenin is observed after FOXO overexpression and cellular oxidative stress, which simultaneously increases binding between beta-catenin and FOXO. Furthermore, small interfering RNA-mediated knock down of FOXO reverts loss of beta-catenin binding to TCF after cellular oxidative stress. Taken together, these results provide evidence for a cross-talk mechanism between FOXO and TCF signaling in which beta-catenin plays a central regulatory role.	[Hoogeboom, Diana; Essers, Marieke A. G.; Polderman, Paulien E.; Voets, Erik; Smits, Lydia M. M.; Burgering, Boudewijn M. Th.] Univ Utrecht, Med Ctr, Ctr Biomed Genet, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; [Essers, Marieke A. G.] Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland	Utrecht University; Swiss Institute Experimental Cancer Research	Burgering, BMT (corresponding author), Univ Utrecht, Med Ctr, Ctr Biomed Genet, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands.	b.m.t.burgering@umcutrecht.nl	Essers, Marieke A.G./B-7758-2017	Essers, Marieke A.G./0000-0003-3117-1809				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; Polakis P, 2000, GENE DEV, V14, P1837; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Shin SY, 2006, CELL SIGNAL, V18, P601, DOI 10.1016/j.cellsig.2005.06.001; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vermeulen S, 1996, PATHOL RES PRACT, V192, P694, DOI 10.1016/S0344-0338(96)80091-4; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087	41	220	226	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9224	9230		10.1074/jbc.M706638200	http://dx.doi.org/10.1074/jbc.M706638200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18250171	hybrid			2022-12-27	WOS:000254465800052
J	Mochizuki, K; Nishiyama, A; Jang, MK; Dey, A; Ghosh, A; Tamura, T; Natsume, H; Yao, HJ; Ozato, K				Mochizuki, Kazuki; Nishiyama, Akira; Jang, Moon Kyoo; Dey, Anup; Ghosh, Anu; Tamura, Tomohiko; Natsume, Hiroko; Yao, Hongjie; Ozato, Keiko			The bromodomain protein Brd4 stimulates G(1) gene transcription and promotes progression to S phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAPILLOMAVIRUS E2 PROTEIN; NF-KAPPA-B; P-TEFB; CHROMOSOMAL-PROTEIN; DNA-REPLICATION; CHROMATIN; EXPRESSION; RECOGNITION; ELONGATION; BLOCKS	Brd4 is a bromodomain protein that binds to acetylated chromatin. It regulates cell growth, although the underlying mechanism has remained elusive. Brd4 has also been shown to control transcription of viral genes, whereas its role in transcription of cellular genes has not been fully elucidated. Here we addressed the role of Brd4 in cell growth and transcription using a small hairpin ( sh) RNA approach. The Brd4 shRNA vector stably knocked down Brd4 protein expression by similar to 90% in NIH3T3 cells and mouse embryonic fibroblasts. Brd4 knockdown cells were growth impaired and grew more slowly than control cells. When synchronized by serum starvation and released, Brd4 knockdown cells were arrested at G(1), whereas control cells progressed to S phase. In microarray analysis, although numerous genes were up-regulated during G(1) in control cells, many of these G(1) genes were not up-regulated in Brd4 knockdown cells. Reintroduction of Brd4 rescued expression of these G(1) genes in Brd4 knockdown cells, allowing cells to progress toward S phase. Chromatin immunoprecipitation analysis showed that Brd4 was recruited to the promoters of these G(1) genes during G(0)-G(1) progression. Furthermore, Brd4 recruitment coincided with increased binding of Cdk9, a component of P-TEFb and RNA polymerase II to these genes. Brd4 recruitment was low to absent at genes not affected by Brd4 shRNA. The results indicate that Brd4 stimulates G(1) gene expression by binding to multiple G(1) gene promoters in a cell cycle-dependent manner.	[Mochizuki, Kazuki; Nishiyama, Akira; Jang, Moon Kyoo; Dey, Anup; Ghosh, Anu; Tamura, Tomohiko; Natsume, Hiroko; Yao, Hongjie; Ozato, Keiko] NICHD, NIH, Lab Mol Growth Regulat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ozato, K (corresponding author), NICHD, NIH, Lab Mol Growth Regulat, Bldg 6,Rm 2A01,6 Ctr Dr, Bethesda, MD 20892 USA.	ozatok@nih.go	Ghosh, Anu/ABF-4180-2020	Jang, Moon Kyoo/0000-0002-1657-2877; Ghosh, Anu/0000-0003-4528-8602	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008815] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008815] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Baxter MK, 2005, J VIROL, V79, P4806, DOI 10.1128/JVI.79.8.4806-4818.2005; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Crowley TE, 2002, MOL ENDOCRINOL, V16, P1727, DOI 10.1210/me.2001-0353; Dahl JA, 2007, FRONT BIOSCI-LANDMRK, V12, P4925, DOI 10.2741/2438; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; DePamphilis ML, 2005, CELL CYCLE, V4, P70, DOI 10.4161/cc.4.1.1333; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Haruki N, 2005, J MED GENET, V42, P558, DOI 10.1136/jmg.2004.029686; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Kadota K, 2001, PHYSIOL GENOMICS, V4, P183, DOI 10.1152/physiolgenomics.2001.4.3.183; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Landgrebe J, 2002, GENOME BIOL, V3; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Nagashima T, 2007, MOL HUM REPROD, V13, P141, DOI 10.1093/molehr/gal115; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; van der Meijden CMJ, 2002, CANCER RES, V62, P3233; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7	44	164	208	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9040	9048		10.1074/jbc.M707603200	http://dx.doi.org/10.1074/jbc.M707603200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18223296	hybrid, Green Published			2022-12-27	WOS:000254465800034
J	Tabata, S; Kuroki, K; Wang, J; Kajikawa, M; Shiratori, I; Kohda, D; Arase, H; Maenaka, K				Tabata, Shigekazu; Kuroki, Kimiko; Wang, Jing; Kajikawa, Mizuho; Shiratori, Ikuo; Kohda, Daisuke; Arase, Hisashi; Maenaka, Katsumi			Biophysical characterization of O-glycosylated CD99 recognition by paired ig-like type 2 receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTORS; INHIBITORY RECEPTOR; SELECTIN BINDING; KINETIC-ANALYSIS; LOW-AFFINITY; PEPTIDE-MHC; THERMODYNAMICS; COMPLEX; LIGAND; CYTOMEGALOVIRUS	Paired Ig-like type 2 receptors ( PILRs) are one of the paired receptor families, which consist of two functionally opposite members, inhibitory ( PILR alpha) and activating ( PILR beta) receptors. PILRs are widely expressed in immune cells and recognize the sialylated O-glycosylated ligand CD99, which is expressed on activated T cells, to regulate immune responses. To date, their biophysical properties have not yet been examined. Here we report the affinity, kinetic, and thermodynamic analyses of PILR-CD99 interactions using surface plasmon resonance ( SPR) together with site-directed mutagenesis. The SPR analysis clearly demonstrated that inhibitory PILR alpha can bind to CD99 with low affinity ( K-d similar to 2.2 mu M), but activating PILR beta binds with similar to 40 times lower affinity ( K-d similar to 85 mu M). In addition to our previous mutagenesis study ( Wang, J., Shiratori, I., Saito, T., Lanier, L. L., and Arase, H. ( 2008) J. Immunol. 180, 1686 - 1693), the SPR analysis showed that PILR alpha can bind to each Ala mutant of the two CD99 O-glycosylated sites ( Thr-45 and Thr-50) with similar binding affinity to wild-type CD99. This indicated that both residues act as independent and equivalent PILR alpha binding sites, consistent with the highly flexible structure of CD99. On the other hand, it is further confirmed that PILR beta can bind the T50A mutant, but not the T45A mutant, indicating a recognition difference between PILR alpha and PILR beta. Kinetic studies demonstrated that the PILR-CD99 interactions show fast dissociation rates, typical of cell-cell recognition receptors. Thermodynamic analyses revealed that the PILR alpha-CD99 interaction is enthalpically driven with a large entropy loss (-T Delta S = 8.9 kcal.mol(-1)), suggesting the reduction of flexibility upon complex formation. This is in contrast to the entropically driven binding of selectins to sugar-modified ligands involved in leukocyte rolling and infiltration, which may reflect their functional differences.	[Tabata, Shigekazu; Kuroki, Kimiko; Kajikawa, Mizuho; Kohda, Daisuke; Maenaka, Katsumi] Kyushu Univ, Div Struct Biol, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Wang, Jing; Shiratori, Ikuo; Arase, Hisashi] Osaka Univ, Dept Immunochem, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Arase, Hisashi] Osaka Univ, World Premier Int Immunol, Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Arase, Hisashi] Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Maenaka, K (corresponding author), Kyushu Univ, Div Struct Biol, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kmaenaka@bioreg.kyushu-u.ac.jp	Kohda, Daisuke/I-4990-2019; Arase, Hisashi/C-8442-2009; Kuroki, Kimiko/F-6906-2012	Kohda, Daisuke/0000-0001-8234-3776; Arase, Hisashi/0000-0002-1153-3166; Shiratori, Ikuo/0000-0003-3713-4910; Wang, Jing/0000-0001-8758-1693				Adams EJ, 2007, P NATL ACAD SCI USA, V104, P10128, DOI 10.1073/pnas.0703735104; Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Arase H, 2002, MICROBES INFECT, V4, P1505, DOI 10.1016/S1286-4579(02)00033-3; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bakker TR, 2002, EUR J IMMUNOL, V32, P1924, DOI 10.1002/1521-4141(200207)32:7<1924::AID-IMMU1924>3.0.CO;2-N; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; Davis-Harrison RL, 2005, J MOL BIOL, V346, P533, DOI 10.1016/j.jmb.2004.11.063; Diefenbach A, 2003, CURR OPIN IMMUNOL, V15, P37, DOI 10.1016/S0952-7915(02)00007-9; Fournier N, 2000, J IMMUNOL, V165, P1197, DOI 10.4049/jimmunol.165.3.1197; Gao GF, 2000, J BIOL CHEM, V275, P15232, DOI 10.1074/jbc.275.20.15232; Garcia KC, 2001, P NATL ACAD SCI USA, V98, P6818, DOI 10.1073/pnas.111161198; Lanier LL, 2001, NAT IMMUNOL, V2, P23, DOI 10.1038/83130; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Mousseau DD, 2000, J BIOL CHEM, V275, P4467, DOI 10.1074/jbc.275.6.4467; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; O'Callaghan CA, 2001, IMMUNITY, V15, P201, DOI 10.1016/S1074-7613(01)00187-X; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Smith HRC, 2001, IMMUNOL REV, V181, P115, DOI 10.1034/j.1600-065X.2001.1810109.x; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Vales-Gomez M, 2000, HUM IMMUNOL, V61, P28, DOI 10.1016/S0198-8859(99)00159-7; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Wang J, 2008, J IMMUNOL, V180, P1686, DOI 10.4049/jimmunol.180.3.1686; Wild MK, 2001, J BIOL CHEM, V276, P31602, DOI 10.1074/jbc.M104844200; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7	32	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8893	8901		10.1074/jbc.M709793200	http://dx.doi.org/10.1074/jbc.M709793200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18234675	hybrid			2022-12-27	WOS:000254465800017
J	Little, JT; Jurica, MS				Little, John T.; Jurica, Melissa S.			Splicing factor SPF30 bridges an interaction between the prespliceosome protein U2AF35 and tri-small nuclear ribonucleoprotein protein hPrp3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEX-LETHAL; SM PROTEIN; COMPLEX; RECOGNITION; GENE; SITE; NETWORK; CLONING; DOMAIN	Spliceosome assembly is a dynamic process involving the sequential recruitment and rearrangement of small nuclear ribonucleoproteins (snRNPs) on a pre-mRNA substrate. Here we identify several spliceosome protein interactions with different domains of human splicing factor SPF30 that have the potential to mediate the addition of the tri-snRNP to the pre-spliceosome. In particular, we show that the C-terminal tails of SmD1, SmD3, and the protein Lsm4 interact with the central Tudor domain of SPF30. We identify a novel interaction between the N-terminal domain of SPF30 and U2AF35, a pre-spliceosome protein that has a role in recognizing the 3' splice site and recruiting U2 snRNP. We also show that the C terminus of SPF30 interacts with a middle domain of hPrp3, a component of U4/U6 di-snRNP and the tri-snRNP. Importantly, we show that the U2AF35 and hPrp3 interactions with SPF30 can occur simultaneously, thereby potentially linking 3' splice site recognition with tri-snRNP addition. Finally, we note that SPF30 and its partner-interacting domains are not conserved in yeast, suggesting this interaction network may play an important role in the complex splicing observed in higher eukaryotes.	Univ Calif Santa Cruz, Dept Cell Mol & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Jurica, MS (corresponding author), MCD Bio, 1156 High St, Santa Cruz, CA 95064 USA.	jurica@biology.ucsc.edu			NIGMS NIH HHS [R01 GM072649] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072649] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Boehringer D, 2004, NAT STRUCT MOL BIOL, V11, P463, DOI 10.1038/nsmb761; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Burge CB, 1999, RNA WORLD, P525; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; Cass DM, 2006, BIOCHEMISTRY-US, V45, P10092, DOI 10.1021/bi060429o; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gonzalez-Santos JM, 2002, J BIOL CHEM, V277, P23764, DOI 10.1074/jbc.M111461200; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Jady BE, 2003, EMBO J, V22, P1878, DOI 10.1093/emboj/cdg187; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Lutzelberger M, 2005, J BIOL CHEM, V280, P25478, DOI 10.1074/jbc.M413737200; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Meister G, 2001, EMBO J, V20, P2304, DOI 10.1093/emboj/20.9.2304; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; MOORE MJ, 1993, RNA WORLD, P333; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Rappsilber J, 2001, J BIOL CHEM, V276, P31142, DOI 10.1074/jbc.M103620200; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Talbot K, 1998, HUM MOL GENET, V7, P2149, DOI 10.1093/hmg/7.13.2149; UTANS U, 1992, GENE DEV, V6, P631, DOI 10.1101/gad.6.4.631; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZHANG M, 1992, P NATL ACAD SCI USA, V89, P8769, DOI 10.1073/pnas.89.18.8769; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597	40	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8145	8152		10.1074/jbc.M707984200	http://dx.doi.org/10.1074/jbc.M707984200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18211889	hybrid			2022-12-27	WOS:000254288000011
J	Liu, BY; Li, Z; Mahesh, SP; Pantanelli, S; Hwang, FS; Siu, WO; Nussenblatt, RB				Liu, Baoying; Li, Zhuqing; Mahesh, Sankaranarayana P.; Pantanelli, Seth; Hwang, Frank S.; Siu, Willie O.; Nussenblatt, Robert B.			Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED TNF RECEPTOR; VERSUS-HOST-DISEASE; T-CELLS; CUTTING EDGE; ANTITUMOR IMMUNITY; SELF-TOLERANCE; PROTEIN GITR; FAMILY; LIGAND; SUPERFAMILY	Glucocorticoid-induced tumor necrosis factor receptor (GITR), found constitutively expressed on human primary natural killer (NK) cells at low levels was up-regulated upon stimulation by either Toll-like receptor ligand or NK cell growth factor, interleukin (IL)-15. cDNA microarray analysis showed that engagement of GITR primarily suppressed the activation of NF-KB pathway of NK cells and up-regulated anti-inflammatory genes heme oxygenase- 1 and IL-10. Further analysis revealed that GITR activation suppressed NK cell proliferation in response to IL-15. GITR activation also suppressed proinflammatory cytokine secretion and increased NK cell apoptosis. GITR activation resulted in blocked phosphorylation of Stat5 and Akt, which may have contributed to the observed antiproliferative effect of GITR on NK cells. Increased apoptosis was independent of the Fas-FasL pathway, but Bcl-XL and phospho-Bad protein expressions were diminished, suggesting involvement of the mitochondrial apoptosis pathway. The results suggest that although GITR is an activation marker for NK cells similar to that for T cells, GITR serves as a negative regulator for NK cell activation. Our studies demonstrate a novel physiological role of GITR on NK cells.	[Liu, Baoying; Li, Zhuqing; Mahesh, Sankaranarayana P.; Pantanelli, Seth; Hwang, Frank S.; Siu, Willie O.; Nussenblatt, Robert B.] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Nussenblatt, RB (corresponding author), NEI, Immunol Lab, NIH, Bldg 10,Room 10N112,10 Ctr Dr, Bethesda, MD 20892 USA.	drbob@nei.nih.gov	Pantanelli, Seth/GRR-5413-2022	Hwang, Frank/0000-0002-9462-9648; Pantanelli, Seth/0000-0003-4992-9606	NATIONAL EYE INSTITUTE [ZIAEY000376, Z01EY000464, Z01EY000376, ZIAEY000464] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baltz KM, 2007, FASEB J, V21, P2442, DOI 10.1096/fj.06-7724com; BANCROFT GJ, 1994, IMMUNOBIOLOGY, V191, P424, DOI 10.1016/S0171-2985(11)80448-1; Bushell A, 2007, AM J TRANSPLANT, V7, P759, DOI 10.1111/j.1600-6143.2006.01716.x; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; CHAN SH, 1991, J EXP MED, V173, P869, DOI 10.1084/jem.173.4.869; Cohen AD, 2006, CANCER RES, V66, P4904, DOI 10.1158/0008-5472.CAN-05-2813; Esparza EM, 2005, J IMMUNOL, V174, P7869, DOI 10.4049/jimmunol.174.12.7869; Esparza EM, 2004, CELL MOL LIFE SCI, V61, P3087, DOI 10.1007/s00018-004-4417-0; Goodsell DS, 2004, ONCOLOGIST, V9, P226, DOI 10.1634/theoncologist.9-2-226; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Gurney AL, 1999, CURR BIOL, V9, P215, DOI 10.1016/S0960-9822(99)80093-1; Hail N, 2005, APOPTOSIS, V10, P687, DOI 10.1007/s10495-005-0792-8; Hanabuchi S, 2006, BLOOD, V107, P3617, DOI 10.1182/blood-2005-08-3419; Ji HB, 2004, J IMMUNOL, V172, P5823, DOI 10.4049/jimmunol.172.10.5823; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim J, 2006, EXP MOL MED, V38, P94, DOI 10.1038/emm.2006.11; Ko HJ, 2007, CANCER RES, V67, P7477, DOI 10.1158/0008-5472.CAN-06-4639; Kohm AP, 2004, J IMMUNOL, V172, P4686, DOI 10.4049/jimmunol.172.8.4686; Kwon BS, 1999, J BIOL CHEM, V274, P6056, DOI 10.1074/jbc.274.10.6056; La S, 2005, EXP MOL MED, V37, P193, DOI 10.1038/emm.2005.26; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Lecoeur H, 1997, J IMMUNOL METHODS, V209, P111, DOI 10.1016/S0022-1759(97)00138-5; Lenardo MJ, 1996, J EXP MED, V183, P721, DOI 10.1084/jem.183.3.721; Li ZQ, 2005, J IMMUNOL, V174, P5187, DOI 10.4049/jimmunol.174.9.5187; Li ZQ, 2003, J AUTOIMMUN, V21, P83, DOI 10.1016/S0896-8411(03)00085-4; Mackay F, 2002, CURR OPIN IMMUNOL, V14, P783, DOI 10.1016/S0952-7915(02)00407-7; Marcenaro E, 2005, AUTOIMMUN REV, V4, P520, DOI 10.1016/j.autrev.2005.04.015; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Muriglan SJ, 2004, J EXP MED, V200, P149, DOI 10.1084/jem.20040116; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Nocentini G, 2005, EUR J IMMUNOL, V35, P1016, DOI 10.1002/eji.200425818; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Parry RV, 2007, TRENDS IMMUNOL, V28, P161, DOI 10.1016/j.it.2007.02.004; Patel M, 2005, EUR J IMMUNOL, V35, P3581, DOI 10.1002/eji.200535421; Ramirez-Montagut T, 2006, J IMMUNOL, V176, P6434, DOI 10.4049/jimmunol.176.11.6434; Ronchetti S, 2002, BLOOD, V100, P350, DOI 10.1182/blood-2001-12-0276; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; Schmidt KN, 2004, J IMMUNOL, V172, P138, DOI 10.4049/jimmunol.172.1.138; Schwarz M, 2007, APOPTOSIS, V12, P869, DOI 10.1007/s10495-007-0748-2; Shi FD, 2006, NAT REV IMMUNOL, V6, P751, DOI 10.1038/nri1935; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Shin HH, 2002, FEBS LETT, V514, P275, DOI 10.1016/S0014-5793(02)02379-7; Suvas S, 2005, J VIROL, V79, P11935, DOI 10.1128/JVI.79.18.11935-11942.2005; Tuyaerts S, 2007, J LEUKOCYTE BIOL, V82, P93, DOI 10.1189/jlb.0906568; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5	50	55	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8202	8210		10.1074/jbc.M708944200	http://dx.doi.org/10.1074/jbc.M708944200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18230609	Green Published, hybrid			2022-12-27	WOS:000254288000017
J	McCulloch, CV; Morrow, V; Milasta, S; Comerford, I; Milligan, G; Graham, GJ; Isaacs, NW; Nibbs, RJB				McCulloch, Clare V.; Morrow, Valerie; Milasta, Sandra; Comerford, Iain; Milligan, Graeme; Graham, Gerard J.; Isaacs, Neil W.; Nibbs, Robert J. B.			Multiple roles for the C-terminal tail of the chemokine scavenger D6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DEPENDENT CHANGES; BETA-ARRESTIN; RECEPTOR D6; CRYSTAL-STRUCTURE; CYTOPLASMIC END; INFLAMMATION; RHODOPSIN; HELIX-8; PHOSPHORYLATION; INTERNALIZATION	D6 is a heptahelical receptor that suppresses inflammation and tumorigenesis by scavenging extracellular pro-inflammatory CC chemokines. Previous studies suggested this is dependent on constitutive trafficking of stable D6 protein to and from the cell surface via recycling endosomes. By internalizing chemokine each time it transits the cell surface, D6 can, over time, remove large quantities of these inflammatory mediators. We have investigated the role of the conserved 58-amino acid C terminus of human D6, which, unlike the rest of the protein, shows no clear homology to other heptahelical receptors. We show that, in human HEK293 cells, a serine cluster in this region controls the constitutive phosphorylation, high stability, and intracellular trafficking itinerary of the receptor and drives green fluorescent protein-tagged beta-arrestins to membranes at, and near, the cell surface. Unexpectedly, however, these properties, and the last 44 amino acids of the C terminus, are dispensable for D6 internalization and effective scavenging of the chemokine CCL3. Even in the absence of the last 58 amino acids, D6 still initially internalizes CCL3 but, surprisingly, exposure to ligand inhibits subsequent CCL3 uptake by this mutant. Progressive scavenging is therefore abrogated. We conclude that the heptahelical body of D6 on its own can engage the endocytotic machinery of HEK293 cells but that the C terminus is indispensable for scavenging because it prevents initial chemokine engagement of D6 from inhibiting subsequent chemokine uptake.	[McCulloch, Clare V.; Morrow, Valerie; Comerford, Iain; Graham, Gerard J.; Nibbs, Robert J. B.] Univ Glasgow, Glasgow Biomed Res Ctr, Div Immunol Infect & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Milasta, Sandra; Milligan, Graeme] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Isaacs, Neil W.] Univ Glasgow, Dept Chem, Glasgow G12 8TA, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Nibbs, RJB (corresponding author), Univ Glasgow, Glasgow Biomed Res Ctr, Div Immunol Infect & Inflammat, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	r.nibbs@clinmed.gla.ac.uk	Milligan, Graeme/F-9426-2011; Graham, Gerard/D-1240-2009	Milligan, Graeme/0000-0002-6946-3519; Graham, Gerard/0000-0002-7801-204X; Nibbs, Robert/0000-0002-8150-0044; Comerford, Iain/0000-0001-8753-4774	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Cancer Research UK Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15493, DOI 10.1021/bi011545o; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15483, DOI 10.1021/bi011546g; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Blackburn PE, 2004, BIOCHEM J, V379, P263, DOI 10.1042/BJ20031266; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Comerford I, 2006, EUR J IMMUNOL, V36, P1904, DOI 10.1002/eji.200535716; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Feng GJ, 2003, J BIOL CHEM, V278, P33400, DOI 10.1074/jbc.M305866200; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; GRAHAM GJ, 1994, J BIOL CHEM, V269, P4974; GRAHAM GJ, 1993, CELL GROWTH DIFFER, V4, P137; Hansell CAH, 2006, BIOCHEM SOC T, V34, P1009, DOI 10.1042/BST0341009; Hoare S, 1999, J BIOL CHEM, V274, P28682, DOI 10.1074/jbc.274.40.28682; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Huttenrauch F, 2002, J BIOL CHEM, V277, P30769, DOI 10.1074/jbc.M204033200; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Kang DS, 2002, MOL PHARMACOL, V62, P281, DOI 10.1124/mol.62.2.281; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Milasta S, 2005, BIOCHEM J, V387, P573, DOI 10.1042/BJ20041745; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; Nibbs RJB, 1997, J BIOL CHEM, V272, P32078, DOI 10.1074/jbc.272.51.32078; Nibbs RJB, 2001, AM J PATHOL, V158, P867, DOI 10.1016/S0002-9440(10)64035-7; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Ridge KD, 2007, J BIOL CHEM, V282, P9297, DOI 10.1074/jbc.R600032200; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; SANTOS DNM, 2006, J BIOL CHEM, V281, P12896; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Verzijl D, 2006, J BIOL CHEM, V281, P35327, DOI 10.1074/jbc.M606877200; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Whitehead GS, 2007, AM J RESP CRIT CARE, V175, P243, DOI 10.1164/rccm.200606-839OC	50	56	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7972	7982		10.1074/jbc.M710128200	http://dx.doi.org/10.1074/jbc.M710128200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18201974	Green Published, hybrid			2022-12-27	WOS:000253997900072
J	Zamyatkin, DF; Parra, F; Alonso, JMM; Harki, DA; Peterson, BR; Grochulski, P; Ng, KKS				Zamyatkin, Dmitry F.; Parra, Francisco; Martin Alonso, Jose M.; Harki, Daniel A.; Peterson, Blake R.; Grochulski, Pawel; Ng, Kenneth K. -S.			Structural insights into mechanisms of catalysis and inhibition in Norwalk virus polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURES; DIFFRACTION DATA; REPLICATION; COMPLEX; RNA-POLYMERASE-(3D(POL)); CONFORMATIONS; INITIATION; FIDELITY; BINDING	Crystal structures of Norwalk virus polymerase bound to an RNA primer-template duplex and either the natural substrate CTP or the inhibitor 5-nitrocytidine triphosphate have been determined to 1.8 A resolution. These structures reveal a closed conformation of the polymerase that differs significantly from previously determined open structures of calicivirus and picornavirus polymerases. These closed complexes are trapped immediately prior to the nucleotidyl transfer reaction, with the triphosphate group of the nucleotide bound to two manganese ions at the active site, poised for reaction to the 3'-hydroxyl group of the RNA primer. The positioning of the 5-nitrocytidine triphosphate nitro group between the alpha-phosphate and the 3'-hydroxyl group of the primer suggests a novel, general approach for the design of antiviral compounds mimicking natural nucleosides and nucleotides.	[Zamyatkin, Dmitry F.; Ng, Kenneth K. -S.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Zamyatkin, Dmitry F.; Ng, Kenneth K. -S.] Univ Calgary, Alberta Ingenu Ctr Carbohydrate Sci, Calgary, AB T2N 1N4, Canada; [Parra, Francisco; Martin Alonso, Jose M.] Univ Oviedo, Inst Univ Biotecnol Asturias, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Harki, Daniel A.; Peterson, Blake R.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Grochulski, Pawel] Univ Saskatchewan, Canadian Light Source Inc, Saskatoon, SK S7N 0X4, Canada	University of Calgary; University of Calgary; University of Oviedo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Saskatchewan	Ng, KKS (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	ngk@ucalgary.ca	Martin Alonso, Jose Manuel/C-7763-2013; Parra, Francisco/D-5401-2009; Peterson, Blake Robert/AAG-8793-2020; Peterson, Blake/O-2497-2016	Martin Alonso, Jose Manuel/0000-0003-1725-6216; Parra, Francisco/0000-0002-1885-9521; Peterson, Blake/0000-0001-8251-3579; Ng, Kenneth K.S./0000-0001-7280-8445	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI054776] Funding Source: NIH RePORTER; NIAID NIH HHS [AI054776] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alberts IL, 2007, J AM CHEM SOC, V129, P11100, DOI 10.1021/ja071533b; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Cameron Craig E., 2002, P255; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; DeLano W.L, PYMOL MOL GRAPHICS S; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Fullerton SWB, 2007, J VIROL, V81, P1858, DOI 10.1128/JVI.01462-06; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gohara DW, 2004, BIOCHEMISTRY-US, V43, P5149, DOI 10.1021/bi035429s; Harki DA, 2006, J MED CHEM, V49, P6166, DOI 10.1021/jm060872x; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Korneeva VS, 2007, J BIOL CHEM, V282, P16135, DOI 10.1074/jbc.M610090200; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng KKS, 2004, J BIOL CHEM, V279, P16638, DOI 10.1074/jbc.M400584200; Ng KKS, 2002, J BIOL CHEM, V277, P1381, DOI 10.1074/jbc.M109261200; Ortin J, 2006, ANNU REV MICROBIOL, V60, P305, DOI 10.1146/annurev.micro.60.080805.142248; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; Vazquez AL, 2000, J VIROL, V74, P3888, DOI 10.1128/JVI.74.8.3888-3891.2000	38	121	124	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7705	7712		10.1074/jbc.M709563200	http://dx.doi.org/10.1074/jbc.M709563200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18184655	hybrid			2022-12-27	WOS:000253997900047
J	Caldara, M; Dupont, G; Leroy, F; Goldbeter, A; De Vuyst, L; Cunin, R				Caldara, Marina; Dupont, Genevieve; Leroy, Frederic; Goldbeter, Albert; De Vuyst, Luc; Cunin, Raymond			Arginine biosynthesis in Escherichia coli - Experimental perturbation and mathematical modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; N-ACETYLGLUTAMATE SYNTHETASE; ASPARTATE-TRANSCARBAMYLASE; ALLOSTERIC REGULATION; INTRAMOLECULAR TRANSMISSION; FEEDBACK INHIBITION; SYNTHASE; PATHWAY; PYRIMIDINE; ENZYME	A basic challenge in cell biology is to understand how interconnected metabolic pathways are regulated to provide the adequate cellular outcome when changing levels of metabolites and enzyme expression. In Escherichia coli, the arginine and pyrimidine biosynthetic pathways are connected through a common metabolite provided by a single enzyme. The different elements of the arginine biosynthetic system of Escherichia coli, including the connection with pyrimidine biosynthesis, and the principal regulatory mechanisms operating at genetic and enzymatic levels were integrated in a mathematical model using a molecular kinetic approach combined with a modular description of the system. The model was then used to simulate a set of perturbed conditions as follows: genetic derepression, feedback resistance of the first enzymatic step, and low constitutive synthesis of the intermediate carbamyl phosphate. In all cases, an excellent quantitative agreement between simulations and experimental results was found. The model was used to gain further insight into the function of the system, including the synergy between the different regulations. The outcome of combinations of perturbations on cellular arginine concentration was predicted accurately, establishing the model as a powerful tool for the design of arginine-overproducing strains.	[Caldara, Marina; Cunin, Raymond] Vrije Univ Brussel, Lab Microbiol & Genet, B-1050 Brussels, Belgium; [Dupont, Genevieve; Goldbeter, Albert] Univ Libre Bruxelles, Fac Sci, Unite Chronbiol Theor, B-1050 Brussels, Belgium; [Goldbeter, Albert; Cunin, Raymond] Vrije Univ Brussel, Lab Ind Microbiol & Food Biotechnol, B-1050 Brussels, Belgium	Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Cunin, R (corresponding author), Vrije Univ Brussel, Lab Microbiol & Genet, Pleinplaan 2, B-1050 Brussels, Belgium.	rcunin@vub.ac.be	Leroy, Frédéric/D-2424-2009	Leroy, Frédéric/0000-0001-8682-9626; De Vuyst, Luc/0000-0002-7534-7186				Abadjieva A, 2001, J BIOL CHEM, V276, P42869, DOI 10.1074/jbc.M103732200; ANDERSON PM, 1965, BIOCHEMISTRY-US, V4, P2803, DOI 10.1021/bi00888a034; ANDERSON PM, 1966, BIOCHEMISTRY-US, V5, P3164, DOI 10.1021/bi00874a013; Bachmann B.J., 1987, ESCHERICHIA COLI SAL, P1190; Bruggeman FJ, 2002, J THEOR BIOL, V218, P507, DOI 10.1006/jtbi.2002.3096; Bruggeman FJ, 2002, MOL BIOL REP, V29, P57, DOI 10.1023/A:1020354302260; Bruggeman FJ, 2007, TRENDS MICROBIOL, V15, P45, DOI 10.1016/j.tim.2006.11.003; CALDARA M, 2007, THESIS VRIJE U BRUSS; Caldara M, 2006, MICROBIOL-SGM, V152, P3343, DOI 10.1099/mic.0.29088-0; Castellanos M, 2004, P NATL ACAD SCI USA, V101, P6681, DOI 10.1073/pnas.0400962101; CHARLIER D, 2004, BIOSYNTHESIS ARGININ; Chassagnole C, 2001, BIOCHEM J, V356, P415, DOI 10.1042/0264-6021:3560415; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Cunin R, 1996, J MOL BIOL, V262, P258, DOI 10.1006/jmbi.1996.0511; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delannay S, 1999, J MOL BIOL, V286, P1217, DOI 10.1006/jmbi.1999.2561; DESTAERCKE C, 1995, J MOL BIOL, V246, P132, DOI 10.1006/jmbi.1994.0072; ELSEVIERS D, 1972, MOL GEN GENET, V117, P349, DOI 10.1007/BF00333028; ENGLAND P, 1992, BIOCHEMISTRY-US, V31, P9725, DOI 10.1021/bi00155a028; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; GERHART JC, 1962, J BIOL CHEM, V237, P891; GLANSDOR.N, 1965, BIOCHIM BIOPHYS ACTA, V108, P308, DOI 10.1016/0005-2787(65)90016-X; GLANSDORFF N, 1965, GENETICS, V51, P167; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; GOLDBETER A, 1973, THESIS U LIBRE BRUXE; HAAS D, 1972, EUR J BIOCHEM, V31, P290, DOI 10.1111/j.1432-1033.1972.tb02531.x; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HERVE G, 1989, ALLOSTERIC ENZYMES, P61; HESS B, 1971, ANNU REV BIOCHEM, V40, P237, DOI 10.1146/annurev.bi.40.070171.001321; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; LEGRAIN C, 1972, EUR J BIOCHEM, V27, P93, DOI 10.1111/j.1432-1033.1972.tb01814.x; LEISINGER T, 1975, J BIOL CHEM, V250, P1690; LIM D, 1987, P NATL ACAD SCI USA, V84, P6697, DOI 10.1073/pnas.84.19.6697; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu CD, 2006, APPL MICROBIOL BIOT, V70, P261, DOI 10.1007/s00253-005-0308-z; MAAS WK, 1994, MICROBIOL REV, V58, P631, DOI 10.1128/MMBR.58.4.631-640.1994; MARVIL DK, 1977, J BIOL CHEM, V252, P3295; MERGEAY M, 1974, MOL GEN GENET, V133, P299, DOI 10.1007/BF00332706; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nandineni MR, 2004, J BACTERIOL, V186, P3539, DOI 10.1128/JB.186.11.3539-3546.2004; NEUHARD J, 1996, BIOSYNTHESIS ARGININ; PIERARD A, 1965, J MOL BIOL, V14, P23, DOI 10.1016/S0022-2836(65)80226-1; PIERARD A, 1966, SCIENCE, V154, P1572, DOI 10.1126/science.154.3756.1572; PIETTE J, 1984, P NATL ACAD SCI-BIOL, V81, P4134, DOI 10.1073/pnas.81.13.4134; PRESCOTT LM, 1969, ANAL BIOCHEM, V32, P408, DOI 10.1016/S0003-2697(69)80008-4; Qi YA, 2006, PLOS COMPUT BIOL, V2, P1502, DOI 10.1371/journal.pcbi.0020174; Rajagopal BS, 1998, APPL ENVIRON MICROB, V64, P1805; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; ROBIN JP, 1989, EUR J BIOCHEM, V183, P519, DOI 10.1111/j.1432-1033.1989.tb21080.x; Rodriguez M, 2005, J THEOR BIOL, V234, P299, DOI 10.1016/j.jtbi.2004.11.023; RUBIO V, 1991, BIOCHEMISTRY-US, V30, P1068, DOI 10.1021/bi00218a027; Schneider BL, 1998, J BACTERIOL, V180, P4278, DOI 10.1128/JB.180.16.4278-4286.1998; Segel I.H, 1993, ENZYME KINETICS; Shi DS, 2005, J BIOL CHEM, V280, P14366, DOI 10.1074/jbc.C500005200; Stelling J, 2004, IEEE T NANOBIOSCI, V3, P172, DOI 10.1109/TNB.2004.833688; Sundararaj S, 2004, NUCLEIC ACIDS RES, V32, pD293, DOI 10.1093/nar/gkh108; VYAS S, 1963, ARCH BIOCHEM BIOPHYS, V100, P542, DOI 10.1016/0003-9861(63)90124-3; WALES ME, 1999, ENCY MOL BIOL, P196; WEBER K, 1968, J BIOL CHEM, V243, P543; WILD JR, 1989, P NATL ACAD SCI USA, V86, P46, DOI 10.1073/pnas.86.1.46; Xu Y, 2007, MICROBIOL MOL BIOL R, V71, P36, DOI 10.1128/MMBR.00032-06; Yang CR, 2005, J BIOL CHEM, V280, P11224, DOI 10.1074/jbc.M411471200; Yu YG, 1996, MOL MICROBIOL, V22, P545, DOI 10.1046/j.1365-2958.1996.1321494.x	67	44	49	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6347	6358		10.1074/jbc.M705884200	http://dx.doi.org/10.1074/jbc.M705884200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165237	Green Submitted, hybrid			2022-12-27	WOS:000253779500042
J	Mason, AK; Jacobs, BE; Welling, PA				Mason, Amanda K.; Jacobs, Brandiese E.; Welling, Paul A.			AP-2-dependent internalization of potassium channel Kir2.3 is driven by a novel di-hydrophobic signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ADAPTER PROTEIN COMPLEXES; COATED VESICLE FORMATION; BASOLATERAL MEMBRANE EXPRESSION; EPITHELIAL SODIUM-CHANNEL; CORTICAL COLLECTING DUCT; SELECTIVE GOLGI EXPORT; RECTIFIER K+ CHANNELS; VIRUS TYPE-1 NEF; SORTING SIGNALS	The localization and density of Kir2.3 channels are influenced by the balance between PDZ protein interaction at the cell surface and routing into the endocytic pathway. Here, we explore mechanisms by which the Kir2.3 channel is directed into the endocytic pathway. We found that Kir2.3 channels are constitutively internalized from the cell surface in a dynamin- dependent manner, indicative of vesicle-mediated endocytosis. The rate of Kir2.3 endocytosis was dramatically attenuated following RNA interference-mediated knockdown of either alpha adaptin (AP-2 clathrin adaptor) or clathrin heavy chain, revealing that Kir2.3 is internalized by an AP-2 clathrin-dependent mechanism. Structure-rationalized mutagenesis studies of a number of different potential AP-2 interaction motifs indicate that internalization of Kir2.3 is largely dependent on a non-canonical di-isoleucine motif (II413) embedded within the C terminus. Internalization assays using CD4-Kir2.3 chimeras demonstrate that the di-isoleucine signal acts in an autonomous and transplantable manner. Kir2.3 co-immunoprecipitates with alpha adaptin, and disruption of the di-isoleucine motif decreased interaction of the channel with AP-2. Replacement of the di-isoleucine motif with a canonical di-leucine internalization signal actually blocked Kir2.3 endocytosis. Moreover, in yeast three-hybrid studies, the Kir2.3 di-isoleucine motif does not bind the AP-2 alpha C-sigma 2 hemi-complex in the way that has been recently observed for canonical di-leucine signals. Altogether, the results indicate that Kir2.3 channels are marked for clathrin-dependent internalization from the plasma membrane by a novel AP-2-dependent signal.	[Mason, Amanda K.; Jacobs, Brandiese E.; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Welling, PA (corresponding author), 655 W Baltimore St,BRB 5-029, Baltimore, MD 21201 USA.	pwelling@umaryland.edu			NIDDK NIH HHS [DK 063049] Funding Source: Medline; NIGMS NIH HHS [T32 GM 08181] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; Alewine C, 2007, AM J PHYSIOL-CELL PH, V293, pC1733, DOI 10.1152/ajpcell.00323.2007; Alewine C, 2006, MOL BIOL CELL, V17, P4200, DOI 10.1091/mbc.E06-02-0129; Baba T, 1995, COLD SPRING HARB SYM, V60, P235, DOI 10.1101/SQB.1995.060.01.027; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bremnes T, 1998, J BIOL CHEM, V273, P8638, DOI 10.1074/jbc.273.15.8638; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chalfant ML, 1999, J BIOL CHEM, V274, P32889, DOI 10.1074/jbc.274.46.32889; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Chu PY, 2003, AM J PHYSIOL-RENAL, V285, pF1179, DOI 10.1152/ajprenal.00150.2003; Coleman SH, 2005, J VIROL, V79, P2066, DOI 10.1128/JVI.79.4.2066-2078.2005; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Craig HM, 2000, VIROLOGY, V271, P9, DOI 10.1006/viro.2000.0277; Cremona O, 2001, J CELL SCI, V114, P1041; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; De Matteis MA, 2004, BBA-BIOMEMBRANES, V1666, P264, DOI 10.1016/j.bbamem.2004.07.002; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Flagg TP, 1999, J GEN PHYSIOL, V114, P685, DOI 10.1085/jgp.114.5.685; Geisler C, 1998, J BIOL CHEM, V273, P21316, DOI 10.1074/jbc.273.33.21316; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Hofmann MW, 1999, J BIOL CHEM, V274, P36153, DOI 10.1074/jbc.274.51.36153; Ihrke G, 2004, TRAFFIC, V5, P946, DOI 10.1111/j.1600-0854.2004.00236.x; Kamsteeg EJ, 2001, BIOCHEM BIOPH RES CO, V282, P683, DOI 10.1006/bbrc.2001.4629; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Le Maout S, 2001, P NATL ACAD SCI USA, V98, P10475, DOI 10.1073/pnas.181481098; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Millar ID, 2006, J MEMBRANE BIOL, V211, P173, DOI 10.1007/s00232-006-0036-z; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; O'Connell AD, 2005, P NATL ACAD SCI USA, V102, P9954, DOI 10.1073/pnas.0504332102; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Olsen O, 2002, AM J PHYSIOL-CELL PH, V282, pC183, DOI 10.1152/ajpcell.00249.2001; PALMER LG, 1994, J GEN PHYSIOL, V104, P693, DOI 10.1085/jgp.104.4.693; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Rappoport JZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1072, DOI 10.1152/ajpcell.00160.2006; Rappoport JZ, 2005, TRAFFIC, V6, P539, DOI 10.1111/j.1600-0854.2005.00280.x; Rodionov DG, 1998, J BIOL CHEM, V273, P6005, DOI 10.1074/jbc.273.11.6005; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; Schmidt U, 2006, J CELL SCI, V119, P2321, DOI 10.1242/jcs.02943; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Simmen T, 2002, NAT CELL BIOL, V4, P154, DOI 10.1038/ncb745; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Stockklausner C, 2003, J BIOL CHEM, V278, P17000, DOI 10.1074/jbc.M212243200; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Tong YH, 2001, J GEN PHYSIOL, V117, P103, DOI 10.1085/jgp.117.2.103; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Wang WH, 2006, AM J PHYSIOL-RENAL, V290, pF14, DOI 10.1152/ajprenal.00093.2005; Welling PA, 1997, AM J PHYSIOL-RENAL, V273, pF825, DOI 10.1152/ajprenal.1997.273.5.F825; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	68	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					5973	5984		10.1074/jbc.M709756200	http://dx.doi.org/10.1074/jbc.M709756200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18180291	hybrid			2022-12-27	WOS:000253779500002
J	Rontein, D; Onillon, S; Herbette, G; Lesot, A; Werck-Reichhart, D; Sallaud, C; Tissier, A				Rontein, Denis; Onillon, Sandrine; Herbette, Gaetan; Lesot, Agnes; Werck-Reichhart, Daniele; Sallaud, Christophe; Tissier, Alain			CYP725A4 from yew catalyzes complex structural rearrangement of taxa-4(5),11(12)-diene into the cyclic ether 5(12)-oxa-3(11)-cyclotaxane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAXUS-CANADENSIS NEEDLES; 1ST OXYGENATION STEP; TAXOL BIOSYNTHESIS; TAXADIENE SYNTHASE; YEAST EXPRESSION; METABOLISM; GENES; DITERPENOIDS; ARABIDOPSIS; ANTICANCER	Taxa-4(5),11(12)-diene is the first committed precursor of functionalized taxanes such as paclitaxel, a successful anticancer drug. Biosynthesis of taxanes in yew involves several oxidations, a number of which have been shown to be catalyzed by cytochrome P-450 oxygenases. Hydroxylation of the C-5 alpha of taxa-4(5),11(12)-diene is believed to be the first of these oxidations, and a gene encoding a taxa-4(5),11(12)-diene 5 alpha-hydroxylase (CYP725A4) was recently described (Jennewein, S., Long, R. M., Williams, R. M., and Croteau, R. (2004) Chem. Biol. 11, 379-387). In an attempt to produce the early components of the paclitaxel pathway by a metabolic engineering approach, cDNAs encoding taxa-4(5),11(12)-diene synthase and CYP725A4 were introduced in Nicotiana sylvestris for specific expression in trichome cells. Their co-expression did not lead to the production of the expected 5 alpha-hydroxytaxa-4(20),11(12)-diene. Instead, taxa-4(5),11(12)-diene was quantitatively converted to a novel taxane that was purified and characterized. Its structure was determined by NMR analysis and found to be that of 5(12)-oxa-3(11)-cyclotaxane (OCT) in which the eight-carbon B-ring from taxa-4(5), 11(12)-diene is divided into two fused five-carbon rings. In addition, OCT contains an ether bridge linking C-5 and C-12 from opposite sides of the molecule. OCT was also the sole major product obtained after incubation of taxa-4(5),11(12)-diene with NADPH and microsomes prepared from recombinant yeast expressing CYP725A4. The rearrangement of the taxa-4(5),11(12)-diene ring system is thus mediated by CYP725A4 only and does not rely on additional enzymes or factors present in the plant. The complex structure of OCT led us to propose a reaction mechanism involving a sequence of events so far unknown in P-450 catalysis.	[Rontein, Denis; Onillon, Sandrine; Sallaud, Christophe; Tissier, Alain] Ctr Cadarache, Librophyt, F-13115 St Paul Les Durance, France; [Herbette, Gaetan] Spectropole, F-13397 Marseille 20, France; [Lesot, Agnes; Werck-Reichhart, Daniele] Univ Strasbourg, CNRS UPR2357, Inst Plant Mol Biol, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Rontein, D (corresponding author), Ctr Cadarache, Librophyt, Batiment 185, F-13115 St Paul Les Durance, France.	denis.rontein@librophyt.com	WERCK-REICHHART, Danièle/U-3713-2019; Tissier, Alain F/B-2108-2017	WERCK-REICHHART, Danièle/0000-0003-2869-4262; Tissier, Alain F/0000-0002-9406-4245; RONTEIN, Denis/0000-0002-3288-3800; HERBETTE, Gaetan/0000-0002-3374-2508				APPENDINO G, 1992, PHYTOCHEMISTRY, V31, P4259, DOI 10.1016/0031-9422(92)80455-N; Baloglu E, 1999, J NAT PROD, V62, P1448, DOI 10.1021/np990176i; Besumbes O, 2004, BIOTECHNOL BIOENG, V88, P168, DOI 10.1002/bit.20237; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORMAN S, 1994, CHEM ENG NEWS, V72, P32, DOI 10.1021/cen-v072n008.p032; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; COMMERCON A, 1995, ACS SYM SER, V583, P233; CRAGG GM, 1993, J NAT PROD, V56, P1657, DOI 10.1021/np50100a001; DeJong JM, 2006, BIOTECHNOL BIOENG, V93, P212, DOI 10.1002/bit.20694; Goldspiel BR, 1997, PHARMACOTHERAPY, V17, pS110; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Hanson JR, 2001, NAT PROD REP, V18, P88, DOI 10.1039/b007477m; Hefner J, 1996, CHEM BIOL, V3, P479, DOI 10.1016/S1074-5521(96)90096-4; Hezari M, 1997, ARCH BIOCHEM BIOPHYS, V337, P185, DOI 10.1006/abbi.1996.9772; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Jennewein S, 2004, P NATL ACAD SCI USA, V101, P9149, DOI 10.1073/pnas.0403009101; Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022; Jennewein S, 2001, APPL MICROBIOL BIOT, V57, P13; Kovacs K, 2007, TRANSGENIC RES, V16, P121, DOI 10.1007/s11248-006-9039-x; KURONO M, 1963, TETRAHEDRON LETT, P2153; Meesters RJW, 2007, XENOBIOTICA, V37, P604, DOI 10.1080/00498250701393191; Nelson SD, 2003, DRUG METAB DISPOS, V31, P1481, DOI 10.1124/dmd.31.12.1481; NICOLAOU KC, 1994, NATURE, V367, P630, DOI 10.1038/367630a0; Petzke TL, 2004, J NAT PROD, V67, P1864, DOI 10.1021/np049836w; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Reilly CA, 2006, DRUG METAB REV, V38, P685, DOI 10.1080/03602530600959557; SALLAUD C, 2004, Patent No. 2005002530; SEVERSON RF, 1984, J AGR FOOD CHEM, V32, P566, DOI 10.1021/jf00123a037; Shi QW, 2004, CHEM COMMUN, P544, DOI 10.1039/b316051c; Shi QW, 2003, CHEM COMMUN, P68, DOI 10.1039/b209312j; SUFFNESS M, 1995, ACS SYM SER, V583, P1; TISSIER A, 2006, Patent No. 2006000188; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Walker K, 2001, PHYTOCHEMISTRY, V58, P1, DOI 10.1016/S0031-9422(01)00160-1; Wang EM, 2003, PLANTA, V216, P686, DOI 10.1007/s00425-002-0904-4; Wang EM, 2002, J EXP BOT, V53, P1891, DOI 10.1093/jxb/erf054; Wang EM, 2001, NAT BIOTECHNOL, V19, P371, DOI 10.1038/86770; Watson C, 2004, ENVIRON SCI TECHNOL, V38, P248, DOI 10.1021/es034535e; Wildung MR, 1996, J BIOL CHEM, V271, P9201, DOI 10.1074/jbc.271.16.9201; WOOLHOUSE HW, 1966, NEW PHYTOL, V65, P518, DOI 10.1111/j.1469-8137.1966.tb05975.x	41	61	69	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6067	6075		10.1074/jbc.M708950200	http://dx.doi.org/10.1074/jbc.M708950200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167342	hybrid			2022-12-27	WOS:000253779500012
J	Caillet-Saguy, C; Turano, P; Piccioli, M; Lukat-Rodgers, GS; Czjzek, M; Guigliarelli, B; Izadi-Pruneyre, N; Rodgers, KR; Delepierre, M; Lecroisey, A				Caillet-Saguy, Celia; Turano, Paola; Piccioli, Mario; Lukat-Rodgers, Gudrun S.; Czjzek, Mirjam; Guigliarelli, Bruno; Izadi-Pruneyre, Nadia; Rodgers, Kenton R.; Delepierre, Muriel; Lecroisey, Anne			Deciphering the structural role of histidine 83 for heme binding in hemophore HasA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; LOW-SPIN STATES; ELECTRONIC-STRUCTURE; SPECTROSCOPIC CHARACTERIZATION; THERMAL-EQUILIBRIUM; ACQUISITION-SYSTEM; PROXIMAL HISTIDINE; PROTEIN; NMR; LIGAND	Heme carrier HasA has a unique type of histidine/ tyrosine heme iron ligation in which the iron ion is in a thermally driven two spin states equilibrium. We recently suggested that the H-bonding between Tyr(75) and the invariantly conserved residue His(83) modulates the strength of the iron-Tyr(75) bond. To unravel the role of His(83), we characterize the iron ligation and the electronic properties of both wild type and H83A mutant by a variety of spectroscopic techniques. Although His(83) in wild type modulates the strength of the Tyr-iron bond, its removal causes detachment of the tyrosine ligand, thus giving rise to a series of pH-dependent equilibria among species with different axial ligation. The five coordinated species detected at physiological pH may represent a possible intermediate of the heme transfer mechanism to the receptor.	[Caillet-Saguy, Celia; Turano, Paola; Piccioli, Mario; Lukat-Rodgers, Gudrun S.; Czjzek, Mirjam; Guigliarelli, Bruno; Izadi-Pruneyre, Nadia; Rodgers, Kenton R.; Delepierre, Muriel; Lecroisey, Anne] CNRS, Inst Pasteur, URA 2185, Unite RMN Biomol, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Caillet-Saguy, C (corresponding author), CNRS, Inst Pasteur, URA 2185, Unite RMN Biomol, Paris, France.	ccaillet@pasteur.fr	Piccioli, Mario/M-1994-2015; Caillet-Saguy, Célia/AAC-1249-2022; Turano, Paola/F-9089-2011	Piccioli, Mario/0000-0001-9882-9754; Turano, Paola/0000-0002-7683-8614; Izadi-Pruneyre, Nadia/0000-0002-6864-2961	NCRR NIH HHS [P20RR15556] Funding Source: Medline; NIAID NIH HHS [1R15AI072719-01, R15 AI072719] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI072719] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI S, 1993, BIOCHEMISTRY-US, V32, P241, DOI 10.1021/bi00052a031; ANTONINI E, 1971, EUR J BIOCHEM, V23, P396, DOI 10.1111/j.1432-1033.1971.tb01633.x; Arnesano F, 2005, Q REV BIOPHYS, V38, P167, DOI 10.1017/S0033583506004161; Arnoux P, 1999, NAT STRUCT BIOL, V6, P516; Arnoux P, 2000, PROTEINS, V41, P202, DOI 10.1002/1097-0134(20001101)41:2<202::AID-PROT50>3.0.CO;2-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANCI L, 1995, CHEM BIOL, V2, P377, DOI 10.1016/1074-5521(95)90218-X; BANCI L, 1993, BIOPHYS J, V65, P806, DOI 10.1016/S0006-3495(93)81122-6; BERTINI I, 1990, ARCH BIOCHEM BIOPHYS, V282, P84, DOI 10.1016/0003-9861(90)90090-L; Bertini I, 2005, J AM CHEM SOC, V127, P12216, DOI 10.1021/ja051058m; BERTINI I, 1993, CHEM REV, V93, P2833, DOI 10.1021/cr00024a009; BERTINI I, 1986, NMR PARAMAGNETIC MOL; BETTLESTONE J, 1964, BIOCHEMISTRY-US, V3, P707; Caillet-Saguy C, 2006, J AM CHEM SOC, V128, P150, DOI 10.1021/ja054902h; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chu GC, 1999, J BIOL CHEM, V274, P24490, DOI 10.1074/jbc.274.35.24490; Das TK, 1999, BIOCHEMISTRY-US, V38, P15360, DOI 10.1021/bi991237e; Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; Heering HA, 2001, BIOCHEMISTRY-US, V40, P10360, DOI 10.1021/bi0106033; Howes BD, 1997, BIOCHEMISTRY-US, V36, P1532, DOI 10.1021/bi962502o; IIZUKA T, 1969, BIOCHIM BIOPHYS ACTA, V194, P351, DOI 10.1016/0005-2795(69)90096-8; IIZUKA T, 1969, BIOCHIM BIOPHYS ACTA, V181, P275, DOI 10.1016/0005-2795(69)90250-5; Indiani C, 2000, J AM CHEM SOC, V122, P7368, DOI 10.1021/ja000587h; ISHIKAWA K, 1995, J BIOL CHEM, V270, P6345, DOI 10.1074/jbc.270.11.6345; Izadi N, 1997, BIOCHEMISTRY-US, V36, P7050, DOI 10.1021/bi962577s; Izadi-Pruneyre N, 1999, EUR J BIOCHEM, V261, P562, DOI 10.1046/j.1432-1327.1999.00305.x; Izadi-Pruneyre N, 1999, J BIOMOL NMR, V14, P193, DOI 10.1023/A:1008308802821; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Jin YY, 2004, BIOCHEMISTRY-US, V43, P8517, DOI 10.1021/bi036170g; KELLER RM, 1972, P NATL ACAD SCI USA, V69, P2073, DOI 10.1073/pnas.69.8.2073; KRAUS DW, 1990, J BIOL CHEM, V265, P16054; LAMAR GN, 1980, J AM CHEM SOC, V102, P1822, DOI 10.1021/ja00526a011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LECOMTE JTJ, 1989, J MOL BIOL, V209, P235, DOI 10.1016/0022-2836(89)90275-1; LESLIE AGW, 1990, CRYSTALLOGRAPHIC COM, P50; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Letoffe S, 2003, MOL MICROBIOL, V50, P77, DOI 10.1046/j.1365-2958.2003.03686.x; Letoffe S, 1998, MOL MICROBIOL, V28, P1223, DOI 10.1046/j.1365-2958.1998.00885.x; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; Letoffe S, 2000, J BACTERIOL, V182, P4401, DOI 10.1128/JB.182.16.4401-4405.2000; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; Lukat-Rodgers GS, 1998, J BIOL INORG CHEM, V3, P274, DOI 10.1007/s007750050232; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MAURUS R, 1994, J BIOL CHEM, V269, P12606; MOTIE M, 1990, BIOCHEMISTRY-US, V29, P1932, DOI 10.1021/bi00459a038; Nagatomo S, 2002, BIOPHYS CHEM, V98, P217, DOI 10.1016/S0301-4622(02)00103-5; PANDE U, 1986, BIOCHEMISTRY-US, V25, P5638, DOI 10.1021/bi00367a044; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pond AE, 1999, BIOCHEMISTRY-US, V38, P7601, DOI 10.1021/bi9825448; QIN J, 1994, J BIOL CHEM, V269, P1083; Rossi MS, 2001, INFECT IMMUN, V69, P6707, DOI 10.1128/IAI.69.11.6707-6717.2001; SHARMA KD, 1989, J BIOL CHEM, V264, P12772; SONG SH, 1993, BIOCHEMISTRY-US, V32, P6330, DOI 10.1021/bi00076a005; Uchida T, 2004, J BIOL CHEM, V279, P51981, DOI 10.1074/jbc.M408963200; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; Wolff N, 2002, PROTEIN SCI, V11, P757, DOI 10.1110/ps.3630102; WU JZ, 1991, BIOCHEMISTRY-US, V30, P2156, DOI 10.1021/bi00222a020; YAMAMOTO Y, 1993, BIOCHIM BIOPHYS ACTA, V1203, P267, DOI 10.1016/0167-4838(93)90093-7; Yeh SR, 2000, J BIOL CHEM, V275, P1679, DOI 10.1074/jbc.275.3.1679	61	45	46	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5960	5970		10.1074/jbc.M703795200	http://dx.doi.org/10.1074/jbc.M703795200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18162469	hybrid			2022-12-27	WOS:000253426700074
J	Fukami, M; Wada, Y; Okada, M; Kato, F; Katsumata, N; Baba, T; Morohashi, K; Laporte, J; Kitagawa, M; Ogata, T				Fukami, Maki; Wada, Yuka; Okada, Michiyo; Kato, Fumiko; Katsumata, Noriyuki; Baba, Takashi; Morohashi, Ken-ichirou; Laporte, Jocelyn; Kitagawa, Motoo; Ogata, Tsutomu			Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTIGUOUS GENE SYNDROME; NOTCH SIGNALING PATHWAY; MYOTUBULAR MYOPATHY; STEROIDOGENIC FACTOR-1; REPRODUCTIVE FUNCTION; DROSOPHILA-HAIRY; TRANSCRIPTION; MASTERMIND; IDENTIFICATION; EXPRESSION	Although chromosome X open reading frame 6 (CXorf6) has been shown to be a causative gene for hypospadias, its molecular function remains unknown. To clarify this, we first examined CXorf6 protein structure, identifying homology to mastermind-like 2 (MAML2) protein, which functions as a co-activator in canonical Notch signaling. Transactivation analysis for wildtype CXorf6 protein by luciferase assays showed that CXorf6 significantly transactivated the promoter of a noncanonical Notch target gene hairy/enhancer of split 3 (Hes3) without demonstrable DNA-binding capacity. Transactivation analysis was also performed for the previously described three apparently pathologic nonsense mutations, indicating that E124X and Q197X proteins had no transactivation function, whereas R653X protein retained a nearly normal transactivation function. Subcellular localization analysis revealed that wild-type and R653X proteins co-localized with MAML2 protein in nuclear bodies, whereas E124X and Q197X proteins were incapable of localizing to nuclear bodies. Thus, further studies were performed for R653X, revealing the occurrence of nonsense mediated mRNA decay in vivo. Next, transient knockdown of CXorf6 was performed using small interfering RNA, showing reduced testosterone production in mouse Leydig tumor cells. Furthermore, steroidogenic factor 1 (SF1) protein bound to a specific sequence in the upstream of the CXorf6 coding region and exerted a transactivation activity. These results suggest that CXorf6 transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence, thereby providing the first clue to clarify the biological role of CXorf6. We designate CXorf6 as MAMLD1 (mastermind-like domain-containing 1) based on its characteristic structure.	[Fukami, Maki; Wada, Yuka; Okada, Michiyo; Kato, Fumiko; Katsumata, Noriyuki; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Tokyo 1578535, Japan; [Baba, Takashi; Morohashi, Ken-ichirou] Natl Inst Basic Biol, Div Sex Differentiat, Okazaki, Aichi 4448787, Japan; [Laporte, Jocelyn] Inst Genet & Biol Mol & Cellulaire, Dept Mol Pathol, F-67404 Illkirch Graffenstaden, France; [Kitagawa, Motoo] Chiba Univ, Grad Sch Med, Dept Mol & Tumor Pathol, Chiba 260, Japan	National Center for Child Health & Development - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Chiba University	Fukami, M (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Tokyo 1578535, Japan.	mfukami@nch.go.jp	laporte, jocelyn/J-7008-2012; Laporte, Jocelyn/H-6801-2016; Kitagawa, Motoo/W-8468-2019; Fukami, Maki/ABE-4694-2020; Baba, Takashi/ABI-2727-2020; laporte, jocelyn/O-4888-2019	Kitagawa, Motoo/0000-0003-1036-840X; Fukami, Maki/0000-0001-9971-4035; Ogata, Tsutomu/0000-0001-7178-9991				Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bartsch O, 1999, CYTOGENET CELL GENET, V85, P310, DOI 10.1159/000015284; Baskin LS, 2006, J PEDIATR SURG, V41, P463, DOI 10.1016/j.jpedsurg.2005.11.059; Freddi S, 2000, AM J MED GENET, V90, P398, DOI 10.1002/(SICI)1096-8628(20000228)90:5<398::AID-AJMG10>3.3.CO;2-Z; Fukami M, 2006, NAT GENET, V38, P1369, DOI 10.1038/ng1900; Grumbach M. M., 2002, WILLIAMS TXB ENDOCRI, P842; Hu LJ, 1996, HUM MOL GENET, V5, P139, DOI 10.1093/hmg/5.1.139; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Laporte J, 1997, GENOMICS, V41, P458, DOI 10.1006/geno.1997.4662; Lin SE, 2002, J BIOL CHEM, V277, P50612, DOI 10.1074/jbc.M209529200; Liu Z, 1997, MOL ENDOCRINOL, V11, P127, DOI 10.1210/me.11.2.127; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998; Morohashi KI, 1996, FASEB J, V10, P1569, DOI 10.1096/fasebj.10.14.9002548; Muroya K, 1999, AM J MED GENET, V84, P384, DOI 10.1002/(SICI)1096-8628(19990604)84:4<384::AID-AJMG17>3.0.CO;2-T; Murphy K, 2005, GENE EXPR PATTERNS, V5, P475, DOI 10.1016/j.modgep.2004.12.007; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; Ozisik G, 2002, MOL GENET METAB, V76, P85, DOI 10.1016/S1096-7192(02)00032-X; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Panesar NS, 2003, STEROIDS, V68, P245, DOI 10.1016/S0039-128X(02)00183-6; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Shimizu K, 2002, BIOCHEM BIOPH RES CO, V291, P775, DOI 10.1006/bbrc.2002.6528; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	34	54	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5525	5532		10.1074/jbc.M703289200	http://dx.doi.org/10.1074/jbc.M703289200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18162467	hybrid			2022-12-27	WOS:000253426700033
J	Vodnala, M; Fijolek, A; Rofougaran, R; Mosimann, M; Maser, P; Hofer, A				Vodnala, Munender; Fijolek, Artur; Rofougaran, Reza; Mosimann, Marc; Maser, Pascal; Hofer, Anders			Adenosine kinase mediates high affinity adenosine salvage in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; TOXOPLASMA-GONDII; RIBONUCLEOTIDE REDUCTION; AFRICAN TRYPANOSOMES; DEAMINASE INHIBITORS; KINETIC MECHANISM; PURINE METABOLISM; PENTAVALENT IONS; N-RIBOHYDROLASE; IN-VITRO	African sleeping sickness is caused by Trypanosoma brucei. This extracellular parasite lacks de novo purine biosynthesis, and it is therefore dependent on exogenous purines such as adenosine that is taken up from the blood and other body fluids by high affinity transporters. The general belief is that adenosine needs to be cleaved to adenine inside the parasites in order to be used for purine nucleotide synthesis. We have found that T. brucei also can salvage this nucleoside by adenosine kinase (AK), which has a higher affinity to adenosine than the cleavage-dependent pathway. The recombinant T. brucei AK (TbAK) preferably used ATP or GTP to phosphorylate both natural and synthetic nucleosides in the following order of catalytic efficiencies: adenosine > cordycepin > deoxyadenosine > adenine arabinoside (Ara-A) > inosine > fludarabine (F-Ara-A). TbAK differed from the AK of the related intracellular parasite Leishmania donovani by having a high affinity to adenosine (K-m = 0.04-0.08 mu M depending on [phosphate]) and by being negatively regulated by adenosine (K-i = 8-14 mu M). These properties make the enzyme functionally related to the mammalian AKs, although a phylogenetic analysis grouped it together with the L. donovani enzyme. The combination of a high affinity AK and efficient adenosine transporters yields a strong salvage system in T. brucei, a potential Achilles' heel making the parasites more sensitive than mammalian cells to adenosine analogs such as Ara-A. Studies of wild-type and AK knockdown trypanosomes showed that Ara-A inhibited parasite proliferation and survival in an AK-dependent manner by affecting nucleotide levels and by inhibiting nucleic acid biosynthesis.	[Vodnala, Munender; Fijolek, Artur; Rofougaran, Reza; Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Mosimann, Marc; Maser, Pascal] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland	Umea University; University of Bern	Hofer, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	anders.hofer@medchem.umu.se		Hofer, Anders/0000-0003-2890-2957; Vodnala, Munender/0000-0002-6219-6243; Maser, Pascal/0000-0003-3122-1941				ANDRES CM, 1979, J BIOL CHEM, V254, P1388; Barrett MP, 2006, LANCET, V367, P1377, DOI 10.1016/S0140-6736(06)68591-7; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BLATT J, 1982, J NATL CANCER I, V68, P391; BRUN R, 1999, KARGER GAZETTE, V63, P5; CARTER NS, 1993, NATURE, V361, P173, DOI 10.1038/361173a0; CASS CE, 1979, CANCER RES, V39, P1563; CASS CE, 1983, CANCER RES, V43, P4791; CHAN VL, 1981, SOMAT CELL GENET, V7, P147; Darling JA, 1999, MOL BIOCHEM PARASIT, V103, P15, DOI 10.1016/S0166-6851(99)00109-7; DATTA AK, 1987, J BIOL CHEM, V262, P5515; DAVIES MJ, 1983, PARASITOLOGY, V87, P211, DOI 10.1017/S0031182000052574; de Koning HP, 1998, J BIOL CHEM, V273, P9486, DOI 10.1074/jbc.273.16.9486; el Kouni MH, 2003, PHARMACOL THERAPEUT, V99, P283, DOI 10.1016/S0163-7258(03)00071-8; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; HASSAN HF, 1986, COMP BIOCHEM PHYS B, V84, P217, DOI 10.1016/0305-0491(86)90209-9; HIRUMI H, 1980, PARASITOLOGY, V80, P371, DOI 10.1017/S0031182000000822; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hofer A, 1997, P NATL ACAD SCI USA, V94, P6959, DOI 10.1073/pnas.94.13.6959; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; HURLEY MC, 1985, J BIOL CHEM, V260, P5675; IVES DH, 1969, ANAL BIOCHEM, V28, P192, DOI 10.1016/0003-2697(69)90170-5; JABS CM, 1990, CLIN CHEM, V36, P81; Johnson SA, 2000, CLIN PHARMACOKINET, V39, P5, DOI 10.2165/00003088-200039010-00002; KUFE DW, 1983, CANCER RES, V43, P2000; Luscher A, 2007, ANTIMICROB AGENTS CH, V51, P3895, DOI 10.1128/AAC.00458-07; Maj M, 2000, BBA-PROTEIN STRUCT M, V1476, P33, DOI 10.1016/S0167-4838(99)00220-4; Maj MC, 2002, BIOCHEMISTRY-US, V41, P4059, DOI 10.1021/bi0119161; MOORE EC, 1967, J BIOL CHEM, V242, P2116; NICANDER B, 1985, J BIOL CHEM, V260, P5376; OGBUNUDE POJ, 1983, MOL BIOCHEM PARASIT, V9, P279, DOI 10.1016/0166-6851(83)90084-1; ONTYD J, 1984, J CHROMATOGR, V307, P404, DOI 10.1016/S0378-4347(00)84113-4; PALELLA TD, 1980, J BIOL CHEM, V255, P5264; Park J, 2004, PROTEIN J, V23, P167, DOI 10.1023/B:JOPC.0000020083.81718.55; Parkin DW, 1996, J BIOL CHEM, V271, P21713, DOI 10.1074/jbc.271.36.21713; Pelle R, 1998, J BIOL CHEM, V273, P2118, DOI 10.1074/jbc.273.4.2118; PFEFFERKORN ER, 1976, J PARASITOL, V62, P993, DOI 10.2307/3279197; PFEFFERKORN ER, 1978, J PARASITOL, V64, P486, DOI 10.2307/3279789; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Rottenberg ME, 2005, J INFECT DIS, V192, P1658, DOI 10.1086/496896; Sahin B, 2004, EUR J BIOCHEM, V271, P3547, DOI 10.1111/j.1432-1033.2004.04291.x; SARUP JC, 1987, BIOCHEMISTRY-US, V26, P590, DOI 10.1021/bi00376a034; SLOWIACZEK P, 1982, ANAL BIOCHEM, V125, P6, DOI 10.1016/0003-2697(82)90376-1; Spychala J, 1996, P NATL ACAD SCI USA, V93, P1232, DOI 10.1073/pnas.93.3.1232; Thorn JA, 1996, GEN PHARMACOL, V27, P613, DOI 10.1016/0306-3623(95)02053-5; VERHOEF V, 1981, CANCER RES, V41, P4478; WHITLEY R, 1981, ANNU REV MED, V32, P335, DOI 10.1146/annurev.me.32.020181.002003	47	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5380	5388		10.1074/jbc.M705603200	http://dx.doi.org/10.1074/jbc.M705603200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167353	hybrid			2022-12-27	WOS:000253426700018
J	Bhattacharyya, S; Gill, R; Chen, ML; Zhang, F; Linhardt, RJ; Dudeja, PK; Tobacman, JK				Bhattacharyya, Sumit; Gill, Ravinder; Chen, Mei Ling; Zhang, Fuming; Linhardt, Robert J.; Dudeja, Pradeep K.; Tobacman, Joanne K.			Toll-like receptor 4 mediates induction of the Bcl10-NF kappa B-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; NF-KAPPA-B; ENDOTOXIN HYPORESPONSIVENESS; SIGNALING PATHWAYS; INSULIN-RESISTANCE; INNATE IMMUNITY; POLYMYXIN-B; LIPOPOLYSACCHARIDE; BCL10; ACTIVATION	The sulfated polysaccharide carrageenan (CGN) induces activation of NF kappa B and interleukin 8 (IL-8) in human colonic epithelial cells through a pathway of innate immunity mediated by Bcl10 (B-cell CLL/lymphoma 10). In this report, we identify Toll-like receptor 4 (TLR4), a member of the family of innate immune receptors, as the surface membrane receptor for CGN in human colonic epithelial cells. Experiments with fluorescence-tagged CGN demonstrated a marked reduction in binding of CGN to human intestinal epithelial cells and to RAW 264.7 mouse macrophages, following exposure to TLR4 blocking antibody (HTA-125). Binding of CGN to 10ScNCr/23 mouse macrophages, which are deficient in the genetic locus for TLR4, was absent. Additional experiments with TLR4 blocking antibody and TLR4 small interfering RNAs showed 80% reductions in CGN-induced increases in Bcl10 and IL-8. Transfection with dominant-negative MyD88 plasmid demonstrated MyD88 dependence of the CGN-TLR4-triggered increases in Bcl10 and IL-8. Therefore, these results indicate that CGN-induced inflammation in human colonocytes proceeds through a pathway of innate immunity, perhaps related to the unusual alpha-1,3-galactosidic linkage characteristic of CGN, and suggest how dietary CGN intake may contribute to human intestinal inflammation. Because CGN is a commonly used food additive in the Western diet, clarification of its effects and mechanisms of action are vital to issues of food safety.	[Bhattacharyya, Sumit; Gill, Ravinder; Dudeja, Pradeep K.; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Chen, Mei Ling] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Dudeja, Pradeep K.; Tobacman, Joanne K.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Zhang, Fuming] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Rensselaer Polytechnic Institute	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, 840 S Wood St,M C 718 440 Clin Sci N, Chicago, IL 60612 USA.	jkt@uic.edu			NHLBI NIH HHS [R01 HL062244, R01 HL062244-05A1, R01 HL052622-05, R01 HL052622] Funding Source: Medline; NIDDK NIH HHS [R01 DK054016, DK54016, P01 DK067887, R01 DK068324, DK68324] Funding Source: Medline; NIGMS NIH HHS [R01 GM038060, R01 GM038060-19] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062244, R01HL052622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054016, R01DK068324, P01DK067887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bhattacharyya S, 2007, J IMMUNOASS IMMUNOCH, V28, P173, DOI 10.1080/15321810701454573; Bhattacharyya S, 2007, AM J PHYSIOL-GASTR L, V293, pG429, DOI 10.1152/ajpgi.00149.2007; Bocker U, 2003, INT J COLORECTAL DIS, V18, P25, DOI 10.1007/s00384-002-0415-6; Borthakur A, 2007, AM J PHYSIOL-GASTR L, V292, pG829, DOI 10.1152/ajpgi.00380.2006; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Dong W, 2006, J BIOL CHEM, V281, P26029, DOI 10.1074/jbc.M513057200; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Gewirtz AT, 2003, CURR PHARM DESIGN, V9, P1, DOI 10.2174/1381612033392422; GLABE CG, 1983, ANAL BIOCHEM, V130, P287, DOI 10.1016/0003-2697(83)90590-0; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; *JOINT FAO WHO EXP, 2007, SUMM CONCL 68 M JOIN, P1; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Lin WJ, 2005, SHOCK, V24, P206, DOI 10.1097/01.shk.0000180074.69143.77; Lorenz E, 2002, INFECT IMMUN, V70, P4892, DOI 10.1128/IAI.70.9.4892-4896.2002; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Naik S, 2001, J PEDIATR GASTR NUTR, V32, P449, DOI 10.1097/00005176-200104000-00011; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Osman N, 1997, P NATL ACAD SCI USA, V94, P14677, DOI 10.1073/pnas.94.26.14677; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.020; Sandrin Mauro S., 1997, Frontiers in Bioscience (online), V2, pE1; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Tanemura M, 2000, J CLIN INVEST, V105, P301, DOI 10.1172/JCI7358; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Toiyama Y, 2006, SURG TODAY, V36, P287, DOI 10.1007/s00595-005-3144-y; Tsubery H, 2000, BIOCHEMISTRY-US, V39, P11837, DOI 10.1021/bi000386q; Tsuji RF, 2003, CLIN EXP ALLERGY, V33, P249, DOI 10.1046/j.1365-2222.2003.01575.x; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Tsuzuki H, 2001, J SURG RES, V100, P127, DOI 10.1006/jsre.2001.6227; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Yokoyama T, 2006, LIVER INT, V26, P467, DOI 10.1111/j.1478-3231.2006.01254.x; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005	47	121	125	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10550	10558		10.1074/jbc.M708833200	http://dx.doi.org/10.1074/jbc.M708833200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18252714	Green Published, hybrid			2022-12-27	WOS:000254894700037
J	Bolourani, P; Spiegelman, GB; Weeks, G				Bolourani, Parvin; Spiegelman, George B.; Weeks, Gerald			Rap1 activation in response to cAMP occurs downstream of Ras activation during Dictyostelium aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; CELL-MOVEMENT; MOLECULAR-GENETICS; SMALL GTPASES; LEADING-EDGE; CHEMOTAXIS; DISCOIDEUM; PROTEIN; MOTILITY; RECEPTOR	We have used a doubly disrupted rasC(-)/rasG(-) strain of Dictyostelium discoideum, which ectopically expresses the carA gene, to explore the relationship between the activation of RasC and RasG, the two proteins that are necessary for optimum cAMP signaling, and the activation of Rap1, a Ras subfamily protein, that is also activated by cAMP. The ectopic expression of carA restored early developmental gene expression to the rasC(-)/rasG(-) strain, rendering it suitable for an analysis of cAMP signal transduction. Because there was negligible signaling through both the cAMP chemotactic pathway and the adenylyl cyclase activation pathway in the rasC(-)/rasG(-)/[act15]:carA strain, it is clear that RasG and RasC are the only two Ras subfamily proteins that directly control these pathways. The position of Rap1 in the signal transduction cascade was clarified by the finding that Rap1 activation was totally abolished in rasC(-)/rasG(-)/[act15]: carA and rasG(-) cells but only slightly reduced in rasC(-) cells. Rap1 activation, therefore, occurs downstream of the Ras proteins and predominantly, if not exclusively, downstream of RasG. The finding that in vitro guanylyl cyclase activation is also abolished in the rasC(-)/rasG(-)/[act15]: carA strain identifies RasGRasC as the presumptive monomeric GTPases required for this activation.	[Bolourani, Parvin; Spiegelman, George B.; Weeks, Gerald] Univ British Columbia, Life Sci Ctr, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Weeks, G (corresponding author), Univ British Columbia, Life Sci Ctr, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	gerwee@interchange.ubc.ca						Alibaud L, 2003, BIOTECHNIQUES, V35, P78, DOI 10.2144/03351st03; Bolourani P, 2006, MOL BIOL CELL, V17, P4543, DOI 10.1091/mbc.E05-11-1019; Bosgraaf L, 2002, J MUSCLE RES CELL M, V23, P781, DOI 10.1023/A:1024431813040; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Chubb JR, 2000, J CELL SCI, V113, P709; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Huang YE, 2003, MOL BIOL CELL, V14, P1913, DOI 10.1091/mbc.E02-10-0703; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Jeon TJ, 2007, J CELL BIOL, V176, P1021, DOI 10.1083/jcb.200607072; JOHNSON RL, 1991, BIOCHEMISTRY-US, V30, P6982, DOI 10.1021/bi00242a025; Kae H, 2004, EMBO REP, V5, P602, DOI 10.1038/sj.embor.7400151; Kae H, 2007, EMBO REP, V8, P477, DOI 10.1038/sj.embor.7400936; Kang RJ, 2002, J CELL SCI, V115, P3675, DOI 10.1242/jcs.00039; Kessin RH., 2001, DICTYOSTELIUM EVOLUT, P1; Kimmel AR, 2003, SCIENCE, V300, P1525, DOI 10.1126/science.1085439; Kortholt A, 2006, J BIOL CHEM, V281, P23367, DOI 10.1074/jbc.M600804200; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Lim CJ, 2005, EXP CELL RES, V306, P47, DOI 10.1016/j.yexcr.2005.02.002; Lim CJ, 2001, EMBO J, V20, P4490, DOI 10.1093/emboj/20.16.4490; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; REBSTEIN PJ, 1993, DEV GENET, V14, P347, DOI 10.1002/dvg.1020140504; Rebstein PJ, 1997, EXP CELL RES, V231, P276, DOI 10.1006/excr.1996.3466; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; ROBBINS SM, 1989, P NATL ACAD SCI USA, V86, P938, DOI 10.1073/pnas.86.3.938; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; SNAARJAGALSKA BE, 1994, METHOD ENZYMOL, V237, P387; Takeda K, 2007, J BIOL CHEM, V282, P11874, DOI 10.1074/jbc.M610984200; THEIBERT A, 1986, J BIOL CHEM, V261, P5121; Tuxworth RI, 1997, J CELL BIOL, V138, P605, DOI 10.1083/jcb.138.3.605; vanHaastert PJM, 1997, FEBS LETT, V410, P25, DOI 10.1016/S0014-5793(97)00416-X; VANHAASTERT PJM, 1983, J BIOL CHEM, V258, P9636; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Weeks G., 2005, DICTYOSTELIUM GENOMI, P211; Wessels D, 2004, EUKARYOT CELL, V3, P646, DOI 10.1128/EC.3.3.646-662.2004; Wilkins A, 2000, GENE DEV, V14, P1407; Wilkins A, 2001, TRENDS GENET, V17, P41, DOI 10.1016/S0168-9525(00)02181-8; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667	51	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10232	10240		10.1074/jbc.M707459200	http://dx.doi.org/10.1074/jbc.M707459200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18180289	hybrid			2022-12-27	WOS:000254894700004
J	Gerson, KD; Foster, CD; Zhang, P; Zhang, ZG; Rosenblatt, MM; Guttentag, SH				Gerson, Kristin D.; Foster, Cherie D.; Zhang, Peggy; Zhang, Zhenguo; Rosenblatt, Michael M.; Guttentag, Susan H.			Pepsinogen C proteolytic processing of surfactant protein B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMELLAR BODY FORMATION; IN-VITRO; LUNG; GASTRICSIN; DEFICIENCY; EXPRESSION; NAPSIN; MICE	Surfactant protein B (SP-B) is essential to the function of pulmonary surfactant and to lamellar body genesis in alveolar epithelial type 2 cells. The bioactive, mature SP-B is derived from multistep post-translational proteolysis of a larger proprotein. The identity of the proteases involved in carboxyl-terminal cleavage of proSP-B remains uncertain. This cleavage event distinguishes SP-B production in type 2 cells from less complete processing in bronchiolar Clara cells. We previously identified pepsinogen C as an alveolar type 2 cell-specific protease that was developmentally regulated in the human fetal lung. We report that pepsinogen C cleaved recombinant proSP-B at Met(302) in addition to an amino-terminal cleavage at Ser(197). Using a well described model of type 2 cell differentiation, small interfering RNA knockdown of pepsinogen C inhibited production of mature SP-B, whereas overexpression of pepsinogen C increased SP-B production. Inhibition of SP-B production recapitulated the SP-B-deficient phenotype evident by aberrant lamellar body genesis. Together, these data support a primary role for pepsinogen C in SP-B proteolytic processing in alveolar type 2 cells.	[Gerson, Kristin D.; Foster, Cherie D.; Zhang, Peggy; Zhang, Zhenguo; Guttentag, Susan H.] Univ Penn, Sch Med, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA; [Rosenblatt, Michael M.] Childrens Hosp Philadelphia, Protein Core Facil, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Guttentag, SH (corresponding author), Childrens Hosp Philadelphia, Abraham Res Ctr 416G, 3516 Civic Ctr Blvd, Philadelphia, PA 19104 USA.	guttentag@email.chop.edu	Guttentag, Susan/ABE-7405-2020; Guttentag, Susan H/D-8705-2013	Guttentag, Susan/0000-0003-4420-5879; Guttentag, Susan H/0000-0003-4420-5879	NHLBI NIH HHS [HL059959, HL077226, R01 HL059959] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059959, R56HL059959] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brasch F, 2003, J BIOL CHEM, V278, P49006, DOI 10.1074/jbc.M306844200; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; DEMELLO DE, 1994, AM J RESP CELL MOL, V11, P230, DOI 10.1165/ajrcmb.11.2.8049084; DIEZITZA I, 1993, BRIT J CANCER, V68, P637, DOI 10.1038/bjc.1993.399; ELJKING EP, 1991, EUR RESPIR J, V4, P1245; Foster C, 2004, AM J PHYSIOL-LUNG C, V286, pL382, DOI 10.1152/ajplung.00310.2003; Foster CD, 2003, AM J RESP CELL MOL, V29, P259, DOI 10.1165/rcmb.2002-0149OC; Foster CD, 2007, PEDIATR RES, V61, P404, DOI 10.1203/pdr.0b013e3180332c6d; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Gunther A, 1996, AM J RESP CRIT CARE, V153, P176; Guttentag S, 2003, AM J RESP CELL MOL, V28, P69, DOI 10.1165/rcmb.2002-0111OC; Guttentag SH, 1998, AM J PHYSIOL-LUNG C, V275, pL559, DOI 10.1152/ajplung.1998.275.3.L559; Hawgood S, 1998, BBA-MOL BASIS DIS, V1408, P150, DOI 10.1016/S0925-4439(98)00064-7; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HUANG WY, 1969, J BIOL CHEM, V244, P1085; Ingenito EP, 2001, AM J RESP CELL MOL, V25, P35, DOI 10.1165/ajrcmb.25.1.4021; Kageyama T, 2002, CELL MOL LIFE SCI, V59, P288, DOI 10.1007/s00018-002-8423-9; Korimilli A, 2000, J BIOL CHEM, V275, P8672, DOI 10.1074/jbc.275.12.8672; Lin S, 1996, J BIOL CHEM, V271, P19689, DOI 10.1074/jbc.271.33.19689; Nesslein LL, 2005, AM J PHYSIOL-LUNG C, V288, pL1154, DOI 10.1152/ajplung.00392.2004; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Powers J C, 1977, Adv Exp Med Biol, V95, P141; RYLE AP, 1960, BIOCHEM J, V75, P145, DOI 10.1042/bj0750145; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sorensen OE, 2003, J BIOL CHEM, V278, P28540, DOI 10.1074/jbc.M301608200; Stahlman MT, 2000, LAB INVEST, V80, P395, DOI 10.1038/labinvest.3780044; TANG J, 1959, J BIOL CHEM, V234, P1174; Ueno T, 2004, J BIOL CHEM, V279, P16178, DOI 10.1074/jbc.M312029200; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Weaver TE, 1998, BBA-MOL BASIS DIS, V1408, P173, DOI 10.1016/S0925-4439(98)00066-0; Zaltash S, 1998, FEBS LETT, V423, P1, DOI 10.1016/S0014-5793(97)01582-2; Zhai YF, 2000, BBA-REV BIOMEMBRANES, V1469, P87, DOI 10.1016/S0304-4157(00)00003-4	33	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10330	10338		10.1074/jbc.M707516200	http://dx.doi.org/10.1074/jbc.M707516200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18256027	hybrid, Green Published			2022-12-27	WOS:000254894700013
J	Park, SY; Kang, KB; Thapa, N; Kim, SY; Lee, SJ; Kim, IS				Park, Seung-Yoon; Kang, Kae-Bok; Thapa, Narendra; Kim, Sang-Yeob; Lee, Sung-Jin; Kim, In-San			Requirement of adaptor protein GULP during stabilin-2-mediated cell corpse engulfment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; APOPTOTIC CELLS; CAENORHABDITIS-ELEGANS; HYALURONAN RECEPTOR; CRKII/DOCK180/RAC PATHWAY; ENDOTHELIAL-CELLS; PTB-DOMAIN; CED-6; PHAGOCYTOSIS; IDENTIFICATION	The prompt clearance of cells undergoing apoptosis is critical during embryonic development and normal tissue turnover, as well as during inflammation and autoimmune responses. We recently demonstrated that stabilin-2 is a phosphatidylserine receptor that mediates the clearance of apoptotic cells, thereby releasing the anti-inflammatory cytokine, transforming growth factor-beta. However, the downstream signaling components of stabilin-2-mediated phagocytosis are not known. Here, we provide evidence that the adaptor protein, GULP, physically and functionally interacts with the stabilin-2 cytoplasmic tail. Using fluorescent resonance energy transfer analysis and biochemical approaches, we show that GULP directly binds to the cytoplasmic tail of stabilin-2. Knockdown of endogenous GULP expression significantly decreased stabilin-2-mediated phagocytosis. Conversely, overexpression of GULP caused an increase in aged cell engulfment. The phosphotyrosine binding (PTB) domain of GULP was sufficient for the interaction with stabilin-2; therefore, transduction of TAT fusion PTB domain acts as a dominant negative, resulting in impaired engulfment of aged red blood cells in stabilin-2 expressing cells. In addition, the PTB domain of GULP was able to specifically interact with the NPXY motif of the stabilin-2 cytoplasmic tail. Taken together, these results indicate that GULP is a likely downstream molecule in the stabilin-2-mediated signaling pathway and plays an important role in stabilin-2-mediated phagocytosis.	[Kang, Kae-Bok; Thapa, Narendra; Kim, Sang-Yeob; Lee, Sung-Jin; Kim, In-San] Kyungpook Natl Univ, Sch Med, Cell & Matrix Res Inst, Dept Biochem & Cell Biol, Jung 700422, Daegu, South Korea; [Park, Seung-Yoon] Dongguk Univ, Sch Med, Dept Biochem, Kyungju 780714, South Korea	Kyungpook National University; Dongguk University	Kim, IS (corresponding author), Kyungpook Natl Univ, Sch Med, Cell & Matrix Res Inst, Dept Biochem & Cell Biol, 101 Dongin Dong, Jung 700422, Daegu, South Korea.	iskim@knu.ac.kr	김, 인산/I-8988-2014; Kim, In-San/D-3956-2017					Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; ELLIS RE, 1991, GENETICS, V129, P79; GIGLI I, 1968, EXP CELL RES, V51, P45, DOI 10.1016/0014-4827(68)90158-4; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Kim JE, 2000, J BIOL CHEM, V275, P30907, DOI 10.1074/jbc.M002752200; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Liu QA, 1999, CURR BIOL, V9, P1347, DOI 10.1016/S0960-9822(00)80061-5; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Ma Z, 2007, CURR BIOL, V17, P722, DOI 10.1016/j.cub.2007.03.014; McCourt PAG, 1999, HEPATOLOGY, V30, P1276, DOI 10.1002/hep.510300521; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Siegal G, 1999, NAT STRUCT BIOL, V6, P7, DOI 10.1038/4873; Smits E, 1999, CURR BIOL, V9, P1351, DOI 10.1016/S0960-9822(00)80062-7; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Su HP, 2000, J BIOL CHEM, V275, P9542, DOI 10.1074/jbc.275.13.9542; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Suzuki E, 2007, EXP CELL RES, V313, P3729, DOI 10.1016/j.yexcr.2007.06.015; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	34	65	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10593	10600		10.1074/jbc.M709105200	http://dx.doi.org/10.1074/jbc.M709105200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18230608	hybrid			2022-12-27	WOS:000254894700041
J	Hsu, JL; Chen, HC; Peng, HL; Chang, HY				Hsu, Jye-Lin; Chen, Hsuan-Cheng; Peng, Hwei-Ling; Chang, Hwan-You			Characterization of the histidine-containing phosphotransfer protein B-mediated multistep phosphorelay system in Pseudomonas aeruginosa PAO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; ESCHERICHIA-COLI; SERINE/THREONINE KINASE; SIGNAL-TRANSDUCTION; BACILLUS-SUBTILIS; TRANSCRIPTION FACTOR; 2-COMPONENT SYSTEMS; PHOSPHATASE 2C; EXPRESSION; VIRULENCE	Certain bacterial two-component sensor kinases possess a histidine-containing phosphotransfer (Hpt) domain to carry out a multistep phosphotransferring reaction to a cognate response regulator. Pseudomonas aeruginosa PAO1 contains three genes that encode proteins with an Hpt domain but lack a kinase domain. To identify the sensor kinase coupled to these Hpt proteins, a phosphorelay profiling assay was performed. Among the 12 recombinant orphan sensor kinases tested, 4 of these sensors (PA1611, PA1976, PA2824, and RetS) transferred the phosphoryl group to HptB (PA3345). The in vivo interaction between HptB and each of the sensors was also confirmed using the bacterial two-hybrid assay. Interestingly, the phosphoryl groups from these sensors all appeared to be transferred via HptB to PA3346, a novel phosphatase consisting of an N-terminal receiver domain and a eukaryotic type Ser/Thr phosphatase domain, and resulted in a significant increase of its phosphatase activity. The subsequent reverse transcription-PCR analysis revealed an operon structure of hptB-PA3346-PA3347, suggesting a coordinate expression of the three genes to carry out a signal transduction. The possibility was supported by the analysis showing PA3347 is able to be phosphorylated on Ser-56, and this phosphoryl group could be removed by PA3346 protein. Finally, analysis of PA3346 and PA3347 gene knock-out mutants revealed that these genes are associated with bacterial swarming activity and biofilm formation. Together, these results disclose a novel multistep phosphorelay system that is essential for P. aeruginosa to respond to a wide spectrum of environmental signals.	[Hsu, Jye-Lin; Chen, Hsuan-Cheng; Chang, Hwan-You] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 300, Taiwan; [Peng, Hwei-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Tsing Hua University; National Yang Ming Chiao Tung University	Chang, HY (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, 101 Guang Fu Rd 2nd Sec, Hsinchu 300, Taiwan.	hychang@life.nthu.edu.tw	Hsu, Jye-Lin/N-3641-2013					Adler E, 1997, MOL MICROBIOL, V23, P57, DOI 10.1046/j.1365-2958.1997.1801552.x; AKERLEY BJ, 1995, CELL, V80, P611, DOI 10.1016/0092-8674(95)90515-4; Arigoni F, 1996, P NATL ACAD SCI USA, V93, P3238, DOI 10.1073/pnas.93.8.3238; Bijisma JJE, 2003, TRENDS MICROBIOL, V11, P359, DOI 10.1016/S0966-842X(03)00176-8; Biondi EG, 2006, MOL MICROBIOL, V59, P386, DOI 10.1111/j.1365-2958.2005.04970.x; Bork P, 1996, PROTEIN SCI, V5, P1421, DOI 10.1002/pro.5560050720; Chang CH, 1996, J BACTERIOL, V178, P4710, DOI 10.1128/jb.178.15.4710-4716.1996; Chen YT, 2004, J MOL EVOL, V59, P725, DOI 10.1007/s00239-004-2663-2; Delumeau O, 2004, J BIOL CHEM, V279, P40927, DOI 10.1074/jbc.M405464200; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gee KR, 1999, ANAL BIOCHEM, V273, P41, DOI 10.1006/abio.1999.4202; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Janiak-Spens F, 2005, BIOCHEMISTRY-US, V44, P377, DOI 10.1021/bi048433s; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Kato M, 1997, CELL, V88, P717, DOI 10.1016/S0092-8674(00)81914-5; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Laskowski MA, 2004, MOL MICROBIOL, V54, P1090, DOI 10.1111/j.1365-2958.2004.04331.x; Lin CT, 2006, RES MICROBIOL, V157, P169, DOI 10.1016/j.resmic.2005.06.012; Lucet I, 1999, J BACTERIOL, V181, P3242, DOI 10.1128/JB.181.10.3242-3245.1999; Matsubara M, 2000, FEBS LETT, V470, P118, DOI 10.1016/S0014-5793(00)01303-X; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mukhopadhyay S, 1999, J BACTERIOL, V181, P6615, DOI 10.1128/JB.181.21.6615-6622.1999; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Pastula C, 2003, COMB CHEM HIGH T SCR, V6, P341; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Rodrigue A, 2000, TRENDS MICROBIOL, V8, P498, DOI 10.1016/S0966-842X(00)01833-3; Rogov VV, 2004, J MOL BIOL, V343, P1035, DOI 10.1016/j.jmb.2004.08.096; Sambrook J., 2001, MOL CLONING LAB MANU; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Takeda S, 2001, MOL MICROBIOL, V40, P440, DOI 10.1046/j.1365-2958.2001.02393.x; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Winstanley C, 2005, J MED MICROBIOL, V54, P519, DOI 10.1099/jmm.0.46005-0; Xu OP, 2003, STRUCTURE, V11, P1569, DOI 10.1016/j.str.2003.10.016; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200	43	69	70	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9933	9944		10.1074/jbc.M708836200	http://dx.doi.org/10.1074/jbc.M708836200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18256026	hybrid, Green Published			2022-12-27	WOS:000254671600050
J	Kim, YB; Choi, S; Choi, MC; Oh, MA; Lee, SA; Cho, M; Mizuno, K; Kim, SH; Lee, JW				Kim, Yong-Bae; Choi, Suyong; Choi, Moon-Chang; Oh, Min-A; Lee, Sin-Ae; Cho, Moonjae; Mizuno, Kensaku; Kim, Sung-Hoon; Lee, Jung Weon			Cell adhesion-dependent cofilin serine 3 phosphorylation by the integrin-linked kinase center dot c-Src complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED ACTIN REORGANIZATION; GASTRIC-CARCINOMA CELLS; PROTEIN-KINASE; FOCAL ADHESION; EPITHELIAL-CELLS; EGF RECEPTOR; ILK; INVASION; GROWTH; ACTOPAXIN	Integrin- linked kinase (ILK) is involved in signal transduction by integrin-mediated cell adhesion that leads to dynamic actin reorganization. Actin (de) polymerization is regulated by cofilin, the Ser(3) phosphorylation (pS(3) cofilin) of which inhibits its actin-severing activity. To determine how ILK regulates pS(3) cofilin, we examined the effects of ILK on pS(3) cofilin using normal RIE1 cells. Compared with suspended cells, fibronectin-adherent cells showed enhanced pS(3) cofilin, depending on ILK expression and c-Src activity. The ILK-mediated pS(3) cofilin in RIE1 cells did not involve Rho-associated kinase, LIM kinase, or testicular protein kinases, which are known to be upstream of cofilin. The kinase domain of ILK, including proline-rich regions, appeared to interact physically with the Src homology 3 domain of c-Src. In vitro kinase assay revealed that ILK immunoprecipitates phosphorylated the recombinant glutathione S-transferase-cofilin, which was abolished by c-Src inhibition. Interestingly, epidermal growth factor treatment abolished the ILK effects, indicating that the linkage from ILK to cofilin is biologically responsive to extracellular cues. Altogether, this study provides evidence for a new signaling connection from ILK to cofilin for dynamic actin polymerization during cell adhesion, depending on the activity of ILK-associated c-Src.	[Kim, Sung-Hoon] Kyung Hee Univ, Coll Oriental Med, Seoul 131701, South Korea; [Kim, Yong-Bae; Choi, Suyong; Choi, Moon-Chang; Oh, Min-A; Lee, Jung Weon] Seoul Natl Univ, Coll Med, Cell Dynam Res Ctr, Canc Res Inst,Dept Tumor Biol, Seoul 110799, South Korea; [Lee, Sin-Ae; Lee, Jung Weon] Seoul Natl Univ, Coll Med, Cell Dynam Res Ctr, Canc Res Inst,Dept Mol & Clin Oncol, Seoul 110799, South Korea; [Cho, Moonjae] Cheju Natl Univ, Dept Med, Cheju 690756, South Korea; [Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Kyung Hee University; Seoul National University (SNU); Seoul National University (SNU); Jeju National University; Tohoku University	Kim, SH (corresponding author), Kyung Hee Univ, Coll Oriental Med, Seoul 131701, South Korea.	sungkim7@khu.ac.kr; jwl@snu.ac.kr	Lee, Jung Weon/AAC-1146-2020; Lee, Jung Weon/F-9149-2012; Mizuno, Kensaku/G-8631-2015	Lee, Jung Weon/0000-0003-2722-8200; 				Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Boulter E, 2006, EUR J CELL BIOL, V85, P255, DOI 10.1016/j.ejcb.2005.09.002; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Dedhar S, 1999, TRENDS CELL BIOL, V9, P319, DOI 10.1016/S0962-8924(99)01612-8; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443; Jung J, 2006, CELL SIGNAL, V18, P2033, DOI 10.1016/j.cellsig.2006.03.014; Kim HP, 2005, BBA-MOL CELL RES, V1743, P151, DOI 10.1016/j.bbamcr.2004.09.014; Kim YB, 2007, AM J PHYSIOL-CELL PH, V292, pC857, DOI 10.1152/ajpcell.00169.2006; LaLonde DP, 2005, J BIOL CHEM, V280, P21680, DOI 10.1074/jbc.m500752200; Lee JW, 2004, MOL CELLS, V17, P188; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; Lee MS, 2005, MOL CELL BIOL, V25, P6921, DOI 10.1128/MCB.25.16.6921-6936.2005; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Leu TH, 2003, FRONT BIOSCI-LANDMRK, V8, pS28, DOI 10.2741/980; Marcoux N, 2005, CELL SIGNAL, V17, P1449, DOI 10.1016/j.cellsig.2005.03.001; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Oh MA, 2007, J CELL SCI, V120, P2717, DOI 10.1242/jcs.003566; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhan Q, 2003, CELL MOTIL CYTOSKEL, V54, P1, DOI 10.1002/cm.10079	37	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10089	10096		10.1074/jbc.M708300200	http://dx.doi.org/10.1074/jbc.M708300200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18252715	Green Submitted, hybrid			2022-12-27	WOS:000254671600063
J	Stack, CM; Caffrey, CR; Donnelly, SM; Seshaadri, A; Lowther, J; Tort, JF; Collins, PR; Robinson, MW; Xu, W; McKerrow, JH; Craik, CS; Geiger, SR; Marion, R; Brinen, LS; Dalton, JP				Stack, Colin M.; Caffrey, Conor R.; Donnelly, Sheila M.; Seshaadri, Amritha; Lowther, Jonathan; Tort, Jose F.; Collins, Peter R.; Robinson, Mark W.; Xu, Weibo; McKerrow, James H.; Craik, Charles S.; Geiger, Sebastian R.; Marion, Rachel; Brinen, Linda S.; Dalton, John P.			Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE SITES; CYSTEINE PROTEASES; PROTEINASES; SPECIFICITY; INHIBITION; AUTOACTIVATION; DETERMINANTS; COLLAGEN; REVEALS; DEGRADE	The helminth parasite Fasciola hepatica secretes cysteine proteases to facilitate tissue invasion, migration, and development within the mammalian host. The major proteases cathepsin L1 (FheCL1) and cathepsin L2 (FheCL2) were recombinantly produced and biochemically characterized. By using site-directed mutagenesis, we show that residues at position 67 and 205, which lie within the S2 pocket of the active site, are critical in determining the substrate and inhibitor specificity. FheCL1 exhibits a broader specificity and a higher substrate turnover rate compared with FheCL2. However, FheCL2 can efficiently cleave substrates with a Pro in the P2 position and degrade collagen within the triple helices at physiological pH, an activity that among cysteine proteases has only been reported for human cathepsin K. The 1.4-angstrom three-dimensional structure of the FheCL1 was determined by x-ray crystallography, and the three-dimensional structure of FheCL2 was constructed via homology-based modeling. Analysis and comparison of these structures and our biochemical data with those of human cathepsins L and K provided an interpretation of the substrate-recognition mechanisms of these major parasite proteases. Furthermore, our studies suggest that a configuration involving residue 67 and the "gatekeeper" residues 157 and 158 situated at the entrance of the active site pocket create a topology that endows FheCL2 with its unusual collagenolytic activity. The emergence of a specialized collagenolytic function in Fasciola likely contributes to the success of this tissue-invasive parasite.	[Stack, Colin M.; Donnelly, Sheila M.; Lowther, Jonathan; Tort, Jose F.; Collins, Peter R.; Robinson, Mark W.; Xu, Weibo; Dalton, John P.] Univ Technol Sydney, Inst Biotechnol Infect Dis, Sydney, NSW 2007, Australia; [Caffrey, Conor R.; Seshaadri, Amritha; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, San Francisco, CA 94158 USA; [Tort, Jose F.] Univ Repub, Fac Med, Dept Genet, Montevideo 11800, Uruguay; [Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Craik, Charles S.] Univ Calif San Francisco, Dept Pharmacol, San Francisco, CA 94158 USA; [Craik, Charles S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Geiger, Sebastian R.; Marion, Rachel; Brinen, Linda S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of Technology Sydney; University of California System; University of California San Francisco; Universidad de la Republica, Uruguay; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dalton, JP (corresponding author), Univ Technol Sydney, Inst Biotechnol Infect Dis, Level 6 Bldg 4 Cornor Thomas & Harris St, Sydney, NSW 2007, Australia.	john.dalton@uts.edu.au	Donnelly, Sheila/H-7733-2014; Dalton, John/K-4457-2014; Stack, Colin M/D-4601-2009; Tort, Jose/AAF-2423-2020	Tort, Jose/0000-0003-3950-9982; Robinson, Mark/0000-0001-7191-0034; Donnelly, Sheila/0000-0003-2005-3698; Stack, Colin/0000-0002-7539-7677	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053247] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI053247, AI 053247] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Arnold, 2001, CRYSTALLOGRAPHY BIOL, P720; Atley LM, 2000, BONE, V26, P241, DOI 10.1016/S8756-3282(99)00270-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckham SA, 2006, BIOL CHEM, V387, P1053, DOI 10.1515/BC.2006.130; Berasain P, 1997, J PARASITOL, V83, P1, DOI 10.2307/3284308; Berasain P, 2000, EXP PARASITOL, V94, P99, DOI 10.1006/expr.1999.4479; Borgsteede FHM, 2005, VET REC, V156, P350, DOI 10.1136/vr.156.11.350; Brinen LS, 2000, STRUCT FOLD DES, V8, P831, DOI 10.1016/S0969-2126(00)00173-8; BROMME D, 1994, J BIOL CHEM, V269, P30238; Buhling F, 2001, J PATHOL, V195, P375; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; Collins PR, 2004, J BIOL CHEM, V279, P17038, DOI 10.1074/jbc.M308831200; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Dalton JP, 2006, PARASITIC FLATWORMS: MOLECULAR BIOLOGY, BIOCHEMISTRY, IMMUNOLOGY AND PHYSIOLOGY, P348, DOI 10.1079/9780851990279.0348; Dalton JP, 2003, INT J PARASITOL, V33, P1173, DOI 10.1016/S0020-7519(03)00171-1; DeLano W.L, PYMOL MOL GRAPHICS S; DOWD AJ, 1995, EUR J BIOCHEM, V232, P241, DOI 10.1111/j.1432-1033.1995.tb20805.x; DOWD AJ, 1994, EUR J BIOCHEM, V223, P91, DOI 10.1111/j.1432-1033.1994.tb18969.x; Dowd AJ, 1997, MOL BIOCHEM PARASIT, V88, P163, DOI 10.1016/S0166-6851(97)00090-X; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gillmor SA, 1997, PROTEIN SCI, V6, P1603, DOI 10.1002/pro.5560060801; GREEN GDJ, 1981, J BIOL CHEM, V256, P1923; HANNA REB, 1983, PARASITE IMMUNOL, V5, P409, DOI 10.1111/j.1365-3024.1983.tb00756.x; Irving JA, 2003, J MOL EVOL, V57, P1, DOI 10.1007/s00239-002-2434-x; Ishidoh K, 1998, BIOL CHEM, V379, P131; KIRSCHKE H, 1988, FEBS LETT, V228, P128, DOI 10.1016/0014-5793(88)80600-8; KIRSCHKE H, 1981, BIOCHEM BIOPH RES CO, V101, P454, DOI 10.1016/0006-291X(81)91281-X; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lecaille F, 2002, BIOCHEMISTRY-US, V41, P8447, DOI 10.1021/bi025638x; Lecaille F, 2007, PROTEIN SCI, V16, P662, DOI 10.1110/ps.062666607; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LI Z, 1994, J BIOL CHEM, V279, P5470; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; McManus DP, 2006, PARASITOLOGY, V133, pS43, DOI 10.1017/S0031182006001806; Mitchell GBB, 1998, VET REC, V143, P399; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; ROCHE L, 1997, EUR J BIOCHEM, V232, P241; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Smooker PM, 2000, PROTEIN SCI, V9, P2567, DOI 10.1110/ps.9.12.2567; Stack CM, 2007, J BIOL CHEM, V282, P16532, DOI 10.1074/jbc.M611501200; TIAN WX, 1982, BIOCHEMISTRY-US, V21, P1028, DOI 10.1021/bi00534a031; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; van den Bedem H, 2005, ACTA CRYSTALLOGR D, V61, P2, DOI 10.1107/S0907444904025697; Wang D, 2002, BIOCHEMISTRY-US, V41, P8849, DOI 10.1021/bi0257080; Wasilewski MM, 1996, MOL BIOCHEM PARASIT, V81, P179, DOI 10.1016/0166-6851(96)02703-X; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	57	78	79	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9896	9908		10.1074/jbc.M708521200	http://dx.doi.org/10.1074/jbc.M708521200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18160404	Green Published, hybrid			2022-12-27	WOS:000254671600046
J	Hausmann, A; Samans, B; Lill, R; Muehlenhoff, U				Hausmann, Anja; Samans, Birgit; Lill, Roland; Muehlenhoff, Ulrich			Cellular and mitochondrial remodeling upon defects in iron-sulfur protein biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CYTOSOLIC FE/S PROTEINS; HEME-SYNTHESIS; CANDIDA-ALBICANS; GENE-EXPRESSION; TRANSCRIPTIONAL CONTROL; CLUSTER BIOSYNTHESIS; HOMEOSTASIS; FRATAXIN; MATURATION	Biogenesis of iron-sulfur (Fe/S) proteins in eukaryotes is an essential process involving the mitochondrial iron-sulfur cluster (ISC) assembly and export machineries and the cytosolic iron/sulfur protein assembly (CIA) apparatus. To define the integration of Fe/S protein biogenesis into cellular homeostasis, we compared the global transcriptional responses to defects in the three biogenesis systems in Saccharomyces cerevisiae using DNA microarrays. Depletion of a member of the CIA machinery elicited only weak (up to 2-fold) alterations in gene expression with no clear preference for any specific cellular process. In contrast, depletion of components of the mitochondrial ISC assembly and export systems induced strong and largely overlapping transcriptional responses of more than 200 genes (2-100-fold changes). These alterations were strikingly similar, yet not identical, to the transcriptional profiles developed upon iron starvation. Hence, mitochondria and their ISC systems serve as primary physiological regulators exerting a global control of numerous iron-dependent processes. First, ISC depletion activates the iron-responsive transcription factors Aft1/2p leading to increased cellular iron acquisition. Second, respiration and heme metabolism are repressed ensuring the balanced utilization of iron by the two major iron-consuming processes, iron-sulfur protein and heme biosynthesis. Third, the decreased respiratory activity is compensated by induction of genes involved in glucose acquisition. Finally, transcriptional remodeling of the citric acid cycle and the biosyntheses of ergosterol and biotin reflect the iron dependence of these pathways. Together, our data suggest a model in which mitochondria perform a global regulatory role in numerous cellular processes linked to iron homeostasis.	[Hausmann, Anja; Lill, Roland; Muehlenhoff, Ulrich] Univ Marburg, Inst Zytobiol & Zytopathol, D-35032 Marburg, Germany; [Samans, Birgit] Univ Marburg, Inst Mol Biol & Tumorforsch, D-35032 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Muehlenhoff, U (corresponding author), Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany.	muehlenh@staff.uni-marburg.de		Lill, Roland/0000-0002-8345-6518				Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Barros MH, 2002, J BIOL CHEM, V277, P9997, DOI 10.1074/jbc.M112025200; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Belli G, 2004, J BIOL CHEM, V279, P12386, DOI 10.1074/jbc.M311879200; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; CAMADRO JM, 1988, J BIOL CHEM, V263, P11675; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; Crisp RJ, 2006, EMBO J, V25, P512, DOI 10.1038/sj.emboj.7600961; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dubacq C, 2006, MOL GENET GENOMICS, V275, P114, DOI 10.1007/s00438-005-0077-5; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Harlow E., 1988, ANTIBODIES LAB MANUA; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Kim D, 2006, BIOCHEMISTRY-US, V45, P14772, DOI 10.1021/bi061429r; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; Kwast KE, 1999, P NATL ACAD SCI USA, V96, P5446, DOI 10.1073/pnas.96.10.5446; KWOK E, 2005, TOPICS CURRENT GENET, P59; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Lange H, 2004, J BIOL CHEM, V279, P29101, DOI 10.1074/jbc.M403721200; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Lesur I, 2004, MOL BIOL CELL, V15, P1297, DOI 10.1091/mbc.E03-10-0742; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; McCammon MT, 2003, MOL BIOL CELL, V14, P958, DOI 10.1091/mbc.E02-07-0422; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Pennaneach V, 2006, MOL MICROBIOL, V59, P1357, DOI 10.1111/j.1365-2958.2006.05026.x; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Popescu BFG, 2007, J INORG BIOCHEM, V101, P957, DOI 10.1016/j.jinorgbio.2007.03.004; Protchenko O, 2003, J BIOL CHEM, V278, P36582, DOI 10.1074/jbc.M306584200; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Rosenfeld E, 2003, YEAST, V20, P1115, DOI 10.1002/yea.1026; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Sambrook J., 2001, MOL CLONING LAB MANU; Santos R, 2004, MOL MICROBIOL, V54, P507, DOI 10.1111/j.1365-2958.2004.04281.x; Santos R, 2003, MICROBIOL-SGM, V149, P579, DOI 10.1099/mic.0.26108-0; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Taura T, 1998, P NATL ACAD SCI USA, V95, P7427, DOI 10.1073/pnas.95.13.7427; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200	71	95	97	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8318	8330		10.1074/jbc.M705570200	http://dx.doi.org/10.1074/jbc.M705570200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18227070	hybrid			2022-12-27	WOS:000254288000030
J	Higashi, T; Ikeda, T; Shirakawa, R; Kondo, H; Kawato, M; Horiguchi, M; Okuda, T; Okawa, K; Fukai, S; Nureki, O; Kita, T; Horiuchi, H				Higashi, Tomohito; Ikeda, Tomoyuki; Shirakawa, Ryutaro; Kondo, Hirokazu; Kawato, Mitsunori; Horiguchi, Masahito; Okuda, Tomohiko; Okawa, Katsuya; Fukai, Shuya; Nureki, Osamu; Kita, Toru; Horiuchi, Hisanori			Biochemical characterization of the Rho GTPase-regulated actin assembly by diaphanous-related formins, mDia1 and daam1, in platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-RHO; SERINE-THREONINE KINASE; INTEGRIN ALPHA(IIB)BETA(3); VERTEBRATE GASTRULATION; AUTOREGULATORY DOMAIN; HOMOLOGY-2 DOMAIN; PUTATIVE TARGET; CAPPING PROTEIN; FISSION YEAST; MOUSE FORMIN	The diaphanous-related formins are actin nucleating and elongating factors. They are kept in an inactive state by an intramolecular interaction between the diaphanous inhibitory domain (DID) and the diaphanous-autoregulatory domain (DAD). It is considered that the dissociation of this autoinhibitory interaction upon binding of GTP-bound Rho to the GTPase binding domain next to DID induces exposure of the FH1-FH2 domains, which assemble actin filaments. Here, we isolated two diaphanous-related formins, mDia1 and Daam1, in platelet extracts by GTP-RhoA affinity column chromatography. We characterized them by a novel assay, where beads coated with the FH1-FH2-DAD domains of either mDia1 or Daam1 were incubated with platelet cytosol, and the assembled actin filaments were observed after staining with rhodamine-phalloidin. Both formins generated fluorescent filamentous structures on the beads. Quantification of the fluorescence intensity of the beads revealed that the initial velocity in the presence of mDia1 was more than 10 times faster than in the presence of Daam1. The actin assembly activities of both FH1-FH2-DADs were inhibited by adding cognate DID domains. GTP-RhoA, -RhoB, and -RhoC, but not GTP-Rac1 or -Cdc42, bound to both mDia1 and Daam1 and efficiently neutralized the inhibition by the DID domains. The association between RhoA and Daam1 was induced by thrombin stimulation in platelets, and RhoA-bound endogenous formins induced actin assembly, which was inhibited by the DID domains of Daam1 and mDia1. Thus, mDia1 and Daam1 are platelet actin assembly factors having distinct efficiencies, and they are directly regulated by Rho GTPases.	[Higashi, Tomohito; Ikeda, Tomoyuki; Shirakawa, Ryutaro; Kondo, Hirokazu; Kawato, Mitsunori; Horiguchi, Masahito; Kita, Toru; Horiuchi, Hisanori] Kyoto Univ, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan; [Okuda, Tomohiko] Kyoto Univ, COE Format Genom Anal Dis Model Anim Multiple Gen, Kyoto 6068507, Japan; [Okawa, Katsuya] Kyoto Univ, Frontier Technol Ctr, Grad Sch Med, Kyoto 6068507, Japan; [Fukai, Shuya] Univ Tokyo, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan; [Fukai, Shuya; Nureki, Osamu] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Fukai, Shuya] Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa 2268501, Japan; [Nureki, Osamu] RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan	Kyoto University; Kyoto University; Kyoto University; University of Tokyo; Tokyo Institute of Technology; Tokyo Institute of Technology; RIKEN	Horiuchi, H (corresponding author), Kyoto Univ, Dept Cardiovasc Med, Sakyo Ku, 54 shogoinkawaharacho, Kyoto 6068507, Japan.	horiuchi@kuhp.kyoto-u.ac.jp	NUREKI, OSAMU/G-4960-2014; Higashi, Tomohito/AHE-7942-2022; Fukai, Shuya/X-4838-2018	Fukai, Shuya/0000-0002-1241-1443; Higashi, Tomohito/0000-0001-5616-1477				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Krebs A, 2001, J CELL SCI, V114, P3663; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Leng LJ, 1998, BLOOD, V91, P4206, DOI 10.1182/blood.V91.11.4206.411k30_4206_4215; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; MORII N, 1992, J BIOL CHEM, V267, P20921; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Nishioka H, 2001, BIOCHEM BIOPH RES CO, V280, P970, DOI 10.1006/bbrc.2001.4237; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sato A, 2006, DEVELOPMENT, V133, P4219, DOI 10.1242/dev.02590; Schoenwaelder SM, 2002, J BIOL CHEM, V277, P14738, DOI 10.1074/jbc.M200661200; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	48	41	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8746	8755		10.1074/jbc.M707839200	http://dx.doi.org/10.1074/jbc.M707839200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18218625	Green Submitted, hybrid			2022-12-27	WOS:000254288000072
J	Perez-Berna, AJ; Guillen, J; Moreno, MR; Bernabeu, A; Pabst, G; Laggner, P; Villalain, J				Perez-Berna, Ana J.; Guillen, Jaime; Moreno, Miguel R.; Bernabeu, Angela; Pabst, Georg; Laggner, Peter; Villalain, Jose			Identification of the membrane-active regions of hepatitis C virus p7 protein - Biophysical characterization of the loop region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE PEPTIDASE; MAJOR EPITOPE REGION; ION-CHANNEL; SECONDARY STRUCTURE; HEPTAD REPEAT; MODEL SYSTEMS; CORE PROTEIN; HIV-1 GP41; BINDING; DOMAIN	We have identified the membrane-active regions of the hepatitis C virus p7 protein by performing an exhaustive study of membrane rupture, hemifusion, and fusion induced by a p7-derived peptide library on model membranes having different phospholipid compositions. We report the identification in p7 of a highly membranotropic region located at the loop domain of the protein. Here, we have investigated the interaction of a peptide patterned after the p7 loop (peptide p7(L)), studying its binding and interaction with the lipid bilayer, and evaluated the binding-induced structural changes of the peptide and the phospholipids. We show that positively rich p7(L) strongly binds to negatively charged phospholipids and it is localized in a shallow position in the bilayer. Furthermore, peptide p7(L) exhibits a high tendency to oligomerize in the presence of phospholipids, which could be the driving force for the formation of the active ion channel. Therefore, our findings suggest that the p7 loop could be an attractive candidate for antiviral drug development, because it could be a target for antiviral compounds that may lead to new vaccine strategies.	[Perez-Berna, Ana J.; Guillen, Jaime; Moreno, Miguel R.; Bernabeu, Angela; Laggner, Peter; Villalain, Jose] Univ Miguel Hernandez, Inst Biol Mol & Celular, E-03202 Alicante, Spain; [Pabst, Georg] Austrian Acad Sci, Inst Biophys & Nanosyst Res, A-8042 Graz, Austria	Universidad Miguel Hernandez de Elche; Austrian Academy of Sciences	Laggner, P (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, E-03202 Alicante, Spain.	jvillalain@umh.es	Perez-Berna, Ana/G-2789-2016; Pabst, Georg/I-6919-2015; Pabst, Georg/O-1452-2019; Guillen, Jaime/K-2892-2014; Guillen, Jaime/K-6175-2019; Bernabeu-Sanz, Angela/B-3111-2009	Pabst, Georg/0000-0003-1967-1536; Pabst, Georg/0000-0003-1967-1536; Guillen, Jaime/0000-0001-7415-1512; Guillen, Jaime/0000-0001-7415-1512; Bernabeu-Sanz, Angela/0000-0003-2506-7626; Villalain, Jose/0000-0002-5148-141X; Moreno Raja, Miguel/0000-0002-6758-3998; Perez-Berna, Ana/0000-0003-4145-532X				Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Ait-Goughoulte M, 2006, J GEN VIROL, V87, P855, DOI 10.1099/vir.0.81664-0; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Berg T, 2003, HEPATOLOGY, V37, P1359, DOI 10.1053/jhep.2003.50219; Bernabeu A, 2007, BBA-BIOMEMBRANES, V1768, P1659, DOI 10.1016/j.bbamem.2007.02.023; Bottcher C. S. F., 1961, ANAL CHIM ACTA, V1061, P203; BRETSCHER MS, 1985, SCI AM, V253, P100, DOI 10.1038/scientificamerican1085-100; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Carrere-Kremer S, 2002, J VIROL, V76, P3720, DOI 10.1128/JVI.76.8.3720-3730.2002; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Cladera J, 1998, BIOPHYS J, V74, P2434, DOI 10.1016/S0006-3495(98)77951-2; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Contreras LM, 2001, BIOCHEMISTRY-US, V40, P3196, DOI 10.1021/bi002613u; DAVENPORT L, 1985, BIOCHEMISTRY-US, V24, P4097, DOI 10.1021/bi00336a044; Delboy MG, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-105; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; EFTINK MR, 1977, BIOCHEMISTRY-US, V16, P5546, DOI 10.1021/bi00644a024; Fisher DB, 2000, PLANT PHYSIOL, V123, P125, DOI 10.1104/pp.123.1.125; Golding C, 1996, BIOCHEMISTRY-US, V35, P10931, DOI 10.1021/bi960905i; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Griffin SDC, 2004, J GEN VIROL, V85, P451, DOI 10.1099/vir.0.19634-0; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; GROSS E, 1994, BIOPHYS J, V67, P208, DOI 10.1016/S0006-3495(94)80471-0; Guillen J, 2005, J VIROL, V79, P1743, DOI 10.1128/JVI.79.3.1743-1752.2005; Korazim O, 2006, J MOL BIOL, V364, P1103, DOI 10.1016/j.jmb.2006.08.091; Laggner P, 1994, Subcell Biochem, V23, P451; LAURENT TC, 1967, BIOCHIM BIOPHYS ACTA, V136, P191, DOI 10.1016/0304-4165(67)90063-3; LENTZ BR, 1993, CHEM PHYS LIPIDS, V64, P99, DOI 10.1016/0009-3084(93)90060-G; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; LIN C, 1994, J VIROL, V68, P5063, DOI 10.1128/JVI.68.8.5063-5073.1994; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Meers P, 2000, BBA-BIOMEMBRANES, V1467, P227, DOI 10.1016/S0005-2736(00)00224-8; MIZUSHIMA H, 1994, J VIROL, V68, P6215, DOI 10.1128/JVI.68.10.6215-6222.1994; Moreno MR, 2007, BIOCHEMISTRY-US, V46, P10572, DOI 10.1021/bi700911g; Moreno MR, 2006, BBA-BIOMEMBRANES, V1758, P111, DOI 10.1016/j.bbamem.2006.01.007; O'Shea P, 2003, BIOCHEM SOC T, V31, P990; Pabst Georg, 2006, Biophysical Reviews and Letters, V1, P57, DOI 10.1142/S1793048006000069; Pascual R, 2005, BIOCHEMISTRY-US, V44, P14275, DOI 10.1021/bi050928+; Pascual R, 2005, J VIROL, V79, P5142, DOI 10.1128/JVI.79.8.5142-5152.2005; Patargias G, 2006, J MED CHEM, V49, P648, DOI 10.1021/jm050721e; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; PEBAYPEYROULA E, 1994, BIOPHYS CHEM, V53, P45, DOI 10.1016/0301-4622(94)00075-1; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Perez-Berna AJ, 2006, BIOCHEMISTRY-US, V45, P3755, DOI 10.1021/bi0523963; Pozzetto B, 1996, NEPHROL DIAL TRANSPL, V11, P2; Qureshi SA, 2007, MED RES REV, V27, P353, DOI 10.1002/med.20063; RABENSTEIN M, 1995, BIOCHEMISTRY-US, V34, P13390, DOI 10.1021/bi00041a016; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; Santos NC, 1998, BIOCHEMISTRY-US, V37, P8674, DOI 10.1021/bi9803933; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Tan SL, 2002, NAT REV DRUG DISCOV, V1, P867, DOI 10.1038/nrd937; Tokita H, 2000, J CLIN MICROBIOL, V38, P3450, DOI 10.1128/JCM.38.9.3450-3452.2000; Vauloup-Fellous C, 2006, J BIOL CHEM, V281, P27679, DOI 10.1074/jbc.M602587200; Veiga AS, 2007, FEBS J, V274, P5096, DOI 10.1111/j.1742-4658.2007.06029.x; WALL J, 1995, MOL MEMBR BIOL, V12, P183, DOI 10.3109/09687689509027506; WALL J, 1995, J CELL SCI, V108, P2673; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; ZHANG YP, 1992, BIOCHEMISTRY-US, V31, P11572, DOI 10.1021/bi00161a041	63	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8089	8101		10.1074/jbc.M709413200	http://dx.doi.org/10.1074/jbc.M709413200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18198177	hybrid			2022-12-27	WOS:000254288000005
J	Dadlani, H; Ballinger, ML; Osman, N; Getachew, R; Little, PJ				Dadlani, Harsha; Ballinger, Mandy L.; Osman, Narin; Getachew, Robel; Little, Peter J.			Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; GROWTH-FACTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; EXTRACELLULAR-MATRIX; CELL-MEMBRANE; IN-VITRO; EXPRESSION; SUPERFAMILY; ACTIVATION; ATHEROSCLEROSIS	Atherosclerosis is the underlying pathological process of most cardiovascular disease. A critical component of the "response to retention" hypothesis of atherogenesis is proteo-glycan/low density lipoprotein (LDL) binding. Transforming growth factor beta (TGF-beta) is present in atherosclerotic lesions, regulates vascular smooth muscle cell (VSMC) proteoglycan synthesis via an unknown signaling pathway, and increases proteoglycan/ LDL binding. This pathway was investigated using the activin receptor-like kinase 5 (ALK5) inhibitor SB431542 and inhibitors of p38 MAP kinase as a possible downstream or alternative mediator. TGF-beta stimulated and SB431542 inhibited the phosphorylation of Smad2/ 3. In human VSMC, TGF-beta increased [S-35] sulfate incorporation into proteoglycans associated with a 19% increase in glycosaminoglycan (GAG) chain size by size exclusion chromatography. SB431542 caused a concentration-dependent decrease in TGF-beta-mediated [S-35] sulfate incorporation with 92% inhibition at 3 mu M. Two different p38 MAP kinase inhibitors, SB203580 and SB202190, but not the inactive analogue SB202474, concentration-dependently blocked TGF-beta-mediated [S-35] sulfate incorporation. TGF-beta increased [H-3] glucosamine incorporation into glycosaminoglycans by 180% and [S-35] Met/Cys incorporation into proteoglycan core proteins by 35% with both effects completely inhibited by SB431542. Blocking both Smad2/3 and p38 MAP kinase pathways prevented the effect of TGF-beta to increase proteoglycan to LDL binding. TGF-beta mediates its effects on proteoglycan synthesis in VSMCs via the ALK5/Smad2/3 phosphorylation pathway as well as via the p38 MAP kinase signaling cascade. Further studies of downstream pathways controlling proteoglycan synthesis may identify potential therapeutic targets for the prevention of atherosclerosis and cardiovascular disease.	[Dadlani, Harsha; Ballinger, Mandy L.; Osman, Narin; Getachew, Robel; Little, Peter J.] Baker Heart Res Inst, Cell Biol Diabet Lab, Melbourne, Vic 3004, Australia; [Osman, Narin; Little, Peter J.] Monash Univ, Alfred Hosp, Cent Eastern Clin Sch, Dept Med & Immunol, Melbourne, Vic 3004, Australia; [Dadlani, Harsha] Univ Melbourne, Dept Mol Biol & Biochem, Parkville, Vic 3010, Australia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne	Little, PJ (corresponding author), Baker Heart Res Inst, Cell Biol Diabet Lab, Melbourne, Vic 3004, Australia.	peter.little@baker.edu.au	Little, Peter J./F-9865-2015	Little, Peter J./0000-0002-0335-3835; Ballinger, Mandy/0000-0002-9706-0514				AGROTIS A, 1994, HYPERTENSION, V23, P593, DOI 10.1161/01.HYP.23.5.593; Agrotis Alex, 2005, Current Vascular Pharmacology, V3, P55, DOI 10.2174/1570161052773951; Ballinger ML, 2004, CELL MOL LIFE SCI, V61, P1296, DOI 10.1007/s00018-004-3389-4; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bobik A, 1999, CIRCULATION, V99, P2883, DOI 10.1161/01.CIR.99.22.2883; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; BYTIELD DS, 2004, MOL PHARM, V65, P744; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Gaedeke J, 2004, KIDNEY INT, V66, P112, DOI 10.1111/j.1523-1755.2004.00713.x; HEINECKE JW, 1986, J CLIN INVEST, V77, P757, DOI 10.1172/JCI112371; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kawakami S, 2002, J CELL PHYSIOL, V191, P310, DOI 10.1002/jcp.10099; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Little PJ, 2002, ARTERIOSCL THROM VAS, V22, P55, DOI 10.1161/hq0102.101100; Little PJ, 2003, DIABETES RES CLIN PR, V59, P93, DOI 10.1016/S0168-8227(02)00201-2; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; McGillicuddy FC, 2006, VASC PHARMACOL, V44, P469, DOI 10.1016/j.vph.2006.03.002; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; Nigro J, 2004, DIABETOLOGIA, V47, P2105, DOI 10.1007/s00125-004-1588-z; Nigro J, 2002, ATHEROSCLEROSIS, V162, P119, DOI 10.1016/S0021-9150(01)00704-3; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983; Prante C, 2007, J BIOL CHEM, V282, P26441, DOI 10.1074/jbc.M702299200; Runyan CE, 2006, CELL SIGNAL, V18, P2077, DOI 10.1016/j.cellsig.2006.05.009; Schmidt A, 2006, EUR J CLIN INVEST, V36, P473, DOI 10.1111/j.1365-2362.2006.01658.x; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Schonherr E, 1997, ARCH BIOCHEM BIOPHYS, V339, P353, DOI 10.1006/abbi.1996.9854; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tanabe K, 2006, J CELL BIOCHEM, V99, P187, DOI 10.1002/jcb.20896; Ungefroren H, 2005, J BIOL CHEM, V280, P2644, DOI 10.1074/jbc.M411925200; Ungefroren H, 2003, J BIOL CHEM, V278, P11041, DOI 10.1074/jbc.M300035200; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0	38	44	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7844	7852		10.1074/jbc.M703125200	http://dx.doi.org/10.1074/jbc.M703125200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18223258	hybrid			2022-12-27	WOS:000253997900060
J	Li, K; Casta, A; Wang, R; Lozada, E; Fan, W; Kane, S; Ge, QY; Gu, W; Orren, D; Luo, JY				Li, Kai; Casta, Alex; Wang, Rui; Lozada, Enerlyn; Fan, Wei; Kane, Susan; Ge, Qingyuan; Gu, Wei; Orren, David; Luo, Jianyuan			Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNER-SYNDROME PROTEIN; HOLLIDAY JUNCTIONS; P53; HELICASE; SIR2; DAMAGE; RPA; COLOCALIZES; INSTABILITY; METABOLISM	Werner syndrome is an autosomal recessive disorder associated with premature aging and cancer predisposition caused by mutations of the WRN gene. WRN is a member of the RecQ DNA helicase family with functions in maintaining genome stability. Sir2, an NAD-dependent histone deacetylase, has been proven to extend life span in yeast and Caenorhabditis elegans. Mammalian Sir2 (SIRT1) has also been found to regulate premature cellular senescence induced by the tumor suppressors PML and p53. SIRT1 plays an important role in cell survival promoted by calorie restriction. Here we show that SIRT1 interacts with WRN both in vitro and in vivo; this interaction is enhanced after DNA damage. WRN can be acetylated by acetyltransferase CBP/p300, and SIRT1 can deacetylate WRN both in vitro and in vivo. WRN acetylation decreases its helicase and exonuclease activities, and SIRT1 can reverse this effect. WRN acetylation alters its nuclear distribution. Down-regulation of SIRT1 reduces WRN translocation from nucleoplasm to nucleoli after DNA damage. These results suggest that SIRT1 regulates WRN-mediated cellular responses to DNA damage through deacetylation of WRN.	[Li, Kai; Wang, Rui; Fan, Wei; Luo, Jianyuan] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Li, Kai; Wang, Rui; Fan, Wei; Luo, Jianyuan] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA; [Casta, Alex; Gu, Wei] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Lozada, Enerlyn; Orren, David] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Kane, Susan; Ge, Qingyuan] Cell Signaling Technol, Danvers, MA 01923 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Columbia University; University of Kentucky	Luo, JY (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, 422 LRB,364 Plantat St, Worcester, MA 01605 USA.	Jianyuan.luo@umassmed.edu	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914	NATIONAL CANCER INSTITUTE [R01CA113371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026534] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA113371] Funding Source: Medline; NIA NIH HHS [R01 AG026534] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Blander G, 1999, J BIOL CHEM, V274, P29463, DOI 10.1074/jbc.274.41.29463; Blander G, 2002, J BIOL CHEM, V277, P50934, DOI 10.1074/jbc.M210479200; Brosh RM, 2001, J BIOL CHEM, V276, P35093, DOI 10.1074/jbc.M103332200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Guarente L, 2000, GENE DEV, V14, P1021; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Karmakar P, 2005, MECH AGEING DEV, V126, P1146, DOI 10.1016/j.mad.2005.06.004; Karmakar P, 2002, J BIOL CHEM, V277, P18291, DOI 10.1074/jbc.M111523200; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Leung AKL, 2003, BIOCHEM J, V376, P553, DOI 10.1042/BJ20031169; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; MARTIN GM, 1970, LAB INVEST, V23, P86; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nguyen DT, 2002, FEBS LETT, V521, P170, DOI 10.1016/S0014-5793(02)02868-5; Ogburn CE, 1997, HUM GENET, V101, P121, DOI 10.1007/s004390050599; Opresko PL, 2003, CARCINOGENESIS, V24, P791, DOI 10.1093/carcin/bgg034; Orren DK, 2006, FRONT BIOSCI-LANDMRK, V11, P2657, DOI 10.2741/1999; Ozgenc A, 2005, MUTAT RES-FUND MOL M, V577, P237, DOI 10.1016/j.mrfmmm.2005.03.020; Poot M, 2001, FASEB J, V15, P1224, DOI 10.1096/fj.00-0611fje; Sakamoto S, 2001, GENES CELLS, V6, P421, DOI 10.1046/j.1365-2443.2001.00433.x; Sommers JA, 2005, CANCER RES, V65, P1223, DOI 10.1158/0008-5472.CAN-03-0231; STEFANINI M, 1989, MUTAT RES, V219, P179, DOI 10.1016/0921-8734(89)90013-1; Vaitiekunaite R, 2007, MECH AGEING DEV, V128, P650, DOI 10.1016/j.mad.2007.09.004; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yang Q, 2002, J BIOL CHEM, V277, P31980, DOI 10.1074/jbc.M204111200; Yannone SM, 2001, J BIOL CHEM, V276, P38242; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	41	130	136	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7590	7598		10.1074/jbc.M709707200	http://dx.doi.org/10.1074/jbc.M709707200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18203716	hybrid			2022-12-27	WOS:000253997900034
J	Loyer, P; Trembley, JH; Grenet, JA; Busson, A; Corlu, A; Zhao, W; Kocak, M; Kidd, VJ; Lahti, JM				Loyer, Pascal; Trembley, Janeen H.; Grenet, Jose A.; Busson, Adeline; Corlu, Anne; Zhao, Wei; Kocak, Mehmet; Kidd, Vincent J.; Lahti, Jill M.			Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors - Influence of cyclin L isoforms on splice site selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; RS DOMAIN; PROTEIN; KINASE; TRANSCRIPTION; COMPLEXES; EXPRESSION; APOPTOSIS; RNPS1; CELLS	Although it has been reported that cyclin L1 alpha and L2 alpha proteins interact with CDK11(p110), the nature of the cyclin L transcripts, the formation of complexes between the five cyclin L and the three CDK11 protein isoforms, and the influence of these complexes on splicing have not been thoroughly investigated. Here we report that cyclin L1 and L2 genes generate 14 mRNA variants encoding six cyclin L proteins, one of which has not been described previously. Using cyclin L gene-specific antibodies, we demonstrate expression of multiple endogenous cyclin L proteins in human cell lines and mouse tissues. Moreover, we characterize interactions between CDK11(p110), mitosis-specific CDK11(p58), and apoptosis-specific CDK11(p46) with both cyclin L alpha and -beta proteins and the co-elution of these proteins following size exclusion chromatography. We further establish that CDK11(p110) and associated cyclin L alpha/beta proteins localize to splicing factor compartments and nucleoplasm and interact with serine/arginine-rich proteins. Importantly, we also determine the effect of CDK11-cyclin L complexes on pre-mRNA splicing. Pre-incubation of nuclear extracts with purified cyclin L alpha and -beta isoforms depletes the extract of in vitro splicing activity. Ectopic expression of cyclin L1 alpha, L1 beta, L2 alpha, or L2 beta or active CDK11(p110) individually enhances intracellular intron splicing activity, whereas expression of CDK11(p58/p46) or kinase-dead CDK11(p110) represses splicing activity. Finally, we demonstrate that expression of cyclins L alpha and -beta and CDK11(p110) strongly and differentially affects alternative splicing in vivo. Together, these data establish that CDK11(p110) interacts physically and functionally with cyclin L alpha and -beta isoforms and SR proteins to regulate splicing.	[Trembley, Janeen H.; Grenet, Jose A.; Kidd, Vincent J.; Lahti, Jill M.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Loyer, Pascal; Busson, Adeline; Corlu, Anne] Univ Rennes 1, INSERM, U Regulat Equilibres Fonct Foie Normal & Pathol 5, IFR140,Hop Pontchaillou, F-35033 Rennes, France; [Zhao, Wei; Kocak, Mehmet] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA	St Jude Children's Research Hospital; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; St Jude Children's Research Hospital	Lahti, JM (corresponding author), St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, 332 N Lauderdale, Memphis, TN 38105 USA.	Jill.Lahti@stjude.org	Corlu, Anne/U-8030-2018; LOYER, Pascal/K-1838-2019	Corlu, Anne/0000-0002-7370-0564; Kocak, Mehmet/0000-0002-3386-1734; LOYER, PASCAL/0000-0002-5656-2673; Trembley, Janeen/0000-0003-3597-2611	NCI NIH HHS [P30CA021765] Funding Source: Medline; NIGMS NIH HHS [R01GM044088] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044088] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berke JD, 2001, NEURON, V32, P277, DOI 10.1016/S0896-6273(01)00465-2; Beyaert R, 1997, J BIOL CHEM, V272, P11694, DOI 10.1074/jbc.272.18.11694; BUNNELL BA, 1990, P NATL ACAD SCI USA, V87, P7467, DOI 10.1073/pnas.87.19.7467; Chen HH, 2006, MOL CELL BIOL, V26, P2736, DOI 10.1128/MCB.26.7.2736-2745.2006; Chen HH, 2007, BIOCHEM BIOPH RES CO, V354, P735, DOI 10.1016/j.bbrc.2007.01.049; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; de Graaf K, 2004, J BIOL CHEM, V279, P4612, DOI 10.1074/jbc.M310794200; Dickinson LA, 2002, J BIOL CHEM, V277, P25465, DOI 10.1074/jbc.M202266200; Even Y, 2006, J CELL BIOCHEM, V99, P890, DOI 10.1002/jcb.20986; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Gururajan R, 1998, GENOME RES, V8, P929, DOI 10.1101/gr.8.9.929; Herrmann A, 2007, FASEB J, V21, P3142, DOI 10.1096/fj.07-8377com; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963; LAHTI JM, 1995, MOL CELL BIOL, V15, P1; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Li TY, 2004, MOL CELL BIOL, V24, P3188, DOI 10.1128/MCB.24.8.3188-3197.2004; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; Loyer P, 1998, J CELL SCI, V111, P1495; Mayeda A, 1999, METH MOL B, V118, P315; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Neugebauer KM, 1997, GENE DEV, V11, P1148, DOI 10.1101/gad.11.9.1148; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; STEPHENS C, 1987, EMBO J, V6, P2027, DOI 10.1002/j.1460-2075.1987.tb02467.x; Trembley JH, 2005, MOL CELL BIOL, V25, P1446, DOI 10.1128/MCB.25.4.1446-1457.2005; Trembley JH, 2004, PROG NUCLEIC ACID RE, V77, P263, DOI 10.1016/S0079-6603(04)77007-5; Trembley JH, 2003, J BIOL CHEM, V278, P2265, DOI 10.1074/jbc.M207518200; Trembley JH, 2002, J BIOL CHEM, V277, P2589, DOI 10.1074/jbc.M109755200; XIANG JL, 1994, J BIOL CHEM, V269, P15786; Yang LJ, 2004, J BIOL CHEM, V279, P11639, DOI 10.1074/jbc.M312895200; Zong HL, 2007, MOL CELL BIOL, V27, P7125, DOI 10.1128/MCB.01753-06	33	86	97	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7721	7732		10.1074/jbc.M708188200	http://dx.doi.org/10.1074/jbc.M708188200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18216018	hybrid			2022-12-27	WOS:000253997900049
J	Shi, Y; Chen, XF; Wu, ZY; Shi, WW; Yang, Y; Cui, N; Jiang, C; Harrison, RW				Shi, Yun; Chen, Xianfeng; Wu, Zhongying; Shi, Weiwei; Yang, Yang; Cui, Ningren; Jiang, Chun; Harrison, Robert W.			cAMP-dependent protein kinase phosphorylation produces interdomain movement in SUR2B leading to activation of the vascular K-ATP channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; MOLECULAR-DYNAMICS SIMULATIONS; ARTERIAL SMOOTH-MUSCLE; ABC TRANSPORTER; SULFONYLUREA RECEPTOR; POTASSIUM CHANNELS; COMPLEX; MECHANISM; ROLES; CONFORMATION	Vascular ATP-sensitive K+ channels are activated by multiple vasodilating hormones and neurotransmitters via PKA. A critical PKA phosphorylation site (Ser-1387) is found in the second nucleotide-binding domain (NBD2) of the SUR2B subunit. To understand how phosphorylation at Ser-1387 leads to changes in channel activity, we modeled the SUR2B using a newly crystallized ABC protein SAV1866. The model showed that Ser-1387 was located on the interface of NBD2 with TMD1 and physically interacted with Tyr-506 in TMD1. A positively charged residue (Arg-1462) in NBD2 was revealed in the close vicinity of Ser-1387. Mutation of either of these three residues abolished PKA-dependent channel activation. Molecular dynamics simulations suggested that Ser-1387, Tyr-506, and Arg-1462 formed a compact triad upon Ser-1387 phosphorylation, leading to reshaping of the NBD2 interface and movements of NBD2 and TMD1. Restriction of the interdomain movements by engineering a disulfide bond between TMD1 and NBD2 prevented the channel activation in a redox-dependent manner. Thus, a channel-gating mechanism is suggested through enhancing the NBD-TMD coupling efficiency following Ser-1387 phosphorylation, which is shared by multiple vasodilators.	[Shi, Yun; Chen, Xianfeng; Wu, Zhongying; Shi, Weiwei; Yang, Yang; Cui, Ningren; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Chen, Xianfeng; Harrison, Robert W.] Georgia State Univ, Dept Comp Sci, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, POB 4010, Atlanta, GA 30302 USA.	cjiang@gsu.edu; rharrison@cs.gsu.edu	Shi, Yun S/T-8845-2018; Yang, Yang/B-3440-2008; SHI, WEIWEI/B-3477-2008; Shi, Yun/B-5623-2009; Chen, Xianfeng/ABG-8256-2021	Yang, Yang/0000-0003-4275-0515; SHI, WEIWEI/0000-0001-6216-712X; Shi, Yun/0000-0002-8842-9818; Yang, Yang/0000-0001-6417-3654; Harrison, Robert/0000-0003-2449-1214	NHLBI NIH HHS [R01 HL067890, HL067890] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067890] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Campbell JD, 2004, DIABETES, V53, pS123, DOI 10.2337/diabetes.53.suppl_3.S123; Campbell JD, 2003, EMBO REP, V4, P1038, DOI 10.1038/sj.embor.7400003; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Chen XF, 2004, J MOL MODEL, V10, P373, DOI 10.1007/s00894-004-0205-x; Cole WC, 2003, J CARDIOVASC ELECTR, V14, P94, DOI 10.1046/j.1540-8167.2003.02376.x; Cui Y, 2002, AM J RESP CELL MOL, V26, P135, DOI 10.1165/ajrcmb.26.1.4622; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; HARRISON RW, 1994, PROTEIN ENG, V7, P1353, DOI 10.1093/protein/7.11.1353; HARRISON RW, 2003, P INT C COMP SCI ITS, P71; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Huopio H, 2000, J CLIN INVEST, V106, P897, DOI 10.1172/JCI9804; Jackson WF, 2005, MICROCIRCULATION, V12, P113, DOI 10.1080/10739680590896072; Li L, 2003, J MEMBRANE BIOL, V196, P61, DOI 10.1007/s00232-003-0625-z; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lu T, 2001, J PHYSIOL-LONDON, V537, P811; Matsuo M, 2005, J MOL CELL CARDIOL, V38, P907, DOI 10.1016/j.yjmcc.2004.11.021; Matsuo M, 2002, EMBO J, V21, P4250, DOI 10.1093/emboj/cdf419; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Moreau C, 2005, J MOL CELL CARDIOL, V38, P951, DOI 10.1016/j.yjmcc.2004.11.030; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Quinn KV, 2004, CIRC RES, V94, P1359, DOI 10.1161/01.RES.0000128513.34817.c4; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8; Wang XR, 2003, CIRC RES, V92, P1225, DOI 10.1161/01.RES.0000075601.95738.6D; Wellman GC, 1998, J PHYSIOL-LONDON, V507, P117, DOI 10.1111/j.1469-7793.1998.117bu.x; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Yamada M, 2004, MOL PHARMACOL, V66, P807, DOI 10.1124/mol.104.002717; Yamada M, 2004, MOL PHARMACOL, V65, P1198, DOI 10.1124/mol.65.5.1198; Yang Y, 2008, BBA-BIOMEMBRANES, V1778, P88, DOI 10.1016/j.bbamem.2007.08.030; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	45	26	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7523	7530		10.1074/jbc.M709941200	http://dx.doi.org/10.1074/jbc.M709941200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18198173	hybrid, Green Published			2022-12-27	WOS:000253997900027
J	Splan, KE; Ignatov, ME; Musier-Forsyth, K				Splan, Kathryn E.; Ignatov, Michael E.; Musier-Forsyth, Karin			Transfer RNA modulates the editing mechanism used by class II prolyl-tRNA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIES-SPECIFIC DIFFERENCES; HAEMOPHILUS-INFLUENZAE YBAK; ESCHERICHIA-COLI; AMINO-ACIDS; INSERTION DOMAIN; ACTIVE-SITE; PROTEIN; DISCRIMINATION; AMINOACYLATION; CYS-TRNA(PRO)	Aminoacyl-tRNA synthetases catalyze the attachment of amino acids to their cognate tRNAs. To prevent errors in protein synthesis, many synthetases have evolved editing pathways by which misactivated amino acids ( pre-transfer editing) and misacylated tRNAs ( post-transfer editing) are hydrolyzed. Previous studies have shown that class II prolyl-tRNA synthetase ( ProRS) possesses both pre- and post-transfer editing functions against noncognate alanine. To assess the relative contributions of pre- and post-transfer editing, presented herein are kinetic studies of an Escherichia coli ProRS mutant in which post-transfer editing is selectively inactivated, effectively isolating the pre-transfer editing pathway. When post-transfer editing is abolished, substantial levels of alanine mischarging are observed under saturating amino acid conditions, indicating that pre-transfer editing alone cannot prevent the formation of Ala-tRNAPro. Steady-state kinetic parameters for aminoacylation measured under these conditions reveal that the preference for proline over alanine is 2000-fold, which is well within the regime where editing is required. Simultaneous measurement of AMP and Ala-tRNAPro formation in the presence of tRNAPro suggested that misactivated alanine is efficiently transferred to tRNA to form the mischarged product. In the absence of tRNA, enzyme-catalyzed Ala-AMP hydrolysis is the dominant form of editing, with "selective release" of noncognate adenylate from the active site constituting a minor pathway. Studies with human and Methanococcus jannaschii ProRS, which lack a post-transfer editing domain, suggest that enzymatic pre- transfer editing occurs within the aminoacylation active site. Taken together, the results reported herein illustrate how both pre- and post-transfer editing pathways work in concert to ensure accurate aminoacylation by ProRS.	[Ignatov, Michael E.; Musier-Forsyth, Karin] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Musier-Forsyth, Karin] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Splan, Kathryn E.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities	Musier-Forsyth, K (corresponding author), 100 W 18th Ave, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu	Ignatov, Michael/GLN-6479-2022		NIGMS NIH HHS [GM049928] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM049928, R29GM049928, R01GM049928] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Beuning PJ, 2001, J BIOL CHEM, V276, P30779, DOI 10.1074/jbc.M104761200; Burke B, 2001, J BIOL CHEM, V276, P20286, DOI 10.1074/jbc.M100456200; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; FERSHT AR, 1981, PROC R SOC SER B-BIO, V212, P351, DOI 10.1098/rspb.1981.0044; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P1250, DOI 10.1021/bi00574a021; FREIST W, 1989, BIOCHEMISTRY-US, V28, P6787, DOI 10.1021/bi00443a001; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Hendrickson TL, 2003, MOL B INT U, P34; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 2000, TRENDS BIOCHEM SCI, V25, P311, DOI 10.1016/S0968-0004(00)01600-5; Ibba M., 2005, AMINOACYL TRNA SYNTH; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JAKUBOWSKI H, 1981, NUCLEIC ACIDS RES, V9, P3105, DOI 10.1093/nar/9.13.3105; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; LEWINSOHN R, 1967, BIOCHIM BIOPHYS ACTA, V140, P24, DOI 10.1016/0005-2795(67)90378-9; LIN SX, 1984, BIOCHEMISTRY-US, V23, P4109, DOI 10.1021/bi00313a015; LIN SX, 1983, BIOCHEMISTRY-US, V22, P681, DOI 10.1021/bi00272a024; LIU HJ, 1995, NUCLEIC ACIDS RES, V23, P165, DOI 10.1093/nar/23.1.165; MASCARENHAS A, 2008, IN PRESS PROTEIN ENG; MUSIERFORSYTH K, 1991, P NATL ACAD SCI USA, V88, P209, DOI 10.1073/pnas.88.1.209; RAUNIO R, 1970, ACTA CHEM SCAND, V24, P2737, DOI 10.3891/acta.chem.scand.24-2737; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; SCHIMMEL P, 1995, TRENDS BIOCHEM SCI, V20, P1, DOI 10.1016/S0968-0004(00)88937-9; Stehlin C, 1997, BIOCHEMISTRY-US, V36, P2932, DOI 10.1021/bi962295s; Stehlin C, 1998, BIOCHEMISTRY-US, V37, P8605, DOI 10.1021/bi980364s; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Wong FC, 2003, J BIOL CHEM, V278, P52857, DOI 10.1074/jbc.M309627200; Wong FC, 2002, BIOCHEMISTRY-US, V41, P7108, DOI 10.1021/bi012178j; Zhang H, 2000, PROTEINS, V40, P86, DOI 10.1002/(SICI)1097-0134(20000701)40:1<86::AID-PROT100>3.0.CO;2-Y	44	53	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7128	7134		10.1074/jbc.M709902200	http://dx.doi.org/10.1074/jbc.M709902200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18180290	hybrid			2022-12-27	WOS:000253779600058
J	Stengel, A; Benz, P; Balsera, M; Soll, J; Bolter, B				Stengel, Anna; Benz, Philipp; Balsera, Monica; Soll, Juergen; Boelter, Bettina			TIC62 redox-regulated translocon composition and dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST PROTEIN IMPORT; CIRCULAR-DICHROISM; CALCIUM REGULATION; ARABIDOPSIS; EXPRESSION; LIGHT; MACHINERY; MEMBRANES; SIGNALS; COMPLEX	The preprotein translocon at the inner envelope of chloroplasts (Tic complex) facilitates the import of nuclear-encoded preproteins into the organelle. Seven distinct subunits have been identified so far. For each of those, specific functions have been proposed based on structural prediction or experimental evidence. Three of those subunits possess modules that could act as redox-active regulatory components in the import process. To date, however, the mode of redox regulation of the import process remains enigmatic. To investigate how the chloroplast redox state influences translocon behavior and composition, we studied the Tic component and the putative redox sensor Tic62 in more detail. The experimental results provide evidence that Tic62 can act as a bona fide dehydrogenase in vitro, and that it changes its localization in the chloroplast dependent on the NADP(+)/NADPH ratio in the stroma. Moreover, the redox state influences the interactions of Tic62 with the translocon and the flavoenzyme ferredoxin-NADP(+) oxidoreductase. Additionally, we give initial experimental insights into the Tic62 structure using circular dichroism measurements and demonstrate that the protein consists of two structurally different domains. Our results indicate that Tic62 possesses redox-dependent properties that would allow it to fulfill a role as redox sensor protein in the chloroplast.	[Stengel, Anna; Benz, Philipp; Balsera, Monica; Soll, Juergen; Boelter, Bettina] Univ Munich, Munich Ctr Integrated Prot Sci CiPSM, D-81377 Munich, Germany; [Stengel, Anna; Benz, Philipp; Balsera, Monica; Soll, Juergen; Boelter, Bettina] Univ Munich, Dept Biol 1, D-80638 Munich, Germany	University of Munich; University of Munich	Bolter, B (corresponding author), Univ Munich, Dept Biol 1, Menzinger Str 67, D-80638 Munich, Germany.	boelter@lrz.uni-muenchen.de	Balsera, Monica/K-2877-2014; Benz, J. Philipp/ABG-5009-2020	Balsera, Monica/0000-0002-5586-6050; Benz, J. Philipp/0000-0001-5361-4514				Balsera M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-43; Becker T, 2004, EMBO J, V23, P520, DOI 10.1038/sj.emboj.7600089; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Caliebe A, 1997, EMBO J, V16, P7342, DOI 10.1093/emboj/16.24.7342; Chigri F, 2005, PLANT J, V42, P821, DOI 10.1111/j.1365-313X.2005.02414.x; Chigri F, 2006, P NATL ACAD SCI USA, V103, P16051, DOI 10.1073/pnas.0607150103; Donahue JL, 1997, PLANT PHYSIOL, V113, P249, DOI 10.1104/pp.113.1.249; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fey V, 2005, J BIOL CHEM, V280, P5318, DOI 10.1074/jbc.M406358200; Gray JC, 2005, ANNU PLANT REV, V13, P237; Heddad M, 2006, PLANT PHYSIOL, V142, P75, DOI 10.1104/pp.106.081489; Hirohashi T, 2001, PLANT PHYSIOL, V125, P2154, DOI 10.1104/pp.125.4.2154; Hormann F, 2004, J BIOL CHEM, V279, P34756, DOI 10.1074/jbc.M402817200; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; KEEGSTRA K, 1986, METHOD ENZYMOL, V118, P316; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; Kuchler M, 2002, EMBO J, V21, P6136, DOI 10.1093/emboj/cdf621; Lintala M, 2007, PLANT J, V49, P1041, DOI 10.1111/j.1365-313X.2006.03014.x; Mano J, 2001, BBA-BIOENERGETICS, V1504, P275, DOI 10.1016/S0005-2728(00)00256-5; Palatnik JF, 1997, PLANT PHYSIOL, V115, P1721, DOI 10.1104/pp.115.4.1721; Stengel A, 2007, BIOL CHEM, V388, P765, DOI 10.1515/BC.2007.099; Trebitsh T, 2000, MOL CELL BIOL, V20, P1116, DOI 10.1128/MCB.20.4.1116-1123.2000; Waegemann K, 1995, METHOD CELL BIOL, V50, P255, DOI 10.1016/S0091-679X(08)61035-3; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Zickermann V, 2000, BBA-BIOENERGETICS, V1459, P61, DOI 10.1016/S0005-2728(00)00113-4	26	66	71	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6656	6667		10.1074/jbc.M706719200	http://dx.doi.org/10.1074/jbc.M706719200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18180301	hybrid			2022-12-27	WOS:000253779600007
J	Zhang, M; Swanson, PC				Zhang, Ming; Swanson, Patrick C.			V(D)J recombinase binding and cleavage of cryptic recombination signal sequences identified from lymphoid malignancies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECEPTOR; CHROMOSOME-TRANSLOCATION; GENOMIC INSTABILITY; TAL-1 GENE; B-CELL; RAG; TRANSPOSITION; LEUKEMIA; LOCUS; REARRANGEMENT	V(D)J recombination is a process integral to lymphocyte development. However, this process is not always benign, since certain lymphoid malignancies exhibit recurrent chromosomal abnormalities, such as translocations and deletions, that harbor molecular signatures suggesting an origin from aberrant V( D) J recombination. Translocations involving LMO2, TAL1, Ttg- 1, and Hox11, as well as a recurrent interstitial deletion at 1p32 involving SIL/SCL, are cited examples of illegitimate V( D) J recombination. Previous studies using extrachromosomal substrates reveal that cryptic recombination signal sequences (cRSSs) identified near the translocation breakpoint in these examples support V( D) J recombination with efficiencies ranging from about 30- to 20,000-fold less than bona fide V( D) J recombination signals. To understand the molecular basis for these large differences, we investigated the binding and cleavage of these cRSSs by the RAG1/2 proteins that initiate V( D) J recombination. We find that the RAG proteins comparably bind all cRSSs tested, albeit more poorly than a consensus RSS. We show that four cRSSs that support levels of V( D) J recombination above background levels in cell culture ( LMO2, TAL1, Ttg- 1, and SIL) are also cleaved by the RAG proteins in vitro with efficiencies ranging from 18 to 70% of a consensus RSS. Cleavage of LMO2 and Ttg- 1 by the RAG proteins can also be detected in cell culture using ligation-mediated PCR. In contrast, Hox11 and SCL are nicked but not cleaved efficiently in vitro, and cleavage at other adventitious sites in plasmid substrates may also limit the ability to detect recombination activity at these cRSSs in cell culture.	[Zhang, Ming; Swanson, Patrick C.] Creighton Univ, Med Ctr, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	Creighton University	Swanson, PC (corresponding author), Creighton Univ, Med Ctr, Dept Med Microbiol & Immunol, 2500 Calif Plaza, Omaha, NE 68178 USA.	pswanson@creighton.edu			NCRR NIH HHS [C06 RR17417-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bergeron S, 2006, METHOD ENZYMOL, V408, P511, DOI 10.1016/S0076-6879(06)08032-3; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; Cayuela JM, 1997, BLOOD, V90, P3720, DOI 10.1182/blood.V90.9.3720; Chatterji M, 2006, MOL CELL BIOL, V26, P1558, DOI 10.1128/MCB.26.4.1558-1568.2006; CHEN Q, 1990, J EXP MED, V172, P1403, DOI 10.1084/jem.172.5.1403; CHENG JT, 1990, J EXP MED, V171, P489, DOI 10.1084/jem.171.2.489; Cowell LG, 2003, J EXP MED, V197, P207, DOI 10.1084/jem.20020250; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; KAGAN J, 1989, P NATL ACAD SCI USA, V86, P4161, DOI 10.1073/pnas.86.11.4161; Kitagawa Y, 2002, J BIOL CHEM, V277, P46289, DOI 10.1074/jbc.M208353200; Kriatchko AN, 2006, MOL CELL BIOL, V26, P4712, DOI 10.1128/MCB.02487-05; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lee AI, 2003, PLOS BIOL, V1, P56, DOI 10.1371/journal.pbio.0000001; Lewis SM, 1997, MOL CELL BIOL, V17, P3125, DOI 10.1128/MCB.17.6.3125; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Marculescu R, 2002, J EXP MED, V195, P85, DOI 10.1084/jem.20011578; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Messier TL, 2003, EMBO J, V22, P1381, DOI 10.1093/emboj/cdg137; Nadel B, 1998, J IMMUNOL, V161, P6068; Neiditch MB, 2002, MOL CELL, V9, P871, DOI 10.1016/S1097-2765(02)00494-X; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; Rahman NS, 2006, J BIOL CHEM, V281, P12370, DOI 10.1074/jbc.M507906200; Reddy YVR, 2006, GENE DEV, V20, P1575, DOI 10.1101/gad.1432706; Swanson PC, 2004, J BIOL CHEM, V279, P4034, DOI 10.1074/jbc.M311100200; Swanson PC, 2002, MOL CELL BIOL, V22, P7790, DOI 10.1128/MCB.22.22.7790-7801.2002; Vanura K, 2007, PLOS BIOL, V5, P515, DOI 10.1371/journal.pbio.0050043; YOFFE G, 1989, BLOOD, V74, P374; ZUTTER M, 1990, P NATL ACAD SCI USA, V87, P3161, DOI 10.1073/pnas.87.8.3161	34	43	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6717	6727		10.1074/jbc.M710301200	http://dx.doi.org/10.1074/jbc.M710301200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18187418	hybrid			2022-12-27	WOS:000253779600013
J	Cao, J; Chiarelli, C; Richman, O; Zarrabi, K; Kozarekar, P; Zucker, S				Cao, Jian; Chiarelli, Christian; Richman, Omer; Zarrabi, Kevin; Kozarekar, Pallavi; Zucker, Stanley			Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-CELL MIGRATION; 1-MATRIX METALLOPROTEINASE; CARCINOMA-CELLS; EXTRACELLULAR-MATRIX; TISSUE INHIBITOR; PRO-GELATINASE; INVASION; METASTASIS; EXPRESSION; GROWTH	By mining DNA microarray data bases at GenBankTM, we identified up-regulation of membrane type 1 matrix metalloproteinase (MT1-MMP) in human primary and metastatic prostate cancer specimens as compared with nonmalignant prostate tissues. To explore the role of up-regulated MT1-MMP in early stage cancer progression, we have employed a three-dimensional cell culture model. Minimally invasive human prostate cancer cells (LNCaP) were transfected with MT1-green fluorescent protein (GFP) chimeric cDNA as compared with GFP cDNA, and morphologic and phenotypic changes were characterized. GFP-expressing LNCaP cells formed multicellular spheroids with cuboidal-like epithelial morphology, whereas MT1-GFP-expressing cells displayed a fibroblast-like morphology and a scattered growth pattern in type I collagen gels. Cell morphologic changes were accompanied by decreased epithelial markers and enhanced mesenchymal markers, consistent with epithelial-to-mesenchymal transition. MT1-MMP-induced morphologic change and cell scattering were abrogated by target inhibition of either the catalytic domain or the hemopexin domain. We further demonstrated that MT1-MMP-induced phenotypic changes were dependent upon up-regulation of Wnt5a, which has been implicated in epithelial-to-mesenchymal transition. We conclude that MT1-MMP plays an important role in early cancer dissemination by converting epithelial cells to migratory mesenchymal-like cells.	[Cao, Jian; Richman, Omer; Zarrabi, Kevin; Kozarekar, Pallavi; Zucker, Stanley] SUNY Stony Brook, Dept Med, Sch Med, Stony Brook, NY 11794 USA; [Chiarelli, Christian; Zucker, Stanley] Vet Adm Med Ctr, Dept Res, Northport, NY 11768 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Cao, J (corresponding author), SUNY Stony Brook, Dept Med, Sch Med, Life Sci Bldg,Rm 004, Stony Brook, NY 11794 USA.	jian.cao@sunysb.edu			NCI NIH HHS [R01 CA 113553-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113553] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Cao J, 2005, THROMB HAEMOSTASIS, V93, P770, DOI 10.1160/TH04-08-0555; Cao J, 1998, J BIOL CHEM, V273, P34745, DOI 10.1074/jbc.273.52.34745; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; CAO J, 1995, J BIOL CHEM, V270, P801, DOI 10.1074/jbc.270.2.801; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cheng SF, 2003, AM J PATHOL, V162, P1937, DOI 10.1016/S0002-9440(10)64327-1; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Civenni G, 2003, EMBO REP, V4, P166, DOI 10.1038/sj.embor.embor735; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Dhanasekaran SM, 2004, FASEB J, V18, P243, DOI 10.1096/fj.04-2415fje; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dwivedi DJ, 2006, AM J PATHOL, V168, P69, DOI 10.2353/ajpath.2006.041089; Enmon RM, 2002, BIOTECHNOL BIOENG, V80, P580, DOI 10.1002/bit.10394; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hess AR, 2003, CANCER RES, V63, P4757; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Illman SA, 2006, J CELL SCI, V119, P3856, DOI 10.1242/jcs.03157; IOZZO RV, 1995, CANCER RES, V55, P3495; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Klingelhofer J, 2003, ONCOGENE, V22, P1181, DOI 10.1038/sj.onc.1206245; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; McGuire JK, 2003, AM J PATHOL, V162, P1831, DOI 10.1016/S0002-9440(10)64318-0; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Nie J, 2007, J BIOL CHEM, V282, P6438, DOI 10.1074/jbc.M607337200; Niggemann B, 2004, EXP CELL RES, V298, P178, DOI 10.1016/j.yexcr.2004.04.001; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nusse R, 2005, NATURE, V438, P747, DOI 10.1038/438747a; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Taki M, 2003, CANCER SCI, V94, P593, DOI 10.1111/j.1349-7006.2003.tb01488.x; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsatas D, 2002, J CLIN NEUROSCI, V9, P282, DOI 10.1054/jocn.2001.1063; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	58	86	90	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6232	6240		10.1074/jbc.M705759200	http://dx.doi.org/10.1074/jbc.M705759200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18174174	hybrid			2022-12-27	WOS:000253779500030
J	Taylor, RP; Parker, GJ; Hazel, MW; Soesanto, Y; Fuller, W; Yazzie, MJ; McClain, DA				Taylor, Rodrick P.; Parker, Glendon J.; Hazel, Mark W.; Soesanto, Yudi; Fuller, William; Yazzie, Marla J.; McClain, Donald A.			Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked N-acetylglucosaminyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; GLYCOGEN-SYNTHASE; SKELETAL-MUSCLE; TETRATRICOPEPTIDE REPEATS; HEXOSAMINE BIOSYNTHESIS; SUBSTRATE-SPECIFICITY; TRANSFERASE; STRESS; GLYCOSYLATION; PATHWAY	O-Linked N-acetylglucosamine (O-GlcNAc) is a post-translational modification of proteins that functions as a nutrient sensing mechanism. Here we report on regulation of O-GlcNAcylation over a broad range of glucose concentrations. We have discovered a significant induction of O-GlcNAc modification of a limited number of proteins under conditions of glucose deprivation. Beginning 12 h after treatment, glucose-deprived human hepatocellular carcinoma (HepG2) cells demonstrate a 7.8-fold increase in total O-GlcNAc modification compared with cells cultured in normal glucose (5 mM; p = 0.008). Some of the targets of glucose deprivation-induced O-GlcNAcylation are distinct from those modified in response to high glucose (20 mM) or glucosamine (10 mM) treatment, suggesting differential targeting with glucose deprivation and glucose excess. O-GlcNAcylation of glycogen synthase is significantly increased with glucose deprivation, and this O-GlcNAc increase contributes to a 60% decrease (p = 0.004) in glycogen synthase activity. Increased O-GlcNAc modification is not mediated by increased UDP-GlcNAc, the rate-limiting substrate for O-GlcNAcylation. Rather, the mRNA for nucleocytoplasmic O-linked N-acetylglucosaminyltransferase (OGT) increases 3.4-fold within 6 h of glucose deprivation (p = 0.006). Within 12 h, OGT protein increases 1.7-fold (p = 0.01) compared with normal glucose-treated cells. In addition, 12-h glucose deprivation leads to a 49% decrease in O-GlcNAcase protein levels (p = 0.03). We conclude that increased O-GlcNAc modification stimulated by glucose deprivation results from increased OGT and decreased O-GlcNAcase levels and that these changes affect cell metabolism, thus inactivating glycogen synthase.	[Taylor, Rodrick P.; Soesanto, Yudi; McClain, Donald A.] Univ Utah, Sch Med, Dept Biochem, Div Endocrinol, Salt Lake City, UT 84132 USA; [Taylor, Rodrick P.; Parker, Glendon J.; Hazel, Mark W.; Soesanto, Yudi; Fuller, William; Yazzie, Marla J.; McClain, Donald A.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA; [McClain, Donald A.] Vet Affairs Med Ctr, Res Serv, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	McClain, DA (corresponding author), Univ Utah, Sch Med, Dept Biochem, Div Endocrinol, 30 N 2030 E, Salt Lake City, UT 84132 USA.	donald.mcclain@hsc.utah.edu		McClain, Don/0000-0002-3310-2359; Fuller, William/0000-0002-5883-4433	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043526] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK 43526] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Cheng XG, 2000, J STEROID BIOCHEM, V75, P147, DOI 10.1016/S0960-0760(00)00167-9; Cooksey RC, 1999, ENDOCRINOLOGY, V140, P1151, DOI 10.1210/en.140.3.1151; Crosson SM, 2003, J CLIN INVEST, V111, P1423, DOI 10.1172/JCI200317975; Gazdag AC, 2000, AM J PHYSIOL-REG I, V278, pR504, DOI 10.1152/ajpregu.2000.278.2.R504; Guinez C, 2006, GLYCOBIOLOGY, V16, P22, DOI 10.1093/glycob/cwj041; Guinez C, 2004, BIOCHEM BIOPH RES CO, V319, P21, DOI 10.1016/j.bbrc.2004.04.144; Guinez C, 2007, BIOCHEM BIOPH RES CO, V361, P414, DOI 10.1016/j.bbrc.2007.07.020; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; Lefebvre T, 2001, BIOCHEM J, V360, P179, DOI 10.1042/0264-6021:3600179; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Luo B, 2007, J BIOL CHEM, V282, P7172, DOI 10.1074/jbc.M607362200; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; Nelson BA, 1997, AM J PHYSIOL-ENDOC M, V272, pE848, DOI 10.1152/ajpendo.1997.272.5.E848; Nolte D, 2002, MAMM GENOME, V13, P62, DOI 10.1007/s00335-001-2108-9; Park KS, 2000, METABOLISM, V49, P962, DOI 10.1053/meta.2000.7717; Parker G, 2004, J BIOL CHEM, V279, P20636, DOI 10.1074/jbc.M312139200; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; Skurat AV, 2000, DIABETES, V49, P1096, DOI 10.2337/diabetes.49.7.1096; Sohn KC, 2004, BIOCHEM BIOPH RES CO, V322, P1045, DOI 10.1016/j.bbrc.2004.08.023; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Yki-Jarvinen H, 1998, METABOLISM, V47, P449, DOI 10.1016/S0026-0495(98)90058-0; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	37	108	113	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6050	6057		10.1074/jbc.M707328200	http://dx.doi.org/10.1074/jbc.M707328200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18174169	hybrid			2022-12-27	WOS:000253779500010
J	Kowieski, TM; Lee, S; Denu, JM				Kowieski, Terri M.; Lee, Susan; Denu, John M.			Acetylation-dependent ADP-ribosylation by Trypanosoma brucei Sir2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILENCING PROTEIN SIR2; PANCREATIC BETA-CELLS; HISTONE/PROTEIN DEACETYLASES; CALORIE RESTRICTION; NAD(+)-DEPENDENT DEACETYLASES; TRANSCRIPTION FACTORS; HISTONE DEACETYLASE; SIR2-LIKE PROTEINS; INSULIN-SECRETION; INCREASED DOSAGE	Sirtuins are a highly conserved family of proteins implicated in diverse cellular processes such as gene silencing, aging, and metabolic regulation. Although many sirtuins catalyze a well characterized protein/histone deacetylation reaction, there are a number of reports that suggest protein ADP-ribosyltransferase activity. Here we explored the mechanisms of ADP-ribosylation using the Trypanosoma brucei Sir2 homologue TbSIR2rp1 as a model for sirtuins that reportedly display both activities. Steady-state kinetic analysis revealed a highly active histone deacetylase (k(cat) = 0.1 s(-1), with K-m values of 42 mu M and for NAD(+) and 65 mu M for acetylated substrate). A series of biochemical assays revealed that TbSIR2rp1 ADP-ribosylation of protein/histone requires an acetylated substrate. The data are consistent with two distinct ADP-ribosylation pathways that involve an acetylated substrate, NAD(+) and TbSIR2rp1 as follows: 1) a noncatalytic reaction between the deacetylation product O-acetyl-ADP-ribose (or its hydrolysis product ADP-ribose) and histones, and 2) a more efficient mechanism involving interception of an ADP-ribose-acetylpeptide-enzyme intermediate by a side-chain nucleophile from bound histone. However, the sum of both ADP-ribosylation reactions was similar to 5 orders of magnitude slower than histone deacetylation under identical conditions. The biological implications of these results are discussed.	[Kowieski, Terri M.; Lee, Susan; Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.	jmdenu@wisc.edu						Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borra MT, 2004, METHOD ENZYMOL, V376, P171; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; CervantesLaurean D, 1996, J BIOL CHEM, V271, P10461, DOI 10.1074/jbc.271.18.10461; CERVANTESLAUREAN D, 1993, BIOCHEMISTRY-US, V32, P1528, DOI 10.1021/bi00057a017; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Garcia-Salcedo JA, 2003, EMBO J, V22, P5851, DOI 10.1093/emboj/cdg553; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luger K, 1999, METH MOL B, V119, P1; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rafty LA, 2002, J BIOL CHEM, V277, P47114, DOI 10.1074/jbc.M208997200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Sereno D, 2006, PARASITOL RES, V100, P1, DOI 10.1007/s00436-006-0280-2; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsang AW, 1998, J BIOL CHEM, V273, P31788, DOI 10.1074/jbc.273.48.31788; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang J, 1997, METHOD ENZYMOL, V280, P255; ZHANG J, 1993, BIOCHEMISTRY-US, V32, P2228, DOI 10.1021/bi00060a014; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	56	50	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5317	5326		10.1074/jbc.M707613200	http://dx.doi.org/10.1074/jbc.M707613200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165239	hybrid			2022-12-27	WOS:000253426700011
J	Thangasamy, A; Rogge, J; Ammanamanchi, S				Thangasamy, Amalraj; Rogge, Jessica; Ammanamanchi, Sudhakar			Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE-STIMULATING PROTEIN; TRANSCRIPTIONAL REPRESSION; RECEPTOR; CARCINOMA; MET; COEXPRESSION; OVEREXPRESSION; IDENTIFICATION; PROGRESSION; ACTIVATION	RON (recepteur d'origine nantais), a tyrosine kinase receptor for macrophage-stimulating protein (MSP) was implicated in tumor progression. However, it was not investigated how this important oncogene is regulated. We show that MSP promotes invasion of MDA MB 231 and MDA MB 468 but not MCF-7 breast cancer cells. Reverse transcription-PCR and Western analysis indicated the expression of RON message and protein, respectively, in MDA MB 231 and MDA MB 468 cells but not in MCF-7 cells. RON expression correlated with Sp1 expression. Initial analysis of a 1.2-kb and 400-bp RON promoter in MDA MB 231 and MDA MB 468 cells suggested the presence of all the necessary regulatory elements within 400 bp from the transcription start site. Site-directed mutagenesis of the 400-bp RON promoter revealed that the overlapping Sp1 sites at -94 (Sp1-3/4) and Sp1 site at -113 (Sp1-5) are essential for RON gene transcription. Electrophoretic mobility shift assays and chromatin immunoprecipitation analysis indicated that Sp1 binding to these sites is required for RON promoter activity. Ectopic Sp1 expression in Sp1 null SL2 cells confirmed the involvement of these Sp1 sites in the regulation of oncogenic RON tyrosine kinase. Treatment of MDA MB 231 cells with mithramycin A, an inhibitor of Sp1 binding, or siRNA knockdown of Sp1 blocked RON gene expression and MSP-mediated invasion of MDA MB 231 cells. This is the first report demonstrating a clear link between Sp1-dependent RON tyrosine kinase expression and invasion of breast carcinoma cells.	[Thangasamy, Amalraj; Rogge, Jessica; Ammanamanchi, Sudhakar] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Med Oncol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Ammanamanchi, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Med Oncol, San Antonio, TX 78229 USA.	ammanamanchi@uthscsa.edu						Ammanamanchi S, 2004, J BIOL CHEM, V279, P32620, DOI 10.1074/jbc.M402691200; Ammanamanchi S, 2001, J BIOL CHEM, V276, P3348, DOI 10.1074/jbc.M002462200; Bardella C, 2004, CANCER RES, V64, P5154, DOI 10.1158/0008-5472.CAN-04-0600; Bezerra JA, 1998, J CLIN INVEST, V101, P1175, DOI 10.1172/JCI1744; Camp ER, 2005, ANN SURG ONCOL, V12, P273, DOI 10.1245/ASO.2005.08.013; Chen QY, 1997, HEPATOLOGY, V26, P59; Chen YQ, 2000, EXP CELL RES, V261, P229, DOI 10.1006/excr.2000.5012; Cheng HL, 2005, BRIT J CANCER, V92, P1906, DOI 10.1038/sj.bjc.6602593; DELGATTO F, 1995, BBA-GENE STRUCT EXPR, V1263, P93, DOI 10.1016/0167-4781(95)00082-R; Lee TJ, 2006, MOL CANCER THER, V5, P2737, DOI 10.1158/1535-7163.MCT-06-0426; Lee WY, 2005, CLIN CANCER RES, V11, P2222, DOI 10.1158/1078-0432.CCR-04-1761; Lin HS, 2004, ARCH OTOLARYNGOL, V130, P311, DOI 10.1001/archotol.130.3.311; Maggiora P, 2003, EXP CELL RES, V288, P382, DOI 10.1016/S0014-4827(03)00250-7; Muraoka RS, 1999, J CLIN INVEST, V103, P1277, DOI 10.1172/JCI6091; Peace BE, 2003, EXP CELL RES, V289, P317, DOI 10.1016/S0014-4827(03)00280-5; Penengo L, 2003, ONCOGENE, V22, P3669, DOI 10.1038/sj.onc.1206585; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Venkatasubbarao K, 2001, CANCER RES, V61, P6239; Waltz SE, 2001, J CLIN INVEST, V108, P567, DOI 10.1172/JCI11881; Wang MH, 2000, CARCINOGENESIS, V21, P1507, DOI 10.1093/carcin/21.8.1507; Wang MH, 2006, ACTA PHARMACOL SIN, V27, P641, DOI 10.1111/j.1745-7254.2006.00361.x; Willett CG, 1998, AM J RESP CELL MOL, V18, P489, DOI 10.1165/ajrcmb.18.4.2978; Yokoyama N, 2005, J BIOL CHEM, V280, P8893, DOI 10.1074/jbc.M412623200; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	25	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5335	5343		10.1074/jbc.M706957200	http://dx.doi.org/10.1074/jbc.M706957200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165235	hybrid			2022-12-27	WOS:000253426700013
J	Chen, YQ; Kuo, MS; Li, SY; Bui, HH; Peake, DA; Sanders, PE; Thibodeaux, SJ; Chu, SY; Qian, YW; Zhao, Y; Bredt, DS; Moller, DE; Konrad, RJ; Beigneux, AP; Young, SG; Cao, GQ				Chen, Yan Qun; Kuo, Ming-Shang; Li, Shuyu; Bui, Hai H.; Peake, David A.; Sanders, Philip E.; Thibodeaux, Stefan J.; Chu, Shaoyou; Qian, Yue-Wei; Zhao, Yang; Bredt, David S.; Moller, David E.; Konrad, Robert J.; Beigneux, Anne P.; Young, Stephen G.; Cao, Guoqing			AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; TANDEM MASS-SPECTROMETRY; FUNCTIONAL-CHARACTERIZATION; TRIACYLGLYCEROL SYNTHESIS; HEPATIC STEATOSIS; ACYL-COA; II CELLS; IDENTIFICATION; CLONING; GENE	AGPAT6 is a member of the 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT) family that appears to be important in triglyceride biosynthesis in several tissues, but the precise biochemical function of the enzyme is unknown. In the current study, we show that AGPAT6 is a microsomal glycerol-3-phosphate acyltransferase (GPAT). Membranes from HEK293 cells overexpressing human AGPAT6 had higher levels of GPAT activity. Substrate specificity studies suggested that AGPAT6 was active against both saturated and unsaturated long-chain fatty acyl-CoAs. Both glycerol 3-phosphate and fatty acyl-CoA increased the GPAT activity, and the activity was sensitive to N-ethylmaleimide, a sulfhydryl-modifying reagent. Purified AGPAT6 protein possessed GPAT activity but not AGPAT activity. Using [C-13(7)] oleic acid labeling and mass spectrometry, we found that overexpression of AGPAT6 increased both lysophosphatidic acid and phosphatidic acid levels in cells. In these studies, total triglyceride and phosphatidylcholine levels were not significantly altered, although there were significant changes in the abundance of specific phosphatidylcholine species. Human AGPAT6 is localized to endoplasmic reticulum and is broadly distributed in tissues. Membranes of mammary epithelial cells from Agpat6-deficient mice exhibited markedly reduced GPAT activity compared with membranes from wildtype mice. Reducing AGPAT6 expression in HEK293 cells through small interfering RNA knockdown suggested that AGPAT6 significantly contributed to HEK293 cellular GPAT activity. Our data indicate that AGPAT6 is a microsomal GPAT, and we propose renaming this enzyme GPAT4.	[Chen, Yan Qun; Kuo, Ming-Shang; Li, Shuyu; Bui, Hai H.; Peake, David A.; Thibodeaux, Stefan J.; Chu, Shaoyou; Qian, Yue-Wei; Zhao, Yang; Bredt, David S.; Moller, David E.; Konrad, Robert J.; Cao, Guoqing] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Beigneux, Anne P.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Dept Med, Los Angeles, CA 90095 USA	Eli Lilly; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cao, GQ (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	Guoqing_cao@lilly.com	lewchavaroj, runglawan/B-5191-2009	Chen, Yan Q/0000-0001-9311-6077; Young, Stephen/0000-0001-7270-3176	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066621] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL 66621] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agarwal AK, 2007, J ENDOCRINOL, V193, P445, DOI 10.1677/JOe-07-0027; Aguado B, 1998, J BIOL CHEM, V273, P4096, DOI 10.1074/jbc.273.7.4096; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; COLEMAN RA, 1978, J BIOL CHEM, V253, P7256; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Gonzalez-Baro MR, 2007, AM J PHYSIOL-GASTR L, V292, pG1195, DOI 10.1152/ajpgi.00553.2006; Gonzalez-Baro MR, 2001, J BIOL CHEM, V276, P43182, DOI 10.1074/jbc.M107885200; Hammond LE, 2002, MOL CELL BIOL, V22, P8204, DOI 10.1128/MCB.22.23.8204-8214.2002; Han XL, 2001, ANAL BIOCHEM, V295, P88, DOI 10.1006/abio.2001.5178; Igal RA, 2001, J BIOL CHEM, V276, P42205, DOI 10.1074/jbc.M103386200; Lewin TM, 2004, J BIOL CHEM, V279, P13488, DOI 10.1074/jbc.M314032200; Li D, 2003, J HUM GENET, V48, P438, DOI 10.1007/s10038-003-0045-z; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Linden D, 2004, J LIPID RES, V45, P1279, DOI 10.1194/jlr.M400010-JLR200; Linden D, 2006, FASEB J, V20, P434, DOI 10.1096/fj.05-4568com; Murata N, 1997, BBA-LIPID LIPID MET, V1348, P10, DOI 10.1016/S0005-2760(97)00115-X; Murphy RC, 2007, ANAL BIOCHEM, V366, P59, DOI 10.1016/j.ab.2007.03.012; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; SHIN DH, 1991, J BIOL CHEM, V266, P23834; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Wang S, 2007, ARCH BIOCHEM BIOPHYS, V465, P347, DOI 10.1016/j.abb.2007.06.033; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200	28	101	114	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10048	10057		10.1074/jbc.M708151200	http://dx.doi.org/10.1074/jbc.M708151200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18238778	hybrid, Green Published			2022-12-27	WOS:000254671600059
J	van Wonderen, JH; Burlat, B; Richardson, DJ; Cheesman, MR; Butt, JN				van Wonderen, Jessica H.; Burlat, Benedicte; Richardson, David J.; Cheesman, Myles R.; Butt, Julea N.			The nitric oxide reductase activity of cytochrome c nitrite reductase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN FILM VOLTAMMETRY; NITROSATIVE STRESS; NITRATE; FLAVORUBREDOXIN; REDOX; DETOXIFICATION; INHIBITION; MECHANISM; MYOGLOBIN; SYNTHASE	Cytochrome c nitrite reductase ( NrfA) from Escherichia coli has a well established role in the respiratory reduction of nitrite to ammonium. More recently the observation that anaerobically grown E. coli nrf mutants were more sensitive to NO center dot than the parent strain led to the proposal that NrfA might also participate in NO center dot detoxification. Here we describe protein film voltammetry that presents a quantitative description of NrfA NO center dot reductase activity. NO center dot reduction is initiated at similar potentials to NrfA-catalyzed reduction of nitrite and hydroxylamine. All three activities are strongly inhibited by cyanide. Together these results suggest a common site for reduction of all three substrates as axial ligands to the lysine-coordinated NrfA heme rather than nonspecific NO center dot reduction at one of the four His-His coordinated hemes also present in each NrfA subunit. NO center dot reduction by NrfA is described by a Km of the order of 300 mu M. The predicted turnover number of similar to 840 NO center dot s(-1) is much higher than that of the dedicated respiratory NO center dot reductases of denitrification and the flavorubredoxin and flavohemoglobin of E. coli that are also proposed to play roles in NO center dot detoxification. In considering the manner by which anaerobically growing E. coli might detoxify exogenously generated NO center dot encountered during invasion of a human host it appears that the periplasmically located NrfA should be effective in maintaining low NO center dot levels such that any NO center dot reaching the cytoplasm is efficiently removed by flavorubredoxin ( K-m similar to 0.4 mu M).	[van Wonderen, Jessica H.; Burlat, Benedicte; Richardson, David J.; Cheesman, Myles R.; Butt, Julea N.] Univ E Anglia, Sch Chem Sci & Pharm, Sch Biol Sci, Ctr Metalloprot Spect & Biol, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Butt, JN (corresponding author), Univ E Anglia, Sch Chem Sci & Pharm, Sch Biol Sci, Ctr Metalloprot Spect & Biol, Norwich NR4 7TJ, Norfolk, England.	j.butt@uea.ac.uk	Butt, Julea/E-2133-2011; Richardson, David J/E-2275-2011; van Wonderen, Jessica/A-9728-2013; Richardson, David/N-5129-2014	Butt, Julea/0000-0002-9624-5226; Richardson, David/0000-0002-7751-1058	Biotechnology and Biological Sciences Research Council [B18695] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Anderson LJ, 2001, BIOCHEMISTRY-US, V40, P11294, DOI 10.1021/bi002706b; Angove HC, 2002, J BIOL CHEM, V277, P23374, DOI 10.1074/jbc.M200495200; Bamford VA, 2002, BIOCHEMISTRY-US, V41, P2921, DOI 10.1021/bi015765d; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Burlat B, 2005, BIOCHEM SOC T, V33, P137, DOI 10.1042/BST0330137; CLARKE TA, 2008, IN PRESS METHODS ENZ; COSTA C, 1990, FEBS LETT, V276, P67, DOI 10.1016/0014-5793(90)80508-G; da Costa PN, 2003, FEMS MICROBIOL LETT, V218, P385, DOI 10.1016/S0378-1097(02)01186-2; Donzelli S, 2006, ANTIOXID REDOX SIGN, V8, P1363, DOI 10.1089/ars.2006.8.1363; Einsle O, 2002, J AM CHEM SOC, V124, P11737, DOI 10.1021/ja0206487; Fujiwara T, 1996, J BACTERIOL, V178, P1866, DOI 10.1128/jb.178.7.1866-1871.1996; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Gwyer JD, 2006, BIOPHYS J, V91, P3897, DOI 10.1529/biophysj.106.089755; Gwyer JD, 2006, BIOCHEM SOC T, V34, P133, DOI 10.1042/BST0340133; Gwyer JD, 2005, J AM CHEM SOC, V127, P14964, DOI 10.1021/ja054160s; Gwyer JD, 2004, BIOELECTROCHEMISTRY, V63, P43, DOI 10.1016/j.bioelechem.2003.10.013; Gwyer JD, 2004, BIOCHEMISTRY-US, V43, P15086, DOI 10.1021/bi049085x; HEISS B, 1989, J BACTERIOL, V171, P3288, DOI 10.1128/jb.171.6.3288-3297.1989; Justino MC, 2005, J BIOL CHEM, V280, P2636, DOI 10.1074/jbc.M411070200; KAJIE SI, 1986, EUR J BIOCHEM, V154, P457, DOI 10.1111/j.1432-1033.1986.tb09419.x; Kelm M, 1999, BBA-BIOENERGETICS, V1411, P273, DOI 10.1016/S0005-2728(99)00020-1; Millar SJ, 1996, MEAT SCI, V42, P277, DOI 10.1016/0309-1740(94)00045-X; Poock SR, 2002, J BIOL CHEM, V277, P23664, DOI 10.1074/jbc.M200731200; Poole RK, 2000, MOL MICROBIOL, V36, P775, DOI 10.1046/j.1365-2958.2000.01889.x; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Raines KW, 2006, INFECT IMMUN, V74, P2268, DOI 10.1128/IAI.74.4.2268-2276.2006; Ridnour LA, 2000, ANAL BIOCHEM, V281, P223, DOI 10.1006/abio.2000.4583; SEWARD HE, 1999, MAGNETO OPTICAL SPEC; Simon J, 2002, FEMS MICROBIOL REV, V26, P285, DOI 10.1111/j.1574-6976.2002.tb00616.x; SNYDER SH, 1992, SCI AM, V266, P68, DOI 10.1038/scientificamerican0592-68; Stach P, 2000, J INORG BIOCHEM, V79, P381, DOI 10.1016/S0162-0134(99)00248-2; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07	35	84	87	4	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9587	9594		10.1074/jbc.M709090200	http://dx.doi.org/10.1074/jbc.M709090200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18245085	hybrid			2022-12-27	WOS:000254671600012
J	Ozaki, S; Kawakami, H; Nakamura, K; Fujikawa, N; Kagawa, W; Park, SY; Yokoyama, S; Kurumizaka, H; Katayama, T				Ozaki, Shogo; Kawakami, Hironori; Nakamura, Kenta; Fujikawa, Norie; Kagawa, Wataru; Park, Sam-Yong; Yokoyama, Shigeyuki; Kurumizaka, Hitoshi; Katayama, Tsutomu			A common mechanism for the ATP-DnaA-dependent formation of open complexes at the replication origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; SINGLE-STRANDED-DNA; IN-VITRO; THERMOTOGA-MARITIMA; INITIATOR PROTEIN; STRUCTURAL BASIS; ABC-PRIMOSOME; E. COLI; MOTIF; BOX	Initiation of chromosomal replication and its cell cycle-coordinated regulation bear crucial and fundamental mechanisms in most cellular organisms. Escherichia coli DnaA protein forms a homomultimeric complex with the replication origin (oriC). ATP-DnaA multimers unwind the duplex within the oriC unwinding element (DUE). In this study, structural analyses suggested that several residues exposed in the central pore of the putative structure of DnaA multimers could be important for unwinding. Using mutation analyses, we found that, of these candidate residues, DnaA Val-211 and Arg-245 are prerequisites for initiation in vivo and in vitro. Whereas DnaA V211A and R245A proteins retained normal affinities for ATP/ADP and DNA and activity for the ATP-specific conformational change of the initiation complex in vitro, oriC complexes of these mutant proteins were inactive in DUE unwinding and in binding to the single-stranded DUE. Unlike oriC complexes including ADP-DnaA or the mutant DnaA, ATP-DnaA-oriC complexes specifically bound the upper strand of single-stranded DUE. Specific T-rich sequences within the strand were required for binding. The corresponding conserved residues of the DnaA ortholog in Thermotoga maritima, an ancient eubacterium, were also required for DUE unwinding, consistent with the idea that the mechanism and regulation for DUE unwinding can be evolutionarily conserved. These findings provide novel insights into mechanisms for pore-mediated origin unwinding, ATP/ADP-dependent regulation, and helicase loading of the initiation complex.	[Ozaki, Shogo; Kawakami, Hironori; Nakamura, Kenta; Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Fukuoka 8128582, Japan; [Fujikawa, Norie; Kagawa, Wataru; Yokoyama, Shigeyuki; Kurumizaka, Hitoshi] RIKEN, Genom Res Ctr, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan; [Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo 1698555, Japan	Kyushu University; RIKEN; University of Tokyo; Waseda University	Katayama, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Fukuoka 8128582, Japan.	katayama@phar.kyushu-u.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Kawakami, Hironori/H-6792-2017	Yokoyama, Shigeyuki/0000-0003-3133-7338; Kawakami, Hironori/0000-0001-8971-1914; Kurumizaka, Hitoshi/0000-0001-7412-3722; Ozaki, Shogo/0000-0002-4384-1366; Katayama, Tsutomu/0000-0001-9994-1684; Kagawa, Wataru/0000-0002-8801-6589				Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Camara JE, 2005, EMBO REP, V6, P736, DOI 10.1038/sj.embor.7400467; CROOKE E, 1993, J MOL BIOL, V233, P16, DOI 10.1006/jmbi.1993.1481; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Goedken ER, 2005, NAT STRUCT MOL BIOL, V12, P183, DOI 10.1038/nsmb889; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; HWANG DS, 1992, J BIOL CHEM, V267, P23087; HWANG DS, 1988, J BIOL CHEM, V263, P10625; Ishida T, 2004, J BIOL CHEM, V279, P45546, DOI 10.1074/jbc.M402762200; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawakami H, 2006, MOL MICROBIOL, V62, P1310, DOI 10.1111/j.1365-2958.2006.05450.x; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kumar A, 2007, J VIROL, V81, P4808, DOI 10.1128/JVI.02451-06; MASAI H, 1995, EUR J BIOCHEM, V230, P384; MASAI H, 1990, J BIOL CHEM, V265, P15134; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Neuwald AF, 1999, GENOME RES, V9, P27; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Okuno T, 2006, J STRUCT BIOL, V156, P109, DOI 10.1016/j.jsb.2006.02.003; Ozaki S, 2006, GENES CELLS, V11, P425, DOI 10.1111/j.1365-2443.2006.00950.x; Pei HD, 2007, NUCLEIC ACIDS RES, V35, P3087, DOI 10.1093/nar/gkm137; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Shimuta T, 2004, GENES CELLS, V9, P1151, DOI 10.1111/j.1365-2443.2004.00800.x; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Su'etsugu M, 2001, MOL MICROBIOL, V40, P376, DOI 10.1046/j.1365-2958.2001.02378.x; Weigel C, 1999, MOL MICROBIOL, V34, P53, DOI 10.1046/j.1365-2958.1999.01568.x; Weigel C, 2002, MOL MICROBIOL, V46, P1149, DOI 10.1046/j.1365-2958.2002.03232.x; YUNG BYM, 1990, J BIOL CHEM, V265, P1282; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x	46	97	97	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8351	8362		10.1074/jbc.M708684200	http://dx.doi.org/10.1074/jbc.M708684200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18216012	hybrid			2022-12-27	WOS:000254288000033
J	Rhee, JE; Sheng, WY; Morgan, LK; Nolet, R; Liao, XB; Kenney, LJ				Rhee, Jee Eun; Sheng, Wanyun; Morgan, Leslie K.; Nolet, Ryan; Liao, Xiubei; Kenney, Linda J.			Amino acids important for DNA recognition by the response regulator OmpR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; NUCLEAR-MAGNETIC-RESONANCE; PATHOGENICITY ISLAND 2; POSITIVE REGULATOR; OUTER-MEMBRANE; SALMONELLA-TYPHIMURIUM; PHOSPHORYLATION SITE; TRANSCRIPTION FACTOR; SHIGELLA-FLEXNERI; RNA-POLYMERASE	Response regulators undergo regulated phosphorylation and dephosphorylation at conserved aspartic acid residues in bacterial signal transduction systems. OmpR is a winged helix-turn-helix DNA-binding protein that functions as a global regulator in bacteria and is also important in pathogenesis. A detailed mechanistic picture of how OmpR binds to DNA and activates transcription is lacking. We used NMR spectroscopy to solve the solution structure of the C-terminal domain of OmpR (OmpR(C)) and to analyze the chemical shift changes that occur upon DNA binding. There is little overlap in the interaction surface with residues of PhoB that were reportedly involved in protein/protein interactions in its head-to-tail dimer. Multiple factors account for the lack of overlap. One is that the spacing between the OmpR half-sites is shorter than observed with PhoB, requiring the arrangement of the two OmpR molecules to be different from that of the PhoB dimer on DNA. A second is the demonstration herein that OmpR can bind to its high affinity site as a monomer. As a result, OmpR(C) appears to be capable of adopting alternative orientations depending on the precise base composition of the binding site, which also contributes to the lack of overlap. In the presence of DNA, chemical shift changes occur in OmpR in the recognition alpha-helix3, the loop between beta-strand 4 and alpha-helix 1, and the loop between beta-strands 5 and 6. DNA contact residues are Val(203) (T), Arg(207) (G), and Arg(209) (phosphate backbone). Our results suggest that OmpR binds to DNA as a monomer and then forms a symmetric or asymmetric dimer, depending on the binding site. We propose that during activation OmpR binds to DNA and undergoes a conformational change that promotes phosphorylation of the N-terminal receiver domain, the receiver domains dimerize, and then the second monomer binds to DNA. The flexible linker of OmpR enables the second monomer to bind in multiple orientations (head-to-tail and head-to-head), depending on the specific DNA contacts.	[Sheng, Wanyun; Nolet, Ryan; Liao, Xiubei] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Rhee, Jee Eun; Morgan, Leslie K.; Kenney, Linda J.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Liao, XB (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA.	xiubei@uic.edu; kenneyl@uic.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058746] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 058746] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIBA H, 1989, J BIOCHEM-TOKYO, V106, P5, DOI 10.1093/oxfordjournals.jbchem.a122817; Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; BERNARDINI ML, 1993, INFECT IMMUN, V61, P3625, DOI 10.1128/IAI.61.9.3625-3635.1993; BERNARDINI ML, 1990, J BACTERIOL, V172, P6274, DOI 10.1128/jb.172.11.6274-6281.1990; Blanco JB, 2003, CHEM BIOL, V10, P713, DOI 10.1016/S1074-5521(03)00172-8; Brzostek K, 2003, FEMS MICROBIOL LETT, V228, P265, DOI 10.1016/S0378-1097(03)00779-1; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; CLORE GM, 1987, BIOCHEMISTRY-US, V26, P8012, DOI 10.1021/bi00398a069; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DELGADO J, 1993, MOL MICROBIOL, V10, P1037, DOI 10.1111/j.1365-2958.1993.tb00974.x; Doreleijers JF, 1998, J MOL BIOL, V281, P149, DOI 10.1006/jmbi.1998.1808; DORMAN CJ, 1989, INFECT IMMUN, V57, P2136, DOI 10.1128/IAI.57.7.2136-2140.1989; Dorrell N, 1998, FEMS MICROBIOL LETT, V165, P145, DOI 10.1016/S0378-1097(98)00267-5; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; HALL MN, 1981, J MOL BIOL, V151, P1, DOI 10.1016/0022-2836(81)90218-7; HALL MN, 1981, J MOL BIOL, V146, P23, DOI 10.1016/0022-2836(81)90364-8; HARLOCKER SL, 1995, J BIOL CHEM, V270, P26849, DOI 10.1074/jbc.270.45.26849; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Hong E, 2007, J BIOL CHEM, V282, P20667, DOI 10.1074/jbc.M609104200; Huang KJ, 1996, J MOL BIOL, V262, P615, DOI 10.1006/jmbi.1996.0540; IGO MM, 1988, J BACTERIOL, V170, P5971, DOI 10.1128/jb.170.12.5971-5973.1988; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; KATO M, 1989, FEBS LETT, V249, P168, DOI 10.1016/0014-5793(89)80617-9; KENNEY LJ, 1995, P NATL ACAD SCI USA, V92, P8866, DOI 10.1073/pnas.92.19.8866; King-Scott J, 2007, J BIOL CHEM, V282, P37717, DOI 10.1074/jbc.M705081200; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Lindgren SW, 1996, P NATL ACAD SCI USA, V93, P4197, DOI 10.1073/pnas.93.9.4197; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; Maris AE, 2005, J MOL BIOL, V350, P843, DOI 10.1016/j.jmb.2005.05.057; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; Mattison K, 2002, J MOL BIOL, V315, P497, DOI 10.1006/jmbi.2001.5222; Mattison K, 2002, J BIOL CHEM, V277, P32714, DOI 10.1074/jbc.M204122200; NARA F, 1986, MOL GEN GENET, V202, P194, DOI 10.1007/BF00331636; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; PICKARD D, 1994, INFECT IMMUN, V62, P3984, DOI 10.1128/IAI.62.9.3984-3993.1994; PRATT LA, 1995, MOL MICROBIOL, V17, P565, DOI 10.1111/j.1365-2958.1995.mmi_17030565.x; RACZKOWSKA A, 2004, ACTA MICROBIOL POL, V53, P11; RAMPERSAUD A, 1994, J BIOL CHEM, V269, P12559; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; RUSSO FD, 1991, J MOL BIOL, V222, P567, DOI 10.1016/0022-2836(91)90497-T; SLAUCH JM, 1989, J MOL BIOL, V210, P281, DOI 10.1016/0022-2836(89)90330-6; TATE S, 1988, FEBS LETT, V242, P27, DOI 10.1016/0014-5793(88)80978-5; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; Tran VK, 2000, J MOL BIOL, V299, P1257, DOI 10.1006/jmbi.2000.3809; TSUZUKI M, 1994, J MOL BIOL, V242, P607, DOI 10.1006/jmbi.1994.1610; VANALPHEN W, 1977, J BACTERIOL, V131, P623; Walthers D, 2003, J BACTERIOL, V185, P317, DOI 10.1128/JB.185.1.317-324.2003; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200	62	64	65	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8664	8677		10.1074/jbc.M705550200	http://dx.doi.org/10.1074/jbc.M705550200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18195018	hybrid, Green Published			2022-12-27	WOS:000254288000065
J	Buttner, S; Bitto, A; Ring, J; Augsten, M; Zabrocki, P; Eisenberg, T; Jungwirth, H; Hutter, S; Carmona-Gutierrez, D; Kroemer, G; Winderickx, J; Madeo, F				Buettner, Sabrina; Bitto, Alessandro; Ring, Julia; Augsten, Manuela; Zabrocki, Piotr; Eisenberg, Tobias; Jungwirth, Helmut; Hutter, Sylvia; Carmona-Gutierrez, Didac; Kroemer, Guido; Winderickx, Joris; Madeo, Frank			Functional mitochondria are required for alpha-synuclein toxicity in aging yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROBLASTOMA SH-SY5Y CELLS; PARKINSONS-DISEASE; SACCHAROMYCES-CEREVISIAE; REGULATES APOPTOSIS; OXIDATIVE STRESS; DEATH; MUTATION; 6-HYDROXYDOPAMINE; NEURODEGENERATION; INVOLVEMENT	alpha-Synuclein is one of the principal toxic triggers of Parkinson disease, an age-associated neurodegeneration. Using old yeast as a model of alpha-synuclein expression in post-mitotic cells, we show that alpha-synuclein toxicity depends on chronological aging and results in apoptosis as well as necrosis. Neither disruption of key components of the unfolded protein response nor deletion of proapoptotic key players (including the yeast caspase YCA1, the apoptosis-inducing factor AIF1, or the serine protease OMI) did prevent alpha-synuclein-induced cell killing. However, abrogation of mitochondrial DNA (rho(0)) inhibited alpha-synuclein-induced reactive oxygen species formation and subsequent apoptotic cell death. Thus, introducing an aging yeast model of alpha-synuclein toxicity, we demonstrate a strict requirement of functional mitochondria.	[Buettner, Sabrina; Ring, Julia; Augsten, Manuela; Eisenberg, Tobias; Jungwirth, Helmut; Hutter, Sylvia; Carmona-Gutierrez, Didac; Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Bitto, Alessandro; Zabrocki, Piotr; Winderickx, Joris] Catholic Univ Louvain, B-3000 Louvain, Belgium; [Kroemer, Guido] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France; [Kroemer, Guido] Univ Paris 11, F-94805 Villejuif, France	University of Graz; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Madeo, F (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50, A-8010 Graz, Austria.	frank.madeo@uni-graz.at	KROEMER, Guido/B-4263-2013; Kroemer, Guido/AAY-9859-2020; Eisenberg, Tobias/AAV-7806-2021	KROEMER, Guido/0000-0002-9334-4405; Buttner, Sabrina/0000-0002-2786-8542; Madeo, Frank/0000-0002-5070-1329; Carmona-Gutierrez, Didac/0000-0001-7548-7771; Eisenberg, Tobias/0000-0003-3559-1130; Ring, Julia/0000-0003-4991-9328; Jungwirth, Helmut/0000-0003-4868-4571				Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; da Costa CA, 2002, J BIOL CHEM, V277, P50980, DOI 10.1074/jbc.M207825200; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Gomez-Santos C, 2003, J NEUROSCI RES, V73, P341, DOI 10.1002/jnr.10663; Gourlay CW, 2005, J CELL SCI, V118, P2119, DOI 10.1242/jcs.02337; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Kroemer G, 2007, PLOS BIOL, V5, P1409, DOI 10.1371/journal.pbio.0050206; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; Liss B, 2001, NEWS PHYSIOL SCI, V16, P214; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Tofaris GK, 2005, MOVEMENT DISORD, V20, pS37, DOI 10.1002/mds.20538; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wood-Kaczmar A, 2006, TRENDS MOL MED, V12, P521, DOI 10.1016/j.molmed.2006.09.007; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yamamuro A, 2006, NEUROCHEM RES, V31, P657, DOI 10.1007/s11064-006-9062-6; Zabrocki P, 2005, FEBS J, V272, P1386, DOI 10.1111/j.1742-4658.2005.04571.x; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	39	115	118	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7554	7560		10.1074/jbc.M708477200	http://dx.doi.org/10.1074/jbc.M708477200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18192273	hybrid			2022-12-27	WOS:000253997900030
J	Perez, JM; Arenas, FA; Pradenas, GA; Sandoval, JM; Vasquez, CC				Perez, Jose Manuel; Arenas, Felipe A.; Pradenas, Gonzalo A.; Sandoval, Juan M.; Vasquez, Claudio C.			Escherichia coli YqhD exhibits aldehyde reductase activity and protects from the harmful effect of lipid peroxidation-derived aldehydes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOL-DEHYDROGENASE; OXIDATIVE STRESS; GENE-EXPRESSION; MECHANISM; PRODUCTS; PROTEINS; ACROLEIN; IDENTIFICATION; INACTIVATION; GLUTATHIONE	Evidence that Escherichia coli YqhD is involved in bacterial response to compounds that generate membrane lipid peroxidation is presented. Overexpression of yqhD results in increased resistance to the reactive oxygen species-generating compounds hydrogen peroxide, paraquat, chromate, and potassium tellurite. Increased tolerance was also observed for the lipid peroxidation-derived aldehydes butanaldehyde, propanaldehyde, acrolein, and malondialdehyde and the membrane-peroxidizing compound tert-butylhydroperoxide. Expression of yqhD was also associated with changes in the concentration of intracellular peroxides and cytoplasmic protein carbonyl content and with a reduction in intracellular acrolein levels. When compared with the wild type strain, an yqhD mutant exhibited a sensitive phenotype to all these compounds and also augmented levels of thiobarbituric acid-reactive substances, which may indicate an increased level of lipid peroxidation. Purified YqhD catalyzes the in vitro reduction of acetaldehyde, malondialdehyde, propanaldehyde, butanaldehyde, and acrolein in a NADPH-dependent reaction. Finally, yqhD transcription was induced in cells that had been exposed to conditions favoring lipid peroxidation. Taken together these results indicate that this enzyme may have a physiological function by protecting the cell against the toxic effect of aldehydes derived from lipid oxidation. We speculate that in Escherichia coli YqhD is part of a glutathione-independent, NADPH-dependent response mechanism to lipid peroxidation.	[Perez, Jose Manuel; Arenas, Felipe A.; Pradenas, Gonzalo A.; Sandoval, Juan M.; Vasquez, Claudio C.] Univ Santiago Chile, Mol Microbiol Lab, Dept Biol, Fac Quim & Biol, Santiago, Chile	Universidad de Santiago de Chile	Vasquez, CC (corresponding author), Univ Santiago Chile, Mol Microbiol Lab, Dept Biol, Fac Quim & Biol, Casilla 40,Correo 33, Santiago, Chile.	cvasquez@usach.cl	Pérez-Donoso, José M./G-3668-2013	Pérez-Donoso, José M./0000-0002-9506-1716				Ackerley DF, 2006, J BACTERIOL, V188, P3371, DOI 10.1128/JB.188.9.3371-3381.2006; Burczynski ME, 2001, J BIOL CHEM, V276, P2890, DOI 10.1074/jbc.M006655200; Calderon IL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000070; Cha MK, 1996, J BACTERIOL, V178, P5610, DOI 10.1128/jb.178.19.5610-5614.1996; Chen JJ, 1998, BBA-GEN SUBJECTS, V1380, P336, DOI 10.1016/S0304-4165(98)00002-6; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denich TJ, 2003, J MICROBIOL METH, V52, P149, DOI 10.1016/S0167-7012(02)00155-0; Echave P, 2003, J BIOL CHEM, V278, P30193, DOI 10.1074/jbc.M304351200; ESTERBAUER H, 1975, Z NATURFORSCH C, V30, P466; Esterbauer H., 1982, FREE RADICAL LIPID P, P101; ESTERBAUER H, 1990, MEMBRANE LIPID OXIDA, V1, P239; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Girotti AW, 1998, J LIPID RES, V39, P1529; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hansen EH, 2004, APPL ENVIRON MICROB, V70, P1749, DOI 10.1128/AEM.70.3.1749-1757.2004; HARTLEY DP, 1995, ARCH BIOCHEM BIOPHYS, V316, P197, DOI 10.1006/abbi.1995.1028; Ho KK, 2005, J BACTERIOL, V187, P1067, DOI 10.1128/JB.187.3.1067-1073.2005; Hua Q, 2004, APPL ENVIRON MICROB, V70, P2354, DOI 10.1128/AEM.70.4.2354-2366.2004; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; ITOH M, 1995, J BIOCHEM, V117, P780, DOI 10.1093/oxfordjournals.jbchem.a124776; Kitagawa M, 2000, FEMS MICROBIOL LETT, V184, P165, DOI 10.1111/j.1574-6968.2000.tb09009.x; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Mano J, 2002, PLANT CELL PHYSIOL, V43, P1445, DOI 10.1093/pcp/pcf187; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; NEUDECKER T, 1991, MUTAT RES, V264, P193, DOI 10.1016/0165-7992(91)90077-H; Perez JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000211; Picklo MJ, 2001, J NEUROPATH EXP NEUR, V60, P686, DOI 10.1093/jnen/60.7.686; PORTER NA, 1984, METHOD ENZYMOL, V105, P273; Refsgaard HHF, 2000, P NATL ACAD SCI USA, V97, P611, DOI 10.1073/pnas.97.2.611; Rice-Evans C, 1991, LAB TECHNIQUES BIOCH, V22, P147; Rittner HL, 1999, J CLIN INVEST, V103, P1007, DOI 10.1172/JCI4711; Semchyshyn H, 2005, CELL BIOL INT, V29, P898, DOI 10.1016/j.cellbi.2005.08.002; Shapiro E, 2002, ANTIMICROB AGENTS CH, V46, P2490, DOI 10.1128/AAC.46.8.2490-2497.2002; SLININGER PJ, 1985, APPL ENVIRON MICROB, V50, P1444, DOI 10.1128/AEM.50.6.1444-1450.1985; Srivastava S, 1998, BIOCHEM J, V329, P469, DOI 10.1042/bj3290469; Sulzenbacher G, 2004, J MOL BIOL, V342, P489, DOI 10.1016/j.jmb.2004.07.034; SZWEDA LI, 1993, J BIOL CHEM, V268, P3342; Turner RJ, 1999, MICROBIOL-UK, V145, P2549, DOI 10.1099/00221287-145-9-2549; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; UCHIDA K, 1993, J BIOL CHEM, V268, P6288; Wang AY, 2005, J BACTERIOL, V187, P3259, DOI 10.1128/JB.187.9.3259-3266.2005; Yang IY, 2001, J BIOL CHEM, V276, P9071, DOI 10.1074/jbc.M008918200; Yoon SJ, 2002, J BIOCHEM MOL BIOL, V35, P297; Zhang Xiao-Mei, 2005, Sheng Wu Gong Cheng Xue Bao, V21, P743; Zu XY, 2007, TOXICOL SCI, V97, P562, DOI 10.1093/toxsci/kfm033	45	134	186	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7346	7353		10.1074/jbc.M708846200	http://dx.doi.org/10.1074/jbc.M708846200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18211903	hybrid			2022-12-27	WOS:000253997900008
J	Froquet, R; Cherix, N; Birke, R; Benghezal, M; Cameroni, E; Letourneur, F; Mosch, HU; De Virgilio, C; Cosson, P				Froquet, Romain; Cherix, Nathalie; Birke, Raphael; Benghezal, Mohammed; Cameroni, Elisabetta; Letourneur, Francois; Moesch, Hans-Ulrich; De Virgilio, Claudio; Cosson, Pierre			Control of cellular physiology by TM9 proteins in yeast and Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; LYSOSOMAL-ENZYMES; GENE DISRUPTION; PSEUDOHYPHAE FORMATION; SIGNALING PATHWAYS; INVASIVE GROWTH; MAP KINASE; FLO11 GENE; SLIME-MOLD	TM9 proteins constitute a well defined family, characterized by the presence of a large variable extracellular domain and nine putative transmembrane domains. This family is highly conserved throughout evolution and comprises three members in Dictyostelium discoideum and Saccharomyces cerevisiae and four in humans and mice. In Dictyostelium, previous analysis demonstrated that TM9 proteins are implicated in cellular adhesion. In this study, we generated TM9 mutants in S. cerevisiae and analyzed their phenotype with particular attention to cellular adhesion. S. cerevisiae strains lacking any one of the three TM9 proteins were severely suppressed for adhesive growth and filamentous growth under conditions of nitrogen starvation. In these mutants, expression of the FLO11-lacZ reporter gene was strongly reduced, whereas expression of FRE(Ty1)-lacZ was not, suggesting that TM9 proteins are implicated at a late stage of nutrient-controlled signaling pathways. We also reexamined the phenotype of Dictyostelium TM9 mutant cells, focusing on nutrient-controlled cellular functions. Although the initiation of multicellular development and autophagy was unaltered in Dictyostelium TM9 mutants, nutrient-controlled secretion of lysosomal enzymes was dysregulated in these cells. These results suggest that in both yeast and amoebae, TM9 proteins participate in the control of specific cellular functions in response to changing nutrient conditions.	[Froquet, Romain; Cherix, Nathalie; Benghezal, Mohammed; Cosson, Pierre] Univ Geneva, Ctr Med Univ, Dept Physiol & Metab Cellulaire, CH-1211 Geneva 4, Switzerland; [Birke, Raphael; Moesch, Hans-Ulrich] Univ Marburg, Dept Genet, D-35043 Marburg, Germany; [Cameroni, Elisabetta; De Virgilio, Claudio] Univ Fribourg, Dept Med, Div Biochem, CH-1700 Fribourg, Switzerland; [Letourneur, Francois] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot,IFR128 Biosci Lyon Gerland, F-69367 Lyon 07, France	University of Geneva; Philipps University Marburg; University of Fribourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Cosson, P (corresponding author), Univ Geneva, Ctr Med Univ, Dept Physiol & Metab Cellulaire, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	Pierre.Cosson@medecine.unige.ch	De Virgilio, Claudio/B-4707-2012	Benghezal, Mohammed/0000-0002-4207-0192; De Virgilio, Claudio/0000-0001-8826-4323; Letourneur, Francois/0000-0003-2232-6127				Benghezal M, 2003, MOL BIOL CELL, V14, P2890, DOI 10.1091/mbc.E02-11-0724; BERTHOLDT G, 1985, CELL DIFFER DEV, V16, P187, DOI 10.1016/0045-6039(85)90516-0; Braus GH, 2003, MOL BIOL CELL, V14, P4272, DOI 10.1091/mbc.e03-01-0042; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; CATERINA MJ, 1994, J BIOL CHEM, V269, P1523; Cherix N, 2006, MOL BIOL CELL, V17, P4982, DOI 10.1091/mbc.E06-07-0619; Chluba-de Tapia J, 1997, GENE, V197, P195, DOI 10.1016/S0378-1119(97)00263-1; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Cutler NS, 2001, MOL BIOL CELL, V12, P4103, DOI 10.1091/mbc.12.12.4103; DIMOND RL, 1983, METHOD ENZYMOL, V96, P815; DIMOND RL, 1981, J BIOL CHEM, V256, P6565; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; Gebbie L, 2004, MOL BIOL CELL, V15, P3915, DOI 10.1091/mbc.E03-12-0908; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Journet A, 1999, J CELL SCI, V112, P3833; Kosta A, 2004, J BIOL CHEM, V279, P48404, DOI 10.1074/jbc.M408924200; Lefkir Y, 2003, MOL BIOL CELL, V14, P1835, DOI 10.1091/mbc.E02-10-0627; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Mosch HU, 1997, GENETICS, V145, P671; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Otto GP, 2004, J BIOL CHEM, V279, P15621, DOI 10.1074/jbc.M311139200; Otto GP, 2004, MOL MICROBIOL, V51, P63, DOI 10.1046/j.1365-2958.2003.03826.x; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Pan XW, 2000, CURR OPIN MICROBIOL, V3, P567, DOI 10.1016/S1369-5274(00)00142-9; Ravanel K, 2001, EUR J CELL BIOL, V80, P754, DOI 10.1078/0171-9335-00215; RICHARDSON JM, 1988, J CELL BIOL, V107, P2097, DOI 10.1083/jcb.107.6.2097; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; SCHIESTL RH, 1991, P NATL ACAD SCI USA, V88, P7585, DOI 10.1073/pnas.88.17.7585; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGERKRUGER B, 1993, J BIOL CHEM, V268, P14376; Sugasawa T, 2001, GENE, V273, P227, DOI 10.1016/S0378-1119(01)00587-X; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310	41	25	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6764	6772		10.1074/jbc.M704484200	http://dx.doi.org/10.1074/jbc.M704484200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18178563	Green Submitted, Green Accepted, hybrid			2022-12-27	WOS:000253779600018
J	Kawahara, K; Hashimoto, M; Bar-On, P; Ho, GJ; Crews, L; Mizuno, H; Rockenstein, E; Imam, SZ; Masliah, E				Kawahara, Kohichi; Hashimoto, Makoto; Bar-On, Pazit; Ho, Gilbert J.; Crews, Leslie; Mizuno, Hideya; Rockenstein, Edward; Imam, Syed Z.; Masliah, Eliezer			alpha-Synuclein aggregates interfere with parkin solubility and distribution - Role in the pathogenesis of Parkinson disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY BODY DISEASE; UBIQUITIN-PROTEIN LIGASE; CENTRAL-NERVOUS-SYSTEM; NEUROBLASTOMA-CELLS; NEURODEGENERATIVE DISORDERS; NACP/ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; IN-VITRO; PROTEASOMAL ACTIVITY; S-NITROSYLATION	Parkinson disease (PD) belongs to a heterogeneous group of neurodegenerative disorders with movement alterations, cognitive impairment, and alpha-synuclein accumulation in cortical and subcortical regions. Jointly, these disorders are denominated Lewy body disease. Mutations in the parkin gene are the most common cause of familial parkinsonism, and a growing number of studies have shown that stress factors associated with sporadic PD promote parkin accumulation in the insoluble fraction. alpha-Synuclein and parkin accumulation and mutations in these genes have been associated with familial PD. To investigate whether alpha-synuclein accumulation might be involved in the pathogenesis of these disorders by interfering with parkin solubility, synuclein-transfected neuronal cells were transduced with lentiviral vectors expressing parkin. Challenging neurons with proteasome inhibitors or amyloid-beta resulted in accumulation of insoluble parkin and, to a lesser extent, alpha-tubulin. Similarly to neurons in the brains of patients with Lewy body disease, in co-transduced cells alpha-synuclein and parkin colocalized and co-immunoprecipitated. These effects resulted in decreased parkin and alpha-tubulin ubiquitination, accumulation of insoluble parkin, and cytoskeletal alterations with reduced neurite outgrowth. Taken together, accumulation of alpha-synuclein might contribute to the pathogenesis of PD and other Lewy body diseases by promoting alterations in parkin and tubulin solubility, which in turn might compromise neural function by damaging the neuronal cytoskeleton. These studies provide a new perspective on the potential nature of pathogenic alpha-synuclein and parkin interactions in Parkinson disease.	[Imam, Syed Z.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Imam, Syed Z.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Imam, Syed Z.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Aging & Longev Studies, San Antonio, TX 78229 USA; [Kawahara, Kohichi; Hashimoto, Makoto; Bar-On, Pazit; Ho, Gilbert J.; Mizuno, Hideya; Rockenstein, Edward; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92039 USA; [Crews, Leslie; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92039 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; University of California System; University of California San Diego	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	emasliah@ucsd.edu	Kawahara, Kohichi/AAQ-5381-2021; Crews, Leslie/B-7584-2014	Crews, Leslie/0000-0003-0704-0067	NATIONAL INSTITUTE ON AGING [R37AG018440, R01AG018440, P01AG022074, P01AG010435] Funding Source: NIH RePORTER; NIA NIH HHS [AG10435, AG22074, AG18440] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Betarbet R, 2005, EXP NEUROL, V191, pS17, DOI 10.1016/j.expneurol.2004.08.021; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Choi P, 2000, NEUROREPORT, V11, P2635, DOI 10.1097/00001756-200008210-00006; Choi P, 2001, NEUROREPORT, V12, P2839, DOI 10.1097/00001756-200109170-00017; Chung KKK, 2005, METHOD ENZYMOL, V396, P139, DOI 10.1016/S0076-6879(05)96014-X; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; De Girolamo LA, 2000, J NEUROCHEM, V75, P133, DOI 10.1046/j.1471-4159.2000.0750133.x; Dickson DW, 2001, CURR OPIN NEUROL, V14, P423, DOI 10.1097/00019052-200108000-00001; Dickson DW, 1996, J NEURAL TRANSM-SUPP, P31; Drolet RE, 2004, NEUROTOXICOLOGY, V25, P761, DOI 10.1016/j.neuro.2004.05.002; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Golbe LI, 2004, ANN NEUROL, V55, P153, DOI 10.1002/ana.20036; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hashimoto M, 2004, GENE THER, V11, P1713, DOI 10.1038/sj.gt.3302349; Hashimoto M, 2003, NEUROCHEM RES, V28, P1743, DOI 10.1023/A:1026073324672; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hashimoto M, 2003, J NEUROCHEM, V85, P1468, DOI 10.1046/j.1471-4159.2003.01791.x; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hattori N, 2003, J NEUROL, V250, P2, DOI 10.1007/s00415-003-1302-y; Haywood AFM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-14; Hyun DH, 2005, J NEUROSCI RES, V82, P232, DOI 10.1002/jnr.20638; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Iwai A, 1996, BRAIN RES, V720, P230, DOI 10.1016/0006-8993(96)00014-5; Jensen LD, 2006, NEUROREPORT, V17, P1205, DOI 10.1097/01.wnr.0000230511.63220.e3; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kahle PJ, 2004, EMBO REP, V5, P681, DOI 10.1038/sj.embor.7400188; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; KOSAKA K, 1984, CLIN NEUROPATHOL, V3, P183; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kyratzi E, 2007, J NEUROCHEM, V102, P1292, DOI 10.1111/j.1471-4159.2007.04620.x; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee HJ, 2006, EUR J NEUROSCI, V24, P3153, DOI 10.1111/j.1460-9568.2006.05210.x; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Marr RA, 2003, J NEUROSCI, V23, P1992; MARSHALL LE, 1978, BIOCHIM BIOPHYS ACTA, V543, P590, DOI 10.1016/0304-4165(78)90315-X; MASLIAH E, 1993, BRAIN PATHOL, V3, P77, DOI 10.1111/j.1750-3639.1993.tb00728.x; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McInerney-Leo A, 2005, MOVEMENT DISORD, V20, P1, DOI 10.1002/mds.20316; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Mouradian MM, 2002, NEUROLOGY, V58, P179, DOI 10.1212/WNL.58.2.179; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Ren Y, 2003, J NEUROSCI, V23, P3316; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Schlossmacher MG, 2002, AM J PATHOL, V160, P1655, DOI 10.1016/S0002-9440(10)61113-3; Shastry BS, 2001, NEUROSCI RES, V41, P5, DOI 10.1016/S0168-0102(01)00254-1; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snyder H, 2004, J MOL NEUROSCI, V24, P425, DOI 10.1385/JMN:24:3:425; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Springer W, 2005, HUM MOL GENET, V14, P3407, DOI 10.1093/hmg/ddi371; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Takeda A, 1998, AM J PATHOL, V152, P367; Takenouchi T, 2001, MOL CELL NEUROSCI, V17, P141, DOI 10.1006/mcne.2000.0923; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Uversky VN, 2001, J BIOL CHEM, V276, P43495, DOI 10.1074/jbc.C100551200; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Wakabayashi K, 1998, ACTA NEUROPATHOL, V96, P445, DOI 10.1007/s004010050918; Wang C, 2005, HUM MOL GENET, V14, P3885, DOI 10.1093/hmg/ddi413; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; Wong ESP, 2007, J BIOL CHEM, V282, P12310, DOI 10.1074/jbc.M609466200; Yamada M, 2005, HUM GENE THER, V16, P262, DOI 10.1089/hum.2005.16.262; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zeng BY, 2005, MECH AGEING DEV, V126, P760, DOI 10.1016/j.mad.2005.01.008; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	80	43	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6979	6987		10.1074/jbc.M710418200	http://dx.doi.org/10.1074/jbc.M710418200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18195004	hybrid			2022-12-27	WOS:000253779600042
J	Liu, MY; Tanaka, WN; Zhu, H; Xie, G; Dooley, DM; Lei, BF				Liu, Mengyao; Tanaka, Wesley N.; Zhu, Hui; Xie, Gang; Dooley, David M.; Lei, Benfang			Direct hemin transfer from IsdA to IsdC in the iron-regulated surface determinant (Isd) heme acquisition system of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PYOGENES; PROTEIN SHP; HTSABC TRANSPORTER; BINDING; IDENTIFICATION; HEMOGLOBIN; DISSOCIATION; HEMOPHORE; ENVELOPE	The iron-regulated surface determinants (Isd) of Staphylococcus aureus, including surface proteins IsdA, IsdB, IsdC, and IsdH and ATP-binding cassette transporter IsdDEF, constitute the machinery for acquiring heme as a preferred iron source. Here we report hemin transfer from hemin-containing IsdA (holo-IsdA) to hemin-free IsdC (apo-IsdC). The reaction has an equilibrium constant of 10 +/- 5 at 22 degrees C in favor of holo-IsdC formation. During the reaction, holo-IsdA binds to apo-IsdC and then transfers the cofactor to apo-IsdC with a rate constant of 54.3 +/- 1.8 s(-1) at 25 degrees C. The transfer rate is > 70,000 times greater than the rate of simple hemin dissociation from holo-IsdA into solvent (k(transfer) = 54.3 s(-1) versus k_(hemin) = 0.00076 s(-1)). The standard free energy change, Delta G(0), is - 27 kJ/mol for the formation of the holo-IsdA-apo-IsdC complex. IsdC has a higher affinity for hemin than IsdA. These results indicate that the IsdA-to-IsdC hemin transfer is through the activated holo-IsdA-apo-IsdC complex and is driven by the higher affinity of apo-IsdC for the cofactor. These findings demonstrate for the first time in the Isd system that heme transfer is rapid, direct, and affinity-driven from IsdA to IsdC. These results also provide the first example of heme transfer from one surface protein to another surface protein in Gram-positive bacteria and, perhaps most importantly, indicate that the mechanism of activated heme transfer, which we previously demonstrated between the streptococcal proteins Shp and HtsA, may apply in general to all bacterial heme transport systems.	[Liu, Mengyao; Tanaka, Wesley N.; Zhu, Hui; Xie, Gang; Lei, Benfang] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59718 USA; [Dooley, David M.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59718 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Lei, BF (corresponding author), Montana State Univ, Dept Vet Mol Biol, POB 173610, Bozeman, MT 59717 USA.	blei@montana.edu		Lei, Benfang Lei/0000-0001-8133-6021	NCRR NIH HHS [P20 RR020185, P20 RR-020185] Funding Source: Medline; NIGMS NIH HHS [R01 GM027659, GM27] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andrade MA, 2002, GENOME BIOL, V3; ANDRADE R, 2007, J MOL BIOL, V374, P374; Ascoli F, 1981, Methods Enzymol, V76, P72; Bates CS, 2003, INFECT IMMUN, V71, P1042, DOI 10.1128/IAI.71.3.1042-1055.2003; Burkhard KA, 2007, J BIOL CHEM, V282, P15126, DOI 10.1074/jbc.M611121200; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; GRITTITHS E, 1999, IRON INFECTION MOL P, P87; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; KLEBBA PE, 1993, J BIOENERG BIOMEMBR, V25, P603; Lei BF, 2003, INFECT IMMUN, V71, P5962, DOI 10.1128/IAI.71.10.5962-5969.2003; Lei BF, 2002, INFECT IMMUN, V70, P4494, DOI 10.1128/IAI.70.8.4494-4500.2002; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Nygaard TK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-82; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	33	103	110	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6668	6676		10.1074/jbc.M708372200	http://dx.doi.org/10.1074/jbc.M708372200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18184657	Green Accepted, hybrid			2022-12-27	WOS:000253779600008
J	Estrella, LA; Krishnamurthy, S; Timme, CR; Hampsey, M				Estrella, Luis A.; Krishnamurthy, Shankarling; Timme, Cindy R.; Hampsey, Michael			The Rsp5 E3 ligase mediates turnover of low affinity phosphate transporters in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST URACIL PERMEASE; UBIQUITIN-PROTEIN LIGASE; GLUCOSE-INDUCED PROTEOLYSIS; PEST-LIKE SEQUENCE; GALACTOSE TRANSPORTER; ACTIN CYTOSKELETON; MALTOSE PERMEASE; DOWN-REGULATION; IN-VIVO; GENE	In an effort to identify novel components of the PHO regulon in Saccharomyces cerevisiae, we have isolated and characterized suppressors of the Pho(-) phenotype associated with deletion of the Pho4 transcriptional activator. Here we report that either a defective form of the Rsp5 E3 ubiquitin ligase or deletion of the End3 component of the endocytic pathway restores growth of the pho4 Delta mutant in the presence of limiting inorganic phosphate (P-i). The spa1-1 suppressor allele of RSP5 encodes a phenylalanine-to-valine replacement at position 748 (F748V) within the catalytic HECT domain of Rsp5. Consistent with suppression due to impaired ubiquitin ligase activity, the heat-sensitive growth defect of the spa1-1 mutant is suppressed either by overexpression of ubiquitin or by osmotic stabilization. Western blot analyses revealed that the cellular levels of the Pho87 and Pho91 low affinity P-i are markedly increased in the spa1-1 mutant, yet Pho84 high affinity P-i transporter levels are unaffected. Furthermore, Pho87 and Pho91 are ubiquitinated in vivo in an Rsp5-dependent manner, and the Pho(-) phenotype of the spa1-1 suppressor is dependent upon Pho87 and Pho91. We conclude that turnover of the low affinity P-i transporters is initiated by Rsp5-mediated ubiquitination followed by internalization and degradation by the endocytic pathway.	[Estrella, Luis A.; Krishnamurthy, Shankarling; Timme, Cindy R.; Hampsey, Michael] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Div Nucleic Acids Enzymol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Hampsey, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 683 Hoes Lane W, Piscataway, NJ 08854 USA.	michael.hampsey@umdnj.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055145, F31GM067388, T32GM008360, R01GM039484] Funding Source: NIH RePORTER; NIGMS NIH HHS [F31 GM67388, R25 GM55145, R01 GM39484, T32 GM08360] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almaguer C, 2003, EUKARYOT CELL, V2, P729, DOI 10.1128/EC.2.4.729-736.2003; Auesukaree C, 2003, BIOCHEM BIOPH RES CO, V306, P843, DOI 10.1016/S0006-291X(03)01068-4; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Horak J, 1997, J BACTERIOL, V179, P1541, DOI 10.1128/jb.179.5.1541-1549.1997; Horak J, 2001, J BACTERIOL, V183, P3083, DOI 10.1128/JB.183.10.3083-3088.2001; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; Kaminska J, 2002, MOL CELL BIOL, V22, P6946, DOI 10.1128/MCB.22.20.6946-6958.2002; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; Medintz I, 2000, BIOCHEMISTRY-US, V39, P4518, DOI 10.1021/bi992455a; Medintz I, 1998, J BIOL CHEM, V273, P34454, DOI 10.1074/jbc.273.51.34454; Mouillon JM, 2005, CURR GENET, V48, P226, DOI 10.1007/s00294-005-0019-0; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Petersson J, 1999, FEBS LETT, V462, P37, DOI 10.1016/S0014-5793(99)01471-4; Pinson B, 2004, J BIOL CHEM, V279, P35273, DOI 10.1074/jbc.M405398200; PRELICH G, 1993, GENETICS, V135, P665; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; RUBIN GM, 1974, EUR J BIOCHEM, V41, P197, DOI 10.1111/j.1432-1033.1974.tb03260.x; Seron K, 1999, J BACTERIOL, V181, P1793; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; TAMAI Y, 1985, J BACTERIOL, V164, P964, DOI 10.1128/JB.164.2.964-968.1985; Tang HY, 2000, MOL CELL BIOL, V20, P12, DOI 10.1128/MCB.20.1.12-25.2000; THIELE DJ, 1986, MOL CELL BIOL, V6, P1158, DOI 10.1128/MCB.6.4.1158; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; VOLLAND C, 1992, J BIOL CHEM, V267, P23767; Wang GL, 1999, MOL CELL BIOL, V19, P342; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yashiroda H, 1996, MOL CELL BIOL, V16, P3255	51	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5327	5334		10.1074/jbc.M703630200	http://dx.doi.org/10.1074/jbc.M703630200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165238	hybrid			2022-12-27	WOS:000253426700012
J	Valton, J; Mathevon, C; Fontecave, M; Niviere, V; Ballou, DP				Valton, Julien; Mathevon, Carole; Fontecave, Marc; Niviere, Vincent; Ballou, David P.			Mechanism and regulation of the two-component FMN-dependent monooxygenase ActVA-ActVB from Streptomyces coelicolor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; PARA-HYDROXYBENZOATE HYDROXYLASE; ACINETOBACTER-BAUMANNII; ANTIBIOTIC ACTINORHODIN; PRISTINAMYCIN-IIB; ESCHERICHIA-COLI; REDUCED FLAVIN; REDUCTASE; BIOSYNTHESIS; OXYGEN	The ActVA-ActVB system from Streptomyces coelicolor is a two-component flavin-dependent monooxygenase involved in the antibiotic actinorhodin biosynthesis. ActVB is a NADH: flavin oxidoreductase that provides a reduced FMN to ActVA, the monooxygenase that catalyzes the hydroxylation of dihydrokalafungin, the precursor of actinorhodin. In this work, using stopped-flow spectrophotometry, we investigated the mechanism of hydroxylation of dihydrokalafungin catalyzed by ActVA and that of the reduced FMN transfer from ActVB to ActVA. Our results show that the hydroxylation mechanism proceeds with the participation of two different reaction intermediates in ActVA active site. First, a C(4a)-FMN-hydroperoxide species is formed after binding of reduced FMN to the monooxygenase and reaction with O-2. This intermediate hydroxylates the substrate and is transformed to a second reaction intermediate, a C(4a)-FMN-hydroxy species. In addition, we demonstrate that reduced FMN can be transferred efficiently from the reductase to the monooxygenase without involving any protein.protein complexes. The rate of transfer of reduced FMN from ActVB to ActVA was found to be controlled by the release of NAD(+) from ActVB and was strongly affected by NAD(+) concentration, with an IC50 of 40 mu M. This control of reduced FMN transfer by NAD(+) was associated with the formation of a strong charge.transfer complex between NAD(+) and reduced FMN in the active site of ActVB. These results suggest that, in Streptomyces coelicolor, the reductase component ActVB can act as a regulatory component of the monooxygenase activity by controlling the transfer of reduced FMN to the monooxygenase.	[Mathevon, Carole; Fontecave, Marc; Niviere, Vincent] iRTSV, DSV, CEA, Lab Chim Biol Metaux, F-38054 Grenoble, France; [Valton, Julien; Ballou, David P.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Mathevon, Carole; Fontecave, Marc; Niviere, Vincent] CNRS, UMR 5249, F-38054 Grenoble, France; [Mathevon, Carole; Fontecave, Marc; Niviere, Vincent] Univ Grenoble 1, F-38000 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Niviere, V (corresponding author), iRTSV, DSV, CEA, Lab Chim Biol Metaux, 17 Ave Martyrs, F-38054 Grenoble, France.	vniviere@cea.fr; dballou@umich.edu		Niviere, Vincent/0000-0002-5132-457X; Valton, Julien/0000-0003-0826-5401	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064711] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM64711] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUSOUD H, 1992, BIOCHEMISTRY-US, V31, P3807, DOI 10.1021/bi00130a011; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; BEATY NB, 1981, J BIOL CHEM, V256, P4619; Beltrametti F, 1997, APPL ENVIRON MICROB, V63, P2232, DOI 10.1128/AEM.63.6.2232-2239.1997; BLANC V, 1995, J BACTERIOL, V177, P5206, DOI 10.1128/jb.177.18.5206-5214.1995; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; CABALLERO JL, 1991, MOL GEN GENET, V230, P401, DOI 10.1007/BF00280297; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; COLE SP, 1987, J ANTIBIOT, V40, P340, DOI 10.7164/antibiotics.40.340; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; ENTSCH B, 1989, BIOCHIM BIOPHYS ACTA, V999, P313, DOI 10.1016/0167-4838(89)90014-9; Fernandes RA, 2005, SYNLETT, P1281, DOI 10.1055/s-2005-868505; FERNANDEZMORENO MA, 1992, J BIOL CHEM, V267, P19278; Filisetti L, 2003, J BIOL CHEM, V278, P296, DOI 10.1074/jbc.M209689200; GHISLA S, 1977, EUR J BIOCHEM, V76, P139, DOI 10.1111/j.1432-1033.1977.tb11579.x; GIBIAN MJ, 1969, BIOCHEM BIOPH RES CO, V34, P594, DOI 10.1016/0006-291X(69)90779-7; Kantz A, 2005, ARCH BIOCHEM BIOPHYS, V442, P102, DOI 10.1016/j.abb.2005.07.020; KENDREW SG, 1995, J BIOL CHEM, V270, P17339, DOI 10.1074/jbc.270.29.17339; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Louie TM, 2003, BIOCHEMISTRY-US, V42, P7509, DOI 10.1021/bi034092r; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MASSEY V, 1973, FLAVIN FLAVOPROTEINS, P25; Moran GR, 1997, BIOCHEMISTRY-US, V36, P7548, DOI 10.1021/bi9706327; MULLER F, 1987, FREE RADICAL BIO MED, V3, P215, DOI 10.1016/0891-5849(87)90009-8; Palfey B. A., 1995, ACTIVE OXYGEN BIOCH, P37, DOI DOI 10.1007/978-94-011-0609-2_2; Panke S, 1998, APPL ENVIRON MICROB, V64, P2032; Parry RJ, 1997, J BIOL CHEM, V272, P23303, DOI 10.1074/jbc.272.37.23303; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; TANAKA H, 1982, J ANTIBIOT, V35, P1565, DOI 10.7164/antibiotics.35.1565; THIBAUT D, 1995, J BACTERIOL, V177, P5199, DOI 10.1128/jb.177.18.5199-5205.1995; Valton J, 2006, J BIOL CHEM, V281, P27, DOI 10.1074/jbc.M506146200; Valton J, 2004, J BIOL CHEM, V279, P44362, DOI 10.1074/jbc.M407722200; van den Heuvel RHH, 2004, J BIOL CHEM, V279, P12860, DOI 10.1074/jbc.M313765200; Xi L, 1997, BIOCHEM BIOPH RES CO, V230, P73, DOI 10.1006/bbrc.1996.5878; Xun LY, 2000, APPL ENVIRON MICROB, V66, P481, DOI 10.1128/AEM.66.2.481-486.2000; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d	42	55	59	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10287	10296		10.1074/jbc.M709730200	http://dx.doi.org/10.1074/jbc.M709730200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18245777	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000254894700009
J	Higashi, S; Miyazaki, K				Higashi, Shouichi; Miyazaki, Kaoru			Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1.8-ANGSTROM CRYSTAL-STRUCTURE; TISSUE INHIBITOR; EXTRACELLULAR-MATRIX; ALZHEIMERS-DISEASE; DEGRADING METALLOPROTEINASE; 1-MATRIX METALLOPROTEINASE; IV COLLAGENASE; CELL INVASION; GELATINASE-A; SURFACE	The extracellular domain of beta-amyloid precursor protein (APP) contains an inhibitor against matrix metalloproteinase-2 (MMP-2, gelatinase A). Our previous study (Higashi, S. and Miyazaki, K. (2003) J Biol Chem 278, 14020 - 14028) demonstrated that the inhibitor is localized within the ISYGN-DALMP sequence of APP, and a synthetic decapeptide containing this sequence (named APP-derived inhibitory peptide, APP-IP) selectively inhibits the activity of MMP-2. To determine the region of interaction that correlates with the selective inhibition, we constructed various MMP-2 mutants. An MMP-2 mutant, which had the hemopexin-like domain and three fibronectin-like type II domains of MMP-2 deleted, and native MMP-2 showed similar affinities for APP-IP, suggesting that only the catalytic domain of MMP-2 is essential for the interaction. Studies of chimeric proteases, consisting of various parts of the MMP-2 catalytic domain and those of MMP-7 (matrilysin) or MMP-9 (gelatinase B), further revealed that Ala88 and Gly94 in the non-prime side and Tyr145 and Thr146 in the prime side of the substrate- binding cleft of MMP-2 contribute separately to the selective inhibition. Replacement of the amino acid residue at position 94 of a chimeric MMP mutant affected its interaction with the C-terminal Pro(10) of APP-IP, whereas that of residues 145 148 affected the interaction with Tyr(3) of the inhibitor, suggesting that the N to C direction of APP-IP relative to the substrate- binding cleft of MMP is analogous to that of propeptide in proMMP, and opposite to that of substrate. When the APP-IP sequence was added to the N terminus of the catalytic domain of MMP-2, the activity of the protease was intramolecularly inhibited. We speculate that the direction of interaction makes the active site-bound APP-IP resistant to cleavage, thereby supporting the inhibitory action of the peptide inhibitor.	[Higashi, Shouichi; Miyazaki, Kaoru] Yokohama City Univ, Kihara Inst Biol Res, Div Cell Biol, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan	Yokohama City University	Higashi, S (corresponding author), Yokohama City Univ, Kihara Inst Biol Res, Div Cell Biol, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan.	shigashi@yokohama-cu.ac.jp						Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; Betz M, 1997, EUR J BIOCHEM, V247, P356, DOI 10.1111/j.1432-1033.1997.00356.x; Brandstetter H, 2001, J BIOL CHEM, V276, P17405, DOI 10.1074/jbc.M007475200; BROWNER MF, 1995, BIOCHEMISTRY-US, V34, P6602, DOI 10.1021/bi00020a004; Caceres J, 1997, J CELL BIOCHEM, V65, P145, DOI 10.1002/(SICI)1097-4644(199705)65:2<145::AID-JCB2>3.0.CO;2-U; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Finzel BC, 1998, PROTEIN SCI, V7, P2118, DOI 10.1002/pro.5560071008; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Higashi S, 2003, BIOCHEMISTRY-US, V42, P6514, DOI 10.1021/bi020643m; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Jia MC, 2000, ADV EXP MED BIOL, V476, P181; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150; Kihira Y, 1996, Urol Oncol, V2, P20, DOI 10.1016/1078-1439(96)00030-0; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; LIOTTA LA, 1986, CANCER RES, V46, P1; MIYAZAKI K, 1990, CANCER RES, V50, P7758; MIYAZAKI K, 1993, NATURE, V362, P839, DOI 10.1038/362839a0; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Ohsawa I, 2001, J NEUROCHEM, V76, P1411, DOI 10.1046/j.1471-4159.2001.00144.x; Oneda H, 1999, J BIOCHEM-TOKYO, V126, P905, DOI 10.1093/oxfordjournals.jbchem.a022533; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Rowsell S, 2002, J MOL BIOL, V319, P173, DOI 10.1016/S0022-2836(02)00262-0; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMALL DH, 1992, J NEUROSCI, V12, P4143; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; UMENISHI F, 1990, J BIOCHEM-TOKYO, V108, P537, DOI 10.1093/oxfordjournals.jbchem.a123238; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; Yamamoto K, 2006, J BIOL CHEM, V281, P9170, DOI 10.1074/jbc.M510377200; Yana I, 2002, CLIN EXP METASTAS, V19, P209, DOI 10.1023/A:1015527220537	44	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10068	10078		10.1074/jbc.M709509200	http://dx.doi.org/10.1074/jbc.M709509200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18238779	hybrid			2022-12-27	WOS:000254671600061
J	Shibata, H; Suzuki, H; Kakiuchi, T; Inuzuka, T; Yoshida, H; Mizuno, T; Maki, M				Shibata, Hideki; Suzuki, Hironori; Kakiuchi, Takeshi; Inuzuka, Tatsutoshi; Yoshida, Haruna; Mizuno, Takako; Maki, Masatoshi			Identification of Alix-type and non-Alix-type ALG-2-binding sites in human phospholipid scramblase 3 - Differential binding to an alternatively spliced isoform and amino acid-substituted mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-DEPENDENT INTERACTION; APOPTOSIS-LINKED GENE-2; PROTEIN ALG-2 INTERACTS; RETICULUM EXIT SITES; TRANSBILAYER MOVEMENT; TERMINAL DOMAIN; ANNEXIN-VII; EF; ALIX/AIP1; CALPAIN	ALG-2, a prototypic member of the penta-EF-hand protein family, interacts with Alix at its C-terminal Pro-rich region containing four tandem PXY repeats. Human phospholipid scramblase 3 (PLSCR3) has a similar sequence (ABS-1) in its N-terminal region. In the present study, we found that ALG-2 interacts with PLSCR3 expressed in HEK293 cells in a Ca2+-dependent manner by co-immunoprecipitation, pulldown with glutathione S-transferase (GST) fused ALG-2 and an overlay assay using biotin-labeled ALG-2. The GST fusion protein of an alternatively spliced isoform of ALG-2, GST-ALG-2(Delta GF122), pulled down green fluorescent protein (GFP)-fused PLSCR3 but not GFP Alix. Deletion of a region containing ABS-1 was not sufficient to abrogate the binding. A second ALG-2-binding site (ABS-2) was essential for interaction with ALG-2(Delta GF122). Real-time interaction analyses with a surface plasmon resonance biosensor using synthetic oligopeptides and recombinant proteins corroborated direct Ca2+-dependent binding of ABS-1 to ALG-2 and that of ABS-2 to ALG-2 as well as to ALG-2(Delta GF122). The sequence of ABS-2 contains multiple prolines and two phenylalanines, among which Phe(49) was found to be critical, because its substitution with Ala or Tyr caused a loss of binding ability by pulldown assays using oligopeptide-immobilized beads. ALG-2-interacting proteins were classified into two groups based on binding ability to ALG-2(Delta GF122): (i) isoform-non-interactive (ABS-1) types, including Alix, annexin A7, annexin A11, and TSG101 and (ii) isoform-interactive (ABS-2) types including PLSCR3, PLSCR4 and Sec31A. GST-pulldown assays using single amino acid-substituted ALG-2 mutants revealed differences in binding specificities between the two groups, suggesting structural flexibility in ALG-2-ligand complex formation.	[Shibata, Hideki; Suzuki, Hironori; Kakiuchi, Takeshi; Inuzuka, Tatsutoshi; Yoshida, Haruna; Mizuno, Takako; Maki, Masatoshi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Maki, M (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	mmaki@agr.nagoya-u.ac.jp	Maki, Masatoshi/AAM-6839-2021	Maki, Masatoshi/0000-0001-9144-5491; Suzuki, Hironori/0000-0001-9754-4992				Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; Brownawell AM, 1997, J BIOL CHEM, V272, P22182, DOI 10.1074/jbc.272.35.22182; Chatellard-Causse C, 2002, J BIOL CHEM, V277, P29108, DOI 10.1074/jbc.M204019200; Chen CM, 2005, BIOCHEM BIOPH RES CO, V333, P51, DOI 10.1016/j.bbrc.2005.05.074; Dikic I, 2004, BIOESSAYS, V26, P604, DOI 10.1002/bies.20068; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; He Y, 2007, J CELL BIOCHEM, V101, P1210, DOI 10.1002/jcb.21243; He YW, 2005, CANCER RES, V65, P10016, DOI 10.1158/0008-5472.CAN-05-1688; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Hwang IS, 2002, FEBS LETT, V529, P183, DOI 10.1016/S0014-5793(02)03329-X; Ichioka F, 2007, ARCH BIOCHEM BIOPHYS, V457, P142, DOI 10.1016/j.abb.2006.11.008; Jang IK, 2002, MOL CELL BIOL, V22, P4094, DOI 10.1128/MCB.22.12.4094-4100.2002; Jekely G, 1999, J MOL EVOL, V49, P272, DOI 10.1007/PL00006549; Jia J, 2001, STRUCTURE, V9, P267, DOI 10.1016/S0969-2126(01)00585-8; Katoh K, 2005, BIOCHEM J, V391, P677, DOI 10.1042/BJ20050398; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kitaura Y, 2002, ARCH BIOCHEM BIOPHYS, V399, P12, DOI 10.1006/abbi.2001.2736; Kitaura Y, 2001, J BIOL CHEM, V276, P14053, DOI 10.1074/jbc.M008649200; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; la Cour JM, 2003, AM J PATHOL, V163, P81, DOI 10.1016/S0002-9440(10)63632-2; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203; Li YJ, 2006, MOL CELL BIOL, V26, P3401, DOI 10.1128/MCB.26.9.3401-3413.2006; Liu JH, 2005, BIOCHEM BIOPH RES CO, V330, P865, DOI 10.1016/j.bbrc.2005.03.048; Liu JH, 2003, MOL CANCER RES, V1, P892; Lo KWH, 1999, BIOCHEMISTRY-US, V38, P7498, DOI 10.1021/bi990034n; Mahul-Mellier AL, 2006, J NEUROSCI, V26, P542, DOI 10.1523/JNEUROSCI.3069-05.2006; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Maki M, 1998, J BIOCHEM, V124, P1170, DOI 10.1093/oxfordjournals.jbchem.a022235; Maki M, 1997, BIOCHEM J, V328, P718; Maki M., 2007, CALCIUM BIND PROTEIN, V2, P4; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Montaville P, 2006, BBA-MOL CELL RES, V1763, P1335, DOI 10.1016/j.bbamcr.2006.09.003; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; Ohkouchi S, 2001, J BIOCHEM-TOKYO, V130, P207, DOI 10.1093/oxfordjournals.jbchem.a002974; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Sadoul R, 2006, BIOL CELL, V98, P69, DOI 10.1042/BC20050007; Satoh H, 2002, BBA-PROTEINS PROTEOM, V1600, P61, DOI 10.1016/S1570-9639(02)00445-4; Satoh H, 2002, BIOCHEM BIOPH RES CO, V291, P1166, DOI 10.1006/bbrc.2002.6600; Schmidt MHH, 2005, J BIOL CHEM, V280, P3414, DOI 10.1074/jbc.M409839200; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Subramanian L, 2004, BIOCHEMISTRY-US, V43, P11175, DOI 10.1021/bi048848d; SUBRAMANIAN L, 1999, BIOCHEM BIOPH RES CO, V322, P1153; TAKANO E, 1995, FEBS LETT, V362, P93, DOI 10.1016/0014-5793(95)00219-Y; Tarabykina S, 2000, J BIOL CHEM, V275, P10514, DOI 10.1074/jbc.275.14.10514; Trioulier Y, 2004, J BIOL CHEM, V279, P2046, DOI 10.1074/jbc.M309243200; Vernarecci S, 2007, MOL MICROBIOL, V65, P1122, DOI 10.1111/j.1365-2958.2007.05852.x; Verzili D, 2000, FEBS LETT, V471, P197, DOI 10.1016/S0014-5793(00)01396-X; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wiedmer T, 2004, P NATL ACAD SCI USA, V101, P13296, DOI 10.1073/pnas.0405354101; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; WORMMEESTER J, 1990, METHOD ENZYMOL, V184, P314; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; YANG HQ, 1994, J BIOL CHEM, V269, P18977; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	64	41	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9623	9632		10.1074/jbc.M800717200	http://dx.doi.org/10.1074/jbc.M800717200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18256029	hybrid			2022-12-27	WOS:000254671600016
J	Georis, I; Tate, JJ; Cooper, TG; Dubois, E				Georis, Isabelle; Tate, Jennifer J.; Cooper, Terrance G.; Dubois, Evelyne			Tor pathway control of the nitrogen-responsive DAL5 gene bifurcates at the level of Gln3 and Gat1 regulation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE SULFOXIMINE TREATMENT; RSP5-BUL1/2 UBIQUITIN LIGASE; CATABOLITE REPRESSION; NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; CARBON STARVATION; 2A PHOSPHATASES; CELL-GROWTH; NPR1 KINASE	The Tor1,2 protein kinases globally influence many cellular processes including nitrogen-responsive gene expression that correlates with intracellular localization of GATA transcription activators Gln3 and Gat1/Nil1. Gln3-Myc(13) and Gat1-Myc(13) are restricted to the cytoplasm of cells provided with good nitrogen sources, e. g. glutamine. Following the addition of the Tor1,2 inhibitor, rapamycin, both transcription factors relocate to the nucleus. Gln3-Myc(13) localization is highly dependent upon Ure2 and type 2A-related phosphatase, Sit4. Ure2 is required for Gln3 to be restricted to the cytoplasm of cells provided with good nitrogen sources, and Sit4 is required for its location to the nucleus following rapamycin treatment. The paucity of analogous information concerning Gat1 regulation prompted us to investigate the effects of deleting SIT4 and URE2 on Gat1-Myc(13) localization, DNA binding, and NCR-sensitive transcription. Our data demonstrate that Tor pathway control of NCR-responsive transcription bifurcates at the regulation of Gln3 and Gat1. Gat1-Myc(13) localization is not strongly influenced by deleting URE2, nor is its nuclear targeting following rapamycin treatment strongly dependent on Sit4. ChIP experiments demonstrated that Gat1-Myc(13) can bind to the DAL5 promoter in the absence of Gln3. Gln3-Myc(13), on the other hand, cannot bind to DAL5 in the absence of Gat1. We conclude that: ( i) Tor pathway regulation of Gat1 differs markedly from that of Gln3, ( ii) nuclear targeting of Gln3-Myc(13) is alone insufficient for its recruitment to the DAL5 promoter, and ( iii) the Tor pathway continues to play an important regulatory role in NCR-sensitive transcription even after Gln3-Myc(13) is localized to the nucleus.	[Tate, Jennifer J.; Cooper, Terrance G.] Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA; [Georis, Isabelle; Dubois, Evelyne] Univ Libre Bruxelles, Microbiol Lab, Inst Rech Microbiol JM Wiame, B-1070 Brussels, Belgium	University of Tennessee System; University of Tennessee Health Science Center; Universite Libre de Bruxelles	Cooper, TG (corresponding author), Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA.	tcooper@utmem.edu		Cooper, Terrance G./0000-0002-7651-9963	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 35642, R01 GM035642-20, R01 GM035642] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Boulay A, 2005, CLIN CANCER RES, V11, P5319, DOI 10.1158/1078-0432.CCR-04-2402; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Coffman JA, 1996, MOL CELL BIOL, V16, P847; COFFMAN JA, 1994, J BACTERIOL, V176, P7476, DOI 10.1128/JB.176.24.7476-7483.1994; COFFMAN JA, 1995, J BACTERIOL, V177, P6910, DOI 10.1128/jb.177.23.6910-6918.1995; Cooper TG, 2004, TOP CURR GENET, V7, P225; COOPER TG, 1989, MOL CELL BIOL, V9, P5440, DOI 10.1128/MCB.9.12.5440; COTLMAN JA, 1997, J BACTERIOL, V179, P3416; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; Crespo JL, 2004, J BIOL CHEM, V279, P37512, DOI 10.1074/jbc.M407372200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; Feller A, 2006, J BIOL CHEM, V281, P28546, DOI 10.1074/jbc.M605551200; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; Kuruvilla FG, 2001, P NATL ACAD SCI USA, V98, P7283, DOI 10.1073/pnas.121186898; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorber MI, 2005, TRANSPLANTATION, V80, P244, DOI 10.1097/01.TP.0000164352.65613.24; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; RAI R, 1995, YEAST, V11, P247, DOI 10.1002/yea.320110307; Rai R, 1999, J BIOL CHEM, V274, P28026, DOI 10.1074/jbc.274.39.28026; Rohde JR, 2004, MOL CELL BIOL, V24, P8332, DOI 10.1128/MCB.24.19.8332-8341.2004; Scherens B, 2006, FEMS YEAST RES, V6, P777, DOI 10.1111/j.1567-1364.2006.00060.x; Schluter Michael, 2005, Am Heart Hosp J, V3, P182, DOI 10.1111/j.1541-9215.2005.04407.x; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2006, J BIOL CHEM, V281, P28460, DOI 10.1074/jbc.M604171200; Tate JJ, 2002, J BIOL CHEM, V277, P20477, DOI 10.1074/jbc.M200962200; Tate JJ, 2003, J BIOL CHEM, V278, P36924, DOI 10.1074/jbc.M301829200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; THOMAS G, 2004, CURRENT TOPICS MICRO; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072	51	49	51	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8919	8929		10.1074/jbc.M708811200	http://dx.doi.org/10.1074/jbc.M708811200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18245087	Green Published, hybrid			2022-12-27	WOS:000254465800020
J	Marshall-Batty, KR; Nakai, H				Marshall-Batty, Kimberly R.; Nakai, Hiroshi			Activation of a dormant ClpX recognition motif of bacteriophage mu repressor by inducing high local flexibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SENSITIVE MUTATIONS; ATP-DEPENDENT PROTEASES; DNA-BINDING; CONFORMATIONAL-CHANGES; IN-VITRO; PROTEIN; DEGRADATION; TRANSPOSITION; SUBSTRATE; OPERATOR	The C-terminal domain (CTD) of bacteriophage Mu immunity repressor ( Rep) regulates DNA binding by the N-terminal domain and degradation by ClpXP protease. Five residues at the Rep C terminus (CTD5) can serve as a ClpX recognition motif, but it is dormant unless activated, a state that can be induced by the presence of dominant-negative mutant repressors ( Vir). Conversion of Rep to ClpXP-sensitive form was associated with not only increased exposure of CTD5 to solvent but also increased CTD motion or flexibility as measured by fluorescence anisotropy. CTD mutations (V183S, K193S, and V196S) promoting ClpXP resistance without destroying the recognition motif prevented increased CTD motion induced by Vir. Suppression of ClpXP protease resistance conferred by the V196S mutation also correlated with restoration of CTD motion. The temperature-sensitive R47Q mutation present in cis within the DNA-binding domain restored ClpXP protease sensitivity to the V196S mutant, and anisotropy analysis indicated that R47Q allows the V196S CTD to gain increased flexibility when Vir was present. The results indicate that the CTD functions to turn the recognition motif on and off, most likely by modulating flexibility of the domain that harbors the ClpX recognition motif, suggesting a general mechanism by which proteins can regulate their own degradation.	[Marshall-Batty, Kimberly R.; Nakai, Hiroshi] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA	Georgetown University	Nakai, H (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Box 571455,3900 Reservoir Rd NW, Washington, DC 20057 USA.	nakaih@georgetown.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058265] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 58265, GM 070441] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alazard R, 1998, EUR J BIOCHEM, V252, P408, DOI 10.1046/j.1432-1327.1998.2520408.x; Bolon DN, 2004, MOL CELL, V13, P443, DOI 10.1016/S1097-2765(04)00027-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantor C. R., 1980, BIOPHYSICAL CHEM TEC; Defenbaugh DA, 2003, J BIOL CHEM, V278, P52333, DOI 10.1074/jbc.M308724200; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; GEUSKENS V, 1992, EMBO J, V11, P5121, DOI 10.1002/j.1460-2075.1992.tb05619.x; Gonciarz-Swiatek M, 1999, J BIOL CHEM, V274, P13999, DOI 10.1074/jbc.274.20.13999; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Hauer JA, 1999, BIOCHEMISTRY-US, V38, P6774, DOI 10.1021/bi983074k; Haugland R.P., 2002, HDB FLUORESCENT PROB; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Jones JM, 1998, J BIOL CHEM, V273, P459, DOI 10.1074/jbc.273.1.459; Jorgensen CI, 1998, MOL MICROBIOL, V27, P41, DOI 10.1046/j.1365-2958.1998.00655.x; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; KRAUSE HM, 1986, J BIOL CHEM, V261, P3744; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Kruklitis R, 1996, EMBO J, V15, P935, DOI 10.1002/j.1460-2075.1996.tb00428.x; Laachouch JE, 1996, EMBO J, V15, P437, DOI 10.1002/j.1460-2075.1996.tb00374.x; Lackowicz J., 1999, PRINCIPLES FLUORESCE; Lamrani S, 1999, MOL MICROBIOL, V32, P327, DOI 10.1046/j.1365-2958.1999.01352.x; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; LEUNG PC, 1989, NATURE, V338, P656, DOI 10.1038/338656a0; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; Marshall-Batty KR, 2008, MOL MICROBIOL, V67, P920, DOI 10.1111/j.1365-2958.2007.06099.x; Marshall-Batty KR, 2003, J BIOL CHEM, V278, P1612, DOI 10.1074/jbc.M209352200; Matouschek A, 2003, CURR OPIN STRUC BIOL, V13, P98, DOI 10.1016/S0959-440X(03)00010-1; MHAMMEDIALAOUI A, 1994, MOL MICROBIOL, V11, P1109, DOI 10.1111/j.1365-2958.1994.tb00387.x; MIZUUCHI M, 1989, CELL, V58, P399, DOI 10.1016/0092-8674(89)90854-4; Mukhopadhyay B, 2003, MOL MICROBIOL, V47, P171, DOI 10.1046/j.1365-2958.2003.03286.x; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; Neuwald AF, 1999, GENOME RES, V9, P27; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Plafker K, 2002, J BIOL CHEM, V277, P30121, DOI 10.1074/jbc.M203006200; Rai SS, 2001, J MOL BIOL, V312, P311, DOI 10.1006/jmbi.2001.4957; Ranquet C, 2001, P NATL ACAD SCI USA, V98, P10220, DOI 10.1073/pnas.171620598; Rousseau P, 1996, J BIOL CHEM, V271, P9739, DOI 10.1074/jbc.271.16.9739; SHAPIRO JA, 1989, J BACTERIOL, V171, P5975, DOI 10.1128/jb.171.11.5975-5986.1989; SHAPIRO JA, 1989, J BACTERIOL, V171, P5963, DOI 10.1128/jb.171.11.5963-5974.1989; Stapelfeldt H, 1999, J AGR FOOD CHEM, V47, P3986, DOI 10.1021/jf9812026; SURETTE MG, 1987, CELL, V49, P253, DOI 10.1016/0092-8674(87)90566-6; Tcherkasskaya O, 2000, BIOCHEMISTRY-US, V39, P1879, DOI 10.1021/bi992117+; VAJDA S, 1994, BIOCHEMISTRY-US, V33, P13977, DOI 10.1021/bi00251a004; VOGEL JL, 1991, J BACTERIOL, V173, P6568, DOI 10.1128/jb.173.20.6568-6577.1991; Vogel JL, 1996, GENETICS, V142, P661; VONHOLDE KE, 1971, PHYS BIOCH; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; Weast R.C., 1985, CRC HDB CHEM PHYS; Welty DJ, 1997, J MOL BIOL, V272, P31, DOI 10.1006/jmbi.1997.1193; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	56	2	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9060	9070		10.1074/jbc.M705508200	http://dx.doi.org/10.1074/jbc.M705508200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18230617	Green Published, hybrid			2022-12-27	WOS:000254465800036
J	Arad, G; Hendel, A; Urbanke, C; Curth, U; Livneh, Z				Arad, Gali; Hendel, Ayal; Urbanke, Claus; Curth, Ute; Livneh, Zvi			Single-stranded DNA-binding protein recruits DNA polymerase V to primer termini on RecA-coated DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTAGENIC TRANSLESION REPLICATION; ESCHERICHIA-COLI-SSB; III HOLOENZYME; POL-V; EXONUCLEASE I; LESION BYPASS; GENE-PRODUCT; BETA-SUBUNIT; CHI SUBUNIT; MUTATIONS	Translesion DNA synthesis (TLS) by DNA polymerase V (polV) in Escherichia coli involves accessory proteins, including RecA and single-stranded DNA-binding protein (SSB). To elucidate the role of SSB in TLS we used an in vitro exonuclease protection assay and found that SSB increases the accessibility of 3' primer termini located at abasic sites in RecA-coated gapped DNA. The mutant SSB-113 protein, which is defective in protein-protein interactions, but not in DNA binding, was as effective as wild-type SSB in increasing primer termini accessibility, but deficient in supporting polV-catalyzed TLS. Consistently, the heterologous SSB proteins gp32, encoded by phage T4, and ICP8, encoded by herpes simplex virus 1, could replace E. coli SSB in the TLS reaction, albeit with lower efficiency. Immunoprecipitation experiments indicated that polV directly interacts with SSB and that this interaction is disrupted by the SSB-113 mutation. Taken together our results suggest that SSB functions to recruit polV to primer termini on RecA-coated DNA, operating by two mechanisms: 1) increasing the accessibility of 3' primer termini caused by binding of SSB to DNA and 2) a direct SSB-polV interaction mediated by the C terminus of SSB.	[Arad, Gali; Hendel, Ayal; Livneh, Zvi] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Urbanke, Claus; Curth, Ute] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany	Weizmann Institute of Science; Hannover Medical School	Livneh, Z (corresponding author), Weizmann Inst Sci, Dept Biol Chem, Hertzl St, IL-76100 Rehovot, Israel.	zvi.livneh@weizmann.ac.il	Hendel, Ayal/GMW-7991-2022	Hendel, Ayal/0000-0002-3388-6202				Avkin S, 2002, P NATL ACAD SCI USA, V99, P3764, DOI 10.1073/pnas.062038699; Berdichevsky A, 2002, MOL CELL, V10, P917, DOI 10.1016/S1097-2765(02)00679-2; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; CHASE JW, 1984, J BIOL CHEM, V259, P805; CLENDENNING JB, 1994, BIOPHYS CHEM, V52, P227, DOI 10.1016/0301-4622(94)00036-J; COX MM, 1981, J BIOL CHEM, V256, P4676; CURTH U, 1991, EUR J BIOCHEM, V196, P87, DOI 10.1111/j.1432-1033.1991.tb15789.x; Fedorov R, 2006, NUCLEIC ACIDS RES, V34, P6708, DOI 10.1093/nar/gkl1002; FRANK EG, 1993, P NATL ACAD SCI USA, V90, P8169, DOI 10.1073/pnas.90.17.8169; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P463; Fujii S, 2004, J MOL BIOL, V341, P405, DOI 10.1016/j.jmb.2004.06.017; Fujii S, 2006, EMBO J, V25, P5754, DOI 10.1038/sj.emboj.7601474; Genschel J, 2000, BIOL CHEM, V381, P183, DOI 10.1515/BC.2000.025; GLASSBERG J, 1979, J BACTERIOL, V140, P14, DOI 10.1128/JB.140.1.14-19.1979; Goodwin BK, 2000, J AGR RESOUR ECON, V25, P195; Handa P, 2001, J BIOL CHEM, V276, P16992, DOI 10.1074/jbc.M100393200; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; Kornberg A., 1991, DNA REPLICATION; LIEBERMAN HB, 1981, MOL GEN GENET, V183, P348, DOI 10.1007/BF00270639; LIEBERMAN HB, 1983, MOL GEN GENET, V190, P92, DOI 10.1007/BF00330329; Liu YH, 1998, J BACTERIOL, V180, P1766, DOI 10.1128/JB.180.7.1766-1770.1998; Livneh Z, 2001, J BIOL CHEM, V276, P25639, DOI 10.1074/jbc.R100019200; LOHMAN TM, 1988, TRENDS BIOCHEM SCI, V13, P250; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Maor-Shoshani A, 2002, BIOCHEMISTRY-US, V41, P14438, DOI 10.1021/bi0262909; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Pham P, 2001, NATURE, V409, P366, DOI 10.1038/35053116; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Reuven NB, 2001, J BIOL CHEM, V276, P5511, DOI 10.1074/jbc.M006828200; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Reuven NB, 1998, MOL CELL, V2, P191, DOI 10.1016/S1097-2765(00)80129-X; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; SALLES B, 1983, P NATL ACAD SCI-BIOL, V80, P65, DOI 10.1073/pnas.80.1.65; Sandigursky M, 1996, RADIAT RES, V145, P619, DOI 10.2307/3579281; Sarov-Blat L, 1998, J BIOL CHEM, V273, P5520, DOI 10.1074/jbc.273.10.5520; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; SCHAAPER RM, 1982, MUTAT RES, V106, P1, DOI 10.1016/0027-5107(82)90186-5; Schlacher K, 2005, MOL CELL, V17, P561, DOI 10.1016/j.molcel.2005.01.006; Schlacher K, 2006, NATURE, V442, P883, DOI 10.1038/nature05042; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; Tomer G, 1999, BIOCHEMISTRY-US, V38, P5948, DOI 10.1021/bi982599+; Tomer G, 1998, P NATL ACAD SCI USA, V95, P14106, DOI 10.1073/pnas.95.24.14106; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Wagner J, 2002, DNA REPAIR, V1, P159, DOI 10.1016/S1568-7864(01)00012-X; WANG TCV, 1982, J BACTERIOL, V151, P186, DOI 10.1128/JB.151.1.186-192.1982; WHITTIER RF, 1981, MOL GEN GENET, V183, P341, DOI 10.1007/BF00270638; WILLIAMS KR, 1984, J BIOL CHEM, V259, P1804; Witte G, 2005, NUCLEIC ACIDS RES, V33, P1662, DOI 10.1093/nar/gki310; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; WOOD RD, 1986, MOL GEN GENET, V204, P82, DOI 10.1007/BF00330191	56	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8274	8282		10.1074/jbc.M710290200	http://dx.doi.org/10.1074/jbc.M710290200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18223256	hybrid			2022-12-27	WOS:000254288000025
J	Levi, S; Rawet, M; Kliouchnikov, L; Parnis, A; Cassel, D				Levi, Sharon; Rawet, Moran; Kliouchnikov, Lena; Parnis, Anna; Cassel, Dan			Topology of amphipathic motifs mediating Golgi localization in ArfGAP1 and its splice isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; ADP-RIBOSYLATION FACTOR; COPI VESICLE FORMATION; MEMBRANE CURVATURE; ARF-GAP; DEPENDENT BINDING; ALPHA-SYNUCLEIN; FACTOR-I; COATOMER; HYDROLYSIS	The interaction of the Arf1-directed GTPase-activating protein ArfGAP1 with the Golgi apparatus depends on motifs in its noncatalytic part that are unstructured in solution but are capable of folding into amphipathic helices in vitro upon interaction with poorly packed lipids. In previous studies a few hydrophobic residues that are critical for lipid binding and Golgi localization were identified, but the precise topology of the amphipathic motifs has not been determined. Here we present a detailed analysis of the Golgi targeting and in vitro folding features of the region encompassing the amphipathic motifs (residues 199 294). Point mutation analysis revealed that most hydrophobic residues within this region contribute to Golgi localization, whereas analysis by proline replacements and alanine insertions revealed that Golgi interaction depends on folding into two amphipathic helices with a short interrupting sequence. Analysis of splice isoforms containing 10-residue in-frame insertions within their first amphipathic motifs revealed that the insertion causes a truncation of the amphipathic helix that does not extend beyond the insertion sequence. Lastly, a lysine replacement mutant recently reported to bind to negatively charged liposomes in a curvature-independent manner showed normal cellular distribution, suggesting that Golgi targeting of ArfGAP1 may involve factors other than sensing lipid packing.	[Levi, Sharon; Rawet, Moran; Kliouchnikov, Lena; Parnis, Anna; Cassel, Dan] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Cassel, D (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	danc@tx.technion.ac.il						Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Antonny B, 2005, BIOCHEM SOC T, V33, P619, DOI 10.1042/BST0330619; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chevalier SA, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-70; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; FRANCO M, 1993, J BIOL CHEM, V268, P24531; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138; Huber I, 1998, J BIOL CHEM, V273, P24786, DOI 10.1074/jbc.273.38.24786; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Mesmin B, 2007, BIOCHEMISTRY-US, V46, P1779, DOI 10.1021/bi062288w; MISHRA VK, 1994, J BIOL CHEM, V269, P7185; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Parnis A, 2006, J BIOL CHEM, V281, P3785, DOI 10.1074/jbc.M508959200; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Szafer E, 2000, J BIOL CHEM, V275, P23615, DOI 10.1074/jbc.M003171200; Szafer E, 2001, J BIOL CHEM, V276, P47834, DOI 10.1074/jbc.M106000200; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TEAL SB, 1994, J BIOL CHEM, V269, P3135; Wong TA, 2005, P NATL ACAD SCI USA, V102, P12777, DOI 10.1073/pnas.0506156102; Yanagisawa LL, 2002, MOL BIOL CELL, V13, P2193, DOI 10.1091/mbc.01-11-0563; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189; Zhao LY, 1999, J BIOL CHEM, V274, P14198, DOI 10.1074/jbc.274.20.14198; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418	47	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8564	8572		10.1074/jbc.M709738200	http://dx.doi.org/10.1074/jbc.M709738200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18195007	hybrid			2022-12-27	WOS:000254288000055
J	Truong, DM; Kaler, G; Khandelwal, A; Swaan, PW; Nigam, SK				Truong, David M.; Kaler, Gregory; Khandelwal, Akash; Swaan, Peter W.; Nigam, Sanjay K.			Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; PROXIMAL TUBULE CELLS; SLC22A FAMILY-MEMBERS; CATION TRANSPORTER; MULTIDRUG-RESISTANCE; NUCLEOTIDE ANALOGS; MOLECULAR-CLONING; OLFACTORY MUCOSA; CHOROID-PLEXUS; RAT-KIDNEY	Long-term exposure to antivirals is associated with serious cellular toxicity to the kidney and other tissues. Organic anion transporters (OATs) are believed to mediate the cellular uptake, and hence cytotoxicity, of many antivirals. However, a systematic in vitro and ex vivo analysis of interactions between these compounds with various OAT isoforms has been lacking. To characterize substrate interactions with mOat1, mOat3, and mOat6, a fluorescence-based competition assay in Xenopus oocytes as well as wild-type and knock-out whole embryonic kidney (WEK) organ culture systems was developed using 6-carboxyfluorescein, 5-carboxyfluorescein, and fluorescein. Of nine common antiviral drugs assessed in oocytes, many manifested higher affinity for SLC22a6 (mOat1), originally identified as NKT (e. g. adefovir and cidofovir), two (ddC and ddI) manifested significantly higher affinity for mOat3, while mOat6 had comparatively low but measurable affinity for certain antivirals. A live organ staining approach combined with fluorescent uptake in WEK cultures allowed the visualization of OAT-mediated uptake ex vivo into developing proximal tubule-like structures, as well as quantification of substrate interactions of individual OAT isoforms. In general, antiviral specificity of SLC22a6 (Oat1) (in Oat3(-/-) WEK culture) and SLC22a8 (Oat3) (in Oat1(-/-) WEK culture) was consistent with the Xenopus oocyte data. The combined observations suggest SLC22a8 (Oat3) is the major transporter interacting with ddC and ddI. Finally, quantitative structure-activity relationship analysis of the nine antivirals' physicochemical descriptors with their OAT affinity indicates that antiviral preferences of mOat1 are explained by high polar surface areas (e. g. phosphate groups), whereas mOat3 prefers hydrogen bond acceptors (e. g. amines, ketones) and low rotatable bond numbers. In contrast, hydrogen bond donors (e. g. amides, alcohols) diminish binding to mOat6. This suggests that, despite sharing close overall sequence homology, Oat1, Oat3, and Oat6 have signficantly different binding pockets. Taken together, the data provide a basis for understanding potential drug interactions in combination antiviral therapy, as well as suggesting structural mdifications for drug design, especially in the context of targeting toward or away from specific tissues.	[Truong, David M.; Kaler, Gregory; Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Khandelwal, Akash; Swaan, Peter W.] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Maryland; University of Maryland Baltimore	Nigam, SK (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	snigam@ucsd.edu		Truong, David/0000-0002-5121-5111; Swaan, Peter/0000-0003-1767-1487; Khandelwal, Akash/0000-0002-0472-7173	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061425] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 057695] Funding Source: Medline; NICHD NIH HHS [HD 40011] Funding Source: Medline; NIDDK NIH HHS [DK 61425] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson PL, 2004, CLIN INFECT DIS, V38, P743, DOI 10.1086/381678; Antonelli A, 1997, BBA-MOL CELL RES, V1358, P39, DOI 10.1016/S0167-4889(97)00027-X; Anzai N, 2005, CURR OPIN NEPHROL HY, V14, P472, DOI 10.1097/01.mnh.0000170751.56527.7e; Bednarczyk D, 2000, PFLUG ARCH EUR J PHY, V440, P184, DOI 10.1007/s004240051038; Bongiovanni M, 2006, CURR MED CHEM, V13, P2789, DOI 10.2174/092986706778521931; BONVENTRE JV, 1988, ANNU REV MED, V39, P531, DOI 10.1146/annurev.med.39.1.531; Brady KP, 1999, GENOMICS, V56, P254, DOI 10.1006/geno.1998.5722; Burckhardt BC, 2003, REV PHYSIOL BIOCH P, V146, P95, DOI 10.1007/s10254-002-0003-8; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Cha SH, 2001, MOL PHARMACOL, V59, P1277, DOI 10.1124/mol.59.5.1277; Cihlar T, 2000, ANAL BIOCHEM, V283, P49, DOI 10.1006/abio.2000.4633; Cihlar T, 1999, MOL PHARMACOL, V56, P570, DOI 10.1124/mol.56.3.570; Cihlar T, 2001, NUCLEOS NUCLEOT NUCL, V20, P641, DOI 10.1081/NCN-100002341; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; DECLERCK LS, 1994, J IMMUNOL METHODS, V172, P115, DOI 10.1016/0022-1759(94)90384-0; Dresser MJ, 2001, J PHARM SCI, V90, P397, DOI 10.1002/1520-6017(200104)90:4<397::AID-JPS1000>3.3.CO;2-4; EPSTEIN FH, 1994, ANN NY ACAD SCI, V718, P72; Epstein FH, 1997, KIDNEY INT, V51, P381, DOI 10.1038/ki.1997.50; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2004, MOL PHARMACOL, V65, P479, DOI 10.1124/mol.65.3.479; Eraly SA, 2003, CURR OPIN NEPHROL HY, V12, P551, DOI 10.1097/00041552-200309000-00011; HITCHCOCK MJM, 1993, CLIN INFECT DIS, V16, pS16, DOI 10.1093/clinids/16.Supplement_1.S16; Jacqz-Aigrain E, 2005, SEMIN FETAL NEONAT M, V10, P139, DOI 10.1016/j.siny.2004.09.015; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; Kojima R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134848; Laitinen L, 1987, J HISTOCHEM CYTOCHEM, V35, P55, DOI 10.1177/35.1.3794309; Lewis W, 2003, PROG CARDIOVASC DIS, V45, P305, DOI 10.1053/pcad.2003.3b; Ljubojevic M, 2004, AM J PHYSIOL-RENAL, V287, pF124, DOI 10.1152/ajprenal.00029.2004; Lopez-Nieto C. E., 1996, Journal of the American Society of Nephrology, V7, P1301; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Miller DS, 2004, ADV DRUG DELIVER REV, V56, P1811, DOI 10.1016/j.addr.2004.07.010; Monte JC, 2004, BIOCHEM BIOPH RES CO, V323, P429, DOI 10.1016/j.bbrc.2004.08.112; Pacifici GM, 2005, EARLY HUM DEV, V81, P647, DOI 10.1016/j.earlhumdev.2005.02.002; Pietruck F, 2006, DRUG METAB DISPOS, V34, P339, DOI 10.1124/dmd.105.006403; ROSS BD, 1986, KIDNEY INT, V29, P54, DOI 10.1038/ki.1986.8; Sweet DH, 2005, TOXICOL APPL PHARM, V204, P198, DOI 10.1016/j.taap.2004.10.016; Sweet DH, 2006, KIDNEY INT, V69, P837, DOI 10.1038/sj.ki.5000170; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Takeda M, 2002, J PHARMACOL EXP THER, V300, P918, DOI 10.1124/jpet.300.3.918; TWENTYMAN PR, 1994, EUR J CANCER, V30A, P1360, DOI 10.1016/0959-8049(94)90187-2; Uwai Y, 2007, PHARM RES, V24, P811, DOI 10.1007/s11095-006-9196-x; Vidal F, 2006, ANTIMICROB AGENTS CH, V50, P3824, DOI 10.1128/AAC.00437-06; Wada S, 2000, J PHARMACOL EXP THER, V294, P844; Young B, 2005, AIDS PATIENT CARE ST, V19, P286, DOI 10.1089/apc.2005.19.286; Zubercova O, 1998, NEOPLASMA, V45, P53	47	78	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8654	8663		10.1074/jbc.M708615200	http://dx.doi.org/10.1074/jbc.M708615200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18174163	hybrid, Green Published			2022-12-27	WOS:000254288000064
J	Gao, N; Asamitsu, K; Hibi, Y; Ueno, T; Okamoto, T				Gao, Nan; Asamitsu, Kaori; Hibi, Yurina; Ueno, Takaharu; Okamoto, Takashi			AKIP1 enhances NF-kappa B-dependent gene expression by promoting the nuclear retention and phosphorylation of p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVITY; MEDIATED TRANSCRIPTION; SIGNAL-TRANSDUCTION; CATALYTIC SUBUNIT; SERINE KINASE; CAMP; INHIBITOR	In this study, we have identified protein kinase A-interacting protein 1 (AKIP1) as a binding partner of NF-kappa B p65 subunit, and AKIP1 enhances the NF-kappa B-mediated gene expression. AKIP1 is a nuclear protein and known to interact with the catalytic subunit of PKA (PKAc). We identified AKIP1 by a yeast two-hybrid screen using the N terminus region of p65 as bait. The interaction between AKIP1 and p65 was confirmed by glutathione S-transferase pull-down assay in vitro and immunoprecipitation-Western blotting assay in vivo. We found that the PKAc was present in the AKIP1 center dot p65 complex and enhanced the transcriptional activity of NF-kappa B by phosphorylating p65. In a transient luciferase assay, AKIP1 cotransfection efficiently increased the transcriptional activity of NF-kappa B induced by phorbol 12-myristate 13-acetate (PMA). When AKIP1 was knocked down by RNA interference, the PMA-mediated NF-kappa B-dependent gene expression was abolished, indicating a physiological role of AKIP1. We found that PKAc, which is maintained in an inactive form by binding to I kappa B alpha and NF-kappa B in resting cells, was activated by PMA-induced signaling and could phosphorylate p65. Overexpression of AKIP1 increased the PKAc binding to p65 and enhanced the PKAc-mediated phosphorylation of p65 at Ser-276. Interestingly, this p65 phosphorylation promoted nuclear translocation of p65 and enhanced NF-kappa B transcription. In fact, we observed that AKIP1 colocalized with p65 within the cells and appeared to retain p65 in nucleus. These findings indicate a positive role of AKIP1 in NF-kappa B signaling and suggest a novel mechanism by which AKIP1 augments the transcriptional competence of NF-kappa B.	[Gao, Nan; Asamitsu, Kaori; Hibi, Yurina; Ueno, Takaharu; Okamoto, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Mol & Cellular Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya City University	Okamoto, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Mol & Cellular Biol, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	tokamoto@med.nagoya-cu.ac.jp		Asamitsu, Kaori/0000-0001-5333-8011				Asamitsu K, 2003, J BIOL CHEM, V278, P26879, DOI 10.1074/jbc.M211831200; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BLOCHLINGER K, 1984, MOL CELL BIOL, V4, P2929, DOI 10.1128/MCB.4.12.2929; Carnegie GK, 2003, GENE DEV, V17, P1557, DOI 10.1101/gad.1095803; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; COBB CE, 1988, METHOD ENZYMOL, V159, P202; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; FANTOZZI DA, 1992, J BIOL CHEM, V267, P16824; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Gao F, 2006, NAT CELL BIOL, V8, P1171, DOI 10.1038/ncb1483; HAYASHI T, 1993, J BIOL CHEM, V268, P26790; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Kim YS, 2006, J BIOL CHEM, V281, P39051, DOI 10.1074/jbc.M604659200; Kitching R, 2003, BBA-GENE STRUCT EXPR, V1625, P116, DOI 10.1016/S0167-4781(02)00562-6; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; Majumdar S, 2003, ONCOGENE, V22, P1206, DOI 10.1038/sj.onc.1206184; Minguet S, 2005, EUR J IMMUNOL, V35, P31, DOI 10.1002/eji.200425524; Moynagh P. N., 2005, J CELL SCI, V118, P4389; NEUMANN M, 1995, EMBO J, V14, P1991, DOI 10.1002/j.1460-2075.1995.tb07191.x; Okamoto T, 1997, CURR TOP CELL REGUL, V35, P149, DOI 10.1016/S0070-2137(97)80006-4; Okamoto T, 2007, CURR PHARM DESIGN, V13, P447, DOI 10.2174/138161207780162944; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Takada N, 2002, J VIROL, V76, P8019, DOI 10.1128/JVI.76.16.8019-8030.2002; Takahashi N, 2002, EUR J BIOCHEM, V269, P4559, DOI 10.1046/j.1432-1033.2002.03157.x; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Tetsuka T, 2004, EUR J BIOCHEM, V271, P3741, DOI 10.1111/j.1432-1033.2004.04314.x; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Victoriano AFB, 2006, ANTIMICROB AGENTS CH, V50, P547, DOI 10.1128/AAC.50.2.547-555.2006; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; WEN W, 1994, J BIOL CHEM, V269, P32214; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wiley JC, 1999, J BIOL CHEM, V274, P6381, DOI 10.1074/jbc.274.10.6381; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yang JP, 1999, ONCOGENE, V18, P5177, DOI 10.1038/sj.onc.1202904; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	48	61	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7834	7843		10.1074/jbc.M710285200	http://dx.doi.org/10.1074/jbc.M710285200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18178962	hybrid			2022-12-27	WOS:000253997900059
J	Huang, L; Cheng, HC; Isom, R; Chen, CS; Levine, RA; Pauli, BU				Huang, Lynn; Cheng, Hung-Chi; Isom, Richard; Chen, Chia-Sui; Levine, Roy A.; Pauli, Bendicht U.			Protein kinase C-epsilon mediates polymeric fibronectin assembly on the surface of blood-borne rat breast cancer cells to promote pulmonary metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL PEPTIDASE-IV; GENE-EXPRESSION PROFILES; PKC-EPSILON; CDNA MICROARRAY; TUMOR-CELLS; DELTA; ACTIVATION; INHIBITION; CARCINOMA; ADHESION	Malignant breast cancer cells that have entered the blood circulation from primary mammary fat pad tumors or are grown in end-over-end suspension culture assemble a characteristic, multi-globular polymeric fibronectin (polyFn) coat on their surfaces. Surface polyFn is critical for pulmonary metastasis, presumably by facilitating lung vascular arrest via endothelial dipeptidylpeptidase IV (CD26). Here, we show that cell-surface polyFn assembly is initiated by the state of suspension, is dependent upon the synthesis and secretion of cellular Fn, and is augmented in a dose-and time-dependent manner by plasma Fn. PolyFn assembly is regulated by protein kinase C-epsilon (PKC epsilon), which translocates rapidly and in increasing amounts from the cytosol to the plasma membrane and is phosphorylated. PolyFn assembly is impeded by select inhibitors of this kinase, i.e. bisindolylmaleimide I, Ro-32-0432, Go6983, and Rottlerin, by the phorbol 12-myristate 13-acetate-mediated and time-dependent loss of PKC epsilon protein and decreased plasma membrane translocation, and more specifically, by stable transfection of lung-metastatic MTF7L breast cancer cells with small interfering RNA-PKC epsilon and dominant-negative PKC epsilon constructs (e.g. RD-PKC epsilon). The inability to assemble a cell surface-associated polyFn coat by knockdown of endogenous Fn or PKC epsilon impedes cancer cells from metastasis to the lungs. The present studies identify a novel regulatory mechanism for polyFn assembly on blood-borne breast cancer cells and depict its effect on pulmonary metastasis.	[Huang, Lynn; Isom, Richard; Chen, Chia-Sui; Levine, Roy A.; Pauli, Bendicht U.] Cornell Univ, Dept Mol Med, Canc Cell Biol Labs, Ithaca, NY 14853 USA; [Cheng, Hung-Chi] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 701, Taiwan	Cornell University; National Cheng Kung University	Pauli, BU (corresponding author), Cornell Univ, Dept Mol Med, Canc Cell Biol Labs, VMC4 151, Ithaca, NY 14853 USA.	bup1@cornell.edu						Abdel-Ghany M, 1998, INVAS METAST, V18, P35, DOI 10.1159/000024497; Abdel-Ghany M, 2001, J BIOL CHEM, V276, P25438, DOI 10.1074/jbc.M100478200; Al Moustafa AE, 2002, ONCOGENE, V21, P2634, DOI 10.1038/sj.onc.1205351; Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; Bandyopadhyay A, 2005, CANCER BIOL THER, V4, P168; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bogatkevich GS, 2003, AM J PHYSIOL-LUNG C, V285, pL334, DOI 10.1152/ajplung.00417.2002; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Cheng HC, 1999, CLIN EXP METASTAS, V17, P609, DOI 10.1023/A:1006757525190; Cheng HC, 2003, J BIOL CHEM, V278, P24600, DOI 10.1074/jbc.M303424200; Cheng HC, 1998, J BIOL CHEM, V273, P24207, DOI 10.1074/jbc.273.37.24207; Cheng JJ, 2001, J BIOL CHEM, V276, P31368, DOI 10.1074/jbc.M011317200; Chun J, 1997, J CELL PHYSIOL, V173, P361, DOI 10.1002/(SICI)1097-4652(199712)173:3<361::AID-JCP8>3.0.CO;2-L; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; De Servi B, 2005, ONCOGENE, V24, P4946, DOI 10.1038/sj.onc.1208676; Di-Capua N, 2003, J NEUROCHEM, V84, P409, DOI 10.1046/j.1471-4159.2003.01563.x; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; FUJIHARA M, 1994, J IMMUNOL, V152, P1898; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gloyna W, 2005, REGUL PEPTIDES, V125, P179, DOI 10.1016/j.regpep.2004.08.023; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hao XS, 2004, CANCER-AM CANCER SOC, V100, P1110, DOI 10.1002/cncr.20095; HAYMAN EG, 1979, J CELL BIOL, V83, P255, DOI 10.1083/jcb.83.1.255; Hoy M, 2003, J BIOL CHEM, V278, P35168, DOI 10.1074/jbc.M303927200; HUMPHRIES MJ, 1989, CANCER INVEST, V7, P373, DOI 10.3109/07357908909039866; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; Imamdi R, 2004, J PHARMACOL EXP THER, V311, P892, DOI 10.1124/jpet.104.072678; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Jerdeva GV, 2005, AM J PHYSIOL-CELL PH, V289, pC1052, DOI 10.1152/ajpcell.00546.2004; Jiang YQ, 2002, ONCOGENE, V21, P2270, DOI 10.1038/sj.onc.1205278; JOHNSON RC, 1991, CANCER RES, V51, P394; JOHNSON RC, 1993, J CELL BIOL, V121, P1423, DOI 10.1083/jcb.121.6.1423; Kiley SC, 1999, ONCOGENE, V18, P6748, DOI 10.1038/sj.onc.1203101; Kiley SC, 1999, CANCER RES, V59, P3230; KORACH S, 1986, CANCER RES, V46, P3624; Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6; Lee HB, 2004, KIDNEY INT, V65, P1170, DOI 10.1111/j.1523-1755.2004.00491.x; Levenson AS, 2005, CANCER RES, V65, P10651, DOI 10.1158/0008-5472.CAN-05-0845; Lopez-Andreo MJ, 2003, MOL BIOL CELL, V14, P4885, DOI 10.1091/mbc.E03-05-0295; Mackay A, 2003, ONCOGENE, V22, P2680, DOI 10.1038/sj.onc.1206349; Masso-Welch PA, 2001, BREAST CANCER RES TR, V68, P211, DOI 10.1023/A:1012265703669; Mendez CF, 2003, J BIOL CHEM, V278, P44753, DOI 10.1074/jbc.M308664200; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Munakata M, 2002, ANN THORAC SURG, V73, P1236, DOI 10.1016/S0003-4975(01)03594-9; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Park YS, 2006, J NEUROSCI, V26, P8999, DOI 10.1523/JNEUROSCI.2828-06.2006; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rinehart-Kim J, 2000, INT J CANCER, V88, P180, DOI 10.1002/1097-0215(20001015)88:2<180::AID-IJC6>3.0.CO;2-H; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Schreckenberg R, 2004, CARDIOVASC RES, V63, P553, DOI 10.1016/j.cardiores.2004.04.032; Smith LM, 1999, ONCOGENE, V18, P6063, DOI 10.1038/sj.onc.1202989; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Stawowy P, 2005, CARDIOVASC RES, V67, P50, DOI 10.1016/j.cardiores.2005.03.002; Tachado SD, 2002, J CELL BIOCHEM, V85, P785, DOI 10.1002/jcb.10164; Tapia JA, 2006, BBA-MOL CELL RES, V1763, P25, DOI 10.1016/j.bbamcr.2005.10.007; Urtreger A, 1998, INT J CANCER, V78, P233, DOI 10.1002/(SICI)1097-0215(19981005)78:2<233::AID-IJC18>3.0.CO;2-B; Valledor AF, 2000, J IMMUNOL, V164, P29, DOI 10.4049/jimmunol.164.1.29; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; WAYS DK, 1992, CANCER RES, V52, P5604; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Zeidman R, 1999, J CELL BIOL, V145, P713, DOI 10.1083/jcb.145.4.713; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhao H, 2004, INT J CANCER, V109, P65, DOI 10.1002/ijc.11676; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101	72	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7616	7627		10.1074/jbc.M705839200	http://dx.doi.org/10.1074/jbc.M705839200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18184652	hybrid			2022-12-27	WOS:000253997900037
J	Zhu, ED; Demay, MB; Gori, F				Zhu, Eric D.; Demay, Marie B.; Gori, Francesca			Wdr5 is essential for osteoblast differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; CHONDROCYTE DIFFERENTIATION; H3K4 METHYLATION; BONE-DEVELOPMENT; GENE-EXPRESSION; WNT; PROTEIN; LRP5; APOPTOSIS; CELLS	Wdr5 is developmentally expressed in osteoblasts and accelerates osteoblast differentiation in vitro and in vivo. To address whether Wdr5 is essential for osteoblast differentiation, plasmid-based small interfering RNAs were used to stably suppress endogenous Wdr5 protein levels in MC3T3-E1 cells. Reduction of endogenous Wdr5 levels markedly inhibited osteoblast differentiation, evidenced by a significant decrease in alkaline phosphatase activity, Runx-2 and osteocalcin mRNAs, and absence of mineralized matrix formation. Wdr5 suppression also resulted in a reduction of histone H3 lysine 4 trimethylation, confirming its critical role in this modification. Because Wdr5 overexpression enhances canonical Wnt signaling in osteoblasts in vivo, the effects of Wdr5 silencing on this pathway were examined. The expression of the canonical Wnt target gene, c-myc, was decreased, whereas that of sfrp2, which is repressed by Wnt signaling, was increased with Wdr5 knockdown. Although only a minimal increase in apoptosis was observed, the antiapoptotic effect of Wnt signaling was also impaired with Wdr5 silencing. The expression of canonical Wnts was significantly decreased with Wdr5 knockdown, resulting in a decrease in nuclear beta-catenin protein levels. Activation of the canonical Wnt signaling pathway did not overcome the effects of Wdr5 knockdown on the expression of Wnt target genes. Chromatin immunoprecipitation demonstrated that Wdr5 is present on the Wnt1 promoter and on canonical Wnt response elements of the c-myc and Runx-2 promoters. These studies demonstrate that Wdr5 suppression interferes with the canonical Wnt signaling pathway at multiple stages and that optimal Wdr5 levels are required for induction of the osteoblast phenotype.	[Zhu, Eric D.; Demay, Marie B.; Gori, Francesca] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Gori, F (corresponding author), 50 Blossom St, Boston, MA 02114 USA.	gori@helix.mgh.harvard.edu			NIDDK NIH HHS [DK36597] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036597] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Anderson PH, 2007, J STEROID BIOCHEM, V103, P601, DOI 10.1016/j.jsbmb.2006.12.084; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Canalis E, 2005, J Endocrinol Invest, V28, P3; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; GAUR T, 2005, J BIOL CHEM; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Gori F, 2006, DEV BIOL, V295, P498, DOI 10.1016/j.ydbio.2006.02.031; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Hwang SG, 2005, J BIOL CHEM, V280, P12758, DOI 10.1074/jbc.M413367200; Johnson ML, 2004, J BONE MINER RES, V19, P1749, DOI 10.1359/JBMR.040816; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lee MK, 2006, J CELL BIOCHEM, V99, P986, DOI 10.1002/jcb.20990; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Reinhold MI, 2007, J BIOL CHEM, V282, P3653, DOI 10.1074/jbc.M608995200; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101	36	47	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7361	7367		10.1074/jbc.M703304200	http://dx.doi.org/10.1074/jbc.M703304200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18201971	hybrid			2022-12-27	WOS:000253997900010
J	Fujii, T; Takahashi, Y; Itomi, Y; Fujita, K; Morii, M; Tabuchi, Y; Asano, S; Tsukada, K; Takeguchi, N; Sakai, H				Fujii, Takuto; Takahashi, Yuji; Itomi, Yasuo; Fujita, Kyosuke; Morii, Magotoshi; Tabuchi, Yoshiaki; Asano, Shinji; Tsukada, Kazuhiro; Takeguchi, Noriaki; Sakai, Hideki			K+-Cl- cotransporter-3a up-regulates Na+,K+-ATPase in lipid rafts of gastric luminal parietal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/K+-ATPASE; NA-K-2CL COTRANSPORTER; NA/K-ATPASE; MICE; SECRETION; EXCHANGER; BINDING; KCC3; RAT; HETEROGENEITY	Gastric parietal cells migrate from the luminal to the basal region of the gland, and they gradually lose acid secretory activity. So far, distribution and function of K+-C- cotransporters (KCCs) in gastric parietal cells have not been reported. We found that KCC3a but not KCC3b mRNA was highly expressed, and KCC3a protein was predominantly expressed in the basolateral membrane of rat gastric parietal cells located in the luminal region of the glands. KCC3a and the Na+, K+-ATPase alpha 1-subunit (alpha 1NaK) were coimmunoprecipitated, and both of them were highly localized in a lipid raft fraction. The ouabain-sensitive K+-dependent ATP-hydrolyzing activity (Na+,K+-ATPase activity) was significantly inhibited by a KCC inhibitor (R-(+)-[(2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]acetic acid (DIOA)). The stable exogenous expression of KCC3a in LLC-PK1 cells resulted in association of KCC3a with endogenous alpha 1NaK, and it recruited alpha 1NaK in lipid rafts, accompanying increases of Na+,K+-ATPase activity and ouabain-sensitive Na+ transport activity that were suppressed by DIOA, whereas the total expression level of alpha 1NaK in the cells was not significantly altered. On the other hand, the expression of KCC4 induced no association with alpha 1NaK. In conclusion, KCC3a forms a functional complex with alpha 1NaK in the basolateral membrane of luminal parietal cells, and it up-regulates alpha 1NaK in lipid rafts, whereas KCC3a is absent in basal parietal cells.	[Fujii, Takuto; Takahashi, Yuji; Itomi, Yasuo; Fujita, Kyosuke; Morii, Magotoshi; Takeguchi, Noriaki; Sakai, Hideki] Toyama Univ, Dept Pharmaceut Physiol, Toyama 9300194, Japan; [Tabuchi, Yoshiaki] Toyama Univ, Life Sci Res Ctr, Toyama 9300194, Japan; [Tsukada, Kazuhiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Surg 2, Toyama 9300194, Japan; [Asano, Shinji] Ritsumeikan Univ, Coll Informat Sci & Engn, Dept Mol Physiol, Shiga 5258577, Japan	University of Toyama; University of Toyama; University of Toyama; Ritsumeikan University	Sakai, H (corresponding author), Toyama Univ, Dept Pharmaceut Physiol, 2630 Sugitani, Toyama 9300194, Japan.	sakaih@pha.u-toyama.ac.jp		Asano, Shinji/0000-0003-1443-8970; Tabuchi, Yoshiaki/0000-0002-6007-6176				Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Balut C, 2006, AM J PHYSIOL-CELL PH, V290, pC87, DOI 10.1152/ajpcell.00184.2005; BAMBERG K, 1994, BBA-BIOMEMBRANES, V1190, P355, DOI 10.1016/0005-2736(94)90094-9; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Carmosino M, 2001, J CELL BIOL, V154, P1235, DOI 10.1083/jcb.200103010; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Fujii T, 2007, EUR J PHARMACOL, V560, P123, DOI 10.1016/j.ejphar.2006.12.031; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GARAY RP, 1988, MOL PHARMACOL, V33, P696; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; HELANDER HF, 1984, GASTROENTEROLOGY, V87, P1064; Ikeda K, 2004, J NEUROSCI, V24, P10693, DOI 10.1523/JNEUROSCI.2909-04.2004; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; Karam SM, 1997, AM J PHYSIOL-GASTR L, V272, pG161, DOI 10.1152/ajpgi.1997.272.1.G161; Kimura T, 2002, J BIOL CHEM, V277, P20671, DOI 10.1074/jbc.M200523200; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Lingwood D, 2005, J BIOL CHEM, V280, P36545, DOI 10.1074/jbc.M506670200; McDaniel N, 2005, AM J PHYSIOL-GASTR L, V289, pG550, DOI 10.1152/ajpgi.00095.2005; McDaniel N, 1999, AM J PHYSIOL-GASTR L, V276, pG1273, DOI 10.1152/ajpgi.1999.276.5.G1273; Mercado A, 2005, AM J PHYSIOL-RENAL, V289, pF1246, DOI 10.1152/ajprenal.00464.2004; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Pearson MM, 2001, NEUROSCIENCE, V103, P481, DOI 10.1016/S0306-4522(00)00567-4; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Race JE, 1999, AM J PHYSIOL-CELL PH, V277, pC1210, DOI 10.1152/ajpcell.1999.277.6.C1210; Rossmann H, 2001, J PHYSIOL-LONDON, V534, P837, DOI 10.1111/j.1469-7793.2001.00837.x; Sachs G, 2001, EUR J GASTROEN HEPAT, V13, pS35; Sakai H, 2003, J PHYSIOL-LONDON, V551, P207, DOI 10.1113/jphysiol.2003.041921; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Teramachi S, 2002, J BIOL CHEM, V277, P37394, DOI 10.1074/jbc.M204772200; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Wang KS, 2000, AM J PHYSIOL-GASTR L, V279, pG448, DOI 10.1152/ajpgi.2000.279.2.G448; Welker P, 2007, AM J PHYSIOL-REG I, V292, pR1328, DOI 10.1152/ajpregu.00166.2006; YODA A, 1970, BIOCHEM BIOPH RES CO, V40, P880, DOI 10.1016/0006-291X(70)90985-X	41	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6869	6877		10.1074/jbc.M708429200	http://dx.doi.org/10.1074/jbc.M708429200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18178552	hybrid, Green Submitted			2022-12-27	WOS:000253779600030
J	Komazin-Meredith, G; Santos, WL; Filman, DJ; Hogle, JM; Verdine, GL; Coen, DM				Komazin-Meredith, Gloria; Santos, Webster L.; Filman, David J.; Hogle, James M.; Verdine, Gregory L.; Coen, Donald M.			The positively charged surface of herpes simplex virus UL42 mediates DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE PROCESSIVITY FACTOR; ACCESSORY PROTEIN UL44; CELL NUCLEAR ANTIGEN; CRYSTAL-STRUCTURE; C-TERMINUS; CATALYTIC SUBUNIT; LAC REPRESSOR; REPLICATION FACTOR; VIRAL REPLICATION; PRIMER-TEMPLATE	Herpes simplex virus DNA polymerase is a heterodimer composed of UL30, a catalytic subunit, and UL42, a processivity subunit. Mutations that decrease DNA binding by UL42 decrease long chain DNA synthesis by the polymerase. The crystal structure of UL42 bound to the C terminus of UL30 revealed an extensive positively charged surface ("back face"). We tested two hypotheses, 1) the C terminus of UL30 affects DNA binding and 2) the positively charged back face mediates DNA binding. Addressing the first hypothesis, we found that the presence of a peptide corresponding to the UL30 C terminus did not result in altered binding of UL42 to DNA. Addressing the second hypothesis, previous work showed that substitution of four conserved arginine residues on the basic face with alanines resulted in decreased DNA affinity. We tested the affinities for DNA and the stimulation of long chain DNA synthesis of mutants in which the four conserved arginine residues were substituted individually or together with lysines and also a mutant in which a conserved glutamine residue was substituted with an arginine to increase positive charge on the back face. We also engineered cysteines onto this surface to permit disulfide cross-linking studies. Last, we assayed the effects of ionic strength on DNA binding by UL42 to estimate the number of ions released upon binding. Our results taken together strongly suggest that the basic back face of UL42 contacts DNA and that positive charge on this surface is important for this interaction.	[Komazin-Meredith, Gloria; Filman, David J.; Hogle, James M.; Coen, Donald M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Santos, Webster L.; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Coen, DM (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 250 Longwood Ave, Boston, MA 02115 USA.	Don_Coen@hms.harvard.edu	Hogle, James/HIG-9121-2022	Santos, Webster/0000-0002-4731-8548; filman, david/0000-0002-8714-1644; Hogle, James/0000-0002-3655-1504	NIAID NIH HHS [AI 26077, R56 AI026077, R01 AI 19838, R01 AI026077] Funding Source: Medline; NIGMS NIH HHS [R01 GM044853, F32 GM 067380, R01 GM044853-15, F32 GM067380, F32 GM067380-03, GM 044853] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI026077, R01AI019838, R01AI026077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067380, R01GM044853] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Appleton BA, 2006, J BIOL CHEM, V281, P5224, DOI 10.1074/jbc.M506900200; Appleton BA, 2004, MOL CELL, V15, P233, DOI 10.1016/j.molcel.2004.06.018; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Bridges KG, 2001, J VIROL, V75, P4990, DOI 10.1128/JVI.75.11.4990-4998.2001; Chaudhuri M, 2002, J VIROL, V76, P10270, DOI 10.1128/JVI.76.20.10270-10281.2002; CHOW CS, 1995, J VIROL, V69, P6965, DOI 10.1128/JVI.69.11.6965-6971.1995; DEHASETH PL, 1977, BIOCHEMISTRY-US, V16, P4783, DOI 10.1021/bi00641a004; DIGARD P, 1993, J VIROL, V67, P1159, DOI 10.1128/JVI.67.3.1159-1168.1993; DIGARD P, 1993, J VIROL, V67, P398, DOI 10.1128/JVI.67.1.398-406.1993; FUKUDA K, 1995, J BIOL CHEM, V270, P22527, DOI 10.1074/jbc.270.38.22527; GOTTLIEB J, 1994, J VIROL, V68, P4937, DOI 10.1128/JVI.68.8.4937-4945.1994; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Jeruzalmi D, 2002, CURR OPIN STRUC BIOL, V12, P217, DOI 10.1016/S0959-440X(02)00313-5; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Loregian A, 2004, J VIROL, V78, P9084, DOI 10.1128/JVI.78.17.9084-9092.2004; Loregian A, 2004, J VIROL, V78, P158, DOI 10.1128/JVI.78.1.158-167.2004; Loregian A, 2007, NUCLEIC ACIDS RES, V35, P4779, DOI 10.1093/nar/gkm506; Maga G, 2000, J MOL BIOL, V295, P791, DOI 10.1006/jmbi.1999.3394; MARSDEN HS, 1994, J GEN VIROL, V75, P3127, DOI 10.1099/0022-1317-75-11-3127; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; PARRIS DS, 1988, J VIROL, V62, P818, DOI 10.1128/JVI.62.3.818-825.1988; Pilger BD, 2004, CHEM BIOL, V11, P647, DOI 10.1016/j.chembiol.2004.01.018; PURIFOY DJM, 1977, NATURE, V269, P621, DOI 10.1038/269621a0; Randell JC, 2001, MOL CELL, V8, P911, DOI 10.1016/S1097-2765(01)00355-0; Randell JCW, 2005, J VIROL, V79, P12025, DOI 10.1128/JVI.79.18.12025-12034.2005; Randell JCW, 2004, J MOL BIOL, V335, P409, DOI 10.1016/j.jmb.2003.10.064; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; STOW ND, 1993, NUCLEIC ACIDS RES, V21, P87, DOI 10.1093/nar/21.1.87; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TENNEY DJ, 1993, J VIROL, V67, P543, DOI 10.1128/JVI.67.1.543-547.1993; Weisshart K, 1999, J VIROL, V73, P55, DOI 10.1128/JVI.73.1.55-66.1999; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	41	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6154	6161		10.1074/jbc.M708691200	http://dx.doi.org/10.1074/jbc.M708691200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18178550	hybrid, Green Accepted			2022-12-27	WOS:000253779500022
J	Ueyama, M; Takemae, H; Ohmae, Y; Yoshida, H; Toyoda, H; Ueda, R; Nishihara, S				Ueyama, Morio; Takemae, Hitoshi; Ohmae, Yoshiko; Yoshida, Hideki; Toyoda, Hidenao; Ueda, Ryu; Nishihara, Shoko			Functional analysis of proteoglycan galactosyltransferase II RNA interference mutant flies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; PROTEIN LINKAGE REGION; FALCIPARUM-INFECTED ERYTHROCYTES; BETA-D-XYLOSYLTRANSFERASE; DALLY-LIKE PROTEIN; UDP-D-XYLOSE; CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; 5'-PHOSPHOSULFATE TRANSPORTER; CHONDROITINASE ABC	Heparan sulfate proteoglycan plays an important role in developmental processes by modulating the distribution and stability of the morphogens Wingless, Hedgehog, and Decapentaplegic. Heparan and chondroitin sulfates share a common linkage tetrasaccharide structure, GlcA beta 1, 3Gal beta 1, 3Gal beta 1, 4Xyl beta-O-Ser. In the present study, we identified Drosophila proteoglycan galactosyltransferase II (d beta 3GalTII), determined its substrate specificity, and performed its functional analysis by using RNA interference (RNAi) mutant flies. The enzyme transferred a galactose to Gal beta 1,4Xyl-pMph, confirming that it is the Drosophila ortholog of human proteoglycan galactosyltransferase II. Real-time PCR analyses revealed that d beta 3GalTII is expressed in various tissues and throughout development. The d beta 3GalTII RNAi mutant flies showed decreased amounts of heparan sulfate proteoglycans. A genetic interaction of d beta 3GalTII with Drosophila beta 1,4-galactoslyltransferase 7 (d beta 4GalT7) or with six genes that encode enzymes contributing to the synthesis of glycosaminoglycans indicated that d beta 3GalTII is involved in heparan sulfate synthesis for wing and eye development. Moreover, d beta 3GalTII knockdown caused a decrease in extracellular Wingless in the wing imaginal disc of the third instar larvae. These results demonstrated that d beta 3GalTII contributes to heparan sulfate proteoglycan synthesis in vitro and in vivo and also modulates Wingless distribution.	[Ueyama, Morio; Takemae, Hitoshi; Ohmae, Yoshiko; Yoshida, Hideki; Ueda, Ryu; Nishihara, Shoko] Soka Univ, Dept Bioinformat, Cell Biol Lab, Fac Engn, Hachioji, Tokyo 1928577, Japan; [Ueyama, Morio; Yoshida, Hideki; Toyoda, Hidenao; Nishihara, Shoko] Japan Sci & Technol Agcy, Kawaguchi Ctr Bldg, CREST, Kawaguchi, Saitama 3320012, Japan; [Toyoda, Hidenao] Chiba Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Chiba 2638522, Japan; [Ueda, Ryu] Natl Inst Genet, Invertebrate Genet Lab, Mishima, Shizuoka 4418540, Japan	Soka University; Japan Science & Technology Agency (JST); Chiba University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Nishihara, S (corresponding author), Soka Univ, Dept Bioinformat, Cell Biol Lab, Fac Engn, 1-236 Tangi Cho, Hachioji, Tokyo 1928577, Japan.	shoko@t.soka.ac.jp	Takemae, Hitoshi/AEP-5503-2022	Nishihara, Shoko/0000-0002-1668-2603; Ueyama, Morio/0000-0002-2950-7361				Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Baeg GH, 2001, DEVELOPMENT, V128, P87; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bao XF, 2005, J BIOL CHEM, V280, P23184, DOI 10.1074/jbc.M503036200; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; Fu WM, 2003, DEVELOPMENT, V130, P5229, DOI 10.1242/dev.00764; Goda E, 2006, J BIOL CHEM, V281, P28508, DOI 10.1074/jbc.M605045200; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Gowda ASP, 2007, J BIOL CHEM, V282, P916, DOI 10.1074/jbc.M604741200; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Hwang HY, 2003, J BIOL CHEM, V278, P11735, DOI 10.1074/jbc.C200518200; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Khare N, 2000, MECH DEVELOP, V99, P199, DOI 10.1016/S0925-4773(00)00502-5; Kim BT, 2003, J BIOL CHEM, V278, P9116, DOI 10.1074/jbc.M209344200; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lin XH, 2002, GLYCOCONJUGATE J, V19, P363, DOI 10.1023/A:1025329323438; Luders F, 2003, EMBO J, V22, P3635, DOI 10.1093/emboj/cdg345; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Muller R, 2002, J BIOL CHEM, V277, P32417, DOI 10.1074/jbc.C200381200; Muthusamy A, 2004, GLYCOBIOLOGY, V14, P635, DOI 10.1093/glycob/cwh077; Nakamura Y, 2002, J BIOL CHEM, V277, P46280, DOI 10.1074/jbc.M203873200; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Nishihara S, 2004, GLYCOCONJUGATE J, V21, P63, DOI 10.1023/B:GLYC.0000043750.80389.14; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Olson SK, 2006, J CELL BIOL, V173, P985, DOI 10.1083/jcb.200603003; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Pinto DO, 2004, GLYCOBIOLOGY, V14, P529, DOI 10.1093/glycob/cwh070; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Rawson JM, 2005, CURR BIOL, V15, P833, DOI 10.1016/j.cub.2005.03.039; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Sango K, 2003, EXP NEUROL, V182, P1, DOI 10.1016/S0014-4886(03)00090-6; Schwientek T, 2002, J BIOL CHEM, V277, P32421, DOI 10.1074/jbc.M206213200; Selleck SB, 2001, SEMIN CELL DEV BIOL, V12, P127, DOI 10.1006/scdb.2000.0242; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Shipp EL, 2007, CHEM BIOL, V14, P195, DOI 10.1016/j.chembiol.2006.12.009; Shiraishi N, 2001, J BIOL CHEM, V276, P3498, DOI 10.1074/jbc.M004800200; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Staatz W D, 2001, Methods Mol Biol, V171, P41; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Takemae H, 2003, J BIOL CHEM, V278, P15571, DOI 10.1074/jbc.M301123200; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; Tropea D, 2003, J NEUROSCI, V23, P7034, DOI 10.1523/JNEUROSCI.23-18-07034.2003; Vadaie N, 2002, GLYCOBIOLOGY, V12, P589, DOI 10.1093/glycob/cwf074; Voigt A, 2002, DEV DYNAM, V224, P403, DOI 10.1002/dvdy.10120; Wilson IBH, 2002, J BIOL CHEM, V277, P21207, DOI 10.1074/jbc.M201634200; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200	70	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6076	6084		10.1074/jbc.M709189200	http://dx.doi.org/10.1074/jbc.M709189200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165227	hybrid			2022-12-27	WOS:000253779500013
J	Ruiz, S; Castro-Castro, A; Bustelo, XR				Ruiz, Sergio; Castro-Castro, Antonio; Bustelo, Xose R.			CD147 inhibits the nuclear factor of activated T-cells by impairing vav1 and rac1 downstream signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASE INDUCER; GDP/GTP EXCHANGE FACTOR; BLOOD-BRAIN-BARRIER; IMMUNOGLOBULIN SUPERFAMILY; RHEUMATOID-ARTHRITIS; BASIGIN GENE; MICE LACKING; TYROSINE PHOSPHORYLATION; BIOLOGICAL-ACTIVITY; RECEPTOR SIGNALS	CD147 is a transmembrane protein that plays crucial roles in the development and function of the reproductive, visual, and nervous systems. CD147 also exerts positive and negative actions in T-cells by still obscure mechanisms. In this study, we have analyzed the expression, localization, and function of CD147 during T-cell receptor signaling responses. We show here that CD147 is an integral component of the T-cell immune synapse and that its overexpression leads to the inhibition of NF-AT ( nuclear factor of activated T-cells) activity induced by Vav1, a Rac1 exchange factor. This inhibitory activity is mediated by the CD147 intracellular tail and is totally independent of its extracellular or transmembrane regions. The molecular dissection of the influence of CD147 on the Vav1 pathway indicates that its inhibitory action takes place downstream of Vav1 and Rac1 but upstream of the serine/threonine kinases JNK and Pak1. The interference of CD147 with these pathways is highly specific because the overexpression of CD147 does not affect the activity of other GDP/GTP exchange factors or the stimulation of the ERK cascade. Finally, we show that the CD147 knockdown in Jurkat cells promotes higher levels of NF-AT stimulation and Pak1 phosphorylation upon T-cell receptor cross-linking. Instead, the lack of CD147 does not affect other signaling cascades that participate in the same cellular response. Taken together, these results indicate that CD147, via the selective inhibition of specific downstream elements of the Vav1/Rac1 route, contributes to the negative regulation of T-cell responses.	[Ruiz, Sergio; Castro-Castro, Antonio; Bustelo, Xose R.] Univ Salamanca, Ctr Invest Canc, Inst Biol Mol & Celular Canc, Consejo Super Invest Cient, E-37007 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Bustelo, XR (corresponding author), Univ Salamanca, Ctr Invest Canc, CSIC, Campus Unamuno, E-37007 Salamanca, Spain.	xbustelo@usal.es	Ruiz, Sergio/G-1561-2016; Bustelo, Xose R./AAD-2081-2022; Bustelo, Xose R./A-9526-2010	Ruiz, Sergio/0000-0002-0177-6965; Bustelo, Xose R./0000-0001-9398-6072; Bustelo, Xose R./0000-0001-9398-6072	NCI NIH HHS [5R01-CA73735-11] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073735] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; ALTRUDA F, 1989, GENE, V85, P445, DOI 10.1016/0378-1119(89)90438-1; Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; Besse F, 2007, J CELL BIOL, V177, P843, DOI 10.1083/jcb.200701111; Boulos S, 2007, NEUROBIOL DIS, V25, P54, DOI 10.1016/j.nbd.2006.08.012; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; BUSTELO XR, 1994, ONCOGENE, V9, P2405; Bustelo XR, 2002, FRONT BIOSCI, V7, pD24, DOI 10.2741/bustelo; BUSTELO XR, 1993, CELL GROWTH DIFFER, V4, P297; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen S, 2004, BIOCHEM BIOPH RES CO, V324, P147, DOI 10.1016/j.bbrc.2004.08.232; Chen ZN, 2005, J INFECT DIS, V191, P755, DOI 10.1086/427811; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Curtin KD, 2007, GLIA, V55, P1542, DOI 10.1002/glia.20568; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; FOSSUM S, 1991, EUR J IMMUNOL, V21, P671, DOI 10.1002/eji.1830210320; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Guillot S, 2006, EXP LUNG RES, V32, P81, DOI 10.1080/01902140600710512; Gwinn WM, 2006, J IMMUNOL, V177, P4870, DOI 10.4049/jimmunol.177.7.4870; Harrod TP, 2002, IMMUNOL RES, V26, P153, DOI 10.1385/IR:26:1-3:153; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; Hori K, 2000, INVEST OPHTH VIS SCI, V41, P3128; Igakura T, 1996, BIOCHEM BIOPH RES CO, V224, P33, DOI 10.1006/bbrc.1996.0980; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; Jiang Jian-Li, 2007, Shengli Xuebao, V59, P517; KANEKURA T, 1991, CELL STRUCT FUNCT, V16, P23, DOI 10.1247/csf.16.23; Koch C, 1999, INT IMMUNOL, V11, P777, DOI 10.1093/intimm/11.5.777; Konttinen YT, 2000, ARTHRITIS RHEUM, V43, P275, DOI 10.1002/1529-0131(200002)43:2<275::AID-ANR6>3.0.CO;2-#; Kuno N, 1998, FEBS LETT, V425, P191, DOI 10.1016/S0014-5793(98)00213-0; Lim M, 1998, FEBS LETT, V441, P88, DOI 10.1016/S0014-5793(98)01474-4; Llorca O, 2005, EMBO J, V24, P1330, DOI 10.1038/sj.emboj.7600617; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; MIYAUCHI T, 1990, J BIOCHEM-TOKYO, V107, P316, DOI 10.1093/oxfordjournals.jbchem.a123045; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Nabeshima K, 2004, J PATHOL, V202, P341, DOI 10.1002/path.1518; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Naruhashi K, 1997, BIOCHEM BIOPH RES CO, V236, P733, DOI 10.1006/bbrc.1997.6993; Ochrietor JD, 2002, VISION RES, V42, P447, DOI 10.1016/S0042-6989(01)00236-X; Ochrietor JD, 2001, EXP EYE RES, V72, P467, DOI 10.1006/exer.2000.0974; Pistol G, 2007, J CELL MOL MED, V11, P339, DOI 10.1111/j.1582-4934.2007.00022.x; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Renno T, 2002, J IMMUNOL, V168, P4946, DOI 10.4049/jimmunol.168.10.4946; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Ruiz S, 2007, MOL CELL BIOL, V27, P8127, DOI 10.1128/MCB.00912-07; Schreiner A, 2007, MOL BIOL CELL, V18, P1272, DOI 10.1091/mbc.E06-07-0637; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; SEULBERGER H, 1990, EMBO J, V9, P2151, DOI 10.1002/j.1460-2075.1990.tb07384.x; Spinale FG, 2000, CIRCULATION, V102, P1944, DOI 10.1161/01.CIR.102.16.1944; Staffler G, 2003, J IMMUNOL, V171, P1707, DOI 10.4049/jimmunol.171.4.1707; Tang Y, 2006, MOL CANCER RES, V4, P371, DOI 10.1158/1541-7786.MCR-06-0042; Taylor PM, 2002, ONCOGENE, V21, P5765, DOI 10.1038/sj.onc.1205702; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Tomita T, 2002, ARTHRITIS RHEUM, V46, P373, DOI 10.1002/art.10050; Toyama Y, 1999, ANAT HISTOL EMBRYOL, V28, P205, DOI 10.1046/j.1439-0264.1999.00194.x; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306; WOODROW M, 1993, J EXP MED, V178, P1517, DOI 10.1084/jem.178.5.1517; WOODROW MA, 1993, J IMMUNOL, V150, P3853; WU J, 1995, MOL CELL BIOL, V15, P4337; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536; Yang JM, 2006, J BIOL CHEM, V281, P9719, DOI 10.1074/jbc.M508421200; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102; Zhu P, 2005, ARTHRITIS RES THER, V7, pR1023, DOI 10.1186/ar1778; Zhu P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1899; Zugaza JL, 2004, ONCOGENE, V23, P5823, DOI 10.1038/sj.onc.1207768; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	78	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5554	5566		10.1074/jbc.M708566200	http://dx.doi.org/10.1074/jbc.M708566200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18160397	hybrid			2022-12-27	WOS:000253426700036
J	Nomura, R; Suzuki, Y; Kakizuka, A; Jingami, H				Nomura, Rei; Suzuki, Yoshikazu; Kakizuka, Akira; Jingami, Hisato			Direct detection of the interaction between recombinant soluble extracellular regions in the heterodimeric metabotropic gamma-aminobutyric acid receptor.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; GABA-B RECEPTOR; LIGAND-BINDING; GLUTAMATE-RECEPTOR; NEGATIVE COOPERATIVITY; DIMER INTERFACE; GB2 SUBUNITS; SUBTYPE 1; DOMAIN; TRAFFICKING	The gamma-aminobutyric acid, type B (GABA(B)) receptor is a heterodimeric receptor consisting of two complementary subunits, GABA(B1) receptor (GBR1) and GABA(B2) receptor (GBR2). GBR1 is responsible for GABA binding, whereas GBR2 is considered to perform a critical role in signal transduction toward downstream targets. Therefore, precise communication between GBR1 and GBR2 is thought to be essential for the proper signal transduction process. However, biochemical data describing the interaction of the two subunits, especially for the extracellular regions, are not sufficient. Thus we began by developing a protein expression system of the soluble extracellular regions. One of the soluble recombinant GBR1 proteins exhibited a ligand binding ability, which is similar to that of the full-length GBR1, and thus the ligand-binding domain was determined. Direct interaction between GBR1 and GBR2 extracellular soluble fragments was confirmed by co-expression followed by affinity column chromatography and a sucrose density gradient sedimentation. In addition, we also found homo-oligomeric states of these soluble extracellular regions. The interaction between the two soluble extracellular regions caused the enhancement of the agonist affinity for GBR1 as previously reported in a cell-based assay. These results not only open the way to future structural studies but also highlight the role of the interaction between the extracellular regions, which controls agonist affinity to the heterodimeric receptor.	[Nomura, Rei; Suzuki, Yoshikazu; Jingami, Hisato] Biomol Engn Res Inst, Dept Mol Biol, Osaka 5650874, Japan; [Nomura, Rei; Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies & Solut Oriented Res Sci & Te, JST,Lab Funct Biol, Sakyo Ku, Kyoto 6068501, Japan; [Jingami, Hisato] Kyoto Univ, Grad Courses Integrated Res Training, Fac Med, Sakyo Ku, Kyoto 6068501, Japan	Japan Science & Technology Agency (JST); Kyoto University; Kyoto University	Jingami, H (corresponding author), Biomol Engn Res Inst, Dept Mol Biol, 6-2-3 Furuedai, Osaka 5650874, Japan.	jingami@mfour.med.kyoto-u.ac.jp						Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; BOWERY NG, 1980, NATURE, V283, P92, DOI 10.1038/283092a0; Calver AR, 2001, J NEUROSCI, V21, P1203; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Deriu D, 2005, BIOCHEM J, V386, P423, DOI 10.1042/BJ20040804; Devi LA, 2001, TRENDS PHARMACOL SCI, V22, P532, DOI 10.1016/S0165-6147(00)01799-5; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Froestl W, 1999, NEUROPHARMACOLOGY, V38, P1641, DOI 10.1016/S0028-3908(99)00134-3; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Green A, 2000, BRIT J PHARMACOL, V131, P1766, DOI 10.1038/sj.bjp.0703755; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kniazeff J, 2002, J NEUROSCI, V22, P7352; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Levoye A, 2006, EMBO REP, V7, P1094, DOI 10.1038/sj.embor.7400838; Liu JF, 2004, J BIOL CHEM, V279, P15824, DOI 10.1074/jbc.M313639200; Malitschek B, 1999, MOL PHARMACOL, V56, P448, DOI 10.1124/mol.56.2.448; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Pagano A, 2001, J NEUROSCI, V21, P1189; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Sato T, 2003, J BIOL CHEM, V278, P4314, DOI 10.1074/jbc.M210278200; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	36	17	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4665	4673		10.1074/jbc.M705202200	http://dx.doi.org/10.1074/jbc.M705202200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18165688	hybrid			2022-12-27	WOS:000253426500024
J	Feng, HT; Cheng, TS; Pavlos, NJ; Yip, KHM; Carrello, A; Seeber, R; Eidne, K; Zheng, MH; Xu, JK				Feng, Haotian; Cheng, Taksum; Pavlos, Nathan J.; Yip, Kirk H. M.; Carrello, Amerigo; Seeber, Ruth; Eidne, Karin; Zheng, Ming H.; Xu, Jiake			Cytoplasmic terminus of vacuolar type proton pump accessory subunit ac45 is required for proper interaction with V-0 domain Subunits and efficient osteoclastic bone resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFANTILE MALIGNANT OSTEOPETROSIS; MEDIATED EXTRACELLULAR ACIDIFICATION; KAPPA-B LIGAND; H+-ATPASE; V-ATPASE; TRANSLOCATING ATPASE; A3 SUBUNIT; TARGETED DISRUPTION; ELECTRON-MICROSCOPY; RECEPTOR ACTIVATOR	Solubilization of mineralized bone by osteoclasts is largely dependent on the acidification of the extracellular resorption lacuna driven by the vacuolar (H+)-ATPases (V-ATPases) polarized within the ruffled border membranes. V-ATPases consist of two functionally and structurally distinct domains, V-1 and V-0. The peripheral cytoplasmically oriented V-1 domain drives ATP hydrolysis, which necessitates the translocation of protons across the integral membrane bound V-0 domain. Here, we demonstrate that an accessory subunit, Ac45, interacts with the V-0 domain and contributes to the vacuolar type proton pump-mediated function in osteoclasts. Consistent with its role in intracellular acidification, Ac45 was found to be localized to the ruffled border region of polarized resorbing osteoclasts and enriched in pH-dependent endosomal compartments that polarized to the ruffled border region of actively resorbing osteoclasts. Interestingly, truncation of the 26-amino acid residue cytoplasmic tail of Ac45, which encodes an autonomous internalization signal, was found to impair bone resorption in vitro. Furthermore, biochemical analysis revealed that although both wild type Ac45 and mutant were capable of associating with subunits a3, c, c '', and d, deletion of the cytoplasmic tail altered its binding proximity with a3, c '', and d. In all, our data suggest that the cytoplasmic terminus of Ac45 contains elements necessary for its proper interaction with V-0 domain and efficient osteoclastic bone resorption.	[Feng, Haotian; Cheng, Taksum; Pavlos, Nathan J.; Yip, Kirk H. M.; Carrello, Amerigo; Zheng, Ming H.; Xu, Jiake] Univ Western Australia, Sch Surg & Pathol, Ctr Orthopaed Res, Mol Orthopaed Lab, Nedlands, WA 6009, Australia; [Seeber, Ruth; Eidne, Karin] Univ Western Australia, Western Australia Inst Med Res, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia	Xu, JK (corresponding author), Univ Western Australia, Sch Surg & Pathol, Ctr Orthopaed Res, Mol Orthopaed Lab, QE2 Med Ctr,2nd Floor M Block, Nedlands, WA 6009, Australia.	jiake.xu@uwa.edu.au	Seeber, Ruth/AAS-9411-2021	Seeber, Ruth/0000-0003-3265-7931; Xu, Jiake/0000-0003-2021-8309; /0000-0002-2151-3433; Pavlos, Nathan/0000-0001-7003-188X; Zheng, Minghao/0000-0003-1185-4768				ADACHI I, 1990, J BIOL CHEM, V265, P967; ARAI H, 1988, J BIOL CHEM, V263, P8796; BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220; BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; CHATTERJEE D, 1992, P NATL ACAD SCI USA, V89, P6257, DOI 10.1073/pnas.89.14.6257; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Dow JAT, 1997, J EXP BIOL, V200, P237; Du J, 2006, J CELL SCI, V119, P2542, DOI 10.1242/jcs.02983; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; GRINSTEIN S, 1992, J EXP BIOL, V172, P179; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Holthuis JCM, 1999, EUR J BIOCHEM, V262, P484, DOI 10.1046/j.1432-1327.1999.00396.x; Hung HC, 2000, MOL BRAIN RES, V75, P330, DOI 10.1016/S0169-328X(99)00325-3; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Inoue H, 1999, BBA-BIOENERGETICS, V1413, P130, DOI 10.1016/S0005-2728(99)00096-1; Jansen EJR, 1998, J CELL SCI, V111, P2999; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kroeger KM, 2001, J BIOL CHEM, V276, P12736, DOI 10.1074/jbc.M011311200; Laitala-Leinonen T, 1999, ANTISENSE NUCLEIC A, V9, P155, DOI 10.1089/oli.1.1999.9.155; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Michigami T, 2002, BONE, V30, P436, DOI 10.1016/S8756-3282(01)00684-6; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura I, 1997, FEBS LETT, V401, P207, DOI 10.1016/S0014-5793(96)01454-8; NELSON N, 1992, J BIOENERG BIOMEMBR, V24, P407, DOI 10.1007/BF00762533; NELSON N, 1992, J EXP BIOL, V172, P149; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Norgett EE, 2007, J BIOL CHEM, V282, P14421, DOI 10.1074/jbc.M701226200; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Oka T, 2000, J BIOL CHEM, V275, P29556, DOI 10.1074/jbc.M002756200; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Pavlos NJ, 2005, MOL CELL BIOL, V25, P5253, DOI 10.1128/MCB.25.12.5253-5269.2005; PERIN MS, 1991, J BIOL CHEM, V266, P3877; Sambade M, 2004, J BIOL CHEM, V279, P17361, DOI 10.1074/jbc.M314104200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schoonderwoert VTG, 2002, MOL MEMBR BIOL, V19, P67, DOI 10.1080/09687680110112910; Scimeca JC, 2003, HUM MUTAT, V21, P151, DOI 10.1002/humu.10165; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Sun-Wada GH, 2003, GENE, V302, P147, DOI 10.1016/S0378-1119(02)01099-5; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; SUNDQUIST KT, 1994, J BONE MINER RES, V9, P1575; SUPEK F, 1994, J BIOL CHEM, V269, P24102; SWALLOW CJ, 1993, J CELL PHYSIOL, V157, P453, DOI 10.1002/jcp.1041570304; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Vaananen HK, 2000, J CELL SCI, V113, P377; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Wassmer T, 2006, MOL BIOL CELL, V17, P917, DOI 10.1091/mbc.E05-06-0511; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443, DOI 10.14670/HH-22.443; Xu J, 2003, J CELL BIOCHEM, V88, P1256, DOI 10.1002/jcb.10477; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Yip KHM, 2006, AM J PATHOL, V169, P503, DOI 10.2353/ajpath.2006.050960; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200	62	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13194	13204		10.1074/jbc.M709712200	http://dx.doi.org/10.1074/jbc.M709712200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18227071	Green Published, hybrid			2022-12-27	WOS:000255499800059
J	Taylor, AB; Hu, G; Hart, PJ; McAlister-Henn, L				Taylor, Alexander B.; Hu, Gang; Hart, P. John; McAlister-Henn, Lee			Allosteric motions in structures of yeast NAD(+)-specific isocitrate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCES; SACCHAROMYCES-CEREVISIAE; ANOMALOUS DIFFRACTION; BINDING-SITES; 3-DIMENSIONAL STRUCTURE; THERMUS-THERMOPHILUS; COMPARATIVE GENOMICS; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; KINETIC-ANALYSIS	Mitochondrial NAD(+)-specific isocitrate dehydrogenases (IDHs) are key regulators of flux through biosynthetic and oxidative pathways in response to cellular energy levels. Here we present the first structures of a eukaryotic member of this enzyme family, the allosteric, hetero-octameric, NAD(+)-specific IDH from yeast in three forms: 1) without ligands, 2) with bound analog citrate, and 3) with bound citrate + AMP. The structures reveal the molecular basis for ligand binding to homologous but distinct regulatory and catalytic sites positioned at the interfaces between IDH1 and IDH2 subunits and define pathways of communication between heterodimers and heterotetramers in the hetero-octamer. Disulfide bonds observed at the heterotetrameric interfaces in the unliganded IDH hetero-octamer are reduced in the ligand-bound forms, suggesting a redox regulatory mechanism that may be analogous to the "on-off" regulation of non-allosteric bacterial IDHs via phosphorylation. The results strongly suggest that eukaryotic IDH enzymes are exquisitely tuned to ensure that allosteric activation occurs only when concentrations of isocitrate are elevated.	[Taylor, Alexander B.; Hu, Gang; Hart, P. John; McAlister-Henn, Lee] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Taylor, Alexander B.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Xray Crystallog Core Lab, San Antonio, TX 78229 USA; [Hart, P. John] S Texas Vet Hlth Care Syst, Dept Vet Affairs, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Hart, PJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	pjhart@biochem.uthscsa.edu; henn@uthscsa.edu		Taylor, Alexander/0000-0003-3517-6033	NIGMS NIH HHS [5R01GM051256] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson SL, 2002, BIOCHEMISTRY-US, V41, P7065, DOI 10.1021/bi0200662; BARNES LD, 1971, BIOCHEMISTRY-US, V10, P3939, DOI 10.1021/bi00797a022; BARNES LD, 1972, BIOCHEMISTRY-US, V11, P4322, DOI 10.1021/bi00773a019; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; CHEN FR, 1963, BIOCHEMISTRY-US, V2, P1023, DOI 10.1021/bi00905a020; CUPP JR, 1992, J BIOL CHEM, V267, P16417; CUPP JR, 1993, BIOCHEMISTRY-US, V32, P9323, DOI 10.1021/bi00087a010; CUPP JR, 1991, J BIOL CHEM, V266, P22199; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dujon B, 2005, CURR OPIN GENET DEV, V15, P614, DOI 10.1016/j.gde.2005.09.005; EHRLICH RS, 1981, J BIOL CHEM, V256, P1276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GABRIEL JL, 1986, METABOLISM, V35, P661, DOI 10.1016/0026-0495(86)90175-7; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hu G, 2006, ARCH BIOCHEM BIOPHYS, V453, P207, DOI 10.1016/j.abb.2006.06.022; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; IMADA K, 1991, J MOL BIOL, V222, P725, DOI 10.1016/0022-2836(91)90508-4; KEYS DA, 1990, J BACTERIOL, V172, P4280, DOI 10.1128/jb.172.8.4280-4287.1990; KIM YO, 1995, BIOCHEM J, V308, P63, DOI 10.1042/bj3080063; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; KUEHN GD, 1971, BIOCHEMISTRY-US, V10, P3945, DOI 10.1021/bi00797a023; LEE ME, 1995, BIOCHEMISTRY-US, V34, P378, DOI 10.1021/bi00001a046; Lin AP, 2003, J BIOL CHEM, V278, P12864, DOI 10.1074/jbc.M300154200; Lin AP, 2002, J BIOL CHEM, V277, P22475, DOI 10.1074/jbc.M202534200; Lin AP, 2001, BIOCHEMISTRY-US, V40, P14291, DOI 10.1021/bi0111707; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miyazaki J, 2005, J BACTERIOL, V187, P6779, DOI 10.1128/JB.187.19.6779-6788.2005; NICHOLS BJ, 1995, BIOCHEM J, V310, P917, DOI 10.1042/bj3100917; NICHOLS BJ, 1993, BIOCHEM J, V295, P347, DOI 10.1042/bj2950347; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panisko EA, 2001, J BIOL CHEM, V276, P1204, DOI 10.1074/jbc.M005056200; Piskur J, 2004, MOL MICROBIOL, V53, P381, DOI 10.1111/j.1365-2958.2004.04182.x; PLAUT GWE, 1970, CURR TOP CELL REGUL, V2, P1; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; RAMACHANDRAN N, 1980, J BIOL CHEM, V255, P8859; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Sols A., 1971, YEASTS, P271; Soundar S, 2003, J BIOL CHEM, V278, P52146, DOI 10.1074/jbc.M306178200; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; WALSH K, 1985, J BIOL CHEM, V260, P8430; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Zhao WN, 1997, J BIOL CHEM, V272, P21811, DOI 10.1074/jbc.272.35.21811	47	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10872	10880		10.1074/jbc.M708719200	http://dx.doi.org/10.1074/jbc.M708719200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18256028	hybrid, Green Published			2022-12-27	WOS:000254894700069
J	Yang, L; Clinton, JM; Blackburn, ML; Zhang, Q; Zou, JH; Zielinska-Kwiatkowska, A; Tang, BL; Chansky, HA				Yang, Liu; Clinton, Jeremiah M.; Blackburn, Michael L.; Zhang, Qi; Zou, Junhui; Zielinska-Kwiatkowska, Anna; Tang, Bor Luen; Chansky, Howard A.			Rab23 regulates differentiation of ATDC5 chondroprogenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; NEGATIVE REGULATOR; GROWTH-PLATE; NEURAL-TUBE; OPEN BRAIN; MOUSE; SOX9; MUTATIONS	Insulin treatment of mouse ATDC5 chondroprogenitors induces these cells to differentiate into mature chondrocytes. To identify novel factors that are involved in this process, we carried out mutagenesis of ATDC5 cells through retroviral insertion and isolated two mutant clones incapable of differentiation. Inverse PCR analysis of these clones revealed that the retroviral DNA was inserted into the promoter region of the Rab23 gene, resulting in increased Rab23 expression. To investigate whether an elevated level of Rab23 protein led to inhibition of chondrogenic differentiation, we characterized ATDC5 cells that either overexpress endogenous Rab23 or stably express ectopic Rab23. Our results revealed that up-regulation of Rab23 can indeed inhibit chondrogenic differentiation with a concomitant down-regulation of matrix genes such as type II collagen and aggrecan. In addition, stable small interfering RNA knockdown of Rab23 also resulted in inhibition of chondrogenic differentiation as well as down-regulation of Sox9, a master regulator of chondrogenesis. Interestingly, Sox9 expression has recently been linked to Gli1, and we found that Rab23 knockdown decreased Gli1 expression in chondrocytes. Because the phenotypes of Rab23 mutations in mice and humans include defects in cartilage and bone development, our study suggests that Rab23 is involved in the control of Sox9 expression via Gli1 protein.	[Yang, Liu; Clinton, Jeremiah M.; Zhang, Qi; Zou, Junhui; Zielinska-Kwiatkowska, Anna; Chansky, Howard A.] Univ Washington, Dept Orthoped & Sports Med, Seattle, WA 98195 USA; [Yang, Liu; Blackburn, Michael L.; Chansky, Howard A.] Vet Affairs Puget Sound Hlth Care Syst, Med Res Serv, Seattle, WA 98108 USA; [Tang, Bor Luen] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; National University of Singapore	Yang, L (corresponding author), Univ Washington, Dept Orthoped, 1660 S Columbian Way,GMR 151, Seattle, WA 98108 USA.	lyang@u.washington.edu	Tang, Bor Luen/E-4548-2012	Tang, Bor Luen/0000-0002-1925-636X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051455] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR051455] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Altaba AR, 2003, CURR OPIN GENET DEV, V13, P513, DOI 10.1016/j.gde.2003.08.005; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bien-Willner GA, 2007, HUM MOL GENET, V16, P1143, DOI 10.1093/hmg/ddm061; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; Eggenschwiler JT, 2006, DEV BIOL, V290, P1, DOI 10.1016/j.ydbio.2005.09.022; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Evans TM, 2003, TRAFFIC, V4, P869, DOI 10.1046/j.1600-0854.2003.00141.x; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GUNTHER T, 1994, DEVELOPMENT, V120, P3119; Guo AC, 2006, J NEUROSCI RES, V83, P1118, DOI 10.1002/jnr.20788; Jenkins D, 2007, AM J HUM GENET, V80, P1162, DOI 10.1086/518047; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; OLKKONEN VM, 1994, GENE, V138, P207, DOI 10.1016/0378-1119(94)90809-5; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Schwartz NB, 1999, PROG NUCLEIC ACID RE, V62, P177; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Smits P, 2004, J CELL BIOL, V164, P747, DOI 10.1083/jcb.200312045; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wang Y, 2006, TRAFFIC, V7, P746, DOI 10.1111/j.1600-0854.2006.00416.x	27	22	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10649	10657		10.1074/jbc.M706795200	http://dx.doi.org/10.1074/jbc.M706795200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18218620	hybrid, Green Published			2022-12-27	WOS:000254894700047
J	Coffinier, C; Hudon, SE; Lee, R; Farber, EA; Nobumori, C; Miner, JH; Andres, DA; Spielmann, HP; Hrycyna, CA; Fong, LG; Young, SG				Coffinier, Catherine; Hudon, Sarah E.; Lee, Roger; Farber, Emily A.; Nobumori, Chika; Miner, Jeffrey H.; Andres, Douglas A.; Spielmann, H. Peter; Hrycyna, Christine A.; Fong, Loren G.; Young, Stephen G.			A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT LAMIN-A; ZMPSTE24-DEFICIENT MICE; RESTRICTIVE DERMOPATHY; ZINC METALLOPROTEINASE; PROGERIA; DISEASE; LIPODYSTROPHY; INFECTION; THERAPY; VIRUS	HIV protease inhibitors ( HIV-PIs) are key components of highly active antiretroviral therapy, but they have been associated with adverse side effects, including partial lipodystrophy and metabolic syndrome. We recently demonstrated that a commonly used HIV- PI, lopinavir, inhibits ZMPSTE24, thereby blocking lamin A biogenesis and leading to an accumulation of prelamin A. ZMPSTE24 deficiency in humans causes an accumulation of prelamin A and leads to lipodystrophy and other disease phenotypes. Thus, an accumulation of prelamin A in the setting of HIV- PIs represents a plausible mechanism for some drug side effects. Here we show, with metabolic labeling studies, that lopinavir leads to the accumulation of the farnesylated form of prelamin A. We also tested whether a new and chemically distinct HIV- PI, darunavir, inhibits ZMPSTE24. We found that darunavir does not inhibit the biochemical activity of ZMPSTE24, nor does it lead to an accumulation of farnesyl-prelamin A in cells. This property of darunavir is potentially attractive. However, all HIV- PIs, including darunavir, are generally administered with ritonavir, an HIV- PI that is used to block the metabolism of other HIV- PIs. Ritonavir, like lopinavir, inhibits ZMPSTE24 and leads to an accumulation of prelamin A.	[Coffinier, Catherine; Lee, Roger; Farber, Emily A.; Nobumori, Chika; Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Young, Stephen G.] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Hudon, Sarah E.; Hrycyna, Christine A.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Miner, Jeffrey H.] Washington Univ, Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA; [Andres, Douglas A.; Spielmann, H. Peter] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Washington University (WUSTL); University of Kentucky	Coffinier, C (corresponding author), 695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	coffinie@ucla.edu	lewchavaroj, runglawan/B-5191-2009	Young, Stephen/0000-0001-7270-3176	NCI NIH HHS [CA 099506] Funding Source: Medline; NHLBI NIH HHS [HL 86683, HL 76839] Funding Source: Medline; NIAMS NIH HHS [AR 050200, AR 049469] Funding Source: Medline; NIGMS NIH HHS [GM 66152] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA099506] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076839, R01HL086683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066152] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Alsina M, 2004, BLOOD, V103, P3271, DOI 10.1182/blood-2003-08-2764; Anderson JL, 2005, J BIOL CHEM, V280, P29454, DOI 10.1074/jbc.M504982200; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Cahn Pedro E, 2004, J Int Assoc Physicians AIDS Care (Chic), V3, P92, DOI 10.1177/154510970400300304; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Caron M, 2003, AIDS, V17, P2437, DOI 10.1097/00002030-200311210-00005; Carr A, 2003, AIDS, V17, pS141, DOI 10.1097/00002030-200304001-00017; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; CLARKE S, 1988, P NATL ACAD SCI USA, V85, P4643, DOI 10.1073/pnas.85.13.4643; Clarke SG, 2007, P NATL ACAD SCI USA, V104, P13857, DOI 10.1073/pnas.0706529104; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; COX AD, 1995, METHOD ENZYMOL, V255, P195; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Dierynck I, 2007, J VIROL, V81, P13845, DOI 10.1128/JVI.01184-07; Eder J, 2007, CURR PHARM DESIGN, V13, P271, DOI 10.2174/138161207779313560; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fenton C, 2007, DRUGS, V67, P2791, DOI 10.2165/00003495-200767180-00010; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Green ML, 2002, J GEN INTERN MED, V17, P797, DOI 10.1046/j.1525-1497.2002.20201.x; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hegele RA, 2000, MOL GENET METAB, V71, P539, DOI 10.1006/mgme.2000.3092; HENNEKES H, 1994, J CELL SCI, V107, P1019; Koh Y, 2003, ANTIMICROB AGENTS CH, V47, P3123, DOI 10.1128/AAC.47.10.3123-3129.2003; Leon A, 2007, J ANTIMICROB CHEMOTH, V60, P824, DOI 10.1093/jac/dkm285; Leung GK, 2001, J BIOL CHEM, V276, P29051, DOI 10.1074/jbc.M102908200; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Mccoy C, 2007, CLIN THER, V29, P1559, DOI 10.1016/j.clinthera.2007.08.016; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Nolan D, 2001, ANTIVIR THER, V6, P145; Schmidt WK, 2000, J BIOL CHEM, V275, P6227, DOI 10.1074/jbc.275.9.6227; Surleraux DLNG, 2005, J MED CHEM, V48, P1965, DOI 10.1021/jm049454n; Surleraux DLNG, 2005, J MED CHEM, V48, P1813, DOI 10.1021/jm049560p; Takahashi M, 2007, BIOL PHARM BULL, V30, P1947, DOI 10.1248/bpb.30.1947; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Troutman JM, 2005, BIOCONJUGATE CHEM, V16, P1209, DOI 10.1021/bc050068+; Vigouroux C, 1999, DIABETES METAB, V25, P383; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Youle M, 2007, J ANTIMICROB CHEMOTH, V60, P1195, DOI 10.1093/jac/dkm364; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	46	49	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9797	9804		10.1074/jbc.M709629200	http://dx.doi.org/10.1074/jbc.M709629200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18230615	Green Published, hybrid			2022-12-27	WOS:000254671600034
J	Cubells, L; de Muga, SV; Tebar, F; Bonventre, JV; Balsinde, J; Pol, A; Grewal, T; Enrich, C				Cubells, Laia; de Muga, Sandra Vila; Tebar, Francesc; Bonventre, Joseph V.; Balsinde, Jesus; Pol, Albert; Grewal, Thomas; Enrich, Carlos			Annexin A6-induced inhibition of cytoplasmic phospholipase A(2) is linked to caveolin-1 export from the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; H-RAS; CHOLESTEROL; PROTEIN; TRAFFICKING; TRANSPORT; COMPLEX; VESICULATION; COMPARTMENTS; ASSOCIATION	] The molecular mechanisms regulating the exit of caveolin from the Golgi complex are not fully understood. Cholesterol and sphingolipid availability affects Golgi vesiculation events and involves the activity of cytoplasmic phospholipase A(2) (cPLA(2)). We recently demonstrated that high expression levels of annexin A6 (AnxA6) perturb the intracellular distribution of cellular cholesterol, thereby inhibiting caveolin export from the Golgi complex. In the present study we show that in Chinese hamster ovary cells overexpressing AnxA6, sequestration of cholesterol in late endosomes, leading to reduced amounts of cholesterol in the Golgi, inhibits cPLA2 activity and its association with the Golgi complex. This correlates with the blockage of caveolin export from the Golgi in cells treated with methyl arachidonyl fluorophosphonate, a Ca2+-dependent cPLA(2) inhibitor. AnxA6-mediated down-regulation of cPLA(2) activity was overcome upon the addition of exogenous cholesterol or transfection with small interfering RNA targeting AnxA6. These findings indicate that AnxA6 interferes with caveolin transport through the inhibition of cPLA(2).	[Grewal, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Cubells, Laia; de Muga, Sandra Vila; Tebar, Francesc; Enrich, Carlos] Univ Barcelona, Dept Cellular Biol, Fac Med, Barcelona 08036, Spain; [Pol, Albert; Enrich, Carlos] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona 08036, Spain; [Bonventre, Joseph V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Balsinde, Jesus] Spanish Res Council, Inst Mol Biol & Genet, Toyota 47003, Japan; [Balsinde, Jesus] Univ Valladolid, Sch Med, Toyota 47003, Japan	University of Sydney; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Brigham & Women's Hospital	Grewal, T (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	tgrewal@pharm.usyd.edu.au	Pol, Albert/M-1865-2014; Tebar, Francesc/H-1498-2015; Balsinde, Jesús/C-7833-2018	Pol, Albert/0000-0002-1750-1085; Tebar, Francesc/0000-0002-9522-9726; Balsinde, Jesús/0000-0002-4157-6714; Grewal, Thomas/0000-0002-7937-8887; Enrich, Carlos/0000-0003-0382-2993				BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Buckland AG, 1998, BIOCHEM J, V329, P369; Casas J, 2006, J BIOL CHEM, V281, P6106, DOI 10.1074/jbc.M505230200; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; de Figueiredo P, 2000, TRAFFIC, V1, P504, DOI 10.1034/j.1600-0854.2000.010608.x; de Figueiredo P, 1998, P NATL ACAD SCI USA, V95, P8642, DOI 10.1073/pnas.95.15.8642; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Evans JH, 2004, J BIOL CHEM, V279, P6005, DOI 10.1074/jbc.M311246200; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Grewal T, 2000, J BIOL CHEM, V275, P33806, DOI 10.1074/jbc.M002662200; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Grewal T, 2006, BIOESSAYS, V28, P1211, DOI 10.1002/bies.20503; Grimmer S, 2005, TRAFFIC, V6, P144, DOI 10.1111/j.1600-0854.2005.00258.x; Herbert SP, 2005, MOL BIOL CELL, V16, P3800, DOI 10.1091/mbc.E05-02-0164; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; Kim SW, 2001, FEBS LETT, V489, P243, DOI 10.1016/S0014-5793(00)02326-7; Kim SW, 2001, J BIOL CHEM, V276, P15712, DOI 10.1074/jbc.M009905200; Klapisz E, 2000, J LIPID RES, V41, P1680; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Llado A, 2004, MOL BIOL CELL, V15, P4877, DOI 10.1091/mbc.E04-02-0127; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; Nakatani Y, 2000, J BIOL CHEM, V275, P1161, DOI 10.1074/jbc.275.2.1161; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Pons M, 2000, EXP CELL RES, V257, P33, DOI 10.1006/excr.2000.4861; Pons M, 2001, EXP CELL RES, V269, P13, DOI 10.1006/excr.2001.5268; Rabut G., 2005, LIVE CELL IMAGING LA, P101; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rentero C, 2006, CELL SIGNAL, V18, P1006, DOI 10.1016/j.cellsig.2005.08.008; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Sehgal PB, 2007, AM J PHYSIOL-LUNG C, V292, pL1526, DOI 10.1152/ajplung.00463.2006; Sheridan AM, 2001, MOL CELL BIOL, V21, P4470, DOI 10.1128/MCB.21.14.4470-4481.2001; Solito E, 1998, BRIT J PHARMACOL, V124, P1675, DOI 10.1038/sj.bjp.0701991; Stuven E, 2003, J BIOL CHEM, V278, P53112, DOI 10.1074/jbc.M300402200; Tebar F, 2002, MOL BIOL CELL, V13, P2057, DOI 10.1091/mbc.01-12-0571; Wang YZ, 2000, TRAFFIC, V1, P952, DOI 10.1034/j.1600-0854.2000.011205.x; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	46	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10174	10183		10.1074/jbc.M706618200	http://dx.doi.org/10.1074/jbc.M706618200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18245088	hybrid			2022-12-27	WOS:000254671600070
J	Sekine, K; Takubo, K; Kikuchi, R; Nishimoto, M; Kitagawa, M; Abe, F; Nishikawa, K; Tsuruo, T; Naito, M				Sekine, Keiko; Takubo, Kohei; Kikuchi, Ryo; Nishimoto, Michie; Kitagawa, Masayuki; Abe, Fuminori; Nishikawa, Kiyohiro; Tsuruo, Takashi; Naito, Mikihiko			Small molecules destabilize cIAP1 by activating auto-ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LIGASE ACTIVITY; X-LINKED INHIBITOR; CELL-DEATH; APOPTOSIS PROTEINS; IAP PROTEINS; CANCER-CELLS; BESTATIN; XIAP; IDENTIFICATION; MITOCHONDRIA	Overexpression of an anti-apoptotic protein cIAP1 caused by its genetic amplification was reported in certain cancers, such as hepatocellular carcinoma, esophageal squamous cell carcinoma, cervical cancer, and lung cancer, which confers resistance to chemotherapy and radiotherapy. Here we report cIAP1 to be selectively down-regulated by a class of small molecules ((-)-N-[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butyryl]-L-leucine methyl ester (ME-BS)), resulting in a sensitization of cancer cells to apoptosis. ME-BS directly interacts with the BIR3 domain of cIAP1, promotes auto-ubiquitylation dependent on its RING domain, and facilitates proteasomal degradation of cIAP1. Other IAPs such as XIAP and cIAP2 were not affected by ME-BS. These results suggest targeted destabilization of cIAP1 by small molecules as a novel method to treat cancers expressing cIAP1, which interferes with treatment. Manipulation of the intrinsic ubiquitin-ligase activity could be a novel strategy to develop small molecules for therapeutic purposes.	[Sekine, Keiko; Takubo, Kohei; Kikuchi, Ryo; Nishimoto, Michie; Tsuruo, Takashi; Naito, Mikihiko] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Sekine, Keiko; Kitagawa, Masayuki; Abe, Fuminori; Nishikawa, Kiyohiro] Nippon Kayaku Co Ltd, Res & Dev Grp, Pharmaceut Res Labs, Kita Ku, Tokyo 1158588, Japan; [Tsuruo, Takashi] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1358550, Japan	University of Tokyo; Nippon Kayaku Co., Ltd.; Japanese Foundation for Cancer Research	Naito, M (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	mnaito@iam.u-tokyo.ac.jp		Kikuchi, Ryota/0000-0002-8839-2891				ABE F, 1990, CANCER IMMUNOL IMMUN, V32, P75, DOI 10.1007/BF01754202; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Chen ZH, 1999, BIOCHEM BIOPH RES CO, V264, P847, DOI 10.1006/bbrc.1999.1585; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Ferreira CG, 2001, ANN ONCOL, V12, P799, DOI 10.1023/A:1011167113067; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Hunter AM, 2003, J BIOL CHEM, V278, P7494, DOI 10.1074/jbc.C200695200; Ichinose Y, 2003, JNCI-J NATL CANCER I, V95, P605, DOI 10.1093/jnci/95.8.605; Imoto I, 2002, CANCER RES, V62, P4860; Imoto I, 2001, CANCER RES, V61, P6629; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; NISHIZAWA R, 1977, J MED CHEM, V20, P510, DOI 10.1021/jm00214a010; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sasaki S, 1998, CLIN EXP IMMUNOL, V111, P30; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; Sekine K, 1999, LEUKEMIA, V13, P729, DOI 10.1038/sj.leu.2401388; Sekine K, 2001, INT J CANCER, V94, P485, DOI 10.1002/ijc.1492; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sun HY, 2004, J MED CHEM, V47, P4147, DOI 10.1021/jm0499108; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; TALMADGE JE, 1986, CANCER RES, V46, P4505; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Wang XD, 2001, GENE DEV, V15, P2922; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	41	107	112	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8961	8968		10.1074/jbc.M709525200	http://dx.doi.org/10.1074/jbc.M709525200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18230607	hybrid			2022-12-27	WOS:000254465800025
J	Sivan, SS; Wachtel, E; Tsitron, E; Sakkee, N; van der Ham, F; DeGroot, J; Roberts, S; Maroudas, A				Sivan, Sarit-Sara; Wachtel, Ellen; Tsitron, Eve; Sakkee, Nico; van der Ham, Frits; DeGroot, Jeroen; Roberts, Sally; Maroudas, Alice			Collagen turnover in normal and degenerate human intervertebral discs as determined by the racemization of aspartic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR-CARTILAGE; AGE-RELATED ACCUMULATION; PERFORMANCE LIQUID-CHROMATOGRAPHY; HYDROSTATIC-PRESSURE; PROTEOGLYCAN SYNTHESIS; AGGRECAN TURNOVER; MATRIX SYNTHESIS; PENTOSIDINE; PROTEIN; DENTIN	Knowledge of rates of protein turnover is important for a quantitative understanding of tissue synthesis and catabolism. In this work, we have used the racemization of aspartic acid as a marker for the turnover of collagen obtained from healthy and pathological human intervertebral disc matrices. We measured the ratio of the D- and L-isomers in collagen extracted from these tissues as a function of age between 16 and 77 years. For collagen taken from healthy discs, the fractional increase of D- Asp was found to be 6.74 x 10(-4)/year; for degenerate discs, the corresponding rate was 5.18 x 10(-4)/year. Using the racemization rate found previously for the stable population of collagen molecules in dentin, we found that the rate of collagen turnover (k(T)) in discs is not constant but rather a decreasing function of age. The average turnover rate in normal disc between the ages of 20 and 40 is 0.00728 +/- 0.00275/year, and that between the ages of 50 and 80 is 0.00323 +/- 0.000947/year, which correspond to average half-lives of 95 and 215 years, respectively. Turnover of collagen from degenerate discs may be more rapid than that found for normal discs; however, statistical analysis leaves this point uncertain. The finding of a similar correlation between the accumulation of D- Asp and that of pentosidine for three normal collagenous tissues further supports the idea that the accumulation of pentosidine in a particular tissue can, along with the racemization of aspartic acid, be used as a reliable measure of protein turnover.	[Sivan, Sarit-Sara] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Sivan, Sarit-Sara; Tsitron, Eve; Roberts, Sally; Maroudas, Alice] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel; [Wachtel, Ellen] Weizmann Inst Sci, Fac Chem, IL-76100 Rehovot, Israel; [Sakkee, Nico; van der Ham, Frits; DeGroot, Jeroen] TNO, Qual Life Business Unit Biosci, NL-2301 CE Leiden, Netherlands; [Roberts, Sally] Robert Jones & Agnes Hunt Orthopaed Hosp, Ctr Spinal Studies, Oswestry SY10 7AG, Shrops, England; [Roberts, Sally] Keele Univ, Res Inst Sci & Technol, Stoke On Trent ST4 7QB, Staffs, England	University of Oxford; Technion Israel Institute of Technology; Weizmann Institute of Science; Netherlands Organization Applied Science Research; Keele University; Keele University	Sivan, SS (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	sarit.sivan@dpag.ox.ac.uk	DeGroot, Jeroen/C-4585-2012	Sivan, Sarit/0000-0002-6074-8032				ADAMS P, 1976, ANN RHEUM DIS, V35, P289, DOI 10.1136/ard.35.4.289; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Arany S, 2004, FORENSIC SCI INT, V141, P127, DOI 10.1016/j.forsciint.2004.01.017; Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; ASWAD DW, 1984, ANAL BIOCHEM, V137, P405, DOI 10.1016/0003-2697(84)90106-4; BADA JL, 1984, METHOD ENZYMOL, V106, P98; BADA JL, 1981, EARTH PLANET SC LETT, V55, P292, DOI 10.1016/0012-821X(81)90108-4; Bank RA, 1997, J CHROMATOGR B, V703, P37, DOI 10.1016/S0378-4347(97)00391-5; Bank RA, 1996, ANAL BIOCHEM, V240, P167, DOI 10.1006/abio.1996.0346; Handa T, 1997, SPINE, V22, P1085, DOI 10.1097/00007632-199705150-00006; HELFMAN PM, 1976, NATURE, V262, P279, DOI 10.1038/262279b0; HELFMAN PM, 1975, P NATL ACAD SCI USA, V72, P2891, DOI 10.1073/pnas.72.8.2891; HIRSCH C., 1953, ACTA ORTHOPAED SCAND, V22, P184; Ishihara H, 1996, J APPL PHYSIOL, V80, P839, DOI 10.1152/jappl.1996.80.3.839; Ishihara H, 1999, J ORTHOP RES, V17, P829, DOI 10.1002/jor.1100170607; Liu GZ, 2001, SPINE, V26, P134, DOI 10.1097/00007632-200101150-00005; MAN EH, 1983, SCIENCE, V220, P1407, DOI 10.1126/science.6857259; Maroudas A, 1998, ARCH BIOCHEM BIOPHYS, V350, P61, DOI 10.1006/abbi.1997.0492; MAROUDAS A, 1975, J ANAT, V120, P113; MAROUDAS A, 1992, CONNECT TISSUE RES, V28, P161, DOI 10.3109/03008209209015033; MASTERS PM, 1983, CALCIFIED TISSUE INT, V35, P43, DOI 10.1007/BF02405005; MASTERS PM, 1977, NATURE, V268, P71, DOI 10.1038/268071a0; MASTERS PM, 1982, NIH822221 PUBL, P120; Matsumoto T, 1999, SPINE, V24, P315, DOI 10.1097/00007632-199902150-00002; MIKAWA Y, 1986, ARCH ORTHOP TRAUM SU, V105, P343, DOI 10.1007/BF00449940; Ohtani S, 1998, J FORENSIC SCI, V43, P949; Ohtani S, 1998, AM J FOREN MED PATH, V19, P284, DOI 10.1097/00000433-199809000-00017; PFEIFFER H, 1995, INT J LEGAL MED, V108, P19, DOI 10.1007/BF01845611; POWELL JT, 1992, ATHEROSCLEROSIS, V97, P201, DOI 10.1016/0021-9150(92)90132-Z; PUUSTJARVI K, 1993, J ORTHOP RES, V11, P738, DOI 10.1002/jor.1100110516; Razaq S, 2003, EUR SPINE J, V12, P341, DOI 10.1007/s00586-003-0582-3; SCHMIDT MB, 1990, J ORTHOPAED RES, V8, P353, DOI 10.1002/jor.1100080307; Sivan SS, 2006, BIOCHEM J, V399, P29, DOI 10.1042/BJ20060579; Sivan SS, 2006, J BIOL CHEM, V281, P13009, DOI 10.1074/jbc.M600296200; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; Verzijl N, 2001, MATRIX BIOL, V20, P409, DOI 10.1016/S0945-053X(01)00158-5; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200	38	90	91	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8796	8801		10.1074/jbc.M709885200	http://dx.doi.org/10.1074/jbc.M709885200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18250164	hybrid, Green Published			2022-12-27	WOS:000254465800005
J	Gelsthorpe, ME; Baumann, N; Millard, E; Gale, SE; Langmade, SJ; Schaffer, JE; Ory, DS				Gelsthorpe, Mark E.; Baumann, Nikola; Millard, Elizabeth; Gale, Sarah E.; Langmade, S. Joshua; Schaffer, Jean E.; Ory, Daniel S.			Niemann-Pick type C1I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; STEROL-SENSING DOMAIN; CELLULAR CHOLESTEROL HOMEOSTASIS; DENSITY-LIPOPROTEIN CHOLESTEROL; CYSTIC-FIBROSIS MUTATION; DISEASE TYPE-C; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; INTRACELLULAR-TRANSPORT; NPC1 PROTEIN; TRAFFICKING	Over 200 disease-causing mutations have been identified in the NPC1 gene. The most prevalent mutation, NPC1(I1061T), is predicted to lie within the cysteine-rich luminal domain and is associated with the classic juvenile-onset phenotype of Niemann-Pick type C disease. To gain insight into the molecular mechanism by which the NPC1(I1061T) mutation causes disease, we examined expression of the mutant protein in human fibroblasts homozygous for the NPC1(I1061T) mutation. Despite similar NPC1 mRNA levels between wild type and NPC1(I1061T) fibroblasts, NPC1 protein levels are decreased by 85% in NPC1(I1061)T cells. Metabolic labeling studies demonstrate that unlike wild type protein, which undergoes a glycosylation pattern shift from Endo H-sensitive to Endo H-resistant species, NPC1(I1061T) protein remains almost exclusively Endo H-sensitive and exhibits a reduced half-life (t(1/2) 6.5 h) versus wild type Endo H-resistant species (t(1/2) 42 h). Treatment with chemical chaperones, growth at permissive temperature, or inhibition of proteasomal degradation increases NPC1(I1061T) protein levels, indicating that the mutant protein is likely targeted for endoplasmic reticulum-associated degradation (ERAD) due to protein misfolding. Overexpression of NPC1(I1061T) in NPC1-deficient cells results in late endosomal localization of the mutant protein and complementation of the NPC mutant phenotype, likely due to a small proportion of the nascent NPC1(I1061T) protein that is able to fold correctly and escape the endoplasmic reticulum quality control checkpoints. Our findings provide the first description of an endoplasmic reticulum trafficking defect as a mechanism for human NPC disease, shedding light on the mechanism by which the NPC1(I1061T) mutation causes disease and suggesting novel approaches to treat NPC disease caused by the NPC1(I1061T) mutation.	[Gelsthorpe, Mark E.; Baumann, Nikola; Millard, Elizabeth; Gale, Sarah E.; Langmade, S. Joshua; Schaffer, Jean E.; Ory, Daniel S.] Washington Univ, Sch Med, Cardiovasc Res Ctr, Dept Internal Med, St Louis, MO 63110 USA; [Schaffer, Jean E.] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; [Ory, Daniel S.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ory, DS (corresponding author), Box 8086,660 S Euclid Ave, St Louis, MO 63110 USA.	dory@wustl.edu			NHLBI NIH HHS [HL 67773, HL 04482, 5 T32 HL 007275-29] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL004482, R01HL067773, T32HL007275] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aridor M, 2002, TRAFFIC, V3, P781, DOI 10.1034/j.1600-0854.2002.31103.x; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Fernandez-Valero EM, 2005, CLIN GENET, V68, P245, DOI 10.1111/j.1399-0004.2005.00490.x; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Frolov A, 2001, J BIOL CHEM, V276, P46414, DOI 10.1074/jbc.M108099200; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Gelman MS, 2002, J CLIN INVEST, V110, P1591, DOI 10.1172/JCI200216786; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Millat G, 1999, AM J HUM GENET, V65, P1321, DOI 10.1086/302626; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Ory DS, 2000, BBA-MOL CELL BIOL L, V1529, P331, DOI 10.1016/S1388-1981(00)00158-X; Park WD, 2003, HUM MUTAT, V22, P313, DOI 10.1002/humu.10255; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Schueler UH, 2004, J INHERIT METAB DIS, V27, P649, DOI 10.1023/B:BOLI.0000042959.44318.7c; SCHWEIZER A, 1995, J CELL SCI, V108, P2477; Scott C, 2004, BBA-MOL CELL BIOL L, V1685, P8, DOI 10.1016/j.bbalip.2004.08.006; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Sifers RN, 2003, SCIENCE, V299, P1330, DOI 10.1126/science.1082718; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; WARD CL, 1994, J BIOL CHEM, V269, P25710; Watari H, 2000, EXP CELL RES, V259, P247, DOI 10.1006/excr.2000.4976; Watari H, 1999, J BIOL CHEM, V274, P21861, DOI 10.1074/jbc.274.31.21861; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Zhang M, 2001, J BIOL CHEM, V276, P3417, DOI 10.1074/jbc.M005393200	39	116	119	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8229	8236		10.1074/jbc.M708735200	http://dx.doi.org/10.1074/jbc.M708735200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18216017	Green Published, hybrid			2022-12-27	WOS:000254288000020
J	Kotake, T; Hojo, S; Tajima, N; Matsuoka, K; Koyama, T; Tsumuraya, Y				Kotake, Toshihisa; Hojo, Sachiko; Tajima, Noriaki; Matsuoka, Koji; Koyama, Tetsuo; Tsumuraya, Yoichi			A bifunctional enzyme with L-fucokinase and GDP-L-fucose pyrophosphorylase activities salvages free L-fucose in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-SUGAR PYROPHOSPHORYLASE; BETA-L-FUCOSE; CELL-WALL; SUBSTRATE-SPECIFICITY; XYLOGLUCAN; PURIFICATION; EXPRESSION; CLONING; KINASE; GENE	Monomeric sugars generated during the metabolism of polysaccharides, glycoproteins, and glycolipids are imported to the cytoplasm and converted to respective nucleotide sugars via monosaccharide 1-phosphates, to be reutilized as activated sugars. Because L-fucose (L-Fuc) is activated mainly in the form of GDP derivatives in seed plants, the salvage reactions for L-Fuc are expected to be independent from those for Glc, Gal, L-arabinose, and glucuronic acid, which are activated as UDP-sugars. For this study we have identified, in the genomic data base of Arabidopsis, the gene (designated AtFKGP) of a bifunctional enzyme with similarity to both L-fucokinase and GDP-L-Fuc pyrophosphorylase. Recombinant AtFKGP (rAt-FKGP) expressed in Escherichia coli showed both L-fucokinase and GDP-L-Fuc pyrophosphorylase activities, generating GDP-L-Fuc from L-Fuc, ATP, and GTPas the starting substrates. Point mutations in rAtFKGPs at either Gly(133) or Gly(830) caused loss of GDP-L-Fuc pyrophosphorylase and L-fucokinase activity, respectively. The apparent Km values of L-fucokinase activity of rAtFKGP for L-Fuc and ATP were 1.0 and 0.45mM, respectively, and those of GDP-L-Fuc pyrophosphorylase activity for L-Fuc 1-phosphate and GTP were 0.052 and 0.17mM, respectively. The expression of AtFKGP was detected in most cell types of Arabidopsis, indicating that salvage reactions for free L-Fuc catalyzed by AtFKGP occur ubiquitously in Arabidopsis. Loss-of-function mutants with tDNA insertion in AtFKGP exhibited higher accumulation of free L-Fuc in the soluble fraction than the wild-type plant. These results indicate that AtFKGP is a bifunctional enzyme with L-fucokinase and GDP-L-Fuc pyrophosphorylase activities, which salvages free L-Fuc in Arabidopsis.	[Kotake, Toshihisa; Hojo, Sachiko; Tsumuraya, Yoichi] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Sakura Ku, Saitama City 3388570, Japan; [Tajima, Noriaki] Saitama Univ, Fac Sci, Dept Biochem & Mol Biol, Sakura Ku, Saitama City 3388570, Japan; [Matsuoka, Koji; Koyama, Tetsuo] Saitama Univ, Grad Sch Sci & Engn, Div Mat Sci, Sakura Ku, Saitama City 3388570, Japan	Saitama University; Saitama University; Saitama University	Kotake, T (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Sakura Ku, 255 Shimo Okubo, Saitama City 3388570, Japan.	kotake@molbiol.saitama-u.ac.jp	Matsuoka, Koji/A-9463-2008; Tsumuraya, Yoichi/C-7903-2012; KOTAKE, TOSHIHISA/F-1117-2011	Matsuoka, Koji/0000-0002-8987-2715; KOTAKE, TOSHIHISA/0000-0002-1110-5006				Albermann C, 2000, GLYCOBIOLOGY, V10, P875, DOI 10.1093/glycob/10.9.875; ASPINALL GO, 1972, CAN J BIOCHEM CELL B, V50, P574, DOI 10.1139/o72-079; Bonin CP, 2000, PLANT J, V21, P445, DOI 10.1046/j.1365-313x.2000.00698.x; Bonin CP, 2003, PLANT PHYSIOL, V132, P883, DOI 10.1104/pp.103.022368; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Hartley A, 2004, J MOL BIOL, V337, P387, DOI 10.1016/j.jmb.2004.01.043; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; Iglesias N, 2006, PLANT CELL PHYSIOL, V47, P55, DOI 10.1093/pcp/pci223; ISHIHARA H, 1968, J BIOL CHEM, V243, P1103; Ishikawa M, 2000, PLANTA, V210, P782, DOI 10.1007/s004250050680; Kaplan CP, 1997, PLANT MOL BIOL, V34, P497, DOI 10.1023/A:1005816104743; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kotake T, 2004, J BIOL CHEM, V279, P45728, DOI 10.1074/jbc.M408716200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange BM, 1999, P NATL ACAD SCI USA, V96, P13714, DOI 10.1073/pnas.96.24.13714; LEVY S, 1991, PLANT J, V1, P195; Levy S, 1997, PLANT J, V11, P373, DOI 10.1046/j.1365-313X.1997.11030373.x; MACDONALD DK, 1962, J ORG CHEM, V27, P1107, DOI 10.1021/jo01050a552; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; Niittymaki J, 2004, EUR J BIOCHEM, V271, P78, DOI 10.1046/j.1432-1033.2003.03904.x; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Ohashi T, 2006, ANAL BIOCHEM, V352, P182, DOI 10.1016/j.ab.2006.02.026; ONeill M., 1990, METHODS PLANT BIOCH, V2, P415, DOI [DOI 10.1016/B978-0-12-461012-5.50018-5, 10.1016/b978-0-12-461012-5.50018-5]; Park SH, 1998, J BIOL CHEM, V273, P5685, DOI 10.1074/jbc.273.10.5685; Pastuszak I, 1998, J BIOL CHEM, V273, P30165, DOI 10.1074/jbc.273.46.30165; Pauly M, 2000, ANAL BIOCHEM, V278, P69, DOI 10.1006/abio.1999.4411; Perrin RM, 1999, SCIENCE, V284, P1976, DOI 10.1126/science.284.5422.1976; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; RUDICK VL, 1974, J BIOL CHEM, V249, P7832; Sarria R, 2001, PLANT PHYSIOL, V127, P1595, DOI 10.1104/pp.010596; SCHMIDT RR, 1991, LIEBIGS ANN CHEM, P121; Sherson S, 1999, PLANT MOL BIOL, V39, P1003, DOI 10.1023/A:1006181908753; Thoden JB, 2003, J BIOL CHEM, V278, P33305, DOI 10.1074/jbc.M304789200; TSAY YH, 1991, MOL CELL BIOL, V11, P620, DOI 10.1128/MCB.11.2.620; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451	39	43	51	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8125	8135		10.1074/jbc.M710078200	http://dx.doi.org/10.1074/jbc.M710078200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18199744	hybrid			2022-12-27	WOS:000254288000009
J	Liu, ZY; Habener, JF				Liu, Zhengyu; Habener, Joel F.			Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-FACTOR-7-LIKE-2 TCF7L2 GENE; DEPENDENT PROTEIN-KINASE; INSULIN-PRODUCING CELLS; EMBRYONIC STEM-CELLS; CYCLIN D1; REGULATES PROLIFERATION; INDEPENDENT ACTIVATION; RECEPTOR AGONISTS; SELF-RENEWAL; CATENIN	The insulinotropic hormone GLP-1 (glucagon-like peptide-1) is a new therapeutic agent that preserves or restores pancreatic beta cell mass. We report that GLP-1 and its agonist, exendin-4 (Exd4), induce Wnt signaling in pancreatic beta cells, both isolated islets, and in INS-1 cells. Basal and GLP-1 agonist-induced proliferation of beta cells requires active Wnt signaling. Cyclin D1 and c-Myc, determinants of cell proliferation, are up-regulated by Exd4. Basal endogenous Wnt signaling activity depends on Wnt frizzled receptors and the protein kinases Akt and GSK3 beta but not cAMP-dependent protein kinase. In contrast, GLP-1 agonists enhance Wnt signaling via GLP-1 receptor-mediated activation of Akt and beta cell independent of GSK3 beta. Inhibition of Wnt signaling by small interfering RNAs to beta-catenin or a dominant-negative TCF7L2 decreases both basal and Exd4-induced beta cell proliferation. Wnt signaling appears to mediate GLP-1-induced beta cell proliferation raising possibilities for novel treatments of diabetes.	[Habener, Joel F.] Massachusetts Gen Hosp, Mol Endocrinol Lab, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Habener, JF (corresponding author), Massachusetts Gen Hosp, Mol Endocrinol Lab, 55 Fruit St,Thier 306, Boston, MA 02114 USA.	jhabener@partners.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, R01DK030834, R01DK055365, P30DK040561] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 30834, P30 DK040561, P30 DK040561-12, P30 DK 57521, DK 55365] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham EJ, 2002, ENDOCRINOLOGY, V143, P3152, DOI 10.1210/en.143.8.3152; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Bai L, 2005, J ENDOCRINOL, V186, P343, DOI 10.1677/joe.1.06078; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Burwinkel B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-268; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cauchi S, 2006, DIABETES, V55, P3189, DOI 10.2337/db06-0692; Cauchi S, 2006, DIABETES, V55, P2903, DOI 10.2337/db06-0474; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; D'Amico M, 2000, J BIOL CHEM, V275, P32649, DOI 10.1074/jbc.M000643200; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Dessimoz J, 2005, CURR BIOL, V15, P1677, DOI 10.1016/j.cub.2005.08.037; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Egan JM, 2003, DIABETES-METAB RES, V19, P115, DOI 10.1002/dmrr.357; Feng ZL, 2004, BIOCHEM BIOPH RES CO, V324, P1333, DOI 10.1016/j.bbrc.2004.09.206; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haraguchi K, 2004, BIOCHEM BIOPH RES CO, V313, P841, DOI 10.1016/j.bbrc.2003.12.021; Hardikar AA, 2002, ENDOCRINOLOGY, V143, P3505, DOI 10.1210/en.2001-211344; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Heller RS, 2003, GENE EXPRESSION, V11, P141, DOI 10.3727/000000003108749035; Heller RS, 2002, DEV DYNAM, V225, P260, DOI 10.1002/dvdy.10157; Heller RS, 1997, DIABETES, V46, P785, DOI 10.2337/diabetes.46.5.785; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hisatomi Y, 2004, HEPATOLOGY, V39, P667, DOI 10.1002/hep.20063; Holst Jens Juul, 2004, Expert Opin Emerg Drugs, V9, P155, DOI 10.1517/14728214.9.1.155; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Hui HX, 2005, DIABETES-METAB RES, V21, P313, DOI 10.1002/dmrr.553; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kim MJ, 2006, J ENDOCRINOL, V188, P623, DOI 10.1677/joe.1.06480; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Ku HT, 2004, STEM CELLS, V22, P1205, DOI 10.1634/stemcells.2004-0027; Kulkarni NH, 2005, J CELL BIOCHEM, V95, P1178, DOI 10.1002/jcb.20506; LACY PE, 1994, MT SINAI J MED, V61, P23; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; List JF, 2004, AM J PHYSIOL-ENDOC M, V286, pE875, DOI 10.1152/ajpendo.00007.2004; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Luo YQ, 2006, NEUROSCI LETT, V398, P291, DOI 10.1016/j.neulet.2006.01.024; Michaelson JS, 2001, ONCOGENE, V20, P5093, DOI 10.1038/sj.onc.1204586; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murtaugh LC, 2005, DEVELOPMENT, V132, P4663, DOI 10.1242/dev.02063; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Papadopoulou S, 2005, DIABETES, V54, P2844, DOI 10.2337/diabetes.54.10.2844; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Quaiser T, 2006, BIOESSAYS, V28, P339, DOI 10.1002/bies.20386; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rukstalis JM, 2006, ENDOCRINOLOGY, V147, P2997, DOI 10.1210/en.2005-1396; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Sable CL, 1997, FEBS LETT, V409, P253, DOI 10.1016/S0014-5793(97)00518-8; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schinner S, 2008, DIABETOLOGIA, V51, P147, DOI 10.1007/s00125-007-0848-0; SHU L, 2008, IN PRESS DIABETES; Skoglund G, 2000, DIABETES, V49, P1156, DOI 10.2337/diabetes.49.7.1156; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Suzuki Y, 2006, J BIOL CHEM, V281, P28499, DOI 10.1074/jbc.M604291200; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Teo R, 2006, DEV BIOL, V289, P91, DOI 10.1016/j.ydbio.2005.10.009; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian Q, 2005, CELL CYCLE, V4, P215; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Trumper J, 2005, DIABETOLOGIA, V48, P1534, DOI 10.1007/s00125-005-1820-5; Trumper K, 2000, ANN NY ACAD SCI, V921, P242; Wang H, 2006, CIRC RES, V98, P1331, DOI 10.1161/01.RES.0000220650.26555.1d; Wang Q, 2004, DIABETOLOGIA, V47, P478, DOI 10.1007/s00125-004-1327-5; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Wang XH, 2004, AM J PHYSIOL-HEART C, V287, pH2376, DOI 10.1152/ajpheart.01173.2003; Wells JM, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-4; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xu LF, 2000, GENE DEV, V14, P585; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Yue ZC, 2006, P NATL ACAD SCI USA, V103, P951, DOI 10.1073/pnas.0506894103; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568	95	232	251	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8723	8735		10.1074/jbc.M706105200	http://dx.doi.org/10.1074/jbc.M706105200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18216022	hybrid, Green Published			2022-12-27	WOS:000254288000070
J	Dries, DR; Newton, AC				Dries, Daniel R.; Newton, Alexandra C.			Kinetic analysis of the interaction of the C1 domain of protein kinase C with lipid membranes by stopped-flow spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; ACTIVATION; PHOSPHATIDYLSERINE; DIACYLGLYCEROL; SPECIFICITY; COOPERATIVITY; MECHANISM; ISOFORMS; DELTA; PHOSPHORYLATION	The diacylglycerol DG)/phorbol ester-dependent translocation of conventional protein kinase C PKC) isozymes is mediated by the C1 domain, a membrane-targeting module that also selectively binds phosphatidylserine PS). Using stopped-flow spectroscopy, we dissect the contribution of DG/phorbol esters C1 ligand) and PS in driving the association and dissociation of the C1 domain from membranes. Specifically, we examine the binding to membranes of the C1B domain of PKC beta with a substituted Trp Y123W) whose fluorescence is quenched upon binding to membranes. Binding of this construct C1B beta-Y123W) to phospholipid vesicles is cooperative with respect to PS content and dependent on C1 ligand, as previously characterized. Stopped-flow analysis reveals that the apparent association rate k(on)(app)), but not the apparent dissociation rate k(off)(app)), is highly sensitive to PS content: the 60-fold increase in membrane affinity for vesicles containing no PS compared with 40 mol% PS results primarily from a robust 30-fold) increase in k(on)(app) with little effect 2-fold) on k(off)(app). Membrane affinity is also controlled by the content and structure of the C1 ligand. In contrast to PS, these ligands markedly alter k(off)(app) with smaller effects on k(on)(app). We also show that the affinity for phorbol ester-containing membranes is 2 orders of magnitude higher than that for DG-containing membranes primarily resulting from differences in k(off)(app). Our data are consistent with a model in which the C1 domain is recruited to the membrane via an initial weak electrostatic interaction with PS, followed by a rapid two-dimensional search for ligand, the binding of which retains the domain at the membrane. Thus, PS drives the initial encounter, and DG/phorbol esters retain the domain on membranes. The decreased effectiveness of DG compared with phorbol esters in retaining the C1 domain on membranes contributes to the molecular dichotomy of the rapid, transient nature of DG-dependent PKC signaling versus the chronic hyperactivity of phorbol ester-activated PKC.	[Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dries, Daniel R.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr,0721, La Jolla, CA 92093 USA.	anewton@ucsd.edu		DRIES, DANIEL/0000-0002-0530-5212	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326, R37GM043154, R01GM043154, T32GM007752] Funding Source: NIH RePORTER; NIGMS NIH HHS [2T32 GM-08326, 2T32 GM-07752, GM-43154] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; BARTLETT GR, 1959, J BIOL CHEM, V234, P468; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Codazzi F, 2001, CURR BIOL, V11, P1089, DOI 10.1016/S0960-9822(01)00326-8; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015; Dibble ARG, 1996, BIOPHYS J, V71, P1877, DOI 10.1016/S0006-3495(96)79387-6; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Giorgione J, 2003, BIOCHEMISTRY-US, V42, P11194, DOI 10.1021/bi0350046; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P12020, DOI 10.1021/bi981107q; KAZANIETZ MG, 1992, J BIOL CHEM, V267, P20878; KHANDWALA AS, 1971, BIOCHIM BIOPHYS ACTA, V233, P348, DOI 10.1016/0005-2736(71)90332-4; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; LEE MH, 1989, J BIOL CHEM, V264, P14797; LEE MH, 1992, BIOCHEMISTRY-US, V31, P5176, DOI 10.1021/bi00137a013; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Mosior M, 1998, BIOCHEMISTRY-US, V37, P17271, DOI 10.1021/bi981344t; MOSIOR M, 1995, J BIOL CHEM, V270, P25526, DOI 10.1074/jbc.270.43.25526; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P13216, DOI 10.1021/bi010761u; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NEWTON AC, 1989, J BIOL CHEM, V264, P14909; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4667, DOI 10.1021/bi00134a019; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4661, DOI 10.1021/bi00134a018; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Radic Z, 1997, J BIOL CHEM, V272, P23265, DOI 10.1074/jbc.272.37.23265; SHARKEY NA, 1984, P NATL ACAD SCI-BIOL, V81, P607, DOI 10.1073/pnas.81.2.607; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	39	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7885	7893		10.1074/jbc.M709943200	http://dx.doi.org/10.1074/jbc.M709943200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18187412	hybrid			2022-12-27	WOS:000253997900064
J	Giganti, A; Rodriguez, M; Fould, B; Moulharat, N; Coge, F; Chomarat, P; Galizzi, JP; Valet, P; Saulnier-Blache, JS; Boutin, JA; Ferry, G				Giganti, Adeline; Rodriguez, Marianne; Fould, Benjamin; Moulharat, Natacha; Coge, Francis; Chomarat, Pascale; Galizzi, Jean-Pierre; Valet, Philippe; Saulnier-Blache, Jean-Sebastien; Boutin, Jean A.; Ferry, Gilles			Murine and human autotaxin alpha, beta, and gamma isoforms - Gene organization, tissue distribution, and biochemical characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHOLIPASE-D ACTIVITY; LYSOPHOSPHATIDIC ACID SYNTHESIS; MOTILITY-STIMULATING PROTEIN; PHOSPHODIESTERASE-I; NUCLEOTIDE PYROPHOSPHATASES/PHOSPHODIESTERASES; PREADIPOCYTE PROLIFERATION; ADIPOCYTE DIFFERENTIATION; MOLECULAR-CLONING; DIVALENT-CATIONS; BREAST-CANCER	Autotaxin is a type II ectonucleotide pyrophosphate phosphodiesterase enzyme. It has been recently discovered that it also has a lysophospholipase D activity. This enzyme probably provides most of the extracellular lysophosphatidic acid from lysophosphatidylcholine. The cloning and tissue distribution of the three isoforms (imaginatively called alpha, beta, and gamma) from human and mouse are reported in this study, as well as their tissue distribution by PCR in the human and mouse. The fate of the alpha isoform from human was also studied after purification and using mass spectrometry. Indeed, this particular isoform expresses the intron 12 in which a cleavage site is present, leading to a rapid catabolism of the isoform. For the human isoform gamma and the total autotaxin mRNA expression, quantitative PCR is presented in 21 tissues. The isoforms were expressed in two different hosts, insect cells and Chinese hamster ovary cells, and were highly purified. The characteristics of the six purified isoforms (pH and temperature dependence, K-m and V-max values, and their dependence on metal ions) are presented in this study. Their sensitivity to a small molecule inhibitor, hypericin, is also shown. Finally, the specificity of the isoforms toward a large family of lysophosphatidylcholines is reported. This study is the first complete description of the reported autotaxin isoforms.	[Giganti, Adeline; Rodriguez, Marianne; Fould, Benjamin; Moulharat, Natacha; Coge, Francis; Chomarat, Pascale; Galizzi, Jean-Pierre; Boutin, Jean A.; Ferry, Gilles] Inst Rech Servier, F-78290 Croissy sur Seine, France; [Valet, Philippe; Saulnier-Blache, Jean-Sebastien] INSERM, U 858 12MR, Dept Metab & Obes, F-31432 Toulouse, France	Servier; Institut de Recherches Internationales Servier; Institut National de la Sante et de la Recherche Medicale (Inserm)	Boutin, JA (corresponding author), Inst Rech Servier, 125,chemin Ronde, F-78290 Croissy sur Seine, France.	jean.boutin@fr.netgrs.com	Valet, Philippe/N-7472-2017; Boutin, Jean Albert/W-9103-2019; Saulnier-Blache, Jean Sebastien/X-7729-2018	Valet, Philippe/0000-0001-6520-7393; Boutin, Jean Albert/0000-0003-0068-7204; Saulnier-Blache, Jean Sebastien/0000-0002-8971-7723				Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Bachner D, 1999, MECH DEVELOP, V84, P121, DOI 10.1016/S0925-4773(99)00048-9; Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; BELLI SI, 1994, BIOCHEM J, V304, P75, DOI 10.1042/bj3040075; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Cimpean A, 2004, BIOCHEM J, V381, P71, DOI 10.1042/BJ20040465; Clair T, 1997, J BIOL CHEM, V272, P996, DOI 10.1074/jbc.272.2.996; Cui P, 2007, BIOORG MED CHEM LETT, V17, P1634, DOI 10.1016/j.bmcl.2006.12.114; Dennis J, 2005, J NEUROSCI RES, V82, P737, DOI 10.1002/jnr.20686; Durgam GG, 2005, J MED CHEM, V48, P4919, DOI 10.1021/jm049609r; Ferguson CG, 2006, ORG LETT, V8, P2023, DOI 10.1021/ol060414i; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Ferry G, 2007, FEBS LETT, V581, P3572, DOI 10.1016/j.febslet.2007.06.064; Gesta S, 2002, J LIPID RES, V43, P904; Gijsbers R, 2003, FEBS LETT, V538, P60, DOI 10.1016/S0014-5793(03)00133-9; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Gududuru V, 2006, BIOORG MED CHEM LETT, V16, P451, DOI 10.1016/j.bmcl.2005.08.096; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; HERINGDORT DMZ, 2006, BIOCHIM BIOPHYS ACTA, V1758, P923; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Jiang GW, 2007, CHEMMEDCHEM, V2, P679, DOI 10.1002/cmdc.200600280; KAWAGOE H, 1995, GENOMICS, V30, P380, DOI 10.1006/geno.1995.0036; KAWASAKI T, 1987, BIOCHIM BIOPHYS ACTA, V920, P85, DOI 10.1016/0005-2760(87)90314-6; Koh E, 2003, CANCER RES, V63, P2042; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HY, 1996, BIOCHEM BIOPH RES CO, V218, P714, DOI 10.1006/bbrc.1996.0127; Lee J, 2001, BIOCHEM PHARMACOL, V62, P219, DOI 10.1016/S0006-2952(01)00658-X; Luquain C, 2003, J LIPID RES, V44, P1963, DOI 10.1194/jlr.M300188-JLR200; Morishige J, 2007, BBA-MOL CELL BIOL L, V1771, P491, DOI 10.1016/j.bbalip.2007.01.005; MOULHARAT N, 2008, IN PRESS CHEM BIOL I; MURATA J, 1994, J BIOL CHEM, V269, P30479; NARITA M, 1994, J BIOL CHEM, V269, P28235; Pages C, 2001, J BIOL CHEM, V276, P11599, DOI 10.1074/jbc.M010111200; Piao JH, 1999, CYTOGENET CELL GENET, V87, P172, DOI 10.1159/000015459; Pradere JP, 2007, BBA-MOL CELL BIOL L, V1771, P93, DOI 10.1016/j.bbalip.2006.11.010; RAZZELL WE, 1959, J BIOL CHEM, V234, P2105; SCOTT WG, 1995, J MOL BIOL, V250, P327, DOI 10.1006/jmbi.1995.0380; Simon MF, 2005, J BIOL CHEM, V280, P14656, DOI 10.1074/jbc.M412585200; Stracke ML, 1997, ADV ENZYME REGUL, V37, P135, DOI 10.1016/S0065-2571(96)00017-9; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Sugimoto S, 2006, BBA-MOL CELL BIOL L, V1761, P1410, DOI 10.1016/j.bbalip.2006.09.013; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tigyi G, 2001, PROSTAG OTH LIPID M, V64, P47, DOI 10.1016/S0090-6980(01)00107-1; Tokumura A, 1998, LIPIDS, V33, P1009, DOI 10.1007/s11745-998-0299-2; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tokumura A, 2007, LIFE SCI, V80, P1641, DOI 10.1016/j.lfs.2006.12.041; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Valet P, 1998, J CLIN INVEST, V101, P1431, DOI 10.1172/JCI806; van Meeteren LA, 2005, J BIOL CHEM, V280, P21155, DOI 10.1074/jbc.M413183200; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; WYKLE RL, 1974, J BIOL CHEM, V249, P1742; WYKLE RL, 1977, ARCH BIOCHEM BIOPHYS, V184, P149, DOI 10.1016/0003-9861(77)90336-8; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196; Zhou M.J., 2000, P SPIE INT SOC OPT E, V3926, P166	59	94	106	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7776	7789		10.1074/jbc.M708705200	http://dx.doi.org/10.1074/jbc.M708705200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18175805	hybrid			2022-12-27	WOS:000253997900054
J	Karcher, A; Schele, A; Hopfner, KP				Karcher, Annette; Schele, Alexandra; Hopfner, Karl-Peter			X-ray structure of the complete ABC enzyme ABCE1 from Pyrococcus abyssi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR PROTEIN MUTS; RNASE-L-INHIBITOR; ATP-BINDING; CRYSTAL-STRUCTURE; RESOLUTION STRUCTURES; BIOGENESIS; MISMATCH; TRANSLATION; FERREDOXIN; MECHANISM	The ATP binding cassette enzyme ABCE1 (also known as RNase-L (ribonuclease L) inhibitor, Pixie, and HP68), one of the evolutionary most sequence-conserved enzymes, functions in translation initiation, ribosome biogenesis, and human immunodeficiency virus capsid assembly. However, its structural mechanism and biochemical role in these processes have not been revealed. We determined the crystal structure of Pyrococcus abyssi ABCE1 in complex with Mg2+ and ADP to 2.8 angstrom resolution. ABCE1 consists of four structural domains. Two nucleotide binding domains are arranged in a head-to-tail orientation by a hinge domain, suggesting that these domains undergo the characteristic tweezers-like powerstroke of ABC enzymes. In contrast to all other known ABC enzymes, ABCE1 has a N-terminal iron-sulfur-cluster (FeS) domain. The FeS domain contains two [4Fe-4S] clusters and is structurally highly related to bacterial-type ferredoxins. However, one cluster is coordinated by an unusual CX4CX3/4C triad. Surprisingly, intimate interactions of the FeS domain with the adenine and ribose binding Y-loop on nucleotide binding domain 1 suggest a linkage between FeS domain function and ATP-induced conformational control of the ABC tandem cassette. The structure substantially expands the functional architecture of ABC enzymes and raises the possibility that ABCE1 is a chemomechanical engine linked to a redox process.	[Karcher, Annette; Schele, Alexandra; Hopfner, Karl-Peter] Univ Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany; Univ Munich, Ctr Adv Photon Gene Ctr, D-81377 Munich, Germany	University of Munich; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Ctr Integrated Prot Sci, Feodor Lynen Str 25, D-81377 Munich, Germany.	hopfner@lmb.uni-muenchen.de	Hopfner, Karl-Peter/B-6864-2014	Hopfner, Karl-Peter/0000-0002-4528-8357				Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Andersen DS, 2007, J BIOL CHEM, V282, P14752, DOI 10.1074/jbc.M701361200; [Anonymous], 2003, ABC PROTEINS BACTERI; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barthelme D, 2007, J BIOL CHEM, V282, P14598, DOI 10.1074/jbc.M700825200; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Bisbal C, 2000, METH MOL B, V160, P183; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Braz ASK, 2004, J MOL EVOL, V59, P20, DOI 10.1007/s00239-004-2600-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Coelho CMA, 2005, DEVELOPMENT, V132, P5411, DOI 10.1242/dev.02148; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dobritzsch D, 2001, EMBO J, V20, P650, DOI 10.1093/emboj/20.4.650; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Estevez AM, 2004, MOL BIOCHEM PARASIT, V133, P137, DOI 10.1016/j.molbiopara.2003.09.009; Fritz G, 2002, P NATL ACAD SCI USA, V99, P1836, DOI 10.1073/pnas.042664399; Fukuyama K, 2002, J MOL BIOL, V315, P1155, DOI 10.1006/jmbi.2001.5292; Giastas P, 2006, J BIOL INORG CHEM, V11, P445, DOI 10.1007/s00775-006-0094-9; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Karcher A, 2005, STRUCTURE, V13, P649, DOI 10.1016/j.str.2005.02.008; Kerr ID, 2004, BIOCHEM BIOPH RES CO, V315, P166, DOI 10.1016/j.bbrc.2004.01.044; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kriek M, 2003, PROTEIN EXPRES PURIF, V28, P241, DOI 10.1016/S1046-5928(02)00680-0; KUO CF, 1992, SCIENCE, V258, P434, DOI 10.1126/science.1411536; Kyritsis P, 1998, J BIOL CHEM, V273, P15404, DOI 10.1074/jbc.273.25.15404; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t; Rees DC, 2003, SCIENCE, V300, P929, DOI 10.1126/science.1083075; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sticht H, 1998, PROG BIOPHYS MOL BIO, V70, P95, DOI 10.1016/S0079-6107(98)00027-3; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; TURCK D, 1992, THESIS TECHNICAL U M; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; van der Does C, 2004, BIOL CHEM, V385, P927, DOI 10.1515/BC.2004.121; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540; Zhao ZY, 2004, BIOCHEM BIOPH RES CO, V323, P104, DOI 10.1016/j.bbrc.2004.08.068; Zimmerman C, 2002, NATURE, V415, P88, DOI 10.1038/415088a	54	69	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7962	7971		10.1074/jbc.M707347200	http://dx.doi.org/10.1074/jbc.M707347200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18160405	Green Published, hybrid			2022-12-27	WOS:000253997900071
J	Kim, CH; Kim, SJ; Kan, H; Kwon, HM; Roh, KB; Jiang, R; Yang, Y; Park, JW; Lee, HH; Ha, NC; Kang, HJ; Nonaka, M; Soderhall, K; Lee, BL				Kim, Chan-Hee; Kim, Su-Jin; Kan, Hongnan; Kwon, Hyun-Mi; Roh, Kyung-Baeg; Jiang, Rui; Yang, Yu; Park, Ji-Won; Lee, Hyeon-Hwa; Ha, Nam-Chul; Kang, Hee Jung; Nonaka, Masaru; Soderhall, Kenneth; Lee, Bok Luel			A three-step proteolytic cascade mediates the activation of the peptidoglycan-induced Toll pathway in an insect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLOTRICHIA-DIOMPHALIA LARVAE; PRO-PHENOL-OXIDASE; SERINE-PROTEASE; INNATE IMMUNITY; PROPHENOLOXIDASE ACTIVATION; MELANIZATION CASCADE; RECOGNITION PROTEIN; MOLECULAR-CLONING; TENEBRIO-MOLITOR; DROSOPHILA	The recognition of lysine-type peptidoglycans (PG) by the PG recognition complex has been suggested to cause activation of the serine protease cascade leading to the processing of Spatzle and subsequent activation of the Toll signaling pathway. So far, two serine proteases involved in the lysine-type PG Toll signaling pathway have been identified. One is a modular serine protease functioning as an initial enzyme to be recruited into the lysine-type PG recognition complex. The other is the Drosophila Spatzle processing enzyme (SPE), a terminal enzyme that converts Spatzle proprotein to its processed form capable of binding to the Toll receptor. However, it remains unclear how the initial PG recognition signal is transferred to Spatzle resulting in Toll pathway activation. Also, the biochemical characteristics and mechanism of action of a serine protease linking the modular serine protease and SPE have not been investigated. Here, we purified and cloned a novel upstream serine protease of SPE that we named SAE, SPE-activating enzyme, from the hemolymph of a large beetle, Tenebrio molitor larvae. This enzyme was activated by Tenebrio modular serine protease and in turn activated the Tenebrio SPE. The biochemical ordered functions of these three serine proteases were determined in vitro, suggesting that the activation of a three-step proteolytic cascade is necessary and sufficient for lysine-type PG recognition signaling. The processed Spatzle by this cascade induced antibacterial activity in vivo. These results demonstrate that the three-step proteolytic cascade linking the PG recognition complex and Spatzle processing is essential for the PG-dependent Toll signaling pathway.	[Kim, Chan-Hee; Kim, Su-Jin; Kan, Hongnan; Kwon, Hyun-Mi; Roh, Kyung-Baeg; Jiang, Rui; Yang, Yu; Park, Ji-Won; Lee, Hyeon-Hwa; Ha, Nam-Chul; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea; [Kang, Hee Jung] Hallym Univ, Coll Med, Dept Lab Med, Anyang 431070, South Korea; [Nonaka, Masaru] Univ Tokyo, Dept Biol Sci, Tokyo 1130033, Japan; [Soderhall, Kenneth] Uppsala Univ, Dept Comparat Physiol, S-75236 Uppsala, Sweden	Pusan National University; Hallym University; University of Tokyo; Uppsala University	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Jiang, Rui/F-9248-2011; NONAKA, MASARU/G-4929-2014; Kim, Chan-Hee/C-6849-2016	Kim, Chan-Hee/0000-0002-5315-4981; Jiang, Rui/0000-0002-5580-9822				Anderson A F, 2000, Am J Knee Surg, V13, P19; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; Dissing M, 2001, EMBO J, V20, P2387, DOI 10.1093/emboj/20.10.2387; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Ji CY, 2004, J BIOL CHEM, V279, P34101, DOI 10.1074/jbc.M404584200; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kawabata S, 1996, FEBS LETT, V398, P146, DOI 10.1016/S0014-5793(96)01224-0; Lee SY, 1998, EUR J BIOCHEM, V254, P50, DOI 10.1046/j.1432-1327.1998.2540050.x; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; LEMAITRE B, 2007, IMMUNOLOGY, V25, P697; LeMosy EK, 2001, P NATL ACAD SCI USA, V98, P5055, DOI 10.1073/pnas.081026598; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; MOON HJ, 1994, J BIOCHEM-TOKYO, V116, P53, DOI 10.1093/oxfordjournals.jbchem.a124502; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Park JW, 2006, J BIOL CHEM, V281, P7747, DOI 10.1074/jbc.M510058200; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; YOSHIDA H, 1986, BIOCHEM BIOPH RES CO, V141, P1177, DOI 10.1016/S0006-291X(86)80168-1; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200	30	119	132	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7599	7607		10.1074/jbc.M710216200	http://dx.doi.org/10.1074/jbc.M710216200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18195005	hybrid			2022-12-27	WOS:000253997900035
J	Bocharov, EV; Mineev, KS; Volynsky, PE; Ermolyuk, YS; Tkach, EN; Sobol, AG; Chupin, VV; Kirpichnikov, MP; Efremov, RG; Arseniev, AS				Bocharov, Eduard V.; Mineev, Konstantin S.; Volynsky, Pavel E.; Ermolyuk, Yaroslav S.; Tkach, Elena N.; Sobol, Alexander G.; Chupin, Vladimir V.; Kirpichnikov, Michail P.; Efremov, Roman G.; Arseniev, Alexander S.			Spatial structure of the dimeric transmembrane domain of the growth factor receptor ErbB2 presumably corresponding to the receptor active state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; ACTIVATION; PEPTIDES; SEQUENCE; DIMERIZATION; DYNAMICS	Proper lateral dimerization of the transmembrane domains of receptor tyrosine kinases is required for biochemical signal transduction across the plasma membrane. The spatial structure of the dimeric transmembrane domain of the growth factor receptor ErbB2 embedded into lipid bicelles was obtained by solution NMR, followed by molecular dynamics relaxation in an explicit lipid bilayer. ErbB2 transmembrane segments associate in a right-handed alpha-helical bundle through the N-terminal tandem GG4-like motif Thr(652)-X(3)Ser(656)-X-3-Gly(660), providing an explanation for the pathogenic power of some oncogenic mutations.	[Bocharov, Eduard V.; Mineev, Konstantin S.; Volynsky, Pavel E.; Sobol, Alexander G.; Chupin, Vladimir V.; Efremov, Roman G.; Arseniev, Alexander S.] Russian Acad Sci, MM Shemyakin Bioorgan Chem Inst, Div Struct Biol, Moscow 117997, Russia; [Ermolyuk, Yaroslav S.; Tkach, Elena N.; Kirpichnikov, Michail P.] Russian Acad Sci, MM Shemyakin Bioorgan Chem Inst, Lab Prot Engn, Moscow 117997, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Bocharov, EV (corresponding author), Russian Acad Sci, MM Shemyakin Bioorgan Chem Inst, Div Struct Biol, Ulitsa Miklukho Maklaya 16-10, Moscow 117997, Russia.	bon@nmr.ru; aars@nmr.ru	Mineev, Konstantin S/Q-3948-2018; Volynsky, Pavel/A-8360-2014; Roman, Efremov/A-7460-2014; Mineev, Konstantin/AAC-6662-2019; Mineev, Konstantin/E-4151-2010; chupin, vladimir/J-8986-2015	Mineev, Konstantin S/0000-0002-2418-9421; Volynsky, Pavel/0000-0002-0471-4188; Roman, Efremov/0000-0002-5474-4721; Mineev, Konstantin/0000-0002-2418-9421; Mineev, Konstantin/0000-0002-2418-9421; 				BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; Beevers AJ, 2006, J MOL BIOL, V361, P945, DOI 10.1016/j.jmb.2006.07.004; Bennasroune A, 2004, MOL BIOL CELL, V15, P3464, DOI 10.1091/mbc.E03-10-0753; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; DeLano W.L, PYMOL MOL GRAPHICS S; Duneau JP, 2007, BIOCHEMISTRY-US, V46, P2010, DOI 10.1021/bi061436f; EFREMOV RG, 1995, J PHYS CHEM-US, V99, P10658, DOI 10.1021/j100026a033; Enosh A, 2007, BIOINFORMATICS, V23, pE212, DOI 10.1093/bioinformatics/btl325; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Langosch D, 1998, PROTEINS, V31, P150, DOI 10.1002/(SICI)1097-0134(19980501)31:2<150::AID-PROT5>3.0.CO;2-Q; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Orekhov VY, 1995, APPL MAGN RESON, V9, P581, DOI 10.1007/BF03162365; Partridge AW, 2002, BIOPOLYMERS, V66, P350, DOI 10.1002/bip.10313; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Smith SO, 2002, BIOCHEMISTRY-US, V41, P9321, DOI 10.1021/bi012117l; Smith SO, 1996, NAT STRUCT BIOL, V3, P252, DOI 10.1038/nsb0396-252; Tanner KG, 1999, J BIOL CHEM, V274, P35985, DOI 10.1074/jbc.274.50.35985; Xie DW, 2000, J NATL CANCER I, V92, P412, DOI 10.1093/jnci/92.5.412; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	35	169	172	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6950	6956		10.1074/jbc.M709202200	http://dx.doi.org/10.1074/jbc.M709202200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18178548	hybrid			2022-12-27	WOS:000253779600039
J	Cunningham, LA; Kahn, RA				Cunningham, Leslie A.; Kahn, Richard A.			Cofactor D functions as a centrosomal protein and is required for the recruitment of the gamma-tubulin ring complex at centrosomes and organization of the mitotic spindle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; BETA-TUBULIN; MICROTUBULE CYTOSKELETON; CENTRIOLE DUPLICATION; MAMMALIAN-CELLS; ANIMAL-CELLS; MITOSIS; ARL2; MUTANTS; PATHWAY	Microtubules are highly dynamic structures, composed of alpha/beta-tubulin heterodimers. Biosynthesis of the functional dimer involves the participation of several chaperones, termed cofactors A-E, that act on folding intermediates downstream of the cytosolic chaperonin CCT ( 1, 2). We show that cofactor D is also a centrosomal protein and that overexpression of either the full-length protein or either of two centrosome localization domains leads to the loss of anchoring of the gamma-tubulin ring complex and of nucleation of microtubule growth at centrosomes. In contrast, depletion of cofactor D by short interfering RNA results in mitotic spindle defects. Because none of these changes in cofactor D activity produced a change in the levels of alpha- or beta-tubulin, we conclude that these newly discovered functions for cofactor D are distinct from its previously described role in tubulin folding. Thus, we describe a new role for cofactor D at centrosomes that is important to its function in polymerization of tubulin and organization of the mitotic spindle.	[Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Biochem Cell & Dev Biol Program, Atlanta, GA 30322 USA	Emory University; Emory University	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601	NIGMS NIH HHS [GM-68029, R01 GM090158] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068029] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abal M, 2005, BIOL CELL, V97, P425, DOI 10.1042/BC20040112; BARON AT, 1992, BIOL CELL, V76, P383, DOI 10.1016/0248-4900(92)90442-4; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bicknell AB, 2001, CELL, V105, P903, DOI 10.1016/S0092-8674(01)00403-2; Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; DIRKSEN ER, 1991, BIOL CELL, V72, P31, DOI 10.1016/0248-4900(91)90075-X; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Ehrhardt AG, 2005, J CELL PHYSIOL, V204, P808, DOI 10.1002/jcp.20335; Fava F, 1999, J CELL BIOL, V147, P857, DOI 10.1083/jcb.147.4.857; Fedyanina OS, 2006, CURR GENET, V50, P281, DOI 10.1007/s00294-006-0095-9; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; GAO YI, 1993, MOL CELL BIOL, V13, P2478, DOI 10.1128/MCB.13.4.2478; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Grishchuk EL, 1998, GENETICS, V149, P1251; Grynberg M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-46; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hirata D, 1998, EMBO J, V17, P658, DOI 10.1093/emboj/17.3.658; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Li YW, 2004, FASEB J, V18, P1834, DOI 10.1096/fj.04-2273com; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; Liu LA, 1999, J BIOL CHEM, V274, P38171, DOI 10.1074/jbc.274.53.38171; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Martin L, 2000, FEBS LETT, V470, P93, DOI 10.1016/S0014-5793(00)01293-X; Mayer U, 1999, EUR J CELL BIOL, V78, P100, DOI 10.1016/S0171-9335(99)80011-9; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663; Nolasco S, 2005, FEBS LETT, V579, P3515, DOI 10.1016/j.febslet.2005.05.022; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Paoletti A, 1996, J CELL SCI, V109, P3089; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Radcliffe PA, 2000, FEBS LETT, V468, P84, DOI 10.1016/S0014-5793(00)01202-3; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; Shultz T, 2008, FASEB J, V22, P168, DOI 10.1096/fj.06-7786com; STEARNS T, 1990, GENETICS, V124, P251; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	51	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7155	7165		10.1074/jbc.M706753200	http://dx.doi.org/10.1074/jbc.M706753200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18171676	hybrid			2022-12-27	WOS:000253779600061
J	Dutertre, S; Croker, D; Daly, NL; Andersson, A; Muttenthaler, M; Lumsden, NG; Craik, DJ; Alewood, PF; Guillon, G; Lewis, RJ				Dutertre, Sebastien; Croker, Daniel; Daly, Norelle L.; Andersson, Asa; Muttenthaler, Markus; Lumsden, Natalie G.; Craik, David J.; Alewood, Paul F.; Guillon, Gilles; Lewis, Richard J.			Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-VASOPRESSIN; OXYTOCIN RECEPTOR; VASOTOCIN; VENOM; CONOTOXINS; PHYSIOLOGY; EVOLUTION; HORMONE; PROGRAM; AGONIST	We report the discovery of conopressin-T, a novel bioactive peptide isolated from Conus tulipa venom. Conopressin-T belongs to the vasopressin- like peptide family and displays high sequence homology to the mammalian hormone oxytocin ( OT) and to vasotocin, the endogenous vasopressin analogue found in teleost fish, the cone snail's prey. Conopressin-T was found to act as a selective antagonist at the human V-1a receptor. All peptides in this family contain two conserved amino acids within the exocyclic tripeptide ( Pro(7) and Gly(9)), which are replaced with Leu(7) and Val(9) in conopressin-T. Whereas conopressin-T binds only to OT and V-1a receptors, an L7P analogue had increased affinity for the V-1a receptor and weak V-2 receptor binding. Surprisingly, replacing Gly(9) with Val(9) in OT and vasopressin revealed that this position can function as an agonist/ antagonist switch at the V-1a receptor. NMR structures of both conopressin-T and L7P analogue revealed a marked difference in the orientation of the exocyclic tripeptide that may serve as templates for the design of novel ligands with enhanced affinity for the V-1a receptor.	[Dutertre, Sebastien; Daly, Norelle L.; Muttenthaler, Markus; Lumsden, Natalie G.; Craik, David J.; Alewood, Paul F.; Lewis, Richard J.] Univ Queensland, Inst Mol Biol, Brisbane, Qld 4072, Australia; [Croker, Daniel; Andersson, Asa] Xenome Ltd, Brisbane, Qld 4072, Australia; [Guillon, Gilles] CNRS, UMR 5203, F-34094 Montpellier, France; [Guillon, Gilles] Inst Genom Fonctionnelle, Dept Endocrinol, F-34094 Montpellier, France; [Guillon, Gilles] INSERM, U 661, F-34094 Montpellier, France; [Guillon, Gilles] Univ Montpellier, F-34094 Montpellier, France	University of Queensland; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biol, Brisbane, Qld 4072, Australia.	r.lewis@imb.uq.edu.au	Lewis, Richard/T-8763-2019; Craik, David/B-1695-2010; Lewis, Richard J/E-8674-2013; Daly, Norelle L/D-4302-2013; Muttenthaler, Markus/AAF-5944-2021; Alewood, Paul F/J-2412-2014; Muttenthaler, Markus/B-4944-2017; Croker, Daniel/N-7134-2013	Lewis, Richard/0000-0003-3470-923X; Craik, David/0000-0003-0007-6796; Lewis, Richard J/0000-0003-3470-923X; Daly, Norelle L/0000-0002-4697-6602; Muttenthaler, Markus/0000-0003-1996-4646; Muttenthaler, Markus/0000-0003-1996-4646; Croker, Daniel/0000-0001-9533-4019; Dutertre, Sebastien/0000-0002-2945-1484; Alewood, Paul/0000-0001-7454-6522				ADEYEMO OM, 1991, TOXICOL APPL PHARM, V108, P489, DOI 10.1016/0041-008X(91)90095-V; Balment RJ, 2006, GEN COMP ENDOCR, V147, P9, DOI 10.1016/j.ygcen.2005.12.022; Barberis C, 1998, J ENDOCRINOL, V156, P223, DOI 10.1677/joe.0.1560223; Birnbaumer M, 2000, TRENDS ENDOCRIN MET, V11, P406, DOI 10.1016/S1043-2760(00)00304-0; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chini B, 1996, FEBS LETT, V397, P201, DOI 10.1016/S0014-5793(96)01135-0; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; Daly NL, 2004, J BIOL CHEM, V279, P25774, DOI 10.1074/jbc.M313002200; Derick S, 2002, ENDOCRINOLOGY, V143, P4655, DOI 10.1210/en.2002-220363; Dutertre S, 2006, FEBS LETT, V580, P3860, DOI 10.1016/j.febslet.2006.06.011; Egashira N, 2004, NEUROSCI LETT, V356, P195, DOI 10.1016/j.neulet.2003.11.050; ELANDS J, 1988, EUR J PHARMACOL, V147, P197, DOI 10.1016/0014-2999(88)90778-9; Febo M, 2005, J NEUROSCI, V25, P11637, DOI 10.1523/JNEUROSCI.3604-05.2005; Ferris CF, 2006, PHARMACOL BIOCHEM BE, V83, P169, DOI 10.1016/j.pbb.2006.01.001; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hiroyama M, 2007, EUR J PHARMACOL, V559, P89, DOI 10.1016/j.ejphar.2006.12.010; Hoyle CHV, 1999, BRAIN RES, V848, P1, DOI 10.1016/S0006-8993(99)01975-7; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Kozorovitskiy Y, 2006, NAT NEUROSCI, V9, P1094, DOI 10.1038/nn1753; KRUSZYNSKI M, 1990, EXPERIENTIA, V46, P771, DOI 10.1007/BF01939964; LARIVE CK, 1992, J AM CHEM SOC, V114, P7331, DOI 10.1021/ja00045a001; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; MAHLMANN S, 1994, P NATL ACAD SCI USA, V91, P1342, DOI 10.1073/pnas.91.4.1342; MCMASTER D, 1992, PEPTIDES, V13, P413, DOI 10.1016/0196-9781(92)90069-F; Moller C, 2007, BIOCHEM J, V404, P413, DOI 10.1042/BJ20061480; NIELSEN DB, 1994, TOXICON, V32, P845, DOI 10.1016/0041-0101(94)90009-4; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SALZET M, 1993, EUR J BIOCHEM, V217, P897, DOI 10.1111/j.1432-1033.1993.tb18319.x; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Treschan TA, 2006, ANESTHESIOLOGY, V105, P599, DOI 10.1097/00000542-200609000-00026; VANKESTEREN RE, 1995, J NEUROSCI, V15, P5989; Windt WAKM, 2006, J RENIN-ANGIO-ALDO S, V7, P217, DOI 10.3317/jraas.2006.041; Wittelsberger A, 2005, J MED CHEM, V48, P6553, DOI 10.1021/jm049205z; Wuthrich K, 1986, NMR PROTEINS NUCL AC	39	65	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7100	7108		10.1074/jbc.M706477200	http://dx.doi.org/10.1074/jbc.M706477200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18174156	Green Published, hybrid			2022-12-27	WOS:000253779600055
J	Li, Z; Wang, C; Jiao, X; Katiyar, S; Casimiro, MC; Prendergast, GC; Powell, MJ; Pestell, RG				Li, Zhiping; Wang, Chenguang; Jiao, Xuanmao; Katiyar, Sanjay; Casimiro, Mathew C.; Prendergast, George C.; Powell, Michael J.; Pestell, Richard G.			Alternate cyclin d1 mRNA splicing modulates p27(KIP1) binding and cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA PROTEIN; ANDROGEN RECEPTOR; BREAST-CANCER; MICE LACKING; GERANYLGERANYLATED RHOB; INHIBITOR P27(KIP1); PROSTATE-CANCER; TUMOR-GROWTH; EXPRESSION; REPRESSION	Cyclin D1 is an important cell cycle regulator, but in cancer its overexpression also increases cellular migration mediated by p27(KIP1) stabilization and RhoA inhibition. Recently, a common polymorphism at the exon 4-intron 4 boundary of the human cyclin D1 gene within a splice donor region was associated with an altered risk of developing cancer. Altered RNA splicing caused by this polymorphism gives rise to a variant cyclin D1 isoform termed cyclin D1b, which has the same N terminus as the canonical cyclin D1a isoform but a distinct C terminus. In this study we show that these different isoforms have unique properties with regard to the cellular migration function of cyclin D1. Although they displayed little difference in transcriptional co-repression assays on idealized reporter genes, microarray cDNA expression analysis revealed differential regulation of genes, including those that influence cellular migration. Additionally, whereas cyclin D1a stabilized p27(KIP1) and inhibited RhoA-induced ROCK kinase activity, promoting cellular migration, cyclin D1b failed to stabilize p27(KIP1) or inhibit ROCK kinase activity and had no effect on migration. Our findings argue that alternate splicing is an important determinant of the function of cyclin D1 in cellular migration.	[Li, Zhiping; Wang, Chenguang; Jiao, Xuanmao; Katiyar, Sanjay; Casimiro, Mathew C.; Powell, Michael J.; Pestell, Richard G.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Li, Zhiping; Wang, Chenguang; Jiao, Xuanmao; Katiyar, Sanjay; Casimiro, Mathew C.; Powell, Michael J.; Pestell, Richard G.] Thomas Jefferson Univ, Dept Med Oncol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Prendergast, George C.] Lankenau Inst Med Res, Wynnewood, PA 19096 USA	Jefferson University; Jefferson University; Lankenau Medical Center; Lankenau Institute for Medical Research	Wang, C (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, 233 S 10th St,Bluemle Life Sci Bldg,Rm 1050, Philadelphia, PA 19107 USA.	chenguang.wang@jefferson.edu; Richard.Pestell@jefferson.edu		Katiyar, Sanjay/0000-0003-1622-5661	NCI NIH HHS [R01CA75503, R01CA70896, R01CA86072, P30CA56036] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA070896, R01CA075503, R01CA086072, P30CA056036] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; BETTICHER DC, 1995, ONCOGENE, V11, P1005; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; Drobnjak M, 2000, CLIN CANCER RES, V6, P1891; Du W, 1999, MOL CELL BIOL, V19, P1831; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fredersdorf S, 1997, P NATL ACAD SCI USA, V94, P6380, DOI 10.1073/pnas.94.12.6380; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Fu MF, 2005, J BIOL CHEM, V280, P29728, DOI 10.1074/jbc.M503188200; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Holley SL, 2001, AM J PATHOL, V159, P1917, DOI 10.1016/S0002-9440(10)63038-6; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Hosokawa Y, 1998, GENE CHROMOSOME CANC, V22, P66, DOI 10.1002/(SICI)1098-2264(199805)22:1<66::AID-GCC9>3.0.CO;2-5; Howe D, 2001, HAEMATOLOGICA, V86, P563; Hulit J, 2006, CANCER RES, V66, P8529, DOI 10.1158/0008-5472.CAN-06-0149; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Jin KL, 2004, FASEB J, V18, P287, DOI 10.1096/fj.03-0973com; Katiyar S, 2007, MOL CELL BIOL, V27, P1356, DOI 10.1128/MCB.01061-06; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Knudsen KE, 1999, CANCER RES, V59, P2297; Kong SM, 2000, CANCER RES, V60, P249; Leveque C, 2007, EXP CELL RES, V313, P2719, DOI 10.1016/j.yexcr.2007.04.018; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Lu FM, 2003, CANCER RES, V63, P7056; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Reutens AT, 2001, MOL ENDOCRINOL, V15, P797, DOI 10.1210/me.15.5.797; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sawa H, 1998, ONCOGENE, V16, P1701, DOI 10.1038/sj.onc.1201691; Sgambato A, 1997, CLIN CANCER RES, V3, P1879; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Solomon DA, 2003, J BIOL CHEM, V278, P30339, DOI 10.1074/jbc.M303969200; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Volpert OV, 2002, CANCER CELL, V2, P473, DOI 10.1016/S1535-6108(02)00209-X; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang CG, 2005, CANCER RES, V65, P6557, DOI 10.1158/0008-5472.CAN-05-0486; Wang CG, 2006, P NATL ACAD SCI USA, V103, P11567, DOI 10.1073/pnas.0603363103; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wilby MJ, 1999, MOL CELL NEUROSCI, V14, P66, DOI 10.1006/mcne.1999.0766; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zwicker J, 1999, ONCOGENE, V18, P19, DOI 10.1038/sj.onc.1202286	62	48	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7007	7015		10.1074/jbc.M706992200	http://dx.doi.org/10.1074/jbc.M706992200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18180298	hybrid			2022-12-27	WOS:000253779600045
J	Qin, SF; De Vries, GW				Qin, Suofu; De Vries, Gerald W.			alpha 2 but not alpha 1 AMP-activated protein kinase mediates oxidative stress-induced inhibition of retinal pigment epithelium cell phagocytosis of photoreceptor outer segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; RAT-LIVER; STIMULATION; GLUCOSE; ENERGY; EXPRESSION; APOPTOSIS; RPE	Oxidative stress causes retinal pigment epithelium (RPE) cell dysfunction and is a major risk factor leading to the development of dry-type age- related macular degeneration. Taking pharmacological and genetic approaches, we address the mechanisms by which sublethal oxidative stress inhibits RPE cell phagocytosis. Sublethal oxidative stress dose-dependently inhibited RPE cell phagocytosis of photoreceptor outer segments (POS) and activated AMP-activated protein kinase ( AMPK) as determined by increased Thr(172) and Ser(79) phosphorylation of AMPK alpha and its substrate acetyl-CoA carboxylase, respectively. Similar to oxidative stress, 5-aminoimidazole-4-carboxamide riboside ( AICAR), a pharmacological activator of AMPK, inhibited RPE cell phagocytosis of POS in a dose-dependent manner. Inhibition of RPE cell phagocytosis by AICAR was fully reversed by blockade of AICAR translocation into cells by dipyridamole or inhibition of AICAR conversion to ZMP by adenosine kinase inhibitor 5-iodotubercidin. In agreement, AICAR-induced activation of AMPK was abolished by preincubation with dipyridamole or 5-iodotubercidin. Knock-out experiments further revealed that alpha 2 but not alpha 1 AMPK was involved in RPE cell phagocytosis and that activation of alpha 2 AMPK contributed to the inhibition of RPE cell phagocytosis by oxidative stress. Inhibition of RPE cell phagocytosis by activation of alpha 2 AMPK was associated with a dramatic increase in acetyl-CoA carboxylase phosphorylation. In comparison, AMPK had no role in oxidative stress-induced breakdown of RPE barrier function. Taken together, reduction in POS load under oxidative stress might direct RPE cells to a self-protected status. Thus, activating AMPK could have therapeutic potential in treating dry macular degeneration.	[Qin, Suofu; De Vries, Gerald W.] Allergan Pharmaceut Inc, Dept Biol Sci, Irvine, CA 92612 USA	AbbVie; Allergan	Qin, SF (corresponding author), Allergan Pharmaceut Inc, Dept Biol Sci, RD3-2D,2525 Dupont Dr, Irvine, CA 92612 USA.	qin_suofu@allergan.com		Qin, Suofu/0000-0002-3323-8846				ALDER VA, 1985, CURR EYE RES, V4, P121, DOI 10.3109/02713688508999977; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CARLING D, 2004, J CELL SCI, V117, P5479; Chen J, 2006, DEV BIOL, V291, P227, DOI 10.1016/j.ydbio.2005.11.039; DOREY CK, 1990, CURR EYE RES, V9, P549, DOI 10.3109/02713689008999595; DOREY CK, 1989, INVEST OPHTH VIS SCI, V30, P1047; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Evans JR, 2001, PROG RETIN EYE RES, V20, P227, DOI 10.1016/S1350-9462(00)00023-9; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; Fryer LGD, 2000, DIABETES, V49, P1978, DOI 10.2337/diabetes.49.12.1978; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Henin N, 1996, BBA-GEN SUBJECTS, V1290, P197, DOI 10.1016/0304-4165(96)00021-9; Honda S, 2001, MOL VIS, V7, P63; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kindzelskii AL, 2004, J GEN PHYSIOL, V124, P139, DOI 10.1085/jgp.200409062; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200; Marmorstein AD, 2001, TRAFFIC, V2, P867, DOI 10.1034/j.1600-0854.2001.21202.x; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; MCLAREN MJ, 1993, INVEST OPHTH VIS SCI, V34, P317; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922; Strauss O, 1998, ACTA ANAT, V162, P101; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; TATE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1271; Thompson DA, 2003, DEV OPHTHALMOL, V37, P141; Turnley AM, 1999, J NEUROCHEM, V72, P1707, DOI 10.1046/j.1471-4159.1999.721707.x; Winkler BS, 1999, MOL VIS, V5; Xavier GD, 2000, P NATL ACAD SCI USA, V97, P4023, DOI 10.1073/pnas.97.8.4023; YOUNG RW, 1987, SURV OPHTHALMOL, V31, P291, DOI 10.1145/1165387.275645; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200	38	31	32	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6744	6751		10.1074/jbc.M708848200	http://dx.doi.org/10.1074/jbc.M708848200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18195011	hybrid			2022-12-27	WOS:000253779600016
J	Sierra, AY; Gratacos, E; Carrasco, P; Clotet, J; Urena, J; Serra, D; Asins, G; Hegardt, FG; Casals, N				Sierra, Adriana Y.; Gratacos, Esther; Carrasco, Patricia; Clotet, Josep; Urena, Jesus; Serra, Dolors; Asins, Guillermina; Hegardt, Fausto G.; Casals, Nuria			CPT1c is localized in endoplasmic reticulum of neurons and has carnitine palmitoyltransferase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; EXPRESSION; TRIACYLGLYCEROL; SPHINGOLIPIDS; ACYLCARNITINE; INHIBITION; CONTAINS; PROTEINS; RESIDUES; MUTATION	CPT1c is a carnitine palmitoyltransferase 1 (CPT1) isoform that is expressed only in the brain. The enzyme has recently been localized in neuron mitochondria. Although it has high sequence identity with the other two CPT1 isoenzymes (a and b), no CPT activity has been detected to date. Our results indicate that CPT1c is expressed in neurons but not in astrocytes of mouse brain sections. Overexpression of CPT1c fused to the green fluorescent protein in cultured cells demonstrates that CPT1c is localized in the endoplasmic reticulum rather than mitochondria and that the N-terminal region of CPT1c is responsible for endoplasmic reticulum protein localization. Western blot experiments with cell fractions from adult mouse brain corroborate these results. In addition, overexpression studies demonstrate that CPT1c does not participate in mitochondrial fatty acid oxidation, as would be expected from its subcellular localization. To identify the substrate of CPT1c enzyme, rat cDNA was overexpressed in neuronal PC-12 cells, and the levels of acylcarnitines were measured by high-performance liquid chromatography-mass spectrometry. Palmitoylcarnitine was the only acylcarnitine to increase in transfected cells, which indicates that palmitoyl-CoA is the enzyme substrate and that CPT1c has CPT1 activity. Microsomal fractions of PC-12 and HEK293T cells overexpressing CPT1c protein showed a significant increase in CPT1 activity of 0.57 and 0.13 nmol.mg(-1).min(-1), respectively, which is similar to 50% higher than endogenous CPT1 activity. Kinetic studies demonstrate that CPT1c has similar affinity to CPT1a for both substrates but 20-300 times lower catalytic efficiency.	[Sierra, Adriana Y.; Gratacos, Esther; Carrasco, Patricia; Clotet, Josep; Casals, Nuria] Univ Int Catalunya, Sch Hlth Sci, Mol & Cellular Unit, Barcelona 08195, Spain; [Urena, Jesus] Univ Barcelona, Fac Biol, Dept Cell Biol, E-08028 Barcelona, Spain; [Urena, Jesus] Inst Rec Biomed Barcelona, Barcelona 08028, Spain; [Serra, Dolors; Asins, Guillermina; Hegardt, Fausto G.] Univ Barcelona, Sch Pharm, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Serra, Dolors; Asins, Guillermina; Hegardt, Fausto G.; Casals, Nuria] Inst Salud Carlos III, Inst Fisiopatol Obesidad & Nutr CB06 03, Ctr Invest Biomed Red CIBER, Madrid 28029, Spain	Universitat Internacional de Catalunya (UIC); University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; Instituto de Salud Carlos III	Casals, N (corresponding author), Univ Int Catalunya, Sch Hlth Sci, Mol & Cellular Unit, Josep Trueta S-N,Sant Cugat Valles, Barcelona 08195, Spain.	ncasals@csc.uic.es	Urena, Jesus/R-5385-2017; Gratacòs-Batlle, Esther/L-8740-2014; Casals, Nuria/L-3378-2014; Serra, Dolors/L-3657-2014; Clotet, Josep/AAF-2618-2019; Clotet, Josep/ABC-8727-2020	Urena, Jesus/0000-0003-1408-6039; Gratacòs-Batlle, Esther/0000-0001-8093-3713; Casals, Nuria/0000-0002-6719-4300; Serra, Dolors/0000-0002-4936-4206; Clotet, Josep/0000-0001-5462-8598				Abo-Hashema KAH, 1999, J BIOL CHEM, V274, P35577, DOI 10.1074/jbc.274.50.35577; ARDUINI A, 1994, J NEUROCHEM, V62, P1530; Broadway NM, 2003, BIOCHEM J, V370, P223, DOI 10.1042/BJ20021269; Buccoliero R, 2003, PHARMACOL RES, V47, P409, DOI 10.1016/S1043-6618(03)00049-5; Cohen I, 2001, J BIOL CHEM, V276, P5403, DOI 10.1074/jbc.M009555200; Dai Y, 2007, BIOCHEM BIOPH RES CO, V359, P469, DOI 10.1016/j.bbrc.2007.05.161; ESSER V, 1993, J BIOL CHEM, V268, P5817; Gooding JM, 2004, EUR J BIOCHEM, V271, P954, DOI 10.1111/j.1432-1033.2004.03997.x; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Jauregui O, 2007, ANAL CHIM ACTA, V599, P1, DOI 10.1016/j.aca.2007.07.066; Lopez-Vinas E, 2007, J BIOL CHEM, V282, P18212, DOI 10.1074/jbc.M700885200; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200; Morillas M, 2001, J BIOL CHEM, V276, P45001, DOI 10.1074/jbc.M106920200; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Prip-Buus C, 1998, FEBS LETT, V429, P173, DOI 10.1016/S0014-5793(98)00584-5; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Sorensen Annette, 2002, Brain Res Gene Expr Patterns, V1, P167; van Echten-Deckert G, 2006, BBA-BIOMEMBRANES, V1758, P1978, DOI 10.1016/j.bbamem.2006.06.009; van Vlies N, 2007, MOL GENET METAB, V90, P24, DOI 10.1016/j.ymgme.2006.07.006; Washington L, 2003, J LIPID RES, V44, P1395, DOI 10.1194/jlr.M300123-JLR200; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; YAMAZAKI N, 1995, FEBS LETT, V363, P41, DOI 10.1016/0014-5793(95)00277-G	25	121	123	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6878	6885		10.1074/jbc.M707965200	http://dx.doi.org/10.1074/jbc.M707965200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18192268	Green Accepted, hybrid			2022-12-27	WOS:000253779600031
J	Park, KY; Russo, AF				Park, Ki-Youb; Russo, Andrew F.			Control of the calcitonin gene-related peptide enhancer by upstream stimulatory factor in trigeminal ganglion neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX-LOOP-HELIX; TRANSCRIPTION FACTOR USF; PROMOTER ACTIVITY; EXPRESSION; MIGRAINE; BINDING; ACTIVATION; CONTRIBUTE; PROTEIN; CGRP	The neuropeptide calcitonin gene-related peptide (CGRP) is a key player in migraine. However, the transcription factors controlling CGRP expression in the migraine-relevant trigeminal ganglion neurons are unknown. Previous in vitro studies demonstrated that upstream stimulatory factor (USF) 1 and USF2 bind to the CGRP neuroendocrine-specific 18-bp enhancer, yet discrepant overexpression results in cell lines, and the ubiquitous nature of the USF cast doubts about its role. To test the functional role of USF, we first demonstrated that small interfering RNAs directed against USF1 and USF2 reduced endogenous CGRP RNA and preferentially targeted the USF binding site at the 18-bp enhancer in the neuronal-like CA77 cell line. In cultured rat trigeminal ganglion neurons, knockdown of either USF1 or USF2 reduced CGRP promoter activity. Conversely, overexpression of USF1 or USF2 increased promoter activity. The activation was even greater upon cotransfection with an upstream activator of mitogen-activated protein kinases and was synergistic in a heterologous cell line. To begin to address the paradox of how ubiquitous USF proteins might direct neuronal-specific activity, we examined USF expression and used a series of adenoviral reporters in the cultured ganglia. Unexpectedly, there was more intense USF immunostaining in neurons than nonneuronal cells. Importantly, the 18-bp USF enhancer driving a minimal promoter was sufficient for neuronal specificity, although it was not the only site that directed neuronal expression. These results demonstrate that USF1 and USF2 are important contributors to neuronal-specific and mitogen-activated protein kinase regulation of the CGRP gene in trigeminal ganglion neurons.	[Russo, Andrew F.] Univ Iowa, Dept Physiol & Mol Biophys, Iowa City, IA 52242 USA; [Park, Ki-Youb] Univ Iowa, Program Mol & Cell Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Russo, AF (corresponding author), Univ Iowa, Dept Physiol & Mol Biophys, Iowa City, IA 52242 USA.	Andrew-russo@uiowa.edu		Russo, Andrew/0000-0002-8156-5649	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE016511, DE016511] Funding Source: Medline; NIDDK NIH HHS [DK54759, P30 DK054759] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bowen EJ, 2006, J NEUROCHEM, V96, P65, DOI 10.1111/j.1471-4159.2005.03524.x; Brain SD, 2004, PHYSIOL REV, V84, P903, DOI 10.1152/physrev.00037.2003; Chen JG, 2005, J VIROL, V79, P4396, DOI 10.1128/JVI.79.7.4396-4406.2005; Chen WG, 2003, J NEUROSCI, V23, P2572; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; COTE GJ, 1986, J BIOL CHEM, V261, P5524; Coulson JM, 1999, BIOCHEM J, V344, P961, DOI 10.1042/0264-6021:3440961; Coulson JM, 2003, BIOCHEM J, V369, P549, DOI 10.1042/BJ20021176; Durham PL, 2006, HEADACHE, V46, pS3, DOI 10.1111/j.1526-4610.2006.00483.x; Durham PL, 2004, BRAIN RES, V997, P103, DOI 10.1016/j.brainres.2003.11.005; Durham PL, 2003, J NEUROSCI, V23, P807; FEINMAN R, 1994, EMBO J, V13, P3852, DOI 10.1002/j.1460-2075.1994.tb06696.x; Frenkel S, 1998, J IMMUNOL, V161, P2881; Fujii G, 2006, BIOCHEM J, V395, P203, DOI 10.1042/BJ20051802; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Gerrard L, 2005, NEUROPEPTIDES, V39, P475, DOI 10.1016/j.npep.2005.08.004; Goadsby Peter J, 2006, Expert Opin Emerg Drugs, V11, P419, DOI 10.1517/14728214.11.3.419; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; HOUGH PVC, 1987, P NATL ACAD SCI USA, V84, P4826, DOI 10.1073/pnas.84.14.4826; JESSEN KR, 1984, J NEUROCYTOL, V13, P187, DOI 10.1007/BF01148114; Juhasz G, 2005, CEPHALALGIA, V25, P179, DOI 10.1111/j.1468-2982.2005.00836.x; Juttner S, 2003, CELL MICROBIOL, V5, P821, DOI 10.1046/j.1462-5822.2003.00324.x; Kutz SM, 2006, EXP CELL RES, V312, P1093, DOI 10.1016/j.yexcr.2005.12.027; Lanigan TM, 1997, J BIOL CHEM, V272, P18316, DOI 10.1074/jbc.272.29.18316; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo X, 1996, P NATL ACAD SCI USA, V93, P1308, DOI 10.1073/pnas.93.3.1308; Luo X, 1996, MOL CELL BIOL, V16, P1367; Martin CC, 2003, BIOCHEM J, V371, P675, DOI 10.1042/BJ20021585; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MONCOLLIN V, 1986, EMBO J, V5, P2577, DOI 10.1002/j.1460-2075.1986.tb04537.x; Nagavarapu U, 2001, J BIOL CHEM, V276, P16749, DOI 10.1074/jbc.M009712200; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; READ ML, 1993, BIOCHEM J, V295, P233, DOI 10.1042/bj2950233; Ribeiro A, 1999, J BIOL CHEM, V274, P1216, DOI 10.1074/jbc.274.3.1216; Sayasith K, 2005, J BIOL CHEM, V280, P28885, DOI 10.1074/jbc.M413434200; SCHWARTZ ML, 1992, J BIOL CHEM, V267, P24596; Sirito M, 1998, P NATL ACAD SCI USA, V95, P3758, DOI 10.1073/pnas.95.7.3758; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; Sun P, 2001, J BIOL CHEM, V276, P45462, DOI 10.1074/jbc.M104793200; TVERBERG LA, 1993, J BIOL CHEM, V268, P15965; Viney TJ, 2004, J BIOL CHEM, V279, P49948, DOI 10.1074/jbc.M406659200; Viollet B, 1996, J BIOL CHEM, V271, P1405, DOI 10.1074/jbc.271.3.1405; Waeber C, 2005, NEUROLOGY, V64, pS9, DOI 10.1212/WNL.64.10_suppl_2.S9; Wood JL, 2001, J BIOL CHEM, V276, P21262, DOI 10.1074/jbc.M007520200; Zhang ZM, 2007, J NEUROSCI, V27, P2693, DOI 10.1523/JNEUROSCI.4542-06.2007	50	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5441	5451		10.1074/jbc.M708662200	http://dx.doi.org/10.1074/jbc.M708662200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167349	hybrid			2022-12-27	WOS:000253426700024
J	Macias-Perez, IM; Zent, R; Carmosino, M; Breyer, MD; Breyer, RM; Pozzi, A				Macias-Perez, Ines M.; Zent, Roy; Carmosino, Monica; Breyer, Matthew D.; Breyer, Richard M.; Pozzi, Ambra			Mouse EP3 alpha, beta, and gamma receptor variants reduce tumor cell proliferation and tumorigenesis in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; C-TERMINAL TAIL; NEURITE RETRACTION; PROSTAGLANDIN E(2); LIGAND-BINDING; 2 ISOFORMS; CONSTITUTIVE ACTIVITY; ERK ACTIVATION; ASPIRIN USE; SUBTYPE	Prostaglandin E-2, which exerts its functions by binding to four G protein-coupled receptors (EP1-4), is implicated in tumorigenesis. Among the four E-prostanoid (EP) receptors, EP3 is unique in that it exists as alternatively spliced variants, characterized by differences in the cytoplasmic C-terminal tail. Although three EP3 variants, alpha,beta,and gamma, have been described in mice, their functional significance in regulating tumorigenesis is unknown. In this study we provide evidence that expressing murine EP3 alpha, beta, and gamma receptor variants in tumor cells reduces to the same degree their tumorigenic potential in vivo. In addition, activation of each of the three mEP3 variants induces enhanced cell-cell contact and reduces cell proliferation in vitro in a Rho-dependent manner. Finally, we demonstrate that EP3-mediated RhoA activation requires the engagement of the heterotrimeric G protein G(12). Thus, our study provides strong evidence that selective activation of each of the three variants of the EP3 receptor suppresses tumor cell function by activating aG(12)-RhoA pathway.	[Macias-Perez, Ines M.; Zent, Roy; Carmosino, Monica; Breyer, Matthew D.; Breyer, Richard M.; Pozzi, Ambra] Vanderbilt Univ, Dept Med, Div Nephrol, Med Ctr N, Nashville, TN 37232 USA; [Macias-Perez, Ines M.; Zent, Roy; Pozzi, Ambra] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Zent, Roy] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Zent, Roy; Pozzi, Ambra] Vet Affairs Hosp, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Pozzi, A (corresponding author), Vanderbilt Univ, Dept Med, Div Nephrol, Med Ctr N, B3109, Nashville, TN 37232 USA.	ambra.pozzi@vanderbilt.edu	Carmosino, Monica/O-2594-2014	Carmosino, Monica/0000-0001-7600-8816; Breyer, Matthew/0000-0003-1880-371X	NATIONAL CANCER INSTITUTE [R01CA094849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074359, R01DK037097, R01DK069921] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA94849] Funding Source: Medline; NIDDK NIH HHS [R01-DK69921, R01-DK074359, DK37097] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bilson HA, 2004, FEBS LETT, V572, P271, DOI 10.1016/j.febslet.2004.06.089; Boie Y, 1997, EUR J PHARMACOL, V340, P227, DOI 10.1016/S0014-2999(97)01383-6; BREYER RM, 1994, J BIOL CHEM, V269, P6163; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Falcetti E, 2007, BIOCHEM BIOPH RES CO, V360, P821, DOI 10.1016/j.bbrc.2007.06.135; Fukui K, 2006, J CANCER RES CLIN, V132, P627, DOI 10.1007/s00432-006-0107-7; Hasegawa H, 1996, J BIOL CHEM, V271, P1857, DOI 10.1074/jbc.271.4.1857; Hasegawa H, 2000, FEBS LETT, V473, P76, DOI 10.1016/S0014-5793(00)01508-8; Hasegawa H, 1997, BIOCHEM BIOPH RES CO, V234, P631, DOI 10.1006/bbrc.1997.6655; Hata AN, 2005, J BIOL CHEM, V280, P32442, DOI 10.1074/jbc.M502563200; Hata AN, 2005, MOL PHARMACOL, V67, P640, DOI 10.1124/mol.104.007971; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; IRIE A, 1993, EUR J BIOCHEM, V217, P313, DOI 10.1111/j.1432-1033.1993.tb18248.x; IRIE A, 1994, BIOCHEM BIOPH RES CO, V204, P303, DOI 10.1006/bbrc.1994.2460; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kanda N, 2005, J PHARMACOL EXP THER, V315, P796, DOI 10.1124/jpet.105.091645; KARGMAN SL, 1995, CANCER RES, V55, P2556; Katoh H, 1996, J BIOL CHEM, V271, P29780, DOI 10.1074/jbc.271.47.29780; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Katoh H, 1998, J BIOL CHEM, V273, P2489, DOI 10.1074/jbc.273.5.2489; Kotani T, 2000, J CLIN ENDOCR METAB, V85, P4315; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Negishi M, 1996, FEBS LETT, V386, P165, DOI 10.1016/0014-5793(96)00354-7; NEGISHI M, 1993, BIOCHIM BIOPHYS ACTA, V1175, P343, DOI 10.1016/0167-4889(93)90227-G; Nelson PJ, 2002, KIDNEY INT S1, V61, P99, DOI DOI 10.1046/J.1523-1755.2002.0610S1099.X; OKA M, 1994, AM J SURG, V167, P264, DOI 10.1016/0002-9610(94)90089-2; Pozzi A, 2004, J BIOL CHEM, V279, P29797, DOI 10.1074/jbc.M313989200; PUGH S, 1994, GUT, V35, P675, DOI 10.1136/gut.35.5.675; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; SANO H, 1995, CANCER RES, V55, P3785; Sasaki M, 2007, PROSTAG OTH LIPID M, V83, P237, DOI 10.1016/j.prostaglandins.2006.12.001; Scherpereel A, 2003, CANCER RES, V63, P6084; Shoji Y, 2004, GUT, V53, P1151, DOI 10.1136/gut.2003.028787; SUGIMOTO Y, 1993, J BIOL CHEM, V268, P2712; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; THUN MJ, 1993, CANCER RES, V53, P1322; Wilson RJ, 2005, BRIT J PHARMACOL, V144, P405, DOI 10.1038/sj.bjp.0706088; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058	43	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12538	12545		10.1074/jbc.M800105200	http://dx.doi.org/10.1074/jbc.M800105200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18230618	Green Published, hybrid			2022-12-27	WOS:000255340000070
J	Wagner, JR; Zhang, JR; von Stetten, D; Guenther, M; Murgida, DH; Mroginski, MA; Walker, JM; Forest, KT; Hildebrandt, P; Vierstra, RD				Wagner, Jeremiah R.; Zhang, Junrui; von Stetten, David; Guenther, Mina; Murgida, Daniel H.; Mroginski, Maria Andrea; Walker, Joseph M.; Forest, Katrina T.; Hildebrandt, Peter; Vierstra, Richard D.			Mutational analysis of Deinococcus radiodurans bacteriophytochrome reveals key amino acids necessary for the photochromicity and proton exchange cycle of phytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOPHORE-BINDING DOMAIN; RESONANCE RAMAN; TETRAPYRROLE CHROMOPHORE; BILIVERDIN CHROMOPHORE; BIOLOGICAL-ACTIVITY; STRUCTURAL-CHANGES; CPH1 PHYTOCHROME; PHOTOTRANSFORMATION; AGP1; PHOTORECEPTORS	The ability of phytochromes (Phy) to act as photointerconvertible light switches in plants and microorganisms depends on key interactions between the bilin chromophore and the apoprotein that promote bilin attachment and photointerconversion between the spectrally distinct red light-absorbing Pr conformer and far red light-absorbing Pfr conformer. Using structurally guided site-directed mutagenesis combined with several spectroscopic methods, we examined the roles of conserved amino acids within the bilin-binding domain of Deinococcus radiodurans bacteriophytochrome with respect to chromophore ligation and Pr/Pfr photoconversion. Incorporation of biliverdin IX alpha(BV), its structure in the Pr state, and its ability to photoisomerize to the first photocycle intermediate are insensitive to most single mutations, implying that these properties are robust with respect to small structural/electrostatic alterations in the binding pocket. In contrast, photoconversion to Pfr is highly sensitive to the chromophore environment. Many of the variants form spectrally bleached Meta-type intermediates in red light that do not relax to Pfr. Particularly important are Asp-207 and His-260, which are invariant within the Phy superfamily and participate in a unique hydrogen bond matrix involving the A, B, and C pyrrole ring nitrogens of BV and their associated pyrrole water. Resonance Raman spectroscopy demonstrates that substitutions of these residues disrupt the Pr to Pfr protonation cycle of BV with the chromophore locked in a deprotonated Meta-R-c-like photoconversion intermediate after red light irradiation. Collectively, the data show that a number of contacts contribute to the unique photochromicity of Phy-type photoreceptors. These include residues that fix the bilin in the pocket, coordinate the pyrrole water, and possibly promote the proton exchange cycle during photoconversion.	[Wagner, Jeremiah R.; Zhang, Junrui; Walker, Joseph M.; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Forest, Katrina T.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [von Stetten, David; Guenther, Mina; Murgida, Daniel H.; Mroginski, Maria Andrea; Hildebrandt, Peter] Tech Univ Berlin, D-10623 Berlin, Germany	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Technical University of Berlin	Vierstra, RD (corresponding author), Univ Wisconsin, Dept Genet, 425-G Henry Mall, Madison, WI 53706 USA.	vierstra@wisc.edu	Hildebrandt, Peter/J-5658-2014; Zhang, Junrui/J-2684-2012; Murgida, Daniel H./F-2350-2018	Hildebrandt, Peter/0000-0003-1030-5900; Murgida, Daniel H./0000-0001-5173-0183; von Stetten, David/0000-0001-7906-9788				Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Andel F, 2000, BIOCHEMISTRY-US, V39, P2667, DOI 10.1021/bi991688z; Andel F, 1997, BIOSPECTROSCOPY, V3, P421, DOI 10.1002/(SICI)1520-6343(1997)3:6<421::AID-BSPY1>3.0.CO;2-3; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Bhoo SH, 1997, J AM CHEM SOC, V119, P11717, DOI 10.1021/ja972875s; Bischoff M, 2001, BIOCHEMISTRY-US, V40, P181, DOI 10.1021/bi0011734; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; Borucki B, 2003, BIOCHEMISTRY-US, V42, P13684, DOI 10.1021/bi035511n; Braslavsky SE, 2003, PHOTOCHROMISM: MOLECULES AND SYSTEMS, P738, DOI 10.1016/B978-044451322-9/50023-3; CHERRY JR, 1993, PLANT CELL, V5, P565, DOI 10.1105/tpc.5.5.565; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Fischer AJ, 2005, BIOCHEMISTRY-US, V44, P15203, DOI 10.1021/bi051633z; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Foerstendorf H, 2001, BIOCHEMISTRY-US, V40, P14952, DOI 10.1021/bi0156916; Froehlich AC, 2005, EUKARYOT CELL, V4, P2140, DOI 10.1128/EC.4.12.2140-2152.2005; Hahn J, 2006, FEBS J, V273, P1415, DOI 10.1111/j.1742-4658.2006.05164.x; Hanzawa H, 2001, P NATL ACAD SCI USA, V98, P3612, DOI 10.1073/pnas.051629698; Inomata K, 2006, J BIOL CHEM, V281, P28162, DOI 10.1074/jbc.M603983200; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; Kneip C, 2000, FEBS LETT, V482, P252, DOI 10.1016/S0014-5793(00)02069-X; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 2001, EUR J BIOCHEM, V268, P4720, DOI 10.1046/j.1432-1327.2001.02395.x; MIZUTANI Y, 1994, BIOCHEMISTRY-US, V33, P153, DOI 10.1021/bi00167a020; Mroginski MA, 2004, J AM CHEM SOC, V126, P16734, DOI 10.1021/ja043959l; Mroginski MA, 2007, ACCOUNTS CHEM RES, V40, P258, DOI 10.1021/ar6000523; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Stevens JM, 2004, ACCOUNTS CHEM RES, V37, P999, DOI 10.1021/ar030266l; STOCKHAUS J, 1992, GENE DEV, V6, P2364, DOI 10.1101/gad.6.12a.2364; Tu SL, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P121, DOI 10.1002/352760510X.ch6; Vierstra RD, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P171, DOI 10.1002/352760510X.ch8; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548	40	163	166	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12212	12226		10.1074/jbc.M709355200	http://dx.doi.org/10.1074/jbc.M709355200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18192276	Green Published, hybrid			2022-12-27	WOS:000255340000037
J	Carlucci, A; Gedressi, C; Lignitto, L; Nezi, L; Villa-Moruzzi, E; Avvedimento, EV; Gottesman, M; Garbi, C; Feliciello, A				Carlucci, Annalisa; Gedressi, Chiara; Lignitto, Luca; Nezi, Luigi; Villa-Moruzzi, Emma; Avvedimento, Enrico V.; Gottesman, Max; Garbi, Corrado; Feliciello, Antonio			Protein-tyrosine phosphatase PTPD1 regulates focal adhesion kinase autophosphorylation and cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; ACTIVATION; COMPLEX; DOMAIN; FAK; RHO; PAXILLIN; MOTILITY; SIGNALS; BETA	PTPD1 is a cytosolic nonreceptor tyrosine phosphatase and a positive regulator of the Src-epidermal growth factor transduction pathway. We show that PTPD1 localizes along actin filaments and at adhesion plaques. PTPD1 forms a stable complex via distinct molecular modules with actin, Src tyrosine kinase, and focal adhesion kinase (FAK), a scaffold protein kinase enriched at adhesion plaques. Overexpression of PTPD1 promoted cell scattering and migration, short hairpin RNA-mediated silencing of endogenous PTPD1, or expression of PTPD1 mutants lacking either catalytic activity (PTPD1(C1108S)) or the FERM domain (PTPD1(Delta 1-325)) significantly reduced cell motility. PTPD1 and Src catalytic activities were both required for epidermal growth factor-induced FAK autophosphorylation at its active site and for downstream propagation of ERK1/2 signaling. Our findings demonstrate that PTPD1 is a component of a multivalent scaffold complex nucleated by FAK at specific intracellular sites. By modulating Src-FAK signaling at adhesion sites, PTPD1 promotes the cytoskeleton events that induce cell adhesion and migration.	[Carlucci, Annalisa; Gedressi, Chiara; Lignitto, Luca; Nezi, Luigi; Avvedimento, Enrico V.; Garbi, Corrado; Feliciello, Antonio] Univ Naples Federico II, Fac Med, Ist Endocrinol & Oncol Sperimentale, CNR,Dipartimento Biol & Patol Mol & Cellulare, I-80131 Naples, Italy; [Villa-Moruzzi, Emma] Univ Pisa, Dipartimento Patol Sperimentale, I-56126 Pisa, Italy; [Gottesman, Max] Columbia Univ, Inst Canc Res, New York, NY 10032 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Pisa; Columbia University	Feliciello, A (corresponding author), Univ Naples Federico II, Fac Med, Ist Endocrinol & Oncol Sperimentale, CNR,Dipartimento Biol & Patol Mol & Cellulare, Via S Pansini, I-80131 Naples, Italy.	feliciel@unina.it	Nezi, Luigi/AAB-1957-2019	Nezi, Luigi/0000-0002-4670-7656; Feliciello, Antonio/0000-0002-7932-2170	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Bianchi M, 2005, MOL CELL BIOCHEM, V272, P85, DOI 10.1007/s11010-005-7639-z; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Dorner C, 1998, J BIOL CHEM, V273, P20267, DOI 10.1074/jbc.273.32.20267; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feliciello A, 2005, CELL SIGNAL, V17, P279, DOI 10.1016/j.cellsig.2004.09.009; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; ILLC D, 1995, NATURE, V377, P539; Iwahara T, 2004, P NATL ACAD SCI USA, V101, P17693, DOI 10.1073/pnas.0408413102; Jui HY, 2000, J BIOL CHEM, V275, P41124, DOI 10.1074/jbc.M007772200; Liang FB, 2005, J BIOL CHEM, V280, P24857, DOI 10.1074/jbc.M502780200; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; Manes S, 1999, MOL CELL BIOL, V19, P3125; MOLLER NPH, 1994, P NATL ACAD SCI USA, V91, P7477, DOI 10.1073/pnas.91.16.7477; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; NOBES CD, 1995, J CELL SCI, V108, P225; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Ren XD, 2000, J CELL SCI, V113, P3673; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sallee JL, 2006, J BIOL CHEM, V281, P16189, DOI 10.1074/jbc.R600003200; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; SEMICH R, 1990, J HISTOCHEM CYTOCHEM, V38, P59, DOI 10.1177/38.1.1688450; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Vuori K, 1996, MOL CELL BIOL, V16, P2606; WEISPOKUTTA S, 2002, CURR OPIN STRUC BIOL, V12, P255; Yamada KM, 2001, J CELL SCI, V114, P2375; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	49	50	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10919	10929		10.1074/jbc.M707248200	http://dx.doi.org/10.1074/jbc.M707248200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18223254	hybrid			2022-12-27	WOS:000254894700073
J	Lopez-Alcala, C; Alvarez-Moya, B; Villalonga, P; Calvo, M; Bachs, O; Agell, N				Lopez-Alcala, Cristina; Alvarez-Moya, Blanca; Villalonga, Priam; Calvo, Maria; Bachs, Oriol; Agell, Neus			Identification of essential interacting elements in K-Ras/calmodulin binding and its role in K-Ras localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; CALMODULIN-BINDING; H-RAS; N-RAS; PHOSPHOINOSITIDE 3-KINASE; SIGNAL-TRANSDUCTION; TERMINAL DOMAIN; GTP-BINDING; PROTEIN; CA2+/CALMODULIN	We previously showed that K-Ras is a calmodulin-binding protein. Involvement of this interaction in anterograde and retrograde transport of K-Ras was then suggested. To test this we have analyzed here the domains of K-Ras essential for the interaction with calmodulin. At least three different regions in the K-Ras molecule were important; they are the hypervariable region, the alpha-helix between amino acids 151 and 166, and the Switch II. Within the hypervariable region, both the hydrophobic farnesyl group and the positive-charged amino acids were essential for the interaction between K-Ras and calmodulin in cellular extracts. Consistently, K-Ras S181D, which mimics phosphorylation of Ser-181 of K-Ras, also completely abolished binding to calmodulin. K-Ras mutants correctly farnesylated that did not bind calmodulin were all located at plasma membrane, showing that calmodulin interaction was not required for the transport of K-Ras to plasma membrane. In NIH3T3 cells, K-Ras and calmodulin colocalized mainly in the plasma membrane even after the addition of Ca2+ ionophore, indicating that interaction did not directly lead to K-Ras internalization. Furthermore, using a K-Ras with impaired binding to calmodulin but with membrane localization, we could demonstrate in striatal neurones that interaction between K-Ras and calmodulin was not required for Golgi K-Ras translocation induced by Ca2+ influx.	[Lopez-Alcala, Cristina; Alvarez-Moya, Blanca; Bachs, Oriol; Agell, Neus] Univ Barcelona, Dept Cellular Biol, Fac Med, Inst Invest Biomed August Pi i Sunyer, E-08036 Barcelona, Spain; [Villalonga, Priam] Inst Univ Invest Ciencies Salut, Grp Biol Cellular Del Canc Oncol Translac, Palma De Mallorca 07122, Spain; [Villalonga, Priam] Univ Illes Balears, Dept Biol Fonamental, Palma De Mallorca 07122, Spain; [Calvo, Maria] Univ Barcelona, Inst Invest Biomed, Unitat Microscopia, Serv Cientif Tecn, E-08036 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat de les Illes Balears; University of Barcelona	Agell, N (corresponding author), Univ Barcelona, Dept Cellular Biol, Fac Med, Inst Invest Biomed August Pi i Sunyer, C Casanova 143, E-08036 Barcelona, Spain.	agell@medicina.ub.es	Villalonga, Priam/K-4350-2014; Agell, Neus/E-9640-2016; Calvo, Maria/I-1872-2015; Moya, Blanca Alvarez/ABG-4314-2020	Villalonga, Priam/0000-0002-7190-6884; Agell, Neus/0000-0002-1205-6074; Calvo, Maria/0000-0002-7473-0474; Moya, Blanca Alvarez/0000-0003-2573-7909				Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; BALLESTER R, 1987, J BIOL CHEM, V262, P2688; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOS JL, 1989, CANCER RES, V49, P4682; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; DYKES DC, 1992, J BIOMOL STRUCT DYN, V9, P1025, DOI 10.1080/07391102.1992.10507977; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Fischer R, 1996, J BIOL CHEM, V271, P25067, DOI 10.1074/jbc.271.41.25067; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; KhosraviFar R, 1998, ADV CANCER RES, V72, P57; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Kloog Y, 2004, SEMIN CANCER BIOL, V14, P253, DOI 10.1016/j.semcancer.2004.04.004; Lee CHJ, 1996, J NEUROSCI, V16, P6784; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Magee T, 1999, CELL, V98, P9, DOI 10.1016/S0092-8674(00)80601-7; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Matsubara M, 2003, J BIOL CHEM, V278, P48898, DOI 10.1074/jbc.M305488200; Olson MF, 2000, SEMIN IMMUNOL, V12, P63, DOI 10.1006/smim.2000.0208; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Park JB, 1997, J BIOL CHEM, V272, P20857, DOI 10.1074/jbc.272.33.20857; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; POLAKIS P, 1993, J BIOL CHEM, V268, P9157; Rebollo A, 1999, BLOOD, V94, P2971, DOI 10.1182/blood.V94.9.2971.421k43_2971_2980; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rotblat B, 2004, CANCER RES, V64, P3112, DOI 10.1158/0008-5472.CAN-04-0026; Sidhu RS, 2005, BIOCHEM BIOPH RES CO, V336, P105, DOI 10.1016/j.bbrc.2005.08.053; Sidhu RS, 2003, BIOCHEM BIOPH RES CO, V304, P655, DOI 10.1016/S0006-291X(03)00635-1; Swindells MB, 1996, NAT STRUCT BIOL, V3, P501, DOI 10.1038/nsb0696-501; Ulrich A, 2000, P NATL ACAD SCI USA, V97, P5191, DOI 10.1073/pnas.090500397; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Vergeres G, 1998, BIOCHEM J, V330, P5, DOI 10.1042/bj3300005; Villalonga P, 2002, J BIOL CHEM, V277, P37929, DOI 10.1074/jbc.M202245200; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wang KL, 1997, J BIOL CHEM, V272, P16002, DOI 10.1074/jbc.272.25.16002; WEINSTEIN H, 1994, ANNU REV PHYSIOL, V56, P213, DOI 10.1146/annurev.ph.56.030194.001241; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052	52	63	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10621	10631		10.1074/jbc.M706238200	http://dx.doi.org/10.1074/jbc.M706238200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18182391	hybrid			2022-12-27	WOS:000254894700044
J	Gyulkhandanyan, AV; Lu, HF; Lee, SC; Bhattacharjee, A; Wijesekara, N; Fox, JEM; MacDonald, PE; Chimienti, F; Dai, FF; Wheeler, MB				Gyulkhandanyan, Armen V.; Lu, Hongfang; Lee, Simon C.; Bhattacharjee, Alpana; Wijesekara, Nadeeja; Fox, Jocelyn E. Manning; MacDonald, Patrick E.; Chimienti, Fabrice; Dai, Feihan F.; Wheeler, Michael B.			Investigation of transport mechanisms and regulation of intracellular Zn2+ in pancreatic alpha-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; MAMMALIAN ZINC TRANSPORTER; BETA-CELL; GLUCAGON-SECRETION; OXIDATIVE STRESS; ELECTRICAL-ACTIVITY; GLUCOSE-INHIBITION; ENDOCRINE PANCREAS; INTACT ISLETS; DELTA-CELLS	During insulin secretion, pancreatic alpha-cells are exposed to Zn2+ released from insulin-containing secretory granules. Although maintenance of Zn2+ homeostasis is critical for cell survival and glucagon secretion, very little is known about Zn2+-transporting pathways and the regulation of Zn2+ in alpha-cells. To examine the effect of Zn2+ on glucagon secretion and possible mechanisms controlling the intracellular Zn2+ level ([Zn2+](i)), we employed a glucagon-producing cell line (alpha-TC6) and mouse islets where non beta-cells were identified using islets expressing green fluorescent protein exclusively in beta-cells. In this study, we first confirmed that Zn2+ treatment resulted in the inhibition of glucagon secretion in alpha-TC6 cells and mouse islets in vitro. The inhibition of secretion was not likely via activation of KATP channels by Zn2+. We then determined that Zn2+ was transported into alpha-cells and was able to accumulate under both low and high glucose conditions, as well as upon depolarization of cells with KCl. The nonselective Ca2+ channel blocker Gd3+ partially inhibited Zn2+ influx in alpha-TC cells, whereas the L-type voltage-gated Ca2+ channel inhibitor nitren-dipine failed to block Zn2+ accumulation. To investigate Zn2+ transport further, we profiled alpha-cells for Zn2+ transporter transcripts from the two families that work in opposite directions, SLC39 (ZIP, Zrt/Irt-like protein) and SLC30 (ZnT, Zn2+ transporter). We observed that Zip1, Zip10, and Zip14 were the most abundantly expressed Zips and ZnT4, ZnT5, and ZnT8 the dominant ZnTs. Because the redox state of cells is also a major regulator of [Zn2+](i), we examined the effects of oxidizing agents on Zn2+ mobilization within alpha-cells. 2,2'-Dithiodipyridine (-SH group oxidant), menadione (superoxide generator), and SIN-1 (3-morpholinosydnonimine) (peroxynitrite generator) all increased [Zn2+](i) in alpha-cells. Together these results demonstrate that Zn2+ inhibits glucagon secretion, and it is transported into alpha-cells in part through Ca2+ channels. Zn2+ transporters and the redox state also modulate [Zn2+](i).	[Gyulkhandanyan, Armen V.; Lu, Hongfang; Lee, Simon C.; Bhattacharjee, Alpana; Wijesekara, Nadeeja; Dai, Feihan F.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Fox, Jocelyn E. Manning; MacDonald, Patrick E.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2E1, Canada; [Chimienti, Fabrice] CEA Grenoble, Mellitech, DRMF SC1B, F-38054 Grenoble, France	University of Toronto; University of Alberta; CEA	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle,Rm 3352, Toronto, ON M5S 1A8, Canada.	michael.wheeler@utoronto.ca	Lu, Hongfang/GZG-7271-2022; MacDonald, Patrick/A-4154-2008; Wijesekara, Nadeeja/AAW-7230-2021	Lu, Hongfang/0000-0002-0350-6475; Wheeler, Michael B./0000-0002-7480-7267; MacDonald, Patrick/0000-0002-5439-6288; Chimienti, fabrice/0000-0002-9907-3394				ARSLAN P, 1985, J BIOL CHEM, V260, P2719; ATAR D, 1995, J BIOL CHEM, V270, P2473, DOI 10.1074/jbc.270.6.2473; BAETENS D, 1979, SCIENCE, V206, P1323, DOI 10.1126/science.390711; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; Bode HP, 1999, PFLUG ARCH EUR J PHY, V437, P324, DOI 10.1007/s004240050786; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chang SA, 2004, METABOLISM, V53, P142, DOI 10.1016/S0026-0495(03)00314-7; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Dineley KE, 2005, MITOCHONDRION, V5, P55, DOI 10.1016/j.mito.2004.11.001; Ducoudret O, 2003, BBA-BIOMEMBRANES, V1611, P171, DOI 10.1016/S0005-2736(03)00052-X; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P50142, DOI 10.1074/jbc.M304163200; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; EMDIN SO, 1980, DIABETOLOGIA, V19, P174, DOI 10.1007/BF00275265; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; FIGLEWICZ DP, 1980, DIABETES, V29, P767, DOI 10.2337/diacare.20.10.767; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Fox JEM, 2006, ENDOCRINOLOGY, V147, P4655, DOI 10.1210/en.2006-0424; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Frazzini V, 2006, BIOGERONTOLOGY, V7, P307, DOI 10.1007/s10522-006-9045-7; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2; GERICH JE, 1976, ANNU REV PHYSIOL, V38, P353, DOI 10.1146/annurev.ph.38.030176.002033; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; Gromada J, 1997, J GEN PHYSIOL, V110, P217, DOI 10.1085/jgp.110.3.217; Gromada J, 2004, DIABETES, V53, pS181, DOI 10.2337/diabetes.53.suppl_3.S181; Gromada J, 2001, J PHYSIOL-LONDON, V535, P519, DOI 10.1111/j.1469-7793.2001.00519.x; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Guan ZX, 2003, J INORG BIOCHEM, V97, P199, DOI 10.1016/S0162-0134(03)00291-5; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; HESKETH TR, 1983, J BIOL CHEM, V258, P4876; Hjortoe GM, 2004, ACTA DIABETOL, V41, P185, DOI 10.1007/s00592-004-0164-9; HUTTON JC, 1983, BIOCHEM J, V210, P297, DOI 10.1042/bj2100297; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kang YJ, 2006, EXP BIOL MED, V231, P1459, DOI 10.1177/153537020623100903; Kanno T, 2002, NEUROSCI RES, V42, P79, DOI 10.1016/S0168-0102(01)00318-2; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Leung YM, 2006, ENDOCRINOLOGY, V147, P2155, DOI 10.1210/en.2005-1249; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; LUDVIGSEN C, 1979, DIABETES, V28, P570, DOI 10.2337/diab.28.6.570; Ma XS, 2005, MOL ENDOCRINOL, V19, P198, DOI 10.1210/me.2004-0059; Malaiyandi LM, 2005, J NEUROCHEM, V93, P1242, DOI 10.1111/j.1471-4159.2005.03116.x; Maret W, 2000, J NUTR, V130, p1455S, DOI 10.1093/jn/130.5.1455S; MARUYAMA H, 1984, J CLIN INVEST, V74, P2296, DOI 10.1172/JCI111658; Ohana E, 2004, J BIOL CHEM, V279, P4278, DOI 10.1074/jbc.M309229200; Olsen HL, 2005, ENDOCRINOLOGY, V146, P4861, DOI 10.1210/en.2005-0800; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Priel T, 2006, BIOCHEM BIOPH RES CO, V346, P205, DOI 10.1016/j.bbrc.2006.05.104; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Robertson RP, 2006, CURR OPIN PHARMACOL, V6, P615, DOI 10.1016/j.coph.2006.09.002; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SARIS NEL, 1994, FEBS LETT, V356, P195, DOI 10.1016/0014-5793(94)01256-3; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sekler I, 2007, MOL MED, V13, P337, DOI 10.2119/2007-00037.Sekler; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 2002, NEUROBIOL DIS, V10, P100, DOI 10.1006/nbdi.2002.0493; Sheline CT, 2002, NEUROBIOL DIS, V10, P41, DOI 10.1006/nbdi.2002.0497; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smidt K, 2007, MOL CELL ENDOCRINOL, V264, P68, DOI 10.1016/j.mce.2006.10.010; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou HR, 2007, DIABETES, V56, P1107, DOI 10.2337/db06-1454	80	85	89	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10184	10197		10.1074/jbc.M707005200	http://dx.doi.org/10.1074/jbc.M707005200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18250168	hybrid			2022-12-27	WOS:000254671600071
J	Mille, C; Bobrowicz, P; Trinel, PA; Li, H; Maes, E; Guerardel, Y; Fradin, C; Martinez-Esparaza, M; Davidson, RC; Janbon, G; Poulain, D; Wildt, S				Mille, Celine; Bobrowicz, Piotr; Trinel, Pierre-Andre; Li, Huijuan; Maes, Emmanuel; Guerardel, Yann; Fradin, Chantal; Martinez-Esparaza, Maria; Davidson, Robert C.; Janbon, Guilhem; Poulain, Daniel; Wildt, Stefan			Identification of a new family of genes involved in beta-1,2-mannosylation of Glycans in Pichia pastoris and Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; CELL-WALL ANTIGENS; SACCHAROMYCES-CEREVISIAE; SEROTYPE-A; NIH B-792; OLIGOMANNOSYL RESIDUES; MONOCLONAL-ANTIBODIES; OVERLAP EXTENSION; YEAST; VIRULENCE	Structural studies of cell wall components of the pathogenic yeast Candida albicans have demonstrated the presence of beta-1,2-linked oligomannosides in phosphopeptidomannan and phospholipomannan. During C. albicans infection, beta-1,2-oligomannosides play an important role in host/pathogen interactions by acting as adhesins and by interfering with the host immune response. Despite the importance of beta-1,2-oligomannosides, the genes responsible for their synthesis have not been identified. The main reason is that the reference species Saccharomyces cerevisiae does not synthesize beta-linked mannoses. On the other hand, the presence of beta-1,2-oligomannosides has been reported in the cell wall of the more genetically tractable C. albicans relative, P. pastoris. Here we present the identification, cloning, and characterization of a novel family of fungal genes involved in beta-mannose transfer. Employing in silico analysis, we identified a family of four related new genes in P. pastoris and subsequently nine homologs in C. albicans. Biochemical, immunological, and structural analyses following deletion of four genes in P. pastoris and deletion of four genes acting specifically on C. albicans mannan demonstrated the involvement of these new genes in beta-1,2-oligomannoside synthesis. Phenotypic characterization of the strains deleted in beta- mannosyltransferase genes (BMTs) allowed us to describe the stepwise activity of Bmtps and acceptor specificity. For C. albicans, despite structural similarities between mannan and phospholipomannan, phospholipomannan beta-mannosylation was not affected by any of the CaBMT1-4 deletions. Surprisingly, depletion in mannan major beta-1,2-oligomannoside epitopes had little impact on cell wall surface beta-1,2-oligomannoside antigenic expression.	[Mille, Celine; Trinel, Pierre-Andre; Fradin, Chantal; Poulain, Daniel] Univ Lille 2, EA 2684, INSERM, U799,Unit Physiopathol Candidoses, F-59045 Lille, France; [Bobrowicz, Piotr; Li, Huijuan; Davidson, Robert C.; Wildt, Stefan] Merck & Co Inc, GlycoFi Inc, Lebanon, NH 03766 USA; [Maes, Emmanuel; Guerardel, Yann] CNRS, UMR 8576, Unit Glycobiol Struct & Fonctionnelle, F-59655 Villeneuve Dascq, France; [Martinez-Esparaza, Maria] Univ Murcia, Sch Med, Dept Biochem Mol Biol & Immunol, E-30100 Murcia, Spain; [Janbon, Guilhem] Inst Pasteur, Unit Mycol Mol, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Merck & Company; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; University of Murcia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Poulain, D (corresponding author), Univ Lille 2, EA 2684, INSERM, U799,Unit Physiopathol Candidoses, F-59045 Lille, France.	dpoulain@univ-lille2.fr	Fradin, Chantal/N-2382-2018; Janbon, Guilhem/AAW-7398-2021; Janbon, Guilhem/AAL-6607-2021; Poulain, Daniel/I-6095-2018	Fradin, Chantal/0000-0002-3883-4401; Janbon, Guilhem/0000-0002-4788-1154; Martinez-Esparza, Maria/0000-0001-5765-8231; Poulain, Daniel/0000-0002-0729-5468; Guerardel, Yann/0000-0003-4967-9512				Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Davidson RC, 2004, GLYCOBIOLOGY, V14, P399, DOI 10.1093/glycob/cwh023; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Dromer F, 2002, ANTIMICROB AGENTS CH, V46, P3869, DOI 10.1128/AAC.46.12.3869-3876.2002; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; FAILLE C, 1992, CARBOHYD RES, V236, P17, DOI 10.1016/0008-6215(92)85004-J; Fradin C, 2000, INFECT IMMUN, V68, P4391, DOI 10.1128/IAI.68.8.4391-4398.2000; Gale CA, 1998, SCIENCE, V279, P1355, DOI 10.1126/science.279.5355.1355; Goins TL, 2000, J CLIN MICROBIOL, V38, P2862, DOI 10.1128/JCM.38.8.2862-2869.2000; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Han Y, 1997, INFECT IMMUN, V65, P4100, DOI 10.1128/IAI.65.10.4100-4107.1997; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Ibata-Ombetta S, 2003, J BIOL CHEM, V278, P13086, DOI 10.1074/jbc.M210680200; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Jouault T, 2000, INFECT IMMUN, V68, P965, DOI 10.1128/IAI.68.2.965-968.2000; KOBAYASHI H, 1992, INFECT IMMUN, V60, P2106, DOI 10.1128/IAI.60.5.2106-2109.1992; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; LINDBERG B, 1988, CARBOHYD RES, V174, P313, DOI 10.1016/0008-6215(88)85100-0; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Martinez-Esparza M, 2006, J IMMUNOL METHODS, V314, P90, DOI 10.1016/j.jim.2006.06.004; Mille C, 2004, J BIOL CHEM, V279, P47952, DOI 10.1074/jbc.M405534200; MOLINARI A, 1993, EUR J CELL BIOL, V60, P146; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Nitz M, 2002, J BIOL CHEM, V277, P3440, DOI 10.1074/jbc.M109274200; Odani T, 1996, GLYCOBIOLOGY, V6, P805, DOI 10.1093/glycob/6.8.805; Oriol R, 2002, MOL BIOL EVOL, V19, P1451, DOI 10.1093/oxfordjournals.molbev.a004208; Papac DI, 1998, GLYCOBIOLOGY, V8, P445, DOI 10.1093/glycob/8.5.445; PONTON J, 1993, INFECT IMMUN, V61, P4842, DOI 10.1128/IAI.61.11.4842-4847.1993; Poulain D, 2004, CURR OPIN MICROBIOL, V7, P342, DOI 10.1016/j.mib.2004.06.011; Ralton JE, 2003, J BIOL CHEM, V278, P40757, DOI 10.1074/jbc.M307660200; Rouabhia M, 2005, INFECT IMMUN, V73, P4571, DOI 10.1128/IAI.73.8.4571-4580.2005; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanglard D, 1996, ANTIMICROB AGENTS CH, V40, P2300, DOI 10.1128/AAC.40.10.2300; Sernee MF, 2006, P NATL ACAD SCI USA, V103, P9458, DOI 10.1073/pnas.0603539103; SHIBATA N, 1985, ARCH BIOCHEM BIOPHYS, V243, P338, DOI 10.1016/0003-9861(85)90511-9; SHIBATA N, 1992, INFECT IMMUN, V60, P4100, DOI 10.1128/IAI.60.10.4100-4110.1992; SHIBATA N, 1992, BIOCHEMISTRY-US, V31, P5680, DOI 10.1021/bi00139a036; Sims CR, 2005, ARCH MED RES, V36, P660, DOI 10.1016/j.arcmed.2005.05.015; Singleton DR, 2005, EUKARYOT CELL, V4, P639, DOI 10.1128/EC.4.4.639-648.2005; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; Sundstrom P, 1999, CURR OPIN MICROBIOL, V2, P353, DOI 10.1016/S1369-5274(99)80062-9; SUZUKI S, 1995, YAKUGAKU ZASSHI, V115, P280, DOI 10.1248/yakushi1947.115.4_280; TRINEL PA, 1992, INFECT IMMUN, V60, P3845, DOI 10.1128/IAI.60.9.3845-3851.1992; Trinel PA, 2002, J BIOL CHEM, V277, P37260, DOI 10.1074/jbc.M202295200; Vinogradov E, 2000, CARBOHYD RES, V325, P216, DOI 10.1016/S0008-6215(99)00332-8; Whiteway M, 2000, CURR OPIN MICROBIOL, V3, P582, DOI 10.1016/S1369-5274(00)00144-2; Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999	62	70	104	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9724	9736		10.1074/jbc.M708825200	http://dx.doi.org/10.1074/jbc.M708825200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18234669	hybrid			2022-12-27	WOS:000254671600027
J	Arias-Olguin, II; Vitko, I; Fortuna, M; Baumgart, JP; Sokolova, S; Shumilin, IA; Van Deusen, A; Soriano-Garcia, M; Gomora, JC; Perez-Reyes, E				Arias-Olguin, Imilla I.; Vitko, Iuliia; Fortuna, Michal; Baumgart, Joel P.; Sokolova, Svetlana; Shumilin, Igor A.; Van Deusen, Amy; Soriano-Garcia, Manuel; Gomora, Juan C.; Perez-Reyes, Edward			Characterization of the gating brake in the I-II loop of Ca(v)3.2 T-type Ca2+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHILDHOOD ABSENCE EPILEPSY; CALCIUM-CHANNELS; VOLTAGE SENSOR; DETERMINANTS; INACTIVATION; CACNA1H; CELLS	Mutations in the I-II loop of Ca(v)3.2 channels were discovered in patients with childhood absence epilepsy. All of these mutations increased the surface expression of the channel, whereas some mutations, and in particular C456S, altered the biophysical properties of channels. Deletions around C456S were found to produce channels that opened at even more negative potentials than control, suggesting the presence of a gating brake that normally prevents channel opening. The goal of the present study was to identify the minimal sequence of this brake and to provide insights into its structure. A peptide fragment of the I-II loop was purified from bacteria, and its structure was analyzed by circular dichroism. These results indicated that the peptide had a high alpha-helical content, as predicted from secondary structure algorithms. Based on homology modeling, we hypothesized that the proximal region of the I-II loop may form a helix-loop-helix structure. This model was tested by mutagenesis followed by electrophysiological measurement of channel gating. Mutations that disrupted the helices, or the loop region, had profound effects on channel gating, shifting both steady state activation and inactivation curves, as well as accelerating channel kinetics. Mutations designed to preserve the helical structure had more modest effects. Taken together, these studies showed that any mutations in the brake, including C456S, disrupted the structural integrity of the brake and its function to maintain these low voltage-activated channels closed at resting membrane potentials.	[Arias-Olguin, Imilla I.; Gomora, Juan C.] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Arias-Olguin, Imilla I.; Vitko, Iuliia; Fortuna, Michal; Sokolova, Svetlana; Van Deusen, Amy; Perez-Reyes, Edward] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Shumilin, Igor A.] Univ Virginia, Dept Mol Phys & Biol Phys, Charlottesville, VA 22908 USA; [Baumgart, Joel P.; Perez-Reyes, Edward] Univ Virginia, Grad Program Neurosci, Charlottesville, VA 22908 USA; [Soriano-Garcia, Manuel] Univ Nacl Autonoma Mexico, Inst Chem, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; University of Virginia; University of Virginia; University of Virginia; Universidad Nacional Autonoma de Mexico	Gomora, JC (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	jgomora@ifc.unam.mx	Baumgart, Joel/K-3139-2014	Baumgart, Joel/0000-0002-1109-2567; Gomora, Juan Carlos/0000-0002-9871-1307; Van Deusen, Amy/0000-0003-2578-7332	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038691] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 038691] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arias JM, 2005, FEBS LETT, V579, P3907, DOI 10.1016/j.febslet.2005.06.008; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; Cataldi M, 2002, J BIOL CHEM, V277, P45969, DOI 10.1074/jbc.M203922200; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Frazier CJ, 2001, J GEN PHYSIOL, V118, P457, DOI 10.1085/jgp.118.5.457; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Lacinova L, 2002, FEBS LETT, V531, P235, DOI 10.1016/S0014-5793(02)03509-3; Lam AD, 2005, PFLUG ARCH EUR J PHY, V451, P349, DOI 10.1007/s00424-005-1407-5; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Marksteiner R, 2001, J PHYSIOL-LONDON, V537, P27, DOI 10.1111/j.1469-7793.2001.0027k.x; MATTESON DR, 1986, J GEN PHYSIOL, V87, P161, DOI 10.1085/jgp.87.1.161; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Talavera K, 2003, J GEN PHYSIOL, V121, P529, DOI 10.1085/jgp.200308794; Talavera K, 2006, PFLUG ARCH EUR J PHY, V453, P189, DOI 10.1007/s00424-006-0129-7; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Vitko I, 2005, J NEUROSCI, V25, P4844, DOI 10.1523/JNEUROSCI.0847-05.2005; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103	27	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8136	8144		10.1074/jbc.M708761200	http://dx.doi.org/10.1074/jbc.M708761200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18218623	Green Published, hybrid			2022-12-27	WOS:000254288000010
J	Shaw, BF; Lelie, HL; Durazo, A; Nersissian, AM; Xu, G; Chan, PK; Gralla, EB; Tiwari, A; Hayward, LJ; Borchelt, DR; Valentine, JS; Whitelegge, JP				Shaw, Bryan F.; Lelie, Herman L.; Durazo, Armando; Nersissian, Aram M.; Xu, Guillan; Chan, Pik K.; Gralla, Edith B.; Tiwari, Ashutosh; Hayward, Lawrence J.; Borchelt, David R.; Valentine, Joan S.; Whitelegge, Julian P.			Detergent-insoluble aggregates associated with amyotrophic lateral sclerosis in transgenic mice contain primarily full-length, unmodified superoxide dismutase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER-BINDING-SITE; ALS-LINKED SOD1; INTRACYTOPLASMIC HYALINE INCLUSIONS; IONIZATION MASS-SPECTROMETRY; MOLECULAR-WEIGHT COMPLEXES; EXPRESSING HUMAN SOD1; FAMILIAL ALS; MUTANT SOD1; CU,ZN-SUPEROXIDE DISMUTASE; PROTEIN AGGREGATION	Determining the composition of aggregated superoxide dismutase 1 (SOD1) species associated with amyotrophic lateral sclerosis (ALS), especially with respect to co-aggregated proteins and post-translational modifications, could identify cellular or biochemical factors involved in the formation of these aggregates and explain their apparent neurotoxicity. The results of mass spectrometric and shotgun-proteomic analyses of SOD1-containing aggregates isolated from spinal cords of symptomatic transgenic ALS mice using two different isolation strategies are presented, including 1) resistance to detergent extraction and 2) size exclusion-coupled anti-SOD1 immunoaffinity chromatography. Forty-eight spinal cords from three different ALS-SOD1 mutant mice were analyzed, namely G93A, G37R, and the unnatural double mutant H46R/H48Q. The analysis consistently revealed that the most abundant proteins recovered from aggregate species were full-length unmodified SOD1 polypeptides. Although aggregates from some spinal cord samples contained trace levels of highly abundant proteins, such as vimentin and neurofilament-3, no proteins were consistently found to co-purify with mutant SOD1 in stoichiometric quantities. The results demonstrate that the principal protein in the high molecular mass aggregates whose appearance correlates with symptoms of the disease is the unmodified, full-length SOD1 polypeptide.	[Whitelegge, Julian P.] Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst, Los Angeles, CA 90095 USA; [Shaw, Bryan F.; Lelie, Herman L.; Durazo, Armando; Chan, Pik K.; Gralla, Edith B.; Valentine, Joan S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Chem, Los Angeles, CA 90095 USA; [Shaw, Bryan F.; Lelie, Herman L.; Durazo, Armando; Chan, Pik K.; Gralla, Edith B.; Valentine, Joan S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biochem, Los Angeles, CA 90095 USA; [Nersissian, Aram M.] Occidental Coll, Dept Chem, Los Angeles, CA 90041 USA; [Xu, Guillan; Borchelt, David R.] Univ Florida, McKnight Brain Inst, Santa Fe Hlth Alzheimers Dis Res Ctr, Dept Neurosci, Gainesville, FL 32611 USA; [Tiwari, Ashutosh; Hayward, Lawrence J.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Occidental College; State University System of Florida; University of Florida; University of Massachusetts System; University of Massachusetts Worcester	Whitelegge, JP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst, 405 Hilgard Ave, Los Angeles, CA 90095 USA.	jpw@chem.ucla.edu	Valentine, Joan S/B-6665-2008; Shaw, Bryan/A-7001-2008; Tiwari, Ashutosh/A-7458-2008	Valentine, Joan S/0000-0002-7174-925X; Tiwari, Ashutosh/0000-0001-7373-349X; Hayward, Lawrence/0000-0003-0579-0358	NINDS NIH HHS [R01 NS 44170, P01 NS 049134-01, R01 NS044170, P01 NS049134] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044170, P01NS049134] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Basso M, 2006, J BIOL CHEM, V281, P33325, DOI 10.1074/jbc.M603489200; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cheroni C, 2005, NEUROBIOL DIS, V18, P509, DOI 10.1016/j.nbd.2004.12.007; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choi JS, 2004, BIOCHEM BIOPH RES CO, V321, P574, DOI 10.1016/j.bbrc.2004.07.010; DE Beus MD, 2004, PROTEIN SCI, V13, P1347, DOI 10.1110/ps.03576904; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Hart PJ, 2006, CURR OPIN CHEM BIOL, V10, P131, DOI 10.1016/j.cbpa.2006.02.034; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kabashi E, 2006, BBA-MOL BASIS DIS, V1762, P1038, DOI 10.1016/j.bbadis.2006.06.006; Kato S, 1996, J NEUROPATH EXP NEUR, V55, P1089, DOI 10.1097/00005072-199655100-00009; Kato S, 2001, NEUROPATHOLOGY, V21, P67, DOI 10.1046/j.1440-1789.2001.00359.x; Kato S, 1997, AM J PATHOL, V151, P611; Kato S, 2000, ACTA NEUROPATHOL, V100, P490, DOI 10.1007/s004010000226; Kazmirski SL, 2002, NAT STRUCT BIOL, V9, P112, DOI 10.1038/nsb745; Kurahashi T, 2001, J AM CHEM SOC, V123, P9268, DOI 10.1021/ja015953r; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Maatkamp A, 2004, EUR J NEUROSCI, V20, P14, DOI 10.1111/j.1460-9568.2004.03430.x; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pieri L, 2006, J BIOL CHEM, V281, P15337, DOI 10.1074/jbc.M511647200; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Sorgjerd K, 2006, J MOL BIOL, V356, P469, DOI 10.1016/j.jmb.2005.11.051; Stieber A, 2000, J NEUROL SCI, V173, P53, DOI 10.1016/S0022-510X(99)00300-7; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Taylor DM, 2007, J BIOL CHEM, V282, P16329, DOI 10.1074/jbc.M610119200; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tortarolo M, 2006, J NEUROSCI RES, V83, P134, DOI 10.1002/jnr.20715; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Valentine JS, 2002, FREE RADICAL BIO MED, V33, P1314, DOI 10.1016/S0891-5849(02)01080-8; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vermeiren C, 2006, J NEUROCHEM, V96, P719, DOI 10.1111/j.1471-4159.2005.03577.x; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Whitelegge JP, 2004, PHYTOCHEMISTRY, V65, P1507, DOI 10.1016/j.phytochem.2004.05.018; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Whitelegge JP, 1998, PROTEIN SCI, V7, P1423, DOI 10.1002/pro.5560070619; Whitelegge JP, 2000, PROTEIN SCI, V9, P1618, DOI 10.1110/ps.9.9.1618; Zhang H, 2004, FREE RADICAL BIO MED, V37, P2018, DOI 10.1016/j.freeradbiomed.2004.08.026	62	71	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8340	8350		10.1074/jbc.M707751200	http://dx.doi.org/10.1074/jbc.M707751200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18192269	hybrid, Green Published			2022-12-27	WOS:000254288000032
J	Montanuy, I; Torremocha, R; Hernandez-Munain, C; Sune, C				Montanuy, Immaculada; Torremocha, Rosana; Hernandez-Munain, Cristina; Sune, Carlos			Promoter influences transcription elongation - TATA-box element mediates the assembly of processive transcription complexes responsive to cyclin-dependent kinase 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; LONG TERMINAL REPEAT; VIRUS TYPE-1 TRANSCRIPTION; C-MYC GENE; P-TEFB; MESSENGER-RNA; IN-VITRO; INDUCED EXPRESSION; INITIATOR ELEMENT; TRANS-ACTIVATION	Pausing of RNA polymerase II ( RNAPII) during transcript elongation is an important mechanism for regulating gene expression at many genes. In this study we investigated the mechanism of regulated elongation of c-myc and human immunodeficiency virus-1 ( HIV-1) using an in vitro elongation assay that reproduces the conditional block to elongation. We found that HIV-1 Tat can activate the RNAPII transcription complexes paused on c-myc by enhancing their elongation efficiency. We determined that cyclin-dependent kinase 9 ( CDK9), the kinase subunit of positive transcription elongation factor b ( P-TEFb) complex, regulates transcriptional elongation of c-myc and is present in transcription pre-initiation complexes formed on the c-myc promoter, which emphasizes a common mechanism of elongation control between HIV-1 and c-myc genes. We also investigated the roles of upstream elements of the HIV-1 and c-myc promoters in CDK9-activated transcriptional elongation. We found that the TATA-box element mediates the assembly of processive transcription complexes responsive to CDK9 and that specific combinations of upstream activation binding sites contribute to the recruitment of these complexes. We propose a common mechanism for elongation control at the c-myc and HIV-1 genes with an essential role for the TATA-box and specific modulatory contribution of upstream regulatory sequences, derived from the unique structure of the promoters, to form a composite surface for efficient recruitment of elongation-competent transcription complexes.	[Montanuy, Immaculada; Torremocha, Rosana; Sune, Carlos] CSIC, Inst Parasitol & Biomed Lopez Neyra, Parque Tecnol Ciencias Salud, Granada 18100, Spain; [Montanuy, Immaculada; Torremocha, Rosana; Sune, Carlos] CSIC, Dept Mol Biol, Granada 18100, Spain; [Hernandez-Munain, Cristina] CSIC, Dept Cell Biol & Immunol, Granada 18100, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC)	Sune, C (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Parque Tecnol Ciencias Salud, Avenida Conocimiento S-N, Granada 18100, Spain.	csune@ipb.csic.es	Suñé, Carlos/AAA-8198-2019; de Munain, Cristina Hernandez Lopez/S-4389-2018	Suñé, Carlos/0000-0002-7991-0458; de Munain, Cristina Hernandez Lopez/0000-0002-6058-2458; Montanuy Sellart, Inmaculada/0000-0001-9743-112X				Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; BIELINSKA A, 1989, J VIROL, V63, P4097, DOI 10.1128/JVI.63.9.4097-4100.1989; BIRAGYN A, 1995, J IMMUNOL, V155, P674; Campanero MR, 1999, MOL CELL BIOL, V19, P8442; CHINSKY JM, 1989, J BIOL CHEM, V264, P14561; CULLEN BR, 1993, CELL, V73, P417, DOI 10.1016/0092-8674(93)90126-B; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; GarciaMartinez LF, 1997, J BIOL CHEM, V272, P6951, DOI 10.1074/jbc.272.11.6951; HARLOW E, 1999, USING ANTIBODIES LAB, P521; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; KRUMM A, 1993, BIOESSAYS, V15, P659, DOI 10.1002/bies.950151005; Lee JM, 1997, J BIOL CHEM, V272, P10990; LONDON L, 1991, MOL CELL BIOL, V11, P4599, DOI 10.1128/MCB.11.9.4599; MAJELLO B, 1995, ONCOGENE, V10, P1841; Majello B, 1999, ONCOGENE, V18, P4598, DOI 10.1038/sj.onc.1202822; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MARCINIAK RA, 1990, CELL, V63, P791, DOI 10.1016/0092-8674(90)90145-5; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; MCGEADY ML, 1986, DNA-J MOLEC CELL BIO, V5, P289, DOI 10.1089/dna.1986.5.289; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; OLSEN HS, 1992, J VIROL, V66, P5594, DOI 10.1128/JVI.66.9.5594-5597.1992; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pinaud S, 1998, J MOL BIOL, V280, P785, DOI 10.1006/jmbi.1998.1905; Ping YH, 1999, J BIOL CHEM, V274, P7399, DOI 10.1074/jbc.274.11.7399; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Raha T, 2005, PLOS BIOL, V3, P221, DOI 10.1371/journal.pbio.0030044; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Raschke EE, 1999, J IMMUNOL, V163, P4375; RATNASABAPATHY R, 1990, GENE DEV, V4, P2061, DOI 10.1101/gad.4.12a.2061; RITTNER K, 1995, J MOL BIOL, V248, P562, DOI 10.1006/jmbi.1995.0243; Rosonina E, 2003, J BIOL CHEM, V278, P43034, DOI 10.1074/jbc.M307289200; Sanchez-Alvarez M, 2006, MOL CELL BIOL, V26, P4998, DOI 10.1128/MCB.01991-05; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SPENCER CA, 1990, ONCOGENE, V5, P777; SUNE C, 1995, J VIROL, V69, P3098; Sune C, 1999, MOL CELL BIOL, V19, P4719; Sune C, 1997, MOL CELL BIOL, V17, P6029, DOI 10.1128/MCB.17.10.6029; Sune C, 2000, VIROLOGY, V274, P356, DOI 10.1006/viro.2000.0480; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; WRIGHT S, 1994, J MOL BIOL, V243, P568, DOI 10.1016/0022-2836(94)90031-0; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yedavalli VSRK, 2003, J BIOL CHEM, V278, P6404, DOI 10.1074/jbc.M209162200; ZEICHNER SL, 1991, J VIROL, V65, P2436, DOI 10.1128/JVI.65.5.2436-2444.1991; ZENZIEGREGORY B, 1993, J BIOL CHEM, V268, P15823; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	57	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7368	7378		10.1074/jbc.M706243200	http://dx.doi.org/10.1074/jbc.M706243200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18218627	hybrid			2022-12-27	WOS:000253997900011
J	Bortner, CD; Sifre, MI; Cidlowski, JA				Bortner, Carl D.; Sifre, Maria I.; Cidlowski, John A.			Cationic gradient reversal and cytoskeleton-independent volume regulatory pathways define an early stage of apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE DEPOLARIZATION; FAS-INDUCED APOPTOSIS; CELL-VOLUME; ACTIN CYTOSKELETON; MEDIATED APOPTOSIS; ACTIVATION; SHRINKAGE; DEATH; K+; MECHANISMS	Cell shrinkage, or apoptotic volume decrease ( AVD), is a ubiquitous characteristic of programmed cell death that is independent of the death stimulus and occurs in all examples of apoptosis. Here we distinguished two specific stages of AVD based on cell size and a unique early reversal of intracellular ions that occurs in response to activation of both intrinsic and extrinsic cell death signal pathways. The primary stage of AVD is characterized by an early exchange of the normal intracellular ion distribution for sodium from 12 to 113.6 mM and potassium from 139.5 to 30 mM. This early ionic reversal is associated with a 20 - 40% decrease in cell volume, externalization of phosphatidylserine, loss of mitochondrial membrane potential, and caspase activation and activity along with nuclear condensation that occurs independent of actin cytoskeleton disruption. Disruption of the actin cytoskeleton, however, prevents a secondary stage of AVD in apoptotic cells, characterized by a loss of both potassium and sodium that results in an 80 - 85% loss in cell volume, DNA degradation, and apoptotic body formation. Together these studies demonstrate that AVD occurs in two distinct stages with the earliest stage reflecting a cellular cationic gradient reversal.	[Bortner, Carl D.; Sifre, Maria I.; Cidlowski, John A.] NIEHS, NIH, Dept Hlth & Human Serv, Lab Signal Transduct, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Bortner, CD (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	bortner@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102486, ZIAES090079] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES090079-12] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BARBIERO G, 1995, EXP CELL RES, V217, P410, DOI 10.1006/excr.1995.1104; Barros LF, 2002, BIOL RES, V35, P209; Benson RSP, 1996, AM J PHYSIOL-CELL PH, V270, pC1190, DOI 10.1152/ajpcell.1996.270.4.C1190; Bortner CD, 1998, BIOCHEM PHARMACOL, V56, P1549, DOI 10.1016/S0006-2952(98)00225-1; Bortner CD, 2004, PFLUG ARCH EUR J PHY, V448, P313, DOI 10.1007/s00424-004-1266-5; Bortner CD, 2003, J BIOL CHEM, V278, P39176, DOI 10.1074/jbc.M303516200; Bortner CD, 2002, ANNU REV PHARMACOL, V42, P259, DOI 10.1146/annurev.pharmtox.42.083101.143836; Bortner CD, 2001, J BIOL CHEM, V276, P4304, DOI 10.1074/jbc.M005171200; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; COTTER TG, 1992, CANCER RES, V52, P997; Domnina LV, 2004, CELL BIOL INT, V28, P471, DOI 10.1016/j.cellbi.2004.03.017; Gomez-Angelats M, 2000, CELL TISSUE RES, V301, P33, DOI 10.1007/s004410000216; Grzanka A, 2003, BIOCHEM PHARMACOL, V66, P1611, DOI 10.1016/S0006-2952(03)00532-X; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoffmann EK, 1995, INT REV CYTOL, V161, P173; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lang F, 2000, CELL PHYSIOL BIOCHEM, V10, P417, DOI 10.1159/000016367; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Levee MG, 1996, AM J PHYSIOL-CELL PH, V271, pC1981, DOI 10.1152/ajpcell.1996.271.6.C1981; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Mann CL, 2001, ENDOCRINOLOGY, V142, P5059, DOI 10.1210/en.142.12.5059; Maruyama W, 2000, HISTOCHEM J, V32, P495, DOI 10.1023/A:1004104619154; Morley SC, 2003, J CELL BIOCHEM, V88, P1066, DOI 10.1002/jcb.10449; Nobel CSI, 2000, APOPTOSIS, V5, P153, DOI 10.1023/A:1009684713784; Papakonstanti EA, 2000, CELL PHYSIOL BIOCHEM, V10, P257, DOI 10.1159/000016366; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; SHENG M, 2000, ANNU REV PHYSIOL, V62, P79; Thompson GJ, 2001, BIOCHEM J, V357, P137, DOI 10.1042/0264-6021:3570137; Yamazaki Y, 2000, EXP CELL RES, V259, P64, DOI 10.1006/excr.2000.4970; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360	33	53	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7219	7229		10.1074/jbc.M707809200	http://dx.doi.org/10.1074/jbc.M707809200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18187415	Green Accepted, hybrid			2022-12-27	WOS:000253779600067
J	Saddar, S; Dienhart, MK; Stuart, RA				Saddar, Sonika; Dienhart, Mary K.; Stuart, Rosemary A.			The F1F0-ATP synthase complex influences the assembly state of the cytochrome bc(1)-cytochrome oxidase supercomplex and its association with the TIM23 machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN SUPERCOMPLEXES; MITOCHONDRIAL ATP SYNTHASE; TRANSLOCATION CONTACT SITES; C-OXIDASE; OXIDATIVE-PHOSPHORYLATION; SUBUNIT-E; SACCHAROMYCES-CEREVISIAE; CRISTAE MORPHOLOGY; YEAST MITOCHONDRIA; INNER MEMBRANE	The enzyme complexes involved in mitochondrial oxidative phosphorylation are organized into higher ordered assemblies termed supercomplexes. Subunits e and g (Su e and Su g, respectively) are catalytically nonessential subunits of the F1F0-ATP synthase whose presence is required to directly support the stable dimerization of the ATP synthase complex. We report here that Su g and Su e are also important for securing the correct organizational state of the cytochrome bc(1)-cytochrome oxidase ( COX) supercomplex. Mitochondria isolated from the Delta su e and Delta su g null mutant strains exhibit decreased levels of COX enzyme activity but appear to have normalCOXsubunit protein levels. An altered stoichiometry of the cytochrome bc(1)-COX supercomplex was observed in mitochondria deficient in Su e and/or Su g, and a perturbation in the association of Cox4, a catalytically important subunit of the COX complex, was also detected. In addition, an increase in the level of the TIM23 translocase associated with the cytochrome bc(1)-COX supercomplex is observed in the absence of Delta Su e and Su g. Together, our data highlight that a further level of complexity exists between the oxidative phosphorylation supercomplexes, whereby the organizational state of one complex, i.e. the ATP synthase, may influence that of another supercomplex, namely the cytochrome bc(1)-COX complex.	[Saddar, Sonika; Dienhart, Mary K.; Stuart, Rosemary A.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	Marquette University	Stuart, RA (corresponding author), Marquette Univ, Dept Biol Sci, 530 N 15th St, Milwaukee, WI 53233 USA.	rosemary.stuart@marquette.edu			NIGMS NIH HHS [R01GM61573] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061573] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arnold I, 1997, FEBS LETT, V411, P195, DOI 10.1016/S0014-5793(97)00691-1; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Bernard DG, 2003, J BIOL CHEM, V278, P49732, DOI 10.1074/jbc.M308881200; Boekema EJ, 2007, J BIOL CHEM, V282, P1, DOI 10.1074/jbc.R600031200; Bornhovd C, 2006, J BIOL CHEM, V281, P13990, DOI 10.1074/jbc.M512334200; Boumans H, 1998, J BIOL CHEM, V273, P4872, DOI 10.1074/jbc.273.9.4872; Boumans H, 1998, BIOCHEM J, V331, P877, DOI 10.1042/bj3310877; Boyle GM, 1999, EUR J BIOCHEM, V262, P315, DOI 10.1046/j.1432-1327.1999.00345.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunner S, 2002, J BIOL CHEM, V277, P48484, DOI 10.1074/jbc.M209382200; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Devenish RJ, 2000, BBA-BIOENERGETICS, V1458, P428, DOI 10.1016/S0005-2728(00)00092-X; Dienhart M, 2002, J BIOL CHEM, V277, P39289, DOI 10.1074/jbc.M205720200; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Dudkina NV, 2006, TRENDS PLANT SCI, V11, P232, DOI 10.1016/j.tplants.2006.03.007; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Everard-Gigot V, 2005, EUKARYOT CELL, V4, P346, DOI 10.1128/EC.4.2.346-355.2005; Gavin PD, 2004, J CELL SCI, V117, P2333, DOI 10.1242/jcs.01074; Gavin PD, 2003, BBA-BIOENERGETICS, V1607, P167, DOI 10.1016/j.bbabio.2003.09.013; Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1; Giraud MF, 2002, BBA-BIOENERGETICS, V1555, P174, DOI 10.1016/S0005-2728(02)00274-8; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemire BD, 2002, BBA-BIOENERGETICS, V1553, P102, DOI 10.1016/S0005-2728(01)00229-8; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Saddar S, 2005, J BIOL CHEM, V280, P24435, DOI 10.1074/jbc.M502804200; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; SHERMAN F, 1964, BIOCHIM BIOPHYS ACTA, V90, P1, DOI 10.1016/0304-4165(64)90113-8; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Soubannier V, 2002, J BIOL CHEM, V277, P10739, DOI 10.1074/jbc.M111882200; Spannagel C, 1998, BBA-BIOMEMBRANES, V1414, P260, DOI 10.1016/S0005-2736(98)00174-6; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Wurm CA, 2006, FEBS LETT, V580, P5628, DOI 10.1016/j.febslet.2006.09.012; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	53	52	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6677	6686		10.1074/jbc.M708440200	http://dx.doi.org/10.1074/jbc.M708440200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18187422	hybrid			2022-12-27	WOS:000253779600009
J	Li, H; Wang, Y; Liu, X				Li, Hongchang; Wang, Yun; Liu, Xiaoqi			Plk1-dependent phosphorylation regulates functions of DNA topoisomerase II alpha in cell cycle progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE; REPLICATION CHECKPOINT RESPONSE; SPINDLE CHECKPOINT; BETA; APOPTOSIS; RECOVERY; CLASPIN; COHESIN; YEAST; PLK1	Plk1 (Polo-like kinase 1) has been documented as a critical regulator of many mitotic events. However, increasing evidence supports the notion that Plk1 might also have functions outside of mitosis. Using biochemical fractionation and RNA interference approaches, we found that Plk1 was required for both G(1)/S and G(2)/M phases and that DNA topoisomerase II alpha (topoII alpha) was a potential target for Plk1 in both interphase and mitosis. Plk1 phosphorylates Ser(1337) and Ser(1524) of topoII alpha. Overexpression of an unphosphorylatable topoII alpha mutant led to S phase arrest, suggesting that Plk1-associated phosphorylation first occurs in S phase. Moreover, overexpression of the unphosphorylatable topoII alpha mutant activated the ATM/R-dependent DNA damage checkpoint, probably due to reduced catalytic activity of topoII alpha, and resulted in accumulation of catenated DNA. Finally, we showed that wild type topoII alpha, but not the unphosphorylatable mutant, was able to rescue topoII alpha depletion-induced defects in sister chromatid segregation, indicating that Plk1-associated phosphorylation is essential for the functions of topoII alpha in mitosis.	Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Purdue Univ, Ctr Canc, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Li, H (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.				NATIONAL CANCER INSTITUTE [K01CA114401] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA 114401] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; BURDEN DA, 1994, BIOCHEMISTRY-US, V33, P14651, DOI 10.1021/bi00253a001; CARDENAS ME, 1993, J CELL SCI, V104, P219; Chang CJ, 2003, J CELL SCI, V116, P4715, DOI 10.1242/jcs.00797; Chikamori K, 2003, J BIOL CHEM, V278, P12696, DOI 10.1074/jbc.M300837200; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; CORBETT AH, 1993, BIOCHEMISTRY-US, V32, P2090, DOI 10.1021/bi00059a029; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; GERDES J, 1984, J IMMUNOL, V133, P1710; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Ishida R, 1996, J BIOL CHEM, V271, P30077, DOI 10.1074/jbc.271.47.30077; Issacs R. J., 1998, BIOCHIM BIOPHYS ACTA, V1400, P121; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; McPherson JP, 1998, CANCER RES, V58, P4519; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; NITISS JL, 1998, BIOCHIM BIOPHYS ACTA, V1400, P121; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Sakaguchi A, 2004, J CELL SCI, V117, P1047, DOI 10.1242/jcs.00977; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9	33	84	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6209	6221		10.1074/jbc.M709007200	http://dx.doi.org/10.1074/jbc.M709007200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18171681	hybrid			2022-12-27	WOS:000253779500028
J	Metz, S; Naeth, G; Heinrich, PC; Muller-Newen, G				Metz, Silke; Naeth, Gudrun; Heinrich, Peter C.; Mueller-Newen, Gerhard			Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE BINDING DOMAIN; HUMAN INTERLEUKIN-6 RECEPTOR; IMMUNOGLOBULIN-LIKE DOMAIN; RHEUMATOID-ARTHRITIS; FACTOR LIF; IN-VITRO; LIGAND-BINDING; SYNOVIAL-FLUID; IL-6 RECEPTOR; ONCOSTATIN-M	Fusion proteins of the extracellular parts of cytokine receptors, also known as cytokine traps, turned out to be promising cytokine inhibitors useful in anti-cytokine therapies. Here we present newly designed cytokine traps for murine and human leukemia inhibitory factor (LIF) as prototypes for inhibitors targeting cytokines that signal through a heterodimer of two signaling receptors of the glycoprotein 130 (gp130) family. LIF signals through a receptor heterodimer of LIF receptor (LIFR) and gp130 and induces the tyrosine phosphorylation of STAT3 leading to target gene expression. The analysis of various receptor fusion and deletion constructs revealed that a truncated form of the murine LIF receptor consisting of the first five extracellular domains was a potent inhibitor for human LIF. For the efficient inhibition of murine LIF, the cytokine-binding module of murine gp130 had to be fused to the first five domains of murine LIFR generating mLIF-RFP (murine LIFR fusion protein). The tyrosine phosphorylation of STAT3 and subsequent gene induction induced by human or murine LIF are completely blocked by the respective inhibitor. Furthermore, both inhibitors are specific and do not alter the bioactivities of the closely related cytokines interleukin (IL)-6 and oncostatin M. The gained knowledge on the construction of LIF inhibitors can be transferred to the design of inhibitors for related cytokines such as IL-31, IL-27, and oncostatin M for the treatment of inflammatory and malignant diseases.	[Metz, Silke; Naeth, Gudrun; Heinrich, Peter C.; Mueller-Newen, Gerhard] Univ Klinikum RWTH Aachen, Inst Biochem, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Muller-Newen, G (corresponding author), Univ Klinikum RWTH Aachen, Inst Biochem, Pauwelsstr 30, D-52074 Aachen, Germany.	mueller-newen@rwth-aachen.de						AARDEN LA, 1987, EUR J IMMUNOL, V17, P1411, DOI 10.1002/eji.1830171004; Aasland D, 2002, J MOL BIOL, V315, P637, DOI 10.1006/jmbi.2001.5282; Ancey C, 2003, J BIOL CHEM, V278, P16968, DOI 10.1074/jbc.C300081200; ARCONE R, 1991, EUR J BIOCHEM, V198, P541, DOI 10.1111/j.1432-1033.1991.tb16048.x; Bitard J, 2003, J BIOL CHEM, V278, P16253, DOI 10.1074/jbc.M207193200; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; DELAGE G, 1995, HUM REPROD, V10, P2483; Diveu C, 2006, J BIOL CHEM, V281, P36673, DOI 10.1074/jbc.M607005200; Economides AN, 2003, NAT MED, V9, P47, DOI 10.1038/nm811; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; FUKUNAGA R, 1991, EMBO J, V10, P2855, DOI 10.1002/j.1460-2075.1991.tb07835.x; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Giese B, 2003, J BIOL CHEM, V278, P39205, DOI 10.1074/jbc.M303347200; Goldenberg MM, 1999, CLIN THER, V21, P75, DOI 10.1016/S0149-2918(00)88269-7; Grotzinger J, 1997, PROTEINS, V27, P96; Hambartsoumian E, 1998, AM J REPROD IMMUNOL, V39, P137; He W, 2005, FEBS LETT, V579, P4317, DOI 10.1016/j.febslet.2005.06.061; He W, 2002, FEBS LETT, V514, P214, DOI 10.1016/S0014-5793(02)02367-0; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hermanns HM, 1999, J IMMUNOL, V163, P6651; HORSTEN U, 1995, FEBS LETT, V360, P43, DOI 10.1016/0014-5793(95)00053-C; Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104; Ichihara M, 1997, BLOOD, V90, P165; Jazayeri JA, 2007, J INTERF CYTOK RES, V27, P281, DOI 10.1089/jir.2006.0138; Laird SM, 1997, HUM REPROD, V12, P569; LAYTON MJ, 1992, P NATL ACAD SCI USA, V89, P8616, DOI 10.1073/pnas.89.18.8616; LAYTON MJ, 1994, J BIOL CHEM, V269, P17048; LOTZ M, 1992, J CLIN INVEST, V90, P888, DOI 10.1172/JCI115964; Metz S, 2007, J BIOL CHEM, V282, P1238, DOI 10.1074/jbc.M606885200; MODRELL B, 1994, GROWTH FACTORS, V11, P81, DOI 10.3109/08977199409001050; Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303; Ogata H, 2006, GASTROENTEROLOGY, V131, P179, DOI 10.1053/j.gastro.2006.04.025; Owczarek CM, 1997, J BIOL CHEM, V272, P23976, DOI 10.1074/jbc.272.38.23976; Piccinni MP, 1998, NAT MED, V4, P1020, DOI 10.1038/2006; Schlaak JF, 1996, CLIN EXP RHEUMATOL, V14, P155; Sharkey AM, 1999, BIOL REPROD, V60, P355, DOI 10.1095/biolreprod60.2.355; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; VANDAM M, 1993, J BIOL CHEM, V268, P15285; Varghese JN, 2002, P NATL ACAD SCI USA, V99, P15959, DOI 10.1073/pnas.232432399; Voisin MB, 2002, J BIOL CHEM, V277, P13682, DOI 10.1074/jbc.M111624200; WARING PM, 1993, ARTHRITIS RHEUM, V36, P911, DOI 10.1002/art.1780360707; WEIERGRABER O, 1995, EUR J BIOCHEM, V234, P661, DOI 10.1111/j.1432-1033.1995.661_b.x	45	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					5985	5995		10.1074/jbc.M706610200	http://dx.doi.org/10.1074/jbc.M706610200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18174171	hybrid			2022-12-27	WOS:000253779500003
J	Xiao, R; Tang, JS; Wang, CB; Colton, CK; Tian, JB; Zhu, MX				Xiao, Rui; Tang, Jisen; Wang, Chunbo; Colton, Craig K.; Tian, Jinbin; Zhu, Michael X.			Calcium plays a central role in the sensitization of TRPV3 channel to repetitive stimulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; GATED ION-CHANNEL; CATION CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; VANILLOID RECEPTOR; HEAT; TEMPERATURE; CALMODULIN; ACTIVATION; DESENSITIZATION	Transient receptor potential channels are involved in sensing chemical and physical changes inside and outside of cells. TRPV3 is highly expressed in skin keratinocytes, where it forms a nonselective cation channel activated by hot temperatures in the innocuous and noxious range. The channel has also been implicated in flavor sensation in oral and nasal cavities as well as being a molecular target of some allergens and skin sensitizers. TRPV3 is unique in that its activity is sensitized upon repetitive stimulations. Here we investigated the role of calcium ions in the sensitization of TRPV3 to repetitive stimulations. We show that the sensitization is accompanied by a decrease of Ca2+-dependent channel inhibition mediated by calmodulin acting at an N-terminal site ( amino acids 108-130) and by an acidic residue (Asp(641)) at the pore loop of TRPV3. These sites also contribute to the voltage dependence of TRPV3. During sensitization, the channel displayed a gradual shift of the voltage dependence to more negative potentials as well as uncoupling from voltage sensing. The initial response to ligand stimulation was increased and sensitization to repetitive stimulations was decreased by increasing the intracellular Ca2+-buffering strength, inhibiting calmodulin, or disrupting the calmodulin-binding site. Mutation of Asp(641) to Asn abolished the high affinity extracellular Ca2+-mediated inhibition and greatly facilitated the activation of TRPV3. We conclude that Ca2+ inhibits TRPV3 from both the extracellular and intracellular sides. The inhibition is sequentially reduced, appearing as sensitization to repetitive stimulations.	[Xiao, Rui; Tang, Jisen; Wang, Chunbo; Colton, Craig K.; Tian, Jinbin; Zhu, Michael X.] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Xiao, Rui; Tang, Jisen; Wang, Chunbo; Colton, Craig K.; Tian, Jinbin; Zhu, Michael X.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Xiao, Rui; Zhu, Michael X.] Ohio State Univ, Biophys Grad Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Zhu, MX (corresponding author), Ohio State Univ, Ctr Mol Neurobiol, 168 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	zhu.55@osu.edu	tian, jinbin/L-6006-2019; Xiao, Rui/G-1193-2011; Tian, JinBin/B-7001-2019	Tian, JinBin/0000-0002-5516-7778; Xiao, Rui/0000-0001-5541-6685	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056942, P30NS045758, R01NS042183] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS042183-03, P30 NS045758-039003, R01 NS042183-04, R01 NS 042183, P30 NS045758, P30 NS 045758, P30 NS045758-049003, R21 NS 056942, R21 NS056942-01, R21 NS056942, R01 NS042183, R21 NS056942-01S1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Calixto JB, 2005, PHARMACOL THERAPEUT, V106, P179, DOI 10.1016/j.pharmthera.2004.11.008; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dalton P, 2002, NAT NEUROSCI, V5, P199, DOI 10.1038/nn803; Delwiche J, 2004, FOOD QUAL PREFER, V15, P137, DOI 10.1016/S0950-3293(03)00041-7; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Liu M, 2003, J BIOL CHEM, V278, P5462, DOI 10.1074/jbc.M209111200; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Naraghi M, 1997, J NEUROSCI, V17, P6961; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Turner H, 2003, BIOCHEM J, V371, P341, DOI 10.1042/BJ20021381; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; XIAO R, 2008, CELL CALCIUM; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	43	75	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6162	6174		10.1074/jbc.M706535200	http://dx.doi.org/10.1074/jbc.M706535200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18178557	Green Accepted, hybrid			2022-12-27	WOS:000253779500023
J	Yang, HJ; Xia, YY; Lu, SQ; Soong, TW; Feng, ZW				Yang, Haijie; Xia, Yinyan; Lu, Song Qing; Soong, Tuck Wah; Feng, Zhi Wei			Basic fibroblast growth factor-induced neuronal differentiation of mouse bone marrow stromal cells requires FGFR-1, MAPK/ERK, and transcription factor AP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; RETINAL-PIGMENT EPITHELIUM; MESENCHYMAL STEM-CELLS; FACTOR RECEPTORS; FACTOR (FGF)-2; NEURAL RETINA; KINASE; PROTEIN; TRANSDIFFERENTIATION; EXPRESSION	It has been reported recently that bone marrow stromal cells (BMSCs) are able to differentiate into various neural cells both in vivo and in vitro (Egusa, H., Schweizer, F. E., Wang, C. C., Matsuka, Y., and Nishimura, I. (2005) J. Biol. Chem. 280, 23691 23697). However, the underlying mechanisms remain largely unknown. In this report, we have demonstrated that basic fibroblast growth factor (bFGF) alone effectively induces mouse BMSC neuronal differentiation. These differentiated neuronal cells exhibit characteristic electrophysiological properties and elevated levels of the neuronal differentiation marker, growth-associated protein-43 (GAP-43). To explore possible signaling pathways, we first analyzed the expression of various FGF receptors in mouse BMSCs. FGF receptor-1, -2, and -3 were detected, but only FGFR-1 was shown to be activated by bFGF. Small interfering RNA knock down of FGFR-1 in BMSCs significantly inhibited neuronal differentiation. Moreover, we have shown that the mitogen-activated protein kinase (ERK1/2) is persistently activated and blockage of ERK activity with the ERK-specific inhibitor U0126 prevents neuronal differentiation. It appears that activation of ERK cascade and neuronal differentiation of BMSCs induced by bFGF are independent of Ras activity but require functions of phospholipase C-gamma pathway. Lastly, we examined the role of the immediate-early transcription factors AP-1 and NF-kappa B and have found that phospholipase C-gamma-dependent c-Jun and ERK-dependent c-fos, but not the NF-kappa B, are strongly activated by bFGF, which in turn regulates the neuronal differentiation of BMSCs.	[Yang, Haijie; Xia, Yinyan; Lu, Song Qing; Soong, Tuck Wah; Feng, Zhi Wei] Natl Inst Neurosci, Res Labs, Singapore 308433, Singapore	National Neuroscience Institute (NNI)	Feng, ZW (corresponding author), NNI Res, 11 Jalan Tan Tock Seng, Singapore, Singapore.	Zhi_Wei_Feng@nni.com.sg		Soong, Tuck Wah/0000-0002-0876-0325				Abe K, 2000, DEV BRAIN RES, V122, P81, DOI 10.1016/S0165-3806(00)00054-7; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BROWN PH, 1994, ONCOGENE, V9, P791; BURRY RW, 1992, J NEUROCYTOL, V21, P413, DOI 10.1007/BF01191506; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Chiba S, 2005, EXP BRAIN RES, V163, P86, DOI 10.1007/s00221-004-2148-y; Chikazu D, 2000, J BIOL CHEM, V275, P31444, DOI 10.1074/jbc.M910132199; Choi DY, 2001, J BIOL CHEM, V276, P5116, DOI 10.1074/jbc.M002959200; Corti S, 2004, J CELL MOL MED, V8, P329, DOI 10.1111/j.1582-4934.2004.tb00322.x; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Dimitropoulou A, 2000, BRAIN RES, V858, P205, DOI 10.1016/S0006-8993(00)01946-6; Doniach T, 1995, CELL, V83, P1067, DOI 10.1016/0092-8674(95)90133-7; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Feng ZW, 1999, J BIOL CHEM, V274, P30341, DOI 10.1074/jbc.274.43.30341; Galy A, 2002, DEV BIOL, V248, P251, DOI 10.1006/dbio.2002.0736; Herdegen T, 2001, ONCOGENE, V20, P2424, DOI 10.1038/sj.onc.1204387; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin K, 2003, EXP NEUROL, V183, P255, DOI 10.1016/S0014-4886(03)00220-6; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Klint P, 1999, ONCOGENE, V18, P3354, DOI 10.1038/sj.onc.1202680; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Ma QF, 2006, J PHYSIOL-LONDON, V575, P379, DOI 10.1113/jphysiol.2006.113449; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; PITTACK C, 1991, DEVELOPMENT, V113, P577; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Sakaguchi DS, 1997, DEV DYNAM, V209, P387, DOI 10.1002/(SICI)1097-0177(199708)209:4<387::AID-AJA6>3.0.CO;2-E; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Tohjima E, 2003, J BONE MINER RES, V18, P1461, DOI 10.1359/jbmr.2003.18.8.1461; Walsh S, 2000, BONE, V27, P185, DOI 10.1016/S8756-3282(00)00319-7; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; Weinstein DC, 1998, NATURE, V394, P904, DOI 10.1038/29808; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; WOODGETT JR, 1994, PIGM CELL RES, V7, P96, DOI 10.1111/j.1600-0749.1994.tb00027.x; Xu YX, 1998, HEMATOPATHOL MOL HEM, V11, P49; YANG Q, 2005, AHONGGUO ZHONG XI YI, V25, P248	51	69	77	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5287	5295		10.1074/jbc.M706917200	http://dx.doi.org/10.1074/jbc.M706917200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18171671	hybrid			2022-12-27	WOS:000253426700008
J	Zou, YL; Wu, J; Giannone, RJ; Boucher, L; Du, HS; Huang, Y; Johnson, DK; Liu, Y; Wang, YS				Zou, Yonglong; Wu, Jun; Giannone, Richard J.; Boucher, Lorrie; Du, Hansen; Huang, Ying; Johnson, Dabney K.; Liu, Yie; Wang, Yisong			Nucleophosmin/B23 negatively regulates GCN5-dependent histone acetylation and transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLTRANSFERASE ACTIVITY; DEPENDENT KINASE; PROTEIN; PHOSPHORYLATION; TRANSCRIPTION; GENE; GCN5; IDENTIFICATION; CHROMATIN; H3	Nucleophosmin/B23 is a multifunctional phosphoprotein that is overexpressed in cancer cells and has been shown to be involved in both positive and negative regulation of transcription. In this study, we first identified GCN5 acetyltransferase as a B23-interacting protein by mass spectrometry, which was then confirmed by in vivo co-immunoprecipitation. An in vitro assay demonstrated that B23 bound the PCAF-N domain of GCN5 and inhibited GCN5-mediated acetylation of both free and mononucleosomal histones, probably through interfering with GCN5 and masking histones from being acetylated. Mitotic B23 exhibited higher inhibitory activity on GCN5-mediated histone acetylation than interphase B23. Immunodepletion experiments of mitotic extracts revealed that phosphorylation of B23 at Thr(199) enhanced the inhibition of GCN5-mediated histone acetylation. Moreover, luciferase reporter and microarray analyses suggested that B23 attenuated GCN5-mediated transactivation in vivo. Taken together, our studies suggest a molecular mechanism of B23 in the mitotic inhibition of GCN5-mediated histone acetylation and transactivation.	[Zou, Yonglong; Wu, Jun; Giannone, Richard J.; Huang, Ying; Johnson, Dabney K.; Wang, Yisong] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Boucher, Lorrie] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Du, Hansen; Liu, Yie] NIH, NIA, Ctr Gerontol Res, Baltimore, MD 21224 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Wang, YS (corresponding author), Oak Ridge Natl Lab, Biosci Div, Bethel Valley Rd, Oak Ridge, TN 37831 USA.	ywa@ornl.gov	Wu, Jun/AAF-1830-2019; Liu, Yie/AAO-2092-2020; Giannone, Richard/ABC-8247-2020	Wu, Jun/0000-0001-9863-1668; Giannone, Richard/0000-0001-8551-0138	NATIONAL INSTITUTE ON AGING [Z01AG000748, ZIAAG000748] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barlev NA, 1998, MOL CELL BIOL, V18, P1349, DOI 10.1128/MCB.18.3.1349; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Candau R, 1997, EMBO J, V16, P555, DOI 10.1093/emboj/16.3.555; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Falini B, 2007, HAEMATOLOGICA, V92, P519, DOI 10.3324/haematol.11007; Fang JY, 2002, WORLD J GASTROENTERO, V8, P400, DOI 10.3748/wjg.v8.i3.400; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Giannone RJ, 2007, BIOTECHNIQUES, V43, P296, DOI 10.2144/000112550; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hsu CY, 2000, INT J CANCER, V88, P392, DOI 10.1002/1097-0215(20001101)88:3<392::AID-IJC11>3.0.CO;2-7; INOUYE CJ, 1994, J BIOL CHEM, V269, P6506; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kobayashi H, 2004, INT J CANCER, V109, P207, DOI 10.1002/ijc.11697; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Liu H, 2007, EMBO REP, V8, P394, DOI 10.1038/sj.embor.7400909; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lu YY, 1996, BIOCHEM J, V317, P321, DOI 10.1042/bj3170321; Maiguel DA, 2004, MOL CELL BIOL, V24, P3703, DOI 10.1128/MCB.24.9.3703-3711.2004; Negi SS, 2006, J CELL SCI, V119, P3676, DOI 10.1242/jcs.03090; OCHS R, 1983, EXP CELL RES, V146, P139, DOI 10.1016/0014-4827(83)90332-4; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; Redner RL, 2000, BLOOD, V95, P2683; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Sekiguchi T, 2006, NUCLEIC ACIDS RES, V34, P4593, DOI 10.1093/nar/gkl603; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sterner DE, 2006, BIOCHEMISTRY-US, V45, P1035, DOI 10.1021/bi051624q; Swaminathan V, 2005, MOL CELL BIOL, V25, P7534, DOI 10.1128/MCB.25.17.7534-7545.2005; Tabb DL, 2005, ANAL CHEM, V77, P2464, DOI 10.1021/ac0487000; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tarapore P, 2006, FEBS LETT, V580, P399, DOI 10.1016/j.febslet.2005.12.022; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Xu WT, 1998, MOL CELL BIOL, V18, P5659, DOI 10.1128/MCB.18.10.5659	52	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5728	5737		10.1074/jbc.M709932200	http://dx.doi.org/10.1074/jbc.M709932200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165222	hybrid			2022-12-27	WOS:000253426700054
J	Barbero, S; Barila, D; Mielgo, A; Stagni, V; Clair, K; Stupack, D				Barbero, Simone; Barila, Daniela; Mielgo, Ainhoa; Stagni, Venturina; Clair, Kiran; Stupack, Dwayne			Identification of a critical tyrosine residue in caspase 8 that promotes cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS; ACTIVATION; KINASE; REQUIREMENT; MOTILITY; INTEGRIN; RECEPTOR	Caspase 8 is a critical upstream initiator of programmed cell death but, paradoxically, has also been shown to promote cell migration. Here, we show that tyrosine 380 in the linker loop of human caspase 8 is a critical switch determining caspase 8 function. Our studies show that, in addition to its cytosolic distribution, caspase 8 is recruited to lamella of migrating cells. Although the catalytic domain of caspase 8 is sufficient for recruitment and promotion of cell migration, catalytic activity per se is not required. Instead, we find that integrin-mediated adhesion promotes caspase 8 phosphorylation on tyrosine 380. Accordingly, mutation of this site compromises localization to the periphery and the potentiation of cell migration. Mechanistically, this linker region of caspase 8 acts as a Src homology 2 binding site. In particular, tyrosine 380 is critical for interaction with Src homology 2 domains. The results identify a novel mechanism by which caspase 8 is recruited to the lamella of a migrating cell, promoting cell migration independent of its protease activity.	[Barbero, Simone; Mielgo, Ainhoa; Clair, Kiran; Stupack, Dwayne] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Barbero, Simone; Mielgo, Ainhoa; Clair, Kiran; Stupack, Dwayne] UCSD Moores Canc Ctr, La Jolla, CA 92093 USA; [Barbero, Simone; Mielgo, Ainhoa; Clair, Kiran; Stupack, Dwayne] Carattere Sci Fdn Santa Lucia, Ist Ricovero & Cura, I-00179 Rome, Italy; [Barila, Daniela; Stagni, Venturina] Univ Roma Tor Vergata, I-00133 Rome, Italy	University of California System; University of California San Diego; IRCCS Santa Lucia; University of Rome Tor Vergata	Stupack, D (corresponding author), Univ Calif San Diego, Ctr Canc, 3855 Hlth Sci Dr,MC0803, La Jolla, CA 92093 USA.	dstupack@ucsd.edu	Barilà, Daniela/K-8506-2016	Barilà, Daniela/0000-0002-6192-1562; stagni, venturina/0000-0002-3971-0398	NATIONAL CANCER INSTITUTE [R01CA107263] Funding Source: NIH RePORTER; NCI NIH HHS [CA107263] Funding Source: Medline; Worldwide Cancer Research [07-0461] Funding Source: Medline; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Worldwide Cancer Research; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Arechiga AF, 2007, J IMMUNOL, V179, P5291, DOI 10.4049/jimmunol.179.8.5291; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3	16	64	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13031	13034		10.1074/jbc.M800549200	http://dx.doi.org/10.1074/jbc.M800549200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18216014	Green Published, hybrid			2022-12-27	WOS:000255499800040
J	Ghosh, R; Chhabra, A; Phatale, PA; Samrat, SK; Sharma, J; Gosain, A; Mohanty, D; Saran, S; Gokhale, RS				Ghosh, Ratna; Chhabra, Arush; Phatale, Pallavi A.; Samrat, Subodh K.; Sharma, Jyoti; Gosain, Anuradha; Mohanty, Debasisa; Saran, Shweta; Gokhale, Rajesh S.			Dissecting the functional role of polyketide synthases in dictyostelium discoideum - Biosynthesis of the differentiation regulating factor 4-methyl-5-pentylbenzene-1,3-diol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR SLIME-MOLDS; ROOT HAIRS; MECHANISM; GENOME; MACHINERY; ACID	Dictyostelium discoideum exhibits the largest repository of polyketide synthase (PKS) proteins of all known genomes. However, the functional relevance of these proteins in the biology of this organism remains largely obscure. On the basis of computational, biochemical, and gene expression studies, we propose that the multifunctional Dictyostelium PKS (DiPKS) protein DiPKS1 could be involved in the biosynthesis of the differentiation regulating factor 4-methyl-5-pentylbenzene-1,3-diol (MPBD). Our cell-free reconstitution studies of a novel acyl carrier protein Type III PKS didomain from DiPKS1 revealed a crucial role of protein-protein interactions in determining the final biosynthetic product. Whereas the Type III PKS domain by itself primarily produces acyl pyrones, the presence of the interacting acyl carrier protein domain modulates the catalytic activity to produce the alkyl resorcinol scaffold of MPBD. Furthermore, we have characterized an O-methyltransferase (OMT12) from Dictyostelium with the capability to modify this resorcinol ring to synthesize a variant of MPBD. We propose that such a modification in vivo could in fact provide subtle variations in biological function and specificity. In addition, we have performed systematic computational analysis of 45 multidomain PKSs, which revealed several unique features in DiPKS proteins. Our studies provide a new perspective in understanding mechanisms by which metabolic diversity could be generated by combining existing functional scaffolds.	[Ghosh, Ratna; Chhabra, Arush; Phatale, Pallavi A.; Samrat, Subodh K.; Sharma, Jyoti; Mohanty, Debasisa; Gokhale, Rajesh S.] Natl Inst Immunol, New Delhi 110067, India; [Gosain, Anuradha; Saran, Shweta] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Gokhale, Rajesh S.] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jawaharlal Nehru University, New Delhi; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Gokhale, RS (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	rsg@nii.res.in	Samrat, Subodh/AAA-2083-2021; Mohanty, Debasisa/A-1428-2009; samrat, subodh/AAN-1043-2021	Samrat, Subodh/0000-0002-8600-3901; MOHANTY, DEBASISA/0000-0002-3374-0588; Sharma, Jyoti/0000-0003-3299-9907	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Austin MB, 2006, NAT CHEM BIOL, V2, P494, DOI 10.1038/nchembio811; Baerson SR, 2008, J BIOL CHEM, V283, P3231, DOI 10.1074/jbc.M706587200; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Chisholm RL, 2006, NUCLEIC ACIDS RES, V34, pD423, DOI 10.1093/nar/gkj090; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Dayan FE, 2007, J EXP BOT, V58, P3263, DOI 10.1093/jxb/erm173; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; FAUNAM EB, 1999, S ADENOSYLMETHIONINE, P1; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Funa N, 2007, J BIOL CHEM, V282, P14476, DOI 10.1074/jbc.M701239200; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gaitatzis N, 2001, P NATL ACAD SCI USA, V98, P11136, DOI 10.1073/pnas.201167098; Gokhale RS, 2007, CURR OPIN STRUC BIOL, V17, P736, DOI 10.1016/j.sbi.2007.08.021; Gokhale RS, 2007, NAT PROD REP, V24, P267, DOI 10.1039/b616817p; Gruschow S, 2007, CHEMBIOCHEM, V8, P863, DOI 10.1002/cbic.200700026; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kikuchi H, 2005, J ORG CHEM, V70, P8854, DOI 10.1021/jo051352x; Kikuchi H, 2002, TETRAHEDRON LETT, V43, P1477, DOI 10.1016/S0040-4039(02)00038-2; Kikuchi H, 2001, J ORG CHEM, V66, P6982, DOI 10.1021/jo015657x; Kopp F, 2006, J AM CHEM SOC, V128, P16478, DOI 10.1021/ja0667458; Kuspa Adam, 2006, V346, P15; MORRIS HR, 1988, BIOCHEM J, V249, P903, DOI 10.1042/bj2490903; Saito T, 2006, BBA-GEN SUBJECTS, V1760, P754, DOI 10.1016/j.bbagen.2005.12.006; Sankaranarayanan R, 2004, NAT STRUCT MOL BIOL, V11, P894, DOI 10.1038/nsmb809; Sankaranarayanan R, 2006, NAT CHEM BIOL, V2, P451, DOI 10.1038/nchembio0906-451; Saxena P, 2003, J BIOL CHEM, V278, P44780, DOI 10.1074/jbc.M306714200; Schracke N, 2005, BIOCHEMISTRY-US, V44, P8507, DOI 10.1021/bi050074t; Serafimidis I, 2005, DEV BIOL, V282, P432, DOI 10.1016/j.ydbio.2005.03.023; Shaulsky G, 2007, CURR BIOL, V17, pR684, DOI 10.1016/j.cub.2007.06.024; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; Strmecki L, 2005, DEV BIOL, V284, P25, DOI 10.1016/j.ydbio.2005.05.011; Takaya Y, 2001, TETRAHEDRON LETT, V42, P61, DOI 10.1016/S0040-4039(00)01879-7; Takaya Y, 2000, J ORG CHEM, V65, P985, DOI 10.1021/jo991338i; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; Trivedi OA, 2005, MOL CELL, V17, P631, DOI 10.1016/j.molcel.2005.02.009; Weijer CJ, 2004, CURR OPIN GENET DEV, V14, P392, DOI 10.1016/j.gde.2004.06.006; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8	39	31	36	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11348	11354		10.1074/jbc.M709588200	http://dx.doi.org/10.1074/jbc.M709588200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18252726	hybrid			2022-12-27	WOS:000255067400031
J	Aiken, KJ; Bickford, JS; Kilberg, MS; Nick, HS				Aiken, Kimberly J.; Bickford, Justin S.; Kilberg, Michael S.; Nick, Harry S.			Metabolic regulation of manganese superoxide dismutase expression via essential amino acid deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; MESSENGER-RNA; GENE-EXPRESSION; OXIDATIVE STRESS; INTERFERON-GAMMA; LIFE-SPAN; HISTONE DEACETYLASE; DOWN-REGULATION; S6 KINASE; INDUCTION	Organisms respond to available nutrient levels by rapidly adjusting metabolic flux, in part through changes in gene expression. A consequence of adaptations in metabolic rate is the production of mitochondria-derived reactive oxygen species. Therefore, we hypothesized that nutrient sensing could regulate the synthesis of the primary defense of the cell against superoxide radicals, manganese superoxide dismutase. Our data establish a novel nutrient-sensing pathway for manganese superoxide dismutase expression mediated through essential amino acid depletion concurrent with an increase in cellular viability. Most relevantly, our results are divergent from current mechanisms governing amino acid-dependent gene regulation. This pathway requires the presence of glutamine, signaling via the tricarboxylic acid cycle/electron transport chain, an intact mitochondrial membrane potential, and the activity of both the MEK/ERK and mammalian target of rapamycin kinases. Our results provide evidence for convergence of metabolic cues with nutrient control of antioxidant gene regulation, revealing a potential signaling strategy that impacts free radical-mediated mutations with implications in cancer and aging.	[Nick, Harry S.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Aiken, Kimberly J.; Bickford, Justin S.; Nick, Harry S.] Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA; [Aiken, Kimberly J.; Bickford, Justin S.; Kilberg, Michael S.; Nick, Harry S.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Nick, HS (corresponding author), Univ Florida, Coll Med, Dept Neurosci, POB 100244, Gainesville, FL 32610 USA.	hnick@ufl.edu			NHLBI NIH HHS [HL06745, HL39593] Funding Source: Medline; NIDDK NIH HHS [R01 DK070647, R01 DK052064, DK52064, DK70647] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052064, R01DK070647] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BAQUET A, 1993, EUR J BIOCHEM, V217, P1083, DOI 10.1111/j.1432-1033.1993.tb18340.x; Bruce-Keller AJ, 1999, J NEUROIMMUNOL, V93, P53, DOI 10.1016/S0165-5728(98)00190-8; Bruhat A, 1999, P NUTR SOC, V58, P625, DOI 10.1017/S0029665199000828; Brunet A, 2004, M S-MED SCI, V20, P856, DOI 10.1051/medsci/20042010856; Chang SH, 2003, BIOCHEM J, V371, P877, DOI 10.1042/BJ20021731; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; COX G, 1994, AM J RESP CELL MOL, V10, P493, DOI 10.1165/ajrcmb.10.5.7514009; DELVECCHIO PJ, 1991, CURR EYE RES, V10, P919, DOI 10.3109/02713689109020327; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; DOUGALL WC, 1991, ENDOCRINOLOGY, V129, P2376, DOI 10.1210/endo-129-5-2376; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Fernandez J, 2002, J BIOL CHEM, V277, P11780, DOI 10.1074/jbc.M110778200; Fonnum F, 1997, GLIA, V21, P106; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; FRANK L, 1980, AM J MED, V69, P117, DOI 10.1016/0002-9343(80)90509-4; Gao N, 2006, BLOOD, V107, P241, DOI 10.1182/blood-2005-06-2409; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Golab J, 2003, J BIOL CHEM, V278, P407, DOI 10.1074/jbc.M209125200; Goncharov NV, 2006, J APPL TOXICOL, V26, P148, DOI 10.1002/jat.1118; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harris N, 2003, FREE RADICAL BIO MED, V34, P1599, DOI 10.1016/S0891-5849(03)00210-7; HATEFI Y, 1975, FED PROC, V34, P1699; Hinnebusch Alan G., 1994, Seminars in Cell Biology, V5, P417, DOI 10.1006/scel.1994.1049; Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x; Huang HM, 2003, J NEUROSCI RES, V74, P309, DOI 10.1002/jnr.10756; HURT J, 1992, NUCLEIC ACIDS RES, V20, P2985, DOI 10.1093/nar/20.12.2985; Kang HT, 2003, J BIOL CHEM, V278, P51223, DOI 10.1074/jbc.M307332200; Keller JN, 1998, J NEUROSCI, V18, P687; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kim DH, 2003, CURR TOP MICROBIOL, V279, P259; Kim YS, 2002, J BIOCHEM MOL BIOL, V35, P443; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Meijer AJ, 2003, J NUTR, V133, p2057S, DOI 10.1093/jn/133.6.2057S; MELENDEZ JA, 1993, FREE RADICAL BIO MED, V14, P601, DOI 10.1016/0891-5849(93)90141-G; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; Neuhaus P, 2001, LIVER TRANSPLANT, V7, P473, DOI 10.1053/jlts.2001.24645; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Raineri I, 1996, J INTERF CYTOK RES, V16, P61, DOI 10.1089/jir.1996.16.61; Rogers RJ, 2000, BIOCHEM J, V347, P233, DOI 10.1042/0264-6021:3470233; Rogers RJ, 2001, J BIOL CHEM, V276, P20419, DOI 10.1074/jbc.M008915200; Roth GS, 2005, J AM GERIATR SOC, V53, pS280, DOI 10.1111/j.1532-5415.2005.53489.x; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Scallet AC, 2003, ANN NY ACAD SCI, V993, P305, DOI 10.1111/j.1749-6632.2003.tb07538.x; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Sun JT, 2002, GENETICS, V161, P661; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Tower J, 2000, MECH AGEING DEV, V118, P1, DOI 10.1016/S0047-6374(00)00152-4; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; VARGA J, 1995, J CLIN INVEST, V96, P475, DOI 10.1172/JCI118058; Varga J, 1996, ADV EXP MED BIOL, V398, P143; VARGA J, 1994, LAB INVEST, V70, P183; VISNER GA, 1990, J BIOL CHEM, V265, P2856; VISNER GA, 1992, BIOCHEM BIOPH RES CO, V188, P453; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Zwacka RM, 1998, HUM GENE THER, V9, P1381, DOI 10.1089/hum.1998.9.9-1381	73	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10252	10263		10.1074/jbc.M709944200	http://dx.doi.org/10.1074/jbc.M709944200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18187411	Green Published, hybrid			2022-12-27	WOS:000254894700006
J	Ray, P; Basu, U; Ray, A; Majumdar, R; Deng, HT; Maitra, U				Ray, Partha; Basu, Uttiya; Ray, Anirban; Majumdar, Romit; Deng, Haiteng; Maitra, Umadas			The Saccharomyces cerevisiae 60 S ribosome biogenesis factor Tif6p is regulated by Hrr25p-mediated phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-I; SACCHAROMYCES-CEREVISIAE HOMOLOG; EUKARYOTIC INITIATION FACTOR-6; BUDDING YEAST; NEGATIVE REGULATION; DISSOCIATION FACTOR; PROTEIN-KINASE; PRE-RIBOSOMES; WHEAT-GERM; SUBUNIT	The biosynthesis of 60 S ribosomal subunits in Saccharomyces cerevisiae requires Tif6p, the yeast homologue of mammalian eIF6. This protein is necessary for the formation of 60 S ribosomal subunits because it is essential for the processing of 35 S pre-rRNA to the mature 25 S and 5.8 S rRNAs. In the present work, using molecular genetic and biochemical analyses, we show that Hrr25p, an isoform of yeast casein kinase I, phosphorylates Tif6p both in vitro and in vivo. Tryptic phosphopeptide mapping of in vitro phosphorylated Tif6p by Hrr25p and P-32-labeled Tif6p isolated from yeast cells followed by mass spectrometric analysis revealed that phosphorylation occurred on a single tryptic peptide at Ser-174. Sucrose gradient fractionation and coimmunoprecipitation experiments demonstrate that a small but significant fraction of Hrr25p is bound to 66 S pre-ribosomal particles that also contain bound Tif6p. Depletion of Hrr25p from a conditional yeast mutant that fails to phosphorylate Tif6p was unable to process pre-rRNAs efficiently, resulting in significant reduction in the formation of 25 S rRNA. These results along with our previous observations that phosphorylatable Ser-174 is required for yeast cell growth and viability, suggest that Hrr25p-mediated phosphorylation of Tif6p plays a critical role in the biogenesis of 60 S ribosomal subunits in yeast cells.	[Deng, Haiteng] Rockefeller Univ, Proteom Res Ctr, New York, NY 10021 USA; [Ray, Partha; Basu, Uttiya; Ray, Anirban; Majumdar, Romit; Maitra, Umadas] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	Maitra, U (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	maitra@aecom.yu.edu	Ray, Partha/AAK-4883-2020	Ray, Partha/0000-0002-7075-5463; Deng, Haiteng/0000-0001-9496-1280	NCI NIH HHS [P30 CA 13330] Funding Source: Medline; NIGMS NIH HHS [GM 15399] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015399] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basu U, 2003, MOL CELL BIOL, V23, P6187, DOI 10.1128/MCB.23.17.6187-6199.2003; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; DEMAGGIO AJ, 1992, P NATL ACAD SCI USA, V89, P7008, DOI 10.1073/pnas.89.15.7008; EVANS CF, 1990, METHOD ENZYMOL, V181, P439; Gross SD, 1999, J CELL SCI, V112, P2647; Gross SD, 1997, J CELL SCI, V110, P3083; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; HOEKSTRA MF, 1991, SCIENCE, V253, P1031, DOI 10.1126/science.1887218; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maiti T, 2003, YEAST, V20, P97, DOI 10.1002/yea.937; McKay RM, 2001, DEV BIOL, V235, P378, DOI 10.1006/dbio.2001.0307; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Merrick WC., 1996, TRANSLATION CONTROL, P31; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Murakami A, 1999, J BIOL CHEM, V274, P3804, DOI 10.1074/jbc.274.6.3804; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; RAYCHAUDHURI P, 1984, J BIOL CHEM, V259, P1930; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; ROSBASH M, 2003, NOVART FDN SYMP, V253, P102; ROSBASH M, 2003, NOVART FDN SYMP, V253, P252; ROSBASH M, 2003, NOVART FDN SYMP, V253, P232; Rosbash Michael, 2003, Novartis Found Symp, V253, P223; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; RUSSELL DW, 1980, ARCH BIOCHEM BIOPHYS, V201, P518, DOI 10.1016/0003-9861(80)90540-8; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Si K, 1997, P NATL ACAD SCI USA, V94, P14285, DOI 10.1073/pnas.94.26.14285; Si K, 1999, MOL CELL BIOL, V19, P1416; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; UDEM SA, 1972, J MOL BIOL, V65, P227, DOI 10.1016/0022-2836(72)90279-3; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712; VANCURA A, 1994, J BIOL CHEM, V269, P19271; Venema J, 1998, METH MOL B, V77, P257; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Vilardell J, 2000, RNA, V6, P1773, DOI 10.1017/S135583820000145X; Wang XM, 1996, MOL CELL BIOL, V16, P5375; [No title captured]	47	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9681	9691		10.1074/jbc.M710294200	http://dx.doi.org/10.1074/jbc.M710294200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18256024	hybrid, Green Published			2022-12-27	WOS:000254671600023
J	Kawachi, M; Kobae, Y; Mimura, T; Maeshima, M				Kawachi, Miki; Kobae, Yoshihiro; Mimura, Tetsuro; Maeshima, Masayoshi			Deletion of a histidine-rich loop of AtMTP1, a vacuolar Zn2+/H+ antiporter of Arabidopsis thaliana, stimulates the transport activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-TRANSPORTER; CONFERS RESISTANCE; METAL TRANSPORT; PLASMA-MEMBRANE; H+-ATPASE; FAMILY; GENE; TOLERANCE; PROTEIN; YEAST	Arabidopsis thaliana AtMTP1 belongs to the cation diffusion facilitator family and is localized on the vacuolar membrane. We investigated the enzymatic kinetics of AtMTP1 by a heterologous expression system in the yeast Saccharomyces cerevisiae, which lacked genes for vacuolar membrane zinc transporters ZRC1 and COT1. The yeast mutant expressing AtMTP1 heterologously was tolerant to 10mM ZnCl2. Active transport of zinc into vacuoles of living yeast cells expressing AtMTP1 was confirmed by the fluorescent zinc indicator FuraZin-1. Zinc transport was quantitatively analyzed by using vacuolar membrane vesicles prepared from AtMTP1-expressing yeast cells and radioisotope Zn-65(2+). Active zinc uptake depended on a pH gradient generated by endogenous vacuolar H+-ATPase. The activity was inhibited by bafilomycin A(1), an inhibitor of the H+-ATPase. The K-m for Zn2+ and Vmax of AtMTP1 were determined to be 0.30 mu M and 1.22 nmol/min/mg, respectively. We prepared a mutant AtMTP1 that lacked the major part (32 residues from 185 to 216) of a long histidine-rich hydrophilic loop in the central part of AtMTP1. Yeast cells expressing the mutant became hyperresistant to high concentrations of Zn2+ and resistant to Co2+. The Km and Vmax values were increased 2 -11-fold. These results indicate that AtMTP1 functions as a Zn2+/H+ antiporter in vacuoles and that a histidine-rich region is not essential for zinc transport. We propose that a histidine-rich loop functions as a buffering pocket of Zn2+ and a sensor of the zinc level at the cytoplasmic surface. This loop may be involved in the maintenance of the level of cytoplasmic Zn2+.	[Kawachi, Miki; Kobae, Yoshihiro; Maeshima, Masayoshi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Cell Dynam, Nagoya, Aichi 4648601, Japan; [Mimura, Tetsuro] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 6578501, Japan	Nagoya University; Kobe University	Maeshima, M (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Cell Dynam, Nagoya, Aichi 4648601, Japan.	maeshima@agr.nagoya-u.ac.jp	Maeshima, Masayoshi/D-3073-2013	Maeshima, Masayoshi/0000-0002-1611-5481; Kobae, Yoshihiro/0000-0002-9997-490X				Anton A, 2004, J BACTERIOL, V186, P7499, DOI 10.1128/JB.186.22.7499-7507.2004; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; Becher M, 2004, PLANT J, V37, P251, DOI 10.1046/j.1365-313X.2003.01959.x; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Bloss T, 2002, PLANTA, V214, P783, DOI 10.1007/s00425-001-0677-1; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; CONKLIN DS, 1994, MOL GEN GENET, V244, P303, DOI 10.1007/BF00285458; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Desbrosses-Fonrouge AG, 2005, FEBS LETT, V579, P4165, DOI 10.1016/j.febslet.2005.06.046; Drager DB, 2004, PLANT J, V39, P425, DOI 10.1111/j.1365-313X.2004.02143.x; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; JONES EW, 1991, METHOD ENZYMOL, V194, P428; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; Kim D, 2004, PLANT J, V39, P237, DOI 10.1111/j.1365-313X.2004.02126.x; Kobae Y, 2004, PLANT CELL PHYSIOL, V45, P1749, DOI 10.1093/pcp/pci015; Kramer U, 2005, CURR OPIN BIOTECH, V16, P133, DOI 10.1016/j.copbio.2005.02.006; Kramer U, 2005, TRENDS PLANT SCI, V10, P313, DOI 10.1016/j.tplants.2005.05.008; Lippard S. J., 1994, PRINCIPLES BIOINORGA; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; MacDiarmid CW, 2003, J BIOL CHEM, V278, P15065, DOI 10.1074/jbc.M300568200; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; MAESHIMA M, 2000, BIOCHIM BIOPHYS ACTA, V1456, P37; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Marschner H, 1995, MINERAL NUTR HIGHER, p[347, 362]; MATSUURAENDO C, 1990, EUR J BIOCHEM, V187, P745, DOI 10.1111/j.1432-1033.1990.tb15362.x; MATSUURAENDO C, 1992, PLANT PHYSIOL, V100, P718, DOI 10.1104/pp.100.2.718; Milon B, 2006, BBA-BIOMEMBRANES, V1758, P1696, DOI 10.1016/j.bbamem.2006.06.005; Nakanishi Y, 1998, PLANT PHYSIOL, V116, P589, DOI 10.1104/pp.116.2.589; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Persans MW, 2001, P NATL ACAD SCI USA, V98, P9995, DOI 10.1073/pnas.171039798; SHANNON RD, 1970, J INORG NUCL CHEM, V32, P1427, DOI 10.1016/0022-1902(70)80629-7; Shigaki T, 2001, ANAL BIOCHEM, V298, P118, DOI 10.1006/abio.2001.5341; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; Ueoka-Nakanishi H, 2000, EUR J BIOCHEM, V267, P3090, DOI 10.1046/j.1432-1033.2000.01343.x; van der Zaal BJ, 1999, PLANT PHYSIOL, V119, P1047, DOI 10.1104/pp.119.3.1047; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Williams LE, 2000, BBA-BIOMEMBRANES, V1465, P104, DOI 10.1016/S0005-2736(00)00133-4; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008	46	111	118	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8374	8383		10.1074/jbc.M707646200	http://dx.doi.org/10.1074/jbc.M707646200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18203721	Green Published, hybrid			2022-12-27	WOS:000254288000035
J	Rouzer, CA; Marnett, LJ				Rouzer, Carol A.; Marnett, Lawrence J.			Non-redundant functions of cyclooxygenases: Oxygenation of endocannabinoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RESIDENT PERITONEAL-MACROPHAGES; COX-2 OXIDATIVE METABOLITE; AMINO-ACID DETERMINANTS; ARACHIDONIC-ACID; PROSTAGLANDIN SYNTHASE; SYNAPTIC-TRANSMISSION; ENDOPLASMIC-RETICULUM; SELECTIVE-INHIBITION; GLYCEROL ESTERS; RAW264.7 CELLS	The two cyclooxygenase (COX) enzymes catalyze the oxygenation of arachidonic acid to prostaglandin endoperoxides, which are the common intermediates in the biosynthesis of the bioactive lipids prostaglandins and thromboxane. COX-1 and COX-2 are similar to 60% identical in aminoacid sequence, exhibit highly homologous three-dimensional structures, and appear functionally similar at the biochemical level. Recent work has uncovered a subtle functional difference between the two enzymes, namely the ability of COX-2 to efficiently utilize neutral derivatives (esters and amides) of arachidonic acid as substrates. Foremost among these neutral substrates are the endocannabinoids 2-arachidonoylglycerol and arachidonoylethanolamide. This raises the possibility that COX-2 oxygenation plays a role in a novel signaling pathway dependent on agonist-induced release of endocannabinoids and their selective oxygenation by COX-2. Among the products of COX-2 oxygenation of endocannabinoids are glyceryl prostaglandins, some of which ( e. g. glyceryl prostaglandin E2 and glyceryl prostaglandin I-2) exhibit interesting biological activities in inflammatory, neurological, and vascular systems. These compounds are produced in intact cells stimulated with physiological agonists and have been isolated from in vivo sources. Important concepts relevant to the hypothesis of a COX-2-selective signaling pathway are presented.	[Marnett, Lawrence J.] Vanderbilt Univ, Sch Med,Dept Biochem,Vanderbilt Inst Chem Biol, Ctr Mol Toxicol,Res Ctr Pharmacol & Drug Toxicol, Vanderbilt Ingram Canc Ctr,AB Hancock Jr Mem Lab, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med,Dept Chem,Vanderbilt Inst Chem Biol, Ctr Mol Toxicol,Res Ctr Pharmacol & Drug Toxicol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med,Dept Pharmacol,Vanderbilt Inst Chem Biol, Ctr Mol Toxicol,Res Ctr Pharmacol & Drug Toxicol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med,Dept Biochem,Vanderbilt Inst Chem Biol, Ctr Mol Toxicol,Res Ctr Pharmacol & Drug Toxicol, Vanderbilt Ingram Canc Ctr,AB Hancock Jr Mem Lab, 23rd Ave Pierce, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu		Rouzer, Carol/0000-0001-6827-1534	NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER; NCI NIH HHS [CA 89450] Funding Source: Medline; NIGMS NIH HHS [GM 15431] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERGSTROM S, 1964, BIOCHIM BIOPHYS ACTA, V90, P207, DOI 10.1016/0304-4165(64)90145-X; Bisogno T, 1997, BIOCHEM J, V322, P671, DOI 10.1042/bj3220671; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Correa F, 2008, BIOCHEM J, V409, P761, DOI 10.1042/BJ20071329; DEWITT DL, 1988, P NATL ACAD SCI USA, V85, P1412, DOI 10.1073/pnas.85.5.1412; Di Marzo V, 2005, HANDB EXP PHARMACOL, V168, P147; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; Ghosh M, 2007, J EXP MED, V204, P2053, DOI 10.1084/jem.20070828; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; HU SSJ, 2007, 17 ANN S CANN QUEB C, P50; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2003, BIOCHEMISTRY-US, V42, P9041, DOI 10.1021/bi034471k; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; Krauss AHP, 2004, SURV OPHTHALMOL, V49, pS5, DOI 10.1016/j.survophthal.2003.12.014; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; KULMACZ RJ, 1995, J BIOL CHEM, V270, P24019, DOI 10.1074/jbc.270.41.24019; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; LIANG Y, 2008, IN PRESS BR J PHARM; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Marnett LJ, 2002, ANNU REV PHARMACOL, V42, P55, DOI 10.1146/annurev.pharmtox.42.082301.164620; MASFERRER JL, 1994, P NATL ACAD SCI USA, V91, P3228, DOI 10.1073/pnas.91.8.3228; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; MIYAMOTO T, 1976, J BIOL CHEM, V251, P2629; Nirodi CS, 2004, P NATL ACAD SCI USA, V101, P1840, DOI 10.1073/pnas.0303950101; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; OGLESBY TD, 1984, BIOCHIM BIOPHYS ACTA, V793, P269, DOI 10.1016/0005-2760(84)90329-1; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Prusakiewicz JJ, 2002, BIOCHEM BIOPH RES CO, V296, P612, DOI 10.1016/S0006-291X(02)00915-4; REGIER MK, 1995, ARCH BIOCHEM BIOPHYS, V317, P457, DOI 10.1006/abbi.1995.1188; REGIER MK, 1993, ARCH BIOCHEM BIOPHYS, V301, P439, DOI 10.1006/abbi.1993.1168; Rouzer CA, 2005, J BIOL CHEM, V280, P26690, DOI 10.1074/jbc.M501021200; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; Rouzer CA, 2006, BIOCHEMISTRY-US, V45, P14795, DOI 10.1021/bi061723j; Rouzer CA, 2006, BIOCHEM J, V399, P91, DOI 10.1042/BJ20060615; Saghatelian A, 2006, BIOCHEMISTRY-US, V45, P9007, DOI 10.1021/bi0608008; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Sang N, 2006, J PHYSIOL-LONDON, V572, P735, DOI 10.1113/jphysiol.2006.105569; Schneider C, 2006, J AM CHEM SOC, V128, P720, DOI 10.1021/ja056517y; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Vane JR, 1971, NATURE, V231, P235; Weber A, 2004, J LIPID RES, V45, P757, DOI 10.1194/jlr.M300475-JLR200; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181; Yu Y, 2007, J BIOL CHEM, V282, P1498, DOI 10.1074/jbc.M609930200	55	94	95	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8065	8069		10.1074/jbc.R800005200	http://dx.doi.org/10.1074/jbc.R800005200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18250160	hybrid, Green Published			2022-12-27	WOS:000254288000001
J	Yang, W; Qiu, C; Biswas, N; Jin, J; Watkins, SC; Montelaro, RC; Coyne, CB; Wang, TY				Yang, Wei; Qiu, Chao; Biswas, Nabanita; Jin, Jing; Watkins, Simon C.; Montelaro, Ronald C.; Coyne, Carolyn B.; Wang, Tianyi			Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAIN; MEMBRANE-PROTEINS; ENTRY; REPLICATION; ENDOCYTOSIS; RECEPTOR; BINDING; CELLS; CD81	Claudin-1 (CLDN1), a tight junction (TJ) protein, has recently been identified as an entry co-receptor for hepatitis C virus (HCV). Ectopic expression of CLDN1 rendered several non-hepatic cell lines permissive to HCV infection. However, little is known about the mechanism by which CLDN1 mediates HCV entry. It is believed that an additional entry receptor(s) is required because ectopic expression of CLDN1 in both HeLa and NIH3T3 cells failed to confer susceptibility to viral infection. Here we found that CLDN1 was co-immunoprecipitated with both HCV envelope proteins when expressed in 293T cells. Results from biomolecular fluorescence complementation assay showed that overexpressed CLDN1 also formed complexes with CD81 and low density lipoprotein receptor. Subsequent imaging analysis revealed that CLDN1 was highly enriched at sites of cell-cell contact in permissive cell lines, co-localizing with the TJ marker, ZO-1. However, in both HeLa and NIH3T3 cells the ectopically expressed CLDN1 appeared to reside predominantly in intracellular vesicles. The CLDN1-CD81 complex formed in HeLa cells was also exclusively distributed intracellularly, co-localizing with EEA1, an early endosomal marker. Correspondingly, transepithelial electric resistance, obtained from the naturally susceptible human liver cell line, Huh7, was much higher than that of the HeLa-CLDN1 cell line, suggesting that Huh7 is likely to form functional tight junctions. Finally, the disruption of TJ-enriched CLDN1 by tumor necrosis factor-alpha treatment markedly reduced the susceptibility of Huh7.5.1 cells to HCV infection. Our results suggest that the specific localization pattern of CLDN1 may be crucial in the regulation of HCV cellular tropism.	[Yang, Wei; Qiu, Chao; Biswas, Nabanita; Jin, Jing; Montelaro, Ronald C.; Wang, Tianyi] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Jin, Jing; Montelaro, Ronald C.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Watkins, Simon C.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, TY (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, 130 DeSoto St, Pittsburgh, PA 15261 USA.	tywang@pitt.edu	Watkins, Simon/ABG-2590-2021; Qiu, Chao/M-6702-2014	Watkins, Simon/0000-0003-4092-1552; Qiu, Chao/0000-0001-9401-5219; Yang, Wei/0000-0003-0162-4221; Jin, Jing/0000-0003-3994-8600	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI068784] Funding Source: NIH RePORTER; NIAID NIH HHS [1 R21 AI 068784-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; CAROLYN B, 2007, CELL HOST MICROBE, V2, P181; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 2003, J VIROL, V77, P10677, DOI 10.1128/JVI.77.19.10677-10683.2003; Cocquerel L, 1999, J VIROL, V73, P2641, DOI 10.1128/JVI.73.4.2641-2649.1999; Codran A, 2006, J GEN VIROL, V87, P2583, DOI 10.1099/vir.0.81710-0; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; De Beeck AO, 2000, J BIOL CHEM, V275, P31428, DOI 10.1074/jbc.M003003200; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Diedrich G, 2006, FEBS J, V273, P3871, DOI 10.1111/j.1742-4658.2006.05379.x; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Frese M, 2003, J GEN VIROL, V84, P1253, DOI 10.1099/vir.0.18997-0; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gregory M, 2001, ENDOCRINOLOGY, V142, P854, DOI 10.1210/en.142.2.854; Hrzenjak A, 2004, CELL MOL LIFE SCI, V61, P1520, DOI 10.1007/s00018-004-4101-4; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jin J, 2007, J VIROL, V81, P11226, DOI 10.1128/JVI.00431-07; Kato T, 2005, J VIROL, V79, P592, DOI 10.1128/JVI.79.1.592-596.2005; Kovalenko OV, 2007, MOL CELL PROTEOMICS, V6, P1855, DOI 10.1074/mcp.M700183-MCP200; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Mee CJ, 2008, J VIROL, V82, P461, DOI 10.1128/JVI.01894-07; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Petracca R, 2000, J VIROL, V74, P4824, DOI 10.1128/JVI.74.10.4824-4830.2000; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Van Itallie CM, 2004, PHYSIOLOGY, V19, P331, DOI 10.1152/physiol.00027.2004; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Yamamoto Y, 2003, BIOCHEM BIOPH RES CO, V308, P270, DOI 10.1016/S0006-291X(03)01358-5; ZAHRAOUI A, 1994, J CELL BIOL, V124, P101, DOI 10.1083/jcb.124.1.101; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	44	86	90	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8643	8653		10.1074/jbc.M709824200	http://dx.doi.org/10.1074/jbc.M709824200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18211898	Green Published, hybrid			2022-12-27	WOS:000254288000063
J	Zemach, A; Gaspan, O; Grafi, G				Zemach, Assaf; Gaspan, Ofer; Grafi, Gideon			The three methyl-CpG-binding domains of AtMBD7 control its subnuclear localization and mobility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; HISTONE H1; MBD PROTEINS; LIVING CELLS; CHROMATIN; ARABIDOPSIS; FAMILY; PLANTS; MECP2	Three methyl-CpG-binding domain (MBD) proteins in Arabidopsis, AtMBD5, AtMBD6, and AtMBD7, are functional in binding methylated CpG dinucleotides in vitro and localize to the highly CpG-methylated chromocenters in vivo. These proteins differ, however, in their subnuclear localization pattern; AtMBD5 and AtMBD6, each containing a single MBD motif, show preference for two perinucleolar chromocenters, whereas AtMBD7, a naturally occurring poly-MBD protein containing three MBD motifs, localizes to all chromocenters. Here we studied the significance of multiple MBD motifs for subnuclear localization and mobility in living cells. We found that the number of MBD motifs determines the subnuclear localization of the MBD protein. Furthermore, live kinetic experiments showed that AtMBD7-green fluorescent protein (GFP) has lower mobility than AtMBD5-GFP and AtMBD6-GFP, which is conferred by cooperative activity of its three MBD motifs. Thus, the number of MBD motifs appears to affect not only binding affinity and mobility within the nucleus, but also the subnuclear localization of the protein. Our results suggest that poly-MBD proteins can directly affect chromatin structure by inducing intra-and inter-chromatin compaction via bridging over multiple methylated CpG sites.	[Zemach, Assaf; Gaspan, Ofer] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Grafi, Gideon] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Albert Katz Dept Dryland Biotechnol, IL-84990 Sede Boqer, Israel	Weizmann Institute of Science; Ben Gurion University	Zemach, A (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	assaf.zemach@weizmann.ac.il		Zemach, Assaf/0000-0003-3282-4445				Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Fatemi M, 2006, J CELL SCI, V119, P3033, DOI 10.1242/jcs.03099; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Grafi G, 1996, P NATL ACAD SCI USA, V93, P8962, DOI 10.1073/pnas.93.17.8962; Grafi G, 2007, BBA-GENE STRUCT EXPR, V1769, P287, DOI 10.1016/j.bbaexp.2007.02.004; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Jorgensen HF, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl527; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Roque A, 2004, NUCLEIC ACIDS RES, V32, P6111, DOI 10.1093/nar/gkh945; Springer NM, 2005, PLANT PHYSIOL, V138, P92, DOI 10.1104/pp.105.060566; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zemach A, 2006, PLANT CELL, V18, P133, DOI 10.1105/tpc.105.036855; Zemach A, 2005, PLANT CELL, V17, P1549, DOI 10.1105/tpc.105.031567; Zemach A, 2003, PLANT J, V34, P565, DOI 10.1046/j.1365-313X.2003.01756.x; Zemach A, 2007, TRENDS PLANT SCI, V12, P80, DOI 10.1016/j.tplants.2006.12.004; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	23	9	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8406	8411		10.1074/jbc.M706221200	http://dx.doi.org/10.1074/jbc.M706221200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18211904	Green Published, hybrid			2022-12-27	WOS:000254288000038
J	Barua, D; Faeder, JR; Haugh, JM				Barua, Dipak; Faeder, James R.; Haugh, Jason M.			Computational models of tandem Src homology 2 domain interactions and application to phosphoinositide 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P85-ALPHA REGULATORY SUBUNIT; RECEPTOR TYROSINE KINASES; SH2 DOMAINS; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; PI 3-KINASE; BINDING; PHOSPHORYLATION; SPECIFICITY; MOTIFS	Intracellular signal transduction proteins typically utilize multiple interaction domains for proper targeting, and thus a broad diversity of distinct signaling complexes may be assembled. Considering the coordination of only two such domains, as in tandem Src homology 2 ( SH2) domain constructs, gives rise to a kinetic scheme that is not adequately described by simple models used routinely to interpret in vitro binding measurements. To analyze the interactions between tandem SH2 domains and bisphosphorylated peptides, we formulated detailed kinetic models and applied them to the phosphoinositide 3-kinase p85 regulatory subunit/platelet-derived growth factor beta-receptor system. Data for this system from different in vitro assay platforms, including surface plasmon resonance, competition binding, and isothermal titration calorimetry, were reconciled to estimate the magnitude of the cooperativity characterizing the sequential binding of the high and low affinity SH2 domains ( C-SH2 and N-SH2, respectively). Compared with values based on an effective volume approximation, the estimated cooperativity is 3 orders of magnitude lower, indicative of significant structural constraints. Homodimerization of full-length p85 was found to be an alternative mechanism for high avidity binding to phosphorylated platelet-derived growth factor receptors, which would render the N-SH2 domain dispensable for receptor binding.	[Barua, Dipak; Haugh, Jason M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Faeder, James R.] Univ Pittsburgh, Sch Med, Dept Computat Biol, Pittsburgh, PA 15260 USA	University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Haugh, JM (corresponding author), Box 7905,911 Partners Way, Raleigh, NC 27695 USA.	jason_haugh@ncsu.edu		Faeder, James/0000-0001-8127-609X; Haugh, Jason/0000-0002-2476-4027; Barua, Dipak/0000-0001-8394-1233	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035556, U54GM064346, R01GM067739, R01GM076570] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067739-04, R01-GM076570, U54-GM064346, R01 GM067739, R01-GM067739, R37-GM35556] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barua D, 2007, BIOPHYS J, V92, P2290, DOI 10.1529/biophysj.106.093484; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Blinov ML, 2004, BIOINFORMATICS, V20, P3289, DOI 10.1093/bioinformatics/bth378; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Eungdamrong NJ, 2004, TRENDS CELL BIOL, V14, P661, DOI 10.1016/j.tcb.2004.10.007; Harpur AG, 1999, J BIOL CHEM, V274, P12323, DOI 10.1074/jbc.274.18.12323; Haugh JM, 2004, J THEOR BIOL, V230, P119, DOI 10.1016/j.jtbi.2004.04.023; HAUGH JM, 2007, CHEM BIOL SMALL MOL, V3, P1061; HERBST JJ, 1994, BIOCHEMISTRY-US, V33, P9376, DOI 10.1021/bi00198a002; Hlavacek William S, 2006, Sci STKE, V2006, pre6, DOI 10.1126/stke.3442006re6; Hlavacek WS, 2003, BIOTECHNOL BIOENG, V84, P783, DOI 10.1002/bit.10842; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; KAPELLER R, 1994, J BIOL CHEM, V269, P1927; Kaur H, 2006, BIOCHEM J, V393, P235, DOI 10.1042/BJ20051022; KAVANAUGH WM, 1992, MOL CELL BIOL, V12, P3415, DOI 10.1128/MCB.12.8.3415; KAZLAUSKAS A, 1990, EMBO J, V9, P3279, DOI 10.1002/j.1460-2075.1990.tb07527.x; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; LAUFFENBURGER DA, 1993, RECEPTORS MODELS BIN, P19; Layton MJ, 1998, J BIOL CHEM, V273, P33379, DOI 10.1074/jbc.273.50.33379; Lenz P, 2006, CURR BIOL, V16, P2150, DOI 10.1016/j.cub.2006.09.013; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; O'Brien R, 2000, PROTEIN SCI, V9, P570; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; PANAYOTOU G, 1992, EMBO J, V11, P4261, DOI 10.1002/j.1460-2075.1992.tb05524.x; Park CS, 2003, J BIOL CHEM, V278, P37064, DOI 10.1074/jbc.M304968200; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHOELSON SE, 1993, EMBO J, V12, P795, DOI 10.1002/j.1460-2075.1993.tb05714.x; Siegal G, 1998, J MOL BIOL, V276, P461, DOI 10.1006/jmbi.1997.1562; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; von Willebrand M, 1998, J BIOL CHEM, V273, P3994, DOI 10.1074/jbc.273.7.3994; Zhou HX, 2003, J MOL BIOL, V329, P1, DOI 10.1016/S0022-2836(03)00372-3; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	40	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7338	7345		10.1074/jbc.M708359200	http://dx.doi.org/10.1074/jbc.M708359200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18204097	hybrid, Green Published			2022-12-27	WOS:000253997900007
J	Inoue, H; Akita, M				Inoue, Hitoshi; Akita, Mitsuru			Three sets of translocation intermediates are formed during the early stage of protein import into chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEINS; ENVELOPE MEMBRANES; TRANSIT SEQUENCE; IDENTIFICATION; BINDING; OUTER; RECOGNITION; COMPONENTS; TRANSPORT; APPARATUS	During the early stage of protein import into chloroplasts, precursor proteins synthesized in the cytosol irreversibly bind to chloroplasts to form the early translocation intermediate under stringent energy conditions. Many efforts have been made to identify the components involved in protein import by analyzing the early intermediate. However, the state of the precursor within the intermediate has not been well investigated so far. In this study, an attempt was made to evaluate the extent of translocation of the precursor by determining the state of the precursor in the early intermediate under various conditions and analyzing the fragments generated by limited proteolysis of the precursors docked to chloroplasts. Our results indicate that three different sets of early intermediate are formed based on temperature and the hydrolysis of GTP/ ATP. These have been identified based on the size of proteolytic fragments of the precursor as "energy-dependent association," "insertion," and "penetration" states. These findings suggest two individual ATP-hydrolyzing steps during the early stage of protein import, one of which is temperature-sensitive. Our results also demonstrate that translocation through the outer envelope membrane is mainly dependent on internal ATP.	[Inoue, Hitoshi; Akita, Mitsuru] Ehime Univ, United Grad Agr Sci, Matsuyama, Ehime 7908566, Japan; [Inoue, Hitoshi; Akita, Mitsuru] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan	Ehime University; Ehime University	Akita, M (corresponding author), Ehime Univ, United Grad Agr Sci, Matsuyama, Ehime 7908566, Japan.	akita@agr.ehime-u.ac.jp		INOUE, Hitoshi/0000-0003-4988-337X				Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Becker T, 2004, MOL BIOL CELL, V15, P5130, DOI 10.1091/mbc.E04-05-0405; Becker T, 2004, EMBO J, V23, P520, DOI 10.1038/sj.emboj.7600089; Bedard J, 2005, J EXP BOT, V56, P2287, DOI 10.1093/jxb/eri243; Bruce BD, 1994, PLANT MOL BIOL MAN J, VJ1, P1; Chen KY, 2007, PLANT J, V49, P149, DOI 10.1111/j.1365-313X.2006.02944.x; CHUA NH, 1978, P NATL ACAD SCI USA, V75, P6110, DOI 10.1073/pnas.75.12.6110; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; Hasunuma K, 2003, J BIOENERG BIOMEMBR, V35, P57, DOI 10.1023/A:1023493823368; Jelic M, 2002, BIOL CHEM, V383, P1875, DOI 10.1515/BC.2002.211; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; Kouranov A, 1997, J CELL BIOL, V139, P1677, DOI 10.1083/jcb.139.7.1677; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHENY EA, 1994, PLANT CELL, V6, P427, DOI 10.2307/3869762; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma YK, 1996, J CELL BIOL, V134, P315, DOI 10.1083/jcb.134.2.315; May T, 2000, PLANT CELL, V12, P53, DOI 10.1105/tpc.12.1.53; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; OBLONG JE, 1992, EMBO J, V11, P4401, DOI 10.1002/j.1460-2075.1992.tb05540.x; OLSEN LJ, 1992, J BIOL CHEM, V267, P433; OLSEN LJ, 1989, J BIOL CHEM, V264, P6724; PERRY SE, 1994, PLANT CELL, V6, P93, DOI 10.1105/tpc.6.1.93; Rensink WA, 2000, J BIOL CHEM, V275, P10265, DOI 10.1074/jbc.275.14.10265; Schleiff E, 2003, P NATL ACAD SCI USA, V100, P4604, DOI 10.1073/pnas.0730860100; SCHNELL DJ, 1993, J CELL BIOL, V120, P103, DOI 10.1083/jcb.120.1.103; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Scott SV, 1996, J CELL BIOL, V132, P63, DOI 10.1083/jcb.132.1.63; THEG SM, 1989, J BIOL CHEM, V264, P6730; WAEGEMANN K, 1991, PLANT J, V1, P149, DOI 10.1111/j.1365-313X.1991.00149.x; Young ME, 1999, PLANT PHYSIOL, V121, P237, DOI 10.1104/pp.121.1.237	31	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7491	7502		10.1074/jbc.M709571200	http://dx.doi.org/10.1074/jbc.M709571200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18199746	hybrid			2022-12-27	WOS:000253997900024
J	Terrones, O; Etxebarria, A; Landajuela, A; Landeta, O; Antonsson, B; Basanez, G				Terrones, Oihana; Etxebarria, Aitor; Landajuela, Ane; Landeta, Olatz; Antonsson, Bruno; Basanez, Gorka			BIM and tBID are not mechanistically equivalent when assisting BAX to permeabilize bilayer membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY; CONFORMATIONAL-CHANGE; ANTIMICROBIAL PEPTIDES; PROAPOPTOTIC MOLECULES; PORE FORMATION; BH3 DOMAINS; CARDIOLIPIN; APOPTOSIS; MITOCHONDRIA	BIM and tBID are two BCL-2 homology 3 (BH3)-only proteins with a particularly strong capacity to trigger BAX-driven mitochondrial outer membrane permeabilization, a crucial event in mammalian apoptosis. However, the means whereby BIM and tBID fulfill this task is controversial. Here, we used a reconstituted liposomal system bearing physiological relevance to explore systematically how the BAX-permeabilizing function is influenced by interactions of BIM/BID-derived proteins and BH3 motifs with multidomain BCL-2 family members and with membrane lipids. We found that nanomolar dosing of BIM proteins sufficed to reverse completely the inhibition of BAX permeabilizing activity exerted by all antiapoptotic proteins tested (BCL-2, BCL-XL, BCL-W, MCL-1, and A1). This effect was reproducible by a peptide representing the BH3 motif of BIM, whereas an equivalent BID BH3 peptide was less potent and more selective, reversing antiapoptotic inhibition. On the other hand, in the absence of BCL-2-type proteins, BIM proteins and the BIM BH3 peptide were inefficient, directly triggering the BAX-permeabilizing function. In contrast, tBID alone potently assisted BAX to permeabilize membranes at least in part by producing a structural distortion in the lipid bilayer via BH3-independent interaction of tBID with cardiolipin. Together, these results support the notion that BIM and tBID follow different strategies to trigger BAX-driven mitochondrial outer membrane permeabilization with strong potency.	[Terrones, Oihana; Etxebarria, Aitor; Landajuela, Ane; Landeta, Olatz; Basanez, Gorka] Univ Pais Vasco Euskal Herriko Unibertistatea, Unidad Biofis CSIC UPV EHU, Leioa 48940, Spain; [Antonsson, Bruno] Merck Serono Int SA, CH-1202 Geneva, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.	Basanez, G (corresponding author), Univ Pais Vasco Euskal Herriko Unibertistatea, Unidad Biofis CSIC UPV EHU, POB 644,Barrio Sarriena S-N, Leioa 48940, Spain.	gbzbaasg@lg.ehu.es	Terrones, Oihana/AAA-8903-2019; Basanez, Gorka/L-9509-2014; Terrones, Oihana/I-4023-2015	Basanez, Gorka/0000-0002-7475-7861; Terrones, Oihana/0000-0001-7421-6486; Landeta, Olatz/0000-0002-5494-0271				Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Basanez G, 2002, FEBS LETT, V532, P115, DOI 10.1016/S0014-5793(02)03651-7; Basanez G, 2002, CELL MOL LIFE SCI, V59, P1478, DOI 10.1007/s00018-002-8523-6; Basanez G, 2001, J BIOL CHEM, V276, P31083, DOI 10.1074/jbc.M103879200; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Day CL, 1999, CELL DEATH DIFFER, V6, P1125, DOI 10.1038/sj.cdd.4400584; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Garcia-Saez AJ, 2005, BIOPHYS J, V88, P3976, DOI 10.1529/biophysj.104.058008; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; Germain M, 2008, J BIOL CHEM, V283, P6384, DOI 10.1074/jbc.M707762200; Giordano A, 2005, CELL DEATH DIFFER, V12, P603, DOI 10.1038/sj.cdd.4401636; Gong XM, 2004, J BIOL CHEM, V279, P28954, DOI 10.1074/jbc.M403490200; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P659, DOI 10.1038/sj.cdd.4401585; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guscetti F, 2005, FASEB J, V19, P464, DOI 10.1096/fj.04-2316fje; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Huang HW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198304; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Liu J, 2004, APOPTOSIS, V9, P533, DOI 10.1023/B:APPT.0000038034.16230.ea; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Mizuta T, 2007, J BIOL CHEM, V282, P16623, DOI 10.1074/jbc.M611060200; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Oh KJ, 2006, J BIOL CHEM, V281, P36999, DOI 10.1074/jbc.M602341200; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Polster BM, 2003, J NEUROSCI, V23, P2735; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; SCHMITT L, 1994, J AM CHEM SOC, V116, P8485, DOI 10.1021/ja00098a008; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Terradillos O, 2002, FEBS LETT, V522, P29, DOI 10.1016/S0014-5793(02)02871-5; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Thuduppathy GR, 2006, BIOCHEMISTRY-US, V45, P14533, DOI 10.1021/bi0616652; Tyurin VA, 2007, CELL DEATH DIFFER, V14, P872, DOI 10.1038/sj.cdd.4402068; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Weber A, 2007, J CELL BIOL, V177, P625, DOI 10.1083/jcb.200610148; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yamaguchi H, 2002, J BIOL CHEM, V277, P41604, DOI 10.1074/jbc.M207516200; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; YIN XM, 2006, GENE, V15, P369; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Youle RJ, 2007, SCIENCE, V315, P776, DOI 10.1126/science.1138870; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200; [No title captured]	63	31	32	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7790	7803		10.1074/jbc.M708814200	http://dx.doi.org/10.1074/jbc.M708814200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18195012	hybrid			2022-12-27	WOS:000253997900055
J	Zhang, XM; Tan, FL; Zhang, YK; Skidgel, RA				Zhang, Xianming; Tan, Fulong; Zhang, Yongkang; Skidgel, Randal A.			Carboxypeptidase M and kinin B1 receptors interact to facilitate efficient b1 signaling from B2 agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME; NITRIC-OXIDE PRODUCTION; MEMBRANE-BOUND CARBOXYPEPTIDASE; KINASE-C-EPSILON; CRYSTAL-STRUCTURE; B-1 RECEPTORS; LIPID RAFTS; BRADYKININ RECEPTORS; ENDOTHELIAL-CELLS; MOLECULAR-CLONING	Kinin B1 receptor (B1R) expression is induced by injury or inflammatory mediators, and its signaling produces both beneficial and deleterious effects. Kinins cleaved from kininogen are agonists of the B2R and must be processed by a carboxypeptidase to generate B1R agonists des-Arg(9)-bradykinin or desArg(10)-kallidin. Carboxypeptidase M(CPM) is a membrane protein potentially well suited for this function. Here we show that CPM expression is required to generate a B1R-dependent increase in [Ca2+](i) in cells stimulated with B2R agonists kallidin or bradykinin. CPM and the B1R interact on the cell membrane, as shown by co-immunoprecipitation, cross-linking, and fluorescence resonance energy transfer analysis. CPM and B1R are also co-localized in lipid raft/caveolin-enriched membrane fractions, as determined by gradient centrifugation. Treatment of cells co-expressing CPM and B1R with methyl-beta-cyclodextrin to disrupt lipid rafts reduced the B1R-dependent increase in [Ca2+](i) in response to B2R agonists, whereas cholesterol treatment enhanced the response. A monoclonal antibody to the C-terminal beta-sheet domain of CPM reduced the B1R response to B2R agonists without inhibiting CPM. Cells expressing a novel fusion protein containing CPM at the N terminus of the B1R also increased [Ca2+] i when stimulated with B2R agonists, but the response was not reduced by methyl-beta-cyclodextrin or CPM antibody. A B1R- and CPM-dependent calcium signal in response to B2R agonist bradykinin was also found in endothelial cells that express both proteins. Thus, a close relationship of B1Rs and CPM on themembraneis required for efficiently generating B1R signals, which play important roles in inflammation.	[Zhang, Xianming; Tan, Fulong; Zhang, Yongkang; Skidgel, Randal A.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Tan, Fulong; Skidgel, Randal A.] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Skidgel, RA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, M-C 868,835 S Wolcott, Chicago, IL 60612 USA.	rskidgel@uic.edu	zhang, xian/GYA-0290-2022		NHLBI NIH HHS [P01 HL060678] Funding Source: Medline; NIDDK NIH HHS [DK 41431] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK041431, R01DK041431, R56DK041431] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Aloy P, 2001, J BIOL CHEM, V276, P16177, DOI 10.1074/jbc.M011457200; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Boldt J, 1998, CRIT CARE MED, V26, P1663, DOI 10.1097/00003246-199810000-00018; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Campos MM, 2006, TRENDS PHARMACOL SCI, V27, P646, DOI 10.1016/j.tips.2006.10.007; Chen ZL, 2006, FASEB J, V20, P2261, DOI 10.1096/fj.06-6113com; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; DEDDISH PA, 1990, J BIOL CHEM, V265, P15083; DEDDISH PA, 1989, BIOCHEM J, V261, P289, DOI 10.1042/bj2610289; Donnini S, 2006, J PHARMACOL EXP THER, V319, P515, DOI 10.1124/jpet.106.108803; EATON DL, 1991, J BIOL CHEM, V266, P21833; Emanueli C, 2002, CIRCULATION, V105, P360, DOI 10.1161/hc0302.102142; Erdos EG, 1999, TRENDS ENDOCRIN MET, V10, P223, DOI 10.1016/S1043-2760(99)00156-3; Erdos EG, 2002, INT IMMUNOPHARMACOL, V2, P1741, DOI 10.1016/S1567-5769(02)00166-2; Erdos EG, 2002, CARDIOVASC RES, V54, P485, DOI 10.1016/S0008-6363(02)00284-5; ERDOS EG, 1962, BIOCHEM PHARMACOL, V11, P585, DOI 10.1016/0006-2952(62)90119-3; Fricker LD, 1999, TRENDS BIOCHEM SCI, V24, P390, DOI 10.1016/S0968-0004(99)01448-6; FRICKER LD, 2004, HDB PROTEOLYTIC ENZY, P844; Fricker LD, 2004, HDB PROTEOLYTIC ENZY, V8, P840; Goldspink PH, 2004, CIRC RES, V95, P424, DOI 10.1161/01.RES.0000138299.85648.92; Hadkar V, 2001, MOL PHARMACOL, V59, P1324, DOI 10.1124/mol.59.5.1324; Hagiwara M, 2004, HYPERTENS RES, V27, P399, DOI 10.1291/hypres.27.399; Ignjatovic T, 2004, MOL PHARMACOL, V66, P1310, DOI 10.1124/mol.104.001990; Ignjatovic T, 2002, J BIOL CHEM, V277, P16847, DOI 10.1074/jbc.M200355200; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kang DS, 2005, MOL PHARMACOL, V67, P309, DOI 10.1124/mol.104.002840; Keil C, 2007, J MOL BIOL, V366, P504, DOI 10.1016/j.jmb.2006.11.025; Kenworthy A, 2002, TRENDS BIOCHEM SCI, V27, P435, DOI 10.1016/S0968-0004(02)02178-3; KUROKI K, 1994, J VIROL, V68, P2091, DOI 10.1128/JVI.68.4.2091-2096.1994; Lamb ME, 2001, BIOCHEM J, V355, P741, DOI 10.1042/bj3550741; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Li JQ, 2002, GENE, V284, P189, DOI 10.1016/S0378-1119(01)00898-8; Liu J, 2004, J BIOL CHEM, V279, P55924, DOI 10.1074/jbc.M410024200; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Marcic B, 2000, J BIOL CHEM, V275, P16110, DOI 10.1074/jbc.M909490199; MCGWIRE GB, 1995, J BIOL CHEM, V270, P17154, DOI 10.1074/jbc.270.29.17154; Michel B, 1996, CIRC RES, V78, P635; Moniwa N, 2006, BIOL CHEM, V387, P203, DOI 10.1515/BC.2006.027; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Parenti A, 2001, FASEB J, V15, P1487, DOI 10.1096/fj.00-0503fje; Parkin ET, 2003, J CELL SCI, V116, P3079, DOI 10.1242/jcs.00626; Pesquero JB, 2006, BIOL CHEM, V387, P119, DOI 10.1515/BC.2006.017; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; REGOLI D, 1980, PHARMACOL REV, V32, P1; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Sabourin T, 2002, MOL PHARMACOL, V61, P546, DOI 10.1124/mol.61.3.546; Sangsree S, 2003, AM J PHYSIOL-HEART C, V284, pH1959, DOI 10.1152/ajpheart.00036.2003; Schremmer-Danninger E, 1998, BIOCHEM BIOPH RES CO, V243, P246, DOI 10.1006/bbrc.1997.7999; SHINOHARA T, 1994, INT ARCH ALLERGY IMM, V103, P400, DOI 10.1159/000236661; Siebeck M, 1996, IMMUNOPHARMACOLOGY, V33, P81, DOI 10.1016/0162-3109(96)00060-4; Skidgel R. A., 1996, ZINC METALLOPROTEASE, P241; Skidgel RA, 2006, BIOL CHEM, V387, P159, DOI 10.1515/BC.2006.021; Skidgel RA, 1998, IMMUNOL REV, V161, P129, DOI 10.1111/j.1600-065X.1998.tb01577.x; SKIDGEL RA, 1989, J BIOL CHEM, V264, P2236; SKIDGEL RA, 1988, TRENDS PHARMACOL SCI, V9, P299, DOI 10.1016/0165-6147(88)90015-6; SKIDGEL RA, 1984, BIOCHEM PHARMACOL, V33, P3471, DOI 10.1016/0006-2952(84)90122-9; SKIDGEL RA, 2004, HDB PROTEOLYTIC ENZY, P851; SKIDGEL RA, 2004, HDB PROTEOLYTIC ENZY, P837; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Stanisavljevic S, 2006, J PHARMACOL EXP THER, V316, P1153, DOI 10.1124/jpet.105.093849; TAN FL, 1995, METHOD ENZYMOL, V248, P663; TAN FL, 1989, J BIOL CHEM, V264, P13165; Tan FL, 2003, BIOCHEM J, V370, P567, DOI 10.1042/BJ20021495; Varlamov O, 1998, J CELL SCI, V111, P877; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Wiel E, 2004, INTENS CARE MED, V30, P1652, DOI 10.1007/s00134-004-2198-4; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200	72	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7994	8004		10.1074/jbc.M709837200	http://dx.doi.org/10.1074/jbc.M709837200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18187413	hybrid			2022-12-27	WOS:000253997900074
J	Anderson, SB; Goldberg, AL; Whitman, M				Anderson, Sarah B.; Goldberg, Alfred L.; Whitman, Malcolm			Identification of a novel pool of extracellular pro-myostatin in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; LATENT TGF-BETA; MOLECULAR-WEIGHT COMPLEX; BINDING-PROTEIN; SUPERFAMILY MEMBER; GDF-8 PROPEPTIDE; HUMAN-PLATELETS; IN-VIVO; MICE; ACTIVATION	Myostatin, a transforming growth factor-beta superfamily ligand, negatively regulates skeletal muscle growth. Generation of the mature signaling peptide requires cleavage of pro-myostatin by a proprotein convertase, which is thought to occur constitutively in the Golgi apparatus. In serum, mature myostatin is found in an inactive, non-covalent complex with its prodomain. We find that in skeletal muscle, unlike serum, myostatin is present extracellularly as uncleaved pro-myostatin. In cultured cells, co-expression of pro-myostatin and latent transforming growth factor-beta-binding protein-3 (LTBP-3) sequesters pro-myostatin in the extracellular matrix, and secreted pro-myostatin can be cleaved extracellularly by the proprotein convertase furin. Co-expression of LTBP-3 with myostatin reduces phosphorylation of Smad2, and ectopic expression of LTBP-3 in mature mouse skeletal muscle increases fiber area, consistent with reduction of myostatin activity. We propose that extracellular pro-myostatin constitutes the major pool of latent myostatin in muscle. Post-secretion activation of this pool by furin family proprotein convertases may therefore represent a major control point for activation of myostatin in skeletal muscle.	[Anderson, Sarah B.; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Anderson, Sarah B.; Whitman, Malcolm] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine	Whitman, M (corresponding author), 188 Longwood Ave, Boston, MA 02115 USA.	mwhitman@hms.harvard.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029468] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-29468] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altmann CR, 2002, DEV BIOL, V248, P118, DOI 10.1006/dbio.2002.0716; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Baqui M, 2003, J BIOL CHEM, V278, P1206, DOI 10.1074/jbc.M210266200; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Chen Y, 2003, J CELL PHYSIOL, V196, P319, DOI 10.1002/jcp.10296; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Dabovic B, 2002, J CELL BIOL, V156, P227, DOI 10.1083/jcb.200111080; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Faure S, 2000, DEVELOPMENT, V127, P2917; FLAUMENHAFT R, 1993, J CELL BIOL, V120, P995, DOI 10.1083/jcb.120.4.995; Gleizes PE, 1996, J BIOL CHEM, V271, P29891, DOI 10.1074/jbc.271.47.29891; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Ho DM, 2006, DEV BIOL, V295, P730, DOI 10.1016/j.ydbio.2006.03.050; Hosoyama T, 2005, ZOOL SCI, V22, P229, DOI 10.2108/zsj.22.229; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; Koli K, 2001, MICROSC RES TECHNIQ, V52, P354, DOI 10.1002/1097-0029(20010215)52:4<354::AID-JEMT1020>3.0.CO;2-G; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee MA, 2001, DEVELOPMENT, V128, P2939; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Leitlein J, 2001, J IMMUNOL, V166, P7238, DOI 10.4049/jimmunol.166.12.7238; Liaw PCY, 2001, J BIOL CHEM, V276, P8364, DOI 10.1074/jbc.M010572200; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; MOREN A, 1994, J BIOL CHEM, V269, P32469; Noguera I, 2003, GENE, V308, P31, DOI 10.1016/S0378-1119(03)00463-3; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; Patel K, 2005, NEUROMUSCULAR DISORD, V15, P117, DOI 10.1016/j.nmd.2004.10.018; Penttinen C, 2002, J CELL SCI, V115, P3457; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Saharinen J, 1996, EMBO J, V15, P245, DOI 10.1002/j.1460-2075.1996.tb00355.x; Saharinen J, 1998, J BIOL CHEM, V273, P18459, DOI 10.1074/jbc.273.29.18459; Sakuma K, 2000, BBA-MOL CELL RES, V1497, P77, DOI 10.1016/S0167-4889(00)00044-6; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Shipley JM, 2000, MOL CELL BIOL, V20, P4879, DOI 10.1128/MCB.20.13.4879-4887.2000; Siriett V, 2006, J CELL PHYSIOL, V209, P866, DOI 10.1002/jcp.20778; Thies RS, 2001, GROWTH FACTORS, V18, P251; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; Wehling M, 2000, FASEB J, V14, P103, DOI 10.1096/fasebj.14.1.103; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wojcik S, 2005, ACTA NEUROPATHOL, V110, P173, DOI 10.1007/s00401-005-1035-3; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; YIN WS, 1995, J BIOL CHEM, V270, P10147, DOI 10.1074/jbc.270.17.10147; Yin WS, 1998, BBA-PROTEIN STRUCT M, V1383, P340, DOI 10.1016/S0167-4838(98)00003-X; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	56	108	123	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7027	7035		10.1074/jbc.M706678200	http://dx.doi.org/10.1074/jbc.M706678200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18175804	hybrid			2022-12-27	WOS:000253779600047
J	Beltzner, CC; Pollard, TD				Beltzner, Christopher C.; Pollard, Thomas D.			Pathway of actin filament branch formation by Arp2/3 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASP/SCAR PROTEINS; FISSION YEAST; ADP-ACTIN; NUCLEATION; POLYMERIZATION; WASP; IDENTIFICATION; ACTIVATION; ENERGETICS; MECHANISM	A spectroscopic assay using pyrene-labeled fission yeast Arp2/3 complex revealed that the complex binds to and dissociates from actin filaments extremely slowly with or without the nucleation-promoting factor fission yeast Wsp1-VCA. Wsp1-VCA binds both Arp2/3 complex and actin monomers with high affinity. These two ligands have only modest impacts on the interaction of the other ligand with VCA. Simulations of a mathematical model based on the kinetic parameters determined in this study and elsewhere account for the full time course of actin polymerization in the presence of Arp2/3 complex and Wsp1-VCA and show that an activation step, postulated to follow binding of a ternary complex of Arp2/ 3 complex, a bound nucleation-promoting factor, and an actin monomer to an actin filament, has a rate constant at least 0.15 s(-1). Kinetic parameters determined in this study constrain the process of actin filament branch formation during cellular motility to one main pathway.	[Beltzner, Christopher C.; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, 219 Prospect St,KBT-548,POB 208103, New Haven, CT 06520 USA.	thomas.pollard@yale.edu			NIGMS NIH HHS [GM-26338] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beltzner CC, 2004, J MOL BIOL, V336, P551, DOI 10.1016/j.jmb.2003.12.017; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1998, MOL BIOL CELL, V9, P841, DOI 10.1091/mbc.9.4.841; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; WHITE HD, 1976, BIOCHEMISTRY-US, V15, P5818, DOI 10.1021/bi00671a020	28	71	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7135	7144		10.1074/jbc.M705894200	http://dx.doi.org/10.1074/jbc.M705894200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18165685	hybrid			2022-12-27	WOS:000253779600059
J	Shi, D; Sagar, V; Jin, ZM; Yu, XL; Caldovic, L; Morizono, H; Allewell, NM; Tuchman, M				Shi, Dashuang; Sagar, Vatsala; Jin, Zhongmin; Yu, Xiaolin; Caldovic, Ljubica; Morizono, Hiroki; Allewell, Norma M.; Tuchman, Mendel			The crystal structure of N-acetyl-L-glutamate synthase from Neisseria gonorrhoeae provides insights into mechanisms of catalysis and regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-BIOSYNTHESIS; ACETYLGLUTAMATE SYNTHASE; ESCHERICHIA-COLI; HISTONE ACETYLTRANSFERASE; CARBAMOYL-PHOSPHATE; PYROCOCCUS-FURIOSUS; PROTEIN-STRUCTURE; KINASE; EXPRESSION; ENZYME	The crystal structures of N-acetylglutamate synthase ( NAGS) in the arginine biosynthetic pathway of Neisseria gonorrhoeae complexed with acetyl-CoA and with CoA plus N-acetylglutamate have been determined at 2.5- and 2.6-angstrom resolution, respectively. The monomer consists of two separately folded domains, an amino acid kinase ( AAK) domain and an N-acetyltransferase ( NAT) domain connected through a 10-angstrom linker. The monomers assemble into a hexameric ring that consists of a trimer of dimers with 32-point symmetry, inner and outer ring diameters of 20 and 100 A, respectively, and a height of 110 A. Each AAK domain interacts with the cognate domains of two adjacent monomers across two 2-fold symmetry axes and with the NAT domain from a second monomer of the adjacent dimer in the ring. The catalytic sites are located within the NAT domains. Three active site residues, Arg(316), Arg(425), and Ser(427), anchor N-acetylglutamate in a position at the active site to form hydrogen bond interactions to the main chain nitrogen atoms of Cys(356) and Leu(314), and hydrophobic interactions to the side chains of Leu(313) and Leu(314). The mode of binding of acetyl-CoA and CoA is similar to other NAT family proteins. The AAK domain, although catalytically inactive, appears to bind arginine. This is the first reported crystal structure of any NAGS, and it provides insights into the catalytic function and arginine regulation of NAGS enzymes.	[Shi, Dashuang; Yu, Xiaolin; Caldovic, Ljubica; Morizono, Hiroki; Tuchman, Mendel] George Washington Univ, Childrens Natl Med Ctr, Childrens Res Inst, Washington, DC 20010 USA; [Sagar, Vatsala; Allewell, Norma M.] Univ Maryland, Dept Chem & Biochem, Coll Chem & Life Sci, College Pk, MD 20742 USA; [Jin, Zhongmin] Argonne Natl Lab, SE Reg Collaborat Access Team Adv Photon Source, Argonne, IL 60439 USA	Children's National Health System; George Washington University; University System of Maryland; University of Maryland College Park; United States Department of Energy (DOE); Argonne National Laboratory	Shi, D (corresponding author), George Washington Univ, Childrens Natl Med Ctr, Childrens Res Inst, 11 Michigan Ave,NW, Washington, DC 20010 USA.	dshi@cnmcresearch.org	Morizono, Hiroki/E-9737-2013	Morizono, Hiroki/0000-0002-9678-5564; Sagar, Vatsala/0000-0003-4980-6462; Shi, Dashuang/0000-0002-5491-1104; Caldovic, Ljubica/0000-0002-9140-5585	NICHD NIH HHS [HD 32652, P01 HD032652] Funding Source: Medline; NIDDK NIH HHS [K01 DK067935, DK064913, DK067935, R01 DK064913] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064913, K01DK067935] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACHMANN C, 1982, ADV EXP MED BIOL, V153, P39; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Briozzo P, 2005, J BIOL CHEM, V280, P25533, DOI 10.1074/jbc.M501849200; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; Caldovic L, 2002, BIOCHEM BIOPH RES CO, V299, P581, DOI 10.1016/S0006-291X(02)02696-7; Caldovic L, 2002, BIOCHEM J, V364, P825, DOI 10.1042/BJ20020161; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Delano W.L, 2002, PYMOL USERS MANUAL; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2005, J BACTERIOL, V187, P3039, DOI 10.1128/JB.187.9.3039-3044.2005; GRISOLIA S, 1953, J BIOL CHEM, V204, P753; HAAS D, 1975, EUR J BIOCHEM, V52, P377; He HZ, 2003, J MOL BIOL, V325, P1019, DOI 10.1016/S0022-2836(02)01284-6; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Labedan B, 2004, MOL BIOL EVOL, V21, P364, DOI 10.1093/molbev/msh024; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Marco-Marin C, 2005, J MOL BIOL, V352, P438, DOI 10.1016/j.jmb.2005.07.045; Marina A, 1999, PROTEIN SCI, V8, P934; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; MAROMARIN C, 2007, J MOL BIOL, V367, P1431; MARTIN PR, 1992, J BACTERIOL, V174, P2694, DOI 10.1128/jb.174.8.2694-2701.1992; MARVIL DK, 1977, J BIOL CHEM, V252, P3295; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Qu Qiuhao, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-4; Ramon-Maiques S, 2000, J MOL BIOL, V299, P463, DOI 10.1006/jmbi.2000.3779; Ramon-Maiques S, 2006, J MOL BIOL, V356, P695, DOI 10.1016/j.jmb.2005.11.079; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shi DS, 2006, ACTA CRYSTALLOGR F, V62, P1218, DOI 10.1107/S1744309106044101; Shi DS, 2005, ACTA CRYSTALLOGR F, V61, P676, DOI 10.1107/S1744309105018051; Sinclair JC, 2000, NAT STRUCT BIOL, V7, P560; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Vetting MW, 2003, PROTEIN SCI, V12, P1954, DOI 10.1110/ps.03153703; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WONG LJC, 1983, BIOCHEMISTRY-US, V22, P4637, DOI 10.1021/bi00289a004; Xu Y, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-4; Xu Y, 2007, MICROBIOL MOL BIOL R, V71, P36, DOI 10.1128/MMBR.00032-06; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849	51	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7176	7184		10.1074/jbc.M707678200	http://dx.doi.org/10.1074/jbc.M707678200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18184660	Green Accepted, hybrid			2022-12-27	WOS:000253779600063
J	Wu, L; Yong, SL; Fan, C; Ni, Y; Yoo, S; Zhang, T; Zhang, X; Obejero-Paz, CA; Rho, HJ; Ke, T; Szafranski, P; Jones, SW; Chen, Q; Wang, QK				Wu, Ling; Yong, Sandro L.; Fan, Chun; Ni, Ying; Yoo, Shin; Zhang, Teng; Zhang, Xianqin; Obejero-Paz, Carlos A.; Rho, Hyun-Jin; Ke, Tie; Szafranski, Przemyslaw; Jones, Stephen W.; Chen, Qiuyun; Wang, Qing Kenneth			Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Na(v)1.5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISM; SCN5A MUTATION; PROTEIN; EXPRESSION; RAN; PHOSPHORYLATION; SUSCEPTIBILITY; ARRHYTHMIA; INTERACTS; SUBUNITS	The cardiac sodium channel Na(v)1.5 is essential for the physiological function of the heart and contributes to lethal cardiac arrhythmias and sudden death when mutated. Here, we report that MOG1, a small protein that is highly conserved from yeast to humans, is a central component of the channel complex and modulates the physiological function of Na(v)1.5. The yeast two-hybrid screen identified MOG1 as a new protein that interacts with the cytoplasmic loop II ( between transmembrane domains DII and DIII) of Na(v)1.5. The interaction was further demonstrated by both in vitro glutathione S-transferase pull-down and in vivo co-immunoprecipitation assays in both HEK293 cells with co-expression of MOG1 and Nav1.5 and native cardiac cells. Co-expression of MOG1 with Na(v)1.5 in HEK293 cells increased sodium current densities. In neonatal myocytes, overexpression of MOG1 increased current densities nearly 2-fold. Western blot analysis revealed that MOG1 increased cell surface expression of Na(v)1.5, which may be the underlying mechanism by which MOG1 increased sodium current densities. Immunostaining revealed that in the heart, MOG1 was expressed in both atrial and ventricular tissues with predominant localization at the intercalated discs. In cardiomyocytes, MOG1 is mostly localized in the cell membrane and co-localized with Na(v)1.5. These results indicate that MOG1 is a critical regulator of sodium channel function in the heart and reveal a new cellular function for MOG1. This study further demonstrates the functional diversity of Na(v)1.5-binding proteins, which serve important functions for Na(v)1.5 under different cellular conditions.	[Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China; [Wang, Qing Kenneth] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Szafranski, Przemyslaw] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Obejero-Paz, Carlos A.; Jones, Stephen W.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Wu, Ling; Wang, Qing Kenneth] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Wu, Ling; Yong, Sandro L.; Fan, Chun; Ni, Ying; Yoo, Shin; Zhang, Teng; Zhang, Xianqin; Rho, Hyun-Jin; Ke, Tie; Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Ctr Cardiovasc Genet NE40,Tausig Canc Ctr, Dept Cardiovasc Med, Lerner Res Inst,Dept Mol Cardiol, Cleveland, OH 44195 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University System of Ohio; Cleveland State University; Baylor College of Medicine; Case Western Reserve University; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation	Wang, QK (corresponding author), Cleveland Clin, Ctr Cardiovasc Genet NE40,Tausig Canc Ctr, Dept Cardiovasc Med, Lerner Res Inst,Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wangq2@ccf.org	Ke, Tie/AIC-5771-2022; Jones, Stephen/AAJ-4465-2020	Ke, Tie/0000-0002-8888-8424; 	NHLBI NIH HHS [R01 HL66251] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066251] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abriel H, 2005, TRENDS CARDIOVAS MED, V15, P35, DOI 10.1016/j.tcm.2005.01.001; Allouis M, 2006, CIRC RES, V98, P1538, DOI 10.1161/01.RES.0000229244.97497.2c; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Fahmi AI, 2001, J PHYSIOL-LONDON, V537, P693; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Herfst LJ, 2004, J MOL CELL CARDIOL, V36, P185, DOI 10.1016/j.yjmcc.2003.11.014; Jespersen T, 2006, BIOCHEM BIOPH RES CO, V348, P1455, DOI 10.1016/j.bbrc.2006.08.014; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Lu JMY, 2004, EUKARYOT CELL, V3, P1544, DOI 10.1128/EC.3.6.1544-1556.2004; Lu JMY, 2003, EUKARYOT CELL, V2, P1304, DOI 10.1128/EC.2.6.1304-1314.2003; Malhotra JD, 2001, CIRCULATION, V103, P1303; Marfatia KA, 2001, GENE, V266, P45, DOI 10.1016/S0378-1119(01)00364-X; Meadows LS, 2005, CARDIOVASC RES, V67, P448, DOI 10.1016/j.cardiores.2005.04.003; Nuss HB, 1995, J GEN PHYSIOL, V106, P1171, DOI 10.1085/jgp.106.6.1171; Oki M, 1998, P NATL ACAD SCI USA, V95, P15388, DOI 10.1073/pnas.95.26.15388; Oki M, 2007, GENE, V400, P114, DOI 10.1016/j.gene.2007.06.012; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; QU YS, 1995, J BIOL CHEM, V270, P25696, DOI 10.1074/jbc.270.43.25696; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Steggerda SM, 2000, J BIOL CHEM, V275, P23175, DOI 10.1074/jbc.C000252200; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Tian XL, 2004, CARDIOVASC RES, V61, P256, DOI 10.1016/j.cardiores.2003.11.007; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Wan XP, 2000, J MOL CELL CARDIOL, V32, P1873, DOI 10.1006/jmcc.2000.1223; Wan XP, 2001, AM J PHYSIOL-HEART C, V280, pH354, DOI 10.1152/ajpheart.2001.280.1.H354; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; WANG Q, 1995, HUM MOL GENET, V4, P1603, DOI 10.1093/hmg/4.9.1603; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Wu L, 2002, NEUROREPORT, V13, P2547, DOI 10.1097/00001756-200212200-00033; Yagi T, 2002, CARDIOVASC RES, V54, P405, DOI 10.1016/S0008-6363(02)00279-1; Yong Sandro L., 2006, V129, P127; Yong SRL, 2007, BIOCHEM BIOPH RES CO, V352, P378, DOI 10.1016/j.bbrc.2006.11.019; Yu FH, 2003, J NEUROSCI, V23, P7577; Zhang T, 2007, BIOCHEM BIOPH RES CO, V355, P444, DOI 10.1016/j.bbrc.2007.01.170; Zhou JS, 2002, CIRC RES, V91, P540, DOI 10.1161/01.RES.0000033598.00903.27; Zicha S, 2004, J MOL CELL CARDIOL, V37, P91, DOI 10.1016/j.yjmcc.2004.04.003	40	61	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6968	6978		10.1074/jbc.M709721200	http://dx.doi.org/10.1074/jbc.M709721200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18184654	hybrid			2022-12-27	WOS:000253779600041
J	Yang, SH; Qiao, X; Farber, E; Chang, SY; Fong, LG; Young, SG				Yang, Shao H.; Qiao, Xin; Farber, Emily; Chang, Sandy Y.; Fong, Loren G.; Young, Stephen G.			Eliminating the synthesis of mature lamin A reduces disease phenotypes in mice carrying a Hutchinson-Gilford progeria syndrome allele	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRELAMIN-A; SYNDROME MUTATION; NUCLEAR-ENVELOPE; MOUSE MODEL; ZMPSTE24; FARNESYLATION; DEFICIENCY; INTEGRITY; B1	Hutchinson-Gilford progeria syndrome is caused by the synthesis of a mutant form of prelamin A, which is generally called progerin. Progerin is targeted to the nuclear rim, where it interferes with the integrity of the nuclear lamina, causes misshapen cell nuclei, and leads to multiple aging-like disease phenotypes. We created a gene-targeted allele yielding exclusively progerin (Lmna(HG)) and found that heterozygous mice (Lmna(HG/+)) exhibit many phenotypes of progeria. In this study, we tested the hypothesis that the phenotypes elicited by the LmnaHG allele might be modulated by compositional changes in the nuclear lamina. To explore this hypothesis, we bred mice harboring one Lmna(HG) allele and one Lmna(LCO) allele ( a mutant allele that produces lamin C but no lamin A). We then compared the phenotypes of Lmna(HG/LCO) mice ( which produce progerin and lamin C) with littermate Lmna(HG/+) mice ( which produce lamin A, lamin C, and progerin). Lmna(HG/LCO) mice exhibited improved body weight curves ( p< 0.0001), reduced numbers of spontaneous rib fractures ( p < 0.0001), and improved survival ( p < 0.0001). In addition, Lmna(HG/LCO) fibroblasts had fewer misshapen nuclei than Lmna(HG/+) fibroblasts ( p < 0.0001). A likely explanation for these differences was uncovered; the amount of progerin in Lmna(HG/LCO) fibroblasts and tissues was lower than in Lmna(HG/+) fibroblasts and tissues. These studies suggest that compositional changes in the nuclear lamina can influence both the steady-state levels of progerin and the severity of progeria-like disease phenotypes.	[Yang, Shao H.; Qiao, Xin; Farber, Emily; Chang, Sandy Y.; Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fong, LG (corresponding author), 695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	lfong@mednet.ucla.edu	lewchavaroj, runglawan/B-5191-2009	Young, Stephen/0000-0001-7270-3176	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086683, R01HL076839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050200] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL76839, HL86683] Funding Source: Medline; NIAMS NIH HHS [AR050200] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BECK LA, 1990, J CELL BIOL, V110, P1489, DOI 10.1083/jcb.110.5.1489; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; DALTON M, 1995, METHOD ENZYMOL, V250, P134; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Delbarre E, 2006, HUM MOL GENET, V15, P1113, DOI 10.1093/hmg/ddl026; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; LIN F, 1993, J BIOL CHEM, V268, P16321; Meta M, 2006, TRENDS MOL MED, V12, P480, DOI 10.1016/j.molmed.2006.08.006; Moulson CL, 2007, HUM MUTAT, V28, P882, DOI 10.1002/humu.20536; Muchir A, 2004, PHYSIOLOGY, V19, P309, DOI 10.1152/physiol.00022.2004; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	27	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7094	7099		10.1074/jbc.M708138200	http://dx.doi.org/10.1074/jbc.M708138200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18178963	hybrid			2022-12-27	WOS:000253779600054
J	Dixon, RDS; Arneman, DK; Rachlin, AS; Sundaresan, NR; Costello, MJ; Campbell, SL; Otey, CA				Dixon, Richard D. S.; Arneman, Daniel K.; Rachlin, Andrew S.; Sundaresan, Naresh R.; Costello, M. Joseph; Campbell, Sharon L.; Otey, Carol A.			Palladin is an actin cross-linking protein that uses immunoglobulin-like domains to bind filamentous actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C C-PROTEIN; H MYBP-C; SARCOMERIC PROTEIN; CELL-ADHESION; F-ACTIN; Z-DISC; MYOSIN; IDENTIFICATION; TITIN; FAMILY	Palladin is a recently described phosphoprotein that plays an important role in cell adhesion and motility. Previous studies have shown that palladin overexpression results in profound changes in actin organization in cultured cells. Palladin binds to the actin-associated proteins alpha-actinin, vasodilator-stimulated phosphoprotein, profilin, Eps8, and ezrin, suggesting that it may affect actin organization indirectly. To determine its molecular function in generating actin arrays, we purified palladin and asked if it is also capable of binding to F-actin directly. In co-sedimentation and differential sedimentation assays, palladin was found to both bind and cross-link actin filaments. This bundling activity was confirmed by fluorescence and electron microscopy. Palladin fragments were then purified and used to determine the sequences necessary to bind and bundle F-actin. The Ig3 domain of palladin bound to F-actin, and a palladin fragment containing Ig3, Ig4, and the region linking these domains was identified as a fragment that was able to bundle F-actin. Because palladin has multiple Ig domains, and only one of them binds to F-actin, this suggests that different Ig domains may be specialized for distinct biological functions. In addition, our results suggest a potential role for palladin in generating specialized, actin-based cell morphologies via both direct actin cross-linking activity and indirect scaffolding activity.	[Arneman, Daniel K.; Rachlin, Andrew S.; Otey, Carol A.] Univ N Carolina, Sch Med, Dept Cel & Mol Physiol, Chapel Hill, NC 27599 USA; [Dixon, Richard D. S.; Sundaresan, Naresh R.; Campbell, Sharon L.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Costello, M. Joseph] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Otey, CA (corresponding author), Univ N Carolina, Sch Med, Dept Cel & Mol Physiol, Chapel Hill, NC 27599 USA.	Carol_Otey@med.unc.edu		campbell, sharon/0000-0003-0311-409X; Arneman, Daniel/0000-0002-4031-8094	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061743, R01GM080568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043253] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM080568, GM 61743, R01 GM080568-01A1] Funding Source: Medline; NINDS NIH HHS [NS 43253] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bassell G, 1997, CURR OPIN CELL BIOL, V9, P109, DOI 10.1016/S0955-0674(97)80159-7; Bennett PM, 1999, REV PHYSIOL BIOCH P, V138, P203, DOI 10.1007/BF02346664; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boukhelifa M, 2006, FEBS J, V273, P26, DOI 10.1111/j.1742-4658.2005.05036.x; Boukhelifa M, 2004, CELL MOTIL CYTOSKEL, V58, P17, DOI 10.1002/cm.10173; Boukhelifa M, 2003, MOL CELL NEUROSCI, V23, P661, DOI 10.1016/S1044-7431(03)00127-1; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Bullard B, 2006, P NATL ACAD SCI USA, V103, P4451, DOI 10.1073/pnas.0509016103; Bullard B, 2005, J MUSCLE RES CELL M, V26, P479, DOI 10.1007/s10974-005-9032-7; DEARRUDA MV, 1992, J BIOL CHEM, V267, P13079; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; EDWARDS RA, 1995, CELL MOTIL CYTOSKEL, V32, P1, DOI 10.1002/cm.970320102; Fischer D, 2003, PROTEINS, V51, P434, DOI 10.1002/prot.10357; Fucini P, 1997, NAT STRUCT BIOL, V4, P223, DOI 10.1038/nsb0397-223; Gerull B, 2006, J MOL MED-JMM, V84, P478, DOI 10.1007/s00109-006-0060-6; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Gilbert R, 1999, J CELL SCI, V112, P69; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Gultice AD, 2006, BIOL REPROD, V74, P1041, DOI 10.1095/biolreprod.105.047845; Hakeda S, 2000, J CELL BIOL, V148, P101, DOI 10.1083/jcb.148.1.101; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Heidemann SR, 2004, TRENDS CELL BIOL, V14, P160, DOI 10.1016/j.tcb.2004.02.003; Heidemann SR, 1999, J CELL BIOL, V145, P109, DOI 10.1083/jcb.145.1.109; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; Huttelmaier S, 1999, FEBS LETT, V451, P68, DOI 10.1016/S0014-5793(99)00546-3; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Jarvenpaa J, 2007, GYNECOL ENDOCRINOL, V23, P351, DOI 10.1080/09513590701350291; Jin L, 2007, CIRC RES, V100, P817, DOI 10.1161/01.RES.0000261351.54147.de; Johnson RP, 2000, J BIOL CHEM, V275, P95, DOI 10.1074/jbc.275.1.95; Kenny PA, 1999, GENE, V232, P11, DOI 10.1016/S0378-1119(99)00122-5; Kreis T., 1999, GUIDEBOOK CYTOSKELET, V2nd; LANGFORD GM, 1995, CURR OPIN CELL BIOL, V7, P82, DOI 10.1016/0955-0674(95)80048-4; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Li XL, 1998, J BIOL CHEM, V273, P19329, DOI 10.1074/jbc.273.30.19329; Linke WA, 2000, HISTOL HISTOPATHOL, V15, P799, DOI 10.14670/HH-15.799; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moolman-Smook J, 2002, CIRC RES, V91, P704, DOI 10.1161/01.RES.0000036750.81083.83; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Oakley CE, 2004, CELL RES, V14, P95, DOI 10.1038/sj.cr.7290208; OKAGAKI T, 1993, J CELL BIOL, V123, P619, DOI 10.1083/jcb.123.3.619; Ono K, 2006, MOL BIOL CELL, V17, P2722, DOI 10.1091/mbc.E06-02-0114; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Politou AS, 1996, J MOL BIOL, V255, P604, DOI 10.1006/jmbi.1996.0050; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006; Ronty M, 2007, EXP CELL RES, V313, P2575, DOI 10.1016/j.yexcr.2007.04.030; Salmikangas P, 1999, HUM MOL GENET, V8, P1329, DOI 10.1093/hmg/8.7.1329; Salmikangas P, 2003, HUM MOL GENET, V12, P189, DOI 10.1093/hmg/ddg020; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Tang JX, 1997, EUR J BIOCHEM, V247, P432, DOI 10.1111/j.1432-1033.1997.00432.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tilney LG, 1998, J CELL BIOL, V143, P121, DOI 10.1083/jcb.143.1.121; Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; VAUGHAN KT, 1993, J BIOL CHEM, V268, P3670; von Nandelstadh P, 2005, EXP CELL RES, V310, P131, DOI 10.1016/j.yexcr.2005.06.027; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Welikson RE, 2002, J CELL SCI, V115, P3517; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Yarmola EG, 2001, J BIOL CHEM, V276, P22351, DOI 10.1074/jbc.M101457200; Zieseniss A, 2008, CELL MOTIL CYTOSKEL, V65, P59, DOI 10.1002/cm.20244	81	75	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6222	6231		10.1074/jbc.M707694200	http://dx.doi.org/10.1074/jbc.M707694200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18180288	hybrid			2022-12-27	WOS:000253779500029
J	Lee, IH; Lim, HJ; Yoon, S; Seong, JK; Bae, DS; Rhee, SG; Bae, YS				Lee, In Hye; Lim, Hee Jung; Yoon, Suhyeon; Seong, Je Kyung; Bae, Duk Soo; Rhee, Sue Goo; Bae, Yun Soo			Ahnak protein activates protein kinase C (PKC) through dissociation of the PKC-protein phosphatase 2A complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC REGULATION; SMALL T-ANTIGEN; CALCIUM-CHANNEL; CA2+ CHANNELS; MEMBRANE; ALPHA; PHOSPHORYLATION; MECHANISMS; CELLS; CYTOSKELETON	We have previously reported that central repeated units (CRUs) of Ahnak act as a scaffolding protein networking phospholipase C gamma and protein kinase C (PKC). Here, we demonstrate that an Ahnak derivative consisting of four central repeated units binds and activates PKC-alpha in a phosphatidylserine/1,2-dioleoyl-sn-glycerol-independent manner. Moreover, NIH3T3 cells expressing the 4 CRUs of Ahnak showed enhanced c-Raf, MEK, and Erk phosphorylation in response to phorbol 12-myristate 13-acetate (PMA) compared with parental cells. To evaluate the effect of loss-of-function of Ahnak in cell signaling, we investigated PKC activation and Raf phosphorylation in embryonic fibroblast cells (MEFs) of the Ahnak knock-out (Ahnak(-/-)) mouse. Membrane translocation of PKC-alpha and phosphorylation of Raf in response to PMA or platelet-derived growth factor were decreased in Ahnak null MEF cells compared with wild type MEFs. Several lines of evidence suggest that PKC-alpha activity is regulated through association with protein phosphatase 2A (PP2A). A co-immunoprecipitation assay indicated that the association of PKC-alpha with PP2A was disrupted in NIH3T3 cells expressing 4 CRUs of Ahnak in response to PMA. Consistently, Ahnak null MEF cells stimulated by PMA showed enhanced PKC-PP2A complex formation, and add-back expression of Ahnak into Ahnak null MEF cells abolished the PKC-PP2A complex formation in response to PMA. These data indicate that Ahnak potentiates PKC activation through inhibiting the interaction of PKC with PP2A.	[Lee, In Hye; Lim, Hee Jung; Yoon, Suhyeon; Rhee, Sue Goo; Bae, Yun Soo] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Bae, Duk Soo] Sungkyunkwan Univ, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul 135710, South Korea; [Seong, Je Kyung] Seoul Natl Univ, Coll Vet Med, Seoul 151742, South Korea	Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU)	Lee, IH (corresponding author), Ewha Womans Univ, Dept Life Sci, 11-1 Daehyun Dong, Seoul 120750, South Korea.	baeys@ewha.ac.kr	LEE, IN HYE/T-2714-2019	LEE, IN HYE/0000-0003-2334-3594				Alvarez J, 2004, J BIOL CHEM, V279, P12456, DOI 10.1074/jbc.M312177200; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Boudreau RTM, 2002, J BIOL CHEM, V277, P5322, DOI 10.1074/jbc.M108623200; CHAPLINE C, 1993, J BIOL CHEM, V268, P6858; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Deval E, 2004, J BIOL CHEM, V279, P19531, DOI 10.1074/jbc.M313078200; Haase H, 2005, FASEB J, V19, P1969, DOI 10.1096/fj.05-3997com; Haase H, 1999, FASEB J, V13, P2161, DOI 10.1096/fasebj.13.15.2161; Haase H, 2007, CARDIOVASC RES, V73, P19, DOI 10.1016/j.cardiores.2006.09.001; HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085; Hohaus A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0855com; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jiffar T, 2004, LEUKEMIA, V18, P505, DOI 10.1038/sj.leu.2403275; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lee IH, 2004, J BIOL CHEM, V279, P26645, DOI 10.1074/jbc.M311525200; Li DJ, 2005, J NEUROSCI, V25, P1914, DOI 10.1523/JNEUROSCI.4790-04.2005; Lorusso A, 2006, EMBO J, V25, P5443, DOI 10.1038/sj.emboj.7601419; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; NEWTON AC, 1994, BIOCHEMISTRY-US, V33, P6651, DOI 10.1021/bi00187a035; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Sekiya F, 1999, J BIOL CHEM, V274, P13900, DOI 10.1074/jbc.274.20.13900; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; SLEIGH MJ, 1978, CELL, V14, P79, DOI 10.1016/0092-8674(78)90303-3; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Sussman J, 2001, J CELL BIOL, V154, P1019, DOI 10.1083/jcb.200105121; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; Yang L, 2005, J BIOL CHEM, V280, P207, DOI 10.1074/jbc.M410509200; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X	43	52	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6312	6320		10.1074/jbc.M706878200	http://dx.doi.org/10.1074/jbc.M706878200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18174170	hybrid			2022-12-27	WOS:000253779500038
J	Parikh, BA; Tortora, A; Li, XP; Tumer, NE				Parikh, Bijal A.; Tortora, Andrew; Li, Xiao-Ping; Tumer, Nilgun E.			Ricin inhibits activation of the unfolded protein response by preventing splicing of the HAC1 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POKEWEED ANTIVIRAL PROTEIN; ENDOPLASMIC-RETICULUM STRESS; RIBOSOME-INACTIVATING PROTEINS; SACCHAROMYCES-CEREVISIAE; A-CHAIN; TRANSMEMBRANE PROTEIN; RETROGRADE TRANSPORT; TRANSCRIPTION FACTOR; GLYCOSIDASE ACTIVITY; CYTOSOL	Ricin A chain (RTA) inhibits protein synthesis by removing a specific adenine from the highly conserved alpha-sarcin/ricin loop in the large rRNA. Expression of RTA with its own signal sequence in yeast resulted in its translocation into the endoplasmic reticulum (ER) and subsequent glycosylation. Because RTA must unfold within the ER, it may be vulnerable to host defenses, such as the unfolded protein response (UPR). UPR was induced in cells expressing an active site mutant but not the wild type RTA, indicating that the active site of RTA played a role in perturbing the ER stress response. The inactive RTA without the signal sequence did not induce UPR, indicating that translocation into the ER was critical for induction of UPR. The wild type RTA inhibited activation of UPR not only due to ER stress induced by the protein itself but also by global effectors such as tunicamycin and dithiothreitol. Mature RTA without the signal sequence also inhibited UPR, providing evidence that inhibition of UPR occurred on the cytosolic face of the ER. RTA could not inhibit UPR when the spliced form of HAC1 mRNA was provided in trans, indicating that it had a direct effect on UPR upstream of HAC1-dependent transcriptional activation. Only the precursor form of HAC1 mRNA was detected in cells expressing RTA after exposure to ER stress, demonstrating that ricin inhibits activation of UPR by preventing HAC1 mRNA splicing. The RTA mutants that depurinated ribosomes but did not kill cells were not able to inhibit activation of UPR by tunicamycin, providing evidence that the inability to activate UPR in response to ER stress contributes to the cytotoxicity of ricin.	Rutgers State Univ, Sch Biol & Environm Sci, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA; Rutgers State Univ, Sch Biol & Environm Sci, Biotechnol Ctr Agr & Environm, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Tumer, NE (corresponding author), Ctr Biotechnol, Foran Hall,SEBS,59 Dudley Rd, New Brunswick, NJ 08901 USA.	tumer@aesop.rutgers.edu	Parikh, Bijal/AAA-5839-2019	Parikh, Bijal/0000-0003-2490-8294	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072425] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI072425-01A1, R01 AI072425-02, AI 072425, R01 AI072425] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barbieri L, 1997, NUCLEIC ACIDS RES, V25, P518, DOI 10.1093/nar/25.3.518; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; Di R, 2005, MOL PLANT MICROBE IN, V18, P762, DOI 10.1094/MPMI-18-0762; ENDO Y, 1987, J BIOL CHEM, V262, P8128; Hartley MR, 2004, BBA-PROTEINS PROTEOM, V1701, P1, DOI 10.1016/j.bbapap.2004.06.004; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hudak KA, 2002, RNA, V8, P1148, DOI 10.1017/S1355838202026638; Isler JA, 2005, J VIROL, V79, P15388, DOI 10.1128/JVI.79.24.15388-15397.2005; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Li XP, 2007, INFECT IMMUN, V75, P417, DOI 10.1128/IAI.01295-06; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; LORD JM, 1994, FASEB J, V8, P201, DOI 10.1096/fasebj.8.2.8119491; McCracken AA, 2005, CURR TOP MICROBIOL, V300, P17; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MORI K, 1993, CELL, V74, P743; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Niwa M, 2005, GENOME BIOL, V6; Parikh BA, 2005, BIOCHEMISTRY-US, V44, P2478, DOI 10.1021/bi048188c; Parikh BA, 2002, J BIOL CHEM, V277, P41428, DOI 10.1074/jbc.M205463200; Picard D, 2005, J BIOL CHEM, V280, P20069, DOI 10.1074/jbc.M413452200; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Simpson JC, 1999, FEBS LETT, V459, P80, DOI 10.1016/S0014-5793(99)01222-3; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Tumer NE, 1998, J VIROL, V72, P1036, DOI 10.1128/JVI.72.2.1036-1042.1998; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; Wesche J, 2002, INT J MED MICROBIOL, V291, P517; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	43	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6145	6153		10.1074/jbc.M707981200	http://dx.doi.org/10.1074/jbc.M707981200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18180297	hybrid, Green Accepted			2022-12-27	WOS:000253779500021
J	Ruggiero, AM; Liu, Y; Vidensky, S; Maier, S; Jung, E; Farhan, H; Robinson, MB; Sitte, HH; Rothstein, JD				Ruggiero, Alicia M.; Liu, Yiting; Vidensky, Svetlana; Maier, Susanne; Jung, Elizabeth; Farhan, Hesso; Robinson, Michael B.; Sitte, Harald H.; Rothstein, Jeffrey D.			The endoplasmic reticulum exit of glutamate transporter is regulated by the inducible mammalian Yip6b/GTRAP3-18 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAB; OLIGOMERIZATION; IDENTIFICATION; TRAFFICKING; MODULATION; EXPRESSION; SUBTYPE; CELLS; ER	GTRAP3-18 interacts with and reduces the activity of the neuronal specific Na+/K+ glutamate transporter, EAAC1 both in vitro and in vivo. GTRAP3-18 and the related isoform, JM4, are distant relatives of the Rab GTPase-interacting factor PRA1, and share a topology of four transmembrane domains and cytosolic termini. GTRAP3-18 and JM4 are resident endoplasmic reticulum ( ER) proteins. The physiological role of GTRAP3-18 is poorly understood. We demonstrate for the first time that GTRAP3-18 is a regulator of ER protein trafficking. Expression of GTRAP3-18 delays the ER exit of EAAC1, as well as other members of the excitatory amino acid transporter family. GTRAP3-18 uses hydrophobic domain interactions in the ER membrane to self-associate and cytoplasmic interactions at the C terminus to regulate trafficking. The features of GTRAP3-18 activity are consistent with recent phylogenic sequence analyses suggesting GTRAP3-18 and JM4 be reclassified as mammalian isoforms of the yeast protein family Yip, Yip6b, and Yip6a, respectively.	[Ruggiero, Alicia M.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; [Maier, Susanne; Farhan, Hesso; Sitte, Harald H.] Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Robinson, Michael B.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat & Pharmacol, Philadelphia, PA 19104 USA	Johns Hopkins University; Medical University of Vienna; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Rothstein, JD (corresponding author), Johns Hopkins Univ, Dept Neurol, Meyer 6-109,625 N Wolfe St, Baltimore, MD 21287 USA.	jrothstein@jhmi.edu	Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013; rothstein, jeffrey d/C-9470-2013; Farhan, Hesso/C-7997-2012	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Farhan, Hesso/0000-0002-0889-8463	Austrian Science Fund FWF [P 18706] Funding Source: Medline; NINDS NIH HHS [R01 NS036465, NS 36465, NS 40151, R01 NS040151] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036465, R01NS040151] Funding Source: NIH RePORTER	Austrian Science Fund FWF(Austrian Science Fund (FWF)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdul-Ghani M, 2001, J BIOL CHEM, V276, P6225, DOI 10.1074/jbc.M009073200; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Calero M, 2002, BIOCHEM BIOPH RES CO, V290, P676, DOI 10.1006/bbrc.2001.6242; Cheng CL, 2002, J NEUROSCI, V22, P10643; Collins RN, 2003, MOL MEMBR BIOL, V20, P105, DOI 10.1080/0968768031000085892; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davis KE, 1998, J NEUROSCI, V18, P2475; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Dowd LA, 1996, J NEUROCHEM, V67, P508, DOI 10.1046/j.1471-4159.1996.67020508.x; Gonzalez MI, 2003, J NEUROSCI, V23, P5589; Ikemoto MJ, 2002, NEUROREPORT, V13, P2079, DOI 10.1097/00001756-200211150-00018; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Kalandadze A, 2004, J NEUROSCI, V24, P5183, DOI 10.1523/JNEUROSCI.0839-04.2004; Lee SP, 2003, LIFE SCI, V74, P173, DOI 10.1016/j.lfs.2003.09.028; Li HW, 2004, P NATL ACAD SCI USA, V101, P647, DOI 10.1073/pnas.0305145101; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Mao Wen-ge, 2004, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V22, P60; Mathews GC, 2003, J NEUROSCI, V23, P2040; Melikian HE, 1996, MOL PHARMACOL, V50, P266; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pfeffer S, 2005, BIOCHEM SOC T, V33, P627, DOI 10.1042/BST0330627; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1999, J NEUROCHEM, V72, P422, DOI 10.1046/j.1471-4159.1999.0720422.x; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Wang H, 2003, INT J ADV MANUF TECH, V21, P215, DOI 10.1007/s001700300024; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; YANG W, 2002, J BIOL CHEM, V31, P31; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	39	57	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6175	6183		10.1074/jbc.M701008200	http://dx.doi.org/10.1074/jbc.M701008200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167356	Green Accepted, hybrid			2022-12-27	WOS:000253779500024
J	Ren, Y; Xu, HW; Davey, F; Taylor, M; Aiton, J; Coote, P; Fang, F; Yao, J; Chen, D; Chen, JX; Yan, SD; Gunn-Moore, FJ				Ren, Yimin; Xu, Hong Wei; Davey, Fleur; Taylor, Margaret; Aiton, Jim; Coote, Peter; Fang, Fang; Yao, Jun; Chen, Doris; Chen, John Xi; Yan, Shi Du; Gunn-Moore, Frank J.			Endophilin I expression is increased in the brains of Alzheimer disease patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; AMYLOID-BETA-PEPTIDE; BINDING ALCOHOL-DEHYDROGENASE; ACTIVATED PROTEIN-KINASES; A-BETA; MITOCHONDRIAL DYSFUNCTION; NEURONAL APOPTOSIS; TRANSGENIC MICE; ABAD; STRESS	Alzheimer patients have increased levels of both the 42 amyloid-beta-peptide(A beta) and the amyloid binding alcohol dehydrogenase (ABAD), which is an intracellular binding site for A beta. The overexpression of A beta and ABAD in transgenic mice has shown that the binding of A beta to ABAD results in amplified neuronal stress and impairment of learning and memory. From a proteomic analysis of the brains from these animals, we have identified for the first time that the protein endophilin I increases in Alzheimer diseased brain. The increase in endophilin I levels in neurons is linked to an increase in the activation of the stress kinase c-Jun N-terminal kinase with the subsequent death of the neurons. We also demonstrate in living animals that the expression level of endophilin I is an indicator for the interaction of ABAD and A beta as its expression levels return to normal if this interaction is perturbed. Therefore this identifies endophilin I as a new indicator of the progression of Alzheimer disease.	[Ren, Yimin; Davey, Fleur; Taylor, Margaret; Aiton, Jim; Coote, Peter; Gunn-Moore, Frank J.] Univ St Andrews, Sch Biol & Med, St Andrews KY16 9TS, Fife, Scotland; [Xu, Hong Wei; Fang, Fang; Yao, Jun; Chen, John Xi; Yan, Shi Du] Columbia Univ Coll Phys & Surg, Dept Surg Pathol, New York, NY 10032 USA; [Chen, John Xi] Harvey Cushing Inst Neurosci, N Shore Long Island Jewish Hlth System, New York 11021, NY USA	University of St Andrews; Columbia University; Northwell Health	Gunn-Moore, FJ (corresponding author), Univ St Andrews, Sch Biol & Med, St Andrews KY16 9TS, Fife, Scotland.	sdy1@columbia.edu; fjg1@st-and.ac.uk		Xu, Hongwei/0000-0001-5763-3894; Coote, Peter John/0000-0001-5190-805X; Gunn-Moore, Francis James/0000-0003-3422-3387	MRC [G0400930] Funding Source: UKRI; Alzheimers Research UK [ART-PhD2004-3, ART-EG2005A-2] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P50AG008702, P01AG017490] Funding Source: NIH RePORTER; Medical Research Council [G0400930] Funding Source: Medline; NIA NIH HHS [P01 AG17490, P050 AG08702] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Bozyczko-Coyne D, 2001, J NEUROCHEM, V77, P849, DOI 10.1046/j.1471-4159.2001.00294.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Du Yan S, 1999, J BIOL CHEM, V274, P2145, DOI 10.1074/jbc.274.4.2145; Ferrer I., 2005, Current Alzheimer Research, V2, P3, DOI 10.2174/1567205052772713; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; He XY, 1999, J BIOL CHEM, V274, P15014, DOI 10.1074/jbc.274.21.15014; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Kissinger CR, 2004, J MOL BIOL, V342, P943, DOI 10.1016/j.jmb.2004.07.071; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Minogue AM, 2003, J BIOL CHEM, V278, P27971, DOI 10.1074/jbc.M302530200; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Powell AJ, 2000, J MOL BIOL, V303, P311, DOI 10.1006/jmbi.2000.4139; Ramjaun AR, 2001, J BIOL CHEM, V276, P28913, DOI 10.1074/jbc.M103198200; Reutens AT, 2002, INT J BIOCHEM CELL B, V34, P1173, DOI 10.1016/S1357-2725(02)00063-8; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Schobel S, 2006, INT J DEV NEUROSCI, V24, P141, DOI 10.1016/j.ijdevneu.2005.11.003; SHOJI M, 2001, BRAIN RES MOL BRAIN, V85, P221; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; Thakur A, 2007, J NEUROSCI RES, V85, P1668, DOI 10.1002/jnr.21298; Trevaskis J, 2005, ENDOCRINOLOGY, V146, P3757, DOI 10.1210/en.2005-0282; Troy CM, 2001, J NEUROCHEM, V77, P157, DOI 10.1046/j.1471-4159.2001.00218.x; Wei WL, 2002, BRAIN, V125, P2036, DOI 10.1093/brain/awf205; Xie YL, 2006, BIOORG MED CHEM LETT, V16, P4657, DOI 10.1016/j.bmcl.2006.05.099; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x; Yan SD, 1997, NATURE, V389, P689; Yan SD, 2000, J BIOL CHEM, V275, P27100; YAO J, 2004, 2004 ABSTR VIEW IT P; Yao J, 2007, MOL CELL NEUROSCI, V35, P377, DOI 10.1016/j.mcn.2007.03.013; Zhu XW, 2001, MECH AGEING DEV, V123, P39, DOI 10.1016/S0047-6374(01)00342-6	35	41	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5685	5691		10.1074/jbc.M707932200	http://dx.doi.org/10.1074/jbc.M707932200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167351	hybrid			2022-12-27	WOS:000253426700049
J	Glenn, KA; Nelson, RF; Wen, HM; Mallinger, AJ; Paulson, HL				Glenn, Kevin A.; Nelson, Rick F.; Wen, Hsiang M.; Mallinger, Adam J.; Paulson, Henry L.			Diversity in tissue expression, substrate binding, and SCF complex formation for a lectin family of ubiquitin ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; ER-ASSOCIATED DEGRADATION; RECOGNIZES SUGAR CHAINS; N-LINKED GLYCANS; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MESSENGER-RNA; CATHEPSIN-B; MURINE BETA-1,4-GALACTOSYLTRANSFERASE; STRUCTURAL BASIS	Post-translational modification of proteins regulates many cellular processes. Some modifications, including N-linked glycosylation, serve multiple functions. For example, the attachment of N-linked glycans to nascent proteins in the endoplasmic reticulum facilitates proper folding, whereas retention of high mannose glycans on misfolded glycoproteins serves as a signal for retrotranslocation and ubiquitin-mediated proteasomal degradation. Here we examine the substrate specificity of the only family of ubiquitin ligase subunits thought to target glycoproteins through their attached glycans. The five proteins comprising this FBA family (FBXO2, FBXO6, FBXO17, FBXO27, and FBXO44) contain a conserved G domain that mediates substrate binding. Using a variety of complementary approaches, including glycan arrays, we show that each family member has differing specificity for glycosylated substrates. Collectively, the F-box proteins in the FBA family bind high mannose and sulfated glycoproteins, with one FBA protein, FBX044, failing to bind any glycans on the tested arrays. Site-directed mutagenesis of two aromatic amino acids in the G domain demonstrated that the hydrophobic pocket created by these amino acids is necessary for high affinity glycan binding. All FBA proteins co-precipitated components of the canonical SCF complex (Skp1, Cullin1, and Rbx1), yet FBXO2 bound very little Cullin1, suggesting that FBXO2 may exist primarily as a heterodimer with Skp1. Using subunit-specific antibodies, we further demonstrate marked divergence in tissue distribution and developmental expression. These differences in substrate recognition, SCF complex formation, and tissue distribution suggest that FBA proteins play diverse roles in glycoprotein quality control.	[Glenn, Kevin A.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Nelson, Rick F.] Univ Iowa Hosp & Clin, Dept Otolaryngol, Iowa City, IA 52242 USA; [Paulson, Henry L.] Univ Michigan Hlth Syst, Dept Neurol, Ann Arbor, MI 48109 USA; [Mallinger, Adam J.] Kansas City Univ Med & Biosci, Kansas City, MO 64106 USA; [Glenn, Kevin A.; Wen, Hsiang M.] Univ Iowa Hosp & Clin, Dept Internal Med, Iowa City, IA 52242 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Michigan System; University of Michigan; Kansas City University of Medicine & Biosciences; University of Iowa	Glenn, KA (corresponding author), Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA.	kevin-glenn@uiowa.edu		Glenn, Kevin/0000-0002-6941-9649; Nelson, Rick/0000-0001-5749-6383	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS047872, R01NS047535] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007337] Funding Source: Medline; NINDS NIH HHS [NS047872, R01 NS47535-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Baici A, 2006, BIOL CHEM, V387, P1017, DOI 10.1515/BC.2006.125; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; BEINTEMA JJ, 1976, EUR J BIOCHEM, V63, P441, DOI 10.1111/j.1432-1033.1976.tb10246.x; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Cabral CM, 2002, MOL BIOL CELL, V13, P2639, DOI 10.1091/mbc.E02-02-0068; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Contino G, 2004, GENE, V328, P69, DOI 10.1016/j.gene.2003.11.017; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; ENDO M, 1982, J BIOL CHEM, V257, P8755; Erhardt JA, 1998, J BIOL CHEM, V273, P35222, DOI 10.1074/jbc.273.52.35222; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groisman B, 2006, ISRAEL J CHEM, V46, P189, DOI 10.1560/2QPD-9WP9-NCYK-58X3; Hagihara S, 2005, J MED CHEM, V48, P3126, DOI 10.1021/jm0489511; HARDUINLEPERS A, 1993, J BIOL CHEM, V268, P14348; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Henzl MT, 2004, HEARING RES, V191, P101, DOI 10.1016/j.heares.2004.01.005; Henzl MT, 1998, HEARING RES, V126, P37, DOI 10.1016/S0378-5955(98)00148-8; Henzl MT, 2001, HEARING RES, V157, P100, DOI 10.1016/S0378-5955(01)00285-4; Hong HY, 2000, ELECTROPHORESIS, V21, P841, DOI 10.1002/(SICI)1522-2683(20000301)21:5<841::AID-ELPS841>3.3.CO;2-W; Ilyin GP, 2002, GENE, V296, P11, DOI 10.1016/S0378-1119(02)00867-3; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kaneko C, 2003, BIOCHEM BIOPH RES CO, V300, P297, DOI 10.1016/S0006-291X(02)02834-6; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KIJIMOTOOCHIAI S, 1985, ANAL BIOCHEM, V147, P222, DOI 10.1016/0003-2697(85)90031-4; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kuhn K, 2004, DEV BRAIN RES, V149, P131, DOI 10.1016/j.devbrainres.2004.02.001; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Mehtani S, 1998, J BIOL CHEM, V273, P13236, DOI 10.1074/jbc.273.21.13236; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Mizushima T, 2004, NAT STRUCT MOL BIOL, V11, P365, DOI 10.1038/nsmb732; Mizushima T, 2007, P NATL ACAD SCI USA, V104, P5777, DOI 10.1073/pnas.0610312104; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Nelson RF, 2007, J NEUROSCI, V27, P5163, DOI 10.1523/JNEUROSCI.0206-07.2007; Nelson RF, 2006, J BIOL CHEM, V281, P20242, DOI 10.1074/jbc.M602423200; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; SHAPER NL, 1990, P NATL ACAD SCI USA, V87, P791, DOI 10.1073/pnas.87.2.791; Shiyan SD, 1997, GLYCOCONJUGATE J, V14, P631, DOI 10.1023/A:1018544711767; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; SPIK G, 1975, FEBS LETT, V50, P296, DOI 10.1016/0014-5793(75)90053-8; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Thalmann R, 2003, ACTA OTO-LARYNGOL, V123, P203, DOI 10.1080/0036554021000028100; TOWNSEND RR, 1982, J BIOL CHEM, V257, P9704; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Wei Z, 2001, J DAIRY SCI, V84, P2584, DOI 10.3168/jds.S0022-0302(01)74712-1; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; West CM, 2004, BBA-GEN SUBJECTS, V1673, P29, DOI 10.1016/j.bbagen.2004.04.007; West CM, 2003, CELL MOL LIFE SCI, V60, P229, DOI 10.1007/s000180300018; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yamaguchi Y, 2007, BIOCHEM BIOPH RES CO, V362, P712, DOI 10.1016/j.bbrc.2007.08.056; YAMASHITA K, 1981, J BIOL CHEM, V256, P1283; Yang K, 2004, BIOCHEM BIOPH RES CO, V324, P432, DOI 10.1016/j.bbrc.2004.09.070; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Yoshida Y, 2005, EMBO REP, V6, P239, DOI 10.1038/sj.embor.7400351; Yoshida Y, 2007, J BIOL CHEM, V282, P7137, DOI 10.1074/jbc.M611168200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou XK, 2006, P NATL ACAD SCI USA, V103, P17214, DOI 10.1073/pnas.0602954103; Zwicky R, 2003, BIOL CHEM, V384, P1007, DOI 10.1515/BC.2003.113	71	58	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12717	12729		10.1074/jbc.M709508200	http://dx.doi.org/10.1074/jbc.M709508200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18203720	hybrid, Green Published			2022-12-27	WOS:000255499800007
J	Mydel, P; Shipley, JM; Adair-Kirk, TL; Kelley, DG; Broekelmann, TJ; Mecham, RP; Senior, RM				Mydel, Piotr; Shipley, J. Michael; Adair-Kirk, Tracy L.; Kelley, Diane G.; Broekelmann, Thomas J.; Mecham, Robert P.; Senior, Robert M.			Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; EPITHELIAL-CELL MIGRATION; HOMOZYGOUS NONSENSE MUTATION; ALPHA-3 CHAIN; GAMMA-2 CHAIN; INTEGRIN ALPHA(3)BETA(1); RESTRICTED DISTRIBUTION; PLASMINOGEN-ACTIVATOR; BASEMENT-MEMBRANES; PROCESSING ENZYME	Proteolytic processing of laminin-332 by matrix metalloproteinase (MMP)-2 and MMP-14 has been shown to yield fragments that are promigratory for epithelial cells. During acute and chronic inflammation, proteases are elaborated by neutrophils and macrophages that can degrade basement membranes. We investigated the susceptibility of laminin-332 to degradation by the following neutrophil and macrophage proteases: neutrophil elastase (NE), cathepsin G, proteinase-3, and MMPs-2, -8, -9, and -12. Protease-specific differences were seen in the capacity to cleave the individual chains of laminin-332. NE and MMP-12 showed the greatest activity toward the gamma 2 chain, generating a fragment similar in size to the gamma 2x fragment generated by MMP-2. The digestion pattern of laminin-332 by degranulated neutrophils was nearly identical to that generated with NE alone. Digestion by supernatants of degranulated neutrophils was blocked by an inhibitor of NE, and NE-deficient neutrophils were essentially unable to digest laminin-332, suggesting that NE is the major neutrophil-derived protease that degrades laminin-332. In vivo, laminin gamma 2 fragments were found in the bronchoalveolar lavage fluid of wild-type mice treated with lipopolysaccharide, whereas that obtained from NE-deficient mice showed a different cleavage pattern. In addition, NE cleaved a synthetic peptide derived from the region of human laminin gamma 2 containing the MMP-2 cleavage site, suggesting that NE may generate laminin-332 fragments that are also promigratory. Both laminin-332 fragments generated by NE digestion and NE-digested laminin gamma 2 peptide were found to be chemotactic for neutrophils. Collectively, these data suggest that degradation of laminin-332 by NE generates fragments with important biological activities.	[Broekelmann, Thomas J.; Mecham, Robert P.; Senior, Robert M.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Mydel, Piotr; Shipley, J. Michael; Adair-Kirk, Tracy L.; Kelley, Diane G.; Senior, Robert M.] Washington Univ, Dept Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Senior, RM (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8052,660 S Euclid Ave, St Louis, MO 63110 USA.	rsenior@im.wustl.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 29594] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abrahamson DR, 2003, KIDNEY INT, V63, P826, DOI 10.1046/j.1523-1755.2003.00800.x; Adair-Kirk TL, 2005, J IMMUNOL, V174, P1621, DOI 10.4049/jimmunol.174.3.1621; Adair-Kirk TL, 2003, J IMMUNOL, V171, P398, DOI 10.4049/jimmunol.171.1.398; Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Bylund J, 2007, EUR J IMMUNOL, V37, P1087, DOI 10.1002/eji.200636651; Chua F, 2007, AM J PATHOL, V170, P65, DOI 10.2353/ajpath.2007.060352; CLARK RAF, 1988, J BIOL CHEM, V263, P12115; Falk M, 1999, MATRIX BIOL, V18, P557, DOI 10.1016/S0945-053X(99)00047-5; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; Franzke CW, 2004, J BIOL CHEM, V279, P24521, DOI 10.1074/jbc.M308835200; Ghosh S, 2000, J BIOL CHEM, V275, P23869, DOI 10.1074/jbc.M000935200; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Gresham HD, 1996, J BIOL CHEM, V271, P30587, DOI 10.1074/jbc.271.48.30587; HARVATH L, 1994, J IMMUNOL, V152, P5447; HECK LW, 1990, AM J PATHOL, V136, P1267; HERSHKOVIZ R, 1995, IMMUNOLOGY, V85, P125; Hintermann E, 2005, J BIOL CHEM, V280, P8004, DOI 10.1074/jbc.M406301200; Hirche TO, 2004, AM J RESP CELL MOL, V30, P576, DOI 10.1165/rcmb.2003-0253OC; Hirosaki T, 2000, J BIOL CHEM, V275, P22495, DOI 10.1074/jbc.M001326200; HORTON MA, 1994, BONE, V15, P639, DOI 10.1016/8756-3282(94)90312-3; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; HUNNINGHAKE GW, 1981, SCIENCE, V212, P925, DOI 10.1126/science.7233186; Khan KMF, 2000, J BIOL CHEM, V275, P4492, DOI 10.1074/jbc.275.6.4492; KIVIRIKKO S, 1995, HUM MOL GENET, V4, P959, DOI 10.1093/hmg/4.5.959; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Koshikawa N, 2005, J BIOL CHEM, V280, P88, DOI 10.1074/jbc.M411824200; Liu Z, 2000, J CLIN INVEST, V105, P113, DOI 10.1172/JCI3693; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; Meng XM, 2003, J INVEST DERMATOL, V121, P720, DOI 10.1046/j.1523-1747.2003.12515.x; Mizushima H, 1997, CELL GROWTH DIFFER, V8, P979; Parikka M, 2006, EXP CELL RES, V312, P1431, DOI 10.1016/j.yexcr.2006.01.015; PFAFF M, 1994, EUR J BIOCHEM, V225, P975, DOI 10.1111/j.1432-1033.1994.0975b.x; Pierce RA, 2000, AM J RESP CELL MOL, V23, P742, DOI 10.1165/ajrcmb.23.6.4202; Pirila E, 2003, BIOCHEM BIOPH RES CO, V303, P1012, DOI 10.1016/S0006-291X(03)00452-2; Plopper G, 1996, J CELL SCI, V109, P1965; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; Rajamaki MM, 2006, VET J, V171, P562, DOI 10.1016/j.tvjl.2004.11.018; Sadowski T, 2005, CELL MOL LIFE SCI, V62, P870, DOI 10.1007/s00018-005-4478-8; Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145; Seftor REB, 2001, CANCER RES, V61, P6322; SENIOR RM, 1989, AM J RESP CELL MOL, V1, P479, DOI 10.1165/ajrcmb/1.6.479; SENIOR RM, 1980, J CLIN INVEST, V66, P859, DOI 10.1172/JCI109926; Shang ML, 2001, J BIOL CHEM, V276, P33045, DOI 10.1074/jbc.M100798200; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Shimanovich I, 2004, J PATHOL, V204, P519, DOI 10.1002/path.1674; Spirito F, 2001, J BIOL CHEM, V276, P18828, DOI 10.1074/jbc.M100381200; STEADMAN R, 1993, J LEUKOCYTE BIOL, V53, P354, DOI 10.1002/jlb.53.4.354; SUNG U, 1993, J CELL BIOL, V123, P1255, DOI 10.1083/jcb.123.5.1255; Sung U, 1997, MOL CELLS, V7, P272; Udayakumar TS, 2003, CANCER RES, V63, P2292; Virtanen I, 2000, EXP CELL RES, V257, P298, DOI 10.1006/excr.2000.4883; Wang SJ, 2005, J CELL SCI, V118, P2067, DOI 10.1242/jcs.02340; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Young RE, 2004, J IMMUNOL, V172, P4493, DOI 10.4049/jimmunol.172.7.4493	58	78	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9513	9522		10.1074/jbc.M706239200	http://dx.doi.org/10.1074/jbc.M706239200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18178964	Green Published, hybrid			2022-12-27	WOS:000254671600004
J	Ura, H; Usuda, M; Kinoshita, K; Sun, C; Mori, K; Akagi, T; Matsuda, T; Koide, H; Yokota, T				Ura, Hiroki; Usuda, Masayuki; Kinoshita, Keita; Sun, Chuanhai; Mori, Keitaro; Akagi, Tadayuki; Matsuda, Takahiko; Koide, Hiroshi; Yokota, Takashi			STAT3 and Oct-3/4 control histone modification through induction of Eed in embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPMENTAL REGULATORS; MOUSE EMBRYOS; SELF-RENEWAL; ES CELLS; POLYCOMB; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; CHROMATIN; PLURIPOTENCY	Mouse embryonic stem (ES) cells can self-renew in the presence of leukemia inhibitory factor (LIF). Several essential transcription factors have been identified for the self-renewal of mouse ES cells, including STAT3, Oct-3/4, and Nanog. The molecular mechanism of ES cell self-renewal, however, is not fully understood. In the present study, we identified Eed, a core component of Polycomb repressive complex 2, as a downstream molecule of STAT3 and Oct-3/4. Artificial activation of STAT3 resulted in increased expression of Eed, whereas expression of a dominant negative mutant of STAT3 or suppression of Oct-3/4 expression led to down-regulation of Eed. Reporter, chromatin immunoprecipitation, and electrophoretic mobility shift assays revealed that STAT3 and Oct-3/4 directly bind to the promoter region of Eed, suggesting that Eed is a common target molecule of STAT3 and Oct-3/4. We also found that suppression of STAT3, Oct-3/4, or Eed causes induction of differentiation-associated genes as well as loss of Lys(27)-trimethylated histone H3 at the promoter regions of the differentiation-associated genes. Suppression of STAT3 and Oct-3/4 also resulted in the absence of Eed at the promoter regions. These results suggest that STAT3 and Oct-3/4 maintain silencing of differentiation-associated genes through up-regulation of Eed in self-renewing ES cells.	[Usuda, Masayuki; Koide, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, Kanazawa, Ishikawa 9208640, Japan	Kanazawa University	Koide, H (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	hkoide@med.kanasawa-u.ac.jp	Ura, Hiroki/ABD-8427-2020; Yokota, Takashi/J-8483-2015; Koide, Hiroshi/E-9000-2011; Yokota, Takashi/F-6021-2011; Akagi, Tadayuki/E-1078-2011	Ura, Hiroki/0000-0002-7600-3481; Akagi, Tadayuki/0000-0002-1733-9452; Koide, Hiroshi/0000-0001-5916-3179				Abate-Shen C, 2003, CANCER CELL, V4, P329, DOI 10.1016/S1535-6108(03)00277-0; Akagi T, 2005, BIOCHEM BIOPH RES CO, V331, P23, DOI 10.1016/j.bbrc.2005.03.118; Arguni E, 2006, INT IMMUNOL, V18, P1079, DOI 10.1093/intimm/dxl041; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; AZUMA S, 1991, Japanese Journal of Animal Reproduction, V37, P37; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Faust C, 1998, DEVELOPMENT, V125, P4495; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Kim SY, 2007, J BIOL CHEM, V282, P9962, DOI 10.1074/jbc.M608722200; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3	35	48	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9713	9723		10.1074/jbc.M707275200	http://dx.doi.org/10.1074/jbc.M707275200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18201968	hybrid			2022-12-27	WOS:000254671600026
J	Foley, JH; Kim, P; Nesheim, ME				Foley, Jonathan H.; Kim, Paula; Nesheim, Michael E.			Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSIC ENZYMATIC-ACTIVITY; PROCARBOXYPEPTIDASE-U TAFI; PLASMA CARBOXYPEPTIDASE; PLASMINOGEN-ACTIVATOR; ANTIFIBRINOLYTIC ACTIVITY; DEGRADATION-PRODUCTS; THERMAL-STABILITY; PROTEIN-C; MECHANISM; SYSTEM	Activated thrombin-activable fibrinolysis inhibitor (TAFIa) plays a significant role in the prolongation of fibrinolysis. During fibrinolysis, plasminogen is activated to plasmin, which lyses a clot by cleaving fibrin after selected arginine and lysine residues. TAFIa attenuates fibrinolysis by removing the exposed C-terminal lysine residues. It was recently reported that TAFI zymogen possesses sufficient carboxypeptidase activity to attenuate fibrinolysis through a mechanism similar to TAFIa. Here, we show with a recently developed TAFIa assay that when thrombin is used to clot TAFI-deficient plasma supplemented with TAFI, there is some TAFI activation. The extent of activation was dependent upon the concentration of zymogen present in the plasma, and lysis times were prolonged by TAFIa in a concentration-dependent manner. Potato tuber carboxypeptidase inhibitor, an inhibitor of TAFIa but not TAFI, abolished the prolongation of lysis in TAFI-deficient plasma supplemented with TAFI zymogen. In addition, TAFIa but not TAFI catalyzed release of plasminogen bound to soluble fibrin degradation products. The data presented confirm that TAFI zymogen is effective in cleaving a small substrate but does not play a role in the attenuation of fibrinolysis because of its inability to cleave plasmin-modified fibrin degradation products.	[Foley, Jonathan H.; Kim, Paula; Nesheim, Michael E.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Nesheim, Michael E.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Nesheim, ME (corresponding author), Queens Univ, Dept Biochem, A212 Botterell Hall, Kingston, ON K7L 3N6, Canada.	nesheimm@queensu.ca		Foley, Jonathan/0000-0002-4593-0469	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL 046703] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Bajzar L, 1996, BLOOD, V88, P2093, DOI 10.1182/blood.V88.6.2093.bloodjournal8862093; BAJZAR L, 1990, J BIOL CHEM, V265, P16948; Boffa MB, 1998, J BIOL CHEM, V273, P2127, DOI 10.1074/jbc.273.4.2127; Boffa MB, 2000, J BIOL CHEM, V275, P12868, DOI 10.1074/jbc.275.17.12868; EATON DL, 1991, J BIOL CHEM, V266, P21833; HENDRIKS D, 1990, BIOCHIM BIOPHYS ACTA, V1034, P86, DOI 10.1016/0304-4165(90)90157-R; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2183; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2176; Kim PYG, 2008, ANAL BIOCHEM, V372, P32, DOI 10.1016/j.ab.2007.09.034; Leurs J, 2004, J THROMB HAEMOST, V2, P416, DOI 10.1111/j.1538-7836.2004.00605.x; Mao SS, 1999, J BIOL CHEM, V274, P35046, DOI 10.1074/jbc.274.49.35046; Neill EKT, 2004, ANAL BIOCHEM, V330, P332, DOI 10.1016/j.ab.2004.04.007; REDLITZ A, 1995, J CLIN INVEST, V96, P2534, DOI 10.1172/JCI118315; Reverter D, 1997, FEBS LETT, V420, P7, DOI 10.1016/S0014-5793(97)01476-2; Sakharov DV, 1997, J BIOL CHEM, V272, P14477, DOI 10.1074/jbc.272.22.14477; Schneider M, 2002, J BIOL CHEM, V277, P1021, DOI 10.1074/jbc.M104444200; Schneider M, 2002, J BIOL CHEM, V277, P9944, DOI 10.1074/jbc.M111685200; SUENSON E, 1984, EUR J BIOCHEM, V140, P513, DOI 10.1111/j.1432-1033.1984.tb08132.x; TAN AK, 1995, BIOCHEMISTRY-US, V34, P5811, DOI 10.1021/bi00017a012; Valnickova Z, 2007, J THROMB HAEMOST, V5, P1336, DOI 10.1111/j.1538-7836.2007.02593.x; Valnickova Z, 2007, J BIOL CHEM, V282, P3066, DOI 10.1074/jbc.M606559200; Walker JB, 2007, J THROMB HAEMOST, V5, P1257, DOI 10.1111/j.1538-7836.2007.02541.x; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; Walker JB, 2004, J BIOL CHEM, V279, P27896, DOI 10.1074/jbc.M401027200; Walker JB, 2001, J BIOL CHEM, V276, P3138, DOI 10.1074/jbc.M005876200; Wang W, 1998, J BIOL CHEM, V273, P27176, DOI 10.1074/jbc.273.42.27176; WANG W, 1994, J BIOL CHEM, V269, P15937; Willemse JL, 2007, J THROMB HAEMOST, V5, P1334, DOI 10.1111/j.1538-7836.2007.02539.x; Willemse JL, 2006, ANAL BIOCHEM, V356, P157, DOI 10.1016/j.ab.2006.05.020	31	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8863	8867		10.1074/jbc.M800127200	http://dx.doi.org/10.1074/jbc.M800127200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18252711	Green Published, hybrid			2022-12-27	WOS:000254465800013
J	Bendjennat, M; Weil, PA				Bendjennat, Mourad; Weil, P. Anthony			The transcriptional repressor activator protein Rap1p is a direct regulator of TATA-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTION; PROMOTERS IN-VIVO; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-PROTEIN; GENE-EXPRESSION; BOX-BINDING; DNA-BINDING; CRYSTAL-STRUCTURE; GENOME-WIDE; FUNCTIONAL-ANALYSIS	Essentially all nuclear eukaryotic gene transcription depends upon the function of the transcription factor TATA-binding protein (TBP). Here we show that the abundant, multifunctional DNA binding transcription factor repressor activator protein Rap1p interacts directly with TBP. TBP-Rap1p binding occurs efficiently in vivo at physiological expression levels, and in vitro analyses confirm that this is a direct interaction. The DNA binding domains of the two proteins mediate interaction between TBP and Rap1p. TBP-Rap1p complex formation inhibits TBP binding to TATA promoter DNA. Alterations in either Rap1p or TBP levels modulate mRNA gene transcription in vivo. We propose that Rap1p represents a heretofore unrecognized regulator of TBP.	[Bendjennat, Mourad; Weil, P. Anthony] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Weil, PA (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	tony.weil@vanderbilt.edu			NIGMS NIH HHS [GM 52461, R01 GM052461, R01 GM052461-12] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM052461, R01GM052461] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander DE, 2004, J BIOL CHEM, V279, P32401, DOI 10.1074/jbc.M405782200; Bai Y, 1997, MOL CELL BIOL, V17, P3081, DOI 10.1128/MCB.17.6.3081; Banik U, 2001, J BIOL CHEM, V276, P49100, DOI 10.1074/jbc.M109246200; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bi X, 1999, GENE DEV, V13, P1089, DOI 10.1101/gad.13.9.1089; Blair WS, 1997, MOL CELL BIOL, V17, P2888, DOI 10.1128/MCB.17.5.2888; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P5086, DOI 10.1128/MCB.8.12.5086; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; COLEMAN RA, 1995, J BIOL CHEM, V270, P13850, DOI 10.1074/jbc.270.23.13850; Coleman RA, 1999, MOL CELL, V4, P451, DOI 10.1016/S1097-2765(00)80453-0; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; CORMACK BP, 1993, SCIENCE, V262, P244, DOI 10.1126/science.8211143; De Sanctis V, 2002, J MOL BIOL, V318, P333, DOI 10.1016/S0022-2836(02)00110-9; Del Vescovo V, 2004, J MOL BIOL, V338, P877, DOI 10.1016/j.jmb.2004.03.047; Deminoff SJ, 2001, GENETICS, V158, P133; Drazinic CM, 1996, MOL CELL BIOL, V16, P3187; DURRIN LK, 1992, MOL CELL BIOL, V12, P1621, DOI 10.1128/MCB.12.4.1621; Fourel G, 2002, J BIOL CHEM, V277, P41736, DOI 10.1074/jbc.M202578200; FREEMAN K, 1995, GENETICS, V141, P1253; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Geisberg JV, 2000, MOL CELL BIOL, V20, P1478, DOI 10.1128/MCB.20.5.1478-1488.2000; Graham IR, 1999, MOL CELL BIOL, V19, P7481; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Hall DB, 2006, MOL CELL BIOL, V26, P3672, DOI 10.1128/MCB.26.9.3672-3679.2006; HAN M, 1988, EMBO J, V7, P2221, DOI 10.1002/j.1460-2075.1988.tb03061.x; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Hinkley CS, 2003, J BIOL CHEM, V278, P18649, DOI 10.1074/jbc.M204247200; Huisinga KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r46; Idrissi FZ, 2001, J BIOL CHEM, V276, P26090, DOI 10.1074/jbc.M101746200; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jackson-Fisher AJ, 1999, MOL CELL, V3, P717, DOI 10.1016/S1097-2765(01)80004-6; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kasahara K, 2007, MOL CELL BIOL, V27, P6686, DOI 10.1128/MCB.00876-07; Kim S, 2000, MOL CELL BIOL, V20, P2455, DOI 10.1128/MCB.20.7.2455-2465.2000; KLEIN C, 1994, SCIENCE, V266, P280, DOI 10.1126/science.7939664; Kotani T, 2000, P NATL ACAD SCI USA, V97, P7178, DOI 10.1073/pnas.120074297; Kou HP, 2004, J BIOL CHEM, V279, P20966, DOI 10.1074/jbc.M401535200; Kou HP, 2003, MOL CELL BIOL, V23, P3186, DOI 10.1128/MCB.23.9.3186-3201.2003; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Metcalf CE, 2006, J BIOL CHEM, V281, P30015, DOI 10.1074/jbc.M606289200; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Moretti P, 2001, MOL CELL BIOL, V21, P8082, DOI 10.1128/MCB.21.23.8082-8094.2001; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; MULLER T, 1994, J STRUCT BIOL, V113, P1, DOI 10.1006/jsbi.1994.1027; Nishikawa J, 1997, P NATL ACAD SCI USA, V94, P85, DOI 10.1073/pnas.94.1.85; Pardo B, 2005, EMBO J, V24, P3117, DOI 10.1038/sj.emboj.7600778; Pereira LA, 2003, GENE, V315, P1, DOI 10.1016/S0378-1119(03)00714-5; Pereira LA, 2001, MOL CELL BIOL, V21, P7523, DOI 10.1128/MCB.21.21.7523-7534.2001; PEREZHOWARD GM, 1995, BIOCHEMISTRY-US, V34, P8005, DOI 10.1021/bi00025a006; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Rossetti L, 2001, J MOL BIOL, V306, P903, DOI 10.1006/jmbi.2001.4458; Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; SCHROEDER SC, 1994, J BIOL CHEM, V269, P28335; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Stavenhagen JB, 1998, GENE DEV, V12, P3044, DOI 10.1101/gad.12.19.3044; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Takemaru K, 1997, P NATL ACAD SCI USA, V94, P7251, DOI 10.1073/pnas.94.14.7251; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Wu WH, 1999, P NATL ACAD SCI USA, V96, P2764, DOI 10.1073/pnas.96.6.2764; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Xu SP, 2004, GENE, V338, P177, DOI 10.1016/j.gene.2004.04.034; Yu LN, 1999, MOL CELL BIOL, V19, P5279; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506; Zhao Y, 2006, MOL CELL BIOL, V26, P4853, DOI 10.1128/MCB.02367-05	96	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8699	8710		10.1074/jbc.M709436200	http://dx.doi.org/10.1074/jbc.M709436200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18195009	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000254288000068
J	Moiseyev, G; Takahashi, Y; Chen, Y; Kim, S; Ma, JX				Moiseyev, Gennadiy; Takahashi, Yusuke; Chen, Ying; Kim, Seoyoung; Ma, Jian-xing			RPE65 from cone-dominant chicken is a more efficient isomerohydrolase compared with that from rod-dominant species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; VISUAL CYCLE; KEY RESIDUES; VISION; ESTERS; 11-CIS-RETINOL; ISOMERIZATION; ISOMERASE; PROTEIN; ACID	Cones recover their photosensitivity faster than rods after bleaching. It has been suggested that a higher rate regeneration of 11-cis-retinal, the chromophore for visual pigments, is required for cones to continuously function under bright light conditions. RPE65 is the isomerohydrolase catalyzing a key step in regeneration of 11-cis-retinal. The present study investigated whether RPE65 in a cone-dominant species is more efficient in its enzymatic activity than that from rod-dominant species. In vitro isomerohydrolase activity assay showed that isomerohydrolase activity in the chicken retinal pigment epithelium (RPE) was 11.7-fold higher than in the bovine RPE, after normalization by RPE65 protein levels. Similar to that of human and bovine, the isomerohydrolase activity in chicken RPE was blocked by two specific inhibitors of lecithin retinal acyltransferase, indicating that chicken RPE65 also uses all-trans-retinyl ester as the direct substrate. To exclude the possibility that the higher isomerohydrolase activity in the chicken RPE could arise from another unknown isomerohydrolase, we expressed chicken and human RPE65 using the adenovirus system in a stable cell line expressing lecithin retinal acyltransferase. Under the same conditions, isomerohydrolase activity of recombinant chicken RPE65 was 7.7-fold higher than that of recombinant human RPE65, after normalization by RPE65 levels. This study demonstrates that RPE65 from the cone-dominant chicken RPE possesses significantly higher specific retinol isomerohydrolase activity, when compared with RPE65 from rod-dominant species, consistent with the faster regeneration rates of visual pigments in cone-dominant retinas.	[Moiseyev, Gennadiy; Takahashi, Yusuke; Chen, Ying; Kim, Seoyoung; Ma, Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Dept Cell Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Ma, JX (corresponding author), 941 Stanton L Young Blvd,BSEB 328B, Oklahoma City, OK 73104 USA.	jian-xing-ma@ouhsc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY015650, R01EY012231, R33EY015650] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR 024215] Funding Source: Medline; NEI NIH HHS [EY 015650, EY 012231] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crouch RK, 1996, PHOTOCHEM PHOTOBIOL, V64, P613, DOI 10.1111/j.1751-1097.1996.tb03114.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P14921, DOI 10.1021/bi0356505; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P5809, DOI 10.1021/bi0341004; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Ma JX, 2001, INVEST OPHTH VIS SCI, V42, P1429; Mata NL, 2005, BIOCHEMISTRY-US, V44, P11715, DOI 10.1021/bi050942m; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; Rando RR, 2001, CHEM REV, V101, P1881, DOI 10.1021/cr960141c; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Schonthaler HB, 2007, EUR J NEUROSCI, V26, P1940, DOI 10.1111/j.1460-9568.2007.05801.x; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016	28	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8110	8117		10.1074/jbc.M703654200	http://dx.doi.org/10.1074/jbc.M703654200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18216020	hybrid, Green Published			2022-12-27	WOS:000254288000007
J	Nguyen, N; Bonzo, JA; Chen, S; Chouinard, S; Kelner, MJ; Hardiman, G; Belanger, A; Tukey, RH				Nguyen, Nghia; Bonzo, Jessica A.; Chen, Shujuan; Chouinard, Sarah; Kelner, Michael J.; Hardiman, Gary; Belanger, Alain; Tukey, Robert H.			Disruption of the Ugt1 locus in mice resembles human Crigler-Najjar type I disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIRUBIN-UDP-GLUCURONOSYLTRANSFERASE; URIDINE DIPHOSPHO-GLUCURONOSYLTRANSFERASES; MYCOPHENOLIC-ACID; GUNN-RATS; HUMAN LIVER; BILE-ACID; DIFFERENTIAL EXPRESSION; UNCONJUGATED BILIRUBIN; GILBERTS-SYNDROME; NUCLEAR RECEPTOR	The 9 UDP-glucuronosyltranferases (UGTs) encoded by the UGT1 locus in humans are key enzymes in the metabolism of most drugs as well as endogenous substances such as bile acids, fatty acids, steroids, hormones, neurotransmitters, and bilirubin. Severe unconjugated hyperbilirubinemia in humans that suffer from Crigler-Najjar type I disease results from lesions in the UGT1A1 gene and is often fatal. To examine the physiological importance of the Ugt1 locus in mice, this locus was rendered non-functional by interrupting exon 4 to create Ugt1(-/-) mice. Because UGT1A1 in humans is responsible for 100% of the conjugated bilirubin, it followed that newborn Ugt1(-/-) mice developed serum levels of unconjugated bilirubin that were 40 - 60 times higher than Ugt1(+/-) or wild-type mice. The result of extreme unconjugated bilirubin in Ugt1(-/-) mice, comparable to the induced levels noted in patients with Crigler-Najjar type 1 disease, is fatal in neonatal Ugt1(-/-) mice within 2 weeks following birth. The extreme jaundice is present as a phenotype in skin color after 8 h. Neonatal Ugt1(-/-) mice exhibit no detectable UGT1A-specific RNA, which corresponds to a complete absence of UGT1A proteins in liver microsomes. Conserved glucuronidation activity attributed to the Ugt1 locus can be defined in Ugt1(-/-) mice, because UGT2-dependent glucuronidation activity is unaffected. Remarkably, the loss of UGT1A functionality in liver results in significant alterations in cellular metabolism as investigated through changes in gene expression. Thus, the loss of UGT1A function in Ugt1(-/-) mice leads to a metabolic syndrome that can serve as a model to further investigate the toxicities associated with unconjugated bilirubin and the impact of this disease in humans.	[Nguyen, Nghia; Bonzo, Jessica A.; Chen, Shujuan; Tukey, Robert H.] Univ Calif San Diego, Dept Chem & Biochem, Lab Environm Toxicol, La Jolla, CA 92093 USA; [Nguyen, Nghia; Bonzo, Jessica A.; Chen, Shujuan; Tukey, Robert H.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kelner, Michael J.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Hardiman, Gary] Univ Calif San Diego, Sch Med, Dept Med, Biomed Genom Microarray Facil, La Jolla, CA 92093 USA; [Chouinard, Sarah; Belanger, Alain] Ctr Hosp Univ Quebec, Oncol & Mol Endocrinol Res Ctr, Quebec City, PQ G1V 4G2, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Laval University	Tukey, RH (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Lab Environm Toxicol, 9500 Gilman Dr,Leichtag Biomed Res Bldg, La Jolla, CA 92093 USA.	rtukey@ucsd.edu		Chen, Shujuan/0000-0002-1068-195X; Hardiman, Gary/0000-0003-4558-0400	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES10337] Funding Source: Medline; PHS HHS [15RT-0251] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Albert C, 1999, ENDOCRINOLOGY, V140, P3292, DOI 10.1210/en.140.7.3292; Barbier O, 1999, BIOCHEM J, V337, P567, DOI 10.1042/0264-6021:3370567; Belanger G, 1999, EUR J BIOCHEM, V260, P701, DOI 10.1046/j.1432-1327.1999.00197.x; Bernard O, 2004, DRUG METAB DISPOS, V32, P775, DOI 10.1124/dmd.32.8.775; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Bosma PJ, 2003, J HEPATOL, V38, P107, DOI 10.1016/S0168-8278(02)00359-8; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Buckley DB, 2007, DRUG METAB DISPOS, V35, P121, DOI 10.1124/dmd.106.012070; CAPDEVILA JH, 1992, FASEB J, V6, P731, DOI 10.1096/fasebj.6.2.1537463; Chen SJ, 2005, J BIOL CHEM, V280, P37547, DOI 10.1074/jbc.M506683200; CHOWDHURY JR, 1993, ADV VET SCI COMP MED, V37, P149; Clarke DJ, 1997, CLIN CHIM ACTA, V266, P63, DOI 10.1016/S0009-8981(97)00167-8; Cole SW, 2003, BIOINFORMATICS, V19, P1808, DOI 10.1093/bioinformatics/btg242; CRIGLER JF, 1952, PEDIATRICS, V10, P169; CRIGLER JF, 1969, J CLIN INVEST, V48, P42, DOI 10.1172/JCI105973; ELAWADY M, 1990, J BIOL CHEM, V265, P10752; Fernandes A, 2006, J NEUROCHEM, V96, P1667, DOI 10.1111/j.1471-4159.2006.03680.x; Fernandes A, 2007, EUR J NEUROSCI, V25, P1058, DOI 10.1111/j.1460-9568.2007.05340.x; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; Graber ALY, 2007, PHARMACOGENET GENOM, V17, P619, DOI 10.1097/FPC.0b013e3280121fe9; Guillemette C, 1997, ENDOCRINOLOGY, V138, P2998, DOI 10.1210/en.138.7.2998; Huang WD, 2003, P NATL ACAD SCI USA, V100, P4156, DOI 10.1073/pnas.0630614100; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; IYANAGI T, 1991, J BIOL CHEM, V266, P24048; KAPITULNIK J, 1993, MOL PHARMACOL, V43, P722; Kato Y, 2004, TOXICOL SCI, V81, P309, DOI 10.1093/toxsci/kfh225; KOMAKI T, 1991, J ENDOCRINOL INVEST, V14, P409, DOI 10.1007/BF03349091; Krishnaswamy S, 2005, J PHARMACOL EXP THER, V313, P1340, DOI 10.1124/jpet.104.081968; Krishnaswamy S, 2003, DRUG METAB DISPOS, V31, P133, DOI 10.1124/dmd.31.1.133; Kurkela M, 2007, PHARMACOGENET GENOM, V17, P115, DOI 10.1097/FPC.0b013e328011b598; LAMB JG, 1994, BIOCHEMISTRY-US, V33, P10513, DOI 10.1021/bi00200a037; Lankisch TO, 2006, HEPATOLOGY, V44, P1324, DOI 10.1002/hep.21361; Lepine J, 2004, J CLIN ENDOCR METAB, V89, P5222, DOI 10.1210/jc.2004-0331; Lin SZ, 2003, NEUROSCI LETT, V353, P209, DOI 10.1016/j.neulet.2003.09.053; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Mackenzie PI, 2000, THER DRUG MONIT, V22, P10, DOI 10.1097/00007691-200002000-00002; Mojarrabi B, 1997, BIOCHEM BIOPH RES CO, V238, P775, DOI 10.1006/bbrc.1997.7388; Monaghan G, 1996, LANCET, V347, P578, DOI 10.1016/S0140-6736(96)91273-8; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Operana TN, 2007, J BIOL CHEM, V282, P4821, DOI 10.1074/jbc.M609417200; Ostrow JD, 2003, PEDIATR RES, V54, P926, DOI 10.1203/01.PDR.0000103388.01854.91; Phelan D, 1998, ARCH BIOCHEM BIOPHYS, V357, P155, DOI 10.1006/abbi.1998.0814; Picard N, 2005, DRUG METAB DISPOS, V33, P139, DOI 10.1124/dmd.104.001651; RITTER JK, 1992, J CLIN INVEST, V90, P150, DOI 10.1172/JCI115829; RITTER JK, 1992, J BIOL CHEM, V267, P3257; RIZZARDINI M, 1993, BIOCHEM J, V290, P343, DOI 10.1042/bj2900343; Rodrigues CMP, 2002, HEPATOLOGY, V35, P1186, DOI 10.1053/jhep.2002.32967; Rodrigues CMP, 2000, MOL MED, V6, P936, DOI 10.1007/BF03401828; Roger C, 1995, EARLY HUM DEV, V43, P133, DOI 10.1016/0378-3782(95)01668-6; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Schauer R, 2003, J PEDIATR SURG, V38, P1227, DOI 10.1016/S0022-3468(03)00273-2; Senekeo-Effenberger K, 2007, DRUG METAB DISPOS, V35, P419, DOI 10.1124/dmd.106.013243d; Servedio V, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9322; Shapiro SM, 2003, PEDIATR NEUROL, V29, P410, DOI 10.1016/j.pediatrneurol.2003.09.011; Shipkova M, 2001, BRIT J PHARMACOL, V132, P1027, DOI 10.1038/sj.bjp.0703898; SOKAL EM, 1995, TRANSPLANTATION, V60, P1095, DOI 10.1097/00007890-199511270-00006; Strassburg CP, 1997, MOL PHARMACOL, V52, P212, DOI 10.1124/mol.52.2.212; Strassburg CP, 1998, MOL PHARMACOL, V54, P647; Strassburg CP, 1999, GASTROENTEROLOGY, V116, P149, DOI 10.1016/S0016-5085(99)70239-8; Strauss KA, 2006, EUR J PEDIATR, V165, P306, DOI 10.1007/s00431-005-0055-2; Takahashi M, 1996, J BIOL CHEM, V271, P26536, DOI 10.1074/jbc.271.43.26536; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Tukey RH, 2002, MOL PHARMACOL, V62, P446, DOI 10.1124/mol.62.3.446; Turgeon D, 2001, ENDOCRINOLOGY, V142, P778, DOI 10.1210/en.142.2.778; Verreault M, 2006, HEPATOLOGY, V44, P368, DOI 10.1002/hep.21259; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Wennberg RP, 2000, CELL MOL NEUROBIOL, V20, P97, DOI 10.1023/A:1006900111744; Yamamura H, 1993, Nagoya J Med Sci, V55, P11; Yueh MF, 2007, J BIOL CHEM, V282, P8749, DOI 10.1074/jbc.M610790200	71	63	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7901	7911		10.1074/jbc.M709244200	http://dx.doi.org/10.1074/jbc.M709244200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18180294	hybrid			2022-12-27	WOS:000253997900066
J	Yang, YW; Zhang, W; Bayrer, JR; Weiss, MA				Yang, Yanwu; Zhang, Wei; Bayrer, James R.; Weiss, Michael A.			Doublesex and the regulation of sexual dimorphism in Drosophila melanogaster - Structure, function, and mutagenesis of a female-specific domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; DNA-BINDING; MAGNETIC-RESONANCE; DISTANCE GEOMETRY; PROTEIN; DIFFERENTIATION; NMR; INTERSEX; BEHAVIOR; COMPLEX	The DSX ( Doublesex) transcription factor regulates somatic sexual differentiation in Drosophila. Female and male isoforms ( DSXF and DSXM) are formed due to sex-specific RNA splicing. DNA recognition, mediated by a shared N-terminal zinc module ( the DM domain), is enhanced by a C-terminal dimerization element. Sex-specific extension of this element in DSXF and DSXM leads to assembly of distinct transcriptional preinitiation complexes. Here, we describe the structure of the extended C-terminal dimerization domain of DSXF as determined by multidimensional NMR spectroscopy. The core dimerization element is well ordered, giving rise to a dense network of interresidue nuclear Overhauser enhancements. The structure contains dimer-related UBA folds similar to those defined by x-ray crystallographic studies of a truncated domain. Whereas the proximal portion of the female tail extends helix 3 of the UBA fold, the distal tail is disordered. Ala substitutions in the proximal tail disrupt the sex-specific binding of IX ( Intersex), an obligatory partner protein and putative transcriptional coactivator; IX-DSXF interaction is, by contrast, not disrupted by truncation of the distal tail. Mutagenesis of the UBA-like dimer of DSXF highlights the importance of steric and electrostatic complementarity across the interface. Two temperature-sensitive mutations at this interface have been characterized in yeast model systems. One weakens a network of solvated salt bridges, whereas the other perturbs the underlying nonpolar interface. These mutations confer graded gene-regulatory activity in yeast within a physiological temperature range and so may provide novel probes for genetic analysis of a sex-specific transcriptional program in Drosophila development.	[Yang, Yanwu; Zhang, Wei; Bayrer, James R.; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	zhang, wei/A-7015-2011		NIGMS NIH HHS [T32 GM07250, GM037731] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037731, T32GM007250, R01GM037731] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad SM, 2002, CELL, V109, P651, DOI 10.1016/S0092-8674(02)00744-4; AN WQ, 1995, EMBO J, V14, P1221, DOI 10.1002/j.1460-2075.1995.tb07105.x; An WQ, 1996, MOL CELL BIOL, V16, P3106; ARROWSMITH C, 1991, EUR J BIOCHEM, V202, P53, DOI 10.1111/j.1432-1033.1991.tb16344.x; Arthur BI, 1998, CURR BIOL, V8, P1187, DOI 10.1016/S0960-9822(07)00491-5; BAKER BS, 1980, GENETICS, V94, P383; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; BAKER BS, 1989, NATURE, V340, P521, DOI 10.1038/340521a0; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Bayrer J, 2004, ACTA CRYSTALLOGR D, V60, P1328, DOI 10.1107/S0907444904012223; Bayrer JR, 2005, J BIOL CHEM, V280, P32989, DOI 10.1074/jbc.M507990200; BELOTE JM, 1987, P NATL ACAD SCI USA, V84, P8026, DOI 10.1073/pnas.84.22.8026; BOWNES M, 1981, MOL GEN GENET, V182, P222, DOI 10.1007/BF00269661; BRUNGER AT, 1993, XPLOR VERSION 3 1 MA; BURTIS KC, 1991, EMBO J, V10, P2577, DOI 10.1002/j.1460-2075.1991.tb07798.x; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Burtis KC, 1993, CURR OPIN CELL BIOL, V5, P1006, DOI 10.1016/0955-0674(93)90085-5; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Cai ML, 2001, EMBO J, V20, P4399, DOI 10.1093/emboj/20.16.4399; CHASE BA, 1995, GENETICS, V139, P1649; Cho S, 1997, J BIOL CHEM, V272, P3185, DOI 10.1074/jbc.272.6.3185; Cho S, 1998, BIOCHEMISTRY-US, V37, P11301, DOI 10.1021/bi972916x; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; CLINE TW, 1989, CELL, V59, P231, DOI 10.1016/0092-8674(89)90280-8; CLORE GM, 1986, EMBO J, V5, P2729, DOI 10.1002/j.1460-2075.1986.tb04557.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Erdman SE, 1996, GENETICS, V144, P1639; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Garrett-Engele CM, 2002, DEVELOPMENT, V129, P4661; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; JIN L, 1994, PROTEIN SCI, V3, P2351, DOI 10.1002/pro.5560031219; Keisman EL, 2001, DEVELOPMENT, V128, P1643; Keisman EL, 2001, DEV CELL, V1, P215, DOI 10.1016/S1534-5807(01)00027-2; Koradi R, 1996, J MOL GRAPHICS, V14, P29; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Legault P, 1998, CELL, V93, P289, DOI 10.1016/S0092-8674(00)81579-2; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; MORGAN T, 1943, CARNEGIE I WASH YB, V42, P171; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Muroya K, 2000, J CLIN ENDOCR METAB, V85, P3094, DOI 10.1210/jc.85.9.3094; Narendra U, 2002, J BIOL CHEM, V277, P43463, DOI 10.1074/jbc.M204616200; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; NOTHIGER R, 1987, GENET RES, V50, P113, DOI 10.1017/S001667230002351X; Oh DB, 2002, P NATL ACAD SCI USA, V99, P16666, DOI 10.1073/pnas.262672699; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; POWERS R, 1993, BIOCHEMISTRY-US, V32, P6744, DOI 10.1021/bi00077a030; Raymond CS, 1999, DEV BIOL, V215, P208, DOI 10.1006/dbio.1999.9461; Raymond CS, 1999, HUM MOL GENET, V8, P989, DOI 10.1093/hmg/8.6.989; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Sanchez L, 2001, BIOESSAYS, V23, P698, DOI 10.1002/bies.1099; Sanchez L, 2001, DEVELOPMENT, V128, P1033; Sato S, 2003, J BIOL CHEM, V278, P49671, DOI 10.1074/jbc.C300444200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Siegal ML, 2005, DEV GENES EVOL, V215, P1, DOI 10.1007/s00427-004-0445-x; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Su LL, 1997, BIOCHEMISTRY-US, V36, P12722, DOI 10.1021/bi971408k; Villella A, 1996, GENETICS, V143, P331; Vincent S, 2001, CELL, V106, P399, DOI 10.1016/S0092-8674(01)00468-8; Waterbury JA, 1999, GENETICS, V152, P1653; WEISS MA, 1990, J MAGN RESON, V86, P626, DOI 10.1016/0022-2364(90)90041-7; WILLIAMSON MP, 1985, J MOL BIOL, V182, P295, DOI 10.1016/0022-2836(85)90347-X; Withers-Ward ES, 2000, BIOCHEMISTRY-US, V39, P14103, DOI 10.1021/bi0017071; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Yamamoto D, 1996, NEUROSCI RES, V26, P95, DOI 10.1016/S0168-0102(96)01087-5; Zhang W, 2006, MOL CELL BIOL, V26, P535, DOI 10.1128/MCB.26.2.535-547.2006; Zhu LY, 2000, GENE DEV, V14, P1750; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	75	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7280	7292		10.1074/jbc.M708742200	http://dx.doi.org/10.1074/jbc.M708742200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18184648	hybrid			2022-12-27	WOS:000253779600073
J	Billington, RA; Travelli, C; Ercolano, E; Galli, U; Roman, CB; Grolla, AA; Canonico, PL; Condorelli, F; Genazzani, AA				Billington, Richard A.; Travelli, Cristina; Ercolano, Emanuela; Galli, Ubaldina; Roman, Cintia Blasi; Grolla, Ambra A.; Canonico, Pier Luigi; Condorelli, Fabrizio; Genazzani, Armando A.			Characterization of NAD uptake in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; CYCLIC ADP-RIBOSE; INTRACELLULAR CALCIUM; CD38; APOPTOSIS; BIOSYNTHESIS; METABOLISM; ASTROCYTES; INFLUX; DEATH	Recent evidence has shown that NAD(P) plays a variety of roles in cell-signaling processes. Surprisingly, the presence of NAD(P) utilizing ectoenzymes suggests that NAD(P) is present extracellularly. Indeed, nanomolar concentrations of NAD have been found in plasma and other body fluids. Although very high concentrations of NAD have been shown to enter cells, it is not known whether lower, more physiological concentrations are able to be taken up. Here we show that two mammalian cell types are able to transport low NAD concentrations effectively. Furthermore, extracellular application of NAD was able to counteract FK866-induced cell death and restore intracellular NAD(P) levels. We propose that NAD uptake may play a role in physiological NAD homeostasis.	Univ Piemonte Orientale, Dipartimento Sci Chim Alimentari Farmaceut & Farm, I-28100 Novara, Italy; Univ Piemonte Orientale, Drug & Food Biotechnol Ctr, I-28100 Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Billington, RA (corresponding author), Univ Piemonte Orientale, Dipartimento Sci Chim Alimentari Farmaceut & Farm, I-28100 Novara, Italy.	billington@pharm.unipmn.it	Billington, Richard/HGB-1970-2022; Genazzani, Armando/AAI-8280-2020; Condorelli, Fabrizio/AAT-1953-2020; Travelli, Cristina/AAA-9450-2022	Condorelli, Fabrizio/0000-0002-9943-0857; Genazzani, Armando/0000-0003-1923-7430; Billington, Richard/0000-0001-7288-8916; Galli, Ubaldina/0000-0003-1126-0142; grolla, ambra/0000-0003-0233-0700				Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; BIEDERMANN E, 2005, US PATENT, V903, P118; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Billington RA, 2000, BIOCHEM BIOPH RES CO, V276, P112, DOI 10.1006/bbrc.2000.3444; Billington RA, 2006, FASEB J, V20, P521, DOI 10.1096/fj.05-5058fje; Billington RA, 2006, MOL MED, V12, P324, DOI 10.2119/2006-00075.Billington; Bruzzone S, 2001, J BIOL CHEM, V276, P48300, DOI 10.1074/jbc.M107308200; Bruzzone S, 2001, FASEB J, V15, P10; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Franco L, 1998, FASEB J, V12, P1507; GASSER A, 2006, J BIOL CHEM, V281, P2008; Guida L, 2004, J BIOL CHEM, V279, P22066, DOI 10.1074/jbc.M314137200; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Hasmann M, 2003, CANCER RES, V63, P7436; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Lee HC, 2006, MOL MED, V12, P317, DOI 10.2119/2006-00086.Lee; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Moreschi I, 2006, J BIOL CHEM, V281, P31419, DOI 10.1074/jbc.M606625200; Morgan A.J., 2005, METHODS CALCIUM SIGN, P265; O'Reilly T, 2003, CAN J VET RES, V67, P229; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Podesta M, 2005, J BIOL CHEM, V280, P5343, DOI 10.1074/jbc.M408085200; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Smyth LM, 2004, J BIOL CHEM, V279, P48893, DOI 10.1074/jbc.M407266200; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Zhu KQ, 2005, NEUROREPORT, V16, P1209, DOI 10.1097/00001756-200508010-00015; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x; Zocchi E, 1999, FASEB J, V13, P273, DOI 10.1096/fasebj.13.2.273; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017	38	66	69	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6367	6374		10.1074/jbc.M706204200	http://dx.doi.org/10.1074/jbc.M706204200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18180302	hybrid			2022-12-27	WOS:000253779500044
J	Muchowski, PJ; Ramsden, R; Nguyen, Q; Arnett, EE; Greiling, TM; Anderson, SK; Clark, JI				Muchowski, Paul J.; Ramsden, Richard; Nguyen, QuangVu; Arnett, Ernest E.; Greiling, Teri M.; Anderson, Susan K.; Clark, John I.			Noninvasive measurement of protein aggregation by mutant huntingtin fragments or alpha-synuclein in the lens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; TRANSGENIC MICE; CATARACT; CELLS; OPACIFICATION; POLYGLUTAMINE; GENE; FORM	Many diverse human diseases are associated with protein aggregation in ordered fibrillar structures called amyloid. Amyloid formation may mediate aberrant protein interactions that culminate in neurodegeneration in Alzheimer, Huntington, and Parkinson diseases and in prion encephalopathies. Studies of protein aggregation in the brain are hampered by limitations in imaging techniques and often require invasive methods that can only be performed postmortem. Here we describe transgenic mice in which aggregation-prone proteins that cause Huntington and Parkinson disease are expressed in the ocular lens. Expression of a mutant huntingtin fragment or alpha-synuclein in the lens leads to protein aggregation and cataract formation, which can be monitored in real time by noninvasive, highly sensitive optical techniques. Expression of a mutant huntingtin fragment in mice lacking the major lens chaperone, alpha B-crystallin, markedly accelerated the onset and severity of aggregation, demonstrating that the endogenous chaperone activity of alpha B-crystallin suppresses aggregation in vivo. These novel mouse models will facilitate the characterization of protein aggregation in vivo and are being used in efficient and economical screens for chemical and genetic modifiers of disease-relevant protein aggregation.	[Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Muchowski, Paul J.; Ramsden, Richard; Nguyen, QuangVu] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Arnett, Ernest E.; Greiling, Teri M.; Anderson, Susan K.; Clark, John I.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Clark, John I.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Muchowski, PJ (corresponding author), Univ Calif San Francisco, Dept Biochem, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	pmuchowski@gladstone.ucsf.edu	Greiling, Teri M./AAL-8924-2020	Greiling, Teri M./0000-0002-0028-8986	NATIONAL EYE INSTITUTE [R01EY004542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054753] Funding Source: NIH RePORTER; NEI NIH HHS [EY 04552, R01 EY004542] Funding Source: Medline; NINDS NIH HHS [R01 NS054753, R01 NS054753-03] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ansari RR, 2003, P SOC PHOTO-OPT INS, V4951, P168, DOI 10.1117/12.479478; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; BURKE JR, 1996, NAT MED, V347, P350; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; HIRAOKA T, 1995, INVEST OPHTH VIS SCI, V36, P2550; Hiraoka T, 1996, EXP EYE RES, V62, P11, DOI 10.1006/exer.1996.0002; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kruger R, 2004, J NEUROL, V251, P2, DOI 10.1007/s00415-004-1602-x; Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAHON KA, 1987, SCIENCE, V235, P1622, DOI 10.1126/science.3029873; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Seeberger TM, 2004, J BIOMED OPT, V9, P116, DOI 10.1117/1.1630034; Taube JR, 2002, TRANSGENIC RES, V11, P397, DOI 10.1023/A:1016364001095; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122	21	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6330	6336		10.1074/jbc.M709678200	http://dx.doi.org/10.1074/jbc.M709678200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167346	hybrid, Green Accepted			2022-12-27	WOS:000253779500040
J	Keszler, A; Piknova, B; Schechter, AN; Hogg, N				Keszler, Agnes; Piknova, Barbora; Schechter, Alan N.; Hogg, Neil			The reaction between nitrite and oxyhemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; MEDIATED OXIDATION; INDUCED METHEMOGLOBINEMIA; AUTOCATALYTIC OXIDATION; NITROGEN-DIOXIDE; HUMAN-HEMOGLOBIN; OXIDE; MYOGLOBIN; MECHANISM; DEOXYHEMOGLOBIN	The nitrite anion (NO2-) has recently received much attention as an endogenous nitric oxide source that has the potential to be supplemented for therapeutic benefit. One major mechanism of nitrite reduction is the direct reaction between this anion and the ferrous heme group of deoxygenated hemoglobin. However, the reaction of nitrite with oxyhemoglobin (oxyHb) is well established and generates nitrate and methemoglobin (metHb). Several mechanisms have been proposed that involve the intermediacy of protein-free radicals, ferryl heme, nitrogen dioxide (NO2), and hydrogen peroxide (H2O2) in an autocatalytic free radical chain reaction, which could potentially limit the usefulness of nitrite therapy. In this study we show that none of the previously published mechanisms is sufficient to fully explain the kinetics of the reaction of nitrite with oxyHb. Based on experimental data and kinetic simulation, we have modified previous models for this reaction mechanism and show that the new model proposed here is consistent with experimental data. The important feature of this model is that, whereas previously both H2O2 and NO2 were thought to be integral to both the initiation and propagation steps, H2O2 now only plays a role as an initiator species, and NO2 only plays a role as an autocatalytic propagatory species. The consequences of uncoupling the roles of H2O2 and NO2 in the reaction mechanism for the in vivo reactivity of nitrite are discussed.	[Keszler, Agnes; Hogg, Neil] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Keszler, Agnes; Hogg, Neil] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [Piknova, Barbora; Schechter, Alan N.] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA	Medical College of Wisconsin; Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hogg, N (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	nhogg@mcw.edu		Schechter, Alan N/0000-0002-5235-9408	NIBIB NIH HHS [EB 001980] Funding Source: Medline; NIGMS NIH HHS [GM 55792] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025093, Z01DK025093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM055792, R01GM055792] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P639; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; De Jesus-Bonilla W, 2001, ARCH BIOCHEM BIOPHYS, V390, P304, DOI 10.1006/abbi.2001.2392; DEE G, 1991, FEBS LETT, V294, P38, DOI 10.1016/0014-5793(91)81338-9; Dejam A, 2005, BLOOD, V106, P734, DOI 10.1182/blood-2005-02-0567; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; DOYLE MP, 1982, BIOCHEM BIOPH RES CO, V105, P127, DOI 10.1016/S0006-291X(82)80020-X; Gamgee A, 1868, PHILOS T ROY SOC LON, V158, P589, DOI DOI 10.1098/RSTL.1868.0025; Goldstein S, 2004, J AM CHEM SOC, V126, P15694, DOI 10.1021/ja046186+; Goldstein S, 2003, J BIOL CHEM, V278, P50949, DOI 10.1074/jbc.M308317200; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; Grzelak A, 2001, BBA-GEN SUBJECTS, V1528, P97, DOI 10.1016/S0304-4165(01)00176-3; Herold S, 2003, FREE RADICAL BIO MED, V34, P531, DOI 10.1016/S0891-5849(02)01355-2; Herold S, 2001, BIOCHEMISTRY-US, V40, P3385, DOI 10.1021/bi002407m; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Hunter CJ, 2004, NAT MED, V10, P1122, DOI 10.1038/nm1109; Jourd'heuil D, 2003, J BIOL CHEM, V278, P15720, DOI 10.1074/jbc.M300203200; Keszler A, 2005, FREE RADICAL BIO MED, V39, pS19; Keszler A, 2006, FREE RADICAL BIO MED, V40, P507, DOI 10.1016/j.freeradbiomed.2005.09.005; Kim-Shapiro DB, 2005, J INORG BIOCHEM, V99, P237, DOI 10.1016/j.jinorgbio.2004.10.034; Kirsch M, 2002, BIOL CHEM, V383, P389, DOI 10.1515/BC.2002.043; Kleinbongard P, 2003, FREE RADICAL BIO MED, V35, P790, DOI 10.1016/S0891-5849(03)00406-4; Kohn MC, 2002, DRUG METAB DISPOS, V30, P676, DOI 10.1124/dmd.30.6.676; KOSAKA H, 1982, BIOCHIM BIOPHYS ACTA, V702, P237; KOSAKA H, 1979, BIOCHIM BIOPHYS ACTA, V581, P184, DOI 10.1016/0005-2795(79)90235-6; Lissi E, 1998, FREE RADICAL BIO MED, V24, P1535, DOI 10.1016/S0891-5849(98)00004-5; Matsui T, 1999, J BIOL CHEM, V274, P2838, DOI 10.1074/jbc.274.5.2838; Nakai K, 2005, FREE RADICAL BIO MED, V39, P1050, DOI 10.1016/j.freeradbiomed.2005.05.019; Nicolis S, 2004, CHEM-EUR J, V10, P2281, DOI 10.1002/chem.200304989; O'Donnell VB, 1999, METHOD ENZYMOL, V301, P454; Pietraforte D, 2004, FREE RADICAL BIO MED, V37, P1244, DOI 10.1016/j.freeradbiomed.2004.06.027; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; ROSSIFANELLI A, 1961, J BIOL CHEM, V236, P391; SPAGNUOLO C, 1987, BIOCHIM BIOPHYS ACTA, V911, P59, DOI 10.1016/0167-4838(87)90270-6; SPEIJERS GJA, 2003, JEFCA WHO FOOD ADDIT, V50; Titov VY, 2005, BIOCHEMISTRY-MOSCOW+, V70, P473, DOI 10.1007/s10541-005-0139-7; Titov VY, 2003, BIOCHEMISTRY-MOSCOW+, V68, P627, DOI 10.1023/A:1024609624652; Tsikas D, 2001, J CHROMATOGR A, V915, P107, DOI 10.1016/S0021-9673(01)00634-3; Wade RS, 1996, CHEM RES TOXICOL, V9, P1382, DOI 10.1021/tx9600457; WATANABE S, 1981, ACTA MED OKAYAMA, V35, P173	40	81	82	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9615	9622		10.1074/jbc.M705630200	http://dx.doi.org/10.1074/jbc.M705630200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18203719	hybrid, Green Published			2022-12-27	WOS:000254671600015
J	Seth, P; Miller, HB; Lasda, EL; Pearson, JL; Garcia-Blanco, MA				Seth, Puneet; Miller, Heather B.; Lasda, Erika L.; Pearson, James L.; Garcia-Blanco, Mariano A.			Identification of an intronic splicing enhancer essential for the inclusion of FGFR2 exon IIIc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR-2; MECHANISM; TIA-1; ACTIVATION; SEQUENCES	The ligand specificity of fibroblast growth factor receptor 2 (FGFR2) is determined by the alternative splicing of exons 8 (IIIb) or 9 (IIIc). Exon IIIb is included in epithelial cells, whereas exon IIIc is included in mesenchymal cells. Although a number of cis elements and trans factors have been identified that play a role in exon IIIb inclusion in epithelium, little is known about the activation of exon IIIc in mesenchyme. We report here the identification of a splicing enhancer required for IIIc inclusion. This 24-nucleotide (nt) downstream intronic splicing enhancer (DISE) is located within intron 9 immediately downstream of exon IIIc. DISE was able to activate the inclusion of heterologous exons rat FGFR2 IIIb and human beta-globin exon 2 in cell lines from different tissues and species and also in HeLa cell nuclear extracts in vitro. DISE was capable of replacing the intronic activator sequence 1 (IAS1), a known IIIb splicing enhancer and vice versa. This fact, together with the requirement for DISE to be close to the 5'-splice site and the ability of DISE to promote binding of U1 snRNP, suggested that IAS1 and DISE belong to the same class of cis-acting elements.	[Seth, Puneet; Miller, Heather B.; Lasda, Erika L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Seth, Puneet; Miller, Heather B.; Lasda, Erika L.; Pearson, James L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Ctr RNA Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Garcia-Blanco, MA (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Box 3053 424 CARL,Res Dr, Durham, NC 27710 USA.	garci001@mc.duke.edu	Miller, Heather B./M-1540-2019; Miller, Heather/R-4812-2019	Miller, Heather/0000-0003-1400-7716	NIGMS NIH HHS [R01 GM 63090] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063090] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baraniak AP, 2006, MOL CELL BIOL, V26, P1209, DOI 10.1128/MCB.26.4.1209-1222.2006; Baraniak AP, 2003, MOL CELL BIOL, V23, P9327, DOI 10.1128/MCB.23.24.9327-9337.2003; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Bonano VI, 2006, RNA, V12, P2073, DOI 10.1261/rna.248506; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carlo T, 1996, RNA, V2, P342; Carstens RP, 1998, MOL CELL BIOL, V18, P2205, DOI 10.1128/MCB.18.4.2205; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; DelGatto F, 1996, NUCLEIC ACIDS RES, V24, P2017, DOI 10.1093/nar/24.11.2017; DELGATTO F, 1995, MOL CELL BIOL, V15, P4825; DelGatto F, 1997, MOL CELL BIOL, V17, P5106, DOI 10.1128/MCB.17.9.5106; DELGATTO F, 1995, GENOMICS, V27, P558, DOI 10.1006/geno.1995.1095; DELL KR, 1992, J BIOL CHEM, V267, P21225; Fededa JP, 2005, MOL CELL, V19, P393, DOI 10.1016/j.molcel.2005.06.035; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; Le Guiner C, 2003, J BIOL CHEM, V278, P10465, DOI 10.1074/jbc.M212378200; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Mistry N, 2003, RNA, V9, P209, DOI 10.1261/rna.2470903; Natalizio BJ, 2005, METHODS, V37, P314, DOI 10.1016/j.ymeth.2005.07.013; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; Oltean S, 2006, P NATL ACAD SCI USA, V103, P14116, DOI 10.1073/pnas.0603090103; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wagner EJ, 1999, ELECTROPHORESIS, V20, P1082, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<1082::AID-ELPS1082>3.0.CO;2-#; Wagner EJ, 2005, J BIOL CHEM, V280, P14017, DOI 10.1074/jbc.M414492200; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7	33	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10058	10067		10.1074/jbc.M800087200	http://dx.doi.org/10.1074/jbc.M800087200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18256031	Green Published, hybrid			2022-12-27	WOS:000254671600060
J	Braun, NA; Theg, SM				Braun, Nikolai A.; Theg, Steven M.			The chloroplast tat pathway transports substrates in the dark	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-TRANSPORT; COUPLING FACTOR-I; ATP SYNTHESIS; THYLAKOID MEMBRANES; PROTON GRADIENT; PRECURSOR PROTEINS; ESCHERICHIA-COLI; PHOTOPHOSPHORYLATION; SYSTEM; TRANSLOCATION	Photosynthetic electron transport pumps protons into the thylakoid lumen, creating an electrochemical potential called the protonmotive force (PMF). The energy of the thylakoid PMF is utilized by such machinery as the chloroplast F0F1-ATPase as well as the chloroplast Tat (cpTat) pathway ( a protein transporter) to do work. The bulk phase thylakoid PMF decays rapidly after the termination of actinic illumination, and it has been well established via potentiometric measurements that there is no detectable electrical or chemical potential in the thylakoid after a brief time in the dark. Yet, we report herein that cpTat transport can occur for long periods in the dark. We show that the thylakoid PMF is actually present long after actinic illumination of the thylakoids ceases and that this energy is present in physiologically useful quantities. Consistent with previous studies, the dark-persisting thylakoid potential is not detectable by established indicators. We propose that cpTat transport in the dark is dependent on a pool of protons in the thylakoid held out of equilibrium with those in the bulk aqueous phase.	[Braun, Nikolai A.; Theg, Steven M.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Theg, SM (corresponding author), Univ Calif Davis, Dept Plant Biol, 1 Shields Ave, Davis, CA 95616 USA.	smtheg@ucdavis.edu						Alder NN, 2003, CELL, V112, P231, DOI 10.1016/S0092-8674(03)00032-1; ARANA JL, 1982, J BIOL CHEM, V257, P1125; ARNON DI, 1949, PLANT PHYSIOL, V24, P15; AUSLANDER W, 1975, FEBS LETT, V59, P310, DOI 10.1016/0014-5793(75)80399-1; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Berry S, 1999, BBA-BIOENERGETICS, V1410, P248, DOI 10.1016/S0005-2728(99)00003-1; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Braun NA, 2007, BIOPHYS J, V93, P1993, DOI 10.1529/biophysj.106.098731; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; CROFTS AR, 1966, BIOCHEM BIOPH RES CO, V24, P725, DOI 10.1016/0006-291X(66)90385-8; DAVENPORT JW, 1986, BIOCHIM BIOPHYS ACTA, V851, P136, DOI 10.1016/0005-2728(86)90256-2; Di Cola A, 2005, J BIOL CHEM, V280, P41165, DOI 10.1074/jbc.M509215200; Dilley RA, 2004, PHOTOSYNTH RES, V80, P245, DOI 10.1023/B:PRES.0000030436.32486.aa; Finazzi G, 2003, EMBO J, V22, P807, DOI 10.1093/emboj/cdg081; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; HANGARTER RP, 1982, BIOCHIM BIOPHYS ACTA, V681, P397, DOI 10.1016/0005-2728(82)90181-5; HIND G, 1963, P NATL ACAD SCI USA, V49, P715, DOI 10.1073/pnas.49.5.715; HOCH G, 1963, BIOCHEM BIOPH RES CO, V12, P223, DOI 10.1016/0006-291X(63)90194-3; JAGENDORF AT, 1966, P NATL ACAD SCI USA, V55, P170, DOI 10.1073/pnas.55.1.170; JUNESCH U, 1987, BIOCHIM BIOPHYS ACTA, V893, P275, DOI 10.1016/0005-2728(87)90049-1; JUNGE W, 1968, Z NATURFORSCH PT B, VB 23, P244, DOI 10.1515/znb-1968-0222; KLOSGEN RB, 1992, PLANT MOL BIOL, V18, P1031, DOI 10.1007/BF00019226; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASZLO JA, 1984, J BIOENERG BIOMEMBR, V16, P37, DOI 10.1007/BF00744144; LYNN WS, 1968, J BIOL CHEM, V243, P1060; McDevitt CA, 2005, BIOCHEM BIOPH RES CO, V329, P693, DOI 10.1016/j.bbrc.2005.02.038; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Mori H, 2001, FEBS LETT, V501, P65, DOI 10.1016/S0014-5793(01)02626-6; MOULD RM, 1991, J BIOL CHEM, V266, P17286; MOULD RM, 1991, J BIOL CHEM, V266, P12189; NALIN CM, 1984, J BIOL CHEM, V259, P7275; OLSEN LJ, 1989, J BIOL CHEM, V264, P6724; ORT DR, 1976, BIOCHIM BIOPHYS ACTA, V449, P95, DOI 10.1016/0005-2728(76)90010-4; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; PICK U, 1973, FEBS LETT, V32, P91, DOI 10.1016/0014-5793(73)80745-8; PORTIS AR, 1974, J BIOL CHEM, V249, P6250; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; ROTTENBERG H, 1972, EUR J BIOCHEM, V25, P54, DOI 10.1111/j.1432-1033.1972.tb01666.x; Sacksteder CA, 2001, PHOTOSYNTH RES, V70, P231, DOI 10.1023/A:1017906626288; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; SETTLES AM, 1997, SCIENCE, V278, P147; Teter SA, 1998, P NATL ACAD SCI USA, V95, P1590, DOI 10.1073/pnas.95.4.1590; THEG SM, 1988, J BIOL CHEM, V263, P673; THEG SM, 1982, FEBS LETT, V145, P25, DOI 10.1016/0014-5793(82)81199-X; THEG SM, 1987, BIOENGERG BIOMEMBR, V19, P53; Walker MB, 1999, J CELL BIOL, V147, P267, DOI 10.1083/jcb.147.2.267; WITT H T, 1971, Quarterly Reviews of Biophysics, V4, P365	51	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8822	8828		10.1074/jbc.M708948200	http://dx.doi.org/10.1074/jbc.M708948200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18187420	hybrid, Green Submitted			2022-12-27	WOS:000254465800008
J	Fisher, AL; Page, KE; Lithgow, GJ; Nash, L				Fisher, Alfred L.; Page, Kathryn E.; Lithgow, Gordon J.; Nash, Lindsey			The Caenorhabditis elegans K10C2.4 gene encodes a member of the fumarylacetoacetate hydrolase family - A caenorhabditis elegans model of type i tyrosinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY TYROSINEMIA; C-ELEGANS; LIFE-SPAN; CRYSTAL-STRUCTURE; MUTATIONS; INTERFERENCE; APOPTOSIS; STRESS; DAF-16; RESCUE	In eukaryotes and many bacteria, tyrosine is degraded to produce energy via a five-step tyrosine degradation pathway. Mutations affecting the tyrosine degradation pathway are also of medical importance as mutations affecting enzymes in the pathway are responsible for type I, type II, and type III tyrosinemia. The most severe of these is type I tyrosinemia, which is caused by mutations affecting the last enzyme in the pathway, fumarylacetoacetate hydrolase ( FAH). So far, tyrosine degradation in the nematode Caenorhabditis elegans has not been studied; however, genes predicted to encode enzymes in this pathway have been identified in several microarray, proteomic, and RNA interference ( RNAi) screens as perhaps being involved in aging and the control of protein folding. We sought to identify and characterize the genes in the worm tyrosine degradation pathway as an initial step in understanding these findings. Here we describe the characterization of the K10C2.4, which encodes a homolog of FAH. RNAi directed against K10C2.4 produces a lethal phenotype consisting of death in young adulthood, extensive damage to the intestine, impaired fertility, and activation of oxidative stress and endoplasmic stress response pathways. This phenotype is due to alterations in tyrosine metabolism as increases in dietary tyrosine enhance it, and inhibition of upstream enzymes in tyrosine degradation with RNAi or genetic mutations reduces the phenotype. We also use our model to identify genes that suppress the damage produced by K10C2.4 RNAi in a pilot genetic screen. Our results establish worms as a model for the study of type I tyrosinemia.	[Fisher, Alfred L.; Nash, Lindsey] Carnegie Mellon Univ, Div Geriatr Med, Dept Med, Pittsburgh, PA 15213 USA; [Page, Kathryn E.; Lithgow, Gordon J.] Buck Inst, Novato, CA 94945 USA	Carnegie Mellon University; Buck Institute for Research on Aging	Fisher, AL (corresponding author), 3471 5th Ave,Suite 500, Pittsburgh, PA 15260 USA.	fishera@dom.pitt.edu	Fisher, Alfred/H-3031-2012	Fisher, Alfred/0000-0001-6451-2644	NATIONAL INSTITUTE ON AGING [K08AG024414, R01AG022868, K08AG028977, R01AG021069] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG022868, R01 AG 21069, K08 AG028977, K08 AG024414, R01 AG021069, R01 AG 22868, K08 AG 028977] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Aponte JL, 2001, P NATL ACAD SCI USA, V98, P641, DOI 10.1073/pnas.98.2.641; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bergeron A, 2001, J BIOL CHEM, V276, P15225, DOI 10.1074/jbc.M009341200; BERGERON A, 2005, J BIOL CHEM; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CITRON BA, 1992, P NATL ACAD SCI USA, V89, P11891, DOI 10.1073/pnas.89.24.11891; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Dieter MZ, 2003, FREE RADICAL BIO MED, V35, P351, DOI 10.1016/S0891-5849(03)00273-9; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; ENDO F, 1983, PEDIATR RES, V17, P92, DOI 10.1203/00006450-198302000-00002; Endo F, 1997, J BIOL CHEM, V272, P24426, DOI 10.1074/jbc.272.39.24426; Fernandez-Canon JM, 2002, MOL CELL BIOL, V22, P4943, DOI 10.1128/MCB.22.13.4943-4951.2002; FERNANDEZCANON JM, 1995, P NATL ACAD SCI USA, V92, P9132, DOI 10.1073/pnas.92.20.9132; Fisher AL, 2006, AGING CELL, V5, P127, DOI 10.1111/j.1474-9726.2006.00203.x; GOLDSMITH LA, 1973, J PEDIATR-US, V83, P798, DOI 10.1016/S0022-3476(73)80372-5; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hodgkin J, 1999, PRACT APPROACH SER, V213, P245; Jorquera R, 1999, FASEB J, V13, P2284, DOI 10.1096/fasebj.13.15.2284; Jorquera R, 1997, BIOCHEM BIOPH RES CO, V232, P42, DOI 10.1006/bbrc.1997.6220; Jorquera R, 2001, HUM MOL GENET, V10, P1741, DOI 10.1093/hmg/10.17.1741; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KELSEY G, 1993, GENE DEV, V7, P2285, DOI 10.1101/gad.7.12a.2285; KNOX WE, 1955, METHOD ENZYMOL, V2, P287, DOI 10.1016/S0076-6879(55)02202-7; Kubo S, 1998, P NATL ACAD SCI USA, V95, P9552, DOI 10.1073/pnas.95.16.9552; Laberge C, 1986, Adv Exp Med Biol, V206, P209; LADU BN, 1958, J BIOL CHEM, V230, P251; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Link CD, 2002, METHOD ENZYMOL, V353, P497; MADURO M, 1995, GENETICS, V141, P977; Manning K, 1999, P NATL ACAD SCI USA, V96, P11928, DOI 10.1073/pnas.96.21.11928; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; MITCHELL GA, 2001, METABOLIC MOL BASES, P1777; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; NATT E, 1987, HUM GENET, V77, P352, DOI 10.1007/BF00291426; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; PHANEUF D, 1991, AM J HUM GENET, V48, P525; Pitkanen ST, 2000, ANN MED, V32, P530, DOI 10.3109/07853890008998832; Praitis V, 2001, GENETICS, V157, P1217; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; RUSSO P, 1990, AM J HUM GENET, V47, P317; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; StLouis M, 1997, HUM MUTAT, V9, P291, DOI 10.1002/(SICI)1098-1004(1997)9:4<291::AID-HUMU1>3.0.CO;2-9; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sun MS, 2000, J AM SOC NEPHROL, V11, P291, DOI 10.1681/ASN.V112291; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timm DE, 1999, STRUCTURE, V7, P1023, DOI 10.1016/S0969-2126(99)80170-1; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Titus GP, 2000, NAT STRUCT BIOL, V7, P542	58	32	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9127	9135		10.1074/jbc.M708341200	http://dx.doi.org/10.1074/jbc.M708341200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18227072	Green Published, hybrid			2022-12-27	WOS:000254465800042
J	Gauntlett, JC; Gebhard, S; Keis, S; Manson, JM; Pos, KM; Cook, GM				Gauntlett, Jonathan C.; Gebhard, Susanne; Keis, Stefanie; Manson, Janet M.; Pos, Klaas M.; Cook, Gregory M.			Molecular analysis of BcrR, a membrane-bound bacitracin sensor and DNA-binding protein from Enterococcus faecalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PROTEIN; VIBRIO-CHOLERAE; BACILLUS-SUBTILIS; ABC-TRANSPORTER; ACTIVATOR TOXR; RESISTANCE; EXPRESSION; REPRESSOR; PROMOTER; SYSTEM	BcrR has been identified as a novel regulatory protein of high level bacitracin resistance encoded by the bcrABD operon in Enterococcus faecalis. The N-terminal domain of BcrR has similarity to the helix-turn-helix motif of DNA-binding proteins, and topological modeling predicts that the C-terminal domain contains four transmembrane alpha-helices. These data have led to the hypothesis that BcrR functions as both a membrane- bound sensor and transducer of bacitracin availability to regulate bcrABD expression. To characterize the bcrABD promoter and identify the promoter elements to which BcrR binds, a series of bcrA-lacZ fusions were constructed. A 69-bp region was identified that was essential for bacitracin-dependent bcrA-lacZ expression. Mutations that targeted this region were used to identify two inverted repeat sequences, each with the sequence 5'-GACA(N)(7)TGTC-3', on the bcrABD promoter that were required for bcrA-lacZ expression. To study BcrR binding to this region, we overproduced BcrR with a C-terminal hexa-histidine tag in Escherichia coli membranes, extracted the protein with n-dodecyl-beta-D-maltoside, and subsequently purified it via Ni2+-nitrilotriacetic acid and gel filtration chromatography to apparent homogeneity. Purified BcrR was reconstituted into liposomes, and BcrR binding to bcrABD promoter DNA was analyzed using electrophoretic mobility shift assays. Both inverted repeat sequences were required for BcrR binding, both in the presence and absence of bacitracin. These data demonstrate that membrane- bound BcrR binds specifically to the bcrABD promoter, irrespective of bacitracin concentration. We therefore propose that bacitracin-dependent induction of bcrABD expression by BcrR occurs after DNA binding.	[Gauntlett, Jonathan C.; Gebhard, Susanne; Keis, Stefanie; Manson, Janet M.; Cook, Gregory M.] Univ Otago, Dept Microbiol & Immunol, Otago Sch Med Sci, Dunedin 9016, New Zealand; [Pos, Klaas M.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Pos, Klaas M.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Otago; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Cook, GM (corresponding author), Univ Otago, Dept Microbiol & Immunol, Otago Sch Med Sci, POB 56, Dunedin 9016, New Zealand.	greg.cook@stonebow.otago.ac.nz	Cook, Gregory/E-5665-2011; Gebhard, Susanne/F-4154-2012	Gebhard, Susanne/0000-0003-4783-6115				AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; ANDERSON JS, 1965, P NATL ACAD SCI USA, V53, P881, DOI 10.1073/pnas.53.4.881; Bernard R, 2007, J BACTERIOL, V189, P8636, DOI 10.1128/JB.01132-07; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Cho JH, 1998, MOL CELL BIOL, V18, P5712, DOI 10.1128/MCB.18.10.5712; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Higgins DE, 1996, J BACTERIOL, V178, P1080, DOI 10.1128/jb.178.4.1080-1087.1996; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hung DT, 2005, P NATL ACAD SCI USA, V102, P3028, DOI 10.1073/pnas.0409559102; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Kuper C, 2005, J MOL MICROB BIOTECH, V10, P26, DOI 10.1159/000090346; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Manson JM, 2004, ANTIMICROB AGENTS CH, V48, P3743, DOI 10.1128/AAC.48.10.3743-3748.2004; Manson JM, 2003, ANTIMICROB AGENTS CH, V47, P204, DOI 10.1128/AAC.47.1.204-210.2003; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Meijer WJJ, 2001, MOL MICROBIOL, V39, P731, DOI 10.1046/j.1365-2958.2001.02260.x; MILLER VL, 1987, CELL, V48, P271, DOI 10.1016/0092-8674(87)90430-2; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Neumuller AM, 2001, EUR J BIOCHEM, V268, P3180, DOI 10.1046/j.1432-1327.2001.02203.x; Ohki R, 2003, MOL MICROBIOL, V49, P1135, DOI 10.1046/j.1365-2958.2003.03653.x; Osorio CR, 2000, J BACTERIOL, V182, P526, DOI 10.1128/JB.182.2.526-528.2000; Poyart C, 1997, FEMS MICROBIOL LETT, V156, P193, DOI 10.1016/S0378-1097(97)00423-0; Provenzano D, 2000, INFECT IMMUN, V68, P1491, DOI 10.1128/IAI.68.3.1491-1497.2000; Rumpel S, 2004, EMBO J, V23, P3632, DOI 10.1038/sj.emboj.7600367; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shepard B D, 1995, Methods Mol Biol, V47, P217; Shi K, 2005, P NATL ACAD SCI USA, V102, P18596, DOI 10.1073/pnas.0506163102; SMITH H, 1983, J BACTERIOL, V156, P101, DOI 10.1128/JB.156.1.101-108.1983; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Tsuda H, 2002, ANTIMICROB AGENTS CH, V46, P3756, DOI 10.1128/AAC.46.12.3756-3764.2002; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; WOOD HE, 1990, GENE, V96, P83, DOI 10.1016/0378-1119(90)90344-Q	40	22	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8591	8600		10.1074/jbc.M709503200	http://dx.doi.org/10.1074/jbc.M709503200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18227063	Green Accepted, hybrid			2022-12-27	WOS:000254288000058
J	Lavery, GG; Walker, EA; Turan, N; Rogoff, D; Ryder, JW; Shelton, JM; Richardson, JA; Falciani, F; White, PC; Stewart, PM; Parker, KL; McMillan, DR				Lavery, Gareth G.; Walker, Elizabeth A.; Turan, Nil; Rogoff, Daniela; Ryder, Jeffery W.; Shelton, John M.; Richardson, James A.; Falciani, Francesco; White, Perrin C.; Stewart, Paul M.; Parker, Keith L.; McMillan, Daniel R.			Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIALLY EXPRESSED GENES; ER-ASSOCIATED DEGRADATION; MUSCLE FIBER-TYPE; ENDOPLASMIC-RETICULUM; TRANSCRIPTIONAL COACTIVATOR; BODY MYOPATHY; MICE; CALCINEURIN; STRESS; TYPE-1	Hexose-6-phosphate dehydrogenase (H6PD) is the initial component of a pentose phosphate pathway inside the endoplasmic reticulum (ER) that generates NADPH for ER enzymes. In liver H6PD is required for the 11-oxoreductase activity of 11 beta-hydroxysteroid dehydrogenase type 1, which converts inactive 11-oxo-glucocorticoids to their active 11-hydroxyl counterparts; consequently, H6PD null mice are relatively insensitive to glucocorticoids, exhibiting fasting hypoglycemia, increased insulin sensitivity despite elevated circulating levels of corticosterone, and increased basal and insulin-stimulated glucose uptake in muscles normally enriched in type II (fast) fibers, which have increased glycogen content. Here, we show that H6PD null mice develop a severe skeletal myopathy characterized by switching of type II to type I (slow) fibers. Running wheel activity and electrically stimulated force generation in isolated skeletal muscle are both markedly reduced. Affected muscles have normal sarcomeric structure at the electron microscopy level but contain large intrafibrillar membranous vacuoles and abnormal triads indicative of defects in structure and function of the sarcoplasmic reticulum (SR). SR proteins involved in calcium metabolism, including the sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA), calreticulin, and calsequestrin, show dysregulated expression. Microarray analysis and real-time PCR demonstrate overexpression of genes encoding proteins in the unfolded protein response pathway. We propose that the absence of H6PD induces a progressive myopathy by altering the SR redox state, thereby impairing protein folding and activating the unfolded protein response pathway. These studies thus define a novel metabolic pathway that links ER stress to skeletal muscle integrity and function.	[Lavery, Gareth G.; Walker, Elizabeth A.; Stewart, Paul M.] Univ Birmingham, Div Med Sci, Birmingham B15 2TH, W Midlands, England; [Turan, Nil; Falciani, Francesco] Univ Birmingham, Sch Biosci, Birmingham B15 2TH, W Midlands, England; [Lavery, Gareth G.; Shelton, John M.; Parker, Keith L.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Rogoff, Daniela; White, Perrin C.; McMillan, Daniel R.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Ryder, Jeffery W.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol & Mol Biol, Dallas, TX 75390 USA	University of Birmingham; University of Birmingham; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	McMillan, DR (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	daniel.mcmillan@UTSouthwestern.edu	Falciani, Francesco/F-3490-2010; Lavery, Gareth/F-9346-2010		NHLBI NIH HHS [T32 HL 007360] Funding Source: Medline; NIDDK NIH HHS [DK 068101, DK 54480] Funding Source: Medline; Wellcome Trust [066357, 074088/Z/04/Z] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054480, R01DK068101] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Banhegyi G, 1997, J BIOL CHEM, V272, P13584, DOI 10.1074/jbc.272.21.13584; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Bujalska IJ, 2005, J MOL ENDOCRINOL, V34, P675, DOI 10.1677/jme.1.01718; Bush E, 2004, P NATL ACAD SCI USA, V101, P2870, DOI 10.1073/pnas.0308723101; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Coll AP, 2005, DIABETES, V54, P2269, DOI 10.2337/diabetes.54.8.2269; Corton JC, 2005, J GERONTOL A-BIOL, V60, P1494, DOI 10.1093/gerona/60.12.1494; Dulhunty AF, 2006, CLIN EXP PHARMACOL P, V33, P763, DOI 10.1111/j.1440-1681.2006.04441.x; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; Hori H, 1999, J BIOCHEM-TOKYO, V126, P722, DOI 10.1093/oxfordjournals.jbchem.a022509; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Lavery GG, 2007, ENDOCRINOLOGY, V148, P6100, DOI 10.1210/en.2007-0963; Lavery GG, 2006, J BIOL CHEM, V281, P6546, DOI 10.1074/jbc.M512635200; Leahy KP, 1999, ARCH BIOCHEM BIOPHYS, V368, P67, DOI 10.1006/abbi.1998.1059; LEFAUCHEUR JP, 1995, ANAT REC, V242, P70, DOI 10.1002/ar.1092420109; Liewluck T, 2007, MUSCLE NERVE, V35, P322, DOI 10.1002/mus.20691; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Manchester J, 1996, P NATL ACAD SCI USA, V93, P10707, DOI 10.1073/pnas.93.20.10707; Mason PJ, 1999, BLOOD CELL MOL DIS, V25, P30, DOI 10.1006/bcmd.1999.0224; MASON R M, 1984, Journal of Orthopaedic Research, V2, P333, DOI 10.1002/jor.1100020405; MORISAKI T, 1992, P NATL ACAD SCI USA, V89, P6457, DOI 10.1073/pnas.89.14.6457; O'Brien KM, 2003, J EXP BIOL, V206, P411, DOI 10.1242/jeb.00088; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Piccirella S, 2006, J BIOL CHEM, V281, P4671, DOI 10.1074/jbc.M509406200; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rogoff D, 2007, ENDOCRINOLOGY, V148, P5072, DOI 10.1210/en.2007-0593; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Ryder JW, 2003, J BIOL CHEM, V278, P44298, DOI 10.1074/jbc.M304510200; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Schroder M, 2006, MOL BIOTECHNOL, V34, P279, DOI 10.1385/MB:34:2:279; SHEHAN DC, 1980, THEORY PRACTICE HIST; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Woods A.E., 1996, LAB HISTOPATHOLOGY C; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	48	66	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8453	8461		10.1074/jbc.M710067200	http://dx.doi.org/10.1074/jbc.M710067200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18222920	Green Published, hybrid			2022-12-27	WOS:000254288000043
J	Taniguchi, N; Tokuda, H				Taniguchi, Naohiro; Tokuda, Hajime			Molecular events involved in a single cycle of ligand transfer from an ATP binding cassette transporter, LolCDE, to a molecular chaperone, LolA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI LIPOPROTEINS; ABC TRANSPORTER; OUTER-MEMBRANE; MALTOSE TRANSPORT; CYTOPLASMIC MEMBRANE; CRYSTAL-STRUCTURE; SORTING SIGNALS; INNER MEMBRANE; ACTIVE-SITE; LOCALIZATION	An ATP binding cassette transporter LolCDE complex releases lipoproteins from the inner membrane of Escherichia coli in an ATP-dependent manner, leading to the formation of a complex between a lipoprotein and a periplasmic chaperone, LolA. LolA is proposed to undergo a conformational change upon the lipoprotein binding. The lipoprotein is then transferred from the LolA-lipoprotein complex to the outer membrane via LolB. Unlike most ATP binding cassette transporters mediating the transmembrane flux of substrates, the LolCDE complex catalyzes the extrusion of lipoproteins anchored to the outer leaflet of the inner membrane. Moreover, the LolCDE complex is unique in that it can be purified as a liganded form, which is an intermediate of the lipoprotein release reaction. Taking advantage of these unique properties, we established an assay system that enabled the analysis of a single cycle of lipoprotein transfer reaction from liganded LolCDE to LolA in a detergent solution. The LolA-lipoprotein complex thus formed was physiologically functional and delivered lipoproteins to the outer membrane in a LolB-dependent manner. Vanadate, a potent inhibitor of the lipoprotein release from proteoliposomes, was found to inhibit the release of ADP from LolCDE. However, a single cycle of lipoprotein transfer occurred from vanadate-treated LolCDE to LolA, indicating that vanadate traps LolCDE at the energized state.	[Taniguchi, Naohiro; Tokuda, Hajime] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Tokuda, H (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	htokuda@iam.u-tokyo.ac.jp	Taniguchi, Naoyuki/A-7086-2016					Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; DAVIDSON AL, 1991, J BIOL CHEM, V266, P8946; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HIROTA Y, 1977, P NATL ACAD SCI USA, V74, P1417, DOI 10.1073/pnas.74.4.1417; HUSSAIN M, 1980, J BIOL CHEM, V255, P3707; Ito Y, 2006, MOL MICROBIOL, V62, P1064, DOI 10.1111/j.1365-2958.2006.05378.x; Kanamaru K, 2007, FEBS J, V274, P3034, DOI 10.1111/j.1742-4658.2007.05832.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Masuda K, 2002, P NATL ACAD SCI USA, V99, P7390, DOI 10.1073/pnas.112085599; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; MATSUYAMA S, 1997, EMBO J, V16, P6847; Miyamoto A, 2001, BIOCHEM BIOPH RES CO, V287, P1125, DOI 10.1006/bbrc.2001.5705; Miyamoto S, 2007, BBA-BIOMEMBRANES, V1768, P1848, DOI 10.1016/j.bbamem.2007.04.005; Narita S, 2002, J BACTERIOL, V184, P1417, DOI 10.1128/JB.184.5.1417-1422.2002; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tajima T, 1998, FEBS LETT, V439, P51, DOI 10.1016/S0014-5793(98)01334-9; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Terada M, 2001, J BIOL CHEM, V276, P47690, DOI 10.1074/jbc.M109307200; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Tokuda H, 2007, PERIPLASM, P67; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Watanabe S, 2006, J BIOL CHEM, V281, P3335, DOI 10.1074/jbc.M509596200; Yakushi T, 1998, J BIOL CHEM, V273, P32576, DOI 10.1074/jbc.273.49.32576; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yokota N, 1999, J BIOL CHEM, V274, P30995, DOI 10.1074/jbc.274.43.30995; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200	37	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8538	8544		10.1074/jbc.M800026200	http://dx.doi.org/10.1074/jbc.M800026200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18218629	hybrid, Green Published			2022-12-27	WOS:000254288000052
J	Muik, M; Frischauf, I; Derler, I; Fahrner, M; Bergsmann, J; Eder, P; Schindl, R; Hesch, C; Polzinger, B; Fritsch, R; Kahr, H; Madl, J; Gruber, H; Groschner, K; Romanin, C				Muik, Martin; Frischauf, Irene; Derler, Isabella; Fahrner, Marc; Bergsmann, Judith; Eder, Petra; Schindl, Rainer; Hesch, Clemens; Polzinger, Bernhard; Fritsch, Reinhard; Kahr, Heike; Madl, Josef; Gruber, Hermann; Groschner, Klaus; Romanin, Christoph			Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; PLASMA-MEMBRANE; CRAC CHANNEL; CALCIUM-ENTRY; ENDOPLASMIC-RETICULUM; STORE DEPLETION; PROTEINS; INFLUX; RELEASE; CALMODULIN	STIM1 and ORAI1 (also termed CRACM1) are essential components of the classical calcium release-activated calcium current; however, the mechanism of the transmission of information of STIM1 to the calcium release-activated calcium/ORAI1 channel is as yet unknown. Here we demonstrate by Forster resonance energy transfer microscopy a dynamic coupling of STIM1 and ORAI1 that culminates in the activation of Ca2+ entry. Forster resonance energy transfer imaging of living cells provided insight into the time dependence of crucial events of this signaling pathway comprising Ca2+ store depletion, STIM1 multimerization, and STIM1-ORAI1 interaction. Accelerated store depletion allowed resolving a significant time lag between STIM1-STIM1 and STIM1-ORAI1 interactions. Store refilling reversed both STIM1 multimerization and STIM1-ORAI1 interaction. The cytosolic STIM1 C terminus itself was able, in vitro as well as in vivo, to associate with ORAI1 and to stimulate channel function, yet without ORAI1-STIM1 cluster formation. The dynamic interaction occurred via the C terminus of ORAI1 that includes a putative coiled-coil domain structure. An ORAI1 C terminus deletion mutant as well as a mutant (L273S) with impeded coiled-coil domain formation lacked both interaction as well as functional communication with STIM1 and failed to generate Ca2+ inward currents. An N-terminal deletion mutant of ORAI1 as well as the ORAI1 R91W mutant linked to severe combined immune deficiency syndrome was similarly impaired in terms of current activation despite being able to interact with STIM1. Hence, the C-terminal coiled-coil motif of ORAI1 represents a key domain for dynamic coupling to STIM1.	[Muik, Martin; Frischauf, Irene; Derler, Isabella; Fahrner, Marc; Bergsmann, Judith; Schindl, Rainer; Hesch, Clemens; Polzinger, Bernhard; Fritsch, Reinhard; Kahr, Heike; Madl, Josef; Gruber, Hermann; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Eder, Petra; Groschner, Klaus] Graz Univ, Dept Pharm, A-8010 Graz, Austria	Johannes Kepler University Linz; University of Graz	Romanin, C (corresponding author), Univ Linz, Inst Biophys, A-4040 Linz, Austria.	christoph.romanin@jku.at	Fahrner, Marc/AAI-7927-2021; Derler, Isabella/B-7871-2019; Romanin, Christoph/D-5399-2009; Schindl, Rainer/V-4205-2019; Schindl, Rainer/E-3959-2013; Groschner, Klaus/A-2550-2010; Frischauf, Irene/AAG-2007-2019	Derler, Isabella/0000-0002-4768-146X; Romanin, Christoph/0000-0003-3756-4136; Schindl, Rainer/0000-0003-0896-8887; Groschner, Klaus/0000-0002-8659-377X; Frischauf, Irene/0000-0003-0661-2932; Fahrner, Marc/0000-0002-2689-0158				Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Chakrabarti R, 2006, J CELL BIOCHEM, V99, P1503, DOI 10.1002/jcb.21102; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Dutta D, 2000, J BIOSCIENCE, V25, P397, DOI 10.1007/BF02703793; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; JODY M, 2004, CHEM BIO CHEM, V5, P170; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; LIOU J, 2007, T P NATL ACAD SCI US, V104, P9301; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Parekh AB, 2006, NATURE, V441, P163, DOI 10.1038/441163a; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2006, NAT CELL BIOL, V8, P655, DOI 10.1038/ncb0706-655; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2004, BBA-MOL CELL RES, V1742, P9, DOI 10.1016/j.bbamcr.2004.09.001; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	40	317	327	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					8014	8022		10.1074/jbc.M708898200	http://dx.doi.org/10.1074/jbc.M708898200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18187424	hybrid			2022-12-27	WOS:000253997900076
J	Dammer, EB; Sewer, MB				Dammer, Eric B.; Sewer, Marion B.			Phosphorylation of CtBP1 by cAMP-dependent protein kinase modulates induction of CYP17 by stimulating partnering of CtBP1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE-ADENINE-DINUCLEOTIDE; TERMINAL BINDING-PROTEIN; TRANSCRIPTIONAL COREPRESSOR; BENZO(A)PYRENE METABOLISM; NUCLEAR-LOCALIZATION; ADENOVIRUS E1A; CO-REPRESSOR; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; RIP140; ACETYLATION	In the human adrenal cortex, the peptide hormone adrenocorticotropin (ACTH) directs cortisol and adrenal androgen biosynthesis by activating a cAMP/cAMP-dependent protein kinase (PKA) pathway. Carboxyl-terminal binding protein 1 (CtBP1) is a corepressor that regulates transcription of the CYP17 gene by periodically interacting with steroidogenic factor-1 in response to ACTH signaling. Given that CtBP1 function is regulated by NADH binding, we hypothesized that ACTH-stimulated changes in cellular pyridine nucleotide concentrations modulate the ability of CtBP1 to repress CYP17 transcription. Further, we postulated that PKA evokes changes in the phosphorylation status of CtBP1 that control the ability of the protein to bind to steroidogenic factor-1 and the coactivator GCN5 (general control nonderepressed 5) and repress CYP17 gene expression. We show that ACTH alters pyridine nucleotide redox state and identify amino acid residues in CtBP1 that are targeted by PKA and PAK6. Both ACTH/cAMP signaling and NADH/NAD(+) ratio stimulate nuclear-cytoplasmic oscillation of both CtBP proteins. We provide evidence that PKA 1) induces metabolic changes in the adrenal cortex and 2) phosphorylates CtBP proteins, particularly CtBP1 at T144, resulting in CtBP protein partnering and ACTH-dependent CYP17 transcription.	Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Sewer, MB (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	marion.sewer@biology.gatech.edu	Dammer, Eric B/V-8652-2019	Dammer, Eric B/0000-0003-2947-7606	NIGMS NIH HHS [GM073241, R01 GM073241, R56 GM073241, R01 GM073241-05] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073241, R56GM073241] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achouri Y, 2007, BIOCHEM BIOPH RES CO, V352, P903, DOI 10.1016/j.bbrc.2006.11.111; Alpatov R, 2004, MOL CELL BIOL, V24, P10223, DOI 10.1128/MCB.24.23.10223-10235.2004; Balasubramanian P, 2003, FEBS LETT, V537, P157, DOI 10.1016/S0014-5793(03)00119-4; Barnes CJ, 2003, NAT STRUCT BIOL, V10, P622, DOI 10.1038/nsb957; Bartholin L, 2006, MOL CELL BIOL, V26, P990, DOI 10.1128/MCB.26.3.990-1001.2006; Castet A, 2004, NUCLEIC ACIDS RES, V32, P1957, DOI 10.1093/nar/gkh524; CAVAILLES V, 1994, P NATL ACAD SCI USA, V91, P10009, DOI 10.1073/pnas.91.21.10009; Christian M, 2004, J BIOL CHEM, V279, P15645, DOI 10.1074/jbc.M313906200; Dammer EB, 2007, MOL ENDOCRINOL, V21, P415, DOI 10.1210/me.2006-0361; FEO F, 1987, INT J CANCER, V39, P560, DOI 10.1002/ijc.2910390504; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Frederiks WM, 2007, J HISTOCHEM CYTOCHEM, V55, P975, DOI 10.1369/jhc.7A7222.2007; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Kim JH, 2005, NAT STRUCT MOL BIOL, V12, P423, DOI 10.1038/nsmb924; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Lopez-Garcia J, 2006, NUCLEIC ACIDS RES, V34, P6126, DOI 10.1093/nar/gkl875; Mellgren G, 2003, MOL CELL ENDOCRINOL, V203, P91, DOI 10.1016/S0303-7207(03)00097-2; MOUNTJOY KG, 1994, MOL CELL ENDOCRINOL, V99, pR17, DOI 10.1016/0303-7207(94)90160-0; PASCALE R, 1990, RES COMMUN CHEM PATH, V69, P361; Quinlan KGR, 2007, BBA-REV CANCER, V1775, P333, DOI 10.1016/j.bbcan.2007.05.001; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; RATT H, 2003, AM J PHYSIOL, V284, pR78; ROSA LFBPC, 1995, BIOCHEM J, V310, P709, DOI 10.1042/bj3100709; SAAD MJA, 1991, HORM RES, V35, P1, DOI 10.1159/000181866; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shorin Iu P, 1976, Biull Eksp Biol Med, V81, P173; STAELS B, 1993, MOL ENDOCRINOL, V7, P423, DOI 10.1210/me.7.3.423; Tazawa H, 2003, MOL CELL BIOL, V23, P4187, DOI 10.1128/MCB.23.12.4187-4198.2003; Thio SSC, 2004, NUCLEIC ACIDS RES, V32, P1836, DOI 10.1093/nar/gkh344; Verger A, 2006, MOL CELL BIOL, V26, P4882, DOI 10.1128/MCB.02402-05; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wei LN, 2001, J BIOL CHEM, V276, P16107, DOI 10.1074/jbc.M010185200; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200	40	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6925	6934		10.1074/jbc.M708432200	http://dx.doi.org/10.1074/jbc.M708432200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18184656	Green Accepted, hybrid			2022-12-27	WOS:000253779600036
J	Grossmann, C; Freudinger, R; Mildenberger, S; Husse, B; Gekle, M				Grossmann, Claudia; Freudinger, Ruth; Mildenberger, Sigrid; Husse, Britta; Gekle, Michael			EF domains are sufficient for nongenomic mineralocorticoid receptor actions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; ESTROGEN-RECEPTOR; HYPERTENSIVE-RATS; ANGIOTENSIN-II; PLASMA-MEMBRANE; GLUCOCORTICOID RECEPTOR; ENDOTHELIAL-CELLS; OXIDATIVE STRESS	The mineralocorticoid receptor ( MR) is important for salt homeostasis and reno-cardiovascular pathophysiology. Signaling mechanisms include, besides classical genomic pathways, nongenomic pathways with putative pathophysiological relevance involving the mitogen-activated protein kinases ERK1/2. We determined the MR domains required for nongenomic signaling and their potential to elicit pathophysiological effects in cultured cells under defined conditions. The expression of full-length human MR or truncated MR consisting of the domains CDEF (MRCDEF), DEF (MRDEF), or EF (MREF) renders cells responsive for the MR ligand aldosterone with respect to nongenomic ERK1/ 2 phosphorylation, whereas only full-length MR and MRCDEF conferred genomic responsiveness. ERK1/ 2 phosphorylation depends on the EGF receptor and cSRC kinase. MREF expression is sufficient to evoke the aldosterone-induced increase of collagen III levels, similar to full-length MR expression. Our data suggest that nongenomic MR signaling is mediated by the EF domains and present the first proof of principle showing that nongenomic signaling can be sufficient for some pathophysiological effects. The minimum amino acid motif required for nongenomic MR signaling and its importance in various effects have yet to be determined.	[Grossmann, Claudia; Freudinger, Ruth; Mildenberger, Sigrid; Husse, Britta; Gekle, Michael] Univ Halle Wittenberg, Julius Bernstein Inst Physiol, D-06097 Halle, Germany	Martin Luther University Halle Wittenberg	Gekle, M (corresponding author), Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Magdeburger Str 6, D-06097 Halle, Germany.	michael.gekle@medizin.uni-halle.de						Alzamora R, 2000, HYPERTENSION, V35, P1099, DOI 10.1161/01.HYP.35.5.1099; Arima S, 2004, HYPERTENSION, V43, P352, DOI 10.1161/01.HYP.0000111138.78714.1a; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Barletta F, 2004, MOL ENDOCRINOL, V18, P1096, DOI 10.1210/me.2003-0335; Bauersachs J, 2002, J AM COLL CARDIOL, V39, P351, DOI 10.1016/S0735-1097(01)01729-6; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Callera GE, 2005, HYPERTENSION, V46, P1032, DOI 10.1161/01.HYP.0000176588.51027.35; CATO ACB, 2002, SCI STKE, V138, P1; Chambliss KL, 2005, MOL ENDOCRINOL, V19, P277, DOI 10.1210/me.2004-0008; Doolan CM, 1996, J BIOL CHEM, V271, P8763, DOI 10.1074/jbc.271.15.8763; Feng WJ, 2001, MOL ENDOCRINOL, V15, P32, DOI 10.1210/me.15.1.32; Fiebeler A, 2001, HYPERTENSION, V37, P787, DOI 10.1161/01.HYP.37.2.787; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Flamant M, 2002, FASEB J, V16, P327, DOI 10.1096/fj.02-0115fje; Funder JW, 2005, ENDOCR REV, V26, P313, DOI 10.1210/er.2005-0004; Gekle M, 2002, AM J PHYSIOL-RENAL, V282, pF669, DOI 10.1152/ajprenal.00159.2001; Gekle M, 1996, P NATL ACAD SCI USA, V93, P10500, DOI 10.1073/pnas.93.19.10500; Gekle M, 2007, PFLUG ARCH EUR J PHY, V454, P403, DOI 10.1007/s00424-007-0211-9; Greger JG, 2007, MOL CELL BIOL, V27, P1904, DOI 10.1128/MCB.01732-06; Grossmann C, 2005, MOL ENDOCRINOL, V19, P1697, DOI 10.1210/me.2004-0469; Grossmann C, 2004, AM J PHYSIOL-RENAL, V286, pF1226, DOI 10.1152/ajprenal.00378.2003; Hafezi-Moghadam A, 2002, NAT MED, V8, P473, DOI 10.1038/nm0502-473; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Hitomi H, 2007, HYPERTENSION, V50, P750, DOI 10.1161/HYPERTENSIONAHA.107.093955; Ishizawa K, 2005, HYPERTENSION, V46, P1046, DOI 10.1161/01.HYP.0000172622.51973.f5; Jaffe IZ, 2005, CIRC RES, V96, P643, DOI 10.1161/01.RES.0000159937.05502.d1; Kagiyama S, 2003, HYPERTENSION, V41, P824, DOI 10.1161/01.HYP.0000047104.42047.9B; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Krietsch T, 2006, MOL ENDOCRINOL, V20, P3146, DOI 10.1210/me.2006-0129; Krug AW, 2003, J BIOL CHEM, V278, P43060, DOI 10.1074/jbc.M308134200; Krug AW, 2002, J BIOL CHEM, V277, P45892, DOI 10.1074/jbc.M208851200; Kumar P, 2007, MOL ENDOCRINOL, V21, P1370, DOI 10.1210/me.2006-0360; Le Moellic C, 2004, J AM SOC NEPHROL, V15, P1145; Levin ER, 2003, MOL ENDOCRINOL, V17, P309, DOI 10.1210/me.2002-0368; Liu SL, 2003, CIRCULATION, V108, P2400, DOI 10.1161/01.CIR.0000093188.53554.44; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Mazak I, 2004, CIRCULATION, V109, P2792, DOI 10.1161/01.CIR.0000131860.80444.AB; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Min LJ, 2005, CIRC RES, V97, P434, DOI 10.1161/01.RES.0000180753.63183.95; Nagai Y, 2005, HYPERTENSION, V46, P1039, DOI 10.1161/01.HYP.0000174593.88899.68; Nakano S, 2005, HYPERTENS RES, V28, P925, DOI 10.1291/hypres.28.925; Ouvrard-Pascaud A, 2004, AM J PHYSIOL-RENAL, V286, pF180, DOI 10.1152/ajprenal.00301.2002; Pfau A, 2007, MOL CELL ENDOCRINOL, V264, P35, DOI 10.1016/j.mce.2006.10.002; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rahman M, 2006, J PHARMACOL EXP THER, V318, P1323, DOI 10.1124/jpet.106.105106; Razandi M, 2003, MOL CELL BIOL, V23, P1633, DOI 10.1128/MCB.23.5.1633-1646.2003; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Stockand JD, 2002, AM J PHYSIOL-RENAL, V282, pF559, DOI 10.1152/ajprenal.00320.2001; Sun Y, 2002, AM J PATHOL, V161, P1773, DOI 10.1016/S0002-9440(10)64454-9; Tsybouleva N, 2004, CIRCULATION, V109, P1284, DOI 10.1161/01.CIR.0000121426.43044.2B; Uhrenholt TR, 2003, CIRC RES, V93, P1258, DOI 10.1161/01.RES.0000106135.02935.E1; Vasudevan N, 2001, P NATL ACAD SCI USA, V98, P12267, DOI 10.1073/pnas.221449798; Versteeg HH, 2000, BIOCHEM J, V350, P717, DOI 10.1042/0264-6021:3500717; Wyckoff MH, 2001, J BIOL CHEM, V276, P27071, DOI 10.1074/jbc.M100312200; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	59	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7109	7116		10.1074/jbc.M708751200	http://dx.doi.org/10.1074/jbc.M708751200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18184651	hybrid			2022-12-27	WOS:000253779600056
J	Wyatt, K; Gao, C; Tsai, JY; Fariss, RN; Ray, S; Wistow, G				Wyatt, Keith; Gao, Chun; Tsai, Jen-Yue; Fariss, Robert N.; Ray, Sugata; Wistow, Graeme			A role for lengsin, a recruited enzyme, in terminal differentiation in the vertebrate lens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBER CELL-DIFFERENTIATION; FIBRILLARY ACIDIC PROTEIN; EYE LENS; GENE-EXPRESSION; NEIBANK PROJECT; VIMENTIN; FILENSIN; MOUSE; CYTOSKELETON; TRANSITION	Lengsin is an eye lens-specific member of the glutamine synthetase (GS) superfamily. Lengsin has no GS activity, suggesting that it has a structural rather than catalytic role in lens. In situ hybridization and immunofluorescence showed that lengsin is expressed in terminally differentiating secondary lens fiber cells. Yeast two-hybrid (Y2H) and recombinant protein experiments showed that full-length lengsin can bind the 2B filament region of vimentin. In affinity chromatography, lengsin also bound the equivalent region of CP49 (BFSP2; phakinin), a related intermediate filament protein specific to the lens. Both the vimentin and CP49 2B fragments bound lengsin in surface plasmon resonance spectroscopy with fast association and slow dissociation kinetics. Lengsin expression correlates with a transition zone in maturing lens fiber cells in which cytoskeleton is reorganized. Lengsin and lens intermediate filament proteins co-localize at the plasma membrane in maturing fiber cells. This suggests that lengsin may act as a component of the cytoskeleton itself or as a chaperone for the reorganization of intermediate filament proteins during terminal differentiation in the lens.	[Wyatt, Keith; Gao, Chun; Tsai, Jen-Yue; Fariss, Robert N.; Ray, Sugata; Wistow, Graeme] NEI, Sect Mol Struct & Funct Genom, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Wistow, G (corresponding author), NEI, Sect Mol Struct & Funct Genom, NIH, Bldg 7,Rm 201, Bethesda, MD 20892 USA.	graeme@helix.nih.gov	Fariss, Robert/ABI-1771-2020	Fariss, Robert/0000-0003-3227-7170	Intramural NIH HHS [Z01 EY000433-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [Z01EY000459, Z01EY000433] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		[Anonymous], 1981, MOL CELLULAR BIOL EY; BASSNETT S, 1992, DEV DYNAM, V194, P85, DOI 10.1002/aja.1001940202; Beebe DC, 2001, INVEST OPHTH VIS SCI, V42, P727; BOYER S, 1990, J NEUROSCI RES, V27, P55, DOI 10.1002/jnr.490270109; CLARKE FM, 1985, CELL MOTILITY MECHAN, P235; GEORGATOS SD, 1994, BIOESSAYS, V16, P413, DOI 10.1002/bies.950160609; Grassi F, 2006, BIOCHEM BIOPH RES CO, V350, P424, DOI 10.1016/j.bbrc.2006.09.062; Harding JJ, 1984, EYE B, V1b, P207; HATFIELD JS, 1984, J CELL BIOL, V98, P1895, DOI 10.1083/jcb.98.5.1895; Hoover SB, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P13; KNULL HR, 1992, CURR TOP CELL REGUL, V33, P15; Kuszak JR, 2004, EXP EYE RES, V78, P673, DOI 10.1016/j.exer.2003.09.016; MASTERS C, 1992, INT J BIOCHEM, V24, P405, DOI 10.1016/0020-711X(92)90031-U; McAvoy JW, 1999, EYE, V13, P425, DOI 10.1038/eye.1999.117; Medvedovic M, 2006, MOL VIS, V12, P422; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; PIATIGORSKY J, 1988, P NATL ACAD SCI USA, V85, P3479, DOI 10.1073/pnas.85.10.3479; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Prescott AR, 1996, OPHTHALMIC RES, V28, P58, DOI 10.1159/000267946; Quinlan RA, 1999, EYE, V13, P409, DOI 10.1038/eye.1999.115; Rose KML, 2006, INVEST OPHTH VIS SCI, V47, P1562, DOI 10.1167/iovs.05-1313; SANDILANDS A, 1995, EUR J CELL BIOL, V67, P238; SANDILANDS A, 1995, J CELL SCI, V108, P1397; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; WISTOW G, 1987, SCIENCE, V236, P1554, DOI 10.1126/science.3589669; Wistow G, 2006, PROG RETIN EYE RES, V25, P43, DOI 10.1016/j.preteyeres.2005.05.003; Wistow G, 2005, FEBS J, V272, P2276, DOI 10.1111/j.1742-4658.2005.04655.x; Wistow G, 2002, MOL VIS, V8, P161; Wistow G, 2002, MOL VIS, V8, P171; WISTOW G, 1993, TRENDS BIOCHEM SCI, V18, P301, DOI 10.1016/0968-0004(93)90041-K; Wistow G, 1995, MOL BIOL EVOLUTION C; WISTOW GJ, 1987, NATURE, V326, P622, DOI 10.1038/326622a0; Wride MA, 2000, APOPTOSIS, V5, P203, DOI 10.1023/A:1009653326511; Wyatt K, 2006, STRUCTURE, V14, P1823, DOI 10.1016/j.str.2006.10.008; Yabe JT, 2003, CELL MOTIL CYTOSKEL, V56, P193, DOI 10.1002/cm.10137; Zelenka PS, 2004, INT J DEV BIOL, V48, P857, DOI 10.1387/ijdb.041871pz	36	24	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6607	6615		10.1074/jbc.M709144200	http://dx.doi.org/10.1074/jbc.M709144200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18178558	Green Accepted, hybrid			2022-12-27	WOS:000253779500066
J	Schubert, SW; Lamoureux, N; Kilian, K; Klein-Hitpass, L; Hashemolhosseini, S				Schubert, Steffen Wolfgang; Lamoureux, Nicolas; Kilian, Karin; Klein-Hitpass, Ludger; Hashemolhosseini, Said			Identification of integrin-alpha 4, Rb1, and syncytin a as murine placental target genes of the transcription factor GCMa/Gcm1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; GLIAL PROMOTING FACTOR; CELL-DIFFERENTIATION; GCM PROTEINS; DROSOPHILA; EXPRESSION; SWITCH; MOUSE; GLIOGENESIS; GLIDE/GCM	Members of the GCM( glial cells missing) transcription factor family have been shown to act as master regulators in different cells during mammalian and fly development being responsible for processes including gliogenesis, hematopoiesis, placental formation, and development of the parathyroidea. In the central nervous system of flies, several target genes for GCM have been reported, namely repo, pointed, and tramtrack. In mammals, two GCM genes are known (GCMa and GCMb), but the knowledge of their target genes is very limited. Here, we present for the first time a global approach aimed to identify GCMa target genes. We found 66 genes up-regulated and 11 genes down-regulated in GCMa-deficient chorionic tissue of mice at embryonic day 9.5. Moreover, we verified by quantitative reverse transcription-PCR all 11 down-regulated genes. The two most strongly down-regulated genes, integrin-alpha 4 and retinoblastoma (Rb1), were further analyzed by promoter studies. Additionally, we identified down-regulation of the murine syncytin A gene, which is fundamental for syncytiotrophoblast formation. Finally, we proved strong down-regulation of integrin-alpha 4 and Rb1 transcript levels by in situ hybridization in murine GCMa-deficient placentae at embryonic day 9.5. Our data demonstrate for the first time that genes encoding key regulators of placental tissue formation and architecture are regulated by GCMa.	[Schubert, Steffen Wolfgang; Lamoureux, Nicolas; Kilian, Karin; Hashemolhosseini, Said] Univ Erlangen Nurnberg, Emil Fisher Zentrum, Inst Biochem, D-91054 Erlangen, Germany; [Klein-Hitpass, Ludger] Univ Essen Gesamthsch, Inst Zellbiol, D-45122 Essen, Germany	University of Erlangen Nuremberg; University of Duisburg Essen	Schubert, SW (corresponding author), Univ Erlangen Nurnberg, Emil Fisher Zentrum, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	sh@biochem.uni-erlangen.de	Hashemolhosseini, Said/N-2464-2013	Hashemolhosseini, Said/0000-0002-6564-5649				*AFF, AFF EXPR S2 MAN; Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Chen CP, 2004, PLACENTA, V25, P413, DOI 10.1016/j.placenta.2003.10.014; Chotard C, 2005, NEURON, V48, P237, DOI 10.1016/j.neuron.2005.09.019; Cohen SX, 2003, EMBO J, V22, P1835, DOI 10.1093/emboj/cdg182; Cohen SX, 2002, FEBS LETT, V528, P95, DOI 10.1016/S0014-5793(02)03257-X; Colonques J, 2007, MECH DEVELOP, V124, P327, DOI 10.1016/j.mod.2007.01.004; Cross JC, 2002, RECENT PROG HORM RES, V57, P221, DOI 10.1210/rp.57.1.221; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; Egger B, 2002, DEVELOPMENT, V129, P3295; Fujito Naoya, 2006, Hiroshima Journal of Medical Sciences, V55, P9; Gong R, 2007, CELL PHYSIOL BIOCHEM, V20, P517, DOI 10.1159/000107535; Granderath S, 2000, MECH DEVELOP, V91, P197, DOI 10.1016/S0925-4773(99)00304-4; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Hashemolhosseini S, 2004, J MOL BIOL, V336, P441, DOI 10.1016/j.jmb.2003.12.029; Hashemolhosseini S, 2002, MECH DEVELOP, V118, P175, DOI 10.1016/S0925-4773(02)00239-3; Hashemothosseini S, 2004, J CELL BIOL, V166, P765, DOI 10.1083/jcb.200406097; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Iwasaki Y, 2003, DEVELOPMENT, V130, P6027, DOI 10.1242/dev.00822; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kammerer M, 2001, EMBO J, V20, P4664, DOI 10.1093/emboj/20.17.4664; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee BP, 2005, MECH DEVELOP, V122, P849, DOI 10.1016/j.mod.2005.01.002; Lee X, 2001, PLACENTA, V22, P808, DOI 10.1053/plac.2001.0722; Miller AA, 1998, EMBO J, V17, P6316, DOI 10.1093/emboj/17.21.6316; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; Schreiber J, 1998, NUCLEIC ACIDS RES, V26, P2337, DOI 10.1093/nar/26.10.2337; Schubert SW, 2004, J BIOL CHEM, V279, P50358, DOI 10.1074/jbc.M404587200; Sengbusch JK, 2002, J CELL BIOL, V157, P873, DOI 10.1083/jcb.200203075; Soustelle L, 2004, DEVELOPMENT, V131, P4521, DOI 10.1242/dev.01290; Spencer C, 2005, GENE EXPR PATTERNS, V5, P687, DOI 10.1016/j.modgep.2005.02.003; Stecca B, 2002, MECH DEVELOP, V115, P27, DOI 10.1016/S0925-4773(02)00095-3; Vincent S, 1996, DEVELOPMENT, V122, P131; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Yamada K, 1999, J BIOL CHEM, V274, P32279, DOI 10.1074/jbc.274.45.32279; YANG JT, 1995, DEVELOPMENT, V121, P549; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Yuasa Y, 2003, DEVELOPMENT, V130, P2419, DOI 10.1242/dev.00468	41	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5460	5465		10.1074/jbc.M710110200	http://dx.doi.org/10.1074/jbc.M710110200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167345	hybrid			2022-12-27	WOS:000253426700026
J	Mukherjee, S; Negi, VS; Keitany, G; Tanaka, Y; Orth, K				Mukherjee, Sohini; Negi, Veera S.; Keitany, Gladys; Tanaka, Yuetsu; Orth, Kim			In vitro activation of the I kappa B kinase complex by human T-cell leukemia virus type-1 tax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED ACTIVATION; LYMPHOTROPIC-VIRUS; YERSINIA EFFECTOR; PHOSPHATASE 2A; IKK-GAMMA; PROTEIN; YOPJ; ACETYLATION; RESIDUES	Human T-cell leukemia virus type-I expresses Tax, a 40-kDa oncoprotein that activates licB kinase (IKK), resulting in constitutive activation of NF kappa B. Herein, we have developed an in vitro signaling assay to analyze IKK complex activation by recombinant Tax. Using this assay in combination with reporter assays, we demonstrate that Tax-mediated activation of IKK is independent of phosphatases. We show that sustained activation of the Tax-mediated activation of the NF kappa B pathway is dependent on an intact Hsp90-IKK complex. By acetylating and thereby preventing activation of the IKK complex by the Yersinia effector YopJ, we demonstrate that Tax-mediated activation of the IKK complex requires a phosphorylation step. Our characterization of an in vitro signaling assay system for the mechanism of Tax-mediated activation of the IKK complex with a variety of mutants and inhibitors results in a working model for the biochemical mechanism of Tax-induced activation.	[Mukherjee, Sohini; Negi, Veera S.; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Keitany, Gladys] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Tanaka, Yuetsu] Univ Ryukyus, Dept Immunol, Nishihara, Okinawa 9030215, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle; University of the Ryukyus	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Kim.Orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072134] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 056404] Funding Source: Medline; NIDDK NIH HHS [R21 DK 072134] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Carter RS, 2003, J BIOL CHEM, V278, P48903, DOI 10.1074/jbc.M310686200; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; Harhaj EW, 2005, IUBMB LIFE, V57, P83, DOI 10.1080/15216540500078715; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; LEE B, 1989, TOHOKU J EXP MED, V157, P1, DOI 10.1620/tjem.157.1; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Nejmeddine M, 2005, J BIOL CHEM, V280, P29653, DOI 10.1074/jbc.M502639200; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Xiao GT, 2000, J BIOL CHEM, V275, P34060, DOI 10.1074/jbc.M002970200; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475	21	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15127	15133		10.1074/jbc.M704831200	http://dx.doi.org/10.1074/jbc.M704831200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18223255	Green Published, hybrid			2022-12-27	WOS:000256232000028
J	Deng, H; Dokshin, GA; Lei, J; Goldsmith, AM; Bitar, KN; Fingar, DC; Hershenson, MB; Bentley, JK				Deng, Huan; Dokshin, Gregoriy A.; Lei, Jing; Goldsmith, Adam M.; Bitar, Khalil N.; Fingar, Diane C.; Hershenson, Marc B.; Bentley, J. Kelley			Inhibition of glycogen synthase kinase-3 beta is sufficient for airway smooth muscle hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; GROWTH-FACTOR-BETA; KINASE 3-BETA; MYOTUBE HYPERTROPHY; CARDIAC MYOCYTES; BRONCHIAL-ASTHMA; GENE-EXPRESSION; PHOSPHORYLATION; PROTEIN; TRANSCRIPTION	We examined the role of glycogen synthase kinase-3 beta(GSK-3 beta) inhibition in airway smooth muscle hypertrophy, a structural change found in patients with severe asthma. LiCl, SB216763, and specific small interfering RNA ( siRNA) against GSK-3 beta, each of which inhibit GSK-3 beta activity or expression, increased human bronchial smooth muscle cell size, protein synthesis, and expression of the contractile proteins alpha-smooth muscle actin, myosin light chain kinase, smooth muscle myosin heavy chain, and SM22. Similar results were obtained following treatment of cells with cardiotrophin (CT)-1, a member of the interleukin-6 superfamily, and transforming growth factor (TGF)-beta, a proasthmatic cytokine. GSK-3 beta inhibition increased mRNA expression of alpha-actin and transactivation of nuclear factors of activated T cells and serum response factor. siRNA against eukaryotic translation initiation factor 2B epsilon (eIF2B epsilon) attenuated LiCl- and SB216763-induced protein synthesis and expression of alpha-actin and SM22, indicating that eIF2B is required for GSK-3 beta-mediated airway smooth muscle hypertrophy. eIF2B epsilon siRNA also blocked CT-1- but not TGF-beta-induced protein synthesis. Infection of human bronchial smooth muscle cells with pMSCV GSK-3 beta-A9, a retroviral vector encoding a constitutively active, nonphosphorylatable GSK-3 beta, blocked protein synthesis and alpha-actin expression induced by LiCl, SB216763, and CT-1- but not TGF-alpha. Finally, lungs from ovalbumin-sensitized and -challenged mice demonstrated increased alpha-actin and CT-1 mRNA expression, and airway myocytes isolated from ovalbumin-treated mice showed increased cell size and GSK-3 beta phosphorylation. These data suggest that inhibition of the GSK-3 beta/eIF2B epsilon translational control pathway contributes to airway smooth muscle hypertrophy in vitro and in vivo. On the other hand, TGF-beta-induced hypertrophy does not depend on GSK-3 beta/eIF2B signaling.	[Deng, Huan; Dokshin, Gregoriy A.; Lei, Jing; Goldsmith, Adam M.; Bitar, Khalil N.; Hershenson, Marc B.; Bentley, J. Kelley] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Hershenson, Marc B.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Fingar, Diane C.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hershenson, MB (corresponding author), 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	mhershen@umich.edu		Bentley, John Kelley/0000-0001-8865-7979; Dokshin, Gregoriy/0000-0002-8780-7143	NHLBI NIH HHS [R01 HL079339, HL 79339] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079339] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Bao JJ, 2002, P NATL ACAD SCI USA, V99, P9556, DOI 10.1073/pnas.142298599; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bosc LVG, 2005, J BIOL CHEM, V280, P26113, DOI 10.1074/jbc.M411972200; Camoretti-Mercado B, 2006, J BIOL CHEM, V281, P20383, DOI 10.1074/jbc.M602748200; Cho JY, 2004, AM J RESP CELL MOL, V30, P651, DOI 10.1165/rcmb.2003-0066OC; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dominguez I, 2001, DEV BIOL, V235, P303, DOI 10.1006/dbio.2001.0317; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Goldsmith AM, 2006, AM J RESP CELL MOL, V34, P247, DOI 10.1165/rcmb.2005-0166OC; Halayko AJ, 2004, AM J RESP CELL MOL, V31, P266, DOI 10.1165/rcmb.2003-0272OC; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2004, CIRC RES, V94, P926, DOI 10.1161/01.RES.0000124977.59827.80; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Nomura A, 2002, CLIN EXP ALLERGY, V32, P860, DOI 10.1046/j.1365-2745.2002.01404.x; Ohno I, 1996, AM J RESP CELL MOL, V15, P404, DOI 10.1165/ajrcmb.15.3.8810646; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Shaw M, 1999, FEBS LETT, V461, P120, DOI 10.1016/S0014-5793(99)01434-9; Silver DL, 1997, J BIOL CHEM, V272, P25353, DOI 10.1074/jbc.272.40.25353; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tillie-Leblond I, 1999, AM J RESP CRIT CARE, V159, P487, DOI 10.1164/ajrccm.159.2.9805115; TSUNEKAWA S, 1989, FEBS LETT, V250, P493, DOI 10.1016/0014-5793(89)80783-5; Vyas DR, 2002, AM J PHYSIOL-CELL PH, V283, pC545, DOI 10.1152/ajpcell.00049.2002; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Woodruff PG, 2004, AM J RESP CRIT CARE, V169, P1001, DOI 10.1164/rccm.200311-1529OC; Zheng XY, 2004, AM J PHYSIOL-LUNG C, V287, pL1165, DOI 10.1152/ajplung.00171.2004; Zhou DY, 2003, BRIT J PHARMACOL, V140, P1237, DOI 10.1038/sj.bjp.0705562; Zhou LM, 2005, AM J RESP CELL MOL, V33, P195, DOI 10.1165/rcmb.2004-0411OC; Zhou LM, 2004, AM J RESP CRIT CARE, V169, P703, DOI 10.1164/rccm.200307-964OC; Zhou LM, 2003, RESP PHYSIOL NEUROBI, V137, P295, DOI 10.1016/S1569-9048(03)00154-X	42	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10198	10207		10.1074/jbc.M800624200	http://dx.doi.org/10.1074/jbc.M800624200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18252708	Green Published, hybrid			2022-12-27	WOS:000254671600072
J	Zhai, DY; Jin, CF; Huang, ZW; Satterthwait, AC; Reed, JC				Zhai, Dayong; Jin, Chaofang; Huang, Ziwei; Satterthwait, Arnold C.; Reed, John C.			Differential regulation of Bax and Bak by anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEINS; CELL-DEATH; BH3 DOMAINS; MITOCHONDRIA; ACTIVATION; MECHANISMS	The pro-apoptotic members of the Bcl-2 family include initiator proteins that contain only BH3 domains and downstream effector multi-BH domain-containing proteins, including Bax and Bak. In this report, we compared the ability of the six human anti-apoptotic Bcl-2 family members to suppress apoptosis induced by overexpression of Bax or Bak, correlating findings with protein interactions measured by three different methods: co-immunoprecipitation, glutathione S-transferase pulldown, and fluorescence polarization assays employing synthetic BH3 peptides from Bax and Bak. Bcl-B and Mcl-1 showed strong preferences for binding to and suppression of Bax and Bak, respectively. In contrast, the other anti-apoptotic Bcl-2 family proteins (Bcl-2, Bcl-X-L, Bcl-W, and Bfl-1) suppressed apoptosis induced by overexpression of either Bax or Bak, and they displayed an ability to bind both Bax and Bak by at least one of the three protein interaction methods. Interestingly, however, full-length Bax and Bak proteins and synthetic Bax and Bak BH3 peptides exhibited discernible differences in their interactions with some anti-apoptotic members of the Bcl-2 family, cautioning against reliance on a single method for detecting protein interactions of functional significance. Altogether, the findings reveal striking distinctions in the behaviors of Bcl-B and Mcl-1 relative to the other anti-apoptotic Bcl-2 family members, where Bcl-B and Mcl-1 display reciprocal abilities to bind and neutralize Bax and Bak.	[Zhai, Dayong; Jin, Chaofang; Huang, Ziwei; Satterthwait, Arnold C.; Reed, John C.] Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@burnham.org			NATIONAL CANCER INSTITUTE [U19CA113318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060554] Funding Source: NIH RePORTER; NCI NIH HHS [CA 113318] Funding Source: Medline; NIGMS NIH HHS [GM 60554] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Luciano F, 2007, BLOOD, V109, P3849, DOI 10.1182/blood-2006-11-056879; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zhai DY, 2003, BIOCHEM J, V376, P229, DOI 10.1042/BJ20030374	25	104	110	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9580	9586		10.1074/jbc.M708426200	http://dx.doi.org/10.1074/jbc.M708426200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18178565	Green Published, hybrid			2022-12-27	WOS:000254671600011
J	Ahmed, BA; Jeffus, BC; Bukhari, SIA; Harney, JT; Unal, R; Lupashin, VV; van der Sluijs, P; Kilic, F				Ahmed, Billow A.; Jeffus, Brandon C.; Bukhari, Syed I. A.; Harney, Justin T.; Unal, Resat; Lupashin, Vladimir V.; van der Sluijs, Peter; Kilic, Fusun			Serotonin transamidates Rab4 and facilitates its binding to the C terminus of serotonin transporter (Publication with Expression of Concern. See vol. 294, pg. 5209, 2019) (Withdrawn Publication. See vol. 294, pg. 9658, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							HETERO-OLIGOMERIZATION; DOPAMINE TRANSPORTER; HOMO-OLIGOMERIZATION; MEMBRANE-TRANSPORT; EXPRESSION; PROTEIN; TRAFFICKING; LOCALIZATION; PATHWAY; CLONING	The serotonin transporter (SERT) on the plasma membrane is the major mechanism for the clearance of plasma serotonin (5-hydroxytryptamine (5HT)). The uptake rates of cells depend on the density of SERT molecules on the plasma membrane. Interestingly, the number of SERT molecules on the platelet surface is down-regulated when plasma 5HT ([5HT] ex) is elevated. It is well reported that stimulation of cells with high [5HT] ex induces transamidation of a small GTPase, Rab4. Modification with 5HT stabilizes Rab4 in its active, GTP-bound form, Rab4GTP. Although investigating the mechanism by which elevated plasma5HTlevel down-regulates the density ofSERTmolecules on the plasma membrane, we studied Rab4 and SERT in heterologous and platelet expression systems. Our data demonstrate that, in response to elevated [5HT] ex, Rab4-GTP co-localizes with and binds to SERT. The association of SERT with Rab4GTP depends on: (i) 5HT modification and (ii) the GTP-binding ability of Rab4. Their association retains transporter molecules intracellularly. Furthermore, we mapped the Rab4-SERT association domain to amino acids 616-624 in the cytoplasmic tail of SERT. This finding provides an explanation for the role of the C terminus in the localization and trafficking of SERT via Rab4 in a plasma 5HT-dependent manner. Therefore, we propose that elevated [5HT](ex) "paralyzes" the translocation of SERT from intracellular locations to the plasma membrane by controlling transamidation and Rab4-GTP formation.	[Ahmed, Billow A.; Jeffus, Brandon C.; Bukhari, Syed I. A.; Harney, Justin T.; Unal, Resat; Kilic, Fusun] Univ Arkansas Med Sci, Coll Med, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Lupashin, Vladimir V.] Univ Arkansas Med Sci, Coll Med, Dept Physiol, Little Rock, AR 72205 USA; [van der Sluijs, Peter] Univ Utrecht, Med Ctr, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Utrecht University	Kilic, F (corresponding author), Univ Arkansas Med Sci, Coll Med, Dept Biochem & Mol Biol, 301 W Markham St,Mail Slot 516, Little Rock, AR 72205 USA.	kilicfusun@uams.edu	Unal, Resat/G-7155-2011; Lupashin, Vladimir/AAB-4312-2020; Bukhari, Syed/B-2885-2017; Lupashin, Vladimir/E-3013-2013	Lupashin, Vladimir/0000-0002-2350-1962; Bukhari, Syed/0000-0003-0203-0003; Lupashin, Vladimir/0000-0002-2350-1962	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083144] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL091196] Funding Source: Medline; NIGMS NIH HHS [R01 GM083144-01A1, R01 GM083144] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Bauman PA, 2002, ARCH BIOCHEM BIOPHYS, V404, P80, DOI 10.1016/S0003-9861(02)00232-1; Binda F, 2006, NEUROPHARMACOLOGY, V50, P354, DOI 10.1016/j.neuropharm.2005.09.012; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Carneiro AMD, 2006, J BIOL CHEM, V281, P24769, DOI 10.1074/jbc.M603877200; Chanrion B, 2007, P NATL ACAD SCI USA, V104, P8119, DOI 10.1073/pnas.0610964104; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Cormont M, 1996, MOL CELL BIOL, V16, P6879; Deneka M, 2003, CRIT REV BIOCHEM MOL, V38, P121, DOI 10.1080/713609214; Distelmaier F, 2004, J NEUROCHEM, V91, P537, DOI 10.1111/j.1471-4159.2004.02729.x; Duan SM, 1999, J NEUROSCI, V19, P10193; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Gerez L, 2000, MOL BIOL CELL, V11, P2201, DOI 10.1091/mbc.11.7.2201; GREGOR P, 1993, MAMM GENOME, V4, P283, DOI 10.1007/BF00417438; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Jess U, 2002, BIOCHEM BIOPH RES CO, V294, P272, DOI 10.1016/S0006-291X(02)00460-6; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kilic F, 1997, J BIOL CHEM, V272, P5298, DOI 10.1074/jbc.272.8.5298; Kilic F, 2003, MOL PHARMACOL, V64, P440, DOI 10.1124/mol.64.2.440; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Kocabas AM, 2003, J NEUROCHEM, V85, P1513, DOI 10.1046/j.1471-4159.2003.01793.x; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Lazzarino DA, 1998, J EXP MED, V188, P1769, DOI 10.1084/jem.188.10.1769; LESCH KP, 1993, J NEURAL TRANSM-GEN, V91, P67, DOI 10.1007/BF01244919; Mochizuki H, 2005, NEUROCHEM INT, V46, P93, DOI 10.1016/j.neuint.2004.08.008; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Muller HK, 2006, J BIOL CHEM, V281, P28901, DOI 10.1074/jbc.M602848200; Murphy DL, 1998, J CLIN PSYCHIAT, V59, P4; Ozaslan D, 2003, J BIOL CHEM, V278, P43991, DOI 10.1074/jbc.M306360200; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Quick MW, 2002, INT J DEV NEUROSCI, V20, P219, DOI 10.1016/S0736-5748(02)00021-7; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; RAMAMOORTHY S, 1993, PLACENTA, V14, P449, DOI 10.1016/S0143-4004(05)80465-5; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Wang XY, 2005, J PHARMACOL EXP THER, V314, P1002, DOI 10.1124/jpet.105.088476; Wersinger C, 2006, EUR J NEUROSCI, V24, P55, DOI 10.1111/j.1460-9568.2006.04900.x; Whitworth TL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0003.2002	48	49	50	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9388	9398		10.1074/jbc.M706367200	http://dx.doi.org/10.1074/jbc.M706367200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18227069	hybrid			2022-12-27	WOS:000254465800069
J	Kawai, Y; Nishikawa, T; Shiba, Y; Saito, S; Murota, K; Shibata, N; Kobayashi, M; Kanayama, M; Uchida, K; Terao, J				Kawai, Yoshichika; Nishikawa, Tomomi; Shiba, Yuko; Saito, Satomi; Murota, Kaeko; Shibata, Noriyuki; Kobayashi, Makio; Kanayama, Masaya; Uchida, Koji; Terao, Junji			Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries - Implication in the anti-atherosclerotic mechanism of dietary flavonoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENTIALLY ANTICARCINOGENIC FLAVONOIDS; LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; NITRIC-OXIDE SYNTHASE; LIPID-PEROXIDATION; ENDOTHELIAL-CELLS; DEFICIENT MICE; RAT PLASMA; IN-VITRO; RECEPTOR	Epidemiological studies suggest that the consumption of flavonoid-rich diets decreases the risk of cardiovascular diseases. However, the target sites of flavonoids underlying the protective mechanism in vivo are not known. Quercetin represents antioxidative/anti-inflammatory flavonoids widely distributed in the human diet. In this study, we raised a novel monoclonal antibody 14A2 targeting the quercetin-3-glucuronide (Q3GA), a major antioxidative quercetin metabolite in human plasma, and found that the activated macrophage might be a potential target of dietary flavonoids in the aorta. Immunohistochemical studies with monoclonal antibody 14A2 demonstrated that the positive staining specifically accumulates in human atherosclerotic lesions, but not in the normal aorta, and that the intense staining was primarily associated with the macrophage-derived foam cells. In vitro experiments with murine macrophage cell lines showed that the Q3GA was significantly taken up and deconjugated into the much more active aglycone, a part of which was further converted to the methylated form, in the activated macrophages. In addition, the mRNA expression of the class A scavenger receptor and CD36, which play an important role for the formation of foam cells, was suppressed by the treatment of Q3GA. These results suggest that injured/inflamed arteries with activated macrophages are the potential targets of the metabolites of dietary quercetin. Our data provide a new insight into the bioavailability of dietary flavonoids and the mechanism for the prevention of cardiovascular diseases.	[Kawai, Yoshichika; Nishikawa, Tomomi; Shiba, Yuko; Saito, Satomi; Murota, Kaeko; Terao, Junji] Univ Tokushima, Grad Sch Nutr & Biosci, Dept Food Sci, Tokushima 7708503, Japan; [Shibata, Noriyuki; Kobayashi, Makio] Tokyo Womens Med Univ, Dept Pathol, Tokyo 1628666, Japan; [Kawai, Yoshichika; Nishikawa, Tomomi; Shiba, Yuko; Saito, Satomi; Murota, Kaeko; Kanayama, Masaya; Uchida, Koji; Terao, Junji] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan	Tokushima University; Tokyo Women's Medical University; Nagoya University	Kawai, Y (corresponding author), Univ Tokushima, Grad Sch Nutr & Biosci, Dept Food Sci, Tokushima 7708503, Japan.	y-kawai@nutr.med.tokushima-u.ac.jp	Kawai, Yoshichika/G-3231-2011; Murota, Kaeko/GRO-6464-2022	Uchida, Koji/0000-0003-3894-5299				Babaev VR, 2000, ARTERIOSCL THROM VAS, V20, P2593, DOI 10.1161/01.ATV.20.12.2593; Bentsath A, 1936, NATURE, V138, P798, DOI 10.1038/138798a0; Burleigh ME, 2002, CIRCULATION, V105, P1816, DOI 10.1161/01.CIR.0000014927.74465.7F; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; da Silva EL, 1998, FEBS LETT, V430, P405, DOI 10.1016/S0014-5793(98)00709-1; Day AJ, 2001, FREE RADICAL RES, V35, P941, DOI 10.1080/10715760100301441; Detmers PA, 2000, J IMMUNOL, V165, P3430, DOI 10.4049/jimmunol.165.6.3430; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Gillotte-Taylor K, 2001, J LIPID RES, V42, P1474; HERTOG MGL, 1994, NUTR CANCER, V22, P175, DOI 10.1080/01635589409514342; HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267; HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Hertog MGL, 1996, EUR J CLIN NUTR, V50, P63; HERTOG MGL, 1992, J AGR FOOD CHEM, V40, P2379, DOI 10.1021/jf00024a011; Isshiki M, 2002, J BIOL CHEM, V277, P43389, DOI 10.1074/jbc.M205411200; Kamada C, 2005, FREE RADICAL RES, V39, P185, DOI 10.1080/10715760400019638; Kato Y, 2003, BIOSCI BIOTECH BIOCH, V67, P1136, DOI 10.1271/bbb.67.1136; Keli SO, 1996, ARCH INTERN MED, V156, P637, DOI 10.1001/archinte.156.6.637; Le Marchand L, 2000, JNCI-J NATL CANCER I, V92, P154, DOI 10.1093/jnci/92.2.154; Lotito SB, 2006, J BIOL CHEM, V281, P37102, DOI 10.1074/jbc.M606804200; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; Mochizuki M, 2004, BIOFACTORS, V22, P201, DOI 10.1002/biof.5520220142; Moon JH, 2000, AM J PHYSIOL-REG I, V279, pR461, DOI 10.1152/ajpregu.2000.279.2.R461; Moon JH, 2001, FREE RADICAL BIO MED, V30, P1274, DOI 10.1016/S0891-5849(01)00522-6; Murota K, 2003, ARCH BIOCHEM BIOPHYS, V417, P12, DOI 10.1016/S0003-9861(03)00284-4; O'Leary KA, 2001, FEBS LETT, V503, P103, DOI 10.1016/S0014-5793(01)02684-9; Raso GM, 2001, LIFE SCI, V68, P921, DOI 10.1016/S0024-3205(00)00999-1; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Shimoi K, 2001, DRUG METAB DISPOS, V29, P1521; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Williamson G, 2005, FREE RADICAL RES, V39, P457, DOI 10.1080/10715760500053610; Yan SY, 2005, SURGERY, V138, P464, DOI 10.1016/j.surg.2005.06.027	37	237	247	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9424	9434		10.1074/jbc.M706571200	http://dx.doi.org/10.1074/jbc.M706571200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18199750	hybrid			2022-12-27	WOS:000254465800072
J	Friedman, MJ; Wang, CE; Li, XJ; Li, SH				Friedman, Meyer J.; Wang, Chuan-En; Li, Xiao-Jiang; Li, Shihua			Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; DOMINANT CEREBELLAR-ATAXIA; DISEASE-LIKE PHENOTYPE; REPEAT EXPANSION; EXPANDED POLYGLUTAMINE; NUCLEAR-LOCALIZATION; GENE-EXPRESSION; TERMINAL DOMAIN; TRANSCRIPTION; TBP	TATA-binding protein (TBP) is essential for eukaryotic gene transcription. Human TBP contains a polymorphic polyglutamine (polyQ) domain in its N terminus and a DNA-binding domain in its highly conserved C terminus. Expansion of the polyQ domain to > 42 glutamines typically results in spinocerebellar ataxia type 17 (SCA17), a neurodegenerative disorder that resembles Huntington disease. Our recent studies have demonstrated that polyQ expansion causes abnormal interaction of TBP with the general transcription factor TFIIB and induces neurodegeneration in transgenic SCA17 mice (Friedman, M. J., Shah, A. G., Fang, Z. H., Ward, E. G., Warren, S. T., Li, S., and Li, X. J. (2007) Nat. Neurosci. 10, 1519 - 1528). However, it remains unknown how polyQ expansion influences DNA binding by TBP. Here we report that polyQ expansion reduces in vitro binding of TBP to DNA and that mutant TBP fragments lacking an intact C-terminal DNA-binding domain are present in transgenic SCA17 mouse brains. polyQ-expanded TBP with a deletion spanning part of the DNA-binding domain does not bind DNA in vitro but forms nuclear aggregates and inhibits TATA-dependent transcription activity in cultured cells. When this TBP double mutant is expressed in transgenic mice, it forms nuclear inclusions in neurons and causes early death. These findings suggest that the polyQ tract affects the binding of TBP to promoter DNA and that polyQ-expanded TBP can induce neuronal toxicity independent of its interaction with DNA.	[Friedman, Meyer J.; Wang, Chuan-En; Li, Xiao-Jiang; Li, Shihua] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Li, XJ (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	xiaoli@genetics.emory.edu; shihual@genetics.emory.edu			NIA NIH HHS [R01 AG031153, AG 019206] Funding Source: Medline; NINDS NIH HHS [R01 NS041669, NS 045106, NS 041669, R01 NS045016] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045106, R01NS045016, R01NS041669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019206, R01AG031153] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Bauer P, 2004, J MED GENET, V41, P230, DOI 10.1136/jmg.2003.015602; Bondareva AA, 2003, MOL BIOL EVOL, V20, P1932, DOI 10.1093/molbev/msg205; Bruni AC, 2004, ARCH NEUROL-CHICAGO, V61, P1314, DOI 10.1001/archneur.61.8.1314; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Fujigasaki H, 2001, BRAIN, V124, P1939, DOI 10.1093/brain/124.10.1939; GOSTOUT B, 1993, AM J HUM GENET, V52, P1182; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; Jackson-Fisher AJ, 1999, MOL CELL, V3, P717, DOI 10.1016/S1097-2765(01)80004-6; KAO CC, 1990, SCIENCE, V248, P1646, DOI 10.1126/science.2194289; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lasek K, 2006, BRAIN, V129, P2341, DOI 10.1093/brain/awl148; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LESCURE A, 1994, EMBO J, V13, P1166, DOI 10.1002/j.1460-2075.1994.tb06366.x; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0; Mittal V, 1997, SCIENCE, V275, P1136, DOI 10.1126/science.275.5303.1136; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Reid SJ, 2003, NEUROBIOL DIS, V13, P37, DOI 10.1016/S0969-9961(03)00014-7; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Rolfs A, 2003, ANN NEUROL, V54, P367, DOI 10.1002/ana.10676; SEIPEL K, 1993, NUCLEIC ACIDS RES, V21, P5609, DOI 10.1093/nar/21.24.5609; Silveira I, 2002, ARCH NEUROL-CHICAGO, V59, P623, DOI 10.1001/archneur.59.4.623; STEVANIN G, 2007, CEREBELLUM, P1; Toyoshima Y, 2004, ANN NEUROL, V55, P281, DOI 10.1002/ana.10824; Walsh R, 2005, NEUROTOX RES, V7, P43, DOI 10.1007/BF03033775; YAMAMOTO T, 1992, P NATL ACAD SCI USA, V89, P2844, DOI 10.1073/pnas.89.7.2844; Zhao XM, 2002, CELL, V108, P615, DOI 10.1016/S0092-8674(02)00648-7; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038; Zuhlke C, 2001, EUR J HUM GENET, V9, P160, DOI 10.1038/sj.ejhg.5200617	38	52	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8283	8290		10.1074/jbc.M709674200	http://dx.doi.org/10.1074/jbc.M709674200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18218637	Green Published, hybrid			2022-12-27	WOS:000254288000026
J	Jokela, TA; Jauhiainen, M; Auriola, S; Kauhanen, M; Tiihonen, R; Tammi, MI; Tammi, RH				Jokela, Tiina A.; Jauhiainen, Marjo; Auriola, Seppo; Kauhanen, Miia; Tiihonen, Riikka; Tammi, Markku I.; Tammi, Raija H.			Mannose inhibits hyaluronan synthesis by down-regulation of the cellular pool of UDP-N-acetylhexosamines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; ACTIVATES HYALURONAN; EPITHELIAL-CELLS; KERATINOCYTES; MIGRATION; SYNTHASES; CANCER; ACID; 4-METHYLUMBELLIFERONE; PROLIFERATION	We found that D-mannose dose-dependently decreases hyaluronan synthesis in cultured epidermal keratinocytes to similar to 50%, whereas glucose, galactose, and fructose up to 20 mM concentration had no effect. The full inhibition occurred within 3 h following introduction of mannose and did not involve down-regulation of hyaluronan synthase (Has1 - 3) mRNA. Following introduction of mannose, there was an similar to 50% reduction in the cellular concentration of UDP-N-acetylhexosamines (UDP-HexNAc, i. e. UDP-N-acetylglucosamine and UDP-N-acetylgalactosamine). On the other hand, 2 mM glucosamine in the culture medium increased UDP-HexNAc content, stimulated hyaluronan secretion, and negated the effect of mannose, supporting the notion that the inhibition by mannose on hyaluronan synthesis was because of down-regulated UDP-HexNAc content. The content of UDP-glucuronic acid, the other building block for hyaluronan synthesis, was not reduced by mannose but declined from 39 to 14% of controls by 0.2-1.0 mM 4-methylumbelliferone, another compound that inhibits hyaluronan synthesis. Applying 4-methylumbelliferone and mannose together produced the expected reductions in both UDP sugars but no additive reduction in hyaluronan production, indicating that the concentration of each substrate alone can limit hyaluronan synthesis. Mannose is a potentially useful tool in studies on hyaluronan-dependent cell functions, as demonstrated by reduced rates of keratinocyte proliferation and migration, functions known to depend on hyaluronan synthesis.	[Jokela, Tiina A.; Kauhanen, Miia; Tiihonen, Riikka; Tammi, Markku I.; Tammi, Raija H.] Univ Kuopio, Inst Biomed Anat, FIN-70211 Kuopio, Finland; [Jauhiainen, Marjo; Auriola, Seppo] Univ Kuopio, Dept Pharmaceut Chem, FIN-70211 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland	Tammi, RH (corresponding author), Univ Kuopio, Inst Biomed Anat, POB 1627, FIN-70211 Kuopio, Finland.	raija.tammi@uku.fi	Jokela, Tiina/O-9206-2015; Tammi, Markku/AAQ-7878-2021	Jokela, Tiina/0000-0002-7521-3866; 				Anttila MA, 2000, CANCER RES, V60, P150; Aoki K, 2004, J BIOL CHEM, V279, P39798, DOI 10.1074/jbc.M402677200; Arreola R, 2003, FEBS LETT, V551, P63, DOI 10.1016/S0014-5793(03)00896-2; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Auvinen PK, 1997, INT J CANCER, V74, P477, DOI 10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.3.CO;2-X; BADEN HP, 1983, J INVEST DERMATOL, V81, P558, DOI 10.1111/1523-1747.ep12523220; Bonder CS, 2006, BLOOD, V107, P4798, DOI 10.1182/blood-2005-09-3581; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cayli A, 1999, BIOTECHNOL BIOENG, V65, P192, DOI 10.1002/(SICI)1097-0290(19991020)65:2<192::AID-BIT9>3.0.CO;2-9; Danese S, 2006, GASTROENTEROLOGY, V130, P2060, DOI 10.1053/j.gastro.2006.03.054; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Kawakita M, 1998, J BIOCHEM, V123, P777; KIM JJ, 1974, J BIOL CHEM, V249, P3091; Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; PILLER F, 1983, J BIOL CHEM, V258, P774; PITSILLIDES AA, 1993, INT J EXP PATHOL, V74, P27; Pummill PE, 1998, J BIOL CHEM, V273, P4976, DOI 10.1074/jbc.273.9.4976; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Rilla K, 2002, J CELL SCI, V115, P3633, DOI 10.1242/jcs.00042; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Sayo T, 2002, J INVEST DERMATOL, V118, P43, DOI 10.1046/j.0022-202x.2001.01613.x; Schleicher ED, 2000, KIDNEY INT, V58, pS13, DOI 10.1046/j.1523-1755.2000.07703.x; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Slevin M, 1998, LAB INVEST, V78, P987; SWEENEY C, 1993, BIOCHEM J, V290, P563, DOI 10.1042/bj2900563; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; Tammi RH, 2000, HISTOCHEM CELL BIOL, V113, P265, DOI 10.1007/s004180000128; Tellbach M, 2002, GLYCOCONJUGATE J, V19, P385, DOI 10.1023/B:GLYC.0000004010.24877.2f; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; WALDMAN BC, 1990, BIOCHEMISTRY-US, V29, P44, DOI 10.1021/bi00453a006; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; Yamada Y, 2004, J INVEST DERMATOL, V122, P631, DOI 10.1111/j.0022-202X.2004.22332.x; Yoshihara S, 2005, FEBS LETT, V579, P2722, DOI 10.1016/j.febslet.2005.03.079	56	59	62	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7666	7673		10.1074/jbc.M706001200	http://dx.doi.org/10.1074/jbc.M706001200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18201970	hybrid			2022-12-27	WOS:000253997900042
J	Ratti, A; Fallini, C; Colombrita, C; Pascale, A; Laforenza, U; Quattrone, A; Silani, V				Ratti, Antonia; Fallini, Claudia; Colombrita, Claudia; Pascale, Alessia; Laforenza, Umberto; Quattrone, Alessandro; Silani, Vincenzo			Post-transcriptional regulation of neuro-oncological ventral antigen 1 by the neuronal RNA-binding proteins ELAV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; UNTRANSLATED REGION; GENE-EXPRESSION; UP-REGULATION; HUD; CELLS; PLASTICITY; LETHAL; BRAIN; DIFFERENTIATION	Alternative splicing of pre-mRNAs plays an important role in generating biological and functional diversity. Neuro-oncological ventral antigen 1 (Nova1) is a neuron-specific splicing factor that controls the alternative processing of a wide array of mRNAs important for synaptic activity. It is essential for the proper development of the mammalian motor system and for the survival of motoneurons. Because Nova1 gene contains putative regulatory AU-rich elements (ARE) in its highly conserved 3'-untranslated region, we investigated whether its expression is regulated by post-transcriptional mechanisms mediated by ARE-binding proteins. Among these, the neuronal ELAV (nELAV) factors are interesting candidates, because their RNA binding activity is necessary for neuronal differentiation and maintenance. By analysis of ribonucleoprotein complexes in vivo and in vitro we demonstrated that the Nova1 mRNA is a novel target of the nELAV proteins. We defined the nELAV binding site by functional experiments with luciferase reporter gene and Nova1 3'-untranslated region deletion sequences. Gene silencing and overexpression of the nELAV member HuD in motoneuronal NSC34 cells indicate that Nova1 mRNA stability and translation are positively and strongly controlled by the nELAV proteins. In addition, nELAV phosphorylation by a PKC-dependent pathway induces the recruitment of Nova1 mRNA to polysomes. Noteworthy, we found that nELAV proteins are also able to modulate Nova1 splicing activity on its target genes. Our data indicate nELAV proteins as the first factors affecting the expression and activity of the neuronal splicing regulator Nova1 and, consequently, as major candidates for the physiological modulation of Nova1-dependent processing of pre-mRNAs in neurons.	[Ratti, Antonia; Fallini, Claudia; Colombrita, Claudia; Silani, Vincenzo] Univ Milan, Sch Med, IRCCS, Ist Auxol Italiano,Dept Neurol Sci,Dino Ferrari C, I-20095 Milan, Italy; [Pascale, Alessia] Univ Pavia, Dept Expt & Appl Pharmacol, I-27100 Pavia, Italy; [Laforenza, Umberto] Univ Pavia, Dept Expt Med, I-27100 Pavia, Italy; [Quattrone, Alessandro] Univ Trent, Ctr Integrat Biol, Lab Translat Genom, I-38100 Trento, Italy	IRCCS Istituto Auxologico Italiano; University of Milan; University of Pavia; University of Pavia; University of Trento	Ratti, A (corresponding author), Univ Milan, Sch Med, IRCCS, Ist Auxol Italiano,Dept Neurol Sci,Dino Ferrari C, Via Zucchi 18, I-20095 Milan, Italy.	antonia.ratti@unimi.it	Silani, Vincenzo/P-4421-2017; Fallini, Claudia/AAZ-1244-2020; colombrita, claudia/A-3295-2009	Silani, Vincenzo/0000-0002-7698-3854; Fallini, Claudia/0000-0001-8329-3467; colombrita, claudia/0000-0001-6567-8910; Quattrone, Alessandro/0000-0003-3333-7630; Laforenza, Umberto/0000-0003-2951-5983				Abe R, 1996, NUCLEIC ACIDS RES, V24, P2011, DOI 10.1093/nar/24.11.2011; Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; Antic D, 1999, GENE DEV, V13, P449, DOI 10.1101/gad.13.4.449; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Antic D, 1998, J CELL SCI, V111, P183; Aranda-Abreu GE, 1999, J NEUROSCI, V19, P6907, DOI 10.1523/JNEUROSCI.19-16-06907.1999; Aronov S, 2002, J CELL SCI, V115, P3817, DOI 10.1242/jcs.00058; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Black D L, 2003, Prog Mol Subcell Biol, V31, P187; Bolognani F, 2004, NEUROSCI LETT, V371, P152, DOI 10.1016/j.neulet.2004.08.074; Borgeson CD, 2005, NUCLEIC ACIDS RES, V33, P6372, DOI 10.1093/nar/gki942; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; Chung SM, 1997, J BIOL CHEM, V272, P6593, DOI 10.1074/jbc.272.10.6593; Deschenes-Furry J, 2006, BIOESSAYS, V28, P822, DOI 10.1002/bies.20449; DESCHENESFURRY J, 2005, CHEM-BIOL INTERACT, V43, P157; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; GRAUS F, 1993, NEUROSCI LETT, V150, P212, DOI 10.1016/0304-3940(93)90538-V; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; MECHLER BM, 1987, METHOD ENZYMOL, V152, P241; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Okano HJ, 1997, J NEUROSCI, V17, P3024; Park HC, 2000, NEUROSCI LETT, V279, P81, DOI 10.1016/S0304-3940(99)00940-4; Pascale A, 2008, CELL MOL LIFE SCI, V65, P128, DOI 10.1007/s00018-007-7017-y; Pascale A, 1996, J NEUROCHEM, V67, P2471; Pascale A, 2005, P NATL ACAD SCI USA, V102, P12065, DOI 10.1073/pnas.0504702102; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Quattrone A, 2001, P NATL ACAD SCI USA, V98, P11668, DOI 10.1073/pnas.191388398; Ratti A, 2006, J CELL SCI, V119, P1442, DOI 10.1242/jcs.02852; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Samson ML, 1998, GENETICS, V150, P723; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Wakamatsu Y, 1997, DEVELOPMENT, V124, P3449; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Zhu H, 2006, MOL BIOL CELL, V17, P5105, DOI 10.1091/mbc.E06-02-0099	48	49	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7531	7541		10.1074/jbc.M706082200	http://dx.doi.org/10.1074/jbc.M706082200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18218628	hybrid			2022-12-27	WOS:000253997900028
J	Reynolds, JM; Takebe, S; Choi, JY; El Bissati, K; Witola, WH; Bobenchik, AM; Hoch, JC; Voelker, DR; Ben Mamoun, C				Reynolds, Jennifer M.; Takebe, Sachiko; Choi, Jae-Yeon; El Bissati, Kamal; Witola, William H.; Bobenchik, April M.; Hoch, Jeffrey C.; Voelker, Dennis R.; Ben Mamoun, Choukri			Biochemical and genetic analysis of the phosphoethanolamine methyltransferase of the human malaria parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-METHYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; PHOSPHOCHOLINE BIOSYNTHESIS; CAENORHABDITIS-ELEGANS; PATHWAY	The PfPMT enzyme of Plasmodium falciparum, the agent of severe human malaria, is a member of a large family of known and predicted phosphoethanolamine methyltransferases (PMTs) recently identified in plants, worms, and protozoa. Functional studies in P. falciparum revealed that PfPMT plays a critical role in the synthesis of phosphatidylcholine via a plant-like pathway involving serine decarboxylation and phosphoethanolamine methylation. Despite their important biological functions, PMT structures have not yet been solved, and nothing is known about which amino acids in these enzymes are critical for catalysis and binding to S-adenosyl-methionine and phosphoethanolamine substrates. Here we have performed a mutational analysis of PfPMT focused on 24 residues within and outside the predicted catalytic motif. The ability of PfPMT to complement the choline auxotrophy of a yeast mutant defective in phospholipid methylation enabled us to characterize the activity of the PfPMT mutants. Mutations in residues Asp-61, Gly-83 and Asp-128 dramatically altered PfPMT activity and its complementation of the yeast mutant. Our analyses identify the importance of these residues in PfPMT activity and set the stage for advanced structural understanding of this class of enzymes.	[Reynolds, Jennifer M.; Takebe, Sachiko; El Bissati, Kamal; Witola, William H.; Bobenchik, April M.; Ben Mamoun, Choukri] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Hoch, Jeffrey C.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA; [Choi, Jae-Yeon; Voelker, Dennis R.] Natl Jewish Ctr Immunol & Resp Med, Dept Med, Cell Biol Program, Denver, CO 80206 USA	University of Connecticut; University of Connecticut; National Jewish Health	Ben Mamoun, C (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	Choukri@up.uchc.edu	Witola, WIlliam Harold/AAD-6647-2020	EL BISSATI, KAMAL/0000-0001-9341-4162; Hoch, Jeffrey/0000-0002-9230-2019	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058962, R01AI051507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032453] Funding Source: NIH RePORTER; NIAID NIH HHS [AI58962, AI51507] Funding Source: Medline; NIGMS NIH HHS [5R37GM32453] Funding Source: Medline; OCPHP CDC HHS [PR033005] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OCPHP CDC HHS		BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Guthrie C, 1991, GUIDE YEAST GENETICS; Nikulina K, 2004, CELL MOTIL CYTOSKEL, V57, P233, DOI 10.1002/cm.10172; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Pessi G, 2006, FUTURE LIPIDOL, V1, P173, DOI 10.2217/17460875.1.2.173; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Vial H., 1998, MALARIA PARASITE BIO, P159; Vial HJ, 2005, MOLECULAR APPROACHES TO MALARIA, P327; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; *WHO EXP COMM MAL, 2000, WORLD HLTH ORG, V892; Witola WH, 2006, J BIOL CHEM, V281, P21305, DOI 10.1074/jbc.M603260200; Witola WH, 2007, EUKARYOT CELL, V6, P1618, DOI 10.1128/EC.00229-07	19	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7894	7900		10.1074/jbc.M709869200	http://dx.doi.org/10.1074/jbc.M709869200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18178564	hybrid			2022-12-27	WOS:000253997900065
J	Yan, L; Lavin, VA; Moser, LR; Cui, QH; Kanies, C; Yang, E				Yan, Ling; Lavin, Viviana A.; Moser, Leta R.; Cui, Qinghua; Kanies, Cindy; Yang, Elizabeth			PP2A regulates the pro-apoptotic activity of FOXO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; PROTEIN PHOSPHATASE 2A; PROTEASOMAL DEGRADATION; PHOSPHORYLATION SITES; TUMOR SUPPRESSION; GENE-EXPRESSION; CELL-SURVIVAL; AKT; BIM; FKHR	FOXO1, a member of the evolutionarily conserved forkhead family of transcription factors, regulates expression of a number of genes that play critical roles in cell cycle and apoptosis. A pivotal regulatory mechanism of FOXO is reversible phosphorylation, catalyzed by kinases and phosphatases. Phosphorylation of FOXO1 is associated with 14-3-3 binding and cytosolic localization, whereas dephosphorylated FOXO1 translocates to the nucleus and is transcriptionally active. Experiments were performed to identify the serine/ threonine phosphatase that dephosphorylates FOXO1. PP2A inhibitors, okadaic acid and fostriecin, increased FOXO1 phosphorylation in vitro and in cells. Microcystin-agarose pull-downs suggested that a phosphatase binds to FOXO1, and PP2A catalytic subunit was identified in endogenous FOXO1 immunocomplexes, indicating that PP2A is a FOXO1 phosphatase. Purified PP2A interacted directly with FOXO1 and dephosphorylated FOXO1 in vitro. Silencing of PP2A protected FOXO1 from dephosphorylation and delayed FOXO1 nuclear translocation, confirming the physiologic role of PP2A in the regulation of FOXO1 function. Furthermore, inhibition of PP2A phosphatases rescued FOXO1-mediated cell death by regulating the level of the proapoptotic protein BIM. We conclude that PP2A is a physiologic phosphatase of FOXO1.	Vanderbilt Univ, Ctr Med, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Yang, E (corresponding author), Vanderbilt Univ, Ctr Med, Dept Pediat, Nashville, TN 37232 USA.	elizabeth.yang@vanderbilt.edu			NCI NIH HHS [T32 CA009592, R01CA92498] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092498, T32CA009592] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Coffer PJ, 2007, NAT CELL BIOL, V9, P251, DOI 10.1038/ncb0307-251; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	50	102	105	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7411	7420		10.1074/jbc.M708083200	http://dx.doi.org/10.1074/jbc.M708083200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18211894	Green Published, hybrid			2022-12-27	WOS:000253997900015
J	Lipson, C; Alalouf, G; Bajorek, M; Rabinovich, E; Atir-Lande, A; Glickman, M; Bar-Nun, S				Lipson, Carni; Alalouf, Guy; Bajorek, Monika; Rabinovich, Efrat; Atir-Lande, Avigail; Glickman, Michael; Bar-Nun, Shoshana			A proteasomal ATPase contributes to dislocation of endoplasmic reticulum-associated degradation (ERAD) substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; AAA-ATPASE; REGULATORY PARTICLE; TRANSLOCATION CHANNEL; RETRO-TRANSLOCATION; UBIQUITIN LIGASES; MEMBRANE-PROTEIN; QUALITY-CONTROL; 26S PROTEASOME; CORE PARTICLE	Endoplasmic reticulum ( ER)-associated degradation ( ERAD) eliminates aberrant proteins from the ER by dislocating them to the cytoplasm where they are tagged by ubiquitin and degraded by the proteasome. Six distinct AAA-ATPases ( Rpt1-6) at the base of the 19S regulatory particle of the 26S proteasome recognize, unfold, and translocate substrates into the 20S catalytic chamber. Here we show unique contributions of individual Rpts to ERAD by employing equivalent conservative substitutions of the invariant lysine in the ATP-binding motif of each Rpt subunit. ERAD of two substrates, luminal CPY*-HA and membrane 6myc-Hmg2, is inhibited only in rpt4R and rpt2RF mutants. Conversely, in vivo degradation of a cytosolic substrate, Delta ssCPY*-GFP, as well as in vitro cleavage of Suc-LLVY-AMC are hardly affected in rpt4R mutant yet are inhibited in rpt2RF mutant. Together, we find that equivalent mutations in RPT4 and RPT2 result in different phenotypes. The Rpt4 mutation is manifested in ERAD defects, whereas the Rpt2 mutation is manifested downstream, in global proteasomal activity. Accordingly, rpt4R strain is particularly sensitive to ER stress and exhibits an activated unfolded protein response, whereas rpt2RF strain is sensitive to general stress. Further characterization of Rpt4 involvement in ERAD reveals that it participates in CPY*-HA dislocation, a function previously attributed to p97/ Cdc48, another AAA-ATPase essential for ERAD of CPY*-HA but dispensable for proteasomal degradation of Delta ssCPY*-GFP. Pointing to Cdc48 and Rpt4 overlapping functions, excess Cdc48 partially restores impaired ERAD in rpt4R, but not in rpt2RF. We discuss models for Cdc48 and Rpt4 cooperation in ERAD.	[Lipson, Carni; Alalouf, Guy; Rabinovich, Efrat; Bar-Nun, Shoshana] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; [Bajorek, Monika; Atir-Lande, Avigail; Glickman, Michael] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Tel Aviv University; Technion Israel Institute of Technology	Bar-Nun, S (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.	shoshbn@tauex.tau.ac.il		Bajorek, Monika/0000-0002-0160-4709; Glickman, Michael/0000-0002-1222-8104				Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Elkabetz Y, 2003, J BIOL CHEM, V278, P18922, DOI 10.1074/jbc.M208730200; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Guttmann-Raviv N, 2002, MOL CELL BIOL, V22, P2047, DOI 10.1128/MCB.22.7.2047-2056.2002; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirsch C, 2000, TRENDS CELL BIOL, V10, P268, DOI 10.1016/S0962-8924(00)01768-2; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; Kaplun L, 2000, P NATL ACAD SCI USA, V97, P10077, DOI 10.1073/pnas.97.18.10077; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kohler A, 2001, BIOCHIMIE, V83, P325, DOI 10.1016/S0300-9084(01)01242-1; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Leggett David S., 2005, V301, P57; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rabinovich E, 2006, ISR MED ASSOC J, V8, P238; Rabinovich E, 2006, ISRAEL J CHEM, V46, P219, DOI 10.1560/DA1X-C4K6-K8F7-RG5F; Rivett AJ, 1998, CURR OPIN IMMUNOL, V10, P110, DOI 10.1016/S0952-7915(98)80040-X; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Sears C, 1998, J BIOL CHEM, V273, P1409, DOI 10.1074/jbc.273.3.1409; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang QQ, 2003, EMBO J, V22, P3792, DOI 10.1093/emboj/cdg378; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	60	53	55	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7166	7175		10.1074/jbc.M705893200	http://dx.doi.org/10.1074/jbc.M705893200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18174173	Green Published, hybrid			2022-12-27	WOS:000253779600062
J	Shao, C; Novakovic, VA; Head, JF; Seaton, BA; Gilbert, GE				Shao, Chenghua; Novakovic, Valerie A.; Head, James F.; Seaton, Barbara A.; Gilbert, Gary E.			Crystal structure of lactadherin C2 domain at 1.7 angstrom resolution with mutational and computational analyses of its membrane-binding motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; FACTOR VIIIC2 DOMAIN; AMINO-ACID-RESIDUES; FACTOR-V; PHOSPHOLIPID-MEMBRANES; BLOOD-COAGULATION; APOPTOTIC CELLS; IDENTIFICATION; PROTEIN; AFFINITY	Lactadherin is a phosphatidyl-L-serine ( Ptd-L-Ser)-binding protein that decorates membranes of milk fat globules. The major Ptd-L- Ser binding function of lactadherin has been localized to its C2 domain, which shares homology with the C2 domains of blood coagulation factor VIII and factor V. Correlating with this homology, purified lactadherin competes efficiently with factors VIII and V for Ptd-L-Ser binding sites, functioning as a potent anticoagulant. We have determined the crystal structure of the lactadherin C2 domain ( Lact-C2) at 1.7 angstrom resolution. The bovine Lact-C2 structure has a beta-barrel core that is homologous with the factor VIII C2 ( fVIII-C2) and factor V C2 ( fV-C2) domains. Two loops at the end of the beta-barrel, designated spikes 1 and 3, display four water-exposed hydrophobic amino acids, reminiscent of the membrane-interactive residues of fVIII-C2 and fV-C2. In contrast to the corresponding loops in fVIII-C2 and fV-C2, spike 1 of Lact-C2 adopts a hairpin turn in which the 7-residue loop is stabilized by internal hydrogen bonds. Further, central glycine residues in two membrane-interactive loops may enhance conformability of Lact-C2 to membrane binding sites. Mutagenesis studies confirmed a membrane-interactive role for the hydrophobic and/ or Gly residues of both spike 1 and spike 3. Substitution of spike 1 of fVIII-C2 into Lact-C2 also diminished binding. Computational ligand docking studies identified two prospective Ptd-L-Ser interaction sites. These results identify two membrane-interactive loops of Lact-C2 and provide a structural basis for the more efficient phospholipid binding of lactadherin as compared with factor VIII and factor V.	[Novakovic, Valerie A.; Gilbert, Gary E.] Brigham & Womens Hosp, Vet Affairs Boston Healthcare Syst, Dept Med, West Roxburgy, MA 02132 USA; [Novakovic, Valerie A.; Gilbert, Gary E.] Harvard Univ, Sch Med, Boston, MA 02132 USA; [Shao, Chenghua; Head, James F.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard Medical School; Boston University	Gilbert, GE (corresponding author), Brigham & Womens Hosp, Vet Affairs Boston Healthcare Syst, Dept Med, 1400 VFW Pkwy, West Roxburgy, MA 02132 USA.	ggilbert@rics.bwh.harvard.edu		Head, James/0000-0002-6226-4146; Seaton, Barbara/0000-0003-4654-7709				ABBOTT AJ, 1987, BIOCHEMISTRY-US, V26, P7994, DOI 10.1021/bi00398a067; Ait-Oufella H, 2007, CIRCULATION, V115, P2168, DOI 10.1161/CIRCULATIONAHA.106.662080; Andersen MH, 2000, BIOCHEMISTRY-US, V39, P6200, DOI 10.1021/bi992221r; Andersen MH, 1997, BIOCHEMISTRY-US, V36, P5441, DOI 10.1021/bi963119m; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; Baumgartner S, 1998, PROTEIN SCI, V7, P1626, DOI 10.1002/pro.5560070717; Boddaert J, 2007, AM J PATHOL, V170, P921, DOI 10.2353/ajpath.2007.060664; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTLER JE, 1980, DIFFERENTIATION, V17, P31, DOI 10.1111/j.1432-0436.1980.tb01079.x; Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; Couto JR, 1996, DNA CELL BIOL, V15, P281, DOI 10.1089/dna.1996.15.281; Ensslin M, 1995, BIOL CHEM H-S, V376, P733, DOI 10.1515/bchm3.1995.376.12.733; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Fodor K, 2005, J MOL BIOL, V350, P156, DOI 10.1016/j.jmb.2005.04.039; GILBERT GE, 1992, J BIOL CHEM, V267, P15861; GILBERT GE, 1990, J BIOL CHEM, V265, P815; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; GILBERT GE, 1991, J BIOL CHEM, V266, P17261; Gilbert GE, 1998, BIOCHEMISTRY-US, V37, P13526, DOI 10.1021/bi972944f; GILBERT GE, 2007, J THROMB HAEMOST S1, V5; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Haggqvist B, 1999, P NATL ACAD SCI USA, V96, P8669, DOI 10.1073/pnas.96.15.8669; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Hvarregaard J, 1996, EUR J BIOCHEM, V240, P628, DOI 10.1111/j.1432-1033.1996.0628h.x; JOHNSON SM, 1971, BIOCHIM BIOPHYS ACTA, V233, P820, DOI 10.1016/0005-2736(71)90184-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim SW, 2000, BIOCHEMISTRY-US, V39, P1951, DOI 10.1021/bi992256r; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin L, 2007, J MOL BIOL, V371, P717, DOI 10.1016/j.jmb.2007.05.054; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng WM, 2004, BIOCHEMISTRY-US, V43, P4385, DOI 10.1021/bi035763o; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Saenko EL, 1998, J BIOL CHEM, V273, P27918, DOI 10.1074/jbc.273.43.27918; Saenko EL, 1999, TRENDS CARDIOVAS MED, V9, P185, DOI 10.1016/S1050-1738(00)00019-0; Saenko EL, 1996, J BIOL CHEM, V271, P27424, DOI 10.1074/jbc.271.44.27424; Saleh M, 2004, THROMB HAEMOSTASIS, V91, P16, DOI 10.1160/TH03-04-0222; Shi J, 2006, CYTOM PART A, V69A, P1193, DOI 10.1002/cyto.a.20345; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Takeshima K, 2003, THROMB HAEMOSTASIS, V89, P788, DOI 10.1055/s-0037-1613463; Taylor MR, 1997, DNA CELL BIOL, V16, P861, DOI 10.1089/dna.1997.16.861; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	57	74	79	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7230	7241		10.1074/jbc.M705195200	http://dx.doi.org/10.1074/jbc.M705195200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18160406	hybrid			2022-12-27	WOS:000253779600068
J	Yarwood, SJ; Borland, G; Sands, WA; Palmer, TM				Yarwood, Stephen J.; Borland, Gillian; Sands, William A.; Palmer, Timothy M.			Identification of CCAAT/enhancer-binding proteins as exchange protein activated by cAMP-activated transcription factors that mediate the induction of the SOCS-3 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; HORMONAL-REGULATION; C/EBP-ALPHA; FACTOR CREB; RAP1; EXPRESSION; PROMOTER; CELLS; PHOSPHODIESTERASES; PHOSPHORYLATION	The prototypical second messenger cAMP is a key regulator of immune and inflammatory responses. Its ability to inhibit interleukin (IL)-6 responses is due to induction of suppressor of cytokine signaling-3 (SOCS-3), a negative regulator of IL-6 receptor signaling. We have determined previously that SOCS-3 induction by cAMP occurs independently of cAMP-dependent protein kinase, instead requiring the recently identified cAMP sensor exchange protein activated by cAMP1 (EPAC1). Here we present evidence to suggest that the C/EBP family of transcription factors link EPAC1 activation to SOCS-3 induction. Firstly, selective activation of EPAC in human umbilical vein endothelial cells increased C/EBP DNA binding activity and recruitment of C/EBP beta to the SOCS-3 promoter. Secondly, knockdown of C/EBP beta and -delta isoforms abolished both SOCS-3 induction and inhibition of IL-6 signaling in response to cAMP. Thirdly, overexpression of C/EBP alpha, -beta, or -delta potentiated EPAC-mediated accumulation of SOCS-3. Finally, these effects were not restricted to human umbilical vein endothelial cells, because similar phenomena were observed in murine embryonic fibroblasts in which C/EBP beta or delta had been deleted. In summary, our findings constitute the first description of an EPAC-C/EBP pathway that can control cAMP-mediated changes in gene expression independently of protein kinase A.	[Yarwood, Stephen J.; Borland, Gillian; Sands, William A.; Palmer, Timothy M.] Univ Glasgow, Fac Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Yarwood, SJ (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	Yarwood@bio.gla.ac.uk; T.Palmer@bio.gla.ac.uk	Palmer, Timothy/C-4975-2009; Palmer, Timothy/E-7290-2013	Palmer, Timothy/0000-0002-9803-7164; Yarwood, Stephen/0000-0001-9489-9253	BBSRC [BB/D015324/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D015324/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [bb/d015324/1] Funding Source: Medline; British Heart Foundation [pg/05/026] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)		Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Brenner S, 2003, J BIOL CHEM, V278, P5597, DOI 10.1074/jbc.M207448200; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Crosson SM, 2000, J BIOL CHEM, V275, P5804, DOI 10.1074/jbc.275.8.5804; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Edelstein LC, 2003, MOL CELL BIOL, V23, P2749, DOI 10.1128/MCB.23.8.2749-2761.2003; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gronning LM, 1999, ENDOCRINOLOGY, V140, P835, DOI 10.1210/en.140.2.835; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; Houslay MD, 1998, SEMIN CELL DEV BIOL, V9, P161, DOI 10.1006/scdb.1997.0221; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kel-Margoulis OV, 2002, NUCLEIC ACIDS RES, V30, P332, DOI 10.1093/nar/30.1.332; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Pelletier N, 1998, FEBS LETT, V439, P275, DOI 10.1016/S0014-5793(98)01388-X; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Roesler WJ, 2001, ANNU REV NUTR, V21, P141, DOI 10.1146/annurev.nutr.21.1.141; Sands WA, 2006, MOL CELL BIOL, V26, P6333, DOI 10.1128/MCB.00207-06; SPIEGEL AM, 1987, MOL CELL ENDOCRINOL, V49, P1, DOI 10.1016/0303-7207(87)90058-X; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Wilson HL, 2002, MOL CELL ENDOCRINOL, V188, P15, DOI 10.1016/S0303-7207(01)00754-7; Wilson HL, 2001, MOL CELL ENDOCRINOL, V181, P27, DOI 10.1016/S0303-7207(01)00540-8; Yarwood SJ, 1998, MOL CELL ENDOCRINOL, V138, P41	33	69	69	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6843	6853		10.1074/jbc.M710342200	http://dx.doi.org/10.1074/jbc.M710342200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18195020	hybrid			2022-12-27	WOS:000253779600027
J	Kawaguchi, M; Toyama, T; Kaneko, R; Hirayama, T; Kawamura, Y; Yagi, T				Kawaguchi, Masahumi; Toyama, Tomoko; Kaneko, Ryosuke; Hirayama, Teruyoshi; Kawamura, Yoshimi; Yagi, Takeshi			Relationship between DNA methylation states and transcription of individual isoforms encoded by the protocadherin-alpha gene cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA DSCAM; PURKINJE-CELLS; CPG ISLAND; BDNF-GENE; EXPRESSION; FAMILY; DIVERSITY; PROMOTER; TISSUE; MOUSE	The protocadherin-alpha (Pcdh-alpha) gene encodes diverse transmembrane proteins that are differentially expressed in individual neurons in the vertebrate central nervous system. The Pcdh-alpha genomic structure contains variable first exons, each regulated by its own promoter. Here, we investigated the effect of DNA methylation on gene regulation in the Pcdh-alpha gene cluster. We studied two mouse cell lines, C1300 and M3, that expressed different combinations of Pcdh-alpha isoforms and found that 1) the transcription of specific Pcdh-alpha isoforms correlated significantly with the methylation state of the promoter and the 5' (but not the 3') region of the first exon and 2) mosaic or mixed methylation states of the promoters were associated with both active and inactive transcription. Demethylation of C1300 cells up-regulated all of the Pcdh-alpha isoforms, and, in a promoter assay, hypermethylation of the promoters repressed their transcriptional activity. Cell lines subcloned from the demethylated C1300 cells transcribed different combinations of Pcdh-alpha isoforms than the parental, nondemethylated cells, and the promoters showed differential mosaic or mixed methylation patterns. In vivo, the promoter and 5'-regions of the Pcdh-alpha C1 and alpha C2 exons, which are transcribed in all neurons, were extensively hypomethylated. In contrast, the promoters of the Pcdh-alpha 1 to -alpha 12 isoforms, which are transcribed differentially by individual Purkinje cells, exhibited mosaic methylation patterns. Overall, our results demonstrated that mosaic or mixed DNA methylation states in the promoter and 5'-region of the first exon may help regulate differential Pcdh-alpha transcription and that hypermethylation is sufficient to repress transcription.	[Kawaguchi, Masahumi; Kaneko, Ryosuke; Hirayama, Teruyoshi; Kawamura, Yoshimi; Yagi, Takeshi] Osaka Univ, Grad Sch Frontier Biosci, KOKORO Biol Grp, Labs Integrated Biol, Suita, Osaka 5650871, Japan; [Toyama, Tomoko] Osaka Univ, Microbial Dis Res Inst, Lab Malariol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Yagi, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, KOKORO Biol Grp, Labs Integrated Biol, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	yagi@fbs.osaka-u.ac.jp	Kawamura, Yoshimi/L-1289-2013	Kawamura, Yoshimi/0000-0002-9864-7974				Bornman DM, 2001, AM J PATHOL, V159, P831, DOI 10.1016/S0002-9440(10)61758-0; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Esumi S, 2006, NAT PROTOC, V1, P2143, DOI 10.1038/nprot.2006.343; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Imamura T, 2001, GENOMICS, V76, P117, DOI 10.1006/geno.2001.6607; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Newell-Price J, 2001, MOL ENDOCRINOL, V15, P338, DOI 10.1210/me.15.2.338; Pao MM, 2001, HUM MOL GENET, V10, P903, DOI 10.1093/hmg/10.9.903; Paulin R, 1998, NUCLEIC ACIDS RES, V26, P5009, DOI 10.1093/nar/26.21.5009; Recillas-Targa F, 2006, J CELL MOL MED, V10, P554, DOI 10.1111/j.1582-4934.2006.tb00420.x; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Sugino H, 2004, GENE, V337, P91, DOI 10.1016/j.gene.2004.04.011; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tomikawa J, 2006, J BIOL CHEM, V281, P12163, DOI 10.1074/jbc.M513782200; Waha A, 2005, NEOPLASIA, V7, P193, DOI 10.1593/neo.04490; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8	33	47	48	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12064	12075		10.1074/jbc.M709648200	http://dx.doi.org/10.1074/jbc.M709648200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18204046	hybrid			2022-12-27	WOS:000255340000022
J	Brocker, MJ; Virus, S; Ganskow, S; Heathcote, P; Heinz, DW; Schubert, WD; Jahn, D; Moser, J				Broecker, Markus J.; Virus, Simone; Ganskow, Stefanie; Heathcote, Peter; Heinz, Dirk W.; Schubert, Wolf-Dieter; Jahn, Dieter; Moser, Juergen			ATP-driven reduction by dark-operative protochlorophyllide oxidoreductase from Chlorobium tepidum mechanistically resembles nitrogenase catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; ELECTRON-TRANSFER; IRON PROTEIN; BIOSYNTHESIS; CLUSTER; IDENTIFICATION; CHLOROPHYLL; SUBSTRATE; PHOTOSYNTHESIS; MOLYBDOPTERIN	During chlorophyll and bacteriochlorophyll biosynthesis in gymnosperms, algae, and photosynthetic bacteria, dark-operative protochlorophyllide oxidoreductase (DPOR) reduces ring D of aromatic protochlorophyllide stereospecifically to produce chlorophyllide. We describe the heterologous overproduction of DPOR subunits BchN, BchB, and BchL from Chlorobium tepidum in Escherichia coli allowing their purification to apparent homogeneity. The catalytic activity was found to be 3.15 nmol min(-1)mg(-1) with K-m values of 6.1 mu M for protochlorophyllide, 13.5 mu M for ATP, and 52.7 mu M for the reductant dithionite. To identify residues important in DPOR function, 21 enzyme variants were generated by site-directed mutagenesis and investigated for their metal content, spectroscopic features, and catalytic activity. Two cysteine residues (Cys(97) and Cys(131)) of homodimeric BchL(2) are found to coordinate an intersubunit [4Fe-4S] cluster, essential for low potential electron transfer to (BchNB)(2) as part of the reduction of the protochlorophyllide substrate. Similarly, Lys(10) and Leu(126) are crucial to ATP-driven electron transfer from BchL(2). The activation energy of DPOR electron transfer is 22.2 kJ mol(-1) indicating a requirement for 4 ATP per catalytic cycle. At the amino acid level, BchL is 33% identical to the nitrogenase subunit NifH allowing a first tentative structural model to be proposed. In (BchNB)(2), we find that four cysteine residues, three from BchN (Cys(21), Cys(46), and Cys(103)) and one from BchB (Cys(94)), coordinate a second intersubunit [4Fe-4S] cluster required for catalysis. No evidence for any type of molybdenum-containing cofactor was found, indicating that the DPOR subunit BchN clearly differs from the homologous nitrogenase subunit NifD. Based on the available data we propose an enzymatic mechanism of DPOR.	[Broecker, Markus J.; Virus, Simone; Jahn, Dieter; Moser, Juergen] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Ganskow, Stefanie] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Heathcote, Peter] Queen Mary Univ London, Sch Biol Sci, London E1 4NS, England; [Heinz, Dirk W.; Schubert, Wolf-Dieter] Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany	Braunschweig University of Technology; Humboldt University of Berlin; University of London; Queen Mary University London; Helmholtz Association; Helmholtz-Center for Infection Research	Moser, J (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	j.moser@tu-bs.de	Heathcote, Peter/B-3749-2011; Schubert, Wolf-Dieter/A-5617-2009	Schubert, Wolf-Dieter/0000-0003-4998-519X; Jahn, Dieter/0000-0002-4064-9205				Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; ANDERSON GL, 1984, BIOCHEMISTRY-US, V23, P2118, DOI 10.1021/bi00305a002; Apel K, 2001, ADV PHOTOSYNTH, V11, P235; Belyaeva OB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P173, DOI 10.1023/A:1002891531118; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; BURKE DH, 1993, J BACTERIOL, V175, P2414, DOI 10.1128/JB.175.8.2414-2422.1993; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; CAMPBELL AM, 1985, P NATL ACAD SCI USA, V82, P227, DOI 10.1073/pnas.82.1.227; Dammeyer T, 2006, J BIOL CHEM, V281, P27081, DOI 10.1074/jbc.M605154200; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; Fisher K, 2006, BIOCHEMISTRY-US, V45, P4190, DOI 10.1021/bi0514109; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; Fujita Y, 1996, PLANT CELL PHYSIOL, V37, P411, DOI 10.1093/oxfordjournals.pcp.a028962; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Heinemann IU, 2007, BIOCHEM J, V402, P575, DOI 10.1042/BJ20061321; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Kim J, 2004, FEMS MICROBIOL REV, V28, P455, DOI 10.1016/j.femsre.2004.03.001; Kurnikov IV, 2001, J PHYS CHEM B, V105, P5359, DOI 10.1021/jp002540o; Lanzilotta WN, 1997, J BIOL CHEM, V272, P4157, DOI 10.1074/jbc.272.7.4157; Lanzilotta WN, 1998, BIOCHEMISTRY-US, V37, P399, DOI 10.1021/bi971681m; Layer G, 2002, J BIOL CHEM, V277, P34136, DOI 10.1074/jbc.M205247200; LI JG, 1982, BIOCHEMISTRY-US, V21, P4393, DOI 10.1021/bi00261a031; Llamas A, 2006, J BIOL CHEM, V281, P18343, DOI 10.1074/jbc.M601415200; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; MCFEETERS RF, 1971, PLANT PHYSIOL, V47, P609, DOI 10.1104/pp.47.5.609; MENSINK RE, 1992, EUR J BIOCHEM, V208, P295, DOI 10.1111/j.1432-1033.1992.tb17186.x; Moulis JM, 1996, J BIOL INORG CHEM, V1, P2, DOI 10.1007/s007750050017; Nichols J, 2002, J BIOL CHEM, V277, P24995, DOI 10.1074/jbc.M203238200; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; PETERS JW, 1995, ANNU REV MICROBIOL, V49, P335, DOI 10.1146/annurev.mi.49.100195.002003; RAJAGOPALAN KV, 1982, FED PROC, V41, P2608; Rees D. C., 2005, PHILOS T A, V363; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Reichelt J, 2005, BIOINFORMATICS, V21, P1291, DOI 10.1093/bioinformatics/bti138; RUDIGER W, 2003, PORPHYRIN HDB, V13, P71; Ryle MJ, 1996, BIOCHEMISTRY-US, V35, P4766, DOI 10.1021/bi960026w; Ryle MJ, 1996, BIOCHEMISTRY-US, V35, P9424, DOI 10.1021/bi9608572; Schmid B, 2002, BIOCHEMISTRY-US, V41, P15557, DOI 10.1021/bi026642b; Schoefs B, 2001, PHOTOSYNTH RES, V70, P257, DOI 10.1023/A:1014769707404; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shen G, 2007, J BIOL CHEM, V282, P31909, DOI 10.1074/jbc.M705554200; Simons A, 2002, BIOCHEMISTRY-US, V41, P9310, DOI 10.1021/bi0258647; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; Sun W, 2005, J CHEM SCI, V117, P317, DOI 10.1007/BF02708444; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Xiong J, 1998, P NATL ACAD SCI USA, V95, P14851, DOI 10.1073/pnas.95.25.14851; Yu SW, 1999, BIOCHEM J, V341, P755, DOI 10.1042/0264-6021:3410755	54	45	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10559	10567		10.1074/jbc.M708010200	http://dx.doi.org/10.1074/jbc.M708010200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18252716	hybrid			2022-12-27	WOS:000254894700038
J	Ogasawara, Y; Kaya, H; Hiraoka, G; Yumoto, F; Kimura, S; Kadota, Y; Hishinuma, H; Senzaki, E; Yamagoe, S; Nagata, K; Nara, M; Suzuki, K; Tanokura, M; Kuchitsu, K				Ogasawara, Yoko; Kaya, Hidetaka; Hiraoka, Goro; Yumoto, Fumiaki; Kimura, Sachie; Kadota, Yasuhiro; Hishinuma, Haruka; Senzaki, Eriko; Yamagoe, Satoshi; Nagata, Koji; Nara, Masayuki; Suzuki, Kazuo; Tanokura, Masaru; Kuchitsu, Kazuyuki			Synergistic activation of the Arabidopsis NADPH oxidase AtrbohD by Ca2+ and phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; PROTEIN PHOSPHATASE INHIBITOR; CULTURED SOYBEAN CELLS; GTP-BINDING PROTEIN; REACTIVE OXYGEN; OXIDATIVE BURST; REGULATORY MECHANISMS; ARACHIDONIC-ACID; CALCIUM-BINDING; TOBACCO CELLS	Plant respiratory burst oxidase homolog ( rboh) proteins, which are homologous to the mammalian 91-kDa glycoprotein subunit of the phagocyte oxidase ( gp91(phox)) or NADPH oxidase 2 ( NOX2), have been implicated in the production of reactive oxygen species ( ROS) both in stress responses and during development. Unlike mammalian gp91(phox)/NOX2 protein, plant rboh proteins have hydrophilic N-terminal regions containing two EF-hand motifs, suggesting that their activation is dependent on Ca2+. However, the significance of Ca2+ binding to the EF-hand motifs on ROS production has been unclear. By employing a heterologous expression system, we showed that ROS production by Arabidopsis thaliana rbohD ( AtrbohD) was induced by ionomycin, which is a Ca2+ ionophore that induces Ca2+ influx into the cell. This activation required a conformational change in the EF-hand region, as a result of Ca2+ binding to the EF-hand motifs. We also showed that AtrbohD was directly phosphorylated in vivo, and that this was enhanced by the protein phosphatase inhibitor calyculin A ( CA). Moreover, CA itself induced ROS production and dramatically enhanced the ionomycin-induced ROS production of AtrbohD. Our results suggest that Ca2+ binding and phosphorylation synergistically activate the ROS-producing enzyme activity of AtrbohD.	[Ogasawara, Yoko; Kaya, Hidetaka; Hiraoka, Goro; Kimura, Sachie; Kadota, Yasuhiro; Hishinuma, Haruka; Senzaki, Eriko; Kuchitsu, Kazuyuki] Tokyo Univ Sci, Dept Appl Biol Sci, Chiba 2788510, Japan; [Kuchitsu, Kazuyuki] Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba 2788510, Japan; [Yumoto, Fumiaki; Nagata, Koji; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Yumoto, Fumiaki] Jikei Univ, Sch Med, Dept Physiol 2, Minato Ku, Tokyo 1058461, Japan; [Yamagoe, Satoshi; Suzuki, Kazuo] Natl Inst Infect Dis, Dept Bioact Mol, Shinjuku Ku, Tokyo 1628640, Japan; [Nara, Masayuki] Tokyo Med & Dent Univ, Chem Lab, Coll Liberal Arts & Sci, Chiba 2720827, Japan	Tokyo University of Science; Tokyo University of Science; University of Tokyo; Jikei University; National Institute of Infectious Diseases (NIID); Tokyo Medical & Dental University (TMDU)	Kuchitsu, K (corresponding author), Tokyo Univ Sci, Dept Appl Biol Sci, Chiba 2788510, Japan.	kuchitsu@rs.noda.tus.ac.jp	Kadota, Yasuhiro/AAC-4545-2019; Kimura, Sachie/AAZ-4468-2020; Nara, Masayuki/L-3712-2019; Kadota, Yasuhiro/AGJ-3017-2022; Kuchitsu, Kazuyuki/G-3024-2013; Kadota, Yasuhiro/A-9406-2011	Kadota, Yasuhiro/0000-0002-4782-1418; Kimura, Sachie/0000-0001-5736-2123; Kadota, Yasuhiro/0000-0002-4782-1418; Kuchitsu, Kazuyuki/0000-0001-8854-0375; Kadota, Yasuhiro/0000-0002-4782-1418; Kaya, Hidetaka/0000-0003-4711-8236; Nagata, Koji/0000-0002-4704-0603; Tanokura, Masaru/0000-0001-5072-2480				Amicucci E, 1999, PLANT BIOLOGY, V1, P524, DOI 10.1111/j.1438-8677.1999.tb00778.x; AUH CK, 1995, PLANT PHYSIOL, V107, P1241, DOI 10.1104/pp.107.4.1241; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; CHANDRA S, 1995, P NATL ACAD SCI USA, V92, P4120, DOI 10.1073/pnas.92.10.4120; FELIX G, 1994, P NATL ACAD SCI USA, V91, P952, DOI 10.1073/pnas.91.3.952; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GRABAREK Z, 1981, J BIOL CHEM, V256, P3121; Groom QJ, 1996, PLANT J, V10, P515, DOI 10.1046/j.1365-313X.1996.10030515.x; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Jones MA, 2007, J EXP BOT, V58, P1261, DOI 10.1093/jxb/erl279; Kadota Y, 2004, PLANT CELL PHYSIOL, V45, P160, DOI 10.1093/pcp/pch020; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Kojo K, 2006, PLANT CELL PHYSIOL, V47, P1035, DOI 10.1093/pcp/pcj074; KUCHITSU K, 1995, PROTOPLASMA, V188, P138, DOI 10.1007/BF01276805; Kurusu T, 2005, PLANT J, V42, P798, DOI 10.1111/j.1365-313X.2005.02415.x; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Morel J, 2004, PLANT J, V37, P282, DOI 10.1046/j.1365-313X.2003.01957.x; Murphy TM, 1996, PLANT PHYSIOL, V110, P621, DOI 10.1104/pp.110.2.621; Nakamura A, 2000, BIOCHEMISTRY-US, V39, P3827, DOI 10.1021/bi991855v; Nara M, 2004, BIOPOLYMERS, V74, P77, DOI 10.1002/bip.20048; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; Park J, 2000, PLANT PHYSIOL, V124, P725, DOI 10.1104/pp.124.2.725; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rajasekhar VK, 1999, PLANT PHYSIOL, V120, P1137, DOI 10.1104/pp.120.4.1137; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Simon-Plas F, 2002, PLANT J, V31, P137, DOI 10.1046/j.1365-313X.2002.01342.x; Takahashi A, 1999, PLANT J, V17, P535, DOI 10.1046/j.1365-313X.1999.00405.x; TANOKURA M, 1984, J BIOCHEM-TOKYO, V95, P643, DOI 10.1093/oxfordjournals.jbchem.a134653; TAVERNIER E, 1995, PLANT PHYSIOL, V109, P1025, DOI 10.1104/pp.109.3.1025; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; VanGestelen P, 1997, PLANT PHYSIOL, V115, P543, DOI 10.1104/pp.115.2.543; WYMANN MP, 1987, ANAL BIOCHEM, V165, P371, DOI 10.1016/0003-2697(87)90284-3; Xing T, 2001, MOL PLANT MICROBE IN, V14, P1261, DOI 10.1094/MPMI.2001.14.10.1261; Ying G, 2004, CURR OPIN PLANT BIOL, V7, P527, DOI 10.1016/j.pbi.2004.07.006; Yoshioka H, 2001, MOL PLANT MICROBE IN, V14, P725, DOI 10.1094/MPMI.2001.14.6.725; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003	55	321	341	5	73	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8885	8892		10.1074/jbc.M708106200	http://dx.doi.org/10.1074/jbc.M708106200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18218618	hybrid			2022-12-27	WOS:000254465800016
J	Ravaud, S; Stjepanovic, G; Wild, K; Sinning, I				Ravaud, Stephanie; Stjepanovic, Goran; Wild, Klemens; Sinning, Irmgard			The crystal structure of the periplasmic domain of the Escherichia coli membrane protein insertase YidC contains a substrate binding cleft	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTALLOGRAPHIC STRUCTURE DETERMINATION; SOLID-STATE NMR; ENDOPLASMIC-RETICULUM; PEPTIDE DEFORMYLASE; CONDUCTING CHANNEL; BACTERIAL YIDC; NASCENT FTSQ; M13 PROCOAT; RECOGNITION; BIOGENESIS	In bacteria the biogenesis of inner membrane proteins requires targeting and insertion factors such as the signal recognition particle and the Sec translocon. YidC is an essential membrane protein involved in the insertion of inner membrane proteins together with the Sec translocon, but also as a separate entity. YidC of Escherichia coli is a member of the conserved YidC (in bacteria)/Oxa1 (in mitochondria)/Alb3 (in chloroplasts) protein family and contains six transmembrane segments and a large periplasmic domain (P1). We determined the crystal structure of the periplasmic domain of YidC from E. coli (P1D) at 1.8 A resolution. The structure of P1D shows the conserved beta-supersandwich fold of carbohydrate-binding proteins and an alpha-helical linker region at the C terminus that packs against the beta-supersandwich by a highly conserved interface. P1D exhibits an elongated cleft of similar architecture as found in the structural homologs. However, the electrostatic properties and molecular details of the cleft make it unlikely to interact with carbohydrate substrates. The cleft in P1D is occupied by a polyethylene glycol molecule suggesting an elongated peptide or acyl chain as a natural ligand. The region of P1D previously reported to interact with SecF maps to a surface area in the vicinity of the cleft. The conserved C-terminal region of the P1 domain was reported to be essential for the membrane insertase function of YidC. The analysis of this region suggests a role in membrane interaction and/or in the regulation of YidC interaction with binding partners.	[Ravaud, Stephanie; Stjepanovic, Goran; Wild, Klemens; Sinning, Irmgard] Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Sinning, I (corresponding author), Univ Heidelberg, Zentrum Biochem, Lm Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de	Stjepanovic, Goran/A-7902-2010; Sinning, Irmgard/A-2982-2010	Stjepanovic, Goran/0000-0002-4841-9949; 				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aleshin AE, 2003, J MOL BIOL, V327, P61, DOI 10.1016/S0022-2836(03)00084-6; Bechinger B, 2001, FEBS LETT, V504, P161, DOI 10.1016/S0014-5793(01)02741-7; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Becker A, 1998, J BIOL CHEM, V273, P11413, DOI 10.1074/jbc.273.19.11413; Becker A, 1998, NAT STRUCT BIOL, V5, P1053, DOI 10.1038/4162; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Chen MY, 2005, BIOCHEMISTRY-US, V44, P10741, DOI 10.1021/bi047418k; Chen MY, 2003, J BIOL CHEM, V278, P23295, DOI 10.1074/jbc.M301008200; Chen MY, 2002, BIOL CHEM, V383, P1565, DOI 10.1515/BC.2002.176; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dalbey RE, 2004, BBA-MOL CELL RES, V1694, P37, DOI 10.1016/j.bbamcr.2004.03.009; Dalbey RE, 2004, J CELL BIOL, V166, P769, DOI 10.1083/jcb.200405161; Dollins DE, 2005, J BIOL CHEM, V280, P30438, DOI 10.1074/jbc.M503761200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Froderberg L, 2004, J BIOL CHEM, V279, P31026, DOI 10.1074/jbc.M403229200; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Holm L, 1996, METHOD ENZYMOL, V266, P653; Imamura H, 2003, J BIOL CHEM, V278, P19378, DOI 10.1074/jbc.M213134200; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Jiang FL, 2002, J BIOL CHEM, V277, P19281, DOI 10.1074/jbc.M110857200; Juers DH, 1999, PROTEIN SCI, V8, P122; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kiefer D, 2007, INT REV CYTOL, V259, P113, DOI 10.1016/S0074-7969(06)59003-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Oliveira MA, 2006, J MOL BIOL, V359, P433, DOI 10.1016/j.jmb.2006.03.054; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Parlitz R, 2007, J BIOL CHEM, V282, P32176, DOI 10.1074/jbc.M705430200; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Qiu W, 2007, J BIOL CHEM, V282, P8368, DOI 10.1074/jbc.M606784200; Ravaud S, 2008, ACTA CRYSTALLOGR F, V64, P144, DOI 10.1107/S1744309108002364; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Tanaka S, 2007, ACTA CRYSTALLOGR D, V63, P1109, DOI 10.1107/S090744490704228X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urbanus ML, 2002, J BIOL CHEM, V277, P12718, DOI 10.1074/jbc.M200311200; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van Bloois E, 2007, BIOCHEM BIOPH RES CO, V362, P727, DOI 10.1016/j.bbrc.2007.08.053; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2005, CURR OPIN MICROBIOL, V8, P182, DOI 10.1016/j.mib.2005.02.004; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Velloso LM, 2002, J BIOL CHEM, V277, P15979, DOI 10.1074/jbc.M112098200; Vogt B, 2000, BIOPHYS J, V79, P2644, DOI 10.1016/S0006-3495(00)76503-9; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z; Yi L, 2005, MOL MEMBR BIOL, V22, P101, DOI 10.1080/09687860500041718; Yuan J, 2007, J BACTERIOL, V189, P8961, DOI 10.1128/JB.01365-07	74	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9350	9358		10.1074/jbc.M710493200	http://dx.doi.org/10.1074/jbc.M710493200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18234665	hybrid			2022-12-27	WOS:000254465800065
J	Theodore, M; Kawai, Y; Yang, JQ; Kleshchenko, Y; Reddy, SP; Villalta, F; Arinze, IJ				Theodore, Melanie; Kawai, Yumiko; Yang, Jianqi; Kleshchenko, Yuliya; Reddy, Sekhar P.; Villalta, Fernando; Arinze, Ifeanyi J.			Multiple nuclear localization signals function in the nuclear import of the transcription factor nrf2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE ADAPTER PROTEIN; NF-KAPPA-B; GENE-EXPRESSION; EXPORT SIGNALS; RESPONSIVE ELEMENTS; FAMILY-MEMBERS; KINASE-C; KEAP1; IDENTIFICATION; ACTIVATION	Nuclear factor erythroid 2-related factor 2 ( Nrf2) mediates the transcriptional response of cells to oxidative stress and is translocated into the nucleus following, or concomitant with, its activation by electrophiles or reactive oxygen species. The mechanism of its translocation into the nucleus is not entirely elucidated. Here we have identified two novel nuclear localization signal ( NLS) motifs in murine Nrf2, one located near the N-terminal region ( amino acid residues 42-53) and the other ( residues 587-593) located near the C-terminal region. Imaging of green fluorescent protein ( GFP)-tagged Nrf2 revealed that mutation(s) in any of these sequences resulted in decreased nuclear fluorescence intensity compared with the wild-type Nrf2 when Nrf2 activation was induced with the electrophile tert-butylhydroquinone. The mutations also impaired Nrf2-induced transactivation of antioxidant response element-driven reporter gene expression to the same extent as the Nrf2 construct bearing mutation in a previously identified bipartite NLS that maps at residues 494-511. When linked to GFP or to GFPPEPCK-C each of the novel NLS motifs was sufficient to drive nuclear translocation of the fusion proteins. Co-immunoprecipitation assays demonstrated that importins alpha 5 and beta 1 associate with Nrf2, an interaction that was blocked by the nuclear import inhibitor SN50. SN50 also blocked tert-butylhydroquinone-induced nuclear fluorescence of GFP-Nrf2 in cells transfected with wild-type GFP-Nrf2. Overall these results reveal that multiple NLS motifs in Nrf2 function in its nuclear translocation in response to pro-oxidant stimuli and that the importin alpha-beta heterodimer nuclear import receptor system plays a critical role in the import process.	[Theodore, Melanie; Kawai, Yumiko; Kleshchenko, Yuliya; Villalta, Fernando; Arinze, Ifeanyi J.] Meharry Med Coll, Sch Med, Nashville, TN 37208 USA; [Yang, Jianqi] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Reddy, Sekhar P.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth, Baltimore, MD 21205 USA	Meharry Medical College; Case Western Reserve University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Arinze, IJ (corresponding author), Meharry Med Coll, Sch Med, Nashville, TN 37208 USA.	iarinze@mmc.edu		Villalta, Fernando/0000-0002-6232-0574	NCI NIH HHS [U54 CA091408, U54 CA 91408] Funding Source: Medline; NCRR NIH HHS [U54 RR 019192-04, G12 RR003032, G12 RR 03032-19, U54 RR019192] Funding Source: Medline; NHLBI NIH HHS [HL 66109, T32 HL 007737] Funding Source: Medline; NIDDK NIH HHS [DK 07319] Funding Source: Medline; NIGMS NIH HHS [S06 GM 08037, 5R25 GM 059994] Funding Source: Medline; NINDS NIH HHS [U54 NS041071, U54 NS 041071-06] Funding Source: Medline; PHS HHS [D34 HP 00003] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA091408] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003032, U54RR019192] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737, R01HL066109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994, S06GM008037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Maqueda M, 2004, J BIOL CHEM, V279, P21929, DOI 10.1074/jbc.M400492200; Arinze IJ, 2005, J BIOL CHEM, V280, P9786, DOI 10.1074/jbc.M414006200; Arinze IJ, 2003, J BIOL CHEM, V278, P17785, DOI 10.1074/jbc.M209430200; Bedard JEJ, 2007, HUM MOL GENET, V16, P187, DOI 10.1093/hmg/ddl461; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Davis MG, 2000, BIOCHEM J, V346, P455, DOI 10.1042/0264-6021:3460455; Do HJ, 2006, FEBS LETT, V580, P1865, DOI 10.1016/j.febslet.2006.02.049; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hu W, 2005, MOL CELL BIOL, V25, P3087, DOI 10.1128/MCB.25.8.3087-3108.2005; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jones SM, 2003, J BIOL CHEM, V278, P10257, DOI 10.1074/jbc.M211021200; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Kawai Y, 2006, CANCER RES, V66, P6563, DOI 10.1158/0008-5472.CAN-06-0814; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Krauer K, 2004, J GEN VIROL, V85, P165, DOI 10.1099/vir.0.19549-0; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li J, 2002, J BIOL CHEM, V277, P388, DOI 10.1074/jbc.M109380200; Li WG, 2006, J BIOL CHEM, V281, P27251, DOI 10.1074/jbc.M602746200; Li WG, 2005, J BIOL CHEM, V280, P28430, DOI 10.1074/jbc.M410601200; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu XY, 2000, J BIOL CHEM, V275, P16774; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Maertens G, 2004, J BIOL CHEM, V279, P33421, DOI 10.1074/jbc.M404700200; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Moehlenkamp JD, 1999, ARCH BIOCHEM BIOPHYS, V363, P98, DOI 10.1006/abbi.1998.1046; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Ossareh-Nazari B, 2001, TRAFFIC, V2, P684, DOI 10.1034/j.1600-0854.2001.21002.x; PAPAIAHGARI S, 2004, ARCH BIOCHEM BIOPHYS, V363, P98; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Russo G, 1997, J BIOL CHEM, V272, P5229, DOI 10.1074/jbc.272.8.5229; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Stewart M, 2001, FEBS LETT, V498, P145, DOI 10.1016/S0014-5793(01)02489-9; Torgerson TR, 1998, J IMMUNOL, V161, P6084; VANDROMME M, 1995, P NATL ACAD SCI USA, V92, P4646, DOI 10.1073/pnas.92.10.4646; Velichkova M, 2005, MOL CELL BIOL, V25, P4501, DOI 10.1128/MCB.25.11.4501-4513.2005; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Yang JQ, 2001, J BIOL CHEM, V276, P25742, DOI 10.1074/jbc.M102821200; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	73	134	140	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8984	8994		10.1074/jbc.M709040200	http://dx.doi.org/10.1074/jbc.M709040200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18238777	Green Published, hybrid			2022-12-27	WOS:000254465800028
J	Zaffagnini, M; Michelet, L; Massot, V; Trost, P; Lemaire, SD				Zaffagnini, Mirko; Michelet, Laure; Massot, Vincent; Trost, Paolo; Lemaire, Stephane D.			Biochemical characterization of glutaredoxins from Chlamydomonas reinhardtii reveals the unique properties of a chloroplastic CGFS-type glutaredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROASCORBATE REDUCTASE-ACTIVITY; PROTEIN DISULFIDE-ISOMERASE; THIOREDOXIN REDUCTASE; ESCHERICHIA-COLI; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ARABIDOPSIS-THALIANA; POPLAR GLUTAREDOXIN; S-GLUTATHIONYLATION; REDOX-REGULATION; THIOLTRANSFERASE GLUTAREDOXIN	Glutaredoxins (GRXs) are small ubiquitous disulfide oxidoreductases known to use GSH as electron donor. In photosynthetic organisms, little is known about the biochemical properties of GRXs despite the existence of similar to 30 different isoforms in higher plants. We report here the biochemical characterization of Chlamydomonas GRX1 and GRX3, the major cytosolic and chloroplastic isoforms, respectively. Glutaredoxins are classified on the basis of the amino acid sequence of the active site. GRX1 is a typical CPYC-type GRX, which is reduced by GSH and exhibits disulfide reductase, dehydroascorbate reductase, and deglutathionylation activities. In contrast, GRX3 exhibits unique properties. This chloroplastic CGFS-type GRX is not reduced by GSH and has an atypically low redox potential ( - 323 +/- 4 mV at pH 7.9). Remarkably, GRX3 can be reduced in the light by photoreduced ferredoxin and ferredoxin-thioredoxin reductase. Both GRXs proved to be very efficient catalysts of A(4)-glyceraldehyde-3-phosphate dehydrogenase deglutathionylation, whereas cytosolic and chloroplastic thioredoxins were inefficient. Glutathionylated A(4)-glyceraldehyde-3-phosphate dehydrogenase is the first physiological substrate identified for a CGFS-type GRX.	[Zaffagnini, Mirko; Michelet, Laure; Massot, Vincent; Lemaire, Stephane D.] Univ Paris 11, CNRS, Inst Biotechnol Plantes, UMR 8618, F-91405 Orsay, France; [Zaffagnini, Mirko; Trost, Paolo] Univ Bologna, Dept Expt Evol Biol, Lab Mol Plant Physiol, I-40126 Bologna, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Bologna	Lemaire, SD (corresponding author), Univ Paris 11, CNRS, Inst Biotechnol Plantes, UMR 8618, Batiment 630, F-91405 Orsay, France.	stephane.lemaire@u-psud.fr	Trost, Paolo/F-2425-2011; Lemaire, Stéphane D/A-3530-2008	Lemaire, Stéphane D/0000-0001-6442-0547; Zaffagnini, Mirko/0000-0001-5115-0859; Trost, Paolo/0000-0002-6347-8701; Massot, Vincent/0000-0002-7858-8145				Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Cheng NH, 2006, J BIOL CHEM, V281, P26280, DOI 10.1074/jbc.M601354200; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; Cotgreave IA, 2002, METHOD ENZYMOL, V348, P175, DOI 10.1016/S0076-6879(02)48636-3; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Dixon DP, 2005, BIOCHEMISTRY-US, V44, P7696, DOI 10.1021/bi047324a; Dixon DP, 2005, PLANT PHYSIOL, V138, P2233, DOI 10.1104/pp.104.058917; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Feng YG, 2006, BIOCHEMISTRY-US, V45, P7998, DOI 10.1021/bi060444t; Fernandes AP, 2005, J BIOL CHEM, V280, P24544, DOI 10.1074/jbc.M500678200; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Gelhaye E, 2004, P NATL ACAD SCI USA, V101, P14545, DOI 10.1073/pnas.0405282101; Ghezzi P, 2005, ANTIOXID REDOX SIGN, V7, P964, DOI 10.1089/ars.2005.7.964; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; HUTCHISON RS, 1995, METHOD ENZYMOL, V252, P220; Ito H, 2003, PLANT CELL PHYSIOL, V44, P655, DOI 10.1093/pcp/pcg098; Jacquot JP, 1997, FEBS LETT, V400, P293, DOI 10.1016/S0014-5793(96)01407-X; JACQUOT JP, 1994, J MOL BIOL, V235, P1357, DOI 10.1006/jmbi.1994.1091; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; Lemaire SD, 2004, PHOTOSYNTH RES, V79, P305, DOI 10.1023/B:PRES.0000017174.60951.74; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1; Meyer Y, 2006, PHOTOSYNTH RES, V89, P179, DOI 10.1007/s11120-006-9095-3; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Molina MM, 2004, J BIOL CHEM, V279, P51923, DOI 10.1074/jbc.M410219200; Noguera-Mazon V, 2006, J BIOL CHEM, V281, P31736, DOI 10.1074/jbc.M602188200; Nulton-Persson AC, 2003, BIOCHEMISTRY-US, V42, P4235, DOI 10.1021/bi027370f; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; RAVICHANDRAN V, 1994, J BIOL CHEM, V269, P25010; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2003, ANTIOXID REDOX SIGN, V5, P15, DOI 10.1089/152308603321223504; Rouhier N, 2002, FEBS LETT, V511, P145, DOI 10.1016/S0014-5793(01)03302-6; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Schurmann P, 2002, METHOD ENZYMOL, V347, P403; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Sparla F, 2005, PLANT PHYSIOL, V138, P2210, DOI 10.1104/pp.105.062117; STEIN M, 1995, PLANT MOL BIOL, V28, P487, DOI 10.1007/BF00020396; Tamarit J, 2003, J BIOL CHEM, V278, P25745, DOI 10.1074/jbc.M303477200; VlamisGardikas A, 1997, J BIOL CHEM, V272, P11236; Washburn MP, 1999, BIOCHEMISTRY-US, V38, P268, DOI 10.1021/bi980480v; WELLS WW, 1990, J BIOL CHEM, V265, P15361; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x	50	107	107	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8868	8876		10.1074/jbc.M709567200	http://dx.doi.org/10.1074/jbc.M709567200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18216016	hybrid			2022-12-27	WOS:000254465800014
J	Gurel, Z; Ronni, T; Ho, S; Kuchar, J; Payne, KJ; Turk, CW; Dovat, S				Gurel, Zafer; Ronni, Tapani; Ho, Sam; Kuchar, Jason; Payne, Kimberly J.; Turk, Christoph W.; Dovat, Sinisa			Recruitment of Ikaros to pericentromeric heterochromatin is regulated by phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-II; DNA-BINDING PROTEINS; TERMINAL TRANSFERASE GENE; TRANSCRIPTION FACTOR; CENTROMERIC HETEROCHROMATIN; SILENT CHROMATIN; CELLS; LYMPHOCYTES; EXPRESSION; COMPLEXES	Ikaros encodes a zinc finger protein that is involved in heritable gene silencing. In hematopoietic cells, Ikaros localizes to pericentromeric heterochromatin (PC-HC) where it recruits its target genes, resulting in their activation or repression via chromatin remodeling. The function of Ikaros is controlled by post-translational modifications. CK2 kinase has been shown to phosphorylate Ikaros at its C terminus, affecting cell cycle progression. Using in vivo labeling of murine thymocytes followed by phosphopeptide mapping, we identified four novel Ikaros phosphorylation sites. Functional analysis of phosphomimetic mutants showed that the phosphorylation of individual amino acids determines the affinity of Ikaros toward probes derived from PC-HC. In vivo experiments demonstrated that targeting of Ikaros to PC-HC is regulated by phosphorylation. The ability of Ikaros to bind the upstream regulatory elements of its known target gene terminal deoxynucleotidyltransferase (TdT) was decreased by phosphorylation of two amino acids. In thymocytes, Ikaros acts as a repressor of the TdT gene. Induction of differentiation of thymocytes with phorbol 12-myristate 13-acetate plus ionomycin results in transcriptional repression of TdT expression. This process has been associated with increased binding of Ikaros to the upstream regulatory element of TdT. Phosphopeptide analysis of in vivo-labeled thymocytes revealed that Ikaros undergoes dephosphorylation during induction of thymocyte differentiation and that dephosphorylation is responsible for increased DNA binding affinity of Ikaros toward the TdT promoter. We propose a model whereby reversible phosphorylation of Ikaros at specific amino acids controls the subcellular localization of Ikaros as well as its ability to regulate TdT expression during thymocyte differentiation.	[Gurel, Zafer; Ronni, Tapani; Ho, Sam; Dovat, Sinisa] Univ Wisconsin, Dept Pediat, Div Pediat Hematol Oncol, Madison, WI 53792 USA; [Kuchar, Jason] Michigan State Univ, E Lansing, MI 48824 USA; [Turk, Christoph W.] Proteom & Biomarkers Max Planck Inst Psychiat, D-80804 Munich, Germany; [Payne, Kimberly J.] Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Payne, Kimberly J.] Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA	University of Wisconsin System; University of Wisconsin Madison; Michigan State University; Max Planck Society; Loma Linda University; Loma Linda University	Dovat, S (corresponding author), Univ Wisconsin, Dept Pediat, Div Pediat Hematol Oncol, 600 Highland Ave,H4-431 CSC, Madison, WI 53792 USA.	dovat@pediatrics.wisc.edu	Gurel, Zafer/AAF-3072-2021; Payne, Kimberly/AAS-6814-2020	Payne, Kimberly/0000-0002-7025-5821; Dovat, Sinisa/0000-0003-3906-6165	NATIONAL CANCER INSTITUTE [K22CA111392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK066163] Funding Source: NIH RePORTER; NCI NIH HHS [K22 CA 111392] Funding Source: Medline; NIDDK NIH HHS [5 K01 DK 066163] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; CARROLL D, 1988, COLD SPRING HARB SYM, V53, P91, DOI 10.1101/SQB.1988.053.01.014; Channavajhala P, 2002, ONCOGENE, V21, P5280, DOI 10.1038/sj.onc.1205640; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Dovat S, 2002, GENE DEV, V16, P2985, DOI 10.1101/gad.1040502; Dovat S, 2005, J IMMUNOL, V175, P3508, DOI 10.4049/jimmunol.175.6.3508; Dumortier A, 2003, BLOOD, V101, P2219, DOI 10.1182/blood-2002-05-1336; Ernst P, 1996, MOL CELL BIOL, V16, P6121; ERNST P, 1993, MOL CELL BIOL, V13, P2982, DOI 10.1128/MCB.13.5.2982; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; GROVES T, 1995, J IMMUNOL, V154, P5011; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; HILL BL, 1988, J BIOL CHEM, V263, P5499; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Liberg D, 2003, TRENDS IMMUNOL, V24, P567, DOI 10.1016/j.it.2003.09.008; MARIN O, 1992, FEBS LETT, V301, P111, DOI 10.1016/0014-5793(92)80221-2; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; O'Neill DW, 2000, MOL CELL BIOL, V20, P7572, DOI 10.1128/MCB.20.20.7572-7582.2000; Rifkin IR, 1998, J IMMUNOL, V161, P5164; Ronni T, 2007, J BIOL CHEM, V282, P2538, DOI 10.1074/jbc.M605627200; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Su RC, 2005, SEMIN IMMUNOL, V17, P129, DOI 10.1016/j.smim.2005.01.003; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; WALTON GM, 1985, J BIOL CHEM, V260, P4745; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Wojcik H, 2007, EUR J IMMUNOL, V37, P1022, DOI 10.1002/eji.200637026; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yu SJ, 2002, MOL ENDOCRINOL, V16, P1069, DOI 10.1210/me.16.5.1069	47	45	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8291	8300		10.1074/jbc.M707906200	http://dx.doi.org/10.1074/jbc.M707906200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18223295	Green Published, hybrid			2022-12-27	WOS:000254288000027
J	Koida, N; Ozaki, T; Yamamoto, H; Ono, S; Koda, T; Ando, K; Okoshi, R; Kamijo, T; Omura, K; Nakagawara, A				Koida, Nami; Ozaki, Toshinori; Yamamoto, Hideki; Ono, Sayaka; Koda, Tadayuki; Ando, Kiyohiro; Okoshi, Rintaro; Kamijo, Takehiko; Omura, Ken; Nakagawara, Akira			Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE-KINASE; P53 FAMILY-MEMBER; C-ABL; P73; EXPRESSION; PROTEIN; ACTIVATION; P73-ALPHA; TARGET; DOMAIN	In response to DNA damage, p73 plays a critical role in cell fate determination. In this study, we have found that Plk1 (pololike kinase 1) associates with p73, phosphorylates p73 at Thr-27, and thereby inhibits its pro-apoptotic activity. During cisplatin-mediated apoptosis in COS7 cells in which the endogenous p53 is inactivated by SV40 large T antigen, p73 was induced to accumulate in association with a significant down-regulation of Plk1. Consistent with these observations, Plk1 reduced the stability of the endogenous p73. Immunoprecipitation and in vitro pulldown assay demonstrated that p73 binds to the kinase domain of Plk1 through its NH2-terminal region. Luciferase reporter assay and reverse transcription-PCR analysis revealed that Plk1 is able to block the p73-mediated transcriptional activation. Of note, kinase-deficient Plk1 mutant (Plk1(K82M)) retained an ability to interact with p73; however, it failed to inactivate the p73-mediated transcriptional activation, suggesting that kinase activity of Plk1 is required for the inhibition of p73. Indeed, in vitro kinase assay indicated that p73 is phosphorylated at Thr-27 by Plk1. Furthermore, small interference RNA-mediated knockdown of the endogenous Plk1 in p53-deficient H1299 cells resulted in a significant increase in the number of cells with sub-G(1) DNA content accompanied by the up-regulation of p73 and pro-apoptotic p53(AIP1) as well as the proteolytic cleavage of poly(ADP-ribose) polymerase. Thus, our present results suggest that Plk1-mediated dysfunction of p73 is one of the novel molecular mechanisms to inhibit the p53-independent apoptosis, and the inhibition of Plk1 might provide an attractive therapeutic strategy for cancer treatment.	[Koida, Nami; Ozaki, Toshinori; Yamamoto, Hideki; Ando, Kiyohiro; Okoshi, Rintaro; Kamijo, Takehiko; Nakagawara, Akira] Chiba Canc Res Inst, Div Biochem, Chiba 2608717, Japan; [Koida, Nami; Omura, Ken] Tokyo Med & Dent Univ, Dept Oral & Maxillofacial Surg, Tokyo 1138549, Japan; [Ono, Sayaka; Koda, Tadayuki] Hisamitsu Pharmaceut Co Inc, Ctr Funct Genom, Chiba 2608717, Japan	Chiba Cancer Center; Tokyo Medical & Dental University (TMDU); Hisamitsu Pharmaceutical Co Ltd	Nakagawara, A (corresponding author), Chiba Canc Res Inst, Div Biochem, Chiba 2608717, Japan.	akiranak@chiba-cc.jp						Agami R, 1999, NATURE, V399, P809; Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Chen J, 2006, FEBS LETT, V580, P3624, DOI 10.1016/j.febslet.2006.05.047; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Gaiddon C, 2003, J BIOL CHEM, V278, P27421, DOI 10.1074/jbc.M300251200; Gong JG, 1999, NATURE, V399, P806; Gonzalez S, 2003, MOL CELL BIOL, V23, P8161, DOI 10.1128/MCB.23.22.8161-8171.2003; Hosoda M, 2005, ONCOGENE, V24, P7156, DOI 10.1038/sj.onc.1208872; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Knecht R, 1999, CANCER RES, V59, P2794; Knecht R, 2000, INT J CANCER, V89, P535; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Liu YS, 2005, CHEM BIOL, V12, P99, DOI 10.1016/j.chembiol.2004.11.009; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Munarriz E, 2005, BIOCHEM BIOPH RES CO, V333, P954, DOI 10.1016/j.bbrc.2005.05.188; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Niizuma H, 2006, ONCOGENE, V25, P5046, DOI 10.1038/sj.onc.1209515; Ozaki T, 2005, CANCER SCI, V96, P729, DOI 10.1111/j.1349-7006.2005.00116.x; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Spankuch-Schmitt B, 2002, ONCOGENE, V21, P3162, DOI 10.1038/sj.onc.1205412; Stiewe T, 2002, CANCER RES, V62, P3598; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Tanaka Y, 2004, BIOCHEM BIOPH RES CO, V317, P865, DOI 10.1016/j.bbrc.2004.03.124; van Vugt MATM, 2001, J BIOL CHEM, V276, P41656, DOI 10.1074/jbc.M101831200; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zeng XY, 2000, MOL CELL BIOL, V20, P1299, DOI 10.1128/MCB.20.4.1299-1310.2000; Zeng XY, 1999, MOL CELL BIOL, V19, P3257	39	47	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8555	8563		10.1074/jbc.M710608200	http://dx.doi.org/10.1074/jbc.M710608200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18174154	hybrid, Green Published			2022-12-27	WOS:000254288000054
J	Aherrahrou, Z; Doehring, LC; Ehlers, EM; Liptau, H; Depping, R; Linsel-Nitschke, P; Kaczmarek, PM; Erdmann, J; Schunkert, H				Aherrahrou, Zouhair; Doehring, Lars C.; Ehlers, Eva-Maria; Liptau, Henrike; Depping, Reinhard; Linsel-Nitschke, Patrick; Kaczmarek, Piotr M.; Erdmann, Jeanette; Schunkert, Heribert			An alternative splice variant in Abcc6, the gene causing dystrophic calcification, leads to protein deficiency in C3H/He mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-CELL NECROSIS; PSEUDOXANTHOMA ELASTICUM; CARDIAC CALCINOSIS; CHROMOSOME 16P13.1; DBA/2 MICE; LOCUS; HYDROCORTISONE; TRANSPORTER; MUTATIONS; TISSUES	Dystrophic cardiac calcification (DCC) is an autosomal recessive trait characterized by calcium phosphate deposits in myocardial tissue. The Abcc6 gene locus was recently found to mediate DCC; however, at the molecular level the causative variants remain to be determined. Examining the sequences of Abcc6 cDNA in DCC-resistant C57BL/6 and DCC-susceptible C3H/He mice, we identified a missense mutation (Cys to Thr at codon 619, rs32756904) at the 3'-border of exon 14 that creates an additional donor splice site (GT). Accordingly, an alternative transcript variant was detected, lacking the last 5 bp of exon 14 (-AGG(C/T) GCTgtga-) in DCC-susceptible C3H/He mice that carry the Thr allele. The 5-bp deletion was found to result in premature termination at codon 684, in turn leading to protein deficiency in DCC-susceptible mouse tissue as well as in cells transfected with Abcc6c DNA lacking the last 5 bp of exon 14. All mouse strains that were found to carry the Thr allele, including C3H/He, DBA/2J, and 129S1/SvJ, were also found to be positive for DCC. In summary, we identified a splice variant leading to a 5-bp deletion in the Abcc6 transcript that gives rise to protein deficiency both in vivo and in vitro. The fact that all mouse strains that carry the deletion also develop dystrophic calcifications further suggests that the underlying splice variant affects the biological function of MRP6 protein and is a cause of DCC in mice.	[Aherrahrou, Zouhair; Doehring, Lars C.; Ehlers, Eva-Maria; Liptau, Henrike; Linsel-Nitschke, Patrick; Kaczmarek, Piotr M.; Erdmann, Jeanette; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, Dept Med 2, D-23538 Lubeck, Germany; [Depping, Reinhard] Med Univ Lubeck, Inst Physiol, D-23538 Lubeck, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Lubeck	Aherrahrou, Z (corresponding author), Med Univ Lubeck, Med Klin 2, Dept Med 2, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	Zouhair.Aherrahrou@uk-sh.de	Depping, Reinhard RD/B-6880-2018; Depping, Reinhard/AAT-3612-2020; Erdmann, Jeanette/A-4417-2009; Erdmann, Jeanette/P-7513-2014	Depping, Reinhard/0000-0002-4860-6058; Erdmann, Jeanette/0000-0002-4486-6231; Aherrahrou, Zouhair/0000-0002-1241-8733				Aherrahrou Z, 2004, AM J PATHOL, V164, P1379, DOI 10.1016/S0002-9440(10)63224-5; Aherrahrou Z, 2007, PHYSIOL GENOMICS, V28, P203, DOI 10.1152/physiolgenomics.00133.2006; Beck K, 2003, J HISTOCHEM CYTOCHEM, V51, P887, DOI 10.1177/002215540305100704; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Brunnert SR, 1999, GENOMICS, V59, P105, DOI 10.1006/geno.1999.5862; Cai L, 2000, J MOL MED-JMM, V78, P36, DOI 10.1007/s001090000079; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Doehring LC, 2006, ANN ANAT, V188, P235, DOI 10.1016/j.aanat.2006.01.013; EATON GJ, 1978, AM J PATHOL, V90, P173; EVERITT JI, 1988, LAB ANIM SCI, V38, P426; GANG DL, 1986, AM J PATHOL, V124, P207; Gorgels TGMF, 2005, HUM MOL GENET, V14, P1763, DOI 10.1093/hmg/ddi183; Hendig D, 2005, J MOL MED, V83, P140, DOI 10.1007/s00109-004-0588-2; HIGHMAN B, 1965, ARCH PATHOL, V52, P221; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Ivandic BT, 2001, PHYSIOL GENOMICS, V6, P137, DOI 10.1152/physiolgenomics.2001.6.3.137; Ivandic BT, 1996, P NATL ACAD SCI USA, V93, P5483, DOI 10.1073/pnas.93.11.5483; Klement JF, 2005, MOL CELL BIOL, V25, P8299, DOI 10.1128/MCB.25.18.8299-8310.2005; LOSTROH A, 1955, NATURE, V176, P504, DOI 10.1038/176504a0; Matsuzaki Y, 2005, J INVEST DERMATOL, V125, P900, DOI 10.1111/j.0022-202X.2005.23897.x; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; PRICE P, 1991, AM J PATHOL, V138, P59; SPARKS LL, 1955, NATURE, V176, P503, DOI 10.1038/176503a0; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; vanSoest S, 1997, GENOME RES, V7, P830, DOI 10.1101/gr.7.8.830; VANVLEET JF, 1987, AM J VET RES, V48, P255	26	51	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7608	7615		10.1074/jbc.M708290200	http://dx.doi.org/10.1074/jbc.M708290200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18201967	hybrid			2022-12-27	WOS:000253997900036
J	Hess, D; Keusch, JJ; Oberstein, SAL; Hennekam, RCM; Hofsteenge, J				Hess, Daniel; Keusch, Jeremy J.; Oberstein, Saskia A. Lesnik; Hennekam, Raoul C. M.; Hofsteenge, Jan			Peters plus syndrome is a new congenital disorder of glycosylation and involves defective O-glycosylation of thrombospondin type 1 repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; C-MANNOSYLATION; FUCOSYLATION; PROTEIN; GLYCOSYLTRANSFERASE; PROPERDIN; FRINGE; IDENTIFICATION; MODULATION; SECRETION	Peters Plus syndrome is an autosomal recessive disorder characterized by anterior eye chamber defects, disproportionate short stature, developmental delay, and cleft lip and/ or palate. It is caused by splice site mutations in what was thought to be a beta 1,3-galactosyltransferase-like gene ( B3GALTL). Recently, we and others found this gene to encode a beta 1,3-glucosyltransferase involved in the synthesis of the disaccharide Glc-beta 1,3-Fuc-O-that occurs on thrombospondin type 1 repeats of many biologically important proteins. No functional tests have been performed to date on the presumed glycosylation defect in Peters Plus syndrome. We have established a sensitive immunopurification-mass spectrometry method, using multiple reaction monitoring, to analyze O-fucosyl glycans. It was used to compare the reporter protein properdin from Peters Plus patients with that from control heterozygous relatives. In properdin from patients, we could not detect the Glc-beta 1,3-Fuc-O-disaccharide, and we only found Fuc-O- at all four O-fucosylation sites. In contrast, properdin from heterozygous relatives and a healthy volunteer carried the Glc-beta 1,3-Fuc-O-disaccharide. These data firmly establish Peters Plus syndrome as a new congenital disorder of glycosylation.	[Hess, Daniel; Keusch, Jeremy J.; Hofsteenge, Jan] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Oberstein, Saskia A. Lesnik] Leiden Univ, Med Ctr, Dept Clin Genet, Ctr Human Clin Genet, NL-2300 RC Leiden, Netherlands; [Hennekam, Raoul C. M.] Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 3JH, England	Friedrich Miescher Institute for Biomedical Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London	Hofsteenge, J (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeer Str 66, CH-4058 Basel, Switzerland.	jan.hofsteenge@fmi.ch	Oberstein, Saskia A.J. Lesnik/C-3643-2016	Oberstein, Saskia A.J. Lesnik/0000-0002-1268-8995				CANEVASCINI S, 2006, EUROPEAN WORM MEETIN, P71; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; DEBUY WPL, 2002, ANN GENET, V45, P97; Fijen CAP, 1999, MOL IMMUNOL, V36, P863, DOI 10.1016/S0161-5890(99)00107-8; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Hartmann S, 2000, J BIOL CHEM, V275, P28569, DOI 10.1074/jbc.M001732200; Heinonen TYK, 2003, BIOCHEM BIOPH RES CO, V309, P166, DOI 10.1016/S0006-291X(03)01540-7; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003; Hulsmeier AJ, 2007, MOL CELL PROTEOMICS, V6, P2132, DOI 10.1074/mcp.M700361-MCP200; Jaeken J, 2001, ANNU REV GENOM HUM G, V2, P129, DOI 10.1146/annurev.genom.2.1.129; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Krieg J, 1998, MOL BIOL CELL, V9, P301, DOI 10.1091/mbc.9.2.301; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Macek B, 2001, RAPID COMMUN MASS SP, V15, P771, DOI 10.1002/rcm.298; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; NOLAN KF, 1993, METHOD ENZYMOL, V223, P35; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; Unwin RD, 2006, TRENDS BIOCHEM SCI, V31, P473, DOI 10.1016/j.tibs.2006.06.003; Wada Y, 2006, J CHROMATOGR B, V838, P3, DOI 10.1016/j.jchromb.2006.02.028; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	30	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7354	7360		10.1074/jbc.M710251200	http://dx.doi.org/10.1074/jbc.M710251200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18199743	hybrid			2022-12-27	WOS:000253997900009
J	Husain, M; Bourret, TJ; McCollister, BD; Jones-Carson, J; Laughlin, J; Vazquez-Torres, A				Husain, Maroof; Bourret, Travis J.; McCollister, Bruce D.; Jones-Carson, Jessica; Laughlin, James; Vazquez-Torres, Andres			Nitric oxide evokes an adaptive response to oxidative stress by arresting respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D TERMINAL OXIDASE; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; SALMONELLA-TYPHIMURIUM; ACTIVATED MACROPHAGES; TRANSCRIPTION FACTOR; REACTIVE OXYGEN; FENTON-REACTION; DNA-DAMAGE; PEROXYNITRITE	Aerobic metabolism generates biologically challenging reactive oxygen species (ROS) by the endogenous autooxidation of components of the electron transport chain (ETC). Basal levels of oxidative stress can dramatically rise upon activation of the NADPH oxidase-dependent respiratory burst. To minimize ROS toxicity, prokaryotic and eukaryotic organisms express a battery of low-molecular-weight thiol scavengers, a legion of detoxifying catalases, peroxidases, and superoxide dismutases, as well as a variety of repair systems. We present herein blockage of bacterial respiration as a novel strategy that helps the intracellular pathogen Salmonella survive extreme oxidative stress conditions. A Salmonella strain bearing mutations in complex I NADH dehydrogenases is refractory to the early NADPH oxidase-dependent antimicrobial activity of IFN gamma-activated macrophages. The ability of NADH-rich, complex I-deficient Salmonella to survive oxidative stress is associated with resistance to peroxynitrite (ONOO-) and hydrogen peroxide (H2O2). Inhibition of respiration with nitric oxide (NO) also triggered a protective adaptive response against oxidative stress. Expression of the NDH-II dehydrogenase decreases NADH levels, thereby abrogating resistance of NO-adapted Salmonella to H2O2. NADH antagonizes the hydroxyl radical (OH center dot) generated in classical Fenton chemistry or spontaneous decomposition of peroxynitrous acid (ONOOH), while fueling AhpCF alkylhydroperoxidase. Together, these findings identify the accumulation of NADH following the NO-mediated inhibition of Salmonella's ETC as a novel antioxidant strategy. NO-dependent respiratory arrest may help mitochondria and a plethora of organisms cope with oxidative stress engendered in situations as diverse as aerobic respiration, ischemia reperfusion, and inflammation.	[Husain, Maroof; Bourret, Travis J.; McCollister, Bruce D.; Jones-Carson, Jessica; Laughlin, James; Vazquez-Torres, Andres] UCHSC Sch Med Fitzsimons, Dept Microbiol, Aurora, CO 80045 USA; [McCollister, Bruce D.; Jones-Carson, Jessica; Vazquez-Torres, Andres] UCHSC Fitzsimons, Dept Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Vazquez-Torres, A (corresponding author), UCHSC Sch Med Fitzsimons, Dept Microbiol, Mail Box 8333,POB 6511,Rm P18-9120, Aurora, CO 80045 USA.	andres.vazquez-torres@uchsc.edu	Bourret, Travis/J-4673-2019	Bourret, Travis/0000-0002-4154-929X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054959, R01AI054959] Funding Source: NIH RePORTER; NIAID NIH HHS [AI54959] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Almeida A, 2001, J NEUROCHEM, V77, P676, DOI 10.1046/j.1471-4159.2001.00276.x; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Bang IS, 2006, J BIOL CHEM, V281, P28039, DOI 10.1074/jbc.M605174200; Barreto Jose C., 1995, Life Sciences, V56, pPL89; Beltran B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602; Brunelli L, 2001, FREE RADICAL BIO MED, V30, P709, DOI 10.1016/S0891-5849(00)00512-8; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Butler CS, 1997, BIOCHEMISTRY-US, V36, P16259, DOI 10.1021/bi971481a; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; CASTRO L, 1994, J BIOL CHEM, V269, P29409; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Freeman JA, 2002, J BACTERIOL, V184, P4971, DOI 10.1128/JB.184.18.4971-4980.2002; GEORGIOU CD, 1988, J BACTERIOL, V170, P961, DOI 10.1128/jb.170.2.961-966.1988; Goldstein S, 2000, CHEM RES TOXICOL, V13, P736, DOI 10.1021/tx000099n; Gorbunov NV, 1997, J BIOL CHEM, V272, P12328, DOI 10.1074/jbc.272.19.12328; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; HIDALGO E, 1994, EMBO J, V13, P138, DOI 10.1002/j.1460-2075.1994.tb06243.x; Hori H, 1996, J BIOL CHEM, V271, P9254, DOI 10.1074/jbc.271.16.9254; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; JOHNSON G, 1991, CRIT CARE MED, V19, P244, DOI 10.1097/00003246-199102000-00021; Jonsson TJ, 2007, BIOCHEMISTRY-US, V46, P5709, DOI 10.1021/bi7001218; Joshi MS, 1999, FREE RADICAL BIO MED, V27, P1357, DOI 10.1016/S0891-5849(99)00179-3; Jung IL, 2003, BIOCHEM BIOPH RES CO, V301, P915, DOI 10.1016/S0006-291X(03)00064-0; Keyer K, 1997, J BIOL CHEM, V272, P27652, DOI 10.1074/jbc.272.44.27652; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; Lu CY, 2005, J BIOL INORG CHEM, V10, P732, DOI 10.1007/s00775-005-0019-z; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; McCollister BD, 2005, J EXP MED, V202, P625, DOI 10.1084/jem.20050246; MILLER MJ, 1986, METHOD ENZYMOL, V126, P87; NUNOSHIBA T, 1993, P NATL ACAD SCI USA, V90, P9993, DOI 10.1073/pnas.90.21.9993; PACELLI R, 1995, J EXP MED, V182, P1469, DOI 10.1084/jem.182.5.1469; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; RADI R, 1993, BIOCHEM J, V290, P51, DOI 10.1042/bj2900051; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; SCHWEIZER M, 1994, BIOCHEM BIOPH RES CO, V204, P169, DOI 10.1006/bbrc.1994.2441; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Trimmer BA, 2001, SCIENCE, V292, P2486, DOI 10.1126/science.1059833; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Yu XJ, 2002, CELL MICROBIOL, V4, P531, DOI 10.1046/j.1462-5822.2002.00211.x	54	69	73	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7682	7689		10.1074/jbc.M708845200	http://dx.doi.org/10.1074/jbc.M708845200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18198179	hybrid			2022-12-27	WOS:000253997900044
J	Paris, S; Burlacu, A; Durocher, Y				Paris, Sebastien; Burlacu, Alina; Durocher, Yves			Opposing roles of syndecan-1 and syndecan-2 in polyethyleneimine-mediated gene delivery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; TRANSIENT TRANSFECTION; CYTOPLASMIC DOMAIN; MAMMALIAN-CELLS; CORE PROTEIN; PDZ PROTEIN; PROTEOGLYCANS; MEMBRANE; EXPRESSION; BINDS	Polyethyleneimines (PEIs) are efficient non-viral vectors for gene transfer. Heparan sulfate proteoglycans have been proposed to be the cell-surface receptors for PEI.DNA complexes (polyplexes). Here, we investigated if syndecan-1 (SDC1) and syndecan-2 (SDC2) are involved in PEI-mediated transfection. Following addition of polyplexes to HEK293 cells, green fluorescent protein-tagged SDCs rapidly formed clusters with PEI that were dependent of lipid raft integrity. However, although SDC1 overexpression slightly enhanced PEI-mediated gene expression, SDC2 dramatically inhibited it. Confocal microscopy analysis showed that SDC1.polyplex endocytosis occurred within minutes after addition of polyplexes, whereas SDC2.polyplex endocytosis took hours. Expression of SDC1 cytoplasmic deletion mutants revealed that the SDC1 cytoplasmic tail is required for gene expression, but not for clustering or endocytosis, whereas overexpression of SDC1/SDC2 chimeras showed that the SDC2 ectodomain is responsible for the inhibitory effect on gene transfer. This study provides evidence that SDCs may have opposing effects on PEI-mediated transfection.	[Paris, Sebastien; Burlacu, Alina; Durocher, Yves] Natl Res Council Canada, Biotechnol Res Inst, Bioproc Sector, Biotechnol Res Inst,Anim Cell Technol Grp, Montreal, PQ H4P 2R2, Canada	National Research Council Canada	Durocher, Y (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, Bioproc Sector, Biotechnol Res Inst,Anim Cell Technol Grp, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	yves.durocher@cnrc-nrc.gc.ca	Durocher, Yves/K-8709-2019					Almeida PFF, 2005, BBA-BIOMEMBRANES, V1720, P1, DOI 10.1016/j.bbamem.2005.12.004; Belting M, 1999, BIOCHEM J, V342, P281, DOI 10.1042/0264-6021:3420281; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Boussif O, 1996, GENE THER, V3, P1074; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; Carey DJ, 1996, J BIOL CHEM, V271, P15253, DOI 10.1074/jbc.271.25.15253; CAREY DJ, 1994, EXP CELL RES, V214, P12, DOI 10.1006/excr.1994.1228; Carey DJ, 1997, BIOCHEM J, V327, P1; Carpentier E, 2007, J BIOTECHNOL, V128, P268, DOI 10.1016/j.jbiotec.2006.10.014; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Demeneix B, 2005, ADV GENET, V53, P217, DOI 10.1016/S0065-2660(05)53008-6; Derouazi M, 2004, BIOTECHNOL BIOENG, V87, P537, DOI 10.1002/bit.20161; Dull RO, 2003, AM J PHYSIOL-LUNG C, V285, pL986, DOI 10.1152/ajplung.00022.2003; Durocher Y, 2001, RECOMBINANT PROTEIN PRODUCTION WITH PROKARYOTIC AND EUKARYOTIC CELLS: A COMPARATIVE VIEW ON HOST PHYSIOLOGY, P331; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Ethell IM, 2000, J CELL BIOL, V151, P53, DOI 10.1083/jcb.151.1.53; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Gautam A, 2001, MOL THER, V3, P551, DOI 10.1006/mthe.2001.0300; Goula D, 1998, GENE THER, V5, P1291, DOI 10.1038/sj.gt.3300717; Goula D, 1998, GENE THER, V5, P712, DOI 10.1038/sj.gt.3300635; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Grosse S, 2006, J GENE MED, V8, P845, DOI 10.1002/jgm.915; Grzelinski M, 2006, HUM GENE THER, V17, P751, DOI 10.1089/hum.2006.17.751; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kircheis R, 1999, J GENE MED, V1, P111; Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Mounkes LC, 1998, J BIOL CHEM, V273, P26164, DOI 10.1074/jbc.273.40.26164; NUMA F, 1995, CANCER RES, V55, P4676; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Pham PL, 2006, MOL BIOTECHNOL, V34, P225, DOI 10.1385/MB:34:2:225; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Rapraeger AC, 1998, CURR OPIN CELL BIOL, V10, P620, DOI 10.1016/S0955-0674(98)80038-0; Shi CH, 2005, BIOCHEMISTRY-US, V44, P15705, DOI 10.1021/bi051292p; Tang GP, 2006, J GENE MED, V8, P736, DOI 10.1002/jgm.874; Thomas M, 2005, PHARM RES-DORDR, V22, P373, DOI 10.1007/s11095-004-1874-y; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Woods A, 1998, MATRIX BIOL, V17, P477, DOI 10.1016/S0945-053X(98)90095-6; Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	51	54	61	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7697	7704		10.1074/jbc.M705424200	http://dx.doi.org/10.1074/jbc.M705424200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18216019	hybrid			2022-12-27	WOS:000253997900046
J	Thakur, M; Chaba, R; Mondal, AK; Chakraborti, PK				Thakur, Meghna; Chaba, Rachna; Mondal, Alok K.; Chakraborti, Pradip K.			Interdomain interaction reconstitutes the functionality of PknA, a eukaryotic type Ser/Thr kinase from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PROTEIN-KINASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; HISTIDINE KINASE; TYROSINE KINASE; ACTIVATION; PHOSPHORYLATION; AUTOPHOSPHORYLATION; DOMAIN; MECHANISM	Eukaryotic type Ser/Thr protein kinases have recently been shown to regulate a variety of cellular functions in bacteria. PknA, a transmembrane Ser/Thr protein kinase from Mycobacterium tuberculosis, when constitutively expressed in Escherichia coli resulted in cell elongation and therefore has been thought to be regulating morphological changes associated with cell division. Bioinformatic analysis revealed that PknA has N-terminal catalytic, juxtamembrane, transmembrane, and C-terminal extracellular domains, like known eukaryotic type Ser/Thr protein kinases from other bacteria. To identify the minimum region capable of exhibiting phosphorylation activity of PknA, we created several deletion mutants. Surprisingly, we found that the catalytic domain itself was not sufficient for exhibiting phosphorylation ability of PknA. However, the juxtamembrane region together with the kinase domain was necessary for the enzymatic activity and thus constitutes the catalytic core of PknA. Utilizing this core, we deduce that the autophosphorylation of PknA is an intermolecular event. Interestingly, the core itself was unable to restore the cell elongation phenotype as manifested by the full-length protein in E. coli; however, its co-expression along with the C-terminal region of PknA can associate them in trans to reconstitute a functional protein in vivo. Therefore, these findings argue that the transmembrane and extracellular domains of PknA, although dispensable for phosphorylation activities, are crucial in responding to signals. Thus, our results for the first time establish the significance of different domains in a bacterial eukaryotic type Ser/Thr kinase for reconstitution of its functionality.	[Thakur, Meghna; Chaba, Rachna; Mondal, Alok K.; Chakraborti, Pradip K.] Inst Microbiol Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Chakraborti, PK (corresponding author), Inst Microbiol Technol, Sector 39A, Chandigarh 160036, India.	pradip@imtech.res.in	Thakur, Meghna/J-4011-2019	Thakur, Meghna/0000-0001-7952-6029				Ascano M, 2004, MOL CELL BIOL, V24, P10397, DOI 10.1128/MCB.24.23.10397-10405.2004; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai SJ, 2003, J MOL BIOL, V329, P495, DOI 10.1016/S0022-2836(03)00446-7; Canova MJ, 2008, PROTEOMICS, V8, P521, DOI 10.1002/pmic.200700442; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DeLano WL, 1998, PYMOL MOL GRAPHICS S; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Gopalaswamy R, 2004, PROTEIN EXPRES PURIF, V36, P82, DOI 10.1016/j.pep.2004.03.011; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Greenstein AE, 2007, J BIOL CHEM, V282, P11427, DOI 10.1074/jbc.M610193200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; IUCHI S, 1993, J BIOL CHEM, V268, P23972; JOHNSON LN, 1996, CELL, V85, P49; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; LAMMERS R, 1990, J BIOL CHEM, V265, P16886; McCarty DR, 2000, CELL, V103, P201, DOI 10.1016/S0092-8674(00)00113-6; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Rogers JA, 1996, J BIOL CHEM, V271, P17519, DOI 10.1074/jbc.271.29.17519; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharma K, 2004, FEMS MICROBIOL LETT, V233, P107, DOI 10.1016/j.femsle.2004.01.045; Sierk ML, 2004, STRUCTURE, V12, P2103, DOI 10.1016/j.str.2004.09.016; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; UDO H, 1995, GENE DEV, V9, P972, DOI 10.1101/gad.9.8.972; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yang W, 2001, PROTEIN EXPRES PURIF, V22, P472, DOI 10.1006/prep.2001.1453; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	44	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					8023	8033		10.1074/jbc.M707535200	http://dx.doi.org/10.1074/jbc.M707535200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18199749	hybrid			2022-12-27	WOS:000253997900077
J	Cenci, C; Barzotti, R; Galeano, F; Corbelli, S; Rota, R; Massimi, L; Di Rocco, C; O'Connell, MA; Gallo, A				Cenci, Caterina; Barzotti, Rita; Galeano, Federica; Corbelli, Sandro; Rota, Rossella; Massimi, Luca; Di Rocco, Concezio; O'Connell, Mary A.; Gallo, Angela			Down-regulation of RNA editing in pediatric astrocytomas - ADAR2 editing activity inhibits cell migration and proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; ADENOSINE-DEAMINASE; GLUTAMATE RECEPTORS; BINDING DOMAINS; GLIAL-CELLS; IN-VIVO; GLUR-B; GENE; DIMERIZATION; ENZYME	Since alterations in post-transcriptional events can contribute to the appearance and/ or progression of cancer, we investigated whether RNA editing, catalyzed by the ADAR ( adenosine deaminases that act on RNA) enzymes, is altered in pediatric astrocytomas. We find a decrease in ADAR2 editing activity that seems to correlate with the grade of malignancy in children. Despite the loss of ADAR2 editing activity in tumor tissues, the high grade astrocytomas do not exhibit alterations in ADAR2 expression when compared with their specific control tissues. However, high expression levels of ADAR1 and ADAR3 were found in tumors when compared with normal tissues dissected in the same area of the brain. We reintroduced either ADAR2 or the inactive version of ADAR2 in three astrocytoma cell lines ( U118, A172, U87). The "reverted" editing status is necessary and sufficient for a significant decrease in cell malignant behavior as measured by proliferation, cell cycle, and migration assays. We show that elevated levels of ADAR1, as found in astrocytomas, do indeed interfere with ADAR2 specific editing activity. Furthermore, we show that the endogenous ADAR1 can form heterodimers with ADAR2 in astrocytes.	[Rota, Rossella] Osped Pediat Bambino Gesu Res Inst, Angiogenesis, I-00165 Rome, Italy; [Cenci, Caterina; Barzotti, Rita; Galeano, Federica; Corbelli, Sandro; Gallo, Angela] Osped Pediat Bambino Gesu Res Inst, RNA Editing Lab, I-00165 Rome, Italy; [Massimi, Luca; Di Rocco, Concezio] Pediat Neurosurg Policlin Gemelli, I-00168 Rome, Italy; [O'Connell, Mary A.] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	IRCCS Bambino Gesu; IRCCS Bambino Gesu; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Edinburgh	Gallo, A (corresponding author), Osped Pediat Bambino Gesu Res Inst, Angiogenesis, Piazza S Onofrio 4, I-00165 Rome, Italy.	gallo@opbg.net	Gallo, Angela/E-7837-2011; Gallo, Angela/AAA-5003-2020; O'Connell, Mary Anne/U-7693-2019; Corbelli, Sandro/AAA-6621-2020; OConnell, Mary Anne/G-4740-2015; Rota, Rossella/AAB-2497-2019	Gallo, Angela/0000-0003-0297-1807; Gallo, Angela/0000-0003-0297-1807; O'Connell, Mary Anne/0000-0003-3844-6174; Corbelli, Sandro/0000-0001-9112-2852; OConnell, Mary Anne/0000-0003-3844-6174; Rota, Rossella/0000-0002-9408-7711	MRC [MC_U127584490] Funding Source: UKRI; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Medical Research Council [MC_U127584490] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; Bernard A, 1999, EUR J NEUROSCI, V11, P604, DOI 10.1046/j.1460-9568.1999.00479.x; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Chilibeck KA, 2006, J BIOL CHEM, V281, P16530, DOI 10.1074/jbc.M511831200; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371; Gallo A, 2003, EMBO J, V22, P3421, DOI 10.1093/emboj/cdg327; Gerber A, 1997, RNA, V3, P453; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Ichimura K, 2004, J NEURO-ONCOL, V70, P137, DOI 10.1007/s11060-004-2747-2; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Koeller KK, 2004, RADIOGRAPHICS, V24, P1693, DOI 10.1148/rg.246045146; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; LAI F, 1995, J BIOL CHEM, V270, P17098, DOI 10.1074/jbc.270.29.17098; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; Liu Y, 1997, J BIOL CHEM, V272, P4419, DOI 10.1074/jbc.272.7.4419; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Maas Stefan, 2006, RNA Biol, V3, P1; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; Paupard MC, 2000, NEUROSCIENCE, V95, P869; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; *PE APPL BIOS, 1997, ABI PRISM 7700 SEQ D, V2; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Poulsen H, 2006, RNA, V12, P1350, DOI 10.1261/rna.2314406; Steinhauser C, 1996, TRENDS NEUROSCI, V19, P339, DOI 10.1016/0166-2236(96)10043-6; Tamber Mandeep S, 2003, Neurosurg Focus, V14, pe1; Toschi E, 2000, J INVEST DERMATOL, V114, P1188, DOI 10.1046/j.1523-1747.2000.00000.x; WAGNER RW, 1990, MOL CELL BIOL, V10, P5586, DOI 10.1128/MCB.10.10.5586; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765	35	150	166	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7251	7260		10.1074/jbc.M708316200	http://dx.doi.org/10.1074/jbc.M708316200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18178553	hybrid			2022-12-27	WOS:000253779600070
J	Lea-Smith, DJ; Martin, KL; Pyke, JS; Tull, D; McConville, MJ; Coppel, RL; Crellin, PK				Lea-Smith, David J.; Martin, Kirstee L.; Pyke, James S.; Tull, Dedreia; McConville, Malcolm J.; Coppel, Ross L.; Crellin, Paul K.			Analysis of a new mannosyltransferase required for the synthesis of phosphatidylinositol mannosides and lipoarbinomannan reveals two lipomannan pools in corynebacterineae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOLIC ACID BIOSYNTHESIS; CELL-WALL; MONOPHOSPHOMANNOSE SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; CLONING VECTORS; LIPOARABINOMANNAN; IDENTIFICATION; GLUTAMICUM; GROWTH; DEFINITION	The cell walls of the Corynebacterineae, which includes the important human pathogen Mycobacterium tuberculosis, contain two major lipopolysaccharides, lipoarabinomannan ( LAM) and lipomannan (LM). LAM is assembled on a subpool of phosphatidylinositol mannosides (PIMs), whereas the identity of the LM lipid anchor is less well characterized. In this study we have identified a new gene (Rv2188c in M. tuberculosis and NCgl2106 in Corynebacterium glutamicum) that encodes a mannosyltransferase involved in the synthesis of the early dimannosylated PIM species, acyl-PIM2, and LAM. Disruption of the C. glutamicum NCgl2106 gene resulted in loss of synthesis of AcPIM2 and accumulation of the monomannosylated precursor, AcPIM1. The synthesis of a structurally unrelated mannolipid, Gl-X, was unaffected. The synthesis of AcPIM2 in C. glutamicum Delta NCgl2106 was restored by complementation with M. tuberculosis Rv2188c. In vivo labeling of the mutant with [H-3] Man and in vitro labeling of membranes with GDP-[H-3] Man confirmed that NCgl2106/Rv2188c catalyzed the second mannose addition in PIM biosynthesis, a function previously ascribed to PimB/Rv0557. The C. glutamicum Delta NCgl2106 mutant lacked mature LAM but unexpectedly still synthesized the major pool of LM. Biochemical analyses of the LM core indicated that this lipopolysaccharide was assembled on Gl-X. These data suggest that NCgl2106/Rv2188c and the previously studied PimB/Rv0557 transfer mannose residues to distinct mannoglycolipids that act as precursors for LAM and LM, respectively.	[Lea-Smith, David J.; Coppel, Ross L.; Crellin, Paul K.] Monash Univ, Dept Microbiol, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic 3800, Australia; [Lea-Smith, David J.; Coppel, Ross L.; Crellin, Paul K.] Monash Univ, Dept Microbiol, Victorian Bioinformat Consortium, Clayton, Vic 3800, Australia; [Martin, Kirstee L.; Pyke, James S.; Tull, Dedreia; McConville, Malcolm J.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	Monash University; Monash University; University of Melbourne	Crellin, PK (corresponding author), Monash Univ, Dept Microbiol, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic 3800, Australia.	paul.crellin@med.monash.edu.au	Lea-Smith, David/U-9151-2019; Coppel, Ross L/A-6626-2008	Lea-Smith, David/0000-0003-2463-406X; Coppel, Ross L/0000-0002-4476-9124; Crellin, Paul K/0000-0002-2017-4935; Tull, Dedreia/0000-0003-2546-6707	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; Billman-Jacobe H, 1999, MOL MICROBIOL, V33, P1244, DOI 10.1046/j.1365-2958.1999.01572.x; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Gibson KJC, 2003, J BIOL CHEM, V278, P40842, DOI 10.1074/jbc.M307988200; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; Kacem R, 2004, MICROBIOL-SGM, V150, P73, DOI 10.1099/mic.0.26583-0; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur D, 2006, P NATL ACAD SCI USA, V103, P13664, DOI 10.1073/pnas.0603049103; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611; McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Morita YS, 2004, BIOCHEM J, V378, P589, DOI 10.1042/BJ20031372; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Puech V, 2000, MOL MICROBIOL, V35, P1026, DOI 10.1046/j.1365-2958.2000.01738.x; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schaeffer ML, 1999, J BIOL CHEM, V274, P31625, DOI 10.1074/jbc.274.44.31625; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; Tatituri RVV, 2007, MICROBIOL-SGM, V153, P2621, DOI 10.1099/mic.0.2007/008078-0; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	39	57	59	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6773	6782		10.1074/jbc.M707139200	http://dx.doi.org/10.1074/jbc.M707139200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18178556	hybrid			2022-12-27	WOS:000253779600019
J	Raggatt, LJ; Qin, L; Tamasi, J; Jefcoat, SC; Shimizu, E; Selvamurugan, N; Liew, FY; Bevelock, L; Feyen, JHM; Partridge, NC				Raggatt, Liza J.; Qin, Ling; Tamasi, Joseph; Jefcoat, Stephen C., Jr.; Shimizu, Emi; Selvamurugan, Nagarajan; Liew, Foo Y.; Bevelock, Laura; Feyen, Jean H. M.; Partridge, Nicola C.			Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; ELEMENT-BINDING PROTEIN; GAMMA-INDUCING FACTOR; GENE-EXPRESSION; OSTEOBLASTIC CELLS; C-FOS; OSTEOPROTEGERIN EXPRESSION; OSTEOCLAST FORMATION; SIGNALING PATHWAYS; MESSENGER-RNA	Interleukin-18 (IL-18) can regulate osteoblast and osteoclast function. We have identified, using cDNA microarray technology, that IL-18 expression is increased in UMR 106-01 rat osteoblastic cells in response to parathyroid hormone (PTH) treatment. Confirmation of these data using real-time reverse transcription-PCR showed that steady-state levels of IL-18 mRNA increased by 2 h (3-fold), peaked by 4 h (10-fold), and had diminished after 12 h (4.4-fold) and that this regulation was via the protein kinase A signaling pathway and did not involve activation of the PKC signal cascade. PTH regulation of IL-18 was confirmed at the protein level, and analysis of differentiating primary rat calvarial osteoblasts verified that both IL-18 mRNA and protein are regulated by PTH in primary rat osteoblasts. Promoter reporter assays revealed that PTH regulated the upstream IL-18 promoter and induced the exon 1 containing 1.1-kb IL-18 mRNA transcript in primary osteoblast cells. The in vivo physiological role of IL- 18 in the anabolic actions of PTH on bone was then assessed using IL- 18 knock-out mice. Female IL-18 null mice and wild-type littermate controls were injected with vehicle or 8 mu g/100 g of human 1-38 PTH for 4 weeks. In IL-18 knock-out animals the anabolic effect of PTH (determined by bone mineral density changes in the proximal tibia) was abolished in trabecular bone but not in the cortical component. These data characterize the PTH regulation of IL-18 expression in osteoblastic cells and suggest that this cytokine is involved in the anabolic actions of PTH.	[Raggatt, Liza J.; Qin, Ling; Jefcoat, Stephen C., Jr.; Shimizu, Emi; Selvamurugan, Nagarajan; Bevelock, Laura; Partridge, Nicola C.] UMDNJ, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Tamasi, Joseph; Feyen, Jean H. M.] Bristol Myers Squibb Pharmaceut Res Inst, Pennington, NJ 08534 USA; [Liew, Foo Y.] Glasgow Biomed Res Ctr, Div Immunol Infect & Inflammat, Glasgow G12 8TA, Lanark, Scotland	Rutgers State University New Brunswick; Rutgers State University Medical Center; Bristol-Myers Squibb; University of Glasgow	Partridge, NC (corresponding author), UMDNJ, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, 675 Hoes Lane, Piscataway, NJ 08854 USA.	partrinc@umdnj.edu	Raggatt, Liza-Jane/S-4530-2016; Raggatt, Liza-Jane/A-5297-2011; Selvamurugan, Nagarajan/P-7894-2016	Raggatt, Liza-Jane/0000-0002-7920-6225; Selvamurugan, Nagarajan/0000-0003-3713-1920; Partridge, Nicola/0000-0002-5406-4814	Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [G9818261] Funding Source: Medline; NIDDK NIH HHS [DK48109] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048109] Funding Source: NIH RePORTER; MRC [G9818261] Funding Source: UKRI	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bikle DD, 2002, J BONE MINER RES, V17, P1570, DOI 10.1359/jbmr.2002.17.9.1570; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; Cornish J, 2003, ENDOCRINOLOGY, V144, P1194, DOI 10.1210/en.2002-220936; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; DOBNIG H, 1995, ENDOCRINOLOGY, V136, P3632, DOI 10.1210/en.136.8.3632; Erclik MS, 2002, AM J PHYSIOL-ENDOC M, V282, pE534, DOI 10.1152/ajpendo.00417.2001; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; HODSMAN AB, 1993, J CLIN INVEST, V91, P1138, DOI 10.1172/JCI116273; Horwood NJ, 1998, J CLIN INVEST, V101, P595, DOI 10.1172/JCI1333; Huang YF, 1998, BONE, V23, P327, DOI 10.1016/S8756-3282(98)00115-X; Iida-Klein A, 2002, J BONE MINER RES, V17, P808, DOI 10.1359/jbmr.2002.17.5.808; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kawase Y, 2003, J BONE MINER RES, V18, P975, DOI 10.1359/jbmr.2003.18.6.975; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Krishnan V, 2003, MOL ENDOCRINOL, V17, P423, DOI 10.1210/me.2002-0225; LEAFFER D, 1995, ENDOCRINOLOGY, V136, P3624, DOI 10.1210/en.136.8.3624; Li X, 2002, BONE, V30, P567, DOI 10.1016/S8756-3282(02)00683-X; Makiishi-Shimobayashi C, 2001, BIOCHEM BIOPH RES CO, V281, P361, DOI 10.1006/bbrc.2001.4380; Miyakoshi N, 2001, ENDOCRINOLOGY, V142, P4349, DOI 10.1210/en.142.10.4349; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Schiller PC, 1999, J BONE MINER RES, V14, P1504, DOI 10.1359/jbmr.1999.14.9.1504; Selvamurugan N, 2000, J CELL BIOCHEM, V79, P182, DOI 10.1002/1097-4644(20001101)79:2<182::AID-JCB20>3.0.CO;2-0; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Selvarnurugan N, 2007, J ORTHOP RES, V25, P1213, DOI 10.1002/jor.20409; SHALHOUB V, 1992, J CELL BIOCHEM, V50, P425, DOI 10.1002/jcb.240500411; Sims JE, 2002, CURR OPIN IMMUNOL, V14, P117, DOI 10.1016/S0952-7915(01)00306-5; Sugama S, 2000, J IMMUNOL, V165, P6287, DOI 10.4049/jimmunol.165.11.6287; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; TAM CS, 1982, ENDOCRINOLOGY, V110, P506, DOI 10.1210/endo-110-2-506; Tone M, 1997, J IMMUNOL, V159, P6156; Tsutsui H, 2004, IMMUNOL REV, V202, P115, DOI 10.1111/j.0105-2896.2004.00205.x; Tyson DR, 1999, ENDOCRINOLOGY, V140, P1255, DOI 10.1210/en.140.3.1255; Udagawa N, 1997, J EXP MED, V185, P1005, DOI 10.1084/jem.185.6.1005; Wei XQ, 2001, J IMMUNOL, V166, P517, DOI 10.4049/jimmunol.166.1.517; Wu YH, 2000, J BONE MINER RES, V15, P879, DOI 10.1359/jbmr.2000.15.5.879; Yamada N, 2002, BONE, V30, P901, DOI 10.1016/S8756-3282(02)00722-6; Yu XP, 1997, ENDOCRINOLOGY, V138, P3085, DOI 10.1210/en.138.8.3085; Zhou H, 2003, BONE, V32, P513, DOI 10.1016/S8756-3282(03)00057-7	46	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6790	6798		10.1074/jbc.M709909200	http://dx.doi.org/10.1074/jbc.M709909200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18165223	hybrid			2022-12-27	WOS:000253779600021
J	Sadaie, M; Shinmyozu, K; Nakayama, JI				Sadaie, Mahito; Shinmyozu, Kaori; Nakayama, Jun-ichi			A conserved SET domain methyltransferase, Set11, modifies ribosomal protein Rpl12 in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC ANALYSIS; SCHIZOSACCHAROMYCES-POMBE; ESCHERICHIA-COLI; L11 METHYLTRANSFERASE; LYSINE METHYLATION; P53 ACTIVITY; HETEROCHROMATIN; SUBUNIT; PRMA; TRIMETHYLATION	SET domain-containing methyltransferases post-translationally modify a variety of cellular proteins, such as histones, cytochrome c, ribulose-bisphosphate carboxylase/ oxygenase, and ribosomal proteins. In the fission yeast Schizosaccharomyces pombe, at least 13 SET domain-containing proteins have been identified in the genome, four of which are involved in transcriptional regulation through their modification of histone tails. However, the roles played by the other SET domain proteins in cellular processes and their physiological substrates remain unresolved. We show here that S. pombe Set11, a SET domain-containing protein encoded by SPCC1223.04c, specifically modifies Rpl12 ( ribosomal protein L12). Recombinant Set11 prepared from Escherichia coli had catalytic activity and methylated a 17-kDa polypeptide in cellular extracts of set11 mutant cells. The methylated protein was isolated by two-dimensional gel electrophoresis or by reverse-phase chromatography and was identified as Rpl12 by mass spectrometry. In vitro methylation experiments using wild-type and mutant Rpl12 proteins verified that Set11 modified recombinant Rpl12 and suggested that its potential target site was lysine 3. The methylation site modified by Set11 was also confirmed by mass spectrometric analysis, which also revealed other unique methylation sites of Rpl12. Finally, we found that Set11 predominantly localized to the nucleolus and that the overproduction of Set11 caused a severe growth defect. These results suggest that Rpl12 methylation occurs during the ribosomal assembly processes and that control of the Set11 expression level is important for its cellular function.	[Sadaie, Mahito; Nakayama, Jun-ichi] RIKEN, Chuo Ku, Lab Chromatin Dynam, Kobe, Hyogo 6500047, Japan; [Shinmyozu, Kaori] RIKEN, Prote Support Unit, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	RIKEN; RIKEN	Nakayama, JI (corresponding author), RIKEN, Chuo Ku, Lab Chromatin Dynam, 2-2-3 Minatojimaminamimachi, Kobe, Hyogo 6500047, Japan.	jnakayam@cdb.riken.jp	Nakayama, Jun-ichi/C-6003-2011	Nakayama, Jun-ichi/0000-0002-5597-8239				Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Cameron DM, 2004, J BACTERIOL, V186, P5819, DOI 10.1128/JB.186.17.5819-5825.2004; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Chern MK, 2002, J BIOL CHEM, V277, P15345, DOI 10.1074/jbc.M111379200; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; COLSON C, 1979, MOL GEN GENET, V169, P245, DOI 10.1007/BF00382270; Cuccurese M, 2005, NUCLEIC ACIDS RES, V33, P5965, DOI 10.1093/nar/gki905; DOGNIN MJ, 1977, FEBS LETT, V84, P342, DOI 10.1016/0014-5793(77)80721-7; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Houtz RL, 2003, ARCH BIOCHEM BIOPHYS, V414, P150, DOI 10.1016/S0003-9861(03)00122-X; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; Louie DF, 1996, J BIOL CHEM, V271, P28189, DOI 10.1074/jbc.271.45.28189; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Meng FY, 2004, ANAL CHEM, V76, P2852, DOI 10.1021/ac0354903; Mitrovich QM, 2000, GENE DEV, V14, P2173, DOI 10.1101/gad.819900; Morris SA, 2005, EUKARYOT CELL, V4, P1446, DOI 10.1128/EC.4.8.1446-1454.2005; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Odintsova TI, 2003, J PROTEIN CHEM, V22, P249, DOI 10.1023/A:1025068419698; Olsson I, 2007, EXP CELL RES, V313, P1778, DOI 10.1016/j.yexcr.2007.03.007; Peng X, 2005, MOL BIOL CELL, V16, P1026, DOI 10.1091/mbc.E04-04-0299; Pilch DR, 2004, METHOD ENZYMOL, V375, P76; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2007, J BIOL CHEM, V282, P12368, DOI 10.1074/jbc.M611896200; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; VANET A, 1994, MOL MICROBIOL, V14, P947, DOI 10.1111/j.1365-2958.1994.tb01330.x; Williamson NA, 1997, EUR J BIOCHEM, V246, P786, DOI 10.1111/j.1432-1033.1997.00786.x; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Yu YH, 2005, PROTEIN SCI, V14, P1438, DOI 10.1110/ps.041293005	44	32	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7185	7195		10.1074/jbc.M709429200	http://dx.doi.org/10.1074/jbc.M709429200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18195021	hybrid			2022-12-27	WOS:000253779600064
J	Siskind, LJ; Feinstein, L; Yu, TX; Davis, JS; Jones, D; Choi, J; Zuckerman, JE; Tan, WZ; Hill, RB; Hardwick, JM; Colombini, M				Siskind, Leah J.; Feinstein, Laurence; Yu, Tingxi; Davis, Joseph S.; Jones, David; Choi, Jinna; Zuckerman, Jonathan E.; Tan, Wenzhi; Hill, R. Blake; Hardwick, J. Marie; Colombini, Marco			Anti-apoptotic Bcl-2 family proteins disassemble ceramide channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAUNORUBICIN-INDUCED APOPTOSIS; PROGRAMMED CELL-DEATH; CYTOCHROME-C RELEASE; MITOCHONDRIAL CERAMIDE; RESPIRATORY-CHAIN; WILD-TYPE; BAX; SPHINGOMYELIN; GENERATION; MEMBRANES	Early in mitochondria- mediated apoptosis, the mitochondrial outer membrane becomes permeable to proteins that, when released into the cytosol, initiate the execution phase of apoptosis. Proteins in the Bcl-2 family regulate this permeabilization, but the molecular composition of the mitochondrial outer membrane pore is under debate. We reported previously that at physiologically relevant levels, ceramides form stable channels in mitochondrial outer membranes capable of passing the largest proteins known to exit mitochondria during apoptosis (Siskind, L. J., Kolesnick, R. N., and Colombini, M. ( 2006) Mitochondrion 6, 118 - 125). Here we show that Bcl-2 proteins are not required for ceramide to form protein-permeable channels in mitochondrial outer membranes. However, both recombinant human Bcl-x(L) and CED-9, the Caenorhabditis elegans Bcl-2 homologue, disassemble ceramide channels in the mitochondrial outer membranes of isolated mitochondria from rat liver and yeast. Importantly, Bcl-xL and CED-9 disassemble ceramide channels in the defined system of solvent-free planar phospholipid membranes. Thus, ceramide channel disassembly likely results from direct interaction with these anti-apoptotic proteins. Mutants of Bcl-xL act on ceramide channels as expected from their ability to be anti-apoptotic. Thus, ceramide channels may be one mechanism for releasing pro-apoptotic proteins from mitochondria during the induction phase of apoptosis.	[Feinstein, Laurence; Davis, Joseph S.; Jones, David; Choi, Jinna; Tan, Wenzhi; Colombini, Marco] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Siskind, Leah J.] Med Univ S Carolina, Dept Gen Internal Med Geriatr, Charleston, SC 29425 USA; [Yu, Tingxi; Hardwick, J. Marie] Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Zuckerman, Jonathan E.; Hill, R. Blake] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland College Park; Medical University of South Carolina; Johns Hopkins University; Johns Hopkins University	Colombini, M (corresponding author), Univ Maryland, Dept Biol, Bldg 144, College Pk, MD 20742 USA.	colombini@umd.edu	Colombini, Marco/A-1540-2014	Siskind, Leah/0000-0001-5026-5187; Hill, Blake/0000-0001-6228-3905	NIGMS NIH HHS [R01 GM067180-04, GM067180, R01 GM067180, GM77875, R01 GM077875, R01 GM077875-03] Funding Source: Medline; NINDS NIH HHS [R01 NS037402, NS37402, NS42025, R01 NS042025] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067180, R01GM077875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042025, R01NS037402] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allouche M, 1997, ONCOGENE, V14, P1837, DOI 10.1038/sj.onc.1201023; Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Basanez G, 2001, J BIOL CHEM, V276, P31083, DOI 10.1074/jbc.M103879200; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; COLOMBINI M, 1987, METHOD ENZYMOL, V148, P465; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Di Paola M, 2004, J BIOENERG BIOMEMBR, V36, P165, DOI 10.1023/B:JOBB.0000023619.97392.0c; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Elrick MJ, 2006, BIOPHYS J, V91, P1749, DOI 10.1529/biophysj.106.088443; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Kawatani M, 2003, EXP CELL RES, V286, P57, DOI 10.1016/S0014-4827(03)00098-3; Kroesen BJ, 2001, J BIOL CHEM, V276, P13606, DOI 10.1074/jbc.M009517200; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Longo VD, 1997, J CELL BIOL, V137, P1581, DOI 10.1083/jcb.137.7.1581; Matsko CM, 2001, BIOCHEM BIOPH RES CO, V287, P1112, DOI 10.1006/bbrc.2001.5696; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Morizono H, 2005, MOL GENET METAB, V86, P431, DOI 10.1016/j.ymgme.2005.08.013; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Rodriguez-Lafrasse C, 2002, INT J CANCER, V101, P589, DOI 10.1002/ijc.10652; Rodriguez-Lafrasse C, 2001, BIOCHEM J, V357, P407, DOI 10.1042/0264-6021:3570407; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Sawada M, 2000, ONCOGENE, V19, P3508, DOI 10.1038/sj.onc.1203699; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shimeno H, 1998, LIPIDS, V33, P601, DOI 10.1007/s11745-998-0246-2; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Siskind LJ, 2003, BIOPHYS J, V85, P1560, DOI 10.1016/S0006-3495(03)74588-3; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Thomas RL, 1999, J BIOL CHEM, V274, P30580, DOI 10.1074/jbc.274.43.30580; Thuduppathy GR, 2006, BIOCHEMISTRY-US, V45, P14533, DOI 10.1021/bi0616652; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wiesner DA, 1997, J BIOL CHEM, V272, P9868; Witty JP, 1996, ENDOCRINOLOGY, V137, P5269, DOI 10.1210/en.137.12.5269; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zhang JD, 1996, P NATL ACAD SCI USA, V93, P5325, DOI 10.1073/pnas.93.11.5325	53	98	104	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6622	6630		10.1074/jbc.M706115200	http://dx.doi.org/10.1074/jbc.M706115200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18171672	hybrid, Green Accepted			2022-12-27	WOS:000253779600003
J	Churbanova, IY; Sevrioukova, IF				Churbanova, Inna Y.; Sevrioukova, Irina F.			Redox-dependent changes in molecular properties of mitochondrial apoptosis-inducing factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH OXIDASE ACTIVITY; FACTOR AIF; CRYSTAL-STRUCTURE; CELL-DEATH; PUTIDAREDOXIN REDUCTASE; PERMEABILITY TRANSITION; OXIDATIVE STRESS; DNA-DEGRADATION; MUTANT; COMPONENT	Mitochondrial apoptosis-inducing factor (AIF) is a central player in the caspase-independent cell death pathway whose normal physiological function remains unclear. Our study showed that naturally folded mouse AIF very slowly reacts with NAD(P)H (k(cat) of 0.2- 0.01 s(-1)) forming tight, dimeric, and airstable FADH(2)-NAD(P) charge-transfer complexes ineffective in electron transfer. FAD reduction is accompanied by a conformational change involving AIF-specific N-terminal and regulatory 509 - 559 peptides and the active site His(453), and it affects susceptibility of AIF to calpain and AIF-DNA interaction, the two events critical for initiating caspase-independent apoptosis. Based on our results, we propose that formation of long lived complexes with NAD(P) H and redox reorganization may be functionally important and enable AIF to act as a redox-signaling molecule linking NAD(P) H-dependent metabolic pathways to apoptosis.	[Churbanova, Inna Y.; Sevrioukova, Irina F.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Sevrioukova, IF (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 MacGaugh Hall, Irvine, CA 92697 USA.	sevrioui@uci.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067637] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM67637] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apostolova N, 2006, CELL DEATH DIFFER, V13, P354, DOI 10.1038/sj.cdd.4401776; Cande C, 2004, J CELL SCI, V117, P4461, DOI 10.1242/jcs.01356; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Collingwood TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/jbc.M706870200; Delettre C, 2006, J BIOL CHEM, V281, P6413, DOI 10.1074/jbc.M509884200; Delettre C, 2006, J BIOL CHEM, V281, P18507, DOI 10.1074/jbc.M601751200; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Massey V., 1991, FLAVINS FLAVOPROTEIN, P581; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; Mayer BJ, 2001, J CELL SCI, V114, P1253; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; OTERA H, 2005, EMBO J, V17, P1; Petit PX, 2001, BIOCHEM J, V353, P357, DOI 10.1042/0264-6021:3530357; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rustin P, 1996, J BIOL CHEM, V271, P14785, DOI 10.1074/jbc.271.25.14785; SAKURAI T, 1966, BIOCHIM BIOPHYS ACTA, V112, P459, DOI 10.1016/0926-6585(66)90248-2; Schmitt E, 2003, CANCER RES, V63, P8233; Senda T, 2000, J MOL BIOL, V304, P397, DOI 10.1006/jmbi.2000.4200; Sevrioukova IF, 2004, J MOL BIOL, V336, P889, DOI 10.1016/j.jmb.2003.12.067; Sevrioukova IF, 2002, J BIOL CHEM, V277, P25831, DOI 10.1074/jbc.M201110200; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vahsen N, 2006, ONCOGENE, V25, P1763, DOI 10.1038/sj.onc.1209206; van Empel VPM, 2006, J AM COLL CARDIOL, V48, P824, DOI 10.1016/j.jacc.2006.02.075; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Yuste VJ, 2005, J BIOL CHEM, V280, P35670, DOI 10.1074/jbc.M504015200; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687; Zhu CL, 2007, J EXP MED, V204, P1741, DOI 10.1084/jem.20070193; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	45	65	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5622	5631		10.1074/jbc.M709147200	http://dx.doi.org/10.1074/jbc.M709147200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167347	hybrid			2022-12-27	WOS:000253426700042
J	Eun, B; Lee, Y; Hong, S; Kim, J; Lee, HW; Kim, K; Sun, W; Kim, H				Eun, Bokkee; Lee, Yool; Hong, Soontaek; Kim, Jaesang; Lee, Han-Woong; Kim, Kyungjin; Sun, Woong; Kim, Hyun			Hes6 controls cell proliferation via interaction with cAMP-response element-binding protein-binding protein in the promyelocytic leukemia nuclear body	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOTCH SIGNALING PATHWAY; LOOP-HELIX FACTORS; TRANSCRIPTIONAL REPRESSION; NEURONAL DIFFERENTIATION; BHLH PROTEINS; CYCLE ARREST; REGULATES DIFFERENTIATION; PREMATURE SENESCENCE; P53 ACETYLATION; MAMMALIAN-CELLS	Hes6 is a basic helix-loop-helix transcription factor that functions in the differentiation of pluripotent progenitor cells and during tumorigenesis. However, the molecular mechanism for its function is largely unknown. Here we show that Hes6 is a component of the promyelocytic leukemia nuclear body (PML-NB) complex in the nuclei and that Hes6 inhibits cell proliferation through induction of p21 cyclin-dependent kinase inhibitor. We further show that Hes6 directly interacts with CREB-binding protein (CBP), one of the key components of PML-NB, via its basic domain. This association is critical for p21 induction through multiple mechanisms, including chromatin remodeling and p53 acetylation. Taken together, these results suggest that the Hes6-CBP complex in PML-NB may influence the proliferation of cells via p53-dependent and -independent pathways.	[Eun, Bokkee; Hong, Soontaek; Sun, Woong; Kim, Hyun] Korea Univ, Coll Med, Seoul 136705, South Korea; [Eun, Bokkee; Lee, Yool; Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Jaesang] Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; [Lee, Han-Woong] Yonsei Univ, Coll Sci, Seoul 120749, South Korea	Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Ewha Womans University; Yonsei University	Kim, H (corresponding author), Korea Univ, Coll Med, Brain Korea 21, Seoul 136705, South Korea.	kimhyun@korea.ac.kr		sun, woong/0000-0003-1792-4894; Kim, Hyun/0000-0002-7210-5798; LEE, YOOL/0000-0003-0498-3342				ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Bae SK, 2000, DEVELOPMENT, V127, P2933; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Castella P, 2000, MOL CELL BIOL, V20, P6170, DOI 10.1128/MCB.20.16.6170-6183.2000; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Ching RW, 2005, J CELL SCI, V118, P847, DOI 10.1242/jcs.01700; Coffman FD, 1999, EXP CELL RES, V248, P58, DOI 10.1006/excr.1999.4457; Cossins J, 2002, DEVELOPMENT, V129, P2195; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Farah MH, 2000, DEVELOPMENT, V127, P693; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Ghiani CA, 1999, DEVELOPMENT, V126, P1077; Gill RM, 1998, EXP CELL RES, V244, P157, DOI 10.1006/excr.1998.4197; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kang SA, 2005, BIOCHEM BIOPH RES CO, V332, P33, DOI 10.1016/j.bbrc.2005.04.089; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kiesslich A, 2002, J STRUCT BIOL, V140, P167, DOI 10.1016/S1047-8477(02)00571-3; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; Lin HK, 2005, ONCOGENE, V24, P5693, DOI 10.1038/sj.onc.1208923; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Mutoh H, 1998, GENE DEV, V12, P820, DOI 10.1101/gad.12.6.820; Nguyen LA, 2005, BLOOD, V105, P292, DOI 10.1182/blood-2004-03-1185; Norton JD, 2000, J CELL SCI, V113, P3897; Ohnuma S, 2001, CURR OPIN NEUROBIOL, V11, P66, DOI 10.1016/S0959-4388(00)00175-6; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Piscione TD, 2004, GENE EXPR PATTERNS, V4, P707, DOI 10.1016/j.modgep.2004.04.007; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Qi RZ, 2003, CANCER RES, V63, P8323; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Wang L, 2001, ENDOCRINOLOGY, V142, P4015, DOI 10.1210/en.142.9.4015; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wu YY, 2003, DEV DYNAM, V226, P675, DOI 10.1002/dvdy.10278; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	67	9	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5939	5949		10.1074/jbc.M707683200	http://dx.doi.org/10.1074/jbc.M707683200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18160400	hybrid			2022-12-27	WOS:000253426700072
J	Vaid, A; Thomas, DC; Sharma, P				Vaid, Ankush; Thomas, Divya C.; Sharma, Pushkar			Role of Ca2+/Calmodulin-PfPKB signaling pathway in erythrocyte invasion by Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MALARIA PARASITES; B-LIKE ENZYME; TOXOPLASMA-GONDII; CELL INVASION; MYOSIN-A; PROTEIN-KINASES; IN-VIVO; CALCIUM; INHIBIT; MEMBRANE	Molecular mechanisms by which signaling pathways operate in the malaria parasite and control its development are promiscuous. Recently, we reported the identification of a signaling pathway in Plasmodium falciparum, which involves activation of protein kinase B-like enzyme (PfPKB) by calcium/calmodulin (Vaid, A., and Sharma, P. (2006) J. Biol. Chem. 281, 27126 27133). Studies carried out to elucidate the function of this pathway suggested that it may be important for erythrocyte invasion. Blocking the function of the upstream activators of this pathway, calmodulin and phospholipase C, resulted in impaired invasion. To evaluate if this signaling cascade controls invasion by regulating PfPKB, inhibitors against this kinase were developed. PfPKB inhibitors dramatically reduced the ability of the parasite to invade erythrocytes. Furthermore, we demonstrate that PfPKB associates with actin-myosin motor and phosphorylates PfGAP45 (glideosome-associated protein 45), one of the important components of the motor complex, which may help explain its role in erythrocyte invasion.	[Vaid, Ankush; Thomas, Divya C.; Sharma, Pushkar] Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Sharma, P (corresponding author), Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India.	pushkar@nii.res.in			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Bosch J, 2006, P NATL ACAD SCI USA, V103, P4852, DOI 10.1073/pnas.0510907103; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Davies TG, 2007, J MOL BIOL, V367, P882, DOI 10.1016/j.jmb.2007.01.004; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; Farias SL, 2005, MOL BIOCHEM PARASIT, V141, P71, DOI 10.1016/j.molbiopara.2005.01.015; Garcia CRS, 1996, EUR J CELL BIOL, V71, P409; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Hotta CT, 2003, BRAZ J MED BIOL RES, V36, P1583, DOI 10.1590/S0100-879X2003001100016; Jones ML, 2006, MOL BIOCHEM PARASIT, V147, P74, DOI 10.1016/j.molbiopara.2006.01.009; Kaidanovich-Beilin O, 2006, PHYSIOLOGY, V21, P411, DOI 10.1152/physiol.00022.2006; Kelemen BR, 2002, J BIOL CHEM, V277, P8741, DOI 10.1074/jbc.M108459200; Kumar A, 2004, J BIOL CHEM, V279, P24255, DOI 10.1074/jbc.M312855200; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Luo Y, 2004, BIOCHEMISTRY-US, V43, P1254, DOI 10.1021/bi034515p; Mamoun CB, 2001, MOL MICROBIOL, V39, P26, DOI 10.1046/j.1365-2958.2001.02222.x; MATSUMOTO Y, 1987, EUR J CELL BIOL, V45, P36; MCCALLUMDEIGHTON N, 1992, MOL BIOCHEM PARASIT, V50, P317, DOI 10.1016/0166-6851(92)90229-D; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mohrle JJ, 1997, BIOCHEM J, V328, P677; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Pinder JC, 1998, J CELL SCI, V111, P1831; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; SCHEIBEL LW, 1987, P NATL ACAD SCI USA, V84, P7310, DOI 10.1073/pnas.84.20.7310; Soldati D, 2004, TRENDS PARASITOL, V20, P567, DOI 10.1016/j.pt.2004.09.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaid A, 2006, J BIOL CHEM, V281, P27126, DOI 10.1074/jbc.M601914200; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; WARD GE, 1994, EXP PARASITOL, V79, P480, DOI 10.1006/expr.1994.1109; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wasserman M, 1996, PARASITOL RES, V82, P102, DOI 10.1007/s004360050078	41	76	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5589	5597		10.1074/jbc.M708465200	http://dx.doi.org/10.1074/jbc.M708465200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165240	hybrid			2022-12-27	WOS:000253426700039
J	Hassan, HH; Bailey, D; Lee, DYD; Iatan, I; Hafiane, A; Ruel, I; Krimbou, L; Genest, J				Hassan, Houssein Hajj; Bailey, Dana; Lee, Dong-Young Donna; Iatan, Iulia; Hafiane, Anouar; Ruel, Isabelle; Krimbou, Larbi; Genest, Jacques			Quantitative analysis of ABCA1-dependent compartmentalization and trafficking of apolipoprotein A-I - Implications for determining cellular kinetics of nascent high density lipoprotein biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER A1; ABCA1-MEDIATED LIPID EFFLUX; APOA-I; CHOLESTEROL EFFLUX; ABCA1 TRANSPORTER; PLASMA-MEMBRANE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; TANGIER-DISEASE; BINDING	The molecular mechanisms underlying the apoA-I/ABCA1 endocytic trafficking pathway in relation to high density lipoprotein (HDL) formation remain poorly understood. We have developed a quantitative cell surface biotinylation assay to determine the compartmentalization and trafficking of apoA-I between the plasma membrane (PM) and intracellular compartments (ICCs). Here we report that I-125-apoA-I exhibited saturable association with the PM and ICCs in baby hamster kidney cells stably overexpressing ABCA1 and in fibroblasts. The PM was found to have a 2-fold higher capacity to accommodate apoA-I as compared with ICCs. Overexpressing various levels of ABCA1 in baby hamster kidney cells promoted the association of apoA-I with PM and ICCs compartments. The C-terminal deletion of apoA-I Delta(187-243) and reconstituted HDL particles exhibited reduced association of apoA-I with both the PM and ICCs. Interestingly, cell surface biotinylation with a cleavable biotin revealed that apoA-I induces ABCA1 endocytosis. Such endocytosis was impaired by naturally occurring mutations of ABCA1 (Q597R and C1477R). To better understand the role of the endocytotic pathway in the dynamics of the lipidation of apoA-I, a pulse-chase experiment was performed, and the dissociation (re-secretion) of I-125-apoA-I from both PM and ICCs was monitored over a 6-h period. Unexpectedly, we found that the time required for 50% dissociation of I-125-apoA-I from the PM was 4-fold slower than that from ICCs at 37 degrees C. Finally, treatment of the cells with phosphatidylcholine-specific phospholipase C, increased the dissociation of apoA-I from the PM. This study provides evidence that the lipidation of apoA-I occurs in two kinetically distinguishable compartments. The finding that apoA-I specifically mediates the continuous endocytic recycling of ABCA1, together with the kinetic data showing that apoA-I associated with ICCs is rapidly re-secreted, suggests that the endocytotic pathway plays a central role in the genesis of nascent HDL.	[Hassan, Houssein Hajj; Bailey, Dana; Lee, Dong-Young Donna; Iatan, Iulia; Hafiane, Anouar; Ruel, Isabelle; Krimbou, Larbi; Genest, Jacques] McGill Univ, Div Cardiol, Hlth Ctr Royal Vic Hosp, Cardiovasc Genet Lab, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital	Genest, J (corresponding author), McGill Univ, Div Cardiol, Hlth Ctr Royal Vic Hosp, Cardiovasc Genet Lab, 687 Pine Ave, Montreal, PQ H3A 1A1, Canada.	jacques.genest@muhc.mcgill.ca	Hafiane, Anouar/AAE-3481-2020	Hafiane, Anouar/0000-0001-7494-722X				Basso F, 2003, J LIPID RES, V44, P296, DOI 10.1194/jlr.M200414-JLR200; Brewer HB, 2004, ARTERIOSCL THROM VAS, V24, P1755, DOI 10.1161/01.ATV.0000142804.27420.5b; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Cavelier C, 2006, CIRC RES, V99, P1060, DOI 10.1161/01.RES.0000250567.17569.b3; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chen WG, 2005, J BIOL CHEM, V280, P29277, DOI 10.1074/jbc.M505566200; Chroni A, 2004, BIOCHEMISTRY-US, V43, P2126, DOI 10.1021/bi035813p; Denis M, 2004, J BIOL CHEM, V279, P41529, DOI 10.1074/jbc.M406881200; Denis M, 2004, J BIOL CHEM, V279, P7384, DOI 10.1074/jbc.M306963200; Denis M, 2007, CIRCULATION, V116, P284; Favari E, 2004, ARTERIOSCL THROM VAS, V24, P2345, DOI 10.1161/01.ATV.0000148706.15947.8a; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fitzgerald ML, 2004, J LIPID RES, V45, P287, DOI 10.1194/jlr.M300355-JLR200; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Frank PG, 1997, BIOCHEMISTRY-US, V36, P1798, DOI 10.1021/bi962118r; Haidar B, 2004, J BIOL CHEM, V279, P9963, DOI 10.1074/jbc.M313487200; Hassan HH, 2005, J LIPID RES, V46, P1457, DOI 10.1194/jlr.M400477-JLR200; Hassan HH, 2007, J LIPID RES, V48, P2428, DOI 10.1194/jlr.M700206-JLR200; JONAS A, 1993, J BIOL CHEM, V268, P1596; Krimbou L, 2005, J LIPID RES, V46, P1668, DOI 10.1194/jlr.M500038-JLR200; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Krimbou L, 2006, CURR OPIN LIPIDOL, V17, P258, DOI 10.1097/01.mol.0000226117.43178.7c; Le Goff W, 2004, ARTERIOSCL THROM VAS, V24, P2155, DOI 10.1161/01.ATV.0000144811.94581.52; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Leventhal AR, 2001, J BIOL CHEM, V276, P44976, DOI 10.1074/jbc.M106455200; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Maric J, 2005, J BIOL CHEM, V280, P39942, DOI 10.1074/jbc.M507733200; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; Neufeld EB, 2004, J BIOL CHEM, V279, P15571, DOI 10.1074/jbc.M314160200; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; RAUB TJ, 1991, J CELL PHYSIOL, V149, P141, DOI 10.1002/jcp.1041490118; SCHMITZ G, 1985, EMBO J, V4, P613, DOI 10.1002/j.1460-2075.1985.tb03674.x; Smith JD, 2002, J BIOL CHEM, V277, P17797, DOI 10.1074/jbc.M201594200; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Takahashi Y, 1999, P NATL ACAD SCI USA, V96, P11358, DOI 10.1073/pnas.96.20.11358; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vedhachalam C, 2004, J BIOL CHEM, V279, P49931, DOI 10.1074/jbc.M406924200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wu CA, 2004, J BIOL CHEM, V279, P30168, DOI 10.1074/jbc.M403765200	44	46	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11164	11175		10.1074/jbc.M707720200	http://dx.doi.org/10.1074/jbc.M707720200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18218626	hybrid			2022-12-27	WOS:000255067400012
J	Mishra, R; Cool, BL; Laderoute, KR; Foretz, M; Viollet, B; Simonson, MS				Mishra, Rangnath; Cool, Barbara L.; Laderoute, Keith R.; Foretz, Marc; Viollet, Benoit; Simonson, Michael S.			AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; DIABETIC-NEPHROPATHY; MESANGIAL CELLS; FIBROTIC RESPONSE; SKELETAL-MUSCLE; RENAL FIBROSIS; IN-VITRO; SMAD3; FIBRONECTIN; COLLAGEN	In wound healing, myofibroblast transdifferentiation (MFT) is a metaplastic change in phenotype producing profibrotic effector cells that secrete and remodel the extracellular matrix. Unlike pathways that induce MFT, the molecular mechanisms that negatively regulate MFT are poorly understood. Here, we report that AMP-activated protein kinase (AMPK) blocks MFT in response to transforming growth factor-beta (TGF beta). Pharmacological activation of AMPK inhibited TGF beta-induced secretion of extracellular matrix proteins collagen types I and IV and fibronectin. AMPK activation also prevented induction of the myofibroblast phenotype markers alpha-smooth muscle actin and the ED-A fibronectin splice variant. AMPK activators did not prevent MFT in cells transduced with an adenovirus expressing dominant negative, kinase-dead AMPK alpha 2. Moreover, AMPK activators did not inhibit MFT induction in AMPK(alpha 1,2)(-/-) fibroblasts, demonstrating a requirement for AMPK alpha expression. Adenoviral transduction of constitutively active AMPK(alpha 2) was sufficient to prevent TGF beta-induced collagen I, alpha-smooth muscle actin, and ED-A fibronectin. AMPK did not reduce TGF beta-stimulated Smad3 COOH-terminal phosphorylation and nuclear translocation, which are necessary for MFT. However, AMPK activation inhibited TGF beta-induced transcription driven by Smad3-binding cis-elements. Consistent with a role for AMPK in transcriptional regulation, nuclear translocation of AMPK alpha 2 correlated with the appearance of active AMPK alpha in the nucleus. Collectively, these results demonstrate that AMPK inhibits TGF beta-induced transcription downstream of Smad3 COOH-terminal phosphorylation and nuclear translocation. Furthermore, activation of AMPK is sufficient to negatively regulate MFT in vitro.	[Mishra, Rangnath; Simonson, Michael S.] Case Western Reserve Univ, Div Nephrol & Hypertens, Dept Med, Cleveland, OH 44106 USA; [Mishra, Rangnath; Simonson, Michael S.] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Cool, Barbara L.] Abbott Labs, Dept Metab Dis Res, Abbott Pk, IL 60064 USA; [Laderoute, Keith R.] SRI Int, Menlo Pk, CA 94025 USA; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] INSERM, U567, F-75014 Paris, France	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Abbott Laboratories; SRI International; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Simonson, MS (corresponding author), Case Western Reserve Univ, Dept Med, Div Nephrol, Biomed Res Bldg,Rm 427, Cleveland, OH 44106 USA.	mss5@po.cwru.edu	Viollet, Benoit/O-6927-2017; FORETZ, Marc/O-7334-2017; Viollet, Benoit/N-2397-2019	Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; , Keith/0000-0002-5121-8072				ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Baelde HJ, 2004, J PATHOL, V204, P248, DOI 10.1002/path.1653; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dai CS, 2004, J AM SOC NEPHROL, V15, P2637, DOI 10.1097/01.ASN.0000139479.09658.EE; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 2005, ONCOGENE, V24, P1936, DOI 10.1038/sj.onc.1208343; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Eddy AA, 2005, PEDIATR NEPHROL, V20, P1369, DOI 10.1007/s00467-005-1995-5; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; HAYMAN EG, 1981, J CELL BIOL, V88, P352, DOI 10.1083/jcb.88.2.352; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; JOHNSON RJ, 1992, J AM SOC NEPHROL, V2, pS190; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Keller CD, 2007, AM J PATHOL, V170, P281, DOI 10.2353/ajpath.2007.060485; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Longnus SL, 2003, AM J PHYSIOL-REG I, V284, pR936, DOI 10.1152/ajpregu.00319.2002; Maeda A, 2005, CELL BIOL INT, V29, P422, DOI 10.1016/j.cellbi.2005.01.005; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; Mishra R, 2005, MOL PHARMACOL, V67, P2049, DOI 10.1124/mol.104.010546; Mishra R, 2007, AM J PHYSIOL-CELL PH, V292, pC1361, DOI 10.1152/ajpcell.00370.2006; Mizui M, 2006, KIDNEY INT, V70, P298, DOI 10.1038/sj.ki.5001541; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; Offersen BV, 2003, AM J PATHOL, V163, P1887, DOI 10.1016/S0002-9440(10)63547-X; Ramirez AM, 2006, AM J TRANSPLANT, V6, P2080, DOI 10.1111/j.1600-6143.2006.01430.x; Roberts AB, 2003, ANN NY ACAD SCI, V995, P1, DOI 10.1111/j.1749-6632.2003.tb03205.x; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; SCHULTZ PJ, 1988, AM J PHYSIOL, V255, pF674; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Simonson MS, 2007, KIDNEY INT, V71, P846, DOI 10.1038/sj.ki.5002180; Suzuki A, 2005, J BIOL CHEM, V280, P31557, DOI 10.1074/jbc.M503714200; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VINCENT MF, 1991, ADV EXP MED BIOL, V309, P359; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Walker GA, 2001, CURR TOP DEV BIOL, V51, P91, DOI 10.1016/S0070-2153(01)51003-0; Wang Y, 1996, MOL CELL BIOL, V16, P5915; Weill FX, 1997, LAB INVEST, V77, P63; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Young Martin E., 1996, Biochemical Society Transactions, V24, p268S; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0; Zheng F, 2002, AM J PHYSIOL-RENAL, V282, pF639, DOI 10.1152/ajprenal.00189.2001	66	99	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10461	10469		10.1074/jbc.M800902200	http://dx.doi.org/10.1074/jbc.M800902200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18250161	hybrid			2022-12-27	WOS:000254894700027
J	Lee, YM; Park, SH; Shin, DI; Hwang, JY; Park, B; Park, YJ; Lee, TH; Chae, HZ; Jin, BK; Oh, TH; Oh, YJ				Lee, Young Mook; Park, Seong H.; Shin, Dong-Ik; Hwang, Jee-Yeon; Park, BoKyung; Park, Yun-Jong; Lee, Tae H.; Chae, Ho Z.; Jin, Byung K.; Oh, Tae H.; Oh, Young J.			Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; MESENCEPHALIC DOPAMINERGIC-NEURONS; AMYOTROPHIC-LATERAL-SCLEROSIS; THIOL-SPECIFIC ANTIOXIDANT; HUMAN SUBSTANTIA-NIGRA; CELL-DEATH; HYDROGEN-PEROXIDE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; GLUTATHIONE-PEROXIDASE	The aim of this study was to investigate changes in protein profiles during the early phase of dopaminergic neuronal death using two-dimensional gel electrophoresis in conjunction with mass spectrometry. Several protein spots were identified whose expression was significantly altered following treatment of MN9D dopaminergic neuronal cells with 6-hydroxydopamine (6-OHDA). In particular, we detected oxidative modification of thioredoxin-dependent peroxidases (peroxiredoxins; PRX) in treated MN9D cells. Oxidative modification of PRX induced by 6-OHDA was blocked in the presence of N-acetylcysteine, suggesting that reactive oxygen species (ROS) generated by 6-OHDA induce oxidation of PRX. These findings were confirmed in primary cultures of mesencephalic neurons and in rat brain injected stereotaxically. Overexpression of PRX1 in MN9D cells (MN9D/PRX1) exerted neuroprotective effects against death induced by 6-OHDA through scavenging of ROS. Consequently, generation of both superoxide anion and hydrogen peroxide following 6-OHDA treatment was decreased in MN9D/PRX1. Furthermore, overexpression of PRX1 protected cells against 6-OHDA-induced activation of p38MAPKand subsequent activation of caspase-3. In contrast, 6-OHDA-induced apoptotic death signals were enhanced by RNA interference-targeted reduction of PRX1 in MN9D cells. Taken together, our data suggest that the redox state of PRX may be intimately involved in 6-OHDA-induced dopaminergic neuronal cell death and also provide a molecular mechanism by which PRX1 exerts a protective role in experimental models of Parkinson disease.	[Lee, Young Mook; Park, Seong H.; Shin, Dong-Ik; Hwang, Jee-Yeon; Park, BoKyung; Park, Yun-Jong; Lee, Tae H.; Oh, Young J.] Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea; [Chae, Ho Z.] Chonnam Natl Univ, Dept Biol Sci, Kwangju 500757, South Korea; [Jin, Byung K.] Ajou Univ, Brain Dis Res Ctr, Suwon 441749, South Korea; [Oh, Tae H.] Kyung Hee Univ, Aging & Brain Dis Res Ctr, Seoul 130701, South Korea	Yonsei University; Chonnam National University; Ajou University; Kyung Hee University	Oh, YJ (corresponding author), Yonsei Univ, Coll Sci, Dept Biol, 134 Shinchon Dong, Seoul 120749, South Korea.	yjoh@yonsei.ac.kr	/ABD-1619-2021					Allen S, 2003, J BIOL CHEM, V278, P6371, DOI 10.1074/jbc.M209915200; AMBANI LM, 1975, ARCH NEUROL-CHICAGO, V32, P114, DOI 10.1001/archneur.1975.00490440064010; Bai J, 2007, ANTIOXID REDOX SIGN, V9, P603, DOI 10.1089/ars.2006.1513; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; BENSHACHAR D, 1991, J NEUROCHEM, V56, P1441, DOI 10.1111/j.1471-4159.1991.tb11444.x; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; CEBALLOS I, 1990, LANCET, V335, P1035, DOI 10.1016/0140-6736(90)91099-V; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Chang JW, 2001, BIOCHEM BIOPH RES CO, V289, P507, DOI 10.1006/bbrc.2001.5989; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; CHOI HK, 1992, P NATL ACAD SCI USA, V89, P8943, DOI 10.1073/pnas.89.19.8943; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Choi SH, 2003, J NEUROSCI, V23, P5877; Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Conway JP, 2006, J BIOL CHEM, V281, P27991, DOI 10.1074/jbc.M605026200; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; Findlay VJ, 2005, BIOMED PHARMACOTHER, V59, P374, DOI 10.1016/j.biopha.2005.07.003; Floor E, 1998, J NEUROCHEM, V70, P268; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Han BS, 2003, J NEUROSCI, V23, P5069; Han BS, 2003, NEUROSCI LETT, V341, P99, DOI 10.1016/S0304-3940(03)00173-3; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Kang SW, 2004, J BIOL CHEM, V279, P2535, DOI 10.1074/jbc.M307698200; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kim SH, 2001, J NEURAL TRANSM-SUPP, P223; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; KISH SJ, 1985, NEUROSCI LETT, V58, P343, DOI 10.1016/0304-3940(85)90078-3; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liu ZH, 2005, CANCER RES, V65, P1647, DOI 10.1158/0008-5472.CAN-04-1754; Lotharius J, 1999, J NEUROSCI, V19, P1284; Masutani H, 2005, CELL DEATH DIFFER, V12, P991, DOI 10.1038/sj.cdd.4401625; Masutani H, 2004, MOL NEUROBIOL, V29, P229, DOI 10.1385/MN:29:3:229; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; Mizusawa H, 2000, NEUROSCI LETT, V283, P57, DOI 10.1016/S0304-3940(00)00910-1; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nakashima I, 2005, ARCH BIOCHEM BIOPHYS, V434, P3, DOI 10.1016/j.abb.2004.06.016; Oh YJ, 1995, NEUROBIOL DIS, V2, P157, DOI 10.1006/nbdi.1995.0017; Pak JH, 2002, J BIOL CHEM, V277, P49927, DOI 10.1074/jbc.M204222200; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Plaisant F, 2003, FREE RADICAL BIO MED, V34, P862, DOI 10.1016/S0891-5849(02)01440-5; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; Sanchez-Font MF, 2003, CELL MOL LIFE SCI, V60, P1513, DOI 10.1007/s00018-003-3048-1; Sarafian TA, 1999, J NEUROSCI RES, V56, P206, DOI 10.1002/(SICI)1097-4547(19990415)56:2<206::AID-JNR1>3.0.CO;2-X; Schapira AHV, 2001, ADV NEUROL, V86, P155; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Strey CW, 2004, AM J PATHOL, V165, P1701, DOI 10.1016/S0002-9440(10)63426-8; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yuan J, 2004, BBA-MOL CELL RES, V1693, P37, DOI 10.1016/j.bbamcr.2004.04.006; Zhou Y, 2000, BIOCHEM BIOPH RES CO, V268, P921, DOI 10.1006/bbrc.2000.2231	74	87	89	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9986	9998		10.1074/jbc.M800426200	http://dx.doi.org/10.1074/jbc.M800426200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18250162	hybrid			2022-12-27	WOS:000254671600055
J	Patel, VN; Likar, KM; Zisman-Rozen, S; Cowherd, SN; Lassiter, KS; Sher, I; Yates, EA; Turnbull, JE; Ron, D; Hoffman, MP				Patel, Vaishali N.; Likar, Karen M.; Zisman-Rozen, Simona; Cowherd, Samuel N.; Lassiter, Keyonica S.; Sher, Ifat; Yates, Edwin A.; Turnbull, Jeremy E.; Ron, Dina; Hoffman, Matthew P.			Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; BRANCHING MORPHOGENESIS; SALIVARY-GLAND; RECEPTOR SPECIFICITY; CRYSTAL-STRUCTURE; FACTOR FAMILY; FGF; BINDING; MOUSE; EXPRESSION	FGF10, a heparan sulfate ( HS)-binding growth factor, is required for branching morphogenesis of mouse submandibular glands ( SMGs). HS increases the affinity of FGF10 for FGFR2b, which forms an FGF10 center dot FGFR2b center dot HS ternary signaling complex, and results in diverse biological outcomes, including proliferation and epithelial morphogenesis. Defining the HS structures involved in specific FGF10-mediated events is critical to understand how HS modulates growth factor signaling in specific developmental contexts. We used HS-deficient BaF3/FGFR2b cells, which require exogenous HS to proliferate, to investigate the HS requirements for FGF10-mediated proliferation and primary SMG epithelia to investigate the structural requirements of HS for FGF10-mediated epithelial morphogenesis. In BaF3/FGFR2b cells, heparin with at least 10 saccharides and 6-O-, 2-O-, and N-sulfates were required for maximal proliferation. During FGF10-mediated SMG epithelial morphogenesis, HS increased proliferation and end bud expansion. Defined heparin decasaccharide libraries showed that 2-O-sulfation with either an N- or 6-O-sulfate induced end bud expansion, whereas decasaccharides with 6-O-sulfation alone induced duct elongation. End bud expansion resulted from increased FGFR1b signaling, with increased FGFR1b, Fgf1, and Spry1 as well as increased Aqp5 expression, a marker of end bud differentiation. Duct elongation was associated with expression of Cp2L1, a marker of developing ducts. Collectively, these findings show that the size and sulfate patterns of HS modulate specific FGF10-mediated events, such as proliferation, duct elongation, end bud expansion, and differentiation, and provide mechanistic insight as to how the developmental localization of specific HS structures in tissues influences FGF10-mediated morphogenesis and differentiation.	[Patel, Vaishali N.; Likar, Karen M.; Cowherd, Samuel N.; Lassiter, Keyonica S.; Hoffman, Matthew P.] NIH, DHHS, NIDCR, LCDB,Matrix & Morphogenesis Unit, Bethesda, MD 20892 USA; [Likar, Karen M.] Howard Hughes Med Inst, Natl Inst Hlth Res Scholars Program, Bethesda, MD 20817 USA; [Zisman-Rozen, Simona; Sher, Ifat; Ron, Dina] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Yates, Edwin A.; Turnbull, Jeremy E.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; Technion Israel Institute of Technology; University of Liverpool	Hoffman, MP (corresponding author), NIH, DHHS, NIDCR, LCDB,Matrix & Morphogenesis Unit, Bldg 30-Rm 430,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	mhoffman@mail.nih.gov	Yates, Edwin A/I-4808-2013	Yates, Edwin/0000-0001-9365-5433	MRC [G117/423] Funding Source: UKRI; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000707] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; Medical Research Council [G117/423] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; AVIVI A, 1993, FEBS LETT, V330, P249, DOI 10.1016/0014-5793(93)80882-U; Berman B, 1999, J BIOL CHEM, V274, P36132, DOI 10.1074/jbc.274.51.36132; de Vega S, 2007, J BIOL CHEM, V282, P30878, DOI 10.1074/jbc.M705847200; Entesarian M, 2005, NAT GENET, V37, P125, DOI 10.1038/ng1507; Ford-Perriss M, 2002, GLYCOBIOLOGY, V12, P721, DOI 10.1093/glycob/cwf072; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; Izvolsky KI, 2003, DEV BIOL, V258, P185, DOI 10.1016/S0012-1606(03)00114-3; Jaskoll T, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-11; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Patel VN, 2007, DEVELOPMENT, V134, P4177, DOI 10.1242/dev.011171; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; Rebustini IT, 2007, DEV BIOL, V308, P15, DOI 10.1016/j.ydbio.2007.04.031; REICHSLOTKY R, 1995, J BIOL CHEM, V270, P29813; RON D, 1993, J BIOL CHEM, V268, P2984; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sperinde GV, 1998, BIOCHEMISTRY-US, V37, P13153, DOI 10.1021/bi980600z; Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; Wei C, 2007, TISSUE ENG, V13, P721, DOI 10.1089/ten.2006.0123; Yamaguchi Y, 2005, DEV DYNAM, V233, P484, DOI 10.1002/dvdy.20348; Yamaguchi Y, 2006, DEVELOPMENT, V133, P4737, DOI 10.1242/dev.02658; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; Yates EA, 2004, J MED CHEM, V47, P277, DOI 10.1021/jm0309755; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	46	80	81	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9308	9317		10.1074/jbc.M709995200	http://dx.doi.org/10.1074/jbc.M709995200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18230614	hybrid, Green Published			2022-12-27	WOS:000254465800061
J	Wen, KK; Mckane, M; Houtman, JCD; Rubenstein, PA				Wen, Kuo-Kuang; Mckane, Melissa; Houtman, Jon C. D.; Rubenstein, Peter A.			Control of the ability of profilin to bind and facilitate nucleotide exchange from G-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ACTIN; ANGSTROM RESOLUTION; ATP HYDROLYSIS; BETA-ACTIN; F-ACTIN; FILAMENT; DYNAMICS; FORMIN; SUBSTITUTION; ELONGATION	A major factor in profilin regulation of actin cytoskeletal dynamics is its facilitation of G-actin nucleotide exchange. However, the mechanism of this facilitation is unknown. We studied the interaction of yeast (YPF) and human profilin 1 (HPF1) with yeast and mammalian skeletal muscle actins. Homologous pairs ( YPF and yeast actin, HPF1 and muscle actin) bound more tightly to one another than heterologous pairs. However, with saturating profilin, HPF1 caused a faster etheno-ATP exchange with both yeast and muscle actins than did YPF. Based on the -fold change in ATP exchange rate/K-d, however, the homologous pairs are more efficient than the heterologous pairs. Thus, strength of binding of profilin to actin and nucleotide exchange rate are not tightly coupled. Actin/HPF interactions were entropically driven, whereas YPF interactions were enthalpically driven. Hybrid yeast actins containing subdomain 1 (sub1) or subdomain 1 and 2 (sub12) muscle actin residues bound more weakly to YPF than did yeast actin (K-d = 2 mu M versus 0.6 mu M). These hybrids bound even more weakly to HPF than did yeast actin (K-d = 5 mu M versus 3.2 mu M). sub1/YPF interactions were entropically driven, whereas the sub12/YPF binding was enthalpically driven. Compared with WT yeast actin, YPF binding to sub1 occurred with a 5 times faster k(off) and a 2 times faster k(on). sub12 bound with a 3 times faster koff and a 1.5 times slower kon. Profilin controls the energetics of its interaction with nonhybrid actin, but interactions between actin sub-domains 1 and 2 affect the topography of the profilin binding site.	[Wen, Kuo-Kuang; Mckane, Melissa; Rubenstein, Peter A.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Houtman, Jon C. D.] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414; Houtman, Jon/0000-0002-5307-9854	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 33689] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arasada R, 2007, BBA-MOL CELL RES, V1773, P631, DOI 10.1016/j.bbamcr.2007.03.009; BABCOCK G, 1993, CELL MOTIL CYTOSKEL, V24, P179, DOI 10.1002/cm.970240305; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Carlier M F, 1990, Adv Biophys, V26, P51, DOI 10.1016/0065-227X(90)90007-G; CARLIER MF, 1991, J BIOL CHEM, V266, P1; CEDERGRENZEPPEZAUER ES, 1994, J MOL BIOL, V240, P459, DOI 10.1006/jmbi.1994.1461; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; COOK RK, 1991, J BIOL CHEM, V266, P16825; CROSBIE RH, 1994, BIOPHYS J, V67, P1957, DOI 10.1016/S0006-3495(94)80678-2; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; GOLDSCHMIDTCLERMONT PJ, 1991, J CELL BIOL, V113, P1081, DOI 10.1083/jcb.113.5.1081; KHAITLINA SY, 1993, EUR J BIOCHEM, V218, P911, DOI 10.1111/j.1432-1033.1993.tb18447.x; Kinosian HJ, 2002, BIOCHEMISTRY-US, V41, P6734, DOI 10.1021/bi016083t; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; MAGDOLEN V, 1993, FEBS LETT, V316, P41, DOI 10.1016/0014-5793(93)81733-G; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Minehardt TJ, 2006, BIOPHYS J, V90, P2445, DOI 10.1529/biophysj.105.072900; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Selden LA, 1999, BIOCHEMISTRY-US, V38, P2769, DOI 10.1021/bi981543c; SOUTHWICK FS, 1990, J CELL BIOL, V110, P1965, DOI 10.1083/jcb.110.6.1965; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Wen KK, 2002, J BIOL CHEM, V277, P41101, DOI 10.1074/jbc.M204025200; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	33	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9444	9453		10.1074/jbc.M709806200	http://dx.doi.org/10.1074/jbc.M709806200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18223293	hybrid, Green Published			2022-12-27	WOS:000254465800074
J	Babu, DA; Chakrabarti, SK; Garmey, JC; Mirmira, RG				Babu, Daniella A.; Chakrabarti, Swarup K.; Garmey, James C.; Mirmira, Raghavendra G.			Pdx1 and BETA2/NeuroD1 participate in a transcriptional complex that mediates short-range DNA looping at the insulin gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; IN-VITRO; GLOBIN LOCUS; DIFFERENTIATION; PROMOTER; P300; MICE; HOMEODOMAIN; METHYLATION; ACTIVATION	The activity of the insulin gene, Ins, in islet beta cells is thought to arise in part from the synergistic action of the transcription factors Pdx1 and BETA2/NeuroD1. We asked how the binding of these factors to A and E elements many tens or hundreds of base pairs upstream of the start site could influence activity of transcriptional machinery. We therefore tested the hypothesis that the complex of Pdx1 and BETA2/NeuroD1 maintains a DNA conformation such that distal regions of the gene are brought into proximity of the promoter and coding region. We show by coimmunoprecipitation that Pdx1 and BETA2/NeuroD1 exist within a complex and that the two physically interact with one another in this complex as assessed by fluorescence resonance energy transfer. Consistent with this interaction, we found that the two factors simultaneously occupy the same fragment of the Ins gene in beta cell lines using the chromatin immunoprecipitation/re-chromatin immunoprecipitation assay. Using a modification of the chromosome conformation capture assay in vitro and in beta cells, we observed that Pdx1 and BETA2/NeuroD1 mediate looping of a segment of Ins that brings EcoRI sites located at -623 and -761 bp (relative to the transcriptional start site) in proximity to one another. This looping appears to be dependent in vitro upon an intact A3 binding element, but not upon the E2 element. Based on our findings, we propose a model whereby Pdx1 and BETA2/NeuroD1 physically interact to form a nucleoprotein complex on the Ins gene that mediates formation of a short DNA loop. Our results suggest that such short loop conformations may be a general mechanism to permit interactions between transcription factors and basal transcriptional machinery.	[Babu, Daniella A.; Mirmira, Raghavendra G.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Chakrabarti, Swarup K.; Garmey, James C.; Mirmira, Raghavendra G.] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Chakrabarti, Swarup K.; Garmey, James C.; Mirmira, Raghavendra G.] Univ Virginia, Ctr Diabet, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Mirmira, RG (corresponding author), Indiana Univ, Sch Med, 635 Barnhill Dr,Rm 2031B, Indianapolis, IN 46202 USA.	rmirmira@iupui.edu	Mirmira, Raghavendra G/AAD-7592-2020	Mirmira, Raghavendra G/0000-0002-5013-6075	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK 60581] Funding Source: Medline; NIGMS NIH HHS [T32 GM 007055] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babu DA, 2007, MOL GENET METAB, V92, P43, DOI 10.1016/j.ymgme.2007.06.008; Chakrabarti SK, 2003, TRENDS ENDOCRIN MET, V14, P78, DOI 10.1016/S1043-2760(02)00039-5; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Day RN, 2005, MOL ENDOCRINOL, V19, P1675, DOI 10.1210/me.2005-0028; Dekker J, 2003, TRENDS BIOCHEM SCI, V28, P277, DOI 10.1016/S0968-0004(03)00089-6; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; Francis J, 2006, MOL ENDOCRINOL, V20, P3133, DOI 10.1210/me.2006-0126; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; GASA R, 2007, DIFFERENTIATION; Glick E, 2000, J BIOL CHEM, V275, P2199, DOI 10.1074/jbc.275.3.2199; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Huang HP, 2002, MOL ENDOCRINOL, V16, P541, DOI 10.1210/me.16.3.541; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Offield MF, 1996, DEVELOPMENT, V122, P983; Ohneda K, 2000, MOL CELL BIOL, V20, P900, DOI 10.1128/MCB.20.3.900-911.2000; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Qiu Y, 1998, MOL CELL BIOL, V18, P2957, DOI 10.1128/MCB.18.5.2957; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Qiu Y, 2004, J BIOL CHEM, V279, P9796, DOI 10.1074/jbc.M307577200; Sharma S, 1997, MOL CELL BIOL, V17, P2598, DOI 10.1128/MCB.17.5.2598; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; YOSHIDA T, 1994, AM J PATHOL, V145, P671	35	35	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8164	8172		10.1074/jbc.M800336200	http://dx.doi.org/10.1074/jbc.M800336200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18252719	hybrid, Green Published			2022-12-27	WOS:000254288000013
J	Reynolds, JG; McCalmon, SA; Donaghey, JA; Naya, FJ				Reynolds, Joseph G.; McCalmon, Sarah A.; Donaghey, Julie A.; Naya, Francisco J.			Deregulated protein kinase A signaling and myospryn expression in muscular dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; GLYCOPROTEIN COMPLEX; GENE-EXPRESSION; BINDING PARTNER; MUSCLE; PHOSPHORYLATION; IDENTIFICATION; PATHOLOGY; SURVIVAL	Alterations in signaling pathway activity have been implicated in the pathogenesis of Duchenne muscular dystrophy, a degenerative muscle disease caused by a deficiency in the costameric protein dystrophin. Accordingly, the notion of the dystrophin-glycoprotein complex, and by extension the costamere, as harboring signaling components has received increased attention in recent years. The localization of most, if not all, signaling enzymes to this subcellular region relies on interactions with scaffolding proteins directly or indirectly associated with the dystrophin-glycoprotein complex. One of these scaffolds is myospryn, a large, muscle-specific protein kinase A (PKA) anchoring protein or AKAP. Previous studies have demonstrated a dysregulation of myospryn expression in human Duchenne muscular dystrophy, suggesting a connection to the pathophysiology of the disorder. Here we report that dystrophic muscle exhibits reduced PKA activity resulting, in part, from severely mislocalized myospryn and the type II regulatory subunit (RII alpha) of PKA. Furthermore, we show that myospryn and dystrophin coimmunoprecipitate in native muscle extracts and directly interact in vitro. Our findings reveal for the first time abnormalities in the PKA signal transduction pathway and myospryn regulation in dystrophin deficiency.	[Reynolds, Joseph G.; McCalmon, Sarah A.; Donaghey, Julie A.; Naya, Francisco J.] Boston Univ, Dept Biol, Cell & Mol Biol Program, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, Cell & Mol Biol Program, 24 Cummington St, Boston, MA 02215 USA.	fnaya@bu.edu						Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Benson MA, 2004, J BIOL CHEM, V279, P10450, DOI 10.1074/jbc.M312664200; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Ceccarini M, 2007, J MOL BIOL, V371, P1174, DOI 10.1016/j.jmb.2007.06.019; Chakkalakal JV, 2004, HUM MOL GENET, V13, P379, DOI 10.1093/hmg/ddh037; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399; Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Durham JT, 2006, J BIOL CHEM, V281, P6841, DOI 10.1074/jbc.M510499200; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; Heydemann A, 2007, TRENDS CARDIOVAS MED, V17, P55, DOI 10.1016/j.tcm.2006.12.002; Johnson BD, 2005, P NATL ACAD SCI USA, V102, P4191, DOI 10.1073/pnas.0409695102; Judge LM, 2006, J CELL SCI, V119, P1537, DOI 10.1242/jcs.02857; Kolodziejczyk SM, 2001, CURR BIOL, V11, P1278, DOI 10.1016/S0960-9822(01)00397-9; Kouloumenta A, 2007, J BIOL CHEM, V282, P35211, DOI 10.1074/jbc.M704733200; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Michalak M, 1996, BIOCHEM CELL BIOL, V74, P431, DOI 10.1139/o96-047; Parsons SA, 2007, J BIOL CHEM, V282, P10068, DOI 10.1074/jbc.M609368200; Rando TA, 2001, MUSCLE NERVE, V24, P1575, DOI 10.1002/mus.1192; Reynolds JG, 2007, BBA-MOL CELL RES, V1773, P891, DOI 10.1016/j.bbamcr.2007.04.004; Russell MA, 2006, ARCH BIOCHEM BIOPHYS, V456, P204, DOI 10.1016/j.abb.2006.06.010; SENTER L, 1995, BIOCHEM BIOPH RES CO, V206, P57, DOI 10.1006/bbrc.1995.1009; Sweeney HL, 2000, P NATL ACAD SCI USA, V97, P13464, DOI 10.1073/pnas.011510597; Tkatchenko AV, 2001, NEUROMUSCULAR DISORD, V11, P269, DOI 10.1016/S0960-8966(00)00198-X; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	37	47	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8070	8074		10.1074/jbc.C700221200	http://dx.doi.org/10.1074/jbc.C700221200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18252718	hybrid, Green Published			2022-12-27	WOS:000254288000002
J	Santhoshkumar, P; Udupa, P; Murugesan, R; Sharma, KK				Santhoshkumar, Puttur; Udupa, Padmanabha; Murugesan, Raju; Sharma, K. Krishna			Significance of interactions of low molecular weight crystallin fragments in lens aging and cataract formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; OXIDIZED BETA-B3-CRYSTALLIN PEPTIDE; UBIQUITIN-PROTEASOME PATHWAY; AGE-RELATED-CHANGES; HEAT-SHOCK-PROTEIN; BOVINE LENS; EPITHELIAL-CELLS; A-CRYSTALLIN; POSTTRANSLATIONAL MODIFICATIONS; LIGHT-SCATTERING	Analysis of aged and cataract lenses shows the presence of increased amounts of crystallin fragments in the high molecular weight aggregates of water-soluble and water-insoluble fractions. However, the significance of accumulation and interaction of low molecular weight crystallin fragments in aging and cataract development is not clearly understood. In this study, 23 low molecular mass (< 3.5-kDa) peptides in the urea-soluble fractions of young, aged, and aged cataract human lenses were identified by mass spectroscopy. Two peptides, alpha B-(1-18) (MDIAIHHPWIRRPFFPFH) and beta A3/A1-(59-74) (SD(N) AYHIERLMSFRPIC), present in aged and cataract lens but not young lens, and a third peptide, gamma S-(167-178) (SPAVQSFRRIVE) present in all three lens groups were synthesized to study the effects of interaction of these peptides with intact alpha-, beta-, and gamma-crystallins and alcohol dehydrogenase, a protein used in aggregation studies. Interaction of alpha B-(1-18) and beta A3/A1-(59-74) peptides increased the scattering of light by beta- and gamma-crystallin and alcohol dehydrogenase. The ability of alpha-crystallin subunits to function as molecular chaperones was significantly reduced by interaction with alpha B-(1-18) and beta A3/A1-(59-74) peptides, whereas gamma S peptide had no effect on chaperone-like activity of alpha-crystallin. The beta A3/A1-(59-74) peptide caused a 5.64-fold increase in alpha B-crystallin oligomeric mass and partial precipitation. Replacing hydrophobic residues in alpha B-(118) and beta A3/A1-(59-74) peptides abolished their ability to induce crystallin aggregation and light scattering. Our study suggests that interaction of crystallin-derived peptides with intact crystallins could be a key event in age-related protein aggregation in lens and cataractogenesis.	[Santhoshkumar, Puttur; Udupa, Padmanabha; Murugesan, Raju; Sharma, K. Krishna] Univ Missouri, Dept Ophthalmol, Columbia Sch Med, Columbia, MO 65212 USA; [Sharma, K. Krishna] Univ Missouri, Dept Biochem, Columbia Sch Med, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sharma, KK (corresponding author), Univ Missouri, Dept Ophthalmol, Columbia Sch Med, EC213,1 Hosp Dr, Columbia, MO 65212 USA.	Sharmak@health.missouri.edu	Santhoshkumar, Puttur/G-1798-2010	Santhoshkumar, Puttur/0000-0002-6897-7278	NATIONAL EYE INSTITUTE [R24EY014795, R01EY009855, R29EY009855, R01EY011981] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011981, R24 EY014795, EY 11981, EY009855, EY 14795] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		DAS KP, 1995, BIOCHEM J, V311, P367, DOI 10.1042/bj3110367; David L L, 1989, Lens Eye Toxic Res, V6, P725; DAVID LL, 1994, INVEST OPHTH VIS SCI, V35, P785; Friguet Bertrand, 2002, TheScientificWorldJOURNAL, V2, P248; GARBER AT, 1984, J BIOL CHEM, V259, P376; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344; Han J, 2006, INVEST OPHTH VIS SCI, V47, P2990, DOI 10.1167/iovs.05-1529; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Harding JJ, 2002, AGEING RES REV, V1, P465, DOI 10.1016/S1568-1637(02)00012-0; Harrington V, 2004, MOL VIS, V10, P476; Hoehenwarter W, 2006, AMINO ACIDS, V30, P369, DOI 10.1007/s00726-005-0283-9; HORWITZ J, 1983, BIOCHEM BIOPH RES CO, V113, P65, DOI 10.1016/0006-291X(83)90432-1; Hosler MR, 2003, INT J BIOCHEM CELL B, V35, P685, DOI 10.1016/S1357-2725(02)00397-7; HUANG LL, 1995, EXP EYE RES, V61, P45, DOI 10.1016/S0014-4835(95)80057-3; Kumar RS, 2000, J PEPT RES, V56, P157, DOI 10.1034/j.1399-3011.2000.00785.x; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Mathur P, 2000, CURR EYE RES, V21, P926, DOI 10.1076/ceyr.21.6.926.6990; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; ROY D, 1978, EXP EYE RES, V26, P429, DOI 10.1016/0014-4835(78)90130-6; Ruotolo R, 2003, MOL VIS, V9, P538; Santhoshkumar P, 2006, PROTEIN SCI, V15, P2488, DOI 10.1110/ps.062338206; Senthilkumar R, 2002, J BIOL CHEM, V277, P39136, DOI 10.1074/jbc.M204684200; Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029; Sharma KK, 1996, CURR EYE RES, V15, P363, DOI 10.3109/02713689608995826; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Shih M, 1998, Mol Vis, V4, P4; Shih M, 2001, CURR EYE RES, V22, P458, DOI 10.1076/ceyr.22.6.458.5483; Sreelakshmi Y, 2004, BIOCHEMISTRY-US, V43, P15785, DOI 10.1021/bi048151s; Srivastava OP, 2004, J BIOL CHEM, V279, P10901, DOI 10.1074/jbc.M308884200; SRIVASTAVA OP, 1988, EXP EYE RES, V47, P525, DOI 10.1016/0014-4835(88)90092-9; Srivastava OP, 1996, CURR EYE RES, V15, P511, DOI 10.3109/02713689609000762; STADTMAN ER, 1990, BIOCHEMISTRY-US, V29, P6323, DOI 10.1021/bi00479a001; SWAMINATHAN S, 1986, BIOCHEM MED METAB B, V35, P184, DOI 10.1016/0885-4505(86)90073-3; SWANSON AA, 1985, CURR EYE RES, V4, P43, DOI 10.3109/02713688508999965; Thampi P, 2002, INVEST OPHTH VIS SCI, V43, P3265; Udupa EGP, 2005, INVEST OPHTH VIS SCI, V46, P2514, DOI 10.1167/iovs.05-0031; Udupa PEG, 2005, EXP EYE RES, V80, P185, DOI 10.1016/j.exer.2004.08.028; Ueda Y, 2002, INVEST OPHTH VIS SCI, V43, P205; Viteri G, 2004, ARCH BIOCHEM BIOPHYS, V427, P197, DOI 10.1016/j.abb.2004.05.006; VOORTER CEM, 1988, J BIOL CHEM, V263, P19020; Werten PJL, 1999, EXP EYE RES, V68, P99, DOI 10.1006/exer.1998.0584; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; Wride Michael A., 2006, Birth Defects Research, V78, P90, DOI 10.1002/bdrc.20063; Zeng JM, 2006, BIOCHEM J, V398, P197, DOI 10.1042/BJ20060019; Zhang H, 2001, HISTOCHEM J, V33, P511, DOI 10.1023/A:1014943522613	47	67	68	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8477	8485		10.1074/jbc.M705876200	http://dx.doi.org/10.1074/jbc.M705876200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18227073	Green Published, hybrid			2022-12-27	WOS:000254288000046
J	Zhu, H; Shuman, S				Zhu, Hui; Shuman, Stewart			Bacterial nonhomologous end joining ligases preferentially seal breaks with a 3 '-OH monoribonucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T4 RNA LIGASE-2; GUIDED MUTATIONAL ANALYSIS; DNA-LIGASE; POLYMERASE COMPONENT; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; NICK RECOGNITION; REPAIR SYSTEM; KU; MYCOBACTERIA	Many bacterial species have a nonhomologous end joining system of DNA repair driven by dedicated DNA ligases (LigD and LigC). LigD is a multifunctional enzyme composed of a ligase domain fused to two other catalytic modules: a polymerase that preferentially adds ribonucleotides to double-strand break ends and a phosphoesterase that trims 3'-oligoribonucleotide tracts until only a single 3'-ribonucleotide remains. LigD and LigC have a feeble capacity to seal 3'-OH/ 5'-PO4 DNA nicks. Here, we report that nick sealing by LigD and LigC enzymes is stimulated by the presence of a single ribonucleotide at the broken 3'-OH end. The ribonucleotide effect on LigD and LigC is specific for the 3'-terminal nucleotide and is either diminished or abolished when additional vicinal ribonucleotides are present. No such 3'-ribonucleotide effect is observed for bacterial LigA or Chlorella virus ligase. We found that in vitro repair of a double-strand break by Pseudomonas LigD requires the polymerase module and results in incorporation of an alkalilabile ribonucleotide at the repair junction. These results illuminate an underlying logic for the domain organization of LigD, whereby the polymerase and phosphoesterase domains can heal the broken 3'-end to generate the monoribonucleotide terminus favored by the nonhomologous end joining ligases.	[Zhu, Hui; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			NIGMS NIH HHS [GM 63611] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akey D, 2006, J BIOL CHEM, V281, P13412, DOI 10.1074/jbc.M513550200; Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Brissett NC, 2007, SCIENCE, V318, P456, DOI 10.1126/science.1145112; Bullard DR, 2006, BIOCHEM J, V398, P135, DOI 10.1042/BJ20060313; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; Doherty AJ, 2001, FEBS LETT, V500, P186, DOI 10.1016/S0014-5793(01)02589-3; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Gong CL, 2004, J BIOL CHEM, V279, P20594, DOI 10.1074/jbc.M401841200; Ho CK, 2002, P NATL ACAD SCI USA, V99, P12709, DOI 10.1073/pnas.192184699; Korycka-Machala M, 2006, FEMS MICROBIOL LETT, V258, P83, DOI 10.1111/j.1574-6968.2006.00199.x; LEHMAN IR, 1974, SCIENCE, V186, P790; Lubini P, 1994, CHEM BIOL, V1, P39, DOI 10.1016/1074-5521(94)90039-6; Moeller R, 2007, J BACTERIOL, V189, P3306, DOI 10.1128/JB.00018-07; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nandakumar J, 2004, MOL CELL, V16, P211, DOI 10.1016/j.molcel.2004.09.022; Nandakumar J, 2004, J BIOL CHEM, V279, P31337, DOI 10.1074/jbc.M402394200; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Nandakumar J, 2006, CELL, V127, P71, DOI 10.1016/j.cell.2006.08.038; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pitcher RS, 2007, DNA REPAIR, V6, P1271, DOI 10.1016/j.dnarep.2007.02.009; Pitcher RS, 2007, J MOL BIOL, V366, P391, DOI 10.1016/j.jmb.2006.10.046; Pitcher RS, 2005, J MOL BIOL, V351, P531, DOI 10.1016/j.jmb.2005.06.038; Sekiguchi J, 1997, BIOCHEMISTRY-US, V36, P9073, DOI 10.1021/bi970705m; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Yakovleva L, 2006, J BIOL CHEM, V281, P25026, DOI 10.1074/jbc.M603302200; Zhu H, 2006, P NATL ACAD SCI USA, V103, P1711, DOI 10.1073/pnas.0509083103; Zhu H, 2005, J BIOL CHEM, V280, P33707, DOI 10.1074/jbc.M506838200; Zhu H, 2005, J BIOL CHEM, V280, P25973, DOI 10.1074/jbc.M504002200; Zhu H, 2005, J BIOL CHEM, V280, P12137, DOI 10.1074/jbc.M413685200; Zhu H, 2005, J BIOL CHEM, V280, P418, DOI 10.1074/jbc.M410110200; Zhu H, 2007, NUCLEIC ACIDS RES, V35, P3631, DOI 10.1093/nar/gkm145	36	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8331	8339		10.1074/jbc.M705476200	http://dx.doi.org/10.1074/jbc.M705476200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18203718	hybrid, Green Published			2022-12-27	WOS:000254288000031
J	Hook, VYH; Kindy, M; Hook, G				Hook, Vivian Y. H.; Kindy, Mark; Hook, Gregory			Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; SELECTIVE INHIBITOR; CHROMAFFIN CELLS; GUINEA-PIGS; HUMAN BRAIN; PEPTIDE; PROTEASES; BACE1; THERAPEUTICS; ACCUMULATION	Elucidation of A beta-lowering agents that inhibit processing of the wild-type (WT) beta-secretase amyloid precursor protein (APP) site, present in most Alzheimer disease (AD) patients, is a logical approach for improving memory deficit in AD. The cysteine protease inhibitors CA074Me and E64d were selected by inhibition of beta-secretase activity in regulated secretory vesicles that produce beta-amyloid (A beta). The regulated secretory vesicle activity, represented by cathepsin B, selectively cleaves the WT beta-secretase site but not the rare Swedish mutant beta-secretase site. In vivo treatment of London APP mice, expressing the WT beta-secretase site, with these inhibitors resulted in substantial improvement in memory deficit assessed by the Morris water maze test. After inhibitor treatment, the improved memory function was accompanied by reduced amyloid plaque load, decreasedA beta 40 and A beta 42, and reduced C-terminal beta-secretase fragment derived from APP by beta-secretase. However, the inhibitors had no effects on any of these parameters in mice expressing the Swedish mutant beta-secretase site of APP. The notable efficacy of these inhibitors to improve memory and reduce A beta in an AD animal model expressing the WT beta-secretase APP site present in the majority of AD patients provides support for CA074Me and E64d inhibitors as potential AD therapeutic agents.	[Hook, Vivian Y. H.] Univ Calif San Diego, Skaggs Sch Phar & Pharmaceut Sci, Dept Neurosci, La Jolla, CA 92093 USA; [Kindy, Mark] Appl Neurotechnol Inc, Charleston, SC 29425 USA; [Hook, Gregory] Amer Life Sci Pharmaceut Inc, San Diego, CA 92109 USA	University of California System; University of California San Diego	Hook, VYH (corresponding author), Univ Calif San Diego, Skaggs Sch Phar & Pharmaceut Sci, Dept Neurosci, 9500 Gilman Dr MC 0744, La Jolla, CA 92093 USA.	vhook@ucsd.edu			NIA NIH HHS [AG18044] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R44AG018044, R43AG018044] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barrett AJ, 2004, HDB PROTEOLYTIC ENZY, P1051; Beck M, 1997, BBA-GENE STRUCT EXPR, V1351, P17, DOI 10.1016/S0167-4781(96)00232-1; Beck M, 2003, NEUROCHEM RES, V28, P637, DOI 10.1023/A:1022850113083; BERNSTEIN HG, 1990, BRAIN RES BULL, V24, P543, DOI 10.1016/0361-9230(90)90157-U; BEYNON R, 2001, PROTEOLYTIC ENZYMES, P293; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; CATALDO AM, 1991, P NATL ACAD SCI USA, V88, P10998, DOI 10.1073/pnas.88.24.10998; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Dewachter I, 2000, EXP GERONTOL, V35, P831, DOI 10.1016/S0531-5565(00)00149-2; Dodart JC, 2002, GENES BRAIN BEHAV, V1, P142, DOI 10.1034/j.1601-183X.2002.10302.x; Gandy S, 2003, ALZ DIS ASSOC DIS, V17, P259, DOI 10.1097/00002093-200310000-00011; Hook G, 2007, BIOL CHEM, V388, P979, DOI 10.1515/BC.2007.117; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Hook V, 2007, BIOL CHEM, V388, P247, DOI 10.1515/BC.2007.027; Hook VYH, 2002, J NEUROCHEM, V81, P237; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; IVERSEN LL, 1995, BIOCHEM J, V311, P1; IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679; KRIEGER TJ, 1991, J BIOL CHEM, V266, P8376; Liang K C, 1994, Chin J Physiol, V37, P201; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; NAKAMURA Y, 1991, NEUROSCI LETT, V130, P195, DOI 10.1016/0304-3940(91)90395-A; NAKANISHI H, 1994, EXP NEUROL, V126, P119, DOI 10.1006/exnr.1994.1048; Rice GI, 2004, BIOCHEM J, V383, P45, DOI 10.1042/BJ20040634; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; SARATH G, 2001, PROTEOLYTIC ENZYMES, P59; SATOYOSHI E, 1992, INTERNAL MED, V31, P841, DOI 10.2169/internalmedicine.31.841; SCHECHTE.I, 1970, EUR J BIOCHEM, V14, P516, DOI 10.1111/j.1432-1033.1970.tb00318.x; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shi XP, 2001, J BIOL CHEM, V276, P10366, DOI 10.1074/jbc.M009200200; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Sisodia SS, 1999, J CLIN INVEST, V104, P1169, DOI 10.1172/JCI8508; Strasser JF, 1995, J PHARMACOL EXP THER, V275, P1647; TOWATARI T, 1991, FEBS LETT, V280, P311, DOI 10.1016/0014-5793(91)80319-X; van Leuven F, 2000, PROG NEUROBIOL, V61, P305, DOI 10.1016/S0301-0082(99)00055-6; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; YAMAMOTO A, 1992, J MOL BIOL, V227, P942, DOI 10.1016/0022-2836(92)90234-B; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang J, 2005, J ALZHEIMERS DIS, V7, P125	52	161	171	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7745	7753		10.1074/jbc.M708362200	http://dx.doi.org/10.1074/jbc.M708362200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18184658	hybrid			2022-12-27	WOS:000253997900051
J	Hurst, DR; Xie, Y; Vaidya, KS; Mehta, A; Moore, BP; Accavitti-Loper, MA; Samant, RS; Saxena, R; Silveira, AC; Welch, DR				Hurst, Douglas R.; Xie, Yi; Vaidya, Kedar S.; Mehta, Alka; Moore, Blake P.; Accavitti-Loper, Mary Ann; Samant, Rajeev S.; Saxena, Ritu; Silveira, Alexandra C.; Welch, Danny R.			Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA METASTASIS; DEACETYLASE COMPLEX; MDA-MB-435 CELLS; IN-VIVO; BRMS1; PROTEINS; RBP1; IDENTIFICATION; MECHANISMS; LINES	The BRMS1 metastasis suppressor interacts with the protein AT-rich interactive domain 4A ( ARID4A, RBBP1) as part of SIN3.histone deacetylase chromatin remodeling complexes. These transcriptional co-repressors regulate diverse cell phenotypes depending upon complex composition. To define BRMS1 complexes and their roles in metastasis suppression, we generated BRMS1 mutants ( BRMS1(mut)) and mapped ARID4A interactions. BRMS1(L174D) disrupted direct interaction with ARID4A in yeast two-hybrid genetic screens but retained an indirect association with ARID4A in MDA-MB-231 and - 435 human breast cancer cell lines by co-immunoprecipitation. Deletion of the first coiled-coil domain ( BRMS1(Delta CC1)) did not disrupt direct interaction in yeast two-hybrid screens but did prevent association by co-immunoprecipitation. These results suggest altered complex composition with BRMS1mut. Although basal transcription repression was impaired and the pro-metastatic protein osteopontin was differentially down-regulated by BRMS1(L174D) and BRMS1(Delta CC1), both down-regulated the epidermal growth factor receptor and suppressed metastasis in MDA-MB-231 and - 435 breast cancer xenograft models. We conclude that BRMS1mut, which modifies the composition of a SIN3.histone deacetylase chromatin remodeling complex, leads to altered gene expression profiles. Because metastasis requires the coordinate expression of multiple genes, down-regulation of at least one important gene, such as the epidermal growth factor receptor, had the ability to suppress metastasis. Understanding which interactions are necessary for particular biochemical/ cellular functions may prove important for future strategies targeting metastasis.	[Hurst, Douglas R.; Xie, Yi; Vaidya, Kedar S.; Mehta, Alka; Moore, Blake P.; Silveira, Alexandra C.; Welch, Danny R.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Welch, Danny R.] Univ Alabama Birmingham, Dept Pharmacol Toxicol, Birmingham, AL 35294 USA; [Saxena, Ritu; Welch, Danny R.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Accavitti-Loper, Mary Ann; Welch, Danny R.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Accavitti-Loper, Mary Ann] Univ Alabama Birmingham, Epitope Recognit & Immunoreagent Core Facil, Birmingham, AL 35294 USA; [Samant, Rajeev S.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of South Alabama	Welch, DR (corresponding author), Univ Alabama Birmingham, Dept Pathol, Univ Blvd,Rm VH-G019, Birmingham, AL 35294 USA.	DanWelch@uab.edu	vaidya, kedar/B-7339-2009; Welch, Danny R/B-7310-2009; Hurst, Douglas R/B-7341-2009	Welch, Danny R/0000-0002-1951-4947; Samant, Rajeev/0000-0001-5681-4976; Vaidya, Kedar/0000-0001-6600-2648; Hurst, Douglas/0000-0002-1296-2210	NATIONAL CANCER INSTITUTE [R01CA087728, F32CA113037] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA087728-08, F32CA113037, R01 CA087728-07, R01 CA087728-05A1, F32 CA113037-01A1, CA87728, F32 CA113037-02, F32 CA113037, R01 CA087728, F32 CA113037-03, R01 CA087728-06] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Champine PJ, 2007, CLIN EXP METASTAS, V24, P551, DOI 10.1007/s10585-007-9092-8; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; Cicek M, 2004, CLIN EXP METASTAS, V21, P149, DOI 10.1023/B:CLIN.0000024729.19084.f0; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Hicks DG, 2006, CLIN CANCER RES, V12, P6702, DOI 10.1158/1078-0432.CCR-06-0635; Hurst DR, 2006, BIOCHEM BIOPH RES CO, V348, P1429, DOI 10.1016/j.bbrc.2006.08.005; Lai A, 1999, ONCOGENE, V18, P2091, DOI 10.1038/sj.onc.1202520; Laj A, 1999, MOL CELL BIOL, V19, P6632; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Le Guezennec X, 2006, NUCLEIC ACIDS RES, V34, P3929, DOI 10.1093/nar/gkl537; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Phadke PA, 2006, CLIN CANCER RES, V12, P1431, DOI 10.1158/1078-0432.CCR-05-1806; PHADKE PA, 2008, IN PRESS AM J PATHOL; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rivera J, 2007, J PROTEOME RES, V6, P4006, DOI 10.1021/pr0703167; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Samant RS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-6; Samant RS, 2001, CLIN EXP METASTAS, V18, P683, DOI 10.1023/A:1013124725690; Saunders MM, 2001, CANCER RES, V61, P1765; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Seraj MJ, 2000, CANCER RES, V60, P2764; Shevde LA, 2002, EXP CELL RES, V273, P229, DOI 10.1006/excr.2001.5452; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10321, DOI 10.1073/pnas.93.19.10321; Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367; Zhang S, 2006, INT J GYNECOL CANCER, V16, P522, DOI 10.1111/j.1525-1438.2006.00547.x	37	62	64	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7438	7444		10.1074/jbc.M709446200	http://dx.doi.org/10.1074/jbc.M709446200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18211900	Green Accepted, hybrid			2022-12-27	WOS:000253997900018
J	Oberhauser, AF; Carrion-Vazquez, M				Oberhauser, Andres F.; Carrion-Vazquez, Mariano			Mechanical biochemistry of proteins one molecule at a time	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ATOMIC-FORCE MICROSCOPY; TITIN IMMUNOGLOBULIN DOMAINS; SINGLE-PROTEIN; UNFOLDING PATHWAYS; CLAMP SPECTROSCOPY; STABILITY; ADHESION; ELASTICITY; CELL; NANOMECHANICS	The activity of proteins and their complexes often involves the conversion of chemical energy ( stored or supplied) into mechanical work through conformational changes. Mechanical forces are also crucial for the regulation of the structure and function of cells and tissues. Thus, the shape of eukaryotic cells ( and by extension, that of the multicellular organisms they form) is the result of cycles of mechanosensing, mechanotransduction, and mechanoresponse. Recently developed single-molecule atomic force microscopy techniques can be used to manipulate single molecules, both in real time and under physiological conditions, and are ideally suited to directly quantify the forces involved in both intra- and intermolecular protein interactions. In combination with molecular biology and computer simulations, these techniques have been applied to characterize the unfolding and refolding reactions in a variety of proteins. Single-molecule mechanical techniques are providing fundamental information on the structure and function of proteins and are becoming an indispensable tool to understand how these molecules fold and work.	[Oberhauser, Andres F.] Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Oberhauser, Andres F.] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Oberhauser, Andres F.] Univ Texas Galveston, Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Carrion-Vazquez, Mariano] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Carrion-Vazquez, Mariano] Ctr Invest Biomed Red Enfermed Neurodegener, E-28002 Madrid, Spain	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED	Oberhauser, AF (corresponding author), Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	afoberha@utmb.edu; mcarrion@cajal.csic.es	Carrion-Vazquez, Mariano/Y-3741-2018	Carrion-Vazquez, Mariano/0000-0001-7319-406X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073394] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK073394-03, R01 DK073394, R01DK073394] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Batey S, 2005, J MOL BIOL, V349, P1045, DOI 10.1016/j.jmb.2005.04.028; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X; Bhasin N, 2004, J BIOL CHEM, V279, P45865, DOI 10.1074/jbc.M404103200; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Bullard B, 2006, P NATL ACAD SCI USA, V103, P4451, DOI 10.1073/pnas.0509016103; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Cao Y, 2007, NAT MATER, V6, P109, DOI 10.1038/nmat1825; Carl P, 2001, P NATL ACAD SCI USA, V98, P1565, DOI 10.1073/pnas.031409698; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P11288, DOI 10.1073/pnas.96.20.11288; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carrion-Vazquez Mariano, 2006, V10, P163; CARRIONVAZQUEZ N, 2000, PROG BIOPHYS MOL BIO, V74, P63; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Dietz H, 2006, P NATL ACAD SCI USA, V103, P1244, DOI 10.1073/pnas.0509217103; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Gao M, 2006, PHYS CHEM CHEM PHYS, V8, P3692, DOI 10.1039/b606019f; Garcia-Manyes S, 2007, BIOPHYS J, V93, P2436, DOI 10.1529/biophysj.107.104422; Howard J., 2001, MECH MOTOR PROTEINS; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Junker JP, 2005, BIOPHYS J, V89, pL46, DOI 10.1529/biophysj.105.072066; Law R, 2003, BIOPHYS J, V84, P533, DOI 10.1016/S0006-3495(03)74872-3; Leake MC, 2006, J STRUCT BIOL, V155, P263, DOI 10.1016/j.jsb.2006.02.017; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Matouschek A, 2003, NAT STRUCT BIOL, V10, P674, DOI 10.1038/nsb0903-674; Matouschek A, 2003, CURR OPIN STRUC BIOL, V13, P98, DOI 10.1016/S0959-440X(03)00010-1; Miller E, 2006, BIOPHYS J, V91, P3848, DOI 10.1529/biophysj.106.088989; Ng SP, 2005, J MOL BIOL, V350, P776, DOI 10.1016/j.jmb.2005.04.070; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Prakash S, 2004, TRENDS BIOCHEM SCI, V29, P593, DOI 10.1016/j.tibs.2004.09.011; Qian F, 2005, J BIOL CHEM, V280, P40723, DOI 10.1074/jbc.M509650200; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Sarkar A, 2004, P NATL ACAD SCI USA, V101, P12882, DOI 10.1073/pnas.0403534101; Sarkar A, 2005, J BIOL CHEM, V280, P6261, DOI 10.1074/jbc.C400573200; Sarkar A, 2007, BIOPHYS J, V92, pL36, DOI 10.1529/biophysj.106.097741; Sato T, 2005, P NATL ACAD SCI USA, V102, P17999, DOI 10.1073/pnas.0504495102; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Schwaiger I, 2005, EMBO REP, V6, P46, DOI 10.1038/sj.embor.7400317; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; Sharma D, 2007, P NATL ACAD SCI USA, V104, P9278, DOI 10.1073/pnas.0700351104; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Sulkowska JI, 2008, BIOPHYS J, V94, P6, DOI 10.1529/biophysj.107.105973; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023; Valbuena A, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2794732; Walther KA, 2007, P NATL ACAD SCI USA, V104, P7916, DOI 10.1073/pnas.0702179104; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102; Yang GL, 2000, P NATL ACAD SCI USA, V97, P139, DOI 10.1073/pnas.97.1.139	69	78	79	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6617	6621		10.1074/jbc.R700050200	http://dx.doi.org/10.1074/jbc.R700050200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18195002	hybrid, Green Accepted			2022-12-27	WOS:000253779600002
J	Akashiba, H; Ikegaya, Y; Nishiyama, N; Matsuki, N				Akashiba, Hiroki; Ikegaya, Yuji; Nishiyama, Nobuyoshi; Matsuki, Norio			Differential involvement of cell cycle reactivation between striatal and cortical neurons in cell death induced by 3-nitropropionic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALPAIN-I ACTIVATION; MITOCHONDRIAL TOXIN; HUNTINGTONS-DISEASE; HIPPOCAMPAL-NEURONS; PROMOTE SURVIVAL; PC12 CELLS; APOPTOSIS; DEGENERATION; INDUCTION; KINASES	Recent evidence suggests that unscheduled cell cycle activity leads to neuronal cell death. 3-Nitropropionic acid (3-NP) is an irreversible inhibitor of succinate dehydrogenase and induces cell death in both striatum and cerebral cortex. Here we analyzed the involvement of aberrant cell cycle progression in 3-NP-induced cell death in these brain regions. 3-NP reduced the level of cyclin-dependent kinase inhibitor p27 in striatum but not in cerebral cortex. 3-NP also induced phosphorylation of retinoblastoma protein, a marker of cell cycle progression at late G(1) phase, only in striatum. Pharmacological experiments revealed that cyclin-dependent kinase activity and N-methyl-D-aspartate (NMDA) receptor were cooperatively involved in cell death by 3-NP in striatal neurons, whereas only NMDA receptor was involved in 3-NP-induced neurotoxicity in cortical neurons. Death of striatal neurons was preceded by elevation of somatic Ca2+ and activation of calpain, a Ca2+-dependent protease. Both striatal p27 down-regulation and cell death provoked by 3-NP were dependent on calpain activity. Moreover, transfection of p27 small interfering RNA reduced striatal cell viability. In cortical neurons, however, there was no change in somatic Ca2+ and calpain activity by 3-NP, and calpain inhibitors were not protective. These results suggest that 3-NP induces aberrant cell cycle progression and neuronal cell death via p27 down-regulation by calpain in striatum but not in the cerebral cortex. This is the first report for differential involvement of cell cycle reactivation in different brain regions and lightens the mechanism for region-selective vulnerability in human disease, including Huntington disease.	[Akashiba, Hiroki; Ikegaya, Yuji; Nishiyama, Nobuyoshi; Matsuki, Norio] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Nishiyama, N (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nisiyama@mol.f.u-tokyo.ac.jp		Ikegaya, Yuji/0000-0003-2260-8191				Abe K, 2000, NEUROSCI RES, V38, P325, DOI 10.1016/S0168-0102(00)00188-7; Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Akashiba H, 2006, CELL MOL LIFE SCI, V63, P2397, DOI 10.1007/s00018-006-6194-4; Akashiba H, 2006, J NEUROCHEM, V99, P733, DOI 10.1111/j.1471-4159.2006.04100.x; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; BEAL MF, 1993, J NEUROSCI, V13, P4181; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; BEHRENS MI, 1995, NEUROREPORT, V6, P545, DOI 10.1097/00001756-199502000-00034; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Bizat N, 2005, NEUROPHARMACOLOGY, V49, P695, DOI 10.1016/j.neuropharm.2005.04.030; Bizat N, 2003, J NEUROSCI, V23, P5020; Bogush A, 2007, J BIOL CHEM, V282, P7352, DOI 10.1074/jbc.M606508200; BORLONGAN CV, 1995, BRAIN RES BULL, V36, P549, DOI 10.1016/0361-9230(94)00242-S; Brecht S, 2001, MOL BRAIN RES, V94, P25, DOI 10.1016/S0006-8993(01)02767-6; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Brouillet E, 1998, J NEUROCHEM, V70, P794; BROUILLET E, 1993, J NEUROCHEM, V60, P356, DOI 10.1111/j.1471-4159.1993.tb05859.x; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Brustovetsky N, 2003, J NEUROSCI, V23, P4858; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Farinelli SE, 1996, J NEUROSCI, V16, P1150, DOI 10.1523/jneurosci.16-03-01150.1996; Fink SL, 1996, EXP NEUROL, V138, P298, DOI 10.1006/exnr.1996.0068; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Galas MC, 2004, NEUROBIOL DIS, V15, P152, DOI 10.1016/j.nbd.2003.09.013; Garcia M, 2002, J NEUROSCI, V22, P2174, DOI 10.1523/JNEUROSCI.22-06-02174.2002; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOULD DH, 1985, TOXICOL LETT, V27, P83, DOI 10.1016/0378-4274(85)90123-7; GOULD DH, 1982, NEUROPATH APPL NEURO, V8, P377, DOI 10.1111/j.1365-2990.1982.tb00306.x; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Guyot MC, 1997, NEUROSCIENCE, V79, P45, DOI 10.1016/S0306-4522(96)00602-1; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; Ino H, 2001, J NEUROSCI, V21, P6086, DOI 10.1523/JNEUROSCI.21-16-06086.2001; Jacquard C, 2006, FASEB J, V20, P1021, DOI 10.1096/fj.05-5085fje; Kim GW, 2000, J CEREBR BLOOD F MET, V20, P119, DOI 10.1097/00004647-200001000-00016; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Nasr P, 2003, NEUROCHEM INT, V43, P89, DOI 10.1016/S0197-0186(02)00229-2; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pang Z, 1997, J NEUROSCI, V17, P3064; Pang Z, 2003, J NEUROPATH EXP NEUR, V62, P633, DOI 10.1093/jnen/62.6.633; Park DS, 2000, NEUROBIOL AGING, V21, P771, DOI 10.1016/S0197-4580(00)00220-7; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Park DS, 1997, J NEUROSCI, V17, P8975; Park DS, 1996, J BIOL CHEM, V271, P8161, DOI 10.1074/jbc.271.14.8161; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; Rideout HJ, 2003, J NEUROSCI, V23, P1237, DOI 10.1523/JNEUROSCI.23-04-01237.2003; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Sato K, 2001, BIOL CHEM, V382, P743, DOI 10.1515/BC.2001.090; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SIMAN R, 1989, J NEUROSCI, V9, P1579; Stefanis L, 1997, CURR OPIN NEUROL, V10, P299, DOI 10.1097/00019052-199708000-00004; Sugino T, 2000, NEUROSCI LETT, V278, P101, DOI 10.1016/S0304-3940(99)00906-4; Tenneti L, 2000, J NEUROCHEM, V74, P134, DOI 10.1046/j.1471-4159.2000.0740134.x; Timsit S, 1999, EUR J NEUROSCI, V11, P263, DOI 10.1046/j.1460-9568.1999.00434.x; Verdaguer E, 2004, NEUROCHEM INT, V44, P251, DOI 10.1016/S0197-0186(03)00147-5; Wen Y, 2005, FEBS LETT, V579, P4591, DOI 10.1016/j.febslet.2005.07.028; WULLNER U, 1994, J NEUROCHEM, V63, P1772	63	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6594	6606		10.1074/jbc.M707730200	http://dx.doi.org/10.1074/jbc.M707730200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18182390	hybrid			2022-12-27	WOS:000253779500065
J	Hamuro, J; Higuchi, O; Okada, K; Ueno, M; Iemura, SI; Natsume, T; Spearman, H; Beeson, D; Yamanashi, Y				Hamuro, Johko; Higuchi, Osamu; Okada, Kumiko; Ueno, Makiko; Iemura, Shun-Ichiro; Natsume, Tohru; Spearman, Hayley; Beeson, David; Yamanashi, Yuji			Mutations causing DOK7 congenital myasthenia ablate functional motifs in dok-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT; FAMILY; PROTEIN; DEFICIENCY; DOMAIN; MEMBER	Dok-7 is a cytoplasmic activator of muscle-specific receptor-tyrosine kinase (MuSK). Both Dok-7 and MuSK are required for neuromuscular synaptogenesis. Mutations in DOK7 underlie a congenital myasthenic syndrome (CMS) associated with small and simplified neuromuscular synapses likely due to impaired Dok-7/MuSK signaling. The overwhelming majority of patients with DOK7 CMS have at least one allele with a frameshift mutation that causes a truncation in the COOH-terminal region of Dok-7 and affects MuSK activation. Dok-7 has pleckstrin homology (PH) and phosphotyrosine binding (PTB) domains in the NH2-terminal moiety, both of which are indispensable for MuSK activation in myotubes, but little is known about additional functional elements. Here, we identify a chromosome region maintenance 1-dependent nuclear export signal (NES) in the COOH-terminal moiety and demonstrate that the NES-mediated cytoplasmic location of Dok-7 is essential for regulating the interaction with MuSK in myotubes. The NH2-terminal PH domain is responsible for the nuclear import of Dok-7. We also show that the Src homology 2 target motifs in the COOH-terminal moiety of Dok-7 are active and crucial for MuSK activation in myotubes. In addition, CMS-associated missense mutations found in the PH or PTB domain inactivate Dok-7. Together, these findings demonstrate that, in addition to the NH2-terminal PH and PTB domains, the COOH-terminal NES and Src homology 2 target motifs play key roles in Dok-7/MuSK signaling for neuromuscular synaptogenesis. Ablation or disruption of these functional elements in Dok-7 probably underlies the neuromuscular junction synaptopathy observed in DOK7 CMS.	[Hamuro, Johko; Higuchi, Osamu; Okada, Kumiko; Ueno, Makiko; Yamanashi, Yuji] Tokyo Med & Dent Univ, Inst Med Res, Dept Cell Regulat, Bunkyo Ku, Tokyo 1138510, Japan; [Iemura, Shun-Ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tokyo 1350064, Japan; [Spearman, Hayley; Beeson, David] Univ Oxford, Weatherall Inst Mol Med, Neurosci Grp, Oxford OX1 2JD, England	Tokyo Medical & Dental University (TMDU); National Institute of Advanced Industrial Science & Technology (AIST); University of Oxford	Yamanashi, Y (corresponding author), Tokyo Med & Dent Univ, Inst Med Res, Dept Cell Regulat, Bunkyo Ku, Tokyo 1138510, Japan.	yamanashi.creg@mri.tmd.ac.jp	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582	MRC [G117/490] Funding Source: UKRI; Medical Research Council [G117/490] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Beeson David, 2005, Neuromuscul Disord, V15, P498, DOI 10.1016/j.nmd.2005.05.001; Biswas R, 2006, DEVELOPMENT, V133, P217, DOI 10.1242/dev.02198; Cabane C, 2003, AM J PHYSIOL-CELL PH, V284, pC658, DOI 10.1152/ajpcell.00078.2002; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333; Cong F, 1999, MOL CELL BIOL, V19, P8314; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; Di Cristofano A, 1998, J BIOL CHEM, V273, P4827, DOI 10.1074/jbc.273.9.4827; Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Engel AG, 2007, NEUROTHERAPEUTICS, V4, P252, DOI 10.1016/j.nurt.2007.01.001; Engel AG, 2006, BRAIN, V129, P1938, DOI 10.1093/brain/awl198; Gomez CM, 1996, ANN NEUROL, V39, P712, DOI 10.1002/ana.410390607; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; Hoffmann K, 2006, AM J HUM GENET, V79, P303, DOI 10.1086/506257; Iwahara T, 2003, ONCOGENE, V22, P5946, DOI 10.1038/sj.onc.1206633; Morgan NV, 2006, AM J HUM GENET, V79, P390, DOI 10.1086/506256; Muller JS, 2007, BRAIN, V130, P1497, DOI 10.1093/brain/awm068; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Palace J, 2007, BRAIN, V130, P1507, DOI 10.1093/brain/awm072; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Shen XM, 2002, NEUROLOGY, V59, P1881, DOI 10.1212/01.WNL.0000042422.87384.2F; SINE SM, 1995, NEURON, V15, P229, DOI 10.1016/0896-6273(95)90080-2; Slater CR, 2006, BRAIN, V129, P2061, DOI 10.1093/brain/awl200; Tsujino A, 2003, P NATL ACAD SCI USA, V100, P7377, DOI 10.1073/pnas.1230273100; Vincent A, 2006, NEURON, V52, P123, DOI 10.1016/j.neuron.2006.09.024; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3	32	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5518	5524		10.1074/jbc.M708607200	http://dx.doi.org/10.1074/jbc.M708607200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165682	hybrid			2022-12-27	WOS:000253426700032
J	Taketa, K; Matsumura, T; Yano, M; Ishii, N; Senokuchi, T; Motoshima, H; Murata, Y; Kim-Mitsuyama, S; Kawada, T; Itabe, H; Takeya, M; Nishikawa, T; Tsuruzoe, K; Araki, E				Taketa, Kayo; Matsumura, Takeshi; Yano, Miyuki; Ishii, Norio; Senokuchi, Takafumi; Motoshima, Hiroyuki; Murata, Yusuke; Kim-Mitsuyama, Shokei; Kawada, Teruo; Itabe, Hiroyuki; Takeya, Motohiro; Nishikawa, Takeshi; Tsuruzoe, Kaku; Araki, Eiichi			Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha(PPAR alpha) and PPAR gamma through MAPK-dependent COX-2 expression in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FOAM CELLS; DIFFERENTIAL EXPRESSION; SIGNALING PATHWAYS; GENE-EXPRESSION; RECEPTOR-GAMMA; KAPPA-B; ALPHA; CHOLESTEROL; CYCLOOXYGENASE-2	It has been reported that oxidized low density lipoprotein ( OxLDL) can activate both peroxisome proliferator-activated receptor-alpha(PPAR alpha) and PPAR gamma. However, the detailed mechanisms of Ox-LDL-induced PPAR alpha and PPAR gamma activation are not fully understood. In the present study, we investigated the effect of Ox-LDL on PPAR alpha and PPAR gamma activation in macrophages. Ox-LDL, but not LDL, induced PPAR alpha and PPAR gamma activation in a dose-dependent manner. Ox-LDL transiently induced cyclooxygenase-2 (COX-2) mRNA and protein expression, and COX-2 specific inhibition by NS-398 or meloxicam or small interference RNA of COX-2 suppressed Ox-LDL-induced PPAR alpha and PPAR gamma activation. Ox-LDL induced phosphorylation of ERK1/2 and p38 MAPK, and ERK1/2 specific inhibition abrogated Ox-LDL-induced COX-2 expression and PPAR alpha and PPAR gamma activation, whereas p38 MAPK-specific inhibition had no effect. Ox-LDL decreased the amounts of intracellular long chain fatty acids, such as arachidonic, linoleic, oleic, and docosahexaenoic acids. On the other hand, Ox-LDL increased intracellular 15-deoxy-Delta(12,14)-prostaglandin J(2)(15d- PGJ(2)) level through ERK1/2- dependent overexpression of COX-2. Moreover, 15d- PGJ(2) induced both PPAR alpha and PPAR gamma activation. Furthermore, COX-2 and 15d- PGJ(2) expression and PPAR activity were increased in atherosclerotic lesions of apoE-deficient mice. Finally, we investigated the involvement of PPAR alpha and PPAR gamma on Ox-LDL-induced mRNA expression of ATP-binding cassette transporter A1 and monocyte chemoattractant protein-1. Interestingly, specific inhibition of PPAR alpha and PPAR gamma suppressed Ox-LDL-induced ATP-binding cassette transporter A1 mRNA expression and enhanced Ox-LDL-induced monocyte chemoattractant protein-1 mRNA expression. In conclusion, Ox-LDL-induced increase in 15d- PGJ(2) level through ERK1/2- dependent COX-2 expression is one of the mechanisms of PPAR alpha and PPAR gamma activation in macrophages. These effects of Ox-LDL may control excess atherosclerotic progression.	[Taketa, Kayo; Matsumura, Takeshi; Yano, Miyuki; Ishii, Norio; Senokuchi, Takafumi; Motoshima, Hiroyuki; Murata, Yusuke; Nishikawa, Takeshi; Tsuruzoe, Kaku; Araki, Eiichi] Kumamoto Univ, Grad Sch Med Sci, Dept Metab Med, Kumamoto 8618556, Japan; [Kim-Mitsuyama, Shokei] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto 8618556, Japan; [Araki, Eiichi] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8618556, Japan; [Kawada, Teruo] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Nutr Chem Lab, Kyoto 6110011, Japan; [Itabe, Hiroyuki] Showa Univ, Sch Pharmaceut Sci, Dept Biol Chem, Tokyo 148555, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kyoto University; Showa University	Nishikawa, T (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Metab Med, 1-1-1 Honjo, Kumamoto 8618556, Japan.	takeshim@gpo.kumamoto-u.ac.jp	板部板部, 洋之/ABC-7746-2020					Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Burleigh ME, 2002, CIRCULATION, V105, P1816, DOI 10.1161/01.CIR.0000014927.74465.7F; CAMPBELL WB, 1996, GOODMAN GILMANS PHAR, P601; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; CHODAKEWITZ JA, 1988, J IMMUNOL, V140, P832; Claus R, 1996, BIOCHEMISTRY-US, V35, P4911, DOI 10.1021/bi952036n; Delerive P, 2000, FEBS LETT, V471, P34, DOI 10.1016/S0014-5793(00)01364-8; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fujiwara Y, 2007, ARTERIOSCL THROM VAS, V27, P2400, DOI 10.1161/ATVBAHA.107.147405; Furberg CD, 2005, CIRCULATION, V111, P249, DOI 10.1161/01.CIR.0000155081.76164.17; HAKAMATA H, 1994, ARTERIOSCLER THROMB, V14, P1860, DOI 10.1161/01.ATV.14.11.1860; HAMILTON TA, 1995, J CLIN INVEST, V95, P2020, DOI 10.1172/JCI117887; Hernandez-Presa MA, 2002, ATHEROSCLEROSIS, V160, P49, DOI 10.1016/S0021-9150(01)00547-0; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; ITABE H, 1994, J BIOL CHEM, V269, P15274; JONES PS, 1995, EUR J BIOCHEM, V233, P219, DOI 10.1111/j.1432-1033.1995.219_1.x; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lee H, 2000, CIRC RES, V87, P516; Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; LINDSTEDT KA, 1993, J BIOL CHEM, V268, P7741; Matsumura T, 1997, ARTERIOSCL THROM VAS, V17, P3013, DOI 10.1161/01.ATV.17.11.3013; Matsumura T, 1999, J BIOL CHEM, V274, P37665, DOI 10.1074/jbc.274.53.37665; Matsuo T, 2004, BIOCHEM BIOPH RES CO, V314, P817, DOI 10.1016/j.bbrc.2003.12.161; Miyamoto T, 1997, J BIOL CHEM, V272, P7752, DOI 10.1074/jbc.272.12.7752; MUNKER R, 1986, NATURE, V323, P79, DOI 10.1038/323079a0; NAGANO Y, 1991, P NATL ACAD SCI USA, V88, P6457, DOI 10.1073/pnas.88.15.6457; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NOBLE RP, 1968, J LIPID RES, V9, P693; Ohlsson BG, 1996, J CLIN INVEST, V98, P78, DOI 10.1172/JCI118780; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; Pontsler AV, 2002, J BIOL CHEM, V277, P13029, DOI 10.1074/jbc.M109546200; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SAKAI M, 1992, FEBS LETT, V314, P199, DOI 10.1016/0014-5793(92)80974-L; Senokuchi T, 2005, J BIOL CHEM, V280, P6627, DOI 10.1074/jbc.M412531200; Senokuchi T, 2004, ATHEROSCLEROSIS, V176, P233, DOI 10.1016/j.atherosclerosis.2004.05.019; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Takahashi N, 2002, FEBS LETT, V514, P315, DOI 10.1016/S0014-5793(02)02390-6; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Wong DR, 2005, CURR OPIN PHARMACOL, V5, P204, DOI 10.1016/j.coph.2005.02.001; Wu KK, 2005, ARTERIOSCL THROM VAS, V25, P679, DOI 10.1161/01.ATV.0000157899.35660.61; Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	54	52	57	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9852	9862		10.1074/jbc.M703318200	http://dx.doi.org/10.1074/jbc.M703318200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18208815	hybrid			2022-12-27	WOS:000254671600041
J	Watanabe, M; Fiji, HDG; Guo, L; Chan, L; Kinderman, SS; Slamon, DJ; Kwon, O; Tamanoi, F				Watanabe, Masaru; Fiji, Hannah D. G.; Guo, Lea; Chan, Lai; Kinderman, Sape S.; Slamon, Dennis J.; Kwon, Ohyun; Tamanoi, Fuyuhiko			Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHINE-CATALYZED SYNTHESIS; PRENYLATION; GTPASES; CELLS; CANCER; P21(WAF1/CIP1); EXPRESSION; COMPLEX; FARNESYLTRANSFERASE; TRANSFERASE	Protein geranylgeranylation is critical for the function of a number of proteins such as RhoA, Rac, and Rab. Protein geranylgeranyltransferase I (GGTase-I) and Rab geranylgeranyltransferase (RabGGTase) catalyze these modifications. In this work, we first describe the identification and characterization of small molecule inhibitors of GGTase-I (GGTI) with two novel scaffolds from a library consisting of allenoate-derived compounds. These compounds exhibit specific inhibition of GGTase-I and act by competing with a substrate protein. Derivatization of a carboxylic acid emanating from the core ring of one of the GGTI compounds dramatically improves their cellular activity. The improved GGTI compounds inhibit proliferation of a variety of human cancer cell lines and cause G(1) cell cycle arrest and induction of p21(CIP1/WAF1). We also report the identification of novel small molecule inhibitors of RabGGTase. These compounds were identified first by screening our GGTI compounds for those that also exhibited RabGGTase inhibition. This led to the discovery of a common structural feature for RabGGTase inhibitors: the presence of a characteristic six-atom aliphatic tail attached to the penta-substituted pyrrolidine core. Further screening led to the identification of compounds with preferential inhibition of RabGGTase. These compounds inhibit RabGGTase activity by competing with the substrate protein. These novel compounds may provide valuable reagents to study protein geranylgeranylation.	[Watanabe, Masaru; Guo, Lea; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Fiji, Hannah D. G.; Kinderman, Sape S.; Kwon, Ohyun] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Chan, Lai] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Slamon, Dennis J.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Tamanoi, F (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 1602 Mol Sci Bldg,609 Charles E Young Dr, Los Angeles, CA 90095 USA.	fuyut@microbio.ucla.edu			NATIONAL CANCER INSTITUTE [P01CA032737, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071779, P41GM081282] Funding Source: NIH RePORTER; NCI NIH HHS [CA 32737, CA 16042] Funding Source: Medline; NIAID NIH HHS [AI 28697] Funding Source: Medline; NIGMS NIH HHS [R01 GM071779, P41 GM081282, GM 071779] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adnane J, 1998, MOL CELL BIOL, V18, P6962, DOI 10.1128/MCB.18.12.6962; Castellano S, 2007, J AM CHEM SOC, V129, P5843, DOI 10.1021/ja070274n; Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W; Coxon FP, 2001, J BIOL CHEM, V276, P48213, DOI 10.1074/jbc.M106473200; Croizet-Berger K, 2002, P NATL ACAD SCI USA, V99, P8277, DOI 10.1073/pnas.122187699; El Oualid F, 2006, CURR MED CHEM, V13, P2385, DOI 10.2174/092986706777935078; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; GLOMSET JA, 1990, TRENDS BIOCHEM SCI, V15, P139, DOI 10.1016/0968-0004(90)90213-U; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Guo WT, 1997, ONCOGENE, V15, P1143, DOI 10.1038/sj.onc.1201287; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; He H, 2002, GENE EXPRESSION, V10, P231, DOI 10.3727/000000002783992406; Kapus A, 1999, J BIOL CHEM, V274, P8093, DOI 10.1074/jbc.274.12.8093; Kato-Stankiewicz J, 2002, P NATL ACAD SCI USA, V99, P14398, DOI 10.1073/pnas.222222699; Lackner MR, 2005, CANCER CELL, V7, P325, DOI 10.1016/j.ccr.2005.03.024; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lu J, 2007, SMALL, V3, P1341, DOI 10.1002/smll.200700005; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Peterson YK, 2006, J BIOL CHEM, V281, P12445, DOI 10.1074/jbc.M600168200; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Pylypenko O, 2006, EMBO J, V25, P13, DOI 10.1038/sj.emboj.7600921; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; SANFORD JC, 1995, ANAL BIOCHEM, V224, P547, DOI 10.1006/abio.1995.1086; Sebti SM, 2004, SEMIN ONCOL, V31, P28, DOI 10.1053/j.seminoncol.2003.12.012; Sjogren AKM, 2007, J CLIN INVEST, V117, P1294, DOI 10.1172/JCI30868; Sun JZ, 2003, CANCER RES, V63, P8922; Sun JZ, 1998, ONCOGENE, V16, P1467, DOI 10.1038/sj.onc.1201656; Tamanoi F., 2001, ENZYMES, V21; Taylor JS, 2003, EMBO J, V22, P5963, DOI 10.1093/emboj/cdg571; Vasudevan A, 1999, J MED CHEM, V42, P1333, DOI 10.1021/jm9900873; Vogt A, 1997, J BIOL CHEM, V272, P27224, DOI 10.1074/jbc.272.43.27224; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhang H, 2000, STRUCTURE, V8, P241, DOI 10.1016/S0969-2126(00)00102-7; Zhu XF, 2005, TETRAHEDRON, V61, P6276, DOI 10.1016/j.tet.2005.03.104; Zhu XF, 2005, ORG LETT, V7, P2977, DOI 10.1021/ol050946j; Zhu XF, 2005, ORG LETT, V7, P1387, DOI 10.1021/ol050203y; Zhu XF, 2003, J AM CHEM SOC, V125, P4716, DOI 10.1021/ja0344009	43	74	78	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9571	9579		10.1074/jbc.M706229200	http://dx.doi.org/10.1074/jbc.M706229200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18230616	hybrid, Green Published			2022-12-27	WOS:000254671600010
J	Gao, JM; Huo, LH; Sun, XO; Liu, M; Li, DW; Dong, JT; Zhou, J				Gao, Jinmin; Huo, Lihong; Sun, Xiaoou; Liu, Min; Li, Dengwen; Dong, Jin-Tang; Zhou, Jun			The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; CAP-GLY DOMAIN; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; TUBULIN; PROTEIN; BINDING; P150(GLUED); DRUGS; RICH	The familial cylindromatosis tumor suppressor CYLD is known to contain three cytoskeleton-associated protein glycine-rich (CAP-Gly) domains, which exist in a number of microtubule-binding proteins and are responsible for their association with microtubules. However, it remains elusive whether CYLD interacts with microtubules and, if so, whether the interaction is mediated by the CAP-Gly domains. In this study, our data demonstrate that CYLD associates with microtubules both in cells and in vitro, and the first CAP-Gly domain of CYLD is mainly responsible for the interaction. Knockdown of cellular CYLD expression dramatically delays microtubule regrowth after nocodazole washout, indicating an activity for CYLD in promoting microtubule assembly. Our data further demonstrate that CYLD enhances tubulin polymerization into microtubules by lowering the critical concentration for microtubule assembly. In addition, we have identified by wound healing assay a critical role for CYLD in mediating cell migration and found that its first CAP-Gly domain is required for this activity. Thus CYLD joins a growing list of CAP-Gly domain-containing proteins that regulate microtubule dynamics and function.	[Gao, Jinmin; Huo, Lihong; Sun, Xiaoou; Liu, Min; Li, Dengwen; Dong, Jin-Tang; Zhou, Jun] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University	Zhou, J (corresponding author), Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	junzhou@nankai.edu.cn	Huo, Lihong/ABI-4909-2020; Zhou, Jun/D-4654-2017; Gao, Jinmin/J-8967-2015	Zhou, Jun/0000-0001-7858-8260; Huo, Lihong/0000-0001-7901-6758; Dong, Jin-Tang/0000-0003-2349-5782; Gao, Jinmin/0000-0002-5894-6515				Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Feierbach B, 1999, J CELL BIOL, V144, P113, DOI 10.1083/jcb.144.1.113; Guasch A, 2002, J MOL BIOL, V318, P1139, DOI 10.1016/S0022-2836(02)00185-7; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Joshi HC, 1998, CURR OPIN CELL BIOL, V10, P35, DOI 10.1016/S0955-0674(98)80084-7; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li HP, 1997, P NATL ACAD SCI USA, V94, P1086, DOI 10.1073/pnas.94.4.1086; Li SL, 2002, J BIOL CHEM, V277, P48596, DOI 10.1074/jbc.M208512200; Liu M, 2006, J BIOL CHEM, V281, P18090, DOI 10.1074/jbc.M601324200; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; PIERRE P, 1994, J CELL SCI, V107, P1909; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Regamey A, 2003, J EXP MED, V198, P1959, DOI 10.1084/jem.20031187; Saito K, 2004, STRUCTURE, V12, P1719, DOI 10.1016/j.str.2004.07.012; Stegmeier F, 2007, P NATL ACAD SCI USA, V104, P8869, DOI 10.1073/pnas.0703268104; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Xuan CH, 2007, J BIOL CHEM, V282, P28800, DOI 10.1074/jbc.M702823200	28	104	112	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8802	8809		10.1074/jbc.M708470200	http://dx.doi.org/10.1074/jbc.M708470200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18222923	hybrid			2022-12-27	WOS:000254465800006
J	Geisinger, E; George, EA; Muir, TW; Novick, RP				Geisinger, Edward; George, Elizabeth A.; Muir, Tom W.; Novick, Richard P.			Identification of ligand specificity determinants in AgrC, the Staphylococcus aureus quorum-sensing receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE TOPOLOGY; GENETIC-VARIABILITY; VIRULENCE; LOCUS; PEPTIDE; CHEMORECEPTOR; ACTIVATION; EXPRESSION; CLONING; SYSTEM	Activation of the agr system, a major regulator of staphylococcal virulence, is initiated by the binding of a specific autoinducing peptide ( AIP) to the extracellular domain of AgrC, a classical receptor histidine protein kinase. There are four known agr specificity groups in Staphylococcus aureus, and we have previously localized the determinant of AIP receptor specificity to the C-terminal half of the AgrC sensor domain. We have now identified the specific amino acid residues that determine ligand activation specificity for agr groups I and IV, the two most closely related. Comparison of the AgrC-I and AgrC-IV sequences revealed a set of five divergent residues in the region of the second extracellular loop of the receptor that could be responsible. Accordingly, we exchanged these residues between AgrC-I and AgrC-IV and tested the resulting constructs for activation by the respective AIPs, measuring activation kinetics with a transcriptional fusion of blaZ to the principal agr promoter, P3. Exchange of all five residues caused a complete switch in receptor specificity. Replacement of two of the AgrC-IV residues by the corresponding residues in AgrC-I caused the receptor to be activated by AIP-I nearly as well as the wild type AgrC-I receptor. Replacement of two different AgrC-I residues by the corresponding AgrC-IV residues broadened receptor recognition specificity to include both AIPs. Various types of intermediate activity were observed with other replacement mutations. Preliminary characterization of the AgrC-I-AIP-I interaction suggests that ligand specificity may be sterically determined.	[Geisinger, Edward; Novick, Richard P.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Geisinger, Edward; Novick, Richard P.] NYU, Sch Med, Dept Microbiol, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Geisinger, Edward; Novick, Richard P.] NYU, Sch Med, Dept Med, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [George, Elizabeth A.; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA	New York University; New York University; New York University; Rockefeller University	Novick, RP (corresponding author), 540 1st Ave, New York, NY 10016 USA.	novick@saturn.med.nyu.edu	Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344; Novick, richard/0000-0003-4418-7893	NIAID NIH HHS [R01 AI 42783] Funding Source: Medline; NIGMS NIH HHS [5T32 GM 07308] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Autret N, 2003, INFECT IMMUN, V71, P4463, DOI 10.1128/IAI.71.8.4463-4471.2003; AZAVEDO JC, 1985, INFECT IMMUN, V50, P304; Bonner G, 2000, EUR J PHARMACOL, V403, P37, DOI 10.1016/S0014-2999(00)00578-1; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Derr P, 2006, J MOL BIOL, V355, P923, DOI 10.1016/j.jmb.2005.11.025; Dufour P, 2002, J BACTERIOL, V184, P1180, DOI 10.1128/jb.184.4.1180-1186.2002; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; GETHER U, 1993, J BIOL CHEM, V268, P7893; Gilot P, 2004, J CLIN MICROBIOL, V42, P1265, DOI 10.1128/JCM.42.3.1265-1269.2004; Hao B, 2002, BIOCHEMISTRY-US, V41, P12952, DOI 10.1021/bi020144l; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Lina G, 1998, MOL MICROBIOL, V28, P655, DOI 10.1046/j.1365-2958.1998.00830.x; Lyon GJ, 2002, BIOCHEMISTRY-US, V41, P10095, DOI 10.1021/bi026049u; Lyon GJ, 2002, J BIOL CHEM, V277, P6247, DOI 10.1074/jbc.M109989200; Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218; MORFELDT E, 1988, MOL GEN GENET, V211, P435, DOI 10.1007/BF00425697; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Rodgers KR, 2005, J INORG BIOCHEM, V99, P963, DOI 10.1016/j.jinorgbio.2005.02.016; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sturme MHJ, 2005, J BACTERIOL, V187, P5224, DOI 10.1128/JB.187.15.5224-5235.2005; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van Leeuwen W, 2000, J BACTERIOL, V182, P5721, DOI 10.1128/JB.182.20.5721-5729.2000; Vojtov N, 2002, P NATL ACAD SCI USA, V99, P10102, DOI 10.1073/pnas.152152499; WOLFF C, 1988, J BACTERIOL, V170, P4509, DOI 10.1128/jb.170.10.4509-4515.1988; Wright JS, 2005, J BACTERIOL, V187, P5585, DOI 10.1128/JB.187.16.5585-5594.2005; Wright JS, 2004, P NATL ACAD SCI USA, V101, P16168, DOI 10.1073/pnas.0404039101	32	64	65	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8930	8938		10.1074/jbc.M710227200	http://dx.doi.org/10.1074/jbc.M710227200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18222919	Green Published, hybrid			2022-12-27	WOS:000254465800021
J	Szegedi, SS; Castro, CC; Koutmos, M; Garrow, TA				Szegedi, Sandra S.; Castro, Carmen C.; Koutmos, Markos; Garrow, Timothy A.			Betaine-homocysteine S-methyltransferase-2 is an S-methylmethionine-homocysteine methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE METABOLISM; CDNA CLONING; VITAMIN-U; ADENOSYLMETHIONINE; EXPRESSION; LIVER; CHOLINE; ZINC; RAT; OLIGOMERIZATION	We demonstrate that purified recombinant human betaine-homocysteine methyltransferase-2 ( BHMT-2) is a zinc metalloenzyme that uses S-methylmethionine ( SMM) as a methyl donor for the methylation of homocysteine. Unlike the highly homologous betaine-homocysteine methyltransferase ( BHMT), BHMT-2 cannot use betaine. The Km of BHMT-2 for SMM was determined to be 0.94 mM, and it has a turnover number similar to BHMT. Several compounds were tested as inhibitors of recombinant human BHMT and BHMT-2. The SMM-specific methyltransferase activity of BHMT-2 is not inhibited by dimethylglycine and betaine, whereas the former is a potent inhibitor of BHMT. Methionine is a stronger inhibitor of BHMT-2 than BHMT, and S-adenosylmethionine does not inhibit BHMT but is a weak inhibitor of BHMT-2. BHMT can use SMM as a methyl donor with a k(cat)/K-m that is 5-fold lower than the k(cat)/K-m for betaine. However, SMM does not inhibit BHMT activity when it is presented to the enzyme at concentrations that are 10-fold greater than the subsaturating amounts of betaine used in the assay. Based on these data, it is our current hypothesis that in vivo most if not all of the SMM-dependent methylation of homocysteine occurs via BHMT-2.	[Szegedi, Sandra S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Garrow, Timothy A.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Castro, Carmen C.] Univ Cadiz, Fac Med, Area Fisiol, Cadiz 11003, Spain; [Koutmos, Markos] Univ Michigan, Div Biophys Res, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Universidad de Cadiz; University of Michigan System; University of Michigan	Garrow, TA (corresponding author), 1201 W Gregory Dr,359 ERML, Urbana, IL 61801 USA.	tagarrow@uiuc.edu	Carmen, Castro/C-7813-2009	Carmen, Castro/0000-0002-6802-0572; Koutmos, Markos/0000-0003-0933-6312	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052501, R29DK052501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048533] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 52501] Funding Source: Medline; NIGMS NIH HHS [GM 48533] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Augspurger NR, 2005, J NUTR, V135, P1712, DOI 10.1093/jn/135.7.1712; AWAD WM, 1983, J BIOL CHEM, V258, P2790; Bose N, 2002, PROTEIN EXPRES PURIF, V25, P73, DOI 10.1006/prep.2001.1611; Breksa AP, 1999, BIOCHEMISTRY-US, V38, P13991, DOI 10.1021/bi991003v; Castro C, 2004, BIOCHEMISTRY-US, V43, P5341, DOI 10.1021/bi049821x; Chadwick LH, 2000, GENOMICS, V70, P66, DOI 10.1006/geno.2000.6319; Collinsova M, 2003, CHEM BIOL, V10, P113, DOI 10.1016/S1074-5521(03)00008-5; DUBNOFF JW, 1948, J BIOL CHEM, V176, P789; Evans JC, 2002, STRUCTURE, V10, P1159, DOI 10.1016/S0969-2126(02)00796-7; FINKELSTEIN JD, 1972, ARCH BIOCHEM BIOPHYS, V153, P320, DOI 10.1016/0003-9861(72)90451-1; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; Gonzalez B, 2004, J MOL BIOL, V338, P771, DOI 10.1016/j.jmb.2004.03.005; Gonzalez B, 2003, BIOCHEM J, V370, P945, DOI 10.1042/BJ20021510; GRUNAU JA, 1991, COMMUN SOIL SCI PLAN, V22, P1873, DOI 10.1080/00103629109368542; HANSON AD, 1994, PLANT PHYSIOL, V105, P103, DOI 10.1104/pp.105.1.103; HEGEDUS M, 1992, ACTA VET HUNG, V40, P145; HOLCOMB ER, 1975, J BACTERIOL, V121, P267, DOI 10.1128/JB.121.1.267-271.1975; Kim GH, 2003, FOOD SCI TECHNOL RES, V9, P316, DOI 10.3136/fstr.9.316; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; LAVINE TF, 1954, J BIOL CHEM, V207, P107; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; MATSUO T, 1980, ARZNEIMITTEL-FORSCH, V30-1, P68; Miller CM, 2005, BIOCHEM J, V392, P443, DOI 10.1042/BJ20050356; Millian NS, 1998, ARCH BIOCHEM BIOPHYS, V356, P93, DOI 10.1006/abbi.1998.0757; Nakajima K, 2006, J NUTR SCI VITAMINOL, V52, P61, DOI 10.3177/jnsv.52.61; Neuhierl B, 1999, J BIOL CHEM, V274, P5407, DOI 10.1074/jbc.274.9.5407; Ranocha P, 2000, J BIOL CHEM, V275, P15962, DOI 10.1074/jbc.M001116200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHAPIRO SK, 1959, BIOCHIM BIOPHYS ACTA, V36, P241, DOI 10.1016/0006-3002(59)90089-7; Steele W, 2005, REPROD BIOMED ONLINE, V10, P755, DOI 10.1016/S1472-6483(10)61120-0; Szegedi SS, 2004, ARCH BIOCHEM BIOPHYS, V426, P32, DOI 10.1016/j.abb.2004.03.040; Thomas D, 2000, J BIOL CHEM, V275, P40718, DOI 10.1074/jbc.M005967200; Ulrey CL, 2005, HUM MOL GENET, V14, pR139, DOI 10.1093/hmg/ddi100	34	63	71	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8939	8945		10.1074/jbc.M710449200	http://dx.doi.org/10.1074/jbc.M710449200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18230605	Green Published, hybrid			2022-12-27	WOS:000254465800022
J	Vinogradov, SN; Moens, L				Vinogradov, Serge N.; Moens, Luc			Diversity of globin function: enzymatic, transport, storage, and sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NITRIC-OXIDE; TRUNCATED HEMOGLOBIN; MYCOBACTERIUM-TUBERCULOSIS; S-NITROSOHEMOGLOBIN; NITROSATIVE STRESS; CARDIAC ENERGETICS; HYDROGEN-PEROXIDE; BACILLUS-SUBTILIS; OXIDATIVE STRESS; GENE-EXPRESSION		[Vinogradov, Serge N.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Moens, Luc] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium	Wayne State University; University of Antwerp	Vinogradov, SN (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	svinogra@med.wayne.edu						Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Ascenzi P, 2007, GENE, V398, P42, DOI 10.1016/j.gene.2007.02.043; Bailly X, 2005, J INORG BIOCHEM, V99, P142, DOI 10.1016/j.jinorgbio.2004.10.012; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Bonamore A, 2007, GENE, V398, P52, DOI 10.1016/j.gene.2007.01.038; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; CHI P, 2008, IN PRESS MICROBIOL R, V163; D'Angelo P, 2004, BIOPHYS J, V86, P3882, DOI 10.1529/biophysj.103.034876; di Prisco G, 2007, GENE, V398, P143, DOI 10.1016/j.gene.2007.02.047; Farres J, 2005, BIOCHEMISTRY-US, V44, P4125, DOI 10.1021/bi047389d; Flogel U, 2007, MAGN RESON MED, V57, P50, DOI 10.1002/mrm.21101; Fordel E, 2007, FEBS J, V274, P1312, DOI 10.1111/j.1742-4658.2007.05679.x; Franzen S, 2007, BBA-PROTEINS PROTEOM, V1774, P121, DOI 10.1016/j.bbapap.2006.09.019; Fraser J, 2006, P NATL ACAD SCI USA, V103, P2977, DOI 10.1073/pnas.0508270103; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gow AJ, 2005, J INORG BIOCHEM, V99, P903, DOI 10.1016/j.jinorgbio.2004.12.001; Halder P, 2007, PROTEINS, V66, P172, DOI 10.1002/prot.21210; Hebelstrup KH, 2006, PHYSIOL PLANTARUM, V127, P157, DOI 10.1111/j.1399-3054.2006.00653.x; Hebelstrup KH, 2007, GENE, V398, P86, DOI 10.1016/j.gene.2007.01.039; Herold S, 2005, COMP BIOCHEM PHYS A, V142, P124, DOI 10.1016/j.cbpb.2005.06.009; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Kanatous SB, 2006, RESP PHYSIOL NEUROBI, V151, P151, DOI 10.1016/j.resp.2005.12.001; Li D, 2007, NEUROCHEM RES, V32, P1375, DOI 10.1007/s11064-007-9317-x; Lin PC, 2007, BIOPHYS J, V92, P2608, DOI 10.1529/biophysj.106.094458; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Nardini M, 2007, GENE, V398, P2, DOI 10.1016/j.gene.2007.02.045; Numoto N, 2005, P NATL ACAD SCI USA, V102, P14521, DOI 10.1073/pnas.0501541102; Ott T, 2005, CURR BIOL, V15, P531, DOI 10.1016/j.cub.2005.01.042; Ouellet H, 2007, J BIOL CHEM, V282, P7491, DOI 10.1074/jbc.M609155200; Pawaria S, 2007, MICROB PATHOGENESIS, V42, P119, DOI 10.1016/j.micpath.2006.12.001; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; Reeder BJ, 2007, IUBMB LIFE, V59, P477, DOI 10.1080/15216540601178083; Rifkind JM, 2006, ANTIOXID REDOX SIGN, V8, P1193, DOI 10.1089/ars.2006.8.1193; Rogstam A, 2007, J BACTERIOL, V189, P3063, DOI 10.1128/JB.01782-06; Singel DJ, 2005, ANNU REV PHYSIOL, V67, P99, DOI 10.1146/annurev.physiol.67.060603.090918; Stevanin TM, 2007, GENE, V398, P62, DOI 10.1016/j.gene.2007.03.021; Urgun-Demirtas M, 2006, CRIT REV BIOTECHNOL, V26, P145, DOI 10.1080/07388550600842794; Vinogradov SN, 2007, GENE, V398, P132, DOI 10.1016/j.gene.2007.02.041; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; WEBER RE, 2001, PHYSIOL REV, V181, P568; Wittenberg JB, 2007, GENE, V398, P156, DOI 10.1016/j.gene.2007.02.040; Xi Y, 2007, GENE, V398, P94, DOI 10.1016/j.gene.2007.01.040; Zhang W, 2005, BIOPHYS J, V88, P2801, DOI 10.1529/biophysj.104.047936	49	152	157	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8773	8777		10.1074/jbc.R700029200	http://dx.doi.org/10.1074/jbc.R700029200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18211906	hybrid			2022-12-27	WOS:000254465800001
J	Carayol, N; Katsoulidis, E; Sassano, A; Altman, JK; Druker, BJ; Platanias, LC				Carayol, Nathalie; Katsoulidis, Efstratios; Sassano, Antonella; Altman, Jessica K.; Druker, Brian J.; Platanias, Leonidas C.			Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; IMATINIB-RESISTANT; TUMOR-SUPPRESSOR; TYROSINE KINASE; LYMPHOBLASTIC-LEUKEMIA; TRANSFORMATION POTENCY; CYTOGENETIC RESPONSES; SELECTIVE INHIBITOR; AMN107 NILOTINIB	There is accumulating evidence that mammalian target of rapamycin (mTOR)-activated pathways play important roles in cell growth and survival of BCR-ABL-transformed cells. We have previously shown that the mTOR/p70 S6 kinase (p70 S6K) pathway is constitutively activated in BCR-ABLtransformed cells and that inhibition of BCR-ABL kinase activity by imatinib mesylate abrogates such activation. We now provide evidence for the existence of a novel regulatory mechanism by which BCR-ABL promotes cell proliferation, involving p70 S6K-mediated suppression of expression of programmed cell death 4 (PDCD4), a tumor suppressor protein that acts as an inhibitor of cap-dependent translation by blocking the translation initiation factor eIF4A. Our data also establish that second generation BCR-ABL kinase inhibitors block activation of p70 S6K and downstream engagement of the S6 ribosomal protein in BCR-ABL-transformed cells. Moreover, PDCD4 protein expression is up-regulated by inhibition of the BCR-ABL kinase in K562 cells and BaF3/BCR-ABL transfectants, suggesting a mechanism for the generation of the proapoptotic effects of such inhibitors. Knockdown of PDCD4 expression results in reversal of the suppressive effects of nilotinib and imatinib mesylate on leukemic progenitor colony formation, suggesting an important role for this protein in the generation of antileukemic responses. Altogether, our studies identify a novel mechanism by which BCR-ABL may promote leukemic cell growth, involving sequential engagement of the mTOR/p70 S6K pathway and downstream suppression of PDCD4 expression.	[Carayol, Nathalie; Katsoulidis, Efstratios; Sassano, Antonella; Altman, Jessica K.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Carayol, Nathalie; Katsoulidis, Efstratios; Sassano, Antonella; Altman, Jessica K.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Carayol, Nathalie; Katsoulidis, Efstratios; Sassano, Antonella; Altman, Jessica K.; Platanias, Leonidas C.] Jess Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Druker, Brian J.] Oregon Hlth & Sci Univ, Dept Hematol & Med Oncol, Portland, OR 97239 USA; [Druker, Brian J.] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu		Druker, Brian/0000-0001-8331-8206	NATIONAL CANCER INSTITUTE [R01CA121192, R01CA077816, R01CA094079, R01CA100579] Funding Source: NIH RePORTER; NCI NIH HHS [CA 100579, CA 94079, CA 121192, CA 77816] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Ahmad S, 1997, J BIOL CHEM, V272, P29991, DOI 10.1074/jbc.272.48.29991; Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Burgess MR, 2006, THESCIENTIFICWORLDJO, V6, P918, DOI 10.1100/tsw.2006.184; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Doggrell S, 2005, EXPERT OPIN INV DRUG, V14, P1063, DOI 10.1517/13543784.14.8.1063; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2003, SEMIN HEMATOL, V40, P50, DOI 10.1053/shem.2003.50000; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2006, NEW ENGL J MED, V354, P2594, DOI 10.1056/NEJMe068073; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gao F, 2007, ONCOL REP, V17, P123; Gingras AC, 2001, GENE DEV, V15, P2852; Goke R, 2004, ANN NY ACAD SCI, V1014, P220, DOI 10.1196/annals.1294.024; Golemovic M, 2005, CLIN CANCER RES, V11, P4941, DOI 10.1158/1078-0432.CCR-04-2601; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Guilhot F, 2007, BLOOD, V109, P4143, DOI 10.1182/blood-2006-09-046839; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Hochhaus A, 2007, BLOOD, V109, P2303, DOI 10.1182/blood-2006-09-047266; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kantarjian H, 2006, NAT REV DRUG DISCOV, V5, P717, DOI 10.1038/nrd2135; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian HM, 2006, ANN INTERN MED, V145, P913, DOI 10.7326/0003-4819-145-12-200612190-00008; Katsoulidis E, 2005, CANCER RES, V65, P9029, DOI 10.1158/0008-5472.CAN-04-4555; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Lankat-Buttgereit B, 2003, BIOL CELL, V95, P515, DOI 10.1016/j.biolcel.2003.09.003; LaRonde-LeBlanc N, 2007, MOL CELL BIOL, V27, P147, DOI 10.1128/MCB.00867-06; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Ly C, 2003, CANCER RES, V63, P5716; Lydon NB, 2004, LEUKEMIA RES, V28, pS29, DOI 10.1016/j.leukres.2003.10.002; Mauro MJ, 2002, J CLIN ONCOL, V20, P325, DOI 10.1200/JCO.20.1.325; Melo JV, 2007, CANCER LETT, V249, P121, DOI 10.1016/j.canlet.2006.07.010; Mohi MG, 2004, P NATL ACAD SCI USA, V101, P3130, DOI 10.1073/pnas.0400063101; Nimmanapalli R, 2002, CURR OPIN ONCOL, V14, P616, DOI 10.1097/00001622-200211000-00005; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; O'Hare T, 2005, CANCER CELL, V7, P117, DOI 10.1016/j.ccr.2005.01.020; Ozpolat B, 2007, MOL CANCER RES, V5, P95, DOI 10.1158/1541-7786.MCR-06-0125; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Parmar S, 2005, BLOOD, V106, P2436, DOI 10.1182/blood-2004-10-4003; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Prabhu S, 2007, ONCOGENE, V26, P1188, DOI 10.1038/sj.onc.1209901; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Ray A, 2007, BLOOD, V109, P5011, DOI 10.1182/blood-2006-01-015347; Shah NP, 2003, ONCOGENE, V22, P7389, DOI 10.1038/sj.onc.1206942; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tauchi T, 2006, INT J HEMATOL, V83, P294, DOI 10.1532/IJH97.06025; Verma A, 2002, LEUKEMIA LYMPHOMA, V43, P703, DOI 10.1080/10428190290016782; von Bubnoff N, 2006, BLOOD, V108, P1328, DOI 10.1182/blood-2005-12-010132; Weisberg E, 2006, BRIT J CANCER, V94, P1765, DOI 10.1038/sj.bjc.6603170; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2007, BLOOD, V109, P2112, DOI 10.1182/BLOOD-2006-06-026377; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634	78	58	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8601	8610		10.1074/jbc.M707934200	http://dx.doi.org/10.1074/jbc.M707934200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18223253	Green Published, hybrid			2022-12-27	WOS:000254288000059
J	Mbonye, UR; Yuan, C; Harris, CE; Sidhu, RS; Song, I; Arakawa, T; Smith, WL				Mbonye, Uri R.; Yuan, Chong; Harris, Clair E.; Sidhu, Ranjinder S.; Song, Inseok; Arakawa, Toshiya; Smith, William L.			Two distinct pathways for cyclooxygenase-2 protein degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; CYTOSOLIC PHOSPHOLIPASE A(2); PROSTAGLANDIN-H SYNTHASE-1; ER-ASSOCIATED DEGRADATION; EPIDERMAL-GROWTH-FACTOR; GLYCOPROTEIN QUALITY-CONTROL; ARACHIDONIC-ACID RELEASE; ENDOPLASMIC-RETICULUM; MANNOSIDASE-I; MISFOLDED GLYCOPROTEINS	Cyclooxygenases (COX-1 and COX-2) are N-glycosylated, endoplasmic reticulum-resident, integral membrane proteins that catalyze the committed step in prostanoid synthesis. COX-1 is constitutively expressed in many types of cells, whereas COX-2 is usually expressed inducibly and transiently. The control of COX-2 protein expression occurs at several levels, and overexpression of COX-2 is associated with pathologies such as colon cancer. Here we have investigated COX-2 protein degradation and demonstrate that it can occur through two independent pathways. One pathway is initiated by post-translational N-glycosylation at Asn-594. The N-glycosyl group is then processed, and the protein is translocated to the cytoplasm, where it undergoes proteasomal degradation. We provide evidence from site-directed mutagenesis that a 27-amino acid instability motif (27-IM) regulates post-translational N-glycosylation of Asn-594. This motif begins with Glu-586 8 residues upstream of the N-glycosylation site and ends with Lys-612 near the C terminus at Leu-618. Key elements of the 27-IM include a helix involving residues Glu-586 to Ser-596 with Asn-594 near the end of this helix and residues Leu-610 and Leu-611, which are located in an apparently unstructured downstream region of the 27-IM. The last 16 residues of the 27-IM, including Leu-610 and Leu-611, appear to promote N-glycosylation of Asn-594 perhaps by causing this residue to become exposed to appropriate glycosyl transferases. A second pathway for COX-2 protein degradation is initiated by substrate-dependent suicide inactivation. Suicide-inactivated protein is then degraded. The biochemical steps have not been resolved, but substrate-dependent degradation is not inhibited by proteasome inhibitors or inhibitors of lysosomal proteases. The pathway involving the 27-IM occurs at a constant rate, whereas degradation through the substrate-dependent process is coupled to the rate of substrate turnover.	[Mbonye, Uri R.; Yuan, Chong; Harris, Clair E.; Sidhu, Ranjinder S.; Song, Inseok; Arakawa, Toshiya; Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.	smithww@umich.edu	Mbonye, Uri/AAG-8861-2020	Mbonye, Uri/0000-0002-7694-0803				Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; DEWITT DL, 1993, ARCH BIOCHEM BIOPHYS, V306, P94, DOI 10.1006/abbi.1993.1485; Donoso G, 2005, BIOCHEM J, V387, P897, DOI 10.1042/BJ20041312; Duquette M, 2002, J BIOL CHEM, V277, P44631, DOI 10.1074/jbc.M207007200; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Heinemann FS, 1998, MOL BIOL CELL, V9, P3445, DOI 10.1091/mbc.9.12.3445; Heinemann FS, 2003, BIOCHEMISTRY-US, V42, P6929, DOI 10.1021/bi034071x; HOECK WG, 1993, P NATL ACAD SCI USA, V90, P4475, DOI 10.1073/pnas.90.10.4475; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Kang YJ, 2006, J IMMUNOL, V177, P8111, DOI 10.4049/jimmunol.177.11.8111; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kitzmuller C, 2003, BIOCHEM J, V376, P687, DOI 10.1042/BJ20030887; Leslie CC, 2004, BIOCHEM CELL BIOL, V82, P1, DOI 10.1139/o03-080; LIN LL, 1992, J BIOL CHEM, V267, P23451; MAXWELL AP, 1993, BIOCHEM J, V295, P763, DOI 10.1042/bj2950763; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Mevkh A T, 1993, Biokhimiia, V58, P1573; MEVKH AT, 1993, FEBS LETT, V321, P205, DOI 10.1016/0014-5793(93)80109-8; MirAfzali Z, 2006, J BIOL CHEM, V281, P28354, DOI 10.1074/jbc.M605206200; Miyakawa T, 1998, BIOCHEM J, V329, P107, DOI 10.1042/bj3290107; MIYAMOTO T, 1976, J BIOL CHEM, V251, P2629; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; MURAKAMI M, 1995, J BIOL CHEM, V270, P3239, DOI 10.1074/jbc.270.7.3239; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; OTTO JC, 1993, J BIOL CHEM, V268, P18234; OTTO JC, 1994, J BIOL CHEM, V269, P19868; Perkins DJ, 1997, BIOCHEM J, V321, P677, DOI 10.1042/bj3210677; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; REDDY ST, 1994, J BIOL CHEM, V269, P15473; Rich G, 1998, J CELL PHYSIOL, V176, P495, DOI 10.1002/(SICI)1097-4652(199809)176:3<495::AID-JCP6>3.0.CO;2-J; RIESE J, 1994, J LEUKOCYTE BIOL, V55, P476, DOI 10.1002/jlb.55.4.476; Rockwell P, 2000, ARCH BIOCHEM BIOPHYS, V374, P325, DOI 10.1006/abbi.1999.1646; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sevigny MB, 2006, FEBS LETT, V580, P6533, DOI 10.1016/j.febslet.2006.10.073; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Tanaka N, 2004, ARTERIOSCL THROM VAS, V24, P607, DOI 10.1161/01.ATV.0000117181.68309.10; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Tsuda H, 2006, THROMB RES, V117, P323, DOI 10.1016/j.thromres.2005.02.017; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; WU T, 1994, J CLIN INVEST, V93, P571, DOI 10.1172/JCI117009; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Wu Y, 2007, J BIOL CHEM, V282, P4841, DOI 10.1074/jbc.M607156200; Xiao GS, 1998, J BIOL CHEM, V273, P6801, DOI 10.1074/jbc.273.12.6801; Xu XM, 1997, J BIOL CHEM, V272, P6943, DOI 10.1074/jbc.272.11.6943; Xu XM, 1996, AM J PHYSIOL-CELL PH, V270, pC259, DOI 10.1152/ajpcell.1996.270.1.C259; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Zaric J, 2005, J BIOL CHEM, V280, P1077, DOI 10.1074/jbc.M410006200	70	83	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8611	8623		10.1074/jbc.M710137200	http://dx.doi.org/10.1074/jbc.M710137200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18203712	hybrid			2022-12-27	WOS:000254288000060
J	Zhao, B; Lin, X; Lei, L; Lamb, DC; Kelly, SL; Waterman, MR; Cane, DE				Zhao, Bin; Lin, Xin; Lei, Li; Lamb, David C.; Kelly, Steven L.; Waterman, Michael R.; Cane, David E.			Biosynthesis of the sesquiterpene antibiotic albaflavenone in Streptomyces coelicolor A3(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-P450 COMPLEMENT CYPOME; COMPLETE GENOME SEQUENCE; MOLECULAR-CLONING; AVERMITILIS; ACID; HYDROXYLATIONS; METABOLITES; MECHANISM; PATHWAY; BINDING	Cytochrome P450 170A1 (CYP170A1) is encoded by the sco5223 gene of the Gram-positive, soil-dwelling bacterium Streptomyces coelicolor A3(2) as part of a two-gene cluster with the sco5222 gene. The SCO5222 protein is a sesquiterpene synthase that catalyzes the cyclization of farnesyl diphosphate to the novel tricyclic hydrocarbon, epi-isozizaene (Lin, X., Hopson, R., and Cane, D. E. (2006) J. Am. Chem. Soc. 128, 6022 - 6023). The presence of CYP170A1 (sco5223) suggested that epiisozizaene might be further oxidized by the transcriptionally coupled P450. We have now established that purified CYP170A1 carries out two sequential allylic oxidations to convert epi-isozizaene to an epimeric mixture of albaflavenols and thence to the sesquiterpene antibiotic albaflavenone. Gas chromatography/ mass spectrometry analysis of S. coelicolor culture extracts established the presence of albaflavenone in the wildtype strain, along with its precursors epi-isozizaene and the albaflavenols. Disruption of the CYP170A1 gene abolished biosynthesis of both albaflavenone and the albaflavenols, but not epi-isozizaene. The combined results establish for the first time the presence of albaflavenone in S. coelicolor and clearly demonstrate that the biosynthesis of this antibiotic involves the coupled action of epi-isozizaene synthase and CYP170A1.	[Zhao, Bin; Lei, Li; Waterman, Michael R.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Zhao, Bin; Lei, Li; Waterman, Michael R.] Vanderbilt Univ, Sch Med, Inst Biol Chem, Nashville, TN 37232 USA; [Zhao, Bin; Lei, Li; Waterman, Michael R.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Lin, Xin; Cane, David E.] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Lamb, David C.; Kelly, Steven L.] Univ Wales Swansea, Swansea Med Sch, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales	Vanderbilt University; Vanderbilt University; Vanderbilt University; Brown University; Swansea University	Zhao, B (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 864 Robinson Res Bldg,23rd & Pierce Aves, Nashville, TN 37232 USA.	bin.zhao@vanderbilt.edu			NIEHS NIH HHS [ES 00267] Funding Source: Medline; NIGMS NIH HHS [GM 30301, GM 69970] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030301, R37GM030301, R01GM069970] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bellucci G, 1996, CHEM RES TOXICOL, V9, P871, DOI 10.1021/tx9600053; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Dewick PM, 2002, NAT PROD REP, V19, P181, DOI 10.1039/b002685i; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; Dubey VS, 2003, J BIOSCIENCES, V28, P637, DOI 10.1007/BF02703339; Groves J. T., 2005, CYTOCHROME P450, P1, DOI DOI 10.1007/0-387-27447-2_1; GURTLER H, 1994, J ANTIBIOT, V47, P434; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; KARP F, 1990, ARCH BIOCHEM BIOPHYS, V276, P219, DOI 10.1016/0003-9861(90)90029-X; Kieser T, 2000, PRACTICAL STREPTOMYC, P405; Lamb DC, 2003, BIOCHEM BIOPH RES CO, V307, P610, DOI 10.1016/S0006-291X(03)01231-2; Lamb DC, 2002, BIOCHEM J, V364, P555, DOI 10.1042/BJ20011380; Lamb DC, 2002, J BIOL CHEM, V277, P24000, DOI 10.1074/jbc.M111109200; Lin X, 2006, J AM CHEM SOC, V128, P6022, DOI 10.1021/ja061292s; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pikuleva IA, 1998, J BIOL CHEM, V273, P18153, DOI 10.1074/jbc.273.29.18153; Quaderer R, 2006, J AM CHEM SOC, V128, P13036, DOI 10.1021/ja0639214; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Scholler CEG, 2002, J AGR FOOD CHEM, V50, P2615, DOI 10.1021/jf0116754; Solenberg PJ, 1997, CHEM BIOL, V4, P195, DOI 10.1016/S1074-5521(97)90288-X; Takahashi S, 2007, J BIOL CHEM, V282, P31744, DOI 10.1074/jbc.M703378200; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Wise M. L., 1999, COMPREHENSIVE NATURA, P97, DOI DOI 10.1016/B978-0-08-091283-7.00038-2; WOOD AW, 1988, J BIOL CHEM, V263, P17322; Zhao B, 2005, J BIOL CHEM, V280, P11599, DOI 10.1074/jbc.M410933200	28	112	118	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8183	8189		10.1074/jbc.M710421200	http://dx.doi.org/10.1074/jbc.M710421200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18234666	Green Published, hybrid			2022-12-27	WOS:000254288000015
J	Burg, MB; Ferraris, JD				Burg, Maurice B.; Ferraris, Joan D.			Intracellular organic osmolytes: Function and regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							STRESS; PROTEINS	Cells of almost all organisms accumulate organic osmolytes when exposed to hyperosmolality, most often in the form of high salt or urea. In this review, we discuss 1) how the organic osmolytes protect; 2) the identity of osmolytes in Archaea, bacteria, yeast, plants, marine animals, and mammals; 3) the mechanisms by which they are accumulated; 4) sensors of osmolality; 5) the signaling pathways involved; and 6) mutual counteraction by urea and methylamines.	[Burg, Maurice B.; Ferraris, Joan D.] NIH, NHLBI, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Burg, MB (corresponding author), NIH, NHLBI, Dept Hlth & Human Serv, Bldg 10,Rm 6N260,9000 Rockville Pike, Bethesda, MD 20892 USA.	Maurice_Burg@nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL001283, ZIAHL001283] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Carr WES, 1996, BIOL BULL, V190, P149, DOI 10.2307/1542535; Chen Y, 2007, AM J PHYSIOL-RENAL, V292, pP981, DOI 10.1152/ajprenal.00493.2005; Dmitrieva NI, 2006, CELL CYCLE, V5, P1320, DOI 10.4161/cc.5.12.2867; Dmitrieva NI, 2005, P NATL ACAD SCI USA, V102, P10730, DOI 10.1073/pnas.0504870102; GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081, DOI 10.1152/physrev.1991.71.4.1081; Gralla JD, 2006, EMBO J, V25, P1515, DOI 10.1038/sj.emboj.7601041; Haussinger D, 1998, CONTRIB NEPHROL, V123, P185, DOI 10.1159/000059913; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kiewietdejonge A, 2006, FEMS YEAST RES, V6, P205, DOI 10.1111/j.1567-1364.2006.00030.x; LAW RO, 1994, J EXP ZOOL, V268, P90, DOI 10.1002/jez.1402680204; Mello CC, 2003, PROTEIN SCI, V12, P1522, DOI 10.1110/ps.0372903; Nagarajavel V, 2007, J BIOL CHEM, V282, P23622, DOI 10.1074/jbc.M702753200; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Wood Janet M, 2006, Sci STKE, V2006, ppe43; Yancey PH, 2002, COMP BIOCHEM PHYS A, V133, P667, DOI 10.1016/S1095-6433(02)00182-4; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	24	434	442	1	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7309	7313		10.1074/jbc.R700042200	http://dx.doi.org/10.1074/jbc.R700042200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18256030	Green Published, hybrid			2022-12-27	WOS:000253997900003
J	Kirkbride, KC; Townsend, TA; Bruinsma, MW; Barnett, JV; Blobe, GC				Kirkbride, Kellye C.; Townsend, Todd A.; Bruinsma, Monique W.; Barnett, Joey V.; Blobe, Gerard C.			Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING SITE; PROSTATE-CANCER; PROTEOGLYCAN BETAGLYCAN; MESENCHYMAL TRANSITION; MEMBRANE PROTEOGLYCAN; CELL-PROLIFERATION; OVARIAN-CANCER; HUMAN-DISEASE; I RECEPTORS; EXPRESSION	The bone morphogenetic protein (BMP) family, the largest subfamily of the structurally conserved transforming growth factor-beta(TGF-beta) superfamily of growth factors, are multifunctional regulators of development, proliferation, and differentiation. The TGF-beta type III receptor (T beta RIII or betaglycan) is an abundant cell surface proteoglycan that has been well characterized as a TGF-beta and inhibin receptor. Here we demonstrate that T beta RIII functions as a BMP cell surface receptor. T beta RIII directly and specifically binds to multiple members of the BMP subfamily, including BMP-2, BMP-4, BMP-7, and GDF-5, with similar kinetics and ligand binding domains as previously identified for TGF-beta. T beta RIII also enhances ligand binding to the BMP type I receptors, whereas short hairpin RNA-mediated silencing of endogenous T beta RIII attenuates BMP-mediated Smad1 phosphorylation. Using a biologically relevant model for T beta RIII function, we demonstrate that BMP-2 specifically stimulates T beta RIII-mediated epithelial to mesenchymal cell transformation. The ability of T beta RIII to serve as a cell surface receptor and mediate BMP, inhibin, and TGF-beta signaling suggests a broader role for T beta RIII in orchestrating TGF-beta superfamily signaling.	[Kirkbride, Kellye C.; Blobe, Gerard C.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Bruinsma, Monique W.; Blobe, Gerard C.] Duke Univ, Dept Med, Durham, NC 27708 USA; [Townsend, Todd A.; Barnett, Joey V.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Duke University; Duke University; Vanderbilt University	Blobe, GC (corresponding author), 354 LSRC Res Dr,Box 91004 DUMC, Durham, NC 27708 USA.	blobe001@mc.duke.edu	Blobe, Gerard/AAJ-5945-2020	Blobe, Gerard/0000-0002-4274-8901; Bruinsma, Monique/0000-0001-8213-1060	NCI NIH HHS [CA106307] Funding Source: Medline; NHLBI NIH HHS [R01 HL052922-10, HL52922, R01 HL052922] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA106307] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052922] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDRES JL, 1991, J BIOL CHEM, V266, P23282; ANDRES JL, 1992, J BIOL CHEM, V267, P5927; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Barnett Joey V., 2003, Birth Defects Research, V69, P58, DOI 10.1002/bdrc.10006; Beck SE, 2006, AM J PHYSIOL-GASTR L, V291, pG135, DOI 10.1152/ajpgi.00482.2005; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Brubaker KD, 2004, J CELL BIOCHEM, V91, P151, DOI 10.1002/jcb.10679; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; CHEIFETZ S, 1988, J BIOL CHEM, V263, P16984; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Clement JH, 2005, INT J ONCOL, V27, P401; Compton LA, 2007, CIRC RES, V101, P784, DOI 10.1161/CIRCRESAHA.107.152082; De Crescenzo G, 2001, J BIOL CHEM, V276, P29632, DOI 10.1074/jbc.M009765200; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; Farnworth PG, 2006, ENDOCRINOLOGY, V147, P3462, DOI 10.1210/en.2006-0023; Fivash M, 1998, CURR OPIN BIOTECH, V9, P97, DOI 10.1016/S0958-1669(98)80091-8; GORDON KJ, 2008, IN PRESS CARCINOGENE; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Harradine KA, 2006, ANN MED, V38, P403, DOI 10.1080/07853890600919911; Hatta T, 2000, BIOPOLYMERS, V55, P399, DOI 10.1002/1097-0282(2000)55:5<399::AID-BIP1014>3.0.CO;2-9; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hempel N, 2007, CANCER RES, V67, P5231, DOI 10.1158/0008-5472.CAN-07-0035; Ide H, 1997, CANCER RES, V57, P5022; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Karlsson R, 2004, J MOL RECOGNIT, V17, P151, DOI 10.1002/jmr.660; Kirkbride KC, 2005, TRENDS BIOCHEM SCI, V30, P611, DOI 10.1016/j.tibs.2005.09.003; Kleeff J, 1999, GASTROENTEROLOGY, V116, P1202, DOI 10.1016/S0016-5085(99)70024-7; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Natsume T, 1997, J BIOL CHEM, V272, P11535; Pepin MC, 1995, FEBS LETT, V377, P368, DOI 10.1016/0014-5793(95)01378-4; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Raida M, 2005, INT J ONCOL, V26, P1465; Rivera-Feliciano J, 2006, DEV BIOL, V295, P580, DOI 10.1016/j.ydbio.2006.03.043; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; SEGARINI PR, 1988, J BIOL CHEM, V263, P8366; Sharifi N, 2007, PROSTATE, V67, P301, DOI 10.1002/pros.20526; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; Velasco-Loyden G, 2004, J BIOL CHEM, V279, P7721, DOI 10.1074/jbc.M306499200; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Wang SN, 2004, J BIOL CHEM, V279, P23200, DOI 10.1074/jbc.M311998200; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; Wiater E, 2006, J BIOL CHEM, V281, P17011, DOI 10.1074/jbc.M601459200; You HJ, 2007, CARCINOGENESIS, V28, P2491, DOI 10.1093/carcin/bgm195; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	73	144	151	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7628	7637		10.1074/jbc.M704883200	http://dx.doi.org/10.1074/jbc.M704883200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18184661	hybrid			2022-12-27	WOS:000253997900038
J	Dittmer, S; Sahin, M; Pantlen, A; Saxena, A; Toutzaris, D; Pina, AL; Geerts, A; Golz, S; Methner, A				Dittmer, Sonja; Sahin, Mert; Pantlen, Anna; Saxena, Ambrish; Toutzaris, Diamandis; Pina, Ana-Luisa; Geerts, Andreas; Golz, Stefan; Methner, Axel			The constitutively active orphan G-protein-coupled receptor GPR39 protects from cell death by increasing secretion of pigment epithelium-derived growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE GLUTAMATE TOXICITY; HORMONE SECRETAGOGUE; SIGNALING PATHWAYS; GENE; IDENTIFICATION; ACTIVATION; EXPRESSION; SURVIVAL; KINASE; FAMILY	GPR39 is a constitutively active orphan G-protein-coupled receptor capable of increasing serum response element-mediated transcription. We found GPR39 to be up-regulated in a hippocampal cell line resistant against diverse stimulators of cell death and show that its overexpression protects against oxidative and endoplasmic reticulum stress, as well as against direct activation of the caspase cascade by Bax overexpression. In contrast, silencing GPR39 rendered cells more susceptible to cell death. An array analysis of transcripts induced by GPR39 revealed up-regulation of RGS16 ( inhibitor of G-protein signaling 16), which suggested coupling to G alpha(13) and induction of serum response element-mediated transcription by the small GTPase RhoA. In line with this, co-expression of GPR39 with RGS16, dominant-negative RhoA, or serum response factor abolished cell protection, whereas overexpression of the serum response factor protected from cell death. Further downstream the signaling cascade, GPR39 overexpression leads to increased secretion of the cytoprotective pigment epithelium-derived growth factor ( PEDF). Medium conditioned by cells overexpressing GPR39 contained 4-fold more PEDF, and when stripped off it lost most but not all of its protective properties. We conclude that GPR39 is a novel inhibitor of cell death, which might represent a therapeutic target with implications for processes involving apoptosis and endoplasmic reticulum stress like cancer, ischemia/ reperfusion injury, and neurodegenerative disease.	[Dittmer, Sonja; Saxena, Ambrish; Toutzaris, Diamandis; Methner, Axel] Univ Dusseldorf, Dept Neurol, Res Grp Protect Signaling, D-40225 Dusseldorf, Germany; [Sahin, Mert; Pantlen, Anna] Zentrum Mol Neurobiol Hamburg, D-20251 Hamburg, Germany; [Pina, Ana-Luisa] Univ Clin Regensburg, Dept Neurosurg, Neurobiol Res Grp, D-93053 Regensburg, Germany; [Geerts, Andreas; Golz, Stefan] Bayer HealthCare, Inst Target Res, D-42096 Wuppertal, Germany	Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg; Bayer AG; Bayer Healthcare Pharmaceuticals	Methner, A (corresponding author), Univ Dusseldorf, Dept Neurol, Res Grp Protect Signaling, Moorenstr 5, D-40225 Dusseldorf, Germany.		Saxena, Ambrish/AAQ-5984-2020	Methner, Axel/0000-0002-8774-0057				Chan CB, 2004, MOL CELL ENDOCRINOL, V214, P81, DOI 10.1016/j.mce.2003.11.020; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; Drews J, 2000, DRUG DISCOV TODAY, V5, P2, DOI 10.1016/S1359-6446(99)01428-2; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Egerod KL, 2007, MOL ENDOCRINOL, V21, P1685, DOI 10.1210/me.2007-0055; Flynn AN, 2004, APOPTOSIS, V9, P729, DOI 10.1023/B:APPT.0000045784.49886.96; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Heiber M, 1996, GENOMICS, V32, P462, DOI 10.1006/geno.1996.0143; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; JOHANSEN FE, 1993, MOL CELL BIOL, V13, P4640, DOI 10.1128/MCB.13.8.4640; Johnson EN, 2003, NAT CELL BIOL, V5, P1095, DOI 10.1038/ncb1065; JOOST P, GENOME BIOL, V3; Lefkowitz RJ, 2000, NAT CELL BIOL, V2, pE133, DOI 10.1038/35017152; Lewerenz J, 2006, J NEUROCHEM, V98, P916, DOI 10.1111/j.1471-4159.2006.03921.x; McKee KK, 1997, GENOMICS, V46, P426, DOI 10.1006/geno.1997.5069; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Sahin M, 2006, FREE RADICAL RES, V40, P1113, DOI 10.1080/10715760600838191; Schratt G, 2004, EMBO J, V23, P1834, DOI 10.1038/sj.emboj.7600188; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; XU C, 1995, J CLIN INVEST, V115, P2656; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255	23	51	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7074	7081		10.1074/jbc.M704323200	http://dx.doi.org/10.1074/jbc.M704323200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18180304	hybrid			2022-12-27	WOS:000253779600052
J	Ha, CH; Bennett, AM; Jin, ZG				Ha, Chang Hoon; Bennett, Anton M.; Jin, Zheng-Gen			A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; SHP-2 TYROSINE PHOSPHATASE; VE-CADHERIN; INDUCED ANGIOGENESIS; CELL-PROLIFERATION; DNA-SYNTHESIS; KINASE; PERMEABILITY; PHOSPHORYLATION; PATHWAY	Vascular endothelial growth factor ( VEGF) is a potent mediator of angiogenesis and vascular permeability, in which c-Src tyrosine kinase plays an essential role. However, the mechanisms by which VEGF stimulates c-Src activation have remained unclear. Here, we demonstrate that vascular endothelial cadherin ( VE-cadherin) plays a critical role in regulating c-Src activation in response to VEGF. In vascular endothelial cells, VE-cadherin was basally associated with c-Src and Csk ( C-terminal Src kinase), a negative regulator of Src activation. VEGF stimulated Csk release from VE-cadherin by recruiting the protein tyrosine phosphatase SHP2 to VE-cadherin signaling complex, leading to an increase in c-Src activation. Silencing VE-cadherin with small interference RNA significantly reduced VEGF-stimulated c-Src activation. Disrupting the association of VE-cadherin and Csk through the reconstitution of Csk binding-defective mutant of VE-cadherin also diminished Src activation. Moreover, inhibiting SHP2 by small interference RNA and adenovirus-mediated expression of a catalytically inactive mutant of SHP2 attenuated c-Src activation by blocking the disassociation of Csk from VE-cadherin. Furthermore, VE-cadherin and SHP2 differentially regulates VEGF downstream signaling. The inhibition of c-Src, VE-cadherin, and SHP2 diminished VEGF-mediated activation of Akt and endothelial nitric-oxide synthase. In contrast, inhibiting VE-cadherin and SHP2 enhanced ERK1/2 activation in response to VEGF. These findings reveal a novel role for VE-cadherin in modulating c-Src activation in VEGF signaling, thus providing new insights into the importance of VE-cadherin in VEGF signaling and vascular function.	[Ha, Chang Hoon; Jin, Zheng-Gen] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14586 USA; [Bennett, Anton M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	University of Rochester; Yale University	Jin, ZG (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, 211 Bailey Rd, Rochester, NY 14586 USA.	zheng-gen_jin@urmc.rochester.edu	Ha, C/GZL-9046-2022	Ha, Chang Hoon/0000-0001-7606-4340; Bennett, Anton/0000-0001-5187-7599	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046524] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL080611, R01 HL080611-05] Funding Source: Medline; NIAMS NIH HHS [R01 AR046524, R01 AR046524-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Dejana E, 2001, THROMB HAEMOSTASIS, V86, P308; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Esser S, 1998, J CELL SCI, V111, P1853; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Jin ZG, 2005, J BIOL CHEM, V280, P12305, DOI 10.1074/jbc.M500294200; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; Kontaridis MI, 2002, MOL CELL BIOL, V22, P3875, DOI 10.1128/MCB.22.11.3875-3891.2002; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; LIEBL EC, 1992, ONCOGENE, V7, P2417; Lungu AO, 2004, J BIOL CHEM, V279, P48794, DOI 10.1074/jbc.M313897200; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Sessa WC, 2005, MEM I OSWALDO CRUZ, V100, P15, DOI 10.1590/S0074-02762005000900004; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Shi ZQ, 1998, J BIOL CHEM, V273, P4904, DOI 10.1074/jbc.273.9.4904; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	42	53	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7261	7270		10.1074/jbc.M702881200	http://dx.doi.org/10.1074/jbc.M702881200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18180305	Green Accepted, hybrid			2022-12-27	WOS:000253779600071
J	Sammarco, MC; Ditch, S; Banerjee, A; Grabczyk, E				Sammarco, Mimi C.; Ditch, Scott; Banerjee, Ayan; Grabczyk, Ed			Ferritin L and H Subunits are differentially regulated on a post-transcriptional level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-RESPONSIVE ELEMENT; RECEPTOR MESSENGER-RNA; TISSUE OXYGEN; HELA-CELLS; MOLECULAR CONTROL; NITRIC-OXIDE; HAIRPIN LOOP; L-CHAINS; IN-VIVO; PROTEIN	Ferritin plays an important role in the storage and release of iron, an element utilized in cellular processes such as respiration, gene regulation, and DNA replication and repair. Ferritin in animals is composed of 24 ferritin L ( FTL) and ferritin H (FTH) subunits in ratios that vary in different cell types. Because the subunits are not functionally interchangeable, both L and H units are critical for maintaining iron homeostasis and protecting against iron overload. FTL and FTH are regulated primarily at a post-transcriptional level in response to cellular iron concentrations. Individual regulation of FTL and FTH is of much interest, and although transcriptional differences between FTL and FTH have been shown, differences in their post-transcriptional regulation have not been evaluated. We report here that FTL and FTH are differentially regulated in 1% oxygen on a post-transcriptional level. We have designed a quantitative assay system sensitive enough to detect differences between FTL and FTH iron regulatory elements (IREs) that a standard electrophoretic mobility shift assay does not. The FTL IRE is the primary responder in the presence of an iron donor in hypoxic conditions, and this response is reflected in endogenous FTL protein levels. These results provide evidence that FTL and FTH subunits respond independently to cellular iron concentrations and underscore the importance of evaluating FTL and FTHIREs separately.	[Sammarco, Mimi C.; Ditch, Scott; Banerjee, Ayan; Grabczyk, Ed] Louisiana State Univ, Dept Genet, Hlth Sci Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Grabczyk, E (corresponding author), Louisiana State Univ, Dept Genet, Hlth Sci Ctr, 533 Bolivar St, New Orleans, LA 70112 USA.	egrabc@lsuhsc.edu		Sammarco, Mimi/0000-0001-9491-5735				Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; AROSIO P, 1991, CURR STUD HEMATOL BL, V58, P127; AROSIO P, 1976, CANCER RES, V36, P1735; BEINERT H, 1996, FEBS LETT, V382; BOMFORD A, 1981, J BIOL CHEM, V256, P948; BOYD D, 1985, J BIOL CHEM, V260, P1755; Braun RD, 2001, AM J PHYSIOL-HEART C, V280, pH2533, DOI 10.1152/ajpheart.2001.280.6.H2533; CAIRO G, 1985, BIOCHEM BIOPH RES CO, V133, P314, DOI 10.1016/0006-291X(85)91877-7; CASKEY JH, 1983, P NATL ACAD SCI-BIOL, V80, P482, DOI 10.1073/pnas.80.2.482; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; Christova T, 2007, MOL CELL BIOCHEM, V301, P21, DOI 10.1007/s11010-006-9393-2; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Ferreira C, 2001, BLOOD, V98, P525, DOI 10.1182/blood.V98.3.525; GOETZE B, 2003, SCI STKE, pPL12; Han J, 2000, CELL MOL BIOL, V46, P517; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hanson ES, 1998, J BIOL CHEM, V273, P7588, DOI 10.1074/jbc.273.13.7588; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; Henderson BR, 1996, BIOESSAYS, V18, P739, DOI 10.1002/bies.950180909; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; Henderson RJ, 2005, BBA-MOL CELL RES, V1743, P162, DOI 10.1016/j.bbamcr.2004.09.032; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Hoffman WE, 1999, SURG NEUROL, V51, P654, DOI 10.1016/S0090-3019(99)00011-7; Irace C, 2005, J NEUROCHEM, V95, P1321, DOI 10.1111/j.1471-4159.2005.03449.x; Kato J, 2001, Rinsho Ketsueki, V42, P403; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Ke YH, 2000, BIOCHEMISTRY-US, V39, P6235, DOI 10.1021/bi9924765; Koorts A. M., 2007, Archives of Physiology and Biochemistry, V113, P30, DOI 10.1080/13813450701318583; Kuriyama-Matsumura K, 1998, BIOCHEM BIOPH RES CO, V249, P241, DOI 10.1006/bbrc.1998.9046; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; LEGGETT BA, 1993, J GASTROEN HEPATOL, V8, P21, DOI 10.1111/j.1440-1746.1993.tb01170.x; LEVI S, 1992, BIOCHEM J, V288, P591, DOI 10.1042/bj2880591; Liu XB, 2002, BLOOD CELL MOL DIS, V29, P315, DOI 10.1006/bcmd.2002.0572; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Mikulits W, 1997, BIOCHEM BIOPH RES CO, V235, P212, DOI 10.1006/bbrc.1997.6647; Muckenthaler M, 2003, BLOOD, V101, P3690, DOI 10.1182/blood-2002-07-2140; Patton SM, 2005, J CELL SCI, V118, P4365, DOI 10.1242/jcs.02570; Pinero DJ, 2001, J NUTR, V131, P2831; Ponka P, 1998, SEMIN HEMATOL, V35, P35; Powell AK, 1998, MET IONS BIOL SYST, V35, P515; Roetto A, 2002, BLOOD CELL MOL DIS, V29, P532, DOI 10.1006/bcmd.2002.0590; Rouault TA, 2002, BLOOD CELL MOL DIS, V29, P309, DOI 10.1006/bcmd.2002.0571; Sammarco MC, 2005, ANAL BIOCHEM, V346, P210, DOI 10.1016/j.ab.2005.08.033; Schlegl J, 1997, RNA, V3, P1159; Schneider BD, 2003, BLOOD, V102, P3404, DOI 10.1182/blood-2003-02-0433; SIERZPUTOWSKAGRACZ H, 1995, NUCLEIC ACIDS RES, V23, P146, DOI 10.1093/nar/23.1.146; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Truty J, 2001, J BIOL CHEM, V276, P48775, DOI 10.1074/jbc.M105392200; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; WHITE K, 1988, J BIOL CHEM, V263, P8938; WORWOOD M, 1985, HUM GENET, V69, P371, DOI 10.1007/BF00291657; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	68	65	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4578	4587		10.1074/jbc.M703456200	http://dx.doi.org/10.1074/jbc.M703456200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18160403	hybrid			2022-12-27	WOS:000253426500014
J	Aliprandi, P; Sizun, C; Perez, J; Mareuil, F; Caputo, S; Leroy, JL; Odaert, B; Laalami, S; Uzan, M; Bontems, F				Aliprandi, Pascale; Sizun, Christina; Perez, Javier; Mareuil, Fabien; Caputo, Sandrine; Leroy, Jean-Louis; Odaert, Benoit; Laalami, Soumaya; Uzan, Marc; Bontems, Francois			S1 ribosomal protein functions in translation initiation and ribonuclease RegB activation are mediated by similar RNA-protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; BINDING DOMAIN; REPLICASE; SUBUNIT; ENDORIBONUCLEASE; SCATTERING; RECOGNITION; EFFICIENCY; EVOLUTION	The ribosomal protein S1, in Escherichia coli, is necessary for the recognition by the ribosome of the translation initiation codon of most messenger RNAs. It also participates in other functions. In particular, it stimulates the T4 endoribonuclease RegB, which inactivates some of the phage mRNAs, when their translation is no longer required, by cleaving them in the middle of their Shine-Dalgarno sequence. In each function, S1 seems to target very different RNAs, which led to the hypothesis that it possesses different RNA-binding sites. We previously demonstrated that the ability of S1 to activate RegB is carried by a fragment of the protein formed of three consecutive domains (domains D3, D4, and D5). The same fragment plays a central role in all other functions. We analyzed its structural organization and its interactions with three RNAs: two RegB substrates and a translation initiation region. We show that these three RNAs bind the same area of the protein through a set of systematic (common to the three RNAs) and specific (RNA-dependent) interactions. We also show that, in the absence of RNA, the D4 and D5 domains are associated, whereas the D3 and D4 domains are in equilibrium between open (noninteracting) and closed (weakly interacting) forms and that RNA binding induces a structural reorganization of the fragment. All of these results suggest that the ability of S1 to recognize different RNAs results from a high adaptability of both its structure and its binding surface.	[Aliprandi, Pascale; Sizun, Christina; Mareuil, Fabien; Caputo, Sandrine; Odaert, Benoit; Bontems, Francois] Ecole Polytech, UPR2301, Antenne ICSN, CNRS, F-91198 Gif Sur Yvette, France; [Perez, Javier] Synchrotron SOLEIL, LOrmedes Merisiers, SWING, F-91192 Gif Sur Yvette, France; [Leroy, Jean-Louis] ICSN, Lab Chim & Biol Struct, CNRS, UPR2301, F-91190 Gif Sur Yvette, France; [Laalami, Soumaya; Uzan, Marc] Univ Paris 06, Inst Jacques Monod, F-75251 Paris 05, France; [Laalami, Soumaya; Uzan, Marc] Univ Paris 07, Inst Jacques Monod, F-75251 Paris 05, France; [Laalami, Soumaya; Uzan, Marc] Inst Jacques Monod, UMR7592, CNRS, F-75251 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Bontems, F (corresponding author), Ecole Polytech, UPR2301, Antenne ICSN, CNRS, 1 Ave Terrase, F-91198 Gif Sur Yvette, France.	Francois.Bontems@icsn.cnrs-gif.fr	Caputo, Sandrine M./C-3860-2018; Mareuil, Fabien/AAO-2844-2020; Caputo, Sandrine M/I-7460-2019	Caputo, Sandrine M./0000-0001-5338-9388; Mareuil, Fabien/0000-0002-3832-9157; Sizun, Christina/0000-0002-5760-2614				Agalarov SC, 2006, FEBS LETT, V580, P6797, DOI 10.1016/j.febslet.2006.11.036; Bernstein JR, 2007, J BIOL CHEM, V282, P18929, DOI 10.1074/jbc.M701395200; Bisaglia M, 2003, J BIOL CHEM, V278, P15261, DOI 10.1074/jbc.M212731200; Boni IV, 2000, J BACTERIOL, V182, P5872, DOI 10.1128/JB.182.20.5872-5879.2000; BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; CALOGERO RA, 1988, P NATL ACAD SCI USA, V85, P6427, DOI 10.1073/pnas.85.17.6427; CANONACO MA, 1989, EUR J BIOCHEM, V182, P501, DOI 10.1111/j.1432-1033.1989.tb14856.x; COMMANS S, 1995, J MOL BIOL, V253, P100, DOI 10.1006/jmbi.1995.0539; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; Draper DE, 1999, NUCLEIC ACIDS RES, V27, P381, DOI 10.1093/nar/27.2.381; Durand S, 2006, NUCLEIC ACIDS RES, V34, P6549, DOI 10.1093/nar/gkl911; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; FARWELL MA, 1992, MOL MICROBIOL, V6, P3375, DOI 10.1111/j.1365-2958.1992.tb02205.x; FRANZETTI B, 1992, J BIOL CHEM, V267, P19075; Glatter O., 1982, SMALL ANGLE XRAY SCA; GUERRIERTAKADA C, 1983, J BIOL CHEM, V258, P3649; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; Kalapos MP, 1997, BIOCHIMIE, V79, P493, DOI 10.1016/S0300-9084(97)82741-1; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Lebars I, 2001, J BIOL CHEM, V276, P13264, DOI 10.1074/jbc.M010680200; Mareuil F, 2007, EUR BIOPHYS J BIOPHY, V37, P95, DOI 10.1007/s00249-007-0170-2; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; McGinness KE, 2004, P NATL ACAD SCI USA, V101, P13454, DOI 10.1073/pnas.0405521101; Miranda G, 1997, J MOL BIOL, V267, P1089, DOI 10.1006/jmbi.1997.0939; MUNIYAPPA K, 1993, BIOCHEM MOL BIOL INT, V31, P1; MURALIKRISHNA P, 1985, BIOCHEM INT, V11, P691; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Rajkowitsch L, 2007, RNA, V13, P2053, DOI 10.1261/rna.671807; RINGQUIST S, 1995, BIOCHEMISTRY-US, V34, P3640, DOI 10.1021/bi00011a019; RUCKMAN J, 1994, J BIOL CHEM, V269, P26655; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schuppli D, 1998, J MOL BIOL, V283, P585, DOI 10.1006/jmbi.1998.2123; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selivanova OM, 2003, J BIOL CHEM, V278, P36311, DOI 10.1074/jbc.M304713200; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Snoussi K, 2001, J MOL BIOL, V309, P139, DOI 10.1006/jmbi.2001.4618; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; SUBRAMANIAN AR, 1983, PROG NUCLEIC ACID RE, V28, P101, DOI 10.1016/S0079-6603(08)60085-9; Sugiura M, 1998, ANNU REV GENET, V32, P437, DOI 10.1146/annurev.genet.32.1.437; Sukhodolets MV, 2006, RNA, V12, P1505, DOI 10.1261/rna.2321606; Todone F, 2001, MOL CELL, V8, P1137, DOI 10.1016/S1097-2765(01)00379-3; Vachette P, 2003, METHOD ENZYMOL, V374, P584, DOI 10.1016/S0076-6879(03)74024-5; WAHBA AJ, 1974, J BIOL CHEM, V249, P3314; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Wower IK, 2000, EMBO J, V19, P6612, DOI 10.1093/emboj/19.23.6612	50	38	39	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13289	13301		10.1074/jbc.M707111200	http://dx.doi.org/10.1074/jbc.M707111200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18211890	hybrid			2022-12-27	WOS:000255499800069
J	Hu, CP; Dandapat, A; Sun, LQ; Khan, JA; Liu, Y; Hermonat, PL; Mehta, JL				Hu, Changping; Dandapat, Abhijit; Sun, Liuqin; Khan, Junaid A.; Liu, Yong; Hermonat, Paul L.; Mehta, Jawahar L.			Regulation of TGF beta(1)-mediated collagen formation by LOX-1 - Studies based on forced overexpression of TGF beta(1) in wild-type and LOX-1 knock-out mouse cardiac fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; LECTIN-LIKE; EXPRESSION; ACTIVATION; OXIDASE; BETA; ATHEROGENESIS; ANGIOGENESIS; BLOCKADE	Transforming growth factor beta(1) (TGF beta(1)) activation leads to tissue fibrosis. Here, we report on the role of LOX-1, a lectin-like 52-kDa receptor for oxidized low density lipoprotein, inTGF beta(1)-mediated collagen expression and underlying signaling in mouse cardiac fibroblasts. TGF beta(1) was overexpressed in wildtype (WT) and LOX-1 knock-out mouse cardiac fibroblasts by transfection with adeno-associated virus type 2 vector carrying the active TGF beta(1) moiety (AAV/TGF beta(ACT)(1)). Transfection of WT mouse cardiac fibroblasts with AAV/TGF beta(ACT)(1) markedly enhanced the expression of NADPH oxidases (p22(phox), p47(phox), and gp91(phox) subunits) and LOX-1, formation of reactive oxygen species, and collagen synthesis, concomitant with an increase in the activation of p38 and p44/42 mitogen-activated protein kinases (MAPK). The TGF beta(1)-mediated increase in collagen synthesis was markedly attenuated in the LOX-1 knock-out mouse cardiac fibroblasts as well as in WT mouse cardiac fibroblasts treated with a specific anti-LOX-1 antibody. Treatment with anti-LOX-1 antibody also reduced NADPH oxidase expression and MAPK activation. The NADPH oxidase inhibitors and gp91phox small interfering RNA reduced LOX-1 expression, MAPK activation, and collagen formation. The p38 MAPK inhibitors as well as the p44/42 MAPK inhibitors reduced collagen formation without affecting LOX-1 expression in cardiac fibroblasts. These observations suggest that collagen synthesis in cardiac fibroblasts involves a facilitative interaction between TGF beta(1)-NADPH oxidase and LOX-1. Further, the activation of MAPK pathway appears to be downstream of TGF beta(1)-reactive oxygen species-LOX-1 cascade.	[Hu, Changping; Dandapat, Abhijit; Sun, Liuqin; Khan, Junaid A.; Liu, Yong; Hermonat, Paul L.; Mehta, Jawahar L.] Univ Arkansas Med Sci, Cardiovasc Med, Little Rock, AR 72205 USA; [Hu, Changping; Dandapat, Abhijit; Sun, Liuqin; Khan, Junaid A.; Liu, Yong; Hermonat, Paul L.; Mehta, Jawahar L.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Hu, Changping] Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha 410078, Peoples R China; [Sun, Liuqin] Heping Hosp, Changzhi Med Coll, Dept Ophthalmol, Changzhi 046000, Peoples R China	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; Central South University; Changzhi Medical College	Mehta, JL (corresponding author), Univ Arkansas Med Sci, Cardiovasc Med, Little Rock, AR 72205 USA.	mehtaJL@uams.edu	Mehta, JL/AAG-7572-2020; Mehta, jl/AAB-8832-2019	Mehta, jl/0000-0003-0384-2097				Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Chen HJ, 2001, CIRC RES, V89, P1155, DOI 10.1161/hh2401.100598; Chen JX, 2007, AM J PHYSIOL-HEART C, V292, pH1664, DOI 10.1152/ajpheart.01138.2006; Chen J, 2006, AM J PHYSIOL-HEART C, V291, pH1738, DOI 10.1152/ajpheart.00341.2006; Chen K, 2005, HYPERTENSION, V46, P622, DOI 10.1161/01.HYP.0000179045.95915.b0; Chen XP, 2007, VASC PHARMACOL, V47, P1, DOI 10.1016/j.vph.2007.01.004; Cominacini L, 2001, J BIOL CHEM, V276, P13750, DOI 10.1074/jbc.M010612200; Dandapat A, 2007, ARTERIOSCL THROM VAS, V27, P2435, DOI 10.1161/ATVBAHA.107.152272; Draude G, 2000, AM J PHYSIOL-HEART C, V278, pH1042, DOI 10.1152/ajpheart.2000.278.4.H1042; Heeneman S, 2003, J PATHOL, V200, P516, DOI 10.1002/path.1395; Hu CP, 2007, AM J PHYSIOL-HEART C, V293, pH1833, DOI 10.1152/ajpheart.00488.2007; Hu CP, 2007, CARDIOVASC RES, V76, P292, DOI 10.1016/j.cardiores.2007.07.003; Huang M, 2002, J CLIN INVEST, V109, P931, DOI 10.1172/JCI200214685; Joseph Jacob, 2003, Journal of Cardiovascular Pharmacology and Therapeutics, V8, P161, DOI 10.1177/107424840300800209; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li DY, 2006, BIOCHEM BIOPH RES CO, V344, P701, DOI 10.1016/j.bbrc.2006.04.010; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Mehta JL, 2007, CARDIOVASC RES, V74, P181, DOI 10.1016/j.cardiores.2007.03.011; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Minami M, 2000, BIOCHEM BIOPH RES CO, V272, P357, DOI 10.1006/bbrc.2000.2778; Nykanen AI, 2006, CIRC RES, V98, P1373, DOI 10.1161/01.RES.0000225987.52765.13; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Yang BC, 1999, J PHARMACOL EXP THER, V291, P733; Zhao WH, 2006, VIROLOGY, V353, P283, DOI 10.1016/j.virol.2006.04.042	27	61	68	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10226	10231		10.1074/jbc.M708820200	http://dx.doi.org/10.1074/jbc.M708820200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18182394	hybrid			2022-12-27	WOS:000254894700003
J	Lai, LS; Xu, ZH; Zhou, JH; Lee, KD; Amidon, GL				Lai, Longsheng; Xu, Zhaohui; Zhou, Jiahai; Lee, Kyung-Dall; Amidon, Gordon L.			Molecular basis of prodrug activation by human valacyclovirase, an alpha-amino acid ester hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-VALYL ESTER; TRICORN PROTEASE; SERINE HYDROLASE; VALACICLOVIR; ACYCLOVIR; PHARMACOKINETICS; VALGANCICLOVIR; IDENTIFICATION; ENZYMES; ACETYLCHOLINESTERASE	Chemical modification to improve biopharmaceutical properties, especially oral absorption and bioavailability, is a common strategy employed by pharmaceutical chemists. The approach often employs a simple structural modification and utilizes ubiquitous endogenous esterases as activation enzymes, although such enzymes are often unidentified. This report describes the crystal structure and specificity of a novel activating enzyme for valacyclovir and valganciclovir. Our structural insights show that human valacyclovirase has a unique binding mode and specificity for amino acid esters. Biochemical data demonstrate that the enzyme hydrolyzes esters of alpha-amino acids exclusively and displays a broad specificity spectrum for the aminoacyl moiety similar to tricorn-interacting aminopeptidase F1. Crystal structures of the enzyme, two mechanistic mutants, and a complex with a product analogue, when combined with biochemical analysis, reveal the key determinants for substrate recognition; that is, a flexible and mostly hydrophobic acyl pocket, a localized negative electrostatic potential, a large open leaving group-accommodating groove, and a pivotal acidic residue, Asp-123, after the nucleophile Ser-122. This is the first time that a residue immediately after the nucleophile has been found to have its side chain directed into the substrate binding pocket and play an essential role in substrate discrimination in serine hydrolases. These results as well as a phylogenetic analysis establish that the enzyme functions as a specific alpha-amino acid ester hydrolase. Valacyclovirase is a valuable target for amino acid ester prodrug-based oral drug delivery enhancement strategies.	[Lai, Longsheng; Lee, Kyung-Dall; Amidon, Gordon L.] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Lai, Longsheng; Lee, Kyung-Dall; Amidon, Gordon L.] Univ Michigan, Ctr Mol Drug Targeting, Ann Arbor, MI 48109 USA; [Xu, Zhaohui; Zhou, Jiahai] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Xu, Zhaohui; Zhou, Jiahai] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Amidon, GL (corresponding author), Univ Michigan, Dept Pharmaceut Sci, 428 Church St, Ann Arbor, MI 48109 USA.	glamidon@umich.edu			NIGMS NIH HHS [GM 37188] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037188] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balimane PV, 1998, BIOCHEM BIOPH RES CO, V250, P246, DOI 10.1006/bbrc.1998.9298; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURNETTE TC, 1995, J BIOL CHEM, V270, P15827, DOI 10.1074/jbc.270.26.15827; CROOKS RJ, 1994, ANTIVIR CHEM CHEMOTH, V5, P31; Curran M, 2001, DRUGS, V61, P1145, DOI 10.2165/00003495-200161080-00013; DEMIRANDA P, 1983, J ANTIMICROB CHEMOTH, V12, P29, DOI 10.1093/jac/12.suppl_B.29; Ettmayer P, 2004, J MED CHEM, V47, P2393, DOI 10.1021/jm0303812; Goettig P, 2002, EMBO J, V21, P5343, DOI 10.1093/emboj/cdf552; Han HK, 1998, PHARMACEUT RES, V15, P1154, DOI 10.1023/A:1011919319810; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Hernaez MJ, 2000, J BACTERIOL, V182, P5448, DOI 10.1128/JB.182.19.5448-5453.2000; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Huhtinen K, 2002, J BIOL CHEM, V277, P3424, DOI 10.1074/jbc.M109040200; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung D, 1999, J CLIN PHARMACOL, V39, P800, DOI 10.1177/00912709922008452; Kim I, 2003, J BIOL CHEM, V278, P25348, DOI 10.1074/jbc.M302055200; Kim I, 2004, MOL PHARMACEUT, V1, P117, DOI 10.1021/mp0499757; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li J, 1996, BIOCHEMISTRY-US, V35, P9967, DOI 10.1021/bi9605292; Liederer BM, 2006, J PHARM SCI-US, V95, P1177, DOI 10.1002/jps.20542; Nandhagopal N, 2001, J MOL BIOL, V309, P1139, DOI 10.1006/jmbi.2001.4737; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pescovitz MD, 2000, ANTIMICROB AGENTS CH, V44, P2811, DOI 10.1128/AAC.44.10.2811-2815.2000; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Puente XS, 1998, GENOMICS, V51, P459, DOI 10.1006/geno.1998.5351; PUENTE XS, 1995, J BIOL CHEM, V270, P12926, DOI 10.1074/jbc.270.21.12926; RIPOLL DR, 1993, P NATL ACAD SCI USA, V90, P5128, DOI 10.1073/pnas.90.11.5128; Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; SOULLAWTON J, 1995, ANTIMICROB AGENTS CH, V39, P2759, DOI 10.1128/AAC.39.12.2759; Stella V., 2007, PRODRUGS CHALLENGES; Sugawara M, 2000, J PHARM SCI-US, V89, P781, DOI 10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7; Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7; Tamura T, 1996, FEBS LETT, V398, P101, DOI 10.1016/S0014-5793(96)01163-5; TAN RC, 1993, BIOCHEMISTRY-US, V32, P401, DOI 10.1021/bi00053a003; WELLER S, 1993, CLIN PHARMACOL THER, V54, P595, DOI 10.1038/clpt.1993.196	43	50	54	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9318	9327		10.1074/jbc.M709530200	http://dx.doi.org/10.1074/jbc.M709530200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18256025	Green Published, hybrid			2022-12-27	WOS:000254465800062
J	Reddy, VS; Singh, AK; Rajasekharan, R				Reddy, Venky Sreedhar; Singh, Arjun Kumar; Rajasekharan, Ram			The Saccharomyces cerevisiae PHM8 gene encodes a soluble magnesium-dependent lysophosphatidic acid phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; RHODOBACTER-SPHAEROIDES; LIPID COMPOSITION; BIOSYNTHESIS; ACCUMULATION; ARABIDOPSIS; STARVATION; YEAST; PURIFICATION; LIMITATION	Phosphate is the essential macronutrient required for the growth of all organisms. In Saccharomyces cerevisiae, phosphatases are up-regulated, and the level of lysophosphatidic acid (LPA) is drastically decreased under phosphate-starved conditions. The reduction in the LPA level is attributed to PHM8, a gene of unknown function. phm8 Delta yeast showed a decreased LPA-hydrolyzing activity under phosphate-limiting conditions. Overexpression of PHM8 in yeast resulted in an increase in the LPA phosphatase activity in vivo. In vitro assays of the purified recombinant Phm8p revealed magnesium-dependent LPA phosphatase activity, with maximal activity at pH 6.5. The purified Phm8p did not hydrolyze any lipid phosphates other than LPA. In silico analysis suggest that Phm8p is a soluble protein with no transmembrane domain. Site-directed mutational studies revealed that aspartate residues in a DXDXT motif are important for the catalysis. These findings indicated that LPA plays a direct role in phosphate starvation. This is the first report of the identification and characterization of magnesium-dependent soluble LPA phosphatase.	[Reddy, Venky Sreedhar; Singh, Arjun Kumar; Rajasekharan, Ram] Indian Inst Sci, Dept Biochem, Lipid Lab, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rajasekharan, R (corresponding author), Indian Inst Sci, Dept Biochem, Lipid Lab, Bangalore 560012, Karnataka, India.	lipid@biochem.iisc.ernet.in	Rajasekharan, Ram/R-2257-2019; R, Rajasekharan/D-3420-2009	Rajasekharan, Ram/0000-0002-2124-6013; Ram, Rajasekharan/0000-0002-4114-0654				ALEXANDER D R, 1990, New Biologist, V2, P1049; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BENNING C, 1993, P NATL ACAD SCI USA, V90, P1561, DOI 10.1073/pnas.90.4.1561; BENNING C, 1995, ARCH BIOCHEM BIOPHYS, V317, P103, DOI 10.1006/abbi.1995.1141; BISHOP WR, 1988, ANNU REV CELL BIOL, V4, P579, DOI 10.1146/annurev.cb.04.110188.003051; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Fiske CH, 1925, J BIOL CHEM, V66, P375; Furneisen JM, 2000, BBA-MOL CELL BIOL L, V1484, P71, DOI 10.1016/S1388-1981(99)00202-4; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; HAYASHI E, 1976, J BIOL CHEM, V251, P5759; Hiroyama M, 1998, BIOCHEM J, V336, P483, DOI 10.1042/bj3360483; Hiroyama R, 1999, J BIOL CHEM, V274, P29172, DOI 10.1074/jbc.274.41.29172; HUNTER K, 1972, BIOCHIM BIOPHYS ACTA, V260, P639, DOI 10.1016/0005-2760(72)90013-6; ILLINGWO.RF, 1973, J BACTERIOL, V113, P373, DOI 10.1128/JB.113.1.373-386.1973; Khozin-Goldberg I, 2006, PHYTOCHEMISTRY, V67, P696, DOI 10.1016/j.phytochem.2006.01.010; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P8684, DOI 10.1021/bi050009j; Mahuren JD, 2001, ANAL BIOCHEM, V298, P241, DOI 10.1006/abio.2001.5402; Nakamura Y, 2005, J BIOL CHEM, V280, P7469, DOI 10.1074/jbc.M408799200; Ndubuisil MI, 2002, BIOCHEMISTRY-US, V41, P7841, DOI 10.1021/bi0255064; Newman JW, 2003, P NATL ACAD SCI USA, V100, P1558, DOI 10.1073/pnas.0437724100; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; PALTAUF F, 1970, Biochimica et Biophysica Acta, V218, P424, DOI 10.1016/0005-2760(70)90005-6; PATTON JL, 1995, J BACTERIOL, V177, P3379, DOI 10.1128/jb.177.12.3379-3385.1995; RAMSAY AM, 1979, GEN MICROBIOL, V110, P185; Reddy MM, 2006, ARCH BIOCHEM BIOPHYS, V455, P99, DOI 10.1016/j.abb.2006.09.009; ROSE AH, 1989, MICROBIAL LIPIDS, V2, P255; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Selengut JD, 2000, BIOCHEMISTRY-US, V39, P8315, DOI 10.1021/bi0005052; Shekar S, 2002, PLANT PHYSIOL, V128, P988, DOI 10.1104/pp.010654; TAMAI Y, 1985, J BACTERIOL, V164, P964, DOI 10.1128/JB.164.2.964-968.1985; VELDHUIZEN RAW, 1991, BIOCHIM BIOPHYS ACTA, V1083, P211, DOI 10.1016/0005-2760(91)90045-J	41	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8846	8854		10.1074/jbc.M706752200	http://dx.doi.org/10.1074/jbc.M706752200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18234677	hybrid			2022-12-27	WOS:000254465800011
J	Kar, NS; Ashraf, MZ; Valiyaveettil, M; Podrez, EA				Kar, Niladri S.; Ashraf, Mohammad Z.; Valiyaveettil, Manojkumar; Podrez, Eugene A.			Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATHEROSCLEROTIC LESIONS; CRYSTAL-STRUCTURE; OXIDANT STRESS; LECTIN-LIKE; IDENTIFICATION; ADHESION; LIGAND; DOMAIN; LDL; FAMILY	Recent studies have identified a novel family of oxidized phosphatidylcholines (oxPC(CD36)) that serve as highly specific ligands for scavenger receptor CD36.oxPC(CD36) accumulate in vivo and mediate macrophage foam cell formation as well as promote platelet hyper-reactivity in hyperlipidemia via CD36. The structural basis of oxPCCD36 binding to CD36 has not been elucidated. We used liquid-phase binding to glutathione S-transferase fusion proteins containing various regions of CD36 to initially identify the region spanning CD36 amino acids 157 171 to contain a major binding site for oxPCCD36. A bell-shaped pH profile and salt concentration dependence suggest an electrostatic mechanism of the binding. Two conserved, positively charged amino acids in the region 157-171 (lysines at positions 164 and 166) were identified as critical for oxPCCD36 and oxidized low density lipoprotein (oxLDL) binding to CD36. Lysine neutralization with chemical modifier or site-directed mutagenesis of lysine 164/166 to alanine or glutamate, but not to arginine, abolished binding. Cells expressing full-length CD36 with mutated lysines (164 and 166) failed to recognize oxPCCD36 and oxLDL. Synthetic peptides mimicking the CD36 binding site, but not mutated or scrambled peptides, effectively prevented: (i) oxLDL binding to CD36, (ii) macrophage foam cell formation induced by oxLDL, and (iii) platelet activation by oxPCCD36. These data indicate that CD36 (160-168) represents the core of the oxPCCD36 binding site with lysines 164/166 being indispensable for the binding.	[Kar, Niladri S.; Ashraf, Mohammad Z.; Valiyaveettil, Manojkumar; Podrez, Eugene A.] Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Podrez, EA (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, 9500 Euclid Ave,ND50, Cleveland, OH 44195 USA.	podreze@ccf.org			NHLBI NIH HHS [HL 077213, HL 053315, R01 HL077213] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077213, R01HL053315] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abumrad NA, 2005, PROSTAG OTH LIPID M, V77, P77, DOI 10.1016/j.prostaglandins.2004.09.012; ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; ASCH AS, 1993, SCIENCE, V262, P1436, DOI 10.1126/science.7504322; Bodart V, 2002, CIRC RES, V90, P844, DOI 10.1161/01.RES.0000016164.02525.B4; Boullier A, 2000, J BIOL CHEM, V275, P9163, DOI 10.1074/jbc.275.13.9163; Chen MY, 2001, FEBS LETT, V499, P215, DOI 10.1016/S0014-5793(01)02557-1; Daviet L, 1997, THROMB HAEMOSTASIS, V78, P65; Demers A, 2004, BIOCHEM J, V382, P417, DOI 10.1042/BJ20040036; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Li XM, 2007, BIOCHEMISTRY-US, V46, P5009, DOI 10.1021/bi700163y; Marleau Sylvie, 2005, FASEB J, V19, P1869; Matsuno K, 1996, BRIT J HAEMATOL, V92, P960, DOI 10.1046/j.1365-2141.1996.422962.x; Navazo MDP, 1996, J BIOL CHEM, V271, P15381, DOI 10.1074/jbc.271.26.15381; Navazo MDP, 1996, ARTERIOSCL THROM VAS, V16, P1033, DOI 10.1161/01.ATV.16.8.1033; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; Ohki I, 2005, STRUCTURE, V13, P905, DOI 10.1016/j.str.2005.03.016; Park H, 2005, J BIOL CHEM, V280, P13593, DOI 10.1074/jbc.M500768200; PEARCE SFA, 1995, J BIOL CHEM, V270, P2981, DOI 10.1074/jbc.270.7.2981; Pearce SFA, 1998, J BIOL CHEM, V273, P34875, DOI 10.1074/jbc.273.52.34875; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Stewart BW, 2006, MOL IMMUNOL, V43, P255, DOI 10.1016/j.molimm.2005.02.007; Sun MJ, 2006, J BIOL CHEM, V281, P4222, DOI 10.1074/jbc.M509769200; Tanaka T, 2001, J LIPID RES, V42, P751; TANDON NN, 1989, J BIOL CHEM, V264, P7576	33	74	75	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8765	8771		10.1074/jbc.M709195200	http://dx.doi.org/10.1074/jbc.M709195200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18245080	Green Published, hybrid			2022-12-27	WOS:000254288000074
J	Zhang, DH; Harry, GJ; Blackshear, PJ; Zeldin, DC				Zhang, Donghui; Harry, G. Jean; Blackshear, Perry J.; Zeldin, Darryl C.			G-protein pathway suppressor 2 (GPS2) interacts with the regulatory factor X4 variant 3 (RFX4_v3) and functions as a transcriptional co-activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; FRACTALKINE; EXPRESSION; BINDS; DIFFERENTIATION; NUCLEUS; SIGNALS; COMPLEX; ROLES; CELLS	RFX4_v3 (regulatory factor X4 variant 3) is a brain-specific isoform of the transcription factor RFX4. Insertional mutagenesis in mice demonstrates that Rfx4_v3 is crucial for normal brain development. Many genes involved in critical processes during brain morphogenesis are dysregulated in Rfx4_v3 mutant brains. For example, Cx3cl1 is a CX3C-type chemokine that is abundant in brain and is a direct transcriptional target of RFX4_v3 through a specific promoter X-box (X-box 1), the responsive element for RFX proteins. To identify potential interacting partners for RFX4_v3, we performed yeast two-hybrid analysis. Nine candidate interactors were identified, including GPS2 (G-protein pathway suppressor 2). Indirect immunofluorescence demonstrated that GPS2 and RFX4_v3 co-localized to the nucleus. Both GPS2 and RFX4_v3 mRNAs were also present in most portions of the adult mouse brain as well as in brains at different ages, suggesting that the two proteins could bind to each other. Co-immunoprecipitation assays indicated that physical interactions between GPS2 and RFX4_v3 did indeed occur. Furthermore, GPS2 was recruited to the Cx3cl1 promoter by RFX4_v3 and potentiated RFX4_v3 transactivation on this promoter through X-box 1, suggesting that the protein-protein interaction was functionally relevant. GPS2 bound to both the carboxyl-terminal region (amino acids 575-735) and the middle region (amino acids 250-574) of the RFX4_v3 protein. RFX4_v3 amino acids 1-574 stimulated the Cx3cl1 promoter to a similar extent as the full-length RFX4_v3 protein; however, deletion of the carboxyl-terminal region of RFX4_v3 impaired the co-activating abilities of GPS2. Based on these data, we conclude that GPS2 interacts with RFX4_v3 to modulate transactivation of genes involved in brain morphogenesis, including Cx3Cl1.	[Zhang, Donghui; Zeldin, Darryl C.] NIEHS, Natl Inst Hlth, Lab Resp Biol, Res Triangle Pk, NC 27709 USA; [Zhang, Donghui; Harry, G. Jean; Blackshear, Perry J.] NIEHS, Natl Inst Hlth, Neurobiol Lab, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.; Zeldin, Darryl C.] NIEHS, Natl Inst Hlth, Off Clin Res, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Zeldin, DC (corresponding author), NIEHS, Natl Inst Hlth, Lab Resp Biol, 111 TW Alexander Dr,Bldg 101,Rm D236, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Harry, Gaylia Jean/AAC-1171-2022; Zeldin, Darryl C/Y-7091-2018; Blackshear, Perry J./C-6206-2019	Harry, Gaylia Jean/0000-0002-0829-7318; Zeldin, Darryl C/0000-0002-2087-7307; Blackshear, Perry J./0000-0002-9561-8529	Intramural NIH HHS [Z01 ES101583-05] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090092, Z01ES021164, ZIAES101583] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alvania RS, 2006, NEURON, V50, P813, DOI 10.1016/j.neuron.2006.06.001; Araki R, 2004, J BIOL CHEM, V279, P10237, DOI 10.1074/jbc.M312761200; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Blackshear PJ, 2003, DEVELOPMENT, V130, P4539, DOI 10.1242/dev.00661; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Breiding DE, 1997, MOL CELL BIOL, V17, P7208, DOI 10.1128/MCB.17.12.7208; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Dateki M, 2005, J BIOL CHEM, V280, P20503, DOI 10.1074/jbc.M414033200; Degenhardt YY, 2001, J VIROL, V75, P151, DOI 10.1128/JVI.75.1.151-160.2001; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Glaser B, 2005, MOL PSYCHIATR, V10, P920, DOI 10.1038/sj.mp.4001689; Hol EM, 2006, EXPERT REV NEUROTHER, V6, P1337, DOI 10.1586/14737175.6.9.1337; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lee TH, 2006, DNA REPAIR, V5, P32, DOI 10.1016/j.dnarep.2005.07.004; Liour SS, 2003, GLIA, V42, P109, DOI 10.1002/glia.10202; Matsushita H, 2005, CANCER SCI, V96, P801, DOI 10.1111/j.1349-7006.2005.00112.x; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Moon SY, 2003, J BIOL CHEM, V278, P4151, DOI 10.1074/jbc.M207789200; Morotami-Yano K, 2002, J BIOL CHEM, V277, P836, DOI 10.1074/jbc.M108638200; Peng YC, 2000, J VIROL, V74, P5872, DOI 10.1128/JVI.74.13.5872-5879.2000; Peng YC, 2001, MOL CELL BIOL, V21, P5913, DOI 10.1128/MCB.21.17.5913-5924.2001; PETERS JM, 1994, J BIOL CHEM, V269, P7709; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Schmidt T, 2000, BBA-GENE STRUCT EXPR, V1493, P249, DOI 10.1016/S0167-4781(00)00163-9; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Soriano SG, 2002, J NEUROIMMUNOL, V125, P59, DOI 10.1016/S0165-5728(02)00033-4; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tarozzo G, 2003, J NEUROSCI RES, V73, P81, DOI 10.1002/jnr.10645; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Tong N, 2000, J IMMUNOL, V164, P1333, DOI 10.4049/jimmunol.164.3.1333; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang DH, 2006, J NEUROCHEM, V98, P860, DOI 10.1111/j.1471-4159.2006.03930.x; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	37	23	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8580	8590		10.1074/jbc.M708209200	http://dx.doi.org/10.1074/jbc.M708209200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18218630	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000254288000057
J	Mitrousis, G; Olia, AS; Walker-Kopp, N; Cingolani, G				Mitrousis, Gregory; Olia, Adam S.; Walker-Kopp, Nancy; Cingolani, Gino			Molecular basis for the recognition of snurportin 1 by importin beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; STRUCTURAL BASIS; NUCLEOCYTOPLASMIC TRANSPORT; RECEPTOR; DOMAIN; RAN; DISSOCIATION; PATHWAYS; ALPHA	The nuclear import of uridine-rich ribonucleoproteins is mediated by the transport adaptor snurportin 1 (SNP1). Similar to importin alpha, SNP1 uses an N-terminal importin beta binding (sIBB) domain to recruit the receptor importin beta and gain access to the nucleus. In this study, we demonstrate that the sIBB domain has a bipartite nature, which contains two distinct binding determinants for importin beta. The first determinant spans residues 25 - 65 and includes the previously identified importin alpha IBB (alpha IBB) region of homology. The second binding determinant encompasses residues 1 - 24 and resembles region 1011 1035 of the nucleoporin 153 (Nup153). The two binding determinants synergize within the sIBB domain to confer a low nanomolar binding affinity for importin beta (K-d similar to 2 nM) in an interaction that, in vitro, is displaced by RanGTP. We propose that in vivo the synergy of Nup153 and nuclear RanGTP promotes translocation of uridine-rich ribonucleoproteins into the nucleus.	[Mitrousis, Gregory; Olia, Adam S.; Walker-Kopp, Nancy; Cingolani, Gino] SUNY Upsate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cingolani, G (corresponding author), SUNY Upsate Med Univ, Dept Biochem & Mol Biol, 750 E,Adams St, Syracuse, NY 13210 USA.	cingolag@upstate.edu			NIGMS NIH HHS [R01 GM074846-02, R01 GM074846, GM074846] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074846] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; DELANO WL, 2002, PYMOL DELANO SCIENTI; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gilchrist D, 2003, J BIOL CHEM, V278, P51937, DOI 10.1074/jbc.M307371200; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Huber J, 2002, J CELL BIOL, V156, P467, DOI 10.1083/jcb.200108114; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Lyman SK, 2002, J CELL BIOL, V159, P55, DOI 10.1083/jcb.200204163; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Olia AS, 2006, J MOL BIOL, V363, P558, DOI 10.1016/j.jmb.2006.08.014; Ospina JK, 2005, MOL BIOL CELL, V16, P4660, DOI 10.1091/mbc.E05-04-0316; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palacios I, 1997, EMBO J, V16, P6783, DOI 10.1093/emboj/16.22.6783; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Rollenhagen C, 2003, MOL BIOL CELL, V14, P2104, DOI 10.1091/mbc.e02-06-0372; Rollenhagen C, 2006, CAN J PHYSIOL PHARM, V84, P367, DOI 10.1139/Y05-101; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strasser A, 2005, EMBO J, V24, P2235, DOI 10.1038/sj.emboj.7600701; Strom AC, 2001, GENOME BIOL, V2; Suel KE, 2006, METHODS, V39, P342, DOI 10.1016/j.ymeth.2006.06.015; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385	41	56	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7877	7884		10.1074/jbc.M709093200	http://dx.doi.org/10.1074/jbc.M709093200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18187419	hybrid			2022-12-27	WOS:000253997900063
J	Spitzner, M; Martins, JR; Soria, RB; Ousingsawat, J; Scheidt, K; Schreiber, R; Kunzelmann, K				Spitzner, Melanie; Martins, Joana Raquel; Soria, Rene Barro; Ousingsawat, Jiraporn; Scheidt, Kerstin; Schreiber, Rainer; Kunzelmann, Karl			Eag1 and bestrophin 1 are up-regulated in fast-growing colonic cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNELS; CHLORIDE CHANNELS; ION CHANNELS; K+ CHANNELS; ELECTROLYTE TRANSPORT; EPITHELIAL-CELLS; PROLIFERATION; CALCIUM; FAMILY; IDENTIFICATION	Ion channels like voltage-gated ether-a-go-go ( Eag1) K+ channels or Ca2+-activated Cl- channels have been shown to support cell proliferation. Bestrophin 1 ( Best1) has been proposed to form Ca2+-activated Cl- channels in epithelial cells. Here we show that original T-84 colonic carcinoma cells grow slowly ( T-84-slow) and express low amounts of Eag1 and Best1, whereas spontaneously transformed T-84 cells grow fast ( T-84-fast) and express high levels of both proteins. Both Eag1 and Best1 currents are up-regulated in T-84-fast cells. Eag1 currents were cell cycle-dependent with up-regulation during G1/ S transition. T-84-slow, but not T-84-fast, cells formed tight monolayers when grown on permeable supports. RNA interference inhibition of Eag1 and Best1 reduced proliferation of T-84-fast cells, whereas overexpression of Best1 turned T-84-slow into fast-growing cells. Eag1 and Best1 improve intracellular Ca2+ signaling and cell volume regulation. These results establish a novel role for bestrophins in cell proliferation.	[Spitzner, Melanie; Martins, Joana Raquel; Soria, Rene Barro; Ousingsawat, Jiraporn; Scheidt, Kerstin; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany	University of Regensburg	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	uqkkunze@mailbox.uq.edu	Martins, Joana/L-2965-2016	Martins, Joana/0000-0002-3784-9775; Kunzelmann, Karl/0000-0002-4583-7037; Spitzner, Melanie/0000-0002-3673-0625				Alessandro R, 2005, J CELL PHYSIOL, V203, P261, DOI 10.1002/jcp.20236; ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; Boyd DD, 2004, CLIN CANCER RES, V10, P1545, DOI 10.1158/1078-0432.CCR-1565-02; Chien LT, 2007, J GEN PHYSIOL, V130, P513, DOI 10.1085/jgp.200709795; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; Fischmeister R, 2005, J PHYSIOL-LONDON, V562, P477, DOI 10.1113/jphysiol.2004.075622; Fraser GM, 1997, PFLUG ARCH EUR J PHY, V434, P801, DOI 10.1007/s004240050468; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; MORRIS AP, 1993, AM J PHYSIOL, V264, pC968, DOI 10.1152/ajpcell.1993.264.4.C968; Ousingsawat J, 2007, CLIN CANCER RES, V13, P824, DOI 10.1158/1078-0432.CCR-06-1940; Pardo LA, 2005, J MEMBRANE BIOL, V205, P115, DOI 10.1007/s00232-005-0776-1; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Pauli BU, 2000, CLIN EXP PHARMACOL P, V27, P901, DOI 10.1046/j.1440-1681.2000.03358.x; Puntheeranurak S, 2007, CELL PHYSIOL BIOCHEM, V19, P77, DOI 10.1159/000099194; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Rao JN, 2002, AM J PHYSIOL-CELL PH, V282, pC885, DOI 10.1152/ajpcell.00361.2001; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Schonherr R, 2005, J MEMBRANE BIOL, V205, P175, DOI 10.1007/s00232-005-0782-3; SCHWAB A, 1994, J CLIN INVEST, V93, P1631, DOI 10.1172/JCI117144; Schwab A, 2001, NEWS PHYSIOL SCI, V16, P29, DOI 10.1152/physiologyonline.2001.16.1.29; SORIA RB, 2006, J BIOL CHEM, V281, P17460; Spitzner M, 2007, FASEB J, V21, P35, DOI 10.1096/fj.06-6200com; Stansfeld CE, 1996, P NATL ACAD SCI USA, V93, P9910, DOI 10.1073/pnas.93.18.9910; Stuhmer W, 2006, FEBS LETT, V580, P2850, DOI 10.1016/j.febslet.2006.03.062; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Szabo I, 1996, J BIOL CHEM, V271, P20465, DOI 10.1074/jbc.271.34.20465; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135	32	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7421	7428		10.1074/jbc.M703758200	http://dx.doi.org/10.1074/jbc.M703758200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18222922	hybrid			2022-12-27	WOS:000253997900016
J	Zhang, H; Li, ZH; Zhang, MQ; Katz, MS; Zhang, BX				Zhang, Hua; Li, Zhen-Hua; Zhang, Michael Q.; Katz, Michael S.; Zhang, Bin-Xian			Heat shock protein 90 beta 1 is essential for polyunsaturated fatty acid-induced mitochondrial Ca2+ efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETIC-PATIENTS; ENDOPLASMIC-RETICULUM; SUBSTRATE OXIDATION; INTRACELLULAR CA2+; CALCIUM-TRANSPORT; SKELETAL-MUSCLE; CELLS; HSP90; DYSFUNCTION; GLUCOSE	Nonesterified fatty acids may influence mitochondrial function by alterations in gene expression, metabolism, and/or mitochondrial Ca2+ ([Ca2+](m)) homeostasis. We have previously reported that polyunsaturated fatty acids induce Ca2+ efflux from mitochondria, an action that may deplete [Ca2+](m) and thus contribute to nonesterified fatty acid-responsive mitochondrial dysfunction. Here we show that the chaperone protein heat shock protein 90 beta 1 (hsp90 beta 1) is required for polyunsaturated fatty acid-induced mitochondrial Ca2+ efflux (PIMCE). Retinoic acid induced differentiation of human teratocarcinoma NT2 cells in association with attenuation of PIMCE. Proteomic analysis of mitochondrial proteins revealed that hsp90 beta 1, among other proteins, was reduced in retinoic acid-differentiated cells. Blockade of PIMCE in NT2 cells by 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin, a known inhibitor of the chaperone activity of hsp90, and hsp90 beta 1 RNA interference demonstrated that hsp90 beta 1 is essential for PIMCE. We also show localization of hsp90 beta 1 in mitochondria by Western blot and immunofluorescence. Distinctive effects of inhibitors binding to the N or C terminus of hsp90 on PIMCE in isolated mitochondria suggested that the C terminus of hsp90 beta 1 plays a critical role in PIMCE.	[Zhang, Hua; Li, Zhen-Hua; Zhang, Michael Q.; Katz, Michael S.; Zhang, Bin-Xian] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Audie L Murphy Div, S Texas Vet Hlth Care Syst,Geriatr Res Educ & Cli, San Antonio, TX 78229 USA	Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Zhang, BX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Audie L Murphy Div, S Texas Vet Hlth Care Syst,Geriatr Res Educ & Cli, GRECC 182,7400 Merton Minter Blvd, San Antonio, TX 78229 USA.				NHLBI NIH HHS [HL075011] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075011] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Asquith KL, 2005, BIOL REPROD, V72, P328, DOI 10.1095/biolreprod.104.034470; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Biden TJ, 2004, DIABETES, V53, pS159, DOI 10.2337/diabetes.53.2007.S159; Deryabina YI, 2004, BIOCHEMISTRY-MOSCOW+, V69, P91, DOI 10.1023/B:BIRY.0000016357.17251.7b; Duchen MR, 1999, J PHYSIOL-LONDON, V516, P1, DOI 10.1111/j.1469-7793.1999.001aa.x; Egorin MJ, 2002, CANCER CHEMOTH PHARM, V49, P7, DOI 10.1007/s00280-001-0380-8; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113; Hawkins TE, 2000, CELL BIOCHEM BIOPHYS, V33, P275, DOI 10.1385/CBB:33:3:275; Hoyt KR, 1998, J PHYSIOL-LONDON, V509, P103, DOI 10.1111/j.1469-7793.1998.103bo.x; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Lambert AJ, 2004, EXP GERONTOL, V39, P289, DOI 10.1016/j.exger.2003.12.009; Liu XB, 2000, CELL DEATH DIFFER, V7, P1119, DOI 10.1038/sj.cdd.4400745; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Mayers RM, 2003, BIOCHEM SOC T, V31, P1165; MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; REITSCHNEIDER NH, 2006, J PROTEOME RES, V5, P1117; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Rodriguez-Sinovas A, 2006, CIRC RES, V99, P93, DOI 10.1161/01.RES.0000230315.56904.de; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Sreedhar AS, 2004, FEBS LETT, V562, P11; Stanley WC, 1997, CARDIOVASC RES, V34, P25, DOI 10.1016/S0008-6363(97)00047-3; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Yi L, 2007, CHEM PHYS LIPIDS, V150, P204, DOI 10.1016/j.chemphyslip.2007.08.002; Yu HY, 2001, DIABETOLOGIA, V44, P614, DOI 10.1007/s001250051668; Zhang BX, 2006, CELL BIOCHEM BIOPHYS, V44, P187, DOI 10.1385/CBB:44:2:187; Zhang BX, 2006, AM J PHYSIOL-CELL PH, V290, pC1321, DOI 10.1152/ajpcell.00335.2005; Zhang BX, 2002, J BIOL CHEM, V277, P48165, DOI 10.1074/jbc.M208077200; Zhang WK, 2007, AM J PHYSIOL-RENAL, V292, pF1054, DOI 10.1152/ajprenal.00286.2006; Zhou YP, 1996, DIABETES, V45, P580, DOI 10.2337/diabetes.45.5.580	40	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7580	7589		10.1074/jbc.M707192200	http://dx.doi.org/10.1074/jbc.M707192200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18178560	hybrid			2022-12-27	WOS:000253997900033
J	Cuddihy, SL; Ali, SS; Musiek, ES; Lucero, J; Kopp, SJ; Morrow, JD; Dugan, LL				Cuddihy, Sarah L.; Ali, Sameh S.; Musiek, Erik S.; Lucero, Jacinta; Kopp, Sarah J.; Morrow, Jason D.; Dugan, Laura L.			Prolonged alpha-tocopherol deficiency decreases oxidative stress and unmasks alpha-tocopherol-dependent regulation of mitochondrial function in the brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-E-DEFICIENCY; CYTOCHROME BC(1) COMPLEX; REACTIVE OXYGEN; LIPID-PEROXIDATION; COENZYME Q(10); AGED MICE; IN-VIVO; DOCOSAHEXAENOIC ACID; MOLECULAR-MECHANISM; SUPEROXIDE ANION	Vitamin E is the major lipid-soluble chain-breaking antioxidant in mammals and plays an important role in normal development and physiology. Deficiency (whether dietary or genetic) results in primarily nervous system pathology, including cerebellar neurodegeneration and progressive ataxia (abnormal gait). However, despite the widely acknowledged antioxidant properties of vitamin E, only a few studies have directly correlated levels of reactive oxygen species with vitamin E availability in animal models. We explored the relationship between vitamin E and reactive oxygen species in two mouse models of vitamin E deficiency: dietary deficiency and a genetic model (tocopherol transfer protein, Ttp(-/-) mice). Both groups of mice developed nearly complete depletion of alpha-tocopherol (the major tocopherol in vitamin E) in most organs, but not in the brain, which was relatively resistant to loss of alpha-tocopherol. F4-neuroprostanes, an index of lipid peroxidation, were unexpectedly lower in brains of deficient mice compared with controls. In vivo oxidation of dihydroethidium by superoxide radical was also significantly lower in brains of deficient animals. Superoxide production by brain mitochondria isolated from vitamin E-deficient and Ttp(-/-) mice, measured by electron paramagnetic resonance spectroscopy, demonstrated a biphasic dependence on exogenously added alpha-tocopherol. At low concentrations, alpha-tocopherol enhanced superoxide flux from mitochondria, a response that was reversed at higher concentrations. Here we propose a mechanism, supported by molecular modeling, to explain decreased superoxide production during alpha-tocopherol deficiency and speculate that this could be a beneficial response under conditions of alpha-tocopherol deficiency.	[Ali, Sameh S.; Lucero, Jacinta; Dugan, Laura L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ali, Sameh S.; Lucero, Jacinta; Dugan, Laura L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Cuddihy, Sarah L.; Ali, Sameh S.; Kopp, Sarah J.; Dugan, Laura L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Musiek, Erik S.; Morrow, Jason D.] Vanderbilt Univ, Sch Med, Dept Med & Pharmacol, Nashville, TN 37232 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Washington University (WUSTL); Vanderbilt University	Dugan, LL (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr MC0746, La Jolla, CA 92093 USA.	ladugan@ucsd.edu		Musiek, Erik/0000-0002-8873-0360; Ali, Sameh Saad/0000-0002-0339-6106	NCI NIH HHS [CA77839] Funding Source: Medline; NIGMS NIH HHS [GM15431] Funding Source: Medline; NINDS NIH HHS [NS41796] Funding Source: Medline; PHS HHS [DDK48831] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041796] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alex G, 2000, J PAEDIATR CHILD H, V36, P515, DOI 10.1046/j.1440-1754.2000.00534.x; Ali SS, 2006, AGING CELL, V5, P565, DOI 10.1111/j.1474-9726.2006.00252.x; Azzi A, 2004, BIOL CHEM, V385, P585, DOI 10.1515/BC.2004.072; Azzi A, 2002, FEBS LETT, V519, P8, DOI 10.1016/S0014-5793(02)02706-0; Azzi A, 2007, FREE RADICAL BIO MED, V43, P16, DOI 10.1016/j.freeradbiomed.2007.03.013; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; Brigelius-Flohe R, 2002, AM J CLIN NUTR, V76, P703, DOI 10.1093/ajcn/76.4.703; Brigelius-Flohe R, 2007, FREE RADICAL BIO MED, V43, P2, DOI 10.1016/j.freeradbiomed.2007.05.016; Burczynski JM, 2001, FREE RADICAL BIO MED, V30, P1029, DOI 10.1016/S0891-5849(01)00497-X; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CADENAS E, 1989, FEBS LETT, V253, P235, DOI 10.1016/0014-5793(89)80966-4; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; ELMADFA I, 1986, Z GERONTOL, V19, P206; Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650; Gabsi S, 2001, EUR J NEUROL, V8, P477, DOI 10.1046/j.1468-1331.2001.00273.x; Gregor W, 2006, BIOCHEM PHARMACOL, V71, P1589, DOI 10.1016/j.bcp.2006.02.012; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Hsieh CC, 2006, NUTRITION, V22, P433, DOI 10.1016/j.nut.2005.10.001; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Kamzalov S, 2003, J NUTR, V133, P3175, DOI 10.1093/jn/133.10.3175; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lass A, 1998, ARCH BIOCHEM BIOPHYS, V352, P229, DOI 10.1006/abbi.1997.0606; Lass A, 1999, FREE RADICAL BIO MED, V26, P1375, DOI 10.1016/S0891-5849(98)00330-X; MacEvilly CJ, 1996, FREE RADICAL BIO MED, V20, P639, DOI 10.1016/0891-5849(95)02147-7; Maggi-Capeyron MF, 2002, J NUTR BIOCHEM, V13, P296, DOI 10.1016/S0955-2863(01)00222-4; Mcdonald SR, 2005, FREE RADICAL BIO MED, V38, P729, DOI 10.1016/j.freeradbiomed.2004.11.014; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Muegge I, 1999, J MED CHEM, V42, P791, DOI 10.1021/jm980536j; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Musiek ES, 2004, J CHROMATOGR B, V799, P95, DOI 10.1016/j.jchromb.2003.10.036; Nicholls D. G., 2004, BIOCHEMISTRY-US, V69, P818, DOI [10.1023/B:BIRY.0000040210.06512.a7, DOI 10.1023/B:BIRY.0000040210.06512.A7]; Nohl H, 2004, ACTA BIOCHIM POL, V51, P223; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; PARAIDATHATHU T, 1994, TOXICOLOGY, V90, P103, DOI 10.1016/0300-483X(94)90209-7; Quick KL, 2008, NEUROBIOL AGING, V29, P117, DOI 10.1016/j.neurobiolaging.2006.09.014; Quick KL, 2001, ANN NEUROL, V49, P627, DOI 10.1002/ana.1005; Quiles JL, 2005, BIOFACTORS, V25, P73, DOI 10.1002/biof.5520250109; QUINTANILHA AT, 1982, ANN NY ACAD SCI, V393, P32, DOI 10.1111/j.1749-6632.1982.tb31230.x; Rafique R, 2004, FREE RADICAL RES, V38, P157, DOI 10.1080/10715760310001643311; Rafique R, 2001, BIOCHEM J, V357, P887, DOI 10.1042/0264-6021:3570887; Raymond LJ, 2004, EXP BIOL MED, V229, P885, DOI 10.1177/153537020422900904; Reich EE, 2001, J NEUROSCI, V21, P5993, DOI 10.1523/JNEUROSCI.21-16-05993.2001; Ricciarelli R, 2001, FASEB J, V15, P2314, DOI 10.1096/fj.01-0258rev; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; SOKOL RJ, 1989, AM J CLIN NUTR, V50, P1064, DOI 10.1093/ajcn/50.5.1064; Sumien N, 2004, FREE RADICAL BIO MED, V36, P1424, DOI 10.1016/j.freeradbiomed.2004.02.081; Tarpey MM, 2004, AM J PHYSIOL-REG I, V286, pR431, DOI 10.1152/ajpregu.00361.2003; Terasawa Y, 2000, P NATL ACAD SCI USA, V97, P13830, DOI 10.1073/pnas.240462697; THOMAS PK, 1993, J ANAT, V183, P451; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Traber MG, 2005, FREE RADICAL BIO MED, V38, P773, DOI 10.1016/j.freeradbiomed.2004.11.027; VATASSERY GT, 1984, J NEUROCHEM, V42, P554, DOI 10.1111/j.1471-4159.1984.tb02713.x; VATASSERY GT, 1984, BIOCHIM BIOPHYS ACTA, V792, P118, DOI 10.1016/0005-2760(84)90211-X; Vatassery GT, 2004, BBA-MOL BASIS DIS, V1688, P265, DOI 10.1016/j.bbadis.2003.12.013; Wang XY, 2000, MOL MEMBR BIOL, V17, P143, DOI 10.1080/09687680010000311	61	41	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6915	6924		10.1074/jbc.M702572200	http://dx.doi.org/10.1074/jbc.M702572200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18180306	hybrid			2022-12-27	WOS:000253779600035
J	Teer, JK; Dutta, A				Teer, Jamie K.; Dutta, Anindya			Human Cdt1 lacking the evolutionarily conserved region that interacts with MCM2-7 is capable of inducing re-replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; EUKARYOTIC DNA-REPLICATION; LICENSING FACTOR CDT1; PREREPLICATION COMPLEXES; TRANSCRIPTIONAL CONTROL; G(2)/M CHECKPOINT; HELICASE ACTIVITY; MAMMALIAN-CELLS; GEMININ BINDING; S-PHASE	Replication initiation must be a carefully regulated process to avoid genomic instability caused by aberrant replication. In eukaryotic cells, distinct steps of protein loading ( origin licensing) and replication activation are choreographed such that a cell can replicate only once per cell cycle. The first proteins recruited to the origins form the pre-replication complex. Of these proteins, Cdt1 is of interest, as it is the focus of several pathways to control replication initiation. It is degraded by two different pathways, mediated by the interaction of Cdt1 with proliferating cell nuclear antigen ( PCNA) or with cyclin-Cdk2 and inhibited by geminin once cells are in S-phase, presumably to prevent reloading of pre-replication complexes once S-phase has begun. Although the requirement of Cdt1 in loading MCM2-7 is known, the mechanism by which overexpressed Cdt1 stimulates re-replication is unclear. In this study we have designed various mutations in Cdt1 to determine which portion of Cdt1 is important for re-replication, providing insight into possible mechanisms. Surprisingly, we found that mutants of Cdt1 that do not interact with MCM2-7 are able to induce rereplication when overexpressed. The re-replication is not due to titration of geminin from endogenous Cdt1 and is not accompanied by stabilization of endogenous Cdt1. Additionally, the N-terminal one-third of Cdt1 is sufficient to induce re-replication. The N terminus contains the PCNA-and cyclin-interacting motifs, and deletion of both motifs simultaneously in the overexpressed Cdt1 prevents re-replication. These findings suggest that exogenous Cdt1 induces re-replication by de-repressing endogenous Cdt1 through the titration of PCNA and cyclin.	[Teer, Jamie K.; Dutta, Anindya] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Teer, Jamie K.; Dutta, Anindya] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA 02115 USA	University of Virginia; Harvard University; Harvard Medical School	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073	NCI NIH HHS [R01CA60499, R01 CA060499-15, R01 CA060499] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA060499] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Devault A, 2002, CURR BIOL, V12, P689, DOI 10.1016/S0960-9822(02)00768-6; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Teer Jamie K., 2006, V42, P31, DOI 10.1007/b137221; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; You ZY, 1999, MOL CELL BIOL, V19, P8003; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhu WG, 2006, MOL CELL BIOL, V26, P4601, DOI 10.1128/MCB.02141-05; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	36	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6817	6825		10.1074/jbc.M708767200	http://dx.doi.org/10.1074/jbc.M708767200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18184650	hybrid			2022-12-27	WOS:000253779600024
J	Caunt, CJ; Rivers, CA; Conway-Campbell, BL; Norman, MR; McArdle, CA				Caunt, Christopher J.; Rivers, Caroline A.; Conway-Campbell, Becky L.; Norman, Michael R.; McArdle, Craig A.			Epidermal growth factor receptor and protein kinase C signaling to ERK2 - Spatiotemporal regulation of ERK2 by dual specificity phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OF-FUNCTION MUTATION; P42 MAP KINASE; NUCLEAR TRANSLOCATION; HORMONE RECEPTORS; RECOMBINANT ADENOVIRUS; DOCKING SITES; IN-VIVO; ACTIVATION; COMPARTMENTALIZATION; RECOGNITION	Spatiotemporal aspects of ERK activation are stimulus-specific and dictate cellular consequences. They are dependent upon dual specificity phosphatases (DUSPs) that bind ERK via docking domains and can both inactivate and anchor ERK in cellular compartments. Using high throughput fluorescence microscopy in combination with a system where endogenous ERKs are removed and replaced with wild-type or mutated ERK2-green fluorescent protein (GFP), we show that ERK2 activation responses to epidermal growth factor (EGF) and protein kinase C (PKC) are transient and sustained, respectively. PKC-mediated ERK2 activation is associated with prolonged nuclear localization in the dephosphorylated form, whereas EGF-stimulated ERK2 activation mediates only transient nuclear accumulation. By using short inhibitory RNAs to nuclear inducible DUSP1, -2, or -4 (alone or in combination), we demonstrate that all three of these enzymes contribute to the dephosphorylation of PKC (but not EGF)-activated ERK2 in the nucleus but that they have opposing effects on localization. DUSP2 and -4 inactivate and anchor ERK2, whereas DUSP1 dephosphorylates ERK in the nucleus but allows its traffic back to the cytoplasm. Overexpression of DUSP1, -2, or -4 prevented ERK2 activation, but only DUSP2 and -4 caused ERK2-GFP nuclear accumulation or could be immunoprecipitated with ERK2. Furthermore, protein synthesis inhibition or replacement of wild-type ERK2-GFP with docking domain mutants selectively increased PKC effects on ERK activity and altered ERK2-GFP localization. These mutations also impaired the ability of ERK2-GFP to bind DUSP2 and -4. Together, our data reveal a novel, stimulus-specific, and phosphatase-specific mechanism of ERK2 regulation in the nucleus by DUSP1, -2, and -4.	[Caunt, Christopher J.; Rivers, Caroline A.; Conway-Campbell, Becky L.; Norman, Michael R.; McArdle, Craig A.] Univ Bristol, Dept Clin Sci, Labs Integrated Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England	University of Bristol	McArdle, CA (corresponding author), Univ Bristol, Dept Clin Sci, Labs Integrated Neurosci & Endocrinol, Whitson St, Bristol BS1 3NY, Avon, England.	craig.mcardle@bris.ac.uk	Conway-Campbell, Becky/B-8571-2009; McArdle, Craig/AAQ-5660-2021	McArdle, Craig/0000-0003-4836-5351	Wellcome Trust [076557, 078407, 062918] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; BOTT CM, 1994, FEBS LETT, V352, P201, DOI 10.1016/0014-5793(94)00958-9; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Casar B, 2007, EMBO J, V26, P635, DOI 10.1038/sj.emboj.7601523; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Hislop JN, 2001, J BIOL CHEM, V276, P39685, DOI 10.1074/jbc.M104542200; Hislop JN, 2000, ENDOCRINOLOGY, V141, P4564, DOI 10.1210/en.141.12.4564; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Tanoue T, 2002, J BIOL CHEM, V277, P22942, DOI 10.1074/jbc.M202096200; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Volmat V, 2001, J CELL SCI, V114, P3433; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhou B, 2001, J BIOL CHEM, V276, P6506, DOI 10.1074/jbc.M009753200	33	59	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6241	6252		10.1074/jbc.M706624200	http://dx.doi.org/10.1074/jbc.M706624200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18178562	hybrid, Green Accepted			2022-12-27	WOS:000253779500031
J	Harper, SM; Wienk, H; Wechselberger, RW; Bos, JL; Boelens, R; Rehmann, H				Harper, Shannon M.; Wienk, Hans; Wechselberger, Rainer W.; Bos, Johannes L.; Boelens, Rolf; Rehmann, Holger			Structural dynamics in the activation of Epac	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; REGULATORY SUBUNIT; CRYSTAL-STRUCTURE; BINDING DOMAINS; CHEMICAL-SHIFT; CAMP; ANCIENT; MUTANT	Epac1 is a cAMP-responsive exchange factor for the small G-protein Rap. It consists of a regulatory region containing a cyclic nucleotide binding (CNB) domain and a catalytic region that activates Rap. In the absence of cAMP, access of Rap to the catalytic site is blocked by the regulatory region. We analyzed the conformational states of the CNB domain in the absence and in the presence of cAMP and cAMP analogues by NMR spectroscopy, resulting in the first direct insights into the activation mechanism of Epac. We prove that the CNB domain exists in equilibrium between the inactive and the active conformation, which is shifted by binding of cAMP. cAMP binding results in conformational changes in both the ligand binding pocket and the outer helical segments. We used two different cAMP antagonists that block these successive changes to elucidate the steps of this process. Highlighting the role of dynamics, the superactivator 8-pCPT-'-O-Me-cAMP induces similar conformational changes as cAMP but causes different internal mobility. The results reveal the critical elements of the CNB domain of Epac required for activation and highlight the role of dynamics in this process.	[Wienk, Hans; Wechselberger, Rainer W.; Boelens, Rolf] Univ Utrecht, Bijvoet Ctr Biomol Res, NMR Spect, NL-3584 CG Utrecht, Netherlands; [Harper, Shannon M.; Bos, Johannes L.; Rehmann, Holger] Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; [Harper, Shannon M.; Bos, Johannes L.; Rehmann, Holger] Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Boelens, R (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, NMR Spect, Padualaan 8, NL-3584 CG Utrecht, Netherlands.	r.boelens@chem.uu.nl; h.rehmann@UMCutrecht.nl	Boelens, Rolf/B-4702-2009; Wienk, Hans/P-8929-2015	Boelens, Rolf/0000-0002-6939-8913; Wienk, Hans/0000-0001-9577-0064				Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Brock M, 2007, J BIOL CHEM, V282, P32256, DOI 10.1074/jbc.M706231200; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; CAVANAGH J, 2007, PROTEIN NMR SPECTROC; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2006, J AM CHEM SOC, V128, P8406, DOI 10.1021/ja060046d; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Gibson RM, 1997, J BIOL CHEM, V272, P16343, DOI 10.1074/jbc.272.26.16343; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; SHABB JB, 1992, J BIOL CHEM, V267, P5723; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yu SN, 2006, BIOCHEMISTRY-US, V45, P15318, DOI 10.1021/bi061701x; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	30	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6501	6508		10.1074/jbc.M707849200	http://dx.doi.org/10.1074/jbc.M707849200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167352	Green Published, hybrid			2022-12-27	WOS:000253779500057
J	Minahk, C; Kim, KW; Nelson, R; Trigatti, B; Lehner, R; Vance, DE				Minahk, Carlos; Kim, Kyung-Wook; Nelson, Randy; Trigatti, Bernardo; Lehner, Richard; Vance, Dennis E.			Conversion of low density lipoprotein-associated phosphatidylcholine to triacylglycerol by primary hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR CLASS-B; PHOSPHOLIPID TRANSFER PROTEIN; HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; MEDIATED SELECTIVE UPTAKE; CHOLESTERYL ESTERS; HUMAN-FIBROBLASTS; SR-BI; LDL RECEPTOR; SULFATE PROTEOGLYCANS; INSULIN-RESISTANCE	We have studied the uptake and metabolism of phosphatidylcholine (PC), the major phospholipid of low density lipoproteins (LDL), by cultures of primary hepatocytes. Strikingly, in the absence of the LDL receptor, PC incorporation into hepatocytes was inhibited by only 30%, whereas cholesteryl ether uptake was inhibited by 60-70%. On the other hand, scavenger receptor class B, type I, the other important receptor for LDL in the liver, was found to be responsible for the uptake of the remaining 30-40% of LDL-cholesteryl ether. PC uptake was, however, only partially inhibited (30%) in scavenger receptor class B, type I, knock-out hepatocytes. Once LDL-PC was taken up by hepatocytes, similar to 50% of LDL-[H-3]oleate-PC was converted to triacylglycerol rather than degraded in lysosomes as occurs for LDL-derived cholesteryl esters. The remainder of the LDL- derived PC was not significantly metabolized to other products. Triacylglycerol synthesis from LDL- PC requires a PC-phospholipase C activity as demonstrated by inhibition with the phospholipase C inhibitor D609 or activation with rattlesnake venom. Small interfering RNA-mediated suppression of acyl-CoA:diacylglycerol acyltransferase 2(DGAT2), but not DGAT1, decreased the acylation of the LDL- derived diacylglycerol. These findings show that PC in LDL particles is taken up not only by the classical receptors but also by additional mechanism(s) followed by metabolism that is completely different from the cholesteryl esters or apoB100, the other main components of LDL.	[Minahk, Carlos; Nelson, Randy; Vance, Dennis E.] Univ Alberta, HMRC 328, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Minahk, Carlos; Nelson, Randy; Lehner, Richard; Vance, Dennis E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Kim, Kyung-Wook; Trigatti, Bernardo] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Lehner, Richard] Univ Alberta, Dept Pediat, Dept Cell Biol, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; McMaster University; University of Alberta	Vance, DE (corresponding author), Univ Alberta, HMRC 328, Dept Biochem, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca		Lehner, Richard/0000-0002-6008-1805; Trigatti, Bernardo (Dino) L./0000-0002-4556-119X; Minahk, Carlos/0000-0001-8765-8398				Albers JJ, 1996, CURR OPIN LIPIDOL, V7, P88, DOI 10.1097/00041433-199604000-00007; Amtmann E, 1996, DRUG EXP CLIN RES, V22, P287; ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; Auger A, 2001, EUR J BIOCHEM, V268, P2322, DOI 10.1046/j.1432-1327.2001.02115.x; AVIRAM M, 1988, J BIOL CHEM, V263, P15416; AZHAR S, 1988, J LIPID RES, V29, P869; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Benitez S, 2004, BIOCHEMISTRY-US, V43, P15863, DOI 10.1021/bi048825z; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1975, P NATL ACAD SCI USA, V72, P2925, DOI 10.1073/pnas.72.8.2925; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Dobner P, 1998, AM J PHYSIOL-ENDOC M, V275, pE777, DOI 10.1152/ajpendo.1998.275.5.E777; Dobner P, 1999, FEBS LETT, V444, P270, DOI 10.1016/S0014-5793(98)01687-1; Engelmann B, 1998, J BIOL CHEM, V273, P27800, DOI 10.1074/jbc.273.43.27800; Engelmann B, 1996, BIOCHEM J, V315, P781, DOI 10.1042/bj3150781; Foger B, 1997, J BIOL CHEM, V272, P27393, DOI 10.1074/jbc.272.43.27393; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P7854; GOLDSTEIN JL, 1974, P NATL ACAD SCI USA, V71, P4288, DOI 10.1073/pnas.71.11.4288; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; GREEN SR, 1991, J LIPID RES, V32, P667; Gu XJ, 2000, J BIOL CHEM, V275, P9120, DOI 10.1074/jbc.275.13.9120; Hagishita S, 1996, J MED CHEM, V39, P3636, DOI 10.1021/jm960395q; Hassan HH, 2007, J LIPID RES, V48, P2428, DOI 10.1194/jlr.M700206-JLR200; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; HUANG CF, 1990, J BIOL CHEM, V265, P14858; Igal RA, 2001, J LIPID RES, V42, P88; ISHIKAWA Y, 1989, ATHEROSCLEROSIS, V80, P1, DOI 10.1016/0021-9150(89)90061-0; Jansen SM, 1999, BBA-MOL CELL BIOL L, V1436, P363, DOI 10.1016/S0005-2760(98)00129-5; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Lie J, 2004, J LIPID RES, V45, P805, DOI 10.1194/jlr.M300487-JLR200; Liu B, 2007, J LIPID RES, V48, P1710, DOI 10.1194/jlr.M700125-JLR200; LOOKENE A, 1994, EUR J BIOCHEM, V222, P395, DOI 10.1111/j.1432-1033.1994.tb18878.x; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; MA PTS, 1986, P NATL ACAD SCI USA, V83, P792, DOI 10.1073/pnas.83.3.792; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Macphee CH, 2006, CURR OPIN PHARMACOL, V6, P154, DOI 10.1016/j.coph.2005.11.008; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Millar JS, 2006, J LIPID RES, V47, P2297, DOI 10.1194/jlr.M600213-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Nieland TJF, 2005, BBA-MOL CELL BIOL L, V1734, P44, DOI 10.1016/j.bbalip.2005.02.007; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; PARTHASARATHY S, 1990, P NATL ACAD SCI USA, V87, P9741, DOI 10.1073/pnas.87.24.9741; Ramoni C, 2004, EXP CELL RES, V299, P370, DOI 10.1016/j.yexcr.2004.05.037; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Rhainds D, 1999, EUR J BIOCHEM, V261, P227, DOI 10.1046/j.1432-1327.1999.00264.x; Rhainds D, 2003, BIOCHEMISTRY-US, V42, P7527, DOI 10.1021/bi026949a; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Rosenson RS, 2004, ATHEROSCLEROSIS, V173, P1, DOI 10.1016/S0021-9150(03)00239-9; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Santamarina-Fojo S, 1998, CURR OPIN LIPIDOL, V9, P211, DOI 10.1097/00041433-199806000-00005; SCAGNELLI GP, 1991, J BIOL CHEM, V266, P18002; Scott J, 2004, CURR OPIN GENET DEV, V14, P271, DOI 10.1016/j.gde.2004.04.012; Seo T, 2000, J BIOL CHEM, V275, P30355, DOI 10.1074/jbc.M910327199; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Sovic A, 2004, NEUROSCI LETT, V368, P11, DOI 10.1016/j.neulet.2004.04.097; SPARROW CP, 1990, BIOCHIM BIOPHYS ACTA, V1043, P203, DOI 10.1016/0005-2760(90)90297-B; STEIN Y, 1984, BIOCHIM BIOPHYS ACTA, V793, P354, DOI 10.1016/0005-2760(84)90249-2; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Swarnakar S, 1999, J BIOL CHEM, V274, P29733, DOI 10.1074/jbc.274.42.29733; Swarnakar S, 2001, J BIOL CHEM, V276, P21121, DOI 10.1074/jbc.M101691200; TALL AR, 1983, J BIOL CHEM, V258, P2174; Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84; Truong TQ, 2000, BBA-MOL CELL BIOL L, V1484, P307, DOI 10.1016/S1388-1981(00)00023-8; Urban S, 2000, J BIOL CHEM, V275, P33409, DOI 10.1074/jbc.M004031200; Walter M, 1996, J CLIN INVEST, V98, P2315, DOI 10.1172/JCI119043; Wiggins D, 1996, BIOCHEM J, V320, P673, DOI 10.1042/bj3200673; Williams SD, 2000, J LIPID RES, V41, P1585; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang Y, 2007, J LIPID RES, V48, P405, DOI 10.1194/jlr.M600326-JLR200; Zhao QT, 2004, TOXICON, V44, P161, DOI 10.1016/j.toxicon.2004.05.015	80	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6449	6458		10.1074/jbc.M706995200	http://dx.doi.org/10.1074/jbc.M706995200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18175806	hybrid			2022-12-27	WOS:000253779500052
J	Paradisi, A; Pasquariello, N; Barcaroli, D; Maccarrone, M				Paradisi, Andrea; Pasquariello, Nicoletta; Barcaroli, Daniela; Maccarrone, Mauro			Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CANNABINOID RECEPTOR; ENDOCANNABINOID SYSTEM; CORNIFIED ENVELOPE; EPIDERMAL DIFFERENTIATION; INTERMEDIATE-FILAMENTS; GENE-EXPRESSION; TUMOR-GROWTH; METHYLTRANSFERASE; ACTIVATION	Anandamide ( arachidonoylethanolamide, AEA) belongs to an important class of endogenous lipids including amides and esters of long chain polyunsaturated fatty acids, collectively termed "endocannabinoids." Recently we have shown that AEA inhibits differentiation of human keratinocytes, by binding to type-1 cannabinoid receptors (CB1R). To further characterize the molecular mechanisms responsible for this effect, we investigated the expression of epidermal differentiation-related genes after AEA treatment. We observed that keratin 1 and 10, transglutaminase 5 and involucrin are transcriptionally down-regulated by AEA. Most importantly, we found that AEA is able to decrease differentiating gene expression by increasing DNA methylation in human keratinocytes, through a p38, and to a lesser extent p42/44, mitogen-activated protein kinase-dependent pathway triggered by CB1R. An effect of AEA on DNA methylation because of CB1R-mediated increase of methyltransferase activity is described here for the first time, and we believe that the importance of this effect clearly extends beyond the regulation of skin differentiation. In fact, the modulation of DNA methylation by endocannabinoids may affect the expression of a number of genes that regulate many cell functions in response to these substances.	[Paradisi, Andrea; Pasquariello, Nicoletta; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, I-64100 Teramo, Italy; [Barcaroli, Daniela] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Barcaroli, Daniela; Maccarrone, Mauro] Ist Ricovero & Cura Carattere Sci St Lucia Fdn, European Ctr Brain Res CERC, I-00196 Rome, Italy	University of Teramo; University of Rome Tor Vergata	Maccarrone, M (corresponding author), Univ Teramo, Dept Biomed Sci, Piazza A Moro 45, I-64100 Teramo, Italy.	mmaccarrone@unite.it	PARADISI, Andrea/AAE-2293-2020; Maccarrone, Mauro/K-5398-2012; PARADISI, Andrea/AAN-6404-2020	PARADISI, Andrea/0000-0003-2218-3859; Maccarrone, Mauro/0000-0002-3990-2963; PARADISI, Andrea/0000-0003-2218-3859				ADAMS RLP, 1991, J BIOCHEM BIOPH METH, V22, P19, DOI 10.1016/0165-022X(91)90077-A; Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Bari M, 2006, MINI-REV MED CHEM, V6, P257, DOI 10.2174/138955706776073466; Battista N., 2005, THERAPY, V2, P141; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Blazquez C, 2006, FASEB J, V20, P2633, DOI 10.1096/fj.06-6638fje; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Bouaboula M, 1999, FEBS LETT, V449, P61, DOI 10.1016/S0014-5793(99)00395-6; Broday L, 1999, MOL CELL BIOL, V19, P3198; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Candi E, 2002, J INVEST DERMATOL, V119, P670, DOI 10.1046/j.1523-1747.2002.01853.x; Candi E, 2001, J BIOL CHEM, V276, P35014, DOI 10.1074/jbc.M010157200; Casanova ML, 2003, J CLIN INVEST, V111, P43, DOI 10.1172/JCI200316116; Cavuoto P, 2007, MOL CELL ENDOCRINOL, V267, P63, DOI 10.1016/j.mce.2006.12.038; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Di Marzo V, 2006, TRENDS PHARMACOL SCI, V27, P134, DOI 10.1016/j.tips.2006.01.010; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Elder JT, 2002, EXP DERMATOL, V11, P406, DOI 10.1034/j.1600-0625.2002.110503.x; ENGELKAMP D, 1993, P NATL ACAD SCI USA, V90, P6547, DOI 10.1073/pnas.90.14.6547; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kalinin A, 2001, J CELL SCI, V114, P3069; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Laezza C, 2006, FEBS LETT, V580, P6076, DOI 10.1016/j.febslet.2006.09.074; LEE YW, 1995, MOL CELL BIOL, V15, P2547; LIGRESTI A, 2005, CURR DRUG TARGETS CN, V4, P615; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LYON SB, 1987, MOL CELL BIOL, V7, P1759, DOI 10.1128/MCB.7.5.1759; Maccarrone M, 2003, J BIOL CHEM, V278, P33896, DOI 10.1074/jbc.M303994200; Maccarrone M, 2006, ENDOCANNABINOIDS: THE BRAIN AND BODY'S MARIJUANA AND BEYOND, P451; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; MING ME, 1994, J INVEST DERMATOL, V103, P780, DOI 10.1111/1523-1747.ep12413024; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Ofek O, 2006, P NATL ACAD SCI USA, V103, P696, DOI 10.1073/pnas.0504187103; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Paradisi A, 2006, CURR DRUG TARGETS, V7, P1539, DOI 10.2174/1389450110607011539; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Portella G, 2003, FASEB J, V17, P1771, DOI 10.1096/fj.02-1129fje; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; ROSL F, 1988, EMBO J, V7, P1321, DOI 10.1002/j.1460-2075.1988.tb02947.x; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Savini I, 2002, J INVEST DERMATOL, V118, P372, DOI 10.1046/j.0022-202x.2001.01624.x; SCHMIDT R, 1989, J CELL PHYSIOL, V140, P281, DOI 10.1002/jcp.1041400213; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; STAIANOCOICO L, 1989, CELL TISSUE KINET, V22, P361, DOI 10.1111/j.1365-2184.1989.tb00221.x; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Telek A, 2007, FASEB J, V21, P3534, DOI 10.1096/fj.06-7689com; VERES DA, 1989, J INVEST DERMATOL, V93, P687, DOI 10.1111/1523-1747.ep12319883; Walker JM, 2002, PROSTAG LEUKOTR ESS, V66, P235, DOI 10.1054/plef.2001.0361; Wang J, 2006, CHAOS SOLITON FRACT, V27, P427, DOI 10.1016/j.chaos.2005.04.024; Werz O, 2002, BLOOD, V99, P1044, DOI 10.1182/blood.V99.3.1044; Xiong YN, 2005, CANCER RES, V65, P2684, DOI 10.1158/0008-5472.CAN-04-2843	69	73	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6005	6012		10.1074/jbc.M707964200	http://dx.doi.org/10.1074/jbc.M707964200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165231	hybrid			2022-12-27	WOS:000253779500005
J	Ryan, KS; Balibar, CJ; Turo, KE; Walsh, CT; Drennan, CL				Ryan, Katherine S.; Balibar, Carl J.; Turo, Kaitlyn E.; Walsh, Christopher T.; Drennan, Catherine L.			The violacein Biosynthetic enzyme VioE shares a fold with lipoprotein transporter proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOPYRROLIC ACID; GENE-CLUSTER; LOLA; MECHANISM; APOPTOSIS; PIGMENT; REARRANGEMENT; CYTOTOXICITY; LOCALIZATION; REBECCAMYCIN	VioE, an unusual enzyme with no characterized homologues, plays a key role in the biosynthesis of violacein, a purple pigment with antibacterial and cytotoxic properties. Without bound cofactors or metals, VioE, from the bacterium Chromobacterium violaceum, mediates a 1,2 shift of an indole ring and oxidative chemistry to generate prodeoxyviolacein, a precursor to violacein. Our 1.21 angstrom resolution structure of VioE shows that the enzyme shares a core fold previously described for lipoprotein transporter proteins LolA and LolB. For both LolB and VioE, a bound polyethylene glycol molecule suggests the location of the binding and/or active site of the protein. Mutations of residues near the bound polyethylene glycol molecule in VioE have identified the active site and five residues important for binding or catalysis. This structural and mutagenesis study suggests that VioE acts as a catalytic chaperone, using a fold previously associated with lipoprotein transporters to catalyze the production of its prodeoxyviolacein product.	[Ryan, Katherine S.; Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Turo, Kaitlyn E.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Balibar, Carl J.; Walsh, Christopher T.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Drennan, CL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cdrennan@mit.edu			NIEHS NIH HHS [P30 ES002109, P30 ES 002109] Funding Source: Medline; NIGMS NIH HHS [GM 20011, R01 GM020011, GM 65337, P50 GM068762, R01 GM065337, GM 68762, F32 GM020011] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, R37GM020011, R01GM020011, R01GM065337] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Asamizu S, 2006, TETRAHEDRON LETT, V47, P473, DOI 10.1016/j.tetlet.2005.11.061; Asamizu S, 2007, TETRAHEDRON LETT, V48, P2923, DOI 10.1016/j.tetlet.2007.02.062; August PR, 2000, J MOL MICROB BIOTECH, V2, P513; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; BALLANTINE JA, 1958, P CHEM SOC, V1, P232; Bassan A, 2003, CHEM-EUR J, V9, P4055, DOI 10.1002/chem.200304768; Brady SF, 2001, ORG LETT, V3, P1981, DOI 10.1021/ol015949k; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; de Carvalho DD, 2006, TOXICOL IN VITRO, V20, P1514, DOI 10.1016/j.tiv.2006.06.007; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DEMOSS RD, 1960, J BACTERIOL, V79, P729, DOI 10.1128/JB.79.5.729-733.1960; DEMOSS RD, 1959, J BACTERIOL, V78, P583, DOI 10.1128/JB.78.4.583-588.1959; Duran N, 2003, CAN J PHYSIOL PHARM, V81, P387, DOI 10.1139/Y03-033; Duran N, 2001, CRIT REV MICROBIOL, V27, P201, DOI 10.1080/20014091096747; DURAN N, 1983, AN ACAD BRAS CIENC, V55, P231; DURAN N, 1989, Anais da Academia Brasileira de Ciencias, V61, P31; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira CV, 2004, BLOOD, V104, P1459, DOI 10.1182/blood-2004-02-0594; Fischer G, 2000, CHEM SOC REV, V29, P119, DOI 10.1039/a803742f; Gao QJ, 2006, CHEM BIOL, V13, P733, DOI 10.1016/j.chembiol.2006.05.009; HASHIM MF, 1990, FEBS LETT, V271, P219, DOI 10.1016/0014-5793(90)80410-K; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSHINO T, 1987, AGR BIOL CHEM TOKYO, V51, P2733; Howard-Jones AR, 2006, J AM CHEM SOC, V128, P12289, DOI 10.1021/ja063898m; Howard-Jones AR, 2005, BIOCHEMISTRY-US, V44, P15652, DOI 10.1021/bi051706e; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim SY, 2007, APPL MICROBIOL BIOT, V75, P1119, DOI 10.1007/s00253-007-0924-x; Kodach LL, 2006, CARCINOGENESIS, V27, P508, DOI 10.1093/carcin/bgi307; Laatsch H, 1984, J CHEM SOC P2, V8, P1331, DOI [10.1039/p29840001331, DOI 10.1039/P29840001331]; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leon LL, 2001, J ANTIMICROB CHEMOTH, V48, P449, DOI 10.1093/jac/48.3.449; Li R, 2006, CHEM BIOL, V13, P513, DOI 10.1016/j.chembiol.2006.03.005; LICHSTEIN HC, 1946, J BACTERIOL, V52, P145, DOI 10.1128/JB.52.1.145-146.1946; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; Melo PD, 2000, IN VITRO CELL DEV-AN, V36, P539, DOI 10.1290/1071-2690(2000)036<0539:VCAIOA>2.0.CO;2; Melo PS, 2003, TOXICOLOGY, V186, P217, DOI 10.1016/S0300-483X(02)00751-5; Miyamoto A, 2001, BIOCHEM BIOPH RES CO, V287, P1125, DOI 10.1006/bbrc.2001.5705; Momen AZMR, 2000, BIOSCI BIOTECH BIOCH, V64, P539, DOI 10.1271/bbb.64.539; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narita S, 2004, ARCH MICROBIOL, V182, P1, DOI 10.1007/s00203-004-0682-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Reilly J, 1927, BIOCHEM J, V21, P1059, DOI 10.1042/bj0211059; Sanchez C, 2006, CHEMBIOCHEM, V7, P1231, DOI 10.1002/cbic.200600029; Saraiva VS, 2004, MELANOMA RES, V14, P421, DOI 10.1097/00008390-200410000-00014; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Strong F. M., 1944, SCIENCE, V100, P287, DOI 10.1126/science.100.2596.287; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Tobie WC, 1935, J BACTERIOL, V29, P223, DOI 10.1128/JB.29.3.223-227.1935; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Watanabe K, 2003, P NATL ACAD SCI USA, V100, P9774, DOI 10.1073/pnas.1632167100; Watanabe S, 2006, J BIOL CHEM, V281, P3335, DOI 10.1074/jbc.M509596200; Yu TW, 2001, J BIOL CHEM, V276, P12546, DOI 10.1074/jbc.M009667200	58	31	31	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6467	6475		10.1074/jbc.M708573200	http://dx.doi.org/10.1074/jbc.M708573200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18171675	hybrid, Green Accepted			2022-12-27	WOS:000253779500054
J	Cifuentes, D; Martinez-Pons, C; Garcia-Rocha, M; Galina, A; de Pouplana, LR; Guinovart, JJ				Cifuentes, Daniel; Martinez-Pons, Carles; Garcia-Rocha, Mar; Galina, Antonio; de Pouplana, Lluis Ribas; Guinovart, Joan J.			Hepatic glycogen synthesis in the absence of glucokinase - The case of embryonic liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PROTEIN; RAT HEPATOCYTES; SUBCELLULAR-LOCALIZATION; GLUCOSE-HOMEOSTASIS; HEXOKINASE I; SYNTHASE; GLUCOSE-6-PHOSPHATE; METABOLISM; ACTIVATION; EXPRESSION	Glucokinase (GK, hexokinase type IV) is required for the accumulation of glycogen in adult liver and hepatoma cells. Paradoxically, mammalian embryonic livers store glycogen successfully in the absence of GK. Here we address how mammalian embryonic livers, but not adult livers or hepatoma cells, manage to accumulate glycogen in the absence of this enzyme. Hexokinase type I or II (HKI, HKII) substitutes for GK in hepatomas and in embryonic livers. We engineered FTO2B cells, a hepatoma cell line in which GK is not expressed, to unveil the modifications required to allow them to accumulate glycogen. In the light of these results, we then examined glycogen metabolism in embryonic liver. Glycogen accumulation in FTO2B cells can be triggered through elevated expression of HKI or either of the protein phosphatase 1 regulatory subunits, namely PTG or G(L). Between these two strategies to activate glycogen deposition in the absence of GK, embryonic livers choose to express massive levels of HKI and HKII. We conclude that although the GK/liver glycogen synthase tandem is ideally suited to store glycogen in liver when blood glucose is high, the substitution of HKI for GK in embryonic livers allows the HKI/liver glycogen synthase tandem to make glycogen independently of the glucose concentration in blood, although it requires huge levels of HK. Moreover, the physiological consequence of the HK isoform switch is that the embryonic liver safeguards its glycogen deposits, required as the main source of energy at birth, from maternal starvation.	[Cifuentes, Daniel; Martinez-Pons, Carles; Garcia-Rocha, Mar; Guinovart, Joan J.] Univ Barcelona, Res Inst Biomed, Barcelona 08028, Spain; [Cifuentes, Daniel; Martinez-Pons, Carles; Garcia-Rocha, Mar; Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona 08028, Spain; [Galina, Antonio] Inst Catalana Rec Estud Avancats, Catalonia 08028, Spain; [de Pouplana, Lluis Ribas] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil	University of Barcelona; University of Barcelona; ICREA; Universidade Federal do Rio de Janeiro	Guinovart, JJ (corresponding author), Inst Res Biomed, Barcelona Sci Park,Joseph Samitier 1-5, E-08028 Barcelona, Spain.	guinovart@irbbarcelona.org	Galina, Antonio/A-9292-2008; de Pouplana, Lluis Ribas/AAA-4738-2019	de Pouplana, Lluis Ribas/0000-0002-2087-0359; Garcia-Rocha, Mar/0000-0003-2467-2090; Cifuentes Buira, Daniel/0000-0001-5442-4843	ICREA Funding Source: Custom	ICREA(ICREA)		Agius L, 1996, J BIOL CHEM, V271, P30479, DOI 10.1074/jbc.271.48.30479; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; BOSCH F, 1983, FEBS LETT, V151, P76, DOI 10.1016/0014-5793(83)80346-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; CARABAZA A, 1986, ARCH BIOCHEM BIOPHYS, V250, P469, DOI 10.1016/0003-9861(86)90751-4; CARABAZA A, 1990, J BIOL CHEM, V265, P2724; Cardenas ML, 1997, BIOCHEM SOC T, V25, P131, DOI 10.1042/bst0250131; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; de la Iglesia N, 1999, FEBS LETT, V456, P332, DOI 10.1016/S0014-5793(99)00971-0; Farrelly D, 1999, P NATL ACAD SCI USA, V96, P14511, DOI 10.1073/pnas.96.25.14511; FernandezNovell JM, 1996, EUR J BIOCHEM, V238, P570, DOI 10.1111/j.1432-1033.1996.0570z.x; Ferre T, 1996, P NATL ACAD SCI USA, V93, P7225, DOI 10.1073/pnas.93.14.7225; GANCEDO JM, 1977, J BIOL CHEM, V252, P4443; Garcia-Rocha M, 2001, BIOCHEM J, V357, P17, DOI 10.1042/0264-6021:3570017; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Gomis RR, 2003, J BIOL CHEM, V278, P9740, DOI 10.1074/jbc.M212151200; Gomis RR, 2002, J BIOL CHEM, V277, P23246, DOI 10.1074/jbc.M111208200; Gomis RR, 2000, BIOCHEM J, V351, P811, DOI 10.1042/0264-6021:3510811; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; KUWAJIMA M, 1986, J BIOL CHEM, V261, P8849; LANG G, 1974, METHOD ENZYMAT AN, V3, P1238; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; ODoherty RM, 1996, J BIOL CHEM, V271, P20524, DOI 10.1074/jbc.271.34.20524; Penso J, 1998, EUR J PHARMACOL, V342, P113, DOI 10.1016/S0014-2999(97)01507-0; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; POSTIC C, 1994, AM J PHYSIOL, V266, pE548, DOI 10.1152/ajpendo.1994.266.4.E548; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; SCHAMHART DHJ, 1979, CANCER RES, V39, P1051; Seoane J, 1996, J BIOL CHEM, V271, P23756, DOI 10.1074/jbc.271.39.23756; Seoane J, 1999, J BIOL CHEM, V274, P31833, DOI 10.1074/jbc.274.45.31833; Towbin H, 1992, Biotechnology, V24, P145; VALERA A, 1994, EUR J BIOCHEM, V222, P533, DOI 10.1111/j.1432-1033.1994.tb18895.x; VanSchaftingen E, 1997, BIOCHEM SOC T, V25, P136, DOI 10.1042/bst0250136; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Zvibel I, 1998, DIFFERENTIATION, V63, P215, DOI 10.1111/j.1432-0436.1998.00215.x	43	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5642	5649		10.1074/jbc.M706334200	http://dx.doi.org/10.1074/jbc.M706334200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165236	hybrid			2022-12-27	WOS:000253426700044
J	Gupta, A; Rozenfeld, R; Gomes, I; Raehal, KM; Decaillot, FM; Bohn, LM; Devi, LA				Gupta, Achla; Rozenfeld, Raphael; Gomes, Ivone; Raehal, Kirsten M.; Decaillot, Fabien M.; Bohn, Laura M.; Devi, Lakshmi A.			Post-activation-mediated changes in opioid receptors detected by N-terminal antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; INVERSE AGONIST; DOWN-REGULATION; DESENSITIZATION; INTERNALIZATION; HETERODIMERIZATION; MUTATIONS; RHODOPSIN; SEGMENT-6	The majority of studies examining activity-induced conformational changes in G protein-coupled receptors have focused on transmembrane helices or intracellular regions. Relatively few studies have examined the involvement of the extracellular region in general and the N-terminal region in particular in this process. To begin to address this, we generated a series of antibodies to the N-terminal region of opioid receptors. Characterization of these antibodies revealed that they differentially recognize activated receptors. Recently, we generated monoclonal antibodies that recognize regions proximal to glycosylation sites in the receptor N terminus. Characterization of these antibodies revealed that agonist treatment leads to a decrease in epitope recognition by the antibody presumably because of a movement of the region of the N terminus proximal to glycosylation sites. The time course of the decrease in antibody recognition suggested that it could be due to a post-activation-mediated event. Examination of the involvement of receptor residues in the C-tail and beta-arrestin binding using site-directed mutagenesis and cells or tissues lacking beta-arrestin 2 suggests a role for these desensitization-related mechanisms in governing antibody binding to the receptor. Thus, these N-terminally directed antibodies can differentially recognize post-activation-mediated changes in the C-terminal (intracellular) region of the receptor. Therefore, these conformation-sensitive antibodies represent powerful reagents to probe receptor activation states and provide a potential tool for identifying and characterizing new compounds of therapeutic interest.	[Gupta, Achla; Rozenfeld, Raphael; Gomes, Ivone; Decaillot, Fabien M.; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Raehal, Kirsten M.; Bohn, Laura M.] Ohio State Univ, Coll Med & Publ Hlth, Dept Pharmacol & Psychiat, Columbus, OH 43210 USA	Icahn School of Medicine at Mount Sinai; University System of Ohio; Ohio State University	Devi, LA (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 19-84 Annenberg Bldg,1 Gustave L Levy Pl, New York, NY 10029 USA.	lakshmi.devi@mssm.edu	Devi P, Lakshmi/GXM-5982-2022; Bohn, Laura M/A-7483-2014	Devi P, Lakshmi/0000-0001-9274-4776; Bohn, Laura M/0000-0002-6474-8179	NIDA NIH HHS [K01 DA014600, DA08863, DA18860, DA19521, R01 DA018860, DA021952, DA14600, K01 DA014600-06, R01 DA018860-04] Funding Source: Medline; NINDS NIH HHS [NS053751] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA021952, R37DA008863, R56DA008863, R01DA018860, K01DA014600, R01DA008863, K05DA019521] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alvarez VA, 2002, J NEUROSCI, V22, P5769; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Borgland S, 2001, CLIN EXP PHARMACOL P, V28, P147, DOI 10.1046/j.1440-1681.2001.03418.x; Brillet Karl, 2003, BMC Pharmacology, V3, P14, DOI 10.1186/1471-2210-3-14; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; Decaillot FM, 2003, NAT STRUCT BIOL, V10, P629, DOI 10.1038/nsb950; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2002, METHODS, V27, P358, DOI 10.1016/S1046-2023(02)00094-4; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Gupta A, 2006, MT SINAI J MED, V73, P673; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; HILL SJ, 2006, BRIT J PHARMACOL, V27, pS37; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kovoor A, 1998, MOL PHARMACOL, V54, P704; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Law PY, 2000, J BIOL CHEM, V275, P32057, DOI 10.1074/jbc.M002395200; Lecat S, 2002, J BIOL CHEM, V277, P42034, DOI 10.1074/jbc.M203606200; Levin MC, 2002, J BIOL CHEM, V277, P30429, DOI 10.1074/jbc.M200681200; Li J, 2001, BIOCHEMISTRY-US, V40, P12039, DOI 10.1021/bi0100945; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; ROZENFLED R, 2008, IN PRESS FASEB J; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Silve C, 2005, J BIOL CHEM, V280, P37917, DOI 10.1074/jbc.M506263200; Trapaidze N, 2000, DNA CELL BIOL, V19, P93, DOI 10.1089/104454900314609; Trapaidze N, 1996, J BIOL CHEM, V271, P29279, DOI 10.1074/jbc.271.46.29279; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	34	18	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10735	10744		10.1074/jbc.M709454200	http://dx.doi.org/10.1074/jbc.M709454200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18256033	Green Published, hybrid			2022-12-27	WOS:000254894700056
J	Hu, YH; Lund, IV; Gravielle, MC; Farb, DH; Brooks-Kayal, AR; Russek, SJ				Hu, Yinghui; Lund, Ingrid V.; Gravielle, Maria C.; Farb, David H.; Brooks-Kayal, Amy R.; Russek, Shelley J.			Surface expression of GABA(A) receptors is transcriptionally controlled by the interplay of cAMP-response element-binding protein and its binding partner inducible cAMP early repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT MESSENGER-RNAS; CEREBELLAR GRANULE NEURONS; AMINOBUTYRIC ACID(A) RECEPTORS; TEMPORAL-LOBE EPILEPSY; RAT-BRAIN; DENTATE GRANULE; DOWN-REGULATION; BENZODIAZEPINE RECEPTORS; DEVELOPMENTAL EXPRESSION; MOLECULAR-BIOLOGY	The regulated expression of type A gamma-aminobutyric acid ( GABA) receptor ( GABA(A)R) subunit genes plays a critical role in neuronal maturation and synaptogenesis. It is also associated with a variety of neurological diseases. Changes in GABA(A) receptor alpha 1 subunit gene ( GABRA1) expression have been reported in animal models of epilepsy, alcohol abuse, withdrawal, and stress. Understanding the genetic mechanism behind such changes in alpha subunit expression will lead to a better understanding of the role that signal transduction plays in control over GABAAR function and brings with it the promise of providing new therapeutic tools for the prevention or cure of a variety of neurological disorders. Here we show that activation of protein kinase C increases alpha 1 subunit levels via phosphorylation of CREB ( pCREB) that is bound to the GABRA1 promoter ( GABRA1p). In contrast, activation of protein kinase A decreases levels of alpha 1 even in the presence of pCREB. Decrease of alpha 1 is dependent upon the inducible cAMP early repressor ( ICER) as directly demonstrated by ICER-induced down-regulation of endogenous alpha 1-containing GABA(A)Rs at the cell surface of cortical neurons. Taken together with the fact that there are less alpha 1 gamma 2-containing GABAARs in neurons after protein kinase A stimulation and that activation of endogenous dopamine receptors down-regulates alpha 1 subunit mRNA levels subsequent to induction of ICER, our studies identify a transcriptional mechanism for regulating the cell surface expression of alpha 1-containing GABAARs that is dependent upon the formation of CREB heterodimers.	[Hu, Yinghui; Russek, Shelley J.] Boston Univ, Sch Med, Lab Translat Epilepsy, Boston, MA 02118 USA; [Hu, Yinghui; Gravielle, Maria C.; Farb, David H.; Russek, Shelley J.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Hu, Yinghui] Univ Penn, Childrens Hosp, Div Neurol, Program BioMed Neurosci, Philadelphia, PA 19104 USA; [Lund, Ingrid V.] Univ Penn, Childrens Hosp, Div Neurol, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Gravielle, Maria C.; Farb, David H.] Univ Penn, Childrens Hosp, Div Neurol, Mol Neurobiol Lab, Philadelphia, PA 19104 USA; [Brooks-Kayal, Amy R.] Univ Penn, Childrens Hosp, Div Neurol, Dept Neurol, Philadelphia, PA 19104 USA; [Brooks-Kayal, Amy R.] Univ Penn, Childrens Hosp, Div Neurol, Dept Pediat, Philadelphia, PA 19104 USA	Boston University; Boston University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Russek, SJ (corresponding author), Boston Univ, Sch Med, Lab Translat Epilepsy, Boston, MA 02118 USA.	srussek@bu.edu	Farb, david H/C-7089-2014	Farb, david H/0000-0002-9050-6480; Gravielle, Maria/0000-0003-4353-5526; Russek, Shelley/0000-0001-7547-3089	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050393, R01NS051710, F31NS051943] Funding Source: NIH RePORTER; NINDS NIH HHS [F31 NS 51943, R01 NS 051710, R01 NS 050393] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barnard EA, 1998, PHARMACOL REV, V50, P291; BAUMGARTNER BJ, 1994, MOL BRAIN RES, V26, P9, DOI 10.1016/0169-328X(94)90068-X; BEATTIE CE, 1993, J NEUROSCI, V13, P1784; Blednov YA, 2003, J PHARMACOL EXP THER, V304, P30, DOI 10.1124/jpet.102.042960; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Brooks-Kayal AR, 1999, J NEUROSCI, V19, P8312; BRUSSAARD AB, 1995, NEUROSCI LETT, V191, P111, DOI 10.1016/0304-3940(95)11539-6; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; Burkart AD, 2006, MOL ENDOCRINOL, V20, P584, DOI 10.1210/me.2005-0204; BURT DR, 1991, FASEB J, V5, P2916, DOI 10.1096/fasebj.5.14.1661244; Cardenas C, 2004, J BIOL CHEM, V279, P39122, DOI 10.1074/jbc.M401044200; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Devaud LL, 1997, J NEUROCHEM, V69, P126; Drewett V, 2001, NUCLEIC ACIDS RES, V29, P479, DOI 10.1093/nar/29.2.479; DUGGAN MJ, 1990, J BIOL CHEM, V265, P3831; ENDO S, 1993, J NEUROCHEM, V60, P1388, DOI 10.1111/j.1471-4159.1993.tb03300.x; Gellersen B, 1997, MOL ENDOCRINOL, V11, P97, DOI 10.1210/me.11.1.97; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924, DOI 10.1152/jn.1997.77.4.1924; Grobin AC, 1998, PSYCHOPHARMACOLOGY, V139, P2, DOI 10.1007/s002130050685; HARRIS BT, 1994, MOL PHARMACOL, V45, P637; Hsu FC, 2003, P NATL ACAD SCI USA, V100, P12213, DOI 10.1073/pnas.2131679100; HUNTSMAN MM, 1994, J NEUROSCI, V14, P2236; Kee BL, 1996, J BIOL CHEM, V271, P2373, DOI 10.1074/jbc.271.5.2373; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; Kralic JE, 2002, J PHARMACOL EXP THER, V302, P1037, DOI 10.1124/jpet.102.036665; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lyons HR, 2000, J NEUROCHEM, V74, P1041, DOI 10.1046/j.1471-4159.2000.0741041.x; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Malatynska E, 2000, NEUROCHEM INT, V36, P45, DOI 10.1016/S0197-0186(99)00100-X; Mao DL, 1998, MOL ENDOCRINOL, V12, P492, DOI 10.1210/me.12.4.492; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; MCKERNAN RM, 1991, NEURON, V7, P667, DOI 10.1016/0896-6273(91)90379-E; MCKERNAN RM, 1991, FEBS LETT, V286, P44, DOI 10.1016/0014-5793(91)80936-W; McLean PJ, 2000, J NEUROCHEM, V74, P1858, DOI 10.1046/j.1471-4159.2000.0741858.x; MEINECKE DL, 1990, DEV BRAIN RES, V55, P73, DOI 10.1016/0165-3806(90)90107-A; Mioduszewska B, 2003, J NEUROCHEM, V87, P1313, DOI 10.1046/j.1471-4159.2003.02116.x; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; MONTPIED P, 1991, J BIOL CHEM, V266, P6011; MONTPIED P, 1993, MOL BRAIN RES, V18, P267, DOI 10.1016/0169-328X(93)90199-Y; Mtchedlishvili Z, 2001, J PHYSIOL-LONDON, V537, P453, DOI 10.1111/j.1469-7793.2001.00453.x; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PUIA G, 1991, MOL PHARMACOL, V39, P691; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Reynolds DS, 2003, NEUROPHARMACOLOGY, V44, P190, DOI 10.1016/S0028-3908(02)00370-2; Roberson ED, 1999, J NEUROSCI, V19, P4337; Russek SJ, 2000, P NATL ACAD SCI USA, V97, P8600, DOI 10.1073/pnas.97.15.8600; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; SEEBURG PH, 1990, COLD SH Q B, V55, P29; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shumate MD, 1998, EPILEPSY RES, V32, P114, DOI 10.1016/S0920-1211(98)00045-X; Sieghart W, 2000, TRENDS PHARMACOL SCI, V21, P411, DOI 10.1016/S0165-6147(00)01564-9; SIEGHART W, 1989, TRENDS PHARMACOL SCI, V10, P407, DOI 10.1016/0165-6147(89)90189-2; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; SUN PQ, 1995, J BIOL CHEM, V270, P7041, DOI 10.1074/jbc.270.13.7041; Sur C, 2001, J NEUROSCI, V21, P3409, DOI 10.1523/JNEUROSCI.21-10-03409.2001; TIETZ EI, 1993, J MOL NEUROSCI, V4, P277, DOI 10.1007/BF02821559; Vicini S, 2001, J NEUROSCI, V21, P3009, DOI 10.1523/JNEUROSCI.21-09-03009.2001; WISDEN W, 1992, J NEUROSCI, V12, P1040; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; ZHENG T, 1993, DEV BRAIN RES, V75, P91, DOI 10.1016/0165-3806(93)90068-L; ZHU WJ, 1995, J NEUROSCI, V15, P7692	71	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9328	9340		10.1074/jbc.M705110200	http://dx.doi.org/10.1074/jbc.M705110200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18180303	Green Published, hybrid			2022-12-27	WOS:000254465800063
J	Ikezawa, N; Iwasa, K; Sato, F				Ikezawa, Nobuhiro; Iwasa, Kinuko; Sato, Fumihiko			Molecular cloning and characterization of CYP80G2, a cytochrome p450 that catalyzes an intramolecular C - C phenol coupling of (S)-reticuline in magnoflorine biosynthesis, from cultured Coptis japonica cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKALOID BIOSYNTHESIS; BENZOPHENANTHRIDINE ALKALOIDS; SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS EXPRESSION; BERBERIS-STOLONIFERA; N-METHYLTRANSFERASE; CRYSTAL-STRUCTURE; ENZYME; BINDING; YEAST	Cytochrome P450s (P450) play a key role in oxidative reactions in plant secondary metabolism. Some of them, which catalyze unique reactions other than the standard hydroxylation, increase the structural diversity of plant secondary metabolites. In isoquinoline alkaloid biosyntheses, several unique P450 reactions have been reported, such as methylenedioxy bridge formation, intramolecular C-C phenol-coupling and intermolecular C-O phenol-coupling reactions. We report here the isolation and characterization of a C-C phenol-coupling P450 cDNA (CYP80G2) from an expressed sequence tag library of cultured Coptis japonica cells. Structural analysis showed that CYP80G2 had high amino acid sequence similarity to Berberis stolonifera CYP80A1, an intermolecular C-O phenol-coupling P450 involved in berbamunine biosynthesis. Heterologous expression in yeast indicated that CYP80G2 had intramolecular C-C phenol-coupling activity to produce ( S)-corytuberine ( aporphinetype) from (S)-reticuline (benzylisoquinoline type). Despite this intriguing reaction, recombinant CYP80G2 showed typical P450 properties: its C-C phenol-coupling reaction required NADPH and oxygen and was inhibited by a typical P450 inhibitor. Based on a detailed substrate-specificity analysis, this unique reaction mechanism and substrate recognition were discussed. CYP80G2 may be involved in magnoflorine biosynthesis in C. japonica, based on the fact that recombinant C. japonica S-adenosyl-L-methionine: coclaurine N-methyltransferase could convert (S)-corytuberine to magnoflorine.	[Ikezawa, Nobuhiro; Sato, Fumihiko] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Iwasa, Kinuko] Kobe Pharmaceut Univ, Kobe, Hyogo 6588558, Japan	Kyoto University; Kobe Pharmaceutical University	Sato, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	fsato@lif.kyoto-u.ac.jp	Sato, Fumihiko/C-1078-2011	Sato, Fumihiko/0000-0001-9497-4452				BAUER W, 1991, PHYTOCHEMISTRY, V30, P2953, DOI 10.1016/S0031-9422(00)98230-X; BHAKUNI DS, 1980, TETRAHEDRON, V36, P2525, DOI 10.1016/0040-4020(80)80233-X; Bischoff D, 2001, ANGEW CHEM INT EDIT, V40, P4688, DOI 10.1002/1521-3773(20011217)40:24<4688::AID-ANIE4688>3.0.CO;2-M; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI 10.1074/jbc.M106405200; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Cui WH, 2006, PHYTOCHEMISTRY, V67, P70, DOI 10.1016/j.phytochem.2005.10.007; DITTRICH H, 1991, P NATL ACAD SCI USA, V88, P9969, DOI 10.1073/pnas.88.22.9969; Durst Francis, 1995, Drug Metabolism and Drug Interactions, V12, P189; Funa N, 2005, J BACTERIOL, V187, P8149, DOI 10.1128/JB.187.23.8149-8155.2005; GERARDY R, 1993, PHYTOCHEMISTRY, V32, P79, DOI 10.1016/0031-9422(92)80111-Q; Graening T, 2004, ANGEW CHEM INT EDIT, V43, P3230, DOI 10.1002/anie.200300615; Herbert RB, 2001, NAT PROD REP, V18, P50, DOI 10.1039/a809393h; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Howard-Jones AR, 2006, J AM CHEM SOC, V128, P12289, DOI 10.1021/ja063898m; Ikezawa N, 2003, J BIOL CHEM, V278, P38557, DOI 10.1074/jbc.M302470200; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwasa K, 2005, J NAT PROD, V68, P992, DOI 10.1021/np0402219; Iwasa K, 2004, PHARMAZIE, V59, P480; KRAUS PFX, 1995, P NATL ACAD SCI USA, V92, P2071, DOI 10.1073/pnas.92.6.2071; KUTCHAN TM, 1998, ALKALOIDS, V50, P257; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Milanowski DJ, 2002, J NAT PROD, V65, P814, DOI 10.1021/np000270v; Miller GP, 2001, BIOCHEMISTRY-US, V40, P7262, DOI 10.1021/bi010402z; Minami H, 2007, J BIOL CHEM, V282, P6274, DOI 10.1074/jbc.M608933200; Morishige T, 2000, J BIOL CHEM, V275, P23398, DOI 10.1074/jbc.M002439200; Morishige T, 2002, EUR J BIOCHEM, V269, P5659, DOI 10.1046/j.1432-1033.2002.03275.x; MUTO N, 1987, BIOCHEM BIOPH RES CO, V146, P487, DOI 10.1016/0006-291X(87)90555-9; Nasreen A, 1996, TETRAHEDRON LETT, V37, P8161, DOI 10.1016/0040-4039(96)01852-7; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; OEDA K, 1985, DNA-J MOLEC CELL BIO, V4, P203, DOI 10.1089/dna.1985.4.203; OMURA T, 1964, J BIOL CHEM, V239, P2379; Ono E, 2006, P NATL ACAD SCI USA, V103, P10116, DOI 10.1073/pnas.0603865103; Pauli HH, 1998, PLANT J, V13, P793, DOI 10.1046/j.1365-313X.1998.00085.x; POULOS TL, 1985, J BIOL CHEM, V260, P6122; PREININGER V, 1986, ALKALOIDS, V29, P1; SAKAKI T, 1990, DNA CELL BIOL, V9, P603, DOI 10.1089/dna.1990.9.603; SAKAKI T, 1992, J BIOL CHEM, V267, P16497; SATO F, 1984, PHYTOCHEMISTRY, V23, P281, DOI 10.1016/S0031-9422(00)80318-0; STADLER R, 1993, J BIOL CHEM, V268, P823; TAKESHITA N, 1995, PLANT CELL PHYSIOL, V36, P29; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Werck-Reichhart D., 2002, ARABIDOPSIS BOOK; ZENK MH, 1994, PURE APPL CHEM, V66, P2023, DOI 10.1351/pac199466102023; Zhao B, 2005, J BIOL CHEM, V280, P11599, DOI 10.1074/jbc.M410933200	48	104	116	4	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8810	8821		10.1074/jbc.M705082200	http://dx.doi.org/10.1074/jbc.M705082200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18230623	hybrid			2022-12-27	WOS:000254465800007
J	Pautsch, A; Stadler, N; Wissdorf, O; Langkopf, E; Moreth, W; Streicher, R				Pautsch, Alexander; Stadler, Nadja; Wissdorf, Oliver; Langkopf, Elke; Moreth, Werner; Streicher, Ruediger			Molecular recognition of the protein phosphatase 1 glycogen targeting subunit by glycogen phosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 1; AMINO-ACID-SEQUENCE; HEPATIC EXPRESSION; LIVER; MUSCLE; INHIBITORS; INSULIN; TISSUE; SITE; PTG	Disrupting the interaction between glycogen phosphorylase and the glycogen targeting subunit ( G(L)) of protein phosphatase 1 is emerging as a novel target for the treatment of type 2 diabetes. To elucidate the molecular basis of binding, we have determined the crystal structure of liver phosphorylase bound to a G(L)-derived peptide. The structure reveals the C terminus of G(L) binding in a hydrophobically collapsed conformation to the allosteric regulator-binding site at the phosphorylase dimer interface. G(L) mimics interactions that are otherwise employed by the activator AMP. Functional studies show that G(L) binds tighter than AMP and confirm that the C-terminal Tyr-Tyr motif is the major determinant for GL binding potency. Our study validates the G(L)-phosphorylase interface as a novel target for small molecule interaction.	[Pautsch, Alexander; Stadler, Nadja; Wissdorf, Oliver] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Lead Discovery, D-88397 Biberach, Germany; [Langkopf, Elke] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Med Chem, D-88397 Biberach, Germany; [Moreth, Werner; Streicher, Ruediger] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Metab Dis Res, D-88397 Biberach, Germany	Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Pautsch, A (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Dept Lead Discovery, Birkendorferstr 65, D-88397 Biberach, Germany.	alexander.pautsch@boehringer-ingelheim.com						ALEMANY S, 1986, FEBS LETT, V198, P194, DOI 10.1016/0014-5793(86)80404-5; Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; Armstrong CG, 1998, BIOCHEM J, V336, P699, DOI 10.1042/bj3360699; BARFORD D, 1991, J MOL BIOL, V218, P233, DOI 10.1016/0022-2836(91)90887-C; Ceulemans H, 2002, BIOESSAYS, V24, P371, DOI 10.1002/bies.10069; CHEN YH, 1994, DIABETES, V43, P1234, DOI 10.2337/diabetes.43.10.1234; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; DOHERTY MJ, 1995, FEBS LETT, V375, P294, DOI 10.1016/0014-5793(95)01184-G; Doherty MJ, 1996, FEBS LETT, V399, P339, DOI 10.1016/S0014-5793(96)01357-9; Ekstrom JL, 2002, CHEM BIOL, V9, P915, DOI 10.1016/S1074-5521(02)00186-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GAN D, 2007, DIABETES ATLAS; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; Gasa R, 2002, J BIOL CHEM, V277, P1524, DOI 10.1074/jbc.M107744200; Henke BR, 2006, MINI-REV MED CHEM, V6, P845, DOI 10.2174/138955706777934991; JOHNSON LN, 1992, FASEB J, V6, P2274, DOI 10.1096/fasebj.6.6.1544539; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kelsall IR, 2007, FEBS LETT, V581, P4749, DOI 10.1016/j.febslet.2007.08.073; Klabunde T, 2005, J MED CHEM, V48, P6178, DOI 10.1021/jm049034y; KOBAYASHI M, 1982, J BIOL CHEM, V257, P4041; Montori-Grau M, 2007, BIOCHEM J, V405, P107, DOI 10.1042/BJ20061572; MOORHEAD G, 1995, FEBS LETT, V362, P101, DOI 10.1016/0014-5793(95)00197-H; Munro S, 2005, FEBS J, V272, P1478, DOI 10.1111/j.1742-4658.2005.04585.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Rath VL, 2000, CHEM BIOL, V7, P677, DOI 10.1016/S1074-5521(00)00004-1; Rath VL, 2000, MOL CELL, V6, P139, DOI 10.1016/S1097-2765(00)00015-0; SERRANO FSJ, 1995, INT J BIOCHEM CELL B, V27, P911, DOI 10.1016/1357-2725(95)00058-W; Yang RJ, 2003, J BIOL CHEM, V278, P23418, DOI 10.1074/jbc.M213112200	30	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8913	8918		10.1074/jbc.M706612200	http://dx.doi.org/10.1074/jbc.M706612200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18198182	hybrid, Green Published			2022-12-27	WOS:000254465800019
J	Rawal, N; Rajagopalan, R; Salvi, VP				Rawal, Nenoo; Rajagopalan, Rema; Salvi, Veena P.			Activation of complement component C5 - Comparison of C5 convertases of the lectin pathway and the classical pathway of complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNAN-BINDING LECTIN; C1S-LIKE SERINE-PROTEASE; 1ST COMPONENT; SUBSTRATE SPECIFICITIES; ALTERNATIVE PATHWAY; INNATE IMMUNITY; MBL; FORMS; ASSOCIATION; EXPRESSION	Although the initiating complex of lectin pathway (called M1 in this study) generates C3/C5 convertases similar to those assembled by the initiating complex (C1) of the classical pathway, activation of complement component C5 via the lectin pathway has not been examined. In the present study kinetic analysis of lectin pathway C3/C5 convertases assembled on two surfaces (zymosan and sheep erythrocytes coated with mannan (E-Man)) revealed that the convertases (ZymM1, C4b, C2a and E-Man M1, C4b, C2a) exhibited a similar but weak affinity for the substrate, C5 indicated by a high K-m (2.73 - 6.88 mu M). Very high affinity C5 convertases were generated when the low affinity C3/C5 convertases were allowed to deposit C3b by cleaving native C3. These C3b-containing convertases exhibited Km (0.0086 - 0.0075 mu M) well below the normal concentration of C5 in blood (0.37 mu M). Although kinetic parameters, K-m and k(cat), of the lectin pathway C3/C5 convertases were similar to those reported for classical pathway C3/C5 convertases, studies on the ability of C4b to bind C2 indicated that every C4b deposited on zymosan or E-Man was capable of forming a convertase. These findings differ from those reported for the classical pathway C3/C5 convertase, where only one of four C4b molecules deposited formed a convertase. The potential for four times more amplification via the lectin pathway than the classical pathway in the generation of C3/C5 convertases and production of pro-inflammatory products, such as C3a, C4a, and C5a, implies that activation of complement via the lectin pathway might be a more prominent contributor to the pathology of inflammatory reactions.	[Rawal, Nenoo; Rajagopalan, Rema; Salvi, Veena P.] Univ Texas Hlth Sci Ctr, Dept Biochem, Tyler, TX 75708 USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Rawal, N (corresponding author), Univ Texas Hlth Sci Ctr, Dept Biochem, US Highway 271, Tyler, TX 75708 USA.	nenoo.rawal@uthct.edu			NHLBI NIH HHS [HL-073804] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073804] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Arlaud GJ, 2002, BIOCHEM SOC T, V30, P1001, DOI 10.1042/bst0301001; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; CHRISTOPHERSON RI, 1983, METHOD ENZYMOL, V91, P278; Dean MM, 2006, MOL IMMUNOL, V43, P950, DOI 10.1016/j.molimm.2005.06.023; DISCIPIO RG, 1981, BIOCHEM J, V199, P485, DOI 10.1042/bj1990485; DODDS AW, 1993, METHOD ENZYMOL, V223, P46; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; EMBER JA, 1998, HUMAN COMPLEMENT SYS, P241; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; Fraser DA, 2006, J LEUKOCYTE BIOL, V80, P107, DOI 10.1189/jlb.1105683; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Gal P, 2007, IMMUNOBIOLOGY, V212, P267, DOI 10.1016/j.imbio.2006.11.002; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Heise CT, 2000, J IMMUNOL, V165, P1403, DOI 10.4049/jimmunol.165.3.1403; IKEDA K, 1987, J BIOL CHEM, V262, P7451; KERR MA, 1978, BIOCHEM J, V171, P99, DOI 10.1042/bj1710099; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P401, DOI 10.1016/S0304-4165(02)00321-5; KOLB WP, 1982, BIOCHEMISTRY-US, V21, P294, DOI 10.1021/bi00531a015; KRISTENSEN MM, 2003, J IMMUNOL METHODS, V282, P159; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Legler DF, 1996, EUR J IMMUNOL, V26, P753, DOI 10.1002/eji.1830260405; LU J, 1990, J IMMUNOL, V144, P2287; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Mayilyan KR, 2006, MOL IMMUNOL, V43, P1286, DOI 10.1016/j.molimm.2005.07.011; Moller-Kristensen M, 2003, SCAND J IMMUNOL, V57, P556, DOI 10.1046/j.1365-3083.2003.01270.x; Nilsson G, 1996, J IMMUNOL, V157, P1693; PANGBURN MK, 1987, J IMMUNOL METHODS, V102, P7, DOI 10.1016/S0022-1759(87)80003-0; Pangburn MK, 2002, BIOCHEM SOC T, V30, P1006, DOI 10.1042/bst0301006; Petersen SV, 2001, MOL IMMUNOL, V38, P133; Rawal N, 1998, J BIOL CHEM, V273, P16828, DOI 10.1074/jbc.273.27.16828; Rawal N, 2003, J BIOL CHEM, V278, P38476, DOI 10.1074/jbc.M307017200; Rawal N, 2001, INT IMMUNOPHARMACOL, V1, P415, DOI 10.1016/S1567-5769(00)00039-4; Rawal N, 2001, J IMMUNOL, V166, P2635, DOI 10.4049/jimmunol.166.4.2635; Rawal N, 2000, J IMMUNOL, V164, P1379, DOI 10.4049/jimmunol.164.3.1379; RAWAL N, 2006, ENCY RESP MED, P546; Rawal N, 2007, MOL IMMUNOL, V44, P1105, DOI 10.1016/j.molimm.2006.07.282; REID KBM, 1998, COMPLEMENT SYSTEM, P68; Roos A, 2003, MOL IMMUNOL, V39, P655, DOI 10.1016/S0161-5890(02)00254-7; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; ROTHER K, 1998, COMPLEMENT SYSTEM, P462; SCHUMAKER VN, 1987, ANNU REV IMMUNOL, V5, P21, DOI 10.1146/annurev.iy.05.040187.000321; SCHUMAKER VN, 1981, J MOL BIOL, V148, P191, DOI 10.1016/0022-2836(81)90511-8; SIEGEL RC, 1981, J IMMUNOL, V127, P2447; STIMLER NP, 1983, IMMUNOPHARMACOLOGY, V5, P251, DOI 10.1016/0162-3109(83)90031-0; TAKATA Y, 1987, J EXP MED, V165, P1494, DOI 10.1084/jem.165.6.1494; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Thiel S, 2000, J IMMUNOL, V165, P878, DOI 10.4049/jimmunol.165.2.878; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; Wallis R, 2002, J IMMUNOL, V168, P4553, DOI 10.4049/jimmunol.168.9.4553; Wallis R, 2007, IMMUNOBIOLOGY, V212, P289, DOI 10.1016/j.imbio.2006.11.004; Wallis R, 2007, J BIOL CHEM, V282, P7844, DOI 10.1074/jbc.M606326200; WETSEL RA, 1995, CURR OPIN IMMUNOL, V7, P48, DOI 10.1016/0952-7915(95)80028-X; Worthley DL, 2005, INTERN MED J, V35, P548, DOI 10.1111/j.1445-5994.2005.00908.x; ZICCARDI RJ, 1981, J IMMUNOL, V126, P1769	61	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7853	7863		10.1074/jbc.M707591200	http://dx.doi.org/10.1074/jbc.M707591200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18204047	hybrid			2022-12-27	WOS:000253997900061
J	Smith, SB; Verhamme, IM; Sun, MF; Bock, PE; Gailani, D				Smith, Stephen B.; Verhamme, Ingrid M.; Sun, Mao-Fu; Bock, Paul E.; Gailani, David			Characterization of novel forms of coagulation factor XIa - Independence of factor XIa subunits in factor IX activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT KININOGEN; PLASMA THROMBOPLASTIN ANTECEDENT; GLYCOPROTEIN IB-ALPHA; 4 TANDEM REPEATS; HUMAN GRANZYME-A; BLOOD-COAGULATION; CHRISTMAS-FACTOR; TISSUE FACTOR; BINDING-SITE; HEAVY-CHAIN	Factor XI is the zymogen of a dimeric plasma protease, factor XIa, with two active sites. In solution, and during contact activation in plasma, conversion of factor XI to factor XIa proceeds through an intermediate with one active site (1/2-FXIa). Factor XIa and 1/2-FXIa activate the substrate factor IX, with similar kinetic parameters in purified and plasma systems. During hemostasis, factor IX is activated by factors XIa or VIIa, by cleavage of the peptide bonds after Arg(145) and Arg(180). Factor VIIa cleaves these bonds sequentially, with accumulation of factor IX alpha, an intermediate cleaved after Arg(145). Factor XIa also cleaves factor IX preferentially after Arg(145), but little intermediate is detected. It has been postulated that the two factor XIa active sites cleave both factor IX peptide bonds prior to releasing factor IXa beta. To test this, we examined cleavage of factor IX by four single active site factor XIa proteases. Little intermediate formation was detected with 1/2-FXIa, factor XIa with one inhibited active site, or a recombinant factor XIa monomer. However, factor IX alpha accumulated during activation by the factor XIa catalytic domain, demonstrating the importance of the factor XIa heavy chain. Fluorescence titration of active site-labeled factor XIa revealed a binding stoichiometry of 1.9 +/- 0.4 mol of factor IX/mol of factor XIa (K-d = 70 +/- 40 nM). The results indicate that two forms of activated factor XI are generated during coagulation, and that each half of a factor XIa dimer behaves as an independent enzyme with respect to factor IX.	[Smith, Stephen B.; Verhamme, Ingrid M.; Sun, Mao-Fu; Bock, Paul E.; Gailani, David] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; [Bock, Paul E.; Gailani, David] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Gailani, D (corresponding author), Vanderbilt Univ, Div Hematol Oncol, 538 Preston Res Bldg,2220 Pierce Ave, Nashville, TN 37232 USA.	dave.gailani@vanderbilt.edu			NHLBI NIH HHS [R01 HL038779, HL080018, HL58837, R01 HL058837, HL07751, R01 HL058837-12, R01 HL080018-03, R01 HL080018, HL38779, R01 HL038779-21] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751, R01HL038779, R29HL038779, R01HL058837, R01HL080018] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aktimur A, 2003, J BIOL CHEM, V278, P7981, DOI 10.1074/jbc.M212748200; ASAKAI R, 1991, NEW ENGL J MED, V325, P153, DOI 10.1056/NEJM199107183250303; Baglia FA, 2004, J BIOL CHEM, V279, P49323, DOI 10.1074/jbc.M407889200; Baglia FA, 2004, J BIOL CHEM, V279, P45470, DOI 10.1074/jbc.M406727200; BAGLIA FA, 1991, J BIOL CHEM, V266, P24190; BAJAJ SP, 1983, BIOCHEMISTRY-US, V22, P4047, DOI 10.1021/bi00286a009; Bell JK, 2003, NAT STRUCT BIOL, V10, P527, DOI 10.1038/nsb944; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BOUMA BN, 1977, J BIOL CHEM, V252, P6432; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; Cheng Q, 2003, J THROMB HAEMOST, V1, P2340, DOI 10.1046/j.1538-7836.2003.00418.x; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; DISCIPIO RG, 1978, J CLIN INVEST, V61, P1528, DOI 10.1172/JCI109073; FUJIKAWA K, 1974, BIOCHEMISTRY-US, V13, P4508, DOI 10.1021/bi00719a006; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; Gailani D, 2001, BLOOD, V97, P3117, DOI 10.1182/blood.V97.10.3117; Hink-Schauer C, 2003, NAT STRUCT BIOL, V10, P535, DOI 10.1038/nsb945; Ho DH, 2000, J BIOL CHEM, V275, P25139, DOI 10.1074/jbc.M001890200; Keularts IMLW, 2001, THROMB HAEMOSTASIS, V85, P1060, DOI 10.1055/s-0037-1615964; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; LAWSON JH, 1991, J BIOL CHEM, V266, P11317; LINDQUIST PA, 1978, J BIOL CHEM, V253, P1902; MANN KG, 1992, SEMIN HEMATOL, V29, P213; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2056, DOI 10.1021/bi00222a008; MEIJERS JCM, 1992, BIOCHEMISTRY-US, V31, P4680, DOI 10.1021/bi00134a021; NAITO K, 1991, J BIOL CHEM, V266, P7353; Ogawa T, 2005, J BIOL CHEM, V280, P23523, DOI 10.1074/jbc.M500894200; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; OSTERUD B, 1978, J BIOL CHEM, V253, P5946; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Samuel D, 2007, P NATL ACAD SCI USA, V104, P15693, DOI 10.1073/pnas.0703080104; Sinha D, 2002, BIOCHEM J, V367, P49, DOI 10.1042/BJ20020232; SINHA D, 1987, BIOCHEMISTRY-US, V26, P3768, DOI 10.1021/bi00387a005; Sinha D, 2007, BIOCHEMISTRY-US, V46, P9830, DOI 10.1021/bi062296c; Sun MF, 1999, J BIOL CHEM, V274, P36373, DOI 10.1074/jbc.274.51.36373; Sun YH, 1996, J BIOL CHEM, V271, P29023, DOI 10.1074/jbc.271.46.29023; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898; VANDERGRAAF F, 1983, J BIOL CHEM, V258, P9669; VONDEMBORNE PAK, 1995, BLOOD, V86, P3035; WARNCRAMER BJ, 1985, BIOCHEM BIOPH RES CO, V133, P417, DOI 10.1016/0006-291X(85)90922-2; Wielders SJH, 2004, ARTERIOSCL THROM VAS, V24, P1138, DOI 10.1161/01.ATV.0000128125.80559.9c; Wolberg AS, 1997, BIOCHEMISTRY-US, V36, P4074, DOI 10.1021/bi962274y	48	26	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6696	6705		10.1074/jbc.M707234200	http://dx.doi.org/10.1074/jbc.M707234200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18192270	Green Accepted, hybrid			2022-12-27	WOS:000253779600011
J	Fatehi, M; Linsdell, P				Fatehi, Mohammad; Linsdell, Paul			State-dependent access of anions to the cystic fibrosis transmembrane conductance regulator chloride channel pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; LINING RESIDUES; BINDING-SITE; CFTR; PERMEATION; CYSTEINE; IDENTIFICATION; PERMEABILITY; VESTIBULE; BLOCK	The cystic fibrosis transmembrane conductance regulator ( CFTR) Cl- channel is gated by intracellular factors; however, conformational changes in the channel pore associated with channel activation have not been identified. We have used patch clamp recording to investigate the state-dependent accessibility of substituted cysteine residues in the CFTR channel pore to a range of cysteine-reactive reagents applied to the extracellular side of the membrane. Using functional modification of the channel current-voltage relationship as a marker of modification, we find that several positively charged reagents are able to penetrate deeply into the pore from the outside irrespective of whether or not the channels have been activated. In contrast, access of three anionic cysteine-reactive reagents, the methanesulfonate sodium (2-sulfonatoethyl) methanesulfonate, the organic mercurial p-chloromercuriphenylsulfonic acid, and the permeant anion Au(CN)(2)(-), to several different sites in the pore is strictly limited prior to channel activation. This suggests that in nonactivated channels some ion selectivity mechanism exists to exclude anions yet permit cations into the channel pore from the extracellular solution. We suggest that activation of CFTR channels involves a conformational change in the pore that removes a strong selectivity against anion entry from the extracellular solution. We propose further that this conformational change occurs in advance of channel opening, suggesting that multiple distinct closed pore conformations exist.	[Fatehi, Mohammad; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 1X5, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 1X5, Canada.	paul.linsdell@dal.ca		Linsdell, Paul/0000-0001-6257-6273				Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gong XD, 2003, J GEN PHYSIOL, V122, P673, DOI 10.1085/jgp.200308889; Gong XD, 2003, J PHYSIOL-LONDON, V549, P387, DOI 10.1113/jphysiol.2002.038232; Gong XD, 2002, J PHYSIOL-LONDON, V540, P39, DOI 10.1113/jphysiol.2001.013235; Kidd JF, 2004, CURR TOP DEV BIOL, V60, P215; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; Linsdell P, 1998, J GEN PHYSIOL, V111, P601, DOI 10.1085/jgp.111.4.601; Linsdell P, 1996, J PHYSIOL-LONDON, V496, P687, DOI 10.1113/jphysiol.1996.sp021719; Liu XH, 2004, BIOPHYS J, V87, P3826, DOI 10.1529/biophysj.104.050534; MCDONOUGH S, 1994, NEURON, V13, P623, DOI 10.1016/0896-6273(94)90030-2; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Serrano JR, 2006, BIOPHYS J, V91, P1737, DOI 10.1529/biophysj.105.078899; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; Smith SS, 1999, J GEN PHYSIOL, V114, P799, DOI 10.1085/jgp.114.6.799; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200; Zhou JJ, 2007, J MEMBRANE BIOL, V216, P129, DOI 10.1007/s00232-007-9056-6	22	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6102	6109		10.1074/jbc.M707736200	http://dx.doi.org/10.1074/jbc.M707736200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167343	hybrid			2022-12-27	WOS:000253779500016
J	Horita, Y; Ohashi, K; Mukai, M; Inoue, M; Mizuno, K				Horita, Yuji; Ohashi, Kazumasa; Mukai, Mutsuko; Inoue, Masahiro; Mizuno, Kensaku			Suppression of the invasive capacity of rat ascites hepatoma cells by knockdown of slingshot or LIM kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-ASSOCIATED KINASE; MEDIATED ACTIN REORGANIZATION; COFILIN PHOSPHORYLATION; LYSOPHOSPHATIDIC-ACID; PROTEIN-KINASE; CYTOSKELETAL DYNAMICS; FILAMENT TURNOVER; CANCER INVASION; FOCAL ADHESION; TUMOR-CELLS	Actin cytoskeletal reorganization is essential for tumor cell migration, adhesion, and invasion. Cofilin and actin-depolymerizing factor (ADF) act as key regulators of actin cytoskeletal dynamics by stimulating depolymerization and severing of actin filaments. Cofilin/ADF are inactivated by phosphorylation of Ser-3 by LIM kinase-1 (LIMK1) and reactivated by dephosphorylation by Slingshot-1 (SSH1) and -2 (SSH2) protein phosphatases. In this study, we examined the roles of cofilin/ADF, LIMK1, and SSH1/SSH2 in tumor cell invasion, using an in vitro transcellular migration assay. In this assay, rat ascites hepatoma (MM1) cells were overlaid on a primary-cultured rat mesothelial cell monolayer and the number of cell foci that transmigrated underneath the monolayer in the presence of lysophosphatidic acid (LPA) was counted. The knockdown of cofilin/ADF, LIMK1, or SSH1/SSH2 expression by small interfering RNAs (siRNAs) significantly decreased the LPA-induced transcellular migration of MM1 cells and their motility in two-dimensional culture. Knockdown of LIMK1 also suppressed fibronectin-mediated cell attachment and focal adhesion formation. Our results suggest that both LIMK1-mediated phosphorylation and SSH1/SSH2-mediated dephosphorylation of cofilin/ADF are critical for the migration and invasion of tumor cells and that LIMK1 is involved in the transcellular migration of tumor cells by enhancing both adhesion and motility of the cells.	[Horita, Yuji; Ohashi, Kazumasa; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Mukai, Mutsuko; Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka 5378511, Japan	Tohoku University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Ohashi, Kazumasa/U-7028-2019; Mizuno, Kensaku/G-8631-2015	Ohashi, Kazumasa/0000-0001-7617-403X; 				AKEDO H, 1986, CANCER RES, V46, P2416; Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Ayaki M, 2000, BBA-MOL CELL RES, V1495, P40, DOI 10.1016/S0167-4889(99)00153-6; Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Imamura F, 2000, JPN J CANCER RES, V91, P811, DOI 10.1111/j.1349-7006.2000.tb01018.x; Imamura F, 1996, INT J CANCER, V65, P627, DOI 10.1002/(SICI)1097-0215(19960301)65:5<627::AID-IJC12>3.0.CO;2-4; IMAMURA F, 1993, BIOCHEM BIOPH RES CO, V193, P497, DOI 10.1006/bbrc.1993.1651; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; MUKAI M, 1987, CANCER RES, V47, P2167; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; Tomiyoshi G, 2004, GENES CELLS, V9, P591, DOI 10.1111/j.1356-9597.2004.00745.x; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Yoshioka K, 1998, J BIOL CHEM, V273, P5146, DOI 10.1074/jbc.273.9.5146; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119	49	47	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6013	6021		10.1074/jbc.M706538200	http://dx.doi.org/10.1074/jbc.M706538200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18171679	hybrid			2022-12-27	WOS:000253779500006
J	Paland, N; Bohme, L; Gurumurthy, RK; Maeurer, A; Szczepek, AJ; Rudel, T				Paland, Nicole; Bohme, Linda; Gurumurthy, Rajendra Kumar; Maeurer, Andre; Szczepek, Agnes J.; Rudel, Thomas			Reduced display of tumor necrosis factor receptor I at the host cell surface supports infection with Chlamydia trachomatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; FACTOR TNF RECEPTOR; NF-KAPPA-B; CHLAMYDOPHILA-PNEUMONIAE; GAMMA-INTERFERON; EPITHELIAL-CELLS; MOLECULAR-CLONING; INDUCED ARTHRITIS; POTENTIAL ROLE; LIPID RAFTS	The obligate intracellular human pathogenic bacterium Chlamydia trachomatis has evolved multiple mechanisms to circumvent the host immune system. Infected cells exhibit a profound resistance to the induction of apoptosis and down-regulate the expression of major histocompatibility complex class I and class II molecules to evade the cytotoxic effect of effector immune cells. Here we demonstrate the down-regulation of tumor necrosis factor receptor 1 (TNFR1) on the surface of infected cells. Interestingly, other members of the TNFR family such as TNFR2 and CD95 (Fas/Apo-1) were not modulated during infection, suggesting a selective mechanism underlying surface reduction of TNFR1. The observed effect was not due to reduced expression since the overall amount of TNFR1 protein was increased in infected cells. TNFR1 accumulated at the chlamydial inclusion and was shed by the infected cell into the culture supernatant. Receptor shedding depended on the infection-induced activation of the MEK-ERK pathway and the metalloproteinase TACE (TNF alpha converting enzyme). Our results point to a new function of TNFR1 modulation by C. trachomatis in controlling inflammatory signals during infection.	[Paland, Nicole; Bohme, Linda; Gurumurthy, Rajendra Kumar; Maeurer, Andre; Szczepek, Agnes J.; Rudel, Thomas] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Paland, Nicole; Bohme, Linda; Rudel, Thomas] Max Planck Inst Infect Biol, Res Grp Mol Infect & Tumor Biol, D-10117 Berlin, Germany	Max Planck Society; Max Planck Society	Rudel, T (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Charitepl 1, D-10117 Berlin, Germany.	rudel@mpiib-berlin.mpg.de	Szczepek, Agnieszka J./C-1434-2019; Szczepek, Agnieszka/AAK-8514-2021; Paland, Nicole/AAK-7591-2020	Szczepek, Agnieszka J./0000-0002-9292-6606; Szczepek, Agnieszka/0000-0002-9292-6606; Paland, Nicole/0000-0003-4295-1501; Gurumurthy, Rajendra Kumar/0000-0001-6479-8080				Aderka Dan, 1996, Cytokine and Growth Factor Reviews, V7, P231, DOI 10.1016/S1359-6101(96)00026-3; Al-Younes HM, 1999, CELL MICROBIOL, V1, P237, DOI 10.1046/j.1462-5822.1999.00024.x; Baillie J, 2003, J VIROL, V77, P7007, DOI 10.1128/JVI.77.12.7007-7016.2003; Balakrishnan A, 2006, J BIOL CHEM, V281, P16691, DOI 10.1074/jbc.M513648200; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; BIGDA J, 1994, J EXP MED, V180, P445, DOI 10.1084/jem.180.2.445; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Buxton D, 2002, J COMP PATHOL, V127, P133, DOI 10.1053/jcpa.2002.0573; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Conway DJ, 1997, INFECT IMMUN, V65, P1003, DOI 10.1128/IAI.65.3.1003-1006.1997; Cottin V, 1999, J BIOL CHEM, V274, P32975, DOI 10.1074/jbc.274.46.32975; Cottin V, 2002, J IMMUNOL, V168, P4095, DOI 10.4049/jimmunol.168.8.4095; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; GRAY PW, 1990, P NATL ACAD SCI USA, V87, P7380, DOI 10.1073/pnas.87.19.7380; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hannu T, 2006, BEST PRACT RES CL RH, V20, P419, DOI 10.1016/j.berh.2006.02.003; Haralambieva IH, 2004, J MED MICROBIOL, V53, P1187, DOI 10.1099/jmm.0.45758-0; Heinemann M, 1996, INFECT IMMUN, V64, P4872, DOI 10.1128/IAI.64.11.4872-4875.1996; HOLTMANN H, 1990, INFECT IMMUN, V58, P3168, DOI 10.1128/IAI.58.10.3168-3172.1990; Jia Wei, 2005, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V21, P1; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kohler L, 1997, AKTUEL RHEUMATOL, V22, P170, DOI 10.1055/s-2008-1043652; KOHNO T, 1990, P NATL ACAD SCI USA, V87, P8331, DOI 10.1073/pnas.87.21.8331; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Morrison TE, 2004, J VIROL, V78, P544, DOI 10.1128/JVI.78.1.544-549.2004; Moss ML, 1997, J NEUROIMMUNOL, V72, P127, DOI 10.1016/S0165-5728(96)00180-4; NOPHAR Y, 1990, EMBO J, V9, P3269, DOI 10.1002/j.1460-2075.1990.tb07526.x; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; Paland N, 2006, CELL MICROBIOL, V8, P1643, DOI 10.1111/j.1462-5822.2006.00739.x; Pedron T, 2003, J BIOL CHEM, V278, P20555, DOI 10.1074/jbc.M203551200; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; RAQIB R, 1995, INFECT IMMUN, V63, P3079, DOI 10.1128/IAI.63.8.3079-3087.1995; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SHEMERAVNI Y, 1988, INFECT IMMUN, V56, P2503, DOI 10.1128/IAI.56.9.2503-2506.1988; Shirey KA, 2006, INFECT IMMUN, V74, P2482, DOI 10.1128/IAI.74.4.2482-2486.2006; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Stenner-Liewen F, 2002, J BIOL CHEM, V277, P9633, DOI 10.1074/jbc.C100693200; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Waetzig GH, 2004, FASEB J, V18, P91, DOI 10.1096/fj.04-2073fje; Wang J, 2003, J BIOL CHEM, V278, P21751, DOI 10.1074/jbc.M212662200; Xanthoulea S, 2004, J EXP MED, V200, P367, DOI 10.1084/jem.20040435; Zeidler H, 2004, CURR OPIN RHEUMATOL, V16, P380, DOI 10.1097/01.bor.0000126150.04251.f9; Zhang XD, 2000, J IMMUNOL, V164, P3961, DOI 10.4049/jimmunol.164.8.3961; Zhong GM, 1999, J EXP MED, V189, P1931, DOI 10.1084/jem.189.12.1931; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935; Zhong GM, 2000, J EXP MED, V191, P1525, DOI 10.1084/jem.191.9.1525	59	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6438	6448		10.1074/jbc.M708422200	http://dx.doi.org/10.1074/jbc.M708422200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167350	hybrid			2022-12-27	WOS:000253779500051
J	Xu, L; Wang, Y; Yamaguchi, N; Pasek, DA; Meissner, G				Xu, Le; Wang, Ying; Yamaguchi, Naohiro; Pasek, Daniel A.; Meissner, Gerhard			Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RYANODINE RECEPTOR; RELEASE CHANNEL; TRANSMEMBRANE SEQUENCE; MALIGNANT HYPERTHERMIA; MUTATIONS; DISEASE; COMPLEX; REGION; IDENTIFICATION; PERMEATION	Skeletal muscle excitation-contraction coupling involves activation of homotetrameric ryanodine receptor ion channels (RyR1s), resulting in the rapid release of Ca2+ from the sarcoplasmic reticulum. Previous work has shown that Ca2+ release is impaired by mutations in RyR1 linked to Central Core Disease and Multiple Minicore Disease. We studied the consequences of these mutations on RyR1 function, following their expression in human embryonic kidney 293 cells and incorporation in lipid bilayers. RyR1-G4898E, -G4898R, and -Delta V4926/I4927 mutants in the C-terminal pore region of RyR1 and N-terminal RyR1-R110W/L486V mutant all showed negligible Ca2+ permeation and loss of Ca2+-dependent channel activity but maintained reduced K+ conductances. Co-expression of wild type and mutant RyR1s resulted in Ca2+-dependent channel activities that exhibited intermediate Ca2+ selectivities compared with K+, which suggested the presence of tetrameric RyR1 complexes composed of wild type and mutant subunits. The number of wild-type subunits to maintain a functional heterotetrameric channel differed among the four RyR1 mutants. The results indicate that homozygous RyR1 mutations associated with core myopathies abolish or greatly reduce sarcoplasmic reticulum Ca2+ release during excitation-contraction coupling. They further suggest that in individuals, expressing wild type and mutant alleles, a substantial portion of RyR1 channels is able to release Ca2+ from sarcoplasmic reticulum.	[Xu, Le; Wang, Ying; Yamaguchi, Naohiro; Pasek, Daniel A.; Meissner, Gerhard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	meissner@med.unc.edu	Xu, Le/HDN-9623-2022		NIAMS NIH HHS [AR 018687, R37 AR018687, R01 AR018687-32, R01 AR018687, R01 AR018687-30, R01 AR018687-31] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Avila G, 2003, J GEN PHYSIOL, V121, P277, DOI 10.1085/jgp.200308791; Davis MR, 2003, NEUROMUSCULAR DISORD, V13, P151, DOI 10.1016/S0960-8966(02)00218-3; Dirksen RT, 2002, TRENDS CARDIOVAS MED, V12, P189, DOI 10.1016/S1050-1738(02)00163-9; Du GG, 2004, BIOCHEM J, V382, P557, DOI 10.1042/BJ20040580; Du WL, 2006, J BIOL CHEM, V281, P30143, DOI 10.1074/jbc.M606541200; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Gillespie D, 2005, J PHYS CHEM B, V109, P15598, DOI 10.1021/jp052471j; Hirata H, 2007, DEVELOPMENT, V134, P2771, DOI 10.1242/dev.004531; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; LAI FA, 1989, J BIOL CHEM, V264, P16776; LEE HB, 1994, J BIOL CHEM, V269, P13305; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Lyfenko AD, 2007, HUM MUTAT, V28, P61, DOI 10.1002/humu.20409; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; Monnier N, 2001, HUM MOL GENET, V10, P2581, DOI 10.1093/hmg/10.22.2581; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Romero NB, 2003, BRAIN, V126, P2341, DOI 10.1093/brain/awg244; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Sutko JL, 1997, PHARMACOL REV, V49, P53; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Tilgen N, 2001, HUM MOL GENET, V10, P2879, DOI 10.1093/hmg/10.25.2879; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; Xiao BL, 2002, J BIOL CHEM, V277, P41778, DOI 10.1074/jbc.M208210200; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Xu L, 1999, J BIOL CHEM, V274, P32680, DOI 10.1074/jbc.274.46.32680; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhou H, 2007, BRAIN, V130, P2024, DOI 10.1093/brain/awm096; Zhou HY, 2006, AM J HUM GENET, V79, P859, DOI 10.1086/508500; Zhou HY, 2006, HUM MOL GENET, V15, P2791, DOI 10.1093/hmg/ddl221; Zorzato F, 2007, IUBMB LIFE, V59, P14, DOI 10.1080/15216540601187803	37	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6321	6329		10.1074/jbc.M707353200	http://dx.doi.org/10.1074/jbc.M707353200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18171678	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000253779500039
J	Otsuguro, KI; Tang, JS; Tang, YF; Xiao, R; Freichel, M; Tsvilovskyy, V; Ito, S; Flockerzi, V; Zhu, MX; Zholos, AV				Otsuguro, Ken-ichi; Tang, Jisen; Tang, Yufang; Xiao, Rui; Freichel, Marc; Tsvilovskyy, Volodymyr; Ito, Shigeo; Flockerzi, Veit; Zhu, Michael X.; Zholos, Alexander V.			Isoform-specific Inhibition of TRPC4 Channel by Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNELS; PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHOLIPASE-C; SMOOTH-MUSCLE; MEDIATED REGULATION; CAPSAICIN RECEPTOR; ION CHANNELS; CA2+ CURRENT; PROTEIN; ACTIVATION	Full-length transient receptor potential (TRP) cation channel TRPC4 alpha and shorter TRPC4 beta lacking 84 amino acids in the cytosolic C terminus are expressed in smooth muscle and endothelial cells where they regulate membrane potential and Ca2+ influx. In common with other "classical" TRPCs, TRPC4 is activated by G(q)/phospholipase C-coupled receptors, but the underlying mechanism remains elusive. Little is also known about any isoform-specific channel regulation. Here we show that TRPC4 alpha but not TRPC4 beta was strongly inhibited by intracellularly applied phosphatidylinositol 4,5-bisphosphate (PIP2). In contrast, several other phosphoinositides (PI), including PI(3,4)P-2, PI(3,5)P-2, and PI(3,4,5)P-3, had no effect or even potentiated TRPC4 alpha indicating that PIP2 inhibits TRPC4 alpha in a highly selective manner. We show that PIP2 binds to the C terminus of TRPC4 & but not that of TRPC4 beta in vitro. Its inhibitory action was dependent on the association of TRPC4 alpha with actin cytoskeleton as it was prevented by cytochalasin D treatment or by the deletion of the C-terminal PDZ-binding motif (Thr-Thr-Arg-Leu) that links TRPC4 to F-actin through the sodium-hydrogen exchanger regulatory factor and ezrin. PIP2 breakdown appears to be a required step in TRPC4 alpha channel activation as PIP2 depletion alone was insufficient for channel opening, which additionally required Ca2+ and pertussis toxin-sensitive G(i/o) proteins. Thus, TRPC4 channels integrate a variety of G-protein-dependent stimuli, including a PIP2/cytoskeleton dependence reminiscent of the TRPC4-like muscarinic agonist activated cation channels in ileal myocytes.	[Otsuguro, Ken-ichi; Zholos, Alexander V.] Queens Univ Belfast, Sch Med & Dent, Cardiovasc Biomed Res Ctr, Belfast BT9 7BL, Antrim, North Ireland; [Tang, Jisen; Tang, Yufang; Xiao, Rui; Zhu, Michael X.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Tang, Jisen; Tang, Yufang; Xiao, Rui; Zhu, Michael X.] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Freichel, Marc; Tsvilovskyy, Volodymyr; Flockerzi, Veit] Univ Saarland, Dept Pharmacol & Toxicol, D-66421 Homburg, Germany; [Ito, Shigeo] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Pharmacol Lab, Sapporo, Hokkaido 0600818, Japan	Queens University Belfast; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Saarland University; Hokkaido University	Zhu, MX (corresponding author), Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA.	zhu.55@osu.edu; a.zholos@qub.ac.uk	Zholos, Alexander/A-7017-2011; Otsuguro, Ken-ichi/A-4840-2012; Xiao, Rui/G-1193-2011	Zholos, Alexander/0000-0002-4320-149X; Otsuguro, Ken-ichi/0000-0002-2481-5592; Xiao, Rui/0000-0001-5541-6685	NINDS NIH HHS [R01 NS042183-04, P30 NS045758-049003, P30 NS045758, P30 NS045758-01A29003, R01 NS042183-02, R21 NS056942, R21 NS056942-01, P30 NS045758-039003, R01 NS042183-03, R01 NS042183] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758, R21NS056942, R01NS042183] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Feisst C, 2005, MOL PHARMACOL, V67, P1751, DOI 10.1124/mol.105.011007; Flockerzi V, 2005, PFLUG ARCH EUR J PHY, V451, P81, DOI 10.1007/s00424-005-1443-1; Freichel M, 2005, J PHYSIOL-LONDON, V567, P59, DOI 10.1113/jphysiol.2005.092999; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Gwanyanya A, 2006, AM J PHYSIOL-CELL PH, V291, pC627, DOI 10.1152/ajpcell.00074.2006; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; INOUE R, 1990, J PHYSIOL-LONDON, V424, P73, DOI 10.1113/jphysiol.1990.sp018056; INOUE R, 1990, AM J PHYSIOL, V258, pC1173, DOI 10.1152/ajpcell.1990.258.6.C1173; Kim YC, 1998, PFLUG ARCH EUR J PHY, V436, P494, DOI 10.1007/s004240050663; KOMORI S, 1992, J PHYSIOL-LONDON, V450, P105, DOI 10.1113/jphysiol.1992.sp019118; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lee J, 2005, J GEN PHYSIOL, V126, P439, DOI 10.1085/jgp.200509314; Lee KP, 2005, MOL CELLS, V20, P435; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mery L, 2002, J CELL SCI, V115, P3497; Nilius B, 2007, BIOCHEM SOC T, V35, P105, DOI 10.1042/BST0350105; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; Okamoto H, 2004, J PHARMACOL SCI, V95, P203, DOI 10.1254/jphs.FP0030635; Plant TD, 2005, N-S ARCH PHARMACOL, V371, P266, DOI 10.1007/s00210-005-1055-5; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V455, P157, DOI 10.1007/s00424-007-0275-6; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V453, P753, DOI 10.1007/s00424-006-0153-7; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tseng PH, 2004, BIOCHEMISTRY-US, V43, P11701, DOI 10.1021/bi049349f; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Walker RL, 2001, AM J PHYSIOL-CELL PH, V280, pC1184, DOI 10.1152/ajpcell.2001.280.5.C1184; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yan HD, 2003, BRIT J PHARMACOL, V139, P605, DOI 10.1038/sj.bjp.0705289; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zholos AV, 2006, ACTA PHARMACOL SIN, V27, P833, DOI 10.1111/j.1745-7254.2006.00392.x; Zholos AV, 1996, BRIT J PHARMACOL, V119, P997, DOI 10.1111/j.1476-5381.1996.tb15770.x; Zholos AV, 2004, BRIT J PHARMACOL, V141, P23, DOI 10.1038/sj.bjp.0705584; Zholos AV, 1997, BRIT J PHARMACOL, V122, P885, DOI 10.1038/sj.bjp.0701438; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	55	133	135	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10026	10036		10.1074/jbc.M707306200	http://dx.doi.org/10.1074/jbc.M707306200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18230622	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000254671600074
J	Shen, XZ; Lukacher, AE; Billet, S; Williams, IR; Bernstein, KE				Shen, Xiao Z.; Lukacher, Aron E.; Billet, Sandrine; Williams, Ifor R.; Bernstein, Kenneth E.			Expression of angiotensin-converting enzyme changes major histocompatibility complex class I peptide presentation by modifying C termini of peptide precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RESPONSES; ANTIGEN PRESENTATION; DENDRITIC CELLS; ENDOPLASMIC-RETICULUM; LYMPHOCYTES; MOLECULES; EPITOPE; MICE; AMINOPEPTIDASE; MACROPHAGE	We recently reported a mouse model called ACE 10/10 in which macrophages overexpress the carboxypeptidase angiotensin-converting enzyme (ACE). These mice have an enhanced inflammatory response to tumors that markedly inhibits tumor growth. Here, we show that ACE modifies the C termini of peptides for presentation by major histocompatibility complex (MHC) class I molecules. The peptide-processing activity of ACE applies to antigens from either the extracellular environment (cross-presentation) or antigens produced endogenously. Consistent with its role in MHC class I antigen processing, ACE localizes to the endoplasmic reticulum. ACE overexpression does not appear to change the overall supply of peptides available to MHC class I molecules. The immunization of wild type mice previously given ACE 10/10 macrophages enhances the efficiency of antigen-specific CD8(+) T cell priming. These data reveal that ACE is a dynamic participant in fashioning the peptide repertoire for MHC class I molecules by modifying the C termini of peptide precursors. Manipulation of peptidase expression by antigen-presenting cells may ultimately prove a useful strategy to enhance the immune response.	[Shen, Xiao Z.; Lukacher, Aron E.; Billet, Sandrine; Williams, Ifor R.; Bernstein, Kenneth E.] Emory Univ, Dept Pathol, Sch Med, Atlanta, GA 30322 USA	Emory University	Bernstein, KE (corresponding author), Emory Univ, Dept Pathol, Sch Med, Rm 7107A WMB,101 Woodruff Circle, Atlanta, GA 30322 USA.	kbernst@emory.edu	Williams, Ifor R/D-3648-2011	Williams, Ifor R/0000-0002-8810-2911; Bernstein, Kenneth/0000-0001-8097-3272	NIDDK NIH HHS [R01 DK 051445, R01 DK 039777] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039777, R01DK051445] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Cole J, 2000, J CLIN INVEST, V106, P1391, DOI 10.1172/JCI10557; Cole JM, 2003, AM J PHYSIOL-RENAL, V284, pF599, DOI 10.1152/ajprenal.00308.2002; CORVOL P, 1995, METHOD ENZYMOL, V248, P283; Daniels MD, 2007, CURR PHARM DESIGN, V13, P1299, DOI 10.2174/138161207780618812; Danilov SM, 2003, EXP HEMATOL, V31, P1301, DOI 10.1016/j.exphem.2003.08.018; Drake DR, 2000, J VIROL, V74, P4093, DOI 10.1128/JVI.74.9.4093-4101.2000; EISENLOHR LC, 1992, CELL, V71, P963, DOI 10.1016/0092-8674(92)90392-P; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2; HOOPER NM, 1991, INT J BIOCHEM, V23, P641, DOI 10.1016/0020-711X(91)90032-I; Kemball CC, 2005, J IMMUNOL, V174, P7950, DOI 10.4049/jimmunol.174.12.7950; KOZLOWSKI S, 1992, J EXP MED, V175, P1417, DOI 10.1084/jem.175.6.1417; Lukacher AE, 1998, J IMMUNOL, V160, P1724; MOERSCHELL RP, 1990, J BIOL CHEM, V265, P19638; Nakagawa Y, 2000, IMMUNOLOGY, V101, P76, DOI 10.1046/j.1365-2567.2000.00092.x; Obeid D, 2007, ONCOGENE, V26, P102, DOI 10.1038/sj.onc.1209779; OKABE T, 1987, JPN J MED, V26, P140, DOI 10.2169/internalmedicine1962.26.140; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Rammensee HG, 2006, IMMUNITY, V25, P693, DOI 10.1016/j.immuni.2006.10.008; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Romer F K, 1984, Acta Med Scand Suppl, V690, P3; Saijonmaa O, 2007, AM J PHYSIOL-HEART C, V292, pH1917, DOI 10.1152/ajpheart.00920.2006; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Scharfstein J, 2007, SCAND J IMMUNOL, V66, P128, DOI 10.1111/j.1365-3083.2007.01983.x; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Shen XZ, 2007, AM J PATHOL, V170, P2122, DOI 10.2353/ajpath.2007.061205; Skidgel R A, 1989, Adv Exp Med Biol, V247A, P25; Sousa CRE, 1999, CURR OPIN IMMUNOL, V11, P392, DOI 10.1016/S0952-7915(99)80066-1; Stevanovic S, 2005, TRANSPL IMMUNOL, V14, P171, DOI 10.1016/j.trim.2005.03.018; Towne CF, 2007, J IMMUNOL, V178, P6923, DOI 10.4049/jimmunol.178.11.6923; WEI L, 1991, J BIOL CHEM, V266, P5540; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x; York IA, 2006, J IMMUNOL, V177, P1434, DOI 10.4049/jimmunol.177.3.1434	40	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9957	9965		10.1074/jbc.M709574200	http://dx.doi.org/10.1074/jbc.M709574200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18252713	Green Published, hybrid			2022-12-27	WOS:000254671600052
J	Yao, ZQ; Xing, LP; Qin, CL; Schwarz, EM; Boyce, BF				Yao, Zhenqiang; Xing, Lianping; Qin, Chunlin; Schwarz, Edward M.; Boyce, Brendan F.			Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; C-FOS; FACTOR-ALPHA; OSTEOPROTEGERIN LIGAND; RHEUMATOID-ARTHRITIS; OSTEOBLASTIC CELLS; RECEPTOR ACTIVATOR; SIBLING PROTEINS; TRANSGENIC MICE	Interleukin-1 (IL-1) and tumor necrosis factor (TNF) mediate bone resorption in a variety of diseases affecting bone. Like TNF, IL-1 is secreted by osteoclast precursors (OCPs), but unlike TNF, it does not induce osteoclast formation directly from OCPs in vitro. TNF induces IL-1 expression and activates c-Fos, a transcription factor required in OCPs for osteoclast formation. Here, we examined whether IL-1 can induce osteoclast formation directly from OCPs overexpressing c-Fos and whether interaction with bone matrix affects OCP cytokine expression. We infected OCPs with c-Fos or green fluorescent protein retrovirus, cultured them with macrophage colony-stimulating factor and IL-1 on bone slices or plastic dishes, and assessed osteoclast and resorption pit formation and expression of IL-1 by OCPs. We used a Transwell assay to determine whether OCPs secrete IL-1 when they interact with bone matrix. IL-1 induced osteoclast formation directly from c-Fos-expressing OCPs on plastic. c-Fos-expressing OCPs formed osteoclasts spontaneously on bone slices without addition of cytokines. OCPs on bone secreted IL-1, which induced osteoclast formation from c-Fos-expressing OCPs in the lower Transwell dishes. The bone matrix proteins dentin sialoprotein and osteopontin, but not transforming growth factor-beta, stimulated OCP expression of IL-1 and induced c-Fos-expressing OCP differentiation into osteoclasts. Osteoclasts eroding inflamed joints have higher c-Fos expression compared with osteoclasts inside bone. We conclude that OCPs expressing c-Fos may induce their differentiation directly into osteoclasts by an autocrine mechanism in which they produce IL-1 through interaction with bone matrix. TNF could induce c-Fos expression in OCPs at sites of inflammation in bone to promote this autocrine mechanism and thus amplify bone loss.	[Yao, Zhenqiang; Xing, Lianping; Boyce, Brendan F.] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA; [Yao, Zhenqiang; Xing, Lianping; Boyce, Brendan F.] Univ Rochester, Med Ctr, Lab Med, Rochester, NY 14642 USA; [Schwarz, Edward M.; Boyce, Brendan F.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Qin, Chunlin] Texas A&M Univ, Syst Hlth Sci Ctr, Dept Biomed Sci, Baylor Coll Dent, Dallas, TX 75246 USA	University of Rochester; University of Rochester; University of Rochester; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Boyce, BF (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, 601 Elmwood Ave,POB 626, Rochester, NY 14642 USA.	Brenden_Boyce@urmc.rochester.edu			NIAMS NIH HHS [AR 48697, AR 43510] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043510, R01AR048697] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Baron R, 2004, NAT MED, V10, P458, DOI 10.1038/nm0504-458; Boyce BF, 2005, J BONE MINER METAB, V23, P11, DOI 10.1007/BF03026317; BOYCE BF, 1989, ENDOCRINOLOGY, V125, P1142, DOI 10.1210/endo-125-3-1142; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; CHAMBERS TJ, 1981, J PATHOL, V135, P1, DOI 10.1002/path.1711350102; CLOHISY JC, 1992, MOL ENDOCRINOL, V6, P1834, DOI 10.1210/me.6.11.1834; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Goldring SR, 2003, CALCIFIED TISSUE INT, V73, P97, DOI 10.1007/s00223-002-1049-y; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320; Jimi E, 1999, J IMMUNOL, V163, P434; JIMI E, 1995, ENDOCRINOLOGY, V136, P808, DOI 10.1210/en.136.2.808; Johnson MR, 2000, ANAL BIOCHEM, V278, P175, DOI 10.1006/abio.1999.4461; Kaplan C, 2003, FRONT BIOSCI-LANDMRK, V8, pD1018, DOI 10.2741/1102; Kapur RP, 2004, J BONE MINER RES, V19, P1689, DOI 10.1359/JBMR.040713; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LEE E, 1994, BIOCHEM BIOPH RES CO, V202, P128, DOI 10.1006/bbrc.1994.1902; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lee SH, 2002, J BIOCHEM, V131, P161, DOI 10.1093/oxfordjournals.jbchem.a003071; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li P, 2004, ARTHRITIS RHEUM, V50, P265, DOI 10.1002/art.11419; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; MUNDY GR, 1990, ANN NY ACAD SCI, V593, P91, DOI 10.1111/j.1749-6632.1990.tb16102.x; Qin C, 2002, J DENT RES, V81, P392, DOI 10.1177/154405910208100607; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Sato K, 2006, CURR OPIN RHEUMATOL, V18, P419, DOI 10.1097/01.bor.0000231912.24740.a5; Sfikakis PP, 2003, CURR OPIN RHEUMATOL, V15, P380, DOI 10.1097/00002281-200307000-00003; Silva TA, 2005, J DENT RES, V84, P79, DOI 10.1177/154405910508400114; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Teitelbaum SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1857; Teitelbaum SL, 2000, J BONE MINER METAB, V18, P344, DOI 10.1007/s007740070007; Teitelbaum SL, 2006, ANN NY ACAD SCI, V1068, P95, DOI 10.1196/annals.1346.017; Valverde P, 2006, J BONE MINER RES, V21, pS167; Valverde P, 2005, J BONE MINER RES, V20, P1669, DOI 10.1359/JBMR.050511; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zwerina J, 2004, ARTHRITIS RHEUM, V50, P277, DOI 10.1002/art.11487	57	77	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9917	9924		10.1074/jbc.M706415200	http://dx.doi.org/10.1074/jbc.M706415200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18250170	hybrid, Green Published			2022-12-27	WOS:000254671600048
J	Hakizimana, P; Masureel, M; Gbaguidi, B; Ruysschaert, JM; Govaerts, C				Hakizimana, Pierre; Masureel, Matthieu; Gbaguidi, Benedicte; Ruysschaert, Jean-Marie; Govaerts, Cedric			Interactions between phosphatidylethanolamine headgroup and LmrP, a multidrug transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; MEMBRANE PHOSPHOLIPID-COMPOSITION; METAL-TETRACYCLINE/H+ ANTIPORTER; ESCHERICHIA-COLI; LACTOSE PERMEASE; TOPOLOGICAL ORGANIZATION; CONFORMATIONAL-CHANGES; BIOLOGICAL-MEMBRANES; SECONDARY STRUCTURE; PROTEIN STRUCTURE	In a number of cases, the function of membrane proteins appears to require the presence of specific lipid species in the bilayer. We have shown that the secondary multidrug transporter LmrP requires the presence of phosphatidylethanolamine (PE), as its replacement by phosphatidylcholine (PC) inhibits transport activity and directly affects its structure, although the underlying mechanism was unknown. Here, we show that the effect of PE on the structure and the function of LmrP is mediated by interactions between the lipid headgroup and the protein. We used methyl-PE and dimethyl-PE analogs of PE to show that only replacement of the three hydrogens by methyl moieties leads to changes in the biochemical and biophysical properties of the reconstituted protein. This suggests that LmrP does not depend on the bulk properties of the phospholipids tested but solely on the hydrogen bonding ability of the headgroup. We then show that a single point mutation in LmrP, D68C, is sufficient to recapitulate precisely every biochemical and biophysical effect observed when PE is replaced by PC, including energy transfer between the protein tryptophan residues and the lipid headgroups. We conclude that the negatively charged Asp-68 is likely to participate in the interaction with PE and that such interaction is required for proton gradient sensing, substrate binding, and transport. Because Asp-68 belongs to a highly conserved motif in the Major Facilitator Superfamily (which includes LacY and EmrD), this interaction might be a general feature of these transporters that is involved in proton gradient sensing and lipid dependence.	[Hakizimana, Pierre; Masureel, Matthieu; Gbaguidi, Benedicte; Ruysschaert, Jean-Marie; Govaerts, Cedric] Univ Libre Bruxelles, Struct Biol & Bioinformat Ctr, Dept Struct & Funct Biol Membranes, B-1050 Brussels, Belgium	Universite Libre de Bruxelles	Ruysschaert, JM (corresponding author), Univ Libre Bruxelles, Struct Biol & Bioinformat Ctr, Dept Struct & Funct Biol Membranes, CP206-2,Blvd Triomphe, B-1050 Brussels, Belgium.	jmruyss@ulb.ac.be		Hakizimana, Pierre/0000-0001-9615-3885				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Bapna A, 2007, J MOL MICROB BIOTECH, V12, P197, DOI 10.1159/000099641; Bechinger B, 1999, BIOPHYS J, V76, P552, DOI 10.1016/S0006-3495(99)77223-1; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; BOLHUIS H, 1995, J BIOL CHEM, V270, P26092, DOI 10.1074/jbc.270.44.26092; CHEN CC, 1984, J BIOL CHEM, V259, P150; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; EFTINK MR, 1987, BIOCHIM BIOPHYS ACTA, V916, P343, DOI 10.1016/0167-4838(87)90179-8; Elmore DE, 2001, BIOPHYS J, V81, P1345, DOI 10.1016/S0006-3495(01)75791-8; Gbaguidi B, 2007, CELL MOL LIFE SCI, V64, P1571, DOI 10.1007/s00018-007-7031-0; Gbaguidi B, 2004, CELL MOL LIFE SCI, V61, P2646, DOI 10.1007/s00018-004-4298-2; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Goormaghtigh E, 1994, Subcell Biochem, V23, P363; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; Grimard V, 2004, J BIOL CHEM, V279, P5528, DOI 10.1074/jbc.M311014200; Grimard V, 2001, BIOCHEMISTRY-US, V40, P11876, DOI 10.1021/bi010017+; Hamai C, 2006, BIOPHYS J, V90, P1241, DOI 10.1529/biophysj.105.069435; Hsieh CH, 1995, BIOPHYS J, V69, P2521, DOI 10.1016/S0006-3495(95)80123-2; JESSENMARSHALL AE, 1995, J BIOL CHEM, V270, P16251, DOI 10.1074/jbc.270.27.16251; Kimura-Someya T, 1998, J BIOL CHEM, V273, P32806, DOI 10.1074/jbc.273.49.32806; Krishnamurthy SS, 1999, FEMS MICROBIOL LETT, V173, P475, DOI 10.1111/j.1574-6968.1999.tb13541.x; Kusube M, 2006, CHEM PHYS LIPIDS, V142, P94, DOI 10.1016/j.chemphyslip.2006.03.004; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lee AG, 2005, MOL BIOSYST, V1, P203, DOI 10.1039/b504527d; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; LEMIEUX MJ, 2005, J ELECT MICROSC T S1, V54, P143; Mazurkiewicz P, 2004, J BIOL CHEM, V279, P103, DOI 10.1074/jbc.M306579200; Mazurkiewicz P, 2002, J BIOL CHEM, V277, P26081, DOI 10.1074/jbc.M203141200; McAuley KE, 1999, P NATL ACAD SCI USA, V96, P14706, DOI 10.1073/pnas.96.26.14706; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Pazdernik NJ, 2000, J MEMBRANE BIOL, V174, P31, DOI 10.1007/s002320001029; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Putman M, 1999, BIOCHEMISTRY-US, V38, P1002, DOI 10.1021/bi981863w; Raussens V, 1997, J BIOL CHEM, V272, P262; Raussens V, 1998, J BIOL CHEM, V273, P25825, DOI 10.1074/jbc.273.40.25825; SQUIER TC, 1988, J BIOL CHEM, V263, P9178; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; YAMAGUCHI A, 1992, J BIOL CHEM, V267, P19155; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200; Zhou FF, 2007, PHARM RES-DORDR, V24, P28, DOI 10.1007/s11095-006-9144-9	46	60	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9369	9376		10.1074/jbc.M708427200	http://dx.doi.org/10.1074/jbc.M708427200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18234676	hybrid			2022-12-27	WOS:000254465800067
J	Tomida, J; Masuda, Y; Hiroaki, H; Ishikawa, T; Song, I; Tsurimoto, T; Tateishi, S; Shiomi, T; Kamei, Y; Kim, J; Kamiya, K; Vaziri, C; Ohmori, H; Todo, T				Tomida, Junya; Masuda, Yuji; Hiroaki, Hidekazu; Ishikawa, Tomoko; Song, Ihnyoung; Tsurimoto, Toshiki; Tateishi, Satoshi; Shiomi, Tadahiro; Kamei, Yasuhiro; Kim, Jinhyeong; Kamiya, Kenji; Vaziri, Cyrus; Ohmori, Haruo; Todo, Takeshi			DNA damage-induced ubiquitylation of RFC2 subunit of replication factor C complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; PROTEIN-A; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; UBIQUITIN LIGASE; CLAMP LOADERS; HUMAN SHPRH; PCNA; REPAIR; CHECKPOINTS	Many proteins involved in DNA replication and repair undergo post-translational modifications such as phosphorylation and ubiquitylation. Proliferating cell nuclear antigen ( PCNA; a homotrimeric protein that encircles double-stranded DNA to function as a sliding clamp for DNA polymerases) is monoubiquitylated by the RAD6-RAD18 complex and further polyubiquitylated by the RAD5-MMS2-UBC13 complex in response to various DNA-damaging agents. PCNA mono- and polyubiquitylation activate an error-prone translesion synthesis pathway and an error-free pathway of damage avoidance, respectively. Here we show that replication factor C ( RFC; a heteropentameric protein complex that loads PCNA onto DNA) was also ubiquitylated in a RAD18-dependent manner in cells treated with alkylating agents or H2O2. A mutant form of RFC2 with a D228A substitution ( corresponding to a yeast Rfc4 mutation that reduces an interaction with replication protein A ( RPA), a single-stranded DNA-binding protein) was heavily ubiquitylated in cells even in the absence of DNA damage. Furthermore RFC2 was ubiquitylated by the RAD6-RAD18 complex in vitro, and its modification was inhibited in the presence of RPA. The inhibitory effect of RPA on RFC2 ubiquitylation was relatively specific because RAD6-RAD18-mediated ubiquitylation of PCNA was RPA-insensitive. Our findings suggest that RPA plays a regulatory role in DNA damage responses via repression of RFC2 ubiquitylation in human cells.	[Ishikawa, Tomoko; Kamei, Yasuhiro; Kim, Jinhyeong; Todo, Takeshi] Osaka Univ, Grad Sch Med, Dept Radiat Biol & Med Genet, Osaka 5650871, Japan; [Tomida, Junya; Ishikawa, Tomoko; Kamei, Yasuhiro; Kim, Jinhyeong; Todo, Takeshi] Kyoto Univ, Ctr Radiat Biol, Kyoto 6068501, Japan; [Tomida, Junya; Ohmori, Haruo] Kyoto Univ, Inst Virus Res, Kyoto 6068501, Japan; [Masuda, Yuji; Tateishi, Satoshi; Kamiya, Kenji] Hiroshima Univ, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan; [Hiroaki, Hidekazu] Kobe Univ, Grad Sch Med, Dept Biotechnol & Mol Biol, Div Struct Biol, Kobe, Hyogo 6500017, Japan; [Song, Ihnyoung; Vaziri, Cyrus] Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; [Tsurimoto, Toshiki] Kyushu Univ, Sch Sci, Dept Biol, Fukuoka 8128581, Japan; [Tateishi, Satoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Shiomi, Tadahiro] Natl Inst Radiol Sci, Chiba 2638555, Japan	Osaka University; Kyoto University; Kyoto University; Hiroshima University; Kobe University; Boston University; Kyushu University; Kumamoto University; National Institutes for Quantum Science & Technology	Todo, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Radiat Biol & Med Genet, B4,2-2 Yamada Oka, Osaka 5650871, Japan.	todo@radbio.med.osaka-u.ac.jp	Kamei, Yasuhiro/AAD-9281-2019; Ishikawa-Fujiwara, Tomoko/GLS-9481-2022; Hiroaki, Hidekazu/G-9564-2012; Masuda, Yuji/I-6315-2014; HIROAKI, HIDEKAZU/N-1658-2019	Kamei, Yasuhiro/0000-0001-6382-1365; Masuda, Yuji/0000-0002-6229-1988; HIROAKI, HIDEKAZU/0000-0003-1621-5893; Tsurimoto, Toshiki/0000-0001-7597-2216; Tomida, Junya/0000-0002-0813-5757	NIEHS NIH HHS [ES 12917, ES 09558] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009558, R29ES009558, R01ES012917] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bowman GD, 2005, FEBS LETT, V579, P863, DOI 10.1016/j.febslet.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Carr AM, 2002, DNA REPAIR, V1, P983, DOI 10.1016/S1568-7864(02)00165-9; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; FUKUDA K, 1995, J BIOL CHEM, V270, P22527, DOI 10.1074/jbc.270.38.22527; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HARRISON SD, 1995, GENETICS, V139, P1701; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; IMAI N, 1992, GENE, V118, P279, DOI 10.1016/0378-1119(92)90200-9; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KELMAN Z, 1995, NUCLEIC ACIDS RES, V23, P3613, DOI 10.1093/nar/23.18.3613; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Kim JY, 2003, CURR BIOL, V13, pR873, DOI 10.1016/j.cub.2003.10.048; Koradi R, 1996, J MOL GRAPHICS, V14, P29; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Neuwald AF, 1999, GENOME RES, V9, P27; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shiomi Y, 2002, GENES CELLS, V7, P861, DOI 10.1046/j.1365-2443.2002.00566.x; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; WYMAN C, 1995, CURR BIOL, V5, P334, DOI 10.1016/S0960-9822(95)00065-0; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	51	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9071	9079		10.1074/jbc.M709835200	http://dx.doi.org/10.1074/jbc.M709835200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18245774	Green Published, hybrid			2022-12-27	WOS:000254465800037
J	Cironi, P; Swinburne, IA; Silver, PA				Cironi, Pablo; Swinburne, Ian A.; Silver, Pamela A.			Enhancement of cell type specificity by quantitative modulation of a chimeric ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; PSEUDOMONAS EXOTOXIN; FACTOR RECEPTOR; FACTOR-ALPHA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; COMPLEX; MODEL; MICE	Evolution modulates the quantitative characteristics of protein interactions and often uses combinations of weak interactions to achieve a particular specificity. We addressed how quantitative optimization might be used in the design of multidomain proteins, using a chimera containing epidermal growth factor (EGF) as a cell targeting element and interferon alpha-2 alpha (IFN alpha-2 alpha) to initiate signal transduction. We first connected EGF and IFN alpha-2 alpha via a linker that allows both ligands to bind to their receptors on a cell surface and then incorporated a series of mutations into the IFN alpha-2 alpha portion that progressively decrease both the on rate and the dissociation constant of the IFN alpha-2 alpha-IFN alpha receptor 2 (IFNAR2) interaction. Using this strategy, we designed chimeric proteins in which the activation of the IFN alpha receptor in HeLa, A431, and engineered Daudi cells depends on the presence of EGF receptor on the same cell. The mutant chimeric proteins also inhibited proliferation of IFN alpha-sensitive cells in an EGF receptor-dependent manner. These results provide insights into the quantitative requirements for specific binding to multisubunit receptors and illustrate the value of a quantitative approach in the design of synthetic-biological constructs.	[Cironi, Pablo; Swinburne, Ian A.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu						Adam G., 1968, STRUCTURAL CHEM MOL, P198; Caraglia M, 1999, CELL DEATH DIFFER, V6, P773, DOI 10.1038/sj.cdd.4400550; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; CLARE JJ, 1991, GENE, V105, P205, DOI 10.1016/0378-1119(91)90152-2; Evinger M, 1981, Methods Enzymol, V79, P362; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; Garcia Julia N., 1995, Biotecnologia Aplicada, V12, P152; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; HEIMBROOK DC, 1990, P NATL ACAD SCI USA, V87, P4697, DOI 10.1073/pnas.87.12.4697; Huston J S, 1993, Cell Biophys, V22, P189; Kreitman R. J., 1999, V137, P89; Liu TF, 2003, MOL CANCER THER, V2, P783; LORBERBOUMGALSKI H, 1988, P NATL ACAD SCI USA, V85, P1922, DOI 10.1073/pnas.85.6.1922; MASUI H, 1984, CANCER RES, V44, P1002; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; PAI LH, 1991, CANCER RES, V51, P2808; Piehler J, 1999, J MOL BIOL, V289, P57, DOI 10.1006/jmbi.1999.2726; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Quadt-Akabayov SR, 2006, PROTEIN SCI, V15, P2656, DOI 10.1110/ps.062283006; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Roisman LC, 2001, P NATL ACAD SCI USA, V98, P13231, DOI 10.1073/pnas.221290398; SIEGALL CB, 1989, FASEB J, V3, P2647, DOI 10.1096/fasebj.3.14.2556314; Todhunter DA, 2004, PROTEIN ENG DES SEL, V17, P157, DOI 10.1093/protein/gzh023	25	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8469	8476		10.1074/jbc.M708502200	http://dx.doi.org/10.1074/jbc.M708502200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18230610	Green Published, hybrid			2022-12-27	WOS:000254288000045
J	Cottevieille, M; Larquet, E; Jonic, S; Petoukhov, MV; Caprini, G; Paravisi, S; Svergun, DI; Vanoni, MA; Boisset, N				Cottevieille, Magali; Larquet, Eric; Jonic, Slavica; Petoukhov, Maxim V.; Caprini, Gianluca; Paravisi, Stefano; Svergun, Dmitri I.; Vanoni, Maria A.; Boisset, Nicolas			The subnanometer resolution structure of the glutamate synthase 1.2-MDa hexamer by cryoelectron microscopy and its oligomerization behavior in solution - Functional implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR FLAVOPROTEIN; HYDROPHOBIC CLUSTER-ANALYSIS; SCATTERING DATA-ANALYSIS; 3D ELECTRON-MICROSCOPY; X-RAY-SCATTERING; AZOSPIRILLUM-BRASILENSE; DIHYDROPYRIMIDINE DEHYDROGENASE; 3-DIMENSIONAL RECONSTRUCTION; CATALYTIC-PROPERTIES; ANGSTROM RESOLUTION	The three-dimensional structure of the hexameric (alpha beta)(6) 1.2-MDa complex formed by glutamate synthase has been determined at subnanometric resolution by combining cryoelectron microscopy, small angle x-ray scattering, and molecular modeling, providing for the first time a molecular model of this complex iron-sulfur flavoprotein. In the hexameric species, interprotomeric alpha-alpha and alpha-beta contacts are mediated by the C-terminal domain of the alpha subunit, which is based on a beta helical fold so far unique to glutamate synthases. The alpha beta protomer extracted from the hexameric model is fully consistent with it being the minimal catalytically active form of the enzyme. The structure clarifies the electron transfer pathway from the FAD cofactor on the beta subunit, to the FMN on the alpha subunit, through the low potential [4Fe-4S](1+/2+) centers on the beta subunit and the [3Fe-4S](0/1+) cluster on the alpha subunit. The(alpha beta)(6) hexamer exhibits a concentration-dependent equilibrium with alpha beta monomers and (alpha beta)(2) dimers, in solution, the hexamer being destabilized by high ionic strength and, to a lower extent, by the reaction product NADP(+). Hexamerization seems to decrease the catalytic efficiency of the alpha beta protomer only 3-fold by increasing the K-m values measured for L-Gln and 2-OG. However, it cannot be ruled out that the (alpha beta)(6) hexamer acts as a scaffold for the assembly of multienzymatic complexes of nitrogen metabolism or that it provides a means to regulate the activity of the enzyme through an as yet unknown ligand.	[Caprini, Gianluca; Paravisi, Stefano; Vanoni, Maria A.] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; [Cottevieille, Magali; Larquet, Eric; Jonic, Slavica; Boisset, Nicolas] Univ Paris 06, Dept Biol Struct, CNRS, IMPMC UMR 7590, F-75252 Paris, France; [Cottevieille, Magali; Larquet, Eric; Jonic, Slavica; Boisset, Nicolas] Univ Paris 07, IPGP, F-75252 Paris, France; [Petoukhov, Maxim V.; Svergun, Dmitri I.] DESY, European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; [Petoukhov, Maxim V.; Svergun, Dmitri I.] Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	University of Milan; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Vanoni, MA (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, Via Celoria 26, I-20133 Milan, Italy.	maria.vanoni@unimi.it	Vanoni, Maria/AAP-2089-2021; larquet, eric/ABB-3063-2021; Petoukhov, Maxim V/R-7371-2016	Vanoni, Maria/0000-0001-7213-732X; larquet, eric/0000-0002-9994-6845; Petoukhov, Maxim V/0000-0001-6760-4595; Jonic, Slavica/0000-0001-5112-2743; Svergun, Dmitri/0000-0003-0830-5696				ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Agnelli P, 2005, ARCH BIOCHEM BIOPHYS, V436, P355, DOI 10.1016/j.abb.2005.02.009; Binda C, 2000, STRUCTURE, V8, P1299, DOI 10.1016/S0969-2126(00)00540-2; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Coschigano KT, 1998, PLANT CELL, V10, P741, DOI 10.1105/tpc.10.5.741; Dobritzsch D, 2001, EMBO J, V20, P650, DOI 10.1093/emboj/20.4.650; Fotin A, 2006, J STRUCT BIOL, V156, P453, DOI 10.1016/j.jsb.2006.07.001; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Hagen WR, 2000, EUR J BIOCHEM, V267, P3640, DOI 10.1046/j.1432-1327.2000.01393.x; Hagen WR, 2000, J BIOL INORG CHEM, V5, P527, DOI 10.1007/s007750050013; HARAUZ G, 1986, OPTIK, V73, P146; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hudson JM, 2005, J AM CHEM SOC, V127, P6977, DOI 10.1021/ja043404q; Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633; Jonic S, 2007, J STRUCT BIOL, V157, P156, DOI 10.1016/j.jsb.2006.06.014; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kong QX, 2007, APPL MICROBIOL BIOT, V73, P1382, DOI 10.1007/s00253-006-0610-4; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lancien M, 2002, PLANT J, V29, P347, DOI 10.1046/j.1365-313X.2002.01218.x; Ludtke SJ, 2004, STRUCTURE, V12, P1129, DOI 10.1016/j.str.2004.05.006; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Martin AG, 2007, J MOL BIOL, V366, P1332, DOI 10.1016/j.jmb.2006.11.075; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Natera V, 2006, CURR MICROBIOL, V53, P479, DOI 10.1007/s00284-006-0146-y; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; PENCZEK PA, 1997, SCANNING MICROSCOPY, V11, P147, DOI DOI 10.1016/0304-3991(92)90011-8; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2003, J BIOL CHEM, V278, P29933, DOI 10.1074/jbc.M304147200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Ravasio S, 2002, BIOCHEMISTRY-US, V41, P8120, DOI 10.1021/bi020083r; Ravasio S, 2001, BIOCHEMISTRY-US, V40, P5533, DOI 10.1021/bi0100889; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Rosenbaum K, 1998, BIOCHEMISTRY-US, V37, P17598, DOI 10.1021/bi9815997; Saban SD, 2006, J VIROL, V80, P12049, DOI 10.1128/JVI.01652-06; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sorzano COS, 2007, EUR BIOPHYS J BIOPHY, V36, P995, DOI 10.1007/s00249-007-0203-x; Stabile H, 2000, EUR J BIOCHEM, V267, P2720, DOI 10.1046/j.1432-1327.2000.01289.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van den Heuvel RHH, 2004, CELL MOL LIFE SCI, V61, P669, DOI 10.1007/s00018-003-3316-0; Vanoni MA, 2005, ARCH BIOCHEM BIOPHYS, V433, P193, DOI 10.1016/j.abb.2004.08.033; VANONI MA, 1992, BIOCHEMISTRY-US, V31, P4613, DOI 10.1021/bi00134a011; Vanoni MA, 1998, BIOCHEMISTRY-US, V37, P1828, DOI 10.1021/bi972342w; VANONI MA, 1994, EUR J BIOCHEM, V226, P505, DOI 10.1111/j.1432-1033.1994.tb20075.x; VANONI MA, 1991, EUR J BIOCHEM, V202, P181, DOI 10.1111/j.1432-1033.1991.tb16361.x; Vanoni MA, 1999, CELL MOL LIFE SCI, V55, P617, DOI 10.1007/s000180050319; VANONI MA, 1991, BIOCHEMISTRY-US, V30, P11478, DOI 10.1021/bi00112a016; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	59	21	21	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8237	8249		10.1074/jbc.M708529200	http://dx.doi.org/10.1074/jbc.M708529200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18199747	hybrid, Green Published			2022-12-27	WOS:000254288000021
J	Gyimesi, M; Kintses, B; Bodor, A; Perczel, A; Fischer, S; Bagshaw, CR; Malnasi-Csizmadia, A				Gyimesi, Mate; Kintses, Balint; Bodor, Andrea; Perczel, Andras; Fischer, Stefan; Bagshaw, Clive R.; Malnasi-Csizmadia, Andras			The mechanism of the reverse recovery step, phosphate release, and actin activation of Dictyostelium myosin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT PSOAS MUSCLE; RATE-LIMITING STEP; DISCOIDEUM MYOSIN; MOTOR DOMAIN; ADENOSINE-TRIPHOSPHATASE; KINETIC CHARACTERIZATION; INORGANIC-PHOSPHATE; NUCLEOTIDE COMPLEXES; MOLECULAR-MECHANISM; TRYPTOPHAN RESIDUE	The rate-limiting step of the myosin basal ATPase (i.e. in absence of actin) is assumed to be a post-hydrolysis swinging of the lever arm ( reverse recovery step), that limits the subsequent rapid product release steps. However, direct experimental evidence for this assignment is lacking. To investigate the binding and the release of ADP and phosphate independently from the lever arm motion, two single tryptophan-containing motor domains of Dictyostelium myosin II were used. The single tryptophans of the W129+ and W501+ constructs are located at the entrance of the nucleotide binding pocket and near the lever arm, respectively. Kinetic experiments show that the rate-limiting step in the basal ATPase cycle is indeed the reverse recovery step, which is a slow equilibrium step (k(forward) = 0.05 s(-1), k(reverse) = 0.15 s(-1)) that precedes the phosphate release step. Actin directly activates the reverse recovery step, which becomes practically irreversible in the actin-bound form, triggering the power stroke. Even at low actin concentrations the power stroke occurs in the actin-attached states despite the low actin affinity of myosin in the pre-power stroke conformation.	[Gyimesi, Mate; Kintses, Balint; Malnasi-Csizmadia, Andras] Eotvos Lorand Univ, Inst Biol, Dept Biochem, H-1117 Budapest, Hungary; [Bodor, Andrea] Eotvos Lorand Univ, Inst Chem, Lab Struct Chem & Biol, H-1117 Budapest, Hungary; [Perczel, Andras] Eotvos Lorand Univ, Inst Chem, Prot Modelling Grp, MTA ELTE, H-1117 Budapest, Hungary; [Fischer, Stefan] Univ Heidelberg, Interdisciplinary Ctr Sci Comp, D-69120 Heidelberg, Germany; [Bagshaw, Clive R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Ruprecht Karls University Heidelberg; University of Leicester	Malnasi-Csizmadia, A (corresponding author), Eotvos Lorand Univ, Inst Biol, Dept Biochem, Pazmany Peter Setany 1-A, H-1117 Budapest, Hungary.	malna@elte.hu	Csizmadia, András Málnási/K-7632-2018; Bodor, Andrea/G-1797-2018; Bagshaw, Clive R./L-5484-2019; Bodor, Andrea/AAL-7854-2020; Gyimesi, Mate/I-2639-2017	Csizmadia, András Málnási/0000-0002-2430-8398; Bodor, Andrea/0000-0002-7422-298X; Bagshaw, Clive R./0000-0002-5396-153X; Bodor, Andrea/0000-0002-7422-298X; Kintses, Balint/0000-0003-0844-0310; Gyimesi, Mate/0000-0002-7195-1925	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		BAGSHAW CR, 1974, BIOCHEM J, V141, P331, DOI 10.1042/bj1410331; Bauer CB, 1997, J MOL BIOL, V274, P394, DOI 10.1006/jmbi.1997.1325; BEYNON RJ, 1996, BUFFERS PH CONTROL B; Conibear PB, 2004, BIOCHEMISTRY-US, V43, P15404, DOI 10.1021/bi048338j; Conibear PB, 2003, NAT STRUCT BIOL, V10, P831, DOI 10.1038/nsb986; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; DANTZIG JA, 1985, J GEN PHYSIOL, V86, P305, DOI 10.1085/jgp.86.3.305; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; GOLDMAN YE, 1987, ANNU REV PHYSIOL, V49, P629; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; GOODY RS, 1977, EUR J BIOCHEM, V78, P317, DOI 10.1111/j.1432-1033.1977.tb11742.x; Gyimesi M, 2008, BIOCHEMISTRY-US, V47, P283, DOI 10.1021/bi701554a; Jahn W, 2007, BIOCHEMISTRY-US, V46, P9654, DOI 10.1021/bi700318t; KAWAI M, 1993, BIOPHYS J, V65, P638, DOI 10.1016/S0006-3495(93)81109-3; KAWAI M, 1991, BIOPHYS J, V59, P329, DOI 10.1016/S0006-3495(91)82227-5; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; Kintses B, 2006, BIOPHYS J, V91, P4605, DOI 10.1529/biophysj.106.092833; Koppole S, 2007, STRUCTURE, V15, P825, DOI 10.1016/j.str.2007.06.008; Koppole S, 2006, J MOL BIOL, V361, P604, DOI 10.1016/j.jmb.2006.06.022; Kovacs M, 2002, J BIOL CHEM, V277, P28459, DOI 10.1074/jbc.M202180200; Kuhlman PA, 1998, J MUSCLE RES CELL M, V19, P491, DOI 10.1023/A:1005304408812; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; Lionne C, 2002, BIOCHEMISTRY-US, V41, P13297, DOI 10.1021/bi0260278; LIONNE C, 1995, FEBS LETT, V364, P59, DOI 10.1016/0014-5793(95)00356-E; Malnasi-Csizmadia A, 2005, J MUSCLE RES CELL M, V26, P31, DOI 10.1007/s10974-005-9004-y; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; Malnasi-Csizmadia A, 2001, J BIOL CHEM, V276, P19483, DOI 10.1074/jbc.M010886200; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; MANNHERZ HG, 1974, EUR J BIOCHEM, V48, P287, DOI 10.1111/j.1432-1033.1974.tb03767.x; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; Mesentean S, 2007, J MOL BIOL, V367, P591, DOI 10.1016/j.jmb.2006.12.058; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; Schwarzl SM, 2006, BIOCHEMISTRY-US, V45, P5830, DOI 10.1021/bi052433q; Siththanandan VB, 2006, BIOPHYS J, V90, P3653, DOI 10.1529/biophysj.105.072413; Smith DA, 2004, BIOPHYS J, V87, P442, DOI 10.1529/biophysj.103.037788; Takagi Y, 2004, PHILOS T R SOC B, V359, P1913, DOI 10.1098/rstb.2004.1561; Tesi C, 2002, J PHYSIOL-LONDON, V541, P187, DOI 10.1113/jphysiol.2001.013418; TRENTHAM DR, 1976, Q REV BIOPHYS, V9, P217, DOI 10.1017/S0033583500002419; TRENTHAM DR, 1972, BIOCHEM J, V126, P635, DOI 10.1042/bj1260635; Wakelin S, 2002, J MUSCLE RES CELL M, V23, P673, DOI 10.1023/A:1024411208497; WELLS C, 1984, J MUSCLE RES CELL M, V5, P97, DOI 10.1007/BF00713154; WERBER MM, 1992, BIOCHEMISTRY-US, V31, P7190, DOI 10.1021/bi00146a023; WHITE HD, 1976, BIOCHEMISTRY-US, V15, P5818, DOI 10.1021/bi00671a020; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Woodward SKA, 1995, BIOCHEMISTRY-US, V34, P16056, DOI 10.1021/bi00049a020; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010; Zeng W, 2004, PHILOS T R SOC B, V359, P1843, DOI 10.1098/rstb.2004.1527	53	40	40	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8153	8163		10.1074/jbc.M708863200	http://dx.doi.org/10.1074/jbc.M708863200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18211892	hybrid			2022-12-27	WOS:000254288000012
J	Gong, RJ; Rifai, A; Ge, Y; Chen, S; Dworkin, LD				Gong, Rujun; Rifai, Abdalla; Ge, Yan; Chen, Shan; Dworkin, Lance D.			Hepatocyte growth factor suppresses proinflammatory NF kappa B activation through GSK3 beta inactivation in renal tubular epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; INFLAMMATORY-BOWEL-DISEASE; SIGNAL-TRANSDUCTION; LIVER-REGENERATION; TYROSINE KINASE; GENE-EXPRESSION; SCATTER FACTOR; MET RECEPTOR; RAT MODEL; PATHWAY	Activation of NF kappa B is a fundamental cellular event central to all inflammatory diseases. Hepatocyte growth factor ( HGF) ameliorates both acute and chronic inflammation in a multitude of organ systems through modulating NF kappa B activity; nevertheless, the exact molecular mechanism remains uncertain. Here we report that HGF through inactivation of GSK3 beta suppresses NF kappa B p65 phosphorylation specifically at position Ser-468. The Ser-468 of RelA/p65 situates in a GSK3 beta consensus motif and could be directly phosphorylated by GSK3 beta both in vivo and in vitro, signifying Ser-468 of RelA/ p65 as a putative substrate for GSK3 beta. In addition, the C terminus of RelA/ p65 harbors a highly conserved domain homologue of the consensus docking sequence for GSK3 beta. Moreover, this domain was required for efficient phosphorylation of Ser- 468 and was indispensable for the physical interaction between RelA/ p65 and GSK3 beta. HGF substantially intercepted this interaction by inactivating GSK3 beta. Functionally, phosphorylation of Ser-468 of RelA/p65 was required for the induced expression of a particular subset of proinflammatory NF kappa B-dependent genes. Diminished phosphorylation at Ser- 468 by HGF resulted in a gene-specific inhibition of these genes' expression. The action of HGF on proinflammatory NF kappa B activation was consistently mimicked by a selective GSK3 beta inhibitor or GSK3 beta knockdown by RNA interference but largely abrogated in cells expressing the mutant uninhibitable GSK3 beta. Collectively, our findings suggest that HGF has a potent suppressive effect on NF kappa B activation, which is mediated by GSK3 beta, an important signaling transducer controlling RelA/ p65 phosphorylation specificity and directing the transcription of selective proinflammatory cytokines implicated in inflammatory kidney disease.	[Gong, Rujun; Ge, Yan; Chen, Shan; Dworkin, Lance D.] Brown Univ, Dept Med, Sch Med, Div Kidney Dis & Hypertens, Providence, RI 02903 USA; [Rifai, Abdalla] Brown Univ, Dept Med, Sch Med, Dept Pathol, Providence, RI 02903 USA; [Chen, Shan] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing 400038, Peoples R China	Brown University; Brown University; Army Medical University	Gong, RJ (corresponding author), Brown Univ, Dept Med, Sch Med, Div Kidney Dis & Hypertens, 593 Eddy St, Providence, RI 02903 USA.	Rujun_Gong@Brown.edu			NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT001465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052314] Funding Source: NIH RePORTER; NCCIH NIH HHS [AT001465-01A2] Funding Source: Medline; NIDDK NIH HHS [R01-DK52314] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arthur LG, 2004, J PEDIATR SURG, V39, P139, DOI 10.1016/j.jpedsurg.2003.10.001; Arthur LG, 2003, J GASTROINTEST SURG, V7, P1062, DOI 10.1016/j.gassur.2003.09.014; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; BOROS P, 1995, LANCET, V345, P293, DOI 10.1016/S0140-6736(95)90279-1; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chen H, 2007, J CELL BIOCHEM, V102, P1281, DOI 10.1002/jcb.21358; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Dignass AU, 2001, EUR J GASTROEN HEPAT, V13, P763, DOI 10.1097/00042737-200107000-00002; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dugo L, 2007, SHOCK, V27, P113, DOI 10.1097/01.shk.0000238059.23837.68; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; Ghosh S, 1999, IMMUNOL RES, V19, P183, DOI 10.1007/BF02786486; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gong R, 2006, KIDNEY INT, V69, P1166, DOI 10.1038/sj.ki.5000246; Gong R, 2003, J AM SOC NEPHROL, V14, P3047, DOI 10.1097/01.ASN.0000098686.72971.DB; Gong RJ, 2005, BIOCHEM BIOPH RES CO, V330, P27, DOI 10.1016/j.bbrc.2005.02.122; Gong RJ, 2004, J AM SOC NEPHROL, V15, P2868, DOI 10.1097/01.ASN.0000141962.44300.3A; Gong RJ, 2006, J AM SOC NEPHROL, V17, P2464, DOI 10.1681/ASN.2006020185; Haefner B, 2003, DRUG DISCOV TODAY, V8, P1062, DOI 10.1016/S1359-6446(03)02898-8; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Herrero-Fresneda I, 2006, KIDNEY INT, V70, P265, DOI 10.1038/sj.ki.5001510; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ito W, 2005, AM J RESP CELL MOL, V32, P268, DOI 10.1165/rcmb.2004-0058OC; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim AJ, 2005, J CELL SCI, V118, P89, DOI 10.1242/jcs.01562; Liu YH, 2004, AM J PHYSIOL-RENAL, V287, pF7, DOI 10.1152/ajprenal.00451.2003; Matsumoto K, 2001, KIDNEY INT, V59, P2023, DOI 10.1046/j.1523-1755.2001.00717.x; MATSUMOTO K, 1991, J GASTROEN HEPATOL, V6, P509, DOI 10.1111/j.1440-1746.1991.tb00897.x; Mattioli I, 2004, BLOOD, V104, P3302, DOI 10.1182/blood-2004-04-1536; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Min JK, 2005, CIRC RES, V96, P300, DOI 10.1161/01.RES.0000155330.07887.EE; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Oh K, 2005, AM J PHYSIOL-GASTR L, V288, pG729, DOI 10.1152/ajpgi.00438.2004; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; OUGOLKOV AV, 2007, BLOOD, V100, P375; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pomerantz JL, 2000, NATURE, V406, P26, DOI 10.1038/35017673; ROSEN EM, 1994, J CELL BIOL, V127, P1783, DOI 10.1083/jcb.127.6.1783; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Sreenivasan Y, 2003, ONCOGENE, V22, P4356, DOI 10.1038/sj.onc.1206486; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Stuart KA, 2000, INT J EXP PATHOL, V81, P17, DOI 10.1046/j.1365-2613.2000.00138.x; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; Xiao CC, 2005, ADV EXP MED BIOL, V560, P41	55	85	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7401	7410		10.1074/jbc.M710396200	http://dx.doi.org/10.1074/jbc.M710396200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18201972	Green Published, hybrid			2022-12-27	WOS:000253997900014
J	Moncada, CA; Clarkson, A; Perez-Leal, O; Merali, S				Moncada, Camilo A.; Clarkson, Allen; Perez-leal, Oscar; Merali, Salim			Mechanism and tissue specificity of nicotine-mediated lung S-adenosylmethionine reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOCYSTIS-CARINII-PNEUMONIA; DL-ALPHA-DIFLUOROMETHYLORNITHINE; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ORNITHINE DECARBOXYLASE ACTIVITY; RAT MODEL; CONTINUOUS-INFUSION; AIDS PATIENTS; EFLORNITHINE; INHIBITOR; DIAGNOSIS	We previously reported that chronic nicotine infusion blocks development of Pneumocystis pneumonia. This discovery developed from our work demonstrating the inability of this fungal pathogen to synthesize the critical metabolic intermediate S-adenosylmethionine and work by others showing nicotine to cause lung-specific reduction of S-adenosylmethionine in guinea pigs. We had found nicotine infusion to cause increased lung ornithine decarboxylase activity (rate-controlling enzyme of polyamine synthesis) and hypothesized that S-adenosylmethionine reduction is driven by up-regulated polyamine biosynthesis. Here we report a critical test of our hypothesis; inhibition of ornithine decarboxylase blocks the effect of nicotine on lung S-adenosylmethionine. Further support is provided by metabolite analyses showing nicotine to cause a strong diversion of S-adenosylmethionine toward polyamine synthesis and away from methylation reactions; these shifts are reversed by inhibition of ornithine decarboxylase. Because the nicotine effect on Pneumocystis is so striking, we considered the possibility of tissue specificity. Using laser capture microdissection, we collected samples of lung alveolar regions (site of infection) and respiratory epithelium for controls. We found nicotine to cause increased ornithine decarboxylase protein in alveolar regions but not airway epithelium; we conclude that tissue specificity likely contributes to the effect of nicotine on Pneumocystis pneumonia. Earlier we reported that the full effect of nicotine requires 3 weeks of treatment, and here we show recovery is symmetrical, also requiring 3 weeks after treatment cessation. Because this time frame is similar to pneumocyte turnover time, the shift in polyamine metabolism may occur as new pneumocytes are produced.	[Moncada, Camilo A.; Perez-leal, Oscar; Merali, Salim] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Clarkson, Allen] NYU, Sch Med, Dept Med Parasitol, New York, NY 10016 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; New York University	Merali, S (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3307 N Broad St, Philadelphia, PA 19140 USA.	smerali@temple.edu	Moncada-Benavides, Camilo/B-9407-2009; Moncada, Camilo/L-7468-2018	Moncada, Camilo/0000-0001-9458-5684; Perez-Leal, Oscar/0000-0002-5641-0311	NIAID NIH HHS [R01 AI064017] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064017] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babbar N, 2006, J BIOL CHEM, V281, P24182, DOI 10.1074/jbc.M601871200; Bergeron C, 2007, J ALLERGY CLIN IMMUN, V119, P391, DOI 10.1016/j.jaci.2006.10.030; Chin K, 1996, ANTIMICROB AGENTS CH, V40, P2318, DOI 10.1128/AAC.40.10.2318; CLARKSON AB, 1988, ANTIMICROB AGENTS CH, V32, P1158, DOI 10.1128/AAC.32.8.1158; FILLET G, 1989, BLOOD, V74, P844; Fojtova M, 1998, EUR J BIOCHEM, V252, P347, DOI 10.1046/j.1432-1327.1998.2520347.x; GODIN CS, 1986, TOXICOL LETT, V31, P23, DOI 10.1016/0378-4274(86)90190-6; GOLDEN JA, 1984, WESTERN J MED, V141, P613; HALLINE AG, 1989, BIOCHEM J, V259, P513, DOI 10.1042/bj2590513; HORN Y, 1987, EUR J CANCER CLIN ON, V23, P1103, DOI 10.1016/0277-5379(87)90141-6; Kee K, 2004, J BIOL CHEM, V279, P40076, DOI 10.1074/jbc.M406002200; Kim K, 2005, BIOCHEM BIOPH RES CO, V331, P78, DOI 10.1016/j.bbrc.2005.03.121; Merali S, 2000, J BIOL CHEM, V275, P14958, DOI 10.1074/jbc.275.20.14958; Merali S, 1996, J CHROMATOGR B, V675, P321, DOI 10.1016/0378-4347(95)00363-0; Merali S, 1996, ANTIMICROB AGENTS CH, V40, P973, DOI 10.1128/AAC.40.4.973; Merali S, 2000, ANTIMICROB AGENTS CH, V44, P337, DOI 10.1128/AAC.44.2.337-343.2000; MERALI S, 1995, ANTIMICROB AGENTS CH, V39, P1442, DOI 10.1128/AAC.39.7.1442; Movsas B, 1997, CHEST, V111, P1061, DOI 10.1378/chest.111.4.1061; OLSON JW, 1985, LIFE SCI, V37, P2165, DOI 10.1016/0024-3205(85)90567-3; OLSON JW, 1985, CARCINOGENESIS, V6, P1517, DOI 10.1093/carcin/6.10.1517; PAULSON YJ, 1992, CHEST, V101, P67, DOI 10.1378/chest.101.1.67; PEGG AE, 1984, BIOCHEM J, V224, P29, DOI 10.1042/bj2240029; SARIC M, 1994, ANTIMICROB AGENTS CH, V38, P2545, DOI 10.1128/AAC.38.11.2545; Shivji M, 2005, J BIOL CHEM, V280, P15219, DOI 10.1074/jbc.M413946200; Skelly M, 2003, LANCET, V361, P1267, DOI 10.1016/S0140-6736(03)12984-4; Skelly MJ, 2008, CLIN INFECT DIS, V46, P467, DOI 10.1086/525854; SMITH D, 1990, AIDS, V4, P1019, DOI 10.1097/00002030-199010000-00012; SMITH DE, 1992, AIDS, V6, P1489, DOI 10.1097/00002030-199212000-00011	28	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7690	7696		10.1074/jbc.M709399200	http://dx.doi.org/10.1074/jbc.M709399200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18180293	hybrid			2022-12-27	WOS:000253997900045
J	Hu, XQ; Peoples, RW				Hu, Xiang-Qun; Peoples, Robert W.			The 5-HT3B subunit confers spontaneous channel opening and altered ligand properties of the 5-HT3 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTONIN-RECEPTOR; GABA(A) RECEPTORS; AGONISM; BINDING; COEXPRESSION; SENSITIVITY; MODULATION; ACTIVATION; MICROSCOPY; INVERSE	Current receptor theory suggests that there is an equilibrium between the inactive ( R) and active (R*) conformations of ligand-gated ion channels and G protein-coupled receptors. The actions of ligands in both receptor types could be appropriately explained by this two-state model. Ligands such as agonists and antagonists affect receptor function by stabilizing one or both conformations. The 5-HT3 receptor is a member of the Cys-loop ligand-gated ion channel superfamily participating in synaptic transmission. Here we show that co-expression of the 5-HT3A and 5-HT3B receptor subunits in the human embryonic kidney (HEK) 293 cells results in a receptor that displays a low level of constitutive ( or agonist- independent) activity. Furthermore, we also demonstrate that the properties of ligands can be modified by receptor composition. Whereas the 5-hydroxytryptamine (5-HT) analog 5-methoxyindole is a partial agonist at the 5-HT3A receptor, it becomes a "protean agonist" ( functioning as an agonist and an inverse agonist at the same receptor) at the 5-HT3AB receptor ( after the Greek god Proteus, who was able to change his shape and appearance at will). In addition, the 5-HT analog 5-hydroxyindole is a positive allosteric modulator for the liganded active (AR*) conformation of the 5-HT3A and 5-HT3AB receptors and a negative allosteric modulator for the spontaneously active ( R*) conformation of the 5-HT3AB receptor, suggesting that the spontaneously active (R*) and liganded active ( AR*) conformations are differentially modulated by 5-hydroxyindole. Thus, the incorporation of the 5-HT3B subunit leads to spontaneous channel opening and altered ligand properties.	[Hu, Xiang-Qun; Peoples, Robert W.] Marquette Univ, Coll Hlth Sci, Dept Biomed Sci, Milwaukee, WI 53201 USA	Marquette University	Hu, XQ (corresponding author), Marquette Univ, Coll Hlth Sci, Dept Biomed Sci, POB 1881, Milwaukee, WI 53201 USA.	xiangqun.hu@marquette.edu			NIAAA NIH HHS [AA015203] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015203] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Barrera NP, 2005, P NATL ACAD SCI USA, V102, P12595, DOI 10.1073/pnas.0503253102; Beckstead MJ, 2002, J NEUROCHEM, V82, P1343, DOI 10.1046/j.1471-4159.2002.01086.x; Bhattacharya A, 2004, J NEUROSCI, V24, P5537, DOI 10.1523/JNEUROSCI.5658-03.2004; Bianchi MT, 2001, J NEUROSCI, V21, P9083, DOI 10.1523/JNEUROSCI.21-23-09083.2001; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; de Ligt RAF, 2000, BRIT J PHARMACOL, V130, P1, DOI 10.1038/sj.bjp.0703311; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Dubin AE, 1999, J BIOL CHEM, V274, P30799, DOI 10.1074/jbc.274.43.30799; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gbahou F, 2003, P NATL ACAD SCI USA, V100, P11086, DOI 10.1073/pnas.1932276100; Grosman C, 2000, J GEN PHYSIOL, V115, P621, DOI 10.1085/jgp.115.5.621; Gunthorpe MJ, 1999, J PHYSIOL-LONDON, V519, P713, DOI 10.1111/j.1469-7793.1999.0713n.x; Hapfelmeier G, 2003, BIOPHYS J, V84, P1720, DOI 10.1016/S0006-3495(03)74980-7; Hayrapetyan V, 2005, MOL BRAIN RES, V142, P146, DOI 10.1016/j.molbraines.2005.09.011; Hu XQ, 2005, J PHYSIOL-LONDON, V568, P381, DOI 10.1113/jphysiol.2005.092866; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Jones BL, 2006, J PHYSIOL-LONDON, V573, P571, DOI 10.1113/jphysiol.2006.106534; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P256, DOI 10.1016/S0165-6147(00)89037-9; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; KOOYMAN AR, 1993, BRIT J PHARMACOL, V108, P287, DOI 10.1111/j.1476-5381.1993.tb12795.x; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Neelands TR, 1999, MOL PHARMACOL, V55, P168, DOI 10.1124/mol.55.1.168; Solt K, 2005, J PHARMACOL EXP THER, V315, P771, DOI 10.1124/jpet.105.090621; Stevens R, 2005, J PHARMACOL EXP THER, V314, P338, DOI 10.1124/jpet.105.085076; Unwin N, 2003, FEBS LETT, V555, P91, DOI 10.1016/S0014-5793(03)01084-6; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Zhang L, 2002, J BIOL CHEM, V277, P46256, DOI 10.1074/jbc.M207683200	32	35	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6826	6831		10.1074/jbc.M707571200	http://dx.doi.org/10.1074/jbc.M707571200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18187416	hybrid			2022-12-27	WOS:000253779600025
J	Sumida, JP; Wu, E; Lehrer, SS				Sumida, John P.; Wu, Eleanor; Lehrer, Sherwin S.			Conserved Asp-137 imparts flexibility to tropomyosin and affects function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; INFECTED INSECT CELLS; SUBFRAGMENT 1 ATPASE; THIN FILAMENT; COILED-COIL; ALPHA-TROPOMYOSIN; INTRINSIC FLUORESCENCE; HYDROGEN-EXCHANGE; STRIATED-MUSCLE	Tropomyosin (Tm) is an alpha-helical coiled-coil that controls muscle contraction by sterically regulating the myosin-actin interaction. Tm moves between three states on F-actin as either a uniform or a non-uniform semi-flexible rod. Tm is stabilized by hydrophobic residues in the "a" and "d" positions of the heptad repeat. The highly conserved Asp-137 is unusual in that it introduces a negative charge on each chain in a position typically occupied by hydrophobic residues. The occurrence of two charged residues in the hydrophobic region is expected to destabilize the region and impart flexibility. To determine whether this region is unstable, we have substituted hydrophobic Leu for Asp-137 and studied changes in Tm susceptibility to limited proteolysis by trypsin and changes in regulation. We found that native and Tm controls that contain Asp-137 were readily cleaved at Arg-133 with t(1/2) of 5 min. In contrast, the Leu-137 mutant was not cleaved under the same conditions. Actin stabilized Tm, causing a 10-fold reduction in the rate of cleavage at Arg-133. The actin- myosin subfragment S1 ATPase activity was greater for the Leu mutant compared with controls in the absence of troponin and in the presence of troponin and Ca2+. We conclude that the highly conserved Asp-137 destabilizes the middle of Tm, resulting in a more flexible region that is important for the cooperative activation of the thin filament by myosin. We thus have shown a link between the dynamic properties of Tm and its function.	[Sumida, John P.; Wu, Eleanor; Lehrer, Sherwin S.] Boston Biomed Res Inst, Cardiovasc Program, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Lehrer, SS (corresponding author), Boston Biomed Res Inst, Cardiovasc Program, Watertown, MA 02472 USA.	Lehrer@bbri.org	Lehrer, Sherwin/ABF-7282-2021		NHLBI NIH HHS [HL22461] Funding Source: Medline; NIAMS NIH HHS [AR41637] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR041637] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anfinsen C B, 1975, Adv Protein Chem, V29, P205, DOI 10.1016/S0065-3233(08)60413-1; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; BETTERIDGE DR, 1983, J MOL BIOL, V167, P481, DOI 10.1016/S0022-2836(83)80346-5; Bottinelli R, 1998, CIRC RES, V82, P106; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; Geeves MA, 2000, BIOCHEMISTRY-US, V39, P9345, DOI 10.1021/bi0002232; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033; HARRISON SM, 1989, AM J PHYSIOL, V256, pC1250, DOI 10.1152/ajpcell.1989.256.6.C1250; Jackman DM, 1996, EUR J BIOCHEM, V242, P363, DOI 10.1111/j.1432-1033.1996.0363r.x; Jagatheesan G, 2007, AM J PHYSIOL-HEART C, V293, pH949, DOI 10.1152/ajpheart.01341.2006; JOHNSON P, 1977, BIOCHEMISTRY-US, V16, P2264, DOI 10.1021/bi00629a035; KLUWE L, 1995, J MUSCLE RES CELL M, V16, P103, DOI 10.1007/BF00122528; LEESMILLER JP, 1991, BIOESSAYS, V13, P429, DOI 10.1002/bies.950130902; Lehrer SS, 1997, BIOCHEMISTRY-US, V36, P13449, DOI 10.1021/bi971568w; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; LEHRER SS, 1978, J MOL BIOL, V118, P209, DOI 10.1016/0022-2836(78)90413-8; LINDERSTROMLANG K, 1949, COLD SPRING HARB SYM, V14, P117, DOI 10.1101/SQB.1950.014.01.016; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MARTELL AE, 1974, CRITICAL STABILITY C, V1, P139; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Michele DE, 2000, J MOL MED, V78, P543, DOI 10.1007/s001090000161; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; ONISHI H, 1995, P NATL ACAD SCI USA, V92, P704, DOI 10.1073/pnas.92.3.704; OTTESEN M, 1967, ANNU REV BIOCHEM, V36, P55, DOI 10.1146/annurev.bi.36.070167.000415; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; PATO MD, 1981, J BIOL CHEM, V256, P602; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; SMILEY LB, 1966, BIOCH SMOOTH MUSCLE, P63; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; Sumida J.P., 2006, BIOPHYS J S, V90, P193; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; UENO H, 1984, BIOCHEMISTRY-US, V23, P4791, DOI 10.1021/bi00315a040; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884	42	58	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6728	6734		10.1074/jbc.M707485200	http://dx.doi.org/10.1074/jbc.M707485200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18165684	hybrid			2022-12-27	WOS:000253779600014
J	Roehrl, J; Yang, D; Oppenheim, JJ; Hehlgans, T				Roehrl, Johann; Yang, De; Oppenheim, Joost J.; Hehlgans, Thomas			Identification and biological characterization of mouse beta-defensin 14, the orthologue of human beta-defensin 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-DEFENSINS; IMMATURE DENDRITIC CELLS; ANTIMICROBIAL PEPTIDES; INDUCTION; IMMUNITY; KERATINOCYTES; EXPRESSION; DISCOVERY; INCREASE; INNATE	beta-Defensins are small antimicrobial polypeptides that are mainly expressed by epithelial cells and play an important role in the antimicrobial innate immune response. In addition to the direct microbicidal effects of these polypeptides, it became evident that certain members of the beta-defensin super family have the capacity to promote local innate inflammatory and systemic adaptive immune responses by interacting with the CC-chemokine receptor CCR6. We have identified mouse beta-defensin 14 (mBD14, Defb14) as an orthologue of human beta-defensin 3 (hBD3 or DEFB103). Based on primary structural analysis, mBD14 demonstrates greater (68%) homology to its human orthologue, containing three conserved cystein linkages, characteristic for the beta-defensin super family. mBD14 is expressed in a wide variety of tissues including spleen, colon, and tissues of the upper and lower respiratory tract. Interestingly, we also detected mBD14 expression in immature CD11c(+) bone marrow-derived dendritic cells. The expression of mBD14 can be induced by Toll-like receptor agonists such as lipopolysaccharide and poly(I:C) and by pro-inflammatory stimuli e. g. tumor necrosis factor and interferon-gamma. Furthermore, expression of mBD14 seems to be regulated by activation of the intracellular pattern recognition receptor NOD2/CARD15 as revealed by reporter gene analysis. We prepared a recombinant mBD14-Ig fusion protein that retained potent antimicrobial activity against several Escherichia coli strains but not against various Gram-positive Staphylococcus aureus strains. hBD3 and also the newly identified mBD14 were chemotactic for cells expressing the mouse CC-chemokine receptor CCR6. In addition, both hBD3 and mBD14 were chemotactic for freshly isolated mouse resident peritoneal cells. Thus, mBD14, based on structural and functional similarities, appears to be an orthologue of hBD3.	[Roehrl, Johann; Hehlgans, Thomas] Univ Regensburg, Inst Immunol, D-93042 Regensburg, Germany; [Yang, De; Oppenheim, Joost J.] NIH, NCI, Div Basic Sci, Mol Immunoregulat Lab, Frederick, MD 21702 USA	University of Regensburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hehlgans, T (corresponding author), Univ Regensburg, Inst Immunol, Franz-Josef-Str-Allee 11, D-93042 Regensburg, Germany.	thomas.hehlgans@klinik.regensburg.de			NATIONAL CANCER INSTITUTE [ZIABC009369, Z01BC009369] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Chen XJ, 2007, EUR J IMMUNOL, V37, P434, DOI 10.1002/eji.200636379; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; Fang XM, 2003, EUR J CLIN INVEST, V33, P82, DOI 10.1046/j.1365-2362.2003.01076.x; Ganz T, 2002, SCIENCE, V298, P977, DOI 10.1126/science.1078708; Harder J, 2004, J INVEST DERMATOL, V123, P522, DOI 10.1111/j.0022-202X.2004.23234.x; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Ishimoto H, 2006, EUR RESPIR J, V27, P253, DOI 10.1183/09031936.06.00105904; Jia HP, 2001, GENE, V263, P211; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; McCray PB, 1997, AM J RESP CELL MOL, V16, P343, DOI 10.1165/ajrcmb.16.3.9070620; MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634, DOI 10.1002/jlb.51.6.634; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; PIERS KL, 1993, GENE, V134, P7, DOI 10.1016/0378-1119(93)90168-3; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Semple CA, 2006, MOL DIVERS, V10, P575, DOI 10.1007/s11030-006-9031-7; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069	27	66	68	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5414	5419		10.1074/jbc.M709103200	http://dx.doi.org/10.1074/jbc.M709103200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167348	hybrid			2022-12-27	WOS:000253426700021
J	Ceradini, DJ; Yao, DC; Grogan, RH; Callaghan, MJ; Edelstein, D; Brownlee, M; Gurtner, GC				Ceradini, Daniel J.; Yao, Dachun; Grogan, Raymon H.; Callaghan, Matthew J.; Edelstein, Diane; Brownlee, Michael; Gurtner, Geoffrey C.			Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL PROGENITOR CELLS; ADVANCED GLYCATION; ANGIOGENESIS; RECRUITMENT; PROTEINS; HYPOXIA; PROLIFERATION; MOBILIZATION; PROMOTER	Tissue ischemia promotes vasculogenesis through chemokine-induced recruitment of bone marrow-derived endothelial progenitor cells (EPCs). Diabetes significantly impairs this process. Because hyperglycemia increases reactive oxygen species in a number of cell types, and because many of the defects responsible for impaired vasculogenesis involve HIF1-regulated genes, we hypothesized that HIF1 function is impaired in diabetes because of reactive oxygen species-induced modification of HIF1 alpha by the glyoxalase 1 (GLO1) substrate methylglyoxal. Decreasing superoxide in diabetic mice by either transgenic expression of manganese superoxide dismutase or by administration of an superoxide dismutase mimetic corrected post-ischemic defects in neovascularization, oxygen delivery, and chemokine expression, and normalized tissue survival. In hypoxic fibroblasts cultured in high glucose, overexpression of GLO1 prevented reduced expression of both the EPC mobilizing chemokine stromal cell-derived factor-1 (SDF-1) and of vascular epidermal growth factor, which modulates growth and differentiation of recruited EPCs. In hypoxic EPCs cultured in high glucose, overexpression of GLO1 prevented reduced expression of both the SDF-1 receptor CXCR4, and endothelial nitric-oxide synthase, an enzyme essential for EPC mobilization. HIF1 alpha modification by methylglyoxal reduced heterodimer formation and HIF1 alpha binding to all relevant promoters. These results provide a basis for the rational design of new therapeutics to normalize impaired ischemia-induced vasculogenesis in patients with diabetes.	[Ceradini, Daniel J.; Grogan, Raymon H.; Callaghan, Matthew J.; Gurtner, Geoffrey C.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Yao, Dachun; Edelstein, Diane; Brownlee, Michael] Albert Einstein Coll Med, Int Ctr Diabet Complicat Res, JDRF, Bronx, NY 10461 USA	Stanford University; Yeshiva University; Albert Einstein College of Medicine	Brownlee, M (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	brownlee@aecom.yu.edu	/ABE-5226-2021		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074153, R01DK074095] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK74153-01, R01 DK74095-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Ahmed N, 2002, BIOCHEM J, V364, P1; Ahmed N, 2003, BIOCHEM SOC T, V31, P1417; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Awad O, 2005, STEM CELLS, V23, P575, DOI 10.1634/stemcells.2004-0185; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chakraborty S, 2001, J CELL BIOCHEM, V82, P310, DOI 10.1002/jcb.1165; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Coulet F, 2003, J BIOL CHEM, V278, P46230, DOI 10.1074/jbc.M305420200; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Fingerman IM, 2004, CELL, V117, P690, DOI 10.1016/j.cell.2004.05.021; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Michel G, 2002, BBA-GENE STRUCT EXPR, V1578, P73, DOI 10.1016/S0167-4781(02)00484-0; Rivard A, 1999, AM J PATHOL, V154, P355, DOI 10.1016/S0002-9440(10)65282-0; Schatteman GC, 2000, J CLIN INVEST, V106, P571, DOI 10.1172/JCI9087; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Yao D, 2007, J BIOL CHEM, V282, P31038, DOI 10.1074/jbc.M704703200; YAROM R, 1992, J PATHOL, V166, P265, DOI 10.1002/path.1711660308	30	180	194	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10930	10938		10.1074/jbc.M707451200	http://dx.doi.org/10.1074/jbc.M707451200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18227068	Green Published, hybrid			2022-12-27	WOS:000254894700074
J	Schar, CR; Blouse, GE; Minor, KH; Peterson, CB				Schar, Christine R.; Blouse, Grant E.; Minor, Kenneth H.; Peterson, Cynthia B.			A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual plasminogen activator inhibitor-1-binding activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; UROKINASE RECEPTOR; INHIBITOR TYPE-1; SELF-ASSOCIATION; BINDING-SITES; STRUCTURAL REQUIREMENTS; 3-DIMENSIONAL STRUCTURE; MULTIMERIC VITRONECTIN; HEPARIN-BINDING; CELL-MIGRATION	Vitronectin and plasminogen activator inhibitor-1 (PAI-1) are important physiological binding partners that work in concert to regulate cellular adhesion, migration, and fibrinolysis. The high affinity binding site for PAI-1 is located within the N-terminal somatomedin B domain of vitronectin; however, several studies have suggested a second PAI-1-binding site within vitronectin. To investigate this secondary site, a vitronectin mutant lacking the somatomedin B domain (r Delta sBVN) was engineered. The short deletion had no effect on heparin-binding, integrin-binding, or cellular adhesion. Binding to the urokinase receptor was completely abolished while PAI-1 binding was still observed, albeit with a lower affinity. Analytical ultracentrifugation on the PAI-1-vitronectin complex demonstrated that increasing NaCl concentration favors 1:1 versus 2:1 PAI-1-vitronectin complexes and hampers formation of higher order complexes, pointing to the contribution of charge-charge interactions for PAI-1 binding to the second site. Furthermore, fluorescence resonance energy transfer between differentially labeled PAI-1 molecules confirmed that two independent molecules of PAI-1 are capable of binding to vitronectin. These results support a model for the assembly of higher order PAI-1-vitronectin complexes via two distinct binding sites in both proteins.	[Schar, Christine R.; Minor, Kenneth H.; Peterson, Cynthia B.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA; [Blouse, Grant E.] Univ Aarhus, Dept Mol & Struct Biol, Lab Cellular Protein Sci, DK-8000 Aarhus, Denmark	University of Tennessee System; University of Tennessee Knoxville; Aarhus University	Peterson, CB (corresponding author), Univ Tennessee, Dept Biochem Cellular & Mol Biol, M407 Walters Life Sci Bldg, Knoxville, TN 37996 USA.	cynthia_peterson@utk.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL050676, R01HL050676] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL50676] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREASEN PA, 1986, FEBS LETT, V209, P213, DOI 10.1016/0014-5793(86)81113-9; BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; BERKENPAS MB, 1995, EMBO J, V14, P2969, DOI 10.1002/j.1460-2075.1995.tb07299.x; BITTORF SV, 1993, J BIOL CHEM, V268, P24838; CHAIN D, 1991, FEBS LETT, V285, P251, DOI 10.1016/0014-5793(91)80810-P; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; DAHLBACK B, 1985, BIOCHEMISTRY-US, V24, P2368, DOI 10.1021/bi00330a036; Deng G, 1996, J BIOL CHEM, V271, P12716, DOI 10.1074/jbc.271.22.12716; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; GECHTMAN Z, 1993, FEBS LETT, V315, P293, DOI 10.1016/0014-5793(93)81181-X; Gibson A, 1997, J BIOL CHEM, V272, P5112, DOI 10.1074/jbc.272.8.5112; Gibson AD, 2001, BBA-PROTEIN STRUCT M, V1545, P289, DOI 10.1016/S0167-4838(00)00290-9; Hagglof P, 2004, J MOL BIOL, V335, P823, DOI 10.1016/j.jmb.2003.11.005; HOLMES R, 1967, J CELL BIOL, V32, P297, DOI 10.1083/jcb.32.2.297; Horn NA, 2004, J BIOL CHEM, V279, P35867, DOI 10.1074/jbc.M405716200; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; IZUMI M, 1988, CELL STRUCT FUNCT, V13, P217, DOI 10.1247/csf.13.217; Jensen JK, 2004, FEBS LETT, V556, P175, DOI 10.1016/S0014-5793(03)01405-4; Jensen JK, 2002, FEBS LETT, V521, P91, DOI 10.1016/S0014-5793(02)02830-2; Kamikubo Y, 2006, BIOCHEMISTRY-US, V45, P3297, DOI 10.1021/bi052278f; Kamikubo Y, 2004, BIOCHEMISTRY-US, V43, P6519, DOI 10.1021/bi049647c; Kamikubo Y, 2002, J BIOL CHEM, V277, P27109, DOI 10.1074/jbc.M200354200; Kanse SM, 1996, EXP CELL RES, V224, P344, DOI 10.1006/excr.1996.0144; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; KOST C, 1992, J BIOL CHEM, V267, P12098; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Lambert V, 2003, INVEST OPHTH VIS SCI, V44, P2791, DOI 10.1167/iovs.02-1179; LAWRENCE DA, 1994, J BIOL CHEM, V269, P15223; Lawrence DA, 1997, J BIOL CHEM, V272, P7676, DOI 10.1074/jbc.272.12.7676; Li XQ, 2007, J BIOL CHEM, V282, P5318, DOI 10.1074/jbc.M611396200; Lynn GW, 2005, BIOCHEMISTRY-US, V44, P565, DOI 10.1021/bi048347s; Mayasundari A, 2004, J BIOL CHEM, V279, P29359, DOI 10.1074/jbc.M401279200; MIMURO J, 1993, BIOCHEMISTRY-US, V32, P2314, DOI 10.1021/bi00060a024; Minor KH, 2005, J BIOL CHEM, V280, P28711, DOI 10.1074/jbc.M500478200; Minor KH, 2002, J BIOL CHEM, V277, P10337, DOI 10.1074/jbc.M109564200; Mondino Anna, 1999, Thrombosis and Haemostasis, V82, P19; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; Okumura Y, 2002, J BIOL CHEM, V277, P9395, DOI 10.1074/jbc.M111225200; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Peterson CB, 1998, TRENDS CARDIOVAS MED, V8, P124, DOI 10.1016/S1050-1738(97)00136-9; PETERSON CB, 1987, J BIOL CHEM, V262, P7567; PHILLIPS DR, 1988, BLOOD, V71, P831; Podor TJ, 2002, J BIOL CHEM, V277, P7520, DOI 10.1074/jbc.M109677200; Podor TJ, 2000, J BIOL CHEM, V275, P25402, DOI 10.1074/jbc.M000362200; PREISSNER KT, 1990, J BIOL CHEM, V265, P18490; PREISSNER KT, 1986, EUR J BIOCHEM, V156, P645, DOI 10.1111/j.1432-1033.1986.tb09626.x; Rich RL, 2001, J MOL RECOGNIT, V14, P223, DOI 10.1002/jmr.535; Royle G, 2001, ANAL BIOCHEM, V296, P245, DOI 10.1006/abio.2001.5316; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schvartz I, 2002, BIOCHEM BIOPH RES CO, V290, P682, DOI 10.1006/bbrc.2001.6273; Seger D, 1998, J BIOL CHEM, V273, P24805, DOI 10.1074/jbc.273.38.24805; SEIFFERT D, 1991, J BIOL CHEM, V266, P2824; SEIFFERT D, 1994, J BIOL CHEM, V269, P2659; Seiffert D, 1996, J BIOL CHEM, V271, P29644, DOI 10.1074/jbc.271.47.29644; SEIFFERT D, 1991, BIOCHIM BIOPHYS ACTA, V1078, P23, DOI 10.1016/0167-4838(91)90087-G; SHARP AM, 1999, STRUCT FOLD DES, V7; Sidenius N, 2002, J BIOL CHEM, V277, P27982, DOI 10.1074/jbc.M111736200; Sivasothy P, 2000, J BIOL CHEM, V275, P33663, DOI 10.1074/jbc.M004054200; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; STOCKMANN A, 1993, J BIOL CHEM, V268, P22874; Stoop AA, 2001, J MOL BIOL, V305, P773, DOI 10.1006/jmbi.2000.4356; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; STRATIKOS E, 1997, P NATL ACAD SCI US, V94; THIAGARAJAN P, 1988, J BIOL CHEM, V263, P3035; Waltz DA, 1997, J CLIN INVEST, V100, P58, DOI 10.1172/JCI119521; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; Wilkins-Port CE, 2003, CELL COMMUN ADHES, V10, P85, DOI 10.1080/714040415; Xu D, 2001, PROTEINS, V44, P312, DOI 10.1002/prot.1096; Yoneda A, 1998, BIOCHEMISTRY-US, V37, P6351, DOI 10.1021/bi972247n; ZHAO Y, 1993, ARCH BIOCHEM BIOPHYS, V304, P434, DOI 10.1006/abbi.1993.1372; Zhou AW, 2007, PROTEIN SCI, V16, P1502, DOI 10.1110/ps.072819107; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943; Zhuang P, 1997, J BIOL CHEM, V272, P6858, DOI 10.1074/jbc.272.11.6858	75	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10297	10309		10.1074/jbc.M708017200	http://dx.doi.org/10.1074/jbc.M708017200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18174166	Green Published, hybrid			2022-12-27	WOS:000254894700010
J	Goyon, V; Fronzes, R; Salin, B; Di-Rago, JP; Velours, J; Brethes, D				Goyon, Vanessa; Fronzes, Remi; Salin, Benedicte; Di-Rago, Jean-Paul; Velours, Jean; Brethes, Daniel			Yeast cells depleted in atp14p fail to assemble Atp6p within the ATP synthase and exhibit altered mitochondrial cristae morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUBUNIT-H; PERIPHERAL STALK; F1FO-ATP SYNTHASE; GENE; COMPLEX; IDENTIFICATION; EXPRESSION; ROTATION; BIOGENESIS	Within the yeast mitochondrial ATP synthase, subunit h is a small nuclear encoded protein belonging to the so-called "peripheral stalk" that connects the enzyme catalytic F-1 component to the mitochondrial inner membrane. This study examines the role of subunit h in ATP synthase function and assembly using a regulatable, doxycycline-repressible subunit h gene to overcome the strong instability of the mtDNA previously observed in strains lacking the native subunit h gene. Yeast cells expressing less than 3% of subunit h, but still containing intact mitochondrial genomes, grew poorly on respiratory substrates because of a major impairment of ATP synthesis originating from the ATP synthase, whereas the respiratory chain complexes were not affected. The lack of ATP synthesis in the subunit h-depleted (delta h) mitochondria was attributed to defects in the assembly/stability of the ATP synthase. A main feature of delta h-mitochondria was a very low content (< 6%) in the mitochondrially encoded Atp6p subunit, an essential component of the enzyme proton channel, which was in large part because of a slowing down in translation. Interestingly, depletion of subunit h resulted in dramatic changes in mitochondrial cristae morphology, which further supports the existence of a link between the ATP synthase and the folding/biogenesis of the inner mitochondrial membrane.	[Goyon, Vanessa; Fronzes, Remi; Salin, Benedicte; Di-Rago, Jean-Paul; Velours, Jean; Brethes, Daniel] Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, UMR5095, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Brethes, D (corresponding author), Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, UMR5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	daniel.brethes@ibgc.u-bordeaux2.fr	Fronzes, Rémi/GLS-0406-2022; Fronzes, Remi/T-2578-2019; fronzes, Rémi/A-4311-2009	Fronzes, Remi/0000-0003-3031-9824				Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986; Ackerman SH, 2002, BBA-BIOENERGETICS, V1555, P101, DOI 10.1016/S0005-2728(02)00262-1; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Brunner S, 2002, J BIOL CHEM, V277, P48484, DOI 10.1074/jbc.M209382200; Chateaubodeau G A, 1976, Biochimie, V58, P601, DOI 10.1016/S0300-9084(76)80230-1; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Drapier D, 2007, EMBO J, V26, P3581, DOI 10.1038/sj.emboj.7601802; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Duvezin-Caubet S, 2003, P NATL ACAD SCI USA, V100, P13235, DOI 10.1073/pnas.2135169100; EGNER R, 1995, MOL CELL BIOL, V15, P5879; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Fronzes R, 2003, BIOCHEMISTRY-US, V42, P12038, DOI 10.1021/bi035270j; Fronzes R, 2006, BIOCHEMISTRY-US, V45, P6715, DOI 10.1021/bi0601407; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GrandierVazeille X, 1996, ANAL BIOCHEM, V242, P248, DOI 10.1006/abio.1996.0460; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HADIKUSUMO RG, 1988, BIOCHIM BIOPHYS ACTA, V933, P212, DOI 10.1016/0005-2728(88)90072-2; Helfenbein KG, 2003, J BIOL CHEM, V278, P19751, DOI 10.1074/jbc.M301679200; Kun E, 1979, Methods Enzymol, V55, P115; Law RHP, 1995, METHOD ENZYMOL, V260, P133, DOI 10.1016/0076-6879(95)60135-X; Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200; Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; ORIAN JM, 1984, J BIOENERG BIOMEMBR, V16, P561, DOI 10.1007/BF00743246; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; RIGOULET M, 1979, FEBS LETT, V102, P18, DOI 10.1016/0014-5793(79)80919-9; Rubinstein JL, 2005, J MOL BIOL, V345, P513, DOI 10.1016/j.jmb.2004.10.060; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Silvester JA, 2006, ACTA CRYSTALLOGR F, V62, P530, DOI 10.1107/S1744309106015338; SOMLO M, 1968, EUR J BIOCHEM, V5, P276, DOI 10.1111/j.1432-1033.1968.tb00368.x; Soubannier V, 1999, BIOCHEMISTRY-US, V38, P15017, DOI 10.1021/bi9916067; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Tzagoloff A, 2004, J BIOL CHEM, V279, P19775, DOI 10.1074/jbc.M401506200; Velours J, 2001, J BIOL CHEM, V276, P8602, DOI 10.1074/jbc.M008123200; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Venard R, 2003, BIOCHEMISTRY-US, V42, P7626, DOI 10.1021/bi034394t; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Zeng XM, 2007, GENETICS, V175, P55, DOI 10.1534/genetics.106.065821; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801; Zhou YT, 1996, BBA-BIOENERGETICS, V1275, P96, DOI 10.1016/0005-2728(96)00056-4	53	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9749	9758		10.1074/jbc.M800204200	http://dx.doi.org/10.1074/jbc.M800204200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18252710	hybrid, Green Published			2022-12-27	WOS:000254671600029
J	Gupta, MP; Samant, SA; Smith, SH; Shroff, SG				Gupta, Mahesh P.; Samant, Sadhana A.; Smith, Stephen H.; Shroff, Sanjeev G.			HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II HISTONE DEACETYLASES; ACTIN CAPPING PROTEIN; TROPONIN-I; DILATED CARDIOMYOPATHY; LENGTH-DEPENDENCE; MUSCLE; PHOSPHORYLATION; ACETYLATION; HYPERTROPHY; TITIN	Reversible acetylation of lysine residues within a protein is considered a biologically relevant modification that rivals phosphorylation (Kouzarides, T. (2000) EMBO J. 19, 1176-1179). The enzymes responsible for such protein modification are called histone acetyltransferases (HATs) and deacetylases (HDACs). A role of protein phosphorylation in regulating muscle contraction is well established (Solaro, R. J., Moir, A. J., and Perry, S. V. (1976) Nature 262, 615 - 617). Here we show that reversible protein acetylation carried out by HATs and HDACs also plays a role in regulating the myofilament contractile activity. We found that a Class II HDAC, HDAC4, and an HAT, PCAF, associate with cardiac myofilaments. Primary cultures of cardiomyocytes as well as mouse heart sections examined by immunohistochemical and electron microscopic analyses revealed that both HDAC4 and PCAF associate with the Z-disc and I- and A-bands of cardiac sacromeres. Increased acetylation of sarcomeric proteins by HDAC inhibition (using class I and II HDAC inhibitors or anti-HDAC4 antibody) enhanced the myofilament calcium sensitivity. We identified the Z-disc-associated protein, MLP, a sensor of cardiac mechanical stretch, as an acetylated target of PCAF and HDAC4. We also show that trichostatin-A, a class I and II HDAC inhibitor, increases myofilament calcium sensitivity of wild- type, but not of MLP knock-out mice, thus demonstrating a role of MLP in acetylation-dependent increased contractile activity of myofilaments. These studies provide the first evidence that HATs and HDACs play a role in regulation of muscle contraction.	[Gupta, Mahesh P.; Samant, Sadhana A.] Univ Chicago, Dept Surg, Div Biol Sci, Committee Mol Med, Chicago, IL 60637 USA; [Smith, Stephen H.; Shroff, Sanjeev G.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA	University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gupta, MP (corresponding author), 5841 S Maryland Ave, Chicago, IL 60637 USA.	mgupta@surgery.bsd.uchicago.edu			NHLBI NIH HHS [HL 77788, HL 83423, R01 HL 68083] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077788, R01HL068083, R01HL083423] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bakin RE, 2004, J BIOL CHEM, V279, P51218, DOI 10.1074/jbc.M409271200; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Cheung WL, 2000, CURR OPIN CELL BIOL, V12, P326, DOI 10.1016/S0955-0674(00)00096-X; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, BIOCHEM CELL BIOL, V79, P337, DOI 10.1139/bcb-79-3-337; Flick MJ, 2000, J CELL SCI, V113, P1553; Fukuda N, 2005, PFLUG ARCH EUR J PHY, V449, P449, DOI 10.1007/s00424-004-1354-6; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Granzier H, 2007, MUSCLE NERVE, V36, P740, DOI 10.1002/mus.20886; Gupta MP, 1997, MOL CELL BIOL, V17, P3924, DOI 10.1128/MCB.17.7.3924; HARRISON SM, 1988, J PHYSIOL-LONDON, V401, P115, DOI 10.1113/jphysiol.1988.sp017154; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Kajiwara H, 2000, BIOCHEM BIOPH RES CO, V272, P104, DOI 10.1006/bbrc.2000.2741; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Mitcheson JS, 1998, CARDIOVASC RES, V39, P280, DOI 10.1016/S0008-6363(98)00128-X; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Pyle WG, 2006, J MOL CELL CARDIOL, V41, P537, DOI 10.1016/j.yjmcc.2006.06.006; Pyle WG, 2002, CIRC RES, V90, P1299, DOI 10.1161/01.RES.0000024389.03152.22; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P14329, DOI 10.1073/pnas.250494697	37	123	129	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10135	10146		10.1074/jbc.M710277200	http://dx.doi.org/10.1074/jbc.M710277200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18250163	hybrid, Green Published			2022-12-27	WOS:000254671600067
J	Simon, GM; Cravatt, BF				Simon, Gabriel M.; Cravatt, Benjamin F.			Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-n-acyl ethanolamine precursors in mouse brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID AMIDES; MOLECULAR CHARACTERIZATION; CANNABINOID RECEPTOR; PATHWAY; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPIDS; METABOLISM; CONGENERS	Anandamide (AEA) is an endogenous ligand of cannabinoid receptors and a well characterized mediator of many physiological processes including inflammation, pain, and appetite. The biosynthetic pathway(s) for anandamide and its N-acyl ethanolamine (NAE) congeners remain enigmatic. Previously, we proposed an enzymatic route for producing NAEs that involves the double-O-deacylation of N-acyl phosphatidylethanolamines (NAPEs) by alpha/beta-hydrolase 4 (ABDH4 or Abh4) to form glycerophospho (GP)-NAEs, followed by conversion of these intermediates to NAEs by an unidentified phosphodiesterase. Here, we report the detection and measurement of GP-NAEs, including the anandamide precursor glycerophospho-N-arachidonoylethanolamine (GP-NArE), as endogenous constituents of mouse brain tissue. Inhibition of the phosphodiesterase-mediated degradation of GP-NAEs ex vivo resulted in a striking accumulation of these lipids in brain extracts, suggesting a rapid endogenous flux through this pathway. Furthermore, we identify the glycerophosphodiesterase GDE1, also known as MIR16, as a broadly expressed membrane enzyme with robust GP-NAE phosphodiesterase activity. Together, these data provide evidence for a multistep pathway for the production of anandamide in the nervous system by the sequential actions of Abh4 and GDE1.	[Simon, Gabriel M.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Simon, Gabriel M.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Cravatt, BF (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cravatt@scripps.edu			NIDA NIH HHS [R01 DA015197-06, R01 DA015197, DA 015197, P01 DA017259-05, DA 017259, P01 DA017259] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015197, P01DA017259] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Almaguer C, 2006, CURR GENET, V50, P367, DOI 10.1007/s00294-006-0096-8; BACHUR NR, 1965, J BIOL CHEM, V240, P1019; Bifulco M, 2007, MOL PHARMACOL, V71, P1445, DOI 10.1124/mol.106.033118; Cadas H, 1997, J NEUROSCI, V17, P1226; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Hansen HH, 2000, J NEUROCHEM, V75, P861, DOI 10.1046/j.1471-4159.2000.0750861.x; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; KUEHL FA, 1957, J AM CHEM SOC, V79, P5577, DOI 10.1021/ja01577a066; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Liu J, 2008, NEUROPHARMACOLOGY, V54, P1, DOI 10.1016/j.neuropharm.2007.05.020; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; NATARAJAN V, 1982, BIOCHIM BIOPHYS ACTA, V712, P342, DOI 10.1016/0005-2760(82)90352-6; Nogusa Y, 2004, GENE, V337, P173, DOI 10.1016/j.gene.2004.04.026; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Okamoto Y, 2007, CHEM BIODIVERS, V4, P1842, DOI 10.1002/cbdv.200790155; Patton-Vogt J, 2007, BBA-MOL CELL BIOL L, V1771, P337, DOI 10.1016/j.bbalip.2006.04.013; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Sugiura T, 1996, BIOCHEM BIOPH RES CO, V218, P113, DOI 10.1006/bbrc.1996.0020; Sun YX, 2004, BIOCHEM J, V380, P749, DOI 10.1042/BJ20040031; TOMMASSEN J, 1991, MOL GEN GENET, V226, P321, DOI 10.1007/BF00273621; van der Rest B, 2002, PLANT PHYSIOL, V130, P244, DOI 10.1104/pp.003392; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100; Zheng B, 2000, P NATL ACAD SCI USA, V97, P3999, DOI 10.1073/pnas.97.8.3999	28	165	171	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9341	9349		10.1074/jbc.M707807200	http://dx.doi.org/10.1074/jbc.M707807200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18227059	Green Published, hybrid			2022-12-27	WOS:000254465800064
J	Bunce, MW; Boronenkov, IV; Anderson, RA				Bunce, Matthew W.; Boronenkov, Igor V.; Anderson, Richard A.			Coordinated activation of the nuclear ubiquitin ligase Cul3-SPOP by the generation of phosphatidylinositol 5-phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE KINASE; DEPENDENT DEGRADATION; TRANSCRIPTION FACTOR; BTB PROTEINS; E3 LIGASE; IN-VIVO; DOMAIN; IDENTIFICATION; 4-KINASE; ADAPTERS	Phosphoinositide signaling pathways regulate numerous processes in eukaryotic cells, including migration, proliferation, and survival. The regulatory lipid phosphatidylinositol 4,5-bisphosphate is synthesized by two distinct classes of phosphatidylinositol phosphate kinases (PIPKs), the type I and II PIPKs. Although numerous physiological functions have been identified for type I PIPKs, little is known about the functions and regulation of type II PIPK. Using a yeast two-hybrid screen, we identified an interaction between the type II beta PIPK isoform (PIPKII beta) and SPOP (speckle-type POZ domain protein), a nuclear speckle-associated protein that recruits substrates to Cul3-based ubiquitin ligases. PIPKII beta and SPOP interact and co-localize at nuclear speckles in mammalian cells, and SPOP mediates the ubiquitylation of PIPKII beta by Cul3-based ubiquitin ligases. Additionally, stimulation of the p38 MAPK pathway enhances the ubiquitin ligase activity of Cul3-SPOP toward multiple substrate proteins. Finally, a kinase-dead PIPKII beta mutant enhanced ubiquitylation of Cul3-SPOP substrates. The kinase- dead PIPKII beta mutant increases the cellular content of its substrate lipid phosphatidylinositol 5-phosphate (PI5P), suggesting that PI5P may stimulate Cul3-SPOP activity through a p38-dependent signaling pathway. Expression of phosphatidylinositol-4,5-bisphosphate 4-phosphatases that generate PI5P dramatically stimulated Cul3-SPOP activity and was blocked by the p38 inhibitor SB203580. Taken together, these data define a novel mechanism whereby the phosphoinositide PI5P leads to stimulation of Cul3-SPOP ubiquitin ligase activity and also implicate PIPKII beta as a key regulator of this signaling pathway through its association with the Cul3-SPOP complex.	[Anderson, Richard A.] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; [Bunce, Matthew W.; Boronenkov, Igor V.] Univ Wisconsin, Biomol Chem Grad Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), 1300 Univ Ave,Rm 3750 MSC, Madison, WI 53706 USA.	raanders@wisc.edu		Anderson, Richard/0000-0001-6265-8359	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051968] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051968] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Bunce MW, 2006, BBA-MOL CELL BIOL L, V1761, P560, DOI 10.1016/j.bbalip.2006.03.002; Carricaburu V, 2003, P NATL ACAD SCI USA, V100, P9867, DOI 10.1073/pnas.1734038100; Ciruela A, 2000, BIOCHEM J, V346, P587, DOI 10.1042/0264-6021:3460587; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Jaffray EG, 2006, METHODS, V38, P35, DOI 10.1016/j.ymeth.2005.07.020; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Krek W, 2003, NAT CELL BIOL, V5, P950, DOI 10.1038/ncb1103-950; Kunz J, 2000, MOL CELL, V5, P1, DOI 10.1016/S1097-2765(00)80398-6; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; La M, 2004, BIOCHEM BIOPH RES CO, V320, P760, DOI 10.1016/j.bbrc.2004.06.022; Lamia KA, 2004, MOL CELL BIOL, V24, P5080, DOI 10.1128/MCB.24.11.5080-5087.2004; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Liu AH, 2004, MOL CELL BIOL, V24, P4372, DOI 10.1128/MCB.24.10.4372-4383.2004; Liu AH, 2006, FEBS LETT, V580, P6701, DOI 10.1016/j.febslet.2006.11.021; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Richardson JP, 2007, CELL SIGNAL, V19, P1309, DOI 10.1016/j.cellsig.2007.01.010; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Ungewickell A, 2005, P NATL ACAD SCI USA, V102, P18854, DOI 10.1073/pnas.0509740102; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	37	55	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8678	8686		10.1074/jbc.M710222200	http://dx.doi.org/10.1074/jbc.M710222200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18218622	hybrid			2022-12-27	WOS:000254288000066
J	Goldsteins, G; Keksa-Goldsteine, V; Ahtoniemi, T; Jaronen, M; Arens, E; Akerman, K; Chan, PH; Koistinaho, J				Goldsteins, Gundars; Keksa-Goldsteine, Velta; Ahtoniemi, Toni; Jaronen, Merja; Arens, Egils; Akerman, Karl; Chan, Pak H.; Koistinaho, Jari			Deleterious role of superoxide dismutase in the mitochondrial intermembrane space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CYTOCHROME-C; OXIDATIVE STRESS; CU,ZN-SUPEROXIDE DISMUTASE; PEROXIDASE-ACTIVITY; HYDROGEN-PEROXIDE; COMPLEX-III; MICE; OVEREXPRESSION; SOD1	This work demonstrates how increased activity of copperzinc superoxide dismutase (SOD1) paradoxically boosts production of toxic reactive oxygen species (ROS) in the intermembrane space (IMS) of mitochondria. Even though SOD1 is a cytosolic enzyme, a fraction of it is found in the IMS, where it is thought to provide protection against oxidative damage. We found that SOD1 controls cytochrome c-catalyzed peroxidation in vitro when superoxide is available. The presence of SOD1 significantly increased the rate of ROS production in mitoplasts, which are devoid of outer membrane and IMS. In response to inhibition of respiration with antimycin A, isolated mouse wildtype mitochondria increased ROS production, but the mitochondria from mice lacking SOD1 (SOD1(-/-)) did not. Also, lymphocytes isolated from SOD1(-/)-mice produced significantly less ROS than did wild-type cells and were more resistant to apoptosis induced by inhibition of respiration. Moreover, an increased amount of the toxic mutant G93A SOD1 in the IMS increased ROS production. The mitochondrial dysfunction and cell damage paradoxically induced by SOD1-mediated ROS production may be implicated in chronic degenerative diseases.	[Goldsteins, Gundars; Keksa-Goldsteine, Velta; Ahtoniemi, Toni; Jaronen, Merja; Arens, Egils; Akerman, Karl; Koistinaho, Jari] Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Neurobiol, FIN-70211 Kuopio, Finland; [Koistinaho, Jari] Kuopio Univ Hosp, Dept Oncol, Kuopio 70211, Finland; [Chan, Pak H.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Stanford University	Goldsteins, G (corresponding author), Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Neurobiol, FIN-70211 Kuopio, Finland.	gundars.goldsteins@uku.fi; jari.koistinaho@uku.fi	Goldsteins, Gundars/X-1240-2019	Ahtoniemi, Toni/0000-0003-3239-7172				Barkats M, 2002, J NEUROCHEM, V82, P101, DOI 10.1046/j.1471-4159.2002.00952.x; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Barr DP, 1996, J BIOL CHEM, V271, P15498, DOI 10.1074/jbc.271.26.15498; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Beni SM, 2006, J CEREBR BLOOD F MET, V26, P478, DOI 10.1038/sj.jcbfm.9600209; Chan PH, 2005, ANN NY ACAD SCI, V1042, P203, DOI 10.1196/annals.1338.022; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen ZY, 2000, FREE RADICAL BIO MED, V29, P589, DOI 10.1016/S0891-5849(00)00363-4; Diederix REM, 2002, BIOCHEMISTRY-US, V41, P13067, DOI 10.1021/bi0260841; Endo T, 2005, FREE RADICAL BIO MED, V38, P492, DOI 10.1016/j.freeradbiomed.2004.11.008; Everse J, 2005, FREE RADICAL BIO MED, V38, P1296, DOI 10.1016/j.freeradbiomed.2005.01.018; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Forman HJ, 1997, FASEB J, V11, P374, DOI 10.1096/fasebj.11.5.9141504; Fujimura M, 2000, J NEUROSCI, V20, P2817; Fullerton HJ, 1998, ANN NEUROL, V44, P357, DOI 10.1002/ana.410440311; GOLDSTEINS G, 2006, AMYOTROPHIC LATER S1, V7, P22; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Inarrea P, 2005, BIOCHEM J, V387, P203, DOI 10.1042/BJ20041683; Inoue M, 2003, CURR MED CHEM, V10, P2495, DOI 10.2174/0929867033456477; Jang B, 2006, BIOCHIMIE, V88, P53, DOI 10.1016/j.biochi.2005.06.016; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; Lawrence A, 2003, J BIOL CHEM, V278, P29410, DOI 10.1074/jbc.M300054200; Lei XG, 2006, BIOCHEM J, V399, P455, DOI 10.1042/BJ20060784; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Qian SY, 2002, BIOCHEM J, V363, P281, DOI 10.1042/0264-6021:3630281; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; van Beek-Harmsen BJ, 2005, J HISTOCHEM CYTOCHEM, V53, P803, DOI 10.1369/jhc.4C6527.2005; WOLVETANG EJ, 1994, FEBS LETT, V339, P40, DOI 10.1016/0014-5793(94)80380-3; Ying WH, 2000, J CEREBR BLOOD F MET, V20, P359, DOI 10.1097/00004647-200002000-00018; Yoo HY, 1999, J BIOTECHNOL, V68, P29, DOI 10.1016/S0168-1656(98)00188-6; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	44	64	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8446	8452		10.1074/jbc.M706111200	http://dx.doi.org/10.1074/jbc.M706111200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18171673	hybrid			2022-12-27	WOS:000254288000042
J	Luo, WJ; Liu, JY; Li, JX; Zhang, DY; Liu, MC; Addo, JK; Patil, S; Zhang, L; Yu, J; Buolamwini, JK; Chen, JY; Huang, CS				Luo, Wenjing; Liu, Jinyi; Li, Jingxia; Zhang, Dongyun; Liu, Mingchao; Addo, James K.; Patil, Shivaputra; Zhang, Lin; Yu, Jian; Buolamwini, John K.; Chen, Jingyuan; Huang, Chuanshu			Anti-cancer effects of JKA97 are associated with its induction of cell apoptosis via a Bax-dependent and p53-independent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION PORE; MITOCHONDRIAL-MEMBRANE; P53 PATHWAY; CANCER; ACTIVATION; TRANSLOCATION; DEATH; OLIGOMERIZATION; PROLIFERATION	p53, one of the most commonly mutated genes in human cancers, is thought to be associated with cancer development. Hence, screening and identifying natural or synthetic compounds with anti-cancer activity via p53-independent pathway is one of the most challenging tasks for scientists in this field. Compound JKA97 (methoxy-1-styryl-9H-pyrid-[3,4-b]-indole) is a small molecule synthetic anti-cancer agent, with unknown mechanism(s). In this study we have demonstrated that the anticancer activity of JKA97 is associated with apoptotic induction via p53-independent mechanisms. We found that co-incubation of human colon cancer HCT116 cells with JKA97 inhibited HCT116 cell anchorage-independent growth in vitro and tumorigenicity in nude mice and also induced a cell apoptotic response, both in the cell culture model and in a tumorigenesis nude mouse model. Further studies showed that JKA97-induced apoptosis was dramatically impaired in Bax knock-out (Bax(-/-)) HCT116 cells, whereas the knock-out of p53 or PUMA did not show any inhibitory effects. The p53-independent apoptotic induction by JKA97 was confirmed in other colon cancer and hepatocarcinoma cell lines. In addition, our results showed an induction of Bax translocation and cytochrome c release from the mitochondria to the cytosol in HCT116 cells, demonstrating that the compound induces apoptosis through a Bax-initiated mitochondria-dependent pathway. These studies provide a molecular basis for the therapeutic application of JKA97 against human cancers with p53 mutations.	[Addo, James K.; Patil, Shivaputra; Buolamwini, John K.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Coll Pharm, Memphis, TN 38163 USA; [Luo, Wenjing; Liu, Jinyi; Li, Jingxia; Zhang, Dongyun; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Luo, Wenjing; Liu, Mingchao; Chen, Jingyuan] Fourth Mil Med Univ, Dept Occupat & Environm Hlth Sci, Xian 710032, Peoples R China; [Zhang, Lin; Yu, Jian] Univ Pittsburgh, Pittsburgh Canc Inst, Dept Pharmacol, Pittsburgh, PA 15213 USA; [Zhang, Lin; Yu, Jian] Univ Pittsburgh, Pittsburgh Canc Inst, Dept Pathol, Pittsburgh, PA 15213 USA	University of Tennessee System; University of Tennessee Health Science Center; New York University; Air Force Military Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Buolamwini, JK (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Coll Pharm, Memphis, TN 38163 USA.	jbuolamw@utmem.edu; jy_chen@fmmu.edu.cn; chuanshu@env.med.nyu.edu	Yu, Jian/A-8301-2009; Zhang, Lin/A-7389-2009	Yu, Jian/0000-0002-4021-1000; Zhang, Lin/0000-0003-0018-3903; Huang, Chuanshu/0000-0003-4133-5096	NCI NIH HHS [CA 1002102, CA 103180, R15 CA100102, CA 094964, CA 112557] Funding Source: Medline; NIEHS NIH HHS [ES 000260, ES 012451] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA112557, R15CA100102, R01CA103180, R01CA094964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012451, P30ES000260] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; Cho HJ, 2006, CANCER LETT, V237, P56, DOI 10.1016/j.canlet.2005.05.039; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; Debatin KM, 2000, TOXICOL LETT, V112, P41, DOI 10.1016/S0378-4274(99)00252-0; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gogvadze V, 2001, J BIOL CHEM, V276, P19066, DOI 10.1074/jbc.M100614200; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hajra KM, 2004, APOPTOSIS, V9, P691, DOI 10.1023/B:APPT.0000045786.98031.1d; Huang CS, 1997, J BIOL CHEM, V272, P27753, DOI 10.1074/jbc.272.44.27753; Jalota A, 2005, J BIOL CHEM, V280, P16019, DOI 10.1074/jbc.M413200200; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; LANE DP, 1993, NATURE, V362, P786, DOI 10.1038/362786a0; Li JX, 2006, J CELL BIOCHEM, V99, P1010, DOI 10.1002/jcb.20834; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Lin CH, 2005, NEUROSCI LETT, V387, P22, DOI 10.1016/j.neulet.2005.06.070; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Marsoni S, 2004, ANN ONCOL, V15, P229, DOI 10.1093/annonc/mdh931; Mullen SF, 2004, METH MOL B, V254, P393; Nagle DG, 2004, CURR MED CHEM, V11, P1725, DOI 10.2174/0929867043364991; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Ouyang WM, 2005, CANCER RES, V65, P9287, DOI 10.1158/0008-5472.CAN-05-0469; Peyruchaud O, 2003, J BIOL CHEM, V278, P45826, DOI 10.1074/jbc.M309024200; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Sarkar FH, 2003, J NUTR, V133, p2434S, DOI 10.1093/jn/133.7.2434S; Song YC, 2004, BIOCHEM BIOPH RES CO, V317, P128, DOI 10.1016/j.bbrc.2004.03.019; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Svec J, 2005, Bratisl Lek Listy, V106, P238; Tachibana M, 2004, INT J ONCOL, V25, P913; Tikhomirov O, 2005, J CELL SCI, V118, P5681, DOI 10.1242/jcs.02676; Tweddle DA, 2003, CANCER LETT, V197, P93, DOI 10.1016/S0304-3835(03)00088-0; Wang J, 2005, CANCER RES, V65, P6601, DOI 10.1158/0008-5472.CAN-04-4184; Yu J, 2003, CANCER CELL, V4, P248, DOI 10.1016/S1535-6108(03)00249-6; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	43	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8624	8633		10.1074/jbc.M707860200	http://dx.doi.org/10.1074/jbc.M707860200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18218619	Green Published, hybrid			2022-12-27	WOS:000254288000061
J	Takagi, Y; Yang, Y; Fujiwara, I; Jacobs, D; Cheney, RE; Sellers, JR; Kovacs, M				Takagi, Yasuharu; Yang, Yi; Fujiwara, Ikuko; Jacobs, Damon; Cheney, Richard E.; Sellers, James R.; Kovacs, Mihaly			Human myosin Vc is a low duty ratio, nonprocessive molecular motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BASED MOTOR; HAND-OVER-HAND; KINETIC CHARACTERIZATION; UNCONVENTIONAL MYOSIN; MUSCLE-CONTRACTION; REAL-TIME; VESICLE TRANSPORT; FLUORESCENT-PROBE; NECK LENGTH; MECHANISM	Myosin Vc is the product of one of the three genes of the class V myosin found in vertebrates. It is widely found in secretory and glandular tissues, with a possible involvement in transferrin trafficking. Transient and steady-state kinetic studies of human myosin Vc were performed using a truncated, single-headed construct. Steady-state actin-activated ATPase measurements revealed a V-max of 1.8 +/- 0.3 s(-1) and a K-ATPase of 43 +/- 11 mu M. Unlike previously studied vertebrate myosin Vs, the rate-limiting step in the actomyosin Vc ATPase pathway is the release of inorganic phosphate (similar to 1.5 s(-1)), rather than the ADP release step (similar to 12.0-16.0 s(-1)). Nevertheless, the ADP affinity of actomyosin Vc (K-d = 0.25 +/- 0.02 mu M) reflects a higher ADP affinity than seen in other myosin V isoforms. Using the measured kinetic rates, the calculated duty ratio of myosin Vc was similar to 10%, indicating that myosin Vc spends the majority of the actomyosin ATPase cycle in weak actin-binding states, unlike the other vertebrate myosin V isoforms. Consistent with this, a fluorescently labeled double-headed heavy meromyosin form showed no processive movements along actin filaments in a single molecule assay, but it did move actin filaments at a velocity of similar to 24 nm/s in ensemble assays. Kinetic simulations reveal that the high ADP affinity of actomyosin Vc may lead to elevations of the duty ratio of myosin Vc to as high as 64% under possible physiological ADP concentrations. This, in turn, may possibly imply a regulatory mechanism that may be sensitive to moderate changes in ADP concentration.	[Takagi, Yasuharu; Yang, Yi; Sellers, James R.] NHLBI, Lab Mol Physiol, Natl Inst Hlth, Bethesda, MD 20892 USA; [Fujiwara, Ikuko] NHLBI, Cell Biol Lab, Natl Inst Hlth, Bethesda, MD 20892 USA; [Jacobs, Damon; Cheney, Richard E.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Eotvos Lorand University	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, Natl Inst Hlth, Bldg 50,Rm 3523, Bethesda, MD 20892 USA.	sellersj@mail.nih.gov; stoci1@gmail.com	Kovacs, Mihaly/A-6841-2011; Fujiwara, Ikuko/H-5717-2016	Fujiwara, Ikuko/0000-0002-9361-636X; Cheney, Richard/0000-0001-6565-7888; Kovacs, Mihaly/0000-0002-1200-4741	FIC NIH HHS [1 R01 TW 007241-01, D43 TW 006230] Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [R01 DC003299] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R01TW007241, R01TW006230] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003299] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Brown SS, 1999, ANNU REV CELL DEV BI, V15, P63, DOI 10.1146/annurev.cellbio.15.1.63; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Brune M, 2001, BIOCHEMISTRY-US, V40, P5087, DOI 10.1021/bi002484h; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Coluccio LR, 1999, J BIOL CHEM, V274, P21575, DOI 10.1074/jbc.274.31.21575; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; DAWSON MJ, 1978, NATURE, V274, P861, DOI 10.1038/274861a0; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; DePina AS, 1999, MICROSC RES TECHNIQ, V47, P93, DOI 10.1002/(SICI)1097-0029(19991015)47:2<93::AID-JEMT2>3.0.CO;2-P; El Mezgueldi M, 2002, J BIOL CHEM, V277, P21514, DOI 10.1074/jbc.M200713200; ESPINDOLA FS, 1992, J CELL BIOL, V118, P359, DOI 10.1083/jcb.118.2.359; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; GEEVES MA, 1991, BIOCHEM J, V274, P1; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Libby RT, 2004, J CELL SCI, V117, P4509, DOI 10.1242/jcs.01316; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Nascimento AAC, 1996, J BIOL CHEM, V271, P17561, DOI 10.1074/jbc.271.29.17561; Ostap EM, 1996, J CELL BIOL, V132, P1053, DOI 10.1083/jcb.132.6.1053; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Provance DW, 1996, P NATL ACAD SCI USA, V93, P14554, DOI 10.1073/pnas.93.25.14554; RADDA GK, 1986, SCIENCE, V233, P640, DOI 10.1126/science.3726553; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Rodriguez OC, 2002, J CELL SCI, V115, P991; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; SELLERS JR, 1999, MYOSINS, P289; Snyder GE, 2004, BIOPHYS J, V87, P1776, DOI 10.1529/biophysj.103.036897; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sweeney HL, 2004, PHILOS T R SOC B, V359, P1829, DOI 10.1098/rstb.2004.1576; SWIATECKA U, 2007, J BIOL CHEM, V282, P23725; Takagi Y, 2006, BIOPHYS J, V90, P1295, DOI 10.1529/biophysj.105.068429; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; TRENTHAM DR, 1972, BIOCHEM J, V126, P635, DOI 10.1042/bj1260635; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Tuxworth RI, 2000, TRAFFIC, V1, P11, DOI 10.1034/j.1600-0854.2000.010103.x; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Watanabe S, 2006, BIOCHEMISTRY-US, V45, P2729, DOI 10.1021/bi051682b; Watanabe S, 2008, J BIOL CHEM, V283, P10581, DOI 10.1074/jbc.M707657200; Westbroek W, 2003, J INVEST DERMATOL, V120, P465, DOI 10.1046/j.1523-1747.2003.12068.x; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu X, 1998, J CELL BIOL, V143, P241, DOI 10.1083/jcb.143.1.241; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yang Y, 2005, J BIOL CHEM, V280, P32061, DOI 10.1074/jbc.M506765200; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	71	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8527	8537		10.1074/jbc.M709150200	http://dx.doi.org/10.1074/jbc.M709150200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18201966	hybrid, Green Published			2022-12-27	WOS:000254288000051
J	Liang, J; Wang, J; Azfer, A; Song, W; Tromp, G; Kolattukudy, PE; Fu, M				Liang, Jian; Wang, Jing; Azfer, Asim; Song, Wenjun; Tromp, Gail; Kolattukudy, Pappachan E.; Fu, Mingui			A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRISTETRAPROLIN; ALPHA; UBIQUITINATION; INHIBITION; DOMAINS; TTP	Activated macrophages play an important role in many inflammatory diseases. However, the molecular mechanisms controlling macrophage activation are not completely understood. Here we report that a novel CCCH-zinc finger protein family, MCPIP1, 2, 3, and 4, encoded by four genes, Zc3h12a, Zc3h12b, Zc3h12c, and Zc3h12d, respectively, regulates macrophage activation. Northern blot analysis revealed that the expression of MCPIP1 and MCPIP3 was highly induced in macrophages in response to treatment with lipopolysaccharide (LPS). Although not affecting cell surface marker expression and phagocytotic function, overexpression of MCPIP1 significantly blunted LPS-induced inflammatory cytokine and NO(2)radical anion. production as well as their gene expression. Conversely, short interfering RNA-mediated reduction in MCPIP1 augmented LPS-induced inflammatory gene expression. Further studies demonstrated that MCPIP1 did not directly affect the mRNA stability of tumor necrosis factor alpha and monocyte chemoattractant protein 1 (MCP-1) but strongly inhibited LPS-induced tumor necrosis factor alpha and inducible nitric-oxide synthase promoter activation. Moreover, we found that forced expression of MCPIP1 significantly inhibited LPS-induced nuclear factor-kappa B activation. These results identify MCP-induced proteins, a novel CCCH-zinc finger protein family, as negative regulators in macrophage activation and may implicate them in host immunity and inflammatory diseases.	[Liang, Jian; Wang, Jing; Azfer, Asim; Song, Wenjun; Tromp, Gail; Kolattukudy, Pappachan E.; Fu, Mingui] Univ Cent Florida, Coll Med, Biomol Sci Ctr, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Fu, M (corresponding author), Univ Cent Florida, Coll Med, Biomol Sci Ctr, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.	mfu@mail.ucf.edu	Song, Wenjun/HGB-4891-2022; kolattukudy, pappachan e/A-1350-2012	Song, Wenjun/0000-0002-6355-2983	NHLBI NIH HHS [HL 69458] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL069458, R01HL069458] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; BURKE B, 2002, MACROPHAGE, P1; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lim W, 2002, J IMMUNOL, V168, P1759, DOI 10.4049/jimmunol.168.4.1759; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; MASHIMA R, 2005, NAT IMMUNOL, V280, P41289; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; McAdam AJ, 1998, IMMUNOL REV, V165, P231; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Woo CH, 2004, J IMMUNOL, V173, P6973, DOI 10.4049/jimmunol.173.11.6973; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao JL, 1996, J EXP MED, V183, P777, DOI 10.1084/jem.183.3.777; Zhou L, 2006, CIRC RES, V98, P1, DOI DOI 10.1161/01	29	193	210	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6337	6346		10.1074/jbc.M707861200	http://dx.doi.org/10.1074/jbc.M707861200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18178554	hybrid, Green Published			2022-12-27	WOS:000253779500041
J	Bompadre, SG; Li, M; Hwang, TC				Bompadre, Silvia G.; Li, Min; Hwang, Tzyh-Chang			Mechanism of G551D-CFTR (cystic fibrosis transmembrane conductance regulator) potentiation by a high affinity ATP analog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; CFTR; CHANNEL; MUTATIONS; DELTA-F508; SITE; PHOSPHORYLATION; IDENTIFICATION; DIMERIZATION; ACTIVATORS	Cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel gated by ATP binding and hydrolysis at its nucleotide binding domains (NBD). The NBDs dimerize in a head-to-tail configuration, forming two ATP binding pockets (ABP) with the ATP molecules buried at the dimer interface. Previous studies have indicated that ABP2, formed by the Walker A and B motifs of NBD2 and the signature sequence of NBD1, is the site critical for the ATP-dependent opening of CFTR. The G551D mutation in ABP2, the third most common cystic fibrosis-associated mutation, abolishes ATP-dependent gating, resulting in an open probability that is similar to 100-fold lower than that of wild-type channels. Interestingly, we found that the ATP analog N-6-(2-phenylethyl)-ATP (P-ATP) increases G551D currents mainly by increasing the open time of the channel. This effect is reduced when P-ATP is applied together with ATP, suggesting a competition between ATP and P-ATP for a common binding site. Introducing mutations that lower the nucleotide binding affinity at ABP2 did not alter significantly the effects of P-ATP on G551D-CFTR, whereas an equivalent mutation at ABP1 (consisting of the Walker A and B motifs of NBD1 and the signature sequence of NBD2) dramatically decreased the potency of P-ATP, indicating that ABP1 is the site where P-ATP binds to increase the activity of G551D-CFTR. These results substantiate the idea that nucleotide binding at ABP1 stabilizes the open channel conformation. Our observation that P-ATP enhances the G551D activity by binding at ABP1 implicates that ABP1 can potentially be a target for drugs to bind and increase the channel activity.	[Bompadre, Silvia G.; Li, Min; Hwang, Tzyh-Chang] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Hwang, Tzyh-Chang] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Bompadre, SG (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	BompadreS@missouri.edu			NHLBI NIH HHS [R01HL53455] Funding Source: Medline; NIDDK NIH HHS [K01DK075408, R01 DK055835, R01DK55835] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK075408, R01DK055835] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ai T, 2004, MOL PHARMACOL, V65, P1415, DOI 10.1124/mol.65.6.1415; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Bompadre SG, 2005, J GEN PHYSIOL, V125, P377, DOI 10.1085/jgp.200409228; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Csanady L, 2000, BIOPHYS J, V78, P785, DOI 10.1016/S0006-3495(00)76636-7; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Illek B, 1999, AM J PHYSIOL-CELL PH, V277, pC833, DOI 10.1152/ajpcell.1999.277.4.C833; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Moran O, 2005, CELL MOL LIFE SCI, V62, P446, DOI 10.1007/s00018-004-4422-3; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Powe AC, 2002, J PHYSIOL-LONDON, V539, P333, DOI 10.1113/jphysiol.2001.013162; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RIORDAN JR, 1989, SCIENCE, V245, P1066; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Zegarra-Moran O, 2007, J BIOL CHEM, V282, P9098, DOI 10.1074/jbc.M611411200; Zhou Z, 2005, J PHYSIOL-LONDON, V569, P447, DOI 10.1113/jphysiol.2005.095083; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	29	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5364	5369		10.1074/jbc.M709417200	http://dx.doi.org/10.1074/jbc.M709417200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167357	hybrid			2022-12-27	WOS:000253426700016
J	Shetty, PK; Huang, FL; Huang, KP				Shetty, Pavan K.; Huang, Freesia L.; Huang, Kuo-Ping			Ischemia-elicited oxidative modulation of Ca2+/calmodulin-dependent protein kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; RAT-BRAIN NEUROGRANIN/RC3; DISULFIDE S-OXIDE; POSTSYNAPTIC DENSITIES; HIPPOCAMPAL-NEURONS; SELF-ASSOCIATION; CEREBRAL-ISCHEMIA; DENDRITIC SPINES; NITRIC-OXIDE; CAMKII	Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) plays a critical role in neuronal signal transduction and synaptic plasticity. Here, we showed that this kinase was very susceptible to oxidative modulation. Treatment of mouse brain synaptosomes with H2O2, diamide, and sodium nitroprusside caused aggregation of CaMKII through formation of disulfide and non-disulfide linkages, and partial inhibition of the kinase activity. These CaMKII aggregates were found to associate with the post synaptic density. However, treatment of purified CaMKII with these oxidants did not replicate those effects observed in the synaptosomes. Using two previously identified potential mediators of oxidants in the brain, glutathione disulfide S-monoxide (GS-DSMO) and glutathione disulfide S-dioxide (GS-DSDO), we showed that they oxidized and inhibited CaMKII in a manner partly related to those of the oxidant-treated synaptosomes as well as the ischemia-elicited oxidative stress in the acutely prepared hippocampal slices. Interestingly, the autophosphorylated and activated CaMKII was relatively refractory to GS-DSMO- and GS-DSDO-mediated aggregation. Short term ischemia (10 min) caused a depression of basal synaptic response of the hippocampal slices, and re-oxygenation (after 10 min) reversed the depression. However, oxidation of CaMKII remained at above the pre-ischemic level throughout the treatment. Oxidation of CaMKII also prevented full recovery of CaMKII autophosphorylation after re-oxygenation. Subsequently, the high frequency stimulation-mediated synaptic potentiation in the hippocampal CA1 region was significantly reduced compared with the control without ischemia. Thus, ischemia-evoked oxidation of CaMKII, probably via the action of glutathione disulfide S-oxides or their analogues, may be involved in the suppression of synaptic plasticity.	[Shetty, Pavan K.; Huang, Freesia L.; Huang, Kuo-Ping] NICHD, Natl Inst Hlth, Dev Neurobiol Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Huang, KP (corresponding author), NIH, Bldg 49,Rm6A10,49 Convent Dr MSC 4510, Bethesda, MD 20892 USA.	huangk@mail.nih.gov	SHETTY, PAVAN/B-9804-2012	Shetty, Pavan/0000-0002-6484-7417	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000187] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000187] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aronowski J, 1996, BRAIN RES, V709, P103, DOI 10.1016/0006-8993(95)01311-3; ARONOWSKI J, 1992, J NEUROCHEM, V58, P1743, DOI 10.1111/j.1471-4159.1992.tb10049.x; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Bindokas VP, 1996, J NEUROSCI, V16, P1324; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHETKOVICH DM, 1993, NEUROREPORT, V4, P919, DOI 10.1097/00001756-199307000-00020; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; HARTLEY Z, 1993, J NEUROSCI, V13, P4690; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Hu BR, 1998, J NEUROSCI, V18, P625; Huang FL, 2006, J NEUROSCI, V26, P6230, DOI 10.1523/JNEUROSCI.1182-06.2006; Huang KP, 2002, BIOCHEM PHARMACOL, V64, P1049, DOI 10.1016/S0006-2952(02)01175-9; Huang KP, 2000, BIOCHEMISTRY-US, V39, P7291, DOI 10.1021/bi000336l; Huang KP, 2007, BIOCHEMISTRY-US, V46, P1961, DOI 10.1021/bi061955i; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Hudmon A, 2001, J NEUROCHEM, V76, P1364, DOI 10.1046/j.1471-4159.2001.00119.x; IRWIN RP, 1994, J NEUROSCI, V14, P1352, DOI 10.1523/JNEUROSCI.14-03-01352.1994; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Li JF, 2001, J BIOL CHEM, V276, P3098, DOI 10.1074/jbc.M008260200; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Robison AJ, 2007, BIOCHEM BIOPH RES CO, V356, P97, DOI 10.1016/j.bbrc.2007.02.087; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; SILVER IA, 1992, J CEREBR BLOOD F MET, V12, P759, DOI 10.1038/jcbfm.1992.107; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; SUCHER NJ, 1991, J NEUROSCI RES, V30, P582, DOI 10.1002/jnr.490300316; SUZUKI T, 1994, J NEUROCHEM, V63, P1529, DOI 10.1046/j.1471-4159.1994.63041529.x; Takahashi H, 2007, NEURON, V53, P53, DOI 10.1016/j.neuron.2006.11.023; Tao-Cheng JH, 2005, NEUROSCIENCE, V130, P651, DOI 10.1016/j.neuroscience.2004.10.008; Tao-Cheng JH, 2002, NEUROSCIENCE, V115, P435, DOI 10.1016/S0306-4522(02)00451-7; Tao-Cheng JH, 2001, NEUROSCIENCE, V106, P69, DOI 10.1016/S0306-4522(01)00262-7; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; WESTGATE SA, 1994, J NEUROCHEM, V63, P2217; Wu JF, 2003, J NEUROCHEM, V86, P1524, DOI 10.1046/j.1471-4159.2003.01963.x; Yamagata Y, 2004, J NEUROCHEM, V91, P745, DOI 10.1111/j.1471-4159.2004.02753.x	53	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5389	5401		10.1074/jbc.M708479200	http://dx.doi.org/10.1074/jbc.M708479200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18174165	hybrid			2022-12-27	WOS:000253426700019
J	Worrall, JAR; Howe, FS; McKay, AR; Robinson, CV; Luisi, BF				Worrall, Jonathan A. R.; Howe, Francoise S.; McKay, Adam R.; Robinson, Carol V.; Luisi, Ben F.			Allosteric activation of the ATPase activity of the Escherichia coli RhIB RNA helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTION CORE COMPLEX; DEAD-BOX HELICASES; MESSENGER-RNA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PROTEIN DBP5; Q-MOTIF; DEGRADOSOME; BINDING; EIF4A	Helicase B (Rh1B) is one of the five DEAD box RNA-dependent ATPases found in Escherichia coli. Unique among these enzymes, Rh1B requires an interaction with the partner protein RNase E for appreciable ATPase and RNA unwinding activities. To explore the basis for this activating effect, we have generated a di-cistronic vector that overexpresses a complex comprising Rh1B and its recognition site within RNase E, corresponding to residues 696 -762. Complex formation has been characterized by isothermal titration calorimetry, revealing an avid, enthalpy-favored interaction between the helicase and RNase E-( 696 762) with an equilibrium binding constant (Ka) of at least 1 X 10(8) M-1. We studied ATPase activity of mutants with substitutions within the ATP binding pocket of Rh1B and on the putative interaction surface that mediates recognition of RNase E. For comparisons, corresponding mutations were prepared in two other E. coli DEAD box ATPases, Rh1E and SrmB. Strikingly, substitutions at a phenylalanine near the Q-motif found in DEAD box proteins boosts the ATPase activity of Rh1B in the absence of RNA, but completely inhibits it in its presence. The data support the proposal that the protein-protein and RNA-binding surfaces both communicate allosterically with the ATPase catalytic center. We conjecture that this communication may govern the mechanical power and efficiency of the helicases, and is tuned in individual helicases in accordance with cellular function.	[Worrall, Jonathan A. R.; Howe, Francoise S.; Luisi, Ben F.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [McKay, Adam R.; Robinson, Carol V.] Univ Cambridge, Chem Lab, Cambridge CB2 1EW, England	University of Cambridge; University of Cambridge	Luisi, BF (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	bf120@mole.bio.cam.ac.uk	Howe, Franklyn A/C-3307-2008	robinson, carol/0000-0001-7829-5505; Howe, Franklyn/0000-0002-7135-3351	Wellcome Trust [042079] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Braman J, 1996, Methods Mol Biol, V57, P31; Braun F, 1996, MOL MICROBIOL, V19, P997, DOI 10.1046/j.1365-2958.1996.440971.x; Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Chandran V, 2007, J MOL BIOL, V367, P113, DOI 10.1016/j.jmb.2006.12.014; Chang TH, 1997, NUCLEIC ACIDS RES, V25, P5033, DOI 10.1093/nar/25.24.5033; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; COHEN SN, 1995, CELL, V80, P829, DOI 10.1016/0092-8674(95)90284-8; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; Iost I, 2006, NUCLEIC ACIDS RES, V34, P4189, DOI 10.1093/nar/gkl500; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Khemici V, 2005, P NATL ACAD SCI USA, V102, P6913, DOI 10.1073/pnas.0501129102; Khemici V, 2004, MOL MICROBIOL, V54, P1422, DOI 10.1111/j.1365-2958.2004.04361.x; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Marcaida MJ, 2006, TRENDS BIOCHEM SCI, V31, P359, DOI 10.1016/j.tibs.2006.05.005; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Tsu CA, 2001, RNA, V7, P702, DOI 10.1017/S1355838201010135; Turner AMW, 2007, J BACTERIOL, V189, P2769, DOI 10.1128/JB.01509-06; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; Yu E, 2000, NUCLEIC ACIDS RES, V28, P3926, DOI 10.1093/nar/28.20.3926	45	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5567	5576		10.1074/jbc.M708620200	http://dx.doi.org/10.1074/jbc.M708620200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165229	hybrid, Green Accepted			2022-12-27	WOS:000253426700037
J	Guo, C; Tang, TS; Bienko, M; Dikic, I; Friedberg, EC				Guo, Caixia; Tang, Tie-Shan; Bienko, Marzena; Dikic, Ivan; Friedberg, Errol C.			Requirements for the interaction of mouse pol kappa with ubiquitin and its biological significance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-KAPPA; REV1 PROTEIN INTERACTS; S-PHASE CHECKPOINT; Y-FAMILY; TRANSLESION SYNTHESIS; REPLICATION FOCI; DAMAGE; PCNA; ETA; LOCALIZATION	Pol kappa protein is a eukaryotic member of the DinB/Pol kappa branch of the Y-family DNA polymerases, which are involved in the tolerance of DNA damage by replicative bypass. Despite universal conservation through evolution, the precise role(s) of Pol kappa in this process has remained unknown. Here we report that mouse Pol kappa can physically interact with ubiquitin by yeast two-hybrid screening, glutathione S-transferase pulldown, and immuno-precipitation methods. The association of Pol kappa with ubiquitin requires the ubiquitin-binding motifs located at the C terminus of Pol kappa. In addition, Pol kappa binds with monoubiquitinated proliferating cell nuclear antigen (PCNA) more robustly than with non-ubiquitinated PCNA. The ubiquitin-binding motifs mediate the enhanced association between monoubiquitinated PCNA and Pol kappa. The ubiquitin-binding motifs are also required for Pol kappa to form nuclear foci after UV radiation. However, the ubiquitin-binding motifs do not affect Pol kappa half-life. Finally, we have examined levels of Pol kappa expression following the exposure of mouse cells to benzo[a] pyrene-dihydrodiol epoxide or UVB radiation.	[Guo, Caixia; Friedberg, Errol C.] Univ Texas SW Med Ctr Dallas, Lab Mol Pathol, Dept Pathol, Dallas, TX 75390 USA; [Tang, Tie-Shan] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Bienko, Marzena; Dikic, Ivan] Univ Frankfurt, Sch Med, Inst Biol 2, D-60590 Frankfurt, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Goethe University Frankfurt	Friedberg, EC (corresponding author), Univ Texas SW Med Ctr Dallas, Lab Mol Pathol, Dept Pathol, Dallas, TX 75390 USA.	friedberg.errol@pathology.swmed.edu	Dikic, Ivan/O-4650-2015; Bienko, Magda/AAM-8867-2020	Dikic, Ivan/0000-0001-8156-9511; Bienko, Magda/0000-0002-6499-9082	NIEHS NIH HHS [ES11344] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011344] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bavoux C, 2005, BIOCHIMIE, V87, P637, DOI 10.1016/j.biochi.2005.02.007; Bavoux C, 2005, CANCER RES, V65, P325; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; Bergoglio V, 2002, J CELL SCI, V115, P4413, DOI 10.1242/jcs.00162; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Gerlach VL, 1999, P NATL ACAD SCI USA, V96, P11922, DOI 10.1073/pnas.96.21.11922; Guo C, 2005, DNA REPAIR, V4, P397, DOI 10.1016/j.dnarep.2004.10.006; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Ogi T, 2005, J CELL SCI, V118, P129, DOI 10.1242/jcs.01603; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ogi T, 2001, GENES CELLS, V6, P943, DOI 10.1046/j.1365-2443.2001.00478.x; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Okada T, 2002, J BIOL CHEM, V277, P48690, DOI 10.1074/jbc.M207957200; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Takenaka K, 2006, J BIOL CHEM, V281, P2000, DOI 10.1074/jbc.M506153200; Tissier A, 2004, DNA REPAIR, V3, P1503, DOI 10.1016/j.dnarep.2004.06.015; Ulrich HD, 2004, CELL CYCLE, V3, P15; Velasco-Miguel S, 2003, DNA REPAIR, V2, P91, DOI 10.1016/S1568-7864(02)00189-1; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383	34	55	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4658	4664		10.1074/jbc.M709275200	http://dx.doi.org/10.1074/jbc.M709275200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18162470	hybrid			2022-12-27	WOS:000253426500023
